Citrus Sinensis ID: 038154

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290---
Protein Sequence
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD
Secondary Structure (PSIPRED)
ccccccEEcccccEEEEEEEEcccccEEEEEEccccccccccccHHHHHHHHHHHccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEcccccccccccccccccccEEEEEcccccccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHccccHHHHHHHHHHHcccccccccHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
HEEEEEEEEccccccEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHcccccccEccEEEEEEccccEEEEEEcccEEHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccccccccccccccHHHccccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHH
Coil and Loop (DISEMBL)
RYTLLEVIREgrygavhrahdsltgdtvvvkkipimnpsegvpssVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDllhfmkteptvtknplKIKKYLHQILHGVAychsqeilhrdlkpanflidrsKDIVKIAdfglarpidvplenytikggslcykaperllgsgrystpVDVWAVACTFAEMVthqrlfhsrwapGLLAAIFSImgtpdsetlpgftsfseefgfepnrspikdlatvvgglepdGVDLLRRMlcldpskrLTAREALRHEYFKDFQSLD
Flexible Loop (DISEMBL)
RYTLLEVIRegrygavhrahdsltgdtvvvkkipimnpsegvpssVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKteptvtknpLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFglarpidvplenytikggslcYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD
Low Complexity Region (SEG)
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPgftsfseefgfePNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD
Disordered region (IsUnstruct)
**TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF*****PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF*******
Disordered Region (DISOPRED)
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPT*TKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ***
Disordered Region (DISEMBL)
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD
Disordered Region (DISPRO)
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	293	2.2.26 [Sep-21-2011]
P23111	294	Cell division control pro	N/A	no	0.986	0.982	0.527	1e-79
P93101	294	Cell division control pro	N/A	no	0.979	0.976	0.527	2e-79
Q41639	294	Cell division control pro	N/A	no	0.986	0.982	0.520	1e-78
P24923	291	Cell division control pro	N/A	no	0.972	0.979	0.524	2e-78
P29618	294	Cyclin-dependent kinase A	yes	no	0.986	0.982	0.517	3e-78
Q05006	294	Cell division control pro	N/A	no	0.986	0.982	0.524	3e-78
Q38772	294	Cell division control pro	N/A	no	0.979	0.976	0.520	9e-78
P24100	294	Cyclin-dependent kinase A	yes	no	0.993	0.989	0.503	1e-76
P29619	292	Cyclin-dependent kinase A	no	no	0.982	0.986	0.510	3e-74
P52389	294	Cell division control pro	N/A	no	0.986	0.982	0.513	6e-73

>sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1

 Score =  296 bits (758), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 153/290 (52%), Positives = 195/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D  T +T+ +KKI +    EGVPS+ IRE+SLLKE+ H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKALDKATNETIALKKIRLEQEDEGVPSTAIREISLLKEMNHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   I LVFE LD DL  FM + P   KNP  IK YL+QILHGVAYCHS  
Sbjct: 63  IVRLHDVVHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILHGVAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLG+ +YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP+ ++ PG +    +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEQSWPGVSCLP-DFKTAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            R   +DLATVV  L+P G+DLL +ML  +PSKR+TAR+AL HEYFKD +
Sbjct: 242 PRWQAQDLATVVPNLDPAGLDLLSKMLRYEPSKRITARQALEHEYFKDLE 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.
Zea mays (taxid: 4577)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|P93101|CDC2_CHERU Cell division control protein 2 homolog OS=Chenopodium rubrum GN=CDC2 PE=2 SV=1

 Score =  296 bits (757), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 152/288 (52%), Positives = 194/288 (67%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   K+P  IK++L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPDFAKDPRMIKRFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRQTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF  +GTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRTLGTPNEETWPGVTSLP-DFKSSF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            +   KDL+ VV  L+P G+DLL +MLCLDPSKR+TAR AL HEYFKD
Sbjct: 242 PKWISKDLSAVVPNLDPAGIDLLNKMLCLDPSKRITARNALEHEYFKD 289

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Chenopodium rubrum (taxid: 3560)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q41639|CDC2_VIGAC Cell division control protein 2 homolog OS=Vigna aconitifolia GN=CDC2 PE=2 SV=1

 Score =  293 bits (749), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 151/290 (52%), Positives = 196/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   K+P ++K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFVKDPRQVKMFLYQILCGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP+ ET PG T+   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNRRPLFPGDSEIDELFKIFRILGTPNEETWPGVTALP-DFKSTF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            + P KDLATVV  L+  G++LL  MLCLDPSKR+TAR A+ HEYFKD +
Sbjct: 242 PKWPPKDLATVVPNLDAAGLNLLSSMLCLDPSKRITARIAVEHEYFKDIK 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Vigna aconitifolia (taxid: 3918)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P24923|CDC21_MEDSA Cell division control protein 2 homolog 1 (Fragment) OS=Medicago sativa GN=CDC2A PE=2 SV=1

 Score =  292 bits (747), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 150/286 (52%), Positives = 193/286 (67%), Gaps = 1/286 (0%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H NIVRL
Sbjct: 4   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRNIVRL 63

Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
            +V  S   + LVFE LD DL   M + P   K+P ++K +L+Q+L G+AYCHS  +LHR
Sbjct: 64  QDVVHSDKRLYLVFEYLDLDLKKHMDSSPEFIKDPRQVKMFLYQMLCGIAYCHSHRVLHR 123

Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVD 184
           DLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YSTPVD
Sbjct: 124 DLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVD 183

Query: 185 VWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSP 244
           VW+V C FAEM   + L         L  IF I+GTP+ +T PG TS   +F     R P
Sbjct: 184 VWSVGCIFAEMANRRPLSPGDSEIDELFKIFRILGTPNEDTWPGVTSLP-DFKSTFPRWP 242

Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            KDLATVV  LEP G+DLL  MLCLDP+KR+TAR A+ HEYFKD +
Sbjct: 243 SKDLATVVPNLEPAGLDLLNSMLCLDPTKRITARSAVEHEYFKDIK 288

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  291 bits (746), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 150/290 (51%), Positives = 195/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y   E I EG YG V+RA D +T +T+ +KKI +    EGVPS+ IRE+SLLKE+ H N
Sbjct: 3   QYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   I LVFE LD DL  FM + P   KNP  IK YL+QIL GVAYCHS  
Sbjct: 63  IVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS +YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W+V C FAEMV  + LF        L  IF ++GTP+ ++ PG +S  +     P
Sbjct: 183 TPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            +   +DLAT+V  L+P G+DLL +ML  +P+KR+TAR+AL HEYFKD +
Sbjct: 243 -KWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q05006|CDC22_MEDSA Cell division control protein 2 homolog 2 OS=Medicago sativa GN=CDC2B PE=2 SV=1

 Score =  291 bits (746), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 152/290 (52%), Positives = 192/290 (66%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D  T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL  FM + P   K+  +IK +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDRS + VK+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRSSNAVKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEM+  + LF        L  IF I GTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMINQRPLFPGDSEIDELFKIFRITGTPNEETWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            + P KDLAT V  LEP G+DLL     LDP++R+TAR AL HEYFKD +
Sbjct: 242 PKWPAKDLATQVPNLEPAGLDLLSSTCRLDPTRRITARGALEHEYFKDIK 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus GN=CDC2A PE=2 SV=2

 Score =  290 bits (742), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 150/288 (52%), Positives = 195/288 (67%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P  +++P  +K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSQDPRLVKMFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF +MGTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVMGTPNEETWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            + P K+LA VV  L+  G+DLL +ML LDPSKR+TAR AL+HEYFKD
Sbjct: 242 PKWPAKELAAVVPNLDASGLDLLDKMLRLDPSKRITARNALQHEYFKD 289

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P24100|CDKA1_ARATH Cyclin-dependent kinase A-1 OS=Arabidopsis thaliana GN=CDKA-1 PE=1 SV=1

 Score =  286 bits (731), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 147/292 (50%), Positives = 191/292 (65%), Gaps = 1/292 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHSN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  S   + LVFE LD DL   M + P  +K+   IK YL+QIL G+AYCHS  
Sbjct: 63  IVKLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W+V C FAEM++ + LF        L  IF IMGTP  +T  G TS  +     P
Sbjct: 183 TPVDIWSVGCIFAEMISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL 292
              P  DL T V  L+PDGVDLL +ML +DP+KR+ AR AL HEYFKD   +
Sbjct: 243 KWKPT-DLETFVPNLDPDGVDLLSKMLLMDPTKRINARAALEHEYFKDLGGM 293

Involved in the control of the cell cycle. Essential for both G1/S and G2/M (mitosis) phase transitions. Functions in cell morphogenesis as well as cell proliferation. Required for cell division (entry into mitosis) of the generative cell in male gametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29619|CDKA2_ORYSJ Cyclin-dependent kinase A-2 OS=Oryza sativa subsp. japonica GN=CDKA-2 PE=2 SV=1

 Score =  278 bits (711), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 148/290 (51%), Positives = 188/290 (64%), Gaps = 2/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++     T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKGKHRHTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V      I LVFE LD DL   M + P   KN   +K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHKEKCIYLVFEYLDLDLKKHMDSSPDF-KNHRIVKSFLYQILRGIAYCHSHR 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLG+  YS
Sbjct: 122 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYS 181

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W+V C FAEMV  + LF        L  IFSIMGTP+ ET PG  S  +     P
Sbjct: 182 TPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFSIMGTPNEETWPGVASLPDYISTFP 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            + P  DLATVV  L+  G+DLL +ML LDPSKR+ AR AL HEYFKD +
Sbjct: 242 -KWPSVDLATVVPTLDSSGLDLLSKMLRLDPSKRINARAALEHEYFKDLE 290

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P52389|CDC2_VIGUN Cell division control protein 2 homolog OS=Vigna unguiculata GN=CDC2 PE=2 SV=1

 Score =  274 bits (700), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 149/290 (51%), Positives = 195/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTDETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   K+P ++K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFVKDPRQVKMFLYQILCGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP+ ET PG T+   +F    
Sbjct: 183 TPVDVWSVGCLFAEMVNRRPLFPGDSEIDELFKIFRILGTPNEETWPGVTALP-DFKSTF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            + P KDLAT+V  L+  G++LL  ML LDPSKR+TAR A+ HEYFKD +
Sbjct: 242 PKWPPKDLATMVPNLDAAGLNLLSSMLSLDPSKRITARIAVEHEYFKDIK 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Vigna unguiculata (taxid: 3917)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	293
454980	294	cdc2Pa [Picea abies] gi|116778762|gb|ABK	0.982	0.979	0.543	9e-81
8671339	294	cdc2Pnc [Pinus contorta]	0.982	0.979	0.536	2e-80
17224978	294	cyclin dependent kinase [Helianthus annu	0.979	0.976	0.545	2e-79
358348197	294	Cyclin-dependent kinase A [Medicago trun	0.986	0.982	0.531	7e-79
449465537	294	PREDICTED: cell division control protein	0.979	0.976	0.527	8e-79
326422262	294	A-type cyclin dependent kinase 1 [Dendro	0.982	0.979	0.539	1e-78
89111297	294	cyclin dependent kinase A [Camellia sine	0.979	0.976	0.531	2e-78
319439585	294	cyclin dependent kinase A [Cucurbita max	0.979	0.976	0.520	3e-78
351726194	294	CDC2 [Glycine max] gi|158198575|gb|ABW23	0.986	0.982	0.527	4e-78
162462987	294	cell division control protein 2 homolog	0.986	0.982	0.527	8e-78

>gi|454980|emb|CAA54746.1| cdc2Pa [Picea abies] gi|116778762|gb|ABK20983.1| unknown [Picea sitchensis]

 Score =  306 bits (783), Expect = 9e-81,   Method: Compositional matrix adjust.
 Identities = 157/289 (54%), Positives = 198/289 (68%), Gaps = 1/289 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D LT +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P + K+P  IK +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPELAKDPRLIKTFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRKTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF ++GTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEETWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            + P KDLATVV GLEP G+DLL +MLCL+PSKR+TAR AL HEYFKD 
Sbjct: 242 PKWPAKDLATVVPGLEPAGIDLLSKMLCLEPSKRITARSALEHEYFKDL 290

Source: Picea abies

Species: Picea abies

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|8671339|emb|CAA56815.2| cdc2Pnc [Pinus contorta]

 Score =  305 bits (780), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 155/289 (53%), Positives = 198/289 (68%), Gaps = 1/289 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D LT +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P + K+P  IK +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPELAKDPRLIKTFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRKTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF ++GTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEETWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            + P KDLATVV GLEP G+D+L +MLCL+PS+R+TAR AL HEYFKD 
Sbjct: 242 PKWPAKDLATVVSGLEPAGIDILSKMLCLEPSRRITARSALEHEYFKDL 290

Source: Pinus contorta

Species: Pinus contorta

Genus: Pinus

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|17224978|gb|AAL37195.1|AF321361_1 cyclin dependent kinase [Helianthus annuus]

 Score =  301 bits (771), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 157/288 (54%), Positives = 196/288 (68%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P  +K+P  +K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSDKRLYLVFEYLDLDLKKHMDSCPEFSKDPRLVKTFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF IMGTP+ ET PG TS  +     P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRIMGTPNEETWPGVTSLPDFKSAFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             S  KDLATVV  LE  G+DLLR+MLCLDPSKR+TAR AL HEYFKD
Sbjct: 243 KWSS-KDLATVVPNLEKTGLDLLRKMLCLDPSKRITARTALEHEYFKD 289

Source: Helianthus annuus

Species: Helianthus annuus

Genus: Helianthus

Family: Asteraceae

Order: Asterales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358348197|ref|XP_003638135.1| Cyclin-dependent kinase A [Medicago truncatula] gi|355504070|gb|AES85273.1| Cyclin-dependent kinase A [Medicago truncatula]

 Score =  300 bits (767), Expect = 7e-79,   Method: Compositional matrix adjust.
 Identities = 154/290 (53%), Positives = 195/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D  T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL  FM + P   K+  +IK +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDRS + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRSSNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEM+  + LF        L  IF I GTP+ ET PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMINQRPLFPGDSEIDELFKIFRITGTPNEETWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            + P KDLAT V  LEP G+DLL  MLCLDP++R+TAR AL HEYFKD +
Sbjct: 242 PKWPAKDLATQVPNLEPAGLDLLSNMLCLDPTRRITARGALEHEYFKDIK 291

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465537|ref|XP_004150484.1| PREDICTED: cell division control protein 2 homolog A-like [Cucumis sativus]

 Score =  299 bits (766), Expect = 8e-79,   Method: Compositional matrix adjust.
 Identities = 152/288 (52%), Positives = 197/288 (68%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P  +K+P ++K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFSKDPRQVKMFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF ++GTP+ +T PG TS  +     P
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSTFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             SP KDLA+VV  LE  G+DLL +MLCLDP+KR+TAR AL HEYFKD
Sbjct: 243 KWSP-KDLASVVPNLEAAGIDLLSKMLCLDPTKRVTARNALEHEYFKD 289

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326422262|gb|ADZ74120.1| A-type cyclin dependent kinase 1 [Dendrobium candidum]

 Score =  299 bits (765), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 156/289 (53%), Positives = 196/289 (67%), Gaps = 1/289 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D LT +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDKLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   I LVFE LD DL   M + P   K+P   K YL+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRIYLVFEYLDLDLKKHMDSCPDFAKDPRLTKSYLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLG+ +YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP  ET PG +S   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRILGTPTEETWPGVSSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            + P KDLATVV  LEP GVDLL +ML L+PSKR+TAR+AL+HEYFKD 
Sbjct: 242 PKWPSKDLATVVPNLEPAGVDLLSKMLRLEPSKRITARQALQHEYFKDL 290

Source: Dendrobium candidum

Species: Dendrobium candidum

Genus: Dendrobium

Family: Orchidaceae

Order: Asparagales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|89111297|dbj|BAE80323.1| cyclin dependent kinase A [Camellia sinensis]

 Score =  298 bits (762), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 153/288 (53%), Positives = 197/288 (68%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE+KH N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMKHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +VRL +V  S   + LVFE LD DL   M + P  +K+P  IK +L+QIL G+AYCHS  
Sbjct: 63  VVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSKDPRLIKMFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP+ +T PG TS + +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRILGTPNEDTWPGVTSLA-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            + P KDLATVV  L+  G+DLL +MLCLDPS+R+TAR AL HEYFKD
Sbjct: 242 PKWPSKDLATVVPNLDSAGIDLLSKMLCLDPSRRITARSALEHEYFKD 289

Source: Camellia sinensis

Species: Camellia sinensis

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|319439585|emb|CBJ18166.1| cyclin dependent kinase A [Cucurbita maxima]

 Score =  298 bits (762), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 150/288 (52%), Positives = 197/288 (68%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   K+P ++K++L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFAKDPRQVKRFLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF ++GTP+ ++ PG TS   +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDSWPGVTSLP-DFKSAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            + P KDLA+VV  LE  G+DLL +MLCLDP+KR+TAR AL HEYFKD
Sbjct: 242 PKWPSKDLASVVPNLESAGIDLLSKMLCLDPTKRVTARSALEHEYFKD 289

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351726194|ref|NP_001237630.1| CDC2 [Glycine max] gi|158198575|gb|ABW23441.1| CDC2 [Glycine max]

 Score =  297 bits (760), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 153/290 (52%), Positives = 194/290 (66%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D  T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   K+P ++K +L+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFVKDPRQVKMFLYQILCGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDRS + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS +YS
Sbjct: 123 VLHRDLKPQNLLIDRSTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W+V C FAEMV  + LF        L  IF IMGTP+ +T PG TS  +     P
Sbjct: 183 TPVDIWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRIMGTPNEDTWPGVTSLPDFKSAFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
              P KDL  VV  LEP G+DLL  ML LDPSKR+TAR AL HEYFKD +
Sbjct: 243 KWQP-KDLKNVVPNLEPAGLDLLSSMLYLDPSKRITARSALEHEYFKDIK 291

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|162462987|ref|NP_001105342.1| cell division control protein 2 homolog [Zea mays] gi|115923|sp|P23111.1|CDC2_MAIZE RecName: Full=Cell division control protein 2 homolog; AltName: Full=p34cdc2 gi|168511|gb|AAA33479.1| protein cdc2 kinase [Zea mays] gi|195624364|gb|ACG34012.1| cell division control protein 2 [Zea mays] gi|219886431|gb|ACL53590.1| unknown [Zea mays] gi|414864400|tpg|DAA42957.1| TPA: putative cyclin-dependent kinase A family protein [Zea mays]

 Score =  296 bits (758), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 153/290 (52%), Positives = 195/290 (67%), Gaps = 1/290 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D  T +T+ +KKI +    EGVPS+ IRE+SLLKE+ H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKALDKATNETIALKKIRLEQEDEGVPSTAIREISLLKEMNHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   I LVFE LD DL  FM + P   KNP  IK YL+QILHGVAYCHS  
Sbjct: 63  IVRLHDVVHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILHGVAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLG+ +YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVDVW+V C FAEMV  + LF        L  IF I+GTP+ ++ PG +    +F    
Sbjct: 183 TPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEQSWPGVSCLP-DFKTAF 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
            R   +DLATVV  L+P G+DLL +ML  +PSKR+TAR+AL HEYFKD +
Sbjct: 242 PRWQAQDLATVVPNLDPAGLDLLSKMLRYEPSKRITARQALEHEYFKDLE 291

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	293
UNIPROTKB|P29618	294	CDKA-1 "Cyclin-dependent kinas	0.986	0.982	0.510	3.7e-71
TAIR|locus:2099478	294	CDC2 "cell division control 2"	0.979	0.976	0.5	1.4e-69
UNIPROTKB|P51958	302	cdk1 "Cyclin-dependent kinase	0.972	0.943	0.451	1.4e-62
ZFIN|ZDB-GENE-010320-1	302	cdk1 "cyclin-dependent kinase	0.972	0.943	0.447	3.8e-62
UNIPROTKB|P35567	302	cdk1-a "Cyclin-dependent kinas	0.972	0.943	0.461	7.9e-62
UNIPROTKB|Q9DGD3	303	cdk1 "Cyclin-dependent kinase	0.972	0.940	0.447	7.1e-61
UNIPROTKB|Q9DG98	303	cdk1 "Cyclin-dependent kinase	0.972	0.940	0.447	9e-61
UNIPROTKB|Q9DGA2	303	cdk1 "Cyclin-dependent kinase	0.972	0.940	0.447	9e-61
UNIPROTKB|P48734	297	CDK1 "Cyclin-dependent kinase	0.982	0.969	0.443	1.2e-60
UNIPROTKB|F1NBD7	303	CDK1 "Cyclin-dependent kinase	0.972	0.940	0.447	1.5e-60

UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 720 (258.5 bits), Expect = 3.7e-71, P = 3.7e-71
 Identities = 148/290 (51%), Positives = 191/290 (65%)

Query:     1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
             +Y   E I EG YG V+RA D +T +T+ +KKI +    EGVPS+ IRE+SLLKE+ H N
Sbjct:     3 QYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHHGN 62

Query:    61 IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
             IVRL +V  S   I LVFE LD DL  FM + P   KNP  IK YL+QIL GVAYCHS  
Sbjct:    63 IVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHSHR 122

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS +YS
Sbjct:   123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVD+W+V C FAEMV  + LF        L  IF ++GTP+ ++ P            P
Sbjct:   183 TPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
              +   +DLAT+V  L+P G+DLL +ML  +P+KR+TAR+AL HEYFKD +
Sbjct:   243 -KWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 705 (253.2 bits), Expect = 1.4e-69, P = 1.4e-69
 Identities = 144/288 (50%), Positives = 186/288 (64%)

Query:     1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
             +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct:     3 QYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHSN 62

Query:    61 IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
             IV+L +V  S   + LVFE LD DL   M + P  +K+   IK YL+QIL G+AYCHS  
Sbjct:    63 IVKLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHSHR 122

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct:   123 VLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVD+W+V C FAEM++ + LF        L  IF IMGTP  +T              P
Sbjct:   183 TPVDIWSVGCIFAEMISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                P  DL T V  L+PDGVDLL +ML +DP+KR+ AR AL HEYFKD
Sbjct:   243 KWKPT-DLETFVPNLDPDGVDLLSKMLLMDPTKRINARAALEHEYFKD 289

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0042023 "DNA endoreduplication" evidence=RCA;IMP

GO:0009555 "pollen development" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0040020 "regulation of meiosis" evidence=IMP

GO:0048229 "gametophyte development" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=IGI

GO:0000910 "cytokinesis" evidence=IMP

GO:0009409 "response to cold" evidence=IEP

GO:0009574 "preprophase band" evidence=TAS

GO:0010005 "cortical microtubule, transverse to long axis" evidence=IDA

UNIPROTKB|P51958 cdk1 "Cyclin-dependent kinase 1" [Carassius auratus (taxid:7957)]

 Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 130/288 (45%), Positives = 182/288 (63%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             Y  +E I EG YG V++  +  TG  V +KKI + +  EGVPS+ +RE+SLLKEL+H N+
Sbjct:     4 YLKIEKIGEGTYGVVYKGRNKTTGQVVAMKKIRLESEEEGVPSTAVREISLLKELQHPNV 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLKIKKYLHQILHGVAYCHSQE 120
             VRLL+V      + LVFE L  DL  ++ + P+    +P+ +K YL+QIL G+ +CH + 
Sbjct:    64 VRLLDVLMQESKLYLVFEFLSMDLKKYLDSIPSGQFMDPMLVKSYLYQILEGILFCHCRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID +K ++K+ADFGLAR   VP+  YT +  +L Y+APE LLG+ RYS
Sbjct:   124 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGASRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVDVW++   FAE+ T + LFH       L  IF  +GTP++E  P            P
Sbjct:   183 TPVDVWSIGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNNEVWPDVESLPDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                   +LA+ V  L+ +G+DLL +ML  DP KR++AR+A+ H YF D
Sbjct:   243 KWKS-GNLASTVKNLDKNGIDLLTKMLIYDPPKRISARQAMTHPYFDD 289

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

ZFIN|ZDB-GENE-010320-1 cdk1 "cyclin-dependent kinase 1" [Danio rerio (taxid:7955)]

 Score = 635 (228.6 bits), Expect = 3.8e-62, P = 3.8e-62
 Identities = 129/288 (44%), Positives = 181/288 (62%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             Y  +E I EG YG V++  +  TG  V +KKI + +  EGVPS+ +RE+SLLKEL+H N+
Sbjct:     4 YLKIEKIGEGTYGVVYKGRNKTTGQVVAMKKIRLESEEEGVPSTAVREISLLKELQHPNV 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLKIKKYLHQILHGVAYCHSQE 120
             VRLL+V      + LVFE L  DL  ++ + P+    +P+ +K YL+QIL G+ +CH + 
Sbjct:    64 VRLLDVLMQESKLYLVFEFLSMDLKKYLDSIPSGEFMDPMLVKSYLYQILEGILFCHCRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID +K ++K+ADFGLAR   VP+  YT +  +L Y+APE LLG+ RYS
Sbjct:   124 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGASRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVD+W++   FAE+ T + LFH       L  IF  +GTP++E  P            P
Sbjct:   183 TPVDLWSIGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNNEVWPDVESLPDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                   +LA  V  L+ +G+DLL +ML  DP KR++AR+A+ H YF D
Sbjct:   243 KWKS-GNLANTVKNLDKNGIDLLMKMLIYDPPKRISARQAMTHPYFDD 289

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0009794 "regulation of mitotic cell cycle, embryonic" evidence=IMP

GO:0051301 "cell division" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|P35567 cdk1-a "Cyclin-dependent kinase 1-A" [Xenopus laevis (taxid:8355)]

 Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
 Identities = 133/288 (46%), Positives = 180/288 (62%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             YT +E I EG YG V++     TG  V +KKI + N  EGVPS+ IRE+SLLKEL+H NI
Sbjct:     4 YTKIEKIGEGTYGVVYKGRHKATGQVVAMKKIRLENEEEGVPSTAIREISLLKELQHPNI 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTK-NPLKIKKYLHQILHGVAYCHSQE 120
             V LL+V      + L+FE L  DL  ++ + P+    + + +K YL+QIL G+ +CHS+ 
Sbjct:    64 VCLLDVLMQDSRLYLIFEFLSMDLKKYLDSIPSGQYIDTMLVKSYLYQILQGIVFCHSRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID SK ++K+ADFGLAR   +P+  YT +  +L Y+APE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-SKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSVRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVDVW++   FAE+ T + LFH       L  IF  +GTP++E  P            P
Sbjct:   183 TPVDVWSIGTIFAEIATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKNSFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    L+  V  ++ DG+DLL +ML  DP+KR++AR+AL H YF D
Sbjct:   243 KWKG-GSLSANVKNIDKDGLDLLAKMLIYDPAKRISARKALLHPYFDD 289

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|Q9DGD3 cdk1 "Cyclin-dependent kinase 1" [Oryzias latipes (taxid:8090)]

 Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
 Identities = 129/288 (44%), Positives = 180/288 (62%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             Y  +E I EG YG V++     TG  V +KKI + +  EGVPS+ +REVSLL+ELKH N+
Sbjct:     4 YVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPNV 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLKIKKYLHQILHGVAYCHSQE 120
             VRLL+V      + L+FE L  DL  ++ + P+    +P+ +K YL+QIL G+ +CH + 
Sbjct:    64 VRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID +K ++K+ADFGLAR   VP+  YT +  +L Y+APE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVDVW+    FAE+ T + LFH       L  IF  +GTP+++  P            P
Sbjct:   183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNNDVWPDVESLPDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    L+++V  L+ +G+DLL +ML  +P KR++AREA+ H YF D
Sbjct:   243 KWKE-GSLSSMVKNLDKNGLDLLAKMLIYNPPKRISAREAMTHPYFDD 289

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|Q9DG98 cdk1 "Cyclin-dependent kinase 1" [Oryzias luzonensis (taxid:104659)]

 Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
 Identities = 129/288 (44%), Positives = 180/288 (62%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             Y  +E I EG YG V++     TG  V +KKI + +  EGVPS+ +REVSLL+ELKH N+
Sbjct:     4 YVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPNV 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLKIKKYLHQILHGVAYCHSQE 120
             VRLL+V      + L+FE L  DL  ++ + P+    +P+ +K YL+QIL G+ +CH + 
Sbjct:    64 VRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID +K ++K+ADFGLAR   VP+  YT +  +L Y+APE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVDVW+    FAE+ T + LFH       L  IF  +GTP+++  P            P
Sbjct:   183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNNDVWPDVESLPDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    L+++V  L+ +G+DLL +ML  +P KR++AREA+ H YF D
Sbjct:   243 KWKG-GSLSSMVKNLDKNGLDLLAKMLIYNPPKRISAREAMTHPYFDD 289

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|Q9DGA2 cdk1 "Cyclin-dependent kinase 1" [Oryzias javanicus (taxid:123683)]

 Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
 Identities = 129/288 (44%), Positives = 180/288 (62%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             Y  +E I EG YG V++     TG  V +KKI + +  EGVPS+ +REVSLL+ELKH N+
Sbjct:     4 YVKIEKIGEGTYGVVYKGRHKSTGQVVAMKKIRLESEEEGVPSTAVREVSLLQELKHPNV 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLKIKKYLHQILHGVAYCHSQE 120
             VRLL+V      + L+FE L  DL  ++ + P+    +P+ +K YL+QIL G+ +CH + 
Sbjct:    64 VRLLDVLMQESRLYLIFEFLSMDLKKYLDSIPSGQYMDPMLVKSYLYQILEGIYFCHRRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID +K ++K+ADFGLAR   VP+  YT +  +L Y+APE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGVPVRVYTHEVVTLWYRAPEVLLGSPRYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVDVW+    FAE+ T + LFH       L  IF  +GTP+++  P            P
Sbjct:   183 TPVDVWSTGTIFAELATKKPLFHGDSEIDQLFRIFRTLGTPNNDVWPDVESLPDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    L+++V  L+ +G+DLL +ML  +P KR++AREA+ H YF D
Sbjct:   243 KWME-GSLSSMVKNLDKNGLDLLAKMLIYNPPKRISAREAMTHPYFDD 289

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|P48734 CDK1 "Cyclin-dependent kinase 1" [Bos taurus (taxid:9913)]

 Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
 Identities = 129/291 (44%), Positives = 176/291 (60%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             YT +E I EG YG V++     TG  V +KKI + +  EGVPS+ IRE+SLLKEL+H NI
Sbjct:     4 YTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELRHPNI 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
             V L +V      + L+FE L  DL  ++ +  P    +   +K YL+QIL G+ +CHS+ 
Sbjct:    64 VSLQDVLMQDSRLYLIFEFLSMDLKKYLDSIPPGQFMDSSLVKSYLYQILQGIVFCHSRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID  K  +K+ADFGLAR   +P+  YT +  +L Y++PE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-DKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSARYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVD+W++   FAE+ T + LFH       L  IF  +GTP++E  P            P
Sbjct:   183 TPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVESLQDYKSTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                P   LA+ V  L+ +G+DLL +ML  DP+KR++ + AL H YF D  S
Sbjct:   243 KWKP-GSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFNDLDS 292

GO:0030496 "midbody" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0005876 "spindle microtubule" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0034501 "protein localization to kinetochore" evidence=IEA

GO:0030544 "Hsp70 protein binding" evidence=IEA

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1NBD7 CDK1 "Cyclin-dependent kinase 1" [Gallus gallus (taxid:9031)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 129/288 (44%), Positives = 176/288 (61%)

Query:     2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
             YT +E I EG YG V++     TG  V +KKI + +  EGVPS+ IRE+SLLKEL H NI
Sbjct:     4 YTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIREISLLKELHHPNI 63

Query:    62 VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTK-NPLKIKKYLHQILHGVAYCHSQE 120
             V L +V      + L+FE L  DL  ++ T P+    +  ++K YL+QIL G+ +CHS+ 
Sbjct:    64 VCLQDVLMQDARLYLIFEFLSMDLKKYLDTIPSGQYLDRSRVKSYLYQILQGIVFCHSRR 123

Query:   121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             +LHRDLKP N LID  K ++K+ADFGLAR   +P+  YT +  +L Y++PE LLGS RYS
Sbjct:   124 VLHRDLKPQNLLID-DKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRSPEVLLGSARYS 182

Query:   181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             TPVD+W++   FAE+ T + LFH       L  IF  +GTP+++  P            P
Sbjct:   183 TPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNDVWPDVESLQDYKNTFP 242

Query:   241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                P   L T V  L+ DG+DLL +ML  DP+KR++ + AL H YF D
Sbjct:   243 KWKP-GSLGTHVQNLDEDGLDLLSKMLIYDPAKRISGKMALNHPYFDD 289

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0030544 "Hsp70 protein binding" evidence=IEA

GO:0034501 "protein localization to kinetochore" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.4738	0.9522	0.9362	yes	no
Q00526	CDK3_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.4911	0.9522	0.9147	yes	no
P34117	CDK5_DICDI	2, ., 7, ., 1, 1, ., 2, 2	0.4232	0.9897	0.9931	yes	no
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.4295	0.9488	0.9328	yes	no
O55076	CDK2_CRIGR	2, ., 7, ., 1, 1, ., 2, 2	0.4773	0.9522	0.9362	yes	no
P48734	CDK1_BOVIN	2, ., 7, ., 1, 1, ., 2, 3	0.4467	0.9829	0.9696	yes	no
P23572	CDK1_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.4375	0.9726	0.9595	yes	no
Q41639	CDC2_VIGAC	2, ., 7, ., 1, 1, ., 2, 3	0.5206	0.9863	0.9829	N/A	no
P24100	CDKA1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5034	0.9931	0.9897	yes	no
P11440	CDK1_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.4432	0.9829	0.9696	yes	no
Q05006	CDC22_MEDSA	2, ., 7, ., 1, 1, ., 2, 2	0.5241	0.9863	0.9829	N/A	no
P93101	CDC2_CHERU	2, ., 7, ., 1, 1, ., 2, 3	0.5277	0.9795	0.9761	N/A	no
P23111	CDC2_MAIZE	2, ., 7, ., 1, 1, ., 2, 3	0.5275	0.9863	0.9829	N/A	no
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.4413	0.9624	0.9791	yes	no
P24923	CDC21_MEDSA	2, ., 7, ., 1, 1, ., 2, 3	0.5244	0.9726	0.9793	N/A	no
Q38772	CDC2A_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5208	0.9795	0.9761	N/A	no
Q38773	CDC2B_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5054	0.9419	0.9857	N/A	no
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5172	0.9863	0.9829	yes	no
P52389	CDC2_VIGUN	2, ., 7, ., 1, 1, ., 2, 3	0.5137	0.9863	0.9829	N/A	no
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.4459	0.9795	0.9663	yes	no
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.4328	0.9488	0.9328	yes	no
Q5E9Y0	CDK2_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.4773	0.9522	0.9362	yes	no
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.4482	0.9624	0.9791	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00000820001 SubName- Full=Chromosome undetermined scaffold_108, whole genome shotgun sequence; (294 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	293
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-117
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-114
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-112
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-96
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-96
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-87
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-86
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-85
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-83
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-81
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-81
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-80
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-78
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-77
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-77
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-76
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-75
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-73
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-73
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-70
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-69
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-67
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-67
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-65
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-63
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-63
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-62
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-62
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-61
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-60
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-59
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-58
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-57
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-56
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-56
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-55
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-55
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-55
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-54
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-53
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-53
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-51
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-50
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-50
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-49
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-47
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-47
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-46
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-46
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-44
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-43
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-42
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-42
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-41
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-41
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-41
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-38
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-35
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-33
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-33
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-30
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-30
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-29
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-27
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-23
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-23
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  337 bits (867), Expect = e-117
 Identities = 138/285 (48%), Positives = 187/285 (65%), Gaps = 3/285 (1%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  LE + EG YG V++A D  TG+ V +KKI + N  EG+PS+ +RE+SLLKELKH NI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+LL+V  +   + LVFE  D DL  ++   P    +P  IK  ++Q+L G+AYCHS  I
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPL-SPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+R   ++K+ADFGLAR   +PL  YT +  +L Y+APE LLGS  YST
Sbjct: 120 LHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
            VD+W+V C FAEM+T + LF        L  IF I+GTP  E+ PG T    ++     
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL-PDYKPTFP 237

Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           + P KDL  V+  L+P+G+DLL +ML  +P+KR++A+EAL+H YF
Sbjct: 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  330 bits (847), Expect = e-114
 Identities = 145/287 (50%), Positives = 190/287 (66%), Gaps = 6/287 (2%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  +E I EG YG V++A D LTG+ V +KKI +    EGVPS+ IRE+SLLKEL H NI
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           VRLL+V  S + + LVFE LD DL  +M + P    +P  IK YL+Q+L G+AYCHS  +
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LIDR   + K+ADFGLAR   VP+  YT +  +L Y+APE LLGS +YST
Sbjct: 121 LHRDLKPQNLLIDREGAL-KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYST 179

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
           PVD+W++ C FAEMV  + LF        L  IF  +GTPD +  PG TS  +   ++P 
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---YKPT 236

Query: 242 --RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             +   +DL+ VV  L+ DG+DLL +ML  DP+KR++A+ AL+H YF
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  326 bits (838), Expect = e-112
 Identities = 158/288 (54%), Positives = 195/288 (67%), Gaps = 1/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +E I EG YG V++A D +T +T+ +KKI +    EGVPS+ IRE+SLLKE++H N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE LD DL   M + P   KNP  IK YL+QIL G+AYCHS  
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LIDR  + +K+ADFGLAR   +P+  +T +  +L Y+APE LLGS  YS
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W+V C FAEMV  + LF        L  IF I+GTP+ ET PG TS  +     P
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP 242

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            + P KDLATVV  LEP GVDLL +ML LDPSKR+TAR AL HEYFKD
Sbjct: 243 -KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  285 bits (731), Expect = 1e-96
 Identities = 136/283 (48%), Positives = 179/283 (63%), Gaps = 4/283 (1%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMK-TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM  +  +    PL IK YL Q+L G+A+CHS  +LH
Sbjct: 65  LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL-IKSYLFQLLQGLAFCHSHRVLH 123

Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+    I K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 124 RDLKPQNLLINTEGAI-KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182

Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    PG TS  +     P + 
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP-KW 241

Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             +D + VV  L+ DG DLL +ML  DP+KR++A+ AL H +F
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  284 bits (728), Expect = 4e-96
 Identities = 132/286 (46%), Positives = 180/286 (62%), Gaps = 3/286 (1%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT +E I EG YG V++  +  TG  V +KKI + +  EGVPS+ IRE+SLLKEL+H NI
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTV-TKNPLKIKKYLHQILHGVAYCHSQE 120
           V L +V      + L+FE L  DL  ++ + P     +   +K YL+QIL G+ +CHS+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LID +K ++K+ADFGLAR   +P+  YT +  +L Y+APE LLGS RYS
Sbjct: 122 VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           TPVD+W++   FAEM T + LFH       L  IF I+GTP  +  PG TS  +     P
Sbjct: 181 TPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  L + V  L+ DG+DLL +ML  DP+KR++A++AL H YF
Sbjct: 241 KWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  262 bits (670), Expect = 4e-87
 Identities = 130/294 (44%), Positives = 178/294 (60%), Gaps = 11/294 (3%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN- 60
           Y  LE I EG YG V++A D  TG  V +KK  +    EG+P + +RE+SLL+ L     
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 61  IVRLLNVQSSVD-----SIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHG 112
           IVRLL+V+   +     S+ LVFE LD DL  FM +       PL    IK +++Q+L G
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           VA+CH   ++HRDLKP N L+D+ K ++KIAD GL R   +P+++YT +  +L Y+APE 
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           LLGS  YSTPVD+W+V C FAEM   Q LF        L  IF ++GTP  +  PG +  
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            +   F P   P  DL+  V  L P+G+DLL++ML  DP+KR++A+ AL H YF
Sbjct: 243 RDWHEF-PQWKPQ-DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 1e-86
 Identities = 115/289 (39%), Positives = 166/289 (57%), Gaps = 6/289 (2%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  +  I EG YG V++A +  TG+ V +KKI + N  EG P + IRE+ LL++L+H NI
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 62  VRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           VRL  + +S    SI +VFE +D DL   + + P V     +IK Y+ Q+L G+ Y HS 
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIKGGSLCYKAPERLLGSGR 178
            ILHRD+K +N LI+    ++K+ADFGLARP       +YT +  +L Y+ PE LLG+ R
Sbjct: 120 GILHRDIKGSNILINN-DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
           Y   VD+W+V C  AE+   + +F        L  IF + G+P  E  PG +        
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238

Query: 239 EPNRSPIKDLATVVGGLE-PDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +P +   + L      L  P  +DLL ++L LDP KR++A +AL+HEYF
Sbjct: 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  256 bits (656), Expect = 8e-85
 Identities = 118/297 (39%), Positives = 163/297 (54%), Gaps = 21/297 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI---PIMNPSEGVPSSVIREVSLLKELK 57
           RY   + + EG Y  V++A D  TG  V +KKI         +G+  + +RE+ LL+ELK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           H NI+ LL+V     +I+LVFE ++ DL   +K + ++   P  IK Y+   L G+ Y H
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIK-DKSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S  ILHRDLKP N LI  S  ++K+ADFGLAR    P    T +  +  Y+APE L G+ 
Sbjct: 120 SNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR 178

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTPDSETLPGFTSF 232
            Y   VD+W+V C FAE++           PG      L  IF  +GTP  E  PG TS 
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFL-----PGDSDIDQLGKIFEALGTPTEENWPGVTSL 233

Query: 233 --SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
               EF   P  +P+K +         D +DLL+R+L L+P+KR+TAR+AL H YF 
Sbjct: 234 PDYVEFKPFPP-TPLKQIFPAASD---DALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  252 bits (646), Expect = 1e-83
 Identities = 130/293 (44%), Positives = 174/293 (59%), Gaps = 18/293 (6%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L  I EG YG V++A D LTG+ V +KKI +   SEG+P + +RE+ LLKEL H NI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           ++LL+V      + LVFE +D DL   +K         L IK YL+Q+L G+A+CHS  I
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESL-IKSYLYQLLQGLAFCHSHGI 119

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+ ++ ++K+ADFGLAR    P+  YT    +  Y+APE LLG   YST
Sbjct: 120 LHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETLPGFTSFSEEF 236
           PVD+W+V C FAE+++ + LF     PG      L  IF  +GTPD E  P FTS +  +
Sbjct: 179 PVDIWSVGCIFAELLSRRPLF-----PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233

Query: 237 GF---EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            F   +    P+     +     P  +DLL +ML  DP KR+TA +AL H YF
Sbjct: 234 KFSFPKKAGMPLP---KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  247 bits (632), Expect = 2e-81
 Identities = 121/288 (42%), Positives = 179/288 (62%), Gaps = 8/288 (2%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  LE + EG Y  V++  +  TG+ V +K+I + +  EG PS+ IRE+SL+KELKHENI
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKELKHENI 60

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTK-NPLKIKKYLHQILHGVAYCHSQE 120
           VRL +V  + + + LVFE +D DL  +M T       +P  +K + +Q+L G+A+CH   
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+  +  +K+ADFGLAR   +P+  ++ +  +L Y+AP+ LLGS  YS
Sbjct: 121 VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           T +D+W+V C  AEM+T + LF        L  IF IMGTP   T PG +   E   ++P
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE---YKP 236

Query: 241 N--RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              R P +DL  +    +P G+DLL R+L L+P  R++A +AL+H +F
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  246 bits (630), Expect = 4e-81
 Identities = 116/292 (39%), Positives = 165/292 (56%), Gaps = 13/292 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +L  I EG +G V +A D  TG+TV +KK+ +     G+P+  +RE+  L+  +H  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVAYCH 117
           +V+LL+V        LV E +  DL   ++ E      PL   ++K Y+  +L GVAY H
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH 116

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLCYKAPERLLGS 176
           +  I+HRDLKPAN LI  +  ++KIADFGLAR         Y+ +  +  Y+APE L G+
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS--E 234
            +Y   VD+WAV C FAE++    LF        LA +F  +GTP+ ET PG TS     
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +  F  ++ PI  L  +     P+ +DLL+ +L  DPSKRL+A EALRH YF
Sbjct: 236 KITFPESK-PIP-LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  242 bits (621), Expect = 9e-80
 Identities = 117/292 (40%), Positives = 170/292 (58%), Gaps = 12/292 (4%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L  I EG YG V+RA D  TG+ V +KK+ +    EG P + +RE+++L +L+H NI
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI 66

Query: 62  VRL--LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVAYC 116
           V +  + V S++D I +V E ++ DL   M+T     K P    ++K  + Q+L GVA+ 
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H   ILHRDLK +N L++  + I+KI DFGLAR    PL+ YT    +L Y+APE LLG+
Sbjct: 123 HDNWILHRDLKTSNLLLNN-RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             YST +D+W+V C FAE++T + LF  +     L  IF ++GTP  +  PGF+      
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241

Query: 237 GFEPNRSPIKDLATV--VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                + P   L        L  +G DLL R+L  DP+KR++A +AL+H YF
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  239 bits (611), Expect = 2e-78
 Identities = 116/292 (39%), Positives = 171/292 (58%), Gaps = 14/292 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V +A +  T + V +K++ + +  EGVPSS +RE+ LLKELKH+N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFM-----KTEPTVTKNPLKIKKYLHQILHGVAY 115
           IVRL +V  S   + LVFE  D DL  +        +P +      +K ++ Q+L G+A+
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI------VKSFMFQLLKGLAF 114

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           CHS  +LHRDLKP N LI+++ ++ K+ADFGLAR   +P+  Y+ +  +L Y+ P+ L G
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGEL-KLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
           +  YST +D+W+  C FAE+    R LF        L  IF ++GTP  E+ PG +    
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP- 232

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           ++   P       L  VV  L   G DLL+ +L  +P +R++A EAL+H YF
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  237 bits (606), Expect = 2e-77
 Identities = 117/295 (39%), Positives = 163/295 (55%), Gaps = 18/295 (6%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---H 58
           Y  L  I EG YG V++A D  TG  V +KK+ +    EG+P S +RE++LLK+L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 59  ENIVRLLNVQSSVD-----SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
            NIVRLL+V           + LVFE++D DL  ++   P     P  IK  + Q+L GV
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAPE 171
            + HS  I+HRDLKP N L+      VKIADFGLAR    ++ L +  +   +L Y+APE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVV---TLWYRAPE 176

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
            LL S  Y+TPVD+W+V C FAE+   + LF        L  IF ++G P  E  P   S
Sbjct: 177 VLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                 F       +   + V  +  +G+DLL++ML  +P KR++A EAL+H YF
Sbjct: 236 LPRS-SFPSY--TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  237 bits (606), Expect = 2e-77
 Identities = 119/295 (40%), Positives = 165/295 (55%), Gaps = 20/295 (6%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L+ + EG Y  V++    LTG  V +K+I  +   EG P + IRE SLLK+LKH NI
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  +  ++ LVFE LD DL  +M        +   ++ +L Q+L G+AYCH + +
Sbjct: 66  VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGL-SMHNVRLFLFQLLRGLAYCHQRRV 124

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI    ++ K+ADFGLAR   VP + Y+ +  +L Y+ P+ LLGS  YST
Sbjct: 125 LHRDLKPQNLLISERGEL-KLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAAIFSIMGTPDSETLPGFTSFSE- 234
            +D+W V C F EM T + LF     PG       L  IF ++GTP  ET PG +S  E 
Sbjct: 184 SLDMWGVGCIFYEMATGRPLF-----PGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 235 ---EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
               F F P R  I     +     P G +L  + L  +P KR++A EA++H YF
Sbjct: 239 KPYSFPFYPPRPLINHAPRL--DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  232 bits (595), Expect = 2e-76
 Identities = 102/286 (35%), Positives = 142/286 (49%), Gaps = 33/286 (11%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +LE + EG +G V+ A D  TG  V +K I      +     ++RE+ +LK+LKH NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNI 59

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRL +V    D + LV E  +  DL   +K    ++    + + YL QIL  + Y HS+ 
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--EDEARFYLRQILSALEYLHSKG 117

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRDLKP N L+D     VK+ADFGLAR +D   +  T   G+  Y APE LLG G Y 
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVLLGKG-YG 174

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+W++     E++T +  F        L  +F  +G P     P     S E     
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWDISPEA---- 227

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                               DL+R++L  DP KRLTA EAL+H +F
Sbjct: 228 -------------------KDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  230 bits (588), Expect = 4e-75
 Identities = 97/286 (33%), Positives = 137/286 (47%), Gaps = 27/286 (9%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL  +  G +G V++A    TG  V VK +   +       +  RE+ +L+ L H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRL++     D + LV E  +  DL  ++     ++    + KK   QIL G+ Y HS  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS--EDEAKKIALQILRGLEYLHSNG 118

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRDLKP N L+D    +VKIADFGLA+ +     + T   G+  Y APE LLG   Y 
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VDVW++     E++T +  F        L  I  I+G P     P ++S SEE     
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA---- 233

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                               DL+++ L  DPSKR TA E L+H +F
Sbjct: 234 -------------------KDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  226 bits (578), Expect = 5e-73
 Identities = 122/310 (39%), Positives = 165/310 (53%), Gaps = 31/310 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y +L  + EG +G V++A    TG  V +KKI + N  +G P + +RE+ +LK+LKH N
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68

Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDL---LHFMKTEPTVTKNPLKIKKYLHQI 109
           +V L+++        +    S+ +V   +D DL   L      P+V     +IK Y+ Q+
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE----NPSVKLTESQIKCYMLQL 124

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC--- 166
           L G+ Y H   ILHRD+K AN LID  + I+KIADFGLARP D P  N    GG      
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 167 --------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
                   Y+ PE LLG  RY+T VD+W + C FAEM T + +   +     L  IF + 
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243

Query: 219 GTPDSETLPGFTSF--SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT 276
           GTP  ET PG+ S    E      N      L    G L P+G+DLL ++L LDP KRLT
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Query: 277 AREALRHEYF 286
           A +AL H YF
Sbjct: 302 ASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  227 bits (580), Expect = 5e-73
 Identities = 113/304 (37%), Positives = 165/304 (54%), Gaps = 24/304 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           RY LL+ I  G YG V  A D  TG  V +KKI   N  + +  +  ++RE+ LL+ L+H
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS--NVFDDLIDAKRILREIKLLRHLRH 58

Query: 59  ENIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           ENI+ LL++       D     +V E ++ DL   +K+   +T     I+ +L+QIL G+
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT--DDHIQYFLYQILRGL 116

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKAP 170
            Y HS  ++HRDLKP+N L++ + D +KI DFGLAR +D   +        +    Y+AP
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCD-LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E LL S RY+  +D+W+V C FAE++T + LF  R     L  I  ++GTP  E L   T
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 231 S-----FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           S     + +    +P     K L+ +  G  P+ +DLL +ML  DP KR+TA EAL H Y
Sbjct: 236 SEKARNYLKSLPKKPK----KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 286 FKDF 289
               
Sbjct: 292 LAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  218 bits (558), Expect = 6e-70
 Identities = 113/286 (39%), Positives = 158/286 (55%), Gaps = 4/286 (1%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           L  I EG YG V+RA D+ +G+ V +KK+ + N  +G+P S +RE++LL  L+H NIV L
Sbjct: 12  LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 65  LNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
             V     +DSI LV E  + DL   +   PT      ++K  + Q+L G+ Y H   I+
Sbjct: 72  KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSES-QVKCLMLQLLRGLQYLHENFII 130

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK +N L+   K  +KIADFGLAR   +P +  T K  +L Y+APE LLG   Y+T 
Sbjct: 131 HRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR 242
           +D+WAV C  AE++ H+ L   +     L  I  ++GTP+    PGF+       F   +
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249

Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            P  +L      L   G+ LL  +L  DP KR TA EAL   YFK+
Sbjct: 250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  216 bits (552), Expect = 4e-69
 Identities = 112/316 (35%), Positives = 162/316 (51%), Gaps = 30/316 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAH--DSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELK 57
           +Y +   I  G YG V++A   +   G    +KK         G+  S  RE++LL+ELK
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 58  HENIVRLLNV--QSSVDSIDLVFENLDFDLLHFMK---TEPTVTKNPLKIKKYLHQILHG 112
           HEN+V L+ V  + +  S+ L+F+  + DL   +K       V+  P  +K  L QIL+G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVPLEN-YTIKGG--SLC 166
           V Y HS  +LHRDLKPAN L+        +VKI D GLAR  + PL+    +     ++ 
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP---------GLLAAIFSI 217
           Y+APE LLG+  Y+  +D+WA+ C FAE++T + +F  R A            L  IF +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 218 MGTPDSETLPGFTSFSE----EFGFEPNRSPIKDLATVV---GGLEPDGVDLLRRMLCLD 270
           +GTP  +  P      E       F+    P   LA  +      +  G DLLR++L  D
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300

Query: 271 PSKRLTAREALRHEYF 286
           P+KR+TA EAL H YF
Sbjct: 301 PTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  212 bits (540), Expect = 1e-67
 Identities = 116/287 (40%), Positives = 165/287 (57%), Gaps = 7/287 (2%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L+ + EG Y  V +    LT + V +K+I + +  EG P + IREVSLLK LKH NI
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  +   + LVFE LD DL  ++     +      +K ++ Q+L G++YCH ++I
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH-NVKIFMFQLLRGLSYCHKRKI 124

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+   ++ K+ADFGLAR   VP + Y+ +  +L Y+ P+ LLGS  YST
Sbjct: 125 LHRDLKPQNLLINEKGEL-KLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE--EFGFE 239
           P+D+W V C   EM T + +F        L  IF ++GTP  ET PG TS  E   + F 
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             R+  + L      L+ DG+DLL  +L  +   R++A  ALRH YF
Sbjct: 244 QYRA--QPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  211 bits (537), Expect = 5e-67
 Identities = 115/285 (40%), Positives = 165/285 (57%), Gaps = 3/285 (1%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L+ + EG Y  V++    LT + V +K+I + +  EG P + IREVSLLK+LKH NI
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 66

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  +  S+ LVFE LD DL  ++        N   +K +L Q+L G+ YCH +++
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSI-NMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+   ++ K+ADFGLAR   +P + Y+ +  +L Y+ P+ LLGS  YST
Sbjct: 126 LHRDLKPQNLLINERGEL-KLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
            +D+W V C F EM T + LF        L  IF I+GTP  ET PG  S  E   +   
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244

Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +     L      L+ DG +LL ++L  +  KR++A EA++H YF
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  207 bits (527), Expect = 2e-65
 Identities = 116/286 (40%), Positives = 170/286 (59%), Gaps = 3/286 (1%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  LE + EG Y  V +    LT + V +K+I + +  EG P + IREVSLLK+LKH NI
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 66

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  +  S+ LVFE LD DL  +M     +  +   +K +L+QIL G+AYCH +++
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIM-SMHNVKIFLYQILRGLAYCHRRKV 125

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+   ++ K+ADFGLAR   VP + Y+ +  +L Y+ P+ LLGS  YST
Sbjct: 126 LHRDLKPQNLLINERGEL-KLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
            +D+W V C F EM + + LF        L  IF ++GTP  ET PG +S  E   +   
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244

Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           +   + L      L+ +G++LL + L  +  KR++A EA++H YF+
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 4e-63
 Identities = 99/289 (34%), Positives = 145/289 (50%), Gaps = 5/289 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y +L V+ EG YG V +  +  TG+ V +KK       E V  + +REV +L++L+HEN
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L         + LVFE ++  LL  ++  P     P  ++ Y+ Q+L  +AYCHS  
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYTIKGGSLCYKAPERLLGSGRY 179
           I+HRD+KP N L+  S  ++K+ DFG AR +        T    +  Y+APE L+G   Y
Sbjct: 121 IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
             PVDVWA+ C  AE++  + LF        L  I   +G         F+S     G  
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 240 -PNRSPIKDLAT-VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            P  S  + L     G +    +D L+  L +DP +RLT  E L+H YF
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 5e-63
 Identities = 108/296 (36%), Positives = 160/296 (54%), Gaps = 24/296 (8%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREV-SLLKELKH 58
           Y +++ + +G +G+V+ A +  TG+ V +KK+     +  E +    +REV SL K  +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            NIV+L  V    D +  VFE ++ +L   MK       +   I+  ++QIL G+A+ H 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPID--VPLENYTIKGGSLCYKAPERLLGS 176
               HRDLKP N L+    ++VKIADFGLAR I    P  +Y     +  Y+APE LL S
Sbjct: 118 HGFFHRDLKPENLLV-SGPEVVKIADFGLAREIRSRPPYTDYV---STRWYRAPEILLRS 173

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTPDSETLPGFTS 231
             YS+PVD+WA+ C  AE+ T + LF     PG      L  I S++GTP  +  P    
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLF-----PGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 232 FSEEFGFE-PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            + + GF  P  +P   L  ++    P+ +DL++ ML  DP KR TA +AL+H YF
Sbjct: 229 LASKLGFRFPQFAPT-SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  197 bits (504), Expect = 6e-62
 Identities = 101/309 (32%), Positives = 151/309 (48%), Gaps = 34/309 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    T   V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 61  IVRLLNVQSSV--------DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +V L+ +  +          S  LVFE  + DL   + +   V     +IKK +  +L+G
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKMLLNG 131

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN----YTIKGGSLCYK 168
           + Y H  +ILHRD+K AN LI +   I+K+ADFGLAR   +   +    YT +  +L Y+
Sbjct: 132 LYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT------PD 222
            PE LLG   Y  P+D+W   C  AEM T   +         L  I  + G+      P 
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250

Query: 223 SETLPGFTSFSEEFGF-----EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
            + L  F       G      E  +  +KD         P  +DL+ ++L LDP+KR+ A
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKD---------PHALDLIDKLLVLDPAKRIDA 301

Query: 278 REALRHEYF 286
             AL H++F
Sbjct: 302 DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  198 bits (506), Expect = 6e-62
 Identities = 121/327 (37%), Positives = 176/327 (53%), Gaps = 54/327 (16%)

Query: 1   RYTLLEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS------------VI 47
           RY      + EG YG V +A+D+LTG  V +KK+ I+  S  V                +
Sbjct: 9   RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 48  REVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLH 107
           RE+ ++ E+KHENI+ L++V    D I+LV + +  DL   +  +  +T++  ++K  L 
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTES--QVKCILL 126

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-----PIDVPL------- 155
           QIL+G+   H    +HRDL PAN  I+ SK I KIADFGLAR     P    L       
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 156 --ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL--- 210
             E  T K  +L Y+APE L+G+ +Y   VD+W+V C FAE++T + LF     PG    
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-----PGENEI 240

Query: 211 --LAAIFSIMGT------PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDL 262
             L  IF ++GT      P ++ LP +T F+        R P KDL T+      D +DL
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP-------RKP-KDLKTIFPNASDDAIDL 292

Query: 263 LRRMLCLDPSKRLTAREALRHEYFKDF 289
           L+ +L L+P +R++A+EAL+HEYFK  
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYFKSD 319

Length = 335

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  197 bits (503), Expect = 2e-61
 Identities = 112/312 (35%), Positives = 165/312 (52%), Gaps = 37/312 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELK- 57
           +Y +L+ + +G YG V +A D  T + V +KKI     N ++       RE+  L+EL  
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA--QRTFREIMFLQELGD 65

Query: 58  HENIVRLLNVQSSVDSID--LVFENLDFDLLHFMKTEPTVTKNPLKI--KKY-LHQILHG 112
           H NIV+LLNV  + +  D  LVFE ++ DL   ++       N L+   K+Y ++Q+L  
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR------ANILEDVHKRYIMYQLLKA 119

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC------ 166
           + Y HS  ++HRDLKP+N L++ S   VK+ADFGLAR +   LE    +   L       
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLN-SDCRVKLADFGLARSLS-ELEENP-ENPVLTDYVATR 176

Query: 167 -YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGT 220
            Y+APE LLGS RY+  VD+W+V C   EM+  + LF     PG      L  I  ++G 
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-----PGTSTLNQLEKIIEVIGP 231

Query: 221 PDSETLPGFTS-FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
           P +E +    S F+          P K L  ++     D +DLL+++L  +P+KRLTA E
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Query: 280 ALRHEYFKDFQS 291
           AL H Y   F +
Sbjct: 292 ALEHPYVAQFHN 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  194 bits (495), Expect = 1e-60
 Identities = 104/295 (35%), Positives = 153/295 (51%), Gaps = 13/295 (4%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + ++  I EG YG V++A D  TG+ V +KK+ + N  EG P + IRE+ +L++L H NI
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 62  VRLLN-VQSSVDSID---------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           V L   V    D++D         LVFE +D DL+  +++   V  +   IK ++ Q+L 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLE 127

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLCYKAP 170
           G+ YCH +  LHRD+K +N L++    I K+ADFGLAR  +      YT K  +L Y+ P
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQI-KLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E LLG  RY   +DVW+  C   E+ T + +F +      L  I  + G+P     P   
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   +P +   + L      +    +DLL  ML LDPSKR TA EAL   +
Sbjct: 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  192 bits (491), Expect = 1e-59
 Identities = 111/303 (36%), Positives = 160/303 (52%), Gaps = 28/303 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKH 58
           RY  L  +  G YG V  A D+ TG  V +KK+    P  S        RE+ LLK + H
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHAKRTYRELRLLKHMDH 73

Query: 59  ENIVRLLNV---QSSVDSID---LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V    SS++      LV   +  DL + +K +  ++ +   I+  ++QIL G
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDD--HIQFLVYQILRG 130

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS  I+HRDLKP+N  ++   + +KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDDEMTGYV---ATRWYRAPEI 186

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETLP 227
           +L    Y+  VD+W+V C  AE++T + LF     PG      L  I +++GTPD E L 
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLF-----PGSDHIDQLKRIMNLVGTPDEELLQ 241

Query: 228 GFTSFS-EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             +S S   +     + P KD   V  G  P  +DLL +ML LDP KR+TA EAL H Y 
Sbjct: 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Query: 287 KDF 289
            ++
Sbjct: 302 AEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  187 bits (476), Expect = 4e-58
 Identities = 103/289 (35%), Positives = 158/289 (54%), Gaps = 8/289 (2%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  LE + EG Y  V++    + G  V +K I  M   EGVP + IRE SLLK LKH NI
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  + +++  VFE +  DL  +M   P    +P  ++ ++ Q+L G+AY H Q I
Sbjct: 66  VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI    ++ K+ADFGLAR   +P + Y+ +  +L Y+ P+ LLG+  YS+
Sbjct: 125 LHRDLKPQNLLISYLGEL-KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 182 PVDVWAVACTFAEMVTHQRLFH-SRWAPGLLAAIFSIMGTPDSETLPGFT---SFSEEFG 237
            +D+W   C F EM+  Q  F         L  I++++G P  +T PG +   ++  E+ 
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  ++ +   +    P   DL  +ML + P  R++A++AL H YF
Sbjct: 244 LPCKPQQLRVVWKRLSRP-PKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  185 bits (473), Expect = 6e-57
 Identities = 93/308 (30%), Positives = 163/308 (52%), Gaps = 24/308 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           RY  +E I  G YG V  A D+ +G  V +KKIP  +  +    +   +RE+ +L+  KH
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIP--HAFDVPTLAKRTLRELKILRHFKH 63

Query: 59  ENIVRLLNVQSS----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           +NI+ + ++          + +V + ++ DL H + ++  +T+    I+ +L+Q+L G+ 
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEE--HIRYFLYQLLRGLK 121

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAP 170
           Y HS  ++HRDLKP+N L++   ++ +I DFG+AR +      +    T    +  Y+AP
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCEL-RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E LL    Y+T +D+W+V C FAEM+  ++LF  +     L  I S++G+P  E L    
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240

Query: 231 S-----FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           S     + +     P + P+   + +     P+ +DLL +ML  DP +R+T  +AL+H +
Sbjct: 241 SDRVRKYIQNL---PRKQPV-PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 286 FKDFQSLD 293
              +   D
Sbjct: 297 LAQYHDPD 304

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (462), Expect = 9e-57
 Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 3/202 (1%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           + EG +G V+ A D  TG  V +K I     S  +   ++RE+ +LK+L H NIV+L  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 68  QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
               + + LV E  +   L   +K E     +  +I + L QIL G+ Y HS  I+HRDL
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVW 186
           KP N L+D     VK+ADFGL++ +           G+  Y APE LLG G YS   D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 187 AVACTFAEMVTHQRLFHSRWAP 208
           ++     E+   + L       
Sbjct: 179 SLGVILYELPELKDLIRKMLQK 200

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  184 bits (467), Expect = 1e-56
 Identities = 116/299 (38%), Positives = 162/299 (54%), Gaps = 22/299 (7%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  LE + EG Y  V++    + G  V +K I  +   EG P + IRE SLLK LKH NI
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKGLKHANI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  + +++ LVFE +  DL  +M   P    +P  +K +L Q+L G++Y H + I
Sbjct: 66  VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYI 124

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI  + ++ K+ADFGLAR   VP   Y+ +  +L Y+ P+ LLGS  YST
Sbjct: 125 LHRDLKPQNLLISDTGEL-KLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAAIFSIMGTPDSETLPGFTSFSEE 235
            +D+W V C F EM+     F     PG+      L  IF ++GTP+ +T PG  S    
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF-----PGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH- 237

Query: 236 FGFEPNRSPI---KDLATVVGGLE--PDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             F+P R  +   K+L      L       DL  ++L   P  RL+A+ AL HEYF D 
Sbjct: 238 --FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  184 bits (469), Expect = 2e-56
 Identities = 109/308 (35%), Positives = 161/308 (52%), Gaps = 42/308 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHE 59
           RY  L  I EG YG V  A    TG  V +KKI P  + +       +RE+ +L+  KHE
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKHE 63

Query: 60  NIVRLLNVQ--SSVDS---IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NI+ +L++    S +S   + +V E ++ DL   +KT+     +   I+ +L+QIL G+ 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH---IQYFLYQILRGLK 120

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC-------Y 167
           Y HS  +LHRDLKP+N L++ + D +KI DFGLAR I  P  ++T   G L        Y
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLAR-IADPEHDHT---GFLTEYVATRWY 175

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTPD 222
           +APE +L S  Y+  +D+W+V C  AEM++++ LF     PG      L  I  ++GTP 
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLILGVLGTPS 230

Query: 223 SETLPGFTS-----FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
            E L    S     + +   F+P          +    +P  +DLL +ML  +P KR+T 
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVP----WNKLFPNADPKALDLLDKMLTFNPHKRITV 286

Query: 278 REALRHEY 285
            EAL H Y
Sbjct: 287 EEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  180 bits (457), Expect = 3e-55
 Identities = 110/296 (37%), Positives = 161/296 (54%), Gaps = 18/296 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           +Y  +  I  G YG V++A D  +G  V +K + +    +G+P S +REV+LLK L+   
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 58  HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H NIVRL++V ++  +     + LVFE++D DL  ++   P        IK  + Q L G
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAP 170
           + + H+  I+HRDLKP N L+  S   VK+ADFGLAR     + L    +   +L Y+AP
Sbjct: 121 LDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVV---TLWYRAP 176

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P   
Sbjct: 177 EVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +      F P R P + + +VV  +E  G  LL  ML  +P KR++A  AL+H +F
Sbjct: 236 TLPRG-AFSP-RGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  178 bits (455), Expect = 4e-55
 Identities = 86/292 (29%), Positives = 139/292 (47%), Gaps = 38/292 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +T  E++  G +G+V+ A D  TG+ + VK + +   SE    ++ RE+ +L  L+H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 61  IVRLL--NVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           IVR          +++++  E +    L   +K    +      I+KY  QIL G+AY H
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL--PEPVIRKYTRQILEGLAYLH 118

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLAR---PIDVPLENYTIKGGSLCYKAPERLL 174
           S  I+HRD+K AN L+D S  +VK+ADFG A+    I+      +++ G+  + APE ++
Sbjct: 119 SNGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVR-GTPYWMAPE-VI 175

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               Y    D+W++ CT  EM T +  +        +AA++ I  + +   +P     SE
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSE--LGNPMAALYKIGSSGEPPEIP--EHLSE 231

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           E                         D LR+ L  DP KR TA E L+H + 
Sbjct: 232 E-----------------------AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  180 bits (457), Expect = 9e-55
 Identities = 106/297 (35%), Positives = 155/297 (52%), Gaps = 21/297 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKH 58
           RY  L+ +  G +G V  A D LTG  V +KKI  M P  +  +     RE+ LLK L+H
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 59  ENIVRLLNV-QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           ENI+ L ++  S ++ I  V E L  DL   + + P        I+ +L+QIL G+ Y H
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVH 125

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S  ++HRDLKP+N LI+ + D+ KI DFGLAR  D  +  Y     +  Y+APE +L   
Sbjct: 126 SAGVVHRDLKPSNILINENCDL-KICDFGLARIQDPQMTGYV---STRYYRAPEIMLTWQ 181

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS-----F 232
           +Y   VD+W+  C FAEM+  + LF  +      + I  ++GTP  + +    S     F
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            +     P R P+   +      +P  +DLL +ML  DP KR++A EAL H Y   +
Sbjct: 242 VQSL---PKREPVP-FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  177 bits (452), Expect = 2e-54
 Identities = 100/292 (34%), Positives = 151/292 (51%), Gaps = 13/292 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L ++ EG YG V +     TG  V +KK       + V    +RE+ +LK+L+HEN
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V L+ V      + LVFE +D  +L  ++  P    +  +++KYL QIL G+ +CHS  
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRD+KP N L+ +S  +VK+ DFG AR +  P E YT    +  Y+APE L+G  +Y 
Sbjct: 121 IIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT--PDSETLPGFTSFSEEFGF 238
             VD+WAV C   EM+T + LF        L  I   +G   P  + +     F +   F
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-----FQKNPLF 234

Query: 239 EPNRSP----IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              R P    I+ L      L    +DL ++ L +DP  R ++ + L HE+F
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  175 bits (446), Expect = 2e-53
 Identities = 101/296 (34%), Positives = 147/296 (49%), Gaps = 21/296 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVI-----REVSLLKE 55
           +Y  L  I EG YG V +  +  TG  V +KK      SE  P  VI     RE+ +LK+
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDP--VIKKIALREIRMLKQ 56

Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           LKH N+V L+ V      + LVFE  D  +L+ ++  P        IKK + Q L  V +
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNF 115

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           CH    +HRD+KP N LI +    +K+ DFG AR +  P ++YT    +  Y+APE L+G
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS-FSE 234
             +Y  PVDVWA+ C FAE++T Q L+  +     L  I   +G    + +P     FS 
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQIFST 230

Query: 235 EFGFE----PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              F+    P     + L +    +    +  L+  L +DP++RL+  E L H YF
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  176 bits (447), Expect = 5e-53
 Identities = 112/299 (37%), Positives = 164/299 (54%), Gaps = 13/299 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L+ +  G YG+V  A D  TG+ V +KK+     SE       RE++LLK ++HEN
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDL-LHFMKTE-PTVTKNPL---KIKKYLHQILHGVAY 115
           ++ LL+V +S  S D   E  DF L + +M+T+   +  +PL   K++  ++Q+L G+ Y
Sbjct: 76  VIGLLDVFTSAVSGD---EFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            HS  I+HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE +L 
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCEL-KILDFGLARHADAEMTGYVV---TRWYRAPEVILN 188

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
              Y+  VD+W+V C  AEM+T + LF  +     L  I  + G P  E +      + +
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248

Query: 236 FGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
              +   + P KD +T+     P  VDLL +ML LD  KRLTA EAL H YF  F+  D
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  171 bits (435), Expect = 2e-51
 Identities = 98/302 (32%), Positives = 157/302 (51%), Gaps = 29/302 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           +Y  ++ I  G YG V  A +S T + V +KKI   N  +    +   +RE+ LL+ L H
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDH 63

Query: 59  ENIVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           EN++ + ++     + + + + +V+E +D DL   +++  T++ +    + +L+Q+L G+
Sbjct: 64  ENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDD--HCQYFLYQLLRGL 121

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            Y HS  +LHRDLKP+N L++ + D+ KI DFGLAR      +  T    +  Y+APE L
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDL-KICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
           L    Y+T +DVW+V C FAE++  + LF  +     L  I  ++G+P  E L       
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL------- 233

Query: 234 EEFGFEPN---------RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
             F               +P +  A +     P  +DLL +ML  DPSKR+T  EAL H 
Sbjct: 234 -GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Query: 285 YF 286
           Y 
Sbjct: 293 YL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  167 bits (425), Expect = 2e-50
 Identities = 105/298 (35%), Positives = 153/298 (51%), Gaps = 29/298 (9%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKK-IPIMNPSEGVPSSVIREVSLLKELK-HE 59
           Y +L  I EG +  V +A    TG    +K         E V +   RE+  L+ L  H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHP 58

Query: 60  NIVRLLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
           NI+RL+ V        + LVFE +D +L   +K      K PL   ++K Y++Q+L  + 
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR----KRPLPEKRVKSYMYQLLKSLD 114

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           + H   I HRD+KP N LI    DI+K+ADFG  R I      YT    +  Y+APE LL
Sbjct: 115 HMHRNGIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLL 171

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTPDSETLPGF 229
             G Y   +D+WAV C F E+++   LF     PG      +A I  ++GTPD+E L  F
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLF-----PGTNELDQIAKIHDVLGTPDAEVLKKF 226

Query: 230 T-SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             S    + F P++     L  ++     +G+DLL+++L  DP +R+TA++ALRH YF
Sbjct: 227 RKSRHMNYNF-PSKKGT-GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  167 bits (425), Expect = 8e-50
 Identities = 105/307 (34%), Positives = 155/307 (50%), Gaps = 28/307 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L+ +  G YG V  A D  TG  V +KK+     SE       RE+ LLK +KHEN
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   S+D      LV   +  DL   MK E        +I+  ++Q+L G+ 
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED---RIQFLVYQMLKGLK 132

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y H+  I+HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE +L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQTDSEMTGYVV---TRWYRAPEVIL 188

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               Y+  VD+W+V C  AEM+T + LF        L  I  + GTP  E       F +
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-------FVQ 241

Query: 235 EFGFEPNRSPI--------KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +   E  ++ +        KD  +++    P  V++L +ML LD   R+TA EAL H YF
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Query: 287 KDFQSLD 293
           ++F   +
Sbjct: 302 EEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  164 bits (415), Expect = 5e-49
 Identities = 107/295 (36%), Positives = 156/295 (52%), Gaps = 15/295 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D   G   V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 58  -HENIVRLLNV--QSSVD---SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
            H N+VRL +V   S  D    + LVFE++D DL  ++   P        IK  + Q+L 
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           G+ + HS  ++HRDLKP N L+  S  I K+ADFGLAR     +   ++   +L Y+APE
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVV-VTLWYRAPE 179

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
            LL S  Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P   +
Sbjct: 180 VLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  F       + +   V  ++  G DLL + L  +P+KR++A  AL H YF
Sbjct: 239 LPRQ-AFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  160 bits (406), Expect = 5e-47
 Identities = 107/302 (35%), Positives = 159/302 (52%), Gaps = 18/302 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 75

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 132

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 188

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L   +S 
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248

Query: 233 SEEFGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
           S     +   + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308

Query: 292 LD 293
            D
Sbjct: 309 PD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  159 bits (404), Expect = 8e-47
 Identities = 95/297 (31%), Positives = 155/297 (52%), Gaps = 15/297 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKELK- 57
           RY L++ + +G YG V  A ++ T +  TV +KKI  +   + +    +RE+ LL+  + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 58  HENIVRLLNVQ----SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H+NI  L ++      + + + L  E ++ DL   +++   +T      + +++QIL G+
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTD--AHFQSFIYQILCGL 118

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV-PLEN---YTIKGGSLCYKA 169
            Y HS  +LHRDLKP N L++ +   +KI DFGLAR     P EN    T    +  Y+A
Sbjct: 119 KYIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE +L    Y+  +DVW+V C  AE++  + +F  +     L  I  ++GTPD ETL   
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 230 TSFS-EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            S   + +       P K   ++     P  +DLL ++L  DP+KR++  EAL H Y
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  157 bits (398), Expect = 7e-46
 Identities = 101/318 (31%), Positives = 160/318 (50%), Gaps = 46/318 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L  +  G  G V  A DS     V VKKI + +P        +RE+ +++ L H+N
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDN 63

Query: 61  IVRLLNV--------------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           IV++  V               + ++S+ +V E ++ DL + ++  P   ++    + ++
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH---ARLFM 120

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---- 162
           +Q+L G+ Y HS  +LHRDLKPAN  I+    ++KI DFGLAR +D    +Y+ KG    
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD---PHYSHKGYLSE 177

Query: 163 --GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---------LL 211
              +  Y++P  LL    Y+  +D+WA  C FAEM+T + LF      G         +L
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF-----AGAHELEQMQLIL 232

Query: 212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP 271
            ++  +     +E L    SF    G EP R P++DL   + G+ P+ +D L ++L  +P
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEP-RRPLRDL---LPGVNPEALDFLEQILTFNP 288

Query: 272 SKRLTAREALRHEYFKDF 289
             RLTA EAL H Y   +
Sbjct: 289 MDRLTAEEALMHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  157 bits (398), Expect = 8e-46
 Identities = 97/304 (31%), Positives = 155/304 (50%), Gaps = 15/304 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY + EVI +G YG V  A D+ TG+ V +KKI  +       + ++RE+ LL+ L+H +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 61  IVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           IV + ++     +     I +VFE ++ DL   +K    +T    +   +L+Q+L  + Y
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF--FLYQLLRALKY 118

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENY-TIKGGSLCYKAPER 172
            H+  + HRDLKP N L + +   +KI DFGLAR    D P   + T    +  Y+APE 
Sbjct: 119 IHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 176

Query: 173 LLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           L GS   +Y+  +D+W++ C FAE++T + LF  +     L  I  ++GTP  ET+    
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236

Query: 231 SF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           +  +  +     +      +      +P  + LL R+L  DP  R TA EAL   YFK  
Sbjct: 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296

Query: 290 QSLD 293
             ++
Sbjct: 297 AKVE 300

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  157 bits (398), Expect = 8e-46
 Identities = 100/300 (33%), Positives = 153/300 (51%), Gaps = 14/300 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L  +  G YG+V  A+D+     V VKK+     S        RE+ LLK +KHEN
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   SI+      LV   +  DL + +K +    ++   ++  ++Q+L G+ 
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH---VQFLIYQLLRGLK 132

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  I+HRDLKP+N  ++   ++ +I DFGLAR  D  +  Y     +  Y+APE +L
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCEL-RILDFGLARQADDEMTGYV---ATRWYRAPEIML 188

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               Y+  VD+W+V C  AE++  + LF        L  I  ++GTP  E L   +S   
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248

Query: 235 EFGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
               +     P +DL  +  G  P  +DLL +ML LD  KR++A EAL H YF  +   +
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  153 bits (387), Expect = 5e-44
 Identities = 81/304 (26%), Positives = 128/304 (42%), Gaps = 32/304 (10%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHE- 59
           Y +L  + EG +G V+ A D      V +K +   +          +RE+ +L  L H  
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 60  NIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTK-NPLKIKKYLHQILHGVAYCH 117
           NIV+L +      S+ LV E +D   L   +K        +  +    L QIL  + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG------GSLCYKAPE 171
           S+ I+HRD+KP N L+DR   +VK+ DFGLA+ +  P    +I        G+  Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 172 RLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
            LLG      S+  D+W++  T  E++T    F         +    I+    + +L   
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            S S                     +     DLL+++L  DP  RL++   L H+     
Sbjct: 239 LSPSNP-----------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281

Query: 290 QSLD 293
           +  +
Sbjct: 282 KLKE 285

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 8e-43
 Identities = 89/293 (30%), Positives = 145/293 (49%), Gaps = 46/293 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y L ++I  G +G V++  +  TGD V +K+I +    E    S+++E+ LLK LKH N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKN--PLK---IKKYLHQILHGVAY 115
           IV+ +    + DS+ ++ E  +   L        + K   P     +  Y++Q+L G+AY
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLR------QIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 116 CHSQEILHRDLKPANFLIDRSKD-IVKIADFGLA-RPIDVPLENYTIKGGSLCYKAPERL 173
            H Q ++HRD+K AN L   +KD +VK+ADFG+A +  DV  ++ ++  G+  + APE +
Sbjct: 115 LHEQGVIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVI 171

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
             SG  ST  D+W++ CT  E++T    ++    P  +AA+F I    D   LP     S
Sbjct: 172 EMSGA-STASDIWSLGCTVIELLTGNPPYYDL-NP--MAALFRI-VQDDHPPLP--EGIS 224

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            E                         D L +    DP+ R TA++ L+H + 
Sbjct: 225 PEL-----------------------KDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  149 bits (377), Expect = 2e-42
 Identities = 103/290 (35%), Positives = 155/290 (53%), Gaps = 25/290 (8%)

Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKHENIVRLLNVQ 68
           G +G V    D   G  V +KK+P  N  + + S   V RE+ +L   KH+N++  L++ 
Sbjct: 11  GAFGVVWSVTDPRDGKRVALKKMP--NVFQNLVSCKRVFRELKMLCFFKHDNVLSALDIL 68

Query: 69  SSVDSIDLVFENLDFDLLHFMKTE---PTVTKNPLK---IKKYLHQILHGVAYCHSQEIL 122
                ID  FE + + +   M+++     V+  PL    +K +L+QIL G+ Y HS  IL
Sbjct: 69  QPPH-IDP-FEEI-YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYS 180
           HRD+KP N L++ S  ++KI DFGLAR ++ P E  + T +  +  Y+APE L+GS  Y+
Sbjct: 126 HRDIKPGNLLVN-SNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           + VD+W+V C FAE++  + LF ++     L  I  ++GTP   +L    S  E      
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP---SLEAMRSACEGARAHI 240

Query: 241 NRSPIKD-----LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            R P K      L T+      + V LL RML  DP KR++A +AL H Y
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  145 bits (368), Expect = 3e-42
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 38/283 (13%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP---SEGVPSSVIREVSLLKELKHENIV 62
           E++  G +G+V+   +   GD   VK++ + +     +     + +E++LL +L+H NIV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           + L  +   D++ +  E +    L  +  +      P+ I+ Y  QIL G+ Y H +  +
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-IRLYTRQILLGLEYLHDRNTV 124

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRYS 180
           HRD+K AN L+D +  +VK+ADFG+A+ +   +E    K   GS  + APE +   G Y 
Sbjct: 125 HRDIKGANILVD-TNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
              D+W++ CT  EM T +  +        +AA+F I  + +   LP             
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKE---LP------------- 221

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
              PI D       L  +  D + + L  DPS R TA E L H
Sbjct: 222 ---PIPD------HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  145 bits (366), Expect = 1e-41
 Identities = 90/289 (31%), Positives = 144/289 (49%), Gaps = 6/289 (2%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ +L V+ EG YG V +     T + V +KK      +E V  + +RE+ +L+ LK EN
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L         + LVFE ++ ++L  ++  P     P K++ Y++Q++  + +CH  +
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP-PEKVRSYIYQLIKAIHWCHKND 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYTIKGGSLCYKAPERLLGSGRY 179
           I+HRD+KP N LI    D++K+ DFG AR +      NYT    +  Y++PE LLG+  Y
Sbjct: 121 IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PY 178

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG-- 237
              VD+W+V C   E+   Q LF        L  I  ++G   +E +  F S     G  
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           F     P       +G L    +DL++ +L L+P+ R    + L H  F
Sbjct: 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  144 bits (365), Expect = 3e-41
 Identities = 106/317 (33%), Positives = 165/317 (52%), Gaps = 46/317 (14%)

Query: 8   IREGRYGAVHRAH--DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +  G YG V++A   D        +K+I       G+  S  RE++LL+ELKH N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVIALQ 64

Query: 66  NV--QSSVDSIDLVFENLDFDLLHFMK--TEPTVTKNPLK-----IKKYLHQILHGVAYC 116
            V    S   + L+F+  + DL H +K        K P++     +K  L+QIL G+ Y 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 117 HSQEILHRDLKPANFLI-----DRSKDIVKIADFGLARPIDVPLE---NYTIKGGSLCYK 168
           H+  +LHRDLKPAN L+     +R +  VKIAD G AR  + PL+   +      +  Y+
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGR--VKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR---------WAPGLLAAIFSIMG 219
           APE LLG+  Y+  +D+WA+ C FAE++T + +FH R         +    L  IFS+MG
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242

Query: 220 TP------DSETLPGFTSFSEEF--GFEPNRSPIKDLATVVGGLEPDG--VDLLRRMLCL 269
            P      D   +P + +  ++F      N S IK +      ++PD     LL+++L +
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK--HKVKPDSKVFLLLQKLLTM 300

Query: 270 DPSKRLTAREALRHEYF 286
           DP+KR+T+ +AL+  YF
Sbjct: 301 DPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  142 bits (360), Expect = 5e-41
 Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 56/296 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y +++ I +G +G V+       G   V+K+I + N SE      + EV +LK+L H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLD-FDLLHFMK---------TEPTVTKNPLKIKKYLHQIL 110
           I++          + +V E  D  DL   +K          E        +I  +  Q+ 
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-------QILDWFVQLC 113

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---- 166
             + Y HS++ILHRD+KP N  +  S  +VK+ DFG+++     L +      ++     
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLT-SNGLVKLGDFGISK----VLSSTVDLAKTVVGTPY 168

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y +PE L  +  Y+   D+W++ C   E+ T +  F       L   I  + G      +
Sbjct: 169 YLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQYPP--I 223

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
           P  + +S E                         +L+  +L  DP +R +  + L+
Sbjct: 224 P--SQYSSEL-----------------------RNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  144 bits (366), Expect = 6e-41
 Identities = 103/328 (31%), Positives = 150/328 (45%), Gaps = 70/328 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++TG  V +KK+  P  N +        RE+ L+K + H
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA--KRAYRELVLMKLVNH 74

Query: 59  ENIVRLLNV---QSSVDS---IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV   Q S++    + LV E +D +L   ++ +     +  ++   L+Q+L G
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCG 130

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC------ 166
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR            G S        
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLAR----------TAGTSFMMTPYVV 179

Query: 167 ---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-----WAPGLLAAIFSIM 218
              Y+APE +LG G Y   VD+W+V C   EM+    LF        W       I   +
Sbjct: 180 TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW-----NKIIEQL 233

Query: 219 GTPDS--------------ETLPGFT--SFSEEFG---FEPNRSPIKDLATVVGGLEPDG 259
           GTP                E  P +   SF E F    F P+      L           
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR----- 288

Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYFK 287
            DLL +ML +DP KR++  +AL+H Y  
Sbjct: 289 -DLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  141 bits (356), Expect = 5e-40
 Identities = 103/315 (32%), Positives = 163/315 (51%), Gaps = 42/315 (13%)

Query: 8   IREGRYGAVHRAH--DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +  G YG V++A   D        +K+I       G+  S  RE++LL+ELKH N++ L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 64

Query: 66  NV-QSSVD-SIDLVFENLDFDLLHFMK--TEPTVTKNPLK-----IKKYLHQILHGVAYC 116
            V  S  D  + L+F+  + DL H +K        K P++     +K  L+QIL G+ Y 
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 117 HSQEILHRDLKPANFLI-----DRSKDIVKIADFGLARPIDVPLE---NYTIKGGSLCYK 168
           H+  +LHRDLKPAN L+     +R +  VKIAD G AR  + PL+   +      +  Y+
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGR--VKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR---------WAPGLLAAIFSIMG 219
           APE LLG+  Y+  +D+WA+ C FAE++T + +FH R         +    L  IF++MG
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 220 TP------DSETLPGFTSFSEEF--GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP 271
            P      D + +P  ++  ++F      N S IK +       +     LL+++L +DP
Sbjct: 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302

Query: 272 SKRLTAREALRHEYF 286
            KR+T+ +A++  YF
Sbjct: 303 IKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  137 bits (346), Expect = 7e-39
 Identities = 86/295 (29%), Positives = 128/295 (43%), Gaps = 42/295 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           R+     I  G +G V+ A +  TG+ + VK+I I +        +  E+ +L+ LKH N
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +V+   V+   + + +  E        +LL   +           I+ Y  Q+L G+AY 
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-----IRVYTLQLLEGLAYL 115

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFG----LARPIDVPLENYTIKGGSLCYKAPER 172
           HS  I+HRD+KPAN  +D +  ++K+ DFG    L        E      G+  Y APE 
Sbjct: 116 HSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 173 LLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           + G     +    D+W++ C   EM T +R +        L   F IM            
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE------LDNEFQIM------------ 216

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            F    G +P   PI D       L P+G D L R L  DP KR TA E L+H +
Sbjct: 217 -FHVGAGHKP---PIPDSLQ----LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (340), Expect = 4e-38
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 48/292 (16%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + +LE I +G +G V++A    TG  V +K I + +  +     +I E+ +LK+ KH NI
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKIINEIQILKKCKHPNI 59

Query: 62  VRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLK---IKKYLHQILHGVA 114
           V+        D + +V E        DLL         T   L    I     ++L G+ 
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLK-------STNQTLTESQIAYVCKELLKGLE 112

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA-RPIDVPLENYTIKGGSLCYKAPERL 173
           Y HS  I+HRD+K AN L+    + VK+ DFGL+ +  D    N  +  G+  + APE +
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVI 169

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
            G   Y    D+W++  T  E+    +  +S   P  + A+F I  T     L     +S
Sbjct: 170 NG-KPYDYKADIWSLGITAIELAE-GKPPYSELPP--MKALFKIA-TNGPPGLRNPEKWS 224

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           +EF                        D L++ L  +P KR TA + L+H +
Sbjct: 225 DEF-----------------------KDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  129 bits (325), Expect = 5e-35
 Identities = 102/314 (32%), Positives = 151/314 (48%), Gaps = 47/314 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A D++ G  V VKK+  P  N +        RE+ LLK + H
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA--KRAYRELVLLKCVNH 79

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      LV E +D +L   +  E     +  ++   L+Q+L G
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME----LDHERMSYLLYQMLCG 135

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP--IDVPLENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR    +  +  Y +   +  Y+AP
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAP 191

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   E+V    +F           +   +GTP +E +    
Sbjct: 192 EVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250

Query: 227 -------------PG--FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP 271
                        PG  F     ++ F P+ S    L T          DLL +ML +DP
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIF-PSESERDKLKT------SQARDLLSKMLVIDP 303

Query: 272 SKRLTAREALRHEY 285
            KR++  EALRH Y
Sbjct: 304 DKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  124 bits (313), Expect = 5e-34
 Identities = 84/297 (28%), Positives = 143/297 (48%), Gaps = 49/297 (16%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR--------EVSLLKELK 57
           E+I +G YG V+ A +  TG+ + VK++ +     G   S  +        E+  LK+L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 58  HENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H NIV+ L  +++ + + +  E     ++   L  + + E  +      ++ +  Q+L G
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL------VRFFTEQVLEG 120

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID---VPLENYTIKGGSLCYKA 169
           +AY HS+ ILHRDLK  N L+D +  I KI+DFG+++  D      +N +++ GS+ + A
Sbjct: 121 LAYLHSKGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMA 178

Query: 170 PERLLGSGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
           PE +    + YS  VD+W++ C   EM   +R +    A   +AA+F +           
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKL----------- 224

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   G + +  PI     V   L P  +D L     ++P  R TARE L+H +
Sbjct: 225 --------GNKRSAPPIPP--DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 8e-34
 Identities = 86/285 (30%), Positives = 128/285 (44%), Gaps = 41/285 (14%)

Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELKHENIVRLLN 66
           +G +G V+  +D  TG  + VK++P    S      V     E+ LLK L+HE IV+   
Sbjct: 12  QGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71

Query: 67  VQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRD 125
                +++ +  E +    +   +K    +T+     +KY  QIL GV Y HS  I+HRD
Sbjct: 72  CLRDDETLSIFMEYMPGGSVKDQLKAYGALTET--VTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 126 LKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIKG--GSLCYKAPERLLGSGRYSTP 182
           +K AN L D S   VK+ DFG ++ +  +      +K   G+  + +PE + G G Y   
Sbjct: 130 IKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRK 187

Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
            DVW+V CT  EM+T +      WA    +AAIF I   P +  LP              
Sbjct: 188 ADVWSVGCTVVEMLTEK----PPWAEFEAMAAIFKIATQPTNPQLP-------------- 229

Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                        + PD  + LRR    +  KR +A E LRH + 
Sbjct: 230 -----------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (310), Expect = 1e-33
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           TL + + EG +G V++             V VK +   + SE      +RE  ++++L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASEQQIEEFLREARIMRKLDH 60

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-KTEPTVTKNPLKIKKYLHQILHGVAYC 116
            N+V+LL V +  + + +V E ++  DLL ++ K  P ++     +  +  QI  G+ Y 
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS--LSDLLSFALQIARGMEYL 118

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLL 174
            S+  +HRDL   N L+     +VKI+DFGL+R +    + Y  +GG L  +  APE L 
Sbjct: 119 ESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESLK 176

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
             G++++  DVW+      E+ T
Sbjct: 177 -EGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 2e-33
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           TL + + EG +G V++             V VK +   + SE      +RE  ++++L H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDH 60

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            NIV+LL V +  + + +V E +   DLL +++       +   +  +  QI  G+ Y  
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLG 175
           S+  +HRDL   N L+     +VKI+DFGL+R +    + Y +KGG L  +  APE L  
Sbjct: 121 SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLK- 177

Query: 176 SGRYSTPVDVWAVACTFAEMVT 197
            G++++  DVW+      E+ T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  124 bits (311), Expect = 4e-33
 Identities = 102/315 (32%), Positives = 154/315 (48%), Gaps = 49/315 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 75

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 131

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLD 270
           P   ++ E      NR     L      L PD +                DLL +ML +D
Sbjct: 247 PTVRNYVE------NRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 271 PSKRLTAREALRHEY 285
           P+KR++  EAL+H Y
Sbjct: 299 PAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (305), Expect = 9e-33
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 32/287 (11%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           V+ +G  G V++     TG    +KKI + +  E     ++RE+  L+  +   +V+   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 67  VQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHR 124
                  I +V E +D   L   +K    + +  L       QIL G+ Y H++  I+HR
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--YIARQILKGLDYLHTKRHIIHR 124

Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVD 184
           D+KP+N LI+ SK  VKIADFG+++ ++  L+      G++ Y +PER+ G   YS   D
Sbjct: 125 DIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAAD 182

Query: 185 VWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSP 244
           +W++  T  E    +  F     P     + +I   P   +LP    FS EF        
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-PPSLPA-EEFSPEF-------- 232

Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                           D +   L  DP KR +A E L+H + K   +
Sbjct: 233 ---------------RDFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  122 bits (306), Expect = 3e-32
 Identities = 95/309 (30%), Positives = 148/309 (47%), Gaps = 37/309 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 227 ----------PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT 276
                     P +  +S E  F     P       +   +    DLL +ML +D SKR++
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ--ARDLLSKMLVIDASKRIS 311

Query: 277 AREALRHEY 285
             EAL+H Y
Sbjct: 312 VDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  115 bits (291), Expect = 9e-31
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            L + + EG +G V++         T   V VK +     SE      + E S++K+L H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE-GASEEEREEFLEEASIMKKLSH 60

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            NIVRLL V +  + + +V E +   DLL F++           + +   QI  G+ Y  
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL-QMALQIAKGMEYLE 119

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLL 174
           S+  +HRDL   N L+  +  +VKI+DFGL+R I    + Y  +GG  L  K  APE L 
Sbjct: 120 SKNFVHRDLAARNCLVTENL-VVKISDFGLSRDIY-EDDYYRKRGGGKLPIKWMAPESLK 177

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
             G++++  DVW+      E+ T
Sbjct: 178 D-GKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (290), Expect = 2e-30
 Identities = 85/289 (29%), Positives = 127/289 (43%), Gaps = 36/289 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  LE I EG  G V++A D  TG  V +KK+ +   ++     +I E+ ++K+ KH NI
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNI 77

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V   +     D + +V E +D   L  + T+  V  N  +I     ++L G+ Y HSQ +
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRD+K  N L+      VK+ADFG A  +           G+  + APE +     Y  
Sbjct: 138 IHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGP 195

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM--GTPDSETLPGFTSFSEEFGFE 239
            VD+W++     EM   +   + R  P  L A+F I   G P    L     +S EF   
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP-YLREPP--LRALFLITTKGIPP---LKNPEKWSPEF--- 246

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                                D L + L  DP KR +A E L+H + K 
Sbjct: 247 --------------------KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  117 bits (294), Expect = 4e-30
 Identities = 90/308 (29%), Positives = 146/308 (47%), Gaps = 36/308 (11%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L  +I  G +G V+ A    T + V +KK+ + +P         RE+ ++K L H NI
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKN-----RELLIMKNLNHINI 121

Query: 62  VRLLN------VQSSVDSI--DLVFENLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILH 111
           + L +       + +  +I  ++V E +   +  +MK             +K Y +Q+  
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-----LC 166
            +AY HS+ I HRDLKP N LID +   +K+ DFG A+          +  G      +C
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------NLLAGQRSVSYIC 232

Query: 167 ---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
              Y+APE +LG+  Y+T +D+W++ C  AEM+    +F  + +   L  I  ++GTP  
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVV-GGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
           + L        +  F P+  P KDL  V   G   D ++ + + L  +P KRL   EAL 
Sbjct: 293 DQLKEMNPNYADIKF-PDVKP-KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350

Query: 283 HEYFKDFQ 290
             +F D +
Sbjct: 351 DPFFDDLR 358

Length = 440

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (283), Expect = 9e-30
 Identities = 80/294 (27%), Positives = 145/294 (49%), Gaps = 49/294 (16%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-------GVPSSVIREVSLLKELKHE 59
           +I  G +G+V+   ++ +G+ + VK++ + + S         +  ++ RE++LLKEL+HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NIV+ L      D +++  E +    +  +       +  L ++ ++ QIL G+ Y H++
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-VRNFVRQILKGLNYLHNR 125

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG------GSLCYKAPERL 173
            I+HRD+K AN L+D +K  +KI+DFG+++ ++    +    G      GS+ + APE +
Sbjct: 126 GIIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL--LAAIFSIMGTPDSETLPGFTS 231
           +    Y+   D+W++ C   EM+T +  F     P    L AIF I G   S  +P  ++
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPF-----PDCTQLQAIFKI-GENASPEIP--SN 235

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            S E                        +D L +   +D +KR TA E L+H +
Sbjct: 236 ISSE-----------------------AIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  112 bits (281), Expect = 2e-29
 Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 51/298 (17%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS----EGVPSSVIREVSLLKELKHENI 61
           + +  G + + ++A D  TG  + VK++  +  +    E V  ++ +E+ L+  L H +I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +R+L         +L  E +    +  + ++    K  + I  Y  Q+L G++Y H  +I
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLHENQI 124

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---------GSLCYKAPER 172
           +HRD+K AN LID +   ++IADFG A  +          G         G++ + APE 
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARL-----AAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI---MGTPDSETLPGF 229
           L G  +Y    DVW+V C   EM T +  +++      LA IF I      P        
Sbjct: 180 LRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS------- 231

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                +   L P   D+  R L L P  R  +RE L+H  F+
Sbjct: 232 ---------------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  110 bits (277), Expect = 9e-29
 Identities = 73/219 (33%), Positives = 104/219 (47%), Gaps = 17/219 (7%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           V+ +G YG V+ A D  T   + +K+IP  +     P  +  E++L   LKH NIV+ L 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRNIVQYLG 72

Query: 67  VQSSVDSIDLVFENL---DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
             S      +  E +       L   K  P        I  Y  QIL G+ Y H  +I+H
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLHDNQIVH 131

Query: 124 RDLKPANFLIDRSKDIVKIADFG----LARPIDVPLENYTIKGGSLCYKAPERLLGSGR- 178
           RD+K  N L++    +VKI+DFG    LA  I+   E +T   G+L Y APE +    R 
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAG-INPCTETFT---GTLQYMAPEVIDKGPRG 187

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
           Y  P D+W++ CT  EM T +  F     P   AA+F +
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKV 224

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-28
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 6   EVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           + + EG +G V++          T V VK +   + SE      ++E  ++K+L H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE-DASEEERKDFLKEARVMKKLGHPNVV 59

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTE----PTVTKNPLKIK---KYLHQILHGVA 114
           RLL V +  + + LV E ++  DLL +++      P+  K+ L +K    +  QI  G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APER 172
           Y  S++ +HRDL   N L+     +VKI+DFGL+R +          GG L  +  APE 
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVT 197
           L   G +++  DVW+      E+ T
Sbjct: 179 LK-DGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (269), Expect = 1e-27
 Identities = 76/291 (26%), Positives = 129/291 (44%), Gaps = 45/291 (15%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + +LE + EG YG+V++A    TG  V +K +P+    +     +I+E+S+LK+     I
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ----EIIKEISILKQCDSPYI 60

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMK-TEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           V+          + +V E      +   MK T  T+T+   +I   L+Q L G+ Y HS 
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE--EIAAILYQTLKGLEYLHSN 118

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + +HRD+K  N L++  +   K+ADFG++  +   +       G+  + APE +   G Y
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-Y 176

Query: 180 STPVDVWAVACTFAEMVT----HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
           +   D+W++  T  EM      +  +   R       AIF I   P   TL     +S E
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFMIPNKP-PPTLSDPEKWSPE 228

Query: 236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           F                        D +++ L  DP +R +A + L+H + 
Sbjct: 229 F-----------------------NDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (270), Expect = 1e-27
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 26/221 (11%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +LE I +G +G V +      G  +V K+I   N +E     ++ EV++L+ELKH NI
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 62  VRLLN--VQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKY---------LHQI 109
           VR  +  +  S  ++ +V E  +  DL         + +   K +KY         L Q+
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDL-------AQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 110 LHGVAYCH-----SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           L  +  CH        +LHRDLKPAN  +D + + VK+ DFGLA+ +           G+
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             Y +PE  L    Y    D+W++ C   E+      F +R
Sbjct: 174 PYYMSPE-QLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  106 bits (266), Expect = 5e-27
 Identities = 76/310 (24%), Positives = 120/310 (38%), Gaps = 65/310 (20%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELK-HENI 61
           ++I EG +  V  A +  T     +K   K  ++   E     V  E  +L  L  H  I
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 62  VRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           ++L       +++  V E   + +LL +++   ++  +    + Y  +IL  + Y HS+ 
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYLHSKG 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC-------------- 166
           I+HRDLKP N L+D+   I KI DFG A+ +D      + KG +                
Sbjct: 123 IIHRDLKPENILLDKDMHI-KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 167 ------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
                 Y +PE LL         D+WA+ C   +M+T +  F           I  +   
Sbjct: 182 FVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL--- 237

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA--- 277
                         E+ F PN               PD  DL+ ++L LDP  RL     
Sbjct: 238 --------------EYSFPPN-------------FPPDAKDLIEKLLVLDPQDRLGVNEG 270

Query: 278 -REALRHEYF 286
             E   H +F
Sbjct: 271 YDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-26
 Identities = 85/299 (28%), Positives = 132/299 (44%), Gaps = 58/299 (19%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-----E 59
           L+ I +G +G+V+ A    TGD   +K +     S+ +  + +  V   + +        
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLK---KSDMIAKNQVTNVKAERAIMMIQGESP 57

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAY 115
            + +L     S D + LV E L+  D    +KT        L     K+Y+ +++ GV  
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVED 112

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            H + I+HRD+KP N LID++  + K+ DFGL+R     LEN     G+  Y APE +LG
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHL-KLTDFGLSR---NGLENKKFV-GTPDYLAPETILG 167

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS---ETLPGFTSF 232
            G      D W++ C   E +     FH+               TPD+     L    ++
Sbjct: 168 VGD-DKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPDAVFDNILSRRINW 212

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA---REALRHEYFKD 288
            EE               V     P+ VDL+ R+LC+DP+KRL A   +E   H +FK 
Sbjct: 213 PEE---------------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  101 bits (253), Expect = 2e-25
 Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 46/295 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHD--SLTGDTV-VVKKIPI--MNPSEGVPSSVIREVSLLKE 55
           RY L + + +G +G V+   D  ++  + + V+K+IP+  +NP+E V ++   E  LL +
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSK 58

Query: 56  LKHENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
           L H  IV+        D+  ++ E     +LD  L     T  T+++N  ++ ++  Q+L
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLL 116

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            GV Y H + ILHRDLK  N  +    +++KI DFG++R +    +  T   G+  Y +P
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L   G Y +  D+W++ C   EM     L H+      L+ +  I+  P + +LP   
Sbjct: 175 EALKHQG-YDSKSDIWSLGCILYEMCC---LAHAFEGQNFLSVVLRIVEGP-TPSLP--- 226

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              E +  + N                    +++ ML  DPS R +A E LR+ +
Sbjct: 227 ---ETYSRQLNS-------------------IMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  101 bits (253), Expect = 2e-25
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 58/297 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  + V+  G +G VH          V++K+IP+   ++    +   E  +LK L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENL--DFDLLHFMKTEPTVT--------KNPL----KIKKYL 106
           I+               +EN   D  L+  M+  P  T         N L     I  + 
Sbjct: 61  IIEY-------------YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
            QIL  + + H++ ILHRDLK  N L+D+ K +VKI DFG+++ +    + YT+  G+ C
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPC 166

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y +PE L     Y+   D+WA+ C   E+ + +R F +   P L+  I S  GT      
Sbjct: 167 YISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GT------ 217

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                           +PI D  +      PD   L+  ML LDPSKR    + +  
Sbjct: 218 ---------------FAPISDRYS------PDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 5e-25
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y L++ I  G YG V++A D  TG+ V +K I  + P +     + +E+S+LKE +H N
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDF-EIIQQEISMLKECRHPN 61

Query: 61  IVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHG 112
           IV         D + +V E     +L  D+         VT+ PL    I     + L G
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQ-------VTRGPLSELQIAYVCRETLKG 113

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           +AY H    +HRD+K AN L+    D VK+ADFG++  +   +       G+  + APE 
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172

Query: 173 LL--GSGRYSTPVDVWAVACTFAEM 195
                 G Y    D+WA+  T  E+
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  100 bits (250), Expect = 6e-25
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 50/289 (17%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELKHEN 60
           + + + I +G++  V++A   L G  V +KK+ I    +       ++E+ LLK+L H N
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMK-------TEPTVTKNPLKIKKYLHQILHG 112
           +++ L      + +++V E  D  DL   +K         P  T     I KY  Q+   
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT-----IWKYFVQLCSA 118

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YK 168
           + + HS+ I+HRD+KPAN  I  +  +VK+ D GL R       + T    SL     Y 
Sbjct: 119 LEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYM 173

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
           +PER+  +G Y+   D+W++ C   EM   Q  F+       L ++   +   D   LP 
Sbjct: 174 SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPA 230

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
              +SEE                         DL+ R +  DP KR   
Sbjct: 231 -DHYSEELR-----------------------DLVSRCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 51/297 (17%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLN 66
           I +G YG V  A    TGD   +K I   +   +     V+ E  +L + +   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 67  VQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                 ++ LV E L       LL  + +           + Y+ +I+  + Y HS  I+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-----ARIYIAEIVLALEYLHSNGII 115

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLA------RPIDVPLENYTIKG--GSLCYKAPERLL 174
           HRDLKP N LID +  + K+ DFGL+      R I++  +    K   G+  Y APE +L
Sbjct: 116 HRDLKPDNILIDSNGHL-KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
           G G +S  VD W++ C   E +     FH                TP+ E      +   
Sbjct: 175 GQG-HSKTVDWWSLGCILYEFLVGIPPFH--------------GETPE-EIFQNILNGKI 218

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR---EALRHEYFKD 288
           E+  +   S              + +DL+ ++L  DP KRL A+   E   H +FK 
Sbjct: 219 EWPEDVEVS-------------DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 82/265 (30%), Positives = 126/265 (47%), Gaps = 35/265 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELKH 58
           + L +++  G +G V+  +D+ TG  + VK++P    S+     V     E+ LLK L+H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFM---------KTEPTVTKNPLKIKKYLHQI 109
           + IV+        +   L         + +M         K    +T+N    ++Y  QI
Sbjct: 64  DRIVQYYGCLRDPEEKKLSI------FVEYMPGGSIKDQLKAYGALTEN--VTRRYTRQI 115

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIKG--GSLC 166
           L GV+Y HS  I+HRD+K AN L D + + VK+ DFG ++ I  + +    IK   G+  
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSET 225
           + +PE + G G Y    DVW+VACT  EM+T +      WA    +AAIF I   P    
Sbjct: 175 WMSPEVISGEG-YGRKADVWSVACTVVEMLTEK----PPWAEYEAMAAIFKIATQPTKPM 229

Query: 226 LP-GFTS----FSEEFGFEPNRSPI 245
           LP G +     F ++   E  R P 
Sbjct: 230 LPDGVSDACRDFLKQIFVEEKRRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.0 bits (239), Expect = 2e-23
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + +L+ + +G YG+V++           +K++ + + S+      + E+ +L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 61  IVRLLNVQSSVDSIDL--VFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAY 115
           I+     ++ +D   L  V E   F  L    ++    +  +    I +   Q+L G+  
Sbjct: 61  IISY--KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            H Q+ILHRDLK AN L+  + D+VKI D G+++ +   +    I  G+  Y APE  + 
Sbjct: 119 LHEQKILHRDLKSANILL-VANDLVKIGDLGISKVLKKNMAKTQI--GTPHYMAPE--VW 173

Query: 176 SGR-YSTPVDVWAVACTFAEMVTHQRLFHSR 205
            GR YS   D+W++ C   EM T    F +R
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.6 bits (238), Expect = 2e-23
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 56/294 (19%)

Query: 1   RYTLLEVIREGRYG-AV--HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
            Y  + V+ +G +G A    R  D      VV K++ +   SE      + E+ +L  L+
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTED---DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57

Query: 58  HENIVRLLNVQSSVDSIDLVFE-------NLDFDLLHFMKT---EPTVTKNPLKIKKYLH 107
           H NI+   N    +D   L+ E        L   ++        E  V         YL 
Sbjct: 58  HPNIIAYYN--HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-------YLF 108

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
           QI+  V+Y H   ILHRD+K  N  + ++  ++K+ DFG+++ +           G+  Y
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYY 167

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
            +PE   G  +Y+   D+WA+ C   E++T +R F    A   L  +  I+         
Sbjct: 168 MSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKIV--------- 214

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                      + N +P      VV     + + L+  +L  DP KR TA E L
Sbjct: 215 -----------QGNYTP------VVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 95.5 bits (237), Expect = 3e-23
 Identities = 80/252 (31%), Positives = 121/252 (48%), Gaps = 42/252 (16%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR----EVSLLKELK 57
           + L +++ +G +G V+  +D+ TG  + VK++   +P     S  +     E+ LLK L 
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLL 62

Query: 58  HENIVR----LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVT-KNPLK---------IK 103
           HE IV+    L +      SI             FM+  P  + K+ LK          +
Sbjct: 63  HERIVQYYGCLRDPMERTLSI-------------FMEHMPGGSIKDQLKSYGALTENVTR 109

Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIKG 162
           KY  QIL GV+Y HS  I+HRD+K AN L D   + VK+ DFG ++ +  + L    +K 
Sbjct: 110 KYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQTICLSGTGMKS 168

Query: 163 --GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMG 219
             G+  + +PE + G G Y    D+W+V CT  EM+T +      WA    +AAIF I  
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEK----PPWAEFEAMAAIFKIAT 223

Query: 220 TPDSETLPGFTS 231
            P +  LP   S
Sbjct: 224 QPTNPVLPPHVS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 95.0 bits (236), Expect = 4e-23
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 37/288 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  + V+ +G YG V        G   V+KK+ + N S     +  +E  LL +LKH NI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 62  VRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           V         D   L++  + F    DL H +K +        ++ ++  QI   + Y H
Sbjct: 62  VAYRESWEGEDG--LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
            + ILHRDLK  N  + R+ +I+K+ D G+AR ++   +  +   G+  Y +PE L  + 
Sbjct: 120 EKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNK 177

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
            Y+   DVWA+ C   EM T +  F+++    L+  I       + +  P    +S E G
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------EGKLPPMPKDYSPELG 231

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                                  +L+  ML   P KR + +  LR  Y
Sbjct: 232 -----------------------ELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 2e-22
 Identities = 82/297 (27%), Positives = 132/297 (44%), Gaps = 58/297 (19%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKI---PIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +++ +G +G V+  +D  TG  +  K++   P    +    S++  E+ LLK L+HE IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPT-VTKNPLK---------IKKYLHQILHG 112
           +             + +  +  L  FM+  P    K+ LK          +KY  QIL G
Sbjct: 68  QYYGC---------LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG 118

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIKG--GSLCYKA 169
           ++Y HS  I+HRD+K AN L D + + VK+ DFG ++ +  + +    I+   G+  + +
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPG 228
           PE + G G Y    DVW++ CT  EM+T +      WA    +AAIF I   P +  LP 
Sbjct: 178 PEVISGEG-YGRKADVWSLGCTVVEMLTEK----PPWAEYEAMAAIFKIATQPTNPQLPS 232

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
             S                             D L  +  ++   R +A E LRH +
Sbjct: 233 HIS-------------------------EHARDFLGCIF-VEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 2e-22
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 52/252 (20%)

Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLK 101
            + E ++L  + H  IV+L     + + + LV   L++    +L   +  E   ++   +
Sbjct: 40  TLTERNILSRINHPFIVKLHYAFQTEEKLYLV---LEYAPGGELFSHLSKEGRFSEE--R 94

Query: 102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
            + Y  +I+  + Y HS  I++RDLKP N L+D    I K+ DFGLA+     L +   +
Sbjct: 95  ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI-KLTDFGLAK----ELSSEGSR 149

Query: 162 GGSLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
             + C    Y APE LLG G Y   VD W++     EM+T +  F++     +   I   
Sbjct: 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK- 207

Query: 218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
               D    P F S                         P+  DL+  +L  DP+KRL +
Sbjct: 208 ----DPLRFPEFLS-------------------------PEARDLISGLLQKDPTKRLGS 238

Query: 278 REA---LRHEYF 286
             A     H +F
Sbjct: 239 GGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (229), Expect = 8e-22
 Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 65/303 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +TLLE I +G +G V++A D  T   V +K I +    + +   + +E+  L + +   
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPY 60

Query: 61  IVRLLNVQSSVDSIDL--VFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           I +     S +    L  + E        DLL   K + T       I   L ++L G+ 
Sbjct: 61  ITKYYG--SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY------IAFILREVLLGLE 112

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG----GSLCYKAP 170
           Y H +  +HRD+K AN L+    D VK+ADFG++      L +   K     G+  + AP
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGD-VKLADFGVS----GQLTSTMSKRNTFVGTPFWMAP 167

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVT----HQRLFHSRWAPGLLAAIFSIMGTPDSE-- 224
           E +  SG Y    D+W++  T  E+         L H       +  +F I   P +   
Sbjct: 168 EVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDL-HP------MRVLFLI---PKNNPP 216

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
           +L G   FS+ F                        D +   L  DP +R +A+E L+H+
Sbjct: 217 SLEG-NKFSKPFK-----------------------DFVSLCLNKDPKERPSAKELLKHK 252

Query: 285 YFK 287
           + K
Sbjct: 253 FIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.3 bits (227), Expect = 1e-21
 Identities = 83/305 (27%), Positives = 120/305 (39%), Gaps = 60/305 (19%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L+EVI  G    V+ A      + V +K+I +      V   + +EV  + +  H N+
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNV 61

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLK------IKKYLHQILHGVA 114
           V+        D + LV   L    LL  MK+       P        I   L ++L G+ 
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKS-----SYPRGGLDEAIIATVLKEVLKGLE 116

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFG----LARPIDVPLENYTIKGGSLCYKAP 170
           Y HS   +HRD+K  N L+      VKIADFG    LA   D   +      G+ C+ AP
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGS-VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT-----PDSET 225
           E +     Y    D+W+   T  E+ T    +           +  +M T     P  ET
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSK------YPPMKVLMLTLQNDPPSLET 229

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRM--LCL--DPSKRLTAREAL 281
              +  +S+ F                           R+M  LCL  DPSKR TA E L
Sbjct: 230 GADYKKYSKSF---------------------------RKMISLCLQKDPSKRPTAEELL 262

Query: 282 RHEYF 286
           +H++F
Sbjct: 263 KHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 3e-21
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 9/200 (4%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--- 58
           Y  LE+I  G YGAV+R     TG  V +K I +  P + V S + REV+LL +L+    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQP 61

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            NI +          + ++ E  +   +   MK  P   K    I   + ++L  + Y H
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---ISVIIREVLVALKYIH 118

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
              ++HRD+K AN L+  + + VK+ DFG+A  ++      +   G+  + APE +    
Sbjct: 119 KVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 178 RYSTPVDVWAVACTFAEMVT 197
            Y T  D+W++  T  EM T
Sbjct: 178 YYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 89.7 bits (222), Expect = 5e-21
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELKHENIVRLLN 66
           I  G++  V+RA   L    V +KK+ I    +       ++E+ LLK+L H N+++ L+
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 67  VQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
                + +++V E     +L   + +F K +  + +    + KY  Q+   V + HS+ +
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER--TVWKYFVQLCSAVEHMHSRRV 127

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRD+KPAN  I  +  +VK+ D GL R             G+  Y +PER+  +G Y+ 
Sbjct: 128 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNF 185

Query: 182 PVDVWAVACTFAEMVTHQRLFHS 204
             D+W++ C   EM   Q  F+ 
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 75/309 (24%), Positives = 123/309 (39%), Gaps = 42/309 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT+++ +  G  G V  A      D VV+K         G   + + E  LL+ + H ++
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSV 119

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHF--MKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +R+ +   S     +V  +   DL  +   ++ P      L I+K   QIL G+ Y H+Q
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK---QILEGLRYLHAQ 176

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPERLLGSGR 178
            I+HRD+K  N  I+   D V I D G A+ P+  P   +    G++   APE +L   +
Sbjct: 177 RIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPE-VLARDK 232

Query: 179 YSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIM-----------------GT 220
           Y++  D+W+      EM+ +   +F    +                              
Sbjct: 233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVG-GLEPDGVDLLRRMLCLDPSKRLTARE 279
           P S  + GF  ++        R P           L  DG  L+ +ML  D + R +A E
Sbjct: 293 PGSRLVRGFIEYA-----SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE 347

Query: 280 ALRHEYFKD 288
            L +  F  
Sbjct: 348 ILNYPMFAQ 356

Length = 357

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 76/303 (25%), Positives = 118/303 (38%), Gaps = 64/303 (21%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELK 57
           + LL VI +G +G V       T     +K    MN  +    G   +V+ E  +L+EL 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMK---YMNKQKCVEKGSVRNVLNERRILQELN 58

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF----DL-LHFMK----TEPTVTKNPLKIKKYLHQ 108
           H  +V   N+  S    + ++  +D     DL  H  +    +E  V       K ++ +
Sbjct: 59  HPFLV---NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-------KFWICE 108

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           I+  + Y HS+ I+HRD+KP N L+D  +  V I DF +A     P    T   G+  Y 
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIAT-KVTPDTLTTSTSGTPGYM 166

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF--HSRWAPGLLAAIFSIMGTPDSETL 226
           APE L   G YS  VD W++  T  E +  +R +  HSR     + A           T 
Sbjct: 167 APEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                                          + +D + ++L  DP KRL        +  
Sbjct: 226 S-----------------------------TEAIDAINKLLERDPQKRLGD----NLKDL 252

Query: 287 KDF 289
           K+ 
Sbjct: 253 KNH 255

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 2e-20
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 2/205 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +++ I EG +G ++ A      +  V+K+I +         +  +EV LL ++KH N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           IV           + +V E  D  DL+  +  +  V  +  +I  +  QI  G+ + H +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +ILHRD+K  N  + ++  + K+ DFG+AR ++  +E      G+  Y +PE +  +  Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE-ICQNRPY 179

Query: 180 STPVDVWAVACTFAEMVTHQRLFHS 204
           +   D+W++ C   E+ T +  F  
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 2e-20
 Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 44/288 (15%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + +L  I +G +G V +           +K+I +   +       I E  +L +L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 62  VRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +R          +++V E     +L   LL   +  P        + ++  QIL G+A+ 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLH-KLLKMQRGRPLPEDQ---VWRFFIQILLGLAHL 117

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLL 174
           HS++ILHRD+K  N  +D   D VKI D G+A+ +     N+  TI G    Y +PE L 
Sbjct: 118 HSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLS-DNTNFANTIVGTPY-YLSPE-LC 173

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               Y+   DVWA+     E  T +  F +     L+  I  I G               
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGV-------------- 217

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
              F P          V          L+ + L  D  +R    + LR
Sbjct: 218 ---FPP----------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 58/180 (32%), Positives = 94/180 (52%), Gaps = 17/180 (9%)

Query: 28  VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL-DFDLL 86
           V VK    + P    P + ++E  ++K+L+H+ +V+L  V S  + I +V E +    LL
Sbjct: 33  VAVK---TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89

Query: 87  HFMKTEPTVTKNPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA 143
            F+K+        L++ + +    QI  G+AY  S+  +HRDL   N L+     + KIA
Sbjct: 90  DFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIA 145

Query: 144 DFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
           DFGLAR I+   + YT + G+   + + APE     GR++   DVW+      E+VT+ R
Sbjct: 146 DFGLARLIED--DEYTAREGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 86.2 bits (213), Expect = 8e-20
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 10/202 (4%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELKHENIVRLLN 66
           I  G++  V+RA   L G  V +KK+ I +  +    +  I+E+ LLK+L H N+++   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 67  VQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
                + +++V E     +L   + HF K +  + +    + KY  Q+   + + HS+ +
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK--TVWKYFVQLCSALEHMHSRRV 127

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRD+KPAN  I  +  +VK+ D GL R             G+  Y +PER+  +G Y+ 
Sbjct: 128 MHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNF 185

Query: 182 PVDVWAVACTFAEMVTHQRLFH 203
             D+W++ C   EM   Q  F+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 10  EGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EG +G V           TG+ V VK +      E   S   RE+ +L+ L HENIV+  
Sbjct: 14  EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDHENIVKYK 72

Query: 66  NVQSSV--DSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
            V       S+ L+ E L    L  +++           +  +  QI  G+ Y  SQ  +
Sbjct: 73  GVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKGMDYLGSQRYI 131

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRY 179
           HRDL   N L++ S+D+VKI+DFGLA+ +    + Y +K  G S + + APE L  S ++
Sbjct: 132 HRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KF 189

Query: 180 STPVDVWAVACTFAEMVTHQRLFHS 204
           S+  DVW+   T  E+ T+     S
Sbjct: 190 SSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 57/298 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS-----VIREVSLLKE 55
            +T L  I  G +GAV+ A D  T + V +KK   M+ S G  S+     +I+EV  L++
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKK---MSYS-GKQSNEKWQDIIKEVRFLQQ 71

Query: 56  LKHENIVRLLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQI 109
           L+H N +          +  LV E       D+L        V K PL+   I    H  
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE-------VHKKPLQEVEIAAICHGA 124

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           L G+AY HS E +HRD+K  N L+      VK+ADFG A  +  P  ++    G+  + A
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSASLVS-PANSFV---GTPYWMA 179

Query: 170 PERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           PE +L    G+Y   VDVW++  T  E+   +    +  A   ++A++ I    DS TL 
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHI-AQNDSPTLS 235

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
               +S+ F                        + +   L   P  R ++ E L+H +
Sbjct: 236 S-NDWSDYF-----------------------RNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 4e-19
 Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR- 63
           L  + EG  G+V +     TG  +   K    +P+  +   ++RE+ + K  K   IV+ 
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTG-MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 64  ---LLNVQSSVDSIDLVF---ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
               L+  SS   I + +    +LD       K    + +  L   K    +L G++Y H
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG--KIAESVLKGLSYLH 122

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S++I+HRD+KP+N L+ R K  VK+ DFG++  +   L   T  G S  Y APER+ G  
Sbjct: 123 SRKIIHRDIKPSNILLTR-KGQVKLCDFGVSGELVNSLAG-TFTGTSF-YMAPERIQG-K 178

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL----LAAIFSIMGTPDSETLPGFT-SF 232
            YS   DVW++  T  E+  ++  F     P L    L +    M  P+ +  PG    +
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           SEEF                        D +++ L  DP++R T  + L H + K  
Sbjct: 239 SEEFK-----------------------DFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.6 bits (206), Expect = 9e-19
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 10  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 125 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 180

Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRV 202

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.4 bits (206), Expect = 1e-18
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 5   LEVIREGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           + V+ EG +G V    +   +  TG+ V VK +      +   S   +E+++LK L HEN
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHEN 67

Query: 61  IVRLLNVQSSV--DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           IV+     S      + L+ E +    L      P    N  ++  +  QI  G+AY HS
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSL--RDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPERLLGS 176
           Q  +HRDL   N L+D  + +VKI DFGLA+ +    E Y ++  G S  +      L  
Sbjct: 126 QHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++S   DVW+   T  E++TH
Sbjct: 185 NKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPS--------SVIREVSL 52
           Y +LE +  G +G V++      G  ++ +K+I + NP+ G            ++ EV++
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 53  LKE-LKHENIVRLLNVQSSVDSIDLVFENLDFDLL--HF--MKTEPTVTKNPLKIKKYLH 107
           +KE L+H NIVR        D + +V + ++   L  HF  +K E        +I     
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFV 120

Query: 108 QILHGVAYCHSQE-ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           Q++  + Y H ++ I+HRDL P N ++    D V I DFGLA+    P    T   G++ 
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQ-PESKLTSVVGTIL 178

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
           Y  PE ++ +  Y    DVWA  C   +M T Q  F+S
Sbjct: 179 YSCPE-IVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.0 bits (205), Expect = 1e-18
 Identities = 55/176 (31%), Positives = 94/176 (53%), Gaps = 11/176 (6%)

Query: 32  KIPIMNPSEGV--PSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL-DFDLLHF 88
           K+ I +  +G   P + + E +L+K+L+H  +VRL  V +  + I ++ E + +  L+ F
Sbjct: 32  KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 90

Query: 89  MKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA 148
           +KT   +     K+     QI  G+A+   +  +HRDL+ AN L+  +    KIADFGLA
Sbjct: 91  LKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC-CKIADFGLA 149

Query: 149 RPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL 201
           R I+     YT + G+   + + APE  +  G ++   DVW+      E+VT+ R+
Sbjct: 150 RLIED--NEYTAREGAKFPIKWTAPEA-INYGTFTIKSDVWSFGILLTEIVTYGRI 202

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVV---VKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           + + +G +G V R   S +G  V+   VK +     S+ +    ++E +++  L HEN++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLH---QILHGVAYCHS 118
           RL  V  +   + +V E      LL  ++ +         I        QI +G+ Y  S
Sbjct: 60  RLYGVVLT-HPLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLES 115

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI---KGGSLCYKAPERLLG 175
           +  +HRDL   N L+  S D VKI DFGL R +    ++Y +         + APE  L 
Sbjct: 116 KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES-LR 173

Query: 176 SGRYSTPVDVWAVACTFAEMVTH 198
           +  +S   DVW    T  EM T+
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTY 196

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 25/206 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVP----SSVIREVSLLKELK 57
           + +L  + +G YG V  A    TG+ V +K    M  S          V+ E  +L   K
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALK---RMKKSLLFKLNEVRHVLTERDILTTTK 59

Query: 58  HENIVRLLNVQSSVDSIDLVFENL---DFDLLHFMKTEPTVTKNPLK---IKKYLHQILH 111
            E +V+LL      + + L  E +   DF  L             L     + Y+ ++  
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTL-------LNNLGVLSEDHARFYMAEMFE 112

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V   H    +HRDLKP NFLID S  I K+ DFGL++ I V   N  +  GS  Y APE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHI-KLTDFGLSKGI-VTYANSVV--GSPDYMAPE 168

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            L G G Y   VD W++ C   E + 
Sbjct: 169 VLRGKG-YDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.2 bits (201), Expect = 5e-18
 Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 38/294 (12%)

Query: 5   LEVIRE---GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           LE + E   G  G V +     TG  + VK I +   +E +   ++RE+ +L +     I
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQKQILRELDILHKCNSPYI 61

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-E 120
           V       +   I +  E +D   L  +  E         + K    +L G+ Y H + +
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRD+KP+N L++ S+  +K+ DFG++  +   L    +  G+  Y APER+ G+  YS
Sbjct: 122 IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFV--GTSSYMAPERIQGND-YS 177

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG---TPDSETLPGFTSFSEEFG 237
              D+W++  +  E+ T  R  +          IF ++          LP    FS +F 
Sbjct: 178 VKSDIWSLGLSLIELAT-GRFPYPPENDPPD-GIFELLQYIVNEPPPRLPS-GKFSPDF- 233

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                                  D +   L  DP +R + +E L H + K ++S
Sbjct: 234 ----------------------QDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 6e-18
 Identities = 57/186 (30%), Positives = 94/186 (50%), Gaps = 15/186 (8%)

Query: 13  YGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD 72
           Y  +HR     TG    +K I   N  + V   + RE+ +L+++ H N+V+  ++     
Sbjct: 91  YKVIHRP----TGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145

Query: 73  SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
            I ++ E +D   L     E T   +   +     QIL G+AY H + I+HRD+KP+N L
Sbjct: 146 EIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200

Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL---LGSGRYSTPV-DVWAV 188
           I+ S   VKIADFG++R +   ++      G++ Y +PER+   L  G Y     D+W++
Sbjct: 201 IN-SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259

Query: 189 ACTFAE 194
             +  E
Sbjct: 260 GVSILE 265

Length = 353

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.6 bits (199), Expect = 8e-18
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 12/201 (5%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +TL   +  G +G V      L  + V V    + +          +EV  LK L+H+++
Sbjct: 8   FTLERKLGSGYFGEVWEG---LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           + L  V S  + + ++ E ++   LL F+++          +     Q+  G+AY   Q 
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124

Query: 121 ILHRDLKPANFLIDRSKDIV-KIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSG 177
            +HRDL   N L+   +D+V K+ADFGLAR I   +  Y      + YK  APE     G
Sbjct: 125 SIHRDLAARNILVG--EDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEA-ASHG 179

Query: 178 RYSTPVDVWAVACTFAEMVTH 198
            +ST  DVW+      EM T+
Sbjct: 180 TFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 83/296 (28%), Positives = 127/296 (42%), Gaps = 53/296 (17%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS-----VIREVSLLKELKHEN 60
           EV+ +G YG V+    +  G  + VK++  ++ S  + +      +  EV LLK LKH N
Sbjct: 6   EVLGKGAYGTVYCGLTN-QGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 61  IVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           IV+ L      ++I +  E     ++   L  F      V        KY  QIL GVAY
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV------FCKYTKQILDGVAY 117

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT----IKG--GSLCYKA 169
            H+  ++HRD+K  N ++     I+K+ DFG AR +     + T    +K   G+  + A
Sbjct: 118 LHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE +  SG Y    D+W++ CT  EM T +    S      LAA+F I G          
Sbjct: 177 PEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASM---DRLAAMFYI-GAHRGLMPRLP 231

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            SFS                          +D +   L  D  +R +A + LRH++
Sbjct: 232 DSFSA-----------------------AAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 39/290 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS-VIREVSLLKELKHE 59
           +YT  E I +G  G V+ A D  TG  V +K+   MN  +      +I E+ +++E KH 
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQ---MNLQQQPKKELIINEILVMRENKHP 76

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NIV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS 
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSN 134

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y
Sbjct: 135 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAY 192

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM--GTPDSETLPGFTSFSEEFG 237
              VD+W++     EMV  +  + +      L A++ I   GTP+   L      S  F 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPE---LQNPEKLSAIFR 246

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                  D L R L +D  KR +A+E L+H + K
Sbjct: 247 -----------------------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
            + L+EVI EG YG V++A    TG  V +K   IM+  E     +  E ++L++   H 
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 60  NIVR------LLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQI 109
           NI          N   + D + LV E        DL+  ++ +    K    I   L + 
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYILRET 122

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           L G+AY H  +++HRD+K  N L+ ++ + VK+ DFG++  +D  L       G+  + A
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 170 PERLLGSGR----YSTPVDVWAVACTFAEM 195
           PE +    +    Y    DVW++  T  E+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.4 bits (198), Expect = 2e-17
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EG +G V    +      TG+ V VK +   +    + + + +E+ +L+ L HENIV+  
Sbjct: 14  EGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVKYK 72

Query: 66  NV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQE 120
            +  +   + I L+ E L    L   K      KN + +K   KY  QI  G+ Y  S++
Sbjct: 73  GICTEDGGNGIKLIMEFLPSGSL---KEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPERLLGSG 177
            +HRDL   N L++ S+  VKI DFGL + I+   E YT+K      + + APE L+ S 
Sbjct: 130 YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 178 RYSTPVDVWAVACTFAEMVTH 198
            Y    DVW+   T  E++T+
Sbjct: 189 FYIAS-DVWSFGVTLYELLTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 33/287 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V  A D  TG  V +K+I +    +     +I E+ ++KELK+ N
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPN 77

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  +  +  +I     + L  + + H+ +
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHANQ 135

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+W++     EMV  +  + +   P     + +  GTP+ +                
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 236

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K        L P   D L R L +D  KR +A+E L+H + K
Sbjct: 237 --NPEK--------LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 80/316 (25%), Positives = 126/316 (39%), Gaps = 88/316 (27%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKELK 57
           +  ++ +  G +G V       +G    +K   I++ ++ V       V+ E  +L+ ++
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALK---ILSKAKIVKLKQVEHVLNEKRILQSIR 59

Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQI 109
           H  +V L        ++ LV E +     F  L     F   EP         + Y  Q+
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF--PEPV-------ARFYAAQV 110

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLC-- 166
           +  + Y HS +I++RDLKP N L+D    I KI DFG A+ +       YT     LC  
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYI-KITDFGFAKRVK---GRTYT-----LCGT 161

Query: 167 --YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
             Y APE +L  G Y   VD W                   WA G+L  I+        E
Sbjct: 162 PEYLAPEIILSKG-YGKAVD-W-------------------WALGIL--IY--------E 190

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGG-------LEPDGVDLLRRMLCLDPSKRL-- 275
            L G+  F ++       +PI+    ++ G         PD  DL+R +L +D +KRL  
Sbjct: 191 MLAGYPPFFDD-------NPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGN 243

Query: 276 ---TAREALRHEYFKD 288
                 +   H +F  
Sbjct: 244 LKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 13/210 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGVPSSVIREVSLLKELKH 58
           +Y  ++ I EG +G          G   V+K+I I  M+P E   S   +EV++L  +KH
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMKH 58

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
            NIV+    Q S +    ++  +D+    DL   +  +  V     +I  +  QI   + 
Sbjct: 59  PNIVQY---QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           + H ++ILHRD+K  N  + +    +K+ DFG+AR ++  +E      G+  Y +PE + 
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
            +  Y+   D+WA+ C   EM T +  F +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)

Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 17  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 71

Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131

Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R   +  + YT   G+   + + APE  L   ++S   D
Sbjct: 132 ARNCLVGENH-LVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 187

Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 188 VWAFGVLLWEIATY 201

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.3 bits (195), Expect = 2e-17
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L++ +  G++G V     +  G+T V   +  + P    P S + E  ++K+L+H+ +V+
Sbjct: 10  LIKKLGNGQFGEVWMG--TWNGNTKVA--VKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V S  + I +V E +    LL F+K  E    K P  +     Q+  G+AY      
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLP-NLVDMAAQVAAGMAYIERMNY 123

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+     + KIADFGLAR I+     YT + G+   + + APE  L  GR
Sbjct: 124 IHRDLRSANILVGDGL-VCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGR 179

Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VT  R+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRV 202

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 9/156 (5%)

Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKK 104
            +RE S++ +L H  IVRL+ V    + + LV E      L  ++K    +      +K+
Sbjct: 43  FLREASVMAQLDHPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPV--SDLKE 99

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
             HQ+  G+AY  S+  +HRDL   N L+  ++   KI+DFG++R +    + Y      
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAG 158

Query: 165 ---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              L + APE  +  G++S+  DVW+   T  E  +
Sbjct: 159 RWPLKWYAPE-CINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 67/203 (33%), Positives = 95/203 (46%), Gaps = 21/203 (10%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHEN 60
           +T L  I  G +GAV+ A D  T + V +KK+      S      +I+EV  L+ +KH N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 61  IVRLLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVA 114
            +          +  LV E       DLL        V K PL+   I    H  L G+A
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLE-------VHKKPLQEVEIAAITHGALQGLA 139

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  ++HRD+K  N L+      VK+ADFG A  I  P  ++    G+  + APE +L
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSAS-IASPANSFV---GTPYWMAPEVIL 194

Query: 175 G--SGRYSTPVDVWAVACTFAEM 195
               G+Y   VDVW++  T  E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 78.7 bits (194), Expect = 3e-17
 Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 18/190 (9%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E I +G +G V++    L G+T V  K         +    ++E  +LK+  H NIV+L+
Sbjct: 1   EKIGKGNFGDVYKG--VLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 66  NVQSSVDSIDLVFE-NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH---GVAYCHSQEI 121
            V      I +V E      LL F++ +    KN L +KK L   L    G+ Y  S+  
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCYKAPERLLGSG 177
           +HRDL   N L+    +++KI+DFG++R  +  +  YT+  G     + + APE  L  G
Sbjct: 115 IHRDLAARNCLVG-ENNVLKISDFGMSREEEGGI--YTVSDGLKQIPIKWTAPEA-LNYG 170

Query: 178 RYSTPVDVWA 187
           RY++  DVW+
Sbjct: 171 RYTSESDVWS 180

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.7 bits (196), Expect = 4e-17
 Identities = 66/200 (33%), Positives = 93/200 (46%), Gaps = 21/200 (10%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVP-SSVIREVSLLKELKHENIVR 63
           L  I  G +GAV+ A +S T + V VKK+             +I+EV  L++LKH N + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 64  LLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCH 117
                    +  LV E       DLL        V K PL+   I    H  L G+AY H
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLE-------VHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG-- 175
           S  ++HRD+K  N L+      VK+ADFG A     P  ++    G+  + APE +L   
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQ-VKLADFGSAS-KSSPANSFV---GTPYWMAPEVILAMD 193

Query: 176 SGRYSTPVDVWAVACTFAEM 195
            G+Y   VDVW++  T  E+
Sbjct: 194 EGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.8 bits (195), Expect = 4e-17
 Identities = 64/302 (21%), Positives = 114/302 (37%), Gaps = 68/302 (22%)

Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQS 69
           G +G V          T  +K +   +  E G    +  E  +L+E  H  IV+L   ++
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL--YRT 61

Query: 70  SVDSIDLVFENLDFDLLHFMKTEPTVTK-------NPLKIKKYLHQILHGVAYCHSQEIL 122
             D   +        L+ +       T        +    + Y+  ++    Y H++ I+
Sbjct: 62  FKDKKYIYM------LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           +RDLKP N L+D S   VK+ DFG A+ +    + +T   G+  Y APE +L  G Y   
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPEIILNKG-YDFS 172

Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR 242
           VD W++     E++T                              G   F      E + 
Sbjct: 173 VDYWSLGILLYELLT------------------------------GRPPFG-----EDDE 197

Query: 243 SPIKDLATVVGGLE---------PDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKD 288
            P++    ++ G               DL++++L  +P +RL       ++  +H++F  
Sbjct: 198 DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257

Query: 289 FQ 290
           F 
Sbjct: 258 FD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 5e-17
 Identities = 54/174 (31%), Positives = 95/174 (54%), Gaps = 11/174 (6%)

Query: 33  IPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT 91
           +  M P      + + E +++K L+H+ +V+L +   + + I ++ E +    LL F+K+
Sbjct: 35  VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKS 93

Query: 92  EPTVTKNPL-KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP 150
           +   +K PL K+  +  QI  G+A+   +  +HRDL+ AN L+  S  + KIADFGLAR 
Sbjct: 94  DEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARV 151

Query: 151 IDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL 201
           I+     YT + G+   + + APE  +  G ++   DVW+      E+VT+ R+
Sbjct: 152 IED--NEYTAREGAKFPIKWTAPEA-INFGSFTIKSDVWSFGILLMEIVTYGRI 202

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 6e-17
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 19/182 (10%)

Query: 28  VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLL 86
           V VK    + P    P   + E  ++K+L+H  +++L  V +  + I +V E + +  LL
Sbjct: 33  VAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89

Query: 87  HFMKTEPTVTKNPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA 143
            +++         LK+ + +    Q+  G+AY  +Q  +HRDL   N L+  + +I K+A
Sbjct: 90  EYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVA 145

Query: 144 DFGLARPIDVPLEN-YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           DFGLAR I    E+ Y  + G+   + + APE  L   R+S   DVW+      E+VT+ 
Sbjct: 146 DFGLARVIK---EDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYG 201

Query: 200 RL 201
           R+
Sbjct: 202 RM 203

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.3 bits (193), Expect = 7e-17
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 3   TLLEVIREGRYGAVHRA---HDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
            L   + EG +G V      H     D   V VK +     ++       RE  LL   +
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-ARKDFEREAELLTNFQ 66

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT---------EPTVTKNPLKIKKYLH 107
           HENIV+   V +  D   +VFE ++  DL  F+++          P      L + + L 
Sbjct: 67  HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 108 ---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
              QI  G+ Y  SQ  +HRDL   N L+     +VKI DFG++R  DV   +Y   GG 
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVG-YDLVVKIGDFGMSR--DVYTTDYYRVGGH 183

Query: 165 ----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
               + +  PE ++   +++T  DVW+      E+ T+ +
Sbjct: 184 TMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.2 bits (192), Expect = 7e-17
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR-EVSLLKELKHEN 60
           Y L++ +  G YG V++A +  TG+   VK   I+    G   S+I+ E+ ++KE KH N
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVK---IIKLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 61  IVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           IV       S + + +  E     +L  D+ H   T P    + L+I     + L G+AY
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQ-DIYHV--TGPL---SELQIAYVCRETLQGLAY 121

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE--RL 173
            HS+  +HRD+K AN L+  + D VK+ADFG+A  I   +       G+  + APE   +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGD-VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQ 199
             +G Y+   D+WAV  T  E+   Q
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 78.3 bits (193), Expect = 9e-17
 Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 37/282 (13%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A D  TG  V VKK+ +          +  EV ++++ +H NIV + + 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   + +   +I      +L  +++ H+Q ++HRD+K
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 128 PANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDV 185
             + L+      VK++DFG    +  +VP     +  G+  + APE ++    Y T VD+
Sbjct: 143 SDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPE-VISRLPYGTEVDI 198

Query: 186 WAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI 245
           W++     EMV                      G P     P   +        P +   
Sbjct: 199 WSLGIMVIEMVD---------------------GEPPYFNEPPLQAMKRIRDNLPPKL-- 235

Query: 246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           K+L  V     P     L RML  DP++R TA E L H +  
Sbjct: 236 KNLHKV----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 1e-16
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 16/202 (7%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIP----IMNPSEGVPSS--VIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP    ++       ++  ++ E  ++  + H
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKV---KIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            ++VRLL +  S   + L+ + +    LL +++           +  +  QI  G++Y  
Sbjct: 69  PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLG 175
            + ++HRDL   N L+ ++   VKI DFGLA+ +DV  + Y  +GG +  K  A E +L 
Sbjct: 127 EKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL- 184

Query: 176 SGRYSTPVDVWAVACTFAEMVT 197
              Y+   DVW+   T  E++T
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 33/287 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 137 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +     ++   +F    
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIFRDF---- 249

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                 L R L +D  KR +A+E L+H++ K
Sbjct: 250 ----------------------LNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)

Query: 33  IPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKT 91
           +  + P      + + E +L+K L+H+ +VRL  V +  + I ++ E +    LL F+K+
Sbjct: 35  VKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS 94

Query: 92  EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI 151
           +        K+  +  QI  G+AY   +  +HRDL+ AN L+  S  + KIADFGLAR I
Sbjct: 95  DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVI 153

Query: 152 DVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL 201
           +     YT + G+   + + APE  +  G ++   DVW+      E+VT+ ++
Sbjct: 154 ED--NEYTAREGAKFPIKWTAPEA-INFGSFTIKSDVWSFGILLYEIVTYGKI 203

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 75/293 (25%), Positives = 118/293 (40%), Gaps = 48/293 (16%)

Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           +G +G V++A    TG     K I I   SE      + E+ +L E KH NIV L     
Sbjct: 15  DGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 70  SVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
             + + ++ E      LD  +L   +  TEP       +I+    Q+L  + + HS +++
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLHSHKVI 125

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N L+    D VK+ADFG++      L+      G+  + APE +        P
Sbjct: 126 HRDLKAGNILLTLDGD-VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 183 ----VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
                D+W++  T  E+       H    P  +  +  I+ + +  TL   + +S  F  
Sbjct: 185 YDYKADIWSLGITLIEL-AQMEPPHHELNP--MRVLLKILKS-EPPTLDQPSKWSSSFN- 239

Query: 239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                                 D L+  L  DP  R TA E L+H +  D   
Sbjct: 240 ----------------------DFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 3e-16
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 33/287 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V +K++ +    +     +I E+ +++E K+ N
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPN 77

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALDFLHSNQ 135

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 136 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+W++     EMV  +  + +   P     + +  GTP+ +               P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQN--------------P 238

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
            R     L+ V         D L R L +D  +R +A+E L+H + K
Sbjct: 239 ER-----LSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 3   TLLEVIREGRYGAVH---------------RAHDSLTGDTVVVKKIPIMNPSEGVPSSVI 47
             +E + EG++G VH                 +D+     +V  K+   + S+      +
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 48  REVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYL 106
           +EV +L  L   NI RLL V +    + ++ E ++  DL  F++     T       K L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 107 H---------QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
                     QI  G+ Y  S   +HRDL   N L+ ++  I KIADFG++R  ++   +
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI-KIADFGMSR--NLYSSD 184

Query: 158 YTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y    G     + + A E +L  G+++T  DVWA   T  E++T
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 16/193 (8%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHEN 60
           T+ +VI  G +G V R    L G   +   I  +    S+      + E S++ +  H N
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 61  IVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+RL  V +    + ++ E     +LD  L      +   T    ++   L  I  G+ Y
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFT--VGQLVGMLRGIASGMKY 121

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG--SLCYKAPERL 173
                 +HRDL   N L++ S  + K++DFGL+R ++     YT KGG   + + APE  
Sbjct: 122 LSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA- 179

Query: 174 LGSGRYSTPVDVW 186
           +   ++++  DVW
Sbjct: 180 IAYRKFTSASDVW 192

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 44/238 (18%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +++ I  GR+G V       T +    K I      E   S ++ EV++++ELKH+NI
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 62  VRLLN------------VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQI 109
           VR ++            +    D+ DL   N+      F K E         I     Q+
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLS-RNIQKCYKMFGKIEEHA------IVDITRQL 127

Query: 110 LHGVAYCHS-------QEILHRDLKPANFLID----------------RSKDIVKIADFG 146
           LH +AYCH+       + +LHRDLKP N  +                   + I KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 147 LARPIDVPLENYTIKGGSLCYKAPERLLGSGR-YSTPVDVWAVACTFAEMVTHQRLFH 203
           L++ I +    ++  G    Y +PE LL   + Y    D+WA+ C   E+ + +  FH
Sbjct: 188 LSKNIGIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244

Length = 1021

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.0 bits (187), Expect = 5e-16
 Identities = 58/191 (30%), Positives = 82/191 (42%), Gaps = 38/191 (19%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +++      IKG  
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN-VRISDLGLA--VELK-GGKKIKGRA 155

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           G+  Y APE L G   Y   VD +A+ CT  EM+  +  F  R                 
Sbjct: 156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRK---------------- 198

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TA 277
                      +E   E  R  ++          P+  DL   +L  DP KRL     +A
Sbjct: 199 -------EKVEKE---ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA 248

Query: 278 REALRHEYFKD 288
            E   H  FKD
Sbjct: 249 DEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 6e-16
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKHEN 60
           T L+ +  G++G VH       G       + I    EG  S    I E  ++ +L H N
Sbjct: 7   TFLKELGSGQFGVVHL------GKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +V+L  V +    I +V E +    LL++++           +      +   + Y  S 
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW-LLDMCSDVCEAMEYLESN 119

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
             +HRDL   N L+    ++VK++DFGLAR   V  + YT   G+   + +  PE +   
Sbjct: 120 GFIHRDLAARNCLVG-EDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPE-VFDY 175

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRW 206
            R+S+  DVW+      E+ +  ++ + R+
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.0 bits (184), Expect = 7e-16
 Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 15/200 (7%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           TL E+I EG +GAV +     TG  V VK I      +    + + E +++ +L H+N+V
Sbjct: 9   TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNLV 62

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           RLL V    + + +V E +   +L++F++T      + +++ ++   +  G+ Y  S+++
Sbjct: 63  RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 122 LHRDLKPANFLIDRSKDIV-KIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +HRDL   N L+  S+D V K++DFGLAR   + ++N  +    + + APE  L   ++S
Sbjct: 122 VHRDLAARNILV--SEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEA-LKHKKFS 175

Query: 181 TPVDVWAVACTFAEMVTHQR 200
           +  DVW+      E+ ++ R
Sbjct: 176 SKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 10  EGRYGAVHRA---HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A   + S T D ++V    + +P+        RE  LL  L+HE+IV+   
Sbjct: 15  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG 74

Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKIKKYLH---QILH 111
           V    D + +VFE +   DL  F++            +P   K  L + + LH   QI  
Sbjct: 75  VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS 134

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCY 167
           G+ Y  SQ  +HRDL   N L+  +  +VKI DFG++R  DV   +Y   GG     + +
Sbjct: 135 GMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRW 191

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
             PE ++   +++T  DVW+      E+ T+ +
Sbjct: 192 MPPESIMYR-KFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 40/192 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I  G+   H + I++RDLKP N L+D    I +I+D GLA  +++P E  TI+G  
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHI-RISDLGLA--VEIP-EGETIRGRV 162

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           G++ Y APE ++ + RY+   D W + C   EM+  +  F  R                 
Sbjct: 163 GTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR----------------- 204

Query: 223 SETLPGFTSFSEEFGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----T 276
                      E+   E   R   +D              + R++L  DP  RL      
Sbjct: 205 ----------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEG 254

Query: 277 AREALRHEYFKD 288
           A E   H +F+ 
Sbjct: 255 AEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 4   LLEVIREGRYGAVHRAH-----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            LE + EG +G V++       + L+  +V +K +   N    V     +E  L+ +L+H
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQH 67

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLH-FM-----------KTEPTVTKNPLKIKKYL 106
            NIV LL V +      ++FE L    LH F+           ++     K+ L    +L
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 107 H---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           H   QI  G+ Y  S   +HRDL   N L+      VKI+DFGL+R I    + Y ++  
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDI-YSADYYRVQSK 185

Query: 164 SLC---YKAPERLLGSGRYSTPVDVWA 187
           SL    +  PE +L  G+++T  D+W+
Sbjct: 186 SLLPVRWMPPEAIL-YGKFTTESDIWS 211

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 5   LEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ + +G +G+V    +D L   TG+ V VKK+              RE+ +LK L+H+N
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--LRDFEREIEILKSLQHDN 66

Query: 61  IVRLLNVQSSV--DSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           IV+   V  S    ++ LV E L +  L  +  K    +     K+  Y  QI  G+ Y 
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR--KLLLYASQICKGMEYL 124

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERL 173
            S+  +HRDL   N L++ S++ VKI DFGL + +    E Y ++  G S + + APE L
Sbjct: 125 GSKRYVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTH 198
             S ++S   DVW+      E+ T+
Sbjct: 184 TES-KFSVASDVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVP-SSVIREVSLLKELKHENIVR 63
           L  I  G +GAV+ A D    + V +KK+             +I+EV  L++L+H N ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 64  LLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCH 117
                    +  LV E       DLL        V K PL+   I    H  L G+AY H
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE-------VHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG-- 175
           S  ++HRD+K  N L+     +VK+ DFG A  I  P   +    G+  + APE +L   
Sbjct: 133 SHNMIHRDVKAGNILLSEP-GLVKLGDFGSAS-IMAPANXFV---GTPYWMAPEVILAMD 187

Query: 176 SGRYSTPVDVWAVACTFAEM 195
            G+Y   VDVW++  T  E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 3e-15
 Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 9/173 (5%)

Query: 33  IPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKT 91
           I  + P   +P + ++E  ++K+L+H+ +V L  V S  + I +V E +    LL F+K 
Sbjct: 35  IKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE 93

Query: 92  EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI 151
                    ++     QI  G+AY      +HRDL+ AN L+  +  + KIADFGLAR I
Sbjct: 94  GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLI 152

Query: 152 DVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL 201
           +     YT + G+   + + APE  L  GR++   DVW+      E+VT  R+
Sbjct: 153 ED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRV 202

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.9 bits (181), Expect = 3e-15
 Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 38/190 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I  G+   H + I++RDLKP N L+D    I +I+D GLA  + VP E  TIKG  
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI-RISDLGLA--VHVP-EGQTIKGRV 162

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           G++ Y APE ++ + RY+   D WA+ C   EM+  Q  F  R        +  ++    
Sbjct: 163 GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TA 277
            E       +SE+F                    PD   L + +LC DP +RL      A
Sbjct: 222 EE-------YSEKF-------------------SPDARSLCKMLLCKDPKERLGCQGGGA 255

Query: 278 REALRHEYFK 287
           RE   H  FK
Sbjct: 256 REVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 6e-15
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 5   LEVIRE---GRYGAVHR--AHDSLTGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           + +IRE   G +G V+   A   + G+  T V  K    N S       + E S++KE  
Sbjct: 8   ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMK-TEPTVTKNPL-------KIKKYLHQ 108
             ++VRLL V S+     +V E +   DL  +++   P    NP        K  +   +
Sbjct: 68  CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---- 164
           I  G+AY  +++ +HRDL   N ++      VKI DFG+ R  D+   +Y  KGG     
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVA-EDLTVKIGDFGMTR--DIYETDYYRKGGKGLLP 184

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           + + APE L   G ++T  DVW+      EM T
Sbjct: 185 VRWMAPESLK-DGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 16/192 (8%)

Query: 3   TLLEVIREGRYGAVHRA-HDSLTGDTVVVK-KIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           TL   I EG++G V++  + S   + + V  K      S  V    ++E  ++++  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYC 116
           IV+L+ V  + + + +V E     +L  +++      K  L +     Y +Q+   +AY 
Sbjct: 69  IVKLIGV-ITENPVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYL 123

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLL 174
            S+  +HRD+   N L+  S D VK+ DFGL+R ++     Y    G L  K  APE  +
Sbjct: 124 ESKRFVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPES-I 180

Query: 175 GSGRYSTPVDVW 186
              R+++  DVW
Sbjct: 181 NFRRFTSASDVW 192

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 38/286 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I  +  +E     + +E+++L +     +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
            +          + ++ E L     L  ++  P    +  +I   L +IL G+ Y HS++
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF---DEFQIATMLKEILKGLDYLHSEK 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGSGRY 179
            +HRD+K AN L+    D VK+ADFG+A  + D  ++  T  G    + APE +  S  Y
Sbjct: 122 KIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSA-Y 178

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
            +  D+W++  T  E+   +                     P+S+  P    F       
Sbjct: 179 DSKADIWSLGITAIELAKGE--------------------PPNSDMHPMRVLF------- 211

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
               P  +  T+ G       + +   L  DPS R TA+E L+H++
Sbjct: 212 --LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 15/188 (7%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L   I +G +G V        G  V VK    +        + + E S++  L+H N+V
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKC---LKDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +LL V    + + +V E +    L+ ++++         +   +   +  G+ Y   +  
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSGRY 179
           +HRDL   N L+     + K++DFGLA+       +     G L  K  APE  L   ++
Sbjct: 124 VHRDLAARNVLVS-EDLVAKVSDFGLAKE-----ASQGQDSGKLPVKWTAPEA-LREKKF 176

Query: 180 STPVDVWA 187
           ST  DVW+
Sbjct: 177 STKSDVWS 184

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.9 bits (173), Expect = 3e-14
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ I  G YG V++A +  TG+   +K I  + P E   + V +E+ ++K+ KH NI
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDF-AVVQQEIIMMKDCKHSNI 68

Query: 62  VRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           V         D + +  E     +L  D+ H   T P    +  +I     + L G+ Y 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQ-DIYHV--TGPL---SESQIAYVSRETLQGLYYL 122

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE--RLL 174
           HS+  +HRD+K AN L+      VK+ADFG++  I   +       G+  + APE   + 
Sbjct: 123 HSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
             G Y+   D+WAV  T  E+   Q
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 57/187 (30%), Positives = 99/187 (52%), Gaps = 13/187 (6%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E++ +G +G V +   +L   T V  K    +  + +    + E  +LK+  H NIV+L+
Sbjct: 1   ELLGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 66  NVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILH---GVAYCHSQEI 121
            V +    I +V E +   D L F++ +    K+ LK K+ +   L    G+AY  S+  
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-IKGGSLCYKAPERLLGSGRYS 180
           +HRDL   N L+  + +++KI+DFG++R  D  + + + +K   + + APE  L  GRYS
Sbjct: 115 IHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEA-LNYGRYS 172

Query: 181 TPVDVWA 187
           +  DVW+
Sbjct: 173 SESDVWS 179

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.4 bits (172), Expect = 3e-14
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 6/206 (2%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y +L V+ EG +G         +     +K+I +   S  V  S  +E  LL ++KH N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-KEAVLLAKMKHPN 59

Query: 61  IVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           IV       +   + +V E  D  DL+  +K +         I ++  Q+  GV + H +
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 120 EILHRDLKPAN-FLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
            +LHRD+K  N FL    K  VK+ DFG AR +  P        G+  Y  PE +  +  
Sbjct: 120 RVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMP 176

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHS 204
           Y+   D+W++ C   E+ T +  F +
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 31/226 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHE 59
           RY ++ +I +G  G V+ A+D +    V +KKI   ++ +  +    +RE  +  +L H 
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 60  NIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT--EPTVTKNPLKIK-------KYLHQI 109
            IV + ++ S  D +      ++ + L   +K+  +       L  K          H+I
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR----------PIDVPLE--- 156
              + Y HS+ +LHRDLKP N L+    ++V I D+G A            IDV      
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 157 --NYTIKG---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             + TI G   G+  Y APERLLG    S   D++A+     +M+T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 44/289 (15%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V++  D+ T + V +K I  +  +E     + +E+++L +     I
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            R          + ++ E L      DLL     E T       I   L +IL G+ Y H
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY------IATILREILKGLDYLH 118

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGS 176
           S+  +HRD+K AN L+    D VK+ADFG+A  + D  ++  T  G    + APE +  S
Sbjct: 119 SERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQS 176

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             Y    D+W++  T  E+   +                     P+S+  P    F    
Sbjct: 177 A-YDFKADIWSLGITAIELAKGE--------------------PPNSDLHPMRVLF---- 211

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              P  SP     T+ G       + +   L  DP  R TA+E L+H++
Sbjct: 212 -LIPKNSP----PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.3 bits (172), Expect = 6e-14
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 14/193 (7%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
            E++  G  G V++A+  LT   + VK IP+    E +   ++ E+ +L +     I+  
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGF 64

Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
                  + I +  E +D   L   +  P      + +      ++ G+ Y  S +ILHR
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLTYLWSLKILHR 119

Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRYSTP 182
           D+KP+N L++ ++  VK+ DFG++      L N   K   G+  Y APER+ G  +Y   
Sbjct: 120 DVKPSNMLVN-TRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGE-QYGIH 173

Query: 183 VDVWAVACTFAEM 195
            DVW++  +F E+
Sbjct: 174 SDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 61/184 (33%), Positives = 86/184 (46%), Gaps = 37/184 (20%)

Query: 51  SLLKELK-------HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM--KTEPTVTKNPL 100
           +L+ ELK       HENIV LL   +    I ++ E   + DLL+F+  K E  +T   L
Sbjct: 84  ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL 143

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
               Y  Q+  G+A+  S+  +HRDL   N L+   K IVKI DFGLAR I +   NY +
Sbjct: 144 LSFSY--QVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDI-MNDSNYVV 199

Query: 161 KGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
           KG +   + + APE +  +  Y+   DVW+                      LL  IFS+
Sbjct: 200 KGNARLPVKWMAPESIF-NCVYTFESDVWSYGI-------------------LLWEIFSL 239

Query: 218 MGTP 221
              P
Sbjct: 240 GSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.3 bits (169), Expect = 7e-14
 Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 17/190 (8%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E I  G +G V           V VK      P + + +  ++E  +LK+  H NIVRL+
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59

Query: 66  NVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILH---GVAYCHSQEI 121
            V +    I +V E +   D L F++TE       LK+K+ +  + +   G+ Y  S+  
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGP----RLKVKELIQMVENAAAGMEYLESKHC 115

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCYKAPERLLGSG 177
           +HRDL   N L+   K+++KI+DFG++R  +  +  Y   GG     + + APE  L  G
Sbjct: 116 IHRDLAARNCLVTE-KNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEA-LNYG 171

Query: 178 RYSTPVDVWA 187
           RYS+  DVW+
Sbjct: 172 RYSSESDVWS 181

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 71/306 (23%), Positives = 127/306 (41%), Gaps = 53/306 (17%)

Query: 5   LEVIRE---GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +EV+ E   G YG+V++     TG T+ +K+I  +   E   + +I E+ +L +     I
Sbjct: 3   IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYI 61

Query: 62  VRLLNVQSSVDSIDLVFENLD---FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           V          ++ +  E +D    D L+            + +++  + ++ G+ +   
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LRRITYAVVKGLKFLKE 120

Query: 119 Q-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +  I+HRD+KP N L++     VK+ DFG++  +   L    I  G   Y APER+   G
Sbjct: 121 EHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGG 177

Query: 178 -----RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-----IMGTPDSETLP 227
                 Y+   DVW++  +  EM     L    + P   A IF+     + G P   TLP
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMA----LGRYPYPPETYANIFAQLSAIVDGDP--PTLP 231

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             + +S                        D  D + + L   P++R T  + L H +  
Sbjct: 232 --SGYS-----------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266

Query: 288 DFQSLD 293
            +++ D
Sbjct: 267 KYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 30/224 (13%)

Query: 1   RYTLLEVIREGRYGAVH------------RAHDSLTGDTVVVK-KIPIMNPSEGVPSSVI 47
           +  L E + EG++G VH                   G  V+V  K+   + ++   +  +
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65

Query: 48  REVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM---KTEPTVTKN----P 99
           +E+ ++  LK+ NI+RLL V  S D + ++ E ++  DL  F+   + E T T       
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125

Query: 100 LKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE 156
           + I   L+   QI  G+ Y  S   +HRDL   N L+     I KIADFG++R +    +
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI-KIADFGMSRNL-YSGD 183

Query: 157 NYTIKGGSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            Y I+G ++    + A E +L  G+++T  DVWA   T  EM T
Sbjct: 184 YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 51/168 (30%), Positives = 75/168 (44%), Gaps = 17/168 (10%)

Query: 44  SSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-KTEPTVTKNPLK 101
              ++E  L+    H NIV+LL V    +   ++ E ++  DLL ++          PL 
Sbjct: 44  KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL 103

Query: 102 IKKYLHQIL----HGVAYCHSQEILHRDLKPANFLIDRS----KDIVKIADFGLARPIDV 153
             K L  I      G  Y      +HRDL   N L+         +VKI DFGLAR  D+
Sbjct: 104 TLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DI 161

Query: 154 PLENYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              +Y  K G     + + APE LL  G+++T  DVW+      E++T
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 1   RYTLLEVIREGRYGAVHRA--HDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKEL 56
           R TL ++++EG +G +      D   G    V VK +   + SE   + +++E  LL  L
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQESCLLYGL 65

Query: 57  KHENIVRLLNVQSSVDSIDLV------FENLDFDLLHFMKTEPTVTKNPLKIKKYLH--- 107
            H+NI+ +L+V         V      + NL    L   +         L  ++ +H   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL-FLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR---PIDVPL----ENYTI 160
           QI  G++Y H + ++H+D+   N +ID     VKI D  L+R   P+D       EN  +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           K     + A E L+    YS+  DVW+      E++T
Sbjct: 184 K-----WMALESLVNK-EYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---------EVSL 52
              ++ +  G +G VH   D ++     +K + I          VIR         E  +
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI--------PEVIRLKQEQHVHNEKRV 54

Query: 53  LKELKHENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           LKE+ H  I+RL   +     + ++ E +   +L  +++     + +      Y  +I+ 
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF--YASEIVC 112

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            + Y HS+EI++RDLKP N L+D+   I K+ DFG A+   +    +T+  G+  Y APE
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHI-KLTDFGFAK--KLRDRTWTL-CGTPEYLAPE 168

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMV 196
            ++ S  ++  VD WA+     EM+
Sbjct: 169 -VIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 6/155 (3%)

Query: 49  EVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKN-PL--KIKKY 105
           E+  L  L HENI+++  +  S  +  ++ +  DFDL  FM  E    K+ PL  + +  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-GS 164
           + Q+L  V Y H ++++HRD+K  N  ++    IV + DFG A P +   E +     G+
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGT 331

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           +   +PE L G G Y    D+W+      +M++H 
Sbjct: 332 VATNSPEILAGDG-YCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 52/216 (24%), Positives = 80/216 (37%), Gaps = 59/216 (27%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA---------------R 149
           Y+ +++  +   H    +HRD+KP N LID    I K+ADFGL                 
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHI-KLADFGLCKKMNKAKDREYYLNDS 164

Query: 150 PIDVPLENYTIKG--------------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEM 195
              +  +N  ++               G+  Y APE L G+  Y    D W++     EM
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEM 223

Query: 196 VTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGL 255
           +     F+S     L      I+            ++ E   F P+             +
Sbjct: 224 LYGFPPFYS---DTLQETYNKII------------NWKESLRFPPDP-----------PV 257

Query: 256 EPDGVDLLRRMLCLDPSKRLT-AREALRHEYFKDFQ 290
            P+ +DL+ R+LC DP  RL    E   H +FK   
Sbjct: 258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 33/280 (11%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A +  TG  V VKK+ +          +  EV ++++  HEN+V + N 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYNS 87

Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++Y H+Q ++HRD+K
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+  S   +K++DFG    +   +       G+  + APE ++    Y T VD+W+
Sbjct: 146 SDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWS 203

Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKD 247
           +     EM+                      G P     P   +        P R  +KD
Sbjct: 204 LGIMVIEMID---------------------GEPPYFNEPPLQAMRRIRDNLPPR--VKD 240

Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
              V   L       L  ML  +PS+R TA+E L+H + K
Sbjct: 241 SHKVSSVLRG----FLDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKHEN 60
           TL++ I  G++G V   +  L    V +K I      EG  S    I E  ++ +L H  
Sbjct: 7   TLVQEIGSGQFGLVWLGY-WLEKRKVAIKTI-----REGAMSEEDFIEEAQVMMKLSHPK 60

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQIL---HGVAYC 116
           +V+L  V +    I LVFE ++   L  +++ +    +     +  L   L    G+AY 
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYL 116

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERL 173
            S  ++HRDL   N L+  ++ +VK++DFG+ R   V  + YT   G+   + + +PE +
Sbjct: 117 ESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPE-V 172

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRL 201
               +YS+  DVW+      E+ +  + 
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKT 200

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 27/301 (8%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +++LE    G  G      D+ T + VV+K         G       E  +L+ + H +I
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTK-NPLKIKKYLHQILHGVAYCHSQE 120
           ++L    +      L+      DL  ++  +  +   + L I++    +L  + Y H   
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER---SVLRAIQYLHENR 202

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLA-RPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           I+HRD+K  N  I+   D+  + DFG A  P+D+    Y    G++   APE LL    Y
Sbjct: 203 IIHRDIKAENIFINHPGDVC-LGDFGAACFPVDINANKYYGWAGTIATNAPE-LLARDPY 260

Query: 180 STPVDVWAVACTFAEMVT-HQRLFHSRWAPG------LLAAIFSIMGTPDSE-TLPGFTS 231
              VD+W+      EM T H  LF      G       +  I    GT  +E  +    +
Sbjct: 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320

Query: 232 FSEEFGFEPNRSPIK----DLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             E +     +S  K     L T +  L  D   L+ +ML  D   R +A   L    F+
Sbjct: 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380

Query: 288 D 288
           D
Sbjct: 381 D 381

Length = 391

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 28/221 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL 56
           R TL + + EG +G V +A     D+    + V  K+   + +E   S ++ E+ ++K +
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 57  -KHENIVRLLNVQSSVDSIDLVFE-----NL-DF------DLLHFMKTEPTVTKNPLKIK 103
            KH+NI+ LL V +    + +V E     NL DF         +    +P   +  L  K
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 104 ---KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
               + +Q+  G+ +  S++ +HRDL   N L+     ++KIADFGLAR  D+   +Y  
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED-HVMKIADFGLAR--DIHHIDYYR 189

Query: 161 K--GGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
           K   G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 53/289 (18%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNS 85

Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 144 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWS 201

Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKD 247
           +     EMV                      G P     P F           N  P+K 
Sbjct: 202 LGIMVIEMVD---------------------GEP-----PYF-----------NEPPLKA 224

Query: 248 LATVVGGLEPDGVDL----------LRRMLCLDPSKRLTAREALRHEYF 286
           +  +   L P   +L          L R+L  DP++R TA E L+H + 
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 67.3 bits (164), Expect = 4e-13
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 7/198 (3%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVR 63
           +VI  G +G V R    + G   V   I  + P  +E      + E S++ +  H NI+R
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 64  LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           L  V +      ++ E ++   L     +     +  ++   L  I  G+ Y      +H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRYS 180
           RDL   N L++ S    K++DFGL+R + D P   YT  GG +   + APE  +   +++
Sbjct: 131 RDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA-IAYRKFT 188

Query: 181 TPVDVWAVACTFAEMVTH 198
           +  DVW+      E+++ 
Sbjct: 189 SASDVWSFGIVMWEVMSF 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.4 bits (164), Expect = 6e-13
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 20/191 (10%)

Query: 26  DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-D 84
           D ++V    + + S+       RE  LL  L+HE+IV+   V    D + +VFE +   D
Sbjct: 34  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93

Query: 85  LLHFMKTEP-----TVTKNP---LKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLI 133
           L  F++            N    L   + LH   QI  G+ Y  SQ  +HRDL   N L+
Sbjct: 94  LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 153

Query: 134 DRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCYKAPERLLGSGRYSTPVDVWAVA 189
             +  +VKI DFG++R  DV   +Y   GG     + +  PE ++   +++T  DVW++ 
Sbjct: 154 GENL-LVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLG 209

Query: 190 CTFAEMVTHQR 200
               E+ T+ +
Sbjct: 210 VVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.0 bits (163), Expect = 8e-13
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 37/281 (13%)

Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A +  +G  V VK + +          +  EV ++++ +H+N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               + + ++ E L    L  + ++  + +   +I      +L  + Y HSQ ++HRD+K
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTRLNEE--QIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 128 PANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDV 185
             + L+      VK++DFG    I  DVP     +  G+  + APE ++    Y T VD+
Sbjct: 145 SDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPE-VISRTPYGTEVDI 200

Query: 186 WAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI 245
           W++     EMV  +        P    +    M        P   +  +           
Sbjct: 201 WSLGIMVIEMVDGE-------PPYFSDSPVQAMKRLRDSPPPKLKNAHK----------- 242

Query: 246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                    + P   D L RML  +P +R TA+E L H + 
Sbjct: 243 ---------ISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 65.6 bits (161), Expect = 2e-12
 Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 43/237 (18%)

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
            + N ++L    +++    L+   +D+    DL   +K E  +++   ++KK + Q++  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLI---MDYIKDGDLFDLLKKEGKLSEA--EVKKIIRQLVEA 121

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           +   H   I+H D+K  N L DR+KD + + D+GL + I  P    +   G+L Y +PE+
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEK 177

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           + G   Y    D WAV     E++T +  F                              
Sbjct: 178 IKGH-NYDVSFDWWAVGVLTYELLTGKHPFK--------------------------EDE 210

Query: 233 SEEFGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-REALRHEYFK 287
            EE   E   +   K L   +  +  +  D ++ ML  + + RLT   E ++H + K
Sbjct: 211 DEELDLESLLKRQQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 10  EGRYGAVHRA---HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A   +     D ++V    +   SE       RE  LL  L+H++IVR   
Sbjct: 15  EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYG 74

Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKTEPTVTK----------NPLKIKKYLH---QILHG 112
           V +    + +VFE +   DL  F+++     K            L + + L    QI  G
Sbjct: 75  VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASG 134

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKA 169
           + Y  S   +HRDL   N L+ +   +VKI DFG++R I    + Y + G ++    +  
Sbjct: 135 MVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMP 192

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           PE +L   +++T  D+W+      E+ T+
Sbjct: 193 PESILYR-KFTTESDIWSFGVVLWEIFTY 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.5 bits (159), Expect = 2e-12
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 48/291 (16%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    + +   + +E+++L +     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 64

Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
            +          + ++ E L      DLL     EP     PL   +I   L +IL G+ 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EP----GPLDETQIATILREILKGLD 115

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS++ +HRD+K AN L+    + VK+ADFG+A  +           G+  + APE ++
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VI 173

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               Y +  D+W++  T  E+        ++  P            P SE  P    F  
Sbjct: 174 KQSAYDSKADIWSLGITAIEL--------AKGEP------------PHSELHPMKVLF-- 211

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                P  +P     T+ G       + +   L  +PS R TA+E L+H++
Sbjct: 212 ---LIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 49/186 (26%), Positives = 92/186 (49%), Gaps = 7/186 (3%)

Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  ++ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 16  GNGGVVTKVQHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74

Query: 71  VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPA 129
              I +  E++D   L  +  E       + + K    +L G+AY   + +I+HRD+KP+
Sbjct: 75  DGEISICMEHMDGGSLDQVLKEAKRIPEEI-LGKVSIAVLRGLAYLREKHQIMHRDVKPS 133

Query: 130 NFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVA 189
           N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++ 
Sbjct: 134 NILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSMG 189

Query: 190 CTFAEM 195
            +  E+
Sbjct: 190 LSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 68/300 (22%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           E +  G +G V  A    TG+   +K     +I  M   +     V +E S+L EL H  
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ----HVAQEKSILMELSHPF 79

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTE-PTVTKNPLKIKKYLH-QILHGVAYCHS 118
           IV   N+  S    + V+  L+F +   + T      + P  + K+ H +++    Y HS
Sbjct: 80  IV---NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           ++I++RDLKP N L+D +K  VK+ DFG A+   VP   +T+  G+  Y APE +   G 
Sbjct: 137 KDIIYRDLKPENLLLD-NKGHVKVTDFGFAK--KVPDRTFTL-CGTPEYLAPEVIQSKG- 191

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
           +   VD W +     E                               + G+  F ++   
Sbjct: 192 HGKAVDWWTMGVLLYEF------------------------------IAGYPPFFDD--- 218

Query: 239 EPNRSPIKDLATVVGG-------LEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYF 286
               +P +    ++ G        +    DL++ +L  D +KRL        +   H YF
Sbjct: 219 ----TPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 7/103 (6%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +IL G+   H +  ++RDLKP N L+D    I +I+D GLA  + +P E  +I+G  
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHI-RISDLGLA--VKIP-EGESIRGRV 162

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
           G++ Y APE +L + RY+   D W + C   EM+  Q  F  R
Sbjct: 163 GTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 33/185 (17%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+ G+ + HS+ I++RDLK  N L+D    I KIADFG+ +   +         G+
Sbjct: 101 YAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHI-KIADFGMCKENMLGDAKTCTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
             Y APE LLG  +Y+T VD W+      EM+  Q  FH                  D E
Sbjct: 160 PDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGH----------------DEE 202

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR-H 283
            L  F S   +    P              L  +  D+L ++   +P +RL  +  +R H
Sbjct: 203 EL--FQSIRMDNPCYPR------------WLTREAKDILVKLFVREPERRLGVKGDIRQH 248

Query: 284 EYFKD 288
            +F++
Sbjct: 249 PFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 7/203 (3%)

Query: 6   EVIREGRYGAV---HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +VI +G +G V    R  D       V++K  I+   E       R V LLK LKH  +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59

Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
            L     + + +  V + ++   L F          P + + Y  ++   + Y HS  I+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-RARFYAAEVASAIGYLHSLNII 118

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           +RDLKP N L+D    +V + DFGL +    P E  +   G+  Y APE +L    Y   
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRT 176

Query: 183 VDVWAVACTFAEMVTHQRLFHSR 205
           VD W +     EM+     F+SR
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.4 bits (157), Expect = 5e-12
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 27/224 (12%)

Query: 1   RYTLLEVIREGR--YGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L E+   GR  +G V  A     +   G+T+V+ K       E + S   RE+ + +
Sbjct: 4   RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR 63

Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT----EPTVTKNPLKIKKYL--- 106
           +L H+N+VRLL +    +   ++ E  D  DL  F++     +  +   PL  K+ +   
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV------PLENYTI 160
            QI  G+ +  +   +HRDL   N L+  S+  VK++   L++  DV       L N  I
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSK--DVYNSEYYKLRNALI 180

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
               L + APE +     +ST  DVW+      E+ T   L   
Sbjct: 181 ---PLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +VI +G +G V  A   L G    VK   K  ++N  E       R V LLK +KH  +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 63  RLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            L     S  + + ++  LDF    +L   ++ E +  +   + + Y  +I   + Y HS
Sbjct: 60  GL---HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP--RARFYAAEIASALGYLHS 114

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
             I++RDLKP N L+D    +V + DFGL +      +  T   G+  Y APE ++    
Sbjct: 115 INIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPE-VIRKQP 172

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSR 205
           Y   VD W +     EM+     F+ R
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)

Query: 8   IREGRYGAVH--RAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           I +G +G V   RA   L     T+V  K+     S  + +   RE +L+ E  H NIV+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 64  LLNVQSSVDSIDLVFENLDF-DLLHFM-----KTEPTVTKNPLKIKKYL----------- 106
           LL V +    + L+FE + + DL  F+     + + +++ +    +K             
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 107 ----HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
                Q+  G+AY   ++ +HRDL   N L+  +  +VKIADFGL+R  ++   +Y    
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSR--NIYSADYYKAS 189

Query: 163 GS----LCYKAPERLLGSGRYSTPVDVWA 187
            +    + +  PE +    RY+T  DVWA
Sbjct: 190 ENDAIPIRWMPPESIF-YNRYTTESDVWA 217

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 6   EVIRE---GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           E+I E   G +G V++A +  TG     K I   +  E      + E+ +L    H  IV
Sbjct: 15  EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIV 72

Query: 63  RLLNVQSSVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHGVAY 115
           +LL        + ++ E      +D  +L   +  TEP       +I+    Q+L  + Y
Sbjct: 73  KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQY 125

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            HS +I+HRDLK  N L+    DI K+ADFG++      L+      G+  + APE ++ 
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDI-KLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 176 SGRYSTP----VDVWAVACTFAEM 195
                TP     D+W++  T  EM
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 6e-12
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 33/291 (11%)

Query: 5   LEVIRE---GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           LE I +   G  G+V +     TG TV+ KK+  +     V   ++RE+ ++ E +   I
Sbjct: 7   LETISDLGAGNGGSVSKVKHIPTG-TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHS 118
           V       + ++I +  E +D   L  +  +      P+ ++   K    ++ G+ Y ++
Sbjct: 66  VSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 119 -QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
              I+HRD+KP+N L++ S+  +K+ DFG++  +   + + T  G S  Y +PER+ G G
Sbjct: 122 VHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIAD-TFVGTST-YMSPERIQG-G 177

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           +Y+   DVW++  +  E+   +  F   ++          MG  D           +E  
Sbjct: 178 KYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDL-----LQQIVQE-- 228

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             P R P  D          D  D +   L  DP++R T ++      F  
Sbjct: 229 -PPPRLPSSDFP-------EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 4   LLEVIREGRYGAVHRAHDSLTG----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            +E + E  +G +++ H  L G      V +K +  +N  +       +E SL+ EL H 
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW-GEFQQEASLMAELHHP 67

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLH---FMKT----------EPTVTKNPLKIKKYL 106
           NIV LL V +    + ++FE L+   LH    M++          E    K+ L    +L
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 107 H---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           H   QI  G+ Y  S   +H+DL   N LI     + KI+D GL+R I    + Y ++  
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV-KISDLGLSREI-YSADYYRVQPK 185

Query: 164 SLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           SL    +  PE ++  G++S+  D+W+      E+ +
Sbjct: 186 SLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 8e-12
 Identities = 35/97 (36%), Positives = 58/97 (59%), Gaps = 5/97 (5%)

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL-ENYT 159
           ++  Y  QI  G+ + HS +I++RD+KP N L+D   +  +++D GLA  +++   +  T
Sbjct: 96  RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLA--VELKDGKTIT 152

Query: 160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
            + G+  Y APE +L    YS PVD +A+ C+  EMV
Sbjct: 153 QRAGTNGYMAPE-ILKEEPYSYPVDWFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 23/213 (10%)

Query: 3   TLLEVIREGRYGAVHRA-----HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           T L+ +  G++G V        +D      V +K I   + SE      I E  ++ +L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSE---DEFIEEAKVMMKLS 57

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           HE +V+L  V +    I +V E +    LL++++ E      P ++ +    +  G+AY 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERL 173
            S++ +HRDL   N L+D  +  VK++DFGL+R   V  + YT   GS   + +  PE L
Sbjct: 117 ESKQFIHRDLAARNCLVDD-QGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW 206
           L S ++S+  DVWA      E+ +  ++ + R+
Sbjct: 174 LYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 43/196 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+ G+ + H + I++RDLK  N L+D+   I KIADFG+ +  ++  E    K  +
Sbjct: 101 YAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI-KIADFGMCK-ENMNGEG---KAST 155

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE L G  +Y+  VD W+      EM+  Q  FH                 
Sbjct: 156 FCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGE--------------- 199

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA 280
            D + L  F S   +    P              +  +  D L ++   DP+KRL     
Sbjct: 200 -DEDEL--FDSILNDRPHFPRW------------ISKEAKDCLSKLFERDPTKRLGVDGD 244

Query: 281 LR-HEYFK--DFQSLD 293
           +R H +F+  D++ L+
Sbjct: 245 IRQHPFFRGIDWERLE 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 39/227 (17%)

Query: 6   EVIREGRYGAVH-----RAHDSLTGD----------TVVVKKIPIMNPSEGVPSSVIREV 50
           E + EG++G VH        D  T             +V  KI   + ++   +  ++EV
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 51  SLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-------KTEPTVTKNP--- 99
            +L  LK  NI+RLL V    D + ++ E ++  DL  F+       K E      P   
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 100 -LKIKKY---LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID 152
            L    Y   LH   QI  G+ Y  S   +HRDL   N L+  +  I KIADFG++R + 
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI-KIADFGMSRNLY 189

Query: 153 VPLENYTIKGGSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
              + Y I+G ++    + A E +L  G+++T  DVWA   T  E++
Sbjct: 190 AG-DYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 6   EVIREGRYGAVHRA--HDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            VI +G +G V+     DS        VK +  +   E V    ++E  ++K+  H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59

Query: 63  RLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLH---QILHGVAY 115
            LL +    +   LV   L +    DL +F+++E   T NP  +K  +    Q+  G+ Y
Sbjct: 60  SLLGICLPSEGSPLVV--LPYMKHGDLRNFIRSE---THNP-TVKDLIGFGLQVAKGMEY 113

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI---KGGSLCYK--AP 170
             S++ +HRDL   N ++D S   VK+ADFGLAR I    E Y++    G  L  K  A 
Sbjct: 114 LASKKFVHRDLAARNCMLDESF-TVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMAL 171

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVT 197
           E  L + +++T  DVW+      E++T
Sbjct: 172 ES-LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 19/246 (7%)

Query: 48  REVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFM-KTEPTVTKNPLKIKKYL 106
           RE+ +LK + H  I+ L++      ++ +V      DL  ++ ++ P   +  + I++ L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL 194

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GS 164
              L  +AY H + I+HRD+K  N  +D  ++ V + DFG A  +D   +     G  G+
Sbjct: 195 ---LEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---LLAAIFSIMGTP 221
           L   +PE LL    Y    D+W+      EM         +        L +I   M   
Sbjct: 251 LETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309

Query: 222 DSETLP--GFTSFSEEFG--FEPNRSPIKDLATVV--GGLEPDGVDLLRRMLCLDPSKRL 275
             E  P  G T+  + F       R P   +  V+   G+  D   L+ +ML  D   R 
Sbjct: 310 PLE-FPQNGSTNLCKHFKQYAIVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367

Query: 276 TAREAL 281
           +A++ L
Sbjct: 368 SAQDIL 373

Length = 392

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVK-KIPIMNPSEGVPSSV--IREVSLLKELKHENI 61
           ++V+  G +G V++      G+TV +   I I+N + G  ++V  + E  ++  + H ++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 62  VRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRLL V  S  +I LV + +    LL ++        + L +  +  QI  G+ Y   + 
Sbjct: 72  VRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLEERR 129

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK-APERLLGSGRY 179
           ++HRDL   N L+ +S + VKI DFGLAR ++   + Y   GG +  K      +   ++
Sbjct: 130 LVHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 180 STPVDVWAVACTFAEMVT 197
           +   DVW+   T  E++T
Sbjct: 189 THQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 66

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 67  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +Y  KGG    
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTR--DIYETDYYRKGGKGLL 183

Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 184 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 9/187 (4%)

Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  ++ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 16  GNGGVVFKVSHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74

Query: 71  VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKI-KKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +      + P +I  K    ++ G+ Y   + +I+HRD+KP
Sbjct: 75  DGEISICMEHMDGGSLD--QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132

Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 133 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 188

Query: 189 ACTFAEM 195
             +  EM
Sbjct: 189 GLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 21/197 (10%)

Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           +G +G V++A +  TG     K I     SE      + E+ +L    H NIV+LL+   
Sbjct: 15  DGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 70  SVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
             +++ ++ E      +D  +L   +  TEP       +I+    Q L  + Y H  +I+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEP-------QIRVVCKQTLEALNYLHENKII 125

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N L     DI K+ADFG++      ++      G+  + APE ++       P
Sbjct: 126 HRDLKAGNILFTLDGDI-KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 183 ----VDVWAVACTFAEM 195
                DVW++  T  EM
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 40/192 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  ++  G+     + I++RDLKP N L+D    I +I+D GLA  + +P E  T++G  
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHI-RISDLGLA--VQIP-EGETVRGRV 162

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           G++ Y APE ++ + +Y+   D W + C   EM+  Q  F  R                 
Sbjct: 163 GTVGYMAPE-VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR----------------- 204

Query: 223 SETLPGFTSFSEEFGFEP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR--- 278
                      E    E  +R   +D          D   + R +L  +P +RL  R   
Sbjct: 205 ----------KERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNG 254

Query: 279 --EALRHEYFKD 288
                +H  FK+
Sbjct: 255 AAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 4   LLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           L + + EG +G V +A         G T V  K+   N S      ++ E +LLK++ H 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----KTEPTVTKN---------------P 99
           ++++L    S    + L+ E   +  L  F+    K  P+   +                
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 100 LKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE 156
           L +   +    QI  G+ Y    +++HRDL   N L+   +  +KI+DFGL+R  DV  E
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLSR--DVYEE 180

Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +  +K       + + A E L     Y+T  DVW+      E+VT
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 72/290 (24%), Positives = 112/290 (38%), Gaps = 41/290 (14%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           ++  G +G V    +  TGD   +K +   ++   E V S    E  +L       I +L
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETV-SFFEEERDILSISNSPWIPQL 66

Query: 65  LNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
                  D++ LV E     DLL  +          +  + YL +++  +   H    +H
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQMGYVH 125

Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDV-PLENYTIKGGSLCYKAPERLL-----GSG 177
           RD+KP N LIDR+  I K+ADFG A  +    + N  +  G+  Y APE L      G G
Sbjct: 126 RDIKPENVLIDRTGHI-KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-IMGTPDSETLPGFTSFSEEF 236
            Y    D W++     EM+  +  FH     G  A  ++ IM        P     S +F
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                                  +DL++ +LC    +RL       H +F
Sbjct: 241 -----------------------LDLIQSLLC-GQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 6   EVIREGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +VI +G +G V    H+A +      V+ KK  I+   E       R V LLK +KH  +
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKK-AILKKKEEKHIMSERNV-LLKNVKHPFL 58

Query: 62  VRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           V L     S  + D ++  LD+    +L + ++ E    +   + + Y  +I   + Y H
Sbjct: 59  VGL---HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP--RARFYAAEIASALGYLH 113

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S  I++RDLKP N L+D    IV + DFGL +         +   G+  Y APE +L   
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQ 171

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            Y   VD W +     EM+     F+SR
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 31/225 (13%)

Query: 1   RYTLLEVIREGRYGAVHR---------AHDSLTGD------TVVVKKIPIMNPSEGVPSS 45
           R T  E + EG++G VH               + D       +V  K+   + ++   + 
Sbjct: 6   RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65

Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM---------KTEPTV 95
            ++E+ ++  LK  NI+RLL V  + D + ++ E ++  DL  F+         +    V
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 96  TKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL 155
           T +   +     QI  G+ Y  S   +HRDL   N L+ +    +KIADFG++R +    
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK-NYTIKIADFGMSRNL-YSG 183

Query: 156 ENYTIKGGSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           + Y I+G ++    + + E +L  G+++T  DVWA   T  E++T
Sbjct: 184 DYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 19/165 (11%)

Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-----KTEPTVTKNPL 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++     + E    + P 
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 101 KIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
            +KK +    +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 172

Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 2/99 (2%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+ G+ + HS+ I++RDLK  N ++DR   I KIADFG+ +         +   G+
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI-KIADFGMCKENVFGDNRASTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH 203
             Y APE L G  +Y+  VD W+      EM+  Q  FH
Sbjct: 160 PDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 19/164 (11%)

Query: 44  SSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL--- 100
           +S + E  LL+ L H  ++ LL+V+       LV      DL  ++         PL   
Sbjct: 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL----RPLGLA 260

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA------RPIDVP 154
           ++     Q+L  + Y H + I+HRD+K  N L++  +DI  + DFG A            
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC-LGDFGAACFARGSWSTPFH 319

Query: 155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
              Y I  G++   APE L G   Y+  VD+W+      E   H
Sbjct: 320 ---YGI-AGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVH 358

Length = 461

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 37/208 (17%)

Query: 84  DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA 143
           +L H ++ E     +  + + Y  ++L  +   H   +++RDLKP N L+D    I  + 
Sbjct: 79  ELFHHLQREGRF--DLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIA-LC 135

Query: 144 DFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH 203
           DFGL +      +      G+  Y APE LLG G Y+  VD W +     EM+T    F+
Sbjct: 136 DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY 194

Query: 204 SRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLL 263
                 +   I                        EP R P         G + D  DLL
Sbjct: 195 DENVNEMYRKILQ----------------------EPLRFP--------DGFDRDAKDLL 224

Query: 264 RRMLCLDPSKRL---TAREALRHEYFKD 288
             +L  DP++RL    A+E   H +F  
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 33/195 (16%)

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           +++ Y  +I+  + + H   I++RD+K  N L+D    +V + DFGL++      +  T 
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTY 164

Query: 161 K-GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG 219
              G++ Y APE + G G +   VD W++     E++T              A+ F++ G
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG-------------ASPFTLEG 211

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---- 275
             ++++             E +R  +K        + P+  DLL ++L  DP KRL    
Sbjct: 212 ERNTQS-------------EVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP 258

Query: 276 -TAREALRHEYFKDF 289
             A E   H +FK  
Sbjct: 259 QGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.7 bits (142), Expect = 5e-10
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 3   TLLEVIREGRYGAVHRA---HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L +++ EG +G+V       D  +   V VK + +   +       + E + +K+  H 
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 60  NIVRLLNV---QSSVDSIDLVFENLDF----DL---LHFMKTEPTVTKNPL-KIKKYLHQ 108
           N+++L+ V    SS+  I      L F    DL   L + +      K PL  + K++  
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           I  G+ Y  ++  +HRDL   N ++     +  +ADFGL++ I     +Y  +G     K
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVC-VADFGLSKKIYS--GDYYRQG--RIAK 176

Query: 169 APERL-----LGSGRYSTPVDVWAVACTFAEMVT 197
            P +      L    Y++  DVWA   T  E+ T
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.4 bits (141), Expect = 5e-10
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 11/183 (6%)

Query: 11  GRYGAVHRAHDSL--TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V +    +  +  TV VK +   N    +   ++RE +++++L +  IVR++ + 
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI- 64

Query: 69  SSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
              +S  LV E  +   L+ F++    VT+    I + +HQ+  G+ Y      +HRDL 
Sbjct: 65  CEAESWMLVMELAELGPLNKFLQKNKHVTEK--NITELVHQVSMGMKYLEETNFVHRDLA 122

Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  ++   KI+DFGL++ +      Y  K      + + APE  +   ++S+  D
Sbjct: 123 ARNVLL-VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CMNYYKFSSKSD 180

Query: 185 VWA 187
           VW+
Sbjct: 181 VWS 183

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE-N 60
           + L+EV+  G YG V++     TG    +K   +M+ +E     +  E+++LK+  H  N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTEDEEEEIKLEINMLKKYSHHRN 74

Query: 61  IVRLLNV---QSSVDSIDLVFENLDF-------DLLHFMKTEPTVTKNPLK---IKKYLH 107
           I         +S     D ++  ++F       DL+   K       N LK   I     
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK------GNALKEDWIAYICR 128

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
           +IL G+A+ H+ +++HRD+K  N L+  + + VK+ DFG++  +D  +       G+  +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYW 187

Query: 168 KAPERLL----GSGRYSTPVDVWAVACTFAEM 195
            APE +         Y    D+W++  T  EM
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HEN 60
           + ++E I +G YG V +  +   G    VK   I++P   +   +  E ++LK L  H N
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 61  IVRLLNV-----QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +V+   +       + D + LV E  +     DL+          + P+ I   LH+ L 
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEALM 135

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           G+ + H  + +HRD+K  N L+  ++  VK+ DFG++  +           G+  + APE
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 172 RLLGSGR----YSTPVDVWAVACTFAEM 195
            +    +    Y    DVW++  T  E+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 7e-10
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 2/101 (1%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +           G+
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGT 160

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             + APE L G   Y   VD +A+  T  EM+  +  F +R
Sbjct: 161 PGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 54/205 (26%), Positives = 76/205 (37%), Gaps = 51/205 (24%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-------------PI 151
           Y  + +  + Y H+  I+HRDLKP N LI  S   +K+ DFGL++              I
Sbjct: 106 YFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 152 DVPLENYTIKG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG 209
           +     +  K   G+  Y APE +L  G Y  PVD WA+     E +     F       
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Query: 210 LLAAIFS--IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRML 267
           L   + S  I      E LP                              D  DL+ R+L
Sbjct: 224 LFGQVISDDIEWPEGDEALP-----------------------------ADAQDLISRLL 254

Query: 268 CLDPSKRL---TAREALRHEYFKDF 289
             +P +RL    A E  +H +F   
Sbjct: 255 RQNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 51/193 (26%), Positives = 77/193 (39%), Gaps = 53/193 (27%)

Query: 109 ILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
           I+  + Y HS+  ++HRD+KP+N LI+R+   VK+ DFG++  +   +   TI  G   Y
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSVAK-TIDAGCKPY 169

Query: 168 KAPERLLGSGR---YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP--- 221
            APER+        Y    DVW++  T  E+ T  R  +  W             TP   
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDSW------------KTPFQQ 216

Query: 222 -------DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR 274
                   S  LP    FS EF                        D + + L  +  +R
Sbjct: 217 LKQVVEEPSPQLPA-EKFSPEF-----------------------QDFVNKCLKKNYKER 252

Query: 275 LTAREALRHEYFK 287
               E L+H +F+
Sbjct: 253 PNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           VI +G +G V  A     G    VK   K  I+   E       R V LLK +KH  +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 64  LLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           L     S  + D ++  LD+    +L   ++ E +  +   + + Y  +I   + Y HS 
Sbjct: 61  L---HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP--RARFYAAEIASALGYLHSL 115

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            I++RDLKP N L+D S+  V + DFGL +      +  +   G+  Y APE L     Y
Sbjct: 116 NIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PY 173

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSR 205
              VD W +     EM+     F+SR
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 47/192 (24%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+  + Y HS ++++RDLK  N ++D+   I KI DFGL +   +   +      +
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHI-KITDFGLCKE-GI---SDGATMKT 154

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE +L    Y   VD W +     EM+  +  F+++               
Sbjct: 155 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------------- 198

Query: 221 PDSETLPGFT-SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---- 275
            D E L  F     EE  F                L P+   LL  +L  DP +RL    
Sbjct: 199 -DHEKL--FELILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGP 242

Query: 276 -TAREALRHEYF 286
             A+E + H +F
Sbjct: 243 EDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 27/205 (13%)

Query: 3   TLLEVIREGRYGAVHRAHDS-LTGDT----VVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TLL  +  G +G V+        GD     V VK +P    SE   S  + E  ++ +  
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFN 67

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNP--LKIKKYLH---QILH 111
           H+NIVRL+ V        ++ E +   DL  F++      + P  L +K  L     +  
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 112 GVAYCHSQEILHRDLKPANFLI-----DRSKDIVKIADFGLARPIDVPLENYTIKGGS-- 164
           G  Y      +HRD+   N L+      R   + KIADFG+AR  D+   +Y  KGG   
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGR---VAKIADFGMAR--DIYRASYYRKGGRAM 182

Query: 165 --LCYKAPERLLGSGRYSTPVDVWA 187
             + +  PE  L  G +++  DVW+
Sbjct: 183 LPIKWMPPEAFL-DGIFTSKTDVWS 206

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 71/252 (28%), Positives = 109/252 (43%), Gaps = 54/252 (21%)

Query: 49  EVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQ 108
           E ++L+ +KH  IV L+    +   + L+ E L    L FM  E            YL +
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMHLEREGIFMEDTACFYLSE 108

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCY 167
           I   + + H Q I++RDLKP N L+D ++  VK+ DFGL +  I      +T   G++ Y
Sbjct: 109 ISLALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEY 166

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
            APE L+ SG +   VD W++     +M+T                     G P      
Sbjct: 167 MAPEILMRSG-HGKAVDWWSLGALMYDMLT---------------------GAP------ 198

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGG-------LEPDGVDLLRRMLCLDPSKRL----- 275
               F+ E     NR   K +  ++ G       L P+  DLL+++L  +PS RL     
Sbjct: 199 ---PFTAE-----NRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPG 248

Query: 276 TAREALRHEYFK 287
            A E   H +F+
Sbjct: 249 DAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 19/104 (18%)

Query: 108 QILHGVAYC------HSQE---ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN- 157
           +IL  +A        + +E   I+HRD+KP+N L+DR+ +I K+ DFG    I   L + 
Sbjct: 107 EILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNI-KLCDFG----ISGQLVDS 161

Query: 158 --YTIKGGSLCYKAPERLLGSGR--YSTPVDVWAVACTFAEMVT 197
              T   G   Y APER+  S R  Y    DVW++  T  E+ T
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 49  EVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKK 104
           E  +L E+ H  IV+L     +   + L+   LDF    DL   +  E   T+  +K   
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKF-- 102

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGG 163
           YL ++   + + HS  I++RDLKP N L+D    I K+ DFGL++  ID   + Y+   G
Sbjct: 103 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSF-CG 160

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
           ++ Y APE +   G ++   D W+      EM+T    F  +
Sbjct: 161 TVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGK 201

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 49/195 (25%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--YTIKG 162
           Y   ++ G+ Y H  +I++RDLK  N L+D  +  VKIADFGL +      E   +  + 
Sbjct: 106 YAACVVLGLQYLHENKIVYRDLKLDNLLLDT-EGFVKIADFGLCK------EGMGFGDRT 158

Query: 163 GSLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
            + C    + APE L  +  Y+  VD W +     EM+  +  F     PG         
Sbjct: 159 STFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPF-----PG--------- 203

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL--- 275
              D E +  F S   +   E  R P          L  + + ++RR+L  +P +RL   
Sbjct: 204 --DDEEEV--FDSIVND---EV-RYPRF--------LSREAISIMRRLLRRNPERRLGSG 247

Query: 276 --TAREALRHEYFKD 288
              A +  +  +F+D
Sbjct: 248 EKDAEDVKKQPFFRD 262

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 43/289 (14%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +++ +G +G V    +  +G      ++KK  I+   E   +  + E  +LK  +H  + 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTRHPFLT 58

Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
            L     + D +  V E ++   L F  +   V     + + Y  +I+  + Y HS +I+
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-RTRFYGAEIVSALDYLHSGKIV 117

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           +RDLK  N ++D+   I KI DFGL +             G+  Y APE +L    Y   
Sbjct: 118 YRDLKLENLMLDKDGHI-KITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRA 175

Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR 242
           VD W +     EM+  +  F+++    L   I                   E+  F    
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----------------LMEDIKFPRT- 217

Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYF 286
                       L  D   LL  +L  DP+KRL      A+E +RH +F
Sbjct: 218 ------------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 56.3 bits (135), Expect = 3e-09
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-EN 60
           + L+E++  G YG V++     TG    +K + +    E     + +E+++LK+  H  N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 61  IVRLL------NVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           I          N     D + LV E      +   +K     T     I     +IL G+
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           ++ H  +++HRD+K  N L+  + + VK+ DFG++  +D  +       G+  + APE +
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 174 L----GSGRYSTPVDVWAVACTFAEM 195
                    Y    D+W++  T  EM
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 67/260 (25%), Positives = 109/260 (41%), Gaps = 34/260 (13%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+       N S      ++ E  ++  +  
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             + RLL +     ++ LV + + +  L     E         +  +  QI  G++Y   
Sbjct: 69  PYVCRLLGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
             ++HRDL   N L+ +S + VKI DFGLAR +D+    Y   GG +  K  A E +L  
Sbjct: 128 VRLVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 177 GRYSTPVDVWAVACTFAEMVTH----QRLFHSRWAPGLLAA-------------IFSIM- 218
            R++   DVW+   T  E++T          +R  P LL               ++ IM 
Sbjct: 187 -RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMV 245

Query: 219 --GTPDSETLPGFTSFSEEF 236
                DSE  P F    +EF
Sbjct: 246 KCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 14/157 (8%)

Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD---FDLLHFMKTEPTVTKNPL-K 101
           +IRE+ +L E     IV       S   I +  E++D    D +  +K    + +N L K
Sbjct: 46  IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV--LKKAGRIPENILGK 103

Query: 102 IKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           I      +L G+ Y   + +I+HRD+KP+N L++   +I K+ DFG++  +   + N  +
Sbjct: 104 ISI---AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI-KLCDFGVSGQLIDSMANSFV 159

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             G+  Y +PERL G+  Y+   D+W++  +  EM  
Sbjct: 160 --GTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 3   TLLEVIREGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            LL+ I +G +G V    +R      G+ V VK I     ++    + + E S++ +L+H
Sbjct: 9   KLLQTIGKGEFGDVMLGDYR------GNKVAVKCIK----NDATAQAFLAEASVMTQLRH 58

Query: 59  ENIVRLLNV-QSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            N+V+LL V       + +V E +    L+ ++++          + K+   +   + Y 
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
            +   +HRDL   N L+    ++ K++DFGL +      +   +    + + APE L   
Sbjct: 119 EANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR-E 173

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++ST  DVW+      E+ +  R+ + R
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 21/192 (10%)

Query: 24  TGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD 82
           TG  V +K +    P  E   +   RE +L   L H NIV LL+  S      L+F   +
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGEAPPGLLFAVFE 59

Query: 83  F----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD 138
           +     L   +  +  +     +  + + Q+L  +A  H+Q I+HRDLKP N ++ ++  
Sbjct: 60  YVPGRTLREVLAADGALP--AGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 139 I--VKIADFGL------ARPIDVP-LENYTIKGGSLCYKAPERLLGSGRYSTP-VDVWAV 188
               K+ DFG+       R  DV  L   T   G+  Y APE+L   G   TP  D++A 
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAW 175

Query: 189 ACTFAEMVTHQR 200
              F E +T QR
Sbjct: 176 GLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.3 bits (133), Expect = 6e-09
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
              + +VI  G +G V      L G  +  V  K      +E      + E S++ +  H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEP---TVTKNPLKIKKYLHQILHGVA 114
            NI+ L  V +    + +V E ++   L  F++      TV    +++   L  I  G+ 
Sbjct: 65  PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQLVGMLRGIASGMK 120

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPE 171
           Y      +HRDL   N L++ S  + K++DFGL+R + D P   YT +GG +   + APE
Sbjct: 121 YLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTH 198
             +   ++++  DVW+      E++++
Sbjct: 180 A-IAYRKFTSASDVWSYGIVMWEVMSY 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.0 bits (132), Expect = 7e-09
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 12/176 (6%)

Query: 29  VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLH- 87
           V  K+      + V   ++RE  ++ +L +  IVR++ V    +++ LV E      L+ 
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV-CEAEALMLVMEMASGGPLNK 83

Query: 88  FM--KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADF 145
           F+  K +     N   + + +HQ+  G+ Y   +  +HRDL   N L+  ++   KI+DF
Sbjct: 84  FLSGKKDEITVSN---VVELMHQVSMGMKYLEGKNFVHRDLAARNVLL-VNQHYAKISDF 139

Query: 146 GLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           GL++ +      Y  +      L + APE +    ++S+  DVW+   T  E  ++
Sbjct: 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 49/194 (25%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--YTIKG 162
           Y  +I+ G+ + H + I++RDLK  N L+D S+  +KIADFG+ +      E     +  
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVLLD-SEGHIKIADFGMCK------EGILGGVTT 153

Query: 163 GSLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
            + C    Y APE L     Y   VD WA+     EM+  Q  F                
Sbjct: 154 STFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGD------------- 199

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL--- 275
              D + L  F S  E+    P              L  +   +L+  L  +P KRL   
Sbjct: 200 ---DEDEL--FQSILEDEVRYPR------------WLSKEAKSILKSFLTKNPEKRLGCL 242

Query: 276 -TAREALR-HEYFK 287
            T  + ++ H +F+
Sbjct: 243 PTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 33/179 (18%)

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLA-RPIDVPLENYTIKGGSLCYKAPERL---L 174
             ++HRD+KP+N L+D S + VK+ DFG++ R +D   +  T   G   Y APER+    
Sbjct: 134 HGVIHRDVKPSNILLDASGN-VKLCDFGISGRLVDS--KAKTRSAGCAAYMAPERIDPPD 190

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
            + +Y    DVW++  +  E+ T Q  + +                  +E    F   ++
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKN----------------CKTE----FEVLTK 230

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
               EP   P         G  PD    +   L  D  KR   RE L+H + + +++ +
Sbjct: 231 ILQEEPPSLPPN------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 28/222 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAH----DSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLL 53
           R  L + + EG +G V RA     D    D   TV VK +   N ++   + +I E+ L+
Sbjct: 13  RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELM 71

Query: 54  KEL-KHENIVRLLNVQSSVDSIDLVFE-NLDFDLLHFMKTE-----------PTVTKNPL 100
           K + KH+NI+ LL V +    + ++ E     +L  F++               V +  L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 101 KIKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLE 156
             K  +   +Q+  G+ Y  S+  +HRDL   N L+    +++KIADFGLAR + D+   
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV-TEDNVMKIADFGLARGVHDIDYY 190

Query: 157 NYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 4   LLEVIREGRYGAVHRAH--DSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLK-ELK 57
            +E + E R+G V++ H   +  G+    V +K +   + +EG      +  ++++  L+
Sbjct: 9   FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQ 66

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLH---FMKT---------EPTVTKNPLKIKKY 105
           H NIV LL V +    + ++F       LH    M++         +    K+ L+   +
Sbjct: 67  HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126

Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           +H   QI  G+ +  S  ++H+DL   N L+   K  VKI+D GL R +    + Y + G
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLV-FDKLNVKISDLGLFREV-YAADYYKLMG 184

Query: 163 GSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            SL    + +PE ++  G++S   D+W+      E+ ++
Sbjct: 185 NSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSY 222

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 27/215 (12%)

Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            L + + EG +G+V        DS+    V   KI I   SE      + E   +KE  H
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDH 59

Query: 59  ENIVRLLNV------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK-----KYLH 107
            N++RL+ V           S  ++   +    LH       +   P  +      K++ 
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
            I  G+ Y  S+  +HRDL   N +++ + + V +ADFGL++ I         + G +  
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKI---YNGDYYRQGRIA- 174

Query: 168 KAPERL-----LGSGRYSTPVDVWAVACTFAEMVT 197
           K P +      L    Y+T  DVW+   T  E+ T
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 25/191 (13%)

Query: 27  TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE-----N 80
           TV VK +   + +E   S ++ E+ ++K + KH+NI+ LL   +    + ++ E     N
Sbjct: 49  TVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107

Query: 81  LDFDL-------LHFMKTEPTVTKNPLKIKKYL---HQILHGVAYCHSQEILHRDLKPAN 130
           L   L       + +      V    +  K  +   +Q+  G+ Y  SQ+ +HRDL   N
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167

Query: 131 FLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYK--APERLLGSGRYSTPVDVW 186
            L+  + +++KIADFGLAR  DV   +Y  K   G L  K  APE L     Y+   DVW
Sbjct: 168 VLVTEN-NVMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVW 223

Query: 187 AVACTFAEMVT 197
           +      E+ T
Sbjct: 224 SFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 44/126 (34%), Positives = 62/126 (49%), Gaps = 26/126 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           + +Q+ +G+ +  S+  +HRDL   N LI   K +VKI DFGLAR I +   NY  KG +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGK-LVKICDFGLARDI-MRDSNYISKGST 301

Query: 165 ---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
              L + APE +  +  Y+T  DVW+                      LL  IF++ GTP
Sbjct: 302 FLPLKWMAPESIFNN-LYTTLSDVWSFGI-------------------LLWEIFTLGGTP 341

Query: 222 DSETLP 227
             E LP
Sbjct: 342 YPE-LP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 34/192 (17%)

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           + K Y+ +++  + + H  +I++RDLKP N L+D +  I  + DFGL++      +    
Sbjct: 97  RAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA-LCDFGLSKANLTDNKTTNT 155

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
             G+  Y APE LL    Y+  VD W++     EM          W+P            
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG-------WSP---------FYA 199

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----T 276
            D++ +    +F +       R P K++      L  +G   ++ +L  +P  RL     
Sbjct: 200 EDTQQMYRNIAFGKV------RFP-KNV------LSDEGRQFVKGLLNRNPQHRLGAHRD 246

Query: 277 AREALRHEYFKD 288
           A E   H +F D
Sbjct: 247 AVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 3   TLLEVIREGRYGAVH----RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKEL 56
           T ++ +  G++G VH    RA        V +K I     +EG  S    I E  ++ +L
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIK-----VAIKAI-----NEGAMSEEDFIEEAKVMMKL 56

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
            H  +V+L  V +    + +V E ++   LL++++         + +      +  G+ Y
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEGMEY 115

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPER 172
                 +HRDL   N L+  S  +VK++DFG+ R   V  + YT   G+   + +  PE 
Sbjct: 116 LERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEV 172

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRL 201
              S +YS+  DVW+      E+ T  ++
Sbjct: 173 FNFS-KYSSKSDVWSFGVLMWEVFTEGKM 200

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 42/125 (33%), Positives = 59/125 (47%), Gaps = 25/125 (20%)

Query: 100 LKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           L +  + +Q+  G+ +  S+  +HRDL   N L+ + K IVKI DFGLAR I +   NY 
Sbjct: 237 LDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDI-MHDSNYV 294

Query: 160 IKGGSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
            KG +     + APE +     Y+T  DVW+                      LL  IFS
Sbjct: 295 SKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGI-------------------LLWEIFS 334

Query: 217 IMGTP 221
           + GTP
Sbjct: 335 LGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 32/219 (14%)

Query: 2   YTLLEVIREGRYGAVHRAH---DSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKEL 56
           +TL  ++ +G +G+V  A    +  +   V VK  K  I + S+      +RE + +KE 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD--IEEFLREAACMKEF 58

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMK--------TEPTVTKNPLKIK----- 103
            H N+++L+ V  S+ S       +   +L FMK            + + P  +      
Sbjct: 59  DHPNVIKLIGV--SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           +++  I  G+ Y  S+  +HRDL   N +++ +   V +ADFGL++ I     +Y  +G 
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT-VCVADFGLSKKIYS--GDYYRQGC 173

Query: 164 SLCYKAPERL-----LGSGRYSTPVDVWAVACTFAEMVT 197
           +   K P +      L    Y+T  DVWA   T  E++T
Sbjct: 174 A--SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           L+++  G +G VH+      GD++   KIP+                +   +  +  L H
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSI---KIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
             IVRLL +     S+ LV +      L  H  +   ++  +P ++  +  QI  G+ Y 
Sbjct: 69  AYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSL--DPQRLLNWCVQIAKGMYYL 125

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLAR---PIDVPLENYTIKGGSLCYKAPERL 173
               ++HR+L   N L+ +S  IV+IADFG+A    P D        K   + + A E +
Sbjct: 126 EEHRMVHRNLAARNILL-KSDSIVQIADFGVADLLYPDDKKYFYSEHKT-PIKWMALESI 183

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTH 198
           L  GRY+   DVW+   T  EM+++
Sbjct: 184 L-FGRYTHQSDVWSYGVTVWEMMSY 207

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 44/255 (17%)

Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKY 105
           + E  +L+  +H  +  L     + D +  V E  +   L F +  E   T+   + + Y
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFY 100

Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--G 163
             +I+  + Y HS+++++RD+K  N ++D+   I KI DFGL +  +   +  T+K   G
Sbjct: 101 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI-KITDFGLCK--EGISDGATMKTFCG 157

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           +  Y APE +L    Y   VD W +     EM+  +  F+++    L   I         
Sbjct: 158 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------- 207

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAR 278
                     EE  F                L P+   LL  +L  DP +RL      A+
Sbjct: 208 --------LMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAK 246

Query: 279 EALRHEYFKDFQSLD 293
           E + H +F      D
Sbjct: 247 EVMEHRFFLSINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 9/107 (8%)

Query: 97  KNPLKIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV 153
           K+PL ++    Y  Q+  G+ +  S++ +HRDL   N L+  + ++VKI DFGLAR I  
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDI-Y 225

Query: 154 PLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              +Y  KG +   L + APE +     Y+T  DVW+      E+ +
Sbjct: 226 KDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)

Query: 49  EVSLLKELKHENIVRLLNVQSSVDSIDLVFE-NLDFDLLHFMKTEPTVTKNPLKIKKY-- 105
           E+  L    H  IV+  +   S D + L+ E     DL   +K      K  L  ++Y  
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPFQEYEV 171

Query: 106 ---LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTI 160
               +QI+  +   HS++++HRDLK AN  +     I+K+ DFG ++     V L+  + 
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
             G+  Y APE L    RYS   D+W++     E++T  R F
Sbjct: 231 FCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 32/190 (16%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GG 163
           Y+ +I+  + + H   I++RD+K  N L+D    +V + DFGL++      E       G
Sbjct: 110 YIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVV-LTDFGLSKEFLAEEEERAYSFCG 168

Query: 164 SLCYKAPERLL-GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           ++ Y APE +  GSG +   VD W++     E++T              A+ F++ G  +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG-------------ASPFTVDGEQN 215

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---TARE 279
           S++             E +R  +K        +  +  D ++++L  DP KRL    A E
Sbjct: 216 SQS-------------EISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262

Query: 280 ALRHEYFKDF 289
              H +F+  
Sbjct: 263 IKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 50/188 (26%), Positives = 74/188 (39%), Gaps = 37/188 (19%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I  G+ + HS+ I++RDLK  N ++D    I KIADFG+ +      +      G+
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI-KIADFGMCKENIFGGKTTRTFCGT 164

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
             Y APE ++    Y   VD WA      EM+  Q  F                   D +
Sbjct: 165 PDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----------------DED 207

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----TAREA 280
            L  F S  E     P              L  + V + + +L   P+KRL    T    
Sbjct: 208 EL--FQSIMEHNVSYPK------------SLSKEAVSICKGLLTKHPAKRLGCGPTGERD 253

Query: 281 LR-HEYFK 287
           +R H +F+
Sbjct: 254 IREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 38/190 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I   + + H + I++RDLK  N L+D      K+ADFG+ +      +  +   G+
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
             Y APE +L    Y   VD WA+     EM+     F +     L  AI          
Sbjct: 160 PDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---------- 208

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA------R 278
                               + D       L  D VD+L+  +  +P+ RL +       
Sbjct: 209 --------------------LNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEE 248

Query: 279 EALRHEYFKD 288
             LRH +FK+
Sbjct: 249 AILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 43/244 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       +     T V  K+   + +E   S +I E+ ++K
Sbjct: 19  RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 78

Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----NLDFDL-------LHFMKTEPTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     NL   L       + +      V +  L 
Sbjct: 79  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR  D+   +Y
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLAR--DIHHIDY 195

Query: 159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSI 217
                   YK       +GR   PV   A    F  + THQ      W+ G LL  IF++
Sbjct: 196 --------YKKTT----NGRL--PVKWMAPEALFDRIYTHQS---DVWSFGVLLWEIFTL 238

Query: 218 MGTP 221
            G+P
Sbjct: 239 GGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 99  PLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL 155
           PL +   L    Q+  G+ +  S+  +HRD+   N L+     + KI DFGLAR I +  
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDI-MND 265

Query: 156 ENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEM 195
            NY +KG +   + + APE +     Y+   DVW+      E+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 69  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 128 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL-H 185

Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 19/208 (9%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHEN 60
           + ++E I +G YG V++  +   G    VK   I++P   V   +  E ++L+ L  H N
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 61  IVRLLNVQSSVDSID-----LVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +V+   +    D +      LV E  +     +L+  +          + I   L+  L 
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM-ISYILYGALL 139

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           G+ + H+  I+HRD+K  N L+  ++  VK+ DFG++  +           G+  + APE
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 172 RLLGSGRYSTP----VDVWAVACTFAEM 195
            +    +Y        DVW++  T  E+
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y  S  I++RDLKP N L+D+    +K+ DFG A+ +D     YT+  G+
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT--RTYTL-CGT 191

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             Y APE LL  G +    D W +     E++
Sbjct: 192 PEYIAPEILLNVG-HGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 9/107 (8%)

Query: 97  KNPLKIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV 153
           K  L ++    Y  Q+  G+ +  S++ +HRDL   N L+    ++VKI DFGLAR I  
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDI-Y 230

Query: 154 PLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              +Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 47/197 (23%), Positives = 87/197 (44%), Gaps = 40/197 (20%)

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           +++ Y  +I+  + + H   I++RD+K  N L+D +  +V + DFGL++      E+   
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEF---HEDEVE 161

Query: 161 KGGSLC----YKAPERLL-GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
           +  S C    Y AP+ +  G G +   VD W++     E++T              A+ F
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG-------------ASPF 208

Query: 216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
           ++ G  +S+              E +R  +K        +     D+++R+L  DP KRL
Sbjct: 209 TVDGEKNSQA-------------EISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRL 255

Query: 276 -----TAREALRHEYFK 287
                 A E  +H +F+
Sbjct: 256 GCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 59/236 (25%), Positives = 78/236 (33%), Gaps = 77/236 (32%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL----------------- 147
           Y+ ++   +   H    +HRD+KP N LIDR   I K+ DFGL                 
Sbjct: 106 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI-KLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 148 ----------------ARPIDVPLENYTIKGGSLC----------YKAPERLLGSGRYST 181
                            R    PLE    +    C          Y APE LL +G Y+ 
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQ 223

Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN 241
             D W+V     EM+  Q  F +               TP +ET     ++         
Sbjct: 224 LCDWWSVGVILYEMLVGQPPFLAD--------------TP-AETQLKVINWETTLHIPSQ 268

Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---TAREALRHEYFK--DFQSL 292
                        L  +  DL+ R LC     RL    A E   H +FK  DF SL
Sbjct: 269 -----------AKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFASL 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 9/205 (4%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L V+ +G +G V  A    T +   +K  K  ++   + V  +++ +  L    K  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            + +L +   ++D +  V E ++   L +   +    K P  +  Y  +I  G+ + HS+
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-YAAEIAIGLFFLHSK 120

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
            I++RDLK  N ++D S+  +KIADFG+ +  +   +  T K   G+  Y APE ++   
Sbjct: 121 GIIYRDLKLDNVMLD-SEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE-IIAYQ 176

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLF 202
            Y   VD WA      EM+  Q  F
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 8/135 (5%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENYTIKGG 163
           Y  +++  +   HS   +HRD+KP N L+D+S  + K+ADFG    ++   +       G
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVG 205

Query: 164 SLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
           +  Y +PE L    G G Y    D W+V     EM+     F   +A  L+     IM  
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTYSKIMNH 262

Query: 221 PDSETLPGFTSFSEE 235
            +S T P     S+E
Sbjct: 263 KNSLTFPDDNDISKE 277

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 34/225 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R TL + + EG +G V  A       D       V  K+   + ++   S ++ E+ ++K
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  +D+        E  +T
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE 156
              L    Y  Q+  G+ Y  SQ+ +HRDL   N L+    +++KIADFGLAR  DV   
Sbjct: 133 FKDLVSCAY--QVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLAR--DVHNI 187

Query: 157 NYTIK--GGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  K   G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 19/157 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           + +++ I  G +G V+              VVKK  ++N  + +   V  E   L   K 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKS 63

Query: 59  ENIVRLLNVQSSVDSIDLVFENL---DF-DLLHFMK--TEPTVTKNPLKIKKYLHQILHG 112
             IV L     S +++ LV E L   D   LLH      E           KY+ ++   
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALA 116

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR 149
           + Y H   I+HRDLKP N LI     I K+ DFGL++
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHI-KLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 6/84 (7%)

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-- 164
           +Q+  G+++  S+  +HRDL   N L+   + I KI DFGLAR I     NY +KG +  
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRND-SNYVVKGNARL 278

Query: 165 -LCYKAPERLLGSGRYSTPVDVWA 187
            + + APE +     Y+   DVW+
Sbjct: 279 PVKWMAPESIFNC-VYTFESDVWS 301

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 43/135 (31%), Positives = 60/135 (44%), Gaps = 30/135 (22%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  Q+  G+ +  S++ +HRDL   N L+    ++VKI DFGLAR I     +Y  KG +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDI-YKDPDYVRKGDA 235

Query: 165 ---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
              L + APE +     Y+T  DVW+                      LL  IFS+  +P
Sbjct: 236 RLPLKWMAPESIFDK-VYTTQSDVWSFGV-------------------LLWEIFSLGASP 275

Query: 222 DSETLPGFTSFSEEF 236
                PG     EEF
Sbjct: 276 ----YPGV-QIDEEF 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 37/172 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           YL +++  +   H    +HRD+KP N L+D +  I ++ADFG    +   +E+ T++   
Sbjct: 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKL---MEDGTVQSSV 162

Query: 163 --GSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
             G+  Y +PE L     G G+Y    D W++     EM+  +  F   +A  L+     
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF---YAESLV----- 214

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLC 268
                  ET     +  E F F    + + + A           DL+RR++C
Sbjct: 215 -------ETYGKIMNHKERFQFPAQVTDVSEDAK----------DLIRRLIC 249

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 8/129 (6%)

Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIK 161
           K Y  +++  +   HS  ++HRD+KP N L+D+   + K+ADFG    +D   +      
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL-KLADFGTCMKMDETGMVRCDTA 203

Query: 162 GGSLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
            G+  Y +PE L    G G Y    D W+V     EM+     F   +A  L+     IM
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF---YADSLVGTYSKIM 260

Query: 219 GTPDSETLP 227
              +S   P
Sbjct: 261 DHKNSLNFP 269

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L V+ +G +G V  A    T +   +K  K  ++   + V  +++ +  L  + K  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            + +L +   +VD +  V E ++   L +   +    K P  +  Y  +I  G+ + H +
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFFLHRR 120

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
            I++RDLK  N ++D S+  +KIADFG+ +  +  ++  T +   G+  Y APE ++   
Sbjct: 121 GIIYRDLKLDNVMLD-SEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPE-IIAYQ 176

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLF 202
            Y   VD WA      EM+  Q  F
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 14/138 (10%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +++  +   HS   +HRD+KP N L+D+S  + K+ADFG    +D    N  ++   
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMD---ANGMVRCDT 202

Query: 163 --GSLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
             G+  Y +PE L    G G Y    D W+V     EM+     F   +A  L+     I
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTYSKI 259

Query: 218 MGTPDSETLPGFTSFSEE 235
           M   +S T P     S++
Sbjct: 260 MDHKNSLTFPDDIEISKQ 277

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 9/200 (4%)

Query: 6   EVIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           EVI  G +G V R    L G  +  V  K      +E      + E S++ +  H NI+ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 64  LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           L  V +    + ++ E ++   L     +       +++   L  I  G+ Y      +H
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLC--YKAPERLLGSGR 178
           RDL   N L++ S  + K++DFGL+R ++    + T     GG +   + APE  +   +
Sbjct: 130 RDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA-IAYRK 187

Query: 179 YSTPVDVWAVACTFAEMVTH 198
           +++  DVW+      E++++
Sbjct: 188 FTSASDVWSYGIVMWEVMSY 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 3/96 (3%)

Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           +++ Y  +I+ G+ + H++ +++RDLKPAN L+D     V+I+D GLA   D   +    
Sbjct: 98  EMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHA 154

Query: 161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             G+  Y APE L     Y +  D +++ C   +++
Sbjct: 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 3/89 (3%)

Query: 102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
           ++ Y  +I+ G+ + H++ +++RDLKPAN L+D     V+I+D GLA   D   +     
Sbjct: 99  MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHAS 155

Query: 162 GGSLCYKAPERLLGSGRYSTPVDVWAVAC 190
            G+  Y APE L     Y +  D +++ C
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGC 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 6   EVIREGRYGAVHRAH---DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +VI EG +G V +A    D L  D  + +     +  +    +   EV L K   H NI+
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 71

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMK------TEPTV-----TKNPLKIKKYLH--- 107
            LL        + L  E     +LL F++      T+P       T + L  ++ LH   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
            +  G+ Y   ++ +HRDL   N L+  +  + KIADFGL+R  +V ++  T+    + +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK-TMGRLPVRW 189

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            A E L  S  Y+T  DVW+      E+V+
Sbjct: 190 MAIESLNYS-VYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 42/190 (22%)

Query: 105 YLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG- 162
           Y  +I+  + Y HS+  +++RDLK  N ++D+   I KI DFGL +  +   +  T+K  
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI-KITDFGLCK--EGIKDGATMKTF 156

Query: 163 -GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
            G+  Y APE +L    Y   VD W +     EM+  +  F+++                
Sbjct: 157 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---------------- 199

Query: 222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----T 276
           D E L       E    E  R P          L P+   LL  +L  DP +RL      
Sbjct: 200 DHEKL------FELILMEEIRFPRT--------LSPEAKSLLSGLLKKDPKQRLGGGPDD 245

Query: 277 AREALRHEYF 286
           A+E ++H++F
Sbjct: 246 AKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 33/172 (19%)

Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG--LARPIDVPLENYTI 160
           + Y+ +++  +   H    +HRD+KP N L+D +  I ++ADFG  L    D  +++ ++
Sbjct: 105 RFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHI-RLADFGSCLKMNQDGTVQS-SV 162

Query: 161 KGGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
             G+  Y +PE L     G G+Y    D W++     EM+  +  F   +A  L+     
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGK 219

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLC 268
           IM            +  E F F  +          +  +  +  DL++R++C
Sbjct: 220 IM------------NHEERFQFPSH----------ITDVSEEAKDLIQRLIC 249

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 4/119 (3%)

Query: 84  DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA 143
           DL+  M+ +  + +   +   Y  +I   + Y H + I++RDLK  N L+D S+  +K+ 
Sbjct: 82  DLMFHMQRQRKLPEEHARF--YSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLT 138

Query: 144 DFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           D+G+ +    P +  +   G+  Y APE L G   Y   VD WA+     EM+  +  F
Sbjct: 139 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 20/212 (9%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTV-VVKKIPIMNPSEGVPSSVIREVSLLKEL-KHEN 60
              +VI EG +G V RA     G  +    K+     SE        E+ +L +L  H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMK------TEPTVTK--------NPLKIKKY 105
           I+ LL    +   + +  E   + +LL F++      T+P   K           ++ ++
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL 165
              +  G+ Y   ++ +HRDL   N L+  +    KIADFGL+R  +V ++  T+    +
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVKK-TMGRLPV 182

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + A E L  S  Y+T  DVW+      E+V+
Sbjct: 183 RWMAIESLNYS-VYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 38/179 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           YL +++  +   H    +HRD+KP N L+D++  I ++ADFG    +     + T++   
Sbjct: 107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI-RLADFGSCLRLL---ADGTVQSNV 162

Query: 163 --GSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
             G+  Y +PE L     G GRY    D W++     EM+  +  F++            
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----------- 211

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
                         S  E +G   N          V  +  +  DL+RR++C  P  RL
Sbjct: 212 --------------SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLIC-SPETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 24/211 (11%)

Query: 6   EVIREGRYGAVHRA---HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE-NI 61
           +VI EG +G V +A    D L  D  +  K      S+        E+ +L +L H  NI
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAI--KRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPL--------------KIKKYL 106
           + LL        + L  E     +LL F++    +  +P               ++  + 
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
             +  G+ Y   ++ +HRDL   N L+  +  + KIADFGL+R  +V ++  T+    + 
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK-TMGRLPVR 176

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           + A E  L    Y+T  DVW+      E+V+
Sbjct: 177 WMAIES-LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 2/98 (2%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I   + + H + I++RDLK  N L+D    I K+ D+G+ +    P +  +   G+
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI-KLTDYGMCKEGLGPGDTTSTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
             Y APE L G   Y   VD WA+     EM+  +  F
Sbjct: 160 PNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 2/100 (2%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  ++   + + H   +++RDLK  N L+D ++   K+ADFG+ +   +     T   G+
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
             Y APE +L    Y   VD WA+     EM+  Q  F +
Sbjct: 160 PDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 28/77 (36%), Positives = 38/77 (49%), Gaps = 3/77 (3%)

Query: 102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
           I+  + QIL  +   HS  I+HRD+KP N +        KI D G A  + V + NY  K
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPK 315

Query: 162 GGSL--CYKAPERLLGS 176
              L   Y APE+ + S
Sbjct: 316 EFLLDPRYAAPEQYIMS 332

Length = 566

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 8   IREGRYGAV--HRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           I  G +G V    AH  ++   VVVK++     P E +    ++EV   +EL H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQC 60

Query: 65  LNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTK---NPLKIKKYLHQILHGVAYCHSQE 120
           L          LV E     DL +++++   +         +++   ++  G+ + H  +
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 121 ILHRDLKPANFLIDRSKDI-VKIADFGLA 148
            +H DL   N  +  + D+ VKI D+GLA
Sbjct: 121 FIHSDLALRNCQL--TADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC- 166
           Q+L  V + HS+ ++HRD+K AN L+  S  +VK+ DFG ++     + +    G + C 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDDV--GRTFCG 207

Query: 167 ---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
              Y APE +     YS   D++++     E++T +R F
Sbjct: 208 TPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 2/92 (2%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I   + + H + I++RDLK  N L+D    I K+ D+G+ +    P +  +   G+
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHI-KLTDYGMCKEGIRPGDTTSTFCGT 159

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             Y APE L G   Y   VD WA+     EM+
Sbjct: 160 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 48/220 (21%)

Query: 104 KYLHQILH--GVA--YCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
           ++L QI+   GVA  Y H++  ++H DLKP N L++ S  +V       A P D P    
Sbjct: 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT-NRALPPD-PCRVR 288

Query: 159 TIKGGSLC--------------YKAPERLLGSG-RYSTPVDVWAVACTFAEMV------- 196
               G  C              Y++PE +LG G  YST  D+W++ C   E+        
Sbjct: 289 ICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYD 346

Query: 197 THQRLFHSRWAP---GLLAAIFSIM-GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVV 252
           TH  L H        G L + ++   GT ++  L  + S  +     P   P K LA + 
Sbjct: 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLL--YNSAGQ---LRPCTDP-KHLARIA 400

Query: 253 GG-------LEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                     +    DL+  +L  D  KRL AR+   H Y
Sbjct: 401 RARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 41/229 (17%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR-EVSLLKELKHENIVR 63
           L+VI  G +G V       TG    +K +   +  E      IR E  +L E     +V+
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK 65

Query: 64  LLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           +        ++ L+ E L   D++  +  + T+T+   +   Y+ + +  +   H    +
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF--YIAETVLAIDSIHQLGFI 123

Query: 123 HRDLKPANFLIDRSKDIVKIADFGL------------------ARPIDVPLENYTIKG-- 162
           HRD+KP N L+D SK  VK++DFGL                  + P D   +N   K   
Sbjct: 124 HRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 163 ---------------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
                          G+  Y APE  + +G Y+   D W++     EM+
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 41/229 (17%)

Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR-EVSLLKELKHENIVR 63
           L+VI  G +G V       TG    +K +   +  E    + IR E  +L E     +V+
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK 65

Query: 64  LLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           +        ++ L+ E L   D++  +  + T+++   +   Y+ + +  +   H    +
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF--YIAETVLAIDAIHQLGFI 123

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLAR------------------PIDVPLENYTIKG-- 162
           HRD+KP N L+D +K  VK++DFGL                    P D   +N   K   
Sbjct: 124 HRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 163 ---------------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
                          G+  Y APE  + +G Y+   D W++     EM+
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 71/325 (21%), Positives = 124/325 (38%), Gaps = 77/325 (23%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS----LLKELKHE 59
            ++++ +G  G V       TG    +K   +++  E +  + ++ V     +L  L H 
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALK---VLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
            +  L    +S  +   +   +D+    +L   ++ +P    +    + Y  ++L  + Y
Sbjct: 62  FLPTLY---ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV-------------------PLE 156
            H   I++RDLKP N L+  S  I+ ++DF L++  DV                    + 
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIM-LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 157 NYTIKG----------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW 206
           + T             G+  Y APE + G G + + VD W +     EM           
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEM----------- 225

Query: 207 APGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRM 266
               L       G+   ET        +E  F P   P+   A           DL+R++
Sbjct: 226 ----LYGTTPFKGSNRDETF--SNILKKEVTF-PGSPPVSSSAR----------DLIRKL 268

Query: 267 LCLDPSKRL----TAREALRHEYFK 287
           L  DPSKRL     A E  +H +F+
Sbjct: 269 LVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 63/239 (26%), Positives = 81/239 (33%), Gaps = 81/239 (33%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--------------- 149
           Y+ ++   V   H    +HRD+KP N LIDR   I K+ DFGL                 
Sbjct: 106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHI-KLTDFGLCTGFRWTHDSKYYQSGD 164

Query: 150 -----PIDV-----------------PLENYTIKGGSLC----------YKAPERLLGSG 177
                 +D                  PLE    +    C          Y APE LL +G
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
            Y+   D W+V     EM+  Q        P  LA       TP  ET     ++     
Sbjct: 225 -YTQLCDWWSVGVILYEMLVGQ--------PPFLAQ------TP-LETQMKVINWQTSLH 268

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---TAREALRHEYFK--DFQS 291
             P              L P+  DL+ + LC  P  RL    A E   H +FK  DF S
Sbjct: 269 IPPQ-----------AKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTIDFSS 315

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 1/47 (2%)

Query: 102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA 148
           IK  + Q+L G+   H   I+HRD+KP N L+      VKI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKIIDFGAA 356

Length = 507

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 18/44 (40%), Positives = 27/44 (61%), Gaps = 1/44 (2%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA 148
           Y+ + +  +   H    +HRD+KP N LIDR   I K++DFGL+
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI-KLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 12/139 (8%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
            TL+    E     VH A    T   V VKKI + + S+     + +E+   ++L+H NI
Sbjct: 3   LTLIGKCFEDL-MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 62  VRLLNVQSSVDSIDLVFENLDF----DLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           +  +        + +V   + +    DLL  HF +  P      L I   L  +L+ + Y
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE-----LAIAFILKDVLNALDY 116

Query: 116 CHSQEILHRDLKPANFLID 134
            HS+  +HR +K ++ L+ 
Sbjct: 117 IHSKGFIHRSVKASHILLS 135

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 29/118 (24%), Positives = 41/118 (34%), Gaps = 40/118 (33%)

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGL------------------ARPIDVPLENY 158
           H    +HRD+KP N L+D    I K++DFGL                  A P +      
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHI-KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 159 TIKG--------------------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
                                   G+  Y APE  L +G Y+   D W++     EM+
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	293
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
smart00090	237	RIO RIO-like kinase.	99.84
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG1243	690	consensus Protein kinase [General function predict	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.61
KOG3087	229	consensus Serine/threonine protein kinase [General	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.47
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
COG4248	637	Uncharacterized protein with protein kinase and he	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.36
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.31
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.26
PRK09902	216	hypothetical protein; Provisional	99.13
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.05
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.03
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.94
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.84
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.65
PF01636	239	APH: Phosphotransferase enzyme family This family	98.64
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
PLN02876	822	acyl-CoA dehydrogenase	98.52
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.32
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.21
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.15
PRK10593	297	hypothetical protein; Provisional	98.14
KOG2270	520	consensus Serine/threonine protein kinase involved	98.12
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.1
PRK05231	319	homoserine kinase; Provisional	98.01
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.96
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.91
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.87
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.85
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.84
PRK12396	409	5-methylribose kinase; Reviewed	97.83
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.83
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.8
PLN02236	344	choline kinase	97.73
PLN02756	418	S-methyl-5-thioribose kinase	97.69
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.43
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.25
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.25
PTZ00384	383	choline kinase; Provisional	97.16
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.07
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.92
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.9
COG2334	331	Putative homoserine kinase type II (protein kinase	96.82
PTZ00296	442	choline kinase; Provisional	96.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.76
PRK11768	325	serine/threonine protein kinase; Provisional	96.43
PRK06148	1013	hypothetical protein; Provisional	95.88
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.75
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.0

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-57  Score=383.24  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=229.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||..++.||+|+|+.+|.+++..+|+.||+|+++.... .....+.+.+|+++.+.|.|||||+++++|++..++|+|.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            69999999999999999999989999999999976443 44566789999999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      .|..+.+..+.+ ....+.+..++.+++||+.||.|||+.+|+|||||..|+|++++.+ |||+|||+|+....+.+...
T Consensus        99 LC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~-VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN-VKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc-EEecccceeeeecCcccccc
Confidence            999555555554 4557899999999999999999999999999999999999999988 99999999999987777777


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+|||.|+|||++... .++..+||||+||++|.|++|+.||...+..+...+|......                   
T Consensus       177 TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-------------------  236 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-------------------  236 (592)
T ss_pred             eecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-------------------
Confidence            88899999999999866 6899999999999999999999999999999999999653332                   


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                 .+..++.++.+||.+||+.||++|||+++||.|+||+
T Consensus       237 -----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  237 -----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             -----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                       3445789999999999999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-57  Score=365.85  Aligned_cols=260  Identities=30%  Similarity=0.455  Sum_probs=218.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      |.+.+.||+|+||.|-+|.++.+|+.||||+++......     .......+|+++|++|+||+|++++++++.+...|+
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym  253 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM  253 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence            788999999999999999999999999999996544322     223456789999999999999999999999999999


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDV  153 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~  153 (293)
                      ||||++ |.+.+.+..+.....+  .-..+++|++.|+.|||+.||+||||||+||+++.+..  .+||+|||+++..+.
T Consensus       254 VlE~v~GGeLfd~vv~nk~l~ed--~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  254 VLEYVEGGELFDKVVANKYLRED--LGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEecCccHHHHHHhccccccc--hhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            999997 7888888887765544  55779999999999999999999999999999987733  599999999998873


Q ss_pred             CCcceeccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      . .-....+|||.|.|||++.+.  ..+..+.|+|||||++|-+++|..||.+...+. ...++.....           
T Consensus       332 ~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y-----------  399 (475)
T KOG0615|consen  332 G-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY-----------  399 (475)
T ss_pred             c-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc-----------
Confidence            3 445567799999999999754  234458899999999999999999999876665 5555543222           


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                     ......+..++.++.+||++||..||++|||++|+|+||||+..+
T Consensus       400 ---------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 ---------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                           222344556899999999999999999999999999999999664

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-57  Score=372.45  Aligned_cols=283  Identities=35%  Similarity=0.556  Sum_probs=256.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccH--HHHHHHHHhcC-CCCcceeeeeeecCC-ccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKELK-HENIVRLLNVQSSVD-SIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~--~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~l   76 (293)
                      ||.++++||.|.||.||+|..+.+|+.||||+++.....   .++.  .+|+..|++|+ ||||+++.+++.+.. .+|+
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            799999999999999999999999999999998654433   2333  35999999998 999999999998887 9999


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||+|+..+.+.+..+ ...+++..++.|+.||++||+|+|++|+.|||+||+||++..... |||+|||+|+.+.+...
T Consensus        88 VfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~-iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   88 VFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV-IKIADFGLAREVRSKPP  165 (538)
T ss_pred             eHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce-eEecccccccccccCCC
Confidence            9999999999998888 778999999999999999999999999999999999999996555 99999999998765422


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                       +..-..|-||+|||++.....|+.+.|+|++|||++|+.+-+..|.+.+.-+.+-+|....+.|....++.........
T Consensus       166 -YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  166 -YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             -cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence             2323368899999999998899999999999999999999999999999999999999999999999999987888888


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+.........+..+.+..+.++.++|.+||.+||.+||||.++|+||||+.-
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            88888888888888988999999999999999999999999999999999864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-56  Score=348.33  Aligned_cols=287  Identities=35%  Similarity=0.579  Sum_probs=240.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|+.+.++|+|+||+||+++++.+|+.||||++..+...+...+-..+|+++|++|.|||+|.++++|...+.+++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            58899999999999999999999999999999976666666667788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      |+...++.+...+. ..++..+.++++|++.|+.|+|+++++||||||+||+|+.++. +||||||+++....+.+.+.-
T Consensus        83 ~dhTvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv-vKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   83 CDHTVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV-VKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             cchHHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc-EEeccchhhHhhcCCcchhhh
Confidence            99999999887665 6788899999999999999999999999999999999999998 999999999988766566555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC-
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE-  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  239 (293)
                      -..|-||+|||.+.+..+|....|||++||++.||++|...|.+...-+.+-.|....+.....-..-+....-..... 
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            5578899999999997789999999999999999999999999988887777777666655443222222111111111 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      +.......+..-.+.++.-+.+++++||..||++|++.+++|.||||..|
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            11111233344456677888999999999999999999999999999765

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-55  Score=335.01  Aligned_cols=286  Identities=41%  Similarity=0.682  Sum_probs=258.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||...++||+|.||+||+|++..+|+.||||+++.....+.......+|++.|+.++|+||+.++++|...+.+.+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            78999999999999999999999999999999988877777778889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++-++...+..+ ...+++..+..++.+++.||+|+|.+.+.||||||.|++|+.+|. +|++|||.++.+.++......
T Consensus        83 m~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~-lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   83 MPTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ-LKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             ccccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc-EEeecccchhccCCCCccccc
Confidence            998887666544 557899999999999999999999999999999999999999998 999999999999887666665


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ...|-||+|||.+.+...|+...|+||.|||+.||+.|...|.+.+.-+++..+++..+.|..+.||+.+.+.+-..+..
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~  240 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ  240 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999988777655442


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .  +......+.+..+.++.+|+.+|+..||.+|+++.++|+|+||+..+
T Consensus       241 ~--P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  241 F--PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             C--CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            2  22223337777899999999999999999999999999999999754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-56  Score=355.55  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=216.8

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-ceeEeecC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-IDLVFENL   81 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~~   81 (293)
                      +.++.||+|..|+||++.++.+++.+|+|++ ......+..+++.+|+++++..+||||+.+++.|..++. .+++||||
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            3468899999999999999999999999999 344556677899999999999999999999999999994 99999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +|+.++.+.... ..+++..+.+++.++++||.|||+ .+|+||||||+||+++..|+ |||+|||.+......  ....
T Consensus       161 DgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe-VKicDFGVS~~lvnS--~a~t  236 (364)
T KOG0581|consen  161 DGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE-VKICDFGVSGILVNS--IANT  236 (364)
T ss_pred             CCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC-EEeccccccHHhhhh--hccc
Confidence            987777666544 458899999999999999999995 89999999999999999998 999999999877554  3344


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR--WAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..||..|||||.+.+. .|+.++||||||+.++|+.+|++||...  +.......+.+....++..              
T Consensus       237 fvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~--------------  301 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR--------------  301 (364)
T ss_pred             ccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC--------------
Confidence            4599999999999887 7999999999999999999999999874  2223333333322222211              


Q ss_pred             CCCCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                  .+.+ +|+++.+||..||+.||++|||+.++++|||+++...
T Consensus       302 ------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  302 ------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             ------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                        2222 7899999999999999999999999999999998754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-54  Score=356.65  Aligned_cols=283  Identities=39%  Similarity=0.658  Sum_probs=251.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e   79 (293)
                      |+.+++||+|.||.||+|++..+|+.||+|++......+....-..+|+.+|++|.||||+++.+...+.  +.+|+|+|
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe  198 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE  198 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence            6778999999999999999999999999999988777777777788999999999999999999987766  68999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      ||+.+|..++.. +...+++.++..+++||+.||.|+|++|+.|||||.+||+|+.+|. +||+|||+++.+...... .
T Consensus       199 YMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~-LKiaDFGLAr~y~~~~~~~~  276 (560)
T KOG0600|consen  199 YMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV-LKIADFGLARFYTPSGSAPY  276 (560)
T ss_pred             cccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC-EEeccccceeeccCCCCccc
Confidence            999988876654 4567899999999999999999999999999999999999999998 999999999977554332 4


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....-|.||+|||.+.+...|+.+.|+||.|||+.||++|+..|.+.+.-+++.+|+...+.|.+..|+ ...+...-.+
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~  355 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIF  355 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCccccc
Confidence            444478999999999999999999999999999999999999999999999999999999999999998 4444433445


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                      .........+......++....+|+..||+.||.+|.||.++|.++||.
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            5555555666677888999999999999999999999999999999993

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=344.34  Aligned_cols=258  Identities=29%  Similarity=0.437  Sum_probs=224.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |+++++||+|+||+|+.++.+.+++.||+|++++..... ...+...+|..+|.+++||.|++++..|++.+.+|+|+||
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~  106 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY  106 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence            789999999999999999999999999999997655433 3567888999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +.| .+...++...  .+++..++-++..|+.||.|||++||+||||||+||+++.+|+ ++|+|||+++..-.......
T Consensus       107 ~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH-i~LtDFgL~k~~~~~~~~t~  183 (357)
T KOG0598|consen  107 LNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH-IKLTDFGLCKEDLKDGDATR  183 (357)
T ss_pred             cCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc-EEEeccccchhcccCCCccc
Confidence            986 5555554433  4788899999999999999999999999999999999999999 99999999986544444445


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+||+.|||||++.+. .++.++|.||||+++|+|++|..||.+.+......++....                     
T Consensus       184 tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------------------  241 (357)
T KOG0598|consen  184 TFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------------------  241 (357)
T ss_pred             cccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------------------
Confidence            56799999999999888 79999999999999999999999999999999988886422                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC----CHHHHhcCcccccCcCC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----TAREALRHEYFKDFQSL  292 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~p~~~~~~~~  292 (293)
                              ....+..++.+++++++++|..||++|.    .+.++-+||||..++|-
T Consensus       242 --------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  242 --------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             --------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                    1222334789999999999999999995    78999999999999873

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-53  Score=334.05  Aligned_cols=286  Identities=38%  Similarity=0.656  Sum_probs=254.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee--cCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS--SVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e   79 (293)
                      |+++.+|++|.||+||+|+++.+++.||+|+++.+...+...---.+|+.+|.+.+||||+.+..+..  +.+..|+|||
T Consensus        78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            77889999999999999999999999999999877665555566778999999999999999988754  3457999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++.++...+.... .++....+.-++.|++.||+|||++.|+||||||+|++++..|. +|++|||+++.++++.....
T Consensus       158 ~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~-lKiaDFGLAR~ygsp~k~~T  235 (419)
T KOG0663|consen  158 YVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI-LKIADFGLAREYGSPLKPYT  235 (419)
T ss_pred             HHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc-EEecccchhhhhcCCcccCc
Confidence            99988887776655 46888899999999999999999999999999999999999898 99999999999999877777


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ....|.||+|||.+.+...|+.+.|+||+|||+.+|+++...|.+...-+.+.+|+...+.|.+..++++......-...
T Consensus       236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~  315 (419)
T KOG0663|consen  236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT  315 (419)
T ss_pred             ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence            77789999999999999999999999999999999999999999999999999999999999999999998877654444


Q ss_pred             CCCCcccchhhhcCC--CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ........+......  ++....+|++.+|..||.+|.||++.|.|+||...
T Consensus       316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            455555555444433  55999999999999999999999999999999874

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-52  Score=347.68  Aligned_cols=283  Identities=40%  Similarity=0.683  Sum_probs=232.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||.|++|+||++.+..++..+|+|++..... ......+.+|++++++++||||+++++++...+..++|||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            59999999999999999999999999999999864432 22345677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.... ..+++..+..++.||+.||++||++|++|+||+|+||+++.++. +||+|||.+............
T Consensus        85 ~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          85 LDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE-LKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEECcCcceeeccCCCccccC
Confidence            9998887776543 34678899999999999999999999999999999999998888 999999998765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+....++......+......
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF  242 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence            44788999999887766789999999999999999999999999988888888888888887777665543322222111


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ............+.++.++.++|++||+.||.+|||++|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1111122233445678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-52  Score=332.66  Aligned_cols=288  Identities=45%  Similarity=0.741  Sum_probs=255.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCC------cc
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVD------SI   74 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~------~~   74 (293)
                      |..+++||+|+||+||+|+++.+|+.||+|++......+.......+|+.+++.++|+| |+.+++++...+      .+
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            55677899999999999999999999999999776665556677889999999999999 999999987776      79


Q ss_pred             eeEeecCCcchHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLDFDLLHFMKTEPT--VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ++|+|++..++..++.....  ...+...+..+++||+.||+|||++||+||||||.||+|+++|. +||+|||.++...
T Consensus        93 ~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~-lKlaDFGlAra~~  171 (323)
T KOG0594|consen   93 YLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV-LKLADFGLARAFS  171 (323)
T ss_pred             EEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc-EeeeccchHHHhc
Confidence            99999999999998877654  35676789999999999999999999999999999999999998 8999999999877


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      -+........+|.+|+|||++.+...|+...|+||+|||++||++++..|.+....+.+..|+...+.|....||.....
T Consensus       172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~  251 (323)
T KOG0594|consen  172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL  251 (323)
T ss_pred             CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence            67676777779999999999999988999999999999999999999999999999999999999999999999998876


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .+....-........+....+...++..+++.+||+.+|.+|.|++..|.||||....
T Consensus       252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            6655322333334556666677778999999999999999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-52  Score=350.33  Aligned_cols=255  Identities=33%  Similarity=0.523  Sum_probs=221.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|.+++.||+|+||+|+.+.+..++..+|+|++......   ......+.+|+.+++++. ||||+++++++......|+
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            589999999999999999999999999999977554211   234567778999999998 9999999999999999999


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC-CCeEEEccCCCcccCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVP  154 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~-~~~v~l~df~~~~~~~~~  154 (293)
                      ||||+. |.+++.+.+  ..++.+..++.+++|++.|++|+|+.|++||||||+||+++.+ ++ +||+|||++......
T Consensus        98 vmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~-~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN-LKLSDFGLSAISPGE  174 (370)
T ss_pred             EEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC-EEEeccccccccCCC
Confidence            999998 588888887  3457889999999999999999999999999999999999999 77 999999999877433


Q ss_pred             CcceeccCccccccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSG-RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .......+|++.|+|||++.+.. +...++||||+|++||.|++|.+||.+.+......++....               
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---------------  239 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---------------  239 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC---------------
Confidence            35556667999999999999886 55689999999999999999999999987777777764311               


Q ss_pred             cccCCCCCCCcccchhhhcCCC-CchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGL-EPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                     -.++..+ ++++.+++.+||..||.+|+|+.+++.||||+.
T Consensus       240 ---------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 ---------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ---------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                           1233345 889999999999999999999999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-53  Score=349.50  Aligned_cols=258  Identities=29%  Similarity=0.422  Sum_probs=224.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |..++.||+|+|++|++|+++.+++.||||++.+.... +.-.+-+..|-.+|.+| .||.|++++..|.+...+|+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            67899999999999999999999999999998654432 23335566788999999 79999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |++ |.+++++...+  .+++.-.+.++.+|+.||+|||++||+||||||+||+++.+++ ++|+|||.++.+...... 
T Consensus       155 ~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh-ikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH-IKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             ecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc-EEEeeccccccCChhhccc
Confidence            998 88888887764  5888899999999999999999999999999999999999999 999999999876432111 


Q ss_pred             ----------e--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCC
Q 038154          158 ----------Y--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET  225 (293)
Q Consensus       158 ----------~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (293)
                                .  .+..||-.|.+||++... ..+..+|+|+||||+|+|+.|..||.+.+.=-+.++|......+    
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f----  306 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF----  306 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC----
Confidence                      1  224488899999987766 78999999999999999999999999999999999998755543    


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCCC
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD  293 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~~  293 (293)
                                                ++++++.+.+||+++|..||++|+|+.+|.+||||..+.|-|
T Consensus       307 --------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  307 --------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             --------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                                      445688999999999999999999999999999999988753

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-51  Score=340.65  Aligned_cols=287  Identities=38%  Similarity=0.618  Sum_probs=221.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||+|.+..+++.+|+|++..... ......+.+|+++++.++||||+++++++......++||||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            58999999999999999999998999999999864432 22334677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. +||+|||.+............
T Consensus        85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          85 VHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE-LKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECCCCcceeccCCCccCCC
Confidence            9999888876543 35788899999999999999999999999999999999998888 999999998755433333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||.+... .+....+....+.+....++............
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            45788999999887766788999999999999999999999987543 34455555444444443333322111100000


Q ss_pred             CCCCcccchhhh--cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          240 PNRSPIKDLATV--VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       240 ~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ............  ....+..+.+++.+||+.||++|||+.++++||||++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            000000111111  112467899999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-54  Score=331.42  Aligned_cols=245  Identities=28%  Similarity=0.400  Sum_probs=211.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeee-eeecCCc-ceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN-VQSSVDS-IDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~-~~lv~e   79 (293)
                      |+|.++||+|+||.||++.+..+|..+|.|.++.........+.+..|+.+|++|+||||+++++ .+..+.. +++|||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            78999999999999999999999999999999865555566678889999999999999999998 4444444 999999


Q ss_pred             cCCcchHHHhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           80 NLDFDLLHFMK---TEPTVTKNPLKIKKYLHQILHGVAYCHS--QE--ILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        80 ~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      +|+++-+..+.   ..+...+++..+|+++.|++.||..+|.  ..  +.||||||.|||++.+|. |||+|||+++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv-vKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV-VKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc-eeeccchhHhHhc
Confidence            99854444333   3455678999999999999999999998  44  999999999999999998 9999999999988


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      +...-..+..|||.||+||.+.+. .|+.+|||||+||++|||+..+.||.+.+-.+...+|.....             
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-------------  245 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-------------  245 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-------------
Confidence            776666667799999999998887 699999999999999999999999999988888888865322             


Q ss_pred             ccccCCCCCCCcccchhhhc-CCCCchHHHHHHHhhccCCCCCCCH
Q 038154          233 SEEFGFEPNRSPIKDLATVV-GGLEPDGVDLLRRMLCLDPSKRLTA  277 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~  277 (293)
                                      +.++ ..+|.++.+||.-|+..||+.||+.
T Consensus       246 ----------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 ----------------PPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ----------------CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                            2223 3468899999999999999999986

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.6e-51  Score=340.43  Aligned_cols=287  Identities=40%  Similarity=0.689  Sum_probs=234.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.++.++..+|+|++..... ......+.+|++++++++|||++++++++..++..++||||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            58999999999999999999998999999999864432 23334677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.... ..++...+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||.+............
T Consensus        86 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          86 LDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECccccceecCCCcccccc
Confidence            9998888776543 34678889999999999999999999999999999999998887 999999998765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+....++.............
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            34788999999887766789999999999999999999999999988888888888877777666554433222211111


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ............+.+++++.++|.+||+.||.+|||+.|+++||||+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            11111222234456889999999999999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-51  Score=333.33  Aligned_cols=269  Identities=26%  Similarity=0.301  Sum_probs=224.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++..+||.|..++||+|+....++.||||++..+....+ .+.+..|++.++.++||||++++..|..++.+|+||.+|
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM  106 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM  106 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence            8899999999999999999999999999999988776665 788999999999999999999999999999999999999


Q ss_pred             C-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce--
Q 038154           82 D-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--  158 (293)
Q Consensus        82 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--  158 (293)
                      . |++++.+...-...+++..+..|+++++.||.|||++|.+|||||+.||+|+.+|. |+|+|||.+..+.......  
T Consensus       107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~-VkLadFgvsa~l~~~G~R~~~  185 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT-VKLADFGVSASLFDSGDRQVT  185 (516)
T ss_pred             cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc-EEEcCceeeeeecccCceeeE
Confidence            8 77888887777778999999999999999999999999999999999999999999 9999999876553322222  


Q ss_pred             --eccCccccccCcccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 --TIKGGSLCYKAPERL-LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 --~~~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        ....|+++|||||++ .....|+.++||||||++..|+.+|..||...-+-+++-.-  ....++..... .      
T Consensus       186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t~-~------  256 (516)
T KOG0582|consen  186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLTS-G------  256 (516)
T ss_pred             eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcccc-c------
Confidence              223589999999994 44567999999999999999999999999877665443332  22333322211 1      


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                                 ......+..+..+.++|..||..||++|||++++|+|+||++.+..
T Consensus       257 -----------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  257 -----------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             -----------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                       1112223456789999999999999999999999999999988754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-51  Score=347.74  Aligned_cols=258  Identities=31%  Similarity=0.504  Sum_probs=231.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEeccc-CCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM-NPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++++-||.|+.|.|-+|++..+|+..|||++... .........+.+|+-+|+.+.|||++.+++++++...+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            78899999999999999999999999999999765 45556678899999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |.+.+++..++.  +.+..+.++++||+.|+.|+|..++||+||||+|++++.+++ |||+|||.|..-... ....
T Consensus        94 v~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~g-klLe  169 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPG-KLLE  169 (786)
T ss_pred             cCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCC-cccc
Confidence            97 788888888765  677799999999999999999999999999999999999999 999999999876544 3344


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+|+|-|.+||++.+..+...++||||.|+|||.|++|.+||++.+....+.+......                    
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--------------------  229 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--------------------  229 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--------------------
Confidence            456999999999999998889999999999999999999999999988888888754222                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCCC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD  293 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~~  293 (293)
                                +++..++.++++||++||..||++|.|..||++|||+....+++
T Consensus       230 ----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  230 ----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             ----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence                      34456899999999999999999999999999999999887654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-52  Score=329.32  Aligned_cols=287  Identities=37%  Similarity=0.589  Sum_probs=240.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-----CCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-----VDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (293)
                      +|...+.||+|++|.|+.+.++.+|+.||||++..........++..+|+++|+.++|+||+.+.+++..     -+..|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            3555799999999999999999999999999987555556667888999999999999999999998755     34689


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-  154 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-  154 (293)
                      +|+|.++-++...+.....  +++..+..++.||+.||.|+|+.|++||||||+|++++.+.. +|++|||+++..... 
T Consensus       103 iV~elMetDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~-lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD-LKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHHhhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC-EEeccccceeeccccC
Confidence            9999998888777766543  788899999999999999999999999999999999999988 899999999987543 


Q ss_pred             -CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          155 -LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       155 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                       ....+.-..|.||+|||.+.....|+.+.||||.|||+.||++|+..|.+.+.-..+..+....+.+..+.........
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             1111222268899999999888899999999999999999999999999999999999999999998766555444211


Q ss_pred             c-ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          234 E-EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      - .+-......+......+.++.++.+.+|+.+||..||.+|+|++|.|+||||..+-
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            1 11111223333556677789999999999999999999999999999999998874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-51  Score=329.67  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=216.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|.+.+.||+|+|++||+|+++.++..||||.+..........+.+..|+.+|+.++||||+.+++++..++..|+||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            48889999999999999999999999999999876655566778889999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC-CC----eEEEccCCCcccCCCC
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS-KD----IVKIADFGLARPIDVP  154 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~-~~----~v~l~df~~~~~~~~~  154 (293)
                      |. |++-.++..++  .+++..++.++.||+.||++||+++|+||||||+||+++.. +.    .+||+|||+++.....
T Consensus        91 C~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            98 56666666654  58899999999999999999999999999999999999975 22    5899999999988744


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       ......+|+|-|||||++... .|+.++|+||+|+++|+|++|..||...+..+....+.....               
T Consensus       169 -~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---------------  231 (429)
T KOG0595|consen  169 -SMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---------------  231 (429)
T ss_pred             -hHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc---------------
Confidence             444556799999999988755 799999999999999999999999999999988875532111               


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                  .....+...+..+.+++...|..+|..|-+..+-+.|+++..
T Consensus       232 ------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  232 ------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                        111222334566678888888888888888888888887653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.2e-50  Score=333.02  Aligned_cols=287  Identities=40%  Similarity=0.673  Sum_probs=232.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|.+..... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            59999999999999999999998999999998864332 22334677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++...+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        86 ~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          86 LDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             cccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc-EEECcCcchhccCCCCCcccc
Confidence            9998887776543 35778899999999999999999999999999999999998887 999999998765433333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+......+....++.............
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY  243 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence            34678899999887766788999999999999999999999999888888888877777766655554322221111111


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ..............+++++.+||.+||+.||.+|||+.+++.||||+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            11111222344556788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.9e-50  Score=331.48  Aligned_cols=280  Identities=37%  Similarity=0.633  Sum_probs=223.8

Q ss_pred             CceeeeeeccccceeEEEEEeCC-CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeeeee-----cC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNVQS-----SV   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~~   71 (293)
                      ||++.+.||+|++|.||++.+.. ++..+|+|.+............+.+|+.+++.+   .||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            79999999999999999998754 567899998866554444445667788877766   6999999999874     34


Q ss_pred             CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           72 DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ...++|||++++++.+.+.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+...
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~  160 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIY  160 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC-EEEccccceEec
Confidence            5689999999998888887666566888999999999999999999999999999999999998887 999999998765


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ... .......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....+.+....++....
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            433 222333478999999988665 688999999999999999999999999988888888887766555444433222


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .....   .............+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus       239 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQA---FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchh---ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            11111   01111122334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-50  Score=333.09  Aligned_cols=283  Identities=31%  Similarity=0.542  Sum_probs=221.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++............+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            69999999999999999999999999999999876554455567788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-cee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~~  159 (293)
                      ++++++..+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          82 VEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccCccccccccccccc
Confidence            9988887776543 35788899999999999999999999999999999999998887 99999999876543221 122


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc--cC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE--FG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  237 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....+..+.............  ..
T Consensus       160 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            23478899999988766 5889999999999999999999999987766665555544443322211111000000  00


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .................++.++.+|+++||+.||++|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0000001111123334578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-51  Score=330.69  Aligned_cols=256  Identities=30%  Similarity=0.462  Sum_probs=205.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--cceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--SIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e   79 (293)
                      |..++.||+|+||+||++.+..+|+..|+|.........  .+.+.+|+++|.+++||+||+++|......  .+++.||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            677899999999999999999889999999876542211  567899999999999999999999744443  6999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-CCCeEEEccCCCcccCCC---CC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDIVKIADFGLARPIDV---PL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~~~---~~  155 (293)
                      |+.++.+..+..+....+++..++.+.+||++||.|||++|++|+||||+||+++. ++. +||+|||.+.....   ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~-~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD-VKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe-EEeccCccccccccccccc
Confidence            99965555554443337899999999999999999999999999999999999998 566 99999999887663   11


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-WAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      .......|++.|||||++........++|||||||++.+|+||..||... ...+..-.+..   .              
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~--------------  238 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---E--------------  238 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---c--------------
Confidence            22334559999999999885323345999999999999999999999874 22222222211   1              


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 .....++..++.++.+|+.+|+..||.+||||+++|.|||.+.
T Consensus       239 -----------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  239 -----------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence                       1112455668999999999999999999999999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=316.17  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=223.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||.|+||.|.+++++.+|..||+|++...... ....++..+|..+|+.+.||.++++++.+.+.+.+|+|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            378899999999999999999999999999998654322 2445678889999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++ |.+..++...+  ++++..++-++.||+.||+|||++++++|||||+||++|.+|. +||+|||+++.....   .
T Consensus       125 yv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~-iKitDFGFAK~v~~r---T  198 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH-IKITDFGFAKRVSGR---T  198 (355)
T ss_pred             ccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc-EEEEeccceEEecCc---E
Confidence            998 55666665543  5788899999999999999999999999999999999999999 999999999987643   4


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+|||.|+|||++... .++.++|-|+||+++|||+.|..||-+.++..+..+|....-                   
T Consensus       199 ~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-------------------  258 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-------------------  258 (355)
T ss_pred             EEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-------------------
Confidence            556699999999988877 699999999999999999999999999999999999875333                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC-----CCHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR-----LTAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-----ps~~~ll~~p~~~~~~~  291 (293)
                                 ..++.++.++++|+.++|+.|-++|     ....+|..||||+.+.|
T Consensus       259 -----------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  259 -----------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             -----------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence                       2345578899999999999999999     46689999999998876

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.7e-50  Score=335.87  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=219.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |+++++||+|+||.||+|+.+.+|+.+|+|+++.+.. .......+..|-.+|..-.+|+||+++..|.+..++||||||
T Consensus       143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy  222 (550)
T KOG0605|consen  143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY  222 (550)
T ss_pred             chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence            7889999999999999999999999999999977653 345668899999999998999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC------
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV------  153 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~------  153 (293)
                      ++ |+....++...  .+++..++.++.+++.|+..||+.|++|+||||+|++||..|+ +||+|||++.....      
T Consensus       223 lPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  223 LPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH-IKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             cCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC-Eeeccccccchhhhhhhhhh
Confidence            98 56666666654  4778899999999999999999999999999999999999999 99999999843311      


Q ss_pred             --------------CCccee---------------------------ccCccccccCcccccCCCCCCCchhHHHHHHHH
Q 038154          154 --------------PLENYT---------------------------IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF  192 (293)
Q Consensus       154 --------------~~~~~~---------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll  192 (293)
                                    ......                           +..|||.|+|||++.+.+ ++...|.||||||+
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIM  378 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHH
Confidence                          000000                           011899999999999984 99999999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCC
Q 038154          193 AEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS  272 (293)
Q Consensus       193 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  272 (293)
                      |||+.|..||.+.++.+..+++........-                          +....++.++++||.+||+ ||.
T Consensus       379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------------------P~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------------------PEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------------------CCcCcccHHHHHHHHHHhc-CHH
Confidence            9999999999999999999999763321110                          0112356899999999999 999


Q ss_pred             CCC---CHHHHhcCcccccCcCC
Q 038154          273 KRL---TAREALRHEYFKDFQSL  292 (293)
Q Consensus       273 ~Rp---s~~~ll~~p~~~~~~~~  292 (293)
                      +|.   ++.||..||||+.+.|-
T Consensus       432 ~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HhcCcccHHHHhcCCccccCCcc
Confidence            997   58999999999999873

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-50  Score=339.80  Aligned_cols=287  Identities=32%  Similarity=0.524  Sum_probs=221.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||++.+.||+|++|.||++.+..+|..||+|++............+.+|+++++.++||||+++++++....     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            799999999999999999999999999999998644333344457889999999999999999999875432     479


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +||||+++++.+.+....  .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+.......
T Consensus        81 lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEccCcccccccccc
Confidence            999999988888776543  4788899999999999999999999999999999999998887 9999999987543221


Q ss_pred             cc---eeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          156 EN---YTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       156 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ..   .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+.+.......+....+.+..........
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            11   1223478899999987652 4688999999999999999999999988777666666655555443332221111


Q ss_pred             cc--cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          232 FS--EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       232 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ..  .... ..............+..++++.+++.+||+.||++|||++++++||||+.+++
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHH-hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            00  0000 00000111122334457889999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-51  Score=339.62  Aligned_cols=256  Identities=27%  Similarity=0.403  Sum_probs=220.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|.-.+++|+|+.|.||.+....+++.||||++....  ....+-+.+|+.+|+..+|+||+++++.+...+.+++||||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4677789999999999999999999999999986644  34457899999999999999999999999888999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+.+..+.....  +++.++..++++++.||+|||.+||+|+|||.+||+++.+|. +||+|||++..+.........
T Consensus       352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~-vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS-VKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc-EEEeeeeeeeccccccCcccc
Confidence            99887887776654  889999999999999999999999999999999999999999 999999999888766656666


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..|||.|||||++... .|+++.||||||++++||+-|+.||-..++-..+-.|.. .+.+                   
T Consensus       429 mVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P-------------------  487 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-------------------  487 (550)
T ss_pred             ccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCC-------------------
Confidence            6699999999988776 699999999999999999999999977555444444322 1211                   


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                             ....+..+|+++++|+.+||+.|+.+|++|.+||+||||+..
T Consensus       488 -------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  488 -------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             -------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                   112344589999999999999999999999999999999654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-49  Score=327.91  Aligned_cols=283  Identities=40%  Similarity=0.729  Sum_probs=225.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..+|+.+++|.++...........+.+|+++++.++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            79999999999999999999999999999999876544444556788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++...+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          81 CDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc-EEECccchhhccCCCCCCcCC
Confidence            9998888776543 35788999999999999999999999999999999999998887 999999998766544333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|..|+ .+.+..+....+....+.+....++........... 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY-  237 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc-
Confidence            446788999998877656789999999999999999999885 555556666666665555444333322211111100 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ........+....+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            11111122234455688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-50  Score=321.20  Aligned_cols=282  Identities=34%  Similarity=0.554  Sum_probs=231.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      +|+-.+++|.|+||+||.|....+++.+|||+.-.+..      --.+|+++|+.+.||||+++..+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            47778999999999999999988899999998743322      2236999999999999999987764332     456


Q ss_pred             eEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           76 LVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +||||++-++...+..  .....++.-.++-+.+||++||.|||..|+|||||||.|+++|.+...+||+|||+|+....
T Consensus        99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen   99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9999999988887763  22345666688889999999999999999999999999999999866799999999987755


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ..... +-.-+--|+|||.+.+...|+.+.||||.||++.||+-|+..|.+.+..+++..|....+.|..+.........
T Consensus       179 ~epni-SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  179 GEPNI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCCce-eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            43332 22245679999999999999999999999999999999999999999999999999999999887766655543


Q ss_pred             cccCCCCCCCcccchh-hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLA-TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ..+.+...+.  ..+. ...+..++++.+|+.++|..+|.+|.++.+++.||||..+..
T Consensus       258 ~~~~~p~ik~--~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  258 TEFKFPQIKA--HPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ccccCccccc--ccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            3333222222  1222 366778999999999999999999999999999999988754

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.1e-49  Score=326.04  Aligned_cols=283  Identities=46%  Similarity=0.749  Sum_probs=226.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||+|.+..++..+++|++............+.+|+.+++++.|||++++++++..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            89999999999999999999889999999998655444444567888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DFDLLHFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~~~~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+.+.... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV-IKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc-EEECcccceeecCCCcccccC
Confidence            988877775533 256788899999999999999999999999999999999998888 999999998765544333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+...++.++|+||||+++++|++|..||......+....+....+.+....++......... ...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK-NTF  239 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH-hhc
Confidence            3467889999988776667899999999999999999999999877766666666555554444433322211110 000


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ..............+++++.++|.+||+.||++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            1111122233345689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.8e-49  Score=324.85  Aligned_cols=280  Identities=38%  Similarity=0.634  Sum_probs=223.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeeeeecC-----C
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNVQSSV-----D   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~-----~   72 (293)
                      ||++.+.||+|++|+||++.+..+++.+|+|.+............+.+|+++++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            79999999999999999999999999999999865444444444566788777766   699999999987543     3


Q ss_pred             cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           73 SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ..++++|++++++...+.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ-VKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccCcccccc
Confidence            578999999998888877655556889999999999999999999999999999999999998888 9999999987654


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||......+...++....+.+....++.....
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         160 CQM-ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             Ccc-cCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            321 11223378899999988765 6899999999999999999999999988888888888776665554444432221


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ....   .............+.++.++.+++.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PRGA---FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccc---cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1110   01111122334556788899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-50  Score=341.83  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=227.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|++.++||+|.||+|+++..+.+++.||||++++.. ...+..+..+.|-+++...+ ||.+++++..|....++|+||
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            3789999999999999999999999999999997765 34566788889999998885 999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||+.|+.+..++  ....+++..++-++..++.||+|||++||++||||.+||++|..|. +||+|||+++..-......
T Consensus       449 ey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe~m~~g~~T  525 (694)
T KOG0694|consen  449 EYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKEGMGQGDRT  525 (694)
T ss_pred             EecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-EEecccccccccCCCCCcc
Confidence            999977733332  2346899999999999999999999999999999999999999999 9999999998665444555


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+|||.|+|||++.+. .|+.+.|-|+||++||+|+.|++||.+.+.+++...|..                      
T Consensus       526 sTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------------------  582 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------------------  582 (694)
T ss_pred             ccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------------
Confidence            667799999999988877 799999999999999999999999999999999999863                      


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcCC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQSL  292 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~~  292 (293)
                              +...++..++.++.++++++|..||++|..     +++|..||||+.+.|.
T Consensus       583 --------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  583 --------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             --------CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence                    223445568999999999999999999985     5889999999999874

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-50  Score=340.85  Aligned_cols=282  Identities=30%  Similarity=0.450  Sum_probs=234.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-C-----CCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-H-----ENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~   74 (293)
                      ||.|.+.||+|+||.|.+|.+..+++.||||+++..   .....+...|+.+|..|+ |     -|+++++++|...++.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            799999999999999999999999999999998643   344567778999999997 4     3899999999999999


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC-CeEEEccCCCcccCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-DIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~-~~v~l~df~~~~~~~~  153 (293)
                      |||+|-+..++.+++.++...+++...++.++.||+.||.+||+.||+|+||||+|||+..-+ ..|||+|||.++....
T Consensus       264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999997543 3699999999997764


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ....   -..+.-|+|||++.+- +++.+.|+||||||+.||++|...|.+.+.-+.++.|.+..+.|+........+..
T Consensus       344 ~vyt---YiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~  419 (586)
T KOG0667|consen  344 RVYT---YIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH  419 (586)
T ss_pred             ccee---eeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence            4332   2256679999999988 79999999999999999999999999999999999999999988776554443333


Q ss_pred             cccCC-CCC------CC-------------------------cccchhhhcC-CCCchHHHHHHHhhccCCCCCCCHHHH
Q 038154          234 EEFGF-EPN------RS-------------------------PIKDLATVVG-GLEPDGVDLLRRMLCLDPSKRLTAREA  280 (293)
Q Consensus       234 ~~~~~-~~~------~~-------------------------~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~l  280 (293)
                      ..+.. ...      ..                         ....+..... .....+.+++++||.+||.+|+|+.+.
T Consensus       420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa  499 (586)
T KOG0667|consen  420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA  499 (586)
T ss_pred             eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence            33221 000      00                         0011111111 234567999999999999999999999


Q ss_pred             hcCcccccC
Q 038154          281 LRHEYFKDF  289 (293)
Q Consensus       281 l~~p~~~~~  289 (293)
                      |+||||...
T Consensus       500 l~Hpfl~~~  508 (586)
T KOG0667|consen  500 LNHPFLTGT  508 (586)
T ss_pred             hcCcccccc
Confidence            999999854

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-49  Score=344.18  Aligned_cols=282  Identities=29%  Similarity=0.458  Sum_probs=217.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--------C
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--------D   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~   72 (293)
                      +|++++.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++...        .
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            589999999999999999999889999999987432      12345799999999999999998875322        2


Q ss_pred             cceeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           73 SIDLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      .+++||||+++++...+..  .....+++..++.++.||+.||+|||+.|++||||||+||+++.++..+||+|||.+..
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            4679999999987776643  23346788899999999999999999999999999999999997765599999999986


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ...... .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+.........
T Consensus       221 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        221 LLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             ccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            643322 2223478899999988776678999999999999999999999999988877777777666555433222111


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .......+.. ..........+...+.++.+||.+||+.||.+|||+.++|.||||..+.
T Consensus       300 ~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        300 PNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             hhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            1000000100 0011112234456788999999999999999999999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-50  Score=338.00  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=228.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+.....+.+|+++++.++||||+.++++|+....+++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            57888999999999999999999999999999988777777778899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.|++...+...+.  ++++.++.++.|+..||.|||+.++.|+|+||.||+++..+. +|++|||+++.+.....-...
T Consensus        83 a~g~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~-~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   83 AVGDLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT-LKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc-eeechhhhhhhcccCceeeee
Confidence            99988888877654  788899999999999999999999999999999999999888 999999999998877666666


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..|+|.|||||++.+. +++..+|+||||||+||+++|+.||-....-+....|......                    
T Consensus       160 ikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--------------------  218 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--------------------  218 (808)
T ss_pred             ccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--------------------
Confidence            6799999999988865 8999999999999999999999999887777777776532222                    


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                .+...+..+++++..+|..||.+|.|..+++.|||++.
T Consensus       219 ----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  219 ----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             ----------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence                      23346788999999999999999999999999999875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=311.78  Aligned_cols=258  Identities=31%  Similarity=0.435  Sum_probs=224.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+|++|+++.+..+|+.+++|.++....+....+++.+|+++-+.|+||||+++.+.+...+..|+|+|.
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~   91 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   91 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence            47888999999999999999999999999999987777777889999999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +.| .+-..+.++  ...++..+-..++||++||.|.|.+||+|+|++|+|+++-...+  -+||+|||.+...+ ....
T Consensus        92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~  168 (355)
T KOG0033|consen   92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEA  168 (355)
T ss_pred             ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cccc
Confidence            985 444555444  34678888999999999999999999999999999999965433  69999999998877 3233


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|+|.|+|||++... +++..+|||+.|++||-++.|..||-+.+.....+.|.......+               
T Consensus       169 ~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~---------------  232 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP---------------  232 (355)
T ss_pred             cccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC---------------
Confidence            4444599999999988776 799999999999999999999999999888888888866433332               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 ...++.+++++++||++||..||.+|.|+.|.|+|||+.+
T Consensus       233 -----------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  233 -----------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             -----------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                       2345568999999999999999999999999999999865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-49  Score=329.05  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=212.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.+|+|++...... ......+.+|+++++++.||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            589999999999999999999989999999998643321 2234568889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.+ ++.+++....  .+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+......   .
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~-~kl~Dfg~~~~~~~~---~  155 (291)
T cd05612          82 YVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDR---T  155 (291)
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEEecCcchhccCC---c
Confidence            9985 5555555443  4778899999999999999999999999999999999998887 999999998765432   1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....                    
T Consensus       156 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------------------  214 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--------------------  214 (291)
T ss_pred             ccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------
Confidence            223488999999988766 57899999999999999999999999887766666654311                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                ...+..++..+.++|++||+.||.+||+     +.++++||||..+++
T Consensus       215 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         215 ----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                      0122345788999999999999999995     999999999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.4e-48  Score=321.24  Aligned_cols=291  Identities=54%  Similarity=0.861  Sum_probs=234.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.++.+|+.+++|.+............+.+|+++++++.|||++++++++......++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            68999999999999999999988999999998865444344456788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++...+........++..++.++.||+.||++||++|++|+||+|+||+++..+..+||+|||.+............
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (294)
T PLN00009         83 LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH  162 (294)
T ss_pred             ccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccccc
Confidence            99988888776665567888899999999999999999999999999999999976656999999999765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+......+....+..............
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T PLN00009        163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP  242 (294)
T ss_pred             CceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcc
Confidence            34678899999887665688999999999999999999999998877777777766666665555443333222211100


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                       ...........+.+++++.+++.+||+.||++||++.++++||||.++...
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        243 -KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             -cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence             111122334456688999999999999999999999999999999987654

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.7e-48  Score=323.87  Aligned_cols=288  Identities=39%  Similarity=0.616  Sum_probs=231.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++............+.+|+.++++++|+|++++++++...  +..++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            58999999999999999999999999999999875544444445667899999999999999999998655  4689999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++++++.+.+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        88 e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~kL~dfg~~~~~~~~~~~~  165 (309)
T cd07845          88 EYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPM  165 (309)
T ss_pred             ecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccceeeecCCccCCC
Confidence            999988777766533 45788899999999999999999999999999999999998887 9999999988765433233


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+....++..........+
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07845         166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF  245 (309)
T ss_pred             CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence            33335678999998877667899999999999999999999999999888888888887777766655544332221111


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .................++++.++|.+||+.||++|||+.++++||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            1111111222333344688999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.4e-49  Score=334.88  Aligned_cols=282  Identities=32%  Similarity=0.477  Sum_probs=213.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||++.+.||+|++|.||++.+..+|..+|+|++............+.+|+.+++.++||||+++++++...+      ..
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            699999999999999999999999999999998654444444567888999999999999999999876543      47


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||+++++...+..    .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus       102 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~-~kl~Dfg~a~~~~~~  176 (359)
T cd07876         102 YLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTACTN  176 (359)
T ss_pred             EEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEecCCCccccccC
Confidence            99999999988776643    3677889999999999999999999999999999999998888 999999998754332


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+....+.+.............
T Consensus       177 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         177 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             c-cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            1 12223478899999988765 688999999999999999999999998776655555554444332211110000000


Q ss_pred             cc-CCCCCCC-----------cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EF-GFEPNRS-----------PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+ .......           ............+.++.++|.+||+.||++|||+.|+|+||||+.|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            00 0000000           0000111222356789999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.5e-48  Score=321.13  Aligned_cols=283  Identities=47%  Similarity=0.753  Sum_probs=229.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||.|++|.||++.+..+|..+++|.+............+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            89999999999999999999989999999988655544445567889999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      .+++...+.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~-~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEeeccchhhcccCccccccc
Confidence            988888776655566888899999999999999999999999999999999998887 9999999987654433333333


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+++.|+|||.+.+...++.++|+||||+++|+|+||..||...+.......+....+.+....++......+.... ..
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS-FP  239 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh-cc
Confidence            46788999998877656788999999999999999999999988777777777776666655444332221111100 00


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ...........+.+++++.++|.+||+.||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            011122233345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.8e-49  Score=331.53  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      +.||+|+||.||++.+..+|+.+|+|++..... .......+.+|++++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999999999999999864322 2233356778999999999999999999999999999999999865


Q ss_pred             hH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           85 LL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        85 ~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      .+ ..+...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||.+..............|
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEeeCCCCcccccCCCcccceec
Confidence            44 444433  35788899999999999999999999999999999999998888 999999998754333233334458


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....                         
T Consensus       158 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------------------  211 (323)
T cd05571         158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------  211 (323)
T ss_pred             CccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence            9999999988765 68999999999999999999999998877666555543210                         


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                           ...+..+++++.++|.+||..||++||     ++.++++||||..+++
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                 012335688999999999999999999     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.1e-49  Score=329.92  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=210.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+++.+|+|++..... .......+.+|++++++++||||+++++++..++..|+|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            48899999999999999999999999999999865332 22344678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.| ++.+.+....  .+++..+..++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||.+.......   
T Consensus        99 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~---  172 (329)
T PTZ00263         99 FVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVPDRT---  172 (329)
T ss_pred             CCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC-EEEeeccCceEcCCCc---
Confidence            9985 5555555433  4677888999999999999999999999999999999998888 9999999987664322   


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+....                    
T Consensus       173 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--------------------  231 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--------------------  231 (329)
T ss_pred             ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence            223488999999988766 57899999999999999999999998776655555543210                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~  290 (293)
                                ...+..++..+.+||.+||+.||++||+     +.++++||||++..
T Consensus       232 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        232 ----------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             ----------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence                      0112235778999999999999999997     79999999998754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-48  Score=321.69  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=210.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++.+.||+|+||.||++.+..+|+.+|+|.+....... .....+.+|+++++.++|++++++.+++..++..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            889999999999999999999999999999886433222 2234577899999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++.+ ..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~-~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeCCCcEEcCCC-Ceec
Confidence            986555 4444444446888899999999999999999999999999999999998887 999999998765432 2223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++|..||...........+......                   
T Consensus       160 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  219 (285)
T cd05631         160 GRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-------------------  219 (285)
T ss_pred             CCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-------------------
Confidence            34588999999988765 6899999999999999999999999876543322222211110                   


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                             .....+..++.++.+|+++||+.||.+||+     ++++++||||..+++
T Consensus       220 -------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         220 -------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             -------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                   001123356889999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-48  Score=334.86  Aligned_cols=285  Identities=32%  Similarity=0.482  Sum_probs=222.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----ccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l   76 (293)
                      |++.+.||+|++|.||++.+..+|+.||+|++............+.+|+++++.++||||+++++++...+     ..|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            78999999999999999999889999999988543333334467888999999999999999999988776     7899


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+||+.+++...+....  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        82 v~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          82 VTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDES  158 (372)
T ss_pred             EeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC-EEeccccceeecccCcc
Confidence            99999988888775543  5788899999999999999999999999999999999998887 99999999876533211


Q ss_pred             -ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc-cc
Q 038154          157 -NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF-SE  234 (293)
Q Consensus       157 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  234 (293)
                       ......+++.|+|||++.+...++.++|+||+|+++|+|++|..||.+.+..+....+....+.+........... ..
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             1122236788999999887666899999999999999999999999998888877777766555443221111000 00


Q ss_pred             cc-CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EF-GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .. ...................++++.++|.+||+.||.+|||+.++|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            00 00000001111122344568899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-48  Score=331.85  Aligned_cols=283  Identities=30%  Similarity=0.456  Sum_probs=217.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||++.+.||+|++|.||++.+...++.+|+|++............+.+|+.+++.++||||+++++++...      ...
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            69999999999999999999999999999999865444444556788899999999999999999887543      357


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||+++++...+..    .+++..+..++.|++.||++||++|++|+||||+||+++.++. ++|+|||.+......
T Consensus       105 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~  179 (364)
T cd07875         105 YIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  179 (364)
T ss_pred             EEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc-EEEEeCCCccccCCC
Confidence            99999999988877643    3677889999999999999999999999999999999998887 999999999765433


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.+.............
T Consensus       180 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         180 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             C-cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            2 12233478899999988765 689999999999999999999999998877777766665544443222111110000


Q ss_pred             cc----------CCCC--CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 EF----------GFEP--NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 ~~----------~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ..          .+..  ...............+.++.++|.+||+.||.+|||+.++|.||||..|.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence            00          0000  00000001111223456889999999999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=299.61  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=228.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||+|.||.||.|+.+.++..+|+|++..+.... .....+.+|+++...|+||||++++++|.+....|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            3789999999999999999999999999999997655433 444678899999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |.+ |.+...+.+.....+++...+.++.|++.||.|+|.++++||||+|+|++++..+. +|++|||.+....  ....
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~-lkiAdfGwsV~~p--~~kR  179 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAP--SNKR  179 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC-eeccCCCceeecC--CCCc
Confidence            997 89999999888888999999999999999999999999999999999999999988 9999999987654  3445


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+||..|.+||...+. .++...|+|++|++.|+++.|..||......+..+.|.....                   
T Consensus       180 ~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-------------------  239 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-------------------  239 (281)
T ss_pred             eeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-------------------
Confidence            566799999999988877 689999999999999999999999999988888888865322                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ..++.++.++.++|.+||..+|.+|.+..|++.|||+.+.
T Consensus       240 -----------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  240 -----------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                       2345678999999999999999999999999999998764

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.7e-48  Score=318.21  Aligned_cols=285  Identities=39%  Similarity=0.636  Sum_probs=229.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||+|.+..+|..+++|++............+.+|+.++++++|||++++++++......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            79999999999999999999988999999999876554455567888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-cee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~~  159 (293)
                      +++++.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus        81 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 MPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc-EEEeeeeecccccCCCCCccc
Confidence            9666666554433 56889999999999999999999999999999999999998887 99999999876654321 122


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...++..|+|||.+.+...++.++|+||||+++++|++|..||...........+....+.+....++......+.....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            33478899999988766567899999999999999999999998877777777776666665554444443322221111


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                      .............+..+.++.++|.+||+.||.+|||++++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            111111223344566789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-48  Score=329.76  Aligned_cols=277  Identities=23%  Similarity=0.311  Sum_probs=211.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.+|+|...        ...+.+|++++++++||||+++++++..+...++++|+
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            5999999999999999999999999999999642        23567899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-Cccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-~~~~~  159 (293)
                      +.+++...+....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||.+...... .....
T Consensus       165 ~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~-vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        165 YKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC-EEEEeCCcccccccccccccc
Confidence            9998888776653  4678899999999999999999999999999999999998888 999999998653221 12223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CchHHHHHHHHHhCCCCCCCCCCCcC-
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-------WAPGLLAAIFSIMGTPDSETLPGFTS-  231 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~-  231 (293)
                      ...|++.|+|||++.+. .++.++|+||||+++|+|++|..||-..       ........+....+..+......... 
T Consensus       242 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        242 GWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             cccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            34589999999988765 6899999999999999999999876432       22344455555444443322211110 


Q ss_pred             ccccc---CCCCC--CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          232 FSEEF---GFEPN--RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       232 ~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ....+   .....  ....... .....++.++.+||.+||+.||.+|||+.++|+||||+.++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLW-TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCH-HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            00000   00000  0000001 11223577899999999999999999999999999999874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-48  Score=328.57  Aligned_cols=284  Identities=35%  Similarity=0.536  Sum_probs=219.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||++.+.||+|+||+||++.+..++..||+|++............+.+|+++++.++||||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            68999999999999999999999999999998864433333345677899999999999999999987543      347


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |++++++++++...+..   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||.+......
T Consensus        96 ~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~~  171 (343)
T cd07878          96 YLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADDE  171 (343)
T ss_pred             EEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC-EEEcCCccceecCCC
Confidence            89999998777665543   34788899999999999999999999999999999999998888 999999998765432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc-
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS-  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (293)
                         .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+............ 
T Consensus       172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence               2223478899999998776678999999999999999999999998887777777776655544333222111100 


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ......................++.+.+||.+||..||.+|||+.++|+||||..+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            0000000011112223334456788999999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-47  Score=315.28  Aligned_cols=283  Identities=41%  Similarity=0.689  Sum_probs=220.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.|++|.+..... ......+.+|+++++.++||||+++++++..+...++||||
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            58999999999999999999988999999999864332 22334567899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++...+..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          85 LDTDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE-LKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             CCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC-EEECccccccccCCCCccccc
Confidence            99987777665433 6788899999999999999999999999999999999998888 999999998754332222222


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW-APGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..++..|+|||++.+...++.++|+||+|+++|+|++|..||.... ..+....+....+.+....++............
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            2367789999988766568899999999999999999999997765 455555555555555444444333222211111


Q ss_pred             CCCCcccchhhhcCCCC--chHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLE--PDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .............+.++  .++.+++.+||+.||++|||+.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            11111111222333445  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=331.14  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=214.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|+||++.+..+|+.||+|++....... .....+..|++++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6999999999999999999999999999999986543222 444678889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC---
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL---  155 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~---  155 (293)
                      |+.| ++.+.+...  ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......   
T Consensus        82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEeecCCCCccCcccCccc
Confidence            9975 555555544  45788899999999999999999999999999999999999888 9999999987664432   


Q ss_pred             --------------------------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 038154          156 --------------------------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG  209 (293)
Q Consensus       156 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  209 (293)
                                                .......|++.|+|||++.+. .++.++|||||||++|+|++|..||...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                      112233488999999988776 78999999999999999999999999887666


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-HHHHhcCccccc
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-AREALRHEYFKD  288 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~p~~~~  288 (293)
                      ....+........                          ......+++++.++|.+||. ||.+||+ ++++++||||++
T Consensus       238 ~~~~i~~~~~~~~--------------------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYNKIINWKESLR--------------------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHhccCCccc--------------------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            5555533111100                          00111268899999999998 9999999 999999999998


Q ss_pred             CcC
Q 038154          289 FQS  291 (293)
Q Consensus       289 ~~~  291 (293)
                      +.+
T Consensus       291 ~~~  293 (350)
T cd05573         291 IDW  293 (350)
T ss_pred             CCH
Confidence            754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.7e-48  Score=324.19  Aligned_cols=256  Identities=24%  Similarity=0.332  Sum_probs=209.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHH---hcCCCCcceeeeeeecCCcceeE
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLK---ELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      |++.+.||+|++|.||++.+..+++.||+|+++.... .......+.+|.+++.   .+.||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            7899999999999999999999999999999864332 2233456666766654   56799999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||+.|+.+......  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. +||+|||.+.........
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc-EEeCcccCCccCCCCCCc
Confidence            999997655544433  35788899999999999999999999999999999999999887 999999988754333233


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+....                   
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------------  217 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-------------------  217 (324)
T ss_pred             ccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------
Confidence            3334588999999988765 68999999999999999999999999887766665553211                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                 ...+..+++++.++|.+||..||.+||     ++.++++||||+++++
T Consensus       218 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         218 -----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                       012234688899999999999999999     7999999999998653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-49  Score=327.17  Aligned_cols=257  Identities=28%  Similarity=0.389  Sum_probs=231.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-ceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-IDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e   79 (293)
                      +|.+++++|+|+||.+++++++..+..+|+|.+..............+|+.+++++.||||+.+.+.|..++. .+|+|+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            4889999999999999999999999999999998887777777788999999999999999999999999888 999999


Q ss_pred             cCCcchHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFDLLHFM-KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++|+.+..+ .......+++.++..++.|++.|+.|||+++++|||||+.|||++.++. |+|+|||.++..++.....
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK-VKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc-eeecchhhhhhcCCchhhh
Confidence            9996665544 4444588999999999999999999999999999999999999999998 8999999999998776555


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|||.|++||.+.+. +|+.++|||||||++|+|++-+.+|.+.+-.....++....                    
T Consensus       164 ~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------------------  222 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------------------  222 (426)
T ss_pred             heecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------------------
Confidence            566699999999988777 79999999999999999999999999999999999987622                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                               ...++...+.++..+|..||..+|..||++.++|++|.+..
T Consensus       223 ---------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  223 ---------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ---------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                     34556678999999999999999999999999999997653

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.3e-48  Score=328.87  Aligned_cols=282  Identities=32%  Similarity=0.479  Sum_probs=214.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||++.+.||+|++|.||++.+...++.+|+|++............+.+|+.+++.++||||+++++++....      ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            699999999999999999999889999999998654444444567788999999999999999999875443      47


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+|||++++++...+..    .+++..+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||.+......
T Consensus        98 ~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~-~kl~Dfg~~~~~~~~  172 (355)
T cd07874          98 YLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  172 (355)
T ss_pred             EEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC-EEEeeCcccccCCCc
Confidence            99999999988877643    3677889999999999999999999999999999999998887 999999999765433


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+.........+.+.............
T Consensus       173 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         173 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             c-ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            2 12233478899999988766 689999999999999999999999988776666555554444332221111100000


Q ss_pred             cc----------CCC--CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EF----------GFE--PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~----------~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+          ...  ................+.++.++|.+||..||++|||+.++|.||||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            00          000  00000000111223346788999999999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-47  Score=316.94  Aligned_cols=286  Identities=40%  Similarity=0.650  Sum_probs=229.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||.+.+.||+|++|.||+|.+..+|+.+++|.+......   ......+..|+++++.++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            799999999999999999999888999999998655433   22335567899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++++++.+.+.... ..+++..+..++.||+.||++||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        81 ~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          81 FEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC-EEEccceeeeeccCCCcc
Confidence            9999777766665543 46888899999999999999999999999999999999998887 999999999876554333


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||.+.+...++.++|+||||+++++|++|..||.+.+..+...++....+.+....++..........
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            33334677899999886655688999999999999999999888888777777777766666655555544333322211


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .  ...............+.++.++|.+||+.||++|||+.+++.||||++..
T Consensus       239 ~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         239 F--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             c--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            1  11111222334456788999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.6e-48  Score=324.83  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=207.2

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      +.||+|+||.||++.+..+|..||+|++..... .......+..|+++++.++||||+++++.+...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            479999999999999999999999999865322 2233456678999999999999999999999999999999999865


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCcc
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS  164 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~  164 (293)
                      .+....... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++. ++|+|||.+..............++
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC-EEecccHHhccccCCCCccccccCC
Confidence            554333322 25788899999999999999999999999999999999998887 9999999887543332333334588


Q ss_pred             ccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCc
Q 038154          165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSP  244 (293)
Q Consensus       165 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
                      +.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....                          
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------------------------  211 (323)
T cd05595         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------------------  211 (323)
T ss_pred             cCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            999999988765 68999999999999999999999998877666555543210                          


Q ss_pred             ccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                          ...+..+++++.++|.+||+.||.+||     ++.++++||||....+
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                012335688999999999999999998     9999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-48  Score=325.36  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=213.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||+|.+..+++.||+|++...... ......+..|++++..++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            599999999999999999999989999999998654322 2334567889999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++|+.+..+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....   ...
T Consensus        82 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          82 YVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEEEeCcCCccccc---ccC
Confidence            99865444443322 24778899999999999999999999999999999999998887 99999999876543   223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+............             
T Consensus       157 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------  222 (333)
T cd05600         157 SVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY-------------  222 (333)
T ss_pred             CcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC-------------
Confidence            33488999999988766 7899999999999999999999999988777666655432111100000             


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                               ......++.++.+++.+||..+|.+||++.++++||||.++.
T Consensus       223 ---------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         223 ---------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             ---------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence                     000134688999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-48  Score=326.51  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=209.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-CeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-DTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|.+.+.||+|++|.||+|.+...+ ..+|+|++..... .......+.+|+++++.++||||+++++++...+..|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            4889999999999999999866544 6899998854332 2334467788999999999999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+.| ++.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+.......  
T Consensus       111 Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-ikL~DFG~a~~~~~~~--  185 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDTRT--  185 (340)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEecCCCCeecCCCc--
Confidence            99975 5555554433  4788899999999999999999999999999999999998887 9999999997664322  


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+....                   
T Consensus       186 -~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------  244 (340)
T PTZ00426        186 -YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-------------------  244 (340)
T ss_pred             -ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence             233488999999988765 57899999999999999999999998877666655553211                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                 ...+..++..+.+++++||+.||++|+     +++++++||||.++.+
T Consensus       245 -----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        245 -----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                       012334678899999999999999995     8999999999998764

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-47  Score=314.70  Aligned_cols=283  Identities=51%  Similarity=0.837  Sum_probs=226.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||.|++|.||++.+..+|..+++|++............+.+|+++++.++||+++++++++.+++..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            78899999999999999999889999999998765544444567888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++++.+.+.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA-LKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc-EEEeecccccccCCCccccCcc
Confidence            988888777665456889999999999999999999999999999999999999887 9999999987654332322333


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+++.|+|||++.+...++.++|+||||+++|+|++|..||...+.......+......+....++......+... ...
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  238 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-TFP  238 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-hcc
Confidence            3678899999887665678999999999999999999999988877666666666555554443332222111100 001


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ...........+.++.++.++|.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            111122234456688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-47  Score=317.33  Aligned_cols=284  Identities=40%  Similarity=0.653  Sum_probs=224.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      .|++.+.||+|++|.||+|.+..+++.+++|.++...........+.+|+++++++.|||++++++++...  +..|+|+
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            37889999999999999999988999999999976554444445677899999999999999999998777  8899999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||+++++.+.+..... .+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        86 e~~~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          86 EYVEHDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             hhcCcCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc-EEEeecCceeeccCCcccc
Confidence            9999877776655433 6889999999999999999999999999999999999998887 9999999988765543333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.+...++.++|+||||+++++|++|..||......+...++....+.+....++...........
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            33446788999998876656789999999999999999999999988887777777766665555444333221111111


Q ss_pred             CCCCCcccchhhhcCC--CCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          239 EPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ..............+.  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            1111111111112222  58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.7e-48  Score=323.72  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      +.||+|++|.||++.+..+|..+|+|++..... .......+.+|+++++.+.||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999999999999999864322 2233456778999999999999999999999999999999999865


Q ss_pred             hH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           85 LL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        85 ~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      .+ ..+...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||.+..............|
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc-EEEecCcCCccCCCcccccccccC
Confidence            44 444333  35788899999999999999999999999999999999998888 999999998754333233333458


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+...                          
T Consensus       158 t~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------------------  210 (328)
T cd05593         158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------------------  210 (328)
T ss_pred             CcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--------------------------
Confidence            9999999988765 6899999999999999999999999877665554443210                          


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                          ....+..+++++.++|.+||+.||.+||     ++.++++||||...++
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         211 ----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             ----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                0112345788999999999999999997     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-48  Score=322.43  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-ch
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DL   85 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~   85 (293)
                      ||+|+||.||++.+..+++.+|+|++..... .......+..|+.++++++||||+++++++...+..++||||+++ ++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999999999999999864321 233345677899999999999999999999999999999999985 45


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                      .+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+..............|++
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc-EEEEECcccccCccCCCccccccCCc
Confidence            4555443  34788899999999999999999999999999999999998888 99999999875433323333345889


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      .|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+...                            
T Consensus       158 ~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~----------------------------  208 (312)
T cd05585         158 EYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE----------------------------  208 (312)
T ss_pred             ccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----------------------------
Confidence            99999988766 6899999999999999999999999887766665554320                            


Q ss_pred             cchhhhcCCCCchHHHHHHHhhccCCCCCC---CHHHHhcCcccccCc
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRL---TAREALRHEYFKDFQ  290 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~p~~~~~~  290 (293)
                        ....+..+++++.+++.+||+.||.+||   ++.++++||||.+.+
T Consensus       209 --~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         209 --PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence              0112334678999999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=317.19  Aligned_cols=258  Identities=28%  Similarity=0.439  Sum_probs=211.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC------------CCcccHHHHHHHHHhcCCCCcceeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------------GVPSSVIREVSLLKELKHENIVRLLNVQ   68 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (293)
                      +|++.+.||+|.||.|-+|++..+++.||||+++......            ...+...+|+.+|+++.|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            6999999999999999999999999999999996533211            1125788999999999999999999998


Q ss_pred             ecC--CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           69 SSV--DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        69 ~~~--~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      .+.  +.+|+|+|||..+-..+.-.... -+++.++++++++++.||.|||.+|++||||||+|++++.+|. |||+|||
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~-VKIsDFG  255 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT-VKISDFG  255 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc-EEeeccc
Confidence            665  47999999999655544433222 1788899999999999999999999999999999999999988 9999999


Q ss_pred             CcccCCC-----CCcceeccCccccccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 038154          147 LARPIDV-----PLENYTIKGGSLCYKAPERLLG---SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       147 ~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      .+.....     .........|||.|+|||.+.+   ....+.+.||||||++||-|+.|+.||.+...-+...+|...-
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p  335 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP  335 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence            9876521     1111222349999999998876   3345778999999999999999999999998888888886421


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      -.+                            ...+.+.+++.+||.+||+.||++|.++.+|..|||...
T Consensus       336 L~f----------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  336 LEF----------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ccC----------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            111                            112246789999999999999999999999999999754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.6e-47  Score=312.30  Aligned_cols=283  Identities=42%  Similarity=0.751  Sum_probs=227.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|.||++.+..+|..+++|++..... ......+.+|++++++++|||++++++++...+..++|||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            58999999999999999999998999999999865432 33345677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++++.+.+.... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~-~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc-EEEeecchhhhhcCCccccc
Confidence            9998888776543 245788999999999999999999999999999999999998887 99999999876544333333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|++||.+.+...++.++|+||||+++|++++|..||.+.+..+....+......+....+....... .+...
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  237 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP-EYKPT  237 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc-hhccc
Confidence            33467889999988776667899999999999999999999999988888888877766666554443332111 11111


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .............+..+.++.+++.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11111122233445678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=319.00  Aligned_cols=258  Identities=31%  Similarity=0.444  Sum_probs=225.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++.+.||+|.||.||++.++.+|+.+|+|.++...... .....+.+|+++|+++. |||++.+.+.+++...+++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            5899999999999999999999999999999996655433 24568899999999998 999999999999999999999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCCCC
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVP  154 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~~~  154 (293)
                      |.+. |.+.+.+...   .+++..+..++.|++.++.|||+.|++|+||||+|+++.....   .++++|||.+..... 
T Consensus       116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            9998 6677777666   3899999999999999999999999999999999999976532   599999999998876 


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ........|++.|+|||++... .++...|+||+|+++|.|++|..||.+.+.......+......+.            
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~------------  258 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT------------  258 (382)
T ss_pred             CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC------------
Confidence            4556666799999999988765 799999999999999999999999999998888887755333222            


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                    ...+..++..+.++|++||..||.+|+|+.++|.|||++..
T Consensus       259 --------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  259 --------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             --------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                          23345678999999999999999999999999999999875

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-47  Score=321.59  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=206.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|+||++.++.+++.||+|++.... ........+..|..++..+ .||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999986432 1233445667788888876 699999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~-~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeeCCCCeecCcCCCcccccc
Confidence            554 444433  35788899999999999999999999999999999999998887 99999999875433323333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+....                        
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------------------------  212 (320)
T cd05590         158 GTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------------------------  212 (320)
T ss_pred             cCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------------
Confidence            89999999988765 68899999999999999999999999888777666653210                        


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH------HHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA------REALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~p~~~~~~~  291 (293)
                            ...+..++.++.+++.+||+.||.+||++      +++++||||..+.+
T Consensus       213 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         213 ------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence                  01123467889999999999999999998      99999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-46  Score=312.80  Aligned_cols=285  Identities=44%  Similarity=0.739  Sum_probs=224.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCc-----c
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDS-----I   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----~   74 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|.+............+.+|+.+++.+. |||++++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            689999999999999999999999999999998665444445567888999999995 6999999998876665     8


Q ss_pred             eeEeecCCcchHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           75 DLVFENLDFDLLHFMKTEP---TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      |++|||+++++.+.+....   ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++..++|+|||.+...
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            9999999998887775432   2457889999999999999999999999999999999999983444999999998765


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......+....++....
T Consensus       162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T cd07837         162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK  241 (295)
T ss_pred             CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence            44333333334678899999887655678999999999999999999999998877777777766555554444433322


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                      ........  ...........+.++.++.++|.+||..||.+||++.+++.||||+
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         242 LRDWHEFP--QWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             ccchhhcC--cccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            22211110  0011122333456889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.6e-47  Score=318.28  Aligned_cols=284  Identities=21%  Similarity=0.319  Sum_probs=209.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            5899999999999999999999999999999886432 223346788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++.+..+.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||.+.......  ..
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~--~~  160 (331)
T cd06649          85 MDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM--AN  160 (331)
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc-EEEccCcccccccccc--cc
Confidence            9865554443322 2478889999999999999999986 6999999999999998888 9999999987654321  22


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc---
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF---  236 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  236 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+..+.+......................   
T Consensus       161 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         161 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             cCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            33488999999988765 68999999999999999999999998766555433321111000000000000000000   


Q ss_pred             ------CCCCCCCc--------ccchhh-hcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          237 ------GFEPNRSP--------IKDLAT-VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       237 ------~~~~~~~~--------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                            ........        ...... -...+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                  00000000        000000 0123678999999999999999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-47  Score=319.73  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=210.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCC-CCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKH-ENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|++.+.||+|++|.||+|.+..+++.+|+|++..... .......+..|.+++..+.| ++++++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48999999999999999999999999999999864322 23344567789999998876 56888999999999999999


Q ss_pred             ecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++|+ +...+....  .+++..+..++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC-EEEeecCcceecCCCCCc
Confidence            999854 444554432  4678899999999999999999999999999999999998887 999999998754333233


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-------------------  217 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-------------------  217 (324)
T ss_pred             eeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence            3444589999999988765 68899999999999999999999999887776666653211                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~~~~~~  291 (293)
                                 ...+..+++++.+++.+||..||.+|++.     .++++||||..+.+
T Consensus       218 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 -----------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                       11223467889999999999999999976     89999999987643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=317.03  Aligned_cols=249  Identities=28%  Similarity=0.354  Sum_probs=204.9

Q ss_pred             eeeeeccccceeEEEEEeCCCCCe-EEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-cceeEeecC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-SIDLVFENL   81 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~-~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~   81 (293)
                      +.+.+|+|+||+||++  .+.|.. +|+|++..........+.+.+|+.+|.+++||||++++|++.++. .+++||||+
T Consensus        45 ~~~~iG~G~~g~V~~~--~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKG--KWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhcccCCceeEEEE--EeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            4567999999999999  566777 999998665544444679999999999999999999999999988 799999999


Q ss_pred             CcchHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           82 DFDLLHFMKTE-PTVTKNPLKIKKYLHQILHGVAYCHSQE-ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        82 ~~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++++..+... ....++...+.+++.||+.|+.|||+++ ++|+||||+||+++.+...+||+|||.++..........
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~  202 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT  202 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence            95555544443 4667899999999999999999999999 999999999999999873499999999987654333333


Q ss_pred             ccCccccccCcccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLG-SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...||+.|||||++.+ ...++.++||||+|+++|+|+||..||......+...........                  
T Consensus       203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R------------------  264 (362)
T KOG0192|consen  203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR------------------  264 (362)
T ss_pred             CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence            3569999999999985 347999999999999999999999999998884444444322221                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ..++...++.+..++.+|+..||.+||+..+++.
T Consensus       265 ----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  265 ----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                      1223336789999999999999999999999876

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-46  Score=309.00  Aligned_cols=283  Identities=33%  Similarity=0.577  Sum_probs=219.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|+.+++|++............+.+|++++++++|||++++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            69999999999999999999998999999999865543344445678999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+..... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          82 CDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             cCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc-EEECccccceecCCCcccccC
Confidence            99888877654433 5788899999999999999999999999999999999998887 999999999876544322233


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC--cCcccccCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF--TSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  238 (293)
                      ..++..|+|||.+.+...++.++|+||||+++++|++|..||.+....+....+...............  .........
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            346788999998876556889999999999999999999999887766555554433322211100000  000000000


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                       .............+.++..+.+++.+||+.||++||++.+++.||||
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 -PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             -CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence             00011111223344678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=308.69  Aligned_cols=260  Identities=25%  Similarity=0.279  Sum_probs=220.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++++.||.|.-|+||+++...++..+|+|++...... .....+...|.+||..+.||.++.+|+.|+.+...|++|||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            67789999999999999999999999999999665433 23345677799999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-----
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-----  154 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-----  154 (293)
                      |+| ++....+.+....+++..++-++..++.||+|||-.||++|||||+||+|.++|+ |.|+||+++......     
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH-IMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH-IMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc-EEeeeccccccCCCCCeeec
Confidence            985 5555666677788999999999999999999999999999999999999999999 999999986322110     


Q ss_pred             -----------------------------C----------------------cceeccCccccccCcccccCCCCCCCch
Q 038154          155 -----------------------------L----------------------ENYTIKGGSLCYKAPERLLGSGRYSTPV  183 (293)
Q Consensus       155 -----------------------------~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~  183 (293)
                                                   .                      ....+..||-.|.|||++.+. ..+.+.
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAV  316 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAV  316 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCchh
Confidence                                         0                      001111267789999999988 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHH
Q 038154          184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLL  263 (293)
Q Consensus       184 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  263 (293)
                      |.|.||+.+|||+.|..||++.+.++....+....-.++..                            +.++.++++||
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------------------------~~vs~~akDLI  368 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------------------------PEVSSAAKDLI  368 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------------------------CcchhHHHHHH
Confidence            99999999999999999999999999999987533332211                            14678899999


Q ss_pred             HHhhccCCCCCCC----HHHHhcCcccccCcC
Q 038154          264 RRMLCLDPSKRLT----AREALRHEYFKDFQS  291 (293)
Q Consensus       264 ~~~l~~dp~~Rps----~~~ll~~p~~~~~~~  291 (293)
                      +++|..||++|..    |.||-+||||+.++|
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW  400 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW  400 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcCccccCCCh
Confidence            9999999999998    999999999999987

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1e-47  Score=324.08  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=213.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|.+.+.||+|++|+||++.+..+|+.+|+|+++.... .......+.+|+.+++.++||+|+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            58999999999999999999999999999999865432 22344567789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      |++++.+..+.......+++..++.++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||.+......... .
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC-EEeccCCCCeECCCCCceee
Confidence            99865554444443346888899999999999999999999999999999999998888 999999999766433222 2


Q ss_pred             eccCccccccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          159 TIKGGSLCYKAPERLLG-----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ....+++.|+|||++..     ...++.++||||||+++|+|++|..||...+.......+........           
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  229 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK-----------  229 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC-----------
Confidence            23358899999998763     34578899999999999999999999988777666555543110000           


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                     ....+.++.++.+++.+||+ ||.+|||+.++++||||..+++
T Consensus       230 ---------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         230 ---------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                           00112467889999999998 9999999999999999997653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-48  Score=298.32  Aligned_cols=258  Identities=31%  Similarity=0.481  Sum_probs=218.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC--CCc----ccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVP----SSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~----~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      |.-.+.||+|..++|-++.++.+|..+++|++.......  +..    +.-.+|+.+|+++ .||+|+++.++++.+..+
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~   98 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV   98 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence            556688999999999999999999999999986544322  112    3334699999998 699999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|+|-++ |.+.+++.+.  ..+++...+.|++|+++++.|||.++|||+||||+||+++.+.+ ++|+|||+++.+..
T Consensus        99 FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~-i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN-IKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc-eEEeccceeeccCC
Confidence            99999998 8888888765  45888999999999999999999999999999999999999888 99999999998865


Q ss_pred             CCcceeccCccccccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          154 PLENYTIKGGSLCYKAPERLL-----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      . +.....+|||+|.|||.+.     +.+.|+...|+|++|+|+|.++.|..||=....--++..|+.....+.+     
T Consensus       176 G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s-----  249 (411)
T KOG0599|consen  176 G-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS-----  249 (411)
T ss_pred             c-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC-----
Confidence            5 5556677999999999874     3456788999999999999999999999766666666666654333332     


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                           +.+.+++...++||.+||+.||++|.|++++|+||||..+
T Consensus       250 ---------------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  250 ---------------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ---------------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence                                 3345678899999999999999999999999999999654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-47  Score=324.89  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=208.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|+||+||++.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            58999999999999999999999999999999865322 22334567789999999999999999999999999999999


Q ss_pred             cCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           80 NLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++|+.+ +.+....  .+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||.+........  
T Consensus        82 ~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEeecccceecccccccc
Confidence            9985544 5554433  4788899999999999999999999999999999999999888 99999998865422110  


Q ss_pred             ------------------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 038154          157 ------------------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR  200 (293)
Q Consensus       157 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  200 (293)
                                                          ......|++.|+|||++.+. .++.++|+|||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCC
Confidence                                                00112488999999988765 68999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC---H
Q 038154          201 LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---A  277 (293)
Q Consensus       201 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~  277 (293)
                      ||...+..+....+........   .                       .....+++++.++|.+||. +|.+|++   +
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~---~-----------------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~  290 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQ---F-----------------------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGV  290 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccC---C-----------------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence            9988776665555532111000   0                       0011367899999999997 9999998   9


Q ss_pred             HHHhcCcccccCc
Q 038154          278 REALRHEYFKDFQ  290 (293)
Q Consensus       278 ~~ll~~p~~~~~~  290 (293)
                      .+++.||||+.+.
T Consensus       291 ~~ll~h~~~~~~~  303 (364)
T cd05599         291 NEIKSHPFFKGVD  303 (364)
T ss_pred             HHHhcCCCcCCCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.6e-47  Score=322.44  Aligned_cols=260  Identities=21%  Similarity=0.300  Sum_probs=208.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|+||++.+..+++.+|+|++..... .......+..|+.++..++||+|+++++.+.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            48999999999999999999999999999999864322 22334567889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++| ++.+.+...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||.+........  
T Consensus        82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~-vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC-EEEeeccCccccccccccc
Confidence            9985 555555443  35788899999999999999999999999999999999998888 99999999875432100  


Q ss_pred             ---------------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          157 ---------------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       157 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                                                       ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123488999999988766 68899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCC---CCCCHHHH
Q 038154          204 SRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS---KRLTAREA  280 (293)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rps~~~l  280 (293)
                      +.+..+....+........   .+                       -...+++++.++|.+|+. +|.   .||+++++
T Consensus       238 ~~~~~~~~~~i~~~~~~~~---~p-----------------------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei  290 (363)
T cd05628         238 SETPQETYKKVMNWKETLI---FP-----------------------PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEI  290 (363)
T ss_pred             CCCHHHHHHHHHcCcCccc---CC-----------------------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence            8877776666643111100   00                       011367889999999876 444   46899999


Q ss_pred             hcCcccccCcC
Q 038154          281 LRHEYFKDFQS  291 (293)
Q Consensus       281 l~~p~~~~~~~  291 (293)
                      ++||||+.+.+
T Consensus       291 ~~hp~f~~~~~  301 (363)
T cd05628         291 KTNPFFEGVDW  301 (363)
T ss_pred             hCCCCCCCCCH
Confidence            99999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-47  Score=319.84  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=206.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|.||+|.+..+++.+|+|++..... .......+..|.+++..+ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999998999999999865322 233345677788888876 799999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeecccceecccCCccccccc
Confidence            544 444433  34778899999999999999999999999999999999998888 99999999875433323333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+.....                       
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-----------------------  213 (321)
T cd05591         158 GTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-----------------------  213 (321)
T ss_pred             cCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence            88999999988765 689999999999999999999999998887777666543110                       


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCC-------CHHHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-------TAREALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~~ll~~p~~~~~~~  291 (293)
                             ..+..++.++.+++.+||+.||++||       ++.++++||||..+.+
T Consensus       214 -------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         214 -------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence                   11223578899999999999999999       9999999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-47  Score=312.72  Aligned_cols=259  Identities=31%  Similarity=0.475  Sum_probs=207.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++++.||+|++|+||++.+..+++.+|+|++...............|+.+++++.||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999998765443333334455999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++ ++.+.+..  ...+++..+..++.|++.||.+||++|++|+||+|+||+++.+++ ++|+|||.+............
T Consensus        81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~-~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE-VKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE-EEESSGTTTEESTSTTSEBSS
T ss_pred             ccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence            97 56666652  234688899999999999999999999999999999999998777 999999999865333344445


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++......+.++|+||||+++++|++|..||...........+.........                 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  220 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP-----------------  220 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH-----------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc-----------------
Confidence            558899999998773457899999999999999999999999987444333333221111000                 


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                            .........+.++.+++.+||+.||++|||+.++++||||
T Consensus       221 ------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  221 ------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                  0000011123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.8e-47  Score=311.84  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=203.6

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcchH
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLL   86 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~   86 (293)
                      ||+|+||+||++.+..+++.+|+|++....... .....+..|+++++.++||+++++.+++......++||||++|+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999999999999999985433222 2235667899999999999999999999999999999999986555


Q ss_pred             H-Hhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           87 H-FMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        87 ~-~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      . .+..  .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..............+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCccceecCCCCccccccCC
Confidence            4 3322  23345788899999999999999999999999999999999998887 999999998766544333333458


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++|..||..................                       
T Consensus       160 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  215 (280)
T cd05608         160 TPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-----------------------  215 (280)
T ss_pred             CcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-----------------------
Confidence            8999999988766 6889999999999999999999999765432222221110000                       


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                         .....+..++.++.+++.+||+.||++||     +++++++||||+.+++
T Consensus       216 ---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         216 ---DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             ---cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence               00122345788999999999999999999     8899999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.4e-46  Score=307.84  Aligned_cols=283  Identities=36%  Similarity=0.617  Sum_probs=215.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|..+++|.+..... ......+.+|+++++.++|+|++++++++..++..++|+|+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            58999999999999999999988999999999865432 23334677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+.... ..+.+..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          85 MHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc-EEEeccccccccCCCCCCCCC
Confidence            9988888776543 34677788899999999999999999999999999999998887 999999988765433222333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||.+.+...++.++|+||||+++++|++|..||.+... .+.........+.+.....+............
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            34678899999887655678899999999999999999999976543 34444444444444433333222211111000


Q ss_pred             CCCCcccchhhhcC--CCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVG--GLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ............+.  ..+.++.+++.+||..||++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00001111111111  136788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.7e-47  Score=322.69  Aligned_cols=261  Identities=22%  Similarity=0.296  Sum_probs=210.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|++..... .......+..|+.+++.++||||+++++++.+++..++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            48899999999999999999999999999999864322 22233457789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      |++|+.+..+....  .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus       124 y~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-~kL~DfG~~~~~~~~~~~~~  200 (370)
T cd05596         124 YMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRC  200 (370)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC-EEEEeccceeeccCCCcccC
Confidence            99865554444332  3677788889999999999999999999999999999999888 99999999876543211 22


Q ss_pred             eccCccccccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 TIKGGSLCYKAPERLLGS---GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ....|++.|+|||++.+.   ..++.++|+||||+++|+|++|..||.+.+.......+.......   ..+        
T Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~--------  269 (370)
T cd05596         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL---TFP--------  269 (370)
T ss_pred             CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC---CCC--------
Confidence            234589999999988653   247889999999999999999999999887766666554311100   000        


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~  290 (293)
                                     ....++.++.++|.+||+.+|.+  |++++++++||||+...
T Consensus       270 ---------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         270 ---------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             ---------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                           11236889999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6e-47  Score=317.53  Aligned_cols=253  Identities=25%  Similarity=0.317  Sum_probs=205.9

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|+||++.+..++..+|+|++..... .......+..|.++++.+ .||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999865432 223345667888898887 699999999999999999999999986


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      +.+....... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..............+
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc-EEecccCCCeecCcCCCcccceec
Confidence            5554333322 25788899999999999999999999999999999999999887 999999988653322222333348


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....                         
T Consensus       159 ~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-------------------------  212 (318)
T cd05570         159 TPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-------------------------  212 (318)
T ss_pred             CccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence            8999999988765 68999999999999999999999998877666555543210                         


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~~~~~~  291 (293)
                           ...+..++.++.++|.+||..||.+||++     .++++||||++..+
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         213 -----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 01223467889999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-46  Score=310.41  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=209.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+++.+|+|++....... .....+.+|+++++.++||+++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4899999999999999999998899999999986433222 223456789999999999999999999999999999999


Q ss_pred             cCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++|+.+ ..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGE-TI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC-EEEeeCCCceecCCCC-cc
Confidence            9986544 4444444446888899999999999999999999999999999999998887 9999999987654322 22


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||.+.........+.......                 
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  220 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED-----------------  220 (285)
T ss_pred             ccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc-----------------
Confidence            233478899999988765 68899999999999999999999998765543333332211100                 


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~  290 (293)
                               ....+..++..+.+++.+||..||.+||     +++++++||||.+..
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         221 ---------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             ---------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence                     0112234678899999999999999999     999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.9e-47  Score=323.61  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=206.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||+|+||+||+|.+..++..+|+|++..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            48999999999999999999999999999999865332 22334578889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++| ++.+.+....  .+++..++.++.||+.||++||+.|++|+||||+||+++.++. ++|+|||.+........  
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~-~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC-EEEeeCcCCcccccccccc
Confidence            9985 5555554433  4778888999999999999999999999999999999998887 99999998753311000  


Q ss_pred             ---------------------------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHH
Q 038154          157 ---------------------------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACT  191 (293)
Q Consensus       157 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l  191 (293)
                                                                   ......|++.|+|||++.+. .++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~i  237 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhH
Confidence                                                         00123488999999988765 68899999999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhcc--
Q 038154          192 FAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCL--  269 (293)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--  269 (293)
                      +|+|++|..||...+..+....+........                          ......+++++.++|.+|+..  
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~dli~~ll~~~~  291 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH--------------------------IPPQVKLSPEAVDLITKLCCSAE  291 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccC--------------------------CCCCCCCCHHHHHHHHHHccCcc
Confidence            9999999999988776655554432111100                          001123688999999997654  


Q ss_pred             CCCCCCCHHHHhcCcccccCcC
Q 038154          270 DPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       270 dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      +|..||++.++++||||..+.+
T Consensus       292 ~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         292 ERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             cccCCCCHHHHhcCcccCCCCh
Confidence            4455999999999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.1e-47  Score=316.03  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||++.++.+|+.+|+|+++.... ..........|..++... .||+++++++++...+..|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999865322 123335566788888754 899999999999999999999999985


Q ss_pred             -chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 -DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 -~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                       ++...+...  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEeCccCCCeecccCCCceeccC
Confidence             444555443  34778899999999999999999999999999999999998887 99999998875433223333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....                        
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------------------------  212 (316)
T cd05620         158 GTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------------------------  212 (316)
T ss_pred             CCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence            89999999988766 68999999999999999999999998877666555543210                        


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-HHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-REALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~~p~~~~~~  290 (293)
                            ...+..++.++.+++.+||..||++||++ ++++.||||..+.
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         213 ------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                  01122367889999999999999999998 5888999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-47  Score=273.27  Aligned_cols=286  Identities=39%  Similarity=0.711  Sum_probs=259.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.-.++||+|.+|+|+++++..+++.||+|........+.......+|+-+++.+.|.||++++++...+..+.+|+|+|
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            55568999999999999999999999999999888888888889999999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ...+..++..-.. .++....+.++.|++.+|.+.|+.++.|+|+||.|.+|+.+|+ .|+.|||.++.++-+....+..
T Consensus        84 dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge-lkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   84 DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE-LKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-EEecccchhhhcCCceEeeece
Confidence            9998888876544 5788899999999999999999999999999999999999998 9999999999999888888888


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+.+|++|.++.+..-++...|+||-|||+.|+.. |...|.+.+.++.+.+|+...+.+.+..+|..+...+-.. -+
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~-yp  240 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP-YP  240 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc-cC
Confidence            889999999999998889999999999999999876 5577889999999999999999999999999887665432 24


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .......+..+.+.++...+++++++|.-+|.+|.++++.++||||.++-
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            45556778888889999999999999999999999999999999999873

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-47  Score=320.68  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=205.7

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      +.||+|+||.||++.+..+|..+|+|++..... .......+..|+++++.++||||+++++.+...+..|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999999999999999865332 2233456678999999999999999999999999999999999865


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      .+....... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++. ++|+|||.+..............+
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC-EEEecCCCCeecCCCCcccccccC
Confidence            554333322 257888999999999999999997 79999999999999998887 999999998754332233333458


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.+.....+....                         
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------------------  212 (325)
T cd05594         159 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------  212 (325)
T ss_pred             CcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence            8999999988765 68999999999999999999999998876665555442210                         


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                           ...+..+++++.+++.+||+.||.+|+     ++.++++||||..+.+
T Consensus       213 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         213 -----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence                 012334688999999999999999996     9999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-46  Score=319.94  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++++.||+|++|.||++.+..+++.||+|++.... .......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            667889999999999999999899999999985322 2233467889999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      .++.+...     ...++..+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus       155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~~~~~~  228 (353)
T PLN00034        155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN-VKIADFGVSRILAQTMDPCNSS  228 (353)
T ss_pred             CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEcccccceeccccccccccc
Confidence            97655321     23456678899999999999999999999999999999998887 9999999987664433333334


Q ss_pred             CccccccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          162 GGSLCYKAPERLLGS----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .|+..|+|||++...    ...+.++||||||+++|+|++|..||......+...........                 
T Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------  291 (353)
T PLN00034        229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-----------------  291 (353)
T ss_pred             ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----------------
Confidence            588999999987432    23456899999999999999999999744333222222111100                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                               ........++.++.+||.+||..||++|||+.++++||||.+-
T Consensus       292 ---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 ---------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                     0011223467899999999999999999999999999999875

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-46  Score=316.66  Aligned_cols=288  Identities=39%  Similarity=0.612  Sum_probs=232.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||++.+.||+|++|.||++.+..++..+++|++............+.+|+.+++.++|||++++.+++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            799999999999999999999888999999998654443455578889999999999999999999987765     789


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|+++++++...+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        81 lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~-~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD-LKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccCceEeecccc
Confidence            999999987777765543  6788899999999999999999999999999999999999887 9999999998765442


Q ss_pred             ---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                         .......+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+....+....+.+...........
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence               12223347788999998877657899999999999999999999999999888888888877766665443321110


Q ss_pred             -ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          233 -SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                       ....................+.++.++.++|.+||+.||.+||++.+++.||||++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence             00000001111222333445668899999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.6e-47  Score=317.64  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=201.1

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|.||++.+..++..||+|+++..... ......+..|..+++.+ +||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999998654322 23345677899999888 699999999999999999999999986


Q ss_pred             c-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 D-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      + +...+...  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEECcCccccccccCCCcccccc
Confidence            4 44444433  35788899999999999999999999999999999999998887 99999999875332223333345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP---------GLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||......         ...+.+.                  
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------  218 (329)
T cd05588         158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL------------------  218 (329)
T ss_pred             CCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH------------------
Confidence            89999999988765 6889999999999999999999999632111         0111111                  


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC------HHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT------AREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~p~~~~~~~  291 (293)
                                  .....++..++.++.+++.+||+.||.+||+      +.++++||||..+.+
T Consensus       219 ------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         219 ------------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             ------------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                        0011233457888999999999999999987      799999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.2e-46  Score=308.81  Aligned_cols=284  Identities=35%  Similarity=0.616  Sum_probs=224.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--------   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (293)
                      +|++.+.||+|++|.||+|.++.+|+.+++|.++...........+.+|++++++++|||++++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            488999999999999999999989999999998765444444567788999999999999999999886654        


Q ss_pred             --cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           73 --SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        73 --~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                        ..++++|++++++...+... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus        88 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~~~  165 (302)
T cd07864          88 KGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLARL  165 (302)
T ss_pred             CCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc-EEeCccccccc
Confidence              78999999999888777654 336788999999999999999999999999999999999998887 99999999876


Q ss_pred             CCCCCcc-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          151 IDVPLEN-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       151 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ....... .....++..|+|||.+.+...++.++|+||||+++++|++|..||...+..+.+..+....+.+.....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T cd07864         166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV  245 (302)
T ss_pred             ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence            5433211 112225678999998876656789999999999999999999999988877777777776665555444433


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .........................++..+.+++.+||..||++||++.++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            222111111111111122223344578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.8e-47  Score=316.89  Aligned_cols=252  Identities=27%  Similarity=0.371  Sum_probs=204.4

Q ss_pred             eeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            5 LEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ++.||+|+||.||++.+.   ..++.+|+|++.....  .......+..|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999763   4788999999864322  12233567789999999999999999999999999999999


Q ss_pred             cCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.|+ +.+.+....  .+.+..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.+..........
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEeeCcCCeecccCCCcc
Confidence            99864 445544332  4677788889999999999999999999999999999998887 9999999987543332223


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+....                    
T Consensus       158 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------  216 (323)
T cd05584         158 HTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------  216 (323)
T ss_pred             cccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            334588999999988765 57899999999999999999999998877666555553210                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~  290 (293)
                                ..+++.+++++.++|.+||+.||++||     ++.++++||||....
T Consensus       217 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         217 ----------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                      112344678999999999999999999     899999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-46  Score=318.97  Aligned_cols=282  Identities=32%  Similarity=0.483  Sum_probs=214.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||++.+.||+|++|.||++.+..+|..+|+|.+............+.+|+.++++++|||++++++++...      ...
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            69999999999999999999999999999998854433334445677899999999999999999987544      357


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+|||++++++...+...    ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        97 ~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~  171 (353)
T cd07850          97 YLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  171 (353)
T ss_pred             EEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCccceeCCCC
Confidence            999999999888776543    678899999999999999999999999999999999999888 999999999866443


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      .. .....+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+....+.+.............
T Consensus       172 ~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         172 FM-MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CC-CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            22 2223367889999988765 689999999999999999999999988776666666655544443221111100000


Q ss_pred             ccC----------CCCCCC---cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EFG----------FEPNRS---PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~~----------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+.          +.....   ............+.++.++|.+||+.||++|||+.++|.||||+.|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            000          000000   0000001122356778999999999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-46  Score=302.64  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=209.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+++.+++|.+............+.+|++++++++|+|++++++.+.. +...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999889999999986554444455678889999999999999999988764 446899999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-IKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc-EEEecccceEEecccCCcc
Confidence            9985 5555665544456789999999999999999999999999999999999998887 9999999987665433333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|+||||++++++++|..||...+.......+....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------------------  218 (257)
T cd08223         160 STLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--------------------  218 (257)
T ss_pred             ccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------------------
Confidence            334478899999987765 68899999999999999999999998766555444332210                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                               ....+...++++.+++.+|++.||++||++.++++||||
T Consensus       219 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ---------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ---------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                     001123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-46  Score=314.84  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=202.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||+|.+..+++.||+|+++.... .......+..|..++... .||||+++++++..++..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999865332 223334555677777654 799999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC-EEEccCcCCeECCCCCCcccccc
Confidence            555 444433  25788899999999999999999999999999999999998887 99999999876543333333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....                        
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------  212 (316)
T cd05592         158 GTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------------------------  212 (316)
T ss_pred             CCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            89999999988766 58999999999999999999999999887766665553210                        


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-HHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-REALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~~p~~~~~~  290 (293)
                            ...+..++.++.+++.+||+.||++||++ .+++.||||....
T Consensus       213 ------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         213 ------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                  11223467889999999999999999986 5888999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-45  Score=309.12  Aligned_cols=284  Identities=41%  Similarity=0.678  Sum_probs=223.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--------   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (293)
                      +|++.++||+|++|.||++.+..++..+++|++............+.+|+++++.++||||+++++++....        
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            589999999999999999999989999999998655444444456788999999999999999998764433        


Q ss_pred             cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           73 SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ..++++||+++++...+... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        89 ~~~lv~~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~  166 (311)
T cd07866          89 SVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI-LKIADFGLARPYD  166 (311)
T ss_pred             eEEEEEecCCcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECcCccchhcc
Confidence            46999999998888777654 336889999999999999999999999999999999999999888 9999999887554


Q ss_pred             CCCcce-----------eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 038154          153 VPLENY-----------TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       153 ~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      ......           ....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            322111           111256789999988766568899999999999999999999999888887777777766666


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ....++............................++.+.++|.+||..||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            55554443322222111111111122222344567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-46  Score=317.61  Aligned_cols=262  Identities=22%  Similarity=0.317  Sum_probs=205.9

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      .|++++.||+|++|+||++.+.   .++..+|+|++.....  .......+..|+++++.+ .||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999763   4788999999864322  223345677899999999 589999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++||||+.+ ++.+.+....  .+++..+..++.||+.||+|||++|++||||||+||+++.++. ++|+|||.+.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~-~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC-EEEeeCcCCccccc
Confidence            999999985 5556665443  4778899999999999999999999999999999999998887 99999999876533


Q ss_pred             CCc-ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          154 PLE-NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       154 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......|++.|+|||++.+...++.++||||||+++|+|++|..||...........+......            
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------  225 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------------  225 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------------
Confidence            222 2223348999999999877656889999999999999999999999754322211111110000            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                    .....+..+++.+.+++.+||+.||++||     ++.++++||||++..+
T Consensus       226 --------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 --------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                          00112334688899999999999999999     8899999999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=315.99  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=229.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.+.+.||+|.|++|-+|++..+|+.||||++............+.+|++.++..+||||+++|++......+|+|.|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            67788999999999999999999999999999877766667789999999999999999999999999999999999988


Q ss_pred             C-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 D-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      + |++.++++.+.. .+++..+.+++.||+.|+.|+|+..+||+||||+||.+.+....|||.|||++-.+... .....
T Consensus       100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~T  177 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLTT  177 (864)
T ss_pred             CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhhc
Confidence            7 577888877655 68999999999999999999999999999999999988776555999999999887654 44455


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      .+|+..|.|||.+.+..+..++.||||||+|||.+++|+.||...+..+.+.+|+++...                    
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------------------  237 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------------------  237 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--------------------
Confidence            569999999999999877789999999999999999999999999999999999764332                    


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                ++..++.++++||.+||..||.+|.+.++|.+++|++..
T Consensus       238 ----------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  238 ----------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             ----------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence                      345678999999999999999999999999999999875

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.8e-47  Score=324.27  Aligned_cols=259  Identities=24%  Similarity=0.329  Sum_probs=207.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|+++++||+|+||.||+|.+..+++.+|+|++..... .......+.+|+++++.+.||||+++++.+.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            68999999999999999999999999999999854321 12334578889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC---
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL---  155 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~---  155 (293)
                      |++| ++.+.+...  ..+++..++.++.||+.||++||++|++|+||||+||+++.++. ++|+|||.+.......   
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~-~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEeECCCCcccccccccc
Confidence            9985 555555443  24678889999999999999999999999999999999999888 9999999875321100   


Q ss_pred             --------------------------------------------cceeccCccccccCcccccCCCCCCCchhHHHHHHH
Q 038154          156 --------------------------------------------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACT  191 (293)
Q Consensus       156 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l  191 (293)
                                                                  .......|++.|+|||++.+. .++.++|+|||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHH
Confidence                                                        000122478899999988766 68999999999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCC
Q 038154          192 FAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP  271 (293)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  271 (293)
                      +|+|++|..||...+..+....+........                          ......+++++.++|.+|+ .+|
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~p~~~~~s~~~~~li~~l~-~~p  290 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH--------------------------IPPQAKLSPEASDLIIKLC-RGP  290 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------------------------CCCcccCCHHHHHHHHHHc-cCH
Confidence            9999999999988776665555432111100                          0011246889999999986 599


Q ss_pred             CCCCC---HHHHhcCcccccCc
Q 038154          272 SKRLT---AREALRHEYFKDFQ  290 (293)
Q Consensus       272 ~~Rps---~~~ll~~p~~~~~~  290 (293)
                      .+|++   ++++++||||+.+.
T Consensus       291 ~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         291 EDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             hHcCCCCCHHHHhcCCCcCCcC
Confidence            99997   99999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-46  Score=315.60  Aligned_cols=256  Identities=23%  Similarity=0.308  Sum_probs=209.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |++.+.||+|++|.||++.+..++..+|+|++..... .......+..|.+++..+ .|++++++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            8899999999999999999999999999999865332 222334566788888777 58999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+++ ++...+....  .+++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||.+..........
T Consensus        82 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          82 YVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc-EEEccCCCceecCCCCCcc
Confidence            9985 5555554433  4778899999999999999999999999999999999999888 9999999987544332333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.....                   
T Consensus       159 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------------------  218 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-------------------  218 (323)
T ss_pred             ccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            344589999999988765 689999999999999999999999998877777666643111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                 ..+..++.++.+++.+||+.||++|++     ..++++||||+.+.|
T Consensus       219 -----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         219 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             -----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                       122346789999999999999999998     489999999987653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.7e-46  Score=302.95  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=212.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.+.+.||+|++|.||++.+..++..+++|.+............+.+|+++++.++|||++++++++...+..++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            78899999999999999999999999999998765555555678889999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +| ++.+.+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~-~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN-VKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC-EEEcccccceeccCccchhhc
Confidence            75 5555555544456888899999999999999999999999999999999998887 999999998876544333334


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+. .++.++|+||||+++++|++|..||...+.......+....                      
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  217 (256)
T cd08529         161 IVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV----------------------  217 (256)
T ss_pred             cccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            4578899999987765 58899999999999999999999998877655555443210                      


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                             .......++.++.+++.+|++.+|++||++.++++|||+
T Consensus       218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 -------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                   011122467889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-46  Score=306.44  Aligned_cols=283  Identities=40%  Similarity=0.685  Sum_probs=227.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e   79 (293)
                      |++.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.+.|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7899999999999999999998899999999976553444456788999999999999999999999888  78999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      |+++++.+.+.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~-~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC-EEEccccceeeccCCCcccc
Confidence            99987777765543 46888899999999999999999999999999999999999888 99999999876654321 11


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....++..|+|||.+.+...++.++|+||||+++++|++|..||...+.......+......+....++...........
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            22235778999998776656889999999999999999999999998888888888776666665555544332111111


Q ss_pred             CCCCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          239 EPNRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ................ .+.++.+++.+||+.||++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            1111111222223333 48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-46  Score=308.15  Aligned_cols=284  Identities=35%  Similarity=0.566  Sum_probs=219.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++............+.+|+++++.++|||++++++++..++..++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            58999999999999999999988899999999865444444456788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          82 VDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             CCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc-EEEEeeeeeeeccCCccccCc
Confidence            99888876654432 4788899999999999999999999999999999999998887 999999998765443333233


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC-C
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF-E  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (293)
                      ..++..|+|||.+.+...++.++|+||||+++++|++|..||......+....+........................ .
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            346788999998876656788999999999999999999999877665555555544333221110000000000000 0


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .............+.++..+.+++.+||+.||++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00111122223456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-47  Score=319.52  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=207.0

Q ss_pred             eeeeccccceeEEEEEe---CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            5 LEVIREGRYGAVHRAHD---SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      ++.||+|++|.||++.+   ..+|+.+|+|++............+..|++++++++||||+++++++..++..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36899999999999876   357899999998754433333456778999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++ ++.+.+...  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc-EEEeeccCCcccCCCCCceec
Confidence            85 555555433  34788899999999999999999999999999999999998887 999999998765443233334


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....                      
T Consensus       158 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~----------------------  214 (318)
T cd05582         158 FCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK----------------------  214 (318)
T ss_pred             ccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            4588999999988765 57899999999999999999999998877666655553210                      


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~  290 (293)
                              ..++..+++++.+++++||+.||++||+     +.+++.||||..+.
T Consensus       215 --------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         215 --------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence                    0123346788999999999999999999     78899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=307.99  Aligned_cols=283  Identities=45%  Similarity=0.740  Sum_probs=228.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++.+..+++.+++|.+............+..|++++++++||+++++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            78899999999999999999889999999998765544445577888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        81 ~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          81 DTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV-LKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             CCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc-EEEeeeeeeEecCCCcccccCc
Confidence            998888776644 46788899999999999999999999999999999999998887 9999999987765543222233


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .++..|+|||.+.+...++.++|+||||+++|++++|+.||...+..+....+......+....+...............
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            46788999998876656899999999999999999999999888777766666665555544444433332121111111


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ...........+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            122222334456678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.5e-47  Score=317.69  Aligned_cols=252  Identities=27%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHH-HHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVS-LLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|+||++.+..+|+.+|+|++...... ......+..|.. +++.++||||+++++.+...+..++||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4799999999999999999999999998643221 122234445544 45778999999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeccCCCcccccCCCcccccc
Confidence            544 455443  35788899999999999999999999999999999999998887 99999999875433223333345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+...                         
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------------------  211 (323)
T cd05575         158 GTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-------------------------  211 (323)
T ss_pred             CChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------------
Confidence            88999999988765 6899999999999999999999999887766655554320                         


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~~~~~~  291 (293)
                           .....+.++.++.++|.+||+.||.+||++    .++++||||..+.+
T Consensus       212 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         212 -----PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                 011233468899999999999999999998    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=315.00  Aligned_cols=264  Identities=21%  Similarity=0.323  Sum_probs=208.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.+|+|++.... ........+.+|+.++..++|++|+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            5999999999999999999999999999999986422 122334567889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-c
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-N  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~  157 (293)
                      |+.| ++.+.+.. ....+++..+..++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC-EEEEECCceeecCCCCCcc
Confidence            9975 44445443 3345788899999999999999999999999999999999998888 99999999876543222 1


Q ss_pred             eeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .....+++.|+|||++..    ...++.++|+||||+++|+|++|..||...+..+....+......             
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------  226 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-------------  226 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-------------
Confidence            222348899999998863    345788999999999999999999999887766655555321110             


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~~  291 (293)
                                  .........++.++.+++++||+.++.+  |+++.+++.||||....+
T Consensus       227 ------------~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         227 ------------FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ------------ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                        0011112337889999999999765544  889999999999987643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.3e-46  Score=328.14  Aligned_cols=281  Identities=21%  Similarity=0.299  Sum_probs=209.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC------CCcceeeeeeecC-Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH------ENIVRLLNVQSSV-DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~~   73 (293)
                      +|++.++||+|+||+||++.+..++..||+|+++...   ........|+++++.+.|      ++++++++++..+ ..
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            6999999999999999999999899999999985321   222455668888887754      4588888887665 47


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCC--------------
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKD--------------  138 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~--------------  138 (293)
                      +|+||+++++.+++.+....  .+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.              
T Consensus       207 ~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        207 MCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            89999999999988887653  47888999999999999999997 59999999999999987653              


Q ss_pred             -eEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 038154          139 -IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI  217 (293)
Q Consensus       139 -~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  217 (293)
                       .+||+|||.+.....   ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus       285 ~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        285 CRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             ceEEECCCCccccCcc---ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             389999998764322   22234488999999988776 6899999999999999999999999988877777777766


Q ss_pred             hCCCCCCCCCCCcCc--ccccCCCCC---CCcccchhh------h-cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          218 MGTPDSETLPGFTSF--SEEFGFEPN---RSPIKDLAT------V-VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~------~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                      .+..+..+.......  ...+.....   .........      . .....+.+.+||.+||+.||.+|||++|+|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            665544332211000  000000000   000000000      0 0012456789999999999999999999999999


Q ss_pred             cccCc
Q 038154          286 FKDFQ  290 (293)
Q Consensus       286 ~~~~~  290 (293)
                      |+++.
T Consensus       441 ~~~~~  445 (467)
T PTZ00284        441 VLKYY  445 (467)
T ss_pred             ccccC
Confidence            99853

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=305.61  Aligned_cols=284  Identities=34%  Similarity=0.585  Sum_probs=222.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|+++...........+.+|+++++++.|+|++++++++..++..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            69999999999999999999998999999999876555555567889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-cee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~~  159 (293)
                      ++++++..+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~-~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          82 VERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEEeeecccccCCCcccccc
Confidence            9998887766543 34788899999999999999999999999999999999998888 99999999877654432 222


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc--ccC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE--EFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  237 (293)
                      ...++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+...............  ...
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            234678899999887765788999999999999999999999988776666555554443333221111110000  000


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ..............+..++.++.++|++||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0000001011112233458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.1e-46  Score=302.83  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=213.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.+|.+.+..+|..+++|.+............+.+|++++++++|||++++.+++...+..++|+|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            79999999999999999999998999999999865544444456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +.+ ++.+.+.......+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++++|||.+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEEeeccceeecCcchhhhh
Confidence            975 5656665544445788899999999999999999999999999999999998887 99999999876654333333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++|+||||++++++++|..||...+..+....+.....                    
T Consensus       160 ~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--------------------  218 (256)
T cd08218         160 TCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY--------------------  218 (256)
T ss_pred             hccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC--------------------
Confidence            33477889999987665 688999999999999999999999987766665555432110                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                               ...+...+.++.++|.+||+.+|++||++.++++||||
T Consensus       219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                     11223467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-45  Score=306.98  Aligned_cols=284  Identities=35%  Similarity=0.577  Sum_probs=218.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--------   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|.+............+.+|+++++++.||+++++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            589999999999999999999999999999988654434433445678999999999999999999876554        


Q ss_pred             cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           73 SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ..++||||+++++...+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        93 ~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~  170 (310)
T cd07865          93 SFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI-LKLADFGLARAFS  170 (310)
T ss_pred             eEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc-EEECcCCCccccc
Confidence            349999999998877776543 35788899999999999999999999999999999999998887 9999999987654


Q ss_pred             CCCcc----eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VPLEN----YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      .....    .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+..+....+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG  250 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            32211    11223567899999887665678899999999999999999999998887777777776666655554444


Q ss_pred             CcCcccccCCCCCCCcc-cchhhh-cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          229 FTSFSEEFGFEPNRSPI-KDLATV-VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ................. .....+ ....+..+.++|.+||..||.+|||++++++||||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            32211110000000000 000111 11235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=322.76  Aligned_cols=259  Identities=24%  Similarity=0.324  Sum_probs=205.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.++...|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            58999999999999999999999999999998854321 22334567889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++| ++...+...  ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||.++.......  
T Consensus        82 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEEeecccccccccccccc
Confidence            9975 555555443  35778889999999999999999999999999999999998887 99999998853211000  


Q ss_pred             ---------------------------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHH
Q 038154          157 ---------------------------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACT  191 (293)
Q Consensus       157 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l  191 (293)
                                                                   ......|++.|+|||++.+. .++.++|+|||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchh
Confidence                                                         00012488899999988765 68999999999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCC
Q 038154          192 FAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP  271 (293)
Q Consensus       192 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  271 (293)
                      +|+|++|..||...+..+....+........   .+                       ....++.++.++|.+||. +|
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p-----------------------~~~~~s~~~~dli~~lL~-~~  290 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLY---FP-----------------------DDIHLSVEAEDLIRRLIT-NA  290 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccC---CC-----------------------CCCCCCHHHHHHHHHHhc-CH
Confidence            9999999999988776665555542111000   00                       012367889999999998 77


Q ss_pred             CCC---CCHHHHhcCcccccCc
Q 038154          272 SKR---LTAREALRHEYFKDFQ  290 (293)
Q Consensus       272 ~~R---ps~~~ll~~p~~~~~~  290 (293)
                      .+|   +++.+++.||||+.+.
T Consensus       291 ~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         291 ENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhcCCCCCHHHHhcCCCcCCCC
Confidence            765   6999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-46  Score=313.80  Aligned_cols=286  Identities=34%  Similarity=0.548  Sum_probs=222.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||++.+.||+|++|+||++.+..++..+++|.+............+.+|+.+++.++|||++++++++....     ..+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            699999999999999999999999999999998654333334456778999999999999999999876542     479


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++||+++++.+.+....  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        86 lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          86 IVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECcCccccccCCCc
Confidence            999999988887776543  5788899999999999999999999999999999999998887 9999999987664432


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC--cc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS--FS  233 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (293)
                      .......++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+.......+....+.+..........  ..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            2222334678899999887644688999999999999999999999988877666666666555444332211110  00


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ..... .............+.+++++.+++++||+.||++|||+.++++||||..++
T Consensus       243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         243 RYIRS-LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHh-cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            00000 001111122334456899999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-45  Score=305.23  Aligned_cols=279  Identities=34%  Similarity=0.554  Sum_probs=216.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecC--CcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      |++.+.||+|++|.||++.+..++..+++|+++....... ......|+.+++++. |+|++++++++.++  +..++|+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            7899999999999999999998999999998865432222 234457888888885 99999999999887  8899999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||+++++++.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+......... 
T Consensus        80 e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~-~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          80 ELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI-LKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             ecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC-eEEEecccccccccCCCc-
Confidence            999999888877643 35788899999999999999999999999999999999998 66 999999998766433221 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.....++.++|+||||+++|+|++|..||...+..+....+....+.+.......... .....+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  234 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK-SRHMNY  234 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc-cccccc
Confidence            2233678899999876555678999999999999999999999998887777666665554444322111000 000011


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ..............+.++.++.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            111111122333445678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.9e-46  Score=310.62  Aligned_cols=277  Identities=35%  Similarity=0.577  Sum_probs=201.5

Q ss_pred             eeeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~   80 (293)
                      +++||+|+||+||+|.++  .++..+|+|.+...    .....+.+|++++++++||||+++++++..  +...++++|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            568999999999999865  46788999987532    223457889999999999999999998754  4568899999


Q ss_pred             CCcchHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe----CCCCeEEEccCCCcc
Q 038154           81 LDFDLLHFMKTE-------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID----RSKDIVKIADFGLAR  149 (293)
Q Consensus        81 ~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~----~~~~~v~l~df~~~~  149 (293)
                      +++++...+...       ....+++..++.++.|++.||+|||+.|++|+||||+||+++    ..+. +||+|||.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~-~kl~DfG~a~  160 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFAR  160 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCc-EEEeecCcee
Confidence            998887766432       223578889999999999999999999999999999999994    3344 9999999997


Q ss_pred             cCCCCCc---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHHH
Q 038154          150 PIDVPLE---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---------PGLLAAIFSI  217 (293)
Q Consensus       150 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~~~~~  217 (293)
                      .......   ......+++.|+|||++.+...++.++|+||+|+++|+|++|..||.....         ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            6643321   122334788999999988766789999999999999999999999975432         2334455554


Q ss_pred             hCCCCCCCCCCCcCcccccC----CCCC---C-CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          218 MGTPDSETLPGFTSFSEEFG----FEPN---R-SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~----~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .+.+....+.......+...    +...   . .............+.++.++|.+||+.||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            44443333222211111000    0000   0 00000111122345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=314.51  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=215.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|+..++||+|+||.||+|.+..+++.||+|++..+... +...++.+|+.+|..++++||.++++.+..+..++++|||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            477789999999999999999999999999999876543 4457899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+....+.+... .+++..+.-++++++.||.|||..+.+|+||++.||++..+|+ |||+|||.+-...........
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~-vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD-VKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc-EEEEecceeeeeechhhcccc
Confidence            98655544444333 2367788889999999999999999999999999999999988 999999999877665555556


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..|||-|||||++.+. .|+.++||||||++.++|.+|..|+....+..++..|       +...               
T Consensus       171 fvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~---------------  227 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSA---------------  227 (467)
T ss_pred             ccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCC---------------
Confidence            6699999999999855 7999999999999999999999999877663222222       1111               


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                             ...+....++.+++||..||+.||+.||+|.++|+|+|+++..
T Consensus       228 -------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  228 -------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             -------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                   1112225788999999999999999999999999999999854

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.6e-46  Score=312.34  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||++.+..+++.+|+|+++.... ..........|..++... .||||+++++++.+.+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999865322 122334566677888764 899999999999999999999999985


Q ss_pred             -chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 -DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 -~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                       ++...+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEccCCcceECCCCCCceeeec
Confidence             555555433  34677889999999999999999999999999999999998887 99999999875433223333345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      +++.|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+..+....+....                        
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------------------------  212 (316)
T cd05619         158 GTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN------------------------  212 (316)
T ss_pred             CCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence            88999999988765 68999999999999999999999998877666555542210                        


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH-HHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR-EALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~p~~~~~~  290 (293)
                            ...+..++.++.+++.+||+.||++||++. +++.||||..+.
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         213 ------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             ------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                  011223577899999999999999999996 899999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.7e-46  Score=319.02  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=207.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.++||||+++++.+.++...|+|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            58999999999999999999999999999999854222 22233567789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      |++|+.+..+....  .+++..+..++.||+.||++||++|++||||||+||+++.++. +||+|||.+........ ..
T Consensus       124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~-~kL~DFG~a~~~~~~~~~~~  200 (370)
T cd05621         124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRC  200 (370)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEEecccceecccCCceec
Confidence            99855444444332  4678889999999999999999999999999999999998888 99999999976643221 22


Q ss_pred             eccCccccccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 TIKGGSLCYKAPERLLGSG---RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ....|++.|+|||++.+..   .++.++|+||||+++|+|++|..||...+.......+........   .+        
T Consensus       201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p--------  269 (370)
T cd05621         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---FP--------  269 (370)
T ss_pred             ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---CC--------
Confidence            3445899999999886542   378899999999999999999999998877666665543111100   00        


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDF  289 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~  289 (293)
                                     ....++..+.+++.+||..++.+  |+++.++++||||+..
T Consensus       270 ---------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         270 ---------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ---------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                           01235788999999999855544  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-46  Score=315.09  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||++.+..+++.+|+|+++..... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999998654322 23345577888888877 799999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||.+..............
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~-~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC-EEEeeCCccccccCCCCcccccc
Confidence            544 444333  35788899999999999999999999999999999999999888 99999999875433223333345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------hH-HHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA--------PG-LLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||.....        .. ....+.                  
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~------------------  218 (329)
T cd05618         158 GTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------------------  218 (329)
T ss_pred             CCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh------------------
Confidence            89999999988766 688999999999999999999999953211        01 111111                  


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC------HHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT------AREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~p~~~~~~~  291 (293)
                                  .....++..++.++.+++.+||..||.+||+      +.++++||||+.+.+
T Consensus       219 ------------~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         219 ------------EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             ------------cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                        0011234457888999999999999999998      589999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.9e-46  Score=307.43  Aligned_cols=261  Identities=24%  Similarity=0.318  Sum_probs=211.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|+++++||+|++|.||++.+..++..+++|.+...  .......+.+|+++++.++|||++++++.+..++..++||||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            488999999999999999999999999999998542  223346678899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+..+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC-EEEccCccceeccccccccce
Confidence            9977766554433446788999999999999999999999999999999999998887 999999988755433333334


Q ss_pred             cCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          161 KGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ..+++.|+|||.+.+    ...++.++|+||||+++|+|++|..||...+......++...  ..+              
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~--------------  233 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP--------------  233 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc--------------
Confidence            447888999998752    334688999999999999999999999876654444333210  000              


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                 ....+..++.++.+++.+||+.||++||++.++++||||..+++
T Consensus       234 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         234 -----------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             -----------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                       00112346778999999999999999999999999999998765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-46  Score=314.81  Aligned_cols=277  Identities=24%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|+...        .....|+.++++++||||+++++++......++|+|+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            48999999999999999999998999999996421        2345699999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.+++...+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||.+...... .....
T Consensus       139 ~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~-~~~~~  215 (357)
T PHA03209        139 YSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ-VCIGDLGAAQFPVVA-PAFLG  215 (357)
T ss_pred             cCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEecCccccccccC-ccccc
Confidence            9998888876543 35788899999999999999999999999999999999998887 999999998754322 12223


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCc---------hHHHHHHHHHhCCCCCCCCCC-C
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWA---------PGLLAAIFSIMGTPDSETLPG-F  229 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~---------~~~~~~~~~~~~~~~~~~~~~-~  229 (293)
                      ..+++.|+|||++.+. .++.++|+||||+++|+|+++..|+ .....         ...+..+....+..+...... .
T Consensus       216 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        216 LAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             ccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            3488999999988766 6899999999999999999866554 33211         122223333323222221110 0


Q ss_pred             cCccc-ccCCCCCC-Ccccc-hhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          230 TSFSE-EFGFEPNR-SPIKD-LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       230 ~~~~~-~~~~~~~~-~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ..... ........ ..... .......++.++.++|.+||+.||.+|||+.|+|+||||+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000 00000000 00000 011123467888999999999999999999999999999874

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-46  Score=322.25  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=206.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+++.+|+|++..... .......+.+|+++++.++||||+++++.+.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            48999999999999999999999999999999854322 22334667889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC---
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL---  155 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~---  155 (293)
                      |++| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||.+..+....   
T Consensus        82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC-EEEEeCCCCcccccccccc
Confidence            9985 5555554432  4678888999999999999999999999999999999998887 9999999875321000   


Q ss_pred             ----------------------------------------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHH
Q 038154          156 ----------------------------------------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEM  195 (293)
Q Consensus       156 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l  195 (293)
                                                              .......|++.|+|||++.+. .++.++|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeeh
Confidence                                                    000123488999999988765 689999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC
Q 038154          196 VTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL  275 (293)
Q Consensus       196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  275 (293)
                      ++|..||...+..+....+........                          ......+++++.++|.+|+ .+|.+|+
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLH--------------------------IPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCcccc--------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            999999988776655444422110000                          0011246788999999987 5999999


Q ss_pred             ---CHHHHhcCcccccCc
Q 038154          276 ---TAREALRHEYFKDFQ  290 (293)
Q Consensus       276 ---s~~~ll~~p~~~~~~  290 (293)
                         ++.++++||||+.+.
T Consensus       291 ~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         291 GKNGADEIKAHPFFKGID  308 (376)
T ss_pred             CCCCHHHHhCCCCcCCCC
Confidence               999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-45  Score=305.14  Aligned_cols=282  Identities=49%  Similarity=0.817  Sum_probs=229.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++....+++.+++|++............+..|+++++++.|++++++++++.+.+..++|+|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            78899999999999999999989999999998765544555577888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++++.+.+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        81 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          81 DMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             CcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC-EEEecCCcccccCCCccccCcc
Confidence            988777776543 35888899999999999999999999999999999999998887 9999999987665443333333


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .++..|+|||.+.+...++.++|+||||++++++++|..||...+..+....+....+.+....++...... .+.....
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  237 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFP  237 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-ccccccc
Confidence            456789999988766578899999999999999999999999988888888887777766655544433332 1111111


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ...........+.++..+.+++++||..||++||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            111122233344568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7e-46  Score=311.61  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=209.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|++.+.||+|++|.||++.+..+|+.||+|++..... .......+..|.+++..+. |++++++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47899999999999999999999999999999864322 2233456777888888885 578888999999999999999


Q ss_pred             ecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++|+ +...+....  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~-ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeccccccccCCCCcc
Confidence            999854 444444332  4788899999999999999999999999999999999998888 999999998754333223


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.....                  
T Consensus       158 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------  218 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------  218 (323)
T ss_pred             ccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            3334588999999988765 689999999999999999999999998877766666543111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                  ..+..++.++.+++.+||+.||.+|++     ..++++||||..+.+
T Consensus       219 ------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         219 ------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                        122346788999999999999999997     589999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.5e-46  Score=313.48  Aligned_cols=286  Identities=31%  Similarity=0.580  Sum_probs=226.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----CCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----VDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..+|..|++|++............+.+|+.+++.++||||+++++++..    ....++
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            5899999999999999999999999999999986544444455678889999999999999999998753    346899


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+||+++++...+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        86 v~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          86 VMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEecccccceeecccCc
Confidence            99999988777765543  3788899999999999999999999999999999999999888 99999999876543221


Q ss_pred             ce----eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 NY----TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..    ....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.++..........
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            11    12347788999998876556899999999999999999999999988877777777776666654443322111


Q ss_pred             c--cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 S--EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .  +... ..............+..+.++.++|.+||+.||++||++.+++.||||..++
T Consensus       243 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         243 RVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            0  0000 0011111222334566799999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.7e-46  Score=326.65  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=210.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--------   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (293)
                      ||++.+.||+|+||+||++.+..+|+.||+|++............+.+|+.++..+.|++++++++.+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            799999999999999999999999999999998765544444567788999999999999999987664332        


Q ss_pred             cceeEeecCC-cchHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154           73 SIDLVFENLD-FDLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus        73 ~~~lv~e~~~-~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      ..++||||+. |++.+.+...  ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+.
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~-vkL~DFGls~  191 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-VKLGDFGFSK  191 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC-EEEEecccCe
Confidence            3679999998 5565655432  2346788899999999999999999999999999999999998887 9999999987


Q ss_pred             cCCCCC--cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          150 PIDVPL--ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       150 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ......  .......|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....         
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~---------  261 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---------  261 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------
Confidence            654321  112234488999999988765 68999999999999999999999998877766655543211         


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                          ....++.+++++.+++.+||+.||.+||++.++++|||++.+
T Consensus       262 --------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 --------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                112334578899999999999999999999999999998764

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-45  Score=303.89  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcchH
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLL   86 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~   86 (293)
                      ||+|+||.||++.++.+|+.+++|++....... .....+..|++++++++||||+++++++..+...++||||++|..+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999999999999985433222 2234556799999999999999999999999999999999986544


Q ss_pred             -HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           87 -HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        87 -~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                       ..+.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC-EEEeeceeeeecCCCc-eeeccCCCC
Confidence             4554445556888899999999999999999999999999999999998887 9999999987664432 223344888


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      .|+|||++.+. .++.++|+||||+++|+|++|..||...........+.......                        
T Consensus       159 ~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  213 (277)
T cd05607         159 GYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED------------------------  213 (277)
T ss_pred             CccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc------------------------
Confidence            99999988766 58999999999999999999999997654322222221110000                        


Q ss_pred             cchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCcccccCcC
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYFKDFQS  291 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~~~~~~  291 (293)
                       ........++.++.+++.+||+.||.+||++    .+++.||||+.+++
T Consensus       214 -~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         214 -EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             -ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence             0000112467889999999999999999999    77889999988753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-45  Score=298.56  Aligned_cols=255  Identities=28%  Similarity=0.459  Sum_probs=212.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..++..+++|.+............+.+|+++++.++|||++++++.+...+..++|+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            69999999999999999999999999999999876554445567888999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++ ++.+.+.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++..++|+|||.+......... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~-~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-Y  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc-c
Confidence            985 55556555444557888999999999999999999999999999999999877766899999999876543222 2


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+.......+....                     
T Consensus       160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~---------------------  217 (256)
T cd08220         160 TVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT---------------------  217 (256)
T ss_pred             ccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC---------------------
Confidence            23377889999988765 57899999999999999999999998877665555443211                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              ....+..+++++.+++.+||..||.+|||+.++++||||
T Consensus       218 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 --------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                    011223467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.2e-45  Score=308.77  Aligned_cols=286  Identities=38%  Similarity=0.603  Sum_probs=225.1

Q ss_pred             Ccee-eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC------------CcccHHHHHHHHHhcCCCCcceeeee
Q 038154            1 RYTL-LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG------------VPSSVIREVSLLKELKHENIVRLLNV   67 (293)
Q Consensus         1 ry~i-~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (293)
                      ||.. .+.||+|++|+||++.+..+++.+|+|++........            ....+.+|+++++.++|||+++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            5764 4779999999999999998999999999854332221            11247789999999999999999999


Q ss_pred             eecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           68 QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        68 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      +...+..+++||++.+++.+.+....  .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~-~kl~dfg~  165 (335)
T PTZ00024         89 YVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI-CKIADFGL  165 (335)
T ss_pred             EecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC-EEECCccc
Confidence            99999999999999998888776543  4778899999999999999999999999999999999998887 99999998


Q ss_pred             cccCCCC--------------CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 038154          148 ARPIDVP--------------LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAA  213 (293)
Q Consensus       148 ~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  213 (293)
                      +......              ........+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8765411              11122223577899999887765678999999999999999999999999888888888


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      +....+.+....++............  ...........+..+.++.++|++||+.+|++|||+++++.||||+..+.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccC--cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            87776666555444332211111100  01112223344567889999999999999999999999999999997653

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-45  Score=310.32  Aligned_cols=286  Identities=20%  Similarity=0.212  Sum_probs=205.8

Q ss_pred             eeeeeccc--cceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            4 LLEVIREG--RYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         4 i~~~lg~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      ++++||+|  ++++||++.+..+|+.||+|.+............+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            57889999  6789999999999999999998655444444456778999999999999999999999999999999999


Q ss_pred             CcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc----
Q 038154           82 DFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE----  156 (293)
Q Consensus        82 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~----  156 (293)
                      +++.+ +.+.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++++||+..........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc-EEEcccchhhccccccccccc
Confidence            85544 5554444445788899999999999999999999999999999999998887 89999976543211100    


Q ss_pred             ---ceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC--------CCCC
Q 038154          157 ---NYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT--------PDSE  224 (293)
Q Consensus       157 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~  224 (293)
                         ......++..|+|||++.+. ..++.++|+||||+++|+|++|..||..................        +...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               01112256679999988653 35889999999999999999999999875544332222211000        0000


Q ss_pred             CCCCCcCcccccCC--------CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          225 TLPGFTSFSEEFGF--------EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       225 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ..........+...        ................+++++.+++.+||+.||++|||++++++||||+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            00000000000000        0000001111223345678999999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-45  Score=299.18  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=212.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||.+.+.||+|++|.||++....+|..+++|.+............+.+|+++++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            69999999999999999999999999999999866544444456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++ .+.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++..++++|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            975 5556665544445788899999999999999999999999999999999998876679999999887655433333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++|+||||++++++++|..||...+..+....+....                     
T Consensus       161 ~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  218 (257)
T cd08225         161 TCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---------------------  218 (257)
T ss_pred             ccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---------------------
Confidence            44578899999977655 68899999999999999999999998766554443332100                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              .....+..+.++.+++.+|+..+|++|||+.+++.||||
T Consensus       219 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 --------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                    011123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-45  Score=297.45  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=215.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||.|++|.||.+....++..+++|.+............+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            79999999999999999999999999999999876555555567788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++ ++.+.+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~-~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC-EEECcCcceEEccccccccc
Confidence            985 5555555544456788899999999999999999999999999999999998887 99999999876654433333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|.|||.+.+. .++.++|+||||+++++|++|..||...+..+....+....                     
T Consensus       160 ~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~---------------------  217 (256)
T cd08221         160 TVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN---------------------  217 (256)
T ss_pred             ccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            44578999999988766 57899999999999999999999998877666666553210                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              .......++.++.+++.+||..+|.+||++.++++|||+
T Consensus       218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 --------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                    011113467889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-47  Score=304.61  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=220.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++.+.||+|.||.|-+|.+...|+.||||.++.+.... ...-.+.+|++++..|+||||++++.+|++.+...+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            7999999999999999999998999999999987655443 445678899999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |.. |.+.+++.+.+.  +++..++.+++||.+|+.|+|+++++|+|||.+||++|.+++ +||+|||++-.+... .-.
T Consensus       134 YaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N-iKIADFGLSNly~~~-kfL  209 (668)
T KOG0611|consen  134 YASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN-IKIADFGLSNLYADK-KFL  209 (668)
T ss_pred             ecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC-eeeeccchhhhhccc-cHH
Confidence            997 788888877654  788899999999999999999999999999999999999999 999999999766433 333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+|+|.|.+||.+.+.++-.+..|.||||++||.++.|..||++.+....+.+|.......                 
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-----------------  272 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-----------------  272 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-----------------
Confidence            456699999999999999878899999999999999999999999999988888885533222                 


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                    +.-|.++.-||+.||..||++|.|+.+|-+|=|++
T Consensus       273 --------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  273 --------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                          12345677899999999999999999999886653

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.2e-45  Score=311.13  Aligned_cols=285  Identities=31%  Similarity=0.529  Sum_probs=214.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC---------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV---------   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------   71 (293)
                      ||++.+.||.|++|.||++.+..+|..+++|++.....  .....+.+|++++++++|||++++++.+...         
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            79999999999999999999999999999998854432  3446788899999999999999999876544         


Q ss_pred             -----CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           72 -----DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        72 -----~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                           ...++++||+++++.+.+...   .+++..++.++.||+.||.+||+.|++|+||+|+||+++..+..++++|||
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 347899999998776666432   477889999999999999999999999999999999998666558999999


Q ss_pred             CcccCCCCCcce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+..........   ....++..|+|||.+.....++.++|+||||+++|+|++|..||.+.+..+....+.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653321111   12236778999998766556889999999999999999999999887776665555443222111


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .............................+.++.++.+++.+||+.||.+|||+.++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            1111110000000000011111222334456889999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.5e-46  Score=317.40  Aligned_cols=260  Identities=22%  Similarity=0.325  Sum_probs=208.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+++.+|+|++.... ........+..|+.++..++||+++++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4889999999999999999999999999999986432 223345677889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++| ++.+.+....  .+++..++.++.|++.||++||+.|++|+||||+||+++.++. ++|+|||.+........  
T Consensus        82 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~-vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEeeccCCcccccccccc
Confidence            9985 4555554433  4788899999999999999999999999999999999998888 99999998864422100  


Q ss_pred             ---------------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          157 ---------------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       157 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                                                       ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCC
Confidence                                             01123488999999988766 68899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC---CHHHH
Q 038154          204 SRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---TAREA  280 (293)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~l  280 (293)
                      ..+..+....+........   .+                       -...++.++.++|.+|+. ||.+|+   ++.++
T Consensus       238 ~~~~~~~~~~i~~~~~~~~---~p-----------------------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei  290 (360)
T cd05627         238 SETPQETYRKVMNWKETLV---FP-----------------------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEI  290 (360)
T ss_pred             CCCHHHHHHHHHcCCCcee---cC-----------------------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH
Confidence            8877766666542110000   00                       011267889999999874 999998   58999


Q ss_pred             hcCcccccCcC
Q 038154          281 LRHEYFKDFQS  291 (293)
Q Consensus       281 l~~p~~~~~~~  291 (293)
                      ++||||..++|
T Consensus       291 ~~hp~f~~~~~  301 (360)
T cd05627         291 KSHPFFEGVDW  301 (360)
T ss_pred             hcCCCCCCCCH
Confidence            99999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.5e-45  Score=306.36  Aligned_cols=277  Identities=35%  Similarity=0.553  Sum_probs=202.8

Q ss_pred             eeeeccccceeEEEEEeCC--CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee--cCCcceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDSL--TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS--SVDSIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~   80 (293)
                      +.+||+|+||.||+|....  ++..+|+|.+...    .....+.+|+++++.++|||++++++++.  .+...++++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            4689999999999998653  5678999987532    22346788999999999999999999874  34578999999


Q ss_pred             CCcchHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe----CCCCeEEEccCCCcc
Q 038154           81 LDFDLLHFMKTE-------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID----RSKDIVKIADFGLAR  149 (293)
Q Consensus        81 ~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~----~~~~~v~l~df~~~~  149 (293)
                      +++++...+...       ....+++..++.++.||+.||.+||+.|++|+||||+||++.    .++. ++|+|||.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~-~kl~DfG~a~  160 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFAR  160 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCc-EEEeecccee
Confidence            999887766422       223577888999999999999999999999999999999994    3344 9999999998


Q ss_pred             cCCCCCcc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHHH
Q 038154          150 PIDVPLEN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---------PGLLAAIFSI  217 (293)
Q Consensus       150 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~~~~~  217 (293)
                      ........   .....+++.|+|||++.+...++.++|+||||+++|+|+||..||.....         ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            66443221   12234788999999887766789999999999999999999999975432         2334455555


Q ss_pred             hCCCCCCCCCCCcCcccccCCC----CC----CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          218 MGTPDSETLPGFTSFSEEFGFE----PN----RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .+.+....+.............    ..    ..............+..+.+++.+||+.||.+|||+.|+|.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            5544444443322211111000    00    000001111122345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=306.90  Aligned_cols=285  Identities=38%  Similarity=0.611  Sum_probs=214.1

Q ss_pred             CceeeeeeccccceeEEEEEeCC--CCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Ccce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL--TGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   75 (293)
                      ||++.+.||+|++|.||+|.+..  .+..+|+|.+.... ........+.+|+.+++.++|||++++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            79999999999999999999887  78999999986533 2233446778899999999999999999999888  7899


Q ss_pred             eEeecCCcchHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC----CCCeEEEccCCCc
Q 038154           76 LVFENLDFDLLHFMKTEP---TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR----SKDIVKIADFGLA  148 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~----~~~~v~l~df~~~  148 (293)
                      +|||++++++...+....   ...+++..++.++.|++.||++||+.|++|+||+|+||+++.    ++. ++|+|||.+
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~-~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV-VKIGDLGLA  159 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce-EEECCCccc
Confidence            999999988877664322   236788899999999999999999999999999999999998    666 999999998


Q ss_pred             ccCCCCCc---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH---------HHHHHHH
Q 038154          149 RPIDVPLE---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---------LLAAIFS  216 (293)
Q Consensus       149 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---------~~~~~~~  216 (293)
                      ........   ......+++.|+|||++.+...++.++|+||||+++++|++|..||.....+.         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            76643322   11222367889999988776568899999999999999999999998655432         3334444


Q ss_pred             HhCCCCCCCCCCCcCcccccC-----CCCCC--CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          217 IMGTPDSETLPGFTSFSEEFG-----FEPNR--SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ....+............+...     .....  .............+.++.+++.+||+.||++|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            333332221111111100000     00000  01111111123678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-46  Score=314.88  Aligned_cols=252  Identities=26%  Similarity=0.355  Sum_probs=202.0

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHH-HHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVS-LLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|+||++.+..+|+.+|+|++..... .......+..|.. +++.++||||+++++++...+..|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999854322 1222234455554 46778999999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||.+..............
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEeecCCcccCCCCCCCccccc
Confidence            544 444433  35788899999999999999999999999999999999999888 99999999875433323333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+...                         
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-------------------------  211 (325)
T cd05604         158 GTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-------------------------  211 (325)
T ss_pred             CChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-------------------------
Confidence            88999999988765 6889999999999999999999999887766655554320                         


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~~~~~~  291 (293)
                           .....+..+..+.+++.+||..||++||++    .++++||||....+
T Consensus       212 -----~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         212 -----PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -----CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                 011223467889999999999999999977    59999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-45  Score=313.90  Aligned_cols=279  Identities=22%  Similarity=0.326  Sum_probs=209.9

Q ss_pred             CceeeeeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|++|.||++...  ..+..+++|.+...       ....+|++++++++||||+++++++......|++|
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            6999999999999999999753  35677899976421       24568999999999999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |++.+++.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++. ++|+|||.+......... 
T Consensus       166 e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~-~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        166 PKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN-AVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             hhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEccCccccccCcccccc
Confidence            99999988888433  35788899999999999999999999999999999999998888 999999998765433221 


Q ss_pred             -eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCCCCCCCCCCcC-c
Q 038154          158 -YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---PGLLAAIFSIMGTPDSETLPGFTS-F  232 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~  232 (293)
                       .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+...   ...+..+....+..+......... .
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             cccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence             2233488999999988765 689999999999999999999999976543   344444444444333222211110 0


Q ss_pred             cccc-CCCCCCCcccchh--hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEF-GFEPNRSPIKDLA--TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ...+ .............  ......+.++.++|.+||..||++|||+.++|+||||.+.+
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0000 0000000000000  01124577899999999999999999999999999998754

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=302.52  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=210.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+++++.+.|||++++++++.++...++|+|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            6899999999999999999999899999999986433 233346788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+.......  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD-VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEcccccceeeccccccccc
Confidence            9865444443332  6788899999999999999999999999999999999999888 999999999877654333344


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....                      
T Consensus       158 ~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------------------  214 (274)
T cd06609         158 FVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN----------------------  214 (274)
T ss_pred             ccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC----------------------
Confidence            4577889999988766 58999999999999999999999998766544433332100                      


Q ss_pred             CCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                             ....... ++.++.+++.+||..||++|||++++++||||++..
T Consensus       215 -------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 -------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                   0001111 677899999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=304.89  Aligned_cols=259  Identities=27%  Similarity=0.364  Sum_probs=211.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|.||++.+..++..+++|.+...  .......+..|++++++++|||++++++++..+...++||||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            588999999999999999998888999999988543  223345688899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+..+.......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD-VKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC-EEEccCccchhhcccccccce
Confidence            9976666665544456888999999999999999999999999999999999998887 999999988765443333334


Q ss_pred             cCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          161 KGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ..+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...........+...  ..+              
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------------  226 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP--------------  226 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC--------------
Confidence            447888999998752    235678999999999999999999999877655544443210  000              


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ....+..++.++.+++.+||+.||.+||++.++++||||.+.
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 -----------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                       001123467889999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-45  Score=314.62  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=207.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.+|+|++..... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            58999999999999999999999999999999854222 22233457789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      |++|+.+..+....  .+++..+..++.||+.||++||++|++|+||||+||+++.++. ++|+|||.+........ ..
T Consensus       124 y~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~-ikL~DfG~a~~~~~~~~~~~  200 (371)
T cd05622         124 YMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRC  200 (371)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC-EEEEeCCceeEcCcCCcccc
Confidence            99865554444332  3677788899999999999999999999999999999999888 99999999876543211 22


Q ss_pred             eccCccccccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 TIKGGSLCYKAPERLLGS---GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ....|++.|+|||++.+.   ..++.++|+||||+++|+|++|..||.+.+.......+........   .         
T Consensus       201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~---------  268 (371)
T cd05622         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F---------  268 (371)
T ss_pred             cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C---------
Confidence            234589999999988654   2378899999999999999999999998777666655542111000   0         


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~  290 (293)
                                    .....++.++.++|.+||..++.+  |+++.++++||||++.+
T Consensus       269 --------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         269 --------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             --------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                          112347889999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-45  Score=308.67  Aligned_cols=285  Identities=35%  Similarity=0.589  Sum_probs=217.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      +|++.+.||+|++|.||++.+..+|..|++|++.... .......+..|++++++++|||++++++++....     ..+
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            6999999999999999999999999999999885322 2233456778999999999999999998765443     479


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++|++++++...+...   .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        85 lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEECcccceeeccccc
Confidence            99999998877766432   5788899999999999999999999999999999999998888 9999999887654322


Q ss_pred             cce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...   ....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+..+........
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            111   12246788999998766556889999999999999999999999887666665555554444433222211110


Q ss_pred             cc-ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SE-EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .. ..................+..+.++.+++.+||+.||++|||+.++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00 00000001111122233456789999999999999999999999999999998774

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-45  Score=302.58  Aligned_cols=262  Identities=25%  Similarity=0.365  Sum_probs=208.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+..|+.++++++|++++++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4889999999999999999999999999999886433222 223456789999999999999999999999999999999


Q ss_pred             cCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.|..+ ..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQ-TI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeccceeecCCCc-cc
Confidence            9986544 5554444456888899999999999999999999999999999999998887 9999999887654322 22


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...................                 
T Consensus       159 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----------------  220 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------------  220 (285)
T ss_pred             cCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------------
Confidence            223488999999988765 68999999999999999999999997654322111111100000                 


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                               .......+++++.+++.+||+.||.+|||     +.++++||||+.+++
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         221 ---------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             ---------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                     00122346788999999999999999999     999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-46  Score=313.01  Aligned_cols=252  Identities=26%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHH-HHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREV-SLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||+||++.+..++..+|+|++...... ......+..|. .+++.+.||||+++++++...+..|+||||+.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999998643221 12223344444 356778999999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++. ++|+|||.+..............
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~-~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEEccCCCCcccccCCCCccccc
Confidence            544 444433  24677888899999999999999999999999999999998887 99999999875433323333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....                        
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------  212 (325)
T cd05602         158 GTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------  212 (325)
T ss_pred             CCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence            89999999988765 68899999999999999999999998877766655553210                        


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH----HHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR----EALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----~ll~~p~~~~~~~  291 (293)
                            ....+.++..+.++|.+||+.||.+||++.    ++++|+||..+.|
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         213 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             ------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                  012235788999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.7e-45  Score=308.41  Aligned_cols=282  Identities=21%  Similarity=0.357  Sum_probs=206.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            5899999999999999999999999999999875432 223345788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +.+ ++.+.+....  .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||.+.......  .
T Consensus        85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~--~  159 (333)
T cd06650          85 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM--A  159 (333)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC-EEEeeCCcchhhhhhc--c
Confidence            986 4545554432  467888999999999999999975 7999999999999998887 9999999987553321  1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC-CCCCCCC-CCCcCccccc
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG-TPDSETL-PGFTSFSEEF  236 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~  236 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+..... .+..... +.........
T Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         160 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             ccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            223478899999988765 688999999999999999999999987654433322211000 0000000 0000000000


Q ss_pred             -CCCCCCCccc------------chhhh-cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 -GFEPNRSPIK------------DLATV-VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 -~~~~~~~~~~------------~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                       ..........            ..... ....+.++.+|+.+||+.||++|||+.+++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence             0000000000            00000 11256789999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-45  Score=315.22  Aligned_cols=276  Identities=23%  Similarity=0.298  Sum_probs=204.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|.+.+.||+|++|.||++.+...+..|++|...        ...+.+|++++++++|+||+++++++...+..+++|++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4899999999999999999999999999999532        23467899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--e
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--Y  158 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--~  158 (293)
                      +.+++..++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.++........  .
T Consensus       242 ~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~-vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        242 YRSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             cCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC-EEEcccCCceecccccccccc
Confidence            99988888765433 5888999999999999999999999999999999999998887 999999998765332111  1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CC------chHHHHHHHHHhCCCCCCCCCCC-c
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS-RW------APGLLAAIFSIMGTPDSETLPGF-T  230 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~-~~------~~~~~~~~~~~~~~~~~~~~~~~-~  230 (293)
                      ....|++.|+|||++.+. .++.++|||||||++|+|++|..|+-. ..      ....+..+............... .
T Consensus       320 ~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             cccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            223489999999988766 689999999999999999998865422 11      11223333322221111111100 0


Q ss_pred             Cccccc-----CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          231 SFSEEF-----GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       231 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      ......     ...........+.. ...++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            000000     00000000011111 1245678999999999999999999999999999974

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-45  Score=311.44  Aligned_cols=284  Identities=38%  Similarity=0.568  Sum_probs=221.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc------c
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS------I   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~   74 (293)
                      +|++.+.||+|++|.||++.+..++..+++|++............+.+|+.+++++.|||++++.+++.....      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            6899999999999999999999899999999886543333344667789999999999999999988766554      8


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++|+|++++++.+.+..   ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        96 ~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~-~kL~dfg~~~~~~~~  171 (343)
T cd07851          96 YLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDDE  171 (343)
T ss_pred             EEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEcccccccccccc
Confidence            99999998877776654   35788899999999999999999999999999999999998887 999999998765432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc-
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS-  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (293)
                         .....++..|+|||.+.+...++.++|+||||+++|++++|..||.+.+.......+....+.+.+.......... 
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence               2222367889999988765568899999999999999999999999887777777776655544433222221100 


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ..+...................++++.++|.+||+.||.+|||+.++++||||.++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence            0000001111112223334456899999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-45  Score=310.90  Aligned_cols=264  Identities=20%  Similarity=0.307  Sum_probs=208.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|+||.||++..+.+++.+|+|++.... ........+..|+.++..+.|++++++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            5899999999999999999999999999999985422 122233457789999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-c
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-N  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~  157 (293)
                      |+.+ ++.+.+.. ....+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||.+........ .
T Consensus        82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~-~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEeecchheecccCCcce
Confidence            9985 55555543 3335788899999999999999999999999999999999998887 99999999875433222 2


Q ss_pred             eeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .....|++.|+|||++..    ...++.++|+||||+++|+|++|..||...+..+....+.......            
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------  227 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------  227 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc------------
Confidence            223358999999998753    3457889999999999999999999998877766666654211100            


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~~  291 (293)
                                   ........+++++.+++++||+.++.+  |+++.++++||||..+.+
T Consensus       228 -------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         228 -------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             -------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                         011112346889999999999765554  789999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=300.38  Aligned_cols=282  Identities=37%  Similarity=0.561  Sum_probs=225.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |.+.+.||+|++|+||+|....+++.+++|++...... .......+|+..++++. |||++++++++..++..++|||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            78999999999999999999888999999988543322 12234456889999998 99999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~-~~l~d~~~~~~~~~~~~-~~~  157 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV-VKIADFGLAREIRSRPP-YTD  157 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC-EEEeecccceeccCCCC-cCC
Confidence            9888888887665456788999999999999999999999999999999999998887 99999999876643322 222


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..++..|+|||++.....++.++|+||||+++++|++|..||......+...++....+.+....++.............
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            33677899999887666689999999999999999999999998888877777777666665554444333333222222


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ............+..+.++.+++++||+.||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            2222222233344457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-46  Score=314.66  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=200.6

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc---CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL---KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ||+|+||+||++.+..++..+|+|++...... .........|..++...   .||+|+++++++......|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999998543211 12223444566666655   699999999999999999999999985


Q ss_pred             -chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 -DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 -~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                       ++...+...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. ++|+|||.+..............
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEecCCcCcCCCCCCCCccCcc
Confidence             555555443  35788899999999999999999999999999999999998888 99999999875433323333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+.......                     
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------  216 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---------------------  216 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC---------------------
Confidence            89999999988766568999999999999999999999998877766655553211000                     


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCC----CHHHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----TAREALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~p~~~~~~  290 (293)
                              -...++.++.++|.+||+.||.+||    ++.++++||||....
T Consensus       217 --------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         217 --------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             --------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                    0112578899999999999999998    799999999998764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-45  Score=309.37  Aligned_cols=253  Identities=22%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|.||++.+..++..+|+|++...... ......+..|..++.++ .||+|+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999998654322 23345677899999888 599999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC-EEEeccccceeccCCCCceeccc
Confidence            544 444433  25788899999999999999999999999999999999998888 99999999875433223333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA------PGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      |++.|+|||++.+. .++.++|+||||+++|+|++|..||.....      .+.......                    
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------  216 (327)
T cd05617         158 GTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------------------  216 (327)
T ss_pred             CCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------------------
Confidence            89999999988765 689999999999999999999999964221      111111110                    


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC------HHHHhcCcccccCcC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT------AREALRHEYFKDFQS  291 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~p~~~~~~~  291 (293)
                               ......+..++..+.+++.+||+.||.+|++      ..++++||||+.+.+
T Consensus       217 ---------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         217 ---------EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ---------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                     0011123446788999999999999999998      579999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-44  Score=301.16  Aligned_cols=258  Identities=29%  Similarity=0.411  Sum_probs=210.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|.||++.+..+++.+++|.+....  ......+.+|+.+++.++|||++++++++......++|+||
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            5899999999999999999998999999999885432  23346788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.+..+..+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS-VKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccchhcccccccCCC
Confidence            9876666555433  4788899999999999999999999999999999999998887 999999988765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+. .++.++|+||||+++|++++|..||...+.......+... ..+.                  
T Consensus       175 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~------------------  234 (296)
T cd06655         175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE------------------  234 (296)
T ss_pred             cCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc------------------
Confidence            4478899999987655 5789999999999999999999999877654443333210 0000                  


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                              ...+..+++.+.++|.+||..||++||++.+++.||||+..+.
T Consensus       235 --------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 --------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             --------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                    0112346788999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-45  Score=322.40  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=207.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCC-CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLT-GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |.+.+.||+|++|.||+|.+..+ +..+++|.+...  .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            88999999999999999988776 778888876432  222334677899999999999999999999999999999999


Q ss_pred             CCc-chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           81 LDF-DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        81 ~~~-~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      +.| ++.+.+..  .....+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||.+........ 
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~-~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-IKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc-EEEEeCcCceecCCcccc
Confidence            985 44444432  22345788899999999999999999999999999999999998887 99999999986643221 


Q ss_pred             -ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          157 -NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       157 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                       ......|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.....                
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------------  288 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----------------  288 (478)
T ss_pred             ccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence             12233489999999988765 689999999999999999999999988777666665543111                


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                   ...+..++.++.++|.+||..||.+||++.+++.|||++.+
T Consensus       289 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 -------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                         11223467889999999999999999999999999998754

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-46  Score=310.83  Aligned_cols=252  Identities=28%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHH-HHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVS-LLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|.||++.+..++..+|+|++..... .......+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999854322 1222334555544 57788999999999999999999999999986


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +.+ ..+...  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++. +||+|||.+..............
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEccCCCCccCCCCCCcccccc
Confidence            544 444433  34778889999999999999999999999999999999999888 99999999875433223333345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      +++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+...                         
T Consensus       158 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------------------------  211 (321)
T cd05603         158 GTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-------------------------  211 (321)
T ss_pred             CCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------------------
Confidence            88999999988765 6889999999999999999999999887665554444210                         


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~~~~~~  291 (293)
                           ....++..+.++.+++.+||+.||.+||++    .++++||||..+.+
T Consensus       212 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 -----PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                 011233467789999999999999999876    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-46  Score=309.15  Aligned_cols=245  Identities=27%  Similarity=0.356  Sum_probs=207.8

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ..++.||+|.||.||.+....+ ..+++|.++....   ..+.+.+|+++|++|+|++|+++++++..++..||||||+.
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCC-CcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3567899999999999965532 3799998865433   33678899999999999999999999999999999999998


Q ss_pred             -cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 -FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 -~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                       |++++++.......++...+..++.|||+|++||++++++||||.+.||+|+.+.- +||+|||+++....+.-.....
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~-vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV-VKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce-EEEcccccccccCCCceeecCC
Confidence             89999999877778889999999999999999999999999999999999998876 9999999999654332222221


Q ss_pred             -CccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          162 -GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       162 -~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                       .-...|.|||.+... .++.+|||||+|++|||++| |+.||...+..+.+..+..                       
T Consensus       364 ~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-----------------------  419 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-----------------------  419 (468)
T ss_pred             CCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-----------------------
Confidence             134579999988755 79999999999999999998 6799999999999999865                       


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                            +....-+..+|.++.+++..|+..+|++|||.+.+..
T Consensus       420 ------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  420 ------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             ------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                  3334455668899999999999999999999987765

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-44  Score=299.09  Aligned_cols=261  Identities=23%  Similarity=0.350  Sum_probs=210.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||+||++.+..+++.+|+|.+....... .....+.+|+++++.++|++++.+.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            5889999999999999999999999999999885433222 223456789999999999999999999999999999999


Q ss_pred             cCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.+..+ ..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~-~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGE-SI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC-EEEecCCcceecCCCC-cc
Confidence            9986544 4444444456889999999999999999999999999999999999998877 9999999886553321 12


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+........                
T Consensus       159 ~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------------  221 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------------  221 (285)
T ss_pred             cCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------------
Confidence            233478999999988765 689999999999999999999999987655444333322111110                


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~  290 (293)
                                ......++.++.+|+.+||+.||.+||+     +.+++.||||+..+
T Consensus       222 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         222 ----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             ----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence                      0122346788999999999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-45  Score=297.39  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=203.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC-------CcccHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-------VPSSVIREVSLLKELKHENIVRLLNVQSSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (293)
                      ||.+++.||+|++|.||+|.+..++..+++|.+........       ....+.+|+.++++++|||++++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            79999999999999999999888899999998854432221       12457789999999999999999999999999


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      .++++||+++..+..+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~-~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG-IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC-EEecccCCCccccc
Confidence            99999999865554443322 34677789999999999999999999999999999999998887 99999999876642


Q ss_pred             CCc------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          154 PLE------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       154 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ...      ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-----------  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-----------
Confidence            211      11122367889999987765 678999999999999999999999987654433332211           


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                        ......+..++.++.+++++||+.||.+||++.++++||||
T Consensus       227 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 ------------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              00111223467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-44  Score=300.81  Aligned_cols=259  Identities=28%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.+.|||++++++.+..+...++||||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            68999999999999999999988999999998854332  2346788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-EEECccccchhccccccccCc
Confidence            9865554444332  3678899999999999999999999999999999999998887 999999988765433222333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. ...+.                  
T Consensus       176 ~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~------------------  235 (296)
T cd06654         176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE------------------  235 (296)
T ss_pred             ccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC------------------
Confidence            3478899999987655 578999999999999999999999977654332222110 00000                  


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                              ...+..++..+.+++.+||..||.+||++.++++||||.....+
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence                    01123467889999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.1e-45  Score=300.66  Aligned_cols=259  Identities=23%  Similarity=0.309  Sum_probs=209.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++.+..++..+++|.+....  ......+.+|+++++.+.|||++++++++...+..++|+||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            678899999999999999999889999999874322  223456788999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +++.+..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC-EEEccccccccccccccccccc
Confidence            977766554433446888899999999999999999999999999999999998887 9999999987654333333334


Q ss_pred             CccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          162 GGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       162 ~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .+++.|+|||++.    ....++.++|+||+|+++|+|++|..||...+..+....+.....  .               
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~---------------  226 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P---------------  226 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C---------------
Confidence            4788999999874    233577899999999999999999999987765554444422100  0               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                ....+..++.++.++|.+||+.||.+||++.+++.||||+.-.
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         227 ----------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence                      0011233577899999999999999999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=306.75  Aligned_cols=284  Identities=37%  Similarity=0.563  Sum_probs=216.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      +|.+.+.||+|++|.||+|.+..+|+.+|+|++............+.+|+++++.+.||||+++++++....      .+
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            689999999999999999999889999999988654433444456888999999999999999999876543      45


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++|+|++...+.....    ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        96 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~-~kL~dfg~~~~~~~~  170 (342)
T cd07879          96 YLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAE  170 (342)
T ss_pred             EEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCCCCcCCCCC
Confidence            8999999876554431    24778899999999999999999999999999999999998887 999999998765322


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc-
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS-  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (293)
                         .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+............ 
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence               1222367789999988765568899999999999999999999999877666665555543333221111110000 


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                      ..+................+..++++.++|.+||+.||.+||++.+++.||||..++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            00000000111122333445678899999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-45  Score=309.47  Aligned_cols=265  Identities=18%  Similarity=0.270  Sum_probs=208.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.+..+++.+|+|++..... .......+.+|..++..+.|++|+++++++...+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            59999999999999999999999999999999854221 12223457788999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      |+.|+.+..+.......+++..+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||.+......... .
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC-EEEEeccceeeccCCCceee
Confidence            99855444443333345788899999999999999999999999999999999998888 999999998765433221 2


Q ss_pred             eccCccccccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          159 TIKGGSLCYKAPERLLGS----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ....|++.|+|||++.+.    ..++.++|+||||+++|+|++|..||...+..+....+.......             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  227 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF-------------  227 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-------------
Confidence            234489999999987642    357889999999999999999999998877666555553211100             


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~~  291 (293)
                                  ........++.++.+++.+||+.++.+  |++++++++||||..+.+
T Consensus       228 ------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         228 ------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                        001112346889999999999976654  579999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=295.84  Aligned_cols=257  Identities=29%  Similarity=0.374  Sum_probs=208.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|.||++.+..+++.+++|++.....  .....+.+|++++++++|||++++++++...+.++++||+
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            58999999999999999999888889999999865432  2457888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC-EEECccccchhhhhhhhcccc
Confidence            9977766655544456888999999999999999999999999999999999998887 999999998766543323333


Q ss_pred             cCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||...+..............+..               
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------  225 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK---------------  225 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc---------------
Confidence            4477889999987543  25788999999999999999999999876654443333211000000               


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                                ......++.++.+++.+|+..||.+|||+.+++.|||
T Consensus       226 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 ----------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                      0011235678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-44  Score=296.62  Aligned_cols=279  Identities=42%  Similarity=0.692  Sum_probs=218.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeeeeecCCc-----
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNVQSSVDS-----   73 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   73 (293)
                      |++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++   .|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999988899999999875544333345666788877766   59999999999988776     


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      .+++||++++++.+.+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~-~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC-EEEeccCcceeccC
Confidence            99999999988877776654446889999999999999999999999999999999999999987 99999999876643


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+...++......+....++......
T Consensus       160 ~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         160 EMA-LTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             Ccc-cccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            322 1222367789999988765 68899999999999999999999999988888777776655443322222111100


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      ... +  ............+.++..+.+++.+||+.||.+||++.+++.||||
T Consensus       238 ~~~-~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         238 RSS-F--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhh-c--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000 0  0001111233344567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=295.62  Aligned_cols=253  Identities=29%  Similarity=0.436  Sum_probs=204.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC---CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE---GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |.+.+.||+|++|.||.+.+..++..+++|.+.......   .....+.+|++++++++|||++++++++..+...++++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            789999999999999999998899999999886543222   22356788999999999999999999999999999999


Q ss_pred             ecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |++++. +.+.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        84 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~-~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          84 EYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceeccccccc
Confidence            999864 444554432  4677889999999999999999999999999999999998887 999999998755332111


Q ss_pred             e---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 Y---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      .   ....++..|+|||++.+. .++.++|+||||+++|++++|..||...+............                
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------  223 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP----------------  223 (263)
T ss_pred             cccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC----------------
Confidence            1   223367889999988776 58899999999999999999999998765544333322100                


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                  .....+..++..+.+++.+||..+|.+|||+.++++||||
T Consensus       224 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                        0112234467889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.2e-45  Score=301.02  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=212.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++..... .......+.+|+++++++.||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            58999999999999999999998999999999864332 22334678889999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++ +++.+.+...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......   .
T Consensus        82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~~~~~~~---~  155 (290)
T cd05580          82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKGR---T  155 (290)
T ss_pred             cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEeeCCCccccCCC---C
Confidence            996 5555665544  35788899999999999999999999999999999999998887 999999998776543   2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...                     
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------------  213 (290)
T cd05580         156 YTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG---------------------  213 (290)
T ss_pred             CCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------------
Confidence            223478899999987665 6789999999999999999999999877755544444210                     


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcCC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQSL  292 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~~  292 (293)
                               ....+..++..+.+++.+||..||.+|+     +++++++||||+.+.|+
T Consensus       214 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         214 ---------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ---------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                     0112234578899999999999999999     99999999999988754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-44  Score=301.36  Aligned_cols=257  Identities=28%  Similarity=0.367  Sum_probs=206.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.+.|||++++++++..++..++||||
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            69999999999999999999988999999998854332  2336678899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+....  .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~-~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEECcCccceEccCCccCcCc
Confidence            9865555444332  3677899999999999999999999999999999999998887 999999998765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+. .++.++|+||||+++|++++|..||...+.......+.. .+.                    
T Consensus       175 ~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~--------------------  232 (297)
T cd06656         175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT--------------------  232 (297)
T ss_pred             ccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC--------------------
Confidence            4478899999987765 678999999999999999999999976543221111100 000                    


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                            .....+..++..+.+++.+||..||++||++.+++.||||+..+
T Consensus       233 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         233 ------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                  00011234678899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=302.46  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....... .....+..|+++++.+.||+|+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6899999999999999999998889999999986543322 244568889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      ++.| ++.+.+.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+......... 
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC-EEEeecchhhccccccccc
Confidence            9986 5555554444456888899999999999999999999999999999999998887 999999987654321110 


Q ss_pred             ----------------------------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 038154          158 ----------------------------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG  209 (293)
Q Consensus       158 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  209 (293)
                                                  .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        0112367789999988765 67899999999999999999999998777665


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC----HHHHhcCcc
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT----AREALRHEY  285 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~~p~  285 (293)
                      ....+......     .                       .....++.++.+++.+||..||.+|||    +++++.|||
T Consensus       240 ~~~~~~~~~~~-----~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         240 TFSNILKKEVT-----F-----------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             HHHHHhcCCcc-----C-----------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            55444210000     0                       001126789999999999999999999    999999999


Q ss_pred             cccCcC
Q 038154          286 FKDFQS  291 (293)
Q Consensus       286 ~~~~~~  291 (293)
                      |+...|
T Consensus       292 ~~~~~~  297 (316)
T cd05574         292 FRGVNW  297 (316)
T ss_pred             hhcCCh
Confidence            998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.7e-46  Score=288.73  Aligned_cols=288  Identities=37%  Similarity=0.590  Sum_probs=235.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   75 (293)
                      .|++.+.||+|.+|.||+|..+.++.    .+|+|+++-+......-....+|+.+++.+.|||++.+..++.. +..++
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            48899999999999999996554433    68999997665555555778899999999999999999998876 78899


Q ss_pred             eEeecCCcchHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC----CCeEEEccCCCc
Q 038154           76 LVFENLDFDLLHFMKTE---PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS----KDIVKIADFGLA  148 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~----~~~v~l~df~~~  148 (293)
                      +++||.+.++++.+..+   ....++...+..|++||+.++.|||++-+.||||||.||+|..+    |. |||+|+|++
T Consensus       105 l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~-VKIaDlGla  183 (438)
T KOG0666|consen  105 LLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR-VKIADLGLA  183 (438)
T ss_pred             EEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe-eEeecccHH
Confidence            99999999999877532   23567888999999999999999999999999999999999877    55 999999999


Q ss_pred             ccCCCCCccee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------chHHHHHHHH
Q 038154          149 RPIDVPLENYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW---------APGLLAAIFS  216 (293)
Q Consensus       149 ~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~---------~~~~~~~~~~  216 (293)
                      +.+..+....-   ....|.+|+|||.+.+...|+.+.|+|+.|||+.||+|....|.+..         .-+.+.+|+.
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~  263 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE  263 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence            98876533331   12267899999999999999999999999999999999999996532         2367889999


Q ss_pred             HhCCCCCCCCCCCcCccccc----CCCCC---CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          217 IMGTPDSETLPGFTSFSEEF----GFEPN---RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ..+.|....++...+..+..    +++..   .......-...+.-++...+|+.+||..||.+|.|+++.|+|+||..-
T Consensus       264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence            99999999999877765542    12111   111222334455567779999999999999999999999999999753

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-44  Score=294.73  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=207.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++....++..+++|.+.....    ...+.+|+++++.++|||++++++++......|+++|+
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            58899999999999999999888889999998854322    57889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ-AKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc-EEEcccccchhcccCcccccc
Confidence            9976665555444456788999999999999999999999999999999999998887 999999998876544333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..++..|+|||.+.+. .++.++|+||||+++++|++|..||...........+..   ..                   
T Consensus       159 ~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~-------------------  215 (256)
T cd06612         159 VIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP-------------------  215 (256)
T ss_pred             ccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC-------------------
Confidence            4477889999988766 688999999999999999999999976544332221100   00                   


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                           ......+..++.++.+++.+|++.||++|||+.+++.||||
T Consensus       216 -----~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 -----PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -----CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                 00011123467789999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9e-45  Score=300.24  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|..+++|.+.... .......+.+|++++++++|||++++++.+..++..++|+||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5889999999999999999998899999999885432 222345788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDFDLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ++|..+..+....  ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++. ++|+|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ-VKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC-EEEeecCCcccccCCcc-
Confidence            9976665554432  2357888999999999999999997 59999999999999998777 99999999876533211 


Q ss_pred             eeccCccccccCcccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          158 YTIKGGSLCYKAPERLLGS-----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                       ....+++.|+|||.+.+.     ..++.++|+||||+++|+|++|..||...........+.......           
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  226 (286)
T cd06622         159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-----------  226 (286)
T ss_pred             -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-----------
Confidence             223367789999987543     235789999999999999999999997655444333332211111           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                                     ....++.++.++.+++.+||..+|++||++.+++.||||..+...
T Consensus       227 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         227 ---------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                           112233468889999999999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-44  Score=306.11  Aligned_cols=284  Identities=36%  Similarity=0.536  Sum_probs=217.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||++.+.||+|++|.||++.+..+|..||+|++............+.+|+++++.++||||+++++++..+.      .+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            699999999999999999999989999999988543333333456888999999999999999999886654      35


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++|++++++++...+..   ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        96 ~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~  171 (343)
T cd07880          96 YLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTDSE  171 (343)
T ss_pred             EEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccccccccC
Confidence            89999997766655543   25788899999999999999999999999999999999998887 999999998765432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc-c
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF-S  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  233 (293)
                      .   ....+++.|+|||.+.+...++.++|+||||+++|++++|..||...+.......+.......+.......... .
T Consensus       172 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         172 M---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             c---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence            1   22236788999998876556889999999999999999999999887766666666554433322211111000 0


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ...................+.+++++.++|.+||..||++|||+.+++.||||+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            0000000011112233445678889999999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.5e-44  Score=292.90  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=213.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|.||++.+..++..+++|++............+..|+++++.++|||++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            69999999999999999999988899999999876555445567788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      +++ ++.+.+....  ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc-EEECCccceeecccCcce
Confidence            986 4555554432  356888999999999999999999999999999999999998887 999999998876554333


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+............                   
T Consensus       160 ~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  219 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------------  219 (258)
T ss_pred             ecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------------
Confidence            3334578889999987665 58899999999999999999999998777655555543211                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                ....+...+.++.+++.+||..+|++|||+.++|.||||
T Consensus       220 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ----------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                      111223467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-44  Score=298.77  Aligned_cols=256  Identities=21%  Similarity=0.345  Sum_probs=203.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++++++++|||++++++++...+..++|+||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4788999999999999999999999999999885432 223345688899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+...     ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......  ....
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~-~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC-EEEeeCCcceecccc--cccC
Confidence            998776543     23577788999999999999999999999999999999999888 999999998765432  1223


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL---LAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|..||........   ...............            
T Consensus       153 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------  219 (279)
T cd06619         153 YVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV------------  219 (279)
T ss_pred             CCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC------------
Confidence            3478899999988765 689999999999999999999999965322110   001111000000000            


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                  ......++++.+++.+||+.||.+||++++++.||||...+
T Consensus       220 ------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         220 ------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             ------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                        00123567899999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-44  Score=295.93  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=202.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC------Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV------DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~   73 (293)
                      +|++.+.||+|++|.||++....+++.+++|++....   .....+.+|+.+++++ +|||++++.+++...      ..
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            5888999999999999999999999999999986432   2335788899999998 699999999987653      35


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      .+++|||+++ ++.+.+.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~-~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC-EEEccCCCceecc
Confidence            7899999985 5555555544456788899999999999999999999999999999999998887 9999999987654


Q ss_pred             CCCcceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ..........+++.|+|||++.+    ...++.++|+||+|+++|+|++|..||..............   ..       
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~-------  232 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP-------  232 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC-------
Confidence            33333334457889999998753    23578899999999999999999999976544333222211   00       


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                        ........++.++.+++.+||..||.+|||+.+++.||||
T Consensus       233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                              0001122357789999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.2e-44  Score=302.94  Aligned_cols=288  Identities=32%  Similarity=0.550  Sum_probs=221.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCC--CCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec----CCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT--GDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS----VDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   73 (293)
                      +|++.+.||+|++|.||++.+...  +..+|+|++............+.+|+++++++ .||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            699999999999999999998877  88999998864433333456778899999999 59999999986432    245


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      .+++++++++++...+....  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~-~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC-EEeCcCCCceeccc
Confidence            78999999988888776543  5788899999999999999999999999999999999998887 99999999876543


Q ss_pred             CCcc----eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          154 PLEN----YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       154 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ....    .....+++.|+|||.+.+...++.++|+||+|++++++++|..||...+.......+....+.++.......
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2111    112247888999998776557899999999999999999999999988877777777766665443222111


Q ss_pred             cCccc-ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          230 TSFSE-EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ..... ..................+..+..+.+++.+||+.||.+|||+.+++.||||.+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence            11000 000000111112223344556889999999999999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.3e-45  Score=307.51  Aligned_cols=287  Identities=36%  Similarity=0.567  Sum_probs=218.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC--cceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD--SIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~--~~~lv   77 (293)
                      +|++.+.||+|++|.||++.+..+|..+++|++............+..|+++++++ +||||+++++++...+  ..++|
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            58899999999999999999988899999998854333334445677899999999 9999999999876543  58999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      ||++++++...+...   .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ 
T Consensus        88 ~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~-~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          88 FEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEEN  163 (337)
T ss_pred             ecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccchhcccccccc
Confidence            999998777776554   5677788899999999999999999999999999999999988 99999998876543221 


Q ss_pred             ----ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 ----NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                          ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+....+.+...........
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                1112236788999998876667889999999999999999999999887776666666555444332211110000


Q ss_pred             -ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          233 -SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                       ....................+.++.++.++|.+||+.||++|||+.++++||||++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence             00000000001111222334457899999999999999999999999999999988753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-44  Score=294.60  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=208.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (293)
                      +|++.+.||.|++|.||++.+..++..+++|.+............+..|++++++++|||++++++++..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999986555444445678889999999999999999997754  34678999


Q ss_pred             ecCCcc-hHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           79 ENLDFD-LLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCH-----SQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        79 e~~~~~-~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ||+++. +.+.+...  ....+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++. ++|+|||.+..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~-~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN-VKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC-EEEeccccccc
Confidence            999854 44444332  2345788899999999999999999     899999999999999998887 99999999987


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ............+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+..              
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------  224 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--------------  224 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------------
Confidence            75543323334478899999987765 588999999999999999999999988765554444321              


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                     ......+...+..+.+++.+||+.+|.+||++.+|++|||+
T Consensus       225 ---------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         225 ---------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                           00112233567889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-44  Score=293.57  Aligned_cols=260  Identities=26%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||.|++|+||++....++..+++|++....... ....+.+|+++++.+.|+|++++++.+......++++|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            5899999999999999999988889999999986443333 457788999999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDFDLL-HFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~~~~-~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++..+ +.+.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~-~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS-VKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEcccchHHHhccCcccc
Confidence            986555 4444332 246788899999999999999999999999999999999998887 9999999987664432221


Q ss_pred             ----eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          159 ----TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       159 ----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                          ....++..|+|||.+.....++.++|+||||+++++|++|..||...+......+....   .+.. ..       
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~-------  228 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-LE-------  228 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC-cC-------
Confidence                22237788999998876656899999999999999999999999876655444443221   0000 00       


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                   .......++.++.+++.+||..||++||++.+++.||||
T Consensus       229 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         229 -------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                         000123567889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-45  Score=300.68  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=206.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||+|.+..++..+++|.+..... ......+.+|+++++++.|||++++++.+..+...++|+||+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            6778899999999999999888899999998754332 233467889999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++..+......  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+.............
T Consensus        85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC-EEEccccccccccCcchhhhcc
Confidence            96555444433  34778899999999999999999999999999999999998887 9999999987654432222333


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .++..|+|||.+.+. .++.++|+||||+++++|++|..||...........+..                         
T Consensus       162 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------------------------  215 (277)
T cd06642         162 VGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-------------------------  215 (277)
T ss_pred             cCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-------------------------
Confidence            477889999988765 688999999999999999999999976544333222110                         


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                          ..........+.++.+++.+|++.+|++||++.++++||||.++.+
T Consensus       216 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         216 ----NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             ----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                0001122345778999999999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=316.45  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=224.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.|+..||.|+||.||+|.++.++-.-|.|++.  ..+.....++.-|+++|..+.||+|+++++.+-.++.++++.|+|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            678899999999999999988888778888863  344566678889999999999999999999988999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +|+..+.++-.-...+.+.++..+++|++.||.|||+++++|+|||+.||++..+|. |+|+|||.+...........+.
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhHHhhhccc
Confidence            999988877666667899999999999999999999999999999999999999999 9999999998776666666777


Q ss_pred             CccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          162 GGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       162 ~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .|||.|||||+..    ...+|++++||||||+.|.+|..+..|-...++--++-++..   ..+               
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SeP---------------  252 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEP---------------  252 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCC---------------
Confidence            8999999999884    345799999999999999999999999887777666555532   111               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                               .....++.++..+.+++.+||..||..||++.++|.||||++..+
T Consensus       253 ---------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  253 ---------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             ---------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence                     111234567889999999999999999999999999999998764

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.5e-45  Score=298.20  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=207.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+..+++.+++|.+..... ......+.+|+++++++.|||++++++.+...+..++++|+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47888999999999999999998999999998865432 23446788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++..+..+.......+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~~~-  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-IKLCDFGVSGQLVNSLAKT-  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC-EEEeecccchhhHHHHhhc-
Confidence            99655555544333567888999999999999999999 99999999999999999887 9999999887654322222 


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA--PGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ..++..|+|||.+.+. .++.++|+||||+++++|++|..||.....  ...............               
T Consensus       159 -~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------  221 (265)
T cd06605         159 -FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP---------------  221 (265)
T ss_pred             -ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC---------------
Confidence             4477889999988766 689999999999999999999999976421  111111111111000               


Q ss_pred             CCCCCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                 ...+.. ++.++.++|.+||..||.+|||+.+++.||||+.+.+
T Consensus       222 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~~  265 (265)
T cd06605         222 -----------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES  265 (265)
T ss_pred             -----------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcccC
Confidence                       001111 6788999999999999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-44  Score=294.67  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=207.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||.|++|.||++.+..++..+++|++....... ...+.+.+|++++++++|||++++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            6999999999999999999999899999999986543322 445788899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++.|..+....... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~-~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDT-LTT  157 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC-EEEeecccccccCCCc-ccc
Confidence            99876555444333 46788899999999999999999999999999999999998888 9999999987665432 223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP---GLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||......   ...+....                    
T Consensus       158 ~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  216 (258)
T cd05578         158 STSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--------------------  216 (258)
T ss_pred             ccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------------------
Confidence            34477889999987765 5899999999999999999999999877642   22211110                    


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH--HHHhcCccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA--REALRHEYF  286 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~~p~~  286 (293)
                                .....+...+.++.++|.+||+.||.+||++  .++++||||
T Consensus       217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                      0111233467899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.8e-44  Score=299.71  Aligned_cols=283  Identities=35%  Similarity=0.558  Sum_probs=217.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (293)
                      +|++.+.||.|++|.||++.+..++..+++|++............+..|+++++.+.|||++++.+++.. ....++++|
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e   90 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE   90 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence            6999999999999999999999999999999886544444445678899999999999999999998865 457899999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++++...+...   .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......   ..
T Consensus        91 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~-~~l~dfg~~~~~~~~---~~  163 (328)
T cd07856          91 LLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD-LKICDFGLARIQDPQ---MT  163 (328)
T ss_pred             hhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC-EEeCccccccccCCC---cC
Confidence            9988776665432   3677788899999999999999999999999999999998887 999999998754322   12


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc-cccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS-EEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  238 (293)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...........+.+..+.++........... ..+..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            22367789999987664568999999999999999999999998877666555555554444322211110000 00000


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ..............+.++.++.++|.+||+.+|++||++.+++.||||..++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            0000011112233456788999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.8e-44  Score=291.05  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=207.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.++.... ....+.+..|+.+++.++|||++++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            69999999999999999999999999999999864332 23446788899999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++ ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+...........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc-EEEcccCcceeecccccccc
Confidence            984 5666665544455788899999999999999999999999999999999998887 99999999876544322223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....                     
T Consensus       159 ~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  216 (255)
T cd08219         159 TYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS---------------------  216 (255)
T ss_pred             cccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC---------------------
Confidence            33478889999987665 68999999999999999999999998776655544442210                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                              ....+..++..+.+++.+||+.||.+|||+.++++.-
T Consensus       217 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         217 --------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             --------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                    0112234577899999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=294.88  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=202.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC------c
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD------S   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~   73 (293)
                      ||++.+.||+|++|.||+|.+..++..+++|++.....   ....+.+|+.+++++ .|+|++++++++....      .
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            69999999999999999999988899999998864332   336788999999999 6999999999986544      4


Q ss_pred             ceeEeecCCcchHHHhhcC-C--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           74 IDLVFENLDFDLLHFMKTE-P--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~-~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      .+++|||+++..+..+... .  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~-~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe-EEECCCcccee
Confidence            8999999997555444322 2  356788899999999999999999999999999999999998887 99999999876


Q ss_pred             CCCCCcceeccCccccccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGS----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      ............+++.|+|||++...    ..++.++|+||||+++++|++|..||...........+..   .....  
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~--  237 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT--  237 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC--
Confidence            54433333344478889999987532    3467889999999999999999999976554443333321   00000  


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                            ......++.++.+++.+||..||++|||+.++++|||+
T Consensus       238 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 ----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                  00112357789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.8e-44  Score=293.58  Aligned_cols=255  Identities=27%  Similarity=0.332  Sum_probs=200.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+..+++.+++|++....  ......+.+|+.++++++|||++++++++...+..++|+||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4889999999999999999998899999999885432  23335678899999999999999999999999999999999


Q ss_pred             CCcchHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++.+. .+...  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD-VKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEECcCccceeecccccccC
Confidence            9965554 44333  35788899999999999999999999999999999999998888 99999999876644333333


Q ss_pred             ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...+++.|+|||.+..  ...++.++|+||+|+++|+|++|..||...........+......                 
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  227 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-----------------  227 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC-----------------
Confidence            3447788999998742  335778999999999999999999998654332221111000000                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                              .........++..+.+++.+||+.||++|||++++++|+|
T Consensus       228 --------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         228 --------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             --------CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                    0000112246788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.2e-44  Score=291.74  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=206.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..++..+++|++.......    .....+..|++++++++|||++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5899999999999999999998999999999886433221    124578889999999999999999999999999999


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+||+.|..+..+.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++..++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999976555444322 25778899999999999999999999999999999999987776699999999876643311


Q ss_pred             c----eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 N----YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .    .....++..|+|||.+.+. .++.++|+||||++++++++|..||...........+.......           
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  227 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-----------  227 (268)
T ss_pred             cCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-----------
Confidence            1    1122367889999987665 68899999999999999999999997654433333222111000           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                    .....+..+++++.+++.+||..||.+||++.+++.||||+
T Consensus       228 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 --------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                          00112234678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.8e-44  Score=291.14  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+..++..+++|++...... .....+..|++.+.+++|+|++++++++..++..++++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            378999999999999999999989999999998654332 4457788999999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++..+ +.+...  ..+++..++.++.|++.+|++||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~-~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE-VKIADFGISKVLENTLDQC  157 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC-EEEccCccceecccCCCcc
Confidence            995544 444433  457888999999999999999999 99999999999999998887 9999999988765544433


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---PGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....   .+....+..   ..              
T Consensus       158 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~--------------  219 (264)
T cd06623         158 NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP--------------  219 (264)
T ss_pred             cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC--------------
Confidence            333477889999987665 688999999999999999999999977642   222222211   00              


Q ss_pred             cCCCCCCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                  ....... ++..+.++|.+||..+|++||++.++++||||+.++
T Consensus       220 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 ------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                        0111222 678899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-44  Score=302.42  Aligned_cols=283  Identities=37%  Similarity=0.553  Sum_probs=214.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||.+.+.||+|++|.||++.+..+++.||+|++............+.+|++++++++||||+++++++...      ...
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   97 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence            69999999999999999999988999999998864333333345677899999999999999999987543      347


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +++++++++++...+...   .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        98 ~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~dfg~~~~~~~~  173 (345)
T cd07877          98 YLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDE  173 (345)
T ss_pred             EEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC-EEEeccccccccccc
Confidence            888998877766555432   4788899999999999999999999999999999999998887 999999998765322


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......+.............
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         174 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             ---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence               22234778899999887655688999999999999999999999988777666666655554443333222111000


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                       .+...................++++.++|.+||+.||.+||++.++++||||+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence             00000000000001111224678899999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-44  Score=325.49  Aligned_cols=259  Identities=28%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (293)
                      +|++++.||+|+||+||++.+..++..+++|++............+..|+.+++.+.||||+++++++..  ...+|+||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            6999999999999999999999999999999987655444555678899999999999999999998754  35689999


Q ss_pred             ecCCc-chHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecccCCCceeEeCCC-----------
Q 038154           79 ENLDF-DLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQ-------EILHRDLKPANFLIDRSK-----------  137 (293)
Q Consensus        79 e~~~~-~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~-------~~~h~dl~~~Ni~i~~~~-----------  137 (293)
                      ||+++ ++...+...  ....+++..++.++.||+.||.|||+.       +|+|+||+|+|||++...           
T Consensus        94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            99985 555555432  224588899999999999999999984       499999999999996421           


Q ss_pred             -----CeEEEccCCCcccCCCCCcceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH
Q 038154          138 -----DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL  211 (293)
Q Consensus       138 -----~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  211 (293)
                           ..++|+|||.+........ .....+++.|+|||++.+. ..++.++|||||||++|+|++|..||.........
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql  252 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL  252 (1021)
T ss_pred             ccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence                 1389999999976543322 2233589999999988643 35789999999999999999999999765443322


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .....  ..+ .                          ......+.++.+||..||..+|.+||++.++|.|||++.+
T Consensus       253 i~~lk--~~p-~--------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        253 ISELK--RGP-D--------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHh--cCC-C--------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            22211  000 0                          0012357889999999999999999999999999999865

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-44  Score=293.70  Aligned_cols=255  Identities=25%  Similarity=0.329  Sum_probs=201.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||+|.+..+++.+++|.++...  ......+.+|+.+++.++|||++++++.+...+..++++||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            4778899999999999999999899999999986432  22235677899999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++.+ +.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECcceeeeEccCcccccc
Confidence            986544 4443332  5788899999999999999999999999999999999998887 99999999876554333334


Q ss_pred             ccCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...+++.|+|||++.  ....++.++|+||||+++|+|++|..||..................++  .            
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~------------  230 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--K------------  230 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--c------------
Confidence            445888999999864  233578899999999999999999999976544332222211000000  0            


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                                 ......++..+.+++.+||..||++||++++++.|||
T Consensus       231 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         231 -----------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                       0001135678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-43  Score=291.14  Aligned_cols=259  Identities=29%  Similarity=0.459  Sum_probs=202.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC--------CcccHHHHHHHHHhcCCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG--------VPSSVIREVSLLKELKHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (293)
                      ||.+.+.||+|++|.||+|.+..+|+.+++|.++.......        ..+.+..|+++++.+.|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999888899999998854322111        1245778999999999999999999999999


Q ss_pred             cceeEeecCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           73 SIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        73 ~~~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ..++|+||+.++.+ +.+...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~-~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-CKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe-EEEeeccccccc
Confidence            99999999986544 444443  35778889999999999999999999999999999999998887 999999998765


Q ss_pred             CCCCc--ceeccCccccccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          152 DVPLE--NYTIKGGSLCYKAPERLLGSG-RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       152 ~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      .....  ......++..|+|||.+.... .++.++|+||||++++++++|..||......+....+..   ...      
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~------  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRS------  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---ccc------
Confidence            32211  112233678899999876553 478999999999999999999999975544332222111   000      


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                     .........+.++.++.+++.+||..||++|||++++++||||
T Consensus       230 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ---------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ---------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                           0000112234568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.8e-44  Score=296.91  Aligned_cols=281  Identities=22%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++++++++||||+++++.+..++..++++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4899999999999999999999899999999875432 222345688899999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++|..+ +.+...  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||.+.......  .
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~--~  155 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM--A  155 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc-EEEccCCCcccccccc--c
Confidence            986554 444433  357788999999999999999997 59999999999999998887 9999999886543221  1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+................... ....
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  233 (308)
T cd06615         156 NSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH-PPDS  233 (308)
T ss_pred             ccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC-CCCc
Confidence            223478899999987665 58899999999999999999999997665433322221111100000000000000 0000


Q ss_pred             CCCCCcc---------cchhhh-cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPI---------KDLATV-VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~---------~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                       ......         ...... ...++.++.+++.+||..||++|||+.+++.||||.++.
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         234 -PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             -cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence             000000         000000 112577899999999999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-44  Score=301.82  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=191.8

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC-Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV-DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   73 (293)
                      ||++.++||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+ +||||+++++++... +.
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            689999999999999999974     234567999988532 2223345788899999999 899999999987654 46


Q ss_pred             ceeEeecCCc-chHHHhhcCC-----------------------------------------------------------
Q 038154           74 IDLVFENLDF-DLLHFMKTEP-----------------------------------------------------------   93 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~-----------------------------------------------------------   93 (293)
                      ++++|||+++ ++.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            8899999985 5555554321                                                           


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--eeccCccccccCc
Q 038154           94 -TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAP  170 (293)
Q Consensus        94 -~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aP  170 (293)
                       ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||.+.........  .....+++.|+||
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~-~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc-EEEeecccccccccCcchhcccCCCCCccccCc
Confidence             123667788899999999999999999999999999999998887 999999998765332111  1122245789999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchh
Q 038154          171 ERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLA  249 (293)
Q Consensus       171 E~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (293)
                      |++.+. .++.++||||||+++|+|++ |..||.+....+..........                            ..
T Consensus       246 E~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~  296 (338)
T cd05102         246 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT----------------------------RM  296 (338)
T ss_pred             HHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC----------------------------CC
Confidence            988765 68999999999999999997 9999987654333222211000                            00


Q ss_pred             hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          250 TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       250 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..+...++++.+++.+||+.||.+|||+.++++
T Consensus       297 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.8e-44  Score=294.80  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=200.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec------CCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS------VDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~   73 (293)
                      +|++.+.||.|++|.||++.+..++..+++|++....   .....+..|+.+++++ +|||++++++++..      ...
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            4889999999999999999999899999999875432   2335678899999998 69999999998742      457


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      .+++|||+++ ++.+.+.......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~-~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCcchhhhh
Confidence            8999999986 5555555444445778888999999999999999999999999999999998887 9999999987654


Q ss_pred             CCCcceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ..........+++.|+|||++..    ...++.++|+||||+++|+|++|..||...........+..   .        
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~--------  241 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N--------  241 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---C--------
Confidence            33233333447889999998753    23578899999999999999999999976543322221110   0        


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                       .........++.++.++|.+||+.||.+||++.+++.||||
T Consensus       242 -----------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 -----------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -----------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                             00001123467899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-43  Score=288.72  Aligned_cols=255  Identities=28%  Similarity=0.412  Sum_probs=206.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||+..+.||+|++|.||+|....++..+++|.+......   ......+.+|+++++.++|++++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            799999999999999999998888999999988653322   23446788899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      +||+++..+..+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~-~kl~d~~~~~~~~~~~-~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFS-F  157 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccceeccccc-c
Confidence            9999865454443322 24678889999999999999999999999999999999998887 9999999887654332 2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|++||.+.....++.++|+||||+++|++++|..||...........+....                   
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------  218 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-------------------  218 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-------------------
Confidence            2333478889999987665448899999999999999999999998765433333322100                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                               .....+..+++.+.+++.+||+.+|.+||++.++++|||+
T Consensus       219 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ---------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ---------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                     0111233467889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-43  Score=287.89  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=206.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||.+.+.||+|++|.||++.+..++..+++|.++...........+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            89999999999999999999888899999999876544434567889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee-
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~-  159 (293)
                      +++..+....... ...++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........... 
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEcccccccccCCCCCcccc
Confidence            9865555444333 23677789999999999999999999999999999999998877 99999999877644322221 


Q ss_pred             ---ccCccccccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          160 ---IKGGSLCYKAPERLLGSG--RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       160 ---~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         ...+++.|+|||.+.+..  ..+.++|+||||++++++++|..||............... ..  ....        
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~--~~~~--------  227 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH--KPPI--------  227 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC--CCCC--------
Confidence               234678899999886552  3788999999999999999999999765432222211110 00  0000        


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                     .....+++.+.+++.+||+.+|.+|||+.+++.|||+
T Consensus       228 ---------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         228 ---------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ---------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                           0112347889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-44  Score=294.18  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|+..+.||.|++|.||.+.+..++..+++|.+..... ......+.+|+.+++++.|||++++++.+.++...++|||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            37788999999999999999988899999998864322 23346788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+.+......  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+............
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC-EEEcccccceeccCCcccccc
Confidence            986544443333  24678889999999999999999999999999999999998887 999999998765443323333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+..                        
T Consensus       161 ~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------------------------  215 (277)
T cd06640         161 FVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------------------------  215 (277)
T ss_pred             ccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc------------------------
Confidence            3477889999987665 588999999999999999999999987654433322210                        


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                           .....+...++..+.+++.+||+.+|.+||++.+++.||||.+...
T Consensus       216 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         216 -----NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             -----CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                 0001122345778999999999999999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-43  Score=292.30  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++.+..++..+|+|.+..... ......+.+|+.+++++.|||++++++.+..+...++|+||+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            6788999999999999999888999999998754322 233467888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +++.+......  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||.+.............
T Consensus        85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~-~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC-EEEeecccceecccchhhhccc
Confidence            86555444433  24788899999999999999999999999999999999998887 9999999887654433333334


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .++..|+|||.+.+. ..+.++|+||||+++++|++|..||...........+...                        
T Consensus       162 ~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------------  216 (277)
T cd06641         162 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN------------------------  216 (277)
T ss_pred             cCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC------------------------
Confidence            477889999987654 6788999999999999999999999876554444333110                        


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                           ........++.++.+++.+|++.+|.+||++.++++||||.+.
T Consensus       217 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         217 -----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                 0011223467889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-43  Score=292.19  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHH-HHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSL-LKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..+|+.||+|+++....... ...+..|+.. ++.+.|||++++++++..++..|++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            48899999999999999999999999999998865432222 2345556654 566689999999999999999999999


Q ss_pred             cCCcchHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+++++.+.+...  ....+++..++.++.|++.||++||++ +++|+||+|+||+++.++. ++|+|||.+........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSVA  159 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeecccccccccccc
Confidence            9998877666432  234688999999999999999999997 9999999999999998887 99999999876543211


Q ss_pred             ceeccCccccccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 NYTIKGGSLCYKAPERLLGS---GRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                       .....++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+.......  ...+  .       
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--~-------  227 (283)
T cd06617         160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP--Q-------  227 (283)
T ss_pred             -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCC--C-------
Confidence             1223377889999987642   3468899999999999999999999975322 122222211  0000  0       


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                       .....++.++.+++.+||..+|.+||++.++++||||++..
T Consensus       228 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         228 -----------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                             00113678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=286.77  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=209.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+............+.+|+++++++.||+++++++++.+.+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            69999999999999999999988999999999876554444557889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC-EEEeccccceecCCCcccccc
Confidence            9865554443332 45788899999999999999999999999999999999998777 999999999877654443333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..++..|+|||...+. .++.++|+||+|+++++|++|..||..............                        
T Consensus       159 ~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------  213 (254)
T cd06627         159 VVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------------------------  213 (254)
T ss_pred             cccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------------------------
Confidence            4478889999987666 488999999999999999999999976654333322210                        


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                           ......+..++..+.+++.+||..+|++|||+.++++||||
T Consensus       214 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 -----DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                 00111233467889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.4e-43  Score=292.38  Aligned_cols=256  Identities=22%  Similarity=0.298  Sum_probs=201.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC-----Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV-----DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~   74 (293)
                      +|.+.+.||+|++|.||++.+..+++.+++|++...   ......+.+|+.+++++ +|||++++++++...     +..
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            589999999999999999999999999999987532   22235677899999998 799999999987643     358


Q ss_pred             eeEeecCCcchH-HHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           75 DLVFENLDFDLL-HFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ++|+||++++.+ +.+..  .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~-~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEeecccchhc
Confidence            999999986555 44332  12345788899999999999999999999999999999999998887 999999998765


Q ss_pred             CCCCcceeccCccccccCcccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSG----RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ...........++..|+|||.+....    .++.++|+||||+++|+|++|..||...........+..   .....   
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~---  252 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT---  252 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC---
Confidence            54333333344788899999875432    367899999999999999999999987665444433321   00000   


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                           .......+..+.++|.+||+.||++||++.+++.||||+
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 ---------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                 001123566799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.9e-43  Score=288.03  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++++.||+|++|.||++... ++..+++|.+.......    .....+.+|+++++.++|+|++++.+++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            6899999999999999999764 78889999876433221    123567889999999999999999999999999999


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC--
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--  154 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~--  154 (293)
                      ++||++|..+..+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......  
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI-IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe-EEeccchhhHhhhhccc
Confidence            99999865554443322 24678899999999999999999999999999999999998887 999999988754221  


Q ss_pred             ----CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          155 ----LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       155 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                          ........++..|+|||.+.+. .++.++|+||||++++++++|..||...+.......+.....           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  225 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-----------  225 (265)
T ss_pred             cccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-----------
Confidence                1111223477889999987765 578999999999999999999999976544333222211100           


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                      .....+..++.++.+++.+||..+|.+||++.++++||||
T Consensus       226 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 ----------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                            0111234568889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=291.41  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=206.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC---CCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|+++++.+.   |||++++++++..+...+++|
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            788999999999999999998899999999886432 2333457888999999986   999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||++|..+..+....  .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC-EEEccCCceeecCCCcccc
Confidence            999865555444433  5788899999999999999999999999999999999998877 9999999988765443333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+..   .                  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~------------------  217 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---S------------------  217 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---C------------------
Confidence            3345788899999876655678999999999999999999999976543322211100   0                  


Q ss_pred             CCCCCcccchhhhc-CCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVV-GGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                              ...... ...+.++.+++.+||+.||.+||++.++++||||++..
T Consensus       218 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 --------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             --------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                    000011 12577899999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-44  Score=295.32  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=205.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.....||+|++|.||++.+..++..+++|.+....  ......+.+|+.+++.++|||++++++.+..++..++|||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            344578999999999999998899999999875422  233456888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +++++..+....  .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus       102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEccCcchhhcccccccCcee
Confidence            976665554433  4678899999999999999999999999999999999998887 9999999887554332322333


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+.......                    
T Consensus       179 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  237 (292)
T cd06658         179 VGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR--------------------  237 (292)
T ss_pred             ecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc--------------------
Confidence            478899999987655 68899999999999999999999998766554444332211000                    


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                             .......+..+.+++.+|+..||.+|||+.++++||||....
T Consensus       238 -------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         238 -------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             -------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence                   001123577899999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-43  Score=291.26  Aligned_cols=255  Identities=27%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-ch
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DL   85 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~   85 (293)
                      ||+|++|+||++.+..+|+.+++|.+...... ......+..|+++++.++||+++++++++...+..|+||||+++ ++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999889999999998653322 22334567899999999999999999999999999999999985 45


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                      .+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... .......++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~-~~l~dfg~~~~~~~~-~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGG-KKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEccCcchhhhccC-CccccccCCC
Confidence            55555555456888899999999999999999999999999999999998887 999999988765432 2222233677


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      .|+|||.+.+. .++.++|+||||+++++|++|..||...........+.....                          
T Consensus       159 ~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------  211 (277)
T cd05577         159 GYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--------------------------  211 (277)
T ss_pred             CcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--------------------------
Confidence            89999988766 488999999999999999999999976543221111111000                          


Q ss_pred             cchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                      ......+..+++.+.++|.+||+.||++||     ++.++++||||.++++
T Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            011122344688999999999999999999     9999999999988765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=304.83  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=219.7

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcch
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDL   85 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (293)
                      ++||+|.||+||-+++..+|+.||||++.+..........+++|+.+|+++.||.|+.+.-.|+..+..++|||.+.|+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            78999999999999999999999999998777777767899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcceeccCc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      ++-+.......+++.....++.||+.||.|||.+||+|+||||+||++.....  .+||+|||+++.+++..-. .+..|
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-rsVVG  728 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-RSVVG  728 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-hhhcC
Confidence            99998888888998888899999999999999999999999999999976543  6999999999998764322 33449


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW-APGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      ||.|.|||++.+. .++...|+||.|+|+|--++|..||+... ..+.++..   ..-.+.+                  
T Consensus       729 TPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---aFMyPp~------------------  786 (888)
T KOG4236|consen  729 TPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---AFMYPPN------------------  786 (888)
T ss_pred             CccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc---ccccCCC------------------
Confidence            9999999999887 58999999999999999999999997542 22322221   1111111                  


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                              -|+.+++++.+||..+|+..-++|.|.+..|+|||+++.+
T Consensus       787 --------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  787 --------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             --------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                    1345889999999999999999999999999999999764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=307.23  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=207.6

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .++.+||+|.||+||+|  .+.|+ ||||+++....+++..+.|.+|+.++++-+|.||+-+.|++..+.. .||+.+|+
T Consensus       395 ~l~~rIGsGsFGtV~Rg--~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRG--RWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             hccceeccccccceeec--ccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence            56789999999999999  45564 9999999988888888999999999999999999999999998877 99999999


Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC--Ccceec
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTI  160 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~--~~~~~~  160 (293)
                      |+.|-....-....++..++++|++||++|+.|||.++|+|+|||..|||+.+++. |||+|||++.....-  ......
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k-VkIgDFGLatvk~~w~g~~q~~q  549 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK-VKIGDFGLATVKTRWSGEQQLEQ  549 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc-EEEecccceeeeeeeccccccCC
Confidence            98876666555667888899999999999999999999999999999999998876 999999998654332  122334


Q ss_pred             cCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      +.+...|||||++.-  ..+++..+|||++|+++|||++|..||...+.+.++-+.-                       
T Consensus       550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-----------------------  606 (678)
T KOG0193|consen  550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-----------------------  606 (678)
T ss_pred             CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-----------------------
Confidence            447789999998853  3578999999999999999999999998555444433221                       


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                        ...-..+........++++.+|+..|+..++++||+..+||.
T Consensus       607 --rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  607 --RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             --ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence              111113444555667889999999999999999999999887

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.1e-43  Score=289.49  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=206.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.-.+.||+|++|.||++.+..++..+++|++....  ......+.+|+.+++.+.|||++++++++...+..++++|++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            344579999999999999988889999999875322  233456888999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      .|..+......  ..+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc-EEEcccccchhhccCCcccccc
Confidence            86555544433  34788899999999999999999999999999999999998887 9999999877554433333334


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+.......+....  ++  .                
T Consensus       176 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~--~----------------  234 (285)
T cd06648         176 VGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PP--K----------------  234 (285)
T ss_pred             cCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CC--C----------------
Confidence            578899999987665 58899999999999999999999998766555444432210  00  0                


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                             ......++..+.+++.+||+.+|++||++.++++||||++..
T Consensus       235 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         235 -------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             -------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence                   001123577899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.9e-43  Score=293.29  Aligned_cols=255  Identities=26%  Similarity=0.347  Sum_probs=206.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++...... ......+.+|+++++.++|||++++.+++..++..++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            588999999999999999999889999999988543322 2233568889999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|++.+.+..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......    
T Consensus        96 ~~~g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~-~kL~dfg~~~~~~~~~----  169 (307)
T cd06607          96 YCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT-VKLADFGSASLVSPAN----  169 (307)
T ss_pred             hhCCCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC-EEEeecCcceecCCCC----
Confidence            999988877754432 5788899999999999999999999999999999999998887 9999999886554321    


Q ss_pred             ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...+++.|+|||++.+  ...++.++|+||||+++|+|++|..||...+.......+..   .....             
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~-------------  233 (307)
T cd06607         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPT-------------  233 (307)
T ss_pred             CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCC-------------
Confidence            2236778999998742  34678899999999999999999999977655443333211   00000             


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                  .....++.++.+++.+||+.||++||++.+++.||||..-
T Consensus       234 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         234 ------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                        0011256789999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-43  Score=290.83  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeee-----cCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQS-----SVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~   74 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++...   ......+.+|+.+++.+ +|||++++++++.     .++..
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            589999999999999999999999999999987432   22235678899999999 6999999999873     44568


Q ss_pred             eeEeecCCcchHH-Hhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           75 DLVFENLDFDLLH-FMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~~~~~-~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      +++|||++|..+. .+..  .....+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC-EEEccCCceeec
Confidence            9999999865554 3332  12345778889999999999999999999999999999999998887 999999998765


Q ss_pred             CCCCcceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ...........+++.|+|||++..    ...++.++|+||+|+++|+|++|..||...........+..   ..      
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~------  245 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NP------  245 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cC------
Confidence            433223333448889999998753    23478899999999999999999999976544332222110   00      


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                        ......+...+.++.+++.+||+.||++|||+.++++||||
T Consensus       246 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 ------------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                              00001122346789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-44  Score=314.60  Aligned_cols=287  Identities=21%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-CeEEEEEe---------------cccCCCCCCcccHHHHHHHHHhcCCCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-DTVVVKKI---------------PIMNPSEGVPSSVIREVSLLKELKHENIVRL   64 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~---------------~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   64 (293)
                      +|++++.||+|+||+||++...... ...+.|.+               +...........+.+|++++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            5999999999999999998643222 11222211               0001111223457789999999999999999


Q ss_pred             eeeeecCCcceeEeecCCcchHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           65 LNVQSSVDSIDLVFENLDFDLLHFMKTEP---TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        65 ~~~~~~~~~~~lv~e~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      ++++...+..|++++++.+.+...+....   ........++.++.||+.||+|||++|++|+||||+||+++.++. +|
T Consensus       229 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-vk  307 (501)
T PHA03210        229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-IV  307 (501)
T ss_pred             eEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EE
Confidence            99999999999999999998888775432   122335567889999999999999999999999999999998888 99


Q ss_pred             EccCCCcccCCCCCcc-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--chHHHHHHHHH
Q 038154          142 IADFGLARPIDVPLEN-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRW--APGLLAAIFSI  217 (293)
Q Consensus       142 l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~--~~~~~~~~~~~  217 (293)
                      |+|||.+......... .....|++.|+|||++.+. .++.++|||||||++|+|++|..+ +....  ....+..+...
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~  386 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS  386 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence            9999999876543222 2233489999999988766 689999999999999999999864 44322  22333333332


Q ss_pred             hCCCCCCCCCCCcCcccccCCCCCCCcccchh--hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLA--TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ................+...............  .....++.++.++|.+||+.||.+|||+.|+|+||||...
T Consensus       387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            22211111110000000000000000000111  1122367788999999999999999999999999999864

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.2e-43  Score=286.72  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=198.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC---CCcccHHHHHHHHHhcCCCCcceeeeeeecC--Cccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE---GVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l   76 (293)
                      |++.+.||+|++|.||++.+..++..+++|++.......   .....+.+|+++++.++|||++++++++...  ...++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            788999999999999999999899999999875443222   2234677899999999999999999987653  56789


Q ss_pred             EeecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|++++. +.+.+....  .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        84 ~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~-~~l~dfg~~~~~~~~~  160 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCCCcccccccc
Confidence            99999864 555554433  3678888999999999999999999999999999999998887 9999999987553211


Q ss_pred             ---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                         .......++..|+|||.+.+. .++.++|+||+|+++|++++|..||..............   ...          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~----------  226 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT----------  226 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC----------
Confidence               111223377889999988765 689999999999999999999999987654433333211   000          


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                     ....+..+++.+.+++ +|+..+|++||+++++++||||+.
T Consensus       227 ---------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~  266 (266)
T cd06651         227 ---------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL  266 (266)
T ss_pred             ---------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence                           0111233567788888 677789999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-43  Score=287.37  Aligned_cols=250  Identities=16%  Similarity=0.175  Sum_probs=198.4

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||.||++..+   ..+..+++|.++... .......+.+|+..+++++|||++++++++..++..++|
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            4889999999999999999754   455689999876432 223335688899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||++++++..+.......+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~-~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc-EEECCCcccccccccchh
Confidence            9999976666554443346788899999999999999999999999999999999998887 999999987654222111


Q ss_pred             -eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          158 -YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                       .....++..|+|||.+.+. .++.++||||||+++|++++ |..||......+....+.....                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------  226 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----------------  226 (266)
T ss_pred             cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------
Confidence             1112245679999987665 68999999999999999775 9999988776665555432100                


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                   ...+..++..+.+++.+|++.+|.+||+++++++
T Consensus       227 -------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 -------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                         0122346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=271.99  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=197.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||+|.+.||+|||+-||++....++..||+|++....  .+..+..++|++..++++|||+++++++...+.     ..|
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            8999999999999999999988899999999986544  455688899999999999999999999865443     489


Q ss_pred             eEeecCC-cchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           76 LVFENLD-FDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      +++.|+. |++++.+..  .....+++.++.+++.++++||.+||...  ++|+||||.||+++..+. +++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~-~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL-PVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc-eEEEeccCccc
Confidence            9999997 778887754  33446899999999999999999999998  999999999999998787 99999999876


Q ss_pred             CCCCCcceecc---------CccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 038154          151 IDVPLENYTIK---------GGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG  219 (293)
Q Consensus       151 ~~~~~~~~~~~---------~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  219 (293)
                      ..-........         .-+..|+|||.+.-  ....+.++|||||||++|.|+.|..||...-..         .+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------GG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------CC
Confidence            53221211111         13568999997643  234688999999999999999999999642110         00


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .........                 .-.......+|..+.++|+.||++||.+||++.+++++
T Consensus       250 SlaLAv~n~-----------------q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALAVQNA-----------------QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEeeecc-----------------ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000000000                 00001112378999999999999999999999999874

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.1e-43  Score=286.15  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=203.3

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-ch
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DL   85 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~   85 (293)
                      ||.|++|.||++.+..++..+++|++...... ......+.+|+++++.++|||++++++.+.++...++++||+++ ++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999888999999998654332 23446788999999999999999999999999999999999985 45


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                      .+.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ......+++
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~-~~l~df~~~~~~~~~~-~~~~~~~~~  156 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQ-KTWTFCGTP  156 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC-EEEeeCCcccccCccc-ccccccCCc
Confidence            45554432  3678889999999999999999999999999999999998887 9999999988765432 222334788


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW--APGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      .|++||.+.+. .++.++|+||+|+++|++++|..||....  .......+....                         
T Consensus       157 ~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------  210 (262)
T cd05572         157 EYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-------------------------  210 (262)
T ss_pred             CccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC-------------------------
Confidence            89999987655 68899999999999999999999998765  333333322100                         


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                         .....+...+.++.+++.+||+.||++||+     +.++++||||+++.|
T Consensus       211 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         211 ---GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence               001112234778999999999999999999     999999999999876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-43  Score=291.93  Aligned_cols=257  Identities=28%  Similarity=0.376  Sum_probs=205.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..++..+++|.+...  .......+.+|+.+++.+.|||++++++++...+..++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            689999999999999999998888999999987532  223346788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+.......  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~-~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC-EEEccCcceeccccccccccc
Confidence            9865554444332  3677789999999999999999999999999999999998887 999999988765443333333


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|++||.+... .++.++|+||||+++|++++|..||...+.......+.. .+.                    
T Consensus       175 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~--------------------  232 (293)
T cd06647         175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT--------------------  232 (293)
T ss_pred             ccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC--------------------
Confidence            4578889999987665 678999999999999999999999976544322211110 000                    


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                           . ....+..++..+.+++.+||..+|++||++++++.||||+.-+
T Consensus       233 -----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         233 -----P-ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             -----C-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                 0 0011223577899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.2e-43  Score=287.04  Aligned_cols=253  Identities=28%  Similarity=0.410  Sum_probs=196.3

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      ...||+|++|.||++.+..++..+++|.+....  ......+.+|+++++.++|+||+++++++..++..++++|++++.
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            468999999999999988889999999875432  223457889999999999999999999999999999999999865


Q ss_pred             hHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           85 LLHFMKTEPTVTK--NPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        85 ~~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      .+...........  ++..+..++.|++.||.+||+.|++|+||+|+||+++.+...++|+|||.+..............
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence            5544333222223  77788889999999999999999999999999999987544599999999876543323233334


Q ss_pred             ccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          163 GSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       163 ~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      +++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||................                       
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------  227 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-----------------------  227 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----------------------
Confidence            78899999987543 247889999999999999999999997543221111100000                       


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                          .....++..+++++.+++.+||+.+|.+|||+.+++.||||
T Consensus       228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                01112234567889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=291.73  Aligned_cols=283  Identities=29%  Similarity=0.448  Sum_probs=226.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--C----CcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E----NIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~----~i~~~~~~~~~~~~~   74 (293)
                      ||.|++.+|+|.||.|-.+.+..++..+|+|+++.   .....+...-|+++|.++.+  |    -++++.++|...+..
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            79999999999999999999998999999998753   23445667779999999942  2    367888999999999


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC-----------------
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-----------------  137 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~-----------------  137 (293)
                      |+|+|-++.++.+++.++...+++...++.|++||+.++.+||+.+++|-||||+||++....                 
T Consensus       167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            999999999999999999999999999999999999999999999999999999999984311                 


Q ss_pred             --CeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 038154          138 --DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       138 --~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  215 (293)
                        ..|+++|||.++......   .....|--|+|||++.+- .++..+||||+||||+|+.+|...|......+.++.+.
T Consensus       247 ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe  322 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME  322 (415)
T ss_pred             CCcceEEEecCCcceeccCc---ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence              148999999998765432   333367789999999988 69999999999999999999999999988888888888


Q ss_pred             HHhCCCCCCCCCCCcC---c---ccccCCCCCC-------CcccchhhhcC---CCCchHHHHHHHhhccCCCCCCCHHH
Q 038154          216 SIMGTPDSETLPGFTS---F---SEEFGFEPNR-------SPIKDLATVVG---GLEPDGVDLLRRMLCLDPSKRLTARE  279 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~---~---~~~~~~~~~~-------~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~  279 (293)
                      ...+..+.........   +   .-++......       ..+..+.....   ....++.+|+++||..||++|+|+.|
T Consensus       323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E  402 (415)
T KOG0671|consen  323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE  402 (415)
T ss_pred             HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence            8888777665554411   0   0011000000       00111111111   12346889999999999999999999


Q ss_pred             HhcCcccccCc
Q 038154          280 ALRHEYFKDFQ  290 (293)
Q Consensus       280 ll~~p~~~~~~  290 (293)
                      +|.||||....
T Consensus       403 AL~HpFF~~~~  413 (415)
T KOG0671|consen  403 ALSHPFFARLT  413 (415)
T ss_pred             HhcCHHhhcCC
Confidence            99999998764

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.7e-43  Score=292.66  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=207.2

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .....||+|++|.||++.+..++..+++|++....  ......+.+|+.+++.+.|||++++++.+..++..++++|+++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            34567999999999999998899999999985432  2334678889999999999999999999999999999999999


Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      +..+..+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..............
T Consensus       102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~-~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc-EEEeechhHhhccccccccccee
Confidence            7666555543  34788899999999999999999999999999999999998887 99999998876544333333445


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      ++..|+|||.+.+. .++.++|+||||+++++|++|..||......+....+..   ...                    
T Consensus       179 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--------------------  234 (297)
T cd06659         179 GTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP--------------------  234 (297)
T ss_pred             cCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC--------------------
Confidence            78899999988765 688999999999999999999999987665554443321   000                    


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                          ........++..+.+++.+||+.+|.+||++.++++||||.+..
T Consensus       235 ----~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         235 ----PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             ----CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                00011234677899999999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.1e-43  Score=291.44  Aligned_cols=260  Identities=25%  Similarity=0.318  Sum_probs=206.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++.+..++..+++|.+...... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            388999999999999999999999999999988644321 2234567789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc---
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE---  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~---  156 (293)
                      +++|..+..+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........   
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~-~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC-EEEeeCCCccccCcCccccc
Confidence            99865554444332 35788889999999999999999999999999999999998887 99999998753211000   


Q ss_pred             ------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          157 ------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       157 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                                  ......++..|+|||.+.+. .++.++|+||||+++|++++|..||.+.+..+............+  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  236 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP--  236 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC--
Confidence                        00112356789999987665 689999999999999999999999987766665555432111100  


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC---HHHHhcCcccccCc
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREALRHEYFKDFQ  290 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~p~~~~~~  290 (293)
                                               .....++.++.+++.+||+.||++||+   +.++++||||..+.
T Consensus       237 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         237 -------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             -------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                                     011236788999999999999999997   89999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.2e-43  Score=283.80  Aligned_cols=256  Identities=32%  Similarity=0.484  Sum_probs=208.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      +|.+.+.||+|++|.||++.+..++..+++|++..........+.+.+|+.++++++|||++++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            68999999999999999999988999999999865554445567888999999999999999999999888  8899999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--  156 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--  156 (293)
                      |++++..+..+..... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEcccccEEecccccccc
Confidence            9997555544433332 6888899999999999999999999999999999999998887 99999999887765432  


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......++..|+|||.+.+. ..+.++|+||||+++++|++|..||.......  ........                 
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-----------------  218 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS-----------------  218 (260)
T ss_pred             cccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc-----------------
Confidence            12334478899999977665 58999999999999999999999998765211  11111000                 


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              ......++..++..+.+++.+|+..||++||++.+++.||||
T Consensus       219 --------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                    011112334458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-42  Score=283.02  Aligned_cols=247  Identities=24%  Similarity=0.307  Sum_probs=200.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++.....+..+++|.+...   ......+.+|+++++.++||+++++++++..++..+++|||+
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            67889999999999999999888999999987532   223457888999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee-
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-  159 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~-  159 (293)
                      ++ ++.+.+.......+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+........... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc-EEeCCCccccccccceeeccC
Confidence            75 5555665555556788899999999999999999999999999999999998887 99999999876644322111 


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+.++....+.....                   
T Consensus       164 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------  223 (263)
T cd05052         164 GAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-------------------  223 (263)
T ss_pred             CCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------------
Confidence            11134579999977655 68899999999999999998 8999987766655444422100                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ...+..++.++.+++.+||+.||++|||+.+++.
T Consensus       224 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                      0112346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-42  Score=281.53  Aligned_cols=252  Identities=28%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|.||++.+..++..+++|++.....  .....+.+|+++++.+.||+++++++.+..+...++++|++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            7899999999999999999988899999999865332  34568889999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++..+..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe-EEEeecccccccccccc-ccce
Confidence            966665555444356888999999999999999999999999999999999998877 99999999887654432 2233


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .++..|+|||.+.+. .++.++|+||||+++++|++|..||...+.......... ...+  ..                
T Consensus       158 ~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~--~~----------------  217 (253)
T cd05122         158 VGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP--GL----------------  217 (253)
T ss_pred             ecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC--Cc----------------
Confidence            477889999987765 588999999999999999999999987654443333221 0000  00                


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                              .....++..+.+++.+||+.||++|||+.+++.|||
T Consensus       218 --------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 --------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                    001114778999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-43  Score=290.18  Aligned_cols=263  Identities=22%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |...+.||+|++|.||++.+..++..+++|.+...... .....+..|+.++.++. |||++++++++..++..+++||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            45667899999999999999999999999988643322 33456788999999996 99999999999998999999999


Q ss_pred             CCcchHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LDFDLLHFM---KTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++++....   .......+++..+..++.|++.||+|||+. |++|+||+|+||+++.++. ++|+|||.+........
T Consensus        85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIA  163 (288)
T ss_pred             ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc-EEEeecchhHHhccCCc
Confidence            987554332   223335688889999999999999999975 9999999999999998887 99999999875543222


Q ss_pred             ceeccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYTIKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ....+++.|+|||++.+.  ..++.++|+||+|+++|+|++|..||.....  ....+...........         
T Consensus       164 ~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~---------  231 (288)
T cd06616         164 K-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL---------  231 (288)
T ss_pred             c-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC---------
Confidence            1 222377889999988765  3688999999999999999999999976541  1112111111000000         


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                   .......++.++.+|+.+||+.||++|||++++++||||+.+.+
T Consensus       232 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         232 -------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             -------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                         00111346788999999999999999999999999999988754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-43  Score=296.61  Aligned_cols=285  Identities=20%  Similarity=0.189  Sum_probs=203.3

Q ss_pred             eeeeccc--cceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            5 LEVIREG--RYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         5 ~~~lg~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ...||+|  ++|+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|+|++.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3456766  88999999999999999999986544334445678889999999999999999999999999999999998


Q ss_pred             c-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce---
Q 038154           83 F-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY---  158 (293)
Q Consensus        83 ~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~---  158 (293)
                      + ++.+.+.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++++||+.+..........   
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~-~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc-EEEechHHHhhhhccCcccccc
Confidence            5 5555555544456888899999999999999999999999999999999998887 8999997543221110000   


Q ss_pred             ----eccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          159 ----TIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       159 ----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                          ....++..|+|||++.+. ..++.++|+||||+++++|++|..||...................+...........
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence                011134569999988654 357899999999999999999999998876554443333211110000000000000


Q ss_pred             cccCC-------------C----CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          234 EEFGF-------------E----PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       234 ~~~~~-------------~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .....             .    ................+..+.+|+++||+.||.+|||++++++||||+.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            00000             0    000000001111234677899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-42  Score=286.64  Aligned_cols=261  Identities=28%  Similarity=0.398  Sum_probs=200.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      +|++.++||.|++|.||++.+..++..+++|.+..... ......+.+|+++++++.||||+++++++...  +.+++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            58999999999999999999988999999998864322 23446788999999999999999999987543  4689999


Q ss_pred             ecCCcchH-HHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           79 ENLDFDLL-HFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        79 e~~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ||++|..+ +.+..  .....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe-EEEeeccccccccccc
Confidence            99986544 33322  22345778889999999999999999999999999999999998887 9999999986554322


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHHHhCCCCCCCCCCCc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-----PGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ..  ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....     .+....+..   ... ...    
T Consensus       160 ~~--~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-~~~----  228 (287)
T cd06621         160 AG--TFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPN-PEL----  228 (287)
T ss_pred             cc--cccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCc-hhh----
Confidence            21  22367789999987655 688999999999999999999999976522     111111111   000 000    


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                     ..........++.+.+++.+||..||++|||+.|++.||||++.
T Consensus       229 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         229 ---------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             ---------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                           00000011245788999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-42  Score=286.20  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=194.0

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-cccHHHHHHHHHh---cCCCCcceeeeeeecCCcceeEeecCC
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKE---LKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .||+|++|.||++.+..++..+|+|.+......... .....+|..+++.   ..||+++.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999889999999988654332221 1223444444443   368999999999999999999999998


Q ss_pred             cchHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 FDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 ~~~~~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      ++.+. .+...  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........  ...
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~-~~l~dfg~~~~~~~~~~--~~~  155 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKP--HAS  155 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC-EEEccCCcceeccccCc--cCc
Confidence            65554 44333  24788899999999999999999999999999999999998887 99999999865543221  223


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.......... +.....                      
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----------------------  212 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----------------------  212 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----------------------
Confidence            488999999987654468899999999999999999999997643322111 100000                      


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                          ......+..++.++.++|.+||..||++||     |+.++++||||+.+++
T Consensus       213 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         213 ----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             ----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence                000112344688999999999999999999     6999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.2e-43  Score=288.84  Aligned_cols=256  Identities=30%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+..++..+++|++.....   ....+.+|+++++.++|+|++++++.+......++++||
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            37778899999999999999988899999999864332   446788899999999999999999999999999999999


Q ss_pred             CCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++|..+ +.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC-EEECccchhhhhccchhhhc
Confidence            995444 4444433 46788899999999999999999999999999999999998887 99999998875544323333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..... +.                 
T Consensus       175 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-----------------  235 (286)
T cd06614         175 SVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PP-----------------  235 (286)
T ss_pred             cccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC-----------------
Confidence            33467889999987665 688999999999999999999999987665544443321000 00                 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                               ......++..+.++|.+||+.+|.+||++.++++||||++.
T Consensus       236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         236 ---------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             ---------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                     00112257789999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-42  Score=282.48  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=198.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC---CcccHHHHHHHHHhcCCCCcceeeeeeecC--Cccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG---VPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l   76 (293)
                      |++.+.||+|++|.||.+.+..+|..+++|.+........   ....+.+|+++++++.|||++++++++.+.  ..+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            8899999999999999999999999999998754332221   234677899999999999999999987664  46789


Q ss_pred             EeecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +||++++. +.+.+....  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC-EEECcCcccccccccc
Confidence            99999865 445544332  3677788999999999999999999999999999999998887 9999999887543211


Q ss_pred             ---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                         .......++..|+|||++.+. .++.++|+||||+++|+|++|..||..............   .+.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~----------  226 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT----------  226 (265)
T ss_pred             ccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC----------
Confidence               112223477889999988765 688999999999999999999999987644443333211   110          


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                     ....+..++..+.+++.+|+. +|.+||++++++.|||++
T Consensus       227 ---------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                           011233457788999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.4e-43  Score=286.21  Aligned_cols=252  Identities=29%  Similarity=0.425  Sum_probs=203.8

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcchH
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLL   86 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~   86 (293)
                      ||.|++|.||++.+..+|+.+++|.+..... .......+.+|+++++++.|||++++++.+......|+++|++.+..+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988899999999864432 123456788899999999999999999999999999999999986444


Q ss_pred             -HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--------c
Q 038154           87 -HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--------N  157 (293)
Q Consensus        87 -~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--------~  157 (293)
                       +.+....  .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........        .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC-EEEEecccchhcccCccccccccccc
Confidence             4444333  5788899999999999999999999999999999999999887 99999998875433311        2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....++..|+|||..... ..+.++|+||||++++++++|..||......+....+......+     +          
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~----------  221 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW-----P----------  221 (265)
T ss_pred             ccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC-----C----------
Confidence            2223367789999987665 58899999999999999999999998877666555543200000     0          


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH---HHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA---REALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~~p~~~~~~~  291 (293)
                                   ....++..+.+++.+||+.+|.+|||+   .++++||||+++.|
T Consensus       222 -------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         222 -------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             -------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                         001147889999999999999999999   99999999998865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-42  Score=288.85  Aligned_cols=257  Identities=22%  Similarity=0.266  Sum_probs=195.0

Q ss_pred             CceeeeeeccccceeEEEEEeCC----------------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL----------------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL   64 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   64 (293)
                      ||++.++||+|+||.||++....                ++..+|+|.+.... .......+.+|+++++++.||||+++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            68999999999999999997532                34479999875432 22334578899999999999999999


Q ss_pred             eeeeecCCcceeEeecCCc-chHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccc
Q 038154           65 LNVQSSVDSIDLVFENLDF-DLLHFMKTEP-----------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL  126 (293)
Q Consensus        65 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl  126 (293)
                      ++++.+.+..+++|||+.+ ++.+.+....                 ...+++..++.++.||+.||.+||+.|++|+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            9999999999999999985 4544443221                 123566788999999999999999999999999


Q ss_pred             CCCceeEeCCCCeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCC
Q 038154          127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT--HQRLF  202 (293)
Q Consensus       127 ~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf  202 (293)
                      +|+||+++.++. +||+|||.+..........  ....++..|+|||++.+. .++.++|+||||+++|+|++  +..||
T Consensus       165 kp~Nill~~~~~-~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         165 ATRNCLVGENLT-IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             chhheEEcCCcc-EEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            999999998887 9999999987653321111  112246789999987655 68999999999999999986  56888


Q ss_pred             CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          203 HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...+..+................                      ....++.++..+.+++.+|++.||.+|||+.+|..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         243 GELTDEQVIENAGEFFRDQGRQV----------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CcCCHHHHHHHHHHHhhhccccc----------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            87766655544432111110000                      00112346788999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9e-43  Score=288.82  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=205.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      ..+||+|++|.||++....++..+++|++...  .......+.+|+.+++.++|+|++++++.+...+..+++|||+++.
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            35799999999999999889999999987432  2233466888999999999999999999999999999999999976


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCcc
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS  164 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~  164 (293)
                      .+..+....  .+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+..............++
T Consensus       103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEcccccceecccccccccccccC
Confidence            665555433  4678899999999999999999999999999999999998887 9999999887654433333334478


Q ss_pred             ccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCc
Q 038154          165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSP  244 (293)
Q Consensus       165 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
                      +.|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+......                        
T Consensus       180 ~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------------------  234 (292)
T cd06657         180 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------------------  234 (292)
T ss_pred             ccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc------------------------
Confidence            889999977654 6789999999999999999999999876655554443221100                        


Q ss_pred             ccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                        . ......++..+.+++.+||+.||.+||++.++++||||.+..
T Consensus       235 --~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         235 --K-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             --c-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence              0 001123578899999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=295.39  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=206.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++.++||+||.+.||++.... ...||+|++...........-+.+|+..|.+|+ |..|+++++|-..++.+|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            48999999999999999997553 356788877666677777889999999999994 8999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +-+-++...+.+....... ..++.+..|++.|+.++|+.||||.||||-|+++. .|. +||+|||.+..+..+.... 
T Consensus       441 ~Gd~DL~kiL~k~~~~~~~-~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~-LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  441 CGDIDLNKILKKKKSIDPD-WFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGR-LKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             cccccHHHHHHhccCCCch-HHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eee-EEeeeechhcccCcccccee
Confidence            9888998888877654333 37888999999999999999999999999999998 455 9999999998887665543 


Q ss_pred             -eccCccccccCcccccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          159 -TIKGGSLCYKAPERLLGSG----------RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       159 -~~~~~~~~~~aPE~~~~~~----------~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                       ....||+.||+||.+....          ..+++|||||||||||+|+-|+.||....  ...+++.+....-.+...+
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIEFP  595 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcccccc
Confidence             3445999999999885321          25689999999999999999999997542  2233333322221111111


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ..                      +  -..+++++++.||.+||.+|||+.+||+|||++-+
T Consensus       596 ~~----------------------~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  596 DI----------------------P--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CC----------------------C--CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            11                      0  01238999999999999999999999999999864

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.6e-43  Score=287.97  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=199.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      .|++.+.||+|++|.||++.....+     ..+++|.+... ........+.+|++++++++|||++++++++...+..+
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            3788999999999999999865544     67899987532 22233456888999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeE
Q 038154           76 LVFENLDF-DLLHFMKTEPT--------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIV  140 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v  140 (293)
                      ++|||+++ ++.+++.....              ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-~  163 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-V  163 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-E
Confidence            99999985 55555543221              35677889999999999999999999999999999999998887 9


Q ss_pred             EEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 038154          141 KIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSI  217 (293)
Q Consensus       141 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (293)
                      +|+|||.+........  ......+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+....+...
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999875533211  11122356789999987665 68999999999999999998 99999887776665554321


Q ss_pred             hCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                   .....+..++.++.+++.+|++.||.+||++.+++++
T Consensus       243 -----------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         243 -----------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             -----------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                         0111234578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-43  Score=284.11  Aligned_cols=254  Identities=28%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHH-HhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLL-KELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|++|.||+|.+..+|+.+|+|.+...... ......+..|..++ ....|+|++++++++..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            6799999999999999889999999988543221 11122334454444 345799999999999999999999999986


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      +.+..+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....    .....+
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~----~~~~~~  155 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-LKLTDFGLSRNGLE----NKKFVG  155 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEeecccceeccc----cccCCC
Confidence            5555444332 24678899999999999999999999999999999999998887 99999998865432    122237


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      ++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.......                      
T Consensus       156 ~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------  212 (260)
T cd05611         156 TPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW----------------------  212 (260)
T ss_pred             CcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC----------------------
Confidence            7889999988766 48899999999999999999999998776665544442211000                      


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCCC---HHHHhcCcccccCcCC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREALRHEYFKDFQSL  292 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~p~~~~~~~~  292 (293)
                          .......+++.+.+++.+||+.||++||+   +.++++||||++++|.
T Consensus       213 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         213 ----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence                00112246889999999999999999995   4799999999998874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.7e-42  Score=280.11  Aligned_cols=246  Identities=21%  Similarity=0.261  Sum_probs=196.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++..+ .+..+++|.+...   ......+.+|++++++++|||++++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            3788999999999999999765 4567999986532   22236788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +++ ++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+.......... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV-VKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe-EEECCCCCccccCCCceecc
Confidence            985 5555554332 35788899999999999999999999999999999999998777 9999999887653322211 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+......                 
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------------  220 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------------  220 (256)
T ss_pred             CCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------------
Confidence            112245679999987655 68899999999999999999 89999887776666665331110                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ..+...+.++.+++.+|++.||++||++.++++
T Consensus       221 ------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                        011224678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-42  Score=283.77  Aligned_cols=247  Identities=23%  Similarity=0.278  Sum_probs=202.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||.|++|.||+|.+.. +..+++|.+....  ......+..|+++++.++|||++++++++......+++|||+
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            7889999999999999999877 7889999875432  223467889999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++ ++.+.+.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~-~kl~d~g~~~~~~~~~~~~~~  163 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV-CKVADFGLARLIKEDVYLSSD  163 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce-EEEccccchhhcCCccccccC
Confidence            85 6666665555556788899999999999999999999999999999999998887 999999998766443222223


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..++..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+.....                    
T Consensus       164 ~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------------  222 (261)
T cd05148         164 KKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--------------------  222 (261)
T ss_pred             CCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc--------------------
Confidence            3356689999987655 68899999999999999998 8999987776665555432100                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                               ...+...++.+.+++.+||+.||++|||+.++++
T Consensus       223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 ---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     0112346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-42  Score=283.68  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=201.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC---CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP---SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||.+.+.||+|++|.||++.+...+..+++|.++....   .......+..|+++++.++|||++++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            89999999999999999998877777677776643222   222334566789999999999999999999999999999


Q ss_pred             eecCCcchHHH-hhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           78 FENLDFDLLHF-MKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        78 ~e~~~~~~~~~-~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +||+++..+.. +..  .....+++..+..++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~-~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL-LKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC-EeecccCceeecCCC
Confidence            99998655543 332  23346788899999999999999999999999999999999974 44 999999998766444


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ........+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.........+...                 
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----------------  220 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-----------------  220 (260)
T ss_pred             cccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----------------
Confidence            3333344578889999987654 5788999999999999999999999766554444433210                 


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                  .....+..++.++.++|.+||..||++||++.++++||||
T Consensus       221 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         221 ------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                        0111223467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-42  Score=286.86  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=206.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|.+.+.||+|++|.||++.+..++..+++|++..... .......+..|+++++++. ||||+++++++..++..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            58999999999999999999988999999999865332 2223356788999999998 999999999999999999999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      |++. +++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+........ 
T Consensus        82 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~-~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEecCCccccccCCcccc
Confidence            9996 56656665443  5788899999999999999999999999999999999998887 99999999876644321 


Q ss_pred             -------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 038154          157 -------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI  217 (293)
Q Consensus       157 -------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  217 (293)
                                         ......++..|+|||+.... .++.++|+||||++++++++|..||...+.....+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                               11222357789999987665 5889999999999999999999999877654444443210


Q ss_pred             hCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCccc
Q 038154          218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYF  286 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~  286 (293)
                                                    ....+..+++.+.+++.+||+.||++||++    .++++||||
T Consensus       238 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 ------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             ------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                                          011223457889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-42  Score=282.66  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=207.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||+|++|.||++.+..++..+++|.+............+..|+++++.++|+||+++.+++......++|+|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            69999999999999999999988999999999865444444456778899999999999999999999999999999999


Q ss_pred             CCcchH-HHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDFDLL-HFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      +++..+ ..+..  .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~-~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL-VKIGDLGISKVLKKNM--  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc-EEEeeccchhhhccCC--
Confidence            986544 44433  12345788899999999999999999999999999999999998777 9999999987665431  


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||.+.+. .++.++|+||||++++++++|..||...+..+....+..                     
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------------  215 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------------------  215 (256)
T ss_pred             cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence            2223477899999987655 678899999999999999999999988766554444321                     


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              ..........+.++.+++.+||..+|.+||++.+++.||++
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                    00111222467889999999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-42  Score=290.61  Aligned_cols=282  Identities=20%  Similarity=0.201  Sum_probs=199.8

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +++.+|.|  +.||.+....+++.+|+|++............+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34444444  5556666577899999999876544455567899999999999999999999999999999999999995


Q ss_pred             chH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc------
Q 038154           84 DLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE------  156 (293)
Q Consensus        84 ~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~------  156 (293)
                      +.+ +.+.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++++||+.+........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~-~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc-eEEecCccceeeccccccccccc
Confidence            544 4554444456788899999999999999999999999999999999998887 99999998764432111      


Q ss_pred             -ceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC----CCCc
Q 038154          157 -NYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL----PGFT  230 (293)
Q Consensus       157 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  230 (293)
                       ......++..|+|||.+... ..++.++|+||+|+++++|++|..||............  ..+.......    +...
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCccccccCchhhhc
Confidence             11122256789999988653 35788999999999999999999999876543322211  1111110000    0000


Q ss_pred             Ccccc--cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEE--FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .....  ...................++.++.+++.+||+.||++|||+.++|+||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            00000  0000001111111222334567889999999999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=299.12  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=221.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.+.+.||+|.|++|.++++..++..||||.++...........+.+|+++++.++||||++++.+.+....+|+||||+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            78999999999999999999999999999999877776666677999999999999999999999999999999999999


Q ss_pred             C-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 D-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      . |.+.+++.+++.  ..+..++.++.|+.+|++|+|++++||+|||++||+++.+.+ +||+|||++..+... .....
T Consensus       138 ~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn-ikIaDfgfS~~~~~~-~~lqt  213 (596)
T KOG0586|consen  138 SGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN-IKIADFGFSTFFDYG-LMLQT  213 (596)
T ss_pred             cCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc-eeeeccccceeeccc-ccccc
Confidence            6 677788877665  445788999999999999999999999999999999999998 999999999988743 55566


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      .+|++.|.|||++.+..+..+..|+||||+++|.|+.|.+||.+.+-.+.......                        
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------------------  269 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------------------  269 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------------------------
Confidence            77999999999999988889999999999999999999999987655443332211                        


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                            ..-.++--++.++.++|+++|-.+|++|++++++++|.|.....
T Consensus       270 ------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  270 ------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence                  11122333678899999999999999999999999999988654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=281.61  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=222.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |..+++||+|.||+|.+++.+.+|+.||+|+++..-. ..+...+-..|-++|+..+||.+..+-..|...+.+|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            5678999999999999999999999999999875443 234445667799999999999999999899999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ..|+-+-+..++. ..+++...+-+...|..||.|||+.++|.+|||.+|.++|++|+ +||+|||+++.--........
T Consensus       250 anGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~~g~t~kT  327 (516)
T KOG0690|consen  250 ANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIKYGDTTKT  327 (516)
T ss_pred             ccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc-eEeeecccchhcccccceecc
Confidence            9866554444443 35788899999999999999999999999999999999999999 999999999876666666777


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      .+|+|.|.|||++..+ .|..+.|-|.+|+++|+|++|+.||-..+.+.....|...                       
T Consensus       328 FCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------------------  383 (516)
T KOG0690|consen  328 FCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------------------  383 (516)
T ss_pred             ccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------------------
Confidence            7899999999998877 7999999999999999999999999888777766666432                       


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcCC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQSL  292 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~~  292 (293)
                             ....+..++++++.|+..+|..||.+|.     .+.||.+|+||..++|-
T Consensus       384 -------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  384 -------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             -------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence                   2234566899999999999999999996     57999999999998874

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=304.29  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=214.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcch
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDL   85 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (293)
                      =+||+|.||+||.|++..+...+|||.++...  ....+-+..|+.+-++|.|.||+++.|.+..++++-+.||.++|++
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            37999999999999999999999999986543  3334778999999999999999999999999999999999999888


Q ss_pred             HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           86 LHFMKTEPTVTK--NPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        86 ~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      +..+....+.++  ++..+..+.+||++||.|||++.|||||||-+||+|+.-...+||+|||.++....-........|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            887777777676  888999999999999999999999999999999999987667999999999876544444555669


Q ss_pred             cccccCcccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          164 SLCYKAPERLLG-SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       164 ~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      |.-|||||++.. ...|..++|||||||.+.||.||+.||.....+........+                         
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-------------------------  793 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-------------------------  793 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-------------------------
Confidence            999999998854 456899999999999999999999999765444332222111                         


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                        .+.-..++..++.+++.+|.+|+.+||.+||+|.++|..||++.=
T Consensus       794 --yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  794 --YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence              122234556678899999999999999999999999999999764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.2e-42  Score=284.53  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=199.3

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      ||++.++||+|++|.||+|..+     ..+..+++|.+.... .......+.+|+.+++.++|||++++++++......+
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            6999999999999999999654     234579999875332 1222345778999999999999999999999999999


Q ss_pred             eEeecCC-cchHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLD-FDLLHFMKTEP--------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      ++|||++ |++.+.+....        ........+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~-~~L~Dfg  164 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT-VKIGDFG  164 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc-EEECcCC
Confidence            9999998 45555554321        123355678889999999999999999999999999999998887 9999999


Q ss_pred             CcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+..........  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+.++....+.....    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----  239 (288)
T cd05061         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY----  239 (288)
T ss_pred             ccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            987543321111  111245679999987655 68999999999999999998 7889988776665554432100    


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc------CcccccCc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR------HEYFKDFQ  290 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~p~~~~~~  290 (293)
                                               ...+...++.+.+++.+||+.||++|||+.++++      ||||..+-
T Consensus       240 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         240 -------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence                                     0112235678999999999999999999999987      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.2e-42  Score=279.23  Aligned_cols=246  Identities=22%  Similarity=0.276  Sum_probs=195.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||+|++|+||.+.... +..+++|.+....   .....+.+|++++++++||||+++++++......+++|||+
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             eEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            7899999999999999997653 4569999875332   22357889999999999999999999999999999999999


Q ss_pred             Ccc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-e
Q 038154           82 DFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-T  159 (293)
Q Consensus        82 ~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-~  159 (293)
                      .++ +.+.+.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......... .
T Consensus        82 ~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~-~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          82 SNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC-VKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC-EEECCCccceecCCCceeecC
Confidence            854 555554433 36788899999999999999999999999999999999998887 9999999987654322111 1


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+......                  
T Consensus       160 ~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  220 (256)
T cd05113         160 GSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL------------------  220 (256)
T ss_pred             CCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC------------------
Confidence            12245679999988655 58899999999999999998 99999877766555554321110                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ......+..+.+++.+||+.||.+||++.+++++
T Consensus       221 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                       0111246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.7e-42  Score=280.41  Aligned_cols=246  Identities=25%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.++||+|++|.||+|.+..+ ..+++|++....   .....+.+|++++++++|||++++++.+.. ...++|||+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            689999999999999999987655 459999875422   223578899999999999999999998754 568999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +++ ++.+.+.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~-~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc-EEeccCCceeeccccccccc
Confidence            985 6666665544445788899999999999999999999999999999999998887 9999999987654332211 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||...+. .++.++|+||||+++|++++ |..||.+....+....+.....                  
T Consensus       161 ~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------  221 (262)
T cd05071         161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------  221 (262)
T ss_pred             cCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC------------------
Confidence            122255679999977655 68999999999999999999 8889987766655544422100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ......++..+.+++.+|++.||++||++.+++.
T Consensus       222 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 -----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                       0112346788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-42  Score=295.11  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=194.3

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|+||+||++..     ..++..+|+|+++... .......+.+|+++++.+ +||||+++++++...+..
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            488999999999999999963     3456689999885332 222345688899999999 899999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCC------------------------------------------------------------
Q 038154           75 DLVFENLD-FDLLHFMKTEP------------------------------------------------------------   93 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~------------------------------------------------------------   93 (293)
                      ++||||++ |++.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999998 55555554321                                                            


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce--
Q 038154           94 -------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--  158 (293)
Q Consensus        94 -------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--  158 (293)
                                   ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||.+..........  
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI-TKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc-EEEecCccceeccCccccccc
Confidence                         124677788999999999999999999999999999999998776 9999999987654332111  


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||.....+....+.......                 
T Consensus       274 ~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------------  335 (375)
T cd05104         274 GNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-----------------  335 (375)
T ss_pred             CCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----------------
Confidence            112245679999988765 68999999999999999998 88999776544333332211000                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ...+...+.++.+++.+||+.||++|||+.++++.
T Consensus       336 -----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 -----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                       00112346789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-42  Score=286.67  Aligned_cols=260  Identities=21%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.+..+|..+++|++.... .......+.+|+++++.++|||++++++++...+.+++|+||
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4788999999999999999998889999999875432 233456788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++.+..+.... ..+++..+..++.+++.+|.|||+ .|++|+||+|+||+++.++. ++|+|||.+........  .
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~-~~l~d~gl~~~~~~~~~--~  160 (284)
T cd06620          85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ-IKLCDFGVSGELINSIA--D  160 (284)
T ss_pred             CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc-EEEccCCcccchhhhcc--C
Confidence            9976665444332 247888999999999999999997 59999999999999998887 99999998765432211  2


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL----LAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ...++..|+|||++.+. .++.++|+||||+++|++++|..||......+.    ...+...........          
T Consensus       161 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  229 (284)
T cd06620         161 TFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----------  229 (284)
T ss_pred             ccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----------
Confidence            23478899999987655 688999999999999999999999986544211    011100000000000          


Q ss_pred             cCCCCCCCcccchhhh-cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          236 FGFEPNRSPIKDLATV-VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                  .... ...++.++.+++.+|++.||.+|||+.++++||||..
T Consensus       230 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 ------------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             ------------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                        0000 0125678999999999999999999999999998865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-42  Score=282.36  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=199.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+..... .......+.+|+++++.++|||++++++++...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            58999999999999999999998999999998754332 22333567889999999999999999999999999999999


Q ss_pred             cCCcchHH-Hhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLLH-FMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~~-~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++++.+. .+..  .....+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~-~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC-EEECccccceeccchhH
Confidence            99965444 3322  22335678889999999999999999999999999999999998887 99999999887654333


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP--GLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||......  .....+.. ...++            
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~------------  227 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPP------------  227 (267)
T ss_pred             HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCC------------
Confidence            33334478899999988765 5789999999999999999999999654322  22222211 00000            


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                     ......+..+.+++.+|++.+|++||++.++++
T Consensus       228 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 ---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                           001235678999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.6e-42  Score=283.40  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=195.1

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-cccHHHHHHH---HHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSL---LKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~---l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .||+|++|.||++.+..+++.||+|.+......... ......|..+   ++...||+++.+.+++...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999889999999988654322211 1223344433   344579999999999999999999999998


Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      |+.+....... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+........  ....
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~-~kl~dfg~~~~~~~~~~--~~~~  156 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKP--HASV  156 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC-EEEccCcCccccCccCC--cCcC
Confidence            66555444332 35888999999999999999999999999999999999998887 99999999875543222  2234


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      ++..|+|||.+.+...++.++|+||+|+++|+|++|..||.............. ..                       
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~-----------------------  212 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TL-----------------------  212 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-hh-----------------------
Confidence            888999999887554688999999999999999999999976532211111000 00                       


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                         ......+...+.++.+++.+||..||.+||     ++.++++||||+.+++
T Consensus       213 ---~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         213 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             ---ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence               000112334678999999999999999999     9999999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=286.97  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=217.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.|+++||+|+||.||++.++.+|..+|||.+++    +....++..|+.+++++..|+++++||.+.....+++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            5678999999999999999999999999999865    344567889999999999999999999988888999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +.+....+......++++..+..++++.+.+|+|||...-+|||||+.||+++.+|. .||.|||.+-.+..........
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~-AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI-AKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-hhhhhccccchhhhhHHhhCcc
Confidence            966666666666678999999999999999999999999999999999999999998 9999999997666555566666


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .|+|-|||||++..- .|+..+||||||+...+|..|+.||.+..+-.   .++-.-..++    |-             
T Consensus       190 IGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PP----PT-------------  248 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPP----PT-------------  248 (502)
T ss_pred             ccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCC----CC-------------
Confidence            799999999998877 58999999999999999999999997654321   1111111111    10             


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCCC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD  293 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~~  293 (293)
                             -..+...+.++.++|++||-.+|++|.|+.+++.|||+++-+-||
T Consensus       249 -------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  249 -------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             -------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence                   011334578899999999999999999999999999999887664

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.4e-42  Score=285.83  Aligned_cols=255  Identities=27%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |...+.||+|++|.||++.+..++..+++|++...... ......+.+|+++++.++|||++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            45668899999999999999889999999998644322 22335678899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.+++...+.... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+......    ..
T Consensus       103 ~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~-~kL~dfg~~~~~~~~----~~  176 (313)
T cd06633         103 CLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASKSSPA----NS  176 (313)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC-EEEeecCCCcccCCC----CC
Confidence            9998887775543 35788899999999999999999999999999999999998887 999999988643221    22


Q ss_pred             cCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+.....  +                
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~----------------  238 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--P----------------  238 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--C----------------
Confidence            347788999998742  34578899999999999999999999987655444443321000  0                


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                ......++..+.+++.+||+.+|.+||++.++++||||+.-+
T Consensus       239 ----------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         239 ----------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                      001123567789999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.1e-42  Score=280.61  Aligned_cols=247  Identities=24%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||+|++|.||++... ++..+++|.+....   ...+.+.+|+.++++++|+|++++++.+...+..++++|+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4899999999999999999865 55679999875322   2346788999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +. +++.+.+........++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc-EEECCCccceecCCCceecc
Confidence            97 56666665555556788889999999999999999999999999999999998887 9999999997664322111 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.....                  
T Consensus       162 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------  222 (261)
T cd05072         162 EGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR------------------  222 (261)
T ss_pred             CCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            112245679999987655 68889999999999999998 9999987766655555432100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ......++.++.+++.+|+..+|++||+++++++
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -----------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0111236788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.2e-42  Score=279.44  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|+++++||+|++|.||+|... +++.+++|.+....   .....+.+|+.++++++|||++++++++. .+..++++|+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             HceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4889999999999999999865 56789999875332   23467889999999999999999999874 4578999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      +. +++.+.+.......++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC-EEEccCcceeecCCCCcccc
Confidence            97 56666665555556888899999999999999999999999999999999998887 99999999876542211 11


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+... .++.++|+||||+++|++++ |..||.+.+..+....+......                 
T Consensus       161 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  222 (260)
T cd05067         161 EGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-----------------  222 (260)
T ss_pred             cCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------------
Confidence            122245679999977655 68899999999999999998 99999887766655554221100                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ..+...+.++.+++.+||+.+|++||+++++++
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                        112335778999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-42  Score=280.86  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||+||+|....+   ...+++|.++... .......+.+|+.++++++|||++++++++...+..+++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            488999999999999999987643   4578999875332 233345678899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++++..+..........+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV-CKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC-EEECccchhhcccccccc
Confidence            9999865554443333336788899999999999999999999999999999999998887 999999999876422222


Q ss_pred             ee--ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 YT--IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ..  ...+++.|+|||.+.+. .++.++|+||||+++|++++ |..||...........+......              
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------  227 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL--------------  227 (266)
T ss_pred             eeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence            11  12245679999987655 68899999999999999998 99999877666555444321000              


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                     ..+...+..+.+++.+|++.+|++||++.+++++
T Consensus       228 ---------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 ---------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                           0122457889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-42  Score=280.16  Aligned_cols=246  Identities=25%  Similarity=0.330  Sum_probs=201.1

Q ss_pred             eeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            6 EVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      +.||+|++|.||++.+...   +..+++|.+....... ....+.+|+++++.+.|+|++++++++......+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4799999999999998765   8899999986543332 45788899999999999999999999999999999999996


Q ss_pred             -cchHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           83 -FDLLHFMKTEP-------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        83 -~~~~~~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                       +++.+.+....       ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc-EEEcccccccccccc
Confidence             55555554431       356889999999999999999999999999999999999999887 999999999876543


Q ss_pred             C--cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          155 L--ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       155 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .  .......+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+...              
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------  223 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------------  223 (262)
T ss_pred             cccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            2  112233367789999987766 68999999999999999999 59999888766665555320              


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                     .....+..++.++.+++.+||+.||++|||+.+++++
T Consensus       224 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 ---------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ---------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                           0111233457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=308.67  Aligned_cols=248  Identities=25%  Similarity=0.337  Sum_probs=199.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeee-ee---cCC---
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNV-QS---SVD---   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~---~~~---   72 (293)
                      |.+|.+.|.+|||+.||+|.+...|..||+|++-..  .+...+.+.+|++++++|. |+|||.+++. ..   .++   
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            568999999999999999999888899999988443  4556678999999999996 9999999993 21   112   


Q ss_pred             cceeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154           73 SIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus        73 ~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      .+.|+||||. |++.+++.++-...+.+..+++|+.|+++|+++||...  ++|||||-+|||++.+++ .||||||.++
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~-~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN-YKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC-EEeCcccccc
Confidence            4779999999 79999998887778999999999999999999999997  999999999999999998 9999999987


Q ss_pred             cCCCCCccee---------ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 038154          150 PIDVPLENYT---------IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       150 ~~~~~~~~~~---------~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      -.-.......         ....|+.|+|||.+.-  ....+.++|||+|||+||.|+....||.....-.++..-+   
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y---  271 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY---  271 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc---
Confidence            5433321111         1126789999998743  3368999999999999999999999997642222111100   


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                   .-.-.+.++..+.+||+.||+.||.+||++-+++.+
T Consensus       272 -----------------------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  272 -----------------------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -----------------------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                                         001123578899999999999999999999999874

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=277.38  Aligned_cols=247  Identities=24%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++... ++..+++|.++...   .....+.+|++++++++|||++++++++...+..+++||+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             heeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4889999999999999999865 45679999875432   2346788999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ +++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI-CKVADFGLARVIKEDIYEAR  161 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC-EEECCcceEEEccCCccccc
Confidence            96 56666665554456788899999999999999999999999999999999998887 99999999876653211111


Q ss_pred             -ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 -IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ....+..|+|||...+. .++.++|+||||+++++|++ |..||.+.+.......+.....                  
T Consensus       162 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------  222 (261)
T cd05068         162 EGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------------  222 (261)
T ss_pred             CCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence             11123579999977655 68999999999999999999 9999988776655554422100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 .......+..+.+++.+|++.||.+||++.+++.
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 -----------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                       0112235788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.8e-42  Score=278.80  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=191.4

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcch
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDL   85 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (293)
                      +.||+|++|.||++.+..+++.+++|.+... ........+.+|+++++++.||||+++++++......++||||+++..
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4699999999999999889999999987432 222334678899999999999999999999999999999999998654


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce--eccCc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--TIKGG  163 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~  163 (293)
                      +..........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........  .....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc-EEECccccCcccccccccccCCCCCC
Confidence            44333333335788899999999999999999999999999999999998887 9999999987543221111  11112


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      +..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+.......+.....                       
T Consensus       159 ~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-----------------------  214 (252)
T cd05084         159 PVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-----------------------  214 (252)
T ss_pred             ceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------------------
Confidence            3569999987655 58899999999999999998 8899977655544333321000                       


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                            ...+...+.++.+++.+||+.||++|||+.+++.
T Consensus       215 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 ------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  0112235778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-42  Score=294.95  Aligned_cols=251  Identities=20%  Similarity=0.281  Sum_probs=193.4

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++++.||+|+||.||++.+..     ++..||+|++..... ......+.+|+++++.+ +|+||+++++++...+..
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            48899999999999999997533     345799998854322 23345688899999999 899999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCC------------------------------------------------------------
Q 038154           75 DLVFENLD-FDLLHFMKTEP------------------------------------------------------------   93 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~------------------------------------------------------------   93 (293)
                      ++||||+. |++.+.+....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999998 45555543211                                                            


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce--eccCc
Q 038154           94 --------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--TIKGG  163 (293)
Q Consensus        94 --------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~  163 (293)
                              ...+++..+++++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.+..........  ....+
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~-~kL~DfGla~~~~~~~~~~~~~~~~~  276 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV-AKICDFGLARDIMNDSNYVVKGNARL  276 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe-EEEeeceeeeeccCCcceeeccCCCC
Confidence                    124677788999999999999999999999999999999998776 9999999987654322111  11124


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      ++.|+|||++.+. .++.++|+||||+++|+|++ |..||..................+                     
T Consensus       277 ~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~---------------------  334 (374)
T cd05106         277 PVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------------  334 (374)
T ss_pred             ccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc---------------------
Confidence            5679999988665 68999999999999999997 999998765544333332211000                     


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                             ..+...++++.+++.+||+.||.+|||+.++++
T Consensus       335 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 -------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   011235789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=269.30  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ++..||.|.+|+|++++...+|...|||.+..... .+..+++...+.+...- .+|+|++++|+|..+..+.+.||.+.
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            45679999999999999999999999999965443 33345666667766655 48999999999999999999999886


Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      --.-..+. .-..++++..+-++...+..||.||.++ |++|||+||+||++|..|+ +||+|||.+-.+.....+..+.
T Consensus       175 ~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn-iKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  175 TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC-EEeecccccceeeccccccccc
Confidence            43322222 2233588888999999999999999965 8999999999999999999 9999999997665544443333


Q ss_pred             CccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          162 GGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       162 ~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                       |-+.|||||.+..  ...|+.++||||||+.++++.||++||...+.+ +++.++.. ...+.                
T Consensus       253 -GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~----------------  314 (391)
T KOG0983|consen  253 -GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPL----------------  314 (391)
T ss_pred             -CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCC----------------
Confidence             7789999998854  457889999999999999999999999986554 55555543 11111                


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                ..-..+.|+.+.+++..||..|+++||...++|+|||+....
T Consensus       315 ----------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 ----------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ----------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                      111223789999999999999999999999999999998764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-42  Score=283.48  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=195.9

Q ss_pred             eeeeeeccccceeEEEEEeC----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            3 TLLEVIREGRYGAVHRAHDS----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .+.+.||.|+||.||+|...    ..+..|+||.++. .........+.+|++.+++++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            46799999999999999876    4567799998843 222233578999999999999999999999999888899999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+. |++.+.+.......+++..+..++.||+.||.|||+++++|++|+++||+++.++. +||+|||.+.........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~-~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ-VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE-EEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            9998 56777777775667899999999999999999999999999999999999998886 999999999876322122


Q ss_pred             --eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 --YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                        .........|+|||.+... .++.++||||||+++|++++ |..||...+..+....+...                 
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-----------------  221 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-----------------  221 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-----------------
T ss_pred             ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-----------------
Confidence              1222256789999987665 48999999999999999999 67999888777766666331                 


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  .....+..++..+.+++.+|+..||.+|||+.++++
T Consensus       222 ------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 ------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                        112233456888999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=317.16  Aligned_cols=260  Identities=23%  Similarity=0.336  Sum_probs=220.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |.|+++||+|+||.|.+++++.+++.||+|++...... -....-|..|-.+|..-+.+.|++++..|.++.++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            78999999999999999999999999999998663322 23335677888999888899999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-Ccce
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENY  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-~~~~  158 (293)
                      ++ |+++..+....  .+++..++.++..+..||..||+.|+|||||||+||++|..|+ +||+|||.+-.+..+ .-.+
T Consensus       157 ~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-ikLADFGsClkm~~dG~V~s  233 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-IKLADFGSCLKMDADGTVRS  233 (1317)
T ss_pred             ccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-EeeccchhHHhcCCCCcEEe
Confidence            98 56666665544  6888999999999999999999999999999999999999999 999999999888643 3445


Q ss_pred             eccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          159 TIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ....|||.|++||++..    .+.|+...|.||+|+++|+|+.|..||-+.+--+...+|+.-...              
T Consensus       234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~--------------  299 (1317)
T KOG0612|consen  234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES--------------  299 (1317)
T ss_pred             ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh--------------
Confidence            56669999999998843    257899999999999999999999999999888888888753111              


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC---HHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~p~~~~~~~  291 (293)
                       +.|          + -...+|+++.+||.+.++ +|+.|..   ++++-.||||..+.|
T Consensus       300 -l~F----------P-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  300 -LSF----------P-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             -cCC----------C-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence             000          0 112379999999999988 8998888   999999999999887

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=277.74  Aligned_cols=247  Identities=25%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++... ++..+++|.+....   .....+.+|+.++++++|||++++++++......+++||+
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            5899999999999999999865 45779999875332   2346788999999999999999999999998999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +++ ++.+.+.......++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV-CKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC-EEECccccceeccchhhhhh
Confidence            985 5666666555456888899999999999999999999999999999999998887 999999998766432111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+..|+|||.+.+. .++.++|+||||++++++++ |..||.+.+.......+.....                  
T Consensus       162 ~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------  222 (261)
T cd05034         162 EGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------------------  222 (261)
T ss_pred             hccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            111234679999987755 68899999999999999998 9999988776666655532110                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+...+.++.+++.+|++.+|.+||+++++++
T Consensus       223 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         223 -----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       0112234678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=274.40  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=209.1

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC----CcceeEeec
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV----DSIDLVFEN   80 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~~~lv~e~   80 (293)
                      ++||-|-.|.|-.+.++.+++.+|+|++.-       ....++|+++--.. .|||||.+++++++.    ..+.+|||.
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            689999999999999999999999998731       14566788876655 699999999987543    457799999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      ++ |.+...+++++...+.+..+..|++||+.|++|||+.+|.||||||+|++....+.  .+||+|||+++.-.++ ..
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-~~  219 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-GD  219 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC-cc
Confidence            98 68889999999999999999999999999999999999999999999999986543  6899999999876553 34


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA----PGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ...++-||.|.|||++... .++...|+||+|+++|-|++|..||-....    +.+..+|......++.          
T Consensus       220 L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~----------  288 (400)
T KOG0604|consen  220 LMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE----------  288 (400)
T ss_pred             ccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC----------
Confidence            4556689999999977655 799999999999999999999999965432    3344444433333332          


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCCC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD  293 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~~  293 (293)
                                      ..|..+|++.+++|+++|.++|++|.|+.++++|||+...+.+|
T Consensus       289 ----------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  289 ----------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             ----------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence                            33445789999999999999999999999999999999876654

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-41  Score=278.43  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=200.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|..+++|.++...... .....+.+|++++++++|++++++++++...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            5899999999999999999998899999999886433322 335678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDF-DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+++ ++...+..  .....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~-~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc-EEEeccceeeeccCCCc
Confidence            9985 45444432  23345788899999999999999999999999999999999998888 99999999876554433


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP--GLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......  .....+...                 
T Consensus       162 ~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------  223 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-----------------  223 (267)
T ss_pred             ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-----------------
Confidence            33334578889999987755 6889999999999999999999999654321  111111100                 


Q ss_pred             ccCCCCCCCcccchhhhc-CCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVV-GGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  .....+ +..+..+.+++.+||..+|++|||+.+|++
T Consensus       224 ------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 ------------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                        000011 145678999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-42  Score=283.17  Aligned_cols=241  Identities=14%  Similarity=0.157  Sum_probs=192.1

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeec----CCcceeEeec
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSS----VDSIDLVFEN   80 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~   80 (293)
                      ..+++|+++.||++..  +|+.||+|.+....... ...+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5789999999999965  68899999986543222 123567799999999999999999998866    3468999999


Q ss_pred             CCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++|+ +.+.+.+..  .+++.....++.|++.||.+||+. +++|+||+|+||+++.++. +||+|||.+.......   
T Consensus       104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~-~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc-EEEcccchHhhhcccc---
Confidence            9965 445554432  467778999999999999999984 9999999999999999887 9999999987654321   


Q ss_pred             eccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.+.+..+....+......+                
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  241 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------------  241 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence            123377899999988652 468999999999999999999999999887666655543211111                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ..+...++++.+++.+||+.||.+|||+.+++.
T Consensus       242 ------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 ------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                        112246788999999999999999999999987

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-41  Score=284.79  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=206.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |...+.||+|++|.||++.+..++..+++|++..... .......+..|+++++.++|||++++++++..+...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            6778899999999999999888999999998854322 223345688899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.|++.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......    ..
T Consensus       107 ~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~-~kl~dfg~~~~~~~~----~~  180 (317)
T cd06635         107 CLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASIASPA----NS  180 (317)
T ss_pred             CCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC-EEEecCCCccccCCc----cc
Confidence            999887766543 335788899999999999999999999999999999999998887 999999988654322    22


Q ss_pred             cCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..+++.|+|||.+.  .....+.++|+||||+++|+|++|..||...+.......+.......                 
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  243 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-----------------  243 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-----------------
Confidence            34778899999874  23457899999999999999999999998765555444443211100                 


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ......++.+.+++.+||+.+|.+||++.++++|+|+..-
T Consensus       244 -----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 -----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                       0112356789999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-41  Score=278.26  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=191.2

Q ss_pred             ceeeeee--ccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVI--REGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~l--g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |++.+.+  |+|++|.||++.++.++..+++|.+.......       .|+.....+ +|||++++++.+..++..++||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            4555555  99999999999999999999999875432111       122223222 6999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+++ ++.+.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++..++|+|||.+.......  
T Consensus        89 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         89 DYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence            99985 5555554443  678999999999999999999999999999999999999888349999999887654321  


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-LAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                        ...++..|+|||++.+. .++.++|+||+|+++|+|++|..||........ ...+.....                 
T Consensus       165 --~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  224 (267)
T PHA03390        165 --CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-----------------  224 (267)
T ss_pred             --cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-----------------
Confidence              22378899999988765 578999999999999999999999986544332 112111000                 


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-HHHHhcCccccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-AREALRHEYFKD  288 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~p~~~~  288 (293)
                                ......+..++.+.++|.+||+.||.+||+ .+++|+||||++
T Consensus       225 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 ----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                      000122357889999999999999999996 599999999974

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-42  Score=277.75  Aligned_cols=247  Identities=20%  Similarity=0.252  Sum_probs=195.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+. ++..+++|.+....   .....+.+|+++++.++|||++++++++...+..++|+|+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3788999999999999999876 45679999875322   2235688899999999999999999999999999999999


Q ss_pred             CCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++|. +.+.+.... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV-VKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc-EEECCcccceeccccccccc
Confidence            9854 555554433 36788899999999999999999999999999999999998887 99999998876543211111


Q ss_pred             -ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 -IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||...+..+....+.....                  
T Consensus       159 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------  219 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------------  219 (256)
T ss_pred             CCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------------
Confidence             11133579999987765 68899999999999999999 7899987666555444321100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ...+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 -----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 -----------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                       01122367899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.7e-42  Score=280.81  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=197.0

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|.+.+.||+|++|.||+|....     .+..+++|.+.... .......+..|+.+++.++|+|++++++++...+..+
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            47899999999999999998876     67788999775322 1222356888999999999999999999999989999


Q ss_pred             eEeecCCc-chHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC--CeEEEccCCC
Q 038154           76 LVFENLDF-DLLHFMKTEP-----TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK--DIVKIADFGL  147 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~  147 (293)
                      ++||++.| ++.+.+....     ...+++..+..++.||+.||++||++|++|+||+|+||+++.++  ..++|+|||.
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            99999975 5555554332     12478889999999999999999999999999999999998654  2489999999


Q ss_pred             cccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +..........  .....+..|+|||++.+. .++.++||||||+++|+|++ |..||...+.++....+.....     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-----  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-----  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-----
Confidence            87653221111  111134579999988765 68999999999999999997 9999988776665544322100     


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                              ...+..++..+.+++.+|++.||++|||+.++++|
T Consensus       240 ------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 ------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    01123467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-41  Score=277.20  Aligned_cols=246  Identities=25%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||+|++|.||++... .+..+++|.+.....   ....+.+|+.++++++|++++++++++.. ...+++||+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            5889999999999999999766 456799998754322   23578899999999999999999998754 568899999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +++ ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~-~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV-CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce-EEeCCceeeeeccCcccccc
Confidence            985 5556665544456788899999999999999999999999999999999998776 9999999987654322111 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+.+..+....+.....                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------  221 (260)
T cd05070         161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------------  221 (260)
T ss_pred             cCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            111245579999977654 68899999999999999999 8899987766655554421100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+...+..+.+++.+||..||.+|||+.++.+
T Consensus       222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 -----------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                       0112345778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=273.93  Aligned_cols=258  Identities=25%  Similarity=0.356  Sum_probs=206.2

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeecCC-c
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLD-F   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~-~   83 (293)
                      +.||+|+++.|-.+.+..+|..||||++.+.  ......++.+|++++.+.+ |+||++++++|+++..+|+|||.+. |
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            6799999999999999999999999998543  4456688999999999995 9999999999999999999999997 6


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcce---
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENY---  158 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~~---  158 (293)
                      .++..++++.  .+++..+.++.++|+.||.+||++||.|+||||+||+-..-..  -|||+||++...........   
T Consensus       162 plLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  162 PLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             hHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            7777777654  4889999999999999999999999999999999999875443  48999998876554332222   


Q ss_pred             ----eccCccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHhC
Q 038154          159 ----TIKGGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-----------PGLLAAIFSIMG  219 (293)
Q Consensus       159 ----~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~  219 (293)
                          ..+.|+..|||||+..    ....|+.+.|.||||+|+|-|++|..||.+...           ..-.++++.-+.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence                2233667899999874    234688999999999999999999999965322           122333332111


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .-                      .......-|..+|.+..++++.+|..|+.+|.++.+++.|||++..
T Consensus       320 EG----------------------kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  320 EG----------------------KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             cc----------------------CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            11                      1112223455689999999999999999999999999999999865

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.4e-42  Score=280.92  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=194.1

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||++...     ..+..+++|++.... .......+.+|+.+++.++|||++++++++......+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            5899999999999999998754     235679999874322 1122346788999999999999999999999999999


Q ss_pred             eEeecCCcchH-HHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLDFDLL-HFMKTEP--------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~~~~~-~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      +||||++++.+ +++....        ....+...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~-~~l~dfg  164 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC-EEECCCC
Confidence            99999985544 4443321        123466788899999999999999999999999999999998887 9999999


Q ss_pred             CcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+..........  ....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||...+.......+.....    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----  239 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL----  239 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc----
Confidence            987553321111  112246679999987765 68999999999999999999 6899987766655544422100    


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                               ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       240 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 -------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     01122356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.6e-42  Score=285.20  Aligned_cols=255  Identities=26%  Similarity=0.336  Sum_probs=205.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|...+.||+|++|.||++.+..++..+++|.+..... .......+.+|+++++.++|+|++++.+++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            36677899999999999999988999999998854322 22334567789999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|++...+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......    .
T Consensus        96 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~----~  169 (308)
T cd06634          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPA----N  169 (308)
T ss_pred             ccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc-EEECCcccceeecCc----c
Confidence            99988777665433 34788899999999999999999999999999999999998877 999999988765432    1


Q ss_pred             ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...+++.|+|||.+.+  ...++.++|+||||+++|+|++|..||...+..+....+.....                  
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------  231 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------------  231 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC------------------
Confidence            2236788999998742  34578899999999999999999999977654443333321000                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                .......++..+.++|.+||+.+|.+||++.++++|||+.+-
T Consensus       232 ----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 ----------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ----------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                      000122467789999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-41  Score=281.34  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=195.6

Q ss_pred             ceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      |.+.+.||+|++|+||++..     ..++..+++|.+...  .......+.+|++++++++||+++++++++...+..++
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            78899999999999999974     234556888877432  22334578899999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEcc
Q 038154           77 VFENLDF-DLLHFMKTEP-----------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIAD  144 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~d  144 (293)
                      ++||+++ ++.+++....           ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-~kl~d  163 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKIGD  163 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-EEecc
Confidence            9999985 4445544322           234788899999999999999999999999999999999998887 99999


Q ss_pred             CCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 038154          145 FGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       145 f~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      ||.+..........  ....+++.|+|||++.+. .++.++|+||||+++++|++ |..||...+..+....+.....  
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~--  240 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--  240 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            99987654322111  112245679999987765 68999999999999999998 8999987776665555432100  


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                                 .......+.++.+++.+||+.||.+|||+.++++
T Consensus       241 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 ---------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                       0112235778999999999999999999999966

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.1e-42  Score=281.70  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|.+.+.||+|++|.||++...     ..+..+++|.+..... ......+.+|+++++.+.|||++++++++......+
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            4788899999999999999764     3357899998754322 223468889999999999999999999999999999


Q ss_pred             eEeecCCcc-hHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEE
Q 038154           76 LVFENLDFD-LLHFMKTEP------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKI  142 (293)
Q Consensus        76 lv~e~~~~~-~~~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l  142 (293)
                      ++|||+++. +.+.+....            ...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~kl  163 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-VKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-EEE
Confidence            999999854 444543321            234677789999999999999999999999999999999998887 999


Q ss_pred             ccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 038154          143 ADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMG  219 (293)
Q Consensus       143 ~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (293)
                      +|||.+.........  .....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+...  
T Consensus       164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--  240 (280)
T cd05049         164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--  240 (280)
T ss_pred             CCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--
Confidence            999998754322111  1122246789999988765 68999999999999999998 99999877666655554310  


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                                 .....+...+..+.+++.+||+.||.+||++.++++
T Consensus       241 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 ---------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ---------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                       001112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-41  Score=285.34  Aligned_cols=249  Identities=20%  Similarity=0.318  Sum_probs=194.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCe----EEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDT----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      .|++.+.||+|++|.||+|....++..    +++|+++.. ........+.+|+.+++.+.||||+++++++... ..++
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            489999999999999999987655554    899987532 2223346788899999999999999999998764 5778


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++++. |++.+.+.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||.+.......
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~-~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc-EEEccccccccccCCC
Confidence            999998 55666665443 35778889999999999999999999999999999999998887 9999999998765433


Q ss_pred             cceec--cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENYTI--KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .....  ...+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+....... ...            
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~------------  229 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GER------------  229 (316)
T ss_pred             cceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-CCC------------
Confidence            32221  1235679999987665 68999999999999999997 9999987655544332211 000            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                      ...++..+.++.+++.+|+..||++||++.+++.+
T Consensus       230 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 ----------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            01122356788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-41  Score=276.44  Aligned_cols=242  Identities=22%  Similarity=0.320  Sum_probs=191.9

Q ss_pred             eeccccceeEEEEEe--CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            7 VIREGRYGAVHRAHD--SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      .||+|++|.||+|..  ..++..+++|++..........+.+..|+.+++.+.|||++++++++.. ...++|||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999853  4567889999886544334445678889999999999999999998754 5678999999855


Q ss_pred             -hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec---
Q 038154           85 -LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI---  160 (293)
Q Consensus        85 -~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~---  160 (293)
                       +.+.+...  ..+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+............   
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY-AKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe-EEECCCccccccCCCCCeeeecCC
Confidence             55555443  25788899999999999999999999999999999999998877 999999999766543222111   


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..++..|+|||.+... .++.++|+||||+++|+|++ |..||.+.+..+....+....                     
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~---------------------  215 (257)
T cd05116         158 GKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE---------------------  215 (257)
T ss_pred             CCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC---------------------
Confidence            1134689999977544 68899999999999999998 999998877666555553210                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                              ....+..+++++.++|.+|++.||++||++.+|..
T Consensus       216 --------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 --------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                    01123347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.5e-41  Score=274.97  Aligned_cols=246  Identities=26%  Similarity=0.320  Sum_probs=195.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+ ..+++|.+....   .....+.+|+++++++.||+++++++++.. +..+++||+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            589999999999999999987654 458999764322   233578889999999999999999998754 568899999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +.+ ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~-~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV-CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe-EEECCCccceEccCCccccc
Confidence            985 6777776555455788899999999999999999999999999999999998887 9999999987654322111 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+....+....+.....                  
T Consensus       161 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------  221 (260)
T cd05069         161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------------------  221 (260)
T ss_pred             CCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            122255679999977655 68999999999999999999 8999988766555444422100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+...+..+.+++.+||..||.+||+++++++
T Consensus       222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 -----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0112245788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=278.92  Aligned_cols=251  Identities=22%  Similarity=0.251  Sum_probs=195.0

Q ss_pred             ceeeeeeccccceeEEEEEeCC---CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-----
Q 038154            2 YTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-----   73 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   73 (293)
                      |.+++.||+|++|.||+|....   .+..+|+|.++...........+.+|++.++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6789999999999999998654   34789999986544444445678899999999999999999998755443     


Q ss_pred             -ceeEeecCCc-chHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           74 -IDLVFENLDF-DLLHFMKT----EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        74 -~~lv~e~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                       .++++||+.+ ++...+..    .....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe-EEECCccc
Confidence             7999999985 44444422    22345788889999999999999999999999999999999998877 99999999


Q ss_pred             cccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +.........  ......+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+....+....      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN------  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            8765432211  1112245679999987655 68999999999999999999 889998776655544432200      


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                             ....+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   011223467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-41  Score=277.46  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|++|.||+|.+..++.   .+++|.++... .......+.+|+.++++++|||++++++++..++..+++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            58999999999999999998764443   68898875422 223345788899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+++++.+..........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe-EEeCCCCcccccccccce
Confidence            9999865444443333345788899999999999999999999999999999999998887 999999998766543222


Q ss_pred             eec---cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTI---KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ...   ..++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+.....              
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------------  227 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR--------------  227 (267)
T ss_pred             eeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--------------
Confidence            111   1124579999988665 68999999999999999886 9999987766555444422100              


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                     ......+++.+.+++.+|++.+|.+||++.++++
T Consensus       228 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 ---------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                           0112345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-41  Score=308.78  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=194.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++.++||+|++|.||+|.+..+|+.||+|++....... ....++.+|++++++++|||++++++++.+++..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            7999999999999999999999999999999986433222 234568889999999999999999999999999999999


Q ss_pred             cCCcchHH-HhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154           80 NLDFDLLH-FMKTE---------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus        80 ~~~~~~~~-~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      |++|+.+. .+...         .....+...+..++.||+.||++||+.|++||||||+||+++.++. ++|+|||.+.
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~-vKLiDFGLAk  161 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE-VVILDWGAAI  161 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC-EEEEecCcce
Confidence            99865544 44321         1123455678889999999999999999999999999999998888 9999999987


Q ss_pred             cCCCCC------------------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH
Q 038154          150 PIDVPL------------------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL  211 (293)
Q Consensus       150 ~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  211 (293)
                      ......                  .......|++.|+|||++.+. .++.++|+||||+++|+|++|..||.........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            652110                  001112488999999988766 6899999999999999999999999764433222


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ....  ...+                        ... .-...+++.+.+++.+||..||++||+..+.+.
T Consensus       241 ~~~~--i~~P------------------------~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        241 YRDV--ILSP------------------------IEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhh--ccCh------------------------hhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1100  0000                        000 011357788999999999999999987665554

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.2e-41  Score=281.29  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++.+.||+|++|.||++.+..++..+++|.++..... .....+..|+.++.+. .|||++++++++......+++||+
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            78899999999999999998888999999998643322 2234556677766666 499999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++.+...+.... ..+++..+..++.|++.+|+|||+ .|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus        96 ~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~-~kL~dfg~~~~~~~~~~~-~  172 (296)
T cd06618          96 MSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN-VKLCDFGISGRLVDSKAK-T  172 (296)
T ss_pred             cCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC-EEECccccchhccCCCcc-c
Confidence            9886665554433 367888899999999999999997 59999999999999998887 999999998765432221 2


Q ss_pred             ccCccccccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          160 IKGGSLCYKAPERLLGS---GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ...+++.|+|||.+.+.   +.++.++|+||||+++|+|++|..||...... +....+....  ..  ..         
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~--~~---------  239 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PP--SL---------  239 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CC--CC---------
Confidence            22367789999987644   34788999999999999999999999764332 2222222100  00  00         


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                    .....++.++.+++.+||..||.+||++.+++.||||..++.
T Consensus       240 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         240 --------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                          001135778999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-41  Score=281.58  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=194.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC--eEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|++|.||++..+.++.  .+++|.++.. ........+.+|++++.++ .|||++++++++...+..+++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            48999999999999999998776664  4677776522 2222345688899999999 799999999999999999999


Q ss_pred             eecCC-cchHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEE
Q 038154           78 FENLD-FDLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKI  142 (293)
Q Consensus        78 ~e~~~-~~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l  142 (293)
                      +||++ +++.+.+....              ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-SKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe-EEE
Confidence            99998 45555654322              124677889999999999999999999999999999999998877 999


Q ss_pred             ccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 038154          143 ADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       143 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      +|||.+........ ......+..|+|||+..+. .++.++||||||+++|+|++ |..||......+....+....   
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~---  235 (297)
T cd05089         161 ADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  235 (297)
T ss_pred             CCcCCCccccceec-cCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---
Confidence            99998864322111 1111234569999977655 68899999999999999997 999998877766555442100   


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                ....+..++.++.+++.+||+.||.+|||+++++..
T Consensus       236 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 --------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      001223467889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=274.28  Aligned_cols=245  Identities=27%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC-cch
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDL   85 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~   85 (293)
                      ||.|++|.||++.+..++..+++|.+....... .....+..|+++++++.||+++++++.+..+...+++||+++ +++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999988889999999986543322 244578889999999999999999999999999999999995 566


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                      .+.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..............++.
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc-EEEeecCcceecccCCCcccCCcCCc
Confidence            56665443  4788899999999999999999999999999999999998887 99999999877654433333344778


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      .|+|||...+. .++.++|+||||+++|++++|..||...........+..  .                          
T Consensus       158 ~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~--------------------------  208 (250)
T cd05123         158 EYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D--------------------------  208 (250)
T ss_pred             cccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C--------------------------
Confidence            89999987665 578899999999999999999999987665454444432  0                          


Q ss_pred             cchhhhcCCCCchHHHHHHHhhccCCCCCCCH---HHHhcCccc
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA---REALRHEYF  286 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~~p~~  286 (293)
                        ....+...+..+.+++.+||..||++||++   +++++||||
T Consensus       209 --~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 --PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence              011223347889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-41  Score=276.88  Aligned_cols=251  Identities=22%  Similarity=0.270  Sum_probs=193.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCC--eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Cc
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DS   73 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   73 (293)
                      +.+++.||+|++|.||++....++.  .+++|.++...........+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999998776665  589998765444444456788899999999999999999876332      24


Q ss_pred             ceeEeecCCc-chHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCc
Q 038154           74 IDLVFENLDF-DLLHFMKT----EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA  148 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~  148 (293)
                      .++++||+.+ ++...+..    .....+++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||.+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC-EEECCCCcc
Confidence            6899999984 54444422    22344788899999999999999999999999999999999998887 999999998


Q ss_pred             ccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCC
Q 038154          149 RPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSET  225 (293)
Q Consensus       149 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (293)
                      .........  ......++.|++||.+.+. .++.++|+||||+++|+|++ |..||......+....+.....      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            866432211  1122356679999987665 68999999999999999999 7899987655544443321000      


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                             ....+.++..+.+++.+||+.||++|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   01123457789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=278.03  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=198.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..++..+++|.+...... ......+.+|+++++.+.|||++++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            488899999999999999998889999999987543322 2233577889999999999999999999999999999999


Q ss_pred             cCCcchH-HHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLL-HFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++++..+ +.+..  .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEECcchhhhccccCCc
Confidence            9986544 44432  22345788899999999999999999999999999999999998887 99999998876654333


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP--GLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....+  .....+....  .             
T Consensus       162 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-------------  225 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--Y-------------  225 (267)
T ss_pred             ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--C-------------
Confidence            33334478899999988665 5788999999999999999999999654332  1111111000  0             


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                   ........+.++.+++.+||..||++|||+.+|+.
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 -------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                         00011235778999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-41  Score=281.22  Aligned_cols=251  Identities=26%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCC-----CCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT-----GDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|++|.||++.....     ...+++|.+.... .......+.+|+++++++ +||||+++++++..++..
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            588999999999999999986533     3678999875432 222335678899999999 799999999999999999


Q ss_pred             eeEeecCCc-chHHHhhc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe
Q 038154           75 DLVFENLDF-DLLHFMKT--------------EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~--------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                      +++|||+.+ ++...+..              .....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. 
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~-  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe-
Confidence            999999985 55555533              22345778899999999999999999999999999999999998887 


Q ss_pred             EEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 038154          140 VKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFS  216 (293)
Q Consensus       140 v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~  216 (293)
                      ++|+|||.+.........  .....++..|+|||++.+. .++.++|+||||+++|++++ |..||......+....+..
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  249 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE  249 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998765432111  1112245679999987655 68899999999999999997 9999988776665554432


Q ss_pred             HhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ...                             ...+...+.++.+++.+|++.||.+|||+.+++.+
T Consensus       250 ~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         250 GYR-----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCc-----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            100                             01122357789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=277.64  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=196.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCC-----CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT-----GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||++.....     +..+++|.+.... .......+.+|+++++.++|||++++++++......+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            588999999999999999987543     3789999875332 2222356788999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLDF-DLLHFMKTEP--------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      ++||++++ ++.+.+....        ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~-~kl~dfg  164 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-VKIGDFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC-EEECCcc
Confidence            99999984 5555554321        223577789999999999999999999999999999999999888 9999999


Q ss_pred             CcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+........  ......++..|+|||.+.+. .++.++|+||||+++|++++ |..||...+..+....+..  .    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~----  237 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--G----  237 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--C----
Confidence            9875533211  11122256789999987655 58899999999999999998 8999987776665554421  0    


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                             .....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       238 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 -----------------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -----------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                   001112235788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-41  Score=277.92  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=195.0

Q ss_pred             ceeeeeeccccceeEEEEEe----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            2 YTLLEVIREGRYGAVHRAHD----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      |++.+.||+|+||+||+|..    ...+..+++|.+.... .......+.+|+++++.+.|||++++++++......|++
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            78899999999999999974    3356789999875322 222335688899999999999999999999999999999


Q ss_pred             eecCCc-chHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           78 FENLDF-DLLHFMKTEP---------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      |||+++ ++.+++....               ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-~k  164 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VK  164 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-EE
Confidence            999985 5555553221               124677788999999999999999999999999999999998877 99


Q ss_pred             EccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHh
Q 038154          142 IADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       142 l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      |+|||.+.........  .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||...........+....
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  243 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ  243 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999765432111  1122245679999987655 68999999999999999998 889997766554444442100


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                   ....+..++.++.+++.+|++.||.+||++.+++++
T Consensus       244 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         244 -----------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                                         011223467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-41  Score=273.00  Aligned_cols=242  Identities=22%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.+.||.|++|.||++..  .|+.+++|.+.....   ....+.+|+.+++.++|+|++++++++......++|||++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             ccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            78899999999999999965  478899998864332   4567889999999999999999999999889999999999


Q ss_pred             C-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 D-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      + +++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........   .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~-~~l~d~g~~~~~~~~~~---~  158 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV-AKVSDFGLAKEASQGQD---S  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC-EEEcccccccccccccc---c
Confidence            8 46666665555446888999999999999999999999999999999999998887 99999999876643222   2


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+..|+|||.+... .++.++|+||||++++++++ |..||......+....+....                     
T Consensus       159 ~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------------  216 (256)
T cd05039         159 GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------------  216 (256)
T ss_pred             CCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence            2245679999987655 68899999999999999997 999998776655544432100                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                              ....+...++++.+++.+||..+|++||++.+++.
T Consensus       217 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 --------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                    00112346789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-41  Score=286.79  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC-Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV-DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   73 (293)
                      ||++.+.||+|+||.||+|...     .+++.|++|++.... .......+..|+++++++ .|+||+++++++... ..
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            6999999999999999999643     345789999885322 222335677899999999 799999999987544 56


Q ss_pred             ceeEeecCCcchH-HHhhcCC-----------------------------------------------------------
Q 038154           74 IDLVFENLDFDLL-HFMKTEP-----------------------------------------------------------   93 (293)
Q Consensus        74 ~~lv~e~~~~~~~-~~~~~~~-----------------------------------------------------------   93 (293)
                      +++++||++++.+ +.+....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8899999985444 4443211                                                           


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--eeccCccccccCcc
Q 038154           94 TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPE  171 (293)
Q Consensus        94 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE  171 (293)
                      ...+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.+.........  .....++..|+|||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~-vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc-EEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            125678889999999999999999999999999999999998887 999999999765332211  11222456799999


Q ss_pred             cccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhh
Q 038154          172 RLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLAT  250 (293)
Q Consensus       172 ~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (293)
                      ++.+. .++.++|+|||||++|+|++ |..||.+....+...........                            ..
T Consensus       246 ~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~  296 (337)
T cd05054         246 SIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------------------------MR  296 (337)
T ss_pred             HhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC----------------------------CC
Confidence            88766 68999999999999999998 99999775444333222210000                            01


Q ss_pred             hcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          251 VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       251 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .+...++++.+++.+||+.+|++||++.+++++
T Consensus       297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            122356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-41  Score=281.57  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCe--EEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |++.+.||+|++|.||+|.+..++..  +++|.+.. .........+.+|++++.++ +|||++++++++...+..++++
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            78899999999999999998777764  46665532 12223345678899999999 8999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEc
Q 038154           79 ENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA  143 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~  143 (293)
                      ||+++ ++.+.+....              ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-~kl~  166 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIA  166 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-EEeC
Confidence            99985 5555554322              124678889999999999999999999999999999999998887 9999


Q ss_pred             cCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 038154          144 DFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPD  222 (293)
Q Consensus       144 df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  222 (293)
                      |||.+...... ........+..|+|||.+.+. .++.++|+||||+++++|+| |..||...+..+....+....    
T Consensus       167 dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----  240 (303)
T cd05088         167 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----  240 (303)
T ss_pred             ccccCcccchh-hhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC----
Confidence            99988643211 111111235679999977655 68899999999999999998 999998766655444331100    


Q ss_pred             CCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                               ....+...+.++.+++.+||+.+|++||++.+++.+
T Consensus       241 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     000112357789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=272.34  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=200.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Ccce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   75 (293)
                      .|++.+.||+|++|.||++.+..++..+++|.+......   ......+.+|++++++++|||++++++++.+.  ..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            489999999999999999999999999999987543221   22335778899999999999999999988664  4588


Q ss_pred             eEeecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +++|++++. +.+.+....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        83 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~  159 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECccccccccccc
Confidence            999999865 445554433  3677889999999999999999999999999999999998887 999999998765321


Q ss_pred             C---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          155 L---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       155 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .   .......++..|+|||.+.+. .++.++|+||||++++++++|..||......+...++..   .+          
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~----------  225 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP----------  225 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC----------
Confidence            1   111223477889999988765 588999999999999999999999987654443333321   11          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                     .....+..+++++.+++.+|+. +|.+||++.++++|||.
T Consensus       226 ---------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 ---------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                           0112344578899999999999 67999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-41  Score=279.77  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=195.8

Q ss_pred             ceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      |++.+.||+|++|.||++....     .+..+|+|++.... .......+..|+.++..++||||+++++++...+..++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            6788999999999999997643     35779999886332 22233567889999999999999999999999999999


Q ss_pred             EeecCCcchH-HHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           77 VFENLDFDLL-HFMKTE--------------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        77 v~e~~~~~~~-~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      ++|++.+..+ ..+...              ....+++..+..++.|++.||++||+.|++|+||||+||+++.++. +|
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-~k  164 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-VK  164 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-eE
Confidence            9999985444 444211              1234677788999999999999999999999999999999998877 99


Q ss_pred             EccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHh
Q 038154          142 IADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       142 l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      |+|||.+.........  .....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||.+....+....+....
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             ecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999988755332111  1122246789999988655 58899999999999999998 888998877666655553311


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .                             ...+...+..+.+++.+|++.+|.+||++.+|++
T Consensus       244 ~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         244 V-----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             c-----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            1                             1123456788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-41  Score=278.57  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=203.0

Q ss_pred             ceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcce
Q 038154            2 YTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   75 (293)
                      |++.+.||.|++|.||++.+.   .+|..+++|++.....  .......+.+|+++++++ +|++|+++++.+..+...|
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            889999999999999999864   4788999999864332  123345678899999999 5899999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +|+|++++ ++.+.+...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC-EEEeeCccceecccc
Confidence            99999985 555555543  24678889999999999999999999999999999999998887 999999988765432


Q ss_pred             C-cceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          155 L-ENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       155 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      . .......++..|+|||.+... ..++.++|+||||+++|+|++|..||...........+.......           
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------  227 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----------  227 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence            1 111223377889999987653 346789999999999999999999997543322222221111000           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                     ....+..+++.+.+++.+||+.||.+||     ++.+++.||||+++++
T Consensus       228 ---------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 ---------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                           0012234678899999999999999997     8999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.2e-41  Score=281.00  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             CceeeeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      +|.+++.||+|+||.||++.+..       ++..+++|.+.... .......+..|+++++.+ +|||++++++++...+
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            58899999999999999997532       23469999876432 233345688899999999 7999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++||||+++ ++.+++....              ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            99999999984 5666665432              12467778999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++|+|||.+..........  ....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+
T Consensus       178 ~-~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         178 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             c-EEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            7 9999999987654221111  111234679999988765 58899999999999999998 88999776655544443


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ....                             ....+...+.++.+++.+||..+|++|||+.+++++
T Consensus       256 ~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         256 KEGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HcCC-----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2100                             011223467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.8e-41  Score=272.33  Aligned_cols=242  Identities=21%  Similarity=0.349  Sum_probs=194.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee-ecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ-SSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e   79 (293)
                      .|++.+.||+|++|.||++..  .|..+++|.+..    ......+.+|+.++++++|++++++++++ ..++..++++|
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            478999999999999999964  477899998743    22345788999999999999999999875 45567899999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+++ ++.+.+.+.....+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+........  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~~--  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc-EEecCCccceeccccCC--
Confidence            9984 6666666555555788899999999999999999999999999999999998887 99999999875543221  


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+.....                  
T Consensus       158 -~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------  217 (256)
T cd05082         158 -TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------  217 (256)
T ss_pred             -CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence             22245679999987655 68899999999999999997 9999987766555544422000                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ......+++.+.+++.+|++.||++|||+.++++
T Consensus       218 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 -----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       0112346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-41  Score=273.13  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=191.8

Q ss_pred             eeeccccceeEEEEEeCCCC---CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            6 EVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ++||+|++|.||+|.....+   ..+++|.+...... .....+.+|+++++.+.|||++++++++.. ...+++||++.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            47999999999999765444   78999988644332 344678889999999999999999998764 56899999997


Q ss_pred             -cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 -FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 -~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                       +++.+.+....  .+++..+..++.|++.+|++||..|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus        79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~-~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc-EEeccccccceeecCCcccccc
Confidence             56666665544  5788899999999999999999999999999999999998887 9999999987664432222111


Q ss_pred             C---ccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          162 G---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       162 ~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .   ++..|+|||.+.+. .++.++|+||||+++|++++ |..||...+..+....+.....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------  216 (257)
T cd05060         156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------  216 (257)
T ss_pred             cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------------
Confidence            1   23579999987655 68999999999999999998 9999988766555444422100                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..++..+.+++.+||+.||.+||++.+++.
T Consensus       217 -----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       0122346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-41  Score=278.62  Aligned_cols=257  Identities=23%  Similarity=0.277  Sum_probs=195.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCC--------------CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT--------------GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN   66 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~--------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (293)
                      ||++.++||+|++|.||++.+...              ...+++|.+... ........+.+|++++++++|||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            699999999999999999976432              235899987532 22233456888999999999999999999


Q ss_pred             eeecCCcceeEeecCCcc-hHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC
Q 038154           67 VQSSVDSIDLVFENLDFD-LLHFMKTEP----------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR  135 (293)
Q Consensus        67 ~~~~~~~~~lv~e~~~~~-~~~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~  135 (293)
                      ++...+..++||||+.+. +.+.+....          ....++..+..++.|++.||++||+.|++|+||+|+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            999999999999999854 444443321          123567788999999999999999999999999999999998


Q ss_pred             CCCeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchHHH
Q 038154          136 SKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT--HQRLFHSRWAPGLL  211 (293)
Q Consensus       136 ~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~~~~  211 (293)
                      ++. ++|+|||.+.........  .....+++.|+|||++.+. .++.++|+||||+++++|++  +..||...+..+..
T Consensus       165 ~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         165 HYT-IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             CCc-EEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            877 999999998755332111  1112245689999987655 68999999999999999988  66888887766665


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .............                      ......+..++.+.+++.+|++.||++|||+++++.
T Consensus       243 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         243 ENTGEFFRNQGRQ----------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHhhhhcccc----------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5543311110000                      000112336788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-43  Score=266.85  Aligned_cols=285  Identities=33%  Similarity=0.552  Sum_probs=233.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--------Cc
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--------DS   73 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~   73 (293)
                      |+-..++|+|.||.||+|+.+.+|+.|++|+...+...........+|+.+|..|.|+|++.++++|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            4556789999999999999999999999988765555566667788899999999999999999876432        35


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +|+||++|+.++...+.+.. ..++...+.+++.++..+|.|+|...+.|||+|+.|++|+.++. ++|+|||.++.+..
T Consensus        99 ~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-lklADFGlar~fs~  176 (376)
T KOG0669|consen   99 FYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-LKLADFGLARAFST  176 (376)
T ss_pred             eeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce-EEeeccccccceec
Confidence            89999999988887776543 46888899999999999999999999999999999999999887 99999999976643


Q ss_pred             CCccee----ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          154 PLENYT----IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       154 ~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      +.....    -...|.+|++||.+.+...++++.|+|.-||++.+|+++...+.+.+....+..|....+....+.||..
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            322211    1124889999999999989999999999999999999999999999999999999999999999999988


Q ss_pred             cCcccccCCCCCCCcccchhhh-----cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATV-----VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      .+..-....+......+....+     +-.-.+++.+|+.+||..||++|+.++++++|.||.+
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            7755444332221111111111     1112468899999999999999999999999999965

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9e-41  Score=275.34  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|+||+|....+|.    .||+|++.... .......+.+|+.+++.+.|||++++++++.. ...++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            47899999999999999998766666    37899875332 22234567889999999999999999998865 45789


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++++++ |++.+.+... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~-~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc-EEECCCCceeeccccc
Confidence            999998 5666655443 335788899999999999999999999999999999999988777 9999999988665332


Q ss_pred             cceec--cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENYTI--KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .....  ..+++.|+|||...+. .++.++|+||||+++|+|++ |..||...........+.....             
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------  229 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-------------  229 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-------------
Confidence            22111  1245679999987655 68999999999999999998 8999977655554443321100             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ...+...+.++.+++.+||..||.+||++.+++.
T Consensus       230 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 ----------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            0112235778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-41  Score=277.79  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      .|.+.+.||+|++|.||++...     .++..+++|.+....  ......+.+|++++++++|||++++++++......+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            3788999999999999999743     234558888764322  222356888999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeE
Q 038154           76 LVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIV  140 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v  140 (293)
                      +||||+++ ++.+++....              ...+++..++.++.||+.||++||++|++|+||+|+||+++.++. +
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~-~  162 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-V  162 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-E
Confidence            99999985 4545554322              234678899999999999999999999999999999999998887 9


Q ss_pred             EEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 038154          141 KIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSI  217 (293)
Q Consensus       141 ~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~  217 (293)
                      +|+|||.+.........  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            99999998765433211  1122256789999987765 68899999999999999998 99999877666555443210


Q ss_pred             hCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .                             ........+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~-----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         242 R-----------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             C-----------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            0                             00112235778999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.3e-41  Score=274.13  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |++.+.||+|++|.||+|....++.   .+++|.+.... .......+..|+.+++++.|||++++++++..+...+++|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            7899999999999999998876654   59999875432 2333467889999999999999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+++++.+..+.......+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~-~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc-EEECCCccccccccCcccc
Confidence            999876555444433446788899999999999999999999999999999999998777 9999999887554322211


Q ss_pred             --eccC---ccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          159 --TIKG---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       159 --~~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                        ....   .+..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+......            
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~------------  230 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL------------  230 (269)
T ss_pred             ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence              1111   13469999987655 68999999999999999886 99999877666555544211000            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                       ..+..++..+.+++.+|+..+|++||++.+++.
T Consensus       231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 -----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             011245778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.8e-41  Score=275.82  Aligned_cols=249  Identities=23%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.++||+|++|.||++..     ..++..+++|.+...  .......+.+|+++++.++|+||+++++++...+..+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            478899999999999999964     234567888876432  2333457889999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           76 LVFENLDF-DLLHFMKTEPT-------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      +++||+++ ++.+.+.....             ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-~k  162 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-VK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC-EE
Confidence            99999985 45455443221             34678889999999999999999999999999999999998777 99


Q ss_pred             EccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHh
Q 038154          142 IADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       142 l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      |+|||.+..........  ....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+....
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            99999987553221111  111135789999987765 68999999999999999998 899998776655544442110


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .                             ...+..+++.+.+++.+||+.||.+||++.++++
T Consensus       242 ~-----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         242 E-----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             c-----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                             0112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.7e-41  Score=278.06  Aligned_cols=257  Identities=23%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC----------------CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG----------------DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL   64 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~----------------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   64 (293)
                      +|++++.||+|++|.||++.+...+                ..+++|.+..... ......+.+|+++++++.|||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            6899999999999999999866533                4578898753322 2334678889999999999999999


Q ss_pred             eeeeecCCcceeEeecCCc-chHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe
Q 038154           65 LNVQSSVDSIDLVFENLDF-DLLHFMKTEP---------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID  134 (293)
Q Consensus        65 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~  134 (293)
                      ++++..++..++++|++.+ ++...+....         ...+++..++.++.|++.||++||+.|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            9999999999999999985 4545544332         12578889999999999999999999999999999999999


Q ss_pred             CCCCeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchHH
Q 038154          135 RSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT--HQRLFHSRWAPGL  210 (293)
Q Consensus       135 ~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~~~  210 (293)
                      .++. ++|+|||.+.........  .....+++.|+|||.+.+. .++.++||||||+++|+|++  +..||...+..+.
T Consensus       165 ~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         165 KNYT-IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             CCCc-eEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            8877 999999998755332111  1122256689999987665 68999999999999999998  7789987766665


Q ss_pred             HHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          211 LAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .............                      ......+...+.++.+++.+||+.||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         243 IENAGHFFRDDGR----------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHhccccccc----------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5554321111000                      0000112345788999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-40  Score=272.84  Aligned_cols=250  Identities=20%  Similarity=0.305  Sum_probs=197.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      .|+..+.||+|++|.||+|..+.++.   .+++|.+.... .......+..|+++++++.|||++++.+++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            37888999999999999998775554   68888775322 222345688899999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++++..+..........+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE-CKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc-EEECCCccceeccccccc
Confidence            9999966555444433345788899999999999999999999999999999999998887 999999998765432221


Q ss_pred             eec---cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTI---KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ...   ...++.|+|||.+.+. .++.++|+||||+++|++++ |..||...+..+....+......             
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~-------------  229 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-------------  229 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-------------
Confidence            111   1123569999987655 68999999999999999997 99999877766655555321100             


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ......+.++.+++.+|+..+|++||++.++++
T Consensus       230 ----------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         230 ----------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                            011235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.8e-41  Score=273.14  Aligned_cols=241  Identities=17%  Similarity=0.196  Sum_probs=186.2

Q ss_pred             eeeccccceeEEEEEeCC------------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSL------------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS   73 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (293)
                      +.||+|++|.||++....            ....+++|++...  .......+..|+.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999997432            2235788876432  22334567888999999999999999999999999


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC------eEEEccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD------IVKIADFGL  147 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~------~v~l~df~~  147 (293)
                      .+++|||++++.+..+.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++.      .++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999977776665544446788899999999999999999999999999999999986553      389999998


Q ss_pred             cccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          148 ARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV-THQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      +......    ....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+.......    .     
T Consensus       159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~-----  225 (262)
T cd05077         159 PITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG----Q-----  225 (262)
T ss_pred             CccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc----C-----
Confidence            8655322    12236778999998875557899999999999999998 58888876544332221100    0     


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                            .......+.++.+++.+||+.||.+||++.+|+++
T Consensus       226 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ----------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                  00111235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.7e-40  Score=276.53  Aligned_cols=251  Identities=23%  Similarity=0.286  Sum_probs=196.2

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|.+.+.||+|++|.||++.+     ...+..+++|.++... .......+.+|+++++++ +||||+++++++...+..
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            478899999999999999974     2345578999875332 222345688899999999 799999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +++|||+. +++.+.+.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++|||.+.....
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~l~dfg~~~~~~~  193 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI-VKICDFGLARDIMN  193 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe-EEECCCcccccccC
Confidence            99999998 45556655444444788899999999999999999999999999999999997776 99999999876543


Q ss_pred             CCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ....  .....+++.|+|||.+.+. .++.++|+||+|+++|+|++ |..||......+...........          
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  262 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR----------  262 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc----------
Confidence            3211  1112245779999987665 58899999999999999998 99999876655444333221000          


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                        ...+...++++.+++.+||+.+|++|||+.+++.
T Consensus       263 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 ------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              0012235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-40  Score=278.89  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             CceeeeeeccccceeEEEEEeC-------CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-------LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      ||.+++.||+|++|.||++.+.       .....+++|.+.... .......+..|+++++++ .||||+++++++...+
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            5889999999999999999752       234568889875322 223345678899999999 5999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++++||+.+ ++.+++....              ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            99999999985 5555554322              13467778899999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++|+|||.+.........  .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       172 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         172 V-MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             c-EEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7 999999999765432111  1111234579999988765 68999999999999999999 88999877666655544


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ....                             ....+..++.++.+++.+||..||.+|||+.+++.
T Consensus       250 ~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         250 REGH-----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3200                             00112345778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=316.58  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=217.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||.-+.++|.|.||.||.+.+..+|+..|+|.++.-.........+.+|+.++..++|||+++++|+-.+...++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            57778899999999999999999999999998866555567778999999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc---
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---  157 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~---  157 (293)
                      |.|+.+..+.+++. -.++.....+..|++.|+.+||+.||||+||||.||+++.+|- +|++|||.+..+..+...   
T Consensus      1316 C~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~-iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL-IKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc-EEeecccceeEecCchhcCCH
Confidence            99888888877765 3566677788999999999999999999999999999999996 999999999988765322   


Q ss_pred             -eeccCccccccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 -YTIKGGSLCYKAPERLLGSG--RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       .....||+.|||||++.+..  ....++|||||||++.||+||+.||...+.+-.+.--++.                 
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~----------------- 1456 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA----------------- 1456 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-----------------
Confidence             22334999999999997642  4578999999999999999999999876555444333332                 


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 +....++..++.+..++|..||..||.+|.++.++++|-|-+.
T Consensus      1457 -----------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1457 -----------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             -----------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                       2222344458899999999999999999999999999987543

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-40  Score=269.89  Aligned_cols=248  Identities=22%  Similarity=0.260  Sum_probs=196.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++.+. ++..+++|.+....   .....+.+|+++++++.||+++++++++......++++|+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            3788999999999999999765 46789999875322   2235788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-ee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~  159 (293)
                      +.+..+..........+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV-VKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe-EEECCCcceeecccCcccccC
Confidence            9866555444333345778899999999999999999999999999999999998777 999999988755432111 11


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+......                  
T Consensus       160 ~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  220 (256)
T cd05112         160 GTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL------------------  220 (256)
T ss_pred             CCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC------------------
Confidence            12245679999987655 68899999999999999998 89999877766655554221000                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ..+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       221 -----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         221 -----------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                       0112246789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-40  Score=270.66  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             eeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            7 VIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      .||+|++|.||++...  ..+..+++|++.... .....+.+.+|+.+++++.|||++++++++.. ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999998654  345568999875432 23334568899999999999999999998764 5789999999865


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec---c
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI---K  161 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~---~  161 (293)
                      .+..........+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+............   .
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY-AKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc-EEeccCCccccccCCccceeccCCC
Confidence            554444333446788999999999999999999999999999999999998877 999999998755433221111   1


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      .+++.|+|||.+... .++.++|+||||+++|++++ |..||......+....+....                      
T Consensus       159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------  215 (257)
T cd05115         159 KWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK----------------------  215 (257)
T ss_pred             CCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC----------------------
Confidence            124679999987655 68899999999999999996 999998876665544442210                      


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                             ....+...++++.+++.+|+..||.+||++.++..
T Consensus       216 -------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 -------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   01122346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-40  Score=272.47  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=193.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|.+.+.||+|++|.||+|.....   ...+++|.+..... ....+.+.+|+++++++.|||++++++++.. ...++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            478899999999999999976533   34688887753321 2334578889999999999999999998875 567899


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ||++++ ++.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC-eEEccCceeeecccccc
Confidence            999985 455555433 335788899999999999999999999999999999999998887 99999999876543321


Q ss_pred             ce-eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NY-TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      .. ....+++.|+|||.+... .++.++|+||||++++++++ |..||...+..+....+....                
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----------------  225 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----------------  225 (270)
T ss_pred             eecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            11 122234679999987655 68899999999999999886 999998877665554442100                


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                   ....+..++.++.+++.+|+..+|++|||+.++++
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 -------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         01123456789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-40  Score=270.78  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCC----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTG----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +++.+.||.|++|.||++.+...+    ..+++|.+.... .......+..|+++++.+.|+|++++++++...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            467899999999999999887765    889999885432 222456888999999999999999999999999999999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ||++.+ ++.+.+.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe-EEEcccCCceecccccc
Confidence            999986 4445554433333788999999999999999999999999999999999998887 99999999876654311


Q ss_pred             cee-ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYT-IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ... ...+++.|+|||...+. .++.++|+||||+++++|++ |..||...+.......+.....               
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  222 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------------  222 (258)
T ss_pred             cccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence            111 12256789999987544 68999999999999999998 7889887766666555432110               


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                    .......+.++.+++.+|++.||++|||+.++++
T Consensus       223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                          0112236788999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-40  Score=276.18  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=193.9

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      .|++.+.||+|+||.||+|....     ....+++|.+..... ......+.+|+++++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            48899999999999999997642     235688887653221 222356888999999999999999999999999999


Q ss_pred             eEeecCCcchH-HHhhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           76 LVFENLDFDLL-HFMKTE----------------------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        76 lv~e~~~~~~~-~~~~~~----------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      +++||+.++.+ +++...                      ....+++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            99999985444 443321                      1234678889999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~  209 (293)
                      ++.++. ++|+|||.+.........  .....++..|+|||.+.+. .++.++||||||+++++|++ |..||.+...+.
T Consensus       160 l~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         160 VAEGRK-MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EcCCCc-EEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            998776 999999998755322111  1222345679999987655 68999999999999999998 999998776665


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..........                             ...+...+.++.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYR-----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCC-----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            5444321000                             0112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=270.43  Aligned_cols=243  Identities=24%  Similarity=0.314  Sum_probs=192.0

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcc-
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD-   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~-   84 (293)
                      ++||+|++|.||++.+.. ++.+++|.+...... .....+.+|+++++++.||+++++++++......++++|++++. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            479999999999998877 899999987543322 23467889999999999999999999999999999999999755 


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee--ccC
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT--IKG  162 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~--~~~  162 (293)
                      +.+.+... ...++...+..++.+++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+...........  ...
T Consensus        79 l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          79 LLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc-EEEeeccccccccCCcceeccccCc
Confidence            44555443 335778889999999999999999999999999999999998887 99999999876542211111  111


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.....                      
T Consensus       157 ~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------------  213 (251)
T cd05041         157 IPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------------  213 (251)
T ss_pred             ceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC----------------------
Confidence            34569999987655 68999999999999999999 8899977765544444321000                      


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                             ...+...+.++.+++.+|++.+|.+|||+.+++.
T Consensus       214 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                   0112235778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-40  Score=277.51  Aligned_cols=251  Identities=24%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             CceeeeeeccccceeEEEEEeC-------CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-------LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      +|.+.+.||+|++|.||++...       ..+..+++|.+... ........+.+|+.+++.+ .||||+++++++...+
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            4789999999999999999642       23457899987532 2233346788999999999 7999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..+++|||+.+ ++.+++....              ...++...+..++.|++.||.|||++|++|+||+|+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            99999999985 5555554321              12456778889999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++|+|||.+..........  ....+++.|+|||++.+. .++.++|+||||+++|++++ |..||......+....+
T Consensus       175 ~-~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  252 (304)
T cd05101         175 V-MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  252 (304)
T ss_pred             c-EEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            7 9999999987664322211  112245679999988765 68899999999999999998 78899877666655554


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                             ...+..++.++.+++.+||..+|.+|||+.++++.
T Consensus       253 ~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         253 KEGHR-----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HcCCc-----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            22100                             01123467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-40  Score=268.68  Aligned_cols=244  Identities=22%  Similarity=0.286  Sum_probs=190.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcch
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDL   85 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (293)
                      +.||+|++|.||++... ++..+++|.+.... .......+.+|+++++.+.|||++++++++...+..++||||++++.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            47899999999999854 67889999875332 22223467889999999999999999999999999999999998554


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee-ccCcc
Q 038154           86 LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-IKGGS  164 (293)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~-~~~~~  164 (293)
                      +..........+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........... ....+
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe-EEECCCccceeccccccccCCCCCCc
Confidence            44333333345788899999999999999999999999999999999998887 99999998865432211111 11234


Q ss_pred             ccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       165 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      +.|+|||.+.+. .++.++|+||||+++|++++ |..||...........+.....                        
T Consensus       158 ~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------------  212 (250)
T cd05085         158 IKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------------------------  212 (250)
T ss_pred             ccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence            679999987654 68899999999999999998 9999987766655444422100                        


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                           ...+..++.++.+++.+|+..+|++||++.+++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                 0112236788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=272.98  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++..+.+|.    .+++|.+..... ......+.+|+++++++.|||++++++++.. ...++
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            58899999999999999998766554    578887654322 2234577889999999999999999999887 78999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|++++ ++.+.+... ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe-EEECCCcccccccCcc
Confidence            9999985 555555443 335788899999999999999999999999999999999998777 9999999997665332


Q ss_pred             cceec--cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENYTI--KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .....  ...+..|+|||.+... .++.++|+||||++++++++ |..||......+....+.....             
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  229 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-------------  229 (279)
T ss_pred             cceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-------------
Confidence            22211  1134679999977654 68899999999999999998 9999988776665555432100             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ...+...+.++.+++.+|+..||.+||++.++++
T Consensus       230 ----------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ----------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            0112234678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.6e-40  Score=269.82  Aligned_cols=246  Identities=24%  Similarity=0.317  Sum_probs=195.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++... .+..+++|.+...   ......+.+|++++++++|+|++++++.+.. ...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            5899999999999999999754 4566999977532   2234678889999999999999999999877 778999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      ++ +++.+.+........+...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV-CKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc-EEECCCcceeeccCCCcccc
Confidence            97 56666666555556778889999999999999999999999999999999998887 999999988765332111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+... .++.++|+||||+++|++++ |..||...+.......+.....                  
T Consensus       161 ~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------  221 (260)
T cd05073         161 EGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------------  221 (260)
T ss_pred             cCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC------------------
Confidence            112245679999987654 68899999999999999998 8999987766555544421000                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 .......+.++.+++.+|++.||++||++.++++
T Consensus       222 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 -----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -----------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                       0112346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-40  Score=272.80  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      .|++.+.||+|++|+||++....++.    .+++|.+... ........+..|+..++.+.||||+++++++.. ...++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            37889999999999999998776666    3667765321 112223566778888899999999999998754 55778


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|++. |++.+.+... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~-~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEEcCCccceeccCCC
Confidence            999998 5555555433 346788899999999999999999999999999999999998877 9999999987653321


Q ss_pred             cc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 EN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..  .....++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+.. ...+           
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-----------  230 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERL-----------  230 (279)
T ss_pred             cccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC-----------
Confidence            11  1222356789999987655 68999999999999999998 9999987765544333211 0000           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                       ..+...+.++.+++.+|+..||.+|||+.+++.
T Consensus       231 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         231 -----------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             011124567889999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-41  Score=274.83  Aligned_cols=241  Identities=17%  Similarity=0.209  Sum_probs=185.6

Q ss_pred             eeeccccceeEEEEEeCCCCC-------eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            6 EVIREGRYGAVHRAHDSLTGD-------TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~-------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +.||+|+||.||++.+...+.       .+++|.+...  .....+.+.+|+.+++.+.|||++++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999998755443       3777776322  1233356788999999999999999999999989999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe-------EEEccCCCcccC
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-------VKIADFGLARPI  151 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~-------v~l~df~~~~~~  151 (293)
                      ||++++.+..+.......+++..+..++.||+.||.+||++|++|+||+|+||+++.++..       ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9998655544443333367888899999999999999999999999999999999877652       699999988654


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ-RLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ...    ....+++.|+|||++.+...++.++|+||||+++|+|++|. .||...+..........              
T Consensus       159 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--------------  220 (258)
T cd05078         159 LPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--------------  220 (258)
T ss_pred             CCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------------
Confidence            322    12236788999998877556899999999999999999995 66655444333222110              


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                       ....+...+.++.+++.+||+.||.+|||++++++.
T Consensus       221 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 -----------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                             001222345678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=280.18  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=214.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |+.-++||+|+||.||-+....+|+-||.|++....... .......+|-++|.+.+.+.||.+-..|+..+.+|+|+.-
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl  266 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL  266 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence            567789999999999999999999999999885433222 2335667899999999999999998889999999999999


Q ss_pred             CCcchHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFM-KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+|+-+.+. .+.+...+++..++-++.+|+.+|++||..+||.||+||+||++|..|+ |.|+|+|++..+..... ..
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh-vRISDLGLAvei~~g~~-~~  344 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH-VRISDLGLAVEIPEGKP-IR  344 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC-eEeeccceEEecCCCCc-cc
Confidence            997666544 4566678999999999999999999999999999999999999999999 99999999998865433 23


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP----GLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ...||.+|||||++.+. .|+...|-|||||++|+|+.|+.||......    ++-+.+.                    
T Consensus       345 ~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--------------------  403 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--------------------  403 (591)
T ss_pred             cccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--------------------
Confidence            33599999999998877 5999999999999999999999999764322    3323322                    


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                .+...++...|+++.+|++.+|..||.+|..     +.++-+||||++++|
T Consensus       404 ----------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  404 ----------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             ----------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence                      2223344568999999999999999999974     579999999999886

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-40  Score=280.52  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=195.8

Q ss_pred             CceeeeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      ||++++.||+|+||.||++.+..       .+..+++|.+... ........+.+|+++++++ +||||+++++++...+
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            68999999999999999997532       2236899977532 2233346788999999999 7999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++++||+++ ++.+++....              ...++...+..++.|++.||.+||++|++|+||+|+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            99999999985 5555554321              22456678889999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++|+|||.+.........  .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||...+.++....+
T Consensus       172 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         172 V-MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             c-EEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            7 999999998765432111  1111234579999988765 68899999999999999998 88999887766665554


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ....                             ....+...+.++.+++.+|+..+|.+|||+.+++.+
T Consensus       250 ~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         250 KEGH-----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HcCC-----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3210                             001123457789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-40  Score=274.55  Aligned_cols=250  Identities=25%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||++.+..     ++..+++|++.... .......+.+|+++++++.|||++++++++..+...+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            58899999999999999998642     56789999875322 2223456888999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe
Q 038154           76 LVFENLDF-DLLHFMKTEP--------------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID  134 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~  134 (293)
                      +++|++++ ++.+.+....                    ...+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            99999985 5555554321                    12456778899999999999999999999999999999999


Q ss_pred             CCCCeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 038154          135 RSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLL  211 (293)
Q Consensus       135 ~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~  211 (293)
                      .++. ++|+|||.+.........  ......+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+..
T Consensus       165 ~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~  242 (288)
T cd05050         165 ENMV-VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI  242 (288)
T ss_pred             CCCc-eEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            8887 999999998754332111  1112245679999987655 68999999999999999997 78899777666655


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..+....                             ....+...+.++.+++.+||+.||++|||+.|++.
T Consensus       243 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         243 YYVRDGN-----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4442200                             00112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-40  Score=284.65  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=192.1

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (293)
                      +|+++++||+|+||.||++.+..     .+..||+|++.... .......+.+|+++++++. ||||+++++++...+..
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            57889999999999999997532     23469999885432 2233467889999999996 99999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCC------------------------------------------------------------
Q 038154           75 DLVFENLDF-DLLHFMKTEP------------------------------------------------------------   93 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~------------------------------------------------------------   93 (293)
                      |+||||+.+ ++.+.+....                                                            
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            999999984 5544443210                                                            


Q ss_pred             ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe
Q 038154           94 ----------------------------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        94 ----------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                                                        ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~-  275 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-  275 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE-
Confidence                                              123667778899999999999999999999999999999998777 


Q ss_pred             EEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 038154          140 VKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFS  216 (293)
Q Consensus       140 v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~  216 (293)
                      ++|+|||.+.........  .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.....+........
T Consensus       276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~  354 (400)
T cd05105         276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK  354 (400)
T ss_pred             EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence            999999998765332111  1122256789999988765 68999999999999999997 9999977544333222211


Q ss_pred             HhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...                            ....+..++.++.+++.+||+.||++||++.++.+
T Consensus       355 ~~~----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         355 SGY----------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cCC----------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            000                            00112346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-40  Score=274.20  Aligned_cols=240  Identities=16%  Similarity=0.165  Sum_probs=185.0

Q ss_pred             eeccccceeEEEEEeCC------------------------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcc
Q 038154            7 VIREGRYGAVHRAHDSL------------------------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV   62 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~------------------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   62 (293)
                      .||+|+||.||++....                        ....+++|.+....  ......+.+|+++++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            68999999999996321                        22357888774322  22235677889999999999999


Q ss_pred             eeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC----
Q 038154           63 RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD----  138 (293)
Q Consensus        63 ~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~----  138 (293)
                      ++++++..+...++||||++++.+..+.......+++..+..++.|++.||+|||++|++|+||+|+||+++..+.    
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            9999999999999999999977776665444446788889999999999999999999999999999999986432    


Q ss_pred             --eEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHH
Q 038154          139 --IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV-THQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       139 --~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~  215 (293)
                        .++++|||.+.......    ...++..|+|||.+.+...++.++|+||||+++|+++ +|..||......+......
T Consensus       160 ~~~~kl~d~g~~~~~~~~~----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALSRE----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE  235 (274)
T ss_pred             cceeeecCCcccccccccc----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence              37999999875443221    1236778999998876557899999999999999984 7899998765544322211


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      . ..                              ..+...++.+.+++.+||+.+|++|||+.+++++
T Consensus       236 ~-~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 K-KH------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             h-cc------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            0 00                              0111235678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-42  Score=289.70  Aligned_cols=250  Identities=30%  Similarity=0.423  Sum_probs=205.5

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC--CCcccHHHHHHHHHhcCCCCcceeeeeeecCCc--ceeEee
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQSSVDS--IDLVFE   79 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~lv~e   79 (293)
                      ....||+|+|.+||+|.+..+|-.||...++......  ....++..|+.+|+.|+||||+++++++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3478999999999999999999999887665554443  344889999999999999999999999887765  778999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ--EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      -+. |++..+......  .+...+..+++||+.||.|||++  .|+|||||=+||||+.+...|||+|+|+|+.......
T Consensus       124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            998 777777777655  56669999999999999999998  4999999999999997755699999999998765444


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ..  ..|||.|||||.+..  .|+...||||||+.++||.|+.+||..++.+ ++..+......+               
T Consensus       202 ks--vIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP---------------  262 (632)
T KOG0584|consen  202 KS--VIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP---------------  262 (632)
T ss_pred             ce--eccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH---------------
Confidence            43  459999999998873  5999999999999999999999999987554 444444321111               


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                .   .+.+--.+++++||.+||.. .+.|||+.|+|.||||..
T Consensus       263 ----------~---sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  263 ----------A---ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             ----------H---HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                      0   11111257899999999998 999999999999999975

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=289.03  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=209.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |.=++.||.|+||.||-|++..+.+.||||++..+.... +...++..|+++|+++.|||.+.+-+.+..+.+.++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            344567999999999999999999999999997665433 4567899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      |-|+..+.+.-.. .++.+..+..|+.+.+.||+|||+.+.+|+|||+.||++++.|. |||+|||.+.....    ..+
T Consensus       108 ClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~-VKLaDFGSAsi~~P----Ans  181 (948)
T KOG0577|consen  108 CLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL-VKLADFGSASIMAP----ANS  181 (948)
T ss_pred             HhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe-eeeccccchhhcCc----hhc
Confidence            9998777665443 36778899999999999999999999999999999999999998 99999999976542    344


Q ss_pred             cCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..|||.|||||++.  ..+.|+-+.||||||++..++.-.+.|+=..+.-..+=-|.   ..    ..|           
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QN----esP-----------  243 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN----ESP-----------  243 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---hc----CCC-----------
Confidence            45999999999984  46789999999999999999999998875443322211111   11    000           


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                              .+  ....++..+.+||..||+.=|.+|||.+++|.|+|...-+
T Consensus       244 --------tL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  244 --------TL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             --------CC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                    00  0233577899999999999999999999999999987543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-40  Score=267.88  Aligned_cols=241  Identities=25%  Similarity=0.383  Sum_probs=193.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++.+.||+|++|.||++  ..++..+++|.+...    .....+.+|+.+++.++|||++++++++..+ ..+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~--~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HceeeeeeccCCCCceEec--ccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            3889999999999999999  457888999987532    2335788999999999999999999998764 47999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +.+ ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......   .
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~-~kl~Dfg~~~~~~~~~---~  155 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV-AKVSDFGLARVGSMGV---D  155 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc-EEECCCccceeccccC---C
Confidence            984 6666666555556788899999999999999999999999999999999998887 9999999887543221   1


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+.....                   
T Consensus       156 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------  215 (254)
T cd05083         156 NSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------------------  215 (254)
T ss_pred             CCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-------------------
Confidence            12245679999977654 68899999999999999997 9999988766655444321000                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ......++.++.+++.+||+.+|.+||++++++.
T Consensus       216 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 ----------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      0012246788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-40  Score=273.88  Aligned_cols=257  Identities=23%  Similarity=0.291  Sum_probs=193.9

Q ss_pred             CceeeeeeccccceeEEEEEeCC----------------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL----------------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL   64 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   64 (293)
                      ||++.+.||+|++|.||++....                ++..+++|++.... .......+.+|+++++.++|+|++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            68999999999999999985332                34468899875332 22334578899999999999999999


Q ss_pred             eeeeecCCcceeEeecCCc-chHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe
Q 038154           65 LNVQSSVDSIDLVFENLDF-DLLHFMKTEPT---------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID  134 (293)
Q Consensus        65 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~  134 (293)
                      ++++...+..+++||++.+ ++..++.....         ..+++..+..++.|++.||++||+.|++|+||+|+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            9999999999999999985 55555543221         2356678999999999999999999999999999999999


Q ss_pred             CCCCeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchHH
Q 038154          135 RSKDIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT--HQRLFHSRWAPGL  210 (293)
Q Consensus       135 ~~~~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~pf~~~~~~~~  210 (293)
                      .++. ++|+|||.+..........  .....++.|++||...+. .++.++|+||||+++|+|++  |..||...+..+.
T Consensus       165 ~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         165 KNYT-IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             CCCC-EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            8887 9999999987653322111  111235679999977655 68999999999999999998  7799987666555


Q ss_pred             HHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          211 LAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .............                      ......+..++..+.+++.+||+.||.+||++.+++.
T Consensus       243 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGR----------------------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhccc----------------------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4433221110000                      0000112335688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-40  Score=274.19  Aligned_cols=262  Identities=21%  Similarity=0.317  Sum_probs=200.9

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      .|++.+.||+|++|.||++...   .+++.+++|++.....  .......+..|++++.++ +||+++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999753   4678899998864322  123345678899999999 599999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++||||+.+ ++...+...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEEECcccccccc
Confidence            999999985 555555433  34778889999999999999999999999999999999998887 99999998876533


Q ss_pred             CCcc-eeccCccccccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          154 PLEN-YTIKGGSLCYKAPERLLGSG-RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       154 ~~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .... .....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...........+......           
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------  226 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-----------  226 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-----------
Confidence            2111 12234788899999876542 3688999999999999999999999653322111111110000           


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC---HHHHhcCcccccCcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREALRHEYFKDFQS  291 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~p~~~~~~~  291 (293)
                                     .....+..++..+.+++.+||+.||++|||   +.++|+||||+.+.+
T Consensus       227 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         227 ---------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ---------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence                           001122346788999999999999999998   567799999999765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-40  Score=268.15  Aligned_cols=245  Identities=25%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             eeeccccceeEEEEEeCC-CCC--eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            6 EVIREGRYGAVHRAHDSL-TGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~-~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ++||+|++|.||++.+.. ++.  .+++|.+...... .....+..|++++++++|||++++++++.. ...++++|+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998754 333  5899987554332 445678899999999999999999999888 88999999997


Q ss_pred             -cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce---
Q 038154           83 -FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY---  158 (293)
Q Consensus        83 -~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~---  158 (293)
                       +++.+.+.......+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+..........   
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE-EEeccccccccccccccceecc
Confidence             56666665544356788999999999999999999999999999999999998887 9999999987764422211   


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||.+.+. .++.++|+||||+++++|++ |..||...+..+....+......                 
T Consensus       158 ~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------  219 (257)
T cd05040         158 EHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----------------  219 (257)
T ss_pred             cCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----------------
Confidence            112256789999977655 68999999999999999998 99999877776655555321000                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+...+..+.+++.+|++.+|++|||+.++++
T Consensus       220 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                       0112235778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.1e-40  Score=271.00  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=194.7

Q ss_pred             CceeeeeeccccceeEEEEEeCC----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   75 (293)
                      +|++.+.||+|++|.||+|.+..    .+..+++|.+.. .........+.+|+++++++.|||++++++++.. +...+
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            68999999999999999998765    357788887642 2233334667889999999999999999998655 56788


Q ss_pred             eEeecCC-cchHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCc
Q 038154           76 LVFENLD-FDLLHFMKTEPT------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA  148 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~  148 (293)
                      +++++++ +++...+.....      ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||.+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kl~d~g~~  164 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALS  164 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc-EEECCCCCc
Confidence            9999998 455555543321      35788899999999999999999999999999999999998877 999999999


Q ss_pred             ccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCC
Q 038154          149 RPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSET  225 (293)
Q Consensus       149 ~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (293)
                      +.........  ....++..|+|||++.+. .++.++||||||+++|++++ |..||...+..+....+.....      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  237 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR------  237 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC------
Confidence            7653322111  112245679999988765 68999999999999999999 9999987766554443321000      


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                             ......+++++.+++.+|+..||++|||+.++++
T Consensus       238 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 -----------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                   0011235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=275.48  Aligned_cols=283  Identities=29%  Similarity=0.401  Sum_probs=223.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-----C---CCcceeeeeeecC-
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-----H---ENIVRLLNVQSSV-   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~~~~~~~-   71 (293)
                      ||.+.++||.|.|++||++.+....+.||+|+.+   ..+...+...+|+++|+++.     +   ..|+++++.|... 
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK---SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK---SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEe---hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            8999999999999999999999999999999864   23444567788999999884     2   4799999988554 


Q ss_pred             ---CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCC-----------
Q 038154           72 ---DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRS-----------  136 (293)
Q Consensus        72 ---~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~-----------  136 (293)
                         .++|+|+|+++..||.++.......++...+.+|++|++.||.|||. .||+|-||||+||++...           
T Consensus       156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a  235 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA  235 (590)
T ss_pred             CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence               47999999999999999999888899999999999999999999996 499999999999998100           


Q ss_pred             --------------------------------------------------------------------------------
Q 038154          137 --------------------------------------------------------------------------------  136 (293)
Q Consensus       137 --------------------------------------------------------------------------------  136 (293)
                                                                                                      
T Consensus       236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~  315 (590)
T KOG1290|consen  236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST  315 (590)
T ss_pred             ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------CCeEEE
Q 038154          137 --------------------------------------------------------------------------KDIVKI  142 (293)
Q Consensus       137 --------------------------------------------------------------------------~~~v~l  142 (293)
                                                                                                .-.|||
T Consensus       316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI  395 (590)
T KOG1290|consen  316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI  395 (590)
T ss_pred             hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence                                                                                      002455


Q ss_pred             ccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC------CCchHHHHHHHH
Q 038154          143 ADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS------RWAPGLLAAIFS  216 (293)
Q Consensus       143 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~------~~~~~~~~~~~~  216 (293)
                      +|||-++...   .++.....|-.|+|||++.+. .|+..+||||++|++|||.||.+.|..      ...++.++.|++
T Consensus       396 aDlGNACW~~---khFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  396 ADLGNACWVH---KHFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             eeccchhhhh---hhhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence            5555555433   222222245569999999998 699999999999999999999999964      455788999999


Q ss_pred             HhCCCCCCCCCCCcCcccccCCCCCCCcc-----cchhhh-------cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          217 IMGTPDSETLPGFTSFSEEFGFEPNRSPI-----KDLATV-------VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                      ..+..+..........++.|+-...-...     +.+..+       ......++.+|+.-||+.+|++||||.+.|.||
T Consensus       472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            99998888887777777766433222111     111111       111345778999999999999999999999999


Q ss_pred             ccccCc
Q 038154          285 YFKDFQ  290 (293)
Q Consensus       285 ~~~~~~  290 (293)
                      |++.+.
T Consensus       552 wLn~~~  557 (590)
T KOG1290|consen  552 WLNPVA  557 (590)
T ss_pred             cccCCC
Confidence            999764

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-40  Score=273.95  Aligned_cols=263  Identities=27%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             Cc-eeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Cc
Q 038154            1 RY-TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DS   73 (293)
Q Consensus         1 ry-~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   73 (293)
                      || ++.+.||+|++|+||++.    ...++..+++|.+.... .......+.+|++++++++|||++++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            55 889999999999998764    34567889999885432 222346778899999999999999999987653  45


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      .+++||++.++.+.......  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc-EEEeecccccccCC
Confidence            88999999865554444332  4788899999999999999999999999999999999998877 99999999876643


Q ss_pred             CCcce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      .....   ....++..|+|||.+.+. .++.++||||||+++++|++|..||......-  ........  ......   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~--~~~~~~---  231 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQ--GQMTVV---  231 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccc--cccchh---
Confidence            22211   111245569999987655 68899999999999999999999986543211  00000000  000000   


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...+..       ........+...+.++.+++.+|++.||++|||++++++
T Consensus       232 ~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 RLIELL-------ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhh-------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000       000011223457889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-40  Score=272.23  Aligned_cols=265  Identities=25%  Similarity=0.341  Sum_probs=191.9

Q ss_pred             ceeeeeeccccceeEEEEEe----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Ccce
Q 038154            2 YTLLEVIREGRYGAVHRAHD----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   75 (293)
                      |++.+.||+|++|.||++..    ..++..+++|.++... .......+.+|+++++.+.|||++++.+++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            57899999999999999973    4568889999875432 233446788999999999999999999988775  5688


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|||++|..+..........+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-~~l~dfg~~~~~~~~~  163 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC-EEECCCccccccccCc
Confidence            999999865555444333335788899999999999999999999999999999999998887 9999999987664332


Q ss_pred             cce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...   ....++..|+|||.+.+. .++.++|+||||+++|+++++..|........  ...   .+.........  ..
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~--~~~---~~~~~~~~~~~--~~  235 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLF--LKM---IGPTHGQMTVT--RL  235 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchh--hhh---cccccccccHH--HH
Confidence            211   122255679999987765 68899999999999999999876653321100  000   00000000000  00


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....       .......+..++..+.+|+.+||+.||.+|||+.+++..
T Consensus       236 ~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         236 VRVLE-------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHH-------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            00000       000112234578899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=269.49  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=188.7

Q ss_pred             eeeccccceeEEEEEeCCCCC--eEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCC
Q 038154            6 EVIREGRYGAVHRAHDSLTGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      +.||+|++|.||++..+.++.  .+++|.++.. ........+.+|++++.++ .|||++++++++...+..+++||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999999877765  4577776422 2223345788899999999 79999999999999999999999998


Q ss_pred             -cchHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           83 -FDLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        83 -~~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                       +++.+.+....              ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~-~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe-EEECCCCC
Confidence             55555554322              124678889999999999999999999999999999999998887 99999998


Q ss_pred             cccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          148 ARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      +....... .......+..|+|||++... .++.++|+||||+++++|++ |..||...+..+....+....        
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------  228 (270)
T cd05047         159 SRGQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--------  228 (270)
T ss_pred             ccccchhh-hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--------
Confidence            75332111 11112235579999987655 68999999999999999997 999998776655554432100        


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                           ....+...+.++.+++.+|+..||.+|||+.+++.
T Consensus       229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                 00111235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=283.95  Aligned_cols=235  Identities=26%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC-c
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-F   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~   83 (293)
                      ++.||+|+.|.||++  ...++.||||+++.         .-..+++-|++|.||||+.+.|+|.....+|||||||. |
T Consensus       129 LeWlGSGaQGAVF~G--rl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLG--RLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeee--eccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            467999999999999  56688999998631         22358889999999999999999999999999999998 7


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                      -+.+.+.....  +....+.++..+|+.++.|||.+.|+|+|||.-||+|+.+.- |||+|||.++....- ....+..|
T Consensus       198 qL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~-VKIsDFGTS~e~~~~-STkMSFaG  273 (904)
T KOG4721|consen  198 QLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV-VKISDFGTSKELSDK-STKMSFAG  273 (904)
T ss_pred             cHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce-EEeccccchHhhhhh-hhhhhhhh
Confidence            77777766544  667799999999999999999999999999999999998776 999999999876544 44445569


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS  243 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
                      |..|||||++.+. +.+.+.||||||++||+|+||..||.+.+...++                        |    ...
T Consensus       274 TVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------------------------w----GVG  324 (904)
T KOG4721|consen  274 TVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------------------------W----GVG  324 (904)
T ss_pred             hHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeE------------------------E----ecc
Confidence            9999999998877 7999999999999999999999999875432211                        0    001


Q ss_pred             cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ....-..++..+|.-++=|++.|++-.|..||+..++|.|
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            1122235667788999999999999999999999999987

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=275.61  Aligned_cols=262  Identities=24%  Similarity=0.302  Sum_probs=191.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-ceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-IDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~   80 (293)
                      |.-...||+|+||.||+|.-. +|..+|||++.......  ..+|.+|+.++.+++|||+++++|||.+.+. .++|+||
T Consensus        77 Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   77 FSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             CchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            334578999999999999755 44899999875444332  3569999999999999999999999999984 9999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE---ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +. |++.+.+.......++|.++.+|+.+++.||+|||...   ++||||||+||++|++.+ .||+|||++........
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~-aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN-AKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC-EEccCccCcccCCcccc
Confidence            98 55556555443327899999999999999999999853   999999999999999998 99999999965543112


Q ss_pred             ceecc-CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHH-HhCCCCCCCCCCCcCc
Q 038154          157 NYTIK-GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW--APGLLAAIFS-IMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (293)
                      ..... .|+.+|++||.+.. +..+.++||||+|++++|++||+.|.....  .+.....+.. .....         ..
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---------~~  302 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---------KL  302 (361)
T ss_pred             ceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---------ch
Confidence            22211 59999999996655 478999999999999999999998877542  1221333221 11110         11


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .+..+-.-........     ..-..+..+..+|++.+|.+||++.+|+.
T Consensus       303 ~eiiD~~l~~~~~~~~-----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDE-----KEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hheeCCCccCCCCChH-----HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1111110000000000     11223678999999999999999999865

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-41  Score=294.90  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             eeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            3 TLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +..+.||+|+||.||+|+-.     .....||||.++. ..+.....+|.+|++++..|+|||||+++|+|..++.+|+|
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            34678999999999999743     2335699998863 33334568999999999999999999999999999999999


Q ss_pred             eecCC-cchHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEcc
Q 038154           78 FENLD-FDLLHFMKTEP------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIAD  144 (293)
Q Consensus        78 ~e~~~-~~~~~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~d  144 (293)
                      +||+. |+|.++|....            ..+++..+.+.|+.||+.|+.||-++.+||+||-+.|++|+++.. |||+|
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~-VKIsD  646 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV-VKISD  646 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE-EEecc
Confidence            99998 88888886432            123678899999999999999999999999999999999998887 99999


Q ss_pred             CCCcccCCCCC-ccee-ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 038154          145 FGLARPIDVPL-ENYT-IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       145 f~~~~~~~~~~-~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      ||+++.+-+.. .+.. -..-..+|||||.+.-. .++.+|||||+|++|||+++ |..||.+.+.++++..+..     
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-----  720 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-----  720 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-----
Confidence            99998664321 1111 11245789999988755 79999999999999999988 6799999999999999854     


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                              +.....+...|.++.+|+.+|++.+|.+||+.+||=+
T Consensus       721 ------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 ------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             ------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                    4445667788999999999999999999999999754

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.1e-40  Score=266.41  Aligned_cols=238  Identities=17%  Similarity=0.225  Sum_probs=184.3

Q ss_pred             eeeccccceeEEEEEeCCCC----------CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            6 EVIREGRYGAVHRAHDSLTG----------DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +.||+|++|.||++.+..++          ..+++|.+......   ...+.+|+++++.++|||++++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999987666          34777765433221   5788899999999999999999999887 7789


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC------eEEEccCCCcc
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD------IVKIADFGLAR  149 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~------~v~l~df~~~~  149 (293)
                      +|+||++++.+..+.......++...+..++.||+.||+|||+.|++|+||+|+||+++.++.      .++|+|||.+.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999966665454433336788889999999999999999999999999999999998771      39999999987


Q ss_pred             cCCCCCcceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          150 PIDVPLENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ....    .....+...|+|||++.+. ..++.++|+||||++++++++ |..||...+..+.......    ..     
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~-----  223 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QH-----  223 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CC-----
Confidence            6543    1122256779999988665 468899999999999999999 5788876654333222210    00     


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                            ..+......+.+++.+||..+|++|||+.++++
T Consensus       224 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 ----------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ----------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                  000011267889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.3e-40  Score=276.73  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=189.1

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecC-Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSV-DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~   73 (293)
                      ||++.+.||+|+||+||+|.+     ..+++.||+|+++... .......+.+|+.++.++ +|||++++++++... ..
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            699999999999999999974     3467789999986432 222345688899999999 689999999987554 46


Q ss_pred             ceeEeecCCc-chHHHhhcCC-----------------------------------------------------------
Q 038154           74 IDLVFENLDF-DLLHFMKTEP-----------------------------------------------------------   93 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~-----------------------------------------------------------   93 (293)
                      .+++|||+++ ++.+.+....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999985 4444443211                                                           


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--eeccCccc
Q 038154           94 ------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--YTIKGGSL  165 (293)
Q Consensus        94 ------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~  165 (293)
                            ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||.+.........  .....+++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc-EEEEecccccccccCcchhhcCCCCCCc
Confidence                  012466678889999999999999999999999999999998887 999999998765322111  11122456


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSP  244 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
                      .|+|||.+.+. .++.++|+||||+++|+|++ |..||..................                        
T Consensus       246 ~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------  300 (343)
T cd05103         246 KWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------------  300 (343)
T ss_pred             ceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------------
Confidence            79999988665 68899999999999999997 88999765433222222110000                        


Q ss_pred             ccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                          ...+...++++.+++.+|+..||.+|||+.++++|
T Consensus       301 ----~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                01112246789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-39  Score=268.76  Aligned_cols=264  Identities=26%  Similarity=0.388  Sum_probs=189.4

Q ss_pred             CceeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   74 (293)
                      +|++.+.||+|++|.||.+.    +..++..+++|.+....  ......+.+|++++++++|||++++++++..  ....
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            58899999999999999986    34578899999875432  2334578899999999999999999997643  3468


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|+||+++ ++.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~~  160 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe-EEECCCcccccccC
Confidence            899999985 555555433 335788899999999999999999999999999999999998887 99999999886643


Q ss_pred             CCccee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLENYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ......   ...++..|+|||.+.+. .++.++|+||||+++++|++|..|+...... ....+    +...... ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~----~~~~~~~-~~~~  233 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMM----GNDKQGQ-MIVY  233 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhc----ccccccc-cchH
Confidence            322111   11133459999988665 6889999999999999999988776433211 00000    0000000 0000


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...+...   .    .........++.++.+++.+||+.+|++|||+.+++.
T Consensus       234 ~~~~~~~---~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLK---N----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHh---c----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000000   0    0011123456789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.3e-40  Score=268.17  Aligned_cols=246  Identities=23%  Similarity=0.298  Sum_probs=190.3

Q ss_pred             eeeccccceeEEEEEeCCCC------CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            6 EVIREGRYGAVHRAHDSLTG------DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +.||+|++|.||++......      ..+++|.+... ........+.+|+++++.++||||+++++++...+..+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999865433      67899987432 222345678889999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC----CeEEEccCCCcc
Q 038154           80 NLD-FDLLHFMKTE-----PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK----DIVKIADFGLAR  149 (293)
Q Consensus        80 ~~~-~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~----~~v~l~df~~~~  149 (293)
                      +++ +++.+.+...     ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++    ..++++|||.+.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            998 4555665432     223467788999999999999999999999999999999999766    149999999987


Q ss_pred             cCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          150 PIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       150 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      ........  ......+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...         
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------  229 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG---------  229 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC---------
Confidence            55322111  1111245789999987655 68999999999999999998 99999876665544443210         


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                          .....+..++..+.+++.+||+.+|.+||+++++++
T Consensus       230 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 --------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                000122346788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-39  Score=266.74  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=197.0

Q ss_pred             ceeeeeeccccceeEEEEEeCC-CCCeEEEEEecccCCC--------CCCcccHHHHHHHHHh-cCCCCcceeeeeeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNPS--------EGVPSSVIREVSLLKE-LKHENIVRLLNVQSSV   71 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~   71 (293)
                      |++.+.||+|++|.||++.+.. .+..+++|.+......        ......+.+|+.++.+ ++|||++++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            8899999999999999999877 6788999987543221        1223456678887765 6899999999999999


Q ss_pred             CcceeEeecCCcchH-HHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           72 DSIDLVFENLDFDLL-HFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      +..+++|||++|..+ +.+..  .....+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+|||.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~-~~l~dfg~  160 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGL  160 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc-EEEecccc
Confidence            999999999986444 44422  223457888999999999999999996 68999999999999998887 99999999


Q ss_pred             cccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          148 ARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      +....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......+.     
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  233 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-----  233 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-----
Confidence            87655432 33344478889999988765 589999999999999999999999987665554444432111000     


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                             .....++++.+++.+||+.||++||++.++.++
T Consensus       234 -----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 -----------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -----------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                   011356889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3e-39  Score=265.76  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=196.0

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||++..+.     ....+++|.+.... .......+.+|++++++++|||++++++++.+.+..+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            47899999999999999998543     34678888764321 1223467889999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           76 LVFENLDF-DLLHFMKTEPT-------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      +|||++++ ++.+.+.....       ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++|||.
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~~~~~  163 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSL  163 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc-EEEccccc
Confidence            99999985 55555544331       25788899999999999999999999999999999999998887 99999998


Q ss_pred             cccCCCCC-cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCC
Q 038154          148 ARPIDVPL-ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSET  225 (293)
Q Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (293)
                      +....... .......++..|+|||.+.+. ..+.++|+||||+++|++++ |..||...........+......     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-----  237 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----  237 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-----
Confidence            86443211 111222356679999987655 57889999999999999998 78899876665555544221000     


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                             .......+..+.+++.+||+.||++||++.+++..
T Consensus       238 -----------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 -----------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                   00122467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-39  Score=270.28  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=190.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..+|.    .+++|.+..... ......+.+|+.+++.+.|||++++++++... ..++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            37888999999999999998776665    468887643221 22233677899999999999999999988654 4678


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++++++ |++.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. +||+|||.+.......
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~-~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc-eEEccccccccccCcc
Confidence            999998 5565555443 335788899999999999999999999999999999999998777 9999999998654322


Q ss_pred             cce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...  ....++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+.. ....           
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-----------  230 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERL-----------  230 (303)
T ss_pred             cccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCC-----------
Confidence            211  112245689999987655 68999999999999999997 8999987654443333211 0000           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                       ..++..+..+.+++.+|+..+|++||++.++++.
T Consensus       231 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 -----------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             0112346788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=281.53  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=202.5

Q ss_pred             eeeeeccccceeEEEEEeCCCCC---e-EEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGD---T-VVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~---~-~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +.++||+|+||.||+|..+..+.   . ||+|..+... ........+..|.+++++++||||++++|+......+++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            45899999999999998765432   3 7999876522 44566788999999999999999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |.|.| ++.+++...+. .++......++.+.+.||+|||+++++||||-+.|++++.++. +||+|||+++........
T Consensus       241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~-vKISDFGLs~~~~~~~~~  318 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV-VKISDFGLSRAGSQYVMK  318 (474)
T ss_pred             EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe-EEeCccccccCCcceeec
Confidence            99985 55566665554 6788899999999999999999999999999999999997776 899999998765411111


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      .....-...|+|||.+... .++.++||||+|+++||+++ |..||.+....+..+.+......                
T Consensus       319 ~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r----------------  381 (474)
T KOG0194|consen  319 KFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR----------------  381 (474)
T ss_pred             cccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc----------------
Confidence            1122245689999988766 89999999999999999998 78999999999888888432111                


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ...+...|.++..++.+|+..||++||++.++.+
T Consensus       382 ------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  382 ------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                        1222345788899999999999999999999876

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-39  Score=264.58  Aligned_cols=244  Identities=23%  Similarity=0.269  Sum_probs=182.0

Q ss_pred             eeeccccceeEEEEEeCC---CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee-cCCcceeEeecC
Q 038154            6 EVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS-SVDSIDLVFENL   81 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~   81 (293)
                      +.||+|++|.||+|....   .+..+++|.+... ........+..|+.+++.++|||++++++++. .++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999997543   3456899976422 11223457778999999999999999999764 456789999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc----
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE----  156 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~----  156 (293)
                      .+ ++..++... ....++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........    
T Consensus        80 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~-~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          80 KHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT-VKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc-EEECCccccccccCCcceeec
Confidence            85 444544433 334566778889999999999999999999999999999998887 99999999875432211    


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++| ..||...+..+....+....                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-----------------  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-----------------  219 (262)
T ss_pred             ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence            11122245679999987655 689999999999999999995 56666555444433332100                 


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ....+..++..+.+++.+||..+|++||++.+++.
T Consensus       220 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 ------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        00112235678999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3e-39  Score=265.42  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=191.4

Q ss_pred             ceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------
Q 038154            2 YTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------   72 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   72 (293)
                      |.+.+.||+|++|.||+|...   .++..+++|++..........+.+.+|+++++++.|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            788999999999999999754   35788999998654444444567889999999999999999999875532      


Q ss_pred             cceeEeecCCcchH-HHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           73 SIDLVFENLDFDLL-HFMKT----EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        73 ~~~lv~e~~~~~~~-~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      ..+++++++.++.+ ..+..    .....++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++++|||.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~-~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT-VCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC-EEECcccc
Confidence            24688899885444 44322    12234677889999999999999999999999999999999998887 99999999


Q ss_pred             cccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +.........  .....+++.|++||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+....      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN------  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            8765432211  1122245679999987665 57899999999999999999 889987765544433332100      


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                             .....+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       233 -----------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 -----------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   00111345778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=269.16  Aligned_cols=257  Identities=24%  Similarity=0.308  Sum_probs=218.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |..+.+||+|+||.|-++..+.+.+.||||+++..-. +++..+--+.|-++|.... -|.+++++..|...+.+|+|||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME  430 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME  430 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence            5678999999999999999999999999999976542 3445555667888887664 6889999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|+-+-+.++.-. .+.++.+.-++..|+-+|-+||++||+.||||.+||+++.+|+ |||+|||.++.--.......
T Consensus       431 yvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH-iKi~DFGmcKEni~~~~TTk  508 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIFDGVTTK  508 (683)
T ss_pred             EecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc-eEeeecccccccccCCccee
Confidence            999766655544332 4667788899999999999999999999999999999999999 99999999986655555566


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+|||.|+|||.+. .++|+...|.||+|++||||+.|+.||.+.+.++..+.|.+..                     
T Consensus       509 TFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------------------  566 (683)
T KOG0696|consen  509 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------------------  566 (683)
T ss_pred             eecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------------------
Confidence            677999999999766 4489999999999999999999999999999999999997522                     


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCcccccCcC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYFKDFQS  291 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~~~~~~  291 (293)
                               ...++.+|.++.++++..|...|.+|..+     .+|-.||||+.+-|
T Consensus       567 ---------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  567 ---------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             ---------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence                     23456789999999999999999999765     68888999998765

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-39  Score=277.20  Aligned_cols=251  Identities=21%  Similarity=0.247  Sum_probs=192.6

Q ss_pred             ceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcce
Q 038154            2 YTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (293)
                      |.+++.||+|+||.||++.+.     ..+..||+|+++... .......+.+|++++.++. ||||+++++++...+..+
T Consensus        39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            677899999999999999853     345689999986432 2223356888999999997 999999999999999999


Q ss_pred             eEeecCC-cchHHHhhcCC-------------------------------------------------------------
Q 038154           76 LVFENLD-FDLLHFMKTEP-------------------------------------------------------------   93 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~-------------------------------------------------------------   93 (293)
                      +|+||+. |++.+.+....                                                             
T Consensus       118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (401)
T cd05107         118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG  197 (401)
T ss_pred             EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence            9999998 45555553221                                                             


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC
Q 038154           94 -----------------------------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD  138 (293)
Q Consensus        94 -----------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~  138 (293)
                                                         ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE
Confidence                                               123556678889999999999999999999999999999998776


Q ss_pred             eEEEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 038154          139 IVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       139 ~v~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~  215 (293)
                       ++|+|||.+........  ......+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||......+......
T Consensus       278 -~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~  355 (401)
T cd05107         278 -VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI  355 (401)
T ss_pred             -EEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence             99999999875432211  11122356789999988765 68899999999999999998 889997655444333222


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                            ...+..++.++.+++.+|+..+|.+||++++|+..
T Consensus       356 ~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         356 KRGYR----------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11000                            01223467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=284.78  Aligned_cols=268  Identities=26%  Similarity=0.330  Sum_probs=198.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cce
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~   75 (293)
                      |...+.||+|+||.||+++++.+|+.+|||.++... .....+...+|++++++++|||||+++++-+...      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            445688999999999999999999999999986544 4556678889999999999999999999854443      467


Q ss_pred             eEeecCCc-chHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC--CC-eEEEccCCCccc
Q 038154           76 LVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS--KD-IVKIADFGLARP  150 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~--~~-~v~l~df~~~~~  150 (293)
                      ++||||.| ++...+.. ....++++..++.++.++..||.|||++||+||||||.||++...  |. ..||+|||.++.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999985 55555543 234678999999999999999999999999999999999988643  33 689999999998


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHHHhCCCCCCCCCC
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL--LAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  228 (293)
                      ...+ ....+..||+.|.+||.+..+..++...|.||+|+++|++.||..||.....+..  ...+....+.+ +.....
T Consensus       174 l~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp-~~v~i~  251 (732)
T KOG4250|consen  174 LDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP-SGVAIG  251 (732)
T ss_pred             CCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC-CceeEe
Confidence            8665 4677778999999999988666899999999999999999999999987655532  11122222222 222111


Q ss_pred             CcCccc-ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC
Q 038154          229 FTSFSE-EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL  275 (293)
Q Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  275 (293)
                      .....+ .+.+...-   +....+.+.+-..+..++..||..+|.+|-
T Consensus       252 ~~~~eNgpv~~s~~l---P~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTL---PQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccC---CCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            111111 11111000   001122222334456788999999999997

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.1e-39  Score=292.74  Aligned_cols=146  Identities=26%  Similarity=0.372  Sum_probs=125.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|.+.++||+|+||.||++.+..+++.||+|++...... ......+..|+.+++.++||+|+++++.+......|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            599999999999999999999989999999998643322 2223567889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      |+.| .+..++....  .+++..++.++.||+.||.|||..|++|+||||+||+++.++. ++|+|||.+.
T Consensus        85 y~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~-vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC-EEEEeCCCCc
Confidence            9975 4555554332  4678889999999999999999999999999999999998887 9999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-39  Score=264.31  Aligned_cols=250  Identities=20%  Similarity=0.248  Sum_probs=184.1

Q ss_pred             eeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||+|...  .....+++|.+... ........+.+|++.++.++||||+++++.+......++|||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            46999999999999643  23456788866432 2222335677899999999999999999999999999999999985


Q ss_pred             -chHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           84 -DLLHFMKTEPT---VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        84 -~~~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                       ++.+.+.....   ...++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||.+........  .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS-VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc-EEEeccccccccccchheec
Confidence             55555544321   22456678899999999999999999999999999999998887 99999998864322111  1


Q ss_pred             eeccCccccccCcccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          158 YTIKGGSLCYKAPERLLG------SGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      .....+++.|+|||++..      ...++.++|+||||+++|+|++ |..||......+.............        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--------  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------
Confidence            122224567999998743      2356889999999999999999 7889987766554444332111000        


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ........++..+.+++..|+ .||++|||+++|++
T Consensus       231 ----------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 ----------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                            001122346788889999888 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-39  Score=261.88  Aligned_cols=228  Identities=21%  Similarity=0.256  Sum_probs=180.9

Q ss_pred             ccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-chHHHh
Q 038154           11 GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM   89 (293)
Q Consensus        11 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~~~~~   89 (293)
                      |.++.||++.++.+++.+|+|++....       ....|...+....|||++++++++......+++|||++| ++.+.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            889999999999999999999985432       233455555566799999999999999999999999985 555555


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccC
Q 038154           90 KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA  169 (293)
Q Consensus        90 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~a  169 (293)
                      ....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+.......   ....++..|+|
T Consensus        77 ~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~df~~~~~~~~~~---~~~~~~~~y~a  150 (237)
T cd05576          77 SKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH-IQLTYFSRWSEVEDSC---DGEAVENMYCA  150 (237)
T ss_pred             HHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEecccchhcccccc---ccCCcCccccC
Confidence            5433  4788899999999999999999999999999999999999888 9999999876554321   12235667999


Q ss_pred             cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchh
Q 038154          170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLA  249 (293)
Q Consensus       170 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (293)
                      ||.+.+. .++.++|+||+|+++|+|++|..|+......     +            ..                 ....
T Consensus       151 PE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~-----------------~~~~  195 (237)
T cd05576         151 PEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT-----------------HTTL  195 (237)
T ss_pred             CcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc-----------------cccc
Confidence            9977554 6789999999999999999999876432100     0            00                 0001


Q ss_pred             hhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCccc
Q 038154          250 TVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYF  286 (293)
Q Consensus       250 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~  286 (293)
                      ..++.+++.+.++|.+||+.||.+||++     .++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1234568889999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3e-40  Score=296.89  Aligned_cols=255  Identities=31%  Similarity=0.494  Sum_probs=195.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee-------------
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ-------------   68 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-------------   68 (293)
                      |+..+.||+||||.||+++++.+|..||||+++... +......+.+|+..+.+|+||||++++..+             
T Consensus       481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            567789999999999999999999999999998766 666678899999999999999999987320             


Q ss_pred             -----------------------------------------------e------------------c-------------
Q 038154           69 -----------------------------------------------S------------------S-------------   70 (293)
Q Consensus        69 -----------------------------------------------~------------------~-------------   70 (293)
                                                                     .                  +             
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                           0                  0             


Q ss_pred             --------------------C--------CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 038154           71 --------------------V--------DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL  122 (293)
Q Consensus        71 --------------------~--------~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  122 (293)
                                          .        ..+||-||||+..++..+.......-.....|+++++|++||.|+|++|++
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI  719 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII  719 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence                                0        125788999998888888766553334668999999999999999999999


Q ss_pred             ecccCCCceeEeCCCCeEEEccCCCcccCC------------------CCCcceeccCccccccCcccccCCC--CCCCc
Q 038154          123 HRDLKPANFLIDRSKDIVKIADFGLARPID------------------VPLENYTIKGGSLCYKAPERLLGSG--RYSTP  182 (293)
Q Consensus       123 h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~------------------~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~  182 (293)
                      ||||||.|||++.+++ |||+|||.++...                  .+....+...||--|+|||++.+..  .++.+
T Consensus       720 HRDLKP~NIFLd~~~~-VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSRNS-VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eccCCcceeEEcCCCC-eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            9999999999998888 9999999997621                  0111223334788899999987765  69999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHH
Q 038154          183 VDVWAVACTFAEMVTHQRLFHSR-WAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVD  261 (293)
Q Consensus       183 ~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (293)
                      +|+||||++++||+-   ||... .....+..+..  +..+..  +                      .....--+.-..
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~--~----------------------~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEP--A----------------------DFFDPEHPEEAS  849 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCC--c----------------------ccccccchHHHH
Confidence            999999999999984   56543 22222333221  111100  0                      001112234568


Q ss_pred             HHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          262 LLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       262 li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                      +|+.||+.||++||||.|+|.+.||.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-39  Score=266.56  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=191.9

Q ss_pred             CceeeeeeccccceeEEEEEeC----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   74 (293)
                      .|++.+.||+|++|.||++...    .++..+|+|++...... .....+.+|+++++.+.|||++++++++..  ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            3678899999999999999754    34788999988643332 235678899999999999999999998877  5578


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +++|||+++ ++.+.+... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEccccccccccc
Confidence            999999985 555555443 335788899999999999999999999999999999999998887 99999999987653


Q ss_pred             CCccee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-----------HHHHHHHhC
Q 038154          154 PLENYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----------LAAIFSIMG  219 (293)
Q Consensus       154 ~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-----------~~~~~~~~~  219 (293)
                      ......   ...++..|++||...+. .++.++|+||||+++++|++|..|+........           ...+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            222111   11234569999987665 688999999999999999999999865322110           111100000


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .                         ......+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       241 ~-------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 E-------------------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             c-------------------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0                         0000112235678999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-38  Score=261.03  Aligned_cols=250  Identities=20%  Similarity=0.236  Sum_probs=184.2

Q ss_pred             eeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||+|...  .++..+++|.+..... ......+.+|+.++++++|||++++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            46899999999999754  3456789998754332 22234678899999999999999999999999999999999985


Q ss_pred             -chHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--
Q 038154           84 -DLLHFMKTE---PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--  157 (293)
Q Consensus        84 -~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--  157 (293)
                       ++.+.+...   .....++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.........  
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~-~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT-VKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEECCccccccccCcceeec
Confidence             444555432   2234566678889999999999999999999999999999998887 999999998654322111  


Q ss_pred             eeccCccccccCcccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          158 YTIKGGSLCYKAPERLLGS------GRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      .....++..|+|||++.+.      ..++.++|+||||+++|+|++ |..||......+.............        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL--------  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC--------
Confidence            1122356789999987542      135789999999999999996 9999987655544332211000000        


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      .........++.+.+++.+|+ .+|++|||+++|+.
T Consensus       231 ----------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         231 ----------------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                            000111235677889999998 68999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-40  Score=277.74  Aligned_cols=241  Identities=29%  Similarity=0.430  Sum_probs=197.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|.+...+|.|+|++|-.+.+..++...++|++....      .+-.+|+.++... +|||++++.+.+.++...|+|||
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            3777888999999999999999999999999985442      2334566666555 69999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE-eCCCCeEEEccCCCcccCCCCCcc
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i-~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      .+.| .++..+......   ...+..|+.+|+.|+.+||.+|++||||+|+||++ +..++ ++|+|||.+......   
T Consensus       397 ~l~g~ell~ri~~~~~~---~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~-lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEF---CSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH-LRLTYFGFWSELERS---  469 (612)
T ss_pred             hccccHHHHHHHhcchh---HHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc-EEEEEechhhhCchh---
Confidence            9985 555555544332   25778899999999999999999999999999999 56777 999999999876644   


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ...++-+..|.|||++... .+++++|+||||++||+|++|+.||.....+ +++..+..    +               
T Consensus       470 ~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~---------------  529 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----P---------------  529 (612)
T ss_pred             hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----C---------------
Confidence            3444577889999988855 7999999999999999999999999876444 44444421    0               


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                   .....+|..+++||..||+.||.+||+++++..||||.
T Consensus       530 -------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  530 -------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             -------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence                         00134789999999999999999999999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1e-40  Score=250.35  Aligned_cols=275  Identities=27%  Similarity=0.496  Sum_probs=210.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCC--cceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVD--SIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~lv~   78 (293)
                      |++.+++|+|.++.|+.|.+..+++.++||+++.     -..+.+.+|+.+|+.|. +|||++++++..++.  ...+|+
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            7889999999999999999888999999999853     33467999999999996 999999999987654  678999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++...-...+..    .++.-.++.++.+++.||.|+|+.||.|+|+||.|++|+....+++|+|||++...-...+ .
T Consensus       115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-Y  189 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  189 (338)
T ss_pred             hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce-e
Confidence            9998755554443    2455589999999999999999999999999999999998877899999999987755432 2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCCCC---------CCCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSE---------TLPG  228 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~---------~~~~  228 (293)
                      .....+-.|--||.+...+.++...|+|||||++..|++.+-|| .+.+..+.+.+|....+.....         ..+.
T Consensus       190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~  269 (338)
T KOG0668|consen  190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ  269 (338)
T ss_pred             eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence            22234556888999988888999999999999999999999887 4556666666665544432211         1111


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCC-CCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGG-LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      +.....   .-..+........-... .++++.+++.++|..|-++|+||.|.+.||||...
T Consensus       270 ~~~i~~---~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  270 FEDILG---RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HhhHhh---ccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            111000   00011111111111122 46999999999999999999999999999999765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-40  Score=275.21  Aligned_cols=282  Identities=30%  Similarity=0.456  Sum_probs=225.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC------CCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH------ENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~   74 (293)
                      ||.+....|+|-||+|.+|.+...|..||||++.......   ..=..|+++|++|+.      -|.+.++..|...+++
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            7999999999999999999999999999999986543221   334579999999963      4899999999999999


Q ss_pred             eeEeecCCcchHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDFDLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      |+|+|.+.-.+.+.+.. .....+....++.++.|++.||..|.+.|++|.||||+||+|++..+++||||||.+.....
T Consensus       510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e  589 (752)
T KOG0670|consen  510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE  589 (752)
T ss_pred             EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence            99999999999988865 33456777799999999999999999999999999999999999999999999999977654


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      +.-  ..-..+--|.|||.+.+. +|+...|+||.||.||++.||+..|.+.+...++...++..+.++.......+-..
T Consensus       590 nei--tPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  590 NEI--TPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             ccc--cHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            311  111133459999999988 79999999999999999999999999999999999999999888776655443322


Q ss_pred             cccCCC--------------------CCCCcccchhhhcC----------CCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          234 EEFGFE--------------------PNRSPIKDLATVVG----------GLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       234 ~~~~~~--------------------~~~~~~~~~~~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      +-|+..                    .+..+..++.....          .+-..+.+|+.+||..||++|.|+.+.|.|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            222111                    01111111111110          122467899999999999999999999999


Q ss_pred             ccccc
Q 038154          284 EYFKD  288 (293)
Q Consensus       284 p~~~~  288 (293)
                      |||+.
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99963

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=262.77  Aligned_cols=254  Identities=16%  Similarity=0.176  Sum_probs=180.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCc---------ccHHHHHHHHHhcCCCCcceeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVP---------SSVIREVSLLKELKHENIVRLLNVQ   68 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~~~~~~   68 (293)
                      ||++.+.||+|+||+||+|....+   +..+++|+...........         .....+...+..+.|++++++++.+
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            699999999999999999987766   5667777543222111000         0111233344556799999999865


Q ss_pred             ecCC----cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEcc
Q 038154           69 SSVD----SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIAD  144 (293)
Q Consensus        69 ~~~~----~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~d  144 (293)
                      ....    ..+++++.+...+...+....  ..++..+..++.|++.||++||+.|++||||||+||+++.++. ++|+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~-~~l~D  169 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR-GYIID  169 (294)
T ss_pred             eEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc-EEEEE
Confidence            4443    346788887766665554332  2467788999999999999999999999999999999998877 99999


Q ss_pred             CCCcccCCCCCc-------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--
Q 038154          145 FGLARPIDVPLE-------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF--  215 (293)
Q Consensus       145 f~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~--  215 (293)
                      ||.++.......       ......+++.|+|||+..+. .++.++||||||+++++|++|..||.............  
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            999876532211       11223488999999987765 68999999999999999999999998764322211111  


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      +.......                        .....+..++.+.+++..|+..+|++||+..++++
T Consensus       249 ~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHE------------------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhh------------------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11010000                        00112345788999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=273.79  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=220.6

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      +++..||-|+||.|=++..+.....+|+|+++.....+ ...+++..|-++|.....|+|+++|..|.++.++|++||.|
T Consensus       423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence            45678999999999999766655568999886554333 44578889999999999999999999999999999999998


Q ss_pred             C-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           82 D-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        82 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      - |.+...+..++.  ++....+-++..+++|++|||.+|++.|||||+|.+++.+|. +||.|||+++.+.+.. ....
T Consensus       503 lGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-~KLVDFGFAKki~~g~-KTwT  578 (732)
T KOG0614|consen  503 LGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-LKLVDFGFAKKIGSGR-KTWT  578 (732)
T ss_pred             cCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc-eEEeehhhHHHhccCC-ceee
Confidence            5 677777766654  677788889999999999999999999999999999999998 9999999999988763 3445


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      .+|||.|.|||.+.+. .++.+.|.|+||+++||+++|..||.+.++-...+.|.....                     
T Consensus       579 FcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------------------  636 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------------------  636 (732)
T ss_pred             ecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------------
Confidence            5699999999999887 589999999999999999999999999999888888865222                     


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                             ....++.+++.+.+||+++..-+|++|..     +.||-+|.||..|.|
T Consensus       637 -------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  637 -------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             -------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence                   22445678899999999999999999976     899999999999877

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=288.71  Aligned_cols=248  Identities=26%  Similarity=0.337  Sum_probs=204.7

Q ss_pred             eeeeeeccccceeEEEEEeCCC-C----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            3 TLLEVIREGRYGAVHRAHDSLT-G----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~-~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ...+.||+|+||.||.|..... |    ..|++|.++. ..+.....+|..|..+++.++||||++++|++.+.+..+|+
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            3568899999999999985432 2    2488888753 33445567899999999999999999999999999999999


Q ss_pred             eecCC-cchHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           78 FENLD-FDLLHFMKTE-----PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        78 ~e~~~-~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      +|||. |+++.++.+.     +...+....+..++.|++.|..||+++++|||||...|+|++.... ||++|||.++.+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~-VKIaDFGlArDi  852 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV-VKIADFGLARDI  852 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc-EEEcccchhHhh
Confidence            99998 6788888765     1346778899999999999999999999999999999999998876 999999999844


Q ss_pred             CC-CCcceec-cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          152 DV-PLENYTI-KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       152 ~~-~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      -. ....... ..-...|||||.+... .++.++||||||+++||++| |..||.+.+..+++.....            
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~------------  919 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE------------  919 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh------------
Confidence            22 1111111 1244689999988864 79999999999999999998 6699999988888876654            


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                       ......++.+|..+.+++..|++.+|++||+...|++
T Consensus       920 -----------------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  920 -----------------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                             2234456678889999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-37  Score=255.06  Aligned_cols=249  Identities=22%  Similarity=0.265  Sum_probs=182.0

Q ss_pred             eeccccceeEEEEEeCCC--CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-
Q 038154            7 VIREGRYGAVHRAHDSLT--GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-   83 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-   83 (293)
                      .||+|+||.||++.....  ...+++|.+..... ......+.+|+.+++.++|||++++++.+......++||||+++ 
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            689999999999964332  23456666543222 23346788899999999999999999999999999999999985 


Q ss_pred             chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC--Cccee
Q 038154           84 DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYT  159 (293)
Q Consensus        84 ~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~--~~~~~  159 (293)
                      ++.+++....  ....+...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+......  .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT-VKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc-EEecccccccccCcchhhhccc
Confidence            5555665432  223556677889999999999999999999999999999998887 999999987542211  11112


Q ss_pred             ccCccccccCcccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          160 IKGGSLCYKAPERLLGS------GRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...++..|+|||++...      ...+.++|+||||+++|+|++ |..||...+..+....+........          
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------  229 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL----------  229 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc----------
Confidence            33467889999987431      235789999999999999997 4678877666555444322111000          


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                    .........++.+.+++..|+ .+|++||+++++++
T Consensus       230 --------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 --------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             --------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                          001112235678899999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=253.79  Aligned_cols=257  Identities=22%  Similarity=0.335  Sum_probs=197.8

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHh-cCCCCcceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE-LKHENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      ..||.|+||+|++..++.+|+..|||++..... .....++..|.+...+ -++|||++++|....++..++.||.+.-+
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhh
Confidence            568999999999999999999999999865443 2233455556655544 36999999999999999999999999854


Q ss_pred             hH---HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           85 LL---HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        85 ~~---~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +-   .....-....+++..+..|......||.||... +++|||+||+||+++..|. |||+|||.+-....+.... .
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~-vKLCDFGIcGqLv~SiAkT-~  226 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD-VKLCDFGICGQLVDSIAKT-V  226 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC-EeeecccchHhHHHHHHhh-h
Confidence            43   333444556688889999999999999999965 8999999999999999999 9999999986554332221 1


Q ss_pred             cCccccccCcccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-HhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLGSGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-IMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..|-.+|||||.+..... ++.+||+||||++|||+.||.+|+..++.  +..++.. ..+.++....+           
T Consensus       227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~-----------  293 (361)
T KOG1006|consen  227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD-----------  293 (361)
T ss_pred             ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc-----------
Confidence            226668999999976655 89999999999999999999999987644  3333322 12222211111           


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ...-..+..+..+|.-||..|.+.||..++++.+||++..
T Consensus       294 -----------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  294 -----------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             -----------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                       1112367889999999999999999999999999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=250.80  Aligned_cols=281  Identities=32%  Similarity=0.474  Sum_probs=218.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||.-++.+|.|+. .|..|.+.-.+.++++|+.-.........++..+|..++..++|+|+++++.++.-..      ..
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6777888999998 8888888889999999988555444556678889999999999999999999875443      58


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+|||++..++-+.+.    ..++...+..++.|.+.|+++||+.|++||||||+||++..+.. +|+.|||++......
T Consensus        97 y~v~e~m~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~-lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT-LKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHhhhhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh-eeeccchhhcccCcc
Confidence            9999999998887776    23667799999999999999999999999999999999998887 999999999876544


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ..+.-..+-.|.|||++.+.+ +....||||+||++.+|++|...|.+.+.-+.-.++.+..+.+............+
T Consensus       172 ~-~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             c-ccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            1 122222667899999999886 99999999999999999999999998887777777777777776554433222111


Q ss_pred             cc----------CCCCCCCcc--cchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EF----------GFEPNRSPI--KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~----------~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+          .+.......  .....-.+.-+..+.+++.+||..||++|.|++++|+|||++-|
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence            11          000000000  00001112234577899999999999999999999999999854

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-37  Score=248.80  Aligned_cols=242  Identities=39%  Similarity=0.551  Sum_probs=193.7

Q ss_pred             cceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-chHHHhh
Q 038154           12 RYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMK   90 (293)
Q Consensus        12 ~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~~~~~~   90 (293)
                      ++|.||++....+|+.+++|++........ ...+.+|++.+++++|++++++++.+......++++|++++ ++.+.+.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            579999999988899999999864332221 57889999999999999999999999998999999999997 5555554


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCc
Q 038154           91 TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP  170 (293)
Q Consensus        91 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  170 (293)
                      ....  ++...++.++.+++.++.+||+.|++|+||+|+||+++.++. ++++|||.+....... ......++..|++|
T Consensus        80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p  155 (244)
T smart00220       80 KRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH-VKLADFGLARQLDPGG-LLTTFVGTPEYMAP  155 (244)
T ss_pred             hccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc-EEEccccceeeecccc-ccccccCCcCCCCH
Confidence            4332  778899999999999999999999999999999999998877 9999999998765432 22333477889999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchh
Q 038154          171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-WAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLA  249 (293)
Q Consensus       171 E~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (293)
                      |...+. .++.++|+||||++++++++|..||... ................                           .
T Consensus       156 E~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~  207 (244)
T smart00220      156 EVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------------------------P  207 (244)
T ss_pred             HHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------------------------c
Confidence            987654 5788999999999999999999999873 3333333322100000                           0


Q ss_pred             hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          250 TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       250 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                      .....++.++.+++.+|+..+|.+||++.++++||||
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            0011156789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=268.48  Aligned_cols=243  Identities=22%  Similarity=0.327  Sum_probs=200.6

Q ss_pred             eeeeccccceeEEEEEeC----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDS----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .+.||.|.||.||.|...    ...-.||||.++.+. ..+..+.|..|.-+++++.||||++++|++.+ ...++|||.
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL  471 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL  471 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence            468999999999999743    233458999887543 34457899999999999999999999999877 568899999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |.+.++++.+.. .++...+..++.||+.||.|||++++|||||-..||+|....- |||+|||+++.+..+.-. .
T Consensus       472 ~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLSR~~ed~~yY-k  548 (974)
T KOG4257|consen  472 APLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLSRYLEDDAYY-K  548 (974)
T ss_pred             ccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchhhhccccchh-h
Confidence            98 788888876554 6788899999999999999999999999999999999997766 999999999988654222 2


Q ss_pred             ccC--ccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          160 IKG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       160 ~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      +..  -...|||||.+.-. .++.+||||.||+.+||++. |..||.+....+++..+..                    
T Consensus       549 aS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------------------  607 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------------------  607 (974)
T ss_pred             ccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--------------------
Confidence            222  34579999987655 79999999999999999654 7799988766666555432                    


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                               +...+.++.+|+.+..|..+|+..+|.+||...++..
T Consensus       608 ---------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  608 ---------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             ---------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence                     5556678889999999999999999999999988754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-38  Score=269.85  Aligned_cols=259  Identities=23%  Similarity=0.329  Sum_probs=207.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |..++.||-|+||.|.++....+...||.|.+.+... ..........|..||..-.++.||+++..|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            5678999999999999999888889999998854332 224456778899999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-----
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-----  154 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-----  154 (293)
                      ++ |++..+|+..+-  +.+..++.++..+.+|++..|+.|++||||||+||+||.+|+ |||+|||+++.+...     
T Consensus       711 IPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc-eeeeeccccccceecccccc
Confidence            98 677777777654  677788999999999999999999999999999999999999 999999998543210     


Q ss_pred             -------------------------------------CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh
Q 038154          155 -------------------------------------LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT  197 (293)
Q Consensus       155 -------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  197 (293)
                                                           ........|++.|+|||++... .++...|.||.|+|||+|+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhh
Confidence                                                 0001111278889999998877 58999999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC--
Q 038154          198 HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL--  275 (293)
Q Consensus       198 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp--  275 (293)
                      |+.||.+.++.+...++.....                          .........+++++.++|.++++ +++.|.  
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~--------------------------~l~~~~~~~ls~e~~~li~kLc~-sad~RLGk  919 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRN--------------------------FLHIPYQGNLSKEALDLIQKLCC-SADSRLGK  919 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhh--------------------------ccccccccccCHHHHHHHHHHhc-Chhhhhcc
Confidence            9999988877665444321100                          00112234578999999999865 788876  


Q ss_pred             -CHHHHhcCcccccCcC
Q 038154          276 -TAREALRHEYFKDFQS  291 (293)
Q Consensus       276 -s~~~ll~~p~~~~~~~  291 (293)
                       .+++|.+||||+.|-+
T Consensus       920 ng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  920 NGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             cchhhhhcCccccccch
Confidence             5678999999998855

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-37  Score=274.24  Aligned_cols=272  Identities=20%  Similarity=0.218  Sum_probs=170.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCC----CCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeee------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT----GDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNV------   67 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~------   67 (293)
                      +|++.+.||+|+||.||+|.+..+    +..+|+|++.....         .|..+..++   .+.++..+...      
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------~e~~~~e~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------VEIWMNERVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------hHHHHHHHHHhhchhhHHHHHHhhhcccc
Confidence            589999999999999999998888    89999998642111         122222222   22222222211      


Q ss_pred             eecCCcceeEeecCCcchH-HHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecccCC
Q 038154           68 QSSVDSIDLVFENLDFDLL-HFMKTEPTV------------------TKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP  128 (293)
Q Consensus        68 ~~~~~~~~lv~e~~~~~~~-~~~~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~  128 (293)
                      .......++|+||+++..+ +.+......                  ......+..++.||+.||.|||+.|++|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence            2455679999999986544 444332210                  011234667999999999999999999999999


Q ss_pred             CceeEeCCCCeEEEccCCCcccCCCCCcc-eeccCccccccCcccccCCC---------------------CCCCchhHH
Q 038154          129 ANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLCYKAPERLLGSG---------------------RYSTPVDVW  186 (293)
Q Consensus       129 ~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~  186 (293)
                      +||+++.+...+||+|||.+......... .....+++.|+|||++....                     .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            99999965434999999999765332111 12334788999999764321                     133456999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHh
Q 038154          187 AVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRM  266 (293)
Q Consensus       187 slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  266 (293)
                      ||||++|+|+++..|+...  ...........+...    ..+..   ..... ..................+++||.+|
T Consensus       364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~----~~~~~---~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDL----VAWRK---LVEPR-ASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcH----HHHHH---hhccc-cchhhhhhhhhccccchHHHHHHHHH
Confidence            9999999999977664321  111111111111000    00000   00000 00000000111222345677999999


Q ss_pred             hccCCCCCCCHHHHhcCcccccCcC
Q 038154          267 LCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       267 l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      |+.||++|||+.++|+||||+....
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999999987543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=272.00  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=212.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeee-----ecCCcce
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQ-----SSVDSID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-----~~~~~~~   75 (293)
                      |+|.+.+|.|.+|.||++.+..+++..|+|+.......+   +++..|.++++.+ .|||++.+++++     ..++.++
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            789999999999999999999999999999876544333   6788899999988 599999999987     3456899


Q ss_pred             eEeecCCcchHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDFDLLHFM-KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +|||+|+|++...+ .+.....+.++.+..|++.++.||.+||...++|+|||-.||+++.++. |||+|||.+....+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~-VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDST  176 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc-EEEeeeeeeeeeecc
Confidence            99999996555544 4444677899999999999999999999999999999999999999998 999999999888777


Q ss_pred             CcceeccCccccccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          155 LENYTIKGGSLCYKAPERLLGS----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ........|+|.|||||++...    ..++..+|+||||++..+|.-|..|+-+..+--.+-.|   ...|+        
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPP--------  245 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPP--------  245 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCC--------
Confidence            6777777799999999998643    34677899999999999999999999776553332222   11111        


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                      .-...++..++++.++|..||..|..+||+..++|.|||+..
T Consensus       246 ----------------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  246 ----------------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ----------------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                            111234556889999999999999999999999999999874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=264.33  Aligned_cols=245  Identities=24%  Similarity=0.285  Sum_probs=208.6

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .+..+||.|.||.||.+..+.-.-.+|||.++.+.   -...+|..|..+++.+.|||+++++++|..+..+|||+|||.
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            35689999999999999998888899999886433   234789999999999999999999999999999999999997


Q ss_pred             -cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 -FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 -~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                       |.+++++.+......+...+++++.||..|+.||.+++++|+||-..|.+|.++.- ||+.|||+++.+..+.......
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi-VKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI-VKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce-EEeeccchhhhhcCCceecccC
Confidence             89999999888777888889999999999999999999999999999999997765 9999999999887654433322


Q ss_pred             C-ccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          162 G-GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       162 ~-~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      . -.+.|.|||.+.-+ .++.++|||+||++||++.| |..||.+.+...+...+..                       
T Consensus       426 AKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-----------------------  481 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-----------------------  481 (1157)
T ss_pred             ccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-----------------------
Confidence            1 34679999987655 68999999999999999988 5689988877776666543                       


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHh
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL  281 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  281 (293)
                            +-...-+.++++.+.+|++.|++++|++||+..|+-
T Consensus       482 ------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  482 ------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                  222234567899999999999999999999998863

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=258.74  Aligned_cols=254  Identities=24%  Similarity=0.290  Sum_probs=208.9

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .++++||+|.||.|.++.-. .+..||+|.++.. .......+|..|+++|.+|+||||+.++++|..++.+++|+||++
T Consensus       541 ~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             ehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            57899999999999999643 4689999998643 344456889999999999999999999999999999999999998


Q ss_pred             -cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec-
Q 038154           83 -FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI-  160 (293)
Q Consensus        83 -~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~-  160 (293)
                       |.+.+++.++............|+.||+.|++||.+.++|||||.+.|++++.+.+ +||+|||.++..-+....... 
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~-iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT-IKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc-EEecCcccccccccCCceeeec
Confidence             88888888875544555667789999999999999999999999999999999998 999999999855433222211 


Q ss_pred             -cCccccccCcccccCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          161 -KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV--THQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       161 -~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ..-..+|||+|.+... .++.+||+|++|+++||++  +...||...+.++.+....+.......              
T Consensus       698 r~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~--------------  762 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR--------------  762 (807)
T ss_pred             ceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc--------------
Confidence             1134689999988766 7999999999999999964  567999999998888887654443321              


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                              ......++-++..+.+++.+|+..|-.+|||.+++-.
T Consensus       763 --------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  763 --------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             --------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                    2233445668899999999999999999999999855

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=243.18  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=213.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |.++.+||+|++++|.+++.+.+.+.||+|+++.+-..+ +..+=...|-.+..+- +||.++-++..|..+..+++|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            678999999999999999999999999999997655433 3445556677777766 69999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++|+-+-+..+.+. .++++.++.+...|+.||.|||+.|++.+|||.+||+++..|. +||+|+|.++.--.+....+
T Consensus       332 yv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh-ikltdygmcke~l~~gd~ts  409 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGLGPGDTTS  409 (593)
T ss_pred             EecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc-eeecccchhhcCCCCCcccc
Confidence            999776666555544 5889999999999999999999999999999999999999999 99999999987666666677


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS-------RWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..+|||.|+|||.+.+. .|....|.|+||+++++|+.|+.||.-       .+.++.+-++.-                
T Consensus       410 tfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil----------------  472 (593)
T KOG0695|consen  410 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL----------------  472 (593)
T ss_pred             cccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh----------------
Confidence            77899999999998887 799999999999999999999999952       233333333221                


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC------HHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT------AREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~p~~~~~~~  291 (293)
                                   .....++..++-.+-.+++.-|+.||.+|..      ..++-+|+||+.+-|
T Consensus       473 -------------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  473 -------------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             -------------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence                         1112334456677788999999999999964      489999999997755

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=273.97  Aligned_cols=248  Identities=28%  Similarity=0.402  Sum_probs=190.7

Q ss_pred             eeeecccccee-EEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCC
Q 038154            5 LEVIREGRYGA-VHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         5 ~~~lg~g~~~~-vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .+.+|.|+.|+ ||+|  ...|+.||||.+-.     +......+|++.|+.- .||||+++++.-.+....||+.|.|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRG--VYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHHcccCCCCcEEEEE--eeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            36788898866 8999  56688999998742     2334677899999988 59999999999999999999999999


Q ss_pred             cchHHHhhcC-C-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CC-CeEEEccCCCcccCCCCCc
Q 038154           83 FDLLHFMKTE-P-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SK-DIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        83 ~~~~~~~~~~-~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~-~~v~l~df~~~~~~~~~~~  156 (293)
                      .++.+++... . .........+.+..|++.||++||+.++|||||||.||+|+.   ++ -.++|+|||.++.......
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999888774 1 111122456788999999999999999999999999999987   34 2689999999998866544


Q ss_pred             cee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 NYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...   ...|+.+|+|||++... .-+.+.|||||||++|+.++| ..||.+.-..+  +.|..                
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~----------------  727 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT----------------  727 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc----------------
Confidence            332   33488999999988776 467799999999999998887 69997642221  12211                


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ....+..+.+....++.+||.+|+..||..||+|.+||.||||=.+
T Consensus       728 -----------~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  728 -----------GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             -----------CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                       0011111111112278999999999999999999999999998544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-35  Score=256.43  Aligned_cols=270  Identities=20%  Similarity=0.249  Sum_probs=177.6

Q ss_pred             CceeeeeeccccceeEEEEEe----------------CCCCCeEEEEEecccCCC------------CCCcccHHHHHHH
Q 038154            1 RYTLLEVIREGRYGAVHRAHD----------------SLTGDTVVVKKIPIMNPS------------EGVPSSVIREVSL   52 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~----------------~~~~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~   52 (293)
                      .|++.++||+|+||+||++..                ...+..||+|++......            ....+....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            488999999999999999964                234567999998543211            1112233446777


Q ss_pred             HHhcCCCCc-----ceeeeeeec--------CCcceeEeecCCcc-hHHHhhcCC----------------------CCC
Q 038154           53 LKELKHENI-----VRLLNVQSS--------VDSIDLVFENLDFD-LLHFMKTEP----------------------TVT   96 (293)
Q Consensus        53 l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~-~~~~~~~~~----------------------~~~   96 (293)
                      +.++.|.++     +++++++..        .+..++||||+++. +.+.+....                      ...
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777765543     566666643        34679999999854 444443211                      112


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-eeccCccccccCcccccC
Q 038154           97 KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLCYKAPERLLG  175 (293)
Q Consensus        97 ~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~  175 (293)
                      .++..++.++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||.+......... ......++.|+|||++..
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc-EEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence            345678889999999999999999999999999999998887 999999998755432111 112224789999998753


Q ss_pred             CCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          176 SGR---------------------YSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       176 ~~~---------------------~~~~~Di~slG~ll~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ...                     .....|+||+|+++++|++|.. ||.+...-.......       ......+.   
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-------~~~~~~~r---  454 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-------DNDLNRWR---  454 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-------cchHHHHH---
Confidence            211                     1134799999999999999985 765321110000000       00000000   


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCC---CCCCCHHHHhcCccccc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP---SKRLTAREALRHEYFKD  288 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~ll~~p~~~~  288 (293)
                            ........ -......+++.++++.+||..+|   .+|+|+.++|+||||..
T Consensus       455 ------~~~~~~~~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        455 ------MYKGQKYD-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ------hhcccCCC-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                  00000000 11234568899999999999866   68999999999999964

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=242.66  Aligned_cols=280  Identities=32%  Similarity=0.556  Sum_probs=218.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cceeEeec
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SIDLVFEN   80 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~   80 (293)
                      +.||.|+||+||.+.++.+|+.+++|++.+....-...+.+.+|+.+|.-++|.|++...++..-..     ..|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            6799999999999999999999999998765544455578889999999999999999988754443     46788888


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-cee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~~  159 (293)
                      +..++...+.....  ++...+.-++.||+++|.|||+.||.|+||||.|.+++.+-- .||+|||+++....+.. ...
T Consensus       139 mQSDLHKIIVSPQ~--Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv-LKICDFGLARvee~d~~~hMT  215 (449)
T KOG0664|consen  139 MQSDLHKIIVSPQA--LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI-LKICDFGLARTWDQRDRLNMT  215 (449)
T ss_pred             HHhhhhheeccCCC--CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce-EEecccccccccchhhhhhhH
Confidence            87777766655544  566688889999999999999999999999999999997765 99999999987654322 223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ....+..|+|||.+.+...|+.+.||||.|||+.|++..+..|.+.++-+.+..|.+..+.+..+....-.+-.+.--.+
T Consensus       216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR  295 (449)
T KOG0664|consen  216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR  295 (449)
T ss_pred             HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence            33367789999999999999999999999999999999999999999999999999988888665443222111111111


Q ss_pred             CCCCcccc---hhhhcC--CCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKD---LATVVG--GLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~---~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      . ..+...   +-.+.+  ....+...++..||..||++|.+.++.+.|+++...
T Consensus       296 ~-~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  296 A-GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             c-CCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            1 111111   111111  334577889999999999999999999999987653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=251.42  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=204.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-----CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC-Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-----PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV-DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~   74 (293)
                      ||-++..||+|+|+.||+|.+....+.+|+|+-....     ......+...+|.++-+.|.||.||++++++.-+ +.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            6788899999999999999999888999999754322     2234456778899999999999999999998554 579


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecccCCCceeEeCCCC--eEEEccCCCccc
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ--EILHRDLKPANFLIDRSKD--IVKIADFGLARP  150 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~  150 (293)
                      |.|.|||+|.-+++...... .+++..++.|+.||+.||.||...  .|+|.||||.||++.....  .+||+|||+++.
T Consensus       544 CTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            99999999988887765443 588999999999999999999976  5999999999999974321  599999999987


Q ss_pred             CCCCCcc-------eeccCccccccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 038154          151 IDVPLEN-------YTIKGGSLCYKAPERLLG---SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT  220 (293)
Q Consensus       151 ~~~~~~~-------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  220 (293)
                      +..+...       .+...||.||.+||.+.-   .+..+.+.||||.|+|+|.++-|+.||.......   .|......
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeNTI  699 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQENTI  699 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhhch
Confidence            7543222       233348999999997742   3457889999999999999999999998764332   22211111


Q ss_pred             CCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      ...          .+..           -+.-+.++.++.++|++||..--+.|....++-.||+|..
T Consensus       700 lkA----------tEVq-----------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  700 LKA----------TEVQ-----------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hcc----------eecc-----------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            000          0000           0112347889999999999999999999999999999864

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=258.22  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=210.2

Q ss_pred             eeeeeccccceeEEEEEeCC-CCC--eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            4 LLEVIREGRYGAVHRAHDSL-TGD--TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~-~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ..+.||+|.||+|+++.... +|+  .||||++...... ....+|.+|+.+|.+|+|+|++++||+..+ ...-+|+|.
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            45789999999999997653 444  4799988643332 256899999999999999999999999877 778899999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |++++.+.......+....+..++.||+.|++||..++++||||-+.|+++-.... |||+|||+.+.++.....+.
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt-VKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT-VKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce-eeeecccceeccCCCCcceE
Confidence            98 88888888766667788899999999999999999999999999999999987555 99999999998876555543


Q ss_pred             ccC---ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          160 IKG---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       160 ~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ...   -...|+|||.+... .++.+||+|++|+++|||+|+ ..||.+...-.++.++-+                   
T Consensus       271 m~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-------------------  330 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-------------------  330 (1039)
T ss_pred             ecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-------------------
Confidence            221   34579999988765 799999999999999999985 599999999888888732                   


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                +....-++.+++++.++++.|+..+|.+|||..+|.+.-++...
T Consensus       331 ----------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  331 ----------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             ----------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence                      34445566789999999999999999999999998765555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-37  Score=264.12  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=209.5

Q ss_pred             eeeeeeccccceeEEEEEeCCCC---CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|.++||.|.||.|++++.+..|   ..||||.++ ....+..+.+|..|..+|-++.||||+++.|+......+.||.|
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK-~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeec-cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            57899999999999999877655   468999986 45556677899999999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ||+.+.|+.+.......+...++.-|++.|+.|++||-+.|+|||||-+.||+|+.+-- +|++|||+++....+.+...
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv-CKVsDFGLSRvledd~~~~y  789 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEAAY  789 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE-EEeccccceeecccCCCccc
Confidence            99965555444444456888899999999999999999999999999999999998776 99999999998765543322


Q ss_pred             -ccCc--cccccCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          160 -IKGG--SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV-THQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       160 -~~~~--~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                       ...|  ..+|.|||.+.-. .++.+|||||+|++|||.+ .|..||=+.+.++++..+...-+-|+             
T Consensus       790 tt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-------------  855 (996)
T KOG0196|consen  790 TTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-------------  855 (996)
T ss_pred             cccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC-------------
Confidence             2223  3579999987655 7999999999999999955 48899999999999999976444444             


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      +.++|..+.+|+..|++.|..+||...+|++
T Consensus       856 ----------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  856 ----------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ----------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                            3346788999999999999999999999887

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=7.1e-36  Score=242.26  Aligned_cols=280  Identities=28%  Similarity=0.443  Sum_probs=201.7

Q ss_pred             ceeeeeeccccceeEEEEEeCC---CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeE
Q 038154            2 YTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      |..++++|+|.|++||++.+..   .++.|++|.+..    ......+.+|+++|..+ .+.||+++.+.+..++...+|
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            6788999999999999998776   788899998743    33446799999999999 589999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC---
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP---  154 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~---  154 (293)
                      +||++......+...    ++...++.+++.++.||+++|++||+|+||||+|++.+.....-.|+|||++......   
T Consensus       114 lp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             ecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            999996555544433    4566999999999999999999999999999999999987777889999998511000   


Q ss_pred             -----------------------------Cccee------------ccCccccccCcccccCCCCCCCchhHHHHHHHHH
Q 038154          155 -----------------------------LENYT------------IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFA  193 (293)
Q Consensus       155 -----------------------------~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  193 (293)
                                                   +....            ...||++|+|||++...+.-+.+.|+||-|+|++
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                                         00000            0018899999999999888899999999999999


Q ss_pred             HHHhCCCCCCCC-CchHHHHHHHHHhCCCCC--------C--CCC-CCcCcccc--cCCCCC------CCcc-cchhhh-
Q 038154          194 EMVTHQRLFHSR-WAPGLLAAIFSIMGTPDS--------E--TLP-GFTSFSEE--FGFEPN------RSPI-KDLATV-  251 (293)
Q Consensus       194 ~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~--------~--~~~-~~~~~~~~--~~~~~~------~~~~-~~~~~~-  251 (293)
                      .++++.+||-.. +.-+.+..+.-..+...-        .  .+. .......+  ..++.-      +... ...... 
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            999999998432 222222222221111100        0  000 00000000  011100      0000 011112 


Q ss_pred             cCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          252 VGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       252 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ....+..+.+++.+||..||.+|.|+++.|.||||...
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            22345689999999999999999999999999999854

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=276.11  Aligned_cols=251  Identities=20%  Similarity=0.204  Sum_probs=178.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |...+.||+|++|.||+|....++..||+|.+....      .....|++.+++++||||+++++++.+.+..++||||+
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            345678999999999999988899999999875322      12235688999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH---SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++.+..+..    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++. .++. ++........    
T Consensus       766 ~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~-~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        766 EGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE-PHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc-eEEE-eccccccccC----
Confidence            8655544443    2677899999999999999999   669999999999999997776 5543 4443222111    


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++||||+|+++|||++|+.||..... ......+........        ......+
T Consensus       836 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  906 (968)
T PLN00113        836 TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--------HLDMWID  906 (968)
T ss_pred             CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--------chhheeC
Confidence            112377899999987755 689999999999999999999999964322 111222221111000        0000000


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ......     .........++.+++.+|++.||++|||+.++++
T Consensus       907 ~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  946 (968)
T PLN00113        907 PSIRGD-----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLK  946 (968)
T ss_pred             ccccCC-----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence            000000     0000111235778999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.4e-32  Score=216.68  Aligned_cols=214  Identities=38%  Similarity=0.581  Sum_probs=178.4

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCcchHH
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLH   87 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~~   87 (293)
                      ||+|++|.||++....+++.+++|++....... ....+.+|++.++.+.|++++++++++......++++|+++|..+.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999988789999999986433221 3467889999999999999999999999999999999999954444


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-CCCeEEEccCCCcccCCCCCcceeccCcccc
Q 038154           88 FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDIVKIADFGLARPIDVPLENYTIKGGSLC  166 (293)
Q Consensus        88 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~  166 (293)
                      .+........+...++.++.+++.+|++||+.|++|+||+|+||+++. .+. ++|+|||.+..............+...
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc-EEEecCCceEEccCCcchhhcccCCCC
Confidence            444333245788899999999999999999999999999999999998 566 999999999866544322233347788


Q ss_pred             ccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCccc
Q 038154          167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIK  246 (293)
Q Consensus       167 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (293)
                      |++||........+.++|+|++|++++++                                                   
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------------  187 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------------  187 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------------
Confidence            99999876544678999999999999998                                                   


Q ss_pred             chhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          247 DLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                                ..+.+++.+|++.||++||++.++++++
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                      2467899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=244.28  Aligned_cols=245  Identities=23%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             eeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      -.++||+|+||+||++..-..|+    +|++|++.. ........++.+|+-++.++.|||++++++++.... .-||++
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            35899999999999998654455    578887743 333444578999999999999999999999987755 889999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++ |.+++++..+.. .+-....+.+..||+.|+.|||++++|||||-+.||+|.+-.. +|+.|||.+.....+....
T Consensus       778 ~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h-vkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH-VKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe-EEEEecchhhccCcccccc
Confidence            999 677777776543 5667788999999999999999999999999999999997776 9999999999887766666


Q ss_pred             eccCc--cccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 TIKGG--SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 ~~~~~--~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ....+  .+.|+|-|.+... .++.++||||+|+.+||++| |..|+.+...+++...+..                   
T Consensus       856 ~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------------------  915 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------------------  915 (1177)
T ss_pred             cccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------------------
Confidence            55544  4679999977655 79999999999999999877 7799988888777666643                   


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                +.....++-.+.++..++.+|+..|+..||+++++.+
T Consensus       916 ----------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  916 ----------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ----------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                      3445566778899999999999999999999998765

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-32  Score=245.30  Aligned_cols=248  Identities=27%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             eeeeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            3 TLLEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      .+.+.||+|+||.|+++.-..       ....||+|.++..... ...+.+..|+++++.+ .|||++.+.+.+...+..
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            356799999999999996321       1456899988654444 6668899999999999 599999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe
Q 038154           75 DLVFENLD-FDLLHFMKTEP------------T--VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~------------~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                      ++|.||+. |+++.++....            .  ..+....+..++.||+.|++||++.+++||||-+.||++..+.. 
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~-  456 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV-  456 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE-
Confidence            99999998 88888887665            0  13777889999999999999999999999999999999998765 


Q ss_pred             EEEccCCCcccCCCCCcce-eccC--ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-chHHHHHH
Q 038154          140 VKIADFGLARPIDVPLENY-TIKG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRW-APGLLAAI  214 (293)
Q Consensus       140 v~l~df~~~~~~~~~~~~~-~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~-~~~~~~~~  214 (293)
                      +|++|||+++......... ....  -...|||||.+... .++.+|||||+|+++||++|. ..||.+.. ..+....+
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l  535 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL  535 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence            9999999998653321211 1111  23459999998874 799999999999999999984 58888754 34444433


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..                             +.....+..++.++.++++.|++.+|++||+..++..
T Consensus       536 ~~-----------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  536 KE-----------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             hc-----------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            22                             3333445567899999999999999999999999876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=237.20  Aligned_cols=197  Identities=30%  Similarity=0.406  Sum_probs=168.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC------CCcccHHHHHHHHHhcC---CCCcceeeeeeecCC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELK---HENIVRLLNVQSSVD   72 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~   72 (293)
                      |...+.+|+|+||.|+++.++.+...|++|.+.++..-.      ...--+..|+++|..++   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            788999999999999999999999999999886544322      11234557999999997   999999999999999


Q ss_pred             cceeEeecCC-c-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           73 SIDLVFENLD-F-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        73 ~~~lv~e~~~-~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ++|++||..+ | ++.+++..++  .+++..+..|++|++.|+++||+.||+|||||-+||.++.+|. +||+|||.+..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~-~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF-VKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe-EEEeeccchhh
Confidence            9999999987 5 4444544444  4778889999999999999999999999999999999999998 99999999987


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                      ..+.+-  ....||..|.|||++.+..+....-|||+||+++|.++....||-
T Consensus       720 ~ksgpf--d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSGPF--DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCCCc--ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            765433  334499999999999999888889999999999999998888874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=205.48  Aligned_cols=207  Identities=25%  Similarity=0.399  Sum_probs=165.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEeecCCc
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +..||+|++|.|=+.++..+|...|+|.+...-. .....+...|+.+..+. .||+++.++|.....+..++.||-+.-
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            4579999999999999999999999999864333 22334555667666554 599999999998888999999999987


Q ss_pred             chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           84 DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        84 ~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++-.+..+  ......++..+-+|+..+..||.|||++ .++|||+||+||+++.+|. ||+||||.+-....+... +.
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq-VKiCDFGIsG~L~dSiAk-t~  207 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ-VKICDFGISGYLVDSIAK-TM  207 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc-EEEcccccceeehhhhHH-HH
Confidence            76655432  3344688889999999999999999976 8999999999999999999 999999998766543222 22


Q ss_pred             cCccccccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHH
Q 038154          161 KGGSLCYKAPERLLG---SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAI  214 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~  214 (293)
                      ..|-..|+|||.+..   +..|+.+|||||||+.+.||.++++||.....+ +.+.++
T Consensus       208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            236678999998753   236889999999999999999999999876443 444444

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=240.10  Aligned_cols=259  Identities=26%  Similarity=0.349  Sum_probs=212.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|+.+.++|+|.+|.||+++++.+++..|+|+++....  +...-+.+|+-+++..+||||+.+++.+......++.|||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            48889999999999999999999999999999876543  4456788899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      |+|+.++.+..-. ..+++.++..+++..+.+|.|||+.|=.|||||-.||+++..++ +|+.|||.+..+.....+..+
T Consensus        94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD-vklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD-VKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc-eeecccCchhhhhhhhhhhhc
Confidence            9988887776543 36888899999999999999999999999999999999999998 999999999888877777778


Q ss_pred             cCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ..|++.|||||+..  ..+.+...+|||++|+...++---+.|--+..+...+..+-.  ..+.....            
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp~l------------  237 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPPTL------------  237 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCCcc------------
Confidence            88999999999762  345688999999999999999887777544433222222211  11100000            


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 .-....++.+.+|++.+|..+|.+||+++.+|.|||...
T Consensus       238 -----------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  238 -----------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             -----------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                       011225678889999999999999999999999999764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=224.46  Aligned_cols=185  Identities=30%  Similarity=0.374  Sum_probs=151.4

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc--CCCCcceeeeeeecCC----cceeE
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL--KHENIVRLLNVQSSVD----SIDLV   77 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~~lv   77 (293)
                      ..+.+|+|.||+||+|  +.+++.||||+++.     ...+.+.+|-++++..  .|+||+++++.-....    .+++|
T Consensus       214 l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKA--QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             hHHHhhcCccceeehh--hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3568999999999999  66789999999864     3346788888888764  7999999998755444    79999


Q ss_pred             eecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           78 FENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS---------QEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        78 ~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      +++.+ |++-+++..+   .+++....+|+..+++||+|||+         -.|+|||||++||+|..++. +-|+|||+
T Consensus       287 t~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT-ccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT-CCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc-EEeeccce
Confidence            99998 7777888765   46888999999999999999995         35999999999999999998 89999999


Q ss_pred             cccCCCCCccee--ccCccccccCcccccCCCCCC-----CchhHHHHHHHHHHHHhCC
Q 038154          148 ARPIDVPLENYT--IKGGSLCYKAPERLLGSGRYS-----TPVDVWAVACTFAEMVTHQ  199 (293)
Q Consensus       148 ~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g~  199 (293)
                      +..+........  ...||.+|||||++.+.-...     .+.||||+|.++||+++..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            987754322221  233899999999997754333     3689999999999999854

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=211.75  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=188.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeee-eecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNV-QSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~~~~~~lv~   78 (293)
                      +|.|.+.||+|.||.+-++++..+...+++|.++..   .....+|.+|..---.| .|.||+..+++ |+..+.+++++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            488899999999999999999999999999987643   34446777776544344 48999998875 67778899999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-CCCeEEEccCCCcccCCCCCc
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |+++ |++...+..   .++-+....+++.|+++|+.|||++++||||||.+||+|.. +...|||+|||.++..+....
T Consensus       102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            9999 565555443   34667788899999999999999999999999999999964 344799999999988775433


Q ss_pred             ceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          157 NYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...   ....|.+||+...    .-...+.+|+|.||+++|.++||..||..... +.....+....+..          
T Consensus       179 ~~~---~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk----------  245 (378)
T KOG1345|consen  179 YLE---YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK----------  245 (378)
T ss_pred             hhh---hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc----------
Confidence            332   4556899997643    22356789999999999999999999974322 22333333322211          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC---CCHHHHhcCccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR---LTAREALRHEYF  286 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~p~~  286 (293)
                                   ..........+++.+.+++++-|..++.+|   -++..-...-|.
T Consensus       246 -------------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  246 -------------NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             -------------CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence                         112233444578899999999999999999   444444444443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=214.39  Aligned_cols=185  Identities=29%  Similarity=0.402  Sum_probs=149.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHh--cCCCCcceeeeeeecCC----cce
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE--LKHENIVRLLNVQSSVD----SID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~~   75 (293)
                      -.+.+.+|+|.||.||+|  .+.|+.||||+|.-  ..   .....+|.++++.  |+|+||+.+++.-..++    +++
T Consensus       213 I~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s--rd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS--RD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             eEEEEEecCccccceeec--cccCCceEEEEecc--cc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            357899999999999999  78899999999742  22   2567888888876  48999999998633222    589


Q ss_pred             eEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-----Q---EILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-----~---~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      +|++|.+ |++.+++...   .++.....+++..++.||++||-     +   .+.|||||+.||+|.+++. +-|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~-C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc-EEEeece
Confidence            9999999 7888887763   57778999999999999999994     2   3999999999999999998 9999999


Q ss_pred             CcccCCCCCcc----eeccCccccccCcccccCCCCC-----CCchhHHHHHHHHHHHHh
Q 038154          147 LARPIDVPLEN----YTIKGGSLCYKAPERLLGSGRY-----STPVDVWAVACTFAEMVT  197 (293)
Q Consensus       147 ~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~  197 (293)
                      ++.........    .....||.+|||||++......     -..+||||||.++||+..
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            99776654332    2333489999999998764322     236899999999999876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-30  Score=206.86  Aligned_cols=211  Identities=35%  Similarity=0.511  Sum_probs=172.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |.+.+.||.|+++.||++....+++.+++|.+...... .....+..|++.++++.|++++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            67899999999999999999888899999998643322 24578888999999999999999999999989999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC-ccee
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL-ENYT  159 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~-~~~~  159 (293)
                      ++ ++.+.+..... .+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus        80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~-~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       80 EGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL-VKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeeCceeeEecCccccccc
Confidence            97 55555544322 2678899999999999999999999999999999999998877 9999999988765432 0112


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCchHHHHHHH
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS--RWAPGLLAAIF  215 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~--~~~~~~~~~~~  215 (293)
                      ...++..|++||.+.+...++.++|+|+||+++++|++|..||..  .....+.+.+.
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            223677899999874444677899999999999999999999977  34445555553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3.6e-31  Score=246.17  Aligned_cols=202  Identities=19%  Similarity=0.243  Sum_probs=143.2

Q ss_pred             hcCC-CCcceeeeee-------ecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccc
Q 038154           55 ELKH-ENIVRLLNVQ-------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL  126 (293)
Q Consensus        55 ~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl  126 (293)
                      .+.| +||.++++++       .....+++++|++++++.+++... ...+++..+..++.||+.||.|||++||+|+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3445 5777777776       233467888999989888887643 345888899999999999999999999999999


Q ss_pred             CCCceeEeCCCC------------------eEEEccCCCcccCCCCC----------------cceeccCccccccCccc
Q 038154          127 KPANFLIDRSKD------------------IVKIADFGLARPIDVPL----------------ENYTIKGGSLCYKAPER  172 (293)
Q Consensus       127 ~~~Ni~i~~~~~------------------~v~l~df~~~~~~~~~~----------------~~~~~~~~~~~~~aPE~  172 (293)
                      ||+||+++..+.                  .+|++|||.++......                .......++++|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999965333                  25666666654321100                00011236788999998


Q ss_pred             ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhc
Q 038154          173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVV  252 (293)
Q Consensus       173 ~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (293)
                      +.+. .++.++|||||||++|||++|..|+....  .....+..... ++ .                           .
T Consensus       187 ~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~-~---------------------------~  234 (793)
T PLN00181        187 DNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PP-Q---------------------------I  234 (793)
T ss_pred             hccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Ch-h---------------------------h
Confidence            8766 68999999999999999999888865321  11111111000 00 0                           0


Q ss_pred             CCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          253 GGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       253 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ....+...+++.+||..||.+||++.+++.||||...
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            0013456789999999999999999999999999763

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=203.62  Aligned_cols=250  Identities=18%  Similarity=0.207  Sum_probs=192.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   74 (293)
                      |++....+-+|.||.||+|+....+     +.+.+|.++ ...++-....+..|-..+..+.|||++++.++... ....
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            4566677889999999999643222     235556553 22334445677788888888899999999998654 4577


Q ss_pred             eeEeecCC-cchHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           75 DLVFENLD-FDLLHFMKT------EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      .+++.+.+ |++..++..      .........++..++.|++.|++|||+.|++|.||-+.|.+|+..-. |||+|=.+
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq-VkltDsaL  442 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ-VKLTDSAL  442 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee-EEeccchh
Confidence            88889888 666666651      22344566678889999999999999999999999999999998776 99999888


Q ss_pred             cccCCCCCcceec--cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPLENYTI--KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      ++..-...-+.-.  ......||+||.+.+. .++.++|+||||+++|||+| |+.|+-..++.++...+.+        
T Consensus       443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd--------  513 (563)
T KOG1024|consen  443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD--------  513 (563)
T ss_pred             ccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc--------
Confidence            8765433222211  1145679999988877 69999999999999999887 6799988888887777654        


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                           +-....+-.+|.++..++.-|+..+|++||+..++..
T Consensus       514 ---------------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 ---------------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ---------------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                 2233344567899999999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-27  Score=196.72  Aligned_cols=254  Identities=22%  Similarity=0.202  Sum_probs=191.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-CeEEEEEecccCCCCCCcccHHHHHHHHHhcC----CCCcceeeeee-ecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-DTVVVKKIPIMNPSEGVPSSVIREVSLLKELK----HENIVRLLNVQ-SSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~   74 (293)
                      +|.+.++||+|+||.||.+.+...+ ..+|+|.-........  ..+..|..++..+.    .+++..+++.+ ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            6999999999999999999877664 5678876543322222  26888999999886    36999999998 577889


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC----CeEEEccCCCccc
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK----DIVKIADFGLARP  150 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~----~~v~l~df~~~~~  150 (293)
                      ++||+.++.++.+.........++..++..++.|++.+|++||+.|++||||||.|+.+....    ..+.|.|||.++.
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999999999988877666667889999999999999999999999999999999999998764    4599999999983


Q ss_pred             CC---CCC------cc-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 038154          151 ID---VPL------EN-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT  220 (293)
Q Consensus       151 ~~---~~~------~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  220 (293)
                      ..   ...      .. .....||..|+++.+..+. ..+++.|+||+++++.++..|..||..........+.......
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence            22   111      11 1233489999999977766 6899999999999999999999999776543333333221111


Q ss_pred             CCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .....                         .....+.++.++...+-..+...+|....+..
T Consensus       256 ~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  256 LLTDR-------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hcccc-------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            11000                         11223456667777776788888888776644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=9.6e-30  Score=225.85  Aligned_cols=265  Identities=26%  Similarity=0.369  Sum_probs=198.5

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEeccc----CCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM----NPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      -...+|.|++|.++.+......+.+..|.+...    .........+..|+-+-..+.||+++.......+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            357889999998888876666666666654321    1111111225556666777889999888887766666555599


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--  157 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--  157 (293)
                      |+++++...+...  ..+....+-.+++|++.||+|||+.|+.|+|+|++|+++..++. +|++|||.+.....+.+.  
T Consensus       402 ~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~-lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  402 YCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI-LKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             cccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc-eEEeecCcceeeccCcchhh
Confidence            9999666666554  23566688899999999999999999999999999999999987 999999998877554443  


Q ss_pred             --eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          158 --YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       158 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        .....|+.+|+|||++.+........||||.|+++..|.+|+.||......+....         ....         
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~~---------  540 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNNY---------  540 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhcc---------
Confidence              23334888999999999886667788999999999999999999976544332210         0000         


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                         ............+...++...+.+|.+||++||.+|.|+++|++.+||+.++-|
T Consensus       541 ---~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  541 ---SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ---ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence               011112234445666788999999999999999999999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.3e-28  Score=187.63  Aligned_cols=167  Identities=18%  Similarity=0.189  Sum_probs=123.6

Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccC
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      |++.+.+... ...+++..++.++.|++.||+|||+.+      ||+||+++.++. +++  ||.+.......     ..
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~-~~~--fG~~~~~~~~~-----~~   65 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL-LKL--DGSVAFKTPEQ-----SR   65 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc-eee--ccceEeecccc-----CC
Confidence            4555555543 346899999999999999999999998      999999998887 788  99887654322     14


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      +++.|+|||++.+. .++.++||||||+++|+|++|..||..... ......+...........                
T Consensus        66 g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------  128 (176)
T smart00750       66 VDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD----------------  128 (176)
T ss_pred             CcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc----------------
Confidence            78999999988766 689999999999999999999999976533 222333322111100000                


Q ss_pred             CCcccchhhhcCCCC--chHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          242 RSPIKDLATVVGGLE--PDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                             ......++  .++.+++.+||..||.+||++.+++.|+|+..
T Consensus       129 -------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 -------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                   00001122  26899999999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-26  Score=183.57  Aligned_cols=208  Identities=22%  Similarity=0.293  Sum_probs=174.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|+|+++||+|.||+++.+.+..++++||||.-+    .......+..|.+.++.|. .++|.+++.+...+.+-.+|+|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3899999999999999999999999999999532    2344578999999999995 7999999999888889999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC----CeEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK----DIVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~----~~v~l~df~~~~~~~~~~  155 (293)
                      .++.++.+++.=.+ ..++..++..++.|++.-++++|++.++.|||||+|++|..-+    +.|.++|||.++....+.
T Consensus       105 LLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            99888777665433 4688899999999999999999999999999999999997643    368999999998775543


Q ss_pred             cc-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHH
Q 038154          156 EN-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---PGLLAAI  214 (293)
Q Consensus       156 ~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~  214 (293)
                      ..       ..+..||.+||+-....+. .-+.+.|+-+||-+++..+.|.+||.+...   .+..++|
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            33       2334489999998888777 468999999999999999999999977543   4444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=174.08  Aligned_cols=210  Identities=20%  Similarity=0.243  Sum_probs=171.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|+++++||+|+||.+|.+....+|+.||||+-    .+......+..|..+++.|+ ...|+.+..+..+..+-.+||+
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~E----s~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLE----SSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEee----cccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            489999999999999999999999999999963    33445567889999999997 4789999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC--CeEEEccCCCcccCCCCCcc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK--DIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~~~~~~~~~~~  157 (293)
                      .++.++.+.+.-. ...++..+++.++-|++.-++|+|.++++|+||||+|++..-..  +.+.++|||+++........
T Consensus        92 LLGPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   92 LLGPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             ccCccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            9988777766543 34678889999999999999999999999999999999987543  47899999999876543222


Q ss_pred             ee-------ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 038154          158 YT-------IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS  216 (293)
Q Consensus       158 ~~-------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  216 (293)
                      ..       ...||..|.+-....+. .-+.+.|+-|+|.+++.+..|..||.+.......++...
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            22       23377888887655554 357889999999999999999999998766665555543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=4.5e-24  Score=179.84  Aligned_cols=262  Identities=31%  Similarity=0.459  Sum_probs=201.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC-CcccHHHHHHHHHhcCCC-CcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELKHE-NIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |.+.+.||.|+++.||.+.+.   ..+++|.+........ ....+.+|++++..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            678999999999999999766   7789998866554443 567888999999999987 79999999977777899999


Q ss_pred             cCCcchHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           80 NLDFDLLHFMKTEPT--VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      ++.+..+..+.....  ..........++.|++.++.++|+.|++|+|++|+||+++..+..++++|||.+........ 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999666554444333  25788899999999999999999999999999999999998874489999999875544322 


Q ss_pred             -----ceeccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHHHhCCC--CC
Q 038154          157 -----NYTIKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWA----PGLLAAIFSIMGTP--DS  223 (293)
Q Consensus       157 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~--~~  223 (293)
                           ......++..|++||.+.+.  .......|+|++|++++++++|..||.....    ......+.. ....  ..
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  237 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE-LPTPSLAS  237 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh-cCCccccc
Confidence                 22444589999999988774  4789999999999999999999999877664    233333222 1111  00


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ......                .      ......+.+++.+++..+|..|.+..+...+++....
T Consensus       238 ~~~~~~----------------~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         238 PLSPSN----------------P------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             ccCccc----------------c------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            000000                0      2233578899999999999999999998888665543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=187.07  Aligned_cols=162  Identities=22%  Similarity=0.229  Sum_probs=122.8

Q ss_pred             CceeeeeeccccceeEEEEEeCC-CCCeEEEEEecccCC---CCCCcccHHHHHHHHHhcCCCCcce-eeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNP---SEGVPSSVIREVSLLKELKHENIVR-LLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|+||+||+|.+.. ++..+|+|+......   .......+.+|++++++++|++++. +++.    +..|
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~   94 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDG   94 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcE
Confidence            59999999999999999998775 677789998642211   1223456889999999999999885 4442    4589


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccc-CCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL-KPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl-~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +||||++|..+.....     ..   ...++.|++.+|.+||+.|++|||| ||+||+++.++. ++|+|||.+......
T Consensus        95 LVmE~~~G~~L~~~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~-ikLiDFGlA~~~~~~  165 (365)
T PRK09188         95 LVRGWTEGVPLHLARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE-AAVIDFQLASVFRRR  165 (365)
T ss_pred             EEEEccCCCCHHHhCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC-EEEEECccceecccC
Confidence            9999999877653311     11   1467889999999999999999999 999999988777 999999999876543


Q ss_pred             Cccee--------ccCccccccCcccccC
Q 038154          155 LENYT--------IKGGSLCYKAPERLLG  175 (293)
Q Consensus       155 ~~~~~--------~~~~~~~~~aPE~~~~  175 (293)
                      .....        ...+++.|.+||.+..
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            22222        1225667888887743

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-26  Score=176.89  Aligned_cols=240  Identities=18%  Similarity=0.226  Sum_probs=193.9

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCC-c
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-F   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~   83 (293)
                      ..+|.+...|..|++  .+.|..+++|+++....+.....+|..|.-.|+-+.||||+.+++.|..+....++..|++ |
T Consensus       195 ~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccc--cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            356788899999999  5677889999998888777777889999999999999999999999999999999999999 7


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCC-eEEEccCCCcccCCCCCcceec
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++...+.+....-.+..++.+++.+++.+++|||+..  +.---|++..++|+++.. .+..+|-.++..       ...
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-------e~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------EVG  345 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-------ccc
Confidence            7888888887777888899999999999999999874  455568999999998765 234444333211       111


Q ss_pred             cCccccccCcccccCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          161 KGGSLCYKAPERLLGSGRY--STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+|.|++||.+...+..  -.++|+||+++++|++.|...||.+..+-+.-.++.-                      
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------------------  403 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------------------  403 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------------------
Confidence            2267889999988765332  3578999999999999999999988766555444421                      


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHh
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL  281 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  281 (293)
                            .+...++++++++.+..|++-|++.||.+||..+.++
T Consensus       404 ------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                  1344577889999999999999999999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=3.1e-25  Score=178.06  Aligned_cols=234  Identities=19%  Similarity=0.221  Sum_probs=146.9

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcC----------CCCcceeeeeee--
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELK----------HENIVRLLNVQS--   69 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~----------~~~i~~~~~~~~--   69 (293)
                      ..++.||.|+++.||.+.+..+|+.+++|++...... ....+.+.+|.-....+.          |-.++..++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            5678999999999999999999999999998554421 223345555544443322          113333333221  


Q ss_pred             -------cC---C-----cceeEeecCCcchHHHhh---cCCCCCCC--HHHHHHHHHHHHHHHHHHHhCCceecccCCC
Q 038154           70 -------SV---D-----SIDLVFENLDFDLLHFMK---TEPTVTKN--PLKIKKYLHQILHGVAYCHSQEILHRDLKPA  129 (293)
Q Consensus        70 -------~~---~-----~~~lv~e~~~~~~~~~~~---~~~~~~~~--~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~  129 (293)
                             ..   .     ..+++|+-+.+++...+.   ........  ......+..|++..+++||..|++|+||+|+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~  174 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE  174 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred             CCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence                   11   1     346788888877766543   22222111  2223456689999999999999999999999


Q ss_pred             ceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCC
Q 038154          130 NFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS-------GRYSTPVDVWAVACTFAEMVTHQRLF  202 (293)
Q Consensus       130 Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l~~g~~pf  202 (293)
                      |++++.+|. ++|+||+.....+..   ......+..|.|||.....       -.++.+.|.|+||+++|.|++|..||
T Consensus       175 nfll~~~G~-v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf  250 (288)
T PF14531_consen  175 NFLLDQDGG-VFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF  250 (288)
T ss_dssp             GEEE-TTS--EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred             eEEEcCCCC-EEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence            999999998 999999988766532   2222355779999966332       23678899999999999999999999


Q ss_pred             CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC
Q 038154          203 HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR  274 (293)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  274 (293)
                      ..........                                 ....... ++|..+++||..||+.||.+|
T Consensus       251 ~~~~~~~~~~---------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  251 GLSSPEADPE---------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCCGGGSTSG---------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCcccccc---------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            7542211100                                 0122222 578999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=9.2e-25  Score=196.14  Aligned_cols=236  Identities=25%  Similarity=0.365  Sum_probs=174.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHH--HHhcCCCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSL--LKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |...+.||++.|=+|.++.+. .|. +++|++-..... -....+.++++-  ...+++||.+++..+...+...|+|-+
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             eeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            456789999999999999654 344 999998443322 223444443333  344589999999999888899999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC--CCCC-c
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPL-E  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~--~~~~-~  156 (293)
                      |...++.+.+..++.  +.......|+.||+.||..+|+.|++|||||.+||+|+. -+.+.|+||..-+..  ..+. .
T Consensus       102 yvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  102 YVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS-WNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee-echhhhhcccccCCccCCCCCcc
Confidence            999999999887765  556677789999999999999999999999999999995 445899999876533  2111 1


Q ss_pred             cee----ccCccccccCcccccCC----------CCCCCchhHHHHHHHHHHHHhC-CCCCCC-----------CCchHH
Q 038154          157 NYT----IKGGSLCYKAPERLLGS----------GRYSTPVDVWAVACTFAEMVTH-QRLFHS-----------RWAPGL  210 (293)
Q Consensus       157 ~~~----~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g-~~pf~~-----------~~~~~~  210 (293)
                      .+.    ....-.+|.|||.+...          ...+++-||||+||+++|+++- ..||.-           .+.+..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            111    11134689999988542          1256789999999999998875 667731           111122


Q ss_pred             HHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          211 LAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      +.+|                                        -...++.+|..|++.||++|.+|++.|..
T Consensus       259 Le~I----------------------------------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKI----------------------------------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhC----------------------------------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2221                                        23578899999999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-25  Score=190.08  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=194.2

Q ss_pred             eeccccceeEEEEEe---CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeecCC
Q 038154            7 VIREGRYGAVHRAHD---SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      .+|+|++|.|+++..   ...|.-+++|+.+..............|..++...+ ||.++++...++.++..+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            478999999998853   345667899988665554444446667888898886 9999999999999999999999998


Q ss_pred             c-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           83 F-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        83 ~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      | .+...+.+..  .+.+.....+...++.+++++|+.|++++|+|++||+++.+|. +++.|||.++..-.....    
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-cccCCchhhhHhHhhhhc----
Confidence            5 5555554433  3566677778899999999999999999999999999999999 999999999765432222    


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      +|+..|||||+..   ....++|.||+|+++++|++|..||..    +.+..|...                        
T Consensus       154 cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~------------------------  202 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA------------------------  202 (612)
T ss_pred             ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh------------------------
Confidence            6899999999775   468899999999999999999999987    455555321                        


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCcccccCcCC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYFKDFQSL  292 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~~~~~~~  292 (293)
                            -...+..++..+.+++..|+..+|..|...     .++++|+||+.+.|.
T Consensus       203 ------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  203 ------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                  112344567888999999999999999755     799999999988663

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.4e-24  Score=168.02  Aligned_cols=171  Identities=12%  Similarity=0.093  Sum_probs=127.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC-Cccc------HHHHHHHHHhcCCCCcceeeeeeecC--
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSS------VIREVSLLKELKHENIVRLLNVQSSV--   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~------~~~e~~~l~~l~~~~i~~~~~~~~~~--   71 (293)
                      ||++.+.||.|++|.||++..  ++..+|+|++........ ....      +.+|++.+.++.||++..+.+++...  
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            799999999999999999754  466899999854332221 1112      57899999999999999998875533  


Q ss_pred             ------CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccC
Q 038154           72 ------DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        72 ------~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                            +..+++|||++|..+..+..     .++    ....+++.+|..+|+.|++|||++|+||+++.++  ++++||
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDf  178 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDL  178 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEEC
Confidence                  35889999999876655421     222    2456999999999999999999999999999877  899999


Q ss_pred             CCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh
Q 038154          146 GLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT  197 (293)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  197 (293)
                      |...........             +.+.-...++.++|+||||+.+.....
T Consensus       179 g~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        179 SGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            988654322111             112222246689999999999877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=8.3e-24  Score=163.17  Aligned_cols=142  Identities=18%  Similarity=0.114  Sum_probs=106.7

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-------ccc-----------------HHHHHHHHHhcCCCC
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-------PSS-----------------VIREVSLLKELKHEN   60 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~-----------------~~~e~~~l~~l~~~~   60 (293)
                      .+.||+|++|.||+|.+. +|+.||+|+++........       ...                 ...|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999987 8999999999654321111       112                 234999999998777


Q ss_pred             cceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecccCCCceeEeCCCCe
Q 038154           61 IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC-HSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        61 i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                      +.....+..  ...++||||++|+.+...... ...++...+..++.|++.+|.++ |+.|++|+||||+||+++. +. 
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~-  155 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK-  155 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc-
Confidence            644433322  234899999997654332111 23577889999999999999999 6999999999999999984 55 


Q ss_pred             EEEccCCCcccCC
Q 038154          140 VKIADFGLARPID  152 (293)
Q Consensus       140 v~l~df~~~~~~~  152 (293)
                      ++|+|||.+....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=170.05  Aligned_cols=190  Identities=26%  Similarity=0.331  Sum_probs=143.1

Q ss_pred             CCCCcceeeeeeec---------------------------CCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHH
Q 038154           57 KHENIVRLLNVQSS---------------------------VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQI  109 (293)
Q Consensus        57 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  109 (293)
                      .||||+.+.+.|.+                           +..+|+||..+..++.+++..+.   .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence            49999999876533                           23589999999999999987654   3455777789999


Q ss_pred             HHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCCC-----CC-cceeccCccccccCcccccCCCCC-
Q 038154          110 LHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDV-----PL-ENYTIKGGSLCYKAPERLLGSGRY-  179 (293)
Q Consensus       110 ~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~~-----~~-~~~~~~~~~~~~~aPE~~~~~~~~-  179 (293)
                      ++|+.|||++|+.|+|+|++||++..+.+   ...++|||++..-..     +. .......|+-..||||+....+.+ 
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999987654   578999998754322     11 111222377889999977554322 


Q ss_pred             ----CCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCC
Q 038154          180 ----STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGL  255 (293)
Q Consensus       180 ----~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (293)
                          -.++|.|+.|.+.||+++...||-....                            ...+.......++..++..+
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----------------------------m~L~~r~Yqe~qLPalp~~v  482 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----------------------------MLLDTRTYQESQLPALPSRV  482 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccch----------------------------heechhhhhhhhCCCCcccC
Confidence                2489999999999999999999965211                            00111112225566777889


Q ss_pred             CchHHHHHHHhhccCCCCCCCH
Q 038154          256 EPDGVDLLRRMLCLDPSKRLTA  277 (293)
Q Consensus       256 ~~~~~~li~~~l~~dp~~Rps~  277 (293)
                      ++.+++++..+|+.||++|+++
T Consensus       483 pp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  483 PPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             ChHHHHHHHHHhcCCccccCCc
Confidence            9999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.4e-22  Score=155.70  Aligned_cols=142  Identities=19%  Similarity=0.120  Sum_probs=108.3

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC------------------------cccHHHHHHHHHhcCCC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV------------------------PSSVIREVSLLKELKHE   59 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~   59 (293)
                      |.+.||+|++|.||+|.+. +|+.||+|+++........                        ...+..|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999877 8999999998654321100                        01124688999999998


Q ss_pred             CcceeeeeeecCCcceeEeecCCcch-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCC
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDFDL-LHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ++.....+...  ..++||||++|.. .......  ..++...+..++.|++.++.++|+ .|++|+||+|+||+++ ++
T Consensus        80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            87554443322  2489999999763 2222222  346777899999999999999999 9999999999999999 66


Q ss_pred             CeEEEccCCCcccCC
Q 038154          138 DIVKIADFGLARPID  152 (293)
Q Consensus       138 ~~v~l~df~~~~~~~  152 (293)
                      . ++|+|||.+....
T Consensus       155 ~-~~liDFG~a~~~~  168 (190)
T cd05145         155 K-PYIIDVSQAVELD  168 (190)
T ss_pred             C-EEEEEcccceecC
Confidence            6 9999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=1.3e-22  Score=182.14  Aligned_cols=221  Identities=28%  Similarity=0.396  Sum_probs=165.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |..++.+..|++|.||.++++.+.+.+++| ++..       ..+.+.  ++..-.+|.++                   
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq-------~lilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-------NLILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhc-cccc-------chhhhc--cccccCCccee-------------------
Confidence            567899999999999999999888899985 3211       111111  22222333333                   


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-----
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-----  156 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-----  156 (293)
                       |+....+...+..+..  .        +.+++|||..|++|+|++|+|.+|..-|. +|++|||.++.......     
T Consensus       136 -gDc~tllk~~g~lPvd--m--------vla~Eylh~ygivhrdlkpdnllIT~mGh-iKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVD--M--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             -chhhhhcccCCCCcch--h--------hHHhHhhccCCeecCCCCCCcceeeeccc-ccccchhhhhhhhhhccchhhh
Confidence             5555555444433332  2        67999999999999999999999999898 99999998764422111     


Q ss_pred             ----------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          157 ----------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       157 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                                .....+|+|.|+|||++..+ .|....|.|+||+|+|+.+-|..||.+.++++...........+++.. 
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d-  281 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED-  281 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-
Confidence                      11222489999999988876 589999999999999999999999999999999888876444443332 


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC---CCHHHHhcCcccccCcC
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR---LTAREALRHEYFKDFQS  291 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~p~~~~~~~  291 (293)
                                                ...++++++++.++|+.+|..|   +.+-++..|+||+.+-|
T Consensus       282 --------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  282 --------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             --------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence                                      2368899999999999999999   46788899999997644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=9.9e-22  Score=150.19  Aligned_cols=186  Identities=18%  Similarity=0.073  Sum_probs=135.2

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC--CcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG--VPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .+...|++|+||+||.+.  ..+..++.+.+.....-..  ....+.+|+++|++|. ++++++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            357889999999999884  4677777776543322111  1125788999999995 5889999886    44699999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccc-CCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL-KPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl-~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.|..+......        ....++.|++.+|.++|+.|++|+|| +|+||+++.++. ++|+|||.+..........
T Consensus        79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~-i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS-PAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC-EEEEECCCceecCCcchHH
Confidence            9998776432211        11347789999999999999999999 799999998887 9999999998654432210


Q ss_pred             -------------eccCccccccCcccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCC
Q 038154          159 -------------TIKGGSLCYKAPERLLGSGRYS-TPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       159 -------------~~~~~~~~~~aPE~~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                                   .-...++.+++|+...--...+ .+.+.++.|+.+|.++|++.|.-
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                         0011466677777543332344 56788899999999999998863

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.7e-21  Score=177.41  Aligned_cols=191  Identities=22%  Similarity=0.283  Sum_probs=153.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC---CCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |.|.+.+|+|++|+||+|.+.. |+.+|+|+-+     ....-+|.--.+++.+|+   -+.|+.+.......+..++|+
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~-----P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSN-GKLVALKVEK-----PPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             EEEEeeeccccceEEEEeecCC-CcEEEEEeec-----CCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            7899999999999999998776 9999999742     223344555566666766   345666666667778889999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC------CCeEEEccCCCcccC
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS------KDIVKIADFGLARPI  151 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~------~~~v~l~df~~~~~~  151 (293)
                      ||.+ |++++.+.  ....+++..+..++.|++..|.+||..+|+||||||+|.++...      ...++|+|||.+-.+
T Consensus       774 ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999 77777666  44467888899999999999999999999999999999999532      225899999999765


Q ss_pred             CC--CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 038154          152 DV--PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL  201 (293)
Q Consensus       152 ~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  201 (293)
                      ..  +.......+++-.+-.+|...|. +|+...|.|.|+.+++-|++|.+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHHH
Confidence            32  22456666788899999988877 799999999999999999998743

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.7e-20  Score=149.50  Aligned_cols=144  Identities=19%  Similarity=0.105  Sum_probs=108.6

Q ss_pred             ceeeeeeccccceeEEEEE-eCCCCCeEEEEEecccCCCCCC----------------------cccHHHHHHHHHhcCC
Q 038154            2 YTLLEVIREGRYGAVHRAH-DSLTGDTVVVKKIPIMNPSEGV----------------------PSSVIREVSLLKELKH   58 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~-~~~~~~~~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~~   58 (293)
                      |++.+.||+|++|.||+|. +..+|..||+|+++........                      ...+..|++++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6788999999999999998 6678999999998654321100                      0124579999999975


Q ss_pred             --CCcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecccCCCceeEeC
Q 038154           59 --ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE-ILHRDLKPANFLIDR  135 (293)
Q Consensus        59 --~~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~h~dl~~~Ni~i~~  135 (293)
                        ..+++++++    ...++|||+++|..+....... .......+..++.|++.+|++||+.| ++|+||+|+||+++ 
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence              334455543    2458999999986554332111 23455567889999999999999999 99999999999999 


Q ss_pred             CCCeEEEccCCCcccCC
Q 038154          136 SKDIVKIADFGLARPID  152 (293)
Q Consensus       136 ~~~~v~l~df~~~~~~~  152 (293)
                      ++. ++|+|||.+...+
T Consensus       184 ~~~-i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGK-VVIIDVSQSVELD  199 (237)
T ss_pred             CCC-EEEEEChhhhccC
Confidence            555 9999999886543

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.9e-19  Score=140.14  Aligned_cols=134  Identities=18%  Similarity=0.154  Sum_probs=99.9

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-----CCCCcceeeeeeecCC---cce-
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-----KHENIVRLLNVQSSVD---SID-   75 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~-   75 (293)
                      .+.||+|+++.||.  ++.++.. +||+......  ...+.+.+|+++++.+     .||||++++++++++.   ..+ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            46899999999996  5666554 7898754322  2346789999999999     5799999999998874   333 


Q ss_pred             eEeecCC--c-chHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecccCCCceeEeCCC---CeEEEccCCCc
Q 038154           76 LVFENLD--F-DLLHFMKTEPTVTKNPLKIKKYLHQILHGV-AYCHSQEILHRDLKPANFLIDRSK---DIVKIADFGLA  148 (293)
Q Consensus        76 lv~e~~~--~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~h~dl~~~Ni~i~~~~---~~v~l~df~~~  148 (293)
                      +|+||.+  + ++.+.+.+ .  .+++.  ..++.|++.++ +|||+++++|+||||+||+++..+   ..++|+|++.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-C--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-c--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            7899954  4 55555543 2  24444  35677888777 999999999999999999998533   14999995444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.5e-19  Score=154.32  Aligned_cols=206  Identities=20%  Similarity=0.283  Sum_probs=151.5

Q ss_pred             HHhcCCCCcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecccCCCce
Q 038154           53 LKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI-LHRDLKPANF  131 (293)
Q Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~h~dl~~~Ni  131 (293)
                      |+.+.|.|+.++++.+.++...++|.++|..+++..+.......++.-....++++|+.+|.|||...+ +||.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356789999999999999999999999999555555555566678888888999999999999998855 9999999999


Q ss_pred             eEeCCCCeEEEccCCCcccCCC--CCcceeccCccccccCcccccCC--CC----CCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          132 LIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLGS--GR----YSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       132 ~i~~~~~~v~l~df~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~--~~----~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                      +++.... +|++|||.......  ............-|.|||.+.+.  ..    .+.+.|+||+|++++++++...||.
T Consensus        81 lvd~~w~-lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   81 LVDSRWV-LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             eeeeeEE-EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            9998776 99999999876642  11111112244569999988653  11    4677999999999999999999997


Q ss_pred             CCCch----HHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHH
Q 038154          204 SRWAP----GLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE  279 (293)
Q Consensus       204 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  279 (293)
                      .....    +....+.. .  ......                   +...... ..++++..++..|+..+|..||++++
T Consensus       160 ~~~~~~~~~eii~~~~~-~--~~~~~r-------------------P~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKK-G--GSNPFR-------------------PSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             cccccCChHHHHHHHHh-c--CCCCcC-------------------cchhhhh-hcchHHHHHHHHhcccChhhCccHHH
Confidence            64332    23333222 0  000000                   0111011 34568999999999999999999988


Q ss_pred             Hhc
Q 038154          280 ALR  282 (293)
Q Consensus       280 ll~  282 (293)
                      +-.
T Consensus       217 i~~  219 (484)
T KOG1023|consen  217 IRS  219 (484)
T ss_pred             HHh
Confidence            754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.1e-19  Score=138.56  Aligned_cols=136  Identities=18%  Similarity=0.172  Sum_probs=108.0

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC------CcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG------VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +.||+|++|.||++..  .|..+++|+.........      ....+.+|++++..+.|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            6799999999999965  677899997643222111      11356779999999999998877777777788999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      |++|..+..+.....    . ....++.+++.+|.++|+.|++|+|++|.||+++ ++. ++++|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~-~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK-IYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC-EEEEECCcccC
Confidence            998766655443321    1 7788999999999999999999999999999999 555 89999998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=1.4e-20  Score=167.62  Aligned_cols=263  Identities=26%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             CceeeeeeccccceeEEEEEeCC-CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|.+.+.||+|+++.|-...... ....++.|.+............+..|..+-+.+. |+|++.+++...+.+..++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            37788889999999998886543 3334555554433333444455566778888886 999999999999999999999


Q ss_pred             ecCCcchHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecccCCCceeEeCCCCeEEEccCCCcccCCC-CC
Q 038154           79 ENLDFDLLHFMK-TEPTVTKNPLKIKKYLHQILHGVAYCH-SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV-PL  155 (293)
Q Consensus        79 e~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~-~~  155 (293)
                      ++..|+.+-... .......+....-.++.|+..++.|+| ..+++|+|++|+|.+++..+...++.|||+++.... ..
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g  180 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG  180 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence            998776665555 333335666688889999999999999 999999999999999999883389999999987654 21


Q ss_pred             --cceeccCc-cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 --ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 --~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                        .......| ++.|+|||...+........|+||.|+++..+++|..|+........                 .+   
T Consensus       181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-----------------~~---  240 (601)
T KOG0590|consen  181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-----------------RY---  240 (601)
T ss_pred             cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-----------------cc---
Confidence              22233447 99999999888766778899999999999999999999965432220                 00   


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                           ..+...........+..++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus       241 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 -----SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----eeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                 000111111122345567888999999999999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.3e-18  Score=135.78  Aligned_cols=138  Identities=23%  Similarity=0.240  Sum_probs=105.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC--------------------CcccHHHHHHHHHhcCCC--
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG--------------------VPSSVIREVSLLKELKHE--   59 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~~--   59 (293)
                      |.+.+.||+|++|.||++... +|+.+++|+++.......                    .......|+.++..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            678899999999999999765 789999998754321110                    011256688888888776  


Q ss_pred             CcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                      .++..++    ....+++||+++|..+..+...       .....++.+++.++.++|+.|++|+||+|+||+++.++. 
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~-  163 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK-  163 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence            4444443    2456899999998766554321       255678899999999999999999999999999998776 


Q ss_pred             EEEccCCCcccCC
Q 038154          140 VKIADFGLARPID  152 (293)
Q Consensus       140 v~l~df~~~~~~~  152 (293)
                      ++|+|||.+....
T Consensus       164 ~~liDfg~~~~~~  176 (198)
T cd05144         164 IYIIDWPQMVSTD  176 (198)
T ss_pred             EEEEECCccccCC
Confidence            9999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.8e-18  Score=134.21  Aligned_cols=133  Identities=20%  Similarity=0.239  Sum_probs=101.8

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccCCCCC------CcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG------VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .||+|++|.||++.  ..|..+++|+.........      ....+.+|+++++.+.++++.....++......+++||+
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999996  4678899998643221111      124566799999999888766555555566778999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ++|..+..+.....      .  .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||.+...
T Consensus        79 ~~g~~l~~~~~~~~------~--~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~-~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN------D--ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK-LYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH------H--HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc-EEEEECCCCcCC
Confidence            98766654433211      1  7899999999999999999999999999999 555 999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=2.3e-19  Score=150.93  Aligned_cols=177  Identities=26%  Similarity=0.427  Sum_probs=126.6

Q ss_pred             cceeEeecCCc-chHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           73 SIDLVFENLDF-DLLHFMK-TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ++|+.|+.|.- .+.+++. .......+......++.|++.++.|   +|.+|+|++|.||+...+.. +||+|||+.+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q-~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ-LKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh-hhhhhhhheee
Confidence            58899999984 5555554 2333445666888999999999999   99999999999999987776 99999999876


Q ss_pred             CCCCC------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          151 IDVPL------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       151 ~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .....      .......|+.+||+||++.++ .++.++|||+||+++++++.- ..++      +......+..    .
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r----~  474 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDIR----D  474 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhhh----c
Confidence            64432      123334489999999999988 699999999999999999971 1111      1111111100    0


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                            ..+.+....--++-..|+..||...|.+||++.+.-.|+|.
T Consensus       475 ----------------------g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  475 ----------------------GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ----------------------CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                  00000111112445689999999999999988888778775

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=1.1e-17  Score=129.60  Aligned_cols=135  Identities=24%  Similarity=0.200  Sum_probs=97.3

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccH----------------------HHHHHHHHhcCCC--
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV----------------------IREVSLLKELKHE--   59 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~~--   59 (293)
                      +.+.||+|++|.||++.+. +|..||+|++.............                      ..|.+.+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999876 78999999986533221111111                      3455666665433  


Q ss_pred             CcceeeeeeecCCcceeEeecCCc-----chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeE
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDF-----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLI  133 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i  133 (293)
                      .++++++.    ...+++||+++|     ..+.....       ...+..++.+++.++.++|. .|++|+||+|+||++
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-------~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-------LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhh-------cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence            34444443    346899999997     23322211       14778899999999999999 999999999999999


Q ss_pred             eCCCCeEEEccCCCcccCC
Q 038154          134 DRSKDIVKIADFGLARPID  152 (293)
Q Consensus       134 ~~~~~~v~l~df~~~~~~~  152 (293)
                      + ++. ++++|||.+....
T Consensus       149 ~-~~~-~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGK-VYIIDVPQAVEID  165 (187)
T ss_pred             E-CCc-EEEEECccccccc
Confidence            9 666 9999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.2e-17  Score=149.20  Aligned_cols=137  Identities=18%  Similarity=0.202  Sum_probs=104.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCC-----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSE-----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      |...+.||+|++|+||++...  +..+++|+..... ...     .....+.+|+++++.+.|++++....+.......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            345789999999999999654  4445555432111 111     11245778999999999999988877777777889


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      +||||++|..+.....         ....++.+++.+|.+||+.|++||||+|+||+++ ++. ++|+|||.+...
T Consensus       413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~-~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR-LYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc-EEEEeCcccccC
Confidence            9999998766554332         3567899999999999999999999999999994 455 899999998653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=2.1e-16  Score=117.96  Aligned_cols=132  Identities=22%  Similarity=0.232  Sum_probs=109.1

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeeeeeecCCcceeEeecC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      +++.||+|.++.||++...  +..+++|.......    ...+..|+.+++.+.+  ..+++++.+....+..++++|++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            5788999999999999754  36799998743322    4578899999999976  58999999888888999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ---EILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      +|..+..+        +......++.+++.+|..||..   +++|+|++|.||+++..+. ++++||+.+..
T Consensus        76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~-~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI-LGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE-EEEEecccccC
Confidence            87655433        4456777899999999999985   7999999999999998655 99999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.70  E-value=5.8e-16  Score=134.23  Aligned_cols=166  Identities=20%  Similarity=0.247  Sum_probs=127.2

Q ss_pred             EEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc--chHHHhhcCCCCC
Q 038154           19 AHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF--DLLHFMKTEPTVT   96 (293)
Q Consensus        19 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~--~~~~~~~~~~~~~   96 (293)
                      +..+..+.++.+..++.+..  .......+.++.|+.++||+|+++++.++..+..|+|+|.+..  ..++.+-      
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~------  102 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELG------  102 (690)
T ss_pred             cceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhH------
Confidence            55567788898888865443  4456778899999999999999999999999999999999863  3333322      


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-hCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccC
Q 038154           97 KNPLKIKKYLHQILHGVAYCH-SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG  175 (293)
Q Consensus        97 ~~~~~~~~i~~~i~~~l~~lh-~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  175 (293)
                        ...+...++||+.||.||| +.+++|++|+.+.|+|+..|+ .||++|.++..................|..|+....
T Consensus       103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE-WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc-EEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence              4467778999999999997 678999999999999999999 899999988655432221222223334666763322


Q ss_pred             CCCCCCchhHHHHHHHHHHHHhC
Q 038154          176 SGRYSTPVDVWAVACTFAEMVTH  198 (293)
Q Consensus       176 ~~~~~~~~Di~slG~ll~~l~~g  198 (293)
                      .   ....|.|.||+++++++.|
T Consensus       180 s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 S---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c---ccchhhhhHHHHHHHHhCc
Confidence            2   2567999999999999998

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.2e-16  Score=126.16  Aligned_cols=136  Identities=18%  Similarity=0.178  Sum_probs=99.0

Q ss_pred             eeec-cccceeEEEEEeCCCCCeEEEEEecccCC-----------CCCCcccHHHHHHHHHhcCCCCc--ceeeeeeecC
Q 038154            6 EVIR-EGRYGAVHRAHDSLTGDTVVVKKIPIMNP-----------SEGVPSSVIREVSLLKELKHENI--VRLLNVQSSV   71 (293)
Q Consensus         6 ~~lg-~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~   71 (293)
                      ..|| .|+.|+||.+..  .+..+++|.+.....           .......+.+|++++..+.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 889999999954  477899998853211           11233567889999999988775  6666654332


Q ss_pred             -Cc---ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           72 -DS---IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        72 -~~---~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                       +.   .++|+|+++| ..+..+....  .+++.    .+.+++.+|.+||+.|++|+||+|.||+++.++. ++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~-v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK-FWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC-EEEEECC
Confidence             22   2599999986 4444443332  23332    3578999999999999999999999999998776 9999999


Q ss_pred             Cccc
Q 038154          147 LARP  150 (293)
Q Consensus       147 ~~~~  150 (293)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.3e-16  Score=136.69  Aligned_cols=255  Identities=22%  Similarity=0.171  Sum_probs=188.9

Q ss_pred             ceeeeeecc--ccceeEEEEEe--CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIRE--GRYGAVHRAHD--SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~--g~~~~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +.+.+.+|.  |.+|.+|.+..  ..++..+++|.-+...........=.+|+.-...+ .|++.++.+..+...+..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            556788999  99999999987  77888999997543333232223334455555555 38899998888899999999


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      -+|.++..+..+...... .++...++..+.+...    ||.++|..+++|-|++|.||+...+...++++|||....+.
T Consensus       196 qtE~~~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  196 QTELCGESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             eeccccchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence            999999877776655433 4667788889999998    99999999999999999999999984449999999998876


Q ss_pred             CCCcceecc-----CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          153 VPLENYTIK-----GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       153 ~~~~~~~~~-----~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ...-.....     .+...|++||+..+  -++..+|+|+||.++.+-.++..+....                   ...
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g-------------------~~~  333 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVG-------------------KNS  333 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCC-------------------CCC
Confidence            654332222     47778999997654  4789999999999999998887655321                   000


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      .      +...++..    .......+.+.++...+..|++.+|..|+++..+++++++..
T Consensus       334 ~------W~~~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  334 S------WSQLRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             C------cccccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            0      00000000    111233345666777999999999999999999999998764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.61  E-value=1.5e-14  Score=110.71  Aligned_cols=141  Identities=16%  Similarity=0.128  Sum_probs=100.1

Q ss_pred             eeeeeccccceeEEEEEeCC------CCCeEEEEEecccCCC----------C----------CCcccHH----HHHHHH
Q 038154            4 LLEVIREGRYGAVHRAHDSL------TGDTVVVKKIPIMNPS----------E----------GVPSSVI----REVSLL   53 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~----------~----------~~~~~~~----~e~~~l   53 (293)
                      |...||.|..+.||.|....      .+..+|+|+++....+          +          .....+.    .|.+.|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            34679999999999997543      3578999998643321          0          0012233    688888


Q ss_pred             HhcCC--CCcceeeeeeecCCcceeEeecCCcchH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecccCCC
Q 038154           54 KELKH--ENIVRLLNVQSSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYC-HSQEILHRDLKPA  129 (293)
Q Consensus        54 ~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~h~dl~~~  129 (293)
                      +++..  -.++.++++    ...++|||++++..+ ......  ..++......+..+++.+|..| |+.|++||||++.
T Consensus        81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~  154 (197)
T cd05146          81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY  154 (197)
T ss_pred             HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            88853  456666764    567899999986421 111111  1234456677889999999988 8999999999999


Q ss_pred             ceeEeCCCCeEEEccCCCcccCC
Q 038154          130 NFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus       130 Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ||+++. +. +.++|||.+....
T Consensus       155 NIL~~~-~~-v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWHD-GK-VWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEEC-Cc-EEEEECCCceeCC
Confidence            999984 44 8999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.56  E-value=3.1e-14  Score=104.98  Aligned_cols=146  Identities=19%  Similarity=0.241  Sum_probs=112.1

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCC-----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSE-----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ....+.+|+.+.|+++  ...|+.++||.-.... ..+     -...+..+|.++|.++.--.|.-..-++.+.....++
T Consensus        11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            3567889999999999  6779998888542111 111     1235666799999888765666666667788888999


Q ss_pred             eecCCc--chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeE--EEccCCCcccC
Q 038154           78 FENLDF--DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIV--KIADFGLARPI  151 (293)
Q Consensus        78 ~e~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v--~l~df~~~~~~  151 (293)
                      ||+++|  ...+++...............++.+|-+.+.-||..+++||||+++||++..+++.+  .++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999998  666676665554455555578999999999999999999999999999999887744  89999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.9e-15  Score=119.50  Aligned_cols=206  Identities=19%  Similarity=0.207  Sum_probs=135.4

Q ss_pred             HHHHHhcCCCCcceeeeeeecCC-----cceeEeecCC-cchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 038154           50 VSLLKELKHENIVRLLNVQSSVD-----SIDLVFENLD-FDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ--  119 (293)
Q Consensus        50 ~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~-~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~--  119 (293)
                      ...+-++.|.|+++++.|+.+..     ...++.||+. |++..++..  .....+......+++.||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34455567999999999876543     5789999998 666666654  3345667778889999999999999987  


Q ss_pred             CceecccCCCceeEeCCCCeEEEccCCCc--ccCCCC--CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHH
Q 038154          120 EILHRDLKPANFLIDRSKDIVKIADFGLA--RPIDVP--LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEM  195 (293)
Q Consensus       120 ~~~h~dl~~~Ni~i~~~~~~v~l~df~~~--~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l  195 (293)
                      -++|+++.-+.|++..++- +|++--.-.  ...-..  .......++.+.|.+||.= ..-..+.++|||++|....+|
T Consensus       198 piihgnlTc~tifiq~ngL-Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGL-IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccccCCcchhheeecCCce-EEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHH
Confidence            4999999999999997776 776543211  111000  0111112256789999832 222467799999999999998


Q ss_pred             HhCCCCC-CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC
Q 038154          196 VTHQRLF-HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR  274 (293)
Q Consensus       196 ~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  274 (293)
                      ..+..-- +....-..-..+..                                 .+...-...-..++.+|++-.|..|
T Consensus       276 ailEiq~tnseS~~~~ee~ia~---------------------------------~i~~len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIAN---------------------------------VIIGLENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             HHheeccCCCcceeehhhhhhh---------------------------------heeeccCccccCcCcccccCCCCCC
Confidence            8765321 11111000000000                                 0000011122468999999999999


Q ss_pred             CCHHHHhcCcccccCc
Q 038154          275 LTAREALRHEYFKDFQ  290 (293)
Q Consensus       275 ps~~~ll~~p~~~~~~  290 (293)
                      |++.+++.||-+-...
T Consensus       323 p~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  323 PDARLLLFHPLLFEVH  338 (458)
T ss_pred             cchhhhhcCceeeecc
Confidence            9999999999665443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=2.2e-13  Score=103.68  Aligned_cols=128  Identities=19%  Similarity=0.124  Sum_probs=93.8

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCcceeEeecCCc
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ++.|+.|..+.||++...  +..+++|.......   ....+..|+.+++.+.+.+ +++++...  ....++|||+++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            467899999999999654  77899998643221   2245678999999886544 34555543  2345899999998


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI-----LHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-----~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ..+...      ..   .......+++.+|..||..++     +|+|++|.||+++ ++. ++++||+.+..
T Consensus        76 ~~l~~~------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~-~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR-LWLIDWEYAGM  136 (170)
T ss_pred             Cccccc------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe-EEEEecccccC
Confidence            655422      01   123456789999999999885     9999999999999 444 89999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=3e-13  Score=117.35  Aligned_cols=142  Identities=18%  Similarity=0.166  Sum_probs=93.3

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC--------------------CC----Cc--------------ccHH
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--------------------EG----VP--------------SSVI   47 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------------------~~----~~--------------~~~~   47 (293)
                      +.||+|+.|.||+|+.+ +|+.||||+.+.....                    ..    ..              -++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999865 7899999997432100                    00    00              1344


Q ss_pred             HHHHHHHhcC-----CCCcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 038154           48 REVSLLKELK-----HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH-GVAYCHSQEI  121 (293)
Q Consensus        48 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~~~~  121 (293)
                      +|.+.+.++.     ++++.-..-+....+..++||||++|..+..+........   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            5555555552     2332211112223345789999999866654432211112   23445666655 5788999999


Q ss_pred             eecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154          122 LHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus       122 ~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      +|+|++|.||+++.++. ++++|||.+....
T Consensus       279 ~H~D~hPgNilv~~~g~-i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGK-IIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCc-EEEEeCCCeeECC
Confidence            99999999999998887 9999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=7.5e-13  Score=98.12  Aligned_cols=133  Identities=20%  Similarity=0.251  Sum_probs=97.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEec-ccCCCCC-----CcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIP-IMNPSEG-----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~-~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +.+++|+.+.+|.+  ..-|.++++|.-. +....+.     ...+-.+|.+++.++.--.+.-..=+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~--~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLT--DFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEee--eccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999999  4456667777542 1112221     12344568888888865555555555567788889999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      |++|.++.......        ...++..+-.-+.-||..|++||||+++||++...+  +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~--i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR--IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc--EEEEECCcccc
Confidence            99999888555433        144667777788899999999999999999999554  89999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=3.9e-14  Score=128.37  Aligned_cols=259  Identities=21%  Similarity=0.246  Sum_probs=180.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +.+.+-+-+|+++.+..+.-..+|....+|+...... .....+.+..+-.++-.-.+|.++...-.+.-....++++++
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY  885 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence            3456677788888888887666776666664422111 111122222332222222345555554445556678999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-----
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-----  154 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-----  154 (293)
                      .++ ++...+.+.+  ..+....+..+..+..++++||...+.|+|++|.|+++..++. .++.+|+.....+.-     
T Consensus       886 ~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh-~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH-RPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             hccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC-cccCccccccccccccCcCC
Confidence            974 4555555444  3455567778888999999999999999999999999999998 789998733211100     


Q ss_pred             -----------------------C---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 038154          155 -----------------------L---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP  208 (293)
Q Consensus       155 -----------------------~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  208 (293)
                                             .   .......+++.|.+||...+. ....++|.|+.|+.+++.++|..||++.+.+
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                                   0   001122278889999988877 6889999999999999999999999999888


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH---HHhcCcc
Q 038154          209 GLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR---EALRHEY  285 (293)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---~ll~~p~  285 (293)
                      .....+....-.+                           ..-+...+.++.+++.+.+..+|.+|..+.   ++-.|||
T Consensus      1042 ~~f~ni~~~~~~~---------------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1042 QIFENILNRDIPW---------------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred             hhhhccccCCCCC---------------------------CCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence            8776664321111                           122234678899999999999999999887   8999999


Q ss_pred             cccCcC
Q 038154          286 FKDFQS  291 (293)
Q Consensus       286 ~~~~~~  291 (293)
                      |+...|
T Consensus      1095 ~~~~~~ 1100 (1205)
T KOG0606|consen 1095 FQDVDW 1100 (1205)
T ss_pred             cCCCCc
Confidence            998765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.44  E-value=1e-11  Score=105.29  Aligned_cols=213  Identities=15%  Similarity=0.165  Sum_probs=154.6

Q ss_pred             ceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee----cCCcceeEeecCC--cchH
Q 038154           13 YGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS----SVDSIDLVFENLD--FDLL   86 (293)
Q Consensus        13 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~--~~~~   86 (293)
                      -.+.|++....+|..|++|+++-..  .........-+++++++.|+|++++.+++.    .+...++|++|.+  +++.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            3678999999999999999984322  222345567889999999999999999875    3446899999998  4555


Q ss_pred             HHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           87 HFMKTE-------------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        87 ~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +..-..             .....++..+|.++.||..||.++|+.|+...-|.+.+|+++.+.. ++++..|......+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R-IriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR-IRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce-EEEecccceeeecC
Confidence            544221             1234567899999999999999999999999999999999997764 89988887765554


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      +.            .+|  +..    ..+.|.=.||.+++.+.||..- +......+.                      
T Consensus       446 d~------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----------------------  485 (655)
T KOG3741|consen  446 DP------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----------------------  485 (655)
T ss_pred             CC------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH----------------------
Confidence            32            111  211    2457899999999999998532 111111111                      


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                    ....+.+.++.++.++|.-+...++++ -++.+++.+
T Consensus       486 --------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  486 --------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                          112234456788888999888888887 677777653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=2.8e-13  Score=116.46  Aligned_cols=248  Identities=19%  Similarity=0.127  Sum_probs=172.8

Q ss_pred             CceeeeeeccccceeEEEEEeC-CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|-.+..||.|.++.|+...-. .++-.|++|..............-..|+.+...+ .|.+++.....+...+..|+--
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            3567889999999999887533 5777889887754443333222333466666666 4889999888888888888999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++.+.....-. .-...+++...+.+..|++.++.++|+..++|+|++|+||++..++...+++||+..+.+...  ..
T Consensus       346 e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~  422 (524)
T KOG0601|consen  346 EFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SG  422 (524)
T ss_pred             hhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--cc
Confidence            999865554333 222245667889999999999999999999999999999999976433789999988643211  11


Q ss_pred             eccCcccccc-CcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          159 TIKGGSLCYK-APERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       159 ~~~~~~~~~~-aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      . ..+.-++. .+|.+.....+..+.|++|||.-+.+.++|... ........+                          
T Consensus       423 ~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i--------------------------  475 (524)
T KOG0601|consen  423 V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI--------------------------  475 (524)
T ss_pred             c-ccccccccccchhhccccccccccccccccccccccccCcccCcccccceee--------------------------
Confidence            1 11333344 356566666788999999999999998887632 221111000                          


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                              ........++...++..+.+.|...++..||++.++..|+=|
T Consensus       476 --------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  476 --------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             --------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                    011112233445778899999999999999999999887744

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.40  E-value=2.4e-11  Score=100.80  Aligned_cols=251  Identities=12%  Similarity=0.014  Sum_probs=152.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeee------eecCCc-cee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNV------QSSVDS-IDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~~~~~-~~l   76 (293)
                      +..||+|+.+.+|..-   .-...+.|+++....     ..-.+-+..|... .||-+-.-+.+      ..+.+. ..+
T Consensus        16 gr~LgqGgea~ly~l~---e~~d~VAKIYh~Ppp-----a~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          16 GRPLGQGGEADLYTLG---EVRDQVAKIYHAPPP-----AAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CccccCCccceeeecc---hhhchhheeecCCCc-----hHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            4679999999999883   223357798864321     1111222333332 35543331221      122222 556


Q ss_pred             EeecCCc--chHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           77 VFENLDF--DLLHFMK----TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        77 v~e~~~~--~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      +|..+.|  .....+.    .......++..+.+.++.|+.+...||..|.+-||++++|++++.++. |.|+|=+.-..
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~-V~LVdsDsfqi  166 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK-VVLVDSDSFQI  166 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce-EEEEcccceee
Confidence            7777764  2222221    122334577889999999999999999999999999999999998887 88888765544


Q ss_pred             CCCCCcceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCc-----hHHHHHHHHHhCC
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWA-----PGLLAAIFSIMGT  220 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~-----~~~~~~~~~~~~~  220 (293)
                      .... .....+.+.+.|.+||...-    ...-+..+|.|.||+++++++.| ..||.+...     ...-..|......
T Consensus       167 ~~ng-~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 NANG-TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             ccCC-ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            3222 33444558899999995431    11346789999999999998887 799976311     1111111111111


Q ss_pred             CCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhcc--CCCCCCCHHH
Q 038154          221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCL--DPSKRLTARE  279 (293)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~~  279 (293)
                      ..+.              ............=+.-+++++..++.+|+..  +++-|||++.
T Consensus       246 ya~~--------------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASD--------------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echh--------------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1100              0111111111112334788999999999985  4678999865

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=7.8e-13  Score=116.22  Aligned_cols=144  Identities=15%  Similarity=0.150  Sum_probs=87.8

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC--------------------CC------------Cc------ccHH
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--------------------EG------------VP------SSVI   47 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------------------~~------------~~------~~~~   47 (293)
                      +.||+|+.|.||+|..+.+|+.||||+.+.....                    ..            ..      -++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            6899999999999998877999999998532100                    00            00      1233


Q ss_pred             HHHHHHHhcC----CCCcceeeeee-ecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHH-HHHHHHHhCCc
Q 038154           48 REVSLLKELK----HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL-HGVAYCHSQEI  121 (293)
Q Consensus        48 ~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~-~~l~~lh~~~~  121 (293)
                      +|...+.++.    +...+.+-.++ ......++||||+.|..+..+..-.....+...   ++...+ ..+..+...|+
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Qif~~Gf  281 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQVFRDGF  281 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHHHHhCCe
Confidence            4444444442    22222222222 223457899999998666543221111222112   222211 22334557899


Q ss_pred             eecccCCCceeEeCCC----CeEEEccCCCcccCCC
Q 038154          122 LHRDLKPANFLIDRSK----DIVKIADFGLARPIDV  153 (293)
Q Consensus       122 ~h~dl~~~Ni~i~~~~----~~v~l~df~~~~~~~~  153 (293)
                      +|+|++|.||+++.++    . ++++|||.+.....
T Consensus       282 fHaDpHPGNIlv~~~g~~~~~-i~llDFGivg~l~~  316 (537)
T PRK04750        282 FHADMHPGNIFVSYDPPENPR-YIALDFGIVGSLNK  316 (537)
T ss_pred             eeCCCChHHeEEecCCCCCCe-EEEEecceEEECCH
Confidence            9999999999999887    5 89999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=4.2e-13  Score=117.18  Aligned_cols=153  Identities=19%  Similarity=0.269  Sum_probs=110.7

Q ss_pred             HHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc---------eeccCccccccCcccccCCC
Q 038154          108 QILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---------YTIKGGSLCYKAPERLLGSG  177 (293)
Q Consensus       108 ~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~  177 (293)
                      +.+.|+.++|.. ++||++|.|++|.++..+. +|++.|+++.....+.+-         .........|.|||.+.+. 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~-wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD-WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcc-eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence            344899999965 9999999999999999998 999999998766543221         1111145579999988774 


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCC
Q 038154          178 RYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLE  256 (293)
Q Consensus       178 ~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (293)
                      ..+.++|+||+|+++|.+..|+.+ +...........-..             ..             .-........+|
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-------------~~-------------~~~~~~~s~~~p  238 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-------------LL-------------NAGAFGYSNNLP  238 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-------------cc-------------ccccccccccCc
Confidence            689999999999999999955544 333322211111100             00             011112235689


Q ss_pred             chHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          257 PDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       257 ~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      .++++=+.++|..++.-||++..++..|||.+
T Consensus       239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D  270 (700)
T KOG2137|consen  239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSD  270 (700)
T ss_pred             HHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence            99999999999999999999999999999976

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.35  E-value=7.4e-12  Score=98.41  Aligned_cols=138  Identities=23%  Similarity=0.237  Sum_probs=102.3

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC----------------C----CCCcccHHHHHHHHHhcCCC--C
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP----------------S----EGVPSSVIREVSLLKELKHE--N   60 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----------------~----~~~~~~~~~e~~~l~~l~~~--~   60 (293)
                      .++..||-|..|.||.+.++ .|..+++|.=..-..                .    ........+|.++|..|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46789999999999999866 688999984211000                0    11223456799999998655  7


Q ss_pred             cceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeE
Q 038154           61 IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIV  140 (293)
Q Consensus        61 i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v  140 (293)
                      +++.+++    +...+|||+++|..+..+.      ++....-.++..|++-+.-+-..|++|||+++-||+++++|. +
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-~  241 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-I  241 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-E
Confidence            8888866    6678999999986554332      133355556677777777777999999999999999999988 8


Q ss_pred             EEccCCCcccCC
Q 038154          141 KIADFGLARPID  152 (293)
Q Consensus       141 ~l~df~~~~~~~  152 (293)
                      .++||..+....
T Consensus       242 ~vIDwPQ~v~~~  253 (304)
T COG0478         242 VVIDWPQAVPIS  253 (304)
T ss_pred             EEEeCcccccCC
Confidence            999998876543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=4.3e-11  Score=95.10  Aligned_cols=141  Identities=18%  Similarity=0.215  Sum_probs=99.4

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeeeeeecC---CcceeEeec
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLNVQSSV---DSIDLVFEN   80 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~lv~e~   80 (293)
                      +.|+.|..+.+|++... +|..+++|........ .....+..|.++++.+.+  ..+++++.+....   +..++|||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            67899999999999764 3578999986433221 245678899999999975  3457777776554   367899999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS------------------------------------------  118 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------  118 (293)
                      ++|..+......  ..+++.....++.+++.+|..||+                                          
T Consensus        82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            998655443211  134455555566666666666652                                          


Q ss_pred             --------------CCceecccCCCceeEeCC-CCeEEEccCCCccc
Q 038154          119 --------------QEILHRDLKPANFLIDRS-KDIVKIADFGLARP  150 (293)
Q Consensus       119 --------------~~~~h~dl~~~Ni~i~~~-~~~v~l~df~~~~~  150 (293)
                                    ..++|||+++.||+++.+ +..+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          347999999999999974 33478999988754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.31  E-value=2.3e-11  Score=92.87  Aligned_cols=128  Identities=27%  Similarity=0.280  Sum_probs=82.9

Q ss_pred             eEEEEEeCCCCCeEEEEEecccCCC----------CCC--------------cccHHHHHHHHHhcCCC--Ccceeeeee
Q 038154           15 AVHRAHDSLTGDTVVVKKIPIMNPS----------EGV--------------PSSVIREVSLLKELKHE--NIVRLLNVQ   68 (293)
Q Consensus        15 ~vy~~~~~~~~~~~~iK~~~~~~~~----------~~~--------------~~~~~~e~~~l~~l~~~--~i~~~~~~~   68 (293)
                      .||.|... +|..+|+|.+.....+          ...              ......|.++|.++..-  ++++++++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48888754 5778999988543211          000              12344699999999754  56777755 


Q ss_pred             ecCCcceeEeecCC--cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecccCCCceeEeCCCCeEEEccC
Q 038154           69 SSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY-CHSQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        69 ~~~~~~~lv~e~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                         ...++||||++  |..+..+.....   +......++.+++..+.. +|+.|++|||+++.||+++.+ . +.++||
T Consensus        79 ---~~~~ivME~I~~~G~~~~~l~~~~~---~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~-~~iIDf  150 (188)
T PF01163_consen   79 ---NRNVIVMEYIGEDGVPLPRLKDVDL---SPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K-VYIIDF  150 (188)
T ss_dssp             ---ETTEEEEE--EETTEEGGCHHHCGG---GGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C-EEE--G
T ss_pred             ---eCCEEEEEecCCCccchhhHHhccc---cchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e-EEEEec
Confidence               34679999999  766666554331   133566778888885554 679999999999999999976 4 999999


Q ss_pred             CCcccCC
Q 038154          146 GLARPID  152 (293)
Q Consensus       146 ~~~~~~~  152 (293)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.26  E-value=7e-11  Score=95.62  Aligned_cols=136  Identities=17%  Similarity=0.121  Sum_probs=91.2

Q ss_pred             cceeEEEEEeCCCCCeEEEEEecccCCCC---------CCcccHHHHHHHHHhcCCCCc--ceeeeeeec-----CCcce
Q 038154           12 RYGAVHRAHDSLTGDTVVVKKIPIMNPSE---------GVPSSVIREVSLLKELKHENI--VRLLNVQSS-----VDSID   75 (293)
Q Consensus        12 ~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~~   75 (293)
                      ....|.++  ...|+.+.+|.........         .-...+.+|.+.+.++..-+|  +.++++.+.     ....+
T Consensus        34 ~~rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            33445566  3467889999763322110         011147789999888853333  344444432     23478


Q ss_pred             eEeecCCcc--hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC------CCeEEEccCCC
Q 038154           76 LVFENLDFD--LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS------KDIVKIADFGL  147 (293)
Q Consensus        76 lv~e~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~------~~~v~l~df~~  147 (293)
                      +|+|++++.  +.+.+........+......++.+++..+..||+.|++|+|++++||+++.+      ...+.++||+.
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999999974  4444432222344556777899999999999999999999999999999852      23589999998


Q ss_pred             cc
Q 038154          148 AR  149 (293)
Q Consensus       148 ~~  149 (293)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            75

>PRK09902 hypothetical protein; Provisional

Probab=99.13  E-value=1.3e-09  Score=83.80  Aligned_cols=140  Identities=15%  Similarity=0.141  Sum_probs=101.1

Q ss_pred             ccccceeEEEEEeCCCCCeEEEEEec-ccCCC---CCCcccHHHHHHHHHhcCCC--Ccceeeeeee---cC--CcceeE
Q 038154            9 REGRYGAVHRAHDSLTGDTVVVKKIP-IMNPS---EGVPSSVIREVSLLKELKHE--NIVRLLNVQS---SV--DSIDLV   77 (293)
Q Consensus         9 g~g~~~~vy~~~~~~~~~~~~iK~~~-~~~~~---~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~---~~--~~~~lv   77 (293)
                      |+||.|-|++..  ..|..+-+|.-. ....+   +-....+.+|...+.+|..-  .++++. ++.   .+  -..+||
T Consensus        27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            568999999984  345578888753 11111   33456788999999998532  255554 222   11  136799


Q ss_pred             eecCCc--chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-eEEEccCCCcccC
Q 038154           78 FENLDF--DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-IVKIADFGLARPI  151 (293)
Q Consensus        78 ~e~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~  151 (293)
                      +|.++|  ++.+.+.+......+......++.+++.++.-||+.|+.|+|+.+.||+++..+. .|.++||..++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            999984  5555665655555677777889999999999999999999999999999985554 5899999877543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.05  E-value=4.7e-09  Score=82.01  Aligned_cols=139  Identities=20%  Similarity=0.147  Sum_probs=92.3

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-----------------cccH-----HHHHHHHHhcC--CC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-----------------PSSV-----IREVSLLKELK--HE   59 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----------------~~~~-----~~e~~~l~~l~--~~   59 (293)
                      +...|+.|..++||+|.. .++..+|+|++.........                 ...+     ..|...|+++.  +-
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            345788899999999963 46889999999654432111                 1111     13556666663  33


Q ss_pred             CcceeeeeeecCCcceeEeecCCcch-H-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCC
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDFDL-L-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRS  136 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~~~-~-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~  136 (293)
                      .+++.+++    ....+|||+++..- . -.|.   ..+........+..++++.+.-|-. .|+|||||+.-||++. +
T Consensus       131 rvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         131 RVPEPIAF----RNNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CCCCceee----cCCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence            44555554    23569999998541 1 1111   1122333566777888888887777 8999999999999999 5


Q ss_pred             CCeEEEccCCCcccCC
Q 038154          137 KDIVKIADFGLARPID  152 (293)
Q Consensus       137 ~~~v~l~df~~~~~~~  152 (293)
                      +. +.++||+.+....
T Consensus       203 ~~-p~iID~~QaV~~~  217 (268)
T COG1718         203 GE-PYIIDVSQAVTID  217 (268)
T ss_pred             Ce-EEEEECccccccC
Confidence            54 8999999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=5.3e-09  Score=81.96  Aligned_cols=107  Identities=22%  Similarity=0.241  Sum_probs=78.9

Q ss_pred             CcccHHHHHHHHHhcCCC--CcceeeeeeecCC----cceeEeecCCc--chHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038154           42 VPSSVIREVSLLKELKHE--NIVRLLNVQSSVD----SIDLVFENLDF--DLLHFMKTEPTVTKNPLKIKKYLHQILHGV  113 (293)
Q Consensus        42 ~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~----~~~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l  113 (293)
                      ......+|.+.+..|..-  ..+.++++.+...    ..++|+|++++  ++.+.+.....  .+......++.+++..+
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLI  131 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHH
Confidence            345677888888887533  3455555544422    35899999986  34444443222  45557788999999999


Q ss_pred             HHHHhCCceecccCCCceeEeCCC--CeEEEccCCCccc
Q 038154          114 AYCHSQEILHRDLKPANFLIDRSK--DIVKIADFGLARP  150 (293)
Q Consensus       114 ~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~~~~  150 (293)
                      .-||..|++|+|+++.||+++.++  ..+.++||+.+..
T Consensus       132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999886  2489999987764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.94  E-value=9.3e-09  Score=79.47  Aligned_cols=137  Identities=17%  Similarity=0.222  Sum_probs=86.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-c------ccHHHHHHHHHhcC---CCCcceeee----
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-P------SSVIREVSLLKELK---HENIVRLLN----   66 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~------~~~~~e~~~l~~l~---~~~i~~~~~----   66 (293)
                      .|.+.+++.......|.+.  ..+|..+++|........... .      ....+.+..+..+.   ......++.    
T Consensus        32 ~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            4778888888888888888  566788999976432211100 0      11222333333332   222222222    


Q ss_pred             -eeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccC
Q 038154           67 -VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        67 -~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                       .+......+++|||++|..+..+..     +++    .+...+.+++..||+.|++|||.+|.|++++.++  ++++||
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~--i~iID~  178 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG--IRIIDT  178 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc--EEEEEC
Confidence             2233345678999999966543322     121    2445677889999999999999999999999555  899999


Q ss_pred             CCccc
Q 038154          146 GLARP  150 (293)
Q Consensus       146 ~~~~~  150 (293)
                      +....
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            76643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.84  E-value=7.3e-08  Score=76.52  Aligned_cols=71  Identities=11%  Similarity=0.048  Sum_probs=53.7

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC--CcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE--NIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ..+|+|..+.||+.    .|..+++|..+.    ......+.+|.++++.+..-  .+++++++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~----~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNP----GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCC----CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            46899999999985    245688897642    22335678899999998643  357778888777788899999998


Q ss_pred             c
Q 038154           84 D   84 (293)
Q Consensus        84 ~   84 (293)
                      .
T Consensus        79 ~   79 (226)
T TIGR02172        79 K   79 (226)
T ss_pred             c
Confidence            5

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.65  E-value=7.5e-07  Score=71.87  Aligned_cols=75  Identities=17%  Similarity=0.103  Sum_probs=52.9

Q ss_pred             eeeccccc-eeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRY-GAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~-~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ..|..|.. +.||++..  .+..+++|......     ...+..|+++++.+. +--+++++++...++..++||++++|
T Consensus         4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            34556665 77999953  34678888764321     346778999998884 44566778877776778999999998


Q ss_pred             chHH
Q 038154           84 DLLH   87 (293)
Q Consensus        84 ~~~~   87 (293)
                      ..+.
T Consensus        77 ~~l~   80 (244)
T cd05150          77 VPAA   80 (244)
T ss_pred             ccHh
Confidence            6544

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.64  E-value=2.3e-07  Score=74.30  Aligned_cols=78  Identities=18%  Similarity=0.132  Sum_probs=53.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC--Ccceeeeee---ecCCcceeEee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE--NIVRLLNVQ---SSVDSIDLVFE   79 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~e   79 (293)
                      ++.|+.|..+.||++....  ..+++|.....    .....+..|..+++.+...  .++.++.+.   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            5789999999999997554  48999986432    3346777899998888533  345666533   23334689999


Q ss_pred             cCCcchHHH
Q 038154           80 NLDFDLLHF   88 (293)
Q Consensus        80 ~~~~~~~~~   88 (293)
                      +++|..+..
T Consensus        76 ~i~g~~~~~   84 (239)
T PF01636_consen   76 YIPGRPLDD   84 (239)
T ss_dssp             EESSEEHHH
T ss_pred             Eeccccccc
Confidence            999864444

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=6.5e-07  Score=66.43  Aligned_cols=128  Identities=21%  Similarity=0.219  Sum_probs=89.4

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEeecCC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      +.+.|++|..|.||++  .+.|..+++|+-.    .++....+..|.++|..+.-.++ .+++.|..+    .+.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~--~~~~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLG--EWRGGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEe--eccCceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            4578999999999999  4567789999753    34445788899999999976555 556766444    34599999


Q ss_pred             cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccC-CC-ceeEeCCCCeEEEccCCCcccC
Q 038154           83 FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK-PA-NFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~-~~-Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      |..+.......        -++-...++++---|-..|+-|+.|+ |. ||++. ++. +.|+||..++..
T Consensus        96 G~~L~~~~~~~--------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~-~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG--------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD-VYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc--------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc-EEEEEccchhhc
Confidence            86554433221        12334456666556778899999986 34 55554 445 899999999743

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=2.7e-07  Score=81.13  Aligned_cols=144  Identities=18%  Similarity=0.163  Sum_probs=88.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC--------------------CC----C--------------cccHH
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--------------------EG----V--------------PSSVI   47 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--------------------~~----~--------------~~~~~   47 (293)
                      +.++.++-|.||+|.-+ +|+.||||+....-..                    ..    .              .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56788999999999865 4999999987432110                    00    0              01222


Q ss_pred             HHHHHHHhcC-----CCCcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 038154           48 REVSLLKELK-----HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL  122 (293)
Q Consensus        48 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  122 (293)
                      .|...+.++.     .|++.=..=|.+..+.-.++|||++|.-...+........+...+.....++  .+..+-..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence            3444444432     1222111112334456789999999866655543333344433333222222  34555568999


Q ss_pred             ecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154          123 HRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus       123 h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      |+|.+|.||++..++. +.+.|||.....+.
T Consensus       288 HaDpHpGNi~v~~~g~-i~~lDfGi~g~l~~  317 (517)
T COG0661         288 HADPHPGNILVRSDGR-IVLLDFGIVGRLDP  317 (517)
T ss_pred             ccCCCccceEEecCCc-EEEEcCcceecCCH
Confidence            9999999999999988 88999999866553

>PLN02876 acyl-CoA dehydrogenase

Probab=98.52  E-value=2.5e-06  Score=80.51  Aligned_cols=80  Identities=16%  Similarity=0.208  Sum_probs=56.5

Q ss_pred             eeeeccccceeEEEEEeCCCC--CeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCc--ceeeeeeecC---Cccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENI--VRLLNVQSSV---DSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~l   76 (293)
                      +..++.|.+..+|++.....+  ..+++|+.+.... ......+.+|.++++.+. |+++  ++++.++.+.   +..++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            567888999999998654332  4678887543221 122346889999999995 6655  7777777664   46789


Q ss_pred             EeecCCcch
Q 038154           77 VFENLDFDL   85 (293)
Q Consensus        77 v~e~~~~~~   85 (293)
                      |||+++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998753

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.41  E-value=1.9e-06  Score=80.63  Aligned_cols=196  Identities=20%  Similarity=0.250  Sum_probs=125.6

Q ss_pred             HHHHHHhcCCCCcceeeeeeecCCc----ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 038154           49 EVSLLKELKHENIVRLLNVQSSVDS----IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH  123 (293)
Q Consensus        49 e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h  123 (293)
                      |...+.+..|+|+..++.|......    ..+..+++.+ ++...++.-.  ..+....+.+..++..+|.++|+..+.|
T Consensus       232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            5556677789999999988644332    3344566664 4444444433  4667788899999999999999996666


Q ss_pred             cccCCC---ceeEeCCCCeEEEc--cCCCcccCCCCCcceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHh
Q 038154          124 RDLKPA---NFLIDRSKDIVKIA--DFGLARPIDVPLENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVT  197 (293)
Q Consensus       124 ~dl~~~---Ni~i~~~~~~v~l~--df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~  197 (293)
                      .-+..+   +--++..+. +..+  ||+.+...... ........+..+.++|..... .......|+|++|.+...+..
T Consensus       310 v~L~~s~~~~~~~~~e~~-~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGEGV-VAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             eEEecccccccccCccce-eecchhhhcccccCCCc-ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            666555   222332332 4444  77777655432 222222244556777755433 223345799999999999998


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCC-chHHHHHHHhhccCCCCCCC
Q 038154          198 HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLE-PDGVDLLRRMLCLDPSKRLT  276 (293)
Q Consensus       198 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dp~~Rps  276 (293)
                      |..+-.....                                        ...+.+..+ ....+++.+|+..++++|++
T Consensus       388 ~~~i~~~~~~----------------------------------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  388 GEDISEKSAV----------------------------------------PVSLLDVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             cCcccccccc----------------------------------------hhhhhccccchhhhhhhhhhcchhhhhccc
Confidence            7755321100                                        001111111 26778999999999999999


Q ss_pred             HHHHhcCccccc
Q 038154          277 AREALRHEYFKD  288 (293)
Q Consensus       277 ~~~ll~~p~~~~  288 (293)
                      +.+++.|||.+.
T Consensus       428 ~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  428 ALELLTHPFLRF  439 (1351)
T ss_pred             hhhhhhchhccc
Confidence            999999998753

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.32  E-value=1.9e-05  Score=61.04  Aligned_cols=134  Identities=18%  Similarity=0.198  Sum_probs=91.2

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccC--------------CCCCCcccHHHHHHHHHhcC------CCCcceee
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN--------------PSEGVPSSVIREVSLLKELK------HENIVRLL   65 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~~   65 (293)
                      ..||+|+.-.||.-  + .+...+||+.....              ..........+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            57899999999976  4 45568899986544              11122456667777766665      78999999


Q ss_pred             eeeecCCcceeEeecCC---c---chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-
Q 038154           66 NVQSSVDSIDLVFENLD---F---DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-  138 (293)
Q Consensus        66 ~~~~~~~~~~lv~e~~~---~---~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-  138 (293)
                      |+.+.+....+|+|-+.   |   .++..+....  .+++    .+...+-+..++|-+.+|+.+|++|.||++..... 
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            99999999999999764   3   2333333222  2332    33344445567788999999999999999986543 


Q ss_pred             --eEEEcc-CCCc
Q 038154          139 --IVKIAD-FGLA  148 (293)
Q Consensus       139 --~v~l~d-f~~~  148 (293)
                        .+.|+| ||..
T Consensus       158 ~~~lvlIDG~G~~  170 (199)
T PF10707_consen  158 EFRLVLIDGLGEK  170 (199)
T ss_pred             ceEEEEEeCCCCc
Confidence              355555 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.31  E-value=6.9e-06  Score=65.87  Aligned_cols=73  Identities=19%  Similarity=0.166  Sum_probs=45.4

Q ss_pred             eeeecccccee-EEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC---CcceeeeeeecC---CcceeE
Q 038154            5 LEVIREGRYGA-VHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE---NIVRLLNVQSSV---DSIDLV   77 (293)
Q Consensus         5 ~~~lg~g~~~~-vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv   77 (293)
                      ++.++.|+.+. ||++     +..+++|..+.    ......+..|.++++.+...   .+.++++.....   +..+++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            35677777664 9987     23578886432    12235788899999888532   344555543332   235789


Q ss_pred             eecCCcchH
Q 038154           78 FENLDFDLL   86 (293)
Q Consensus        78 ~e~~~~~~~   86 (293)
                      |++++|..+
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999987433

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=9.7e-08  Score=83.69  Aligned_cols=182  Identities=16%  Similarity=0.107  Sum_probs=125.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCcceeEeecCCcc
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      +.+++++++++++.+........ .+.+.     ..  ....-++++|.+.+||| .+..++-+..+....+.++++.+.
T Consensus       248 h~fvK~altknpKkRptaeklL~-h~fvs-----~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ-HPFVS-----QT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee-ceeec-----cc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            45678889999888644333222 33321     11  34556889999999999 555566666677888999999854


Q ss_pred             -hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCc
Q 038154           85 -LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG  163 (293)
Q Consensus        85 -~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~  163 (293)
                       ............+.+-.+..+.+.-+.+++++|+.-=+|+|    ||+-.+..  .+..+|+....+.... ......+
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~--~~~~~~~v~~~L~~~~-~~~t~~~  392 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE--VKLLDFAVPPQLTRTM-KPRTAIG  392 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc--cccccccCCcccCccc-ccccCCC
Confidence             22222222233344445666777788899999988767887    77766533  7999999887665443 3344458


Q ss_pred             cccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       164 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                      ++.++|||+.... .+...-|.|++|.-..++--|-.|-.
T Consensus       393 ~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  393 TPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCC
Confidence            8999999987766 68899999999987677776766643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=2.1e-05  Score=60.41  Aligned_cols=125  Identities=22%  Similarity=0.295  Sum_probs=84.8

Q ss_pred             ceeeeeeccccc-eeEEEEEeCCCCCeEEEEEecc---cCCC------C----------CCcccHHHHHHHHHhcC---C
Q 038154            2 YTLLEVIREGRY-GAVHRAHDSLTGDTVVVKKIPI---MNPS------E----------GVPSSVIREVSLLKELK---H   58 (293)
Q Consensus         2 y~i~~~lg~g~~-~~vy~~~~~~~~~~~~iK~~~~---~~~~------~----------~~~~~~~~e~~~l~~l~---~   58 (293)
                      ++.++.||.|.. |.||++  ...|..||+|++..   ....      .          .....|..|-++.-+|+   +
T Consensus        39 I~flefLg~g~~~~~V~kv--~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   39 IEFLEFLGHGSHDGYVFKV--EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             EeeeeecCCCCceeEEEEE--EECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            467899999999 999999  56788999999421   1100      0          22345677887777774   4


Q ss_pred             CCc--ceeeeeeecC------------------CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 038154           59 ENI--VRLLNVQSSV------------------DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS  118 (293)
Q Consensus        59 ~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  118 (293)
                      .++  ++++||..-.                  ....||.|+.....          ....    .-+.++.+-+..+|+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence            555  8999985211                  12346666655332          1222    234456667788999


Q ss_pred             CCceecccCCCceeEeCCCCeEEEccCCCc
Q 038154          119 QEILHRDLKPANFLIDRSKDIVKIADFGLA  148 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~  148 (293)
                      .||+-+|+++.|..   +|   +|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc---CC---EEEecccC
Confidence            99999999999987   33   78999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=9.3e-06  Score=71.52  Aligned_cols=142  Identities=18%  Similarity=0.199  Sum_probs=88.5

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCC-----------------------------CCCc------ccHHHHH
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-----------------------------EGVP------SSVIREV   50 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-----------------------------~~~~------~~~~~e~   50 (293)
                      +.||..+.+.||+|+.+. |+.||||+-+..-..                             ++..      -+|..|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            568889999999998775 999999976421111                             0000      1233344


Q ss_pred             HHHHhc----CCCC------cceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhC
Q 038154           51 SLLKEL----KHEN------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA-YCHSQ  119 (293)
Q Consensus        51 ~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~  119 (293)
                      +..+++    .|-+      |++++-  .......++|||++|.-...+..-....++...   ++..+.++.. .+=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHHhc
Confidence            433333    2333      344433  233457899999998555544433333455443   4444444333 34477


Q ss_pred             CceecccCCCceeEeCC---CCeEEEccCCCcccCCC
Q 038154          120 EILHRDLKPANFLIDRS---KDIVKIADFGLARPIDV  153 (293)
Q Consensus       120 ~~~h~dl~~~Ni~i~~~---~~~v~l~df~~~~~~~~  153 (293)
                      |++|+|=+|.||++..+   +..+.+.|||.......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            99999999999999953   33589999999876653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.21  E-value=3e-05  Score=62.18  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=47.2

Q ss_pred             eeeeccccceeEEEEEeCC-CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC-CcceeeeeeecCCcceeEeecCC
Q 038154            5 LEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE-NIVRLLNVQSSVDSIDLVFENLD   82 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~~   82 (293)
                      ++.|..|-...+|++.... .+..+++|+....   ........+|+.+++.+... -.+++++...    ..++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~---~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK---TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC---ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence            4678888888999996432 2567899976432   11223445789999888533 3445554432    237999998


Q ss_pred             cch
Q 038154           83 FDL   85 (293)
Q Consensus        83 ~~~   85 (293)
                      |..
T Consensus        76 G~~   78 (235)
T cd05157          76 GRT   78 (235)
T ss_pred             CCc
Confidence            743

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.20  E-value=1.4e-05  Score=64.96  Aligned_cols=135  Identities=19%  Similarity=0.221  Sum_probs=76.8

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEeecCCcch
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFENLDFDL   85 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~   85 (293)
                      .+..|-.+.+|++.  .++..+++|.......  ....+..+|.++++.+....+ ++++....    .++|+|+++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45677788899995  4567889986532211  111245789999998864333 44454432    368999998754


Q ss_pred             HHH------------------hhcCC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceecccC
Q 038154           86 LHF------------------MKTEP--TVTKNPL-KIKKYLHQI---------LHGVAYCHS--------QEILHRDLK  127 (293)
Q Consensus        86 ~~~------------------~~~~~--~~~~~~~-~~~~i~~~i---------~~~l~~lh~--------~~~~h~dl~  127 (293)
                      +..                  +....  ....+.. .+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            321                  11111  1111111 111111111         111222211        258999999


Q ss_pred             CCceeEeCCCCeEEEccCCCcccC
Q 038154          128 PANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus       128 ~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      |.||+++.++  +.++||+++..-
T Consensus       155 ~~Nil~~~~~--~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG--LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC--CEEEeccccCcC
Confidence            9999999766  789999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.15  E-value=9.2e-05  Score=63.49  Aligned_cols=77  Identities=19%  Similarity=0.156  Sum_probs=53.8

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-----CCCcccHHHHHHHHHhcC---CCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-----EGVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l   76 (293)
                      .+.||.|-...||++.....++.++||.-......     .-..++...|.+.|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36789999999999987644458999974311110     123456777888888863   3467778877  4466889


Q ss_pred             EeecCCc
Q 038154           77 VFENLDF   83 (293)
Q Consensus        77 v~e~~~~   83 (293)
                      |||++++
T Consensus       109 VME~L~~  115 (401)
T PRK09550        109 VMEDLSD  115 (401)
T ss_pred             EEecCCC
Confidence            9999874

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=7.3e-05  Score=62.06  Aligned_cols=74  Identities=20%  Similarity=0.128  Sum_probs=53.0

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC---CCcceeeeeeec---CCcceeEe
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH---ENIVRLLNVQSS---VDSIDLVF   78 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv~   78 (293)
                      .+.||+|..+.||+....  +..+++|..+.    ......+..|.+.++.+..   -.++++++++..   .+..++||
T Consensus        19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         19 VECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            467899999999999533  23477776421    1123578899999998853   367888877654   36689999


Q ss_pred             ecCCcc
Q 038154           79 ENLDFD   84 (293)
Q Consensus        79 e~~~~~   84 (293)
                      |+++|.
T Consensus        93 E~i~G~   98 (297)
T PRK10593         93 ERLRGV   98 (297)
T ss_pred             eccCCE
Confidence            999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.12  E-value=2.1e-05  Score=65.34  Aligned_cols=141  Identities=18%  Similarity=0.164  Sum_probs=91.9

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-------------------CCCcccH-----HHHHHHHHhcCCC
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-------------------EGVPSSV-----IREVSLLKELKHE   59 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-------------------~~~~~~~-----~~e~~~l~~l~~~   59 (293)
                      |-..|+.|..+.||.|... +|..+|||+++.+...                   ......+     ..|++.|+++..-
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3467888999999999744 6788999998643211                   1111111     2377888888655


Q ss_pred             CcceeeeeeecCCcceeEeecCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecccCCCceeEeCCC
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH-SQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      .|+-.--+  .-....|||+++++. ...-....  ..++...+..+-.+++.-+.-|. .+++||.||+--|+++.. |
T Consensus       227 GIP~PePI--lLk~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  227 GIPCPEPI--LLKNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCCCCce--eeecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence            54322211  113467999999842 22111111  23556677777777777776654 569999999999999984 4


Q ss_pred             CeEEEccCCCcccC
Q 038154          138 DIVKIADFGLARPI  151 (293)
Q Consensus       138 ~~v~l~df~~~~~~  151 (293)
                      . +.++|.+.+...
T Consensus       302 ~-lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 K-LYIIDVSQSVEH  314 (520)
T ss_pred             E-EEEEEccccccC
Confidence            4 899999887543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.10  E-value=2.8e-05  Score=64.63  Aligned_cols=138  Identities=16%  Similarity=0.078  Sum_probs=79.6

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC--Ccceeeee------eecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE--NIVRLLNV------QSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~~~l   76 (293)
                      .+.+..|....+|++..  .+..+++|++..     .....+..|+++++.+.+.  .+++++..      ...++..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            45677788889999853  345689998743     2234567788888887432  24444432      233456789


Q ss_pred             EeecCCcchHHH---------------hhc---CCCC------CCCHHHH--H--------HHHHHHHHHHHHHHh----
Q 038154           77 VFENLDFDLLHF---------------MKT---EPTV------TKNPLKI--K--------KYLHQILHGVAYCHS----  118 (293)
Q Consensus        77 v~e~~~~~~~~~---------------~~~---~~~~------~~~~~~~--~--------~i~~~i~~~l~~lh~----  118 (293)
                      ++++++|.....               +..   ....      ...+...  .        .....+..++..+.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999998744321               000   0000      0000000  0        001112233444443    


Q ss_pred             ---CCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          119 ---QEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       119 ---~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                         .+++|||+.|.||+++.++. +.|+||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~-~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDEL-SGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCce-EEEeehhhhcC
Confidence               47999999999999997543 57999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=98.01  E-value=5.5e-05  Score=63.61  Aligned_cols=72  Identities=10%  Similarity=0.006  Sum_probs=42.6

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceeeee------eecCCcceeE
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLLNV------QSSVDSIDLV   77 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv   77 (293)
                      +.++.|....+|++...  +..+++|++. . .   ....+..++++++.|...+  +++++..      ....+..+++
T Consensus        28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l  100 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT--QGEYVLTLFE-R-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI  100 (319)
T ss_pred             chhccccccceEEEEeC--CCcEEEEEec-c-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence            45667777889998643  3368999874 1 1   1234445666666663211  3333321      2234567899


Q ss_pred             eecCCcc
Q 038154           78 FENLDFD   84 (293)
Q Consensus        78 ~e~~~~~   84 (293)
                      +++++|.
T Consensus       101 ~~~l~G~  107 (319)
T PRK05231        101 VTFLEGK  107 (319)
T ss_pred             EEecCCC
Confidence            9999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.96  E-value=7e-05  Score=62.61  Aligned_cols=139  Identities=14%  Similarity=0.101  Sum_probs=78.5

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceeeee------eecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLLNV------QSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l   76 (293)
                      .+.++.|....+|++..  ++..+++|++...    .....+..|++++..|....  +++++..      ....+..++
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            45667777789999853  2346888976431    11245667788887774222  3444432      123456789


Q ss_pred             EeecCCcchHH---------------Hhhc-CCCC--C----CCHHH---HH------------HHHHHHHHHHHHHH--
Q 038154           77 VFENLDFDLLH---------------FMKT-EPTV--T----KNPLK---IK------------KYLHQILHGVAYCH--  117 (293)
Q Consensus        77 v~e~~~~~~~~---------------~~~~-~~~~--~----~~~~~---~~------------~i~~~i~~~l~~lh--  117 (293)
                      ++++++|....               .+.. ....  .    .....   ..            .....+...++++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            99999873211               0110 0000  0    00000   00            00111233444443  


Q ss_pred             -----hCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          118 -----SQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       118 -----~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                           ..+++|||+++.||+++.++. +.++||+.+..
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~-~~vIDfd~~~~  217 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSV-KGVIDFYFACT  217 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCce-EEEeecccccC
Confidence                 258999999999999997663 68999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.91  E-value=0.00024  Score=58.87  Aligned_cols=138  Identities=20%  Similarity=0.238  Sum_probs=84.9

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeeeeeecCC--cceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLNVQSSVD--SIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~lv~e~   80 (293)
                      +.....|....+|.....  ++.+++. .+.............+|+++++.+.-  --+...++++..+.  ..+.||++
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            444444544556666433  7888888 43223334455677789999988753  34445566665554  77999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHH-HHHHHHHHHHh-----------------------------------------
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLH-QILHGVAYCHS-----------------------------------------  118 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~i~~~l~~lh~-----------------------------------------  118 (293)
                      ++|.....-..    ...  .-.+++. .+...|..||+                                         
T Consensus       107 veGe~~~~~~~----~~~--~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         107 VEGEVVWSALP----PES--LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ecceeccCcCC----ccc--chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            99842111000    000  0012222 44444444443                                         


Q ss_pred             -----------------CCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154          119 -----------------QEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus       119 -----------------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                                       -.++|||+++.|++++..+. +-+.||+.+..-.
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lGD  230 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP-TGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe-eEEEeccccccCC
Confidence                             24999999999999998887 8899999987644

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.87  E-value=0.00029  Score=59.23  Aligned_cols=74  Identities=16%  Similarity=0.105  Sum_probs=50.4

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccC-----CCCCCcccHHHHHHHHHhcC--CC-CcceeeeeeecCCcceeEe
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-----PSEGVPSSVIREVSLLKELK--HE-NIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~   78 (293)
                      .+|.|-...||++.....++.++||.-....     .-+-..++...|.+.|+...  .| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4688888999999875444679999653111     11334466677888888764  34 56667665  556677999


Q ss_pred             ecCC
Q 038154           79 ENLD   82 (293)
Q Consensus        79 e~~~   82 (293)
                      |+++
T Consensus        80 EdL~   83 (370)
T TIGR01767        80 EDLS   83 (370)
T ss_pred             hhCc
Confidence            9986

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.85  E-value=4e-05  Score=66.34  Aligned_cols=172  Identities=19%  Similarity=0.286  Sum_probs=111.2

Q ss_pred             ccHHHHHHHHHhcCCCCcceeeeeeecC-CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 038154           44 SSVIREVSLLKELKHENIVRLLNVQSSV-DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL  122 (293)
Q Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  122 (293)
                      ..+.-..++++.+.|++..+++++.+.. ....+|+|+++-++.+.+..+.-...+          +   +    ..|+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~~s----------~---~----~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKDES----------L---L----AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccchhh----------h---c----ccccc
Confidence            4566788899999999999999876443 357899999999888877665421111          1   1    11222


Q ss_pred             ecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 038154          123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF  202 (293)
Q Consensus       123 h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  202 (293)
                      |     .|+        ++.+| ...+.                |  |-      +..+++||||+|.++.++.-|...+
T Consensus        90 ~-----~~~--------~~~td-~~~t~----------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   90 H-----LNI--------IYITD-HFLTK----------------Y--PS------PIGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             e-----ehh--------hhccc-ccccc----------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence            2     122        23333 11110                0  11      1124999999999999999999888


Q ss_pred             CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          203 HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ......+....+......+.+.....                  .........+.....+..+|+-..|..||...++..
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a------------------~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTA------------------MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHH------------------HHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            77766666666655433332222111                  111223345677789999999999999999999999


Q ss_pred             Cccccc
Q 038154          283 HEYFKD  288 (293)
Q Consensus       283 ~p~~~~  288 (293)
                      ++-|..
T Consensus       194 ~~i~~e  199 (725)
T KOG1093|consen  194 RCSFTE  199 (725)
T ss_pred             CccHHH
Confidence            887754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.84  E-value=2.2e-05  Score=64.23  Aligned_cols=137  Identities=13%  Similarity=0.200  Sum_probs=92.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC---------------CCCCC-----cccHHHHHHHHHhcCC--C
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN---------------PSEGV-----PSSVIREVSLLKELKH--E   59 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------~~~~~-----~~~~~~e~~~l~~l~~--~   59 (293)
                      +.++..||-|..+.+|.+-+. .|.+.++|.=..-.               .....     .-....|...++.|..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            467889999999999999654 57888888321100               00111     1123347777777743  2


Q ss_pred             CcceeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe
Q 038154           60 NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI  139 (293)
Q Consensus        60 ~i~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~  139 (293)
                      -+++.+++    +..++|||.+.|-.+-.+..-    .   ....+...+...+--|...|++|||.+-=||++..++. 
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-  240 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-  240 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence            34555544    667899999987655433321    1   33345556666677788999999999999999998777 


Q ss_pred             EEEccCCCcccC
Q 038154          140 VKIADFGLARPI  151 (293)
Q Consensus       140 v~l~df~~~~~~  151 (293)
                      ++++||......
T Consensus       241 i~vIDFPQmvS~  252 (465)
T KOG2268|consen  241 IVVIDFPQMVST  252 (465)
T ss_pred             EEEeechHhhcc
Confidence            899999866443

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.83  E-value=0.00027  Score=60.18  Aligned_cols=76  Identities=17%  Similarity=0.111  Sum_probs=52.4

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCC----CCCcccHHHHHHHHHhcC--CC-CcceeeeeeecCCcceeE
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS----EGVPSSVIREVSLLKELK--HE-NIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv   77 (293)
                      .+.||.|--.-||++.+...+..++||.-...-..    .-..++...|.+.|+...  .| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            56789999999999976444567999865221111    234466777889998774  34 56667765  55667788


Q ss_pred             eecCC
Q 038154           78 FENLD   82 (293)
Q Consensus        78 ~e~~~   82 (293)
                      ||+++
T Consensus       112 MEdL~  116 (409)
T PRK12396        112 MEDLS  116 (409)
T ss_pred             HHhCc
Confidence            88886

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.83  E-value=0.00013  Score=56.15  Aligned_cols=99  Identities=19%  Similarity=0.134  Sum_probs=75.2

Q ss_pred             HHHHHHHhcCC-CCcceeeeeeecCCcceeEeecCCc-chHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 038154           48 REVSLLKELKH-ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHS---QEI  121 (293)
Q Consensus        48 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~-~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~  121 (293)
                      .|.-+++.+++ +++++++|+|-.    .++.|+.+. .+...... ......++..+.+++.++++.+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888875 699999999733    578899884 33321000 112345788999999999999999997   358


Q ss_pred             eecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154          122 LHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus       122 ~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      .-.|++++|+-++.++. +|++|.+.....
T Consensus        84 ~lcDv~~~nfgv~~~~~-lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGR-LKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCc-EEEEechhcchh
Confidence            88899999999998887 999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.80  E-value=0.00041  Score=57.89  Aligned_cols=73  Identities=15%  Similarity=0.078  Sum_probs=46.9

Q ss_pred             eeeeccccceeEEEEEeCC------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCcceeE
Q 038154            5 LEVIREGRYGAVHRAHDSL------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv   77 (293)
                      ++.|..|-...+|++....      .++.+++|+.....   ....+..+|.++++.+.... .+++++++..    ..|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            4567777778899996433      25789999864322   22346778998998885333 3455555432    257


Q ss_pred             eecCCcc
Q 038154           78 FENLDFD   84 (293)
Q Consensus        78 ~e~~~~~   84 (293)
                      +++++|.
T Consensus        76 ~e~i~G~   82 (302)
T cd05156          76 EEFIPSR   82 (302)
T ss_pred             hheeCCC
Confidence            8888764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.73  E-value=0.00046  Score=58.60  Aligned_cols=139  Identities=16%  Similarity=0.127  Sum_probs=78.0

Q ss_pred             eeeeccccceeEEEEEeCC----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEee
Q 038154            5 LEVIREGRYGAVHRAHDSL----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e   79 (293)
                      +..|..|-...+|++....    .++.+++|+.....  . ..-+-.+|..+++.+..-++ +++++.+...    .|.+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            3456567778899986332    24678999764322  2 22234679999998864333 4556655332    4788


Q ss_pred             cCCcchHHH------------------hhcCC-C--C-CCCHHHHHHHHHH-----------------HHHHHHHHH---
Q 038154           80 NLDFDLLHF------------------MKTEP-T--V-TKNPLKIKKYLHQ-----------------ILHGVAYCH---  117 (293)
Q Consensus        80 ~~~~~~~~~------------------~~~~~-~--~-~~~~~~~~~i~~~-----------------i~~~l~~lh---  117 (293)
                      |++|..+..                  +.+.. .  . ......+.++..+                 +...+..|.   
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            887643321                  01100 0  0 1111222222211                 111122221   


Q ss_pred             -----hCCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          118 -----SQEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       118 -----~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                           ...++|+|+++.||+++.....+.++||.++..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                 235999999999999986444499999998854

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.69  E-value=0.0012  Score=56.63  Aligned_cols=75  Identities=13%  Similarity=0.125  Sum_probs=51.2

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCC--CC---CCcccHHHHHHHHHhcC---CCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SE---GVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l   76 (293)
                      .+.+|.|-...||++.+.  +..++||.-.....  ..   ....+...|.+.|+.+.   ...+++++.++.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            467888889999999753  45689997542111  11   23455666778887664   247888888866  45778


Q ss_pred             EeecCCc
Q 038154           77 VFENLDF   83 (293)
Q Consensus        77 v~e~~~~   83 (293)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.66  E-value=0.00063  Score=57.42  Aligned_cols=139  Identities=16%  Similarity=0.148  Sum_probs=77.0

Q ss_pred             eeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~   80 (293)
                      ++.|..|=...+|++.....   +..+++|+.....   +..-+-.+|..+++.+..-++ +++++++.. +   +|.+|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~f   91 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSF   91 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehh
Confidence            45565677777998864432   3378999764322   222344679999998865444 455655532 2   47888


Q ss_pred             CCcchHHH------------------hhcCC-C--CCC-CHHHHHHHHHH----------------------HHHHHHHH
Q 038154           81 LDFDLLHF------------------MKTEP-T--VTK-NPLKIKKYLHQ----------------------ILHGVAYC  116 (293)
Q Consensus        81 ~~~~~~~~------------------~~~~~-~--~~~-~~~~~~~i~~~----------------------i~~~l~~l  116 (293)
                      ++|..++.                  +.... .  ... -...+..+..+                      +...+..+
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            87643311                  11111 0  001 11122222211                      11122222


Q ss_pred             H----hC----CceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          117 H----SQ----EILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       117 h----~~----~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      .    ..    -++|+|+.+.||++++++..++++||.++..
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            2    11    2899999999999986544499999998854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.43  E-value=0.0018  Score=53.14  Aligned_cols=31  Identities=29%  Similarity=0.559  Sum_probs=25.8

Q ss_pred             CceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          120 EILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       120 ~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      .++|||+++.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999996555456999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.25  E-value=0.00099  Score=52.43  Aligned_cols=29  Identities=41%  Similarity=0.715  Sum_probs=19.3

Q ss_pred             CceecccCCCceeE-eCCCCeEEEccCCCcc
Q 038154          120 EILHRDLKPANFLI-DRSKDIVKIADFGLAR  149 (293)
Q Consensus       120 ~~~h~dl~~~Ni~i-~~~~~~v~l~df~~~~  149 (293)
                      .++|+|+.+.||++ ..++. ++++||.++.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~-~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGE-VKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSC-EEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCe-EEEecHHHHh
Confidence            59999999999999 55555 9999999884

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.25  E-value=0.0021  Score=53.87  Aligned_cols=30  Identities=23%  Similarity=0.351  Sum_probs=26.5

Q ss_pred             CceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          120 EILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       120 ~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ++||||+.++|++++.++. +.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~-~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG-GYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC-EEEEEhhhccc
Confidence            7999999999999988776 88999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=97.16  E-value=0.005  Score=52.93  Aligned_cols=75  Identities=13%  Similarity=0.045  Sum_probs=44.7

Q ss_pred             eeeeccccceeEEEEEeCCC-CCe-----EEEEEecccCCCCCCcccHHHHHHHHHhcCCC-CcceeeeeeecCCcceeE
Q 038154            5 LEVIREGRYGAVHRAHDSLT-GDT-----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHE-NIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~-~~~-----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv   77 (293)
                      ++.|..|-...+|++..... +..     |.++.+   .......-+-.+|+++++.+... .-+++++.+..    +++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~---g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS---STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEec---cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            45666677888999964432 223     333332   12222223345689999999654 44566766543    489


Q ss_pred             eecCCcchH
Q 038154           78 FENLDFDLL   86 (293)
Q Consensus        78 ~e~~~~~~~   86 (293)
                      .||++|..+
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999987544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.07  E-value=0.0071  Score=50.63  Aligned_cols=29  Identities=24%  Similarity=0.450  Sum_probs=25.0

Q ss_pred             CCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          119 QEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      .+++|||+.+.||+++. +. +.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~-i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NE-VYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-Cc-EEEEECcccc
Confidence            47899999999999986 44 7899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.92  E-value=0.0042  Score=52.08  Aligned_cols=107  Identities=15%  Similarity=0.184  Sum_probs=71.5

Q ss_pred             CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           72 DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      .+.|++|++.++.+.- +     .....+++..++++.+..+.-+.++ .+-|+++...||+|+ +|+ |.|+||.+++.
T Consensus       299 ~y~yl~~kdhgt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn-vtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDHGTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN-VTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecCCceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc-eEEEEeeeeec
Confidence            3567777776655442 1     1234568888999999888888876 799999999999999 888 99999999984


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHH
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFA  193 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~  193 (293)
                      -..+ .....    -.+-.|-.+.|.  .+...+||-+--.+.
T Consensus       371 ~~~q-~~isy----~rldhp~lF~G~--dd~QFeIYrlMr~l~  406 (488)
T COG5072         371 SYSQ-GIISY----NRLDHPDLFNGV--DDYQFEIYRLMRRLL  406 (488)
T ss_pred             ccCC-ceeec----cccCchhhhcCc--cceeeeHHHHHHHHh
Confidence            3222 11111    122334434433  477788887654433

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.90  E-value=0.018  Score=47.49  Aligned_cols=72  Identities=21%  Similarity=0.195  Sum_probs=48.3

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC---CCCcceeeeeeecCCcceeEeecC
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      .+.++.|.-+.+|++.  .++..+++|+-.     ......+..|.+-|+.|.   .-.+++++++....+..++|+|++
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            4678888889999995  678889999753     233357888999999884   345778899888888889999998


Q ss_pred             Cc
Q 038154           82 DF   83 (293)
Q Consensus        82 ~~   83 (293)
                      +.
T Consensus        95 ~~   96 (288)
T PF03881_consen   95 EM   96 (288)
T ss_dssp             --
T ss_pred             cC
Confidence            74

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.82  E-value=0.0095  Score=50.03  Aligned_cols=136  Identities=18%  Similarity=0.165  Sum_probs=76.2

Q ss_pred             eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC------cceeee--eeecCC--ccee
Q 038154            7 VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN------IVRLLN--VQSSVD--SIDL   76 (293)
Q Consensus         7 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~--~~~~~~--~~~l   76 (293)
                      .|.+ ....+|++...  +..+++|+++..    .....+..|+..+..|....      +...=|  ...-.+  ...-
T Consensus        33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          33 GLNS-EENSNFRVQTE--DGRYILKIYRPG----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             cccc-ccCceEEEEec--CCCeEEEEecCC----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            3444 56778888543  334588987542    33467888999998884211      111111  112223  6778


Q ss_pred             EeecCCcchHHH-h---------------hc--CCC-------C-CCCHH----HH---------HHHHHHHHHHHHHHH
Q 038154           77 VFENLDFDLLHF-M---------------KT--EPT-------V-TKNPL----KI---------KKYLHQILHGVAYCH  117 (293)
Q Consensus        77 v~e~~~~~~~~~-~---------------~~--~~~-------~-~~~~~----~~---------~~i~~~i~~~l~~lh  117 (293)
                      ++++++|..+.. .               ..  ...       . ...+.    ..         .....++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            899998865551 1               00  000       0 01111    00         012233444444444


Q ss_pred             h-------C-C--ceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          118 S-------Q-E--ILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       118 ~-------~-~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      +       . +  ++|+|+.|.||+++.+...+.++||+-+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2       2 3  99999999999999776547899999774

>PTZ00296 choline kinase; Provisional

Probab=96.77  E-value=0.031  Score=49.12  Aligned_cols=73  Identities=19%  Similarity=0.054  Sum_probs=44.3

Q ss_pred             eeeeccccceeEEEEEeCCC--------CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcce
Q 038154            5 LEVIREGRYGAVHRAHDSLT--------GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSID   75 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   75 (293)
                      ++.|..|=.-.+|++.....        ++.|+++++-..   .+..-.-.+|..+++.+..-++ .++++.+.    .+
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~---te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg  182 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD---VDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GG  182 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC---ccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence            45666677777888864421        467888876322   2222245568888888864444 34555543    24


Q ss_pred             eEeecCCcc
Q 038154           76 LVFENLDFD   84 (293)
Q Consensus        76 lv~e~~~~~   84 (293)
                      .|.+|++|.
T Consensus       183 ~I~efi~g~  191 (442)
T PTZ00296        183 RIEEWLYGD  191 (442)
T ss_pred             EEEEeeCCc
Confidence            578888865

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.76  E-value=0.00011  Score=71.26  Aligned_cols=209  Identities=13%  Similarity=-0.007  Sum_probs=125.8

Q ss_pred             HHHHHHHHhcCCCCcceeeeee--ecCCcceeEeecCC-cchHHHhhcCCCCCCC--HHHHHHHHHHHHHHHHHHHhC--
Q 038154           47 IREVSLLKELKHENIVRLLNVQ--SSVDSIDLVFENLD-FDLLHFMKTEPTVTKN--PLKIKKYLHQILHGVAYCHSQ--  119 (293)
Q Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~-~~~~~~~~~~~~~~~~--~~~~~~i~~~i~~~l~~lh~~--  119 (293)
                      ..|..-++...|+++.....-.  .....-+..++++. |.....+.++.....+  .........+.+....-.|..  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3344445556787776655433  23345678888887 5666666654433322  112222223324445555533  


Q ss_pred             ---CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 038154          120 ---EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV  196 (293)
Q Consensus       120 ---~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~  196 (293)
                         --+|.++++.|.+|..+.+ ++++++|..+..............++-|+.|+... ...++.++|+|..|+.+|...
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~-v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN-VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCc-ccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHh
Confidence               1789999999999998888 99999999984433333333334566788888543 446777899999999999998


Q ss_pred             hCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC
Q 038154          197 THQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT  276 (293)
Q Consensus       197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  276 (293)
                      .|..+|...........+                             .......+..-.|.++-.....+|-+....||.
T Consensus      1435 ~~n~~fi~flq~~Lkgii-----------------------------dn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGII-----------------------------DNHTFFSIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             cccHHHHHHHHHHHcCcc-----------------------------cccccccccccCCCcccHHHHHHHHHHhhhcch
Confidence            887776322111111000                             001111122223455556677777777888888


Q ss_pred             HHHHhcCccc
Q 038154          277 AREALRHEYF  286 (293)
Q Consensus       277 ~~~ll~~p~~  286 (293)
                      -..+++.+.|
T Consensus      1486 q~isls~d~~ 1495 (2724)
T KOG1826|consen 1486 QYISLSRDHF 1495 (2724)
T ss_pred             hhhhcccccc
Confidence            8888876654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.43  E-value=0.078  Score=44.75  Aligned_cols=70  Identities=17%  Similarity=0.074  Sum_probs=41.2

Q ss_pred             ccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceee---e--eeecCCcceeEeecCCc
Q 038154           11 GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLL---N--VQSSVDSIDLVFENLDF   83 (293)
Q Consensus        11 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~---~--~~~~~~~~~lv~e~~~~   83 (293)
                      +....||++.. .+|..+++|++....   .....+..|++.+..|....  ++...   +  ....++..+.++++++|
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            34567898853 345679999764221   23456778888888774211  12211   1  12334567788888887


Q ss_pred             c
Q 038154           84 D   84 (293)
Q Consensus        84 ~   84 (293)
                      .
T Consensus       112 ~  112 (325)
T PRK11768        112 R  112 (325)
T ss_pred             C
Confidence            4

>PRK06148 hypothetical protein; Provisional

Probab=95.88  E-value=0.099  Score=51.06  Aligned_cols=32  Identities=31%  Similarity=0.514  Sum_probs=26.1

Q ss_pred             CCceecccCCCceeEeCCC--CeEEEccCCCccc
Q 038154          119 QEILHRDLKPANFLIDRSK--DIVKIADFGLARP  150 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~~~~  150 (293)
                      .+++|+|+++.||+++.++  ...-|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999775  4344999998754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.75  E-value=0.055  Score=44.88  Aligned_cols=74  Identities=18%  Similarity=0.157  Sum_probs=45.0

Q ss_pred             ccccceeEEEEEeCC----C----CCeEEEEEecccCCC---CCCcccHHHHHHHHHhcC-------------CCCccee
Q 038154            9 REGRYGAVHRAHDSL----T----GDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELK-------------HENIVRL   64 (293)
Q Consensus         9 g~g~~~~vy~~~~~~----~----~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~-------------~~~i~~~   64 (293)
                      |.|-.|.+|++.-..    +    ...++||..+.....   ......+.+|+.+++.+-             ....+++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            667788888886532    2    235788876521111   123356777888877552             1235666


Q ss_pred             eeeeecCCcceeEeecCC
Q 038154           65 LNVQSSVDSIDLVFENLD   82 (293)
Q Consensus        65 ~~~~~~~~~~~lv~e~~~   82 (293)
                      +....+++..++|||.+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            666555556789998774

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.00  E-value=0.045  Score=44.73  Aligned_cols=45  Identities=20%  Similarity=0.302  Sum_probs=33.1

Q ss_pred             HHHHHHHHHHHHhC--CceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154          106 LHQILHGVAYCHSQ--EILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus       106 ~~~i~~~l~~lh~~--~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      +..+-.++.-.+..  -+||+|+.|+|++.+..+. ++|+||.++..-
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~-l~LIDWEyAg~~  184 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG-LFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCc-EEEEecccCCCc
Confidence            33344444444433  5999999999999998676 999999998653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	293
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-63
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-62
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-62
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-62
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-62
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-62
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-62
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-62
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-62
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-62
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-62
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-62
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-62
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-62
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-62
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-62
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-62
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-62
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-62
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-62
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-62
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-62
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-62
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-62
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-62
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-62
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-62
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-62
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-62
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-62
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-62
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-62
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-62
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-62
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-62
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-62
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-62
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-61
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-61
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-61
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-54
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-54
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-52
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-52
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-51
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-42
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-42
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-42
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-42
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-42
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-40
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-39
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-39
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-39
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-39
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-39
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-39
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-39
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-39
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-39
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-39
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-39
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-39
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-39
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-39
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-39
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-39
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-39
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-39
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-39
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-39
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-39
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-39
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-38
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-38
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-38
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-38
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-38
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-38
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-38
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-38
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-38
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-38
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-37
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-37
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-37
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-36
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-36
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-36
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-36
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-36
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-36
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-36
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-36
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-34
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-34
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-34
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-34
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-34
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-34
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-34
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-34
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-34
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-34
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-34
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-34
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-34
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-34
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-33
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-33
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-33
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-33
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-33
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-33
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-33
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-33
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-33
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-33
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-32
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-32
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-31
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-29
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-29
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-29
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-29
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-29
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-28
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-28
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-28
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-28
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-28
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-28
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-28
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-28
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-28
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-28
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-28
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-28
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-28
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-28
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-28
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-28
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-28
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-28
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-28
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-28
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-28
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-28
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-28
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-28
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-28
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-28
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-28
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-28
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-28
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-28
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-27
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-27
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-27
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-27
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-27
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-27
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-27
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-27
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-26
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-26
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-26
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-26
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-25
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-25
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-25
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-25
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-25
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-25
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-24
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-24
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-24
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-22
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-22
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-22
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-22
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-22
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-22
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-22
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-22
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-22
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-21
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-21
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-21
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-21
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-21
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-21
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-21
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-21
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-21
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-21
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-21
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-20
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-20
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-20
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-20
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-20
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-20
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-20
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-20
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-19
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-19
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-19
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-18
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-18
3soa_A	444	Full-Length Human Camkii Length = 444		1e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-15
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-14
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-09
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		7e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-08
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-06

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 180/288 (62%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE++D DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 127 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 127/289 (43%), Positives = 179/289 (61%), Gaps = 3/289 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE + EG YG V++A DS  G  V +K+I +    EG+PS+ IRE+SLLKEL H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L++V  S   + LVFE ++ DL   +    T  ++  +IK YL+Q+L GVA+CH   
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQHR 139
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ILHRDLKP N LI+ S   +K+ADFGLAR   +P+ +YT +  +L Y+AP+ L+GS +YS
Sbjct: 140 ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEM+T + LF        L  IFSI+GTP+    P             
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                K  ++++ G   +G+DLL  MLC DP+KR++AR+A+ H YFKD 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 127/289 (43%), Positives = 179/289 (61%), Gaps = 3/289 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE + EG YG V++A DS  G  V +K+I +    EG+PS+ IRE+SLLKEL H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L++V  S   + LVFE ++ DL   +    T  ++  +IK YL+Q+L GVA+CH   
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQHR 139
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ILHRDLKP N LI+ S   +K+ADFGLAR   +P+ +YT +  +L Y+AP+ L+GS +YS
Sbjct: 140 ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEM+T + LF        L  IFSI+GTP+    P             
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                K  ++++ G   +G+DLL  MLC DP+KR++AR+A+ H YFKD 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 126 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 126 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 69  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 128 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 247 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  236 bits (601), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 179/288 (62%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YS
Sbjct: 131 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 250 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  236 bits (601), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 125 VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 244 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  236 bits (601), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 179/288 (62%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YS
Sbjct: 131 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 250 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  236 bits (601), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 127 VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  236 bits (601), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 179/288 (62%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YS
Sbjct: 128 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 247 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 70  LDVIHTENKLYLVFEFLSMDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YST V
Sbjct: 129 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 248 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 179/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE++  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 67  LDVIHTENKLYLVFEHVHQDLKTFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 126 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  235 bits (600), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 71  LDVIHTENKLYLVFEFLSMDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YST V
Sbjct: 130 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 249 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  235 bits (599), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 178/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+++CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLSFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V + KI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V + KI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YST V
Sbjct: 126 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 123 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 242 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 124 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 243 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 123 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 242 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 124 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 243 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  234 bits (597), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 124 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 243 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  234 bits (597), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 127 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 127 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 126 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 125 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 244 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 125 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 244 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 126 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  234 bits (596), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 125 VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 244 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  234 bits (596), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 132/285 (46%), Positives = 177/285 (62%), Gaps = 4/285 (1%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NIV+L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQEILH 123
           L+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  +LH
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YST V
Sbjct: 127 RDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 184 DVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRS 243
           D+W++ C FAEMVT + LF        L  IF  +GTPD    P            P  +
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 244 PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 R-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  234 bits (596), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 128 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 247 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  234 bits (596), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 126 VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 245 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  233 bits (595), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 132/288 (45%), Positives = 178/288 (61%), Gaps = 4/288 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H NI
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLHQILHGVAYCHSQE 120
           V+LL+V  + + + LVFE L  DL  FM     +T  PL  IK YL Q+L G+A+CHS  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  Y  +  +L Y+APE LLG   YS
Sbjct: 127 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    P            P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 246 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 127/290 (43%), Positives = 184/290 (63%), Gaps = 8/290 (2%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V++A ++  G+T  +KKI +    EG+PS+ IRE+S+LKELKH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  +   + LVFE+LD DL   +       ++ +  K +L Q+L+G+AYCH + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES-VTAKSFLLQLLNGIAYCHDRR 120
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R  ++ KIADFGLAR   +P+  YT +  +L Y+AP+ L+GS +YS
Sbjct: 121 VLHRDLKPQNLLINREGEL-KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T +D+W+V C FAEMV    LF        L  IF I+GTP+S+  P            P
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP---NVTELPKYDP 236
Query: 241 NRSPIKDL--ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           N +  + L   + + GL+  G+DLL +ML LDP++R+TA++AL H YFK+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  232 bits (591), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 127/290 (43%), Positives = 184/290 (63%), Gaps = 8/290 (2%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V++A ++  G+T  +KKI +    EG+PS+ IRE+S+LKELKH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  +   + LVFE+LD DL   +       ++ +  K +L Q+L+G+AYCH + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES-VTAKSFLLQLLNGIAYCHDRR 120
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R  ++ KIADFGLAR   +P+  YT +  +L Y+AP+ L+GS +YS
Sbjct: 121 VLHRDLKPQNLLINREGEL-KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T +D+W+V C FAEMV    LF        L  IF I+GTP+S+  P            P
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWP---NVTELPKYDP 236
Query: 241 NRSPIKDL--ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           N +  + L   + + GL+  G+DLL +ML LDP++R+TA++AL H YFK+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  232 bits (591), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 127/290 (43%), Positives = 184/290 (63%), Gaps = 8/290 (2%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V++A ++  G+T  +KKI +    EG+PS+ IRE+S+LKELKH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  +   + LVFE+LD DL   +       ++ +  K +L Q+L+G+AYCH + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES-VTAKSFLLQLLNGIAYCHDRR 120
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R  ++ KIADFGLAR   +P+  YT +  +L Y+AP+ L+GS +YS
Sbjct: 121 VLHRDLKPQNLLINREGEL-KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
           T +D+W+V C FAEMV    LF        L  IF I+GTP+S+  P            P
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP---NVTELPKYDP 236
Query: 241 NRSPIKDL--ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           N +  + L   + + GL+  G+DLL +ML LDP++R+TA++AL H YFK+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 118/290 (40%), Positives = 168/290 (57%), Gaps = 4/290 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V +A +  T + V +K++ + +  EGVPSS +RE+ LLKELKH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE  D DL  +  +      +P  +K +L Q+L G+ +CHS+ 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R+ ++ K+ADFGLAR   +P+  Y+ +  +L Y+ P+ L G+  YS
Sbjct: 122 VLHRDLKPQNLLINRNGEL-KLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 181 TPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXX 239
           T +D+W+  C FAE+    R LF        L  IF ++GTP  E  P            
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKLPDYKPY 239
Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           P       L  VV  L   G DLL+ +L  +P +R++A EAL+H YF DF
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  207 bits (526), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 117/290 (40%), Positives = 168/290 (57%), Gaps = 4/290 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V +A +  T + V +K++ + +  EGVPSS +RE+ LLKELKH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE  D DL  +  +      +P  +K +L Q+L G+ +CHS+ 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R+ ++ K+A+FGLAR   +P+  Y+ +  +L Y+ P+ L G+  YS
Sbjct: 122 VLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 181 TPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXX 239
           T +D+W+  C FAE+    R LF        L  IF ++GTP  E  P            
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKLPDYKPY 239
Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           P       L  VV  L   G DLL+ +L  +P +R++A EAL+H YF DF
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 118/299 (39%), Positives = 175/299 (58%), Gaps = 14/299 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++  LE +  G Y  V++  +  TG  V +K++  ++  EG PS+ IRE+SL+KELKHEN
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHEN 64
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNP----LKIKKYLH-QILHGVAY 115
           IVRL +V  + + + LVFE +D DL  +M +  TV   P    L + KY   Q+L G+A+
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSR-TVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           CH  +ILHRDLKP N LI++ +  +K+ DFGLAR   +P+  ++ +  +L Y+AP+ L+G
Sbjct: 124 CHENKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXX 235
           S  YST +D+W+  C  AEM+T + LF        L  IF IMGTP+    P        
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 236 XXXXPNRSPIKDLATVVG--GLEP-DG--VDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                 R P +DL  V+     EP DG  +D L  +L L+P  RL+A++AL H +F ++
Sbjct: 243 NPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  201 bits (510), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 167/291 (57%), Gaps = 8/291 (2%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  +  + EG YG V++A D++T +TV +K+I + +  EGVP + IREVSLLKEL+H N
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           I+ L +V      + L+FE  + DL  +M   P V+     IK +L+Q+++GV +CHS+ 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMR--VIKSFLYQLINGVNFCHSRR 152
Query: 121 ILHRDLKPANFLIDRS----KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
            LHRDLKP N L+  S      ++KI DFGLAR   +P+  +T +  +L Y+ PE LLGS
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXX 236
             YST VD+W++AC +AEM+    LF        L  IF ++G PD  T P         
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRR-MLCLDPSKRLTAREALRHEYF 286
              P     K L  V+G L  D    L   ML +DP KR++A+ AL H YF
Sbjct: 273 QSFPKFRG-KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  197 bits (502), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 112/285 (39%), Positives = 163/285 (57%), Gaps = 3/285 (1%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L+ + EG Y  V++    LT + V +K+I + +  EG P + IREVSLLK+LKH NI
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 62
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  +  S+ LVFE LD DL  ++     +  N   +K +L Q+L G+AYCH Q++
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNII-NMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           LHRDLKP N LI+   ++ K+ADFGLAR   +P + Y  +  +L Y+ P+ LLGS  YST
Sbjct: 122 LHRDLKPQNLLINERGEL-KLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 182 PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPN 241
            +D+W V C F EM T + LF        L  IF I+GTP  ET P              
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240
Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           +   + L +    L+ DG DLL ++L  +   R++A +A++H +F
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/294 (37%), Positives = 159/294 (54%), Gaps = 14/294 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---K 57
           RY  +  I  G YG V++A D  +G  V +K + + N  EG+P S +REV+LL+ L   +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 58  HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H N+VRL++V ++  +     + LVFE++D DL  ++   P        IK  + Q L G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + + H+  I+HRDLKP N L+  S   VK+ADFGLAR     +  + +   +L Y+APE 
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVV-VTLWYRAPEV 182
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P     
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP--RDV 239
Query: 233 XXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  P R P + + +VV  +E  G  LL  ML  +P KR++A  AL+H Y 
Sbjct: 240 SLPRGAFPPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 159/302 (52%), Gaps = 21/302 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D   G   V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 58  -HENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            H N+VRL +V  +V   D      LVFE++D DL  ++   P        IK  + Q+L
Sbjct: 72  EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYK 168
            G+ + HS  ++HRDLKP N L+  S  I K+ADFGLAR     + L +  +   +L Y+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE LL S  Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P 
Sbjct: 187 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                       +  PI+   T +  L   G DLL + L  +P+KR++A  AL H YF+D
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDEL---GKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 289 FQ 290
            +
Sbjct: 303 LE 304

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 159/302 (52%), Gaps = 21/302 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D   G   V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 58  -HENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            H N+VRL +V  +V   D      LVFE++D DL  ++   P        IK  + Q+L
Sbjct: 72  EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYK 168
            G+ + HS  ++HRDLKP N L+  S  I K+ADFGLAR     + L +  +   +L Y+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE LL S  Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P 
Sbjct: 187 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                       +  PI+   T +  L   G DLL + L  +P+KR++A  AL H YF+D
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDEL---GKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 289 FQ 290
            +
Sbjct: 303 LE 304

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 110/298 (36%), Positives = 160/298 (53%), Gaps = 22/298 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---K 57
           RY  +  I  G YG V++A D  +G  V +K + + N  EG+P S +REV+LL+ L   +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 58  HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H N+VRL++V ++  +     + LVFE++D DL  ++   P        IK  + Q L G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCYK 168
           + + H+  I+HRDLKP N L+  S   VK+ADFGLAR     + +Y +       +L Y+
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLAR-----IYSYQMALAPVVVTLWYR 178
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P 
Sbjct: 179 APEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 236
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                      P R P + + +VV  +E  G  LL  ML  +P KR++A  AL+H Y 
Sbjct: 237 -RDVSLPRGAFPPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  168 bits (425), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 18/296 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---K 57
           RY  +  I  G YG V++A D  +G  V +K + + N  EG+P S +REV+LL+ L   +
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 58  HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H N+VRL++V ++  +     + LVFE++D DL  ++   P        IK  + Q L G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAP 170
           + + H+  I+HRDLKP N L+  S   VK+ADFGLAR     + L+   +   +L Y+AP
Sbjct: 125 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVV---TLWYRAP 180
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P   
Sbjct: 181 EVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP--R 237
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                    P R P + + +VV  +E  G  LL  ML  +P KR++A  AL+H Y 
Sbjct: 238 DVSLPRGAFPPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 110/299 (36%), Positives = 157/299 (52%), Gaps = 21/299 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT-VVVKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D   G   V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 58  -HENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            H N+VRL +V  +V   D      LVFE++D DL  ++   P        IK  + Q+L
Sbjct: 72  EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYK 168
            G+ + HS  ++HRDLKP N L+  S  I K+ADFGLAR     + L +  +   +L Y+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE LL S  Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P 
Sbjct: 187 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                       +  PI+   T +  L   G DLL + L  +P+KR++A  AL H YF+
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDEL---GKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  160 bits (405), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 147/291 (50%), Gaps = 7/291 (2%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE---GVPSSVIREVSLLKELK 57
           RY  L+ + EG++  V++A D  T   V +KKI + + SE   G+  + +RE+ LL+EL 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           H NI+ LL+      +I LVF+ ++ DL   +K    V   P  IK Y+   L G+ Y H
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTLQGLEYLH 129
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
              ILHRDLKP N L+D +  ++K+ADFGLA+    P   Y  +  +  Y+APE L G+ 
Sbjct: 130 QHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGAR 188
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y   VD+WAV C  AE++              L  IF  +GTP  E  P          
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                 P   L  +      D +DL++ +   +P  R+TA +AL+ +YF +
Sbjct: 249 F--KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 156/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L +  Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 195
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 292 LD 293
            D
Sbjct: 316 PD 317

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 106/302 (35%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  I  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 142
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 292 LD 293
            D
Sbjct: 319 PD 320

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 143
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 199
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 292 LD 293
            D
Sbjct: 320 PD 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 148
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 204
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 292 LD 293
            D
Sbjct: 325 PD 326

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 142
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 292 LD 293
            D
Sbjct: 319 PD 320

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--KPFQSIIHAKRTYRELRLLKHMKH 92
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 149
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 205
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 292 LD 293
            D
Sbjct: 326 PD 327

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 148
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 204
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 292 LD 293
            D
Sbjct: 325 PD 326

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 157
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 213
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 292 LD 293
            D
Sbjct: 334 PD 335

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 157
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 213
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 274 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 292 LD 293
            D
Sbjct: 334 PD 335

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 133
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 189
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 292 LD 293
            D
Sbjct: 310 PD 311

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 156
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 212
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 273 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 292 LD 293
            D
Sbjct: 333 PD 334

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 160
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMXGYV---ATRWYRAPEI 216
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 292 LD 293
            D
Sbjct: 337 PD 338

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 149
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 205
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 292 LD 293
            D
Sbjct: 326 PD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 149
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 205
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 292 LD 293
            D
Sbjct: 326 PD 327

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 142
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 292 LD 293
            D
Sbjct: 319 PD 320

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 143
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 199
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 292 LD 293
            D
Sbjct: 320 PD 321

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 160
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 216
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 292 LD 293
            D
Sbjct: 337 PD 338

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 90
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 147
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 203
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 263
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 264 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 323
Query: 292 LD 293
            D
Sbjct: 324 PD 325

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 134
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 190
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 292 LD 293
            D
Sbjct: 311 PD 312

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 78
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 135
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 191
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 251
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 252 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 311
Query: 292 LD 293
            D
Sbjct: 312 PD 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 153/300 (51%), Gaps = 14/300 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L  +  G YG+V  A D+ TG  V VKK+     S        RE+ LLK +KHEN
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G+ 
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRGLK 145
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE +L
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEIML 201
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L        
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 261
Query: 235 XXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
                   + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +   D
Sbjct: 262 RNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K++     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGL R  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSEL-KILDFGLCRHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 133
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 189
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 292 LD 293
            D
Sbjct: 310 PD 311

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 134
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 190
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 292 LD 293
            D
Sbjct: 311 PD 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 195
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 292 LD 293
            D
Sbjct: 316 PD 317

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 153/300 (51%), Gaps = 14/300 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L  +  G YG+V  A D+ TG  V VKK+     S        RE+ LLK +KHEN
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G+ 
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRGLK 145
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE +L
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEIML 201
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L        
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 261
Query: 235 XXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
                   + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +   D
Sbjct: 262 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 195
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 292 LD 293
            D
Sbjct: 316 PD 317

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 195
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 292 LD 293
            D
Sbjct: 316 PD 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 144
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 292 LD 293
            D
Sbjct: 321 PD 322

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 157/297 (52%), Gaps = 17/297 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG---VPSSVIREVSLLKELK 57
           RY  +  I  G YG V++A D  +G  V +K + + N   G   +P S +REV+LL+ L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 58  ---HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQI 109
              H N+VRL++V ++  +     + LVFE++D DL  ++   P        IK  + Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           L G+ + H+  I+HRDLKP N L+  S   VK+ADFGLAR     +   T    +L Y+A
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRA 187
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P  
Sbjct: 188 PEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-- 244
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                     P R P + + +VV  +E  G  LL  ML  +P KR++A  AL+H Y 
Sbjct: 245 RDVSLPRGAFPPRGP-RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 156
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 212
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 273 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 292 LD 293
            D
Sbjct: 333 PD 334

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 142
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 292 LD 293
            D
Sbjct: 319 PD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 79
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 136
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 192
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 252
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 253 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 312
Query: 292 LD 293
            D
Sbjct: 313 PD 314

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  +     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMAGFV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K       +   ++  ++QIL G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDH---VQFLIYQILRG 133
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 189
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 292 LD 293
            D
Sbjct: 310 PD 311

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 133
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  +     +  Y+APE 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMAGFV---ATRWYRAPEI 189
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 292 LD 293
            D
Sbjct: 310 PD 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  +     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMAGFV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI D+GLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDYGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 151/294 (51%), Gaps = 16/294 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  L+ +  G YGAV  A D  TG  V +KK+     SE       RE+ LLK ++HEN+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 62  VRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + LL+V +  +++D      LV   +  DL   MK E        +I+  ++Q+L G+ Y
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---RIQFLVYQMLKGLRY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            H+  I+HRDLKP N  ++   ++ KI DFGLAR  D  +    +   +  Y+APE +L 
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQADSEMXGXVV---TRWYRAPEVILN 199
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXX 235
             RY+  VD+W+V C  AEM+T + LF        L  I  + GTP +E +         
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 236 XXXX--PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                 P     KD A+++    P  V+LL +ML LD  +R+TA EAL H YF+
Sbjct: 260 NYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 155/302 (51%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D   +  T    +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTD---DEMTGXVATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DF LAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFYLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI  FGLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILGFGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 144
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR     +  Y     +  Y+APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTADEMTGYV---ATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 292 LD 293
            D
Sbjct: 321 PD 322

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 157
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +        +  Y+APE 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMXGXV---ATRWYRAPEI 213
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 292 LD 293
            D
Sbjct: 334 PD 335

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 144
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR     +  Y     +  Y+APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTADEMTGYV---ATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 292 LD 293
            D
Sbjct: 321 PD 322

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 24/307 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHEN 60
           + L  ++ EG YG V  A    TG+ V +KKI P   P   +    +RE+ +LK  KHEN
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL--RTLREIKILKHFKHEN 70
Query: 61  IVRLLNVQ-----SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + N+Q      + + + ++ E +  DL   + T+     +   I+ +++Q L  V  
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---IQYFIYQTLRAVKV 127
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----------SL 165
            H   ++HRDLKP+N LI+ + D+ K+ DFGLAR ID    + +   G          + 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDL-KVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP--DS 223
            Y+APE +L S +YS  +DVW+  C  AE+   + +F  R     L  IF I+GTP  D+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           +                   P   L  +   + P G+DLL+RML  DP+KR+TA+EAL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 284 EYFKDFQ 290
            Y + + 
Sbjct: 307 PYLQTYH 313

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 24/307 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHEN 60
           + L  ++ EG YG V  A    TG+ V +KKI P   P   +    +RE+ +LK  KHEN
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL--RTLREIKILKHFKHEN 70
Query: 61  IVRLLNVQ-----SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + N+Q      + + + ++ E +  DL   + T+     +   I+ +++Q L  V  
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---IQYFIYQTLRAVKV 127
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----------SL 165
            H   ++HRDLKP+N LI+ + D+ K+ DFGLAR ID    + +   G          + 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDL-KVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP--DS 223
            Y+APE +L S +YS  +DVW+  C  AE+   + +F  R     L  IF I+GTP  D+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           +                   P   L  +   + P G+DLL+RML  DP+KR+TA+EAL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 284 EYFKDFQ 290
            Y + + 
Sbjct: 307 PYLQTYH 313

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 24/307 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHEN 60
           + L  ++ EG YG V  A    TG+ V +KKI P   P   +    +RE+ +LK  KHEN
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL--RTLREIKILKHFKHEN 70
Query: 61  IVRLLNVQ-----SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + N+Q      + + + ++ E +  DL   + T+     +   I+ +++Q L  V  
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---IQYFIYQTLRAVKV 127
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----------SL 165
            H   ++HRDLKP+N LI+ + D+ K+ DFGLAR ID    + +   G          + 
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDL-KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP--DS 223
            Y+APE +L S +YS  +DVW+  C  AE+   + +F  R     L  IF I+GTP  D+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 224 ETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           +                   P   L  +   + P G+DLL+RML  DP+KR+TA+EAL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 284 EYFKDFQ 290
            Y + + 
Sbjct: 307 PYLQTYH 313

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 144
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR     +  Y     +  Y+APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTADEMTGYV---ATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 292 LD 293
            D
Sbjct: 321 PD 322

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 151/289 (52%), Gaps = 13/289 (4%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           +  G YG+V  A D  +G+ V +KK+     SE       RE+ LLK ++HEN++ LL+V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 68  QSSVDSIDLVFENLDFDL-LHFMKTEPT----VTKNPLKIKKYLHQILHGVAYCHSQEIL 122
            +   S+   +   DF L + FM+T+      +  +  KI+  ++Q+L G+ Y HS  ++
Sbjct: 92  FTPASSLRNFY---DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE +L    Y+  
Sbjct: 149 HRDLKPGNLAVNEDCEL-KILDFGLARHADAEMTGYVV---TRWYRAPEVILSWMHYNQT 204
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP-N 241
           VD+W+V C  AEM+T + LF  +     L  I  + G P +E +                
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
           ++P KD   +     P   DLL +ML LD  KRLTA +AL H +F+ F+
Sbjct: 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  154 bits (388), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 151/289 (52%), Gaps = 13/289 (4%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           +  G YG+V  A D  +G+ V +KK+     SE       RE+ LLK ++HEN++ LL+V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 68  QSSVDSIDLVFENLDFDL-LHFMKTEPT----VTKNPLKIKKYLHQILHGVAYCHSQEIL 122
            +   S+   +   DF L + FM+T+      +  +  KI+  ++Q+L G+ Y HS  ++
Sbjct: 110 FTPASSLRNFY---DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE +L    Y+  
Sbjct: 167 HRDLKPGNLAVNEDCEL-KILDFGLARHADAEMTGYVV---TRWYRAPEVILSWMHYNQT 222
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP-N 241
           VD+W+V C  AEM+T + LF  +     L  I  + G P +E +                
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
           ++P KD   +     P   DLL +ML LD  KRLTA +AL H +F+ F+
Sbjct: 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI D GLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDAGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI D GLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDGGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +       RE+ LLK +KH
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI D GLAR  D  +  Y     +  Y+APE 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDRGLARHTDDEMTGYV---ATRWYRAPEI 193
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L      
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +  
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 292 LD 293
            D
Sbjct: 314 PD 315

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 99/295 (33%), Positives = 149/295 (50%), Gaps = 17/295 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L ++ EG YG V +  +  TG  V +KK    +  + V    +RE+ LLK+L+HEN
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V LL V        LVFE +D  +L  ++  P      + ++KYL QI++G+ +CHS  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV-VQKYLFQIINGIGFCHSHN 144
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRD+KP N L+ +S  +VK+ DFG AR +  P E Y  +  +  Y+APE L+G  +Y 
Sbjct: 145 IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT--PDSETL--PXXXXXXXXX 236
             VDVWA+ C   EM   + LF        L  I   +G   P  + L            
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 237 XXXPNRSPIK----DLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                R P++     L+ VV       +DL ++ L +DP KR    E L H++F+
Sbjct: 264 PEIKEREPLERRYPKLSEVV-------IDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/302 (33%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV--PSSVIREVSLLKELKH 58
           RY  L  +  G YG+V  ++D  +G  + VKK+    P + +       RE+ LLK +KH
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 109
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +     +   ++  ++QIL G
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---VQFLIYQILRG 166
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR  D  +  Y     +  Y+APE 
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYV---ATRWYRAPEI 222
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    Y+  VD+W+V C  AE++T + LF        L  I  + GTP +  +      
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSH 282
Query: 233 XXXXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                     + P ++ A V  G  P  VDLL +ML LD  KR+TA EAL H YF  +  
Sbjct: 283 EARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHD 342
Query: 292 LD 293
            D
Sbjct: 343 PD 344

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 152/302 (50%), Gaps = 20/302 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +V L+ +             SI LVF+  + DL   + +   V     +IK+ +  +L+G
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN----YTIKGGSLCYK 168
           + Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +   +    Y  +  +L Y+
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
            PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P 
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 229 X---XXXXXXXXXXPNRSPIKD-LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
                           +  +KD L   V   +P  +DL+ ++L LDP++R+ + +AL H+
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 285 YF 286
           +F
Sbjct: 315 FF 316

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           R   L  +  G YG+V  A+D+     V VKK+     S        RE+ LLK LKHEN
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   SI+      LV   +  DL + +K++    ++   ++  ++Q+L G+ 
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEH---VQFLVYQLLRGLK 145
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  I+HRDLKP+N  ++   ++ +I DFGLAR  D  +  Y     +  Y+APE +L
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSEL-RILDFGLARQADEEMTGYV---ATRWYRAPEIML 201
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y+  VD+W+V C  AE++  + LF        L  I  ++GTP  E L        
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 235 XXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P KDL+++  G  P  +DLL RML LD  +R++A EAL H YF  +
Sbjct: 262 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 22/303 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILH 111
           +V L+ +             SI LVF+  + DL   +     + K  L +IK+ +  +L+
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLN 135
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN----YTIKGGSLCY 167
           G+ Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +   +    Y  +  +L Y
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           + PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 228 XX---XXXXXXXXXXPNRSPIKD-LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                            +  +KD L   V   +P  +DL+ ++L LDP++R+ + +AL H
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 284 EYF 286
           ++F
Sbjct: 313 DFF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 22/303 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILH 111
           +V L+ +             SI LVF+  + DL   +     + K  L +IK+ +  +L+
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLN 136
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN----YTIKGGSLCY 167
           G+ Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +   +    Y  +  +L Y
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           + PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 228 XX---XXXXXXXXXXPNRSPIKD-LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                            +  +KD L   V   +P  +DL+ ++L LDP++R+ + +AL H
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 284 EYF 286
           ++F
Sbjct: 314 DFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 22/303 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILH 111
           +V L+ +             SI LVF+  + DL   +     + K  L +IK+ +  +L+
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLN 136
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN----YTIKGGSLCY 167
           G+ Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +   +    Y  +  +L Y
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           + PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 228 XX---XXXXXXXXXXPNRSPIKD-LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                            +  +KD L   V   +P  +DL+ ++L LDP++R+ + +AL H
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 284 EYF 286
           ++F
Sbjct: 314 DFF 316

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 153/304 (50%), Gaps = 16/304 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y ++E I  G YG V  A   LTG  V +KKIP            +RE+ +LK  KH+NI
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 62  VRLLNV------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++           S+ +V + ++ DL   + +   +T     ++ +L+Q+L G+ Y
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE--HVRYFLYQLLRGLKY 173
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLEN---YTIKGGSLCYKAPE 171
            HS +++HRDLKP+N L++ + ++ KI DFG+AR +   P E+    T    +  Y+APE
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCEL-KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX--X 229
            +L    Y+  +D+W+V C F EM+  ++LF  +     L  I  ++GTP    +     
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P R P+    TV  G +   + LL RML  +PS R++A  ALRH +   +
Sbjct: 293 ERVRAYIQSLPPRQPVP-WETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 290 QSLD 293
              D
Sbjct: 352 HDPD 355

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 97/300 (32%), Positives = 161/300 (53%), Gaps = 18/300 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L+ I EG YG V  A+D +    V +KKI      +      +RE+ +L   +HEN
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE-HQTYCQRTLREIQILLRFRHEN 102
Query: 61  IVRLLNV--QSSVDSIDLVF---ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           ++ + ++   S+++++  V+   + ++ DL   +K++     +   I  +L+QIL G+ Y
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH---ICYFLYQILRGLKY 159
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT----IKGGSLCYKAPE 171
            HS  +LHRDLKP+N LI+ + D+ KI DFGLAR  D P  ++T        +  Y+APE
Sbjct: 160 IHSANVLHRDLKPSNLLINTTCDL-KICDFGLARIAD-PEHDHTGFLTEXVATRWYRAPE 217
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XX 229
            +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L     
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P+++ +   A +    +   +DLL RML  +P+KR+T  EAL H Y + +
Sbjct: 278 MKARNYLQSLPSKTKVA-WAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           R   L  +  G YG+V  A+D+     V VKK+     S        RE+ LLK LKHEN
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   SI+      LV   +  DL + +K +    ++   ++  ++Q+L G+ 
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH---VQFLVYQLLRGLK 145
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  I+HRDLKP+N  ++   ++ +I DFGLAR  D  +  Y     +  Y+APE +L
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSEL-RILDFGLARQADEEMTGYV---ATRWYRAPEIML 201
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y+  VD+W+V C  AE++  + LF        L  I  ++GTP  E L        
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHA 261
Query: 235 XXXXXP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P KDL+++  G  P  +DLL RML LD  +R++A EAL H YF  +
Sbjct: 262 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 153/304 (50%), Gaps = 16/304 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y ++E I  G YG V  A   LTG  V +KKIP            +RE+ +LK  KH+NI
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 62  VRLLNV------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++           S+ +V + ++ DL   + +   +T     ++ +L+Q+L G+ Y
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE--HVRYFLYQLLRGLKY 174
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLEN---YTIKGGSLCYKAPE 171
            HS +++HRDLKP+N L++ + ++ KI DFG+AR +   P E+    T    +  Y+APE
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCEL-KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX--X 229
            +L    Y+  +D+W+V C F EM+  ++LF  +     L  I  ++GTP    +     
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P R P+    TV  G +   + LL RML  +PS R++A  ALRH +   +
Sbjct: 294 ERVRAYIQSLPPRQPVP-WETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 290 QSLD 293
              D
Sbjct: 353 HDPD 356

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/292 (33%), Positives = 149/292 (51%), Gaps = 14/292 (4%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           L  +  G YG+V  A+D+     V VKK+     S        RE+ LLK LKHEN++ L
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 65  LNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           L+V +   SI+      LV   +  DL + +K +    ++   ++  ++Q+L G+ Y HS
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH---VQFLVYQLLRGLKYIHS 141
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
             I+HRDLKP+N  ++   ++ +I DFGLAR  D  +  Y     +  Y+APE +L    
Sbjct: 142 AGIIHRDLKPSNVAVNEDCEL-RILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMH 197
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           Y+  VD+W+V C  AE++  + LF        L  I  ++GTP  E L            
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 257
Query: 239 XP-NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                 P KDL+++  G  P  +DLL RML LD  +R++A EAL H YF  +
Sbjct: 258 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 309

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYXQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 155/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 80
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 137
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P+ E L      
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINL 256
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 257 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 155/300 (51%), Gaps = 18/300 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT----IKGGSLCYKAPE 171
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D P  ++T        +  Y+APE
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVAD-PDHDHTGFLXEXVATRWYRAPE 201
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XX 229
            +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L     
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 262 LKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 155/300 (51%), Gaps = 18/300 (6%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 87
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 144
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT----IKGGSLCYKAPE 171
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D P  ++T        +  Y+APE
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVAD-PDHDHTGFLXEXVATRWYRAPE 202
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XX 229
            +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L     
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 LKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 5/295 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +  I EG YG V +  +  TG  V +KK         +    +RE+ +LK+LKH N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V LL V      + LVFE  D  +LH +          L +K    Q L  V +CH   
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL-VKSITWQTLQAVNFCHKHN 122
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
            +HRD+KP N LI +   ++K+ DFG AR +  P + Y  +  +  Y++PE L+G  +Y 
Sbjct: 123 CIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG--TPDSETLPXXXXXXXXXXX 238
            PVDVWA+ C FAE+++   L+  +     L  I   +G   P  + +            
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV-FSTNQYFSGVK 240
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            P+   ++ L      +    + LL+  L +DP++RLT  + L H YF++ + ++
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 80
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 137
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 256
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 257 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 87
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 144
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 264 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 88
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 145
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 264
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 265 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 79
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 136
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 255
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 256 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 155/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 82
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX--XX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 82
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 155/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 82
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDL-KIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX--XX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLAFRHEN 84
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 141
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINL 260
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y   +
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 82
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 84
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 141
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 318

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V ++KI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 152/299 (50%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 102
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + LV   +  DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDH---ICYFLYQILRGLKY 159
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 279 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 90
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 147
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 266
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 267 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 82
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 154/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 102
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 159
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 279 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLAFRHEN 84
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---ICYFLYQILRGLKY 141
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y   +
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D+L    V +KKI      +      +RE+ +L   +HEN
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 86
Query: 61  IVRLLNVQSS-----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +     +  + +V + ++ DL   +K +     +   I  +L+QIL G+ Y
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDH---ICYFLYQILRGLKY 143
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPER 172
            HS  +LHRDLKP+N L++ + D+ KI DFGLAR  D   ++    T    +  Y+APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDL-KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP--XXX 230
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L      
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    P+++ +     +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 104/353 (29%), Positives = 156/353 (44%), Gaps = 69/353 (19%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +  +I  G YG V  A+D L    V +KKI  +         ++RE+++L  L H++
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 61  IVRLLNVQ-----SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           +V++L++         D + +V E  D D     +T   +T+  L IK  L+ +L GV Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE--LHIKTLLYNLLVGVKY 171
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT---------------- 159
            HS  ILHRDLKPAN L+++    VK+ DFGLAR +D P    +                
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 160 ---------IKGGSLC--YKAPERLLGSGRYSTPVDVWAVACTFAEMVT----------- 197
                    + G  +   Y+APE +L    Y+  +DVW++ C FAE++            
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 198 --------------------HQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
                               +   FH+R     L  IF+I+GTP  E +           
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350
Query: 238 XX--PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
               P R    DLA        D + LL+RML  +P+KR+T  E L H +FK+
Sbjct: 351 IRIFPKREGT-DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 147/306 (48%), Gaps = 28/306 (9%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L+ +  G  G V  A D+     V +KKI + +P        +RE+ +++ L H+N
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIRRLDHDN 69
Query: 61  IVRLLNVQ--------------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           IV++  +               + ++S+ +V E ++ DL + ++  P + ++    + ++
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA---RLFM 126
Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG--- 163
           +Q+L G+ Y HS  +LHRDLKPAN  I+    ++KI DFGLAR +D    +Y+ KG    
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---PHYSHKGHLSE 183
Query: 164 ---SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
              +  Y++P  LL    Y+  +D+WA  C FAEM+T + LF        +  I   +  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 221 PDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA 280
              E                   P K L  ++ G+  + VD L ++L   P  RLTA EA
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 281 LRHEYF 286
           L H Y 
Sbjct: 304 LSHPYM 309

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 94/280 (33%), Positives = 144/280 (51%), Gaps = 36/280 (12%)
Query: 41  GVPSSVIREVSLLKELKHENIVRLLNV-QSSVD-SIDLVFENLDFDLLHFMKTE--PTVT 96
           G+  S  RE++LL+ELKH N++ L  V  S  D  + L+F+  + DL H +K        
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 97  KNPLK-----IKKYLHQILHGVAYCHSQEILHRDLKPANFLI-----DRSKDIVKIADFG 146
           K P++     +K  L+QIL G+ Y H+  +LHRDLKPAN L+     +R +  VKIAD G
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR--VKIADMG 177
Query: 147 LARPIDVPLENYTIKGG---SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH 203
            AR  + PL+          +  Y+APE LLG+  Y+  +D+WA+ C FAE++T + +FH
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237
Query: 204 SR---------WAPGLLAAIFSIMGTP------DSETLPXXXXXXX--XXXXXPNRSPIK 246
            R         +    L  IF++MG P      D + +P               N S IK
Sbjct: 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 297
Query: 247 DLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            +       +     LL+++L +DP KR+T+ +A++  YF
Sbjct: 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 145/300 (48%), Gaps = 21/300 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V +A   +  D V +KK+      +       RE+ +++ +KH N+
Sbjct: 42  YTNCKVIGNGSFGVVFQAK-LVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNV 94
Query: 62  VRLLNV-QSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           V L     S+ D  D VF NL  + +         H+ K + T+    L IK Y++Q+L 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM--LLIKLYMYQLLR 152
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ I +  E       S  Y+APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK-ILIAGEPNVSXICSRYYRAPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y+T +D+W+  C  AE++  Q LF        L  I  ++GTP  E +     
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI-KTMN 270
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                   P   P            PD +DL+ R+L   PS RLTA EAL H +F + ++
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 99/344 (28%), Positives = 153/344 (44%), Gaps = 61/344 (17%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +  +I  G YG V+ A+D  T   V +KK+  M         ++RE+++L  LK + I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 62  VRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +RL ++         D + +V E  D DL    KT   +T+    IK  L+ +L G  + 
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE--HIKTILYNLLLGENFI 145
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE----------------NYTI 160
           H   I+HRDLKPAN L+++    VK+ DFGLAR I+   +                N  +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 161 KGG------SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT----------------- 197
           K        +  Y+APE +L    Y+  +D+W+  C FAE++                  
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 198 -----------HQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX--XXXXXXXXPNRSP 244
                      + +  H +     L  IF+I+GTP  + L               P+R P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           I +L      +  DG++LL  ML  +P+KR+T  +AL H Y KD
Sbjct: 325 I-NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKXVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYLLYQMLXG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKXVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKXVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 75
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYLLYQMLXG 131
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 244
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 245 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 303 ISVDDALQHPY 313

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 94/332 (28%), Positives = 162/332 (48%), Gaps = 45/332 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
           +Y L++ + +G YG V ++ D  TG+ V VKKI     +        RE+ +L EL  HE
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 60  NIVRLLNVQSSVDSID--LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV LLNV  + +  D  LVF+ ++ DL   ++        P+  +  ++Q++  + Y H
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH 126
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--------DVPL------ENY----- 158
           S  +LHRD+KP+N L++ ++  VK+ADFGL+R          ++PL      EN+     
Sbjct: 127 SGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 159 --TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
             T    +  Y+APE LLGS +Y+  +D+W++ C   E++  + +F        L  I  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 217 IMGTPDSETLPXXXXXXXXXXXXP-------NRSPIKDLATVVGGL----------EPDG 259
           ++  P +E +                      +S  +D+ T    L            + 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
           +DLL ++L  +P+KR++A +AL+H +   F +
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME----LDHERMSYLLYQMLXG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 99/311 (31%), Positives = 148/311 (47%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A D++ G  V VKK+  P  N +        RE+ LLK + H
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA--KRAYRELVLLKCVNH 80
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   +  E     +  ++   L+Q+L G
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME----LDHERMSYLLYQMLCG 136
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR    +  +  Y +   +  Y+AP
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTASTNFMMTPYVV---TRYYRAP 192
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   E+V    +F           +   +GTP +E +    
Sbjct: 193 EVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     +A     L PD +                DLL +ML +DP KR
Sbjct: 252 PTVRNYVE--NRPAYPGIA--FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR 307
Query: 275 LTAREALRHEY 285
           ++  EALRH Y
Sbjct: 308 ISVDEALRHPY 318

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 120
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 176
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 232
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 289
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 290 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 348 ISVDDALQHPY 358

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 120
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 176
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 232
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 233 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 289
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 290 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 348 ISVDDALQHPY 358

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 83
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 252
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 253 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 310
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 311 ISVDDALQHPY 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 83
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 252
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 253 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 310
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 311 ISVDDALQHPY 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 81
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 137
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 193
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 194 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 250
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 251 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 308
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 309 ISVDDALQHPY 319

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 251
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 252 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 309
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 310 ISVDDALQHPY 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 75
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 131
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 244
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 245 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 303 ISVDDALQHPY 313

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 147/311 (47%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A D++ G  V VKK+  P  N +        RE+ LLK + H
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA--KRAYRELVLLKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   +  E     +  ++   L+Q+L G
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP--IDVPLENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR    +  +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y+  VD+W+V C   E+V    +F           +   +GTP +E +    
Sbjct: 195 EVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                      + P          L PD +                DLL +ML +DP KR
Sbjct: 254 PTVRNYVENRPKYP----GIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR 309
Query: 275 LTAREALRHEY 285
           ++  EALRH Y
Sbjct: 310 ISVDEALRHPY 320

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 132
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 245
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 246 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 304 ISVDDALQHPY 314

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/311 (31%), Positives = 150/311 (48%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 132
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 189 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM--KK 245
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGV----------------DLLRRMLCLDPSKR 274
                     NR     L      L PD +                DLL +ML +DP+KR
Sbjct: 246 LQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 303
Query: 275 LTAREALRHEY 285
           ++  +AL+H Y
Sbjct: 304 ISVDDALQHPY 314

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D+V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 192
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 247
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 248 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 304 SFFDELR 310

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 247
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 248 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 302 AHSFFDELR 310

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 141/299 (47%), Gaps = 20/299 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 192
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI-REMN 251
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
                   P                P+ + L  R+L   P+ RLT  EA  H +F + +
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 24/301 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI-RE 249
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                     P                P+ + L  R+L   P+ RLT  EA  H +F + 
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 290 Q 290
           +
Sbjct: 310 R 310

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  121 bits (303), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 99/347 (28%), Positives = 150/347 (43%), Gaps = 64/347 (18%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +  +I  G YG V+ A+D      V +KK+  M         ++RE+++L  LK + I
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 62  VRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +RL ++         D + +V E  D DL    KT   +T+    +K  L+ +L G  + 
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQ--HVKTILYNLLLGEKFI 147
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-------------------N 157
           H   I+HRDLKPAN L+++    VKI DFGLAR I+   +                   N
Sbjct: 148 HESGIIHRDLKPANCLLNQDCS-VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 158 YTIKGG------SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR----------- 200
             +K        +  Y+APE +L    Y+  +D+W+  C FAE++   +           
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 201 LF-----------------HSRWAPGLLAAIFSIMGTPDSETLP--XXXXXXXXXXXXPN 241
           LF                 H +     L  IF+++GTP  E L               P 
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPT 326
Query: 242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           R  I DL+     +  +G+DLL  ML  +  KR+T  +AL H Y KD
Sbjct: 327 RDGI-DLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKD 372

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  120 bits (302), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 83
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 141
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 200
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 255
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 256 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 311
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 312 SFFDELR 318

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 145
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 204
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 259
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 260 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 316 SFFDELR 322

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 94
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 152
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 266
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 267 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 322
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 323 SFFDELR 329

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 76
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 134
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 193
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 248
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 249 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 304
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 305 SFFDELR 311

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 192
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 247
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 248 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 304 SFFDELR 310

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 192
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 247
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 248 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 304 SFFDELR 310

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 145
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 204
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 259
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 260 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 315
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 316 SFFDELR 322

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 79
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 137
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 196
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 251
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 252 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 307
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 308 SFFDELR 314

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 97/307 (31%), Positives = 149/307 (48%), Gaps = 33/307 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 87
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 143
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 199
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 200 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAR 278
           P               S  K    V+   + +          DLL +ML +D SKR++  
Sbjct: 259 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 318
Query: 279 EALRHEY 285
           EAL+H Y
Sbjct: 319 EALQHPY 325

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 103
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 161
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 162 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 218
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 275
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 276 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 330 AHSFFDELR 338

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 167
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICSRYYRAPE 226
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 281
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 282 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 338 SFFDELR 344

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 80
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 138
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 195
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 252
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 253 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 307 AHSFFDELR 315

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 97/307 (31%), Positives = 149/307 (48%), Gaps = 33/307 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 76
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 132
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 188
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 189 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAR 278
           P               S  K    V+   + +          DLL +ML +D SKR++  
Sbjct: 248 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 307
Query: 279 EALRHEY 285
           EAL+H Y
Sbjct: 308 EALQHPY 314

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 133
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 247
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 248 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 304 SFFDELR 310

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 154
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 212
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 269
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 326
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 327 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 381 AHSFFDELR 389

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 36/307 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 88
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 146
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 205
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +     
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI----- 260
Query: 232 XXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   PN +  K                  P+ + L  R+L   P+ RLT  EA  H
Sbjct: 261 ----REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 316
Query: 284 EYFKDFQ 290
            +F + +
Sbjct: 317 SFFDELR 323

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 113
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 171
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 172 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 228
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 285
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 286 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 340 AHSFFDELR 348

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 167
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 224
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 281
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 282 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 336 AHSFFDELR 344

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H NI
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 111
Query: 62  VRL-LNVQSSVDSIDLVFENLDFDLL---------HFMKTEPTVTKNPLKIKKYLHQILH 111
           VRL     SS +  D V+ NL  D +         H+ + + T+    + +K Y++Q+  
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV--IYVKLYMYQLFR 169
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKA 169
            +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +    P  +Y     S  Y+A
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 226
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXX 229
           PE + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +   
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--- 283
Query: 230 XXXXXXXXXXPNRSPIKD--------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
                     PN +  K                  P+ + L  R+L   P+ RLT  EA 
Sbjct: 284 ------REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 282 RHEYFKDFQ 290
            H +F + +
Sbjct: 338 AHSFFDELR 346

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 97/307 (31%), Positives = 149/307 (48%), Gaps = 33/307 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +E   +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAR 278
           P               S  K    V+   + +          DLL +ML +D SKR++  
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 279 EALRHEY 285
           EAL+H Y
Sbjct: 314 EALQHPY 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 93/310 (30%), Positives = 144/310 (46%), Gaps = 23/310 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----------VPSSVIREVS 51
           YT+   I  G YGAV    DS  G  V +K++     S+G          +   V+RE+ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 52  LLKELKHENIVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           LL    H NI+ L ++     + ++  + LV E +  DL   +  +  V  +P  I+ ++
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYFM 140
Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           + IL G+   H   ++HRDL P N L+  + DI  I DF LAR  D    N T       
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT-ICDFNLARE-DTADANKTHYVTHRW 198
Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y+APE ++    ++  VD+W+  C  AEM   + LF        L  I  ++GTP  E +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258
Query: 227 PXXXXXXXXXXXXPNRS--PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
                         + S  P +    VV   +P  +DL+ +ML  +P +R++  +ALRH 
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 285 YFKD-FQSLD 293
           YF+  F  LD
Sbjct: 319 YFESLFDPLD 328

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 146/311 (46%), Gaps = 41/311 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +E   +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EMV H+ LF  R        +   +GTP     P   
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP----CPAFM 249
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPD----------------GVDLLRRMLCLDPSKR 274
                       +  K        L PD                  DLL +ML +D SKR
Sbjct: 250 KKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 275 LTAREALRHEY 285
           ++  EAL+H Y
Sbjct: 310 ISVDEALQHPY 320

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 93/310 (30%), Positives = 144/310 (46%), Gaps = 23/310 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----------VPSSVIREVS 51
           YT+   I  G YGAV    DS  G  V +K++     S+G          +   V+RE+ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 52  LLKELKHENIVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           LL    H NI+ L ++     + ++  + LV E +  DL   +  +  V  +P  I+ ++
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYFM 140
Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           + IL G+   H   ++HRDL P N L+  + DI  I DF LAR  D    N T       
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT-ICDFNLARE-DTADANKTHYVTHRW 198
Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y+APE ++    ++  VD+W+  C  AEM   + LF        L  I  ++GTP  E +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258
Query: 227 PXXXXXXXXXXXXPNRS--PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
                         + S  P +    VV   +P  +DL+ +ML  +P +R++  +ALRH 
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 285 YFKD-FQSLD 293
           YF+  F  LD
Sbjct: 319 YFESLFDPLD 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKVVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKVVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLVG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 146/307 (47%), Gaps = 33/307 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAR 278
           P               S  K    V+   + +          DLL +ML +D SKR++  
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 279 EALRHEY 285
           EAL+H Y
Sbjct: 314 EALQHPY 320

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 145/305 (47%), Gaps = 29/305 (9%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR         T +  +  Y+APE 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPEVVTRYYRAPEV 196
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL----PX 228
           +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    P 
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAREA 280
                         S  K    V+   + +          DLL +ML +D SKR++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 281 LRHEY 285
           L+H Y
Sbjct: 316 LQHPY 320

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 146/307 (47%), Gaps = 33/307 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 83
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 139
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 195
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL---- 226
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 196 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPD--------GVDLLRRMLCLDPSKRLTAR 278
           P               S  K    V+   + +          DLL +ML +D SKR++  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 279 EALRHEY 285
           EAL+H Y
Sbjct: 315 EALQHPY 321

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 148/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNH 84
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 140
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  + +   +  Y+AP
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMVPFVV---TRYYRAP 196
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V C   EM+    LF           +   +GTP  E +    
Sbjct: 197 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 256 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 307
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 308 ASKRISVDEALQHPY 322

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 147/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKVVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLVG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V     EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 147/315 (46%), Gaps = 49/315 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+  P  N +        RE+ L+K + H
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA--KRAYRELVLMKVVNH 82
Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E     +  ++   L+Q+L G
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME----LDHERMSYLLYQMLVG 138
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGSLCYKAP 170
           + + HS  I+HRDLKP+N ++ +S   +KI DFGLAR       +  Y +   +  Y+AP
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E +LG G Y   VD+W+V     EM+    LF           +   +GTP  E +    
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 231 XXXXXXXXXPNRSPIKDLATVVG----GLEPD----------------GVDLLRRMLCLD 270
                      R+ +++     G     L PD                  DLL +ML +D
Sbjct: 254 PTV--------RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 271 PSKRLTAREALRHEY 285
            SKR++  EAL+H Y
Sbjct: 306 ASKRISVDEALQHPY 320

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHE 59
           Y +++ + EG +G V  A+ + TG  V +K I   ++  S+ +   + RE+S L+ L+H 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHP 64
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +I++L +V  S D I +V E    +L  ++     +++   + +++  QI+  V YCH  
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIISAVEYCHRH 122
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
           +I+HRDLKP N L+D   + VKIADFGL+   ++  +   +K   GS  Y APE + G  
Sbjct: 123 KIVHRDLKPENLLLDEHLN-VKIADFGLS---NIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
                VDVW+       M+  +  F     P L   I     +    TLP          
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-----SNGVYTLPKF-------- 225
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                            L P    L++RML ++P  R++  E ++ ++FK
Sbjct: 226 -----------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHE 59
           Y +++ + EG +G V  A+ + TG  V +K I   ++  S+ +   + RE+S L+ L+H 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHP 68
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +I++L +V  S D I +V E    +L  ++     +++   + +++  QI+  V YCH  
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIISAVEYCHRH 126
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
           +I+HRDLKP N L+D   + VKIADFGL+   ++  +   +K   GS  Y APE + G  
Sbjct: 127 KIVHRDLKPENLLLDEHLN-VKIADFGLS---NIMTDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
                VDVW+       M+  +  F     P L   I     +    TLP          
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-----SNGVYTLPKF-------- 229
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                            L P    L++RML ++P  R++  E ++ ++FK
Sbjct: 230 -----------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHE 59
           Y +++ + EG +G V  A+ + TG  V +K I   ++  S+ +   + RE+S L+ L+H 
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHP 73
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +I++L +V  S D I +V E    +L  ++     +++   + +++  QI+  V YCH  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIISAVEYCHRH 131
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
           +I+HRDLKP N L+D   + VKIADFGL+   ++  +   +K   GS  Y APE + G  
Sbjct: 132 KIVHRDLKPENLLLDEHLN-VKIADFGLS---NIMTDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
                VDVW+       M+  +  F     P L   I     +    TLP          
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-----SNGVYTLPKF-------- 234
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                            L P    L++RML ++P  R++  E ++ ++FK
Sbjct: 235 -----------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHE 59
           Y +++ + EG +G V  A+ + TG  V +K I   ++  S+ +   + RE+S L+ L+H 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHP 74
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +I++L +V  S D I +V E    +L  ++     +++   + +++  QI+  V YCH  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIISAVEYCHRH 132
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
           +I+HRDLKP N L+D   + VKIADFGL+   ++  +   +K   GS  Y APE + G  
Sbjct: 133 KIVHRDLKPENLLLDEHLN-VKIADFGLS---NIMTDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
                VDVW+       M+  +  F     P L   I     +    TLP          
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-----SNGVYTLPKF-------- 235
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                            L P    L++RML ++P  R++  E ++ ++FK
Sbjct: 236 -----------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 137/299 (45%), Gaps = 27/299 (9%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-EN 60
           Y L+  +  G+Y  V  A +    + VVVK   I+ P +   + + RE+ +L+ L+   N
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVK--KNKIKREIKILENLRGGPN 93
Query: 61  IVRLLNVQSSVDSID--LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ L ++     S    LVFE   N DF  L+   T+         I+ Y+++IL  + Y
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDY 146
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           CHS  I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVD 205
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
              Y   +D+W++ C  A M+  +   FH       L  I  ++GT D            
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 235 XXXXXP--NRSPIKDLATVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                    R   K     V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 145/330 (43%), Gaps = 56/330 (16%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y+L + +  G +G V    D  +G    +KK+         P    RE+ ++K L H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVN 61
Query: 61  IVRLLNV--------------------------------------QSSVDSIDLVFENLD 82
           I++L++                                        S    ++++ E + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 83  FDLLH-----FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK 137
            D LH     F+++  ++  N + I  Y++Q+   V + HS  I HRD+KP N L++   
Sbjct: 122 -DTLHKVLKSFIRSGRSIPMNLISI--YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 138 DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           + +K+ DFG A+ + +P E       S  Y+APE +LG+  Y+  +D+W++ C F E++ 
Sbjct: 179 NTLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 198 HQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEP 257
            + LF    +   L  I  IMGTP  E +               ++  KD   ++    P
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA--KDWRKILPEGTP 295
Query: 258 D-GVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +DLL ++L  +P  R+   EA+ H +F
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 43/290 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELKHE 59
           Y + E + EG +G V  A    T   V +K I   ++  S+ +   V RE+S LK L+H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD-MHMRVEREISYLKLLRHP 69
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +I++L +V ++   I +V E    +L  ++  +  +T++  + +++  QI+  + YCH  
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--EGRRFFQQIICAIEYCHRH 127
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
           +I+HRDLKP N L+D + + VKIADFGL+   ++  +   +K   GS  Y APE + G  
Sbjct: 128 KIVHRDLKPENLLLDDNLN-VKIADFGLS---NIMTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-IMGTPDSETLPXXXXXXXXX 236
                VDVW+       M+  +  F   + P L   + S +   PD              
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF------------- 230
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                             L P    L+RRM+  DP +R+T +E  R  +F
Sbjct: 231 ------------------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 145/311 (46%), Gaps = 33/311 (10%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R+ +  +  +G +G V    +  TG +V +KK+ I +P         RE+ ++++L    
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPR-----FRNRELQIMQDLAVLH 77
Query: 58  HENIVRLLNVQSSVDS-------IDLVFENLDFDLLH-----FMKTEPTVTKNPLKIKKY 105
           H NIV+L +   ++         +++V E +  D LH     + + +  V   P+ IK +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQ--VAPPPILIKVF 134
Query: 106 LHQILHGVAYCH--SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           L Q++  +   H  S  + HRD+KP N L++ +   +K+ DFG A+ +  P E       
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYIC 193
Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           S  Y+APE + G+  Y+T VD+W+V C FAEM+  + +F    + G L  I  ++G P  
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 224 ETL----PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
           E L    P               S +    ++    E    DLL  +L   P +R+   E
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE--AYDLLSALLQYLPEERMKPYE 311
Query: 280 ALRHEYFKDFQ 290
           AL H YF +  
Sbjct: 312 ALCHPYFDELH 322

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 132/298 (44%), Gaps = 42/298 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGVPSSVI-REVSLLKELKH 58
           Y L EVI +G +  V R  +  TG    VK + +     S G+ +  + RE S+   LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHF---MKTEPTVTKNPLKIKKYLHQILHGVAY 115
            +IV LL   SS   + +VFE +D   L F    + +     +      Y+ QIL  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 116 CHSQEILHRDLKPANFLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLC---YKAP 170
           CH   I+HRD+KP N L+   ++   VK+ DFG+A  +    E+  + GG +    + AP
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG---ESGLVAGGRVGTPHFMAP 202
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E ++    Y  PVDVW              LF       LL+      GT   E L    
Sbjct: 203 E-VVKREPYGKPVDVWGCGVI---------LFI------LLSGCLPFYGT--KERLFEGI 244
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                       S I + A           DL+RRML LDP++R+T  EAL H + K+
Sbjct: 245 IKGKYKMNPRQWSHISESAK----------DLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 234 XXXXXXP-----NRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 140
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 199
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXX-- 231
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 259
Query: 232 ---XXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 260 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319
Query: 287 KDFQS 291
           +  ++
Sbjct: 320 QQVRA 324

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 234 XXXXXXP-----NRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 234 XXXXXXP-----NRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXX-- 231
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 232 ---XXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 234 XXXXXXP-----NRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 139
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 198
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 234 XXXXXXP-----NRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 287 KDFQS 291
           +  ++
Sbjct: 319 QQVRA 323

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 141
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 142 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 200
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXX-- 231
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 201 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 260
Query: 232 ---XXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 261 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 320
Query: 287 KDFQS 291
           +  ++
Sbjct: 321 QQVRA 325

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 160
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 161 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 219
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXX-- 231
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 220 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIE 279
Query: 232 ---XXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 280 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 339
Query: 287 KDFQS 291
           +  ++
Sbjct: 340 QQVRA 344

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 21/245 (8%)
Query: 60  NIVRLLNVQSSVDSI--DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NIV+LL++     S    L+FE   N DF +L+     PT+T     I+ Y++++L  + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY-----PTLTD--YDIRYYIYELLKALD 140
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHSQ I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 199
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXX-- 231
               Y   +D+W++ C FA M+  +   F+       L  I  ++GT             
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 259
Query: 232 ---XXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +R P            + P+ +D L ++L  D  +RLTA EA+ H YF
Sbjct: 260 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319
Query: 287 KDFQS 291
           +  ++
Sbjct: 320 QQVRA 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 29/244 (11%)
Query: 60  NIVRLLN-VQSSVDSI-DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NI++L++ V+  V     LVFE   N DF  L+ + T+         I+ Y++++L  + 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD-------FDIRFYMYELLKALD 146
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHS+ I+HRD+KP N +ID  +  +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH-PAQEYNVRVASRYFKGPELLV 205
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C  A M+  +   FH +     L  I  ++GT +           
Sbjct: 206 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEEL----YGYLKK 261
Query: 234 XXXXXXPNRSPI------KDLATVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALR 282
                 P+ + I      K     +       + P+ +DLL ++L  D  +RLTA+EA+ 
Sbjct: 262 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 321
Query: 283 HEYF 286
           H YF
Sbjct: 322 HPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 29/244 (11%)
Query: 60  NIVRLLN-VQSSVDSI-DLVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NI++L++ V+  V     LVFE   N DF  L+ + T+         I+ Y++++L  + 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD-------FDIRFYMYELLKALD 151
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           YCHS+ I+HRD+KP N +ID  +  +++ D+GLA     P + Y ++  S  +K PE L+
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH-PAQEYNVRVASRYFKGPELLV 210
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
               Y   +D+W++ C  A M+  +   FH +     L  I  ++GT +           
Sbjct: 211 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEEL----YGYLKK 266
Query: 234 XXXXXXPNRSPI------KDLATVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALR 282
                 P+ + I      K     +       + P+ +DLL ++L  D  +RLTA+EA+ 
Sbjct: 267 YHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAME 326
Query: 283 HEYF 286
           H YF
Sbjct: 327 HPYF 330

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++ ++ +G +G V +  D +T     VK I   +      S+++REV LLK+L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKY--------LHQILHG 112
           I++L  +     S  +V E         + T   +    +K K++        + Q+  G
Sbjct: 83  IMKLFEILEDSSSFYIVGE---------LYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 113 VAYCHSQEILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKG--GSLCYK 168
           + Y H   I+HRDLKP N L++ + KD  +KI DFGL+       +N  +K   G+  Y 
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYI 190
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE L G+  Y    DVW+       +++    F+ +    +L  + +     D      
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------ 242
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                      P    I D          D  DL+R+ML   PS R+TA + L H + + 
Sbjct: 243 ----------LPQWRTISD----------DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
Query: 289 FQS 291
           + S
Sbjct: 283 YSS 285

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++ ++ +G +G V +  D +T     VK I   +      S+++REV LLK+L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKY--------LHQILHG 112
           I++L  +     S  +V E         + T   +    +K K++        + Q+  G
Sbjct: 83  IMKLFEILEDSSSFYIVGE---------LYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 113 VAYCHSQEILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKG--GSLCYK 168
           + Y H   I+HRDLKP N L++ + KD  +KI DFGL+       +N  +K   G+  Y 
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYI 190
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE L G+  Y    DVW+       +++    F+ +    +L  + +     D      
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------ 242
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                      P    I D          D  DL+R+ML   PS R+TA + L H + + 
Sbjct: 243 ----------LPQWRTISD----------DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
Query: 289 FQS 291
           + S
Sbjct: 283 YSS 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++ ++ +G +G V +  D +T     VK I   +      S+++REV LLK+L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKY--------LHQILHG 112
           I++L  +     S  +V E         + T   +    +K K++        + Q+  G
Sbjct: 83  IMKLFEILEDSSSFYIVGE---------LYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 113 VAYCHSQEILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKG--GSLCYK 168
           + Y H   I+HRDLKP N L++ + KD  +KI DFGL+       +N  +K   G+  Y 
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYI 190
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE L G+  Y    DVW+       +++    F+ +    +L  + +     D      
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------ 242
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                      P    I D          D  DL+R+ML   PS R+TA + L H + + 
Sbjct: 243 ----------LPQWRTISD----------DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
Query: 289 FQS 291
           + S
Sbjct: 283 YSS 285

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N L
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVL 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 110 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 163 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 109 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 162 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 110 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 163 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 116 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 168
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 169 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 227
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 228 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 287
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 288 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 76  LVFE---NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL 132
           LVFE   N DF  L+   T+         I+ Y+++IL  + YCHS  I+HRD+KP N +
Sbjct: 111 LVFEHVNNTDFKQLYQTLTD-------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           ID     +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  
Sbjct: 164 IDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 193 AEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLA 249
           A M+  +   FH       L  I  ++GT D                     R   K   
Sbjct: 223 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 282
Query: 250 TVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             V       + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           V+ +G YG V+   D      + +K+IP  +     P  +  E++L K LKH+NIV+ L 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKNIVQYLG 86
Query: 67  VQSSVDSIDLVFENLDFDLLHFM---KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
             S    I +  E +    L  +   K  P +  N   I  Y  QIL G+ Y H  +I+H
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 124 RDLKPANFLIDRSKDIVKIADFGLAR---PIDVPLENYTIKGGSLCYKAPERL-LGSGRY 179
           RD+K  N LI+    ++KI+DFG ++    I+   E +T   G+L Y APE +  G   Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEIIDKGPRGY 202
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
               D+W++ CT  EM T +  F+    P   AA+F +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKV 238

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           V+ +G YG V+   D      + +K+IP  +     P  +  E++L K LKH+NIV+ L 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKNIVQYLG 72
Query: 67  VQSSVDSIDLVFENLDFDLLHFM---KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
             S    I +  E +    L  +   K  P +  N   I  Y  QIL G+ Y H  +I+H
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 124 RDLKPANFLIDRSKDIVKIADFGLAR---PIDVPLENYTIKGGSLCYKAPERL-LGSGRY 179
           RD+K  N LI+    ++KI+DFG ++    I+   E +T   G+L Y APE +  G   Y
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEIIDKGPRGY 188
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
               D+W++ CT  EM T +  F+    P   AA+F +
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKV 224

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 13/219 (5%)
Query: 76  LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR 135
           LVFE+++     F +   T+T     I+ Y+++IL  + YCHS  I+HRD+KP N +ID 
Sbjct: 111 LVFEHVN--NTDFKQLRQTLTD--YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 136 SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEM 195
               +++ D+GLA     P + Y ++  S  +K PE L+    Y   +D+W++ C  A M
Sbjct: 167 EHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 196 VTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP--NRSPIKDLATVV 252
           +  +   FH       L  I  ++GT D                     R   K     V
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 253 GG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  + P+ +D L ++L  D   RLTAREA+ H YF
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/298 (30%), Positives = 130/298 (43%), Gaps = 42/298 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGVPSSVI-REVSLLKELKH 58
           Y L EVI +G +  V R  +  TG    VK + +     S G+ +  + RE S+   LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHF---MKTEPTVTKNPLKIKKYLHQILHGVAY 115
            +IV LL   SS   + +VFE +D   L F    + +     +      Y+ QIL  + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 116 CHSQEILHRDLKPANFLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLC---YKAP 170
           CH   I+HRD+KP   L+   ++   VK+  FG+A  +    E+  + GG +    + AP
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG---ESGLVAGGRVGTPHFMAP 204
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E ++    Y  PVDVW              LF       LL+      GT   E L    
Sbjct: 205 E-VVKREPYGKPVDVWGCGVI---------LFI------LLSGCLPFYGT--KERLFEGI 246
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                       S I + A           DL+RRML LDP++R+T  EAL H + K+
Sbjct: 247 IKGKYKMNPRQWSHISESAK----------DLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 31/284 (10%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E++  GR+G VH+  ++ TG  +  K I      +     V  E+S++ +L H N+++L 
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLY 152
Query: 66  NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRD 125
           +   S + I LV E +D   L     + +     L    ++ QI  G+ + H   ILH D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 126 LKPANFL-IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVD 184
           LKP N L ++R    +KI DFGLAR    P E   +  G+  + APE ++     S P D
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPE-VVNYDFVSFPTD 270
Query: 185 VWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSP 244
           +W+V                  A  LL+ +   +G  D+ETL               R  
Sbjct: 271 MWSVGVI---------------AYMLLSGLSPFLGDNDAETLNNILAC---------RWD 306
Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           ++D       +  +  + + ++L  + S R++A EAL+H +  D
Sbjct: 307 LED--EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/298 (30%), Positives = 130/298 (43%), Gaps = 42/298 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGVPSSVI-REVSLLKELKH 58
           Y L EVI +G +  V R  +  TG    VK + +     S G+ +  + RE S+   LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHF---MKTEPTVTKNPLKIKKYLHQILHGVAY 115
            +IV LL   SS   + +VFE +D   L F    + +     +      Y+ QIL  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 116 CHSQEILHRDLKPANFLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLC---YKAP 170
           CH   I+HRD+KP   L+   ++   VK+  FG+A  +    E+  + GG +    + AP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG---ESGLVAGGRVGTPHFMAP 202
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXX 230
           E ++    Y  PVDVW              LF       LL+      GT   E L    
Sbjct: 203 E-VVKREPYGKPVDVWGCGVI---------LFI------LLSGCLPFYGT--KERLFEGI 244
Query: 231 XXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                       S I + A           DL+RRML LDP++R+T  EAL H + K+
Sbjct: 245 IKGKYKMNPRQWSHISESAK----------DLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 125 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGE 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 123/292 (42%), Gaps = 44/292 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELK 57
           Y L + +  G +G V      LTG  V VK   I+N  +     V   + RE+  LK  +
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H +I++L  V S+   I +V E +   +L  ++     + +   + ++   QIL GV YC
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK--ESRRLFQQILSGVDYC 132
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H   ++HRDLKP N L+D   +  KIADFGL+  +    E      GS  Y APE + G 
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMS-DGEFLRXSCGSPNYAAPEVISGR 190
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF-SIMGTPDSETLPXXXXXXXX 235
                 VD+W+       ++     F     P L   I   I  TP              
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY------------ 238
Query: 236 XXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                              L P  + LL+ ML +DP KR T ++   HE+FK
Sbjct: 239 -------------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG YG V  A + +T + V VK I  M  +   P ++ +E+ +   L HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 127 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR- 63
           + V+ +G +G V +A ++L      +KKI     +E   S+++ EV LL  L H+ +VR 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  ---------LLNVQSSVDSIDLVFENLDF-------DLLHFMKTEPTVTKNPLKIKKYLH 107
                     +   ++V     +F  +++       DL+H       + +   +  +   
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFR 123
Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL------------ 155
           QIL  ++Y HSQ I+HRDLKP N  ID S++ VKI DFGLA+ +   L            
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 156 --ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             +N T   G+  Y A E L G+G Y+  +D++++   F EM+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR- 63
           + V+ +G +G V +A ++L      +KKI     +E   S+++ EV LL  L H+ +VR 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  ---------LLNVQSSVDSIDLVFENLDF-------DLLHFMKTEPTVTKNPLKIKKYLH 107
                     +   ++V     +F  +++       DL+H       + +   +  +   
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH----SENLNQQRDEYWRLFR 123
Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL------------ 155
           QIL  ++Y HSQ I+HRDLKP N  ID S++ VKI DFGLA+ +   L            
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 156 --ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             +N T   G+  Y A E L G+G Y+  +D++++   F EM+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V VK I     +      + REV ++K L H NI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 62  VRLLNVQSSVDSIDLVFEN------LDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVA 114
           V+L  V  +  ++ LV E        D+ + H +MK +    K          QI+  V 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAK--------FRQIVSAVQ 120
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPER 172
           YCH + I+HRDLK  N L+D   +I KIADFG +        L+ +    GS  Y APE 
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNI-KIADFGFSNEFTFGNKLDTFC---GSPPYAAPEL 176
Query: 173 LLGSGRYSTP-VDVWAVACTFAEMVT 197
             G  +Y  P VDVW++      +V+
Sbjct: 177 FQGK-KYDGPEVDVWSLGVILYTLVS 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 5/200 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + L++ + EG  G V  A + +T + V VK I  M  +   P ++ +E+ + K L HEN+
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+    +   +   L  E      L F + EP +       +++ HQ++ GV Y H   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGRY 179
            HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     +
Sbjct: 126 THRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 180 STPVDVWAVACTFAEMVTHQ 199
           + PVDVW+       M+  +
Sbjct: 185 AEPVDVWSCGIVLTAMLAGE 204

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 33/292 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I      +     S++REV LLK+L H 
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI++L           LV E      L F +       + +   + + Q+L G+ Y H  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 120 EILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +I+HRDLKP N L++ +SKD  ++I DFGL+   +   +    K G+  Y APE L G+ 
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 209
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    DVW+                      LL+      G  + + L           
Sbjct: 210 -YDEKCDVWSTGVILYI---------------LLSGCPPFNGANEYDILK-KVEKGKYTF 252
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P    + + A           DL+R+ML   PS R++AR+AL HE+ + +
Sbjct: 253 ELPQWKKVSESAK----------DLIRKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 139/323 (43%), Gaps = 43/323 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +L+VI +G +G V +A+D      V +K   ++   +        E+ +L+ L+ + 
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 60  -----NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                N++ +L   +  + I + FE L  +L   +K       +   ++K+ H IL  + 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 115 YCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
             H   I+H DLKP N L+  + +  +K+ DFG +       +       S  Y+APE +
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAPEVI 271
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           LG+ RY  P+D+W++ C  AE++T   L         LA +  ++G P  + L       
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330
Query: 234 X--XXXXXPNRSPIKDLA---------------------------TVVGGLEPDGVDLLR 264
                   P    +  L+                            + G  +P  +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 265 RMLCLDPSKRLTAREALRHEYFK 287
           + L  DP+ R+T  +ALRH + +
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E + +G +  V R    L G     K I     S      + RE  + + LKH NI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           VRL +  S      L+F+ +    L F         +       + QIL  V +CH   +
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGEL-FEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 122 LHRDLKPANFLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +HRDLKP N L+        VK+ADFGLA  ++   + +    G+  Y +PE +L    Y
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPY 201
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXXXXXXX 236
             PVD+WA                     G++  I  ++G P   D +            
Sbjct: 202 GKPVDLWAC--------------------GVILYIL-LVGYPPFWDEDQHRLYQQIKAGA 240
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              P  SP  D  T      P+  DL+ +ML ++PSKR+TA EAL+H +
Sbjct: 241 YDFP--SPEWDTVT------PEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 139/323 (43%), Gaps = 43/323 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +L+VI +G +G V +A+D      V +K   ++   +        E+ +L+ L+ + 
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 60  -----NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                N++ +L   +  + I + FE L  +L   +K       +   ++K+ H IL  + 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 115 YCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
             H   I+H DLKP N L+  + +  +K+ DFG +       +       S  Y+APE +
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAPEVI 271
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           LG+ RY  P+D+W++ C  AE++T   L         LA +  ++G P  + L       
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330
Query: 234 X--XXXXXPNRSPIKDLA---------------------------TVVGGLEPDGVDLLR 264
                   P    +  L+                            + G  +P  +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 265 RMLCLDPSKRLTAREALRHEYFK 287
           + L  DP+ R+T  +ALRH + +
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I      +     S++REV LLK+L H 
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI++L           LV E      L F +       + +   + + Q+L G+ Y H  
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 120 EILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +I+HRDLKP N L++ +SKD  ++I DFGL+   +   +    K G+  Y APE L G+ 
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 227
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    DVW+       +++    F+      +L  +                       
Sbjct: 228 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------------EKGKYTF 270
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P    + + A           DL+R+ML   PS R++AR+AL HE+ + +
Sbjct: 271 ELPQWKKVSESAK----------DLIRKMLTYVPSMRISARDALDHEWIQTY 312

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I      +     S++REV LLK+L H 
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI++L           LV E      L F +       + +   + + Q+L G+ Y H  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 120 EILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +I+HRDLKP N L++ +SKD  ++I DFGL+   +   +    K G+  Y APE L G+ 
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 226
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    DVW+       +++    F+      +L  +                       
Sbjct: 227 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------------EKGKYTF 269
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P    + + A           DL+R+ML   PS R++AR+AL HE+ + +
Sbjct: 270 ELPQWKKVSESAK----------DLIRKMLTYVPSMRISARDALDHEWIQTY 311

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I      +     S++REV LLK+L H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI++L           LV E      L F +       + +   + + Q+L G+ Y H  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 120 EILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +I+HRDLKP N L++ +SKD  ++I DFGL+   +   +    K G+  Y APE L G+ 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT- 203
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    DVW+       +++    F+      +L  +                       
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------------EKGKYTF 246
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P    + + A           DL+R+ML   PS R++AR+AL HE+ + +
Sbjct: 247 ELPQWKKVSESAK----------DLIRKMLTYVPSMRISARDALDHEWIQTY 288

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKELKH 58
           Y LL+ I +G +  V  A   LTG  V +K   I++ ++  P+S+    REV ++K L H
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFEN------LDFDLLHF-MKTEPTVTKNPLKIKKYLHQILH 111
            NIV+L  V  +  ++ L+ E        D+ + H  MK +   +K          QI+ 
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--------FRQIVS 122
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKA 169
            V YCH + I+HRDLK  N L+D   +I KIADFG +    V   L+ +    GS  Y A
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDADMNI-KIADFGFSNEFTVGGKLDTFC---GSPPYAA 178
Query: 170 PERLLGSGRYSTP-VDVWAVACTFAEMVT 197
           PE   G  +Y  P VDVW++      +V+
Sbjct: 179 PELFQGK-KYDGPEVDVWSLGVILYTLVS 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPAFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 139/323 (43%), Gaps = 43/323 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +L+VI +G +G V +A+D      V +K   ++   +        E+ +L+ L+ + 
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALK---MVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 60  -----NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                N++ +L   +  + I + FE L  +L   +K       +   ++K+ H IL  + 
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 115 YCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
             H   I+H DLKP N L+  + +  +K+ DFG +       +       S  Y+APE +
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQSRFYRAPEVI 271
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           LG+ RY  P+D+W++ C  AE++T   L         LA +  ++G P  + L       
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAK 330
Query: 234 X--XXXXXPNRSPIKDLA---------------------------TVVGGLEPDGVDLLR 264
                   P    +  L+                            + G  +P  +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 265 RMLCLDPSKRLTAREALRHEYFK 287
           + L  DP+ R+T  +ALRH + +
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V VK I     +      + REV ++K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCHQKF 133
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLGSGR 178
           I+HRDLK  N L+D   +I KIADFG +        L+ +    GS  Y APE   G  +
Sbjct: 134 IVHRDLKAENLLLDADMNI-KIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGK-K 188
Query: 179 YSTP-VDVWAVACTFAEMVT 197
           Y  P VDVW++      +V+
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 126/294 (42%), Gaps = 46/294 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E + +G +  V R     TG     K I     S      + RE  + + LKH NI
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  V +C
Sbjct: 66  VRLH------DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H   I+HRDLKP N L+  +SK   VK+ADFGLA  +    + +    G+  Y +PE +L
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VL 178
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXX 231
               Y  PVD+WA                     G++  I  ++G P   D +       
Sbjct: 179 RKDPYGKPVDMWAC--------------------GVILYIL-LVGYPPFWDEDQHRLYQQ 217
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   P  SP  D  T      P+  DL+ +ML ++P+KR+TA EAL+H +
Sbjct: 218 IKAGAYDFP--SPEWDTVT------PEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V VK I     +      + REV ++K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCHQKF 133
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLGSGR 178
           I+HRDLK  N L+D   +I KIADFG +        L+ +    GS  Y APE   G  +
Sbjct: 134 IVHRDLKAENLLLDADMNI-KIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGK-K 188
Query: 179 YSTP-VDVWAVACTFAEMVT 197
           Y  P VDVW++      +V+
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 126/294 (42%), Gaps = 46/294 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E + +G +  V R     TG     K I     S      + RE  + + LKH NI
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  V +C
Sbjct: 66  VRLH------DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H   I+HRDLKP N L+  +SK   VK+ADFGLA  +    + +    G+  Y +PE +L
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VL 178
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXX 231
               Y  PVD+WA                     G++  I  ++G P   D +       
Sbjct: 179 RKDPYGKPVDMWAC--------------------GVILYIL-LVGYPPFWDEDQHRLYQQ 217
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   P  SP  D  T      P+  DL+ +ML ++P+KR+TA EAL+H +
Sbjct: 218 IKAGAYDFP--SPEWDTVT------PEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 125/294 (42%), Gaps = 46/294 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E I +G +  V R     TG     K I     S      + RE  + + LKH NI
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNI 65
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  V +C
Sbjct: 66  VRLH------DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H   ++HRDLKP N L+  + K   VK+ADFGLA  +    + +    G+  Y +PE +L
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VL 178
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXX 231
               Y  PVD+WA                     G++  I  ++G P   D +       
Sbjct: 179 RKEAYGKPVDIWAC--------------------GVILYIL-LVGYPPFWDEDQHKLYQQ 217
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   P  SP  D  T      P+  +L+ +ML ++P+KR+TA EAL+H +
Sbjct: 218 IKAGAYDFP--SPEWDTVT------PEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 129
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 187
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 188 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 231
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 232 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 129
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 187
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 188 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 231
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 232 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKELKH 58
           Y LL+ I +G +  V  A   LTG  V +K   I++ ++  P+S+    REV ++K L H
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 59  ENIVRLLNVQSSVDSIDLVFEN------LDFDLLHF-MKTEPTVTKNPLKIKKYLHQILH 111
            NIV+L  V  +  ++ L+ E        D+ + H  MK +   +K          QI+ 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--------FRQIVS 125
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKA 169
            V YCH + I+HRDLK  N L+D   +I KIADFG +    V   L+ +    G+  Y A
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNI-KIADFGFSNEFTVGGKLDAFC---GAPPYAA 181
Query: 170 PERLLGSGRYSTP-VDVWAVACTFAEMVT 197
           PE   G  +Y  P VDVW++      +V+
Sbjct: 182 PELFQGK-KYDGPEVDVWSLGVILYTLVS 209

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V VK I     +      + REV ++K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCHQKF 133
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKAPERLLGS 176
           I+HRDLK  N L+D   +I KIADFG +         +  K  + C    Y APE   G 
Sbjct: 134 IVHRDLKAENLLLDADMNI-KIADFGFSNEF-----TFGNKLDAFCGAPPYAAPELFQGK 187
Query: 177 GRYSTP-VDVWAVACTFAEMVT 197
            +Y  P VDVW++      +V+
Sbjct: 188 -KYDGPEVDVWSLGVILYTLVS 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V V+ I     +      + REV ++K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCHQKF 133
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLGSGR 178
           I+HRDLK  N L+D   +I KIADFG +        L+ +    GS  Y APE   G  +
Sbjct: 134 IVHRDLKAENLLLDADMNI-KIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGK-K 188
Query: 179 YSTP-VDVWAVACTFAEMVT 197
           Y  P VDVW++      +V+
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V V+ I     +      + REV ++K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCHQKF 133
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLGSGR 178
           I+HRDLK  N L+D   +I KIADFG +        L+ +    GS  Y APE   G  +
Sbjct: 134 IVHRDLKAENLLLDADMNI-KIADFGFSNEFTFGNKLDEFC---GSPPYAAPELFQGK-K 188
Query: 179 YSTP-VDVWAVACTFAEMVT 197
           Y  P VDVW++      +V+
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKELKH 58
           Y L + I +G +  V  A   LTG  V VK   I++ ++  P+S+    REV ++K L H
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 59  ENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            NIV+L  V  +  ++ LV E     ++  ++     + +   + K    QI+  V YCH
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK--FRQIVSAVQYCH 131
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV--PLENYTIKGGSLCYKAPERLLG 175
            + I+HRDLK  N L+D   +I KIADFG +    V   L+ +    GS  Y APE   G
Sbjct: 132 QKYIVHRDLKAENLLLDGDMNI-KIADFGFSNEFTVGNKLDTFC---GSPPYAAPELFQG 187
Query: 176 SGRYSTP-VDVWAVACTFAEMVT 197
             +Y  P VDVW++      +V+
Sbjct: 188 K-KYDGPEVDVWSLGVILYTLVS 209

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELKHENIVRLLN 66
           I  G++  V+RA   L G  V +KK+ I +  +    +  I+E+ LLK+L H N+++   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 67  VQSSVDSIDLVFENLDFDLL-----HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
                + +++V E  D   L     HF K +  + +    + KY  Q+   + + HS+ +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TVWKYFVQLCSALEHMHSRRV 157
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRD+KPAN  I  +  +VK+ D GL R             G+  Y +PER+  +G Y+ 
Sbjct: 158 MHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNF 215
Query: 182 PVDVWAVACTFAEMVTHQRLFHS 204
             D+W++ C   EM   Q  F+ 
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYG 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G++  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP----SEGVPSSVIREVSLLKELK 57
           Y L + +  G +G V      LTG  V VK   I+N     S  V   + RE+  LK  +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H +I++L  V S+     +V E +   +L  ++     V +  ++ ++   QIL  V YC
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRLFQQILSAVDYC 127
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H   ++HRDLKP N L+D   +  KIADFGL+  +    E      GS  Y APE +  S
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVI--S 183
Query: 177 GR-YSTP-VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-FSIMGTPDSETLPXXXXXX 233
           GR Y+ P VD+W+       ++     F     P L   I   +   P+           
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----------- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  NRS    +AT           LL  ML +DP KR T ++   HE+FK
Sbjct: 233 -----YLNRS----VAT-----------LLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 136/294 (46%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y   E +  G +  V +  +  TG       +KK    +   GV    I REVS+LKE++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 58  HENIVRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L  V  +   + L+ E +   +L  F+  + ++T+   +  ++L QIL+GV Y 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--EATEFLKQILNGVYYL 130
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N  L+DR+  K  +KI DFGLA  ID   E   I  G+  + APE +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPE-I 188
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      ++T+           LL+     +G    ETL       
Sbjct: 189 VNYEPLGLEADMWSIG-----VITYI----------LLSGASPFLGDTKQETLANVSAV- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  N     +  +    L     D +RR+L  DP KR+T +++L+H + K
Sbjct: 233 -------NYEFEDEYFSNTSAL---AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 33/292 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I      +     S++REV LLK+L H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI +L           LV E      L F +       + +   + + Q+L G+ Y H  
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 120 EILHRDLKPANFLID-RSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           +I+HRDLKP N L++ +SKD  ++I DFGL+   +   +    K G+  Y APE L G+ 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKDKIGTAYYIAPEVLHGT- 203
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    DVW+       +++    F+      +L  +                       
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------------EKGKYTF 246
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P    + + A           DL+R+ L   PS R++AR+AL HE+ + +
Sbjct: 247 ELPQWKKVSESAK----------DLIRKXLTYVPSXRISARDALDHEWIQTY 288

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 121/289 (41%), Gaps = 36/289 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E + +G +  V R    L G       I     S      + RE  + + LKH NI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           VRL +  S      L+F+ +    L F         +       + QIL  V +CH   +
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGEL-FEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 122 LHRDLKPANFLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +HR+LKP N L+        VK+ADFGLA  ++   + +    G+  Y +PE +L    Y
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPY 190
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXXXXXXX 236
             PVD+WA                     G++  I  ++G P   D +            
Sbjct: 191 GKPVDLWAC--------------------GVILYIL-LVGYPPFWDEDQHRLYQQIKAGA 229
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              P  SP  D  T      P+  DL+ +ML ++PSKR+TA EAL+H +
Sbjct: 230 YDFP--SPEWDTVT------PEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP----SEGVPSSVIREVSLLKELK 57
           Y L + +  G +G V      LTG  V VK   I+N     S  V   + RE+  LK  +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H +I++L  V S+     +V E +   +L  ++     V +  ++ ++   QIL  V YC
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRLFQQILSAVDYC 127
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H   ++HRDLKP N L+D   +  KIADFGL+  +    E      GS  Y APE +  S
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVI--S 183
Query: 177 GR-YSTP-VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-FSIMGTPDSETLPXXXXXX 233
           GR Y+ P VD+W+       ++     F     P L   I   +   P+           
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----------- 232
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  NRS    +AT           LL  ML +DP KR T ++   HE+FK
Sbjct: 233 -----YLNRS----VAT-----------LLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y LL+ I +G +  V  A   LTG  V VK I     +      + REV + K L H NI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFEN------LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           V+L  V  +  ++ LV E        D+ + H    E          +    QI+  V Y
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA-------RAKFRQIVSAVQY 128
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKAPE 171
           CH + I+HRDLK  N L+D   +I KIADFG +         +  K  + C    Y APE
Sbjct: 129 CHQKFIVHRDLKAENLLLDADXNI-KIADFGFSNEF-----TFGNKLDAFCGAPPYAAPE 182
Query: 172 RLLGSGRYSTP-VDVWAVACTFAEMVT 197
              G  +Y  P VDVW++      +V+
Sbjct: 183 LFQGK-KYDGPEVDVWSLGVILYTLVS 208

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E +  G +G VHR  +  TG+    K +  M P E    +V +E+  +  L+H  +
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L +     + + +++E +    L     +     +  +  +Y+ Q+  G+ + H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 170
Query: 122 LHRDLKPAN--FLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS--G 177
           +H DLKP N  F   RS ++ K+ DFGL   +D P ++  +  G+  + APE   G   G
Sbjct: 171 VHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y+   D+W+V                  +  LL+ +    G  D ETL           
Sbjct: 229 YYT---DMWSVGVL---------------SYILLSGLSPFGGENDDETLRNVKSCDWNMD 270
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +   G+  DG D +R++L  DP+ R+T  +AL H + 
Sbjct: 271 D-----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E +  G +G VHR  +  TG+    K +  M P E    +V +E+  +  L+H  +
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L +     + + +++E +    L     +     +  +  +Y+ Q+  G+ + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 122 LHRDLKPAN--FLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS--G 177
           +H DLKP N  F   RS ++ K+ DFGL   +D P ++  +  G+  + APE   G   G
Sbjct: 277 VHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y+   D+W+V                  +  LL+ +    G  D ETL           
Sbjct: 335 YYT---DMWSVGVL---------------SYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                       +   G+  DG D +R++L  DP+ R+T  +AL H + 
Sbjct: 377 D-----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y  ++ +  G YG V    D +T     +K I   + S    S ++ EV++LK L H NI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 62  VRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           ++L +      +  LV E      L  +++H MK       N +     + Q+L GV Y 
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF------NEVDAAVIIKQVLSGVTYL 152
Query: 117 HSQEILHRDLKPANFLID-RSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H   I+HRDLKP N L++ + KD ++KI DFGL+   +   +    + G+  Y APE L 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL- 210
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
              +Y    DVW++            LF       LLA      G  D E L        
Sbjct: 211 -RKKYDEKCDVWSIGVI---------LFI------LLAGYPPFGGQTDQEIL-RKVEKGK 253
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                P    + + A           DL+++ML  D  +R++A++AL H + K+  S
Sbjct: 254 YTFDSPEWKNVSEGAK----------DLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLL 65
           ++ +G +  V+RA    TG  V +K I      + G+   V  EV +  +LKH +I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 66  NVQSSVDSIDLVFENL-DFDLLHFMKTE-PTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           N     + + LV E   + ++  ++K      ++N  + + ++HQI+ G+ Y HS  ILH
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN--EARHFMHQIITGMLYLHSHGILH 135
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPV 183
           RDL  +N L+ R+ +I KIADFGLA  + +P E +    G+  Y +PE    S  +    
Sbjct: 136 RDLTLSNLLLTRNMNI-KIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLES 193
Query: 184 DVWAVACTFAEMV 196
           DVW++ C F  ++
Sbjct: 194 DVWSLGCMFYTLL 206

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR- 63
           + V+ +G +G V +A ++L      +KKI     +E   S+++ EV LL  L H+ +VR 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  ---------LLNVQSSVDSIDLVFENLDF-------DLLHFMKTEPTVTKNPLKIKKYLH 107
                     +   ++V     +F   ++       DL+H       + +   +  +   
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH----SENLNQQRDEYWRLFR 123
Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL------------ 155
           QIL  ++Y HSQ I+HR+LKP N  ID S++ VKI DFGLA+ +   L            
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 156 --ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
             +N T   G+  Y A E L G+G Y+  +D +++   F E +
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 118/283 (41%), Gaps = 38/283 (13%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR-EVSLLKELKHENIVRLLNVQS 69
           G +G VH   +  +G   V+K I        VP   I  E+ +LK L H NI+++  V  
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTIN--KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 70  SVDSIDLVFENLDF-DLLHFMKTEPTVTK--NPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              ++ +V E  +  +LL  + +     K  +   + + + Q+++ +AY HSQ ++H+DL
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150
Query: 127 KPANFLIDRSK--DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVD 184
           KP N L   +     +KI DFGLA       E+ T   G+  Y APE       +    D
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRDVTFK--CD 207
Query: 185 VWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSP 244
           +W+                      LL       GT   E               PN   
Sbjct: 208 IWSAGVVMY---------------FLLTGCLPFTGTSLEEV------QQKATYKEPN--- 243
Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
               A     L P  VDLL++ML  DP +R +A + L HE+FK
Sbjct: 244 ---YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 126/300 (42%), Gaps = 45/300 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT---VVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           RY  ++ +  G YG V    D LTG      ++KK  +   S     +++ EV++LK+L 
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN--SGALLDEVAVLKQLD 79
Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H NI++L        +  LV E       FD +   +    V    +     + Q+L G 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI-----MKQVLSGT 134
Query: 114 AYCHSQEILHRDLKPANFLID-RSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            Y H   I+HRDLKP N L++ +S+D ++KI DFGL+   +V       + G+  Y APE
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERLGTAYYIAPE 193
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            L    +Y    DVW+                      LL       G  D E L     
Sbjct: 194 VL--RKKYDEKCDVWSCGVILYI---------------LLCGYPPFGGQTDQEILK-RVE 235
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                   P+ + + D A            L++ ML  +PSKR++A EAL H +   F S
Sbjct: 236 KGKFSFDPPDWTQVSDEAK----------QLVKLMLTYEPSKRISAEEALNHPWIVKFCS 285

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 73  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 131 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 186
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 12  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 68  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 126 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 181
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRI 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 23  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 79  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 137 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 192
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRI 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 22  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 78  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 136 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 191
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGRI 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 27  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 83  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 141 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 196
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRI 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 126/300 (42%), Gaps = 45/300 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDT---VVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           RY  ++ +  G YG V    D LTG      ++KK  +   S     +++ EV++LK+L 
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN--SGALLDEVAVLKQLD 62
Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H NI++L        +  LV E       FD +   +    V    +     + Q+L G 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI-----MKQVLSGT 117
Query: 114 AYCHSQEILHRDLKPANFLID-RSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            Y H   I+HRDLKP N L++ +S+D ++KI DFGL+   +V       + G+  Y APE
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERLGTAYYIAPE 176
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            L    +Y    DVW+                      LL       G  D E L     
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYI---------------LLCGYPPFGGQTDQEILK-RVE 218
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                   P+ + + D A            L++ ML  +PSKR++A EAL H +   F S
Sbjct: 219 KGKFSFDPPDWTQVSDEAK----------QLVKLMLTYEPSKRISAEEALNHPWIVKFCS 268

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 124/294 (42%), Gaps = 46/294 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L E + +G +  V R            K I     S      + RE  + + LKH NI
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 92
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       +HQIL  V + 
Sbjct: 93  VRLH------DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H  +I+HRDLKP N L+  + K   VK+ADFGLA  +    + +    G+  Y +PE +L
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPE-VL 205
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP---DSETLPXXXX 231
               Y  PVD+WA                     G++  I  ++G P   D +       
Sbjct: 206 RKDPYGKPVDIWAC--------------------GVILYIL-LVGYPPFWDEDQHKLYQQ 244
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   P  SP  D  T      P+  +L+ +ML ++P+KR+TA +AL+H +
Sbjct: 245 IKAGAYDFP--SPEWDTVT------PEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +L  I  G YG   +      G  +V K++   + +E     ++ EV+LL+ELKH NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 62  VRLLN--VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYC 116
           VR  +  +  +  ++ +V E  +   L  + T+ T  +  L    + + + Q+   +  C
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 117 HSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           H +      +LHRDLKPAN  +D  K  VK+ DFGLAR ++          G+  Y +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 172 RLLGSGRYSTPVDVWAVACTFAEM 195
           + +    Y+   D+W++ C   E+
Sbjct: 187 Q-MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVV---VKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +     TG       +KK  + +   GV    I REV++L+E++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H NI+ L ++  +   + L+ E +   +L  F+  + ++T++  +  ++L QIL GV Y 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYL 124
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS+ I H DLKP N  L+D++     +K+ DFG+A  I+   E   I  G+  + APE +
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPE-I 182
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        L  I ++    D E         
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF------- 235
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                    S   +LA           D +RR+L  DP +R+T  ++L H + K
Sbjct: 236 ---------SNTSELAK----------DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +L  I  G YG   +      G  +V K++   + +E     ++ EV+LL+ELKH NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 62  VRLLN--VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYC 116
           VR  +  +  +  ++ +V E  +   L  + T+ T  +  L    + + + Q+   +  C
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 117 HSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           H +      +LHRDLKPAN  +D  K  VK+ DFGLAR ++          G+  Y +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 186
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
           + +    Y+   D+W++ C   E+  
Sbjct: 187 Q-MNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 3/217 (1%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L+ I EG +G       +  G   V+K+I I   S        REV++L  +KH N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 61  IVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           IV+         S+ +V +  +  DL   +  +  V     +I  +  QI   + + H +
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +ILHRD+K  N  + +    V++ DFG+AR ++  +E      G+  Y +PE +  +  Y
Sbjct: 145 KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE-ICENKPY 202
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
           +   D+WA+ C   E+ T +  F +     L+  I S
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H NI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  +AYC
Sbjct: 68  VRLH------DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           HS  I+HR+LKP N L+  ++K   VK+ADFGLA  ++   E +    G+  Y +PE +L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE-VL 179
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               YS PVD+WA       ++     F       L A I +  G  D            
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYP---------- 227
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
                   SP  D  T      P+   L+  ML ++P KR+TA +AL+
Sbjct: 228 --------SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H NI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  +AYC
Sbjct: 68  VRLH------DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           HS  I+HR+LKP N L+  ++K   VK+ADFGLA  ++   E +    G+  Y +PE +L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE-VL 179
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               YS PVD+WA       ++     F       L A I +  G  D            
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYP---------- 227
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
                   SP  D  T      P+   L+  ML ++P KR+TA +AL+
Sbjct: 228 --------SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H NI
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLH----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+     F         +       + QIL  +AYC
Sbjct: 67  VRLH------DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           HS  I+HR+LKP N L+  ++K   VK+ADFGLA  ++   E +    G+  Y +PE +L
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE-VL 178
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               YS PVD+WA       ++     F       L A I +  G  D            
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYP---------- 226
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
                   SP  D  T      P+   L+  ML ++P KR+TA +AL+
Sbjct: 227 --------SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALK 260

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H NI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 62  VRLLNVQSSVDSI-DLVFENLDFDLLHFMKT-EPTVTK---NPLKIKKYLHQILHGVAYC 116
           VRL       DSI +  F  L FDL+   +  E  V +   +       + QIL  +AYC
Sbjct: 91  VRLH------DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 117 HSQEILHRDLKPANFLI-DRSKDI-VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           HS  I+HR+LKP N L+  ++K   VK+ADFGLA  ++   E +    G+  Y +PE +L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE-VL 202
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               YS PVD+WA       ++     F       L A I +  G  D            
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYP---------- 250
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
                   SP  D  T      P+   L+  ML ++P KR+TA +AL+
Sbjct: 251 --------SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALK 284

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 19  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLH---QILHGVAYCHSQ 119
           L  V S  + I +V E ++   LL F+K E   T   L++ + +    QI  G+AY    
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGE---TGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
             +HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  
Sbjct: 131 NYVHRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-Y 186
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRL 201
           GR++   DVW+      E+ T  R+
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 13  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 69  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HR+L+ AN L+  +    KIADFGLAR I+     YT + G+   + + APE  +  G 
Sbjct: 127 IHRNLRAANILVSDTLS-CKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-AINYGT 182
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRI 205

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +L  I  G YG   +      G  +V K++   + +E     ++ EV+LL+ELKH NI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 62  VRLLN--VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYC 116
           VR  +  +  +  ++ +V E  +   L  + T+ T  +  L    + + + Q+   +  C
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 117 HSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           H +      +LHRDLKPAN  +D  K  VK+ DFGLAR ++   +      G+  Y +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE 186
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
           + +    Y+   D+W++ C   E+  
Sbjct: 187 Q-MNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L++ +  G++G V     +  G+T V   I  + P    P S + E  ++K+LKH+ +V+
Sbjct: 13  LIKRLGNGQFGEVWMG--TWNGNTKVA--IKTLKPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMK-TEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V S  + I +V E ++   LL F+K  E    K P  +     Q+  G+AY      
Sbjct: 69  LYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLP-NLVDMAAQVAAGMAYIERMNY 126
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+     I KIADFGLAR I+      T + G+   + + APE  L  GR
Sbjct: 127 IHRDLRSANILVGNGL-ICKIADFGLARLIED--NEXTARQGAKFPIKWTAPEAAL-YGR 182
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VT  R+
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRV 205

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 15  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 71  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 129
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 130 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 185
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 186 TIKSDVWSFGILLTELTTKGRV 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 188 LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 303 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 358
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRV 380

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y + E +  G +G VHR  ++ +  T + K + +    + +   V +E+S+L   +H N
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHRN 62
Query: 61  IVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           I+ L     S++ + ++FE +   D+   + T      N  +I  Y+HQ+   + + HS 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 120 EILHRDLKPANFLID-RSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
            I H D++P N +   R    +KI +FG AR +  P +N+ +   +  Y APE +     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPE-VHQHDV 179
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
            ST  D+W++      +++    F +     ++  I +   T D E              
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE---------- 229
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                           +  + +D + R+L  +   R+TA EAL+H + K 
Sbjct: 230 ----------------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 188 LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 303 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 358
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRV 380

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 188 LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 244 LYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 303 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 358
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRV 380

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 137 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +                
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 237
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K L+ +         D L R L +D  KR +A+E L+H++ K
Sbjct: 238 --NPEK-LSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 137 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTRKAYG 194
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +                
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 237
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K L+ +         D L R L +D  KR +A+E L+H++ K
Sbjct: 238 --NPEK-LSAIFR-------DFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 271 LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 386 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 441
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRV 463

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVV---VKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +     TG       +KK  + +   GV    I REV++L+E++
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H NI+ L ++  +   + L+ E +   +L  F+  + ++T++  +  ++L QIL GV Y 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYL 145
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS+ I H DLKP N  L+D++     +K+ DFG+A  I+   E   I  G+  + APE +
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPE-I 203
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        L  I ++    D E         
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF------- 256
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                    S   +LA           D +RR+L  DP +R+   ++L H + K
Sbjct: 257 ---------SNTSELAK----------DFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 13  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 69  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 128 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 183
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 184 TIKSDVWSFGILLTELTTKGRV 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 11  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 67  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 126 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 181
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 182 TIKSDVWSFGILLTELTTKGRV 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 19  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLH---QILHGVAYCHSQ 119
           L  V S  + I +V E ++   LL F+K E   T   L++ + +    QI  G+AY    
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGE---TGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
             +HRDL+ AN L+  +  + K+ADFGLAR I+     +T + G+   + + APE  L  
Sbjct: 131 NYVHRDLRAANILVGENL-VCKVADFGLARLIED--NEWTARQGAKFPIKWTAPEAAL-Y 186
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRL 201
           GR++   DVW+      E+ T  R+
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 38/294 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVV---VKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +     TG       +KK  + +   GV    I REV++L+E++
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H NI+ L ++  +   + L+ E +   +L  F+  + ++T++  +  ++L QIL GV Y 
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRS--KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS+ I H DLKP N  L+D++     +K+ DFG+A  I+   E   I  G+  + APE +
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        L  I ++    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                    S   +LA           D +RR+L  DP +R+   ++L H + K
Sbjct: 243 ---------SNTSELAK----------DFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V +K     K  I +  E  P+ +V  E+ +LK+
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 72  LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 188
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 189 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 228
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 229 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 18  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 74  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 132 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 187
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRI 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 73  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 131 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 186
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V +K     K  I +  E  P+ +V  E+ +LK+
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 78  LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 194
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 195 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 234
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 235 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 19  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 75  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 133 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 188
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRI 211

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +++ + EG +G V    D   G   V   + I+   +    +   E+ +L+ L   +
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVA--VKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                  V++L        I +VFE L      F+K    +      I+K  +QI   V 
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 115 YCHSQEILHRDLKPANFLIDRSKDI------------------VKIADFGLARPIDVPLE 156
           + HS ++ H DLKP N L  +S                     +K+ DFG A   D   E
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD---E 189
Query: 157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
           +++    +  Y+APE +L  G +S P DVW++ C   E      +F +  +   LA +  
Sbjct: 190 HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 217 IMG--------------TPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDL 262
           I+G                  + L                 P+K+             DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 263 LRRMLCLDPSKRLTAREALRHEYF 286
           +++ML  DP+KR+T REAL+H +F
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFF 332

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V +K     K  I +  E  P+ +V  E+ +LK+
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 72  LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 188
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 189 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 228
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 229 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V +K     K  I +  E  P+ +V  E+ +LK+
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 71  LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 187
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 188 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 227
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 228 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 26  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 82  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 140 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 195
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRI 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V +K     K  I +  E  P+ +V  E+ +LK+
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 72  LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 188
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 189 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 228
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 229 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 34/287 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +   E +  G +  V  A +  TG    VK IP     +G  SS+  E+++L+++KHENI
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIP-KKALKGKESSIENEIAVLRKIKHENI 82
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  S + + LV + +    L F +               + Q+L  V Y H   I
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGEL-FDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 122 LHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +HRDLKP N L    D    I+ I+DFGL++ ++   +  +   G+  Y APE +L    
Sbjct: 142 VHRDLKPENLLYYSQDEESKIM-ISDFGLSK-MEGKGDVMSTACGTPGYVAPE-VLAQKP 198
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           YS  VD W++      ++     F+      L   I       DS               
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDS--------------- 243
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            P    I D A           D +R ++  DP+KR T  +A RH +
Sbjct: 244 -PYWDDISDSAK----------DFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 73  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 131 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 186
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 23  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 79  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 137 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 192
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRI 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 79
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 137
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 138 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-VVTRKAYG 195
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +                
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 238
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K L+ +         D L R L +D  KR +A+E ++H++ K
Sbjct: 239 --NPEK-LSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G++G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 25  LVERLGAGQFGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 81  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 139 IHRDLRAANILVSDTLS-CKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-AINYGT 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRI 217

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+++HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 137 VIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE-VVTRKAYG 194
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +                
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 237
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K L+ +         D L R L +D  KR +A+E L+H++ K
Sbjct: 238 --NPEK-LSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V ++     K  I +  E  P+ +V  E+ +LK+
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 197 LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 313
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 314 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 353
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 354 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 118/288 (40%), Gaps = 32/288 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L++ I  G +G      D  + + V VK I      E + ++V RE+   + L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIAANVKREIINHRSLRHPN 76
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVR   V  +   + +V E      L F +       +  + + +  Q++ GV+YCH+ +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 121 ILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + HRDLK  N L+D S    +KI DFG ++   V         G+  Y APE LL     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
               DVW+   T   M+     F     P      I  I+                    
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV------------------ 236
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  I D   +     P+   L+ R+   DP+KR++  E   HE+F
Sbjct: 237 ---QYAIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL  AN L+  +  + K+ADFGLAR I+     YT + G+   + + APE  L  GR+
Sbjct: 137 HRDLAAANILVGENL-VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM-NPSEGVPSSVIREVSLLKELKHE 59
           RY +++ +  G    V+ A D++    V +K I I     E       REV    +L H+
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYC 116
           NIV +++V    D   LV E ++   L    +E   +  PL +     + +QIL G+ + 
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTL----SEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLG 175
           H   I+HRD+KP N LID +K  +KI DFG+A+ + +  L       G++ Y +PE+  G
Sbjct: 128 HDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA 207
                   D++++     EM+  +  F+   A
Sbjct: 187 EAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK-----KIPIMNPSEGVPS-SVIREVSLLKE 55
           Y + + +  G  G V  A +  T   V ++     K  I +  E  P+ +V  E+ +LK+
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           L H  I+++ N   + D   +V E ++   L F K            K Y +Q+L  V Y
Sbjct: 211 LNHPCIIKIKNFFDAEDYY-IVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            H   I+HRDLKP N L+   ++  ++KI DFG ++ +       T+  G+  Y APE L
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVL 327
Query: 174 --LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
             +G+  Y+  VD W++                    G++  I      P SE       
Sbjct: 328 VSVGTAGYNRAVDCWSL--------------------GVILFICLSGYPPFSEHRTQVSL 367
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                    N  P      V   +    +DL++++L +DP  R T  EALRH + +D
Sbjct: 368 KDQITSGKYNFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 189 LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 245 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGL R I+     YT + G+   + + APE  L  GR+
Sbjct: 304 HRDLRAANILVGENL-VCKVADFGLGRLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 359
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 360 TIKSDVWSFGILLTELTTKGRV 381

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHEN 60
           ++ L  I  G +GAV+ A D    + V +KK+      S      +I+EV  L++L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 61  IVRLLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVA 114
            ++         +  LV E       DLL        V K PL+   I    H  L G+A
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE-------VHKKPLQEVEIAAVTHGALQGLA 168
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  ++HRD+K  N L+     +VK+ DFG A  I  P   +    G+  + APE +L
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSAS-IMAPANXFV---GTPYWMAPEVIL 223
Query: 175 G--SGRYSTPVDVWAVACTFAEMV 196
               G+Y   VDVW++  T  E+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 31/287 (10%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +LE +  G +G VHR  +  TG   V K I    P +    +V  E+S++ +L H  +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKL 110
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           + L +       + L+ E L    L           +  ++  Y+ Q   G+ + H   I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 122 LHRDLKPANFLIDRSK-DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +H D+KP N + +  K   VKI DFGLA  ++ P E   +   +  + APE ++      
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPE-IVDREPVG 228
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
              D+WA+                     LL+ +    G  D ETL              
Sbjct: 229 FYTDMWAIGVL---------------GYVLLSGLSPFAGEDDLETLQNV----------- 262
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
            R   +        + P+  D ++ +L  +P KRLT  +AL H + K
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 13/229 (5%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L++ +  G++G V   + +     V VK    + P      + + E +L+K L+H+ +VR
Sbjct: 17  LVKRLGAGQFGEVWMGYYN-NSTKVAVK---TLKPGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 64  LLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V +  + I ++ E +    LL F+K++        K+  +  QI  G+AY   +  +
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 132
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  S  + KIADFGLAR I+     YT + G+   + + APE  +  G +
Sbjct: 133 HRDLRAANVLVSESL-MCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE-AINFGCF 188
Query: 180 STPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLP 227
           +   DVW+      E+VT+ ++ +  R    ++ A+      P  E  P
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCP 237

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 1   RYTLLEVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           +Y + +++ EG YG V    DS  L    V + K   +       ++V +E+ LL+ L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 59  ENIVRLLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +N+++L++V        + +V E     +   + + P       +   Y  Q++ G+ Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPERLL 174
           HSQ I+H+D+KP N L+  +   +KI+  G+A  +     + T +   GS  ++ PE   
Sbjct: 126 HSQGIVHKDIKPGNLLL-TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 175 GSGRYST-PVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           G   +S   VD+W+   T   + T    F        +  +F  +G              
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIG-------------- 226
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                       K    + G   P   DLL+ ML  +P+KR + R+  +H +F+
Sbjct: 227 ------------KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 129/324 (39%), Gaps = 44/324 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +++ + EG +G V    D   G   V   + I+   +    +   E+ +L+ L   +
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVA--VKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                  V++L        I +VFE L      F+K    +      I+K  +QI   V 
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 115 YCHSQEILHRDLKPANFLIDRSKDI------------------VKIADFGLARPIDVPLE 156
           + HS ++ H DLKP N L  +S                     +K+ DFG A   D   E
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD---E 189
Query: 157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
           +++       Y+APE +L  G +S P DVW++ C   E      +F +  +   LA +  
Sbjct: 190 HHSTLVXXRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 217 IMG--------------TPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDL 262
           I+G                  + L                 P+K+             DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 263 LRRMLCLDPSKRLTAREALRHEYF 286
           +++ML  DP+KR+T REAL+H +F
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFF 332

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I S+    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                    S   +LA           D +R++L  +  KRLT +EALRH +
Sbjct: 243 ---------SHTSELAK----------DFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 121/295 (41%), Gaps = 34/295 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y   +V+  G +  V  A D  T   V +K I      EG   S+  E+++L ++KH NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  S   + L+ + +    L F +             + + Q+L  V Y H   I
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGEL-FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 122 LHRDLKPANFL---IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +HRDLKP N L   +D    I+ I+DFGL++  D P    +   G+  Y APE +L    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSKMED-PGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           YS  VD W++      ++     F+      L   I       DS               
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--------------- 239
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            P    I D A           D +R ++  DP KR T  +AL+H +     +LD
Sbjct: 240 -PYWDDISDSAK----------DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 121/295 (41%), Gaps = 34/295 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y   +V+  G +  V  A D  T   V +K I      EG   S+  E+++L ++KH NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  S   + L+ + +    L F +             + + Q+L  V Y H   I
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGEL-FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 122 LHRDLKPANFL---IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +HRDLKP N L   +D    I+ I+DFGL++  D P    +   G+  Y APE +L    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSKMED-PGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           YS  VD W++      ++     F+      L   I       DS               
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--------------- 239
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            P    I D A           D +R ++  DP KR T  +AL+H +     +LD
Sbjct: 240 -PYWDDISDSAK----------DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHEN 60
           ++ L  I  G +GAV+ A D    + V +KK+      S      +I+EV  L++L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 61  IVRLLNVQSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVA 114
            ++         +  LV E       DLL        V K PL+   I    H  L G+A
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE-------VHKKPLQEVEIAAVTHGALQGLA 129
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS  ++HRD+K  N L+     +VK+ DFG A  I  P   +    G+  + APE +L
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA-SIMAPANXFV---GTPYWMAPEVIL 184
Query: 175 G--SGRYSTPVDVWAVACTFAEMV 196
               G+Y   VDVW++  T  E+ 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELA 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 72
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HR+L   N L++ +++ VKI DFGL + +    E Y +K  G S + + APE L 
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 192 ES-KFSVASDVWSFGVVLYELFTY 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I S+    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                    S   +LA           D +R++L  +  KRLT +EALRH
Sbjct: 243 ---------SHTSELAK----------DFIRKLLVKETRKRLTIQEALRH 273

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 121/295 (41%), Gaps = 34/295 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y   +V+  G +  V  A D  T   V +K I      EG   S+  E+++L ++KH NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  S   + L+ + +    L F +             + + Q+L  V Y H   I
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGEL-FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 122 LHRDLKPANFL---IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +HRDLKP N L   +D    I+ I+DFGL++  D P    +   G+  Y APE +L    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSKMED-PGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           YS  VD W++      ++     F+      L   I       DS               
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--------------- 239
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            P    I D A           D +R ++  DP KR T  +AL+H +     +LD
Sbjct: 240 -PYWDDISDSAK----------DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 121/295 (41%), Gaps = 34/295 (11%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y   +V+  G +  V  A D  T   V +K I      EG   S+  E+++L ++KH NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V L ++  S   + L+ + +    L F +             + + Q+L  V Y H   I
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGEL-FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 122 LHRDLKPANFL---IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +HRDLKP N L   +D    I+ I+DFGL++  D P    +   G+  Y APE +L    
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSKMED-PGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           YS  VD W++      ++     F+      L   I       DS               
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS--------------- 239
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            P    I D A           D +R ++  DP KR T  +AL+H +     +LD
Sbjct: 240 -PYWDDISDSAK----------DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 117/288 (40%), Gaps = 32/288 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L++ I  G +G      D  + + V VK I      E +  +V RE+   + L+H N
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSLRHPN 75
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVR   V  +   + +V E      L F +       +  + + +  Q++ GV+YCH+ +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 121 ILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + HRDLK  N L+D S    +KI DFG ++   V         G+  Y APE LL     
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 193
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
               DVW+   T   M+     F     P      I  I+                    
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV------------------ 235
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  I D   +     P+   L+ R+   DP+KR++  E   HE+F
Sbjct: 236 ---QYAIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 40/291 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YTL   I  G +G V  A    T      KKIP     +       +E+ ++K L H NI
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNI 85
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCHS 118
           +RL         I LV E      L     E  V K   +     + +  +L  VAYCH 
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELF----ERVVHKRVFRESDAARIMKDVLSAVAYCHK 141
Query: 119 QEILHRDLKPANFLI--DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
             + HRDLKP NFL   D     +K+ DFGLA     P +    K G+  Y +P+ L G 
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEG- 199
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXX 236
                   ++   C               W+ G++  +  + G P   + P         
Sbjct: 200 --------LYGPEC-------------DEWSAGVMMYVL-LCGYPPF-SAPTDXEVMLKI 236
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  P KD   V     P    L+RR+L   P +R+T+ +AL HE+F+
Sbjct: 237 REGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 12  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 68  LYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+      T + G+   + + APE  L  GR+
Sbjct: 127 HRDLRAANILVGENL-VCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEAAL-YGRF 182
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 183 TIKSDVWSFGILLTELTTKGRV 204

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I S+    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                    S   +LA           D +R++L  +  KRLT +EALRH +
Sbjct: 243 ---------SHTSELAK----------DFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 5   LEV-IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LEV + +G +G V     +  G T V   I  + P    P + ++E  ++K+L+HE +V+
Sbjct: 22  LEVKLGQGCFGEVWMG--TWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 64  LLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      +
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  +  + K+ADFGLAR I+      T + G+   + + APE  L  GR+
Sbjct: 137 HRDLRAANILVGENL-VCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEAAL-YGRF 192
Query: 180 STPVDVWAVACTFAEMVTHQRL 201
           +   DVW+      E+ T  R+
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 71
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E + +K  G S + + APE L 
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 191 ES-KFSVASDVWSFGVVLYELFTY 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 79
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 137
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HR++K  N L+      VK+ DFG    I       +   G+  + APE ++    Y 
Sbjct: 138 VIHRNIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 195
Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXP 240
             VD+W++     EM+  +  + +   P     + +  GTP+ +                
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQ---------------- 238
Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             +P K L+ +         D L R L +D  KR +A+E ++H++ K
Sbjct: 239 --NPEK-LSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 114/229 (49%), Gaps = 13/229 (5%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L++ +  G++G V   + +     V VK    + P      + + E +L+K L+H+ +VR
Sbjct: 16  LVKKLGAGQFGEVWMGYYN-NSTKVAVK---TLKPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 64  LLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           L  V +  + I ++ E +    LL F+K++        K+  +  QI  G+AY   +  +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 131
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRY 179
           HRDL+ AN L+  S  + KIADFGLAR I+     YT + G+   + + APE  +  G +
Sbjct: 132 HRDLRAANVLVSESL-MCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEA-INFGCF 187
Query: 180 STPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLP 227
           +   +VW+      E+VT+ ++ +  R    +++A+      P  E  P
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCP 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 10  EGRYGAVHRAHD---SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A     S T D ++V    + +P+        RE  LL  L+HE+IV+   
Sbjct: 25  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG 84
Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKIKKYLH---QILH 111
           V    D + +VFE +   DL  F++            +P   K  L + + LH   QI  
Sbjct: 85  VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS 144
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS----LCY 167
           G+ Y  SQ  +HRDL   N L+  +  +VKI DFG++R  DV   +Y   GG     + +
Sbjct: 145 GMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRW 201
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
             PE ++   +++T  DVW+      E+ T+ +
Sbjct: 202 MPPESIMYR-KFTTESDVWSFGVILWEIFTYGK 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EV+  G +G V +A        V +K+I     SE    + I E+  L  + H NIV+L 
Sbjct: 14  EVVGRGAFGVVCKA--KWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 66  NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE- 120
              + ++ + LV E  +    +++LH    EP           +  Q   GVAY HS + 
Sbjct: 68  G--ACLNPVCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 121 --ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
             ++HRDLKP N L+     ++KI DFG A  I   + N     GS  + APE   GS  
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVFEGS-N 179
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           YS   DV++      E++T ++ F     P      F IM    + T P
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGTRP 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 40/291 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           YTL   I  G +G V  A    T      KKIP     +       +E+ ++K L H NI
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNI 68
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCHS 118
           +RL         I LV E      L     E  V K   +     + +  +L  VAYCH 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELF----ERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 119 QEILHRDLKPANFLI--DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
             + HRDLKP NFL   D     +K+ DFGLA     P +    K G+  Y +P+ L G 
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEG- 182
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXX 236
                   ++   C               W+ G++  +  + G P   + P         
Sbjct: 183 --------LYGPEC-------------DEWSAGVMMYVL-LCGYPPF-SAPTDXEVMLKI 219
Query: 237 XXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  P KD   V     P    L+RR+L   P +R+T+ +AL HE+F+
Sbjct: 220 REGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I ++    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                    S   +LA           D +R++L  +  KRLT +EALRH
Sbjct: 243 ---------SQTSELAK----------DFIRKLLVKETRKRLTIQEALRH 273

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           L+E +  G+ G V   +    G T V  K   +      P + + E +L+K+L+H+ +VR
Sbjct: 17  LVERLGAGQAGEVWMGY--YNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L  V  Q  +  I    EN    L+ F+KT   +     K+     QI  G+A+   +  
Sbjct: 73  LYAVVTQEPIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL+ AN L+  +    KIADFGLAR I+      T + G+   + + APE  +  G 
Sbjct: 131 IHRDLRAANILVSDTLS-CKIADFGLARLIEDA--EXTAREGAKFPIKWTAPE-AINYGT 186
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           ++   DVW+      E+VTH R+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EV+  G +G V +A        V +K+I     SE    + I E+  L  + H NIV+L 
Sbjct: 15  EVVGRGAFGVVCKA--KWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 68
Query: 66  NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE- 120
              + ++ + LV E  +    +++LH    EP           +  Q   GVAY HS + 
Sbjct: 69  G--ACLNPVCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 121 --ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
             ++HRDLKP N L+     ++KI DFG A  I   + N     GS  + APE   GS  
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVFEGS-N 180
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
           YS   DV++      E++T ++ F     P      F IM    + T P
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGTRP 224

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I ++    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                    S   +LA           D +R++L  +  KRLT +EALRH +
Sbjct: 243 ---------SQTSELAK----------DFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 102
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 222 ES-KFSVASDVWSFGVVLYELFTY 244

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 76
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 196 ES-KFSVASDVWSFGVVLYELFTY 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 77
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 197 ES-KFSVASDVWSFGVVLYELFTY 219

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 78
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 198 ES-KFSVASDVWSFGVVLYELFTY 220

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 75
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 195 ES-KFSVASDVWSFGVVLYELFTY 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 89
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 209 ES-KFSVASDVWSFGVVLYELFTY 231

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 89
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 209 ES-KFSVASDVWSFGVVLYELFTY 231

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 69
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 189 ES-KFSVASDVWSFGVVLYELFTY 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 74
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 194 ES-KFSVASDVWSFGVVLYELFTY 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 71
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 191 ES-KFSVASDVWSFGVVLYELFTY 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 71
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 191 ES-KFSVASDVWSFGVVLYELFTY 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 70
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 190 ES-KFSVASDVWSFGVVLYELFTY 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G++G V  A  +    T V  K   M P      + + E +++K L+H+ +V+L  V + 
Sbjct: 26  GQFGEVWMA--TYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 71  VDSIDLVFENL-DFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGVAYCHSQEILHRDLKP 128
            + I ++ E +    LL F+K++   +K PL K+  +  QI  G+A+   +  +HRDL+ 
Sbjct: 82  -EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDV 185
           AN L+  S  + KIADFGLAR I+     YT + G+   + + APE  +  G ++   DV
Sbjct: 140 ANILVSASL-VCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE-AINFGSFTIKSDV 195
Query: 186 WAVACTFAEMVTHQRL 201
           W+      E+VT+ R+
Sbjct: 196 WSFGILLMEIVTYGRI 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L+ + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 74
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L           + +K+ +Y  QI  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 194 ES-KFSVASDVWSFGVVLYELFTY 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVI-REVSLLKELK 57
           Y + E +  G++  V +  +  TG       +KK        GV    I REVS+L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H NI+ L +V  +   + L+ E +   +L  F+  + ++++   +   ++ QIL GV Y 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--EATSFIKQILDGVNYL 131
Query: 117 HSQEILHRDLKPAN-FLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           H+++I H DLKP N  L+D++  I  +K+ DFGLA  I+  +E   I  G+  + APE +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FGTPEFVAPE-I 189
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +         D+W++      +++    F        LA I ++    D E         
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF------- 242
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                    S   +LA           D +R++L  +  KRLT +EALRH +
Sbjct: 243 ---------SQTSELAK----------DFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G++G V  A  +    T V   +  M P      + + E +++K L+H+ +V+L  V + 
Sbjct: 199 GQFGEVWMA--TYNKHTKVA--VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 71  VDSIDLVFENL-DFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGVAYCHSQEILHRDLKP 128
            + I ++ E +    LL F+K++   +K PL K+  +  QI  G+A+   +  +HRDL+ 
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDV 185
           AN L+  S  + KIADFGLAR I+     YT + G+   + + APE  +  G ++   DV
Sbjct: 313 ANILVSASL-VCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE-AINFGSFTIKSDV 368
Query: 186 WAVACTFAEMVTHQRL 201
           W+      E+VT+ R+
Sbjct: 369 WSFGILLMEIVTYGRI 384

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 25  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 79
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 137
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E   +  G+  Y APE L   G +S  
Sbjct: 138 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFE 195
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 196 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 228
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 229 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVP--SSVIREVSLLKELKHENIVR 63
           EG +G V    +      TG+ V VK    + P  G    + + +E+ +L+ L HENIV+
Sbjct: 19  EGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHS 118
              +  +   + I L+ E L    L   K      KN + +K   KY  QI  G+ Y  S
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPERLLG 175
           ++ +HRDL   N L++ S+  VKI DFGL + I+   E  T+K      + + APE L+ 
Sbjct: 133 RQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 176 SGRYSTPVDVWAVACTFAEMVTH 198
           S ++    DVW+   T  E++T+
Sbjct: 192 S-KFYIASDVWSFGVTLHELLTY 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVP--SSVIREVSLLKELKHENIVR 63
           EG +G V    +      TG+ V VK    + P  G    + + +E+ +L+ L HENIV+
Sbjct: 31  EGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 64  LLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHS 118
              +  +   + I L+ E L    L   K      KN + +K   KY  QI  G+ Y  S
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPERLLG 175
           ++ +HRDL   N L++ S+  VKI DFGL + I+   E  T+K      + + APE L+ 
Sbjct: 145 RQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 176 SGRYSTPVDVWAVACTFAEMVTH 198
           S ++    DVW+   T  E++T+
Sbjct: 204 S-KFYIASDVWSFGVTLHELLTY 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L  + +G +G+V    +D L   TG+ V VKK+   + +E       RE+ +LK L+H+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHD 74
Query: 60  NIVRLLNVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           NIV+   V  S    ++ L+ E L +  L     +     + +K+ +Y  QI  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLL 174
           ++  +HRDL   N L++ +++ VKI DFGL + +    E   +K  G S + + APE L 
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
            S ++S   DVW+      E+ T+
Sbjct: 194 ES-KFSVASDVWSFGVVLYELFTY 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 49  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 103
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 161
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E   +  G+  Y APE L   G +S  
Sbjct: 162 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFE 219
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 220 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 252
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 253 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 51  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 105
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 163
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E   +  G+  Y APE L   G +S  
Sbjct: 164 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFE 221
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 222 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 254
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 255 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 116/288 (40%), Gaps = 32/288 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L++ I  G +G      D  + + V VK I      E +  +V RE+   + L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSLRHPN 76
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVR   V  +   + +V E      L F +       +  + + +  Q++ GV+YCH+ +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 121 ILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + HRDLK  N L+D S    +KI  FG ++   V         G+  Y APE LL     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
               DVW+   T   M+     F     P      I  I+                    
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV------------------ 236
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  I D   +     P+   L+ R+   DP+KR++  E   HE+F
Sbjct: 237 ---QYAIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 50/267 (18%)
Query: 36  MNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV-----FENLDF------- 83
           M+  E     V+ +  LLK  + E +   + +  S+D+  +V     FE+ DF       
Sbjct: 64  MDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 84  ----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI 139
                LL   K    VT+   + + ++ Q + GV Y H+  ++HRDLK  N  ++   D 
Sbjct: 124 CRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           VKI DFGLA  I+   E      G+  Y APE L   G +S  VD+W++ C    +    
Sbjct: 181 VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL---- 235
Query: 200 RLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDG 259
                            ++G P  ET                    K+  +V   + P  
Sbjct: 236 -----------------LVGKPPFETSCLKETYIRIK---------KNEYSVPRHINPVA 269
Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYF 286
             L+RRML  DP+ R +  E L  E+F
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 116/288 (40%), Gaps = 32/288 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L++ I  G +G      D  + + V VK I      E +  +V RE+   + L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSLRHPN 76
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVR   V  +   + +V E      L F +       +  + + +  Q++ GV+YCH+ +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 121 ILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + HRDLK  N L+D S    +KI  FG ++   V         G+  Y APE LL     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
               DVW+   T   M+     F     P      I  I+                    
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV------------------ 236
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  I D   +     P+   L+ R+   DP+KR++  E   HE+F
Sbjct: 237 ---QYAIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 116/288 (40%), Gaps = 32/288 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L++ I  G +G      D    + V VK I      E +  +V RE+   + L+H N
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYI---ERGEKIDENVKREIINHRSLRHPN 76
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVR   V  +   + +V E      L F +       +  + + +  Q++ GV+Y H+ +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 121 ILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + HRDLK  N L+D S    +KIADFG ++   V         G+  Y APE LL     
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
               DVW+   T   M+     F     P      I  I+                    
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV------------------ 236
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              +  I D   +     P+   L+ R+   DP+KR++  E   HE+F
Sbjct: 237 ---QYAIPDYVHI----SPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 50/267 (18%)
Query: 36  MNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV-----FENLDF------- 83
           M+  E     V+ +  LLK  + E +   + +  S+D+  +V     FE+ DF       
Sbjct: 64  MDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 84  ----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI 139
                LL   K    VT+   + + ++ Q + GV Y H+  ++HRDLK  N  ++   D 
Sbjct: 124 CRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           VKI DFGLA  I+   E      G+  Y APE L   G +S  VD+W++ C    +    
Sbjct: 181 VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL---- 235
Query: 200 RLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDG 259
                            ++G P  ET                    K+  +V   + P  
Sbjct: 236 -----------------LVGKPPFETSCLKETYIRIK---------KNEYSVPRHINPVA 269
Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYF 286
             L+RRML  DP+ R +  E L  E+F
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E+I  G +G V +A   + G T V++++   N          REV  L +L H NI
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEK------AEREVKALAKLDHVNI 67
Query: 62  VRLLNVQSSVD----SIDLVFENLDFDLLHFMKTEPTVTK-------------------- 97
           V         D    + D   E+ D+D  +   +  + TK                    
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 98  -NPLKIKKYL-----HQILHGVAYCHSQEILHRDLKPAN-FLIDRSKDIVKIADFGLARP 150
               K+ K L      QI  GV Y HS++++HRDLKP+N FL+D  +  VKI DFGL   
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ--VKIGDFGLVTS 185
Query: 151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
           +    +  T   G+L Y +PE+ + S  Y   VD++A+    AE++
Sbjct: 186 LKNDGKR-TRSKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELL 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 31  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 85
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 143
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E      G+  Y APE L   G +S  
Sbjct: 144 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFE 201
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 202 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 234
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 235 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 27  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 81
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 139
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E      G+  Y APE L   G +S  
Sbjct: 140 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFE 197
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 198 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 230
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 231 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 46/284 (16%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           +G +       D+ T +    K +P   ++ P +    S+  E+S+ + L H+++V    
Sbjct: 27  KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV---G 81
Query: 67  VQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                +  D VF  L+      LL   K    +T+   + + YL QI+ G  Y H   ++
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNRVI 139
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N  ++   + VKI DFGLA  ++   E      G+  Y APE L   G +S  
Sbjct: 140 HRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFE 197
Query: 183 VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNR 242
           VDVW++ C    +                     ++G P  ET                 
Sbjct: 198 VDVWSIGCIMYTL---------------------LVGKPPFETSCLKETYLRIK------ 230
Query: 243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
              K+  ++   + P    L+++ML  DP+ R T  E L  E+F
Sbjct: 231 ---KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 8/210 (3%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  ++ I  G +G      D LT + V VK I        +  +V RE+   + L+H N
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPN 77
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           IVR   V  +   + ++ E     +L   +      +++  +   +  Q+L GV+YCHS 
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF--FFQQLLSGVSYCHSM 135
Query: 120 EILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +I HRDLK  N L+D S    +KI DFG ++   V         G+  Y APE LL    
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAP 208
                DVW+   T   M+     F     P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/332 (25%), Positives = 135/332 (40%), Gaps = 54/332 (16%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
           RY +  +I +G +G V +A+D +  + V +K   I+   +   +    EV LL+ + KH+
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 60  N-----IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                 IV L       + + LVFE L ++L   ++       +    +K+  Q+   + 
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 115 YCHSQE--ILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           +  + E  I+H DLKP N L+ +  +  +KI DFG +  +   +        S  Y++PE
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI---QSRFYRSPE 228
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            LLG   Y   +D+W++ C   EM T + LF        +  I  ++G P +  L     
Sbjct: 229 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287
Query: 232 XXXXXXXXP----NRSPIKD----------------LATVVGGLEPDG------------ 259
                   P    N    KD                L    GG  P G            
Sbjct: 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG--PGGRRAGESGHTVAD 345
Query: 260 ----VDLLRRMLCLDPSKRLTAREALRHEYFK 287
                DL+ RML  DP  R+    AL+H +FK
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 50/267 (18%)
Query: 36  MNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV-----FENLDF------- 83
           M+  E     V+ +  LLK  + E +   + +  S+D+  +V     FE+ DF       
Sbjct: 48  MDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 107
Query: 84  ----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI 139
                LL   K    VT+   + + ++ Q + GV Y H+  ++HRDLK  N  ++   D 
Sbjct: 108 CRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 164
Query: 140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           VKI DFGLA  I+   E      G+  Y APE L   G +S  VD+W++ C    +    
Sbjct: 165 VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL---- 219
Query: 200 RLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDG 259
                            ++G P  ET                    K+  +V   + P  
Sbjct: 220 -----------------LVGKPPFETSCLKETYIRIK---------KNEYSVPRHINPVA 253
Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYF 286
             L+RRML  DP+ R +  E L  E+F
Sbjct: 254 SALIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 38/286 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    +     + +E+++L +     +
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSSYV 83
Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
            +          + ++ E L     L  ++  P    +  +I   L +IL G+ Y HS++
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF---DEFQIATMLKEILKGLDYLHSEK 140
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGSGRY 179
            +HRD+K AN L+    D VK+ADFG+A  + D  ++  T  G    + APE +  S  Y
Sbjct: 141 KIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSA-Y 197
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXX 239
            +  D+W++  T  E+   +                     P+S+  P            
Sbjct: 198 DSKADIWSLGITAIELAKGE--------------------PPNSDMHPMRVLFLI----- 232
Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           P  +P     T+VG       + +   L  DPS R TA+E L+H++
Sbjct: 233 PKNNP----PTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 50/267 (18%)
Query: 36  MNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV-----FENLDF------- 83
           M+  E     V+ +  LLK  + E +   + +  S+D+  +V     FE+ DF       
Sbjct: 64  MDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 84  ----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI 139
                LL   K    VT+   + + ++ Q + GV Y H+  ++HRDLK  N  ++   D 
Sbjct: 124 CRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD- 180
Query: 140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           VKI DFGLA  I+   E      G+  Y APE L   G +S  VD+W++ C    +    
Sbjct: 181 VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL---- 235
Query: 200 RLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDG 259
                            ++G P  ET                    K+  +V   + P  
Sbjct: 236 -----------------LVGKPPFETSCLKETYIRIK---------KNEYSVPRHINPVA 269
Query: 260 VDLLRRMLCLDPSKRLTAREALRHEYF 286
             L+RRML  DP+ R +  E L  E+F
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 84/332 (25%), Positives = 135/332 (40%), Gaps = 54/332 (16%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
           RY +  +I +G +G V +A+D +  + V +K   I+   +   +    EV LL+ + KH+
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 60  N-----IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                 IV L       + + LVFE L ++L   ++       +    +K+  Q+   + 
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 115 YCHSQE--ILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           +  + E  I+H DLKP N L+ +  +  +KI DFG +  +   +        S  Y++PE
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXI---QSRFYRSPE 228
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            LLG   Y   +D+W++ C   EM T + LF        +  I  ++G P +  L     
Sbjct: 229 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287
Query: 232 XXXXXXXXP----NRSPIKD----------------LATVVGGLEPDG------------ 259
                   P    N    KD                L    GG  P G            
Sbjct: 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG--PGGRRAGESGHTVAD 345
Query: 260 ----VDLLRRMLCLDPSKRLTAREALRHEYFK 287
                DL+ RML  DP  R+    AL+H +FK
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 84/332 (25%), Positives = 135/332 (40%), Gaps = 54/332 (16%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
           RY +  +I +G +G V +A+D +  + V +K   I+   +   +    EV LL+ + KH+
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHD 92
Query: 60  N-----IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                 IV L       + + LVFE L ++L   ++       +    +K+  Q+   + 
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 115 YCHSQE--ILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           +  + E  I+H DLKP N L+ +  +  +KI DFG +  +   +        S  Y++PE
Sbjct: 153 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI---QSRFYRSPE 209
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXX 231
            LLG   Y   +D+W++ C   EM T + LF        +  I  ++G P +  L     
Sbjct: 210 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 268
Query: 232 XXXXXXXXP----NRSPIKD----------------LATVVGGLEPDG------------ 259
                   P    N    KD                L    GG  P G            
Sbjct: 269 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG--PGGRRAGESGHTVAD 326
Query: 260 ----VDLLRRMLCLDPSKRLTAREALRHEYFK 287
                DL+ RML  DP  R+    AL+H +FK
Sbjct: 327 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 358

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 133/325 (40%), Gaps = 46/325 (14%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++  + EG +G V    D   G + V  KI I N  +   ++ + E+++LK++K ++
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-IRNVGKYREAARL-EINVLKKIKEKD 77
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGV 113
                  V + +  +    + + FE L  +   F+K E      PL  ++   +Q+ H +
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK-ENNFQPYPLPHVRHMAYQLCHAL 136
Query: 114 AYCHSQEILHRDLKPANFLIDRSK------------------DIVKIADFGLARPIDVPL 155
            + H  ++ H DLKP N L   S+                    +++ADFG A       
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDH 193
Query: 156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
           E++T    +  Y+ PE +L  G ++ P DVW++ C   E      LF +      L  + 
Sbjct: 194 EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 216 SIMGTPDSETLPXXXXXXXXXX--------------XXPNRSPIKDLATVVGGLEPDGVD 261
            I+G   S  +                            N  P+K              D
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 262 LLRRMLCLDPSKRLTAREALRHEYF 286
           L+RRML  DP++R+T  EAL H +F
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 133/325 (40%), Gaps = 46/325 (14%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++  + EG +G V    D   G + V  KI I N  +   ++ + E+++LK++K ++
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-IRNVGKYREAARL-EINVLKKIKEKD 86
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGV 113
                  V + +  +    + + FE L  +   F+K E      PL  ++   +Q+ H +
Sbjct: 87  KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK-ENNFQPYPLPHVRHMAYQLCHAL 145
Query: 114 AYCHSQEILHRDLKPANFLIDRSK------------------DIVKIADFGLARPIDVPL 155
            + H  ++ H DLKP N L   S+                    +++ADFG A       
Sbjct: 146 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDH 202
Query: 156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
           E++T    +  Y+ PE +L  G ++ P DVW++ C   E      LF +      L  + 
Sbjct: 203 EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 261
Query: 216 SIMGTPDSETLPXXXXXXXXXX--------------XXPNRSPIKDLATVVGGLEPDGVD 261
            I+G   S  +                            N  P+K              D
Sbjct: 262 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 321
Query: 262 LLRRMLCLDPSKRLTAREALRHEYF 286
           L+RRML  DP++R+T  EAL H +F
Sbjct: 322 LMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L E I  G +G V           V VK      P + + +  ++E  +LK+  H NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIV 175
Query: 63  RLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQI---LHGVAYCHS 118
           RL+ V +    I +V E +   D L F++TE       L++K  L  +     G+ Y  S
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLES 231
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG----SLCYKAPERLL 174
           +  +HRDL   N L+   K+++KI+DFG++R  +     Y   GG     + + APE  L
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPE-AL 287
Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
             GRYS+  DVW+      E  +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 133/325 (40%), Gaps = 46/325 (14%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++  + EG +G V    D   G + V  KI I N  +   ++ + E+++LK++K ++
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-IRNVGKYREAARL-EINVLKKIKEKD 109
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGV 113
                  V + +  +    + + FE L  +   F+K E      PL  ++   +Q+ H +
Sbjct: 110 KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK-ENNFQPYPLPHVRHMAYQLCHAL 168
Query: 114 AYCHSQEILHRDLKPANFLIDRSK------------------DIVKIADFGLARPIDVPL 155
            + H  ++ H DLKP N L   S+                    +++ADFG A       
Sbjct: 169 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDH 225
Query: 156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
           E++T    +  Y+ PE +L  G ++ P DVW++ C   E      LF +      L  + 
Sbjct: 226 EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 284
Query: 216 SIMGTPDSETLPXXXXXXXXXX--------------XXPNRSPIKDLATVVGGLEPDGVD 261
            I+G   S  +                            N  P+K              D
Sbjct: 285 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 344
Query: 262 LLRRMLCLDPSKRLTAREALRHEYF 286
           L+RRML  DP++R+T  EAL H +F
Sbjct: 345 LMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +E+I  G +G V +A   + G T V+K++   N          REV  L +L H NI
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNI 66
Query: 62  VRLLNV-------------QSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKK 104
           V                   SS      +F  ++F     L  +++       + +   +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 105 YLHQILHGVAYCHSQEILHRDLKPAN-FLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
              QI  GV Y HS+++++RDLKP+N FL+D  +  VKI DFGL   +    +    K G
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRXRSK-G 183
Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
           +L Y +PE+ + S  Y   VD++A+    AE++
Sbjct: 184 TLRYMSPEQ-ISSQDYGKEVDLYALGLILAELL 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 23  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 83  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 142 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIEGR-XHDEKVDLWSL 197
Query: 189 ACTFAEMV 196
                E +
Sbjct: 198 GVLCYEFL 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 22  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 82  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 141 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 196
Query: 189 ACTFAEMV 196
                E +
Sbjct: 197 GVLCYEFL 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMV 196
                E +
Sbjct: 196 GVLCYEFL 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EG +G V    +   +  TG+ V VK +   +      S   +E+ +L+ L HE+I++  
Sbjct: 41  EGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 66  NV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
                +   S+ LV E +    L       ++    L +  +  QI  G+AY H+Q  +H
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQHYIH 157
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPERLLGSGRYST 181
           RDL   N L+D  + +VKI DFGLA+ +    E Y ++  G S  +      L   ++  
Sbjct: 158 RDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYY 216
Query: 182 PVDVWAVACTFAEMVTH 198
             DVW+   T  E++TH
Sbjct: 217 ASDVWSFGVTLYELLTH 233

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 17  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 76
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 77  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 135
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 136 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 191
Query: 189 ACTFAEMV 196
                E +
Sbjct: 192 GVLCYEFL 199

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 22  KGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 82  HDATRVYLILEYAPLGTV-YRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 141 ENLLLGSNGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 196
Query: 189 ACTFAEMV 196
                E +
Sbjct: 197 GVLCYEFL 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/324 (23%), Positives = 129/324 (39%), Gaps = 44/324 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++  + EG +G V +  D   G   V  KI  +   E    +   E+++L+++  ++
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKI--IKNVEKYKEAARLEINVLEKINEKD 91
Query: 61  ------IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                  V++ +       + + FE L      F+K    +     +++    Q+   V 
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVK 151
Query: 115 YCHSQEILHRDLKPANFL-----------IDRSKD-------IVKIADFGLARPIDVPLE 156
           + H  ++ H DLKP N L           +++ +D        V++ DFG A       E
Sbjct: 152 FLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA---TFDHE 208
Query: 157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
           +++    +  Y+APE +L  G +S P DVW++ C   E      LF +      LA +  
Sbjct: 209 HHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 267
Query: 217 IMGTPDSET--------------LPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDL 262
           I+G   S                L              N  P++   T          DL
Sbjct: 268 ILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDL 327
Query: 263 LRRMLCLDPSKRLTAREALRHEYF 286
           +  ML  +P+KRLT  EAL+H +F
Sbjct: 328 IESMLEYEPAKRLTLGEALQHPFF 351

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 23  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 83  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 142 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 197
Query: 189 ACTFAEMV 196
                E +
Sbjct: 198 GVLCYEFL 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMV 196
                E +
Sbjct: 196 GVLCYEFL 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L E I  G +G V           V VK      P + + +  ++E  +LK+  H NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIV 175
Query: 63  RLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQI---LHGVAYCHS 118
           RL+ V +    I +V E +   D L F++TE       L++K  L  +     G+ Y  S
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLES 231
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAPERLLGS 176
           +  +HRDL   N L+   K+++KI+DFG++R     V   +  ++   + + APE  L  
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE-ALNY 289
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
           GRYS+  DVW+      E  +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 33/280 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A +  TG  V VKK+ +          +  EV ++++  H+N+V + + 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++Y H+Q ++HRD+K
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+  S   +K++DFG    +   +       G+  + APE ++    Y T VD+W+
Sbjct: 169 SDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWS 226
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EM+                      G P     P            P R  +KD
Sbjct: 227 LGIMVIEMID---------------------GEPPYFNEPPLQAMRRIRDSLPPR--VKD 263
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           L  V   L       L  ML  +PS+R TA+E L H + K
Sbjct: 264 LHKVSSVLR----GFLDLMLVREPSQRATAQELLGHPFLK 299

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + +LE + EG YG+V++A    TG  V +K++P+    E     +I+E+S++++    ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPHV 86
Query: 62  VRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           V+          + +V E        D++       T+T++  +I   L   L G+ Y H
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTED--EIATILQSTLKGLEYLH 142
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
               +HRD+K  N L++ ++   K+ADFG+A  +   +       G+  + APE +   G
Sbjct: 143 FMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 178 RYSTPVDVWAVACTFAEMV 196
            Y+   D+W++  T  EM 
Sbjct: 202 -YNCVADIWSLGITAIEMA 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHD----SLTGDTVVVKKIPIMNPS----------------- 39
           +YTL + I +G YG V  A++    +     V+ KK  I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 40  ---EGVPSSVIREVSLLKELKHENIVRLLNV--QSSVDSIDLVFENLDFDLLHFMKTEPT 94
               G    V +E+++LK+L H N+V+L+ V    + D + +VFE ++   +  + T   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 95  VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--- 151
           ++++  +   Y   ++ G+ Y H Q+I+HRD+KP+N L+     I KIADFG++      
Sbjct: 134 LSEDQARF--YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI-KIADFGVSNEFKGS 190
Query: 152 DVPLENYTIKGGSLCYKAPERLLGSGRY--STPVDVWAVACTFAEMVTHQRLF 202
           D  L N     G+  + APE L  + +      +DVWA+  T    V  Q  F
Sbjct: 191 DALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 80
Query: 59  ENIVRLLNVQ--------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 81  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 131
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++        +
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 191 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +      + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 15  KGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 74
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 75  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 134 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 189
Query: 189 ACTFAEMV 196
                E +
Sbjct: 190 GVLCYEFL 197

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 79  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +     P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 138 ENLLLGSAGEL-KIADFGWS--CHAPSSRRTTLSGTLDYLPPEMIEGR-MHDEKVDLWSL 193
Query: 189 ACTFAEMV 196
                E +
Sbjct: 194 GVLCYEFL 201

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 95/196 (48%), Gaps = 6/196 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 44  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 104 HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 163 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 218
Query: 189 ACTFAEMVTHQRLFHS 204
                E +  +  F +
Sbjct: 219 GVLCYEFLVGKPPFEA 234

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 70
Query: 59  ENIVRLLNVQ--------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 71  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 121
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++        +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 181 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 210

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 74
Query: 59  ENIVRLLNVQ--------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 75  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 125
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++        +
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 185 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 70
Query: 59  ENIVRLLNVQ--------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 71  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 121
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++        +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 181 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 35  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 94
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 95  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 153
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 154 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 209
Query: 189 ACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDL 248
                               G+L   F ++G P     P             +R      
Sbjct: 210 --------------------GVLCYEF-LVGKP-----PFEANTYQETYKRISRVEFTFP 243
Query: 249 ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
             V  G      DL+ R+L  +PS+R   RE L H +
Sbjct: 244 DFVTEG----ARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 74
Query: 59  ENIVRLLNVQ--------SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 75  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 125
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++        +
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 185 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 214

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 41/299 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI----MNPS--EGVPSSVIREVSLLK 54
           +Y   +VI  G    V R     TG    VK + +    ++P   E V  +  RE  +L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 55  ELK-HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           ++  H +I+ L++   S   + LVF+ +    L    TE  V  +  + +  +  +L  V
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAV 213
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           ++ H+  I+HRDLKP N L+D +  I +++DFG +  ++ P E      G+  Y APE L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQI-RLSDFGFSCHLE-PGEKLRELCGTPGYLAPEIL 271
Query: 174 LGSGR-----YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
             S       Y   VD+WA       ++     F   W    +  +  IM      + P 
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF---WHRRQILMLRMIMEGQYQFSSPE 328
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                             D ++ V        DL+ R+L +DP  RLTA +AL+H +F+
Sbjct: 329 ----------------WDDRSSTVK-------DLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 23  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 83  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 142 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 197
Query: 189 ACTFAEMV 196
                E +
Sbjct: 198 GVLCYEFL 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 79  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 138 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 193
Query: 189 ACTFAEMV 196
                E +
Sbjct: 194 GVLCYEFL 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIA+FG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMV 196
                E +
Sbjct: 196 GVLCYEFL 203

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 111/248 (44%), Gaps = 33/248 (13%)
Query: 42  VPSSVIR-EVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL 100
           V   ++R E+ +L  L H NI++L  +  +   I LV E +    L F +       +  
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL-FDRIVEKGYYSER 148
Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDI-VKIADFGLARPIDVPLENY 158
                + QIL  VAY H   I+HRDLKP N L    + D  +KIADFGL++ ++  +   
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVA-CTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
           T+  G+  Y APE L G   Y   VD+W+V   T+  +   +  +  R    +   I + 
Sbjct: 209 TV-CGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266
Query: 218 MGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
                                    SP  D  ++      +  DL+R+++ LDP KRLT 
Sbjct: 267 --------------------EYYFISPWWDEVSL------NAKDLVRKLIVLDPKKRLTT 300
Query: 278 REALRHEY 285
            +AL+H +
Sbjct: 301 FQALQHPW 308

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 20  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 80  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIA+FG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 139 ENLLLGSAGEL-KIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 194
Query: 189 ACTFAEMV 196
                E +
Sbjct: 195 GVLCYEFL 202

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 41/254 (16%)
Query: 45  SVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
           + ++EV +L+++  H NI++L +   +     LVF+ +    L    TE  VT +  + +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETR 127
Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           K +  +L  +   H   I+HRDLKP N L+D   +I K+ DFG +  +D P E      G
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI-KLTDFGFSCQLD-PGEKLRSVCG 185
Query: 164 SLCYKAPERLLGSGR-----YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-- 216
           +  Y APE +  S       Y   VD+W+       ++     F  R    +L  I S  
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 217 -IMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
              G+P+ +                      D +  V        DL+ R L + P KR 
Sbjct: 246 YQFGSPEWD----------------------DYSDTVK-------DLVSRFLVVQPQKRY 276
Query: 276 TAREALRHEYFKDF 289
           TA EAL H +F+ +
Sbjct: 277 TAEEALAHPFFQQY 290

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 115/293 (39%), Gaps = 48/293 (16%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVV---VKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           +  +EV+  G +  V      LTG       +KK P    S     S+  E+++LK++KH
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-----SLENEIAVLKKIKH 65
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           ENIV L ++  S     LV + +   +L   +      T+    +   + Q+L  V Y H
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAVKYLH 123
Query: 118 SQEILHRDLKPAN--FLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPER 172
              I+HRDLKP N  +L       + I DFGL++     +E   I     G+  Y APE 
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-----MEQNGIMSTACGTPGYVAPE- 177
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXX 232
           +L    YS  VD W++                    G++  I      P  E        
Sbjct: 178 VLAQKPYSKAVDCWSI--------------------GVITYILLCGYPPFYEETESKLFE 217
Query: 233 XXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                     SP  D       +     D +  +L  DP++R T  +AL H +
Sbjct: 218 KIKEGYYEFESPFWD------DISESAKDFICHLLEKDPNERYTCEKALSHPW 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMV 196
                E +
Sbjct: 196 GVLCYEFL 203

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS---VIREVSLLKELKHE 59
           TL E+I  G +G V+RA     GD V VK     +P E +  +   V +E  L   LKH 
Sbjct: 10  TLEEIIGIGGFGKVYRAF--WIGDEVAVKAAR-HDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI+ L  V     ++ LV E      L+ + +   +   P  +  +  QI  G+ Y H +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNWAVQIARGMNYLHDE 124
Query: 120 EI---LHRDLKPANFLI-------DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
            I   +HRDLK +N LI       D S  I+KI DFGLAR  +          G+  + A
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWMA 182
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
           PE +  S  +S   DVW+      E++T +  F  
Sbjct: 183 PEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 41/254 (16%)
Query: 45  SVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
           + ++EV +L+++  H NI++L +   +     LVF+ +    L    TE  VT +  + +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETR 127
Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           K +  +L  +   H   I+HRDLKP N L+D   +I K+ DFG +  +D P E      G
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI-KLTDFGFSCQLD-PGEKLREVCG 185
Query: 164 SLCYKAPERLLGSGR-----YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-- 216
           +  Y APE +  S       Y   VD+W+       ++     F  R    +L  I S  
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 217 -IMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
              G+P+ +                      D +  V        DL+ R L + P KR 
Sbjct: 246 YQFGSPEWD----------------------DYSDTVK-------DLVSRFLVVQPQKRY 276
Query: 276 TAREALRHEYFKDF 289
           TA EAL H +F+ +
Sbjct: 277 TAEEALAHPFFQQY 290

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMV 196
                E +
Sbjct: 196 GVLCYEFL 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 144 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 199
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 200 VWAFGVLLWEIATY 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 23  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 83  HDATRVYLILEYAPRGEV-YKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P    T   G+L Y  PE + G   +   VD+W++
Sbjct: 142 ENLLLGSAGEL-KIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 197
Query: 189 ACTFAEMV 196
                E +
Sbjct: 198 GVLCYEFL 205

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 41/254 (16%)
Query: 45  SVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
           + ++EV +L+++  H NI++L +   +     LVF+ +    L    TE  VT +  + +
Sbjct: 56  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETR 114
Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           K +  +L  +   H   I+HRDLKP N L+D   +I K+ DFG +  +D P E      G
Sbjct: 115 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI-KLTDFGFSCQLD-PGEKLREVCG 172
Query: 164 SLCYKAPERLLGSGR-----YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-- 216
           +  Y APE +  S       Y   VD+W+       ++     F  R    +L  I S  
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 232
Query: 217 -IMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
              G+P+ +                      D +  V        DL+ R L + P KR 
Sbjct: 233 YQFGSPEWD----------------------DYSDTVK-------DLVSRFLVVQPQKRY 263
Query: 276 TAREALRHEYFKDF 289
           TA EAL H +F+ +
Sbjct: 264 TAEEALAHPFFQQY 277

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 78  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMV 196
                E +
Sbjct: 193 GVLCYEFL 200

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHENIVRL 64
           EG +G V    +   +  TG+ V VK +     P     S   +E+ +L+ L HE+I++ 
Sbjct: 24  EGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH--RSGWKQEIDILRTLYHEHIIKY 81
Query: 65  LNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                     S+ LV E +    L       ++    L +  +  QI  G+AY HSQ  +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHSQHYI 139
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRY 179
           HR+L   N L+D  + +VKI DFGLA+ +    E Y ++  G S + + APE  L   ++
Sbjct: 140 HRNLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKEYKF 197
Query: 180 STPVDVWAVACTFAEMVTH 198
               DVW+   T  E++TH
Sbjct: 198 YYASDVWSFGVTLYELLTH 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 124/285 (43%), Gaps = 52/285 (18%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 18  KGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS++++HRD+KP
Sbjct: 78  HDSTRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 137 ENLLLGSAGEL-KIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGR-MHDEKVDLWSL 192
Query: 189 ACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDL 248
                               G+L   F ++G P  E                  +  +D 
Sbjct: 193 --------------------GVLCYEF-LVGKPPFEA-----------------NTYQDT 214
Query: 249 ATVVGGLE---PDGV-----DLLRRMLCLDPSKRLTAREALRHEY 285
              +  +E   PD V     DL+ R+L  +PS+R   RE L H +
Sbjct: 215 YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 22  KGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 82  HDATRVYLILEYAPLGTV-YRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 141 ENLLLGSNGEL-KIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 196
Query: 189 ACTFAEMV 196
                E +
Sbjct: 197 GVLCYEFL 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 46/259 (17%)
Query: 40  EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPT 94
           E     +  E+SLLK L H NI++L +V        LV E      L   +++  K +  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 95  VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI--VKIADFGLARPID 152
              N +K      QIL G+ Y H   I+HRD+KP N L++    +  +KI DFGL+    
Sbjct: 147 DAANIMK------QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 153 VPLENYTIKG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL 210
              ++Y ++   G+  Y APE L    +Y+   DVW+                      +
Sbjct: 201 ---KDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMY----------------I 239
Query: 211 LAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLD 270
           L   +   G  + + +              +   I D A           +L++ ML  D
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK----------ELIKLMLTYD 289
Query: 271 PSKRLTAREALRHEYFKDF 289
            +KR TA EAL   + K +
Sbjct: 290 YNKRCTAEEALNSRWIKKY 308

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 79  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 138 ENLLLGSAGEL-KIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGR-MHDEKVDLWSL 193
Query: 189 ACTFAEMV 196
                E +
Sbjct: 194 GVLCYEFL 201

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---------IMNPSEGVPSSVIREVS 51
           +Y+ +  +  G +G V  A D      VVVK I          I +P  G    V  E++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG---KVTLEIA 81
Query: 52  LLKELKHENIVRLLNVQSSVDSIDLVFE--NLDFDLLHFMKTEPTVTKNPLKIKKYLHQI 109
           +L  ++H NI+++L++  +     LV E      DL  F+   P + + PL       Q+
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-PLA-SYIFRQL 139
Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           +  V Y   ++I+HRD+K  N +I     I K+ DFG A  ++     YT   G++ Y A
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTI-KLIDFGSAAYLERGKLFYTF-CGTIEYCA 197
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE L+G+      +++W++  T   +V  +  F
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 20  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 80  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 139 ENLLLGSAGEL-KIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGR-MHDEKVDLWSL 194
Query: 189 ACTFAEMV 196
                E +
Sbjct: 195 GVLCYEFL 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 44/303 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L EVI  G    V  A+ +   + V +K+I  +   +     +++E+  + +  H NI
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
           V         D + LV + L      D++  +  +       L    I   L ++L G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFG----LARPIDVPLENYTIKG--GSLCYK 168
           Y H    +HRD+K  N L+      V+IADFG    LA   D+   N   K   G+ C+ 
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLATGGDIT-RNKVRKTFVGTPCWM 193
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE +     Y    D+W+   T  E+ T    +H    P +   + ++   P S     
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY--PPMKVLMLTLQNDPPS----- 246
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRM--LCL--DPSKRLTAREALRHE 284
                       ++  +K                 R+M  LCL  DP KR TA E LRH+
Sbjct: 247 ------LETGVQDKEMLKKYGKS-----------FRKMISLCLQKDPEKRPTAAELLRHK 289
Query: 285 YFK 287
           +F+
Sbjct: 290 FFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 44/303 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y L EVI  G    V  A+ +   + V +K+I  +   +     +++E+  + +  H NI
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
           V         D + LV + L      D++  +  +       L    I   L ++L G+ 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFG----LARPIDVPLENYTIKG--GSLCYK 168
           Y H    +HRD+K  N L+      V+IADFG    LA   D+   N   K   G+ C+ 
Sbjct: 131 YLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLATGGDIT-RNKVRKTFVGTPCWM 188
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPX 228
           APE +     Y    D+W+   T  E+ T    +H    P +   + ++   P S     
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY--PPMKVLMLTLQNDPPS----- 241
Query: 229 XXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRM--LCL--DPSKRLTAREALRHE 284
                       ++  +K                 R+M  LCL  DP KR TA E LRH+
Sbjct: 242 ------LETGVQDKEMLKKYGKS-----------FRKMISLCLQKDPEKRPTAAELLRHK 284
Query: 285 YFK 287
           +F+
Sbjct: 285 FFQ 287

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 144 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 199
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 200 VWAFGVLLWEIATY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK +    M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 140
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 141 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 196
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 197 VWAFGVLLWEIATY 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G++G V  A  +    T V   +  M P      + + E +++K L+H+ +V+L  V + 
Sbjct: 193 GQFGEVWMA--TYNKHTKVA--VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 71  VDSIDLVFENL-DFDLLHFMKTEPTVTKNPL-KIKKYLHQILHGVAYCHSQEILHRDLKP 128
            + I ++ E +    LL F+K++   +K PL K+  +  QI  G+A+   +  +HRDL+ 
Sbjct: 249 -EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 306
Query: 129 ANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
           AN L+  S  + KIADFGLAR     P++          + APE  +  G ++   DVW+
Sbjct: 307 ANILVSASL-VCKIADFGLARVGAKFPIK----------WTAPE-AINFGSFTIKSDVWS 354
Query: 188 VACTFAEMVTHQRL 201
                 E+VT+ R+
Sbjct: 355 FGILLMEIVTYGRI 368

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 144 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 199
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 200 VWAFGVLLWEIATY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 82
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 142
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 143 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 198
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 199 VWAFGVLLWEIATY 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVP----SSVIREVSLLKELKHENI 61
           EG +G V    +   +  TG+ V VK +      EG      S   RE+ +L+ L HE+I
Sbjct: 18  EGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 62  VRLLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           V+           S+ LV E +    L        V    L +  +  QI  G+AY H+Q
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQ 130
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGS 176
             +HR L   N L+D  + +VKI DFGLA+ +    E Y ++  G S + + APE  L  
Sbjct: 131 HYIHRALAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKE 188
Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++    DVW+   T  E++T+
Sbjct: 189 CKFYYASDVWSFGVTLYELLTY 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 91
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 151
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 152 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 207
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 208 VWAFGVLLWEIATY 221

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EG +G V    +   +  TG+ V VK +        + S   RE+ +L+ L HE+IV+  
Sbjct: 19  EGHFGKVSLYCYDPTNDGTGEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYK 77
Query: 66  NV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
                    S+ LV E +    L        V    L +  +  QI  G+AY H+Q  +H
Sbjct: 78  GCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQHYIH 135
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRYS 180
           R L   N L+D  + +VKI DFGLA+ +    E Y ++  G S + + APE  L   ++ 
Sbjct: 136 RALAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKECKFY 193
Query: 181 TPVDVWAVACTFAEMVTH 198
              DVW+   T  E++T+
Sbjct: 194 YASDVWSFGVTLYELLTY 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 140
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 141 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 196
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 197 VWAFGVLLWEIATY 210

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 92/341 (26%), Positives = 128/341 (37%), Gaps = 82/341 (24%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIR---EVSLLK 54
           +Y L   I +G YG V  A   +   T  ++ I IMN +   +  P  V R   EV L+K
Sbjct: 27  KYHLKGAIGQGSYGVVRVA---IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 55  ELKHENIVRLLNVQSSVDSIDLVFE-----------NLDFD------LLHFMKTE--PTV 95
           +L H NI RL  V      I LV E           N+  D       +  +KT+  P  
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 96  TKNPLKIKKYLH--------------------QILHGVAYCHSQEILHRDLKPANFLIDR 135
             N   I   +H                    QI   + Y H+Q I HRD+KP NFL   
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 136 SKDI-VKIADFGLARPIDVPLEN-----YTIKGGSLCYKAPERLLGSGR-YSTPVDVWAV 188
           +K   +K+ DFGL++     L N      T K G+  + APE L  +   Y    D W+ 
Sbjct: 204 NKSFEIKLVDFGLSKEF-YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 189 ACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDL 248
                       L H      LL       G  D++T+             PN + +  L
Sbjct: 263 GV----------LLHL-----LLMGAVPFPGVNDADTIS-QVLNKKLCFENPNYNVLSPL 306
Query: 249 ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           A           DLL  +L  +  +R  A  AL+H +   F
Sbjct: 307 AR----------DLLSNLLNRNVDERFDAMRALQHPWISQF 337

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 139
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 140 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPES-LAYNKFSIKSD 195
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 196 VWAFGVLLWEIATY 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 114/279 (40%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 89
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 148 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 205
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 206 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 242
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V     P     L R+L  DP++R TA E L+H + 
Sbjct: 243 LHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 85
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 144 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 201
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 202 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 238
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V   L+      L R+L  DP++R TA E L+H + 
Sbjct: 239 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 140
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 141 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPES-LAYNKFSIKSD 196
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 197 VWAFGVLLWEIATY 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 6/196 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 21  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 81  HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 140 ENLLLGSAGEL-KIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 195
Query: 189 ACTFAEMVTHQRLFHS 204
                E +  +  F +
Sbjct: 196 GVLCYEFLVGKPPFEA 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 94
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 153 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 210
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 211 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 247
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V   L+      L R+L  DP++R TA E L+H + 
Sbjct: 248 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           ++ +  G +G V  A + +      +K+I + N  E     V+REV  L +L+H  IVR 
Sbjct: 10  IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRY 68
Query: 65  LN----------VQSSVDSIDLVFENL---DFDLLHFMKTEPTVTKNPLKIKKYLH-QIL 110
            N          +Q S   + L  +       +L  +M    T+ +    +  ++  QI 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 111 HGVAYCHSQEILHRDLKPAN--FLIDRSKDIVKIADFGLARPIDVPLENYTI-------- 160
             V + HS+ ++HRDLKP+N  F +D   D+VK+ DFGL   +D   E  T+        
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 161 ----KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMV 196
               + G+  Y +PE++ G+  YS  VD++++     E++
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 96
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 155 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 212
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 213 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 249
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V   L+      L R+L  DP++R TA E L+H + 
Sbjct: 250 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 10  EGRYGAV----HRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHENIVRL 64
           EG +G V    +   +  TG+ V VK +     P     S   +E+ +L+ L HE+I++ 
Sbjct: 24  EGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH--RSGWKQEIDILRTLYHEHIIKY 81
Query: 65  LNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
                     S+ LV E +    L       ++    L +  +  QI  G+AY H+Q  +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQHYI 139
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRY 179
           HR+L   N L+D  + +VKI DFGLA+ +    E Y ++  G S + + APE  L   ++
Sbjct: 140 HRNLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKEYKF 197
Query: 180 STPVDVWAVACTFAEMVTH 198
               DVW+   T  E++TH
Sbjct: 198 YYASDVWSFGVTLYELLTH 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 139
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 198 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 255
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 256 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 292
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V   L+      L R+L  DP++R TA E L+H + 
Sbjct: 293 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 80
Query: 59  ENIVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 81  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 131
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++  ++        +
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 191 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 220

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 20/191 (10%)
Query: 26  DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-D 84
           D ++V    + + S+       RE  LL  L+HE+IV+   V    D + +VFE +   D
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 85  LLHFMKTEP-----TVTKNP---LKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLI 133
           L  F++            NP   L   + LH   QI  G+ Y  SQ  +HRDL   N L+
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161
Query: 134 DRSKDIVKIADFGLARPIDVPLENYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVA 189
             +  +VKI DFG++R  DV   +Y   GG     + +  PE ++   +++T  DVW++ 
Sbjct: 162 GENL-LVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLG 217
Query: 190 CTFAEMVTHQR 200
               E+ T+ +
Sbjct: 218 VVLWEIFTYGK 228

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I   + SE      I E  ++ +L H  +V
Sbjct: 30  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIKEGSMSE---DDFIEEAEVMMKLSHPKLV 85
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LVFE ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACV 144
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 145 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 200
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKI 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 6/188 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 23  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 83  HDATRVYLILEYAPRGEV-YKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 142 ENLLLGSAGEL-KIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEGR-MHDEKVDLWSL 197
Query: 189 ACTFAEMV 196
                E +
Sbjct: 198 GVLCYEFL 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 6/196 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   + +K +        GV   + REV +   L+H NI+RL    
Sbjct: 44  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                + L+ E      + + + +     +  +   Y+ ++ + ++YCHS+ ++HRD+KP
Sbjct: 104 HDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+  + ++ KIADFG +  +  P        G+L Y  PE + G   +   VD+W++
Sbjct: 163 ENLLLGSAGEL-KIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEGR-MHDEKVDLWSL 218
Query: 189 ACTFAEMVTHQRLFHS 204
                E +  +  F +
Sbjct: 219 GVLCYEFLVGKPPFEA 234

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 4   LLEVIREGRYGAVHRAH-DSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELKH 58
           LLE + +G +G V R   D+ +G TV V     K  +++  E +    IREV+ +  L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDH 70
Query: 59  ENIVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
            N++RL  V         + +  +  + + L     HF+            + +Y  Q+ 
Sbjct: 71  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQVA 121
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCY 167
            G+ Y  S+  +HRDL   N L+  ++D+VKI DFGL R +    ++  ++        +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            APE  L +  +S   D W    T  EM T+
Sbjct: 181 CAPES-LKTRTFSHASDTWMFGVTLWEMFTY 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I     SE      I E  ++ +L H  +V
Sbjct: 10  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLV 65
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LVFE ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEASV 124
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 125 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 180
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELKH 58
           + + E +  G +G V R     TG+ V +K+       E  P +  R   E+ ++K+L H
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 71
Query: 59  ENIVRLLNVQSSVDSI---DLVFENLDF----DLLHFMKT-EPTVTKNPLKIKKYLHQIL 110
            N+V    V   +  +   DL    +++    DL  ++   E         I+  L  I 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
             + Y H   I+HRDLKP N ++       I KI D G A+ +D   E  T   G+L Y 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYL 190
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP 208
           APE LL   +Y+  VD W+      E +T  R F   W P
Sbjct: 191 APE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 7/188 (3%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  ++ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 27  GNGGVVTKVQHRPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 85
Query: 71  VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPA 129
              I +  E++D   L  +  E       + + K    +L G+AY   + +I+HRD+KP+
Sbjct: 86  DGEISICMEHMDGGSLDQVLKEAKRIPEEI-LGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 130 NFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVA 189
           N L++ S+  +K+ DFG++  +   + N  +  G+  Y APERL G+  YS   D+W++ 
Sbjct: 145 NILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMAPERLQGT-HYSVQSDIWSMG 200
Query: 190 CTFAEMVT 197
            +  E+  
Sbjct: 201 LSLVELAV 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELKH 58
           + + E +  G +G V R     TG+ V +K+       E  P +  R   E+ ++K+L H
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 72
Query: 59  ENIVRLLNVQSSVDSI---DLVFENLDF----DLLHFMKT-EPTVTKNPLKIKKYLHQIL 110
            N+V    V   +  +   DL    +++    DL  ++   E         I+  L  I 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
             + Y H   I+HRDLKP N ++       I KI D G A+ +D   E  T   G+L Y 
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYL 191
Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP 208
           APE LL   +Y+  VD W+      E +T  R F   W P
Sbjct: 192 APE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 37/281 (13%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A +  +G  V VK + +          +  EV ++++ +H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               + + ++ E L    L  + ++  V  N  +I      +L  +AY H+Q ++HRD+K
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 128 PANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDV 185
             + L+      VK++DFG    I  DVP     +  G+  + APE ++    Y+T VD+
Sbjct: 169 SDSILLTLDGR-VKLSDFGFCAQISKDVPKRKXLV--GTPYWMAPE-VISRSLYATEVDI 224
Query: 186 WAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPI 245
           W++     EMV  +  + S                 DS   P            P     
Sbjct: 225 WSLGIMVIEMVDGEPPYFS-----------------DS---PVQAMKRLRDSPPPKLKNS 264
Query: 246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             ++ V+        D L RML  DP +R TA+E L H + 
Sbjct: 265 HKVSPVLR-------DFLERMLVRDPQERATAQELLDHPFL 298

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMN--PSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           EG +G V++ +  +   TV VKK+  M    +E +     +E+ ++ + +HEN+V LL  
Sbjct: 41  EGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 68  QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQE 120
            S  D + LV+  +      D L  +   P     PL      K      +G+ + H   
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-----PLSWHMRCKIAQGAANGINFLHENH 153
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGR 178
            +HRD+K AN L+D +    KI+DFGLAR  +   +        G+  Y APE L   G 
Sbjct: 154 HIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGE 210
Query: 179 YSTPVDVWAVACTFAEMVT 197
            +   D+++      E++T
Sbjct: 211 ITPKSDIYSFGVVLLEIIT 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I EG  G V  A    +G  V VKK+ +          +  EV ++++ +HEN+V + N 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYNS 216
Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
               D + +V E L+   L  + T   +  N  +I      +L  ++  H+Q ++HRD+K
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTRM--NEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWA 187
             + L+      VK++DFG    +   +       G+  + APE L+    Y   VD+W+
Sbjct: 275 SDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWS 332
Query: 188 VACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKD 247
           +     EMV                      G P     P            P R  +K+
Sbjct: 333 LGIMVIEMVD---------------------GEPPYFNEPPLKAMKMIRDNLPPR--LKN 369
Query: 248 LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           L  V   L+      L R+L  DP++R TA E L+H + 
Sbjct: 370 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 78/265 (29%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           ++ +  G +G V  A + +      +K+I + N  E     V+REV  L +L+H  IVR 
Sbjct: 11  IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRY 69
Query: 65  LNV---------QSSVDSIDLVFENLDFDL----------LHFMKTEPTVTKN------P 99
            N          Q  +D I L  E+ D+ L          +   + +P  TKN      P
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 100 LKIKKYLH----------------------------------QILHGVAYCHSQEILHRD 125
              K YL+                                  QI   V + HS+ ++HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 126 LKPAN--FLIDRSKDIVKIADFGLARPIDVPLENYTI------------KGGSLCYKAPE 171
           LKP+N  F +D   D+VK+ DFGL   +D   E  T+            + G+  Y +PE
Sbjct: 190 LKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMV 196
           ++ G+  YS  VD++++     E++
Sbjct: 247 QIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKEL-KHEN 60
           +V+  G +G V  A       T V  ++ +    E   SS    ++ E+ ++ +L  HEN
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-------EPTVTKNPLKIKK-------- 104
           IV LL   +    I L+FE   + DLL+++++       +    +N  ++++        
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 105 ------YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
                 + +Q+  G+ +   +  +HRDL   N L+   K +VKI DFGLAR I +   NY
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDI-MSDSNY 228
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            ++G +   + + APE L   G Y+   DVW+      E+ +
Sbjct: 229 VVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFS 269

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMN--PSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           EG +G V++ +  +   TV VKK+  M    +E +     +E+ ++ + +HEN+V LL  
Sbjct: 41  EGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 68  QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQE 120
            S  D + LV+  +      D L  +   P     PL      K      +G+ + H   
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-----PLSWHMRCKIAQGAANGINFLHENH 153
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGR 178
            +HRD+K AN L+D +    KI+DFGLAR  +   +        G+  Y APE L   G 
Sbjct: 154 HIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGE 210
Query: 179 YSTPVDVWAVACTFAEMVT 197
            +   D+++      E++T
Sbjct: 211 ITPKSDIYSFGVVLLEIIT 229

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 144 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 199
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 200 VWAFGVLLWEIATY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMN--PSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           EG +G V++ +  +   TV VKK+  M    +E +     +E+ ++ + +HEN+V LL  
Sbjct: 35  EGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 68  QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQE 120
            S  D + LV+  +      D L  +   P     PL      K      +G+ + H   
Sbjct: 93  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-----PLSWHMRCKIAQGAANGINFLHENH 147
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGR 178
            +HRD+K AN L+D +    KI+DFGLAR  +   +        G+  Y APE L   G 
Sbjct: 148 HIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGE 204
Query: 179 YSTPVDVWAVACTFAEMVT 197
            +   D+++      E++T
Sbjct: 205 ITPKSDIYSFGVVLLEIIT 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 57/259 (22%)
Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPL 100
            + E  +L+++    +V L     + D++ LV       +L F + H  +      +   
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
               Y  +I  G+   H + I++RDLKP N L+D    I +I+D GLA  + VP E  TI
Sbjct: 291 ----YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHI-RISDLGLA--VHVP-EGQTI 342
Query: 161 KG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
           KG  G++ Y APE ++ + RY+   D WA+ C   EM+  Q  F  R             
Sbjct: 343 KGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR------------- 388
Query: 219 GTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVV-----GGLEPDGVDLLRRMLCLDPSK 273
                                  R  ++ L   V         P    L  ++LC DP++
Sbjct: 389 ------------------KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 274 RL-----TAREALRHEYFK 287
           RL     +ARE   H  FK
Sbjct: 431 RLGCRGGSAREVKEHPLFK 449

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 139 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 194
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 195 VWAFGVLLWEIATY 208

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I     SE      I E  ++ +L H  +V
Sbjct: 13  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLV 68
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LVFE ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACV 127
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 128 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 183
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +Y  KGG    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 195 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 10  EGRYGAVHRA--HDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A  H+ L   D ++V    +   SE       RE  LL  L+H++IVR   
Sbjct: 22  EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG 81
Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKTE----------PTVTKNPLKIKKYL---HQILHG 112
           V +    + +VFE +   DL  F+++             V   PL + + L    Q+  G
Sbjct: 82  VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 141
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKA 169
           + Y      +HRDL   N L+ +   +VKI DFG++R I    + Y + G ++    +  
Sbjct: 142 MVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMP 199
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
           PE +L   +++T  DVW+      E+ T+ +
Sbjct: 200 PESILYR-KFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 17  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 76
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 77  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +Y  KGG    
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIYETDYYRKGGKGLL 193
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 194 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 139
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    +  T   G+   + + APE  L   ++S   D
Sbjct: 140 ARNCLVGENH-LVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPES-LAYNKFSIKSD 195
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 196 VWAFGVLLWEIATY 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 10  EGRYGAVHRA--HDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A  H+ L   D ++V    +   SE       RE  LL  L+H++IVR   
Sbjct: 28  EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG 87
Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKTE----------PTVTKNPLKIKKYL---HQILHG 112
           V +    + +VFE +   DL  F+++             V   PL + + L    Q+  G
Sbjct: 88  VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 147
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKA 169
           + Y      +HRDL   N L+ +   +VKI DFG++R I    + Y + G ++    +  
Sbjct: 148 MVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMP 205
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
           PE +L   +++T  DVW+      E+ T+ +
Sbjct: 206 PESILYR-KFTTESDVWSFGVVLWEIFTYGK 235

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 10  EGRYGAVHRA--HDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           EG +G V  A  H+ L   D ++V    +   SE       RE  LL  L+H++IVR   
Sbjct: 51  EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG 110
Query: 67  VQSSVDSIDLVFENLDF-DLLHFMKTE----------PTVTKNPLKIKKYL---HQILHG 112
           V +    + +VFE +   DL  F+++             V   PL + + L    Q+  G
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKA 169
           + Y      +HRDL   N L+ +   +VKI DFG++R I    + Y + G ++    +  
Sbjct: 171 MVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMP 228
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
           PE +L   +++T  DVW+      E+ T+ +
Sbjct: 229 PESILYR-KFTTESDVWSFGVVLWEIFTYGK 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I     SE      I E  ++ +L H  +V
Sbjct: 10  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLV 65
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LVFE ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACV 124
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 125 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 180
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 57/259 (22%)
Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPL 100
            + E  +L+++    +V L     + D++ LV       +L F + H  +      +   
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
               Y  +I  G+   H + I++RDLKP N L+D    I +I+D GLA  + VP E  TI
Sbjct: 291 ----YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHI-RISDLGLA--VHVP-EGQTI 342
Query: 161 KG--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
           KG  G++ Y APE ++ + RY+   D WA+ C   EM+  Q  F  R             
Sbjct: 343 KGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR------------- 388
Query: 219 GTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVV-----GGLEPDGVDLLRRMLCLDPSK 273
                                  R  ++ L   V         P    L  ++LC DP++
Sbjct: 389 ------------------KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 274 RL-----TAREALRHEYFK 287
           RL     +ARE   H  FK
Sbjct: 431 RLGCRGGSAREVKEHPLFK 449

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 3   TLLEVIREGRYGAVHRAH-DSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHE 59
           T  +VI  G +G V++    + +G   V   I  +    +E      + E  ++ +  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI+RL  V S    + ++ E ++   L     E     + L++   L  I  G+ Y  + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGS 176
             +HRDL   N L++ S  + K++DFGL+R + D P   YT  GG +   + APE  +  
Sbjct: 167 NYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-AISY 224
Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++++  DVW+      E++T+
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTY 246

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I     SE      I E  ++ +L H  +V
Sbjct: 8   TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLV 63
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LVFE ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACV 122
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 123 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 178
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI 201

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           T+   +  G+YG V+         TV VK  K   M   E      ++E +++KE+KH N
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPN 316
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +V+LL V +      ++ E + + +LL +++       N + +     QI   + Y   +
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 376
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
             +HR+L   N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L  
Sbjct: 377 NFIHRNLAARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAY 432
Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++S   DVWA      E+ T+
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATY 454

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKELK 57
           Y L  ++ +G +G V   H       V +K IP        P S       EV+LL ++ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 58  ----HENIVRLLNVQSSVDSIDLVFENL--DFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
               H  ++RLL+   + +   LV E      DL  ++  +  + + P +   +  Q++ 
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC--FFGQVVA 150
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            + +CHS+ ++HRD+K  N LID  +   K+ DFG    +    E YT   G+  Y  PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPE 208
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     ++ P  VW++     +MV 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVC 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E+I +GR+G V+  H    G+ V ++ I I   +E    +  REV   ++ +HEN+V  +
Sbjct: 39  ELIGKGRFGQVY--HGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 66  NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRD 125
               S   + ++        L+ +  +  +  +  K ++   +I+ G+ Y H++ ILH+D
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 126 LKPANFLIDRSKDIVKIADFGLARPIDV-----PLENYTIKGGSLCYKAPE--RLLGSGR 178
           LK  N   D  K  V I DFGL     V       +   I+ G LC+ APE  R L    
Sbjct: 156 LKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 179 ------YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
                 +S   DV+A+   + E+  H R +  +  P    AI   MGT
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYEL--HAREWPFKTQPA--EAIIWQMGT 257

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       N + +     QI   + Y   +  +HRDL 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 143
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    +  T   G+   + + APE  L   ++S   D
Sbjct: 144 ARNCLVGENH-LVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPES-LAYNKFSIKSD 199
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 200 VWAFGVLLWEIATY 213

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 128/297 (43%), Gaps = 65/297 (21%)
Query: 22  SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN 80
           S  G  V VK++ I           + E+ LL E   H N++R    +++   + +  E 
Sbjct: 36  SFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90
Query: 81  LDFDLLHFMKTEPTVTKNPLKIKK------YLHQILHGVAYCHSQEILHRDLKPANFLID 134
            + +L   ++++  V+   LK++K       L QI  GVA+ HS +I+HRDLKP N L+ 
Sbjct: 91  CNLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 149
Query: 135 RSKDI------------VKIADFGLARPIDVPLENYTIK----GGSLCYKAPERLLGSG- 177
            S               + I+DFGL + +D    ++        G+  ++APE L  S  
Sbjct: 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN 209
Query: 178 -----RYSTPVDVWAVACTFAEMVTHQRL-FHSRWA--PGLLAAIFSIMGTPDSETLPXX 229
                R +  +D++++ C F  +++  +  F  +++    ++  IFS+            
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL------------ 257
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                      +RS I            +  DL+ +M+  DP KR TA + LRH  F
Sbjct: 258 ----DEMKCLHDRSLI-----------AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 61/293 (20%)
Query: 22  SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN 80
           S  G  V VK++ I           + E+ LL E   H N++R    +++   + +  E 
Sbjct: 54  SFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 108
Query: 81  LDFDLLHFMKTEPTVTKNPLKIKK------YLHQILHGVAYCHSQEILHRDLKPANFLID 134
            + +L   ++++  V+   LK++K       L QI  GVA+ HS +I+HRDLKP N L+ 
Sbjct: 109 CNLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 167
Query: 135 RSKDI------------VKIADFGLARPIDVPL----ENYTIKGGSLCYKAPERLLGSG- 177
            S               + I+DFGL + +D        N     G+  ++APE L  S  
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 178 -RYSTPVDVWAVACTFAEMVTHQRL-FHSRWA--PGLLAAIFSIMGTPDSETLPXXXXXX 233
            R +  +D++++ C F  +++  +  F  +++    ++  IFS+                
Sbjct: 228 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL---------------- 271
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  +RS I            +  DL+ +M+  DP KR TA + LRH  F
Sbjct: 272 DEMKCLHDRSLI-----------AEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 61/293 (20%)
Query: 22  SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN 80
           S  G  V VK++ I           + E+ LL E   H N++R    +++   + +  E 
Sbjct: 54  SFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 108
Query: 81  LDFDLLHFMKTEPTVTKNPLKIKK------YLHQILHGVAYCHSQEILHRDLKPANFLID 134
            + +L   ++++  V+   LK++K       L QI  GVA+ HS +I+HRDLKP N L+ 
Sbjct: 109 CNLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 167
Query: 135 RSKDI------------VKIADFGLARPIDVPL----ENYTIKGGSLCYKAPERLLGSG- 177
            S               + I+DFGL + +D        N     G+  ++APE L  S  
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 178 -RYSTPVDVWAVACTFAEMVTHQRL-FHSRWA--PGLLAAIFSIMGTPDSETLPXXXXXX 233
            R +  +D++++ C F  +++  +  F  +++    ++  IFS+                
Sbjct: 228 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL---------------- 271
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                  +RS I            +  DL+ +M+  DP KR TA + LRH  F
Sbjct: 272 DEMKCLHDRSLI-----------AEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 136
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + +T   G+   + + APE  L   ++S   D
Sbjct: 137 ARNCLVGENH-LVKVADFGLSRLMTG--DTFTAHAGAKFPIKWTAPES-LAYNKFSIKSD 192
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 193 VWAFGVLLWEIATY 206

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+    Y  KGG    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIYETAYYRKGGKGLL 194
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 195 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMN--PSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           EG +G V++ +  +   TV VKK+  M    +E +     +E+ +  + +HEN+V LL  
Sbjct: 32  EGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 68  QSSVDSIDLVF----ENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQE 120
            S  D + LV+         D L  +   P     PL      K      +G+ + H   
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-----PLSWHXRCKIAQGAANGINFLHENH 144
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGR 178
            +HRD+K AN L+D +    KI+DFGLAR  +   +        G+  Y APE L   G 
Sbjct: 145 HIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGE 201
Query: 179 YSTPVDVWAVACTFAEMVT 197
            +   D+++      E++T
Sbjct: 202 ITPKSDIYSFGVVLLEIIT 220

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E I  G +G VHRA     G  V VK +   +      +  +REV+++K L+H NIV  +
Sbjct: 43  EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 66  NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE- 120
              +   ++ +V E L     + LLH  K+      +  +     + +  G+ Y H++  
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 121 -ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            I+HRDLK  N L+D+ K  VK+ DFGL+R             G+  + APE +L     
Sbjct: 159 PIVHRDLKSPNLLVDK-KYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE-VLRDEPS 216
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI 214
           +   DV++      E+ T Q+ + +     ++AA+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 27  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 63  RLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYL---HQILHGVAYCHS 118
             +   S+   + +V +  +   L H +    T      ++KK +    Q   G+ Y H+
Sbjct: 84  LFMGY-STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHA 138
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +    + VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 139 KSIIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
            S  YS   DV+A      E++T Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM--KTEPTVTKN-- 98
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F+  K E  + K   
Sbjct: 87  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 146
Query: 99  -PLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP 154
            PL+++  LH   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLAR I + 
Sbjct: 147 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARDI-MN 204
Query: 155 LENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 205 DSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM--KTEPTVTKN-- 98
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F+  K E  + K   
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 154
Query: 99  -PLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP 154
            PL+++  LH   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLAR I + 
Sbjct: 155 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARDI-MN 212
Query: 155 LENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 213 DSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 42/288 (14%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T L+ I +G +G V++  D+ T + V +K I +    + +   + +E+++L +     I
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYI 79
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
            R          + ++ E L      DLL     E T       I   L +IL G+ Y H
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETY------IATILREILKGLDYLH 133
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S+  +HRD+K AN L+    D VK+ADFG+A  +           G+  + APE ++   
Sbjct: 134 SERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQS 191
Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXX 237
            Y    D+W++  T  E+   +                     P+S+  P          
Sbjct: 192 AYDFKADIWSLGITAIELAKGE--------------------PPNSDLHP-----MRVLF 226
Query: 238 XXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
             P  SP     T+ G       + +   L  DP  R TA+E L+H++
Sbjct: 227 LIPKNSP----PTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKF 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 36  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 94
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 95  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 152
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 153 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 208
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 209 GLSLVEMAV 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 19  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 78
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 79  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HR+L   N ++      VKI DFG+ R  D+   +Y  KGG    
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDF-TVKIGDFGMTR--DIYETDYYRKGGKGLL 195
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 196 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HR+L   N ++      VKI DFG+ R  D+   +Y  KGG    
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDF-TVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 195 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 65/297 (21%)
Query: 22  SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN 80
           S  G  V VK++ I           + E+ LL E   H N++R    +++   + +  E 
Sbjct: 36  SFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90
Query: 81  LDFDLLHFMKTEPTVTKNPLKIKK------YLHQILHGVAYCHSQEILHRDLKPANFLID 134
            + +L   ++++  V+   LK++K       L QI  GVA+ HS +I+HRDLKP N L+ 
Sbjct: 91  CNLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 149
Query: 135 RSKDI------------VKIADFGLARPIDVPL----ENYTIKGGSLCYKAPERLLGSG- 177
            S               + I+DFGL + +D        N     G+  ++APE L  S  
Sbjct: 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNN 209
Query: 178 -----RYSTPVDVWAVACTFAEMVTHQRL-FHSRWA--PGLLAAIFSIMGTPDSETLPXX 229
                R +  +D++++ C F  +++  +  F  +++    ++  IFS+            
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL------------ 257
Query: 230 XXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                      +RS I            +  DL+ +M+  DP KR TA + LRH  F
Sbjct: 258 ----DEMKCLHDRSLI-----------AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           EV+ +G +G   +     TG+ +V+K++  +   E    + ++EV +++ L+H N+++ +
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 66  NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK-KYLHQILHGVAYCHSQEILHR 124
            V      ++ + E +    L  +  +   ++ P   +  +   I  G+AY HS  I+HR
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGI-IKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 125 DLKPANFLIDRSKDIVKIADFGLAR-PIDVPLE--------------NYTIKGGSLCYKA 169
           DL   N L+  +K++V +ADFGLAR  +D   +               YT+ G    + A
Sbjct: 133 DLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMA 190
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMV 196
           PE + G   Y   VDV++      E++
Sbjct: 191 PEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK +    M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 97
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      +V E + + +LL +++         + +     QI   + Y   +  +HRDL 
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLA 157
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L    +S   D
Sbjct: 158 ARNCLVGENH-VVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNTFSIKSD 213
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 214 VWAFGVLLWEIATY 227

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           + L +++ +G +G V  A    T     +K  K  ++   + V  +++ +  L    +H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  +     + +++  V E L+  DL++ +++      +  +   Y  +I+ G+ + HS
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLHS 136
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           + I++RDLK  N L+D+   I KIADFG+ +   +         G+  Y APE LLG  +
Sbjct: 137 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ-K 194
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           Y+  VD W+      EM+  Q  FH +    L  +I       D+   P           
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----RMDNPFYPR---------- 239
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR-HEYFKD 288
                           LE +  DLL ++   +P KRL  R  +R H  F++
Sbjct: 240 ---------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 44  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 161 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 216
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 217 GLSLVEMAV 225

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 136
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    +  T   G+   + + APE  L   ++S   D
Sbjct: 137 ARNCLVGENH-LVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPES-LAYNKFSIKSD 192
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 193 VWAFGVLLWEIATY 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 15  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 74
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 75  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +   KGG    
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIXETDXXRKGGKGLL 191
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 192 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVK-KIPIMNPSEGVPSSV--IREVSLLKELKHENI 61
           ++V+  G +G V++      G+TV +   I I+N + G  ++V  + E  ++  + H ++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 62  VRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRLL V  S  +I LV + +    LL ++        + L +  +  QI  G+ Y   + 
Sbjct: 103 VRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGMMYLEERR 160
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK-APERLLGSGRY 179
           ++HRDL   N L+ +S + VKI DFGLAR ++   + Y   GG +  K      +   ++
Sbjct: 161 LVHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 180 STPVDVWAVACTFAEMVT 197
           +   DVW+   T  E++T
Sbjct: 220 THQSDVWSYGVTIWELMT 237

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G+YG V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 285
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HR+L 
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    + YT   G+   + + APE  L   ++S   D
Sbjct: 346 ARNCLVGENH-LVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 401
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 402 VWAFGVLLWEIATY 415

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +   KGG    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 195 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 6/197 (3%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHEN 60
           + ++  + +G++G V+ A +      + +K +       EGV   + RE+ +   L+H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           I+R+ N       I L+ E      L + + +     +  +   ++ ++   + YCH ++
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGEL-YKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+KP N L+   K  +KIADFG +  +  P        G+L Y  PE + G   + 
Sbjct: 135 VIHRDIKPENLLMG-YKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIEGKT-HD 190
Query: 181 TPVDVWAVACTFAEMVT 197
             VD+W       E + 
Sbjct: 191 EKVDLWCAGVLCYEFLV 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 27  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 63  RLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYL---HQILHGVAYCHS 118
             +   S+   + +V +  +   L H +    T      ++KK +    Q   G+ Y H+
Sbjct: 84  LFMGY-STKPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHA 138
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +    + VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 139 KSIIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
            S  YS   DV+A      E++T Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 1   RYTLLEVIREGRYGAVHR--AHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKEL 56
           + TLL  + +G +G V+   A D + G+      +  +N S  +   +  + E S++K  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH--- 111
              ++VRLL V S      +V E +   DL  ++++  P    NP +    L +++    
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 112 ----GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--- 164
               G+AY ++++ +HRDL   N ++      VKI DFG+ R  D+   +   KGG    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 165 -LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            + + APE  L  G ++T  D+W+      E+ +
Sbjct: 195 PVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 8   IREGRYGAVHRAHDS----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           I EG +G V +A           T+V  K+     S  + +   RE +L+ E  + NIV+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 64  LLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVT-------------------KNPLKIK 103
           LL V +    + L+FE + + DL  F+++    T                     PL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 104 KYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           + L    Q+  G+AY   ++ +HRDL   N L+  +  +VKIADFGL+R I    + Y  
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNI-YSADYYKA 232
Query: 161 KGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            G     + +  PE +    RY+T  DVWA      E+ ++
Sbjct: 233 DGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSY 272

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E I  G Y    R     T     VK   +++ S+  PS  I    LL+  +H NI
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVK---VIDKSKRDPSEEIE--ILLRYGQHPNI 83
Query: 62  VRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           + L +V      + LV E +   +LL  +  +   ++        LH I   V Y HSQ 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF--VLHTIGKTVEYLHSQG 141
Query: 121 ILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK----APERL 173
           ++HRDLKP+N L +D S +   ++I DFG A+ +    EN  +   + CY     APE L
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA--ENGLLM--TPCYTANFVAPEVL 197
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS-ETLPXXXXX 232
              G Y    D+W++      M+     F +              G  D+ E +      
Sbjct: 198 KRQG-YDEGCDIWSLGILLYTMLAGYTPFAN--------------GPSDTPEEILTRIGS 242
Query: 233 XXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   N + + + A           DL+ +ML +DP +RLTA++ L+H +
Sbjct: 243 GKFTLSGGNWNTVSETAK----------DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVK-KIPIMNPSEGVPSSV--IREVSLLKELKHENI 61
           ++V+  G +G V++      G+TV +   I I+N + G  ++V  + E  ++  + H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 62  VRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRLL V  S  +I LV + +    LL ++        + L +  +  QI  G+ Y   + 
Sbjct: 80  VRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN-WCVQIAKGMMYLEERR 137
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE-RLLGSGRY 179
           ++HRDL   N L+ +S + VKI DFGLAR ++   + Y   GG +  K      +   ++
Sbjct: 138 LVHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 180 STPVDVWAVACTFAEMVT 197
           +   DVW+   T  E++T
Sbjct: 197 THQSDVWSYGVTIWELMT 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 17  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 134 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 189
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 190 GLSLVEMAV 198

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 17  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 134 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 189
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 190 GLSLVEMAV 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 20  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 78
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 79  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 136
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 137 SNILVN-SRGEIKLCDFGVSGQLIDEMANEFV--GTRSYMSPERLQGT-HYSVQSDIWSM 192
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 193 GLSLVEMAV 201

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 17  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 134 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 189
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 190 GLSLVEMAV 198

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           E I  G +G VHRA     G  V VK +   +      +  +REV+++K L+H NIV  +
Sbjct: 43  EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 66  NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE- 120
              +   ++ +V E L     + LLH  K+      +  +     + +  G+ Y H++  
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 121 -ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            I+HR+LK  N L+D+ K  VK+ DFGL+R       +     G+  + APE +L     
Sbjct: 159 PIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPS 216
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI 214
           +   DV++      E+ T Q+ + +     ++AA+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 17  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 134 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 189
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 190 GLSLVEMAV 198

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E I  G Y    R     T     VK   +++ S+  PS  I    LL+  +H NI
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVK---VIDKSKRDPSEEIE--ILLRYGQHPNI 83
Query: 62  VRLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           + L +V      + LV E +   +LL  +  +   ++        LH I   V Y HSQ 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF--VLHTIGKTVEYLHSQG 141
Query: 121 ILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK----APERL 173
           ++HRDLKP+N L +D S +   ++I DFG A+ +    EN  +   + CY     APE L
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA--ENGLLM--TPCYTANFVAPEVL 197
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS-ETLPXXXXX 232
              G Y    D+W++      M+     F +              G  D+ E +      
Sbjct: 198 KRQG-YDEGCDIWSLGILLYTMLAGYTPFAN--------------GPSDTPEEILTRIGS 242
Query: 233 XXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   N + + + A           DL+ +ML +DP +RLTA++ L+H +
Sbjct: 243 GKFTLSGGNWNTVSETAK----------DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 67
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E ++   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 125
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 183
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVC 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 9/188 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 79  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 137
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 138 DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 195
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 196 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 251
Query: 189 ACTFAEMV 196
             +  EM 
Sbjct: 252 GLSLVEMA 259

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS 70
           G  G V +     +G  V+ +K+  +     + + +IRE+ +L E     IV       S
Sbjct: 17  GNGGVVFKVSHKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 71  VDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKP 128
              I +  E++D   L   +K    + +  L   K    ++ G+ Y   + +I+HRD+KP
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
           +N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G+  YS   D+W++
Sbjct: 134 SNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT-HYSVQSDIWSM 189
Query: 189 ACTFAEMVT 197
             +  EM  
Sbjct: 190 GLSLVEMAV 198

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    +     + +E+++L +     +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYV 87
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
            +          + ++ E L      DLL     EP     PL   +I   L +IL G+ 
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EP----GPLDETQIATILREILKGLD 138
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERL 173
           Y HS++ +HRD+K AN L+    + VK+ADFG+A  + D  ++  T  G    + APE +
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE-V 195
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +    Y +  D+W++  T  E+        +R  P            P SE  P      
Sbjct: 196 IKQSAYDSKADIWSLGITAIEL--------ARGEP------------PHSELHP-----M 230
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                 P  +P     T+ G       + +   L  +PS R TA+E L+H++
Sbjct: 231 KVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 278

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 87/189 (46%), Gaps = 6/189 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +      + +K +       EGV   + RE+ +   L+H NI+R+ N  
Sbjct: 25  KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 84
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                I L+ E      L + + +     +  +   ++ ++   + YCH ++++HRD+KP
Sbjct: 85  HDRKRIYLMLEFAPRGEL-YKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 143
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+   K  +KIADFG +  +  P        G+L Y  PE + G   +   VD+W  
Sbjct: 144 ENLLMG-YKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCA 199
Query: 189 ACTFAEMVT 197
                E + 
Sbjct: 200 GVLCYEFLV 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           + L +++ +G +G V  A    T     +K  K  ++   + V  +++ +  L    +H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  +     + +++  V E L+  DL++ +++      +  +   Y  +I+ G+ + HS
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLHS 137
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           + I++RDLK  N L+D+   I KIADFG+ +   +         G+  Y APE LLG  +
Sbjct: 138 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ-K 195
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXX 238
           Y+  VD W+      EM+  Q  FH +    L  +I       D+   P           
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----RMDNPFYPR---------- 240
Query: 239 XPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR-HEYFKD 288
                           LE +  DLL ++   +P KRL  R  +R H  F++
Sbjct: 241 ---------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 66  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 181
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 182 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 50/292 (17%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    + +   + +E+++L +     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 67
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
            +          + ++ E L      DLL     EP     PL   +I   L +IL G+ 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EP----GPLDETQIATILREILKGLD 118
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERL 173
           Y HS++ +HRD+K AN L+    + VK+ADFG+A  + D  ++  T  G    + APE +
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE-V 175
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
           +    Y +  D+W++  T  E+        +R  P            P SE  P      
Sbjct: 176 IKQSAYDSKADIWSLGITAIEL--------ARGEP------------PHSELHP-----M 210
Query: 234 XXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                 P  +P     T+ G       + +   L  +PS R TA+E L+H++
Sbjct: 211 KVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 258

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 15  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 63  RLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYL---HQILHGVAYCHS 118
             +   S+   + +V +  +   L H +    T      ++KK +    Q   G+ Y H+
Sbjct: 72  LFMGY-STKPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHA 126
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +    + VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 127 KSIIHRDLKSNNIFL-HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
            S  YS   DV+A      E++T Q
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDT-------VVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + LL V+ +G YG V +       +T       V+ K + + N  +   +   R +  L+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LE 76
Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           E+KH  IV L+    +   + L+ E L    L FM+ E            YL +I   + 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPE 171
           + H + I++RDLKP N +++     VK+ DFGL +     + + T+     G++ Y APE
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKE---SIHDGTVTHXFCGTIEYMAPE 191
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            L+ SG ++  VD W++     +M+T
Sbjct: 192 ILMRSG-HNRAVDWWSLGALMYDMLT 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 191
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDT-------VVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + LL V+ +G YG V +       +T       V+ K + + N  +   +   R +  L+
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LE 76
Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           E+KH  IV L+    +   + L+ E L    L FM+ E            YL +I   + 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPE 171
           + H + I++RDLKP N +++     VK+ DFGL +     + + T+     G++ Y APE
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKE---SIHDGTVTHTFCGTIEYMAPE 191
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            L+ SG ++  VD W++     +M+T
Sbjct: 192 ILMRSG-HNRAVDWWSLGALMYDMLT 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 10  EGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +G +G+V    +D L   TG  V VK++    P +       RE+ +LK L  + IV+  
Sbjct: 33  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYR 90
Query: 66  NVQ--SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
            V       S+ LV E L    L           +  ++  Y  QI  G+ Y  S+  +H
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRYS 180
           RDL   N L++ S+  VKIADFGLA+ + +  + Y ++  G S + + APE  L    +S
Sbjct: 151 RDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES-LSDNIFS 208
Query: 181 TPVDVWAVACTFAEMVTH 198
              DVW+      E+ T+
Sbjct: 209 RQSDVWSFGVVLYELFTY 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKELK 57
           + +L  I +G +G V         DT  +  +  MN  + V  +    V +E+ +++ L+
Sbjct: 17  FEILRAIGKGSFGKVCIVQ---KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 58  HENIVRLL-NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H  +V L  + Q   D   +V   L  DL + ++      +  +K+  ++ +++  + Y 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL--FICELVMALDYL 131
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYTIKGGSLCYKAPERL-- 173
            +Q I+HRD+KP N L+D     V I DF +A  +  P E   T   G+  Y APE    
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAML--PRETQITTMAGTKPYMAPEMFSS 188
Query: 174 -LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             G+G YS  VD W++  T  E++  +R +H R
Sbjct: 189 RKGAG-YSFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 10  EGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +G +G+V    +D L   TG  V VK++    P +       RE+ +LK L  + IV+  
Sbjct: 20  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYR 77
Query: 66  NVQ--SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
            V       S+ LV E L    L           +  ++  Y  QI  G+ Y  S+  +H
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 137
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRYS 180
           RDL   N L++ S+  VKIADFGLA+ + +  + Y ++  G S + + APE  L    +S
Sbjct: 138 RDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES-LSDNIFS 195
Query: 181 TPVDVWAVACTFAEMVTH 198
              DVW+      E+ T+
Sbjct: 196 RQSDVWSFGVVLYELFTY 213

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 10  EGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +G +G+V    +D L   TG  V VK++    P +       RE+ +LK L  + IV+  
Sbjct: 21  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYR 78
Query: 66  NVQ--SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
            V       S+ LV E L    L           +  ++  Y  QI  G+ Y  S+  +H
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 138
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGS-LCYKAPERLLGSGRYS 180
           RDL   N L++ S+  VKIADFGLA+ + +  + Y ++  G S + + APE  L    +S
Sbjct: 139 RDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES-LSDNIFS 196
Query: 181 TPVDVWAVACTFAEMVTH 198
              DVW+      E+ T+
Sbjct: 197 RQSDVWSFGVVLYELFTY 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T ++ I  G++G VH  +  L  D V +K I     SE      I E  ++ +L H  +V
Sbjct: 11  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLV 66
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V      I LV E ++   L  +++T+  +      +   L  +  G+AY     +
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEACV 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+  ++ ++K++DFG+ R   V  + YT   G+   + + +PE +    R
Sbjct: 126 IHRDLAARNCLVGENQ-VIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPE-VFSFSR 181
Query: 179 YSTPVDVWAVACTFAEMVTHQRL 201
           YS+  DVW+      E+ +  ++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 185
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 186 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDT---VVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           T+  VI  G +G V      L G     V +K + +   +E      + E S++ +  H 
Sbjct: 25  TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHP 83
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI+ L  V +    + +V E ++   L     +       +++   L  I  G+ Y    
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGS 176
             +HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + APE  +  
Sbjct: 144 GYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAF 201
Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++++  DVW+      E+V++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSY 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 6/196 (3%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           +G++G V+ A +  +   V +K +       EGV   + RE+ +   L H NI+RL N  
Sbjct: 33  KGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYF 92
Query: 69  SSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP 128
                I L+ E      L + + + + T +  +    + ++   + YCH ++++HRD+KP
Sbjct: 93  YDRRRIYLILEYAPRGEL-YKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKP 151
Query: 129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAV 188
            N L+   K  +KIADFG +  +  P        G+L Y  PE + G   ++  VD+W +
Sbjct: 152 EN-LLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGR-MHNEKVDLWCI 207
Query: 189 ACTFAEMVTHQRLFHS 204
                E++     F S
Sbjct: 208 GVLCYELLVGNPPFES 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 184
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 63
Query: 56  LK--HENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 121
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 179
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMV 196
            +     +     VW++     +MV
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 178
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 67  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 182
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 183 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 38/290 (13%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-ENIVRLLNVQS 69
           G++  V +     TG     K +      +   + ++ E+++L+  K    ++ L  V  
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 70  SVDSIDLVFENL---DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
           +   I L+ E     +   L   +    V++N   + + + QIL GV Y H   I+H DL
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSEN--DVIRLIKQILEGVYYLHQNNIVHLDL 157
Query: 127 KPANFLIDRSKDI--VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVD 184
           KP N L+     +  +KI DFG++R I    E   I G    Y APE +L     +T  D
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE-YLAPE-ILNYDPITTATD 215
Query: 185 VWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSP 244
           +W +      ++TH   F               +G  + ET                 S 
Sbjct: 216 MWNIGIIAYMLLTHTSPF---------------VGEDNQETY-LNISQVNVDYSEETFSS 259
Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK--DFQSL 292
           +  LAT          D ++ +L  +P KR TA   L H + +  DF++L
Sbjct: 260 VSQLAT----------DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 98  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 213
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 214 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 2   YTLLEVIREGRYGAV----HRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKEL 56
           +  L+VI +G +G V    H+A +      V+ KK  +    E     ++ E + LLK +
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE---KHIMSERNVLLKNV 96
Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           KH  +V L     + D +  V + ++   L +          P + + Y  +I   + Y 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAAEIASALGYL 155
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           HS  I++RDLKP N L+D    IV + DFGL +         +   G+  Y APE +L  
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHK 213
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             Y   VD W +     EM+     F+SR
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 191
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYET 184
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 125/253 (49%), Gaps = 30/253 (11%)
Query: 49  EVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKN-----PLK- 101
           E+ ++ ++K+E  +    + ++ D + +++E ++ D +L F +    + KN     P++ 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 102 IKKYLHQILHGVAYCHSQE-ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
           IK  +  +L+  +Y H+++ I HRD+KP+N L+D++   VK++DFG +      + +  I
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE----YMVDKKI 207
Query: 161 KG--GSLCYKAPERLLGSGRYS-TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
           KG  G+  +  PE       Y+   VD+W++      M  +   F  + +   L  +F+ 
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFNN 264
Query: 218 MGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRL 275
           + T + E  P                P+ +  +      L  + +D L+  L  +P++R+
Sbjct: 265 IRTKNIE-YPLDRNHFLY--------PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 276 TAREALRHEYFKD 288
           T+ +AL+HE+  D
Sbjct: 316 TSEDALKHEWLAD 328

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           +G +G V++A +  TG     K I     SE      I E+ +L    H  IV+LL    
Sbjct: 21  DGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 70  SVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
               + ++ E      +D  +L   +  TEP       +I+    Q+L  + + HS+ I+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKRII 131
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N L+    DI ++ADFG++      L+      G+  + APE ++      TP
Sbjct: 132 HRDLKAGNVLMTLEGDI-RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 183 ----VDVWAVACTFAEMV 196
                D+W++  T  EM 
Sbjct: 191 YDYKADIWSLGITLIEMA 208

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + ++  + +G +G V++A +  T  +V+     I   SE      + E+ +L    H NI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKET--SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHF----------MKTEPTVTKNPLKIKKYLHQILH 111
           V+LL+           +EN  + L+ F          ++ E  +T++ +++     Q L 
Sbjct: 97  VKLLDA--------FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV--VCKQTLD 146
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            + Y H  +I+HRDLK  N L     DI K+ADFG++      ++      G+  + APE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDI-KLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 172 RLLGSGR----YSTPVDVWAVACTFAEMV 196
            ++        Y    DVW++  T  EM 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           +G +G V++A +  TG     K I     SE      I E+ +L    H  IV+LL    
Sbjct: 29  DGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 70  SVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
               + ++ E      +D  +L   +  TEP       +I+    Q+L  + + HS+ I+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKRII 139
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTP 182
           HRDLK  N L+    DI ++ADFG++      L+      G+  + APE ++      TP
Sbjct: 140 HRDLKAGNVLMTLEGDI-RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 183 ----VDVWAVACTFAEMV 196
                D+W++  T  EM 
Sbjct: 199 YDYKADIWSLGITLIEMA 216

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 89  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 146
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 147 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 261
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 262 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 287 K 287
           +
Sbjct: 297 Q 297

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 89  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 146
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 147 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 261
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 262 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 287 K 287
           +
Sbjct: 297 Q 297

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 133/329 (40%), Gaps = 50/329 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLT----------GDTVV-------VKKIPIMNPSEGVP 43
           RY L+  +  G +  V  A D +           GD V        +K +  +N ++   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 44  SSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
              +    +LK L H N      V      + +VFE L  +LL  +K         + +K
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVH-----VVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 104 KYLHQILHGVAYCHSQ-EILHRDLKPANFL---IDRSKDIV--KIADFGLARPIDVPLEN 157
           +   Q+L G+ Y H +  I+H D+KP N L   +D  ++++  KIAD G A   D   E+
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EH 191
Query: 158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------L 211
           YT    +  Y++PE LLG+  +    D+W+ AC   E++T   LF              +
Sbjct: 192 YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 212 AAIFSIMGTPDSETLPXXXXXXXXXXXXP---NRS-----PIKDLATVVGGLEPDGV--- 260
           A I  ++G   S  L                 N S     P++D+ T       D     
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 261 -DLLRRMLCLDPSKRLTAREALRHEYFKD 288
            D L  ML LDP KR  A   + H + KD
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 39  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 96  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 150
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 133/329 (40%), Gaps = 50/329 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLT----------GDTVV-------VKKIPIMNPSEGVP 43
           RY L+  +  G +  V  A D +           GD V        +K +  +N ++   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 44  SSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
              +    +LK L H N      V      + +VFE L  +LL  +K         + +K
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVH-----VVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 104 KYLHQILHGVAYCHSQ-EILHRDLKPANFL---IDRSKDIV--KIADFGLARPIDVPLEN 157
           +   Q+L G+ Y H +  I+H D+KP N L   +D  ++++  KIAD G A   D   E+
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EH 191
Query: 158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------L 211
           YT    +  Y++PE LLG+  +    D+W+ AC   E++T   LF              +
Sbjct: 192 YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 212 AAIFSIMGTPDSETLPXXXXXXXXXXXXP---NRS-----PIKDLATVVGGLEPDGV--- 260
           A I  ++G   S  L                 N S     P++D+ T       D     
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 261 -DLLRRMLCLDPSKRLTAREALRHEYFKD 288
            D L  ML LDP KR  A   + H + KD
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 11  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 68  LFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 122
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 31  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 88  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 142
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G++G V+         TV VK  K   M   E      ++E +++KE+KH N+V+LL V 
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 69  SSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
           +      ++ E + + +LL +++       + + +     QI   + Y   +  +HRDL 
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 136
Query: 128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVD 184
             N L+  +  +VK+ADFGL+R +    +  T   G+   + + APE  L   ++S   D
Sbjct: 137 ARNCLVGENH-LVKVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPES-LAYNKFSIKSD 192
Query: 185 VWAVACTFAEMVTH 198
           VWA      E+ T+
Sbjct: 193 VWAFGVLLWEIATY 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGLAR + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 90
Query: 56  LK--HENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 148
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 206
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVC 232

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 14  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 73  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 130
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 131 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 245
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 246 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 280
Query: 287 K 287
           +
Sbjct: 281 Q 281

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 11  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 68  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 122
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 10  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 69  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 126
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 127 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 241
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 242 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 276
Query: 287 K 287
           +
Sbjct: 277 Q 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 63
Query: 56  LK--HENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 121
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 179
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + ++  + +G +G V++A +  T  +V+     I   SE      + E+ +L    H NI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKET--SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHF----------MKTEPTVTKNPLKIKKYLHQILH 111
           V+LL+           +EN  + L+ F          ++ E  +T++ +++     Q L 
Sbjct: 97  VKLLDA--------FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV--VCKQTLD 146
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            + Y H  +I+HRDLK  N L     DI K+ADFG++      ++      G+  + APE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDI-KLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 172 RLLGSGR----YSTPVDVWAVACTFAEMV 196
            ++        Y    DVW++  T  EM 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 83
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 141
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 199
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 82
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 140
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 198
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVC 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 83
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 141
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 199
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 82
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 140
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 198
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVC 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 83
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 141
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 199
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 174
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 175 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 289
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 290 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 287 K 287
           +
Sbjct: 325 Q 325

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 68
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 126
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 184
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 63
Query: 56  LK--HENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 121
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 179
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 68
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 126
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 184
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMV 196
            +     +     VW++     +MV
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 110
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 168
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 226
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           + ++  + +G +G V++A +  T  +V+     I   SE      + E+ +L    H NI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKET--SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHF----------MKTEPTVTKNPLKIKKYLHQILH 111
           V+LL+           +EN  + L+ F          ++ E  +T++ +++     Q L 
Sbjct: 97  VKLLDA--------FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV--VCKQTLD 146
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            + Y H  +I+HRDLK  N L     DI K+ADFG++      ++      G+  + APE
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDI-KLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 172 RLLGSGR----YSTPVDVWAVACTFAEMV 196
            ++        Y    DVW++  T  EM 
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 110
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 168
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 226
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 95
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 153
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 102
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 160
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 218
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVC 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 96
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 154
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 212
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 115
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 173
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 231
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVC 257

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 70  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 127
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 128 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 242
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 243 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 277
Query: 287 K 287
           +
Sbjct: 278 Q 278

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 96
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 154
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 212
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 95
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 153
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    + +   + +E+++L +     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 67
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
            +          + ++ E L      DLL     EP     PL   +I   L +IL G+ 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EP----GPLDETQIATILREILKGLD 118
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS++ +HRD+K AN L+    + VK+ADFG+A  +           G+  + APE ++
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VI 176
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y +  D+W++  T  E+        +R  P            P SE  P       
Sbjct: 177 KQSAYDSKADIWSLGITAIEL--------ARGEP------------PHSELHP-----MK 211
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                P  +P     T+ G       + +   L  +PS R TA+E L+H++
Sbjct: 212 VLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 258

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 66
Query: 56  LK--HENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 124
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 182
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVC 208

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 95
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 153
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 96
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 154
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 212
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMK-------TEPT- 94
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F++       T+P  
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 95  -VTKNPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP 150
            +  + L  +  LH   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLAR 
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARD 213
Query: 151 IDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           I +   NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 214 I-MNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 261

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 67
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 125
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 183
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVC 209

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 38  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 95  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 149
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 68
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 126
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 184
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 95
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 153
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 211
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +T LE I +G +G V +  D+ T   V +K I +    + +   + +E+++L +     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 82
Query: 62  VRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
            +          + ++ E L      DLL     EP     PL   +I   L +IL G+ 
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EP----GPLDETQIATILREILKGLD 133
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS++ +HRD+K AN L+    + VK+ADFG+A  +           G+  + APE ++
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VI 191
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXX 234
               Y +  D+W++  T  E+        +R  P            P SE  P       
Sbjct: 192 KQSAYDSKADIWSLGITAIEL--------ARGEP------------PHSELHP-----MK 226
Query: 235 XXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                P  +P     T+ G       + +   L  +PS R TA+E L+H++
Sbjct: 227 VLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 39  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 96  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 150
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 1   RYTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKE 55
           +Y +  ++  G +G+V+   R  D+L      V+K  I +  E +P+   V  EV LLK+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKK 96
Query: 56  LKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + +  Q+L 
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RSFFWQVLE 154
Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+  Y  PE
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 212
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
            +     +     VW++     +MV 
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVC 238

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 174
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 175 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 289
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 290 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 287 K 287
           +
Sbjct: 325 Q 325

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 11  GRYGAVHRAHDSLTGDTV-VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           G +G+V +    +    + V  K+      +     ++RE  ++ +L +  IVRL+ V  
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-C 79
Query: 70  SVDSIDLVFENLDFDLLH-FM--KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
             +++ LV E      LH F+  K E     N   + + LHQ+  G+ Y   +  +HRDL
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPV 183
              N L+  ++   KI+DFGL++ +      YT +      L + APE  +   ++S+  
Sbjct: 137 AARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRS 194
Query: 184 DVWAVACTFAEMVTH-QRLFHSRWAPGLLAAI 214
           DVW+   T  E +++ Q+ +     P ++A I
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 53/300 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           ++ LL+V+ +G +G V         D   +  + ++  +       +R   E  +L E+ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H  IV+L     +   + L+   LDF    DL   +  E   T+  +K   YL ++   +
Sbjct: 85  HPFIVKLHYAFQTEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKF--YLAELALAL 139
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPER 172
            + HS  I++RDLKP N L+D    I K+ DFGL++  ID   + Y+   G++ Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSF-CGTVEYMAPEV 197
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI-MGTPDSETLPXXXX 231
           +   G ++   D W+      EM+T    F  +     +  I    +G P          
Sbjct: 198 VNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------- 248
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYF 286
                                  L P+   LLR +   +P+ RL A      E  RH +F
Sbjct: 249 -----------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 48/301 (15%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--E 59
           Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H  
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQH 174
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERL--L 174
            I+H DLKPANFLI     ++K+ DFG+A  +  P     +K    G++ Y  PE +  +
Sbjct: 175 GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQ-PDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 175 GSGRYS--------TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            S R +           DVW++ C    M   +  F        ++ + +I+        
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIEF 289
Query: 227 PXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P                P KDL            D+L+  L  DP +R++  E L H Y 
Sbjct: 290 PDI--------------PEKDLQ-----------DVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 287 K 287
           +
Sbjct: 325 Q 325

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 71  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 127 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES-I 184
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMH 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 53/300 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           ++ LL+V+ +G +G V         D   +  + ++  +       +R   E  +L E+ 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H  IV+L     +   + L+   LDF    DL   +  E   T+  +K   YL ++   +
Sbjct: 86  HPFIVKLHYAFQTEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKF--YLAELALAL 140
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPER 172
            + HS  I++RDLKP N L+D    I K+ DFGL++  ID   + Y+   G++ Y APE 
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSF-CGTVEYMAPEV 198
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI-MGTPDSETLPXXXX 231
           +   G ++   D W+      EM+T    F  +     +  I    +G P          
Sbjct: 199 VNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------- 249
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYF 286
                                  L P+   LLR +   +P+ RL A      E  RH +F
Sbjct: 250 -----------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 16  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 73  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 127
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N  +  ++D  VKI DFG+ R  D+   
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXV--AEDFTVKIGDFGMTR--DIYET 178
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +Y  KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 13  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 70  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 124
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELKH 58
           + LL+V+ +G +G V         D+  +  + ++  +       +R   E  +L ++ H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
             +V+L     +   + L+   LDF    DL   +  E   T+  +K   YL ++  G+ 
Sbjct: 90  PFVVKLHYAFQTEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKF--YLAELALGLD 144
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPERL 173
           + HS  I++RDLKP N L+D    I K+ DFGL++  ID   + Y+   G++ Y APE +
Sbjct: 145 HLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKEAIDHEKKAYSF-CGTVEYMAPEVV 202
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
              G +S   D W+      EM+T    F  +
Sbjct: 203 NRQG-HSHSADWWSYGVLMFEMLTGSLPFQGK 233

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 16  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 73  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 127
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 123/300 (41%), Gaps = 53/300 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           ++ LL+V+ +G +G V         D   +  + ++  +       +R   E  +L E+ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H  IV+L     +   + L+   LDF    DL   +  E   T+  +K   YL ++   +
Sbjct: 85  HPFIVKLHYAFQTEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKF--YLAELALAL 139
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR-PIDVPLENYTIKGGSLCYKAPER 172
            + HS  I++RDLKP N L+D    I K+ DFGL++  ID   + Y+   G++ Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSF-CGTVEYMAPEV 197
Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF-SIMGTPDSETLPXXXX 231
           +   G ++   D W+      EM+T    F  +     +  I  + +G P          
Sbjct: 198 VNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------- 248
Query: 232 XXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYF 286
                                  L P+   LLR +   +P+ RL A      E  RH +F
Sbjct: 249 -----------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 141 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 198
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 199 TSASDVWSYGIVLWEVMSY 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++      GD V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 11  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   S+   + +V +  +    +  LH ++T+  +    +K+     Q   G+ Y H+
Sbjct: 68  LFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETKFEM----IKLIDIARQTAQGMDYLHA 122
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK--GGSLCYKAPE--RLL 174
           + I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE  R+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQ 199
               YS   DV+A      E++T Q
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 158 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 215
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 216 TSASDVWSYGIVLWEVMSY 234

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 141 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 198
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 199 TSASDVWSYGIVLWEVMSY 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 76  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 132 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 189
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMH 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 73  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 129 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 186
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMH 210

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL+R + D P   YT +GG +   + +PE  +   ++
Sbjct: 168 HRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 225
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 226 TSASDVWSYGIVLWEVMSY 244

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 71  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 127 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 184
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMH 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 74  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 130 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 187
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMH 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 99  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 155 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 212
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMH 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 71  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 127 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 184
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMH 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 68  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 124 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 181
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMH 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +V+  G +G V      L      +V +K + +   +E      + E S++ +  H NI+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63  RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           RL  V +    + +V E ++   L     +       +++   L  I  G+ Y      +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRY 179
           HRDL   N LI+ S  + K++DFGL R + D P   YT +GG +   + +PE  +   ++
Sbjct: 170 HRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKF 227
Query: 180 STPVDVWAVACTFAEMVTH 198
           ++  DVW+      E++++
Sbjct: 228 TSASDVWSYGIVLWEVMSY 246

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 7/197 (3%)
Query: 7   VIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
           VI  G +G V      L G  D  V  K   +  +E      + E S++ +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
             V +    + +V E ++   L     +       +++   L  I  G+ Y      +HR
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHR 169
Query: 125 DLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLC--YKAPERLLGSGRYST 181
           DL   N L++ S  + K++DFGL+R I D P   YT  GG +   + APE +    ++++
Sbjct: 170 DLAARNILVN-SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR-KFTS 227
Query: 182 PVDVWAVACTFAEMVTH 198
             DVW+      E++++
Sbjct: 228 ASDVWSYGIVMWEVMSY 244

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIXET 185
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +   KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 186 DXXRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT-EPTVTKNPL---- 100
           + E S++KE    ++VRLL V S      ++ E +   DL  ++++  P +  NP+    
Sbjct: 61  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLE 156
              K+ +   +I  G+AY ++ + +HRDL   N ++  ++D  VKI DFG+ R  D+   
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIXET 176
Query: 157 NYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +   KGG     + + +PE  L  G ++T  DVW+      E+ T
Sbjct: 177 DXXRKGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 120/307 (39%), Gaps = 41/307 (13%)
Query: 2   YTLLE-VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELK-H 58
           Y L E V+ EG +  V    + +T     VK   I+    G + S V REV +L + + H
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFD--LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            N++ L+      D   LVFE +     L H  K       N L+    +  +   + + 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALDFL 127
Query: 117 HSQEILHRDLKPANFLIDRSKDI--VKIADFGLA---------RPIDVPLENYTIKGGSL 165
           H++ I HRDLKP N L +    +  VKI DFGL           PI  P        GS 
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP--ELLTPCGSA 185
Query: 166 CYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
            Y APE +      +  Y    D+W++      +++          P  +    S  G  
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY--------PPFVGRCGSDCGWD 237
Query: 222 DSETLPXXXXXXXXXXXXPNRS-PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA 280
             E  P                 P KD A +    +    DL+ ++L  D  +RL+A + 
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK----DLISKLLVRDAKQRLSAAQV 293
Query: 281 LRHEYFK 287
           L+H + +
Sbjct: 294 LQHPWVQ 300

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 4   LLEVIREGRYGAVHRAHDSLTG-----DTVVVKKIPIMNPSEGVPSSVIREVSLLK-ELK 57
            +E + E R+G V++ H  L G      T  V    + + +EG      R  ++L+  L+
Sbjct: 13  FMEELGEDRFGKVYKGH--LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 70
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLH---FMKT---------EPTVTKNPLKIKKY 105
           H N+V LL V +    + ++F       LH    M++         +    K+ L+   +
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           +H   QI  G+ Y  S  ++H+DL   N L+   K  VKI+D GL R +    + Y + G
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-YDKLNVKISDLGLFREV-YAADYYKLLG 188
Query: 163 GSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            SL    + APE ++  G++S   D+W+      E+ ++
Sbjct: 189 NSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSY 226

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 116/297 (39%), Gaps = 51/297 (17%)
Query: 10  EGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQ 68
           EG +    +     +     VK I     S+ + ++  +E++ LK  + H NIV+L  V 
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 69  SSVDSIDLVFENLDFDLL--------HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
                  LV E L+   L        HF +TE +           + +++  V++ H   
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---------MRKLVSAVSHMHDVG 126
Query: 121 ILHRDLKPANFLIDRSKDI--VKIADFGLAR---PIDVPLENYTIKGGSLCYKAPERLLG 175
           ++HRDLKP N L     D   +KI DFG AR   P + PL+       +L Y APE LL 
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF---TLHYAAPE-LLN 182
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXX 235
              Y    D+W++      M++ Q  F S        +   IM                 
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----------------- 225
Query: 236 XXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL 292
                 +            +  +  DL++ +L +DP+KRL       +E+ +D   L
Sbjct: 226 --KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+       N S      ++ E  ++  +  
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             + RLL +     ++ LV + + +  L     E         +  +  QI  G++Y   
Sbjct: 79  PYVSRLLGI-CLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED 137
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
             ++HRDL   N L+ +S + VKI DFGLAR +D+    Y   GG +  K  A E +L  
Sbjct: 138 VRLVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-R 195
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
            R++   DVW+   T  E++T
Sbjct: 196 RRFTHQSDVWSYGVTVWELMT 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +           G+
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGT 352
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             + APE LLG   Y   VD +A+  T  EM+  +  F +R
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +           G+
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGT 352
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             + APE LLG   Y   VD +A+  T  EM+  +  F +R
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 4   LLEVIREGRYGAVHRAHDSLTG-----DTVVVKKIPIMNPSEGVPSSVIREVSLLK-ELK 57
            +E + E R+G V++ H  L G      T  V    + + +EG      R  ++L+  L+
Sbjct: 30  FMEELGEDRFGKVYKGH--LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 87
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLH---FMKT---------EPTVTKNPLKIKKY 105
           H N+V LL V +    + ++F       LH    M++         +    K+ L+   +
Sbjct: 88  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 147
Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           +H   QI  G+ Y  S  ++H+DL   N L+   K  VKI+D GL R +    + Y + G
Sbjct: 148 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-YDKLNVKISDLGLFREV-YAADYYKLLG 205
Query: 163 GSLC---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
            SL    + APE ++  G++S   D+W+      E+ ++
Sbjct: 206 NSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSY 243

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +           G+
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGT 352
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             + APE LLG   Y   VD +A+  T  EM+  +  F +R
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 451 PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  S D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 507 LESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 564
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH 588

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1   RYTLLEVIREGRYGAV--HRAHDSLTGDTVVVKKIPIMNPSEGVPS--SVIREVSLLKEL 56
           R +  + +  G +G V    A+  +  D  +   + ++ PS  +    +++ E+ +L  L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----------KTEPTV------TKN 98
             H NIV LL   +      ++ E   + DLL+F+          KT P +        +
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +  + +Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR I     NY
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKND-SNY 201
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 202 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 242

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+ G+ + H + I++RDLKP N L+D   + V+I+D GLA  +           G+
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGT 352
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
             + APE LLG   Y   VD +A+  T  EM+  +  F +R
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMK-------TEPT- 94
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F++       T+P  
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 95  -VTKNPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP 150
            +  +    +  LH   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLAR 
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARD 213
Query: 151 IDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           I +   NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 214 I-MNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 261

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 2   YTLLEVIREGRYGAVH---RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           + +L  +  G +G VH     H+       V+KK  ++   +   ++   E  +L  + H
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN--DERLMLSIVTH 65
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             I+R+         I ++ + ++   L  +  +     NP+  K Y  ++   + Y HS
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-KFYAAEVCLALEYLHS 124
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           ++I++RDLKP N L+D++  I KI DFG A+   VP   Y +  G+  Y APE ++ +  
Sbjct: 125 KDIIYRDLKPENILLDKNGHI-KITDFGFAKY--VPDVTYXL-CGTPDYIAPE-VVSTKP 179
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFH 203
           Y+  +D W+      EM+     F+
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 11  GRYGAVHRAHDSLTGDTV-VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS 69
           G +G+V +    +    + V  K+      +     ++RE  ++ +L +  IVRL+ V  
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-C 405
Query: 70  SVDSIDLVFENLDFDLLH-FM--KTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
             +++ LV E      LH F+  K E     N   + + LHQ+  G+ Y   +  +HR+L
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPV 183
              N L+  ++   KI+DFGL++ +      YT +      L + APE  +   ++S+  
Sbjct: 463 AARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRS 520
Query: 184 DVWAVACTFAEMVTH-QRLFHSRWAPGLLAAI 214
           DVW+   T  E +++ Q+ +     P ++A I
Sbjct: 521 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1   RYTLLEVIREGRYGAV--HRAHDSLTGDTVVVKKIPIMNPSEGVPS--SVIREVSLLKEL 56
           R +  + +  G +G V    A+  +  D  +   + ++ PS  +    +++ E+ +L  L
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 99
Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----------KTEPTV------TKN 98
             H NIV LL   +      ++ E   + DLL+F+          KT P +        +
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 159
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +  + +Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR I     NY
Sbjct: 160 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKND-SNY 217
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 218 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1   RYTLLEVIREGRYGAV--HRAHDSLTGDTVVVKKIPIMNPSEGVPS--SVIREVSLLKEL 56
           R +  + +  G +G V    A+  +  D  +   + ++ PS  +    +++ E+ +L  L
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 101
Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----------KTEPTV------TKN 98
             H NIV LL   +      ++ E   + DLL+F+          KT P +        +
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 161
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +  + +Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR I     NY
Sbjct: 162 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKND-SNY 219
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 220 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 260

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 10  EGRYGAVHRA-HDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +G +G+V    +D L   TG  V VK++    P +       RE+ +LK L  + IV+  
Sbjct: 17  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVKYR 74
Query: 66  NVQSSVD--SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
            V        + LV E L    L           +  ++  Y  QI  G+ Y  S+  +H
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 134
Query: 124 RDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGS-LCYKAPERLLGSGRYS 180
           RDL   N L++ S+  VKIADFGLA+  P+D         G S + + APE  L    +S
Sbjct: 135 RDLAARNILVE-SEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES-LSDNIFS 192
Query: 181 TPVDVWAVACTFAEMVTH 198
              DVW+      E+ T+
Sbjct: 193 RQSDVWSFGVVLYELFTY 210

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1   RYTLLEVIREGRYGAV--HRAHDSLTGDTVVVKKIPIMNPSEGVPS--SVIREVSLLKEL 56
           R +  + +  G +G V    A+  +  D  +   + ++ PS  +    +++ E+ +L  L
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----------KTEPTV------TKN 98
             H NIV LL   +      ++ E   + DLL+F+          KT P +        +
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +  + +Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR I     NY
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKND-SNY 224
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 225 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 265

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 29/179 (16%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTE------PTVT 96
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F++ +      P++ 
Sbjct: 80  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLA 139
Query: 97  KN------------PLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK 141
                         PL+++  LH   Q+  G+A+  S+  +HRD+   N L+     + K
Sbjct: 140 PGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAK 198
Query: 142 IADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           I DFGLAR I +   NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 199 IGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 255

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 71  PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  + D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 127 LESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 184
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMH 208

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 1   RYTLLEVIREGRYGAV--HRAHDSLTGDTVVVKKIPIMNPSEGVPS--SVIREVSLLKEL 56
           R +  + +  G +G V    A+  +  D  +   + ++ PS  +    +++ E+ +L  L
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM----------KTEPTV------TKN 98
             H NIV LL   +      ++ E   + DLL+F+          KT P +        +
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +  + +Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR I     NY
Sbjct: 167 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARHIKND-SNY 224
Query: 159 TIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 225 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 265

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 7   VIREGRYGAVH------RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           VI +G +G V+      +A + +      + +I  M   E    + +RE  L++ L H N
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE----AFLREGLLMRGLNHPN 83
Query: 61  IVRLLNVQSSVDSIDLVF--ENLDFDLLHFMKT---EPTVTKNPLKIKKYLHQILHGVAY 115
           ++ L+ +    + +  V        DLL F+++    PTV      +  +  Q+  G+ Y
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD----LISFGLQVARGMEY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-----LCYKAP 170
              Q+ +HRDL   N ++D S   VK+ADFGLAR I +  E Y+++        + + A 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTAL 197
Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVT 197
           E  L + R++T  DVW+      E++T
Sbjct: 198 ES-LQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +K+ADFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIKVADFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +K+ADFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIKVADFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +K+ADFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIKVADFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-EN 60
           + L+E++  G YG V++     TG    +K + +    E     + +E+++LK+  H  N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 61  IVRLL------NVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           I          N     D + LV E      +   +K     T     I     +IL G+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           ++ H  +++HRD+K  N L+  + + VK+ DFG++  +D  +       G+  + APE +
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 174 LG----SGRYSTPVDVWAVACTFAEMV 196
                    Y    D+W++  T  EM 
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 49  EVSLLKELKH--ENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKK 104
           EV LLK++      ++RLL+     DS  L+ E  +   DL  F+ TE    +  L  + 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELA-RS 161
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           +  Q+L  V +CH+  +LHRD+K  N LID ++  +K+ DFG    +   +  YT   G+
Sbjct: 162 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGT 219
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             Y  PE +     +     VW++     +MV 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +K+ADFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIKVADFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 67
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 124
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 125 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++S+  D+WA      E+ +  ++ + R
Sbjct: 182 -KFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELKH 58
           + L +++ +G    V R     TGD   +K    I  + P +      +RE  +LK+L H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLNH 66
Query: 59  ENIVRLLNVQSSVDSID--LVFENLDFDLLHFMKTEPTVTKN--PLKIKKYLHQILHGVA 114
           +NIV+L  ++    +    L+ E      L+ +  EP+        +    L  ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 115 YCHSQEILHRDLKPANFL---IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           +     I+HR++KP N +    +  + + K+ DFG AR ++   E +    G+  Y  P+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVXLYGTEEYLHPD 185
Query: 172 -------RLLGSGRYSTPVDVWAVACTFAEMVT 197
                  R     +Y   VD+W++  TF    T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 1   RYTLLEVIREGRYGAVHRA-HDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+  + S     + V      N  S+ V    ++E   +++  H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAY 115
            +IV+L+ V +     + V+  ++   L  +++   V K  L +     Y +Q+   +AY
Sbjct: 451 PHIVKLIGVITE----NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG-SLCYKAPERLL 174
             S+  +HRD+   N L+  + D VK+ DFGL+R ++        KG   + + APE  +
Sbjct: 507 LESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-I 564
Query: 175 GSGRYSTPVDVWAVACTFAEMVTH 198
              R+++  DVW       E++ H
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH 588

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 4   LLEVIREGRYGAVHRAH---DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           L +++ EG +G+V   +   +  T   V VK + + N S+      + E + +K+  H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 61  IVRLLNVQSSVDSIDL-----VFENLDFDLLH----FMKTEPTVTKNPLK-IKKYLHQIL 110
           ++RLL V   + S  +     +   + +  LH    + + E      PL+ + K++  I 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            G+ Y  ++  LHRDL   N ++ R    V +ADFGL++ I         + G +  K P
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCML-RDDMTVCVADFGLSKKI---YSGDYYRQGRIA-KMP 212
Query: 171 ERL-----LGSGRYSTPVDVWAVACTFAEMVT 197
            +      L    Y++  DVWA   T  E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           TLL+ +  G++G V         D V VK I   + SE       +E   + +L H  +V
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLV 66
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +   V S    I +V E + +  LL+++++     + P ++ +  + +  G+A+  S + 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE-PSQLLEMCYDVCEGMAFLESHQF 125
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGR 178
           +HRDL   N L+DR    VK++DFG+ R   V  + Y    G+   + + APE +    +
Sbjct: 126 IHRDLAARNCLVDRDL-CVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPE-VFHYFK 181
Query: 179 YSTPVDVWAVACTFAEMVT 197
           YS+  DVWA      E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 128/310 (41%), Gaps = 65/310 (20%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E I  G Y    R     T     VK   I++ S+  P+  I    LL+  +H NI
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTEEIE--ILLRYGQHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           + L +V      + +V E +   +LL  +  +   ++   +    L  I   V Y H+Q 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER--EASAVLFTITKTVEYLHAQG 136
Query: 121 ILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK----APERL 173
           ++HRDLKP+N L +D S +   ++I DFG A+ +    EN  +   + CY     APE L
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLM--TPCYTANFVAPEVL 192
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
              G Y    D+W++      M+T     ++ +A G                        
Sbjct: 193 ERQG-YDAACDIWSLGVLLYTMLTG----YTPFANG------------------------ 223
Query: 234 XXXXXXPNRSPIKDLATVVGG-----------LEPDGVDLLRRMLCLDPSKRLTAREALR 282
                 P+ +P + LA +  G           +     DL+ +ML +DP +RLTA   LR
Sbjct: 224 ------PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 283 HEYFKDFQSL 292
           H +   +  L
Sbjct: 278 HPWIVHWDQL 287

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 73
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 130
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 131 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++S+  D+WA      E+ +  ++ + R
Sbjct: 188 -KFSSKSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 82
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 139
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 140 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++S+  D+WA      E+ +  ++ + R
Sbjct: 197 -KFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 67
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 124
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 125 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++S+  D+WA      E+ +  ++ + R
Sbjct: 182 -KFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 66
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 123
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 124 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSR 205
            ++S+  D+WA      E+ +  ++ + R
Sbjct: 181 -KFSSKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 82
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 139
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + LHRDL   N L++  + +VK++DFGL+R +    E  ++        +P  +L   ++
Sbjct: 140 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSR 205
           S+  D+WA      E+ +  ++ + R
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LLEV   GR+G V +A   L  + V VK  PI +           EV  L  +KHENI++
Sbjct: 28  LLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEY---EVYSLPGMKHENILQ 82
Query: 64  LLNVQSSVDSIDL------VFENLDFDLLHFMKTEPTVTKNPL--------KIKKYLHQI 109
            +  +    S+D+       F      L  F+K    V+ N L        +   YLH+ 
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHE-KGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHED 140
Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCY 167
           + G+   H   I HRD+K  N L+ ++     IADFGLA   +         G  G+  Y
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLL-KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 168 KAPERLLGSGRYSTP----VDVWAVACTFAEMVT 197
            APE L G+  +       +D++A+     E+ +
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T L+ +  G++G V         D V +K I   + SE      I E  ++  L HE +V
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 62
Query: 63  RLLNVQSSVDSIDLVFENL-DFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +L  V +    I ++ E + +  LL++++       T+  L++ K    +   + Y  S+
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK---DVCEAMEYLESK 119
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS   + +  PE L+ S
Sbjct: 120 QFLHRDLAARNCLVN-DQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWA 207
            ++S+  D+WA      E+ +  ++ + R+ 
Sbjct: 177 -KFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFGLA+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGLAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELKH 58
           + L +++ +G    V R     TGD   +K    I  + P +      +RE  +LK+L H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLNH 66
Query: 59  ENIVRLLNVQSSVDSID--LVFENLDFDLLHFMKTEPTVTKN--PLKIKKYLHQILHGVA 114
           +NIV+L  ++    +    L+ E      L+ +  EP+        +    L  ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 115 YCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           +     I+HR++KP N +    +  + + K+ DFG AR ++   E +    G+  Y  P+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPD 185
Query: 172 -------RLLGSGRYSTPVDVWAVACTFAEMVT 197
                  R     +Y   VD+W++  TF    T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 119/307 (38%), Gaps = 41/307 (13%)
Query: 2   YTLLE-VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELK-H 58
           Y L E V+ EG +  V    + +T     VK   I+    G + S V REV +L + + H
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFD--LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            N++ L+      D   LVFE +     L H  K       N L+    +  +   + + 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALDFL 127
Query: 117 HSQEILHRDLKPANFLIDRSKDI--VKIADF---------GLARPIDVPLENYTIKGGSL 165
           H++ I HRDLKP N L +    +  VKI DF         G   PI  P        GS 
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP--ELLTPCGSA 185
Query: 166 CYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
            Y APE +      +  Y    D+W++      +++          P  +    S  G  
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG--------YPPFVGRCGSDCGWD 237
Query: 222 DSETLPXXXXXXXXXXXXPNRS-PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA 280
             E  P                 P KD A +    +    DL+ ++L  D  +RL+A + 
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK----DLISKLLVRDAKQRLSAAQV 293
Query: 281 LRHEYFK 287
           L+H + +
Sbjct: 294 LQHPWVQ 300

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 22/172 (12%)
Query: 45  SVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM--KTEPTV----- 95
           +++ E+ ++  L +HENIV LL   +    + ++ E   + DLL+F+  K  P +     
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN 154
Query: 96  -TKNP---LKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA 148
            + NP   L  +  LH   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLA
Sbjct: 155 PSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLA 213
Query: 149 RPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           R I +   NY +KG +   + + APE +     Y+   DVW+      E+ +
Sbjct: 214 RDI-MNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 263

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+   V    +T+  G+
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTL-CGT 202
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             Y APE +L  G Y+  VD WA+     EM  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I  G +G V++      GD V VK + +++P+     +   EV++L++ +H NI+  +  
Sbjct: 44  IGSGSFGTVYKG--KWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 68  QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
            +  D++ +V +  +    +  LH  +T+  +     ++     Q   G+ Y H++ I+H
Sbjct: 101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQM----FQLIDIARQTAQGMDYLHAKNIIH 155
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPE--RLLGSGRY 179
           RD+K  N  +      VKI DFGLA        +  ++   GS+ + APE  R+  +  +
Sbjct: 156 RDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 180 STPVDVWAVACTFAEMVT 197
           S   DV++      E++T
Sbjct: 215 SFQSDVYSYGIVLYELMT 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+   V    +T+  G+
Sbjct: 132 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTL-CGT 187
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             Y APE +L  G Y+  VD WA+     EM  
Sbjct: 188 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 219

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 81/195 (41%), Gaps = 20/195 (10%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK--ELKHENIVRLLNVQ 68
           G +G VHR  D  TG    VKK+ +          V R   L+    L    IV L    
Sbjct: 104 GSFGEVHRMEDKQTGFQCAVKKVRL---------EVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 69  SSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
                +++  E L+   L   +K +  + ++  +   YL Q L G+ Y HS+ ILH D+K
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPED--RALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 128 PANFLIDRSKDIVKIADFGLARPIDV-PLENYTIKG----GSLCYKAPERLLGSGRYSTP 182
             N L+        + DFG A  +    L    + G    G+  + APE +LG       
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR-SCDAK 271
Query: 183 VDVWAVACTFAEMVT 197
           VDVW+  C    M+ 
Sbjct: 272 VDVWSSCCMMLHMLN 286

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG- 163
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG  
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGAT 216
Query: 164 -SLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 217 WTLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 91/368 (24%), Positives = 143/368 (38%), Gaps = 92/368 (25%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-- 58
           RY ++  +  G +  V  + D + G   V  K+  +  +E    + + E+ LLK +++  
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWD-IQGKKFVAMKV--VKSAEHYTETALDEIRLLKSVRNSD 78
Query: 59  ------ENIVRLLN--VQSSVDS--IDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLH 107
                 E +V+LL+    S V+   I +VFE L   LL ++  +      PL  +KK + 
Sbjct: 79  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWI-IKSNYQGLPLPCVKKIIQ 137
Query: 108 QILHGVAYCHSQ-EILHRDLKPANFLI--------------------------------- 133
           Q+L G+ Y H++  I+H D+KP N L+                                 
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 134 ---------------DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
                          +  K  VKIAD G A  +    +++T    +  Y++ E L+GSG 
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGSG- 253
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAAIFSIMGTPDSETLPXXXXX 232
           Y+TP D+W+ AC   E+ T   LF              +A I  ++G    + +      
Sbjct: 254 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 313
Query: 233 XXXXXXXPNRSPIKDLATVVGGL-------------EPDG-VDLLRRMLCLDPSKRLTAR 278
                   +   I  L     GL             E  G  D L  ML L P KR TA 
Sbjct: 314 KEFFTKKGDLKHITKLKP--WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 371
Query: 279 EALRHEYF 286
           E LRH + 
Sbjct: 372 ECLRHPWL 379

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK--ELKHENIVRLLNVQ 68
           G +G VHR  D  TG    VKK+ +          V R   L+    L    IV L    
Sbjct: 85  GSFGEVHRMEDKQTGFQCAVKKVRL---------EVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 69  SSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
                +++  E L+   L   +K +  + ++  +   YL Q L G+ Y HS+ ILH D+K
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPED--RALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 128 PANFLIDRSKDIVKIADFGLARPI-------DVPLENYTIKGGSLCYKAPERLLGSGRYS 180
             N L+        + DFG A  +       D+   +Y    G+  + APE +LG     
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP--GTETHMAPEVVLGR-SCD 250
Query: 181 TPVDVWAVACTFAEMVT 197
             VDVW+  C    M+ 
Sbjct: 251 AKVDVWSSCCMMLHMLN 267

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 91/368 (24%), Positives = 143/368 (38%), Gaps = 92/368 (25%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-- 58
           RY ++  +  G +  V  + D + G   V  K+  +  +E    + + E+ LLK +++  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWD-IQGKKFVAMKV--VKSAEHYTETALDEIRLLKSVRNSD 94
Query: 59  ------ENIVRLLN--VQSSVDS--IDLVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLH 107
                 E +V+LL+    S V+   I +VFE L   LL ++  +      PL  +KK + 
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWI-IKSNYQGLPLPCVKKIIQ 153
Query: 108 QILHGVAYCHSQ-EILHRDLKPANFLI--------------------------------- 133
           Q+L G+ Y H++  I+H D+KP N L+                                 
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 134 ---------------DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
                          +  K  VKIAD G A  +    +++T    +  Y++ E L+GSG 
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGSG- 269
Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAAIFSIMGTPDSETLPXXXXX 232
           Y+TP D+W+ AC   E+ T   LF              +A I  ++G    + +      
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 233 XXXXXXXPNRSPIKDLATVVGGL-------------EPDG-VDLLRRMLCLDPSKRLTAR 278
                   +   I  L     GL             E  G  D L  ML L P KR TA 
Sbjct: 330 KEFFTKKGDLKHITKLKP--WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 279 EALRHEYF 286
           E LRH + 
Sbjct: 388 ECLRHPWL 395

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+   V    + +  G+
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWXL-AGT 201
Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             Y APE +L  G Y+  VD WA+     EM  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +K+ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIKVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +++ DFGLA+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIQVTDFGLAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 141 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 190
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 191 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 228

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 188
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 189 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 226

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 11/203 (5%)
Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           ++  G +G V++    L   T+V  K       +G       EV ++    H N++RL  
Sbjct: 45  ILGRGGFGKVYKGR--LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRG 102
Query: 67  VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL---HGVAYCHSQ---E 120
              +     LV+  +    +     E   ++ PL   K     L    G+AY H     +
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYKAPERLLGSGRY 179
           I+HRD+K AN L+D   + V + DFGLA+ +D    +      G++ + APE  L +G+ 
Sbjct: 163 IIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE-YLSTGKS 220
Query: 180 STPVDVWAVACTFAEMVTHQRLF 202
           S   DV+       E++T QR F
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAF 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 45/253 (17%)
Query: 48  REVSLLKEL-KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKN----PLKI 102
           REV LL+E  +H N++R    +      D  F+ +  +L      E    K+     L+ 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAIELCAATLQEYVEQKDFAHLGLEP 120
Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLID----RSKDIVKIADFGLARPIDVPLENY 158
              L Q   G+A+ HS  I+HRDLKP N LI       K    I+DFGL + + V   ++
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 159 TIKG---GSLCYKAPERLLGSGRY--STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAA 213
           + +    G+  + APE L    +   +  VD+++  C F  +++        +   L   
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS---HPFGKSLQRQ 237
Query: 214 IFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
              ++G    + L                 P K    +         +L+ +M+ +DP K
Sbjct: 238 ANILLGACSLDCL----------------HPEKHEDVI-------ARELIEKMIAMDPQK 274
Query: 274 RLTAREALRHEYF 286
           R +A+  L+H +F
Sbjct: 275 RPSAKHVLKHPFF 287

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 188
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 189 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 226

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 163 ----GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G+  Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLXGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 196
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 197 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 6   EVIREGRYGAVHRAHDSLTGDT-----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           EVI  G +G V+  H +L  +        VK +  +    G  S  + E  ++K+  H N
Sbjct: 54  EVIGRGHFGCVY--HGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPN 110
Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGVA 114
           ++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+ 
Sbjct: 111 VLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMK 165
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y  S++ +HRDL   N ++D  K  VK+ADFGLAR  D+  + Y         K P + +
Sbjct: 166 YLASKKFVHRDLAARNCMLDE-KFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 222
Query: 175 G-----SGRYSTPVDVWAVACTFAEMVT 197
                 + +++T  DVW+      E++T
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLN 66
           ++  G +G V++   +  G  V VK++     ++G       EV ++    H N++RL  
Sbjct: 37  ILGRGGFGKVYKGRLA-DGXLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 67  VQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL---HGVAYCHSQ---E 120
              +     LV+  +    +     E   ++ PL   K     L    G+AY H     +
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYKAPERLLGSGRY 179
           I+HRD+K AN L+D   + V + DFGLA+ +D    +      G + + APE  L +G+ 
Sbjct: 155 IIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE-YLSTGKS 212
Query: 180 STPVDVWAVACTFAEMVTHQRLF 202
           S   DV+       E++T QR F
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAF 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 33  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 89  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 143
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 144 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 198
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LL+ I +G +G V        G+ V VK I     ++    + + E S++ +L+H N+V+
Sbjct: 25  LLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 64  LLNV-QSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           LL V       + +V E +    L+ ++++          + K+   +   + Y      
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRDL   N L+    ++ K++DFGL +      +   +    + + APE L    ++ST
Sbjct: 139 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR-EKKFST 193
Query: 182 PVDVWAVACTFAEMVTHQRLFHSR 205
             DVW+      E+ +  R+ + R
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPR 217

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 36  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 92  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 146
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 147 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 201
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 34  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 90  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 144
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 145 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 199
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 216
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 217 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 28  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 84  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 138
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 139 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 193
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 6   EVIREGRYGAVHRAHDSLTGDT-----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           EVI  G +G V+  H +L  +        VK +  +    G  S  + E  ++K+  H N
Sbjct: 55  EVIGRGHFGCVY--HGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPN 111
Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGVA 114
           ++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+ 
Sbjct: 112 VLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMK 166
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y  S++ +HRDL   N ++D  K  VK+ADFGLAR  D+  + Y         K P + +
Sbjct: 167 YLASKKFVHRDLAARNCMLDE-KFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 223
Query: 175 G-----SGRYSTPVDVWAVACTFAEMVT 197
                 + +++T  DVW+      E++T
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 5/217 (2%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  + V+ +G +G V  A    TGD   VK  K  ++   + V  ++  +  L     H 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            + +L     + D +  V E ++   L F   + +   +  + + Y  +I+  + + H +
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMF-HIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            I++RDLK  N L+D      K+ADFG+ +             G+  Y APE +L    Y
Sbjct: 144 GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQEMLY 201
Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
              VD WA+     EM+     F +     L  AI +
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 216
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 217 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKY 105
           + E S++ +  H NI+RL  V +      +V E ++   L  F++T        +++   
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGM 156
Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGS 164
           L  +  G+ Y      +HRDL   N L+D S  + K++DFGL+R + D P   YT  GG 
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 165 LC--YKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           +   + APE  +    +S+  DVW+      E++ +
Sbjct: 216 IPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLAY 250

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 116/302 (38%), Gaps = 40/302 (13%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-VPSSVIREVSLLKELK-HENIVR 63
           E++ EG Y  V  A     G    VK   I+    G   S V REV  L + + ++NI+ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVK---IIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 64  LLNVQSSVDSIDLVFENLDFD--LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           L+          LVFE L     L H  K +     N  +  + +  +   + + H++ I
Sbjct: 76  LIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHF---NEREASRVVRDVAAALDFLHTKGI 132
Query: 122 LHRDLKPANFLIDRSKDI--VKIADFGLAR---------PIDVPLENYTIKGGSLCYKAP 170
            HRDLKP N L +  + +  VKI DF L           PI  P    T   GS  Y AP
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP--ELTTPCGSAEYMAP 190
Query: 171 ERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           E +      +  Y    D+W++      M++          P  +    +  G    E  
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG--------YPPFVGHCGADCGWDRGEVC 242
Query: 227 PXXXXXXXXXXXXPNRS-PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                             P KD A +      +  DL+ ++L  D  +RL+A + L+H +
Sbjct: 243 RVCQNKLFESIQEGKYEFPDKDWAHI----SSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 286 FK 287
            +
Sbjct: 299 VQ 300

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 35  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 91  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 145
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 146 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 200
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 36  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 92  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 146
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 147 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 201
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID  +  +++ DFG A+          +KG +
Sbjct: 133 YAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAK---------RVKGRT 182
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 183 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 65
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 123
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLFH 203
           Y   VD W +     EM+          H+RLF 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 31  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 87  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 141
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI--KGGSLCYKAPE 171
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +    E Y++  K G+   K P 
Sbjct: 142 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDM-YDKEYYSVHNKTGA---KLPV 196
Query: 172 RLLG-----SGRYSTPVDVWAVACTFAEMVT 197
           + +      + +++T  DVW+      E++T
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 35  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 91  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 145
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI----DVPLENYTIKGGSLCYKA 169
            Y  S++ +HRDL   N ++D  K  VK+ADFGLAR +       + N T     + + A
Sbjct: 146 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVT 197
            E  L + +++T  DVW+      E++T
Sbjct: 205 LES-LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LL+ I +G +G V        G+ V VK I     ++    + + E S++ +L+H N+V+
Sbjct: 16  LLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQ 69
Query: 64  LLNV-QSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           LL V       + +V E +    L+ ++++          + K+   +   + Y      
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 129
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRDL   N L+    ++ K++DFGL +      +   +    + + APE L  +  +ST
Sbjct: 130 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREAA-FST 184
Query: 182 PVDVWAVACTFAEMVTHQRLFHSR 205
             DVW+      E+ +  R+ + R
Sbjct: 185 KSDVWSFGILLWEIYSFGRVPYPR 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LL+ I +G +G V        G+ V VK I     ++    + + E S++ +L+H N+V+
Sbjct: 10  LLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 64  LLNV-QSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           LL V       + +V E +    L+ ++++          + K+   +   + Y      
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 123
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRDL   N L+    ++ K++DFGL +      +   +    + + APE L    ++ST
Sbjct: 124 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR-EKKFST 178
Query: 182 PVDVWAVACTFAEMVTHQRLFHSR 205
             DVW+      E+ +  R+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 68
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 126
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 127 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 184
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLF 202
           Y   VD W +     EM+          H+RLF
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 65
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 123
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLF 202
           Y   VD W +     EM+          H+RLF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 70
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 128
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 129 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 186
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLFH 203
           Y   VD W +     EM+          H+RLF 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 220

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 13/204 (6%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LL+ I +G +G V        G+ V VK I     ++    + + E S++ +L+H N+V+
Sbjct: 197 LLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQ 250
Query: 64  LLNV-QSSVDSIDLVFENL-DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           LL V       + +V E +    L+ ++++          + K+   +   + Y      
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRDL   N L+    ++ K++DFGL +      +   +    + + APE L    ++ST
Sbjct: 311 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR-EKKFST 365
Query: 182 PVDVWAVACTFAEMVTHQRLFHSR 205
             DVW+      E+ +  R+ + R
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPR 389

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 65
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 123
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLFH 203
           Y   VD W +     EM+          H+RLF 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 65
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 123
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLF 202
           Y   VD W +     EM+          H+RLF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 37  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 93  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 147
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARP-IDVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR  +D   ++   K G+   K P +
Sbjct: 148 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMLDKEFDSVHNKTGA---KLPVK 203
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK--KIPIMNPSEGVPSSVIREVSLLKELKHE 59
           +  L+++ +G +G V    +  TG    +K  +  ++   + V  +V  E  +L+  +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHP 65
Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHF-MKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +  L     + D +  V E  +   L F +  E   T+   + + Y  +I+  + Y HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS 123
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +++++RD+K  N ++D+   I KI DFGL +             G+  Y APE +L    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 179 YSTPVDVWAVACTFAEMVT---------HQRLF 202
           Y   VD W +     EM+          H+RLF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 36  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 92  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 146
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P +
Sbjct: 147 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVK 202
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 37  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 93  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 147
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P +
Sbjct: 148 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVK 203
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 36  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 92  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 146
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P +
Sbjct: 147 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVK 202
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 34  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 90  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 144
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P +
Sbjct: 145 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVK 200
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 6   EVIREGRYGAVHRAHDSLTGDT-----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           EVI  G +G V+  H +L  +        VK +  +    G  S  + E  ++K+  H N
Sbjct: 95  EVIGRGHFGCVY--HGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPN 151
Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGVA 114
           ++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+ 
Sbjct: 152 VLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMK 206
Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERL 173
           +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P + 
Sbjct: 207 FLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVKW 262
Query: 174 LG-----SGRYSTPVDVWAVACTFAEMVT 197
           +      + +++T  DVW+      E++T
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 33/230 (14%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
           R  +  V+ EG +  V+ A D  +G    +K++  ++  E    ++I+EV  +K+L  H 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 60  NIVRLLNVQS--------SVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQ 108
           NIV+  +  S              L+ E     L+ F+K     ++ PL    + K  +Q
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK--MESRGPLSCDTVLKIFYQ 144
Query: 109 ILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPID------------VP 154
               V + H Q+  I+HRDLK  N L+  ++  +K+ DFG A  I               
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 155 LENYTIKGGSLCYKAPE--RLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           +E    +  +  Y+ PE   L  +       D+WA+ C    +   Q  F
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKELKHE 59
           EVI  G +G V+  H +L  +    KKI     S       G  S  + E  ++K+  H 
Sbjct: 41  EVIGRGHFGCVY--HGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 96
Query: 60  NIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPL--KIKKYLHQILHGV 113
           N++ LL +    +   LV   L +    DL +F++ E   T NP    +  +  Q+  G+
Sbjct: 97  NVLSLLGICLRSEGSPLVV--LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM 151
Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPER 172
            +  S++ +HRDL   N ++D  K  VK+ADFGLAR + D   ++   K G+   K P +
Sbjct: 152 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGA---KLPVK 207
Query: 173 LLG-----SGRYSTPVDVWAVACTFAEMVT 197
            +      + +++T  DVW+      E++T
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE +L  G Y+  VD WA+     +M  
Sbjct: 196 WXLCGTPEYLAPEIILSKG-YNKAVDWWALGVLIYQMAA 233

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVR 63
           +VI  G +G V   H  L G   +   I  +    +E      + E S++ +  H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 64  LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           L  V +    + ++ E ++   L     +       +++   L  I  G+ Y      +H
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 158
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGS---LCYKAPERLLGSGR 178
           RDL   N L++ S  + K++DFGL+R +  D     YT   G    + + APE +    +
Sbjct: 159 RDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 216
Query: 179 YSTPVDVWAVACTFAEMVTH 198
           +++  DVW+      E++++
Sbjct: 217 FTSASDVWSYGIVMWEVMSY 236

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 81  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 140 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 199 LHR-IYTHQSDVWSYGVTVWELMT 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 136 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 195 -IYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 76  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 135 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 194 LHR-IYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 78  PHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 137 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 196 -IYTHQSDVWSYGVTVWELMT 215

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N +ID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLIIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y APE ++  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPEIIISKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 77  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 136 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 195 LHR-IYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 78  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 137 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 196 LHR-IYTHQSDVWSYGVTVWELMT 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 78  PHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 137 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 196 -IYTHQSDVWSYGVTVWELMT 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           RY L E++  G    VH A D      V VK +      +  PS  +R   E      L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN 70
Query: 58  HENIVRLLNVQSSVDSID----LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H  IV + +   +         +V E +D   L   + TE  +T  P +  + +      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 128
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKA 169
           + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T      G+  Y +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE+  G        DV+++ C   E++T +  F
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           RY L E++  G    VH A D      V VK +      +  PS  +R   E      L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN 70
Query: 58  HENIVRLLNVQSSVDSID----LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H  IV + +   +         +V E +D   L   + TE  +T  P +  + +      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 128
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKA 169
           + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T      G+  Y +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE+  G        DV+++ C   E++T +  F
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           RY L E++  G    VH A D      V VK +      +  PS  +R   E      L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN 70
Query: 58  HENIVRLLNVQSSVDSID----LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H  IV + +   +         +V E +D   L   + TE  +T  P +  + +      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 128
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKA 169
           + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T      G+  Y +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE+  G        DV+++ C   E++T +  F
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 81  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 140 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 199 LHR-IYTHQSDVWSYGVTVWELMT 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           RY L E++  G    VH A D      V VK +      +  PS  +R   E      L 
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN 87
Query: 58  HENIVRLLNVQSSVDSID----LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H  IV + +   +         +V E +D   L   + TE  +T  P +  + +      
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 145
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKA 169
           + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T      G+  Y +
Sbjct: 146 LNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 204
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE+  G        DV+++ C   E++T +  F
Sbjct: 205 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 20  IKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 136 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 195 -IYTHQSDVWSYGVTVWELMT 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVP----SSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP  IM   E         ++ E  ++  + +
Sbjct: 54  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 111 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 169
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 170 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 229 -IYTHQSDVWSYGVTVWELMT 248

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC    Y AP  +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEYLAPAIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 17  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 74  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED 132
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 133 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 192 -IYTHQSDVWSYGVTVWELMT 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 6   EVIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           EVI  G +G V R      G  ++ V  K      +E      + E S++ + +H NI+R
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 64  LLNVQSSVDSIDLV---FENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           L  V ++   + ++    EN   D  L     + TV    +++   L  I  G+ Y    
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRYLAEM 137
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDV----PLENYTIKGG-SLCYKAPERLL 174
             +HRDL   N L++ S  + K++DFGL+R ++     P E  ++ G   + + APE  +
Sbjct: 138 SYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE-AI 195
Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
              ++++  D W+      E+++
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 77  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 136 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 195 LHR-IYTHQSDVWSYGVTVWELMT 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 125/310 (40%), Gaps = 65/310 (20%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y + E I  G Y    R     T     VK   I++ S+  P+  I    LL+  +H NI
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVK---IIDKSKRDPTEEIE--ILLRYGQHPNI 78
Query: 62  VRLLNVQSSVDSIDLVFE-NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           + L +V      + +V E     +LL  +  +   ++   +    L  I   V Y H+Q 
Sbjct: 79  ITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSER--EASAVLFTITKTVEYLHAQG 136
Query: 121 ILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK----APERL 173
           ++HRDLKP+N L +D S +   ++I DFG A+ +    EN  +   + CY     APE L
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLX--TPCYTANFVAPEVL 192
Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXX 233
              G Y    D+W++       +T     ++ +A G                        
Sbjct: 193 ERQG-YDAACDIWSLGVLLYTXLTG----YTPFANG------------------------ 223
Query: 234 XXXXXXPNRSPIKDLATVVGG-----------LEPDGVDLLRRMLCLDPSKRLTAREALR 282
                 P+ +P + LA +  G           +     DL+ + L +DP +RLTA   LR
Sbjct: 224 ------PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLR 277
Query: 283 HEYFKDFQSL 292
           H +   +  L
Sbjct: 278 HPWIVHWDQL 287

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 136 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 195 -IYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 81  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 140 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 199 LHR-IYTHQSDVWSYGVTVWELMT 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR--EVSLLKELKHENIVRLL 65
           +  G +G VHR  D  TG    VKK+ +          V R  E+     L    IV L 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLY 116
Query: 66  NVQSSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
                   +++  E L+   L   +K    + ++  +   YL Q L G+ Y H++ ILH 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRRILHG 174
Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDV-PLENYTIKG----GSLCYKAPERLLGSGRY 179
           D+K  N L+        + DFG A  +    L    + G    G+  + APE ++G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PC 233
Query: 180 STPVDVWAVACTFAEMVT 197
              VD+W+  C    M+ 
Sbjct: 234 DAKVDIWSSCCMMLHMLN 251

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 133 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 192 LHR-IYTHQSDVWSYGVTVWELMT 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDXXK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 83
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 84  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 143 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 202 LHR-IYTHQSDVWSYGVTVWELMT 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLL----KELK 57
           +  L  +  G YG V +      G    VK+   M+P  G P    R+++ +    K  +
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS--MSPFRG-PKDRARKLAEVGSHEKVGQ 115
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           H   VRL         + L  E     L    +     +    ++  YL   L  +A+ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH 174
Query: 118 SQEILHRDLKPAN-FLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           SQ ++H D+KPAN FL  R +   K+ DFGL   +        ++ G   Y APE L GS
Sbjct: 175 SQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG-EVQEGDPRYMAPELLQGS 231
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHS 204
             Y T  DV+++  T  E+  +  L H 
Sbjct: 232 --YGTAADVFSLGLTILEVACNMELPHG 257

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 79  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 138 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 197 -IYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 79
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 80  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +
Sbjct: 139 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 198 LHR-IYTHQSDVWSYGVTVWELMT 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 71  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 130 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 189 -IYTHQSDVWSYGVTVWELMT 208

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 80  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 139 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 198 -IYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 136 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 195 -IYTHQSDVWSYGVTVWELMT 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 20/195 (10%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR--EVSLLKELKHENIVRLLNVQ 68
           G +G VHR  D  TG    VKK+ +          V R  E+     L    IV L    
Sbjct: 83  GSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 69  SSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLK 127
                +++  E L+   L   +K    + ++  +   YL Q L G+ Y H++ ILH D+K
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 128 PANFLIDRSKDIVKIADFGLARPIDV-PLENYTIKG----GSLCYKAPERLLGSGRYSTP 182
             N L+        + DFG A  +    L    + G    G+  + APE ++G       
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAK 250
Query: 183 VDVWAVACTFAEMVT 197
           VD+W+  C    M+ 
Sbjct: 251 VDIWSSCCMMLHMLN 265

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 80  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 139 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 198 -IYTHQSDVWSYGVTVWELMT 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR--EVSLLKELKHENIVRLL 65
           +  G +G VHR  D  TG    VKK+ +          V R  E+     L    IV L 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVEELVACAGLSSPRIVPLY 132
Query: 66  NVQSSVDSIDLVFENLDFDLL-HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
                   +++  E L+   L   +K    + ++  +   YL Q L G+ Y H++ ILH 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTRRILHG 190
Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDV-PLENYTIKG----GSLCYKAPERLLGSGRY 179
           D+K  N L+        + DFG A  +    L    + G    G+  + APE ++G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PC 249
Query: 180 STPVDVWAVACTFAEMVT 197
              VD+W+  C    M+ 
Sbjct: 250 DAKVDIWSSCCMMLHMLN 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDXXK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKELKH 58
           ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  + +
Sbjct: 45  IKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 102 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 160
Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
           + ++HRDL   N L+ ++   VKI DFGLA+ +    + Y  +GG +  K  A E +L  
Sbjct: 161 RRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 177 GRYSTPVDVWAVACTFAEMVT 197
             Y+   DVW+   T  E++T
Sbjct: 220 -IYTHQSDVWSYGVTVWELMT 239

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 87/366 (23%), Positives = 142/366 (38%), Gaps = 88/366 (24%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++  +  G +  V    D + G   V  K+  +  ++    + + E+ LLK ++  +
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWD-MQGKRFVAMKV--VKSAQHYTETALDEIKLLKCVRESD 88
Query: 61  --------IVRLLN--VQSSVDSID--LVFENLDFDLLHFMKTEPTVTKNPLK-IKKYLH 107
                   +V+L++    S ++ I   +VFE L   LL ++  +      P++ +K  + 
Sbjct: 89  PSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWI-IKSNYQGLPVRCVKSIIR 147
Query: 108 QILHGVAYCHSQ-EILHRDLKPANFLI--------------------------------- 133
           Q+L G+ Y HS+ +I+H D+KP N L+                                 
Sbjct: 148 QVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTA 207
Query: 134 -------------DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
                        +  K  VKIAD G A  +    +++T    +  Y++ E L+G+G YS
Sbjct: 208 PAADLLVNPLDPRNADKIRVKIADLGNACWVH---KHFTEDIQTRQYRSIEVLIGAG-YS 263
Query: 181 TPVDVWAVACTFAEMVTHQRLF-------------HSRWAPGLLAAI---FSIMGTPDSE 224
           TP D+W+ AC   E+ T   LF             H      LL +I   F++ G    E
Sbjct: 264 TPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSRE 323
Query: 225 TLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGV---DLLRRMLCLDPSKRLTAREAL 281
                          P  S    L    G    D     D L  ML + P KR +A E L
Sbjct: 324 FFNRRGELRHITKLKP-WSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECL 382
Query: 282 RHEYFK 287
           RH +  
Sbjct: 383 RHPWLN 388

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 96  TKNPLKIKKYLHQI---LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID 152
           T+ P+  K+ +  I      + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIA 167
Query: 153 VPLENYTIKG---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
               + T      G+  Y +PE+  G        DV+++ C   E++T +  F
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 17/99 (17%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  QI+    Y HS ++++RDLKP N LID+ +  +++ DFG A+          +KG +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAK---------RVKGRT 195
Query: 165 --LCYK----APERLLGSGRYSTPVDVWAVACTFAEMVT 197
             LC      APE +L  G Y+  VD WA+     EM  
Sbjct: 196 WXLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR---EVSLLKELK 57
           RY L E++  G    VH A D      V VK +      +  PS  +R   E      L 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN 70
Query: 58  HENIVRLLNVQSSVDSID----LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           H  IV + +   +         +V E +D   L   + TE  +T  P +  + +      
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIADACQA 128
Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKA 169
           + + H   I+HRD+KPAN LI  + + VK+ DFG+AR I     +        G+  Y +
Sbjct: 129 LNFSHQNGIIHRDVKPANILIS-ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLS 187
Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
           PE+  G        DV+++ C   E++T +  F
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 NTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 47  IREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKY 105
           + E S++ +  H NI+RL  V +      +V E ++   L  F++T        +++   
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGM 156
Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGS 164
           L  +  G+ Y      +HRDL   N L+D S  + K++DFGL+R + D P    T  GG 
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 165 LC--YKAPERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           +   + APE  +    +S+  DVW+      E++ +
Sbjct: 216 IPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLAY 250

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 25/120 (20%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  Q+  G+ +  S++ +HRDL   N L+  + ++VKI DFGLAR I     +Y  KG +
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSEN-NVVKICDFGLARDI-YKNPDYVRKGDT 261
Query: 165 ---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
              L + APE +     YST  DVW+                      LL  IFS+ G+P
Sbjct: 262 RLPLKWMAPESIFDK-IYSTKSDVWSYGV-------------------LLWEIFSLGGSP 301

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 88
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L+F        E  ++
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE 156
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I     
Sbjct: 149 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDX 205
Query: 157 NYTIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
                 G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 247

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 57/244 (23%)
Query: 101 KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--------- 151
           ++++Y+  +   +   H   I+HRD+KP+NFL +R      + DFGLA+           
Sbjct: 118 EVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 152 ----DVPLENYTIKGGSLC---------------YKAPERLLGSGRYSTPVDVWAVACTF 192
               +   E  +    S+C               ++APE L      +T +D+W+    F
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 193 AEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPXXXXXXXXXXXXPNRSPIKDL---- 248
             +++ +  F+   A   L A+  IM    S                    P +DL    
Sbjct: 238 LSLLSGRYPFYK--ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC 295
Query: 249 --------------------ATVVGGLE--PD-GVDLLRRMLCLDPSKRLTAREALRHEY 285
                               AT + G    PD   DLL ++L L+P+ R+TA EAL H +
Sbjct: 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355
Query: 286 FKDF 289
           FKD 
Sbjct: 356 FKDM 359

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR- 178
           +I+HRD+KP+N L+DRS +I K+ DFG++  + V     T   G   Y APER+  S   
Sbjct: 146 KIIHRDIKPSNILLDRSGNI-KLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 179 --YSTPVDVWAVACTFAEMVTHQRLFHSRW 206
             Y    DVW++  T  E+ T  R  + +W
Sbjct: 204 QGYDVRSDVWSLGITLYELATG-RFPYPKW 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            L + + EG +G V +A         G T V  K+   N S      ++ E ++LK++ H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLK---------------- 101
            ++++L    S    + L+ E   +  L  F++    V    L                 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 102 ------IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL 155
                 +  +  QI  G+ Y    +++HRDL   N L+   + + KI+DFGL+R  DV  
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM-KISDFGLSR--DVYE 202
Query: 156 ENYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           E+  +K       + + A E L     Y+T  DVW+      E+VT
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVT 247

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 7   VIREGRYGAVHRA-HDSLTGDTVVV-----KKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ EG +G V+   + +  G+ + V     KK   ++  E      + E  ++K L H +
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE----KFMSEAVIMKNLDHPH 86
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAYC 116
           IV+L+ +    +   ++ E   + +L H+++      KN LK+     Y  QI   +AY 
Sbjct: 87  IVKLIGIIEE-EPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYL 141
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLG 175
            S   +HRD+   N L+  S + VK+ DFGL+R I D      ++    + + +PE  + 
Sbjct: 142 ESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES-IN 199
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQR 200
             R++T  DVW  A    E+++  +
Sbjct: 200 FRRFTTASDVWMFAVCMWEILSFGK 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 7   VIREGRYGAVHRA-HDSLTGDTVVV-----KKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ EG +G V+   + +  G+ + V     KK   ++  E      + E  ++K L H +
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE----KFMSEAVIMKNLDHPH 74
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAYC 116
           IV+L+ +    +   ++ E   + +L H+++      KN LK+     Y  QI   +AY 
Sbjct: 75  IVKLIGIIEE-EPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYL 129
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLG 175
            S   +HRD+   N L+  S + VK+ DFGL+R I D      ++    + + +PE  + 
Sbjct: 130 ESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES-IN 187
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQR 200
             R++T  DVW  A    E+++  +
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGK 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            L + + EG +G V +A         G T V  K+   N S      ++ E ++LK++ H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLK---------------- 101
            ++++L    S    + L+ E   +  L  F++    V    L                 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 102 ------IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL 155
                 +  +  QI  G+ Y    +++HRDL   N L+   + + KI+DFGL+R  DV  
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM-KISDFGLSR--DVYE 202
Query: 156 ENYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           E+  +K       + + A E L     Y+T  DVW+      E+VT
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVT 247

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 7   VIREGRYGAVHRA-HDSLTGDTVVV-----KKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ EG +G V+   + +  G+ + V     KK   ++  E   S    E  ++K L H +
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----EAVIMKNLDHPH 70
Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKK---YLHQILHGVAYC 116
           IV+L+ +    +   ++ E   + +L H+++      KN LK+     Y  QI   +AY 
Sbjct: 71  IVKLIGIIEE-EPTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYL 125
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLG 175
            S   +HRD+   N L+  S + VK+ DFGL+R I D      ++    + + +PE  + 
Sbjct: 126 ESINCVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES-IN 183
Query: 176 SGRYSTPVDVWAVACTFAEMVTHQR 200
             R++T  DVW  A    E+++  +
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGK 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 35/226 (15%)
Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            L + + EG +G V +A         G T V  K+   N S      ++ E ++LK++ H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLK---------------- 101
            ++++L    S    + L+ E   +  L  F++    V    L                 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 102 ------IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL 155
                 +  +  QI  G+ Y     ++HRDL   N L+   + + KI+DFGL+R  DV  
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKM-KISDFGLSR--DVYE 202
Query: 156 ENYTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           E+  +K       + + A E L     Y+T  DVW+      E+VT
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVT 247

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +L 
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKLN 92
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 210
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 211 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +L 
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKLN 106
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 224
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 225 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 76  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 135 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 194 LHR-IYTHQSDVWSYGVTVWELMT 216

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 87/200 (43%), Gaps = 9/200 (4%)
Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVR 63
           +VI  G +G V   H  L G   +   I  +    +E      + E S++ +  H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 64  LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILH 123
           L  V +    + ++ E ++   L     +       +++   L  I  G+ Y      +H
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 132
Query: 124 RDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGS---LCYKAPERLLGSGR 178
           R L   N L++ S  + K++DFGL+R +  D     YT   G    + + APE  +   +
Sbjct: 133 RALAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE-AIQYRK 190
Query: 179 YSTPVDVWAVACTFAEMVTH 198
           +++  DVW+      E++++
Sbjct: 191 FTSASDVWSYGIVMWEVMSY 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 78  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 137 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 196 LHR-IYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 76  VDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 135 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 194 LHR-IYTHQSDVWSYGVTVWELMT 216

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 84
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 85  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 203
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 204 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 87
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 88  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 206
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 207 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 82
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 83  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTEN-NVMKIADFGLARDINNIDYYK 201
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 202 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 241

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENYTIKGG 163
           Y  +++  +   HS   +HRD+KP N L+D+S  + K+ADFG    ++   +       G
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVG 231
Query: 164 SLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
           +  Y +PE L    G G Y    D W+V     EM+     F+   A  L+     IM  
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY---ADSLVGTYSKIMNH 288
Query: 221 PDSETLP 227
            +S T P
Sbjct: 289 KNSLTFP 295

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENYTIKGG 163
           Y  +++  +   HS   +HRD+KP N L+D+S  + K+ADFG    ++   +       G
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVG 236
Query: 164 SLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
           +  Y +PE L    G G Y    D W+V     EM+     F+   A  L+     IM  
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY---ADSLVGTYSKIMNH 293
Query: 221 PDSETLP 227
            +S T P
Sbjct: 294 KNSLTFP 300

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+      
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYK 260
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 261 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 300

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-LENYTIKGG 163
           Y  +++  +   HS   +HRD+KP N L+D+S  + K+ADFG    ++   +       G
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVG 236
Query: 164 SLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
           +  Y +PE L    G G Y    D W+V     EM+     F+   A  L+     IM  
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY---ADSLVGTYSKIMNH 293
Query: 221 PDSETLP 227
            +S T P
Sbjct: 294 KNSLTFP 300

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 6   EVIREGRYGAVHRAHDSLTG--DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           EVI  G +G V R      G  ++ V  K      +E      + E S++ + +H NI+R
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 64  LLNVQSSVDSIDLV---FENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           L  V ++   + ++    EN   D  L     + TV    +++   L  I  G+ Y    
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRYLAEM 135
Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-----YTIKGGS---LCYKAPE 171
             +HRDL   N L++ S  + K++DFGL+R ++   EN     YT   G    + + APE
Sbjct: 136 SYVHRDLAARNILVN-SNLVCKVSDFGLSRFLE---ENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVT 197
             +   ++++  D W+      E+++
Sbjct: 192 -AIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKEL 56
           ++TL  ++ +G +G+V  A      D   VK    M  ++ + SS     +RE + +KE 
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLK-QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 57  KHENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIK-----KY 105
            H ++ +L+ V     +        ++   +    LH       + +NP  +      ++
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLENYTIKGGS 164
           +  I  G+ Y  S+  +HRDL   N ++  ++D+ V +ADFGL+R I     +Y  +G +
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKIYSG--DYYRQGCA 198
Query: 165 LCYKAPERL-----LGSGRYSTPVDVWAVACTFAEMVT 197
              K P +      L    Y+   DVWA   T  E++T
Sbjct: 199 --SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           + TL + + EG +G V  A       D       V  K+   + +E   S ++ E+ ++K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTE-----------PTVTKNPLK 101
            + KH+NI+ LL   +    + ++ E     +L  +++               V +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
            K  +   +Q+  G+ Y  SQ+ +HRDL   N L+  + ++++IADFGLAR I+      
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMRIADFGLARDINNIDYYK 214
Query: 159 TIKGGSLCYK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
               G L  K  APE L     Y+   DVW+      E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANSFV 195
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL     S   D+WA+ C   ++V 
Sbjct: 196 GTAQYVSPE-LLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 29  RLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 86
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDFDLLHFMKTEPTVTKNPLKIKK--- 104
               H N+V LL   +      +V      F NL    L   + E    K P  + K   
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS-TYLRSKRNEFVPYKTPEDLYKDFL 145
Query: 105 -------YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
                  Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR  D+  + 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLAR--DIXKDP 202
Query: 158 YTIKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
             ++ G     L + APE +     Y+   DVW+      E+ +
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 245

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 81  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 140 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 199 LHR-IYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 76  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 135 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 194 LHR-IYTHQSDVWSYGVTVWELMT 216

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELK 57
           +++  +I  G +G V+    + TG    +K    K   M   E +  +    +SL+    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
              IV +     + D +  + + ++   LH+  ++  V      ++ Y  +I+ G+ + H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 309
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           ++ +++RDLKPAN L+D     V+I+D GLA   D   +      G+  Y APE L    
Sbjct: 310 NRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 178 RYSTPVDVWAVACTFAEMV 196
            Y +  D +++ C   +++
Sbjct: 367 AYDSSADWFSLGCMLFKLL 385

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 92
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 210
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 211 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 25  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 83
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 84  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 144 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 201
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 202 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 88
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLDFDLL--HFMKTEP---TVTKNP-------LK 101
            + KH+NI+ LL   +    + ++ E      L  +    EP     + NP       L 
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 102 IKKYL---HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLEN 157
            K  +   +Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +    
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYK 207
Query: 158 YTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELK 57
           +++  +I  G +G V+    + TG    +K    K   M   E +  +    +SL+    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
              IV +     + D +  + + ++   LH+  ++  V      ++ Y  +I+ G+ + H
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 308
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           ++ +++RDLKPAN L+D     V+I+D GLA   D   +      G+  Y APE L    
Sbjct: 309 NRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGV 365
Query: 178 RYSTPVDVWAVACTFAEMV 196
            Y +  D +++ C   +++
Sbjct: 366 AYDSSADWFSLGCMLFKLL 384

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELK 57
           +++  +I  G +G V+    + TG    +K    K   M   E +  +    +SL+    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
              IV +     + D +  + + ++   LH+  ++  V      ++ Y  +I+ G+ + H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 309
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           ++ +++RDLKPAN L+D     V+I+D GLA   D   +      G+  Y APE L    
Sbjct: 310 NRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 178 RYSTPVDVWAVACTFAEMV 196
            Y +  D +++ C   +++
Sbjct: 367 AYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK----KIPIMNPSEGVPSSVIREVSLLKELK 57
           +++  +I  G +G V+    + TG    +K    K   M   E +  +    +SL+    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
              IV +     + D +  + + ++   LH+  ++  V      ++ Y  +I+ G+ + H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 309
Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           ++ +++RDLKPAN L+D     V+I+D GLA   D   +      G+  Y APE L    
Sbjct: 310 NRFVVYRDLKPANILLDEHGH-VRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 178 RYSTPVDVWAVACTFAEMV 196
            Y +  D +++ C   +++
Sbjct: 367 AYDSSADWFSLGCMLFKLL 385

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVY-SEQDELDFLMEALIISKFN 106
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 224
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 225 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 89/230 (38%), Gaps = 20/230 (8%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
           I  G +  V++  D+ T   V   ++     ++        E   LK L+H NIVR  + 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 68  QSSV----DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--I 121
             S       I LV E      L        V K  + ++ +  QIL G+ + H++   I
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV-LRSWCRQILKGLQFLHTRTPPI 152
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST 181
           +HRDLK  N  I      VKI D GLA           I  G+  + APE      +Y  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFXAPEXY--EEKYDE 208
Query: 182 PVDVWAVACTFAEMVTHQRLF---------HSRWAPGLLAAIFSIMGTPD 222
            VDV+A      E  T +  +         + R   G+  A F  +  P+
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 91
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 209
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 210 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 106
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 107 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 224
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 225 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIM------NPSEGVPSSVIREVSLLKE 55
           +  ++V+  G +G V++      G+ V   KIP+         S      ++ E  ++  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           + + ++ RLL +     ++ L+ + + F  L     E         +  +  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERL 173
              + ++HRDL   N L+ ++   VKI DFG A+ +    + Y  +GG +  K  A E +
Sbjct: 133 LEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
           L    Y+   DVW+   T  E++T
Sbjct: 192 LHR-IYTHQSDVWSYGVTVWELMT 214

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 91
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 209
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 210 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 40  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 98
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 99  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 159 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 216
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 217 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 50  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 108
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 109 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 169 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 226
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 227 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 87
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDF-------DLLHFMKTEPTVTKNPL 100
               H N+V LL   +      +V      F NL         + + + +    + K+ L
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 101 KIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
            ++    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPD 205
Query: 158 YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 206 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 51  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 109
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 110 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+    Y  KGG     +
Sbjct: 170 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPV 227
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 228 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 132
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+    Y  KGG     +
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPV 250
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 251 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR 63
           LLE+   GR+G V +A   L  D V VK  P+ +          RE+     +KHEN+++
Sbjct: 19  LLEIKARGRFGCVWKAQ--LMNDFVAVKIFPLQDKQSWQSE---REIFSTPGMKHENLLQ 73
Query: 64  LLNVQSSVDSIDL------VFENLDFDLLHFMKTEPTVTKNPL-----KIKKYLHQILHG 112
            +  +    ++++       F +    L  ++K    +T N L      + + L  +   
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHD-KGSLTDYLKGN-IITWNELCHVAETMSRGLSYLHED 131
Query: 113 VAYC----HSQEILHRDLKPANFLIDRSKDIVKIADFGLA---RPIDVPLENYTIKGGSL 165
           V +C    H   I HRD K  N L+ +S     +ADFGLA    P   P + +  + G+ 
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLL-KSDLTAVLADFGLAVRFEPGKPPGDTHG-QVGTR 189
Query: 166 CYKAPERLLGSGRYSTP----VDVWAVACTFAEMVT 197
            Y APE L G+  +       +D++A+     E+V+
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKK-IPIMNPSEGVPS--SVIREVSLLKELKHENI 61
           L+V+  G +G VH+      G+++ +   I ++    G  S  +V   +  +  L H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           VRLL +     S+ LV + L    L     +      P  +  +  QI  G+ Y     +
Sbjct: 78  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +HR+L   N L+ +S   V++ADFG+A   P D     Y+     + + A E +   G+Y
Sbjct: 137 VHRNLAARNVLL-KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-HFGKY 194
Query: 180 STPVDVWAVACTFAEMVT 197
           +   DVW+   T  E++T
Sbjct: 195 THQSDVWSYGVTVWELMT 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 16  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 74
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 75  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 131
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 132 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 188
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 189 SDVWSFGVLMWEAFSY 204

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 60  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 118
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 119 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 179 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 236
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 237 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 86
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 87  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 143
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 144 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 200
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 201 SDVWSFGVLMWEAFSY 216

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 18  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 76
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 77  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 133
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 134 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 190
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 191 SDVWSFGVLMWEAFSY 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 22  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 80
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 81  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 137
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 138 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 194
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 195 SDVWSFGVLMWEAFSY 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHR--ALMSELKILI 85
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDFDLLHFMKTEPTVTKNPLK------ 101
               H N+V LL   +      +V      F NL    L   + E    K+  K      
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS-TYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 102 -IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
            +  Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +Y  
Sbjct: 145 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDI-YKDPDYVR 202
Query: 161 KGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 203 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 241

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 38  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 96
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 97  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 153
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 154 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 210
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 211 SDVWSFGVLMWEAFSY 226

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 38  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 96
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 97  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 153
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 154 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 210
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 211 SDVWSFGVLMWEAFSY 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 5   LEVIREGRYGAVHRAHDSLTGDTVVVKK-IPIMNPSEGVPS--SVIREVSLLKELKHENI 61
           L+V+  G +G VH+      G+++ +   I ++    G  S  +V   +  +  L H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           VRLL +     S+ LV + L    L     +      P  +  +  QI  G+ Y     +
Sbjct: 96  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 154
Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLAR--PIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +HR+L   N L+ +S   V++ADFG+A   P D     Y+     + + A E +   G+Y
Sbjct: 155 VHRNLAARNVLL-KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI-HFGKY 212
Query: 180 STPVDVWAVACTFAEMVT 197
           +   DVW+   T  E++T
Sbjct: 213 THQSDVWSYGVTVWELMT 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 36  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 94
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 95  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 151
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 152 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 208
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 209 SDVWSFGVLMWEAFSY 224

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+          G L 
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 167 YK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
            K  APE L     Y+   DVW+      E+ T
Sbjct: 223 VKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           +Q+  G+ Y  SQ+ +HRDL   N L+  + +++KIADFGLAR I+          G L 
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 167 YK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
            K  APE L     Y+   DVW+      E+ T
Sbjct: 223 VKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHR--ALMSELKILI 85
Query: 58  ----HENIVRLLNVQSSVDS-IDLVFENLDF-DLLHFMKTEPT-------VTKNPLKIKK 104
               H N+V LL   +     + ++ E   F +L  +++++         + K+ L ++ 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 105 ---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
              Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +Y  K
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPDYVRK 203
Query: 162 GGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G +   L + APE +     Y+   DVW+      E+ +
Sbjct: 204 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 241

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 8/129 (6%)
Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID-VPLENYTIK 161
           K Y  +++  +   HS  ++HRD+KP N L+D+   + K+ADFG    +D   + +    
Sbjct: 177 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL-KLADFGTCMKMDETGMVHCDTA 235
Query: 162 GGSLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
            G+  Y +PE L    G G Y    D W+V     EM+     F+   A  L+     IM
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY---ADSLVGTYSKIM 292
Query: 219 GTPDSETLP 227
              +S   P
Sbjct: 293 DHKNSLCFP 301

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 37/172 (21%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           YL +++  +   H    +HRD+KP N L+D +  I ++ADFG    +   +E+ T++   
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKL---MEDGTVQSSV 235
Query: 163 --GSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
             G+  Y +PE L     G GRY    D W++     EM+  +  F+   A  L+     
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGK 292
Query: 217 IMGTPDSETLPXXXXXXXXXXXXPNRSPIKDLATVVGGLEPDGVDLLRRMLC 268
           IM   +    P                      T V  +  +  DL+RR++C
Sbjct: 293 IMNHKERFQFP----------------------TQVTDVSENAKDLIRRLIC 322

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 80
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L++        E  ++
Sbjct: 81  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPL 155
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +  
Sbjct: 141 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 197
Query: 156 ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 88
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L++        E  ++
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPL 155
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +  
Sbjct: 149 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 205
Query: 156 ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 247

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANAFV 193
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 194 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 81
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L++        E  ++
Sbjct: 82  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPL 155
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +  
Sbjct: 142 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 198
Query: 156 ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 43/244 (17%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 88
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT--------------EPTVTKN 98
            + KH+NI+ LL   +    + ++ E     +L  +++                P    +
Sbjct: 89  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY 158
              +    +Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR  D+   +Y
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLAR--DIHHIDY 205
Query: 159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSI 217
             K              +GR   PV   A    F  + THQ      W+ G LL  IF++
Sbjct: 206 YKK------------TTNGR--LPVKWMAPEALFDRIYTHQ---SDVWSFGVLLWEIFTL 248
Query: 218 MGTP 221
            G+P
Sbjct: 249 GGSP 252

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 77
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L++        E  ++
Sbjct: 78  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPL 155
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +  
Sbjct: 138 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 194
Query: 156 ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 6   EVIREGRYGAVHRAH---DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +VI EG +G V +A    D L  D  + +     +  +    +   EV L K   H NI+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 89
Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMK------TEPTV-----TKNPLKIKKYLH--- 107
            LL        + L  E     +LL F++      T+P       T + L  ++ LH   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
            +  G+ Y   ++ +HRDL   N L+  +  + KIADFGL+R  +V ++  T+    + +
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK-TMGRLPVRW 207
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            A E L  S  Y+T  DVW+      E+V+
Sbjct: 208 MAIESLNYS-VYTTNSDVWSYGVLLWEIVS 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFE-----------------NLDFDLLHFMKTEPTVT 96
            + KH+NI+ LL   +    + ++ E                  L++        E  ++
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPL 155
              L    Y  Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +  
Sbjct: 190 SKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 246
Query: 156 ENYTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
              T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 288

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/195 (21%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 22  GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 80
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 81  CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 137
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS---LCYKAPERLLGSGRYSTPV 183
              N L+  ++   KI+DFGL++ +      Y  +      + + APE  +   ++S+  
Sbjct: 138 AARNVLL-VTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE-CINYYKFSSKS 195
Query: 184 DVWAVACTFAEMVTH 198
           DVW+      E  ++
Sbjct: 196 DVWSFGVLMWEAFSY 210

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 6   EVIREGRYGAVHRAH---DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           +VI EG +G V +A    D L  D  + +     +  +    +   EV L K   H NI+
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 79
Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMK------TEPTV-----TKNPLKIKKYLH--- 107
            LL        + L  E     +LL F++      T+P       T + L  ++ LH   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
            +  G+ Y   ++ +HRDL   N L+  +  + KIADFGL+R  +V ++  T+    + +
Sbjct: 140 DVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK-TMGRLPVRW 197
Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            A E  L    Y+T  DVW+      E+V+
Sbjct: 198 MAIES-LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 7/103 (6%)
Query: 109 ILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
           I+  + + HS+  ++HRD+KP+N LI+ +   VK+ DFG++  + V     TI  G   Y
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYL-VDSVAKTIDAGCKPY 219
Query: 168 KAPERL---LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA 207
            APER+   L    YS   D+W++  T  E+    R  +  W 
Sbjct: 220 MAPERINPELNQKGYSVKSDIWSLGITMIELAIL-RFPYDSWG 261

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 1   RYTLLEVIREGRYGAVHRAH------DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK 54
           R  L + + EG +G V  A       D     T V  K+   + +E   S +I E+ ++K
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 55  EL-KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKT--------------EPTVTKN 98
            + KH+NI+ LL   +    + ++ E     +L  +++                P    +
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 99  PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLEN 157
              +    +Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I  +    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYK 192
Query: 158 YTIKGG-SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            T  G   + + APE L     Y+   DVW+      E+ T
Sbjct: 193 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 232

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 2   YTLLEVIREGRYGAVH----RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           + LL VI  G Y  V     +  D +    VV K++  +N  E +      +    +   
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASN 68
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H  +V L +   +   +  V E ++  DL+  M+ +  + +   +   Y  +I   + Y 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--YSAEISLALNYL 126
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H + I++RDLK  N L+D S+  +K+ D+G+ +    P +  +   G+  Y APE L G 
Sbjct: 127 HERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLF 202
             Y   VD WA+     EM+  +  F
Sbjct: 186 D-YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 438
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 439 CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 495
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 496 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 552
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 553 SDVWSFGVLMWEAFSY 568

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANSFV 196
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 197 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 11  GRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--GVPSSVIREVSLLKELKHENIVRLLNVQ 68
           G +G V + +  +      V    + N +    +   ++ E +++++L +  IVR++ + 
Sbjct: 381 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI- 439
Query: 69  SSVDSIDLVFENLDFDLL--HFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
              +S  LV E  +   L  +  +      KN +++   +HQ+  G+ Y      +HRDL
Sbjct: 440 CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL---VHQVSMGMKYLEESNFVHRDL 496
Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYSTP 182
              N L+  ++   KI+DFGL++ +    ENY    T     + + APE  +   ++S+ 
Sbjct: 497 AARNVLL-VTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE-CINYYKFSSK 553
Query: 183 VDVWAVACTFAEMVTH 198
            DVW+      E  ++
Sbjct: 554 SDVWSFGVLMWEAFSY 569

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 2   YTLLEVIREGRYGAVH----RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           + LL VI  G Y  V     +  D +    VV K++  +N  E +      +    +   
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASN 79
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H  +V L +   +   +  V E ++  DL+  M+ +  + +   +   Y  +I   + Y 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--YSAEISLALNYL 137
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H + I++RDLK  N L+D S+  +K+ D+G+ +    P +  +   G+  Y APE L G 
Sbjct: 138 HERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLF 202
             Y   VD WA+     EM+  +  F
Sbjct: 197 D-YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 2   YTLLEVIREGRYGAVH----RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           + LL VI  G Y  V     +  D +    VV K++  +N  E +      +    +   
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASN 64
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H  +V L +   +   +  V E ++  DL+  M+ +  + +   +   Y  +I   + Y 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--YSAEISLALNYL 122
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H + I++RDLK  N L+D S+  +K+ D+G+ +    P +  +   G+  Y APE L G 
Sbjct: 123 HERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLF 202
             Y   VD WA+     EM+  +  F
Sbjct: 182 D-YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 8   IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV------IREVSLLKELKHENI 61
           I +G +G VH+         V +K + I+  SEG    +       REV ++  L H NI
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE- 120
           V+L  +  +   + + F     DL H +  +    K  +K++  L  I  G+ Y  +Q  
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCG-DLYHRLLDKAHPIKWSVKLRLML-DIALGIEYMQNQNP 143
Query: 121 -ILHRDLKPANFLI----DRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERL 173
            I+HRDL+  N  +    + +    K+ADFGL++        +++ G  G+  + APE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETI 198
Query: 174 LGSGR-YSTPVDVWAVACTFAEMVTHQRLF 202
                 Y+   D ++ A     ++T +  F
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANSFV 192
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 193 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 76
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDF-------DLLHFMKTEPTVTKNPL 100
               H N+V LL   +      +V      F NL         + + +      + K+ L
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 101 KIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
            ++    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPD 194
Query: 158 YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 195 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 122
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDF-------DLLHFMKTEPTVTKNPL 100
               H N+V LL   +      +V      F NL         + + +      + K+ L
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 101 KIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
            ++    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPD 240
Query: 158 YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 241 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 282

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 85
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDF-------DLLHFMKTEPTVTKNPL 100
               H N+V LL   +      +V      F NL         + + +      + K+ L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 101 KIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
            ++    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPD 203
Query: 158 YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHR--ALMSELKILI 87
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDFDLL----HFMKTEPT-VTKNPLKI 102
               H N+V LL   +      +V      F NL   L      F+  +P  + K+ L +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 103 K---KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           +    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR  D+  +   
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKICDFGLAR--DIXKDPDX 204
Query: 160 IKGGS----LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           ++ G     L + APE +     Y+   DVW+      E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 245

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 3   TLLEVIREGRYGAVHRAHDS-LTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+    S +  D     V VK +P +  SE      + E  ++ +  
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFN 92
Query: 58  HENIVRLLNVQ-SSVDSIDLVFENLDFDLLHFMK-TEPTVTK-NPLKIKKYLH---QILH 111
           H+NIVR + V   S+    L+      DL  F++ T P  ++ + L +   LH    I  
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 112 GVAYCHSQEILHRDLKPANFLID--RSKDIVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+A+  D+   +Y  KGG     +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ--DIYRASYYRKGGCAMLPV 210
Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  PE  +  G +++  D W+      E+ +
Sbjct: 211 KWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 2   YTLLEVIREGRYGAVH----RAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           + LL VI  G Y  V     +  D +    VV K++  +N  E +      +    +   
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL--VNDDEDIDWVQTEKHVFEQASN 111
Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H  +V L +   +   +  V E ++  DL+  M+ +  + +   +   Y  +I   + Y 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--YSAEISLALNYL 169
Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H + I++RDLK  N L+D S+  +K+ D+G+ +    P +  +   G+  Y APE L G 
Sbjct: 170 HERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLF 202
             Y   VD WA+     EM+  +  F
Sbjct: 229 D-YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R  L + +  G +G V  A       T   + + +    EG   S  R  +L+ ELK   
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 76
Query: 58  ----HENIVRLLNVQSSVDSIDLV------FENLDF-------DLLHFMKTEPTVTKNPL 100
               H N+V LL   +      +V      F NL         + + +      + K+ L
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 101 KIKK---YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
            ++    Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I     +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDI-YKDPD 194
Query: 158 YTIKGGS---LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           Y  KG +   L + APE +     Y+   DVW+      E+ +
Sbjct: 195 YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANXFV 195
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 196 GTAQYVSPE-LLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANXFV 193
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 194 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 112 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANXFV 170
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 171 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I+  + Y H + I+HRDLKP N L++    I +I DFG A+ +    +        
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANXFV 171
Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           G+  Y +PE LL         D+WA+ C   ++V 
Sbjct: 172 GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 205
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	293
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-118
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-117
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-116
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-116
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-116
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-115
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-115
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-114
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-113
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-113
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-110
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-109
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-104
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-100
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-91
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-91
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-86
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-85
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-82
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-80
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-77
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-77
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-76
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-75
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-74
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-74
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-73
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-71
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-70
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-69
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-69
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-61
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-60
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-59
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-57
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-55
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-53
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-51
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-51
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-51
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-50
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-50
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-50
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-50
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-50
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-50
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-49
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-49
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-49
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-48
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-48
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-48
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-48
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-48
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-48
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-47
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-46
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-46
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-46
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-45
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-45
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-45
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-45
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-44
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-44
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-43
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-43
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-43
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-43
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-43
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-43
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-42
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-42
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-42
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-41
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-41
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-41
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-41
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-40
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-40
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-39
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-38
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-38
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-38
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-38
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-38
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-36
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-31
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-20
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-09

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  339 bits (872), Expect = e-117
 Identities = 89/291 (30%), Positives = 142/291 (48%), Gaps = 3/291 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  +  I EG YG V +  +  TG  V +KK         +    +RE+ +LK+LKH N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V LL V      + LVFE  D  +LH +            +K    Q L  V +CH   
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKHN 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
            +HRD+KP N LI +   ++K+ DFG AR +  P + Y  +  +  Y++PE L+G  +Y 
Sbjct: 123 CIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE- 239
            PVDVWA+ C FAE+++   L+  +     L  I   +G         F++     G + 
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
           P+   ++ L      +    + LL+  L +DP++RLT  + L H YF++ +
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  336 bits (863), Expect = e-116
 Identities = 115/289 (39%), Positives = 166/289 (57%), Gaps = 3/289 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y  L+ + EG Y  V++    LT + V +K+I  +   EG P + IREVSLLK+LKH N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L ++  +  S+ LVFE LD DL  ++     +  N   +K +L Q+L G+AYCH Q+
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNII-NMHNVKLFLFQLLRGLAYCHRQK 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+  +  +K+ADFGLAR   +P + Y  +  +L Y+ P+ LLGS  YS
Sbjct: 121 VLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           T +D+W V C F EM T + LF        L  IF I+GTP  ET PG  S  E   +  
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            +   + L +    L+ DG DLL ++L  +   R++A +A++H +F   
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  335 bits (862), Expect = e-116
 Identities = 96/289 (33%), Positives = 143/289 (49%), Gaps = 3/289 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L ++ EG YG V +  +  TG  V +KK    +  + V    +RE+ LLK+L+HEN
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V LL V        LVFE +D  +L  ++  P    +   ++KYL QI++G+ +CHS  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHN 144

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I+HRD+KP N L+ +   +VK+ DFG AR +  P E Y  +  +  Y+APE L+G  +Y 
Sbjct: 145 IIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE- 239
             VDVWA+ C   EM   + LF        L  I   +G         F       G   
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
           P     + L      L    +DL ++ L +DP KR    E L H++F+ 
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  334 bits (860), Expect = e-116
 Identities = 126/289 (43%), Positives = 176/289 (60%), Gaps = 3/289 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE + EG YG V++A DS  G  V +K+I +    EG+PS+ IRE+SLLKEL H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV L++V  S   + LVFE ++ DL   +    T      +IK YL+Q+L GVA+CH   
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCHQHR 139

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ILHRDLKP N LI+     +K+ADFGLAR   +P+ +YT +  +L Y+AP+ L+GS +YS
Sbjct: 140 ILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           T VD+W++ C FAEM+T + LF        L  IFSI+GTP+    P             
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                K  ++++ G   +G+DLL  MLC DP+KR++AR+A+ H YFKD 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  333 bits (857), Expect = e-115
 Identities = 118/290 (40%), Positives = 169/290 (58%), Gaps = 4/290 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V +A +  T + V +K++ + +  EGVPSS +RE+ LLKELKH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE  D DL  +  +      +P  +K +L Q+L G+ +CHS+ 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R    +K+A+FGLAR   +P+  Y+ +  +L Y+ P+ L G+  YS
Sbjct: 122 VLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 181 TPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
           T +D+W+  C FAE+    R LF        L  IF ++GTP  E  P  T    ++   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP-DYKPY 239

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           P       L  VV  L   G DLL+ +L  +P +R++A EAL+H YF DF
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  332 bits (854), Expect = e-115
 Identities = 127/291 (43%), Positives = 181/291 (62%), Gaps = 10/291 (3%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V++A ++  G+T  +KKI +    EG+PS+ IRE+S+LKELKH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  +   + LVFE+LD DL   +          +  K +L Q+L+G+AYCH + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRR 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R  ++ KIADFGLAR   +P+  YT +  +L Y+AP+ L+GS +YS
Sbjct: 121 VLHRDLKPQNLLINREGEL-KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS---FSEEFG 237
           T +D+W+V C FAEMV    LF        L  IF I+GTP+S+  P  T    +   F 
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF- 238

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                 P     + + GL+  G+DLL +ML LDP++R+TA++AL H YFK+
Sbjct: 239 --TVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  332 bits (853), Expect = e-114
 Identities = 119/292 (40%), Positives = 172/292 (58%), Gaps = 6/292 (2%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  +  + EG YG V++A D++T +TV +K+I + +  EGVP + IREVSLLKEL+H N
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           I+ L +V      + L+FE  + DL  +M   P V+     IK +L+Q+++GV +CHS+ 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVIKSFLYQLINGVNFCHSRR 152

Query: 121 ILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
            LHRDLKP N L+  S      ++KI DFGLAR   +P+  +T +  +L Y+ PE LLGS
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             YST VD+W++AC +AEM+    LF        L  IF ++G PD  T PG T+  +  
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
              P          +   L+ +G+DLL  ML +DP KR++A+ AL H YF  
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  329 bits (847), Expect = e-113
 Identities = 110/298 (36%), Positives = 173/298 (58%), Gaps = 12/298 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++  LE +  G Y  V++  +  TG  V +K++  ++  EG PS+ IRE+SL+KELKHEN
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHEN 64

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTK----NPLKIKKYLHQILHGVAYC 116
           IVRL +V  + + + LVFE +D DL  +M +              +K +  Q+L G+A+C
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H  +ILHRDLKP N LI++ +  +K+ DFGLAR   +P+  ++ +  +L Y+AP+ L+GS
Sbjct: 125 HENKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             YST +D+W+  C  AEM+T + LF        L  IF IMGTP+    P  T    ++
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP-KY 242

Query: 237 GFEPNRSPIKDLATVVG-----GLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                + P +DL  V+       L+ + +D L  +L L+P  RL+A++AL H +F ++
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  328 bits (844), Expect = e-113
 Identities = 103/296 (34%), Positives = 154/296 (52%), Gaps = 17/296 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE---GVPSSVIREVSLLKELK 57
           RY  L+ + EG++  V++A D  T   V +KKI + + SE   G+  + +RE+ LL+EL 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           H NI+ LL+      +I LVF+ ++ DL   +K   ++   P  IK Y+   L G+ Y H
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
              ILHRDLKP N L+D    ++K+ADFGLA+    P   YT +  +  Y+APE L G+ 
Sbjct: 130 QHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETLPGFTSF 232
            Y   VD+WAV C  AE++           PG      L  IF  +GTP  E  P   S 
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFL-----PGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            +   F+    P   L  +      D +DL++ +   +P  R+TA +AL+ +YF +
Sbjct: 244 PDYVTFKSF--PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  320 bits (823), Expect = e-110
 Identities = 104/298 (34%), Positives = 153/298 (51%), Gaps = 15/298 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDS-LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D    G  V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71

Query: 58  -HENIVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
            H N+VRL +V           + LVFE++D DL  ++   P        IK  + Q+L 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           G+ + HS  ++HRDLKP N L+      +K+ADFGLAR     +   T    +L Y+APE
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPE 189

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
            LL S  Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P   +
Sbjct: 190 VLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                    +    + +   V  ++  G DLL + L  +P+KR++A  AL H YF+D 
Sbjct: 249 LPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  316 bits (813), Expect = e-109
 Identities = 106/299 (35%), Positives = 151/299 (50%), Gaps = 17/299 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG---VPSSVIREVSLLKELK 57
           RY  +  I  G YG V++A D  +G  V +K + + N   G   +P S +REV+LL+ L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 58  ---HENIVRLLNV-----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQI 109
              H N+VRL++V           + LVFE++D DL  ++   P        IK  + Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           L G+ + H+  I+HRDLKP N L+      VK+ADFGLAR     +   T    +L Y+A
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQM-ALTPVVVTLWYRA 187

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE LL S  Y+TPVD+W+V C FAEM   + LF        L  IF ++G P  +  P  
Sbjct: 188 PEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            S              + + +VV  +E  G  LL  ML  +P KR++A  AL+H Y   
Sbjct: 247 VSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  306 bits (786), Expect = e-104
 Identities = 96/302 (31%), Positives = 152/302 (50%), Gaps = 16/302 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77

Query: 61  IVRLLNV--------QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +V L+ +             SI LVF+  + DL   +     V     +IK+ +  +L+G
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNG 136

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL----ENYTIKGGSLCYK 168
           + Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +        YT +  +L Y+
Sbjct: 137 LYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
            PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P 
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGL--EPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             ++      E  +   + +   +     +P  +DL+ ++L LDP++R+ + +AL H++F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

Query: 287 KD 288
             
Sbjct: 316 WS 317

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  299 bits (766), Expect = e-100
 Identities = 97/315 (30%), Positives = 147/315 (46%), Gaps = 38/315 (12%)

Query: 8   IREGRYGAVHRA--HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           +  G YG V++A   D        +K+I       G+  S  RE++LL+ELKH N++ L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 84

Query: 66  NV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK-------IKKYLHQILHGVAYC 116
            V    +   + L+F+  + DL H +K       N          +K  L+QIL G+ Y 
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 117 HSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVPLENYTIKGGS---LCYKAP 170
           H+  +LHRDLKPAN L+         VKIAD G AR  + PL+             Y+AP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL---------LAAIFSIMGTP 221
           E LLG+  Y+  +D+WA+ C FAE++T + +FH R              L  IF++MG P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264

Query: 222 DSETLPGFTSFSEEFGFEP--------NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
             +         E              N S IK +       +     LL+++L +DP K
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324

Query: 274 RLTAREALRHEYFKD 288
           R+T+ +A++  YF +
Sbjct: 325 RITSEQAMQDPYFLE 339

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  275 bits (705), Expect = 3e-91
 Identities = 91/298 (30%), Positives = 140/298 (46%), Gaps = 19/298 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            YT  +VI  G +G V +A    + + V +KK+      +       RE+ +++ +KH N
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPN 93

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKN--PLKIKKYLHQILHG 112
           +V L     S           LV E +   +    +    + +    L IK Y++Q+L  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + +  E       S  Y+APE 
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYYRAPEL 212

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           + G+  Y+T +D+W+  C  AE++  Q LF        L  I  ++GTP  E +      
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272

Query: 233 SEEFGFEPNRSPIKDLATVV-GGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             E  F P   P    + V      PD +DL+ R+L   PS RLTA EAL H +F + 
Sbjct: 273 YMEHKF-PQIRP-HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  275 bits (704), Expect = 8e-91
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 26/302 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            YT  +VI  G +G V++A    +G+ V +KK+      +       RE+ ++++L H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCN 108

Query: 61  IVRLLNVQSSVDS------IDLVFENLDFDLLHFMKTEPTVTKN--PLKIKKYLHQILHG 112
           IVRL     S         ++LV + +   +    +      +    + +K Y++Q+   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           +AY HS  I HRD+KP N L+D    ++K+ DFG A+ + V  E       S  Y+APE 
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPEL 227

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETLP 227
           + G+  Y++ +DVW+  C  AE++  Q +F     PG      L  I  ++GTP  E + 
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIF-----PGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                  EF F P                P+ + L  R+L   P+ RLT  EA  H +F 
Sbjct: 283 EMNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

Query: 288 DF 289
           + 
Sbjct: 342 EL 343

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  259 bits (663), Expect = 8e-86
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 23/301 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
            Y L+  +  G+Y  V  A +    + VVVK +  +   +     + RE+ +L+ L+   
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 91

Query: 60  NIVRLLNVQSSVDSID--LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           NI+ L ++     S    LVFE+++  D     +T          I+ Y+++IL  + YC
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEILKALDYC 146

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           HS  I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDY 205

Query: 177 GRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
             Y   +D+W++ C  A M+  +   FH       L  I  ++GT D        +   +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 236 FGFEPN--RSPIKDLATVVGG-----LEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             F     R   K     V       + P+ +D L ++L  D   RLTAREA+ H YF  
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325

Query: 289 F 289
            
Sbjct: 326 V 326

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  258 bits (661), Expect = 4e-85
 Identities = 82/306 (26%), Positives = 136/306 (44%), Gaps = 25/306 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           R+ +  +  +G +G V    +  TG +V +KK+         P    RE+ ++++L    
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAVLH 77

Query: 58  HENIVRLLNVQSSVDSID-------LVFENLDFDLLHFMKTEPTVTKN--PLKIKKYLHQ 108
           H NIV+L +   ++   D       +V E +   L    +          P+ IK +L Q
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 109 ILHGVAYCH--SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           ++  +   H  S  + HRD+KP N L++ +   +K+ DFG A+ +  P E       S  
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICSRY 196

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y+APE + G+  Y+T VD+W+V C FAEM+  + +F    + G L  I  ++G P  E L
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256

Query: 227 PGFTSFSEEFGFEPNRSPI---KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                   +     N   I      +        +  DLL  +L   P +R+   EAL H
Sbjct: 257 RKLNPSHTDVDL-YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 284 EYFKDF 289
            YF + 
Sbjct: 316 PYFDEL 321

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  254 bits (651), Expect = 2e-82
 Identities = 105/357 (29%), Positives = 154/357 (43%), Gaps = 75/357 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY +  +I  G YG V  A+D L    V +KKI  +         ++RE+++L  L H++
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 61  IVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           +V++L++    D        +V E  D D     +T   +T   L IK  L+ +L GV Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT--ELHIKTLLYNLLVGVKY 171

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC--------- 166
            HS  ILHRDLKPAN L+++    VK+ DFGLAR +D P    +    S           
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 167 ------------------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA- 207
                             Y+APE +L    Y+  +DVW++ C FAE++   +   +  A 
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 208 -----PGL-------------------------LAAIFSIMGTPDSETLPGFTS-----F 232
                PG                          L  IF+I+GTP  E +          +
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
              F   P R    DLA        D + LL+RML  +P+KR+T  E L H +FK+ 
Sbjct: 351 IRIF---PKREG-TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  246 bits (629), Expect = 5e-80
 Identities = 82/336 (24%), Positives = 140/336 (41%), Gaps = 62/336 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y+L + +  G +G V    D  +G    +KK+         P    RE+ ++K L H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVN 61

Query: 61  IVRLLNVQSSVDSID--------------------------------------LVFENLD 82
           I++L++   +    +                                      ++ E + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 83  FDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI 139
             L   +K+    +   +    I  Y++Q+   V + HS  I HRD+KP N L++   + 
Sbjct: 122 DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180

Query: 140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ 199
           +K+ DFG A+ + +P E       S  Y+APE +LG+  Y+  +D+W++ C F E++  +
Sbjct: 181 LKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 200 RLFHSRWAPGL-----LAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGG 254
            LF      G      L  I  IMGTP  E +        E  F P     KD   ++  
Sbjct: 240 PLF-----SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF-PTLKA-KDWRKILPE 292

Query: 255 LEP-DGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
             P   +DLL ++L  +P  R+   EA+ H +F   
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  237 bits (606), Expect = 2e-77
 Identities = 90/311 (28%), Positives = 140/311 (45%), Gaps = 32/311 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L+ +  G  G V  A D+     V +KKI + +P        +RE+ +++ L H+N
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV--KHALREIKIIRRLDHDN 69

Query: 61  IVRLLNVQSSVDSID--------------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           IV++  +     S                +V E ++ DL + ++  P         + ++
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL---LEEHARLFM 126

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
           +Q+L G+ Y HS  +LHRDLKPAN  I+    ++KI DFGLAR +D    +       L 
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186

Query: 167 ---YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIM 218
              Y++P  LL    Y+  +D+WA  C FAEM+T + LF      G      +  I   +
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-----AGAHELEQMQLILESI 241

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR 278
                E      S    +       P K L  ++ G+  + VD L ++L   P  RLTA 
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301

Query: 279 EALRHEYFKDF 289
           EAL H Y   +
Sbjct: 302 EALSHPYMSIY 312

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  237 bits (608), Expect = 3e-77
 Identities = 97/298 (32%), Positives = 151/298 (50%), Gaps = 19/298 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
            Y     +  G YG+V  A D  +G+ V +KK+    P +    +    RE+ LLK ++H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S+       LV   +  DL   M  + +      KI+  ++Q+L G
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS----EEKIQYLVYQMLKG 138

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS  ++HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE 
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCEL-KILDFGLARHADAEMTGYVV---TRWYRAPEV 194

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS- 231
           +L    Y+  VD+W+V C  AEM+T + LF  +     L  I  + G P +E +      
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            ++ +     ++P KD   +     P   DLL +ML LD  KRLTA +AL H +F+ F
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  236 bits (604), Expect = 2e-76
 Identities = 106/303 (34%), Positives = 159/303 (52%), Gaps = 28/303 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           RY  L  +  G YG+V  A D+ TG  V VKK+    P + +  +    RE+ LLK +KH
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 87

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +   S++      LV   +  DL + +K +         ++  ++QIL G
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---TDDHVQFLIYQILRG 144

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y HS +I+HRDLKP+N  ++   ++ KI DFGLAR     +  Y     +  Y+APE 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTADEMTGYVA---TRWYRAPEI 200

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETLP 227
           +L    Y+  VD+W+V C  AE++T + LF     PG      L  I  ++GTP +E L 
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRLVGTPGAELLK 255

Query: 228 GFTS-FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             +S  +  +     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 287 KDF 289
             +
Sbjct: 316 AQY 318

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  233 bits (597), Expect = 2e-75
 Identities = 103/298 (34%), Positives = 156/298 (52%), Gaps = 18/298 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
            Y  L+ +  G YGAV  A D  TG  V +KK+    P +    +    RE+ LLK ++H
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRH 83

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           EN++ LL+V +  +++D      LV   +  DL   MK E        +I+  ++Q+L G
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---GEDRIQFLVYQMLKG 140

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + Y H+  I+HRDLKP N  ++   ++ KI DFGLAR  D  +  Y +   +  Y+APE 
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQADSEMTGYVV---TRWYRAPEV 196

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS- 231
           +L   RY+  VD+W+V C  AEM+T + LF        L  I  + GTP +E +    S 
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            ++ +         KD A+++    P  V+LL +ML LD  +R+TA EAL H YF+  
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  231 bits (590), Expect = 2e-74
 Identities = 94/304 (30%), Positives = 152/304 (50%), Gaps = 26/304 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI-PIMNPSEGVPSSVIREVSLLKELKHE 59
           RYT L  I EG YG V  A+D+L    V +KKI P  + +       +RE+ +L   +HE
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFRHE 85

Query: 60  NIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           NI+ + ++  +          +V + ++ DL   +KT+     +   I  +L+QIL G+ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL---SNDHICYFLYQILRGLK 142

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKAPE 171
           Y HS  +LHRDLKP+N L++ + D +KI DFGLAR  D   ++       +    Y+APE
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSIMGTPDSETL 226
            +L S  Y+  +D+W+V C  AEM++++ +F     PG      L  I  I+G+P  E L
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-----PGKHYLDQLNHILGILGSPSQEDL 256

Query: 227 PGFTS-FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
               +  +  +              +    +   +DLL +ML  +P KR+   +AL H Y
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 286 FKDF 289
            + +
Sbjct: 317 LEQY 320

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  230 bits (588), Expect = 4e-74
 Identities = 102/319 (31%), Positives = 152/319 (47%), Gaps = 48/319 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
            + L  ++ EG YG V  A    TG+ V +KKI    P +    +   +RE+ +LK  KH
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKH 68

Query: 59  ENIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQIL 110
           ENI+ + N+Q      +     ++ E +  DL   + T        L    I+ +++Q L
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST------QMLSDDHIQYFIYQTL 122

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---- 166
             V   H   ++HRDLKP+N LI+ + D +K+ DFGLAR ID    + +   G       
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 167 ------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIF 215
                 Y+APE +L S +YS  +DVW+  C  AE+   + +F     PG      L  IF
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-----PGRDYRHQLLLIF 236

Query: 216 SIMGTPDSETLPGFTSFSEEFGFE-----PNRSPIKDLATVVGGLEPDGVDLLRRMLCLD 270
            I+GTP S+              E     P       L  +   + P G+DLL+RML  D
Sbjct: 237 GIIGTPHSDND--LRCIESPRAREYIKSLPMYPA-APLEKMFPRVNPKGIDLLQRMLVFD 293

Query: 271 PSKRLTAREALRHEYFKDF 289
           P+KR+TA+EAL H Y + +
Sbjct: 294 PAKRITAKEALEHPYLQTY 312

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  227 bits (580), Expect = 7e-73
 Identities = 87/315 (27%), Positives = 139/315 (44%), Gaps = 40/315 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS---------VIREVS 51
            YT+   I  G YGAV    DS  G  V +K++          +          V+RE+ 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 52  LLKELKHENIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLK---IK 103
           LL    H NI+ L ++    +        LV E +  DL   +  +    +  +    I+
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ----RIVISPQHIQ 137

Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIK 161
            +++ IL G+   H   ++HRDL P N L+  + D + I DF LAR    D    +Y   
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVT- 195

Query: 162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFS 216
                Y+APE ++    ++  VD+W+  C  AEM   + LF      G      L  I  
Sbjct: 196 --HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-----RGSTFYNQLNKIVE 248

Query: 217 IMGTPDSETLPGFTSFS--EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR 274
           ++GTP  E +  F+S S  +      +  P +    VV   +P  +DL+ +ML  +P +R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 275 LTAREALRHEYFKDF 289
           ++  +ALRH YF+  
Sbjct: 309 ISTEQALRHPYFESL 323

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  224 bits (573), Expect = 5e-71
 Identities = 94/350 (26%), Positives = 146/350 (41%), Gaps = 69/350 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
            Y +  +I  G YG V+ A+D  T   V +KK+      E +     ++RE+++L  LK 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCKRILREITILNRLKS 84

Query: 59  ENIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQIL 110
           + I+RL ++    D +      +V E  D DL    KT        L    IK  L+ +L
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-----PIFLTEEHIKTILYNLL 139

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---- 166
            G  + H   I+HRDLKPAN L+++    VK+ DFGLAR I+   +   +          
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 167 ------------------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA- 207
                             Y+APE +L    Y+  +D+W+  C FAE++   +   +    
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

Query: 208 -----PGL----------------------LAAIFSIMGTPDSETLPGFTS-FSEEFGFE 239
                PG                       L  IF+I+GTP  + L         ++   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                  +L      +  DG++LL  ML  +P+KR+T  +AL H Y KD 
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  221 bits (566), Expect = 2e-70
 Identities = 91/340 (26%), Positives = 154/340 (45%), Gaps = 65/340 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELK- 57
           +Y L++ + +G YG V ++ D  TG+ V VKKI   +  +    +    RE+ +L EL  
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRTFREIMILTELSG 67

Query: 58  HENIVRLLNVQSSVDSID--LVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHG 112
           HENIV LLNV  + +  D  LVF+ ++ DL   ++       N L+    +  ++Q++  
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA------NILEPVHKQYVVYQLIKV 121

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC------ 166
           + Y HS  +LHRD+KP+N L++     VK+ADFGL+R              S+       
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 167 ---------------YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL- 210
                          Y+APE LLGS +Y+  +D+W++ C   E++  + +F     PG  
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-----PGSS 235

Query: 211 ----LAAIFSIMGTPDSETLPGFTS-----------------FSEEFGFEPNRSPIKDLA 249
               L  I  ++  P +E +    S                  S +         +    
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295

Query: 250 TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                   + +DLL ++L  +P+KR++A +AL+H +   F
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  219 bits (560), Expect = 9e-69
 Identities = 88/311 (28%), Positives = 143/311 (45%), Gaps = 33/311 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+    P +    +    RE+ L+K + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   +++      LV E +D +L   ++ E        ++   L+Q+L G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCG 176

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAP 170
           + + HS  I+HRDLKP+N ++      +KI DFGLAR       ++ +     +  Y+AP
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG---TSFMMTPYVVTRYYRAP 232

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E +LG   Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +    
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291

Query: 231 SFSEEFGFEPNRSPIKDLATV------------VGGLEPDGVDLLRRMLCLDPSKRLTAR 278
                +     +        +                     DLL +ML +DP+KR++  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 279 EALRHEYFKDF 289
           +AL+H Y   +
Sbjct: 352 DALQHPYINVW 362

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  216 bits (553), Expect = 9e-69
 Identities = 87/309 (28%), Positives = 137/309 (44%), Gaps = 29/309 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS--VIREVSLLKELKH 58
           RY  L+ I  G  G V  A+D++    V +KK+    P +    +    RE+ L+K + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 59  ENIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +NI+ LLNV +   S++      +V E +D +L   ++ E        ++   L+Q+L G
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD----HERMSYLLYQMLCG 139

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           + + HS  I+HRDLKP+N ++      +KI DFGLAR         T    +  Y+APE 
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG-TSFMMTPYVVTRYYRAPEV 197

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           +LG   Y   VD+W+V C   EM+    LF           +   +GTP  E +      
Sbjct: 198 ILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 233 SEEFGFEPNRSPIKDLATVVGG------------LEPDGVDLLRRMLCLDPSKRLTAREA 280
              +     +        +                     DLL +ML +D SKR++  EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 281 LRHEYFKDF 289
           L+H Y   +
Sbjct: 317 LQHPYINVW 325

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  197 bits (502), Expect = 1e-61
 Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-- 58
            Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           + I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 145

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY---TIKGGSLCYKAPERLLG 175
             I+H DLKPANFLI     ++K+ DFG+A  +     +    +   G++ Y  PE +  
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKD 202

Query: 176 SG----------RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
                       + S   DVW++ C    M   +  F        ++ + +I+       
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAIIDPNHEIE 260

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            P                              D  D+L+  L  DP +R++  E L H Y
Sbjct: 261 FPDIPE-------------------------KDLQDVLKCCLKRDPKQRISIPELLAHPY 295

Query: 286 FK 287
            +
Sbjct: 296 VQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  194 bits (496), Expect = 1e-60
 Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-- 58
            Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           + I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 126

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY---TIKGGSLCYKAPERLLG 175
             I+H DLKPANFLI     ++K+ DFG+A  +     +    +   G++ Y  PE +  
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKD 183

Query: 176 SG----------RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
                       + S   DVW++ C    M   +  F        ++ + +I+       
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIE 241

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            P                              D  D+L+  L  DP +R++  E L H Y
Sbjct: 242 FPDIPE-------------------------KDLQDVLKCCLKRDPKQRISIPELLAHPY 276

Query: 286 FK 287
            +
Sbjct: 277 VQ 278

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  193 bits (491), Expect = 3e-59
 Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-- 58
            Y++L+ I  G    V +  +        +K + +         S   E++ L +L+   
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           + I+RL + + +   I +V E  + DL  ++K + ++  +P + K Y   +L  V   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 173

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YTIKGGSLCYKAPERLLG 175
             I+H DLKPANFLI     ++K+ DFG+A  +     +    +   G++ Y  PE +  
Sbjct: 174 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKD 230

Query: 176 SG----------RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
                       + S   DVW++ C    M   +  F        ++ + +I+       
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDPNHEIE 288

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
            P                              D  D+L+  L  DP +R++  E L H Y
Sbjct: 289 FPDIPE-------------------------KDLQDVLKCCLKRDPKQRISIPELLAHPY 323

Query: 286 FK 287
            +
Sbjct: 324 VQ 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  184 bits (468), Expect = 8e-57
 Identities = 71/314 (22%), Positives = 125/314 (39%), Gaps = 61/314 (19%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  + V+ +G +G V +A ++L      +KKI     +E   S+++ EV LL  L H+ +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYV 64

Query: 62  VRLLNVQSSVDSIDLVFENLDF--------------DLLHFMKTEPTVTKNPLKIKKYLH 107
           VR         +       +                 L   + +E  + +   +  +   
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFR 123

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG----- 162
           QIL  ++Y HSQ I+HRDLKP N  ID S+++ KI DFGLA+ +   L+   +       
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNV-KIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 163 ---------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAA 213
                    G+  Y A E L G+G Y+  +D++++   F EM+             +L  
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240

Query: 214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
           + S+      +             F+ N+                   ++R ++  DP+K
Sbjct: 241 LRSVSIEFPPD-------------FDDNKM-------------KVEKKIIRLLIDHDPNK 274

Query: 274 RLTAREALRHEYFK 287
           R  AR  L   +  
Sbjct: 275 RPGARTLLNSGWLP 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  181 bits (461), Expect = 3e-55
 Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 40/293 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L+ I EG +G       +  G   V+K+I I   S        REV++L  +KH N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPL---KIKKYLHQILHGVAYC 116
           IV+         S+ +V +  +  DL   +  +           +I  +  QI   + + 
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHV 141

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H ++ILHRD+K  N  + +    V++ DFG+AR ++  +E      G+  Y +PE     
Sbjct: 142 HDRKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM-GTPDSETLPGFTSFSEE 235
             Y+   D+WA+ C   E+ T +  F    A  +   +  I+ G+     +     +S +
Sbjct: 201 P-YNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKIISGSFPP--VS--LHYSYD 252

Query: 236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                                     L+ ++   +P  R +    L   +   
Sbjct: 253 L-----------------------RSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  179 bits (457), Expect = 9e-54
 Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 43/300 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
            +   +V+  G  G +           V VK+I     S        REV LL+E  +H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFS-----FADREVQLLRESDEHP 78

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           N++R    +       +  E     L  +++ +       L+    L Q   G+A+ HS 
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 120 EILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLENYTI---KGGSLCYKAPER 172
            I+HRDLKP N LI            I+DFGL + + V   +++      G+  + APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 173 LLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           L        +  VD+++  C F  +++        +   L      ++G    + L    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP---FGKSLQRQANILLGACSLDCLHPEK 254

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
                                         +L+ +M+ +DP KR +A+  L+H +F   +
Sbjct: 255 HEDVIA-----------------------RELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  173 bits (440), Expect = 6e-53
 Identities = 63/305 (20%), Positives = 104/305 (34%), Gaps = 60/305 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +  +E+I  G +G V +A   + G T V+K++   N          REV  L +L H N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVN 65

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-----------------DLLHFMKTEPTVTKNPLKIK 103
           IV         D                             L  +++       + +   
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           +   QI  GV Y HS+++++RDLKP+N  +      VKI DFGL   +    +    K G
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSK-G 183

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           +L Y +PE++     Y   VD++A+    AE++                 +         
Sbjct: 184 TLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG------ 234

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
             +     F ++                          LL+++L   P  R    E LR 
Sbjct: 235 -IIS--DIFDKKE-----------------------KTLLQKLLSKKPEDRPNTSEILRT 268

Query: 284 EYFKD 288
                
Sbjct: 269 LTVWK 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  174 bits (443), Expect = 7e-53
 Identities = 60/304 (19%), Positives = 115/304 (37%), Gaps = 31/304 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
            + L +++ +G    V R     TGD   +K       + P +      +RE  +LK+L 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLN 65

Query: 58  HENIVRLLNVQSSVDSID--LVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           H+NIV+L  ++    +    L+ E       + +L        + ++  +    L  ++ 
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVG 123

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           G+ +     I+HR++KP N +    +D   + K+ DFG AR ++   +  ++  G+  Y 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182

Query: 169 APE-------RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS--IMG 219
            P+       R     +Y   VD+W++  TF    T    F     P     +    I G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
            P         + +    +  +      L+    GL+     +L  +L  D  K     +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSR---GLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 280 ALRH 283
               
Sbjct: 300 FFAE 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  172 bits (437), Expect = 2e-52
 Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 43/299 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y +L  I  G YG   +      G  +V K++   + +E     ++ EV+LL+ELKH N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 61  IVRLLN--VQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPL---KIKKYLHQILHGVA 114
           IVR  +  +  +  ++ +V E  +  DL   +  + T  +  L    + + + Q+   + 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 115 YCHSQ-----EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
            CH +      +LHRDLKPAN  +D  K  VK+ DFGLAR ++          G+  Y +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE++     Y+   D+W++ C   E+      F +     L   I    G      +P  
Sbjct: 185 PEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRR--IP-- 237

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +S+E                         +++ RML L    R +  E L +    +
Sbjct: 238 YRYSDEL-----------------------NEIITRMLNLKDYHRPSVEEILENPLILE 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (437), Expect = 4e-52
 Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 38/290 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
            + + + I  G++  V+RA   L G  V +KK+ I +       +  I+E+ LLK+L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 60  NIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           N+++        + +++V E     +L   + HF K +  + +    + KY  Q+   + 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TVWKYFVQLCSALE 150

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YTIKGGSLCYKAPERL 173
           + HS+ ++HRD+KPAN  I     +VK+ D GL R         +++  G+  Y +PER+
Sbjct: 151 HMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 208

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
             +G Y+   D+W++ C   EM   Q  F+      L +    I    D   LP    +S
Sbjct: 209 HENG-YNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIE-QCDYPPLPS-DHYS 264

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           EE                          L+   +  DP KR         
Sbjct: 265 EEL-----------------------RQLVNMCINPDPEKRPDVTYVYDV 291

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  170 bits (433), Expect = 1e-51
 Identities = 78/294 (26%), Positives = 119/294 (40%), Gaps = 48/294 (16%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
            V+ +G YG V+   D      + +K+IP  +        +  E++L K LKH+NIV+ L
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYL 85

Query: 66  NVQSSVDSIDLVFENLD----FDLLH-----FMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
              S    I +  E +       LL          E T       I  Y  QIL G+ Y 
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-------IGFYTKQILEGLKYL 138

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLG 175
           H  +I+HRD+K  N LI+    ++KI+DFG ++ +  +     T   G+L Y APE +  
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDK 197

Query: 176 SGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
             R Y    D+W++ CT  EM T +  F+    P   AA+F +        +P   S   
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVHPEIPESMS--- 252

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                                  +    + +    DP KR  A + L  E+ K 
Sbjct: 253 ----------------------AEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  173 bits (441), Expect = 2e-51
 Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 60/319 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
                +++  G  G V     S  G  V VK++ I           + E+ LL E   H 
Sbjct: 16  LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMK-----TEPTVTKNPLKIKKYLHQILHGVA 114
           N++R    +++   + +  E  + +L   ++      E    +        L QI  GVA
Sbjct: 70  NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 115 YCHSQEILHRDLKPANFLIDRSKDI------------VKIADFGLARPIDVPLENYTIK- 161
           + HS +I+HRDLKP N L+  S               + I+DFGL + +D    ++    
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 162 ---GGSLCYKAPERLLGSG------RYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLL 211
               G+  ++APE L  S       R +  +D++++ C F  +++  +  F  +++    
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--E 247

Query: 212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP 271
           + I   + + D        S   E                         DL+ +M+  DP
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAE-----------------------ATDLISQMIDHDP 284

Query: 272 SKRLTAREALRHEYFKDFQ 290
            KR TA + LRH  F    
Sbjct: 285 LKRPTAMKVLRHPLFWPKS 303

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  169 bits (431), Expect = 2e-51
 Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 46/298 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +     +  G +G VH   +  +G   V+K I        +   +  E+ +LK L H N
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPN 81

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKN--PLKIKKYLHQILHGVAYCH 117
           I+++  V     ++ +V E  +  +LL  + +     K      + + + Q+++ +AY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 118 SQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           SQ ++H+DLKP N L   +     +KI DFGLA       E+ T   G+  Y APE    
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAPEVF-- 198

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
               +   D+W+        V +  L     F       +                    
Sbjct: 199 KRDVTFKCDIWSAGV-----VMYFLLTGCLPFTGTSLEEVQQKA-----------TYK-- 240

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
               E  +     P+   A          VDLL++ML  DP +R +A + L HE+FK 
Sbjct: 241 ----EPNYAVECRPLTPQA----------VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  173 bits (441), Expect = 7e-51
 Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 48/301 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y  ++ +  G YG V    D +T     +K I   + S    S ++ EV++LK L H N
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           I++L +      +  LV E       FD +     F   E             + Q+L G
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDA-------AVIIKQVLSG 148

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           V Y H   I+HRDLKP N L++  +   ++KI DFGL+   +   +    + G+  Y AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAP 207

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L    +Y    DVW++      ++     F  +    +L  +                
Sbjct: 208 EVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV---------------- 249

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
               ++ F+               +     DL+++ML  D  +R++A++AL H + K+  
Sbjct: 250 -EKGKYTFDSPEWK---------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299

Query: 291 S 291
           S
Sbjct: 300 S 300

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  168 bits (428), Expect = 2e-50
 Identities = 74/339 (21%), Positives = 112/339 (33%), Gaps = 74/339 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
           +Y L   I +G YG V  A ++ T     +K +    I   +      +  EV L+K+L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL------------- 100
           H NI RL  V      I LV E        D L+    + T                   
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 101 ----------------------KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD 138
                                  I   + QI   + Y H+Q I HRD+KP NFL   +K 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 139 -IVKIADFGLARPIDV--PLENYTIKG--GSLCYKAPERLLGSGR-YSTPVDVWAVACTF 192
             +K+ DFGL++        E Y +    G+  + APE L  +   Y    D W+     
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 193 AEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVV 252
             ++     F        ++ +  +      E  P +   S                   
Sbjct: 267 HLLLMGAVPFPGVNDADTISQV--LNKKLCFEN-PNYNVLSPL----------------- 306

Query: 253 GGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                   DLL  +L  +  +R  A  AL+H +   F  
Sbjct: 307 ------ARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  166 bits (423), Expect = 3e-50
 Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 60/319 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +  ++ +  G +G V  A + +      +K+I + N        V+REV  L +L+H  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPG 64

Query: 61  IVRLLNV---------QSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLK-IKKYL 106
           IVR  N                   ++  +      +L  +M    T+ +          
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---- 162
            QI   V + HS+ ++HRDLKP+N       D+VK+ DFGL   +D   E  T+      
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 163 --------GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI 214
                   G+  Y +PE++ G+  YS  VD++++     E++              L  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLYP--FSTQMERVRTLTDV 240

Query: 215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR 274
                  + +  P FT                               +++ ML   P +R
Sbjct: 241 ------RNLKFPPLFTQKYPCE-----------------------YVMVQDMLSPSPMER 271

Query: 275 LTAREALRHEYFKDFQSLD 293
             A   + +  F+D     
Sbjct: 272 PEAINIIENAVFEDLDFPG 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  168 bits (427), Expect = 5e-50
 Identities = 45/324 (13%), Positives = 83/324 (25%), Gaps = 58/324 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHE 59
           +  L+E +R G    V    D    +   +K   +    S      +         L  E
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 60  NIVRLLNVQSSVDSID--------------------------LVFENLDFDLLHFMKTEP 93
           +     + +  +   D                          L+      DL     T  
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 94  TVTKN-----PLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLA 148
            V         L +     Q++   A   S+ ++H    P N  I      + + D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP-DGRLMLGDVSAL 241

Query: 149 RPIDVPLENYTIKGGSLCYKAPERLLGSGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWA 207
             +             + Y   E L  S   ++  ++ W +  +   +      F     
Sbjct: 242 WKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 208 PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRML 267
               +     +  P +++L         FG                        L+ R L
Sbjct: 299 GIKGSWKRPSLRVPGTDSLA--------FGSCTPLP-------------DFVKTLIGRFL 337

Query: 268 CLDPSKRLTAREALRHEYFKDFQS 291
             D  +RL   EA+    F   Q+
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQLQN 361

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  166 bits (423), Expect = 5e-50
 Identities = 63/290 (21%), Positives = 95/290 (32%), Gaps = 41/290 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKEL-K 57
            +  L  +  G YG V +      G    VK+   P   P +      + EV   +++ +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA--RKLAEVGSHEKVGQ 115

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           H   VRL         + L  E     L    +          ++  YL   L  +A+ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEA-QVWGYLRDTLLALAHLH 174

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           SQ ++H D+KPAN  +   +   K+ DFGL   +         +G    Y APE L   G
Sbjct: 175 SQGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELL--QG 230

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
            Y T  DV+++  T  E+  +  L H             +               S E  
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHG------GEGWQQLRQGYLPPEFTA--GLSSEL- 281

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                   +L  ML  DP  R TA   L     +
Sbjct: 282 ----------------------RSVLVMMLEPDPKLRATAEALLALPVLR 309

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  168 bits (427), Expect = 8e-50
 Identities = 61/304 (20%), Positives = 114/304 (37%), Gaps = 31/304 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
            + L +++ +G    V R     TGD   +K       + P +      +RE  +LK+L 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----VQMREFEVLKKLN 65

Query: 58  HENIVRLLNVQSSVDSID--LVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           H+NIV+L  ++    +    L+ E       + +L        + ++  +    L  ++ 
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVG 123

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           G+ +     I+HR++KP N +    +D   + K+ DFG AR ++   E +    G+  Y 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYL 182

Query: 169 APE-------RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS--IMG 219
            P+       R     +Y   VD+W++  TF    T    F     P     +    I G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
            P         + +    +  +      L+    GL+     +L  +L  D  K     +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSR---GLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 280 ALRH 283
               
Sbjct: 300 FFAE 303

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  166 bits (423), Expect = 9e-50
 Identities = 60/298 (20%), Positives = 93/298 (31%), Gaps = 53/298 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
             T    +  G +G VHR  D  TG    VKK+ +           + E+     L    
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPR 111

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL-HFMK-TEPTVTKNPLKIKKYLHQILHGVA 114
           IV L         +++  E L+      L+       E            YL Q L G+ 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-------ALYYLGQALEGLE 164

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-----GSLCYKA 169
           Y H++ ILH D+K  N L+        + DFG A  +       ++       G+  + A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE ++G       VD+W+  C    M+     +   +          I   P        
Sbjct: 225 PEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLCLKIASEP-------- 272

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                     P    I           P     ++  L  +P  R +A E  R     
Sbjct: 273 ----------PPIREIPP------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  166 bits (423), Expect = 2e-49
 Identities = 83/328 (25%), Positives = 134/328 (40%), Gaps = 48/328 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           RY L+  +  G +  V  A D +    V +K   I+   +    +   E+ LL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDAD 76

Query: 58  --------HENIVRLLNV----QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKY 105
                     +I++LL+       +   + +VFE L  +LL  +K         + +K+ 
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 106 LHQILHGVAYCHSQE-ILHRDLKPANFLIDRSKD-----IVKIADFGLARPIDVPLENYT 159
             Q+L G+ Y H +  I+H D+KP N L++          +KIAD G A   D    N  
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS- 195

Query: 160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAA 213
           I+  +  Y++PE LLG+  +    D+W+ AC   E++T   LF              +A 
Sbjct: 196 IQ--TREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 214 IFSIMGTPDSETLPGFTSFSEEF----GFEPNRSPIK------DLATVVGGLEPDG---V 260
           I  ++G   S  L     ++  F    G   N S +K       L       + +     
Sbjct: 253 IIELLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 261 DLLRRMLCLDPSKRLTAREALRHEYFKD 288
           D L  ML LDP KR  A   + H + KD
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  169 bits (430), Expect = 2e-49
 Identities = 76/303 (25%), Positives = 128/303 (42%), Gaps = 48/303 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++ ++ +G +G V +  D +T     VK I   +      S+++REV LLK+L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           I++L  +     S  +V E       FD +     F  +E           + + Q+  G
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEH-------DAARIIKQVFSG 133

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           + Y H   I+HRDLKP N L++  +    +KI DFGL+            + G+  Y AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAP 192

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L   G Y    DVW+       +++    F+ +    +L  +                
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---------------- 234

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
             + ++ F+  +            +  D  DL+R+ML   PS R+TA + L H + + + 
Sbjct: 235 -ETGKYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

Query: 291 SLD 293
           S  
Sbjct: 285 SET 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  168 bits (428), Expect = 4e-49
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 47/301 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
           RY    V+ +G +G V    D +TG    VK I       +    S++REV LLK+L H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 60  NIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLHQILHG 112
           NI++L           LV E       FD +        +++         + + Q+L G
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--------ISRKRFSEVDAARIIRQVLSG 138

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           + Y H  +I+HRDLKP N L++       ++I DFGL+   +   +    K G+  Y AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIAP 197

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L   G Y    DVW+       +++    F+      +L  +                
Sbjct: 198 EVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 239

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
               ++ FE  +            +     DL+R+ML   PS R++AR+AL HE+ + + 
Sbjct: 240 -EKGKYTFELPQWK---------KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289

Query: 291 S 291
            
Sbjct: 290 K 290

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  167 bits (425), Expect = 6e-49
 Identities = 81/304 (26%), Positives = 122/304 (40%), Gaps = 58/304 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y L E + +G +  V R    L G       I     S      + RE  + + LKH N
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           IVRL +  S      L+F+ +     F+ +    ++  +E             + QIL  
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEA-------DASHCIQQILEA 122

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           V +CH   ++HR+LKP N L   + K   VK+ADFGLA  ++   + +    G+  Y +P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           E L     Y  PVD+WA        + +  L     F       L   I           
Sbjct: 183 EVLRKDP-YGKPVDLWACGV-----ILYILLVGYPPFWDEDQHRLYQQI----------- 225

Query: 226 LPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
             G   F S E+      +             P+  DL+ +ML ++PSKR+TA EAL+H 
Sbjct: 226 KAGAYDFPSPEW---DTVT-------------PEAKDLINKMLTINPSKRITAAEALKHP 269

Query: 285 YFKD 288
           +   
Sbjct: 270 WISH 273

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  162 bits (412), Expect = 1e-48
 Identities = 58/300 (19%), Positives = 108/300 (36%), Gaps = 49/300 (16%)

Query: 1   RYT-LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           R+      I  G +  V++  D+ T   V   ++     ++        E  +LK L+H 
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF--------DLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           NIVR  +   S        + +           L  ++K    +      ++ +  QIL 
Sbjct: 86  NIVRFYDSWESTVKGK---KCIVLVTELMTSGTLKTYLKRFKVMKIK--VLRSWCRQILK 140

Query: 112 GVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKA 169
           G+ + H++   I+HRDLK  N  I      VKI D GLA           +  G+  + A
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVI-GTPEFMA 198

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS-ETLPG 228
           PE  +   +Y   VDV+A      EM T +  +         A I+  + +     +   
Sbjct: 199 PE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGVKPASFDK 253

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                                       P+  +++   +  +  +R + ++ L H +F++
Sbjct: 254 VAI-------------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  163 bits (415), Expect = 2e-48
 Identities = 83/303 (27%), Positives = 122/303 (40%), Gaps = 50/303 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGV-PSSVIREVSLLKELK 57
            Y L EVI +G +  V R  +  TG    VK + +     S G+    + RE S+   LK
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H +IV LL   SS   + +VFE +D       +   + +     +      Y+ QIL  +
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-VKRADAGFVYSEAVASHYMRQILEAL 143

Query: 114 AYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            YCH   I+HRD+KP   L   +     VK+  FG+A  +         + G+  + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSETL 226
            +     Y  PVDVW         +    L     F+      L   I  I G       
Sbjct: 204 VVKREP-YGKPVDVWGCGV-----ILFILLSGCLPFYG-TKERLFEGI--IKGKYK---- 250

Query: 227 PGFTSFSEEFGFEPNRSPI-KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                   ++    + S   KD              L+RRML LDP++R+T  EAL H +
Sbjct: 251 --MN--PRQW---SHISESAKD--------------LVRRMLMLDPAERITVYEALNHPW 289

Query: 286 FKD 288
            K+
Sbjct: 290 LKE 292

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  166 bits (423), Expect = 3e-48
 Identities = 70/312 (22%), Positives = 114/312 (36%), Gaps = 59/312 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP-----------IMNPSEGVPSSVIRE 49
            Y  +  +  G YG V    +        +K I                 E     +  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 50  VSLLKELKHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLK 101
           +SLLK L H NI++L +V        LV E  +    F+ +     F   E         
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DE-------CD 147

Query: 102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI--VKIADFGLARPIDVPLENYT 159
               + QIL G+ Y H   I+HRD+KP N L++    +  +KI DFGL+           
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLR 206

Query: 160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG 219
            + G+  Y APE L    +Y+   DVW+       ++     F  +    ++  +     
Sbjct: 207 DRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----- 259

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
                          ++ F+ N             +  +  +L++ ML  D +KR TA E
Sbjct: 260 ------------EKGKYYFDFNDWK---------NISDEAKELIKLMLTYDYNKRCTAEE 298

Query: 280 ALRHEYFKDFQS 291
           AL   + K + +
Sbjct: 299 ALNSRWIKKYAN 310

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  161 bits (409), Expect = 4e-48
 Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 58/308 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY ++ ++ +G +G V +  D +T     VK I   +      S+++REV LLK+L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           I++L  +     S  +V E       FD +     F  +E           + + Q+  G
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEH-------DAARIIKQVFSG 133

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           + Y H   I+HRDLKP N L++  +    +KI DFGL+            + G+  Y AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAP 192

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           E L   G Y    DVW+        + +  L     F+ +    +L  +    G      
Sbjct: 193 EVL--RGTYDEKCDVWSAGV-----ILYILLSGTPPFYGKNEYDILKRV--ETGKYA--- 240

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              F     ++      S              D  DL+R+ML   PS R+TA + L H +
Sbjct: 241 ---FD--LPQW---RTIS-------------DDAKDLIRKMLTFHPSLRITATQCLEHPW 279

Query: 286 FKDFQSLD 293
            + + S +
Sbjct: 280 IQKYSSEE 287

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  161 bits (410), Expect = 4e-48
 Identities = 78/325 (24%), Positives = 126/325 (38%), Gaps = 79/325 (24%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP------------------------IM 36
           +YTL + I +G YG V  A++        +K +                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 37  NPSEGVPSSVIREVSLLKELKHENIVRLLNV--QSSVDSIDLVFENLD----FDLLHFMK 90
               G    V +E+++LK+L H N+V+L+ V    + D + +VFE ++     ++     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----- 128

Query: 91  TEPTVTKNPLKIK---KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL 147
                T  PL       Y   ++ G+ Y H Q+I+HRD+KP+N L+      +KIADFG+
Sbjct: 129 ----PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGV 183

Query: 148 A---RPIDVPLENYTIKGGSLCYKAPERLLGSGR-YSTP-VDVWAVACTFAEMVTHQRLF 202
           +   +  D  L N     G+  + APE L  + + +S   +DVWA+  T    V  Q  F
Sbjct: 184 SNEFKGSDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 203 HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDL 262
                  L + I S      +   P     +                        D  DL
Sbjct: 241 MDERIMCLHSKIKS-----QALEFPDQPDIA-----------------------EDLKDL 272

Query: 263 LRRMLCLDPSKRLTAREALRHEYFK 287
           + RML  +P  R+   E   H +  
Sbjct: 273 ITRMLDKNPESRIVVPEIKLHPWVT 297

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  160 bits (408), Expect = 5e-48
 Identities = 82/303 (27%), Positives = 124/303 (40%), Gaps = 57/303 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H N
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           IVRL +         LVF+ +     F+ +     +  +E             + QIL  
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEA-------DASHCIQQILES 117

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           +AYCHS  I+HR+LKP N L   ++K   VK+ADFGLA  ++   E +    G+  Y +P
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           E L     YS PVD+WA        + +  L     F       L A I    G  D   
Sbjct: 177 EVLKKDP-YSKPVDIWACGV-----ILYILLVGYPPFWDEDQHRLYAQI--KAGAYD--- 225

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
              +   S E+        +   A            L+  ML ++P KR+TA +AL+  +
Sbjct: 226 ---YP--SPEW------DTVTPEAK----------SLIDSMLTVNPKKRITADQALKVPW 264

Query: 286 FKD 288
             +
Sbjct: 265 ICN 267

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  162 bits (412), Expect = 8e-48
 Identities = 81/304 (26%), Positives = 123/304 (40%), Gaps = 59/304 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y + E + +G +  V R     TG     K I     S      + RE  + ++L+H N
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           IVRL +         LVF+ +     F+ +     +  +E             + QIL  
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEA-------DASHCIQQILES 140

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           +AYCHS  I+HR+LKP N L   ++K   VK+ADFGLA  ++   E +    G+  Y +P
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 199

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           E L     YS PVD+WA        + +  L     F       L A I           
Sbjct: 200 EVLKKDP-YSKPVDIWACGV-----ILYILLVGYPPFWDEDQHRLYAQI----------- 242

Query: 226 LPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
             G   + S E+        +   A            L+  ML ++P KR+TA +AL+  
Sbjct: 243 KAGAYDYPSPEW------DTVTPEAK----------SLIDSMLTVNPKKRITADQALKVP 286

Query: 285 YFKD 288
           +  +
Sbjct: 287 WICN 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  160 bits (408), Expect = 9e-48
 Identities = 54/302 (17%), Positives = 99/302 (32%), Gaps = 50/302 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y  ++ + EG +  V        G    +K+I      +       RE  + +   H N
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPN 87

Query: 61  IVRLLNV----QSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLK---IKKYLHQILHG 112
           I+RL+      + +     L+        L + ++       N L    I   L  I  G
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL-KDKGNFLTEDQILWLLLGICRG 146

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP---------LENYTIKGG 163
           +   H++   HRDLKP N L+   +    + D G      +          L+++  +  
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 164 SLCYKAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
           ++ Y+APE              DVW++ C    M+  +  +   +  G   A+ ++    
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQN-- 262

Query: 222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
              ++P     S                            LL  M+ +DP +R      L
Sbjct: 263 -QLSIPQSPRHSSAL-----------------------WQLLNSMMTVDPHQRPHIPLLL 298

Query: 282 RH 283
             
Sbjct: 299 SQ 300

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  166 bits (421), Expect = 1e-47
 Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 59/303 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y + E +  G +G VHR  +  TG+    K +   + S+    +V +E+  +  L+H  
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPT 215

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL---HFMKTEPTVTKNPLKIKKYLHQILHGV 113
           +V L +     + + +++E +     F+ +   H   +E        +  +Y+ Q+  G+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-------DEAVEYMRQVCKGL 268

Query: 114 AYCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
            + H    +H DLKP N +   +  + +K+ DFGL   +D P ++  +  G+  + APE 
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEV 327

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIMGTPDSET 225
             G        D+W+V                    G+L+ I       F   G  D ET
Sbjct: 328 AEGKP-VGYYTDMWSV--------------------GVLSYILLSGLSPF--GGENDDET 364

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           L    S             I +             D +R++L  DP+ R+T  +AL H +
Sbjct: 365 LRNVKSCDWNMDDSAFSG-ISEDGK----------DFIRKLLLADPNTRMTIHQALEHPW 413

Query: 286 FKD 288
              
Sbjct: 414 LTP 416

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  159 bits (405), Expect = 2e-47
 Identities = 66/311 (21%), Positives = 111/311 (35%), Gaps = 62/311 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
            +  LE I  G +G+V +    L G    +K+            + +REV     L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAY 115
           ++VR  +  +  D + +  E  +   L   +  E     +  K   +K  L Q+  G+ Y
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 116 CHSQEILHRDLKPANFLIDR------------------SKDIVKIADFGLARPIDVPLEN 157
            HS  ++H D+KP+N  I R                  +K + KI D G    I  P   
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--- 187

Query: 158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
              +G S  + A E L  +  +    D++A+A T       + L  +            I
Sbjct: 188 QVEEGDS-RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN------GDQWHEI 240

Query: 218 M-GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT 276
             G      +P     S+EF                        +LL+ M+  DP +R +
Sbjct: 241 RQGRL--PRIPQ--VLSQEF-----------------------TELLKVMIHPDPERRPS 273

Query: 277 AREALRHEYFK 287
           A   ++H    
Sbjct: 274 AMALVKHSVLL 284

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  158 bits (401), Expect = 5e-47
 Identities = 80/303 (26%), Positives = 115/303 (37%), Gaps = 60/303 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            YTL   I  G +G V  A    T      KKIP     +       +E+ ++K L H N
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPN 67

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           I+RL         I LV E       F+ +     F   E           + +  +L  
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RES-------DAARIMKDVLSA 118

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           VAYCH   + HRDLKP NFL         +K+ DFGLA     P +    K G+  Y +P
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSP 177

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           + L   G Y    D W+        + +  L     F +     ++  I           
Sbjct: 178 QVL--EGLYGPECDEWSAGV-----MMYVLLCGYPPFSAPTDSEVMLKI----------- 219

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
             G  +F E+     N S             P    L+RR+L   P +R+T+ +AL HE+
Sbjct: 220 REGTFTFPEKDW--LNVS-------------PQAESLIRRLLTKSPKQRITSLQALEHEW 264

Query: 286 FKD 288
           F+ 
Sbjct: 265 FEK 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  161 bits (408), Expect = 1e-46
 Identities = 76/319 (23%), Positives = 122/319 (38%), Gaps = 80/319 (25%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP------IMNPSEGVPSSVIREVSLLK 54
            Y + + +  G  G V  A +  T   V ++ I                 +V  E+ +LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL---KIKKYLH 107
           +L H  I+++ N   + +   +V E ++    FD +        V    L     K Y +
Sbjct: 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV--------VGNKRLKEATCKLYFY 246

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSL 165
           Q+L  V Y H   I+HRDLKP N L+   ++  ++KI DFG ++ +           G+ 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 305

Query: 166 CYKAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
            Y APE L+  G   Y+  VD W++                         I  I      
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGV-----------------------ILFIC----- 337

Query: 224 ETLPGFTSFSEE--------------FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCL 269
             L G+  FSE               + F P              +    +DL++++L +
Sbjct: 338 --LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA---------EVSEKALDLVKKLLVV 386

Query: 270 DPSKRLTAREALRHEYFKD 288
           DP  R T  EALRH + +D
Sbjct: 387 DPKARFTTEEALRHPWLQD 405

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  158 bits (401), Expect = 1e-46
 Identities = 68/310 (21%), Positives = 124/310 (40%), Gaps = 74/310 (23%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y + E +  G +G VHR  ++ +  T + K + +    +     V +E+S+L   +H N
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL-----HFMKTEPTVTKNPLKIKKYLHQILH 111
           I+ L     S++ + ++FE +     F+ +          E        +I  Y+HQ+  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NER-------EIVSYVHQVCE 113

Query: 112 GVAYCHSQEILHRDLKPANFL-IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            + + HS  I H D++P N +   R    +KI +FG AR +  P +N+ +   +  Y AP
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAP 172

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIMGTPDS 223
           E        ST  D+W++                    G L  +       F  +   + 
Sbjct: 173 EVHQHDV-VSTATDMWSL--------------------GTLVYVLLSGINPF--LAETNQ 209

Query: 224 ET----LPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR 278
           +     +    +F  E F      S              + +D + R+L  +   R+TA 
Sbjct: 210 QIIENIMNAEYTFDEEAF---KEIS-------------IEAMDFVDRLLVKERKSRMTAS 253

Query: 279 EALRHEYFKD 288
           EAL+H + K 
Sbjct: 254 EALQHPWLKQ 263

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  164 bits (415), Expect = 3e-46
 Identities = 75/306 (24%), Positives = 112/306 (36%), Gaps = 29/306 (9%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + + E +  G +G V R     TG+ V +K+      S         E+ ++K+L H N
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPN 73

Query: 61  IVRLLNVQSSVDSID------LVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQIL 110
           +V    V   +  +       L  E  +       L+  +    + +    I+  L  I 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDIS 131

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
             + Y H   I+HRDLKP N ++       I KI D G A+ +D   E  T   G+L Y 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYL 190

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF---SIMGTPDSET 225
           APE LL   +Y+  VD W+      E +T  R F   W P          S       + 
Sbjct: 191 APE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           L G   FS       + S I         L       L+ ML     +R T  +      
Sbjct: 250 LTGAVKFSSVLPTPNHLSGI---------LAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

Query: 286 FKDFQS 291
           F+   S
Sbjct: 301 FQALDS 306

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  156 bits (396), Expect = 8e-46
 Identities = 77/321 (23%), Positives = 123/321 (38%), Gaps = 84/321 (26%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP------IMNPSEGVPSSVIREVSLLK 54
            Y + + +  G  G V  A +  T   V +K I                 +V  E+ +LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYL 106
           +L H  I+++ N   + +   +V E ++    FD +         E          K Y 
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRL--KEA-------TCKLYF 120

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGS 164
           +Q+L  V Y H   I+HRDLKP N L+   ++  ++KI DFG ++ +           G+
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGT 179

Query: 165 LCYKAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
             Y APE L+  G   Y+  VD W++                         I  I     
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGV-----------------------ILFIC---- 212

Query: 223 SETLPGFTSFSEE--------------FGFEPNRSP-IKDLATVVGGLEPDGVDLLRRML 267
              L G+  FSE               + F P     + + A          +DL++++L
Sbjct: 213 ---LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA----------LDLVKKLL 259

Query: 268 CLDPSKRLTAREALRHEYFKD 288
            +DP  R T  EALRH + +D
Sbjct: 260 VVDPKARFTTEEALRHPWLQD 280

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  157 bits (399), Expect = 1e-45
 Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 67/307 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y +LE +  G +G VHR  +  TG   V K I    P +    +V  E+S++ +L H  
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 109

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL---HFMKTEPTVTKNPLKIKKYLHQILHGV 113
           ++ L +       + L+ E L     FD +    +  +E        ++  Y+ Q   G+
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACEGL 162

Query: 114 AYCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
            + H   I+H D+KP N +   +    VKI DFGLA  ++ P E   +   +  + APE 
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEI 221

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIMGTPDSET 225
           +          D+WA+                    G+L  +       F   G  D ET
Sbjct: 222 VDREP-VGFYTDMWAI--------------------GVLGYVLLSGLSPF--AGEDDLET 258

Query: 226 LP----GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
           L         F E+  F  + S             P+  D ++ +L  +P KRLT  +AL
Sbjct: 259 LQNVKRCDWEFDEDA-F-SSVS-------------PEAKDFIKNLLQKEPRKRLTVHDAL 303

Query: 282 RHEYFKD 288
            H + K 
Sbjct: 304 EHPWLKG 310

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  155 bits (393), Expect = 1e-45
 Identities = 78/308 (25%), Positives = 120/308 (38%), Gaps = 60/308 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +  +EV+  G +  V      LTG    +K I          SS+  E+++LK++KHEN
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHEN 67

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           IV L ++  S     LV + +     FD +     +  TE             + Q+L  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY--TEK-------DASLVIQQVLSA 118

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           V Y H   I+HRDLKP N L +   ++  + I DFGL++         +   G+  Y AP
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAP 176

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAIFSIMGTPDSET 225
           E L     YS  VD W++       +T+  L     F+      L   I           
Sbjct: 177 EVLAQKP-YSKAVDCWSIGV-----ITYILLCGYPPFYEETESKLFEKI----------- 219

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
             G+  F   F        I + A           D +  +L  DP++R T  +AL H +
Sbjct: 220 KEGYYEFESPF-----WDDISESAK----------DFICHLLEKDPNERYTCEKALSHPW 264

Query: 286 FKDFQSLD 293
                +L 
Sbjct: 265 IDGNTALH 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  155 bits (394), Expect = 2e-45
 Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 66/313 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKEL 56
            Y + E +  G++  V +  +  TG     K I                + REVS+L+++
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQ 108
            H N++ L +V  +   + L+ E +     FD L        +E        +   ++ Q
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEE-------EATSFIKQ 123

Query: 109 ILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLENYTIKGGSL 165
           IL GV Y H+++I H DLKP N ++   +     +K+ DFGLA  I+     +    G+ 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTP 182

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIM 218
            + APE +          D+W++                    G++  I       F  +
Sbjct: 183 EFVAPEIVNYEP-LGLEADMWSI--------------------GVITYILLSGASPF--L 219

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR 278
           G    ETL   TS S +F  E       +LA           D +R++L  +  KRLT +
Sbjct: 220 GDTKQETLANITSVSYDFDEEFFSH-TSELA----------KDFIRKLLVKETRKRLTIQ 268

Query: 279 EALRHEYFKDFQS 291
           EALRH +     +
Sbjct: 269 EALRHPWITPVDN 281

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  154 bits (391), Expect = 2e-45
 Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 52/297 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
           RY     + +G +       D+ T +    K +P   ++ P       +  E+S+ + L 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLA 73

Query: 58  HENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQIL 110
           H+++V         D + +V E     +L  +L    K  TEP         + YL QI+
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEA-------RYYLRQIV 125

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            G  Y H   ++HRDLK  N  ++   + VKI DFGLA  ++   E   +  G+  Y AP
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L   G +S  VDVW++ C    ++  +  F +         I                
Sbjct: 185 EVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------- 230

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
               E+    + +             P    L+++ML  DP+ R T  E L  E+F 
Sbjct: 231 ----EYSIPKHIN-------------PVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  153 bits (389), Expect = 4e-45
 Identities = 78/315 (24%), Positives = 121/315 (38%), Gaps = 68/315 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-------MNPSEGVPSSVIREVSLL 53
            Y   E++  G    V R     T     VK I +           + +  + ++EV +L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 54  KELK-HENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKK 104
           +++  H NI++L +   +     LVF+ +     FD L        +E        + +K
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK-------ETRK 128

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
            +  +L  +   H   I+HRDLKP N L+D   +I K+ DFG +  +D P E      G+
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNI-KLTDFGFSCQLD-PGEKLREVCGT 186

Query: 165 LCYKAPERLLGSG-----RYSTPVDVWAVACTFAEMVTHQRL-----FHSRWAPGLLAAI 214
             Y APE +  S       Y   VD+W+        + +  L     F  R    +L  I
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGV-----IMYTLLAGSPPFWHRKQMLMLRMI 241

Query: 215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR 274
             + G         F S        P      D             DL+ R L + P KR
Sbjct: 242 --MSGNYQ------FGS--------PEWDDYSDTVK----------DLVSRFLVVQPQKR 275

Query: 275 LTAREALRHEYFKDF 289
            TA EAL H +F+ +
Sbjct: 276 YTAEEALAHPFFQQY 290

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  156 bits (397), Expect = 5e-45
 Identities = 74/330 (22%), Positives = 137/330 (41%), Gaps = 55/330 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +L+VI +G +G V +A+D      V +K   ++   +        E+ +L+ L+ + 
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFHRQAAEEIRILEHLRKQD 154

Query: 60  -----NIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQ 108
                N++ +L      ++        + FE L  +L   +K       +   ++K+ H 
Sbjct: 155 KDNTMNVIHML------ENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 109 ILHGVAYCHSQEILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCY 167
           IL  +   H   I+H DLKP N L+  + +  +K+ DFG +      +  Y     S  Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFY 265

Query: 168 KAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP------ 221
           +APE +LG+  Y  P+D+W++ C  AE++T   L         LA +  ++G P      
Sbjct: 266 RAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 222 ---------DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDG------------- 259
                     S+  P + + +         +  +     + G                  
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 260 -VDLLRRMLCLDPSKRLTAREALRHEYFKD 288
            +D L++ L  DP+ R+T  +ALRH + + 
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  152 bits (387), Expect = 5e-45
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 76/315 (24%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI--MNPSEGVPS--SVIREVSLLKEL 56
            Y + E +  G++  V +     TG     K I    ++ S    S   + REV++L+E+
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQ 108
           +H NI+ L ++  +   + L+ E +     FD L        TE        +  ++L Q
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TED-------EATQFLKQ 116

Query: 109 ILHGVAYCHSQEILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSL 165
           IL GV Y HS+ I H DLKP N + +D++     +K+ DFG+A  I+     +    G+ 
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTP 175

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIM 218
            + APE +          D+W++                    G++  I       F  +
Sbjct: 176 EFVAPEIVNYEP-LGLEADMWSI--------------------GVITYILLSGASPF--L 212

Query: 219 GTPDSET----LPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
           G    ET          F  E F      S   +LA           D +RR+L  DP +
Sbjct: 213 GETKQETLTNISAVNYDFDEEYF------SNTSELA----------KDFIRRLLVKDPKR 256

Query: 274 RLTAREALRHEYFKD 288
           R+T  ++L H + K 
Sbjct: 257 RMTIAQSLEHSWIKA 271

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  153 bits (389), Expect = 8e-45
 Identities = 82/313 (26%), Positives = 129/313 (41%), Gaps = 66/313 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKEL 56
            Y   E +  G++  V +  +  TG     K I                + REVS+LKE+
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQ 108
           +H N++ L  V  +   + L+ E +     FD L        TE        +  ++L Q
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEE-------EATEFLKQ 122

Query: 109 ILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLENYTIKGGSL 165
           IL+GV Y HS +I H DLKP N ++   +  K  +KI DFGLA  ID     +    G+ 
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTP 181

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIM 218
            + APE +          D+W++                    G++  I       F  +
Sbjct: 182 EFVAPEIVNYEP-LGLEADMWSI--------------------GVITYILLSGASPF--L 218

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR 278
           G    ETL   ++ + EF  E   +    LA           D +RR+L  DP KR+T +
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSN-TSALA----------KDFIRRLLVKDPKKRMTIQ 267

Query: 279 EALRHEYFKDFQS 291
           ++L+H + K   +
Sbjct: 268 DSLQHPWIKPKDT 280

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  153 bits (389), Expect = 2e-44
 Identities = 75/318 (23%), Positives = 122/318 (38%), Gaps = 76/318 (23%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPS----SVIREVSLLKEL 56
            Y + E +  G++  V +  +  TG     K I                + REVS+L+++
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQ 108
            H NI+ L +V  +   + L+ E +     FD L        +E        +   ++ Q
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEE-------EATSFIKQ 123

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPIDVPLENYTIKGGSL 165
           IL GV Y H+++I H DLKP N ++         +K+ DFGLA  I+     +    G+ 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTP 182

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIM 218
            + APE +          D+W++                    G++  I       F  +
Sbjct: 183 EFVAPEIVNYEP-LGLEADMWSI--------------------GVITYILLSGASPF--L 219

Query: 219 GTPDSET----LPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
           G    ET          F  E F      S   +LA           D +R++L  +  K
Sbjct: 220 GDTKQETLANITAVSYDFDEEFF------SQTSELA----------KDFIRKLLVKETRK 263

Query: 274 RLTAREALRHEYFKDFQS 291
           RLT +EALRH +     +
Sbjct: 264 RLTIQEALRHPWITPVDT 281

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  152 bits (387), Expect = 2e-44
 Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 52/297 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
           RY     + +G +       D+ T +    K +P   ++ P       +  E+S+ + L 
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLA 99

Query: 58  HENIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMK--TEPTVTKNPLKIKKYLHQIL 110
           H+++V         D + +V E     +L  +L    K  TEP         + YL QI+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEA-------RYYLRQIV 151

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            G  Y H   ++HRDLK  N  ++   ++ KI DFGLA  ++   E   +  G+  Y AP
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEV-KIGDFGLATKVEYDGERKKVLCGTPNYIAP 210

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L   G +S  VDVW++ C    ++  +  F +         I                
Sbjct: 211 EVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------- 256

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
               E+    + +             P    L+++ML  DP+ R T  E L  E+F 
Sbjct: 257 ----EYSIPKHIN-------------PVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  152 bits (387), Expect = 5e-44
 Identities = 83/305 (27%), Positives = 135/305 (44%), Gaps = 61/305 (20%)

Query: 1   RYTL--LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
            YT+   E++  GR+G VH+  ++ TG  +  K I      +     V  E+S++ +L H
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDH 145

Query: 59  ENIVRLLNVQSSVDSIDLVFENLD----FDLL---HFMKTEPTVTKNPLKIKKYLHQILH 111
            N+++L +   S + I LV E +D    FD +    +  TE       L    ++ QI  
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-------LDTILFMKQICE 198

Query: 112 GVAYCHSQEILHRDLKPANFL-IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           G+ + H   ILH DLKP N L ++R    +KI DFGLAR    P E   +  G+  + AP
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAP 257

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI-------FSIMGTPDS 223
           E +      S P D+W+V                    G++A +       F  +G  D+
Sbjct: 258 EVVNYDF-VSFPTDMWSV--------------------GVIAYMLLSGLSPF--LGDNDA 294

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           ETL    +   +   E  +  I + A           + + ++L  + S R++A EAL+H
Sbjct: 295 ETLNNILACRWDLEDEEFQD-ISEEA----------KEFISKLLIKEKSWRISASEALKH 343

Query: 284 EYFKD 288
            +  D
Sbjct: 344 PWLSD 348

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  152 bits (385), Expect = 7e-44
 Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 71/314 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI------MNPSEGVPSSVIREVSLLK 54
           +Y   +VI  G    V R     TG    VK + +          E V  +  RE  +L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 55  ELK-HENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKY 105
           ++  H +I+ L++   S   + LVF+ +     FD L        +E        + +  
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK-------ETRSI 205

Query: 106 LHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL 165
           +  +L  V++ H+  I+HRDLKP N L+D +  I +++DFG +  ++ P E      G+ 
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI-RLSDFGFSCHLE-PGEKLRELCGTP 263

Query: 166 CYKAPERLLGSG-----RYSTPVDVWAVA-------CTFAEMVTHQRLFHSRWAPGLLAA 213
            Y APE L  S       Y   VD+WA                     F  R    +L  
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-------PPFWHRRQILMLRM 316

Query: 214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
           I  + G         F+S        P                    DL+ R+L +DP  
Sbjct: 317 I--MEGQYQ------FSS--------PEWDDRSSTVK----------DLISRLLQVDPEA 350

Query: 274 RLTAREALRHEYFK 287
           RLTA +AL+H +F+
Sbjct: 351 RLTAEQALQHPFFE 364

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  150 bits (381), Expect = 9e-44
 Identities = 72/300 (24%), Positives = 126/300 (42%), Gaps = 50/300 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELKH 58
           +Y + +++ EG YG V    DS T     VK +    +       ++V +E+ LL+ L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 59  ENIVRLLNV--QSSVDSIDLVFE---NLDFDLLHFMKTEPTVTKNPLKIK---KYLHQIL 110
           +N+++L++V        + +V E       ++L        V +    +     Y  Q++
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS------VPEKRFPVCQAHGYFCQLI 119

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYK 168
            G+ Y HSQ I+H+D+KP N L+     + KI+  G+A  +     + T +   GS  ++
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 169 APERLLGSGRYSTP-VDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP 227
            PE   G   +S   VD+W+   T   + T    F       L   I    G+     +P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSY---AIP 233

Query: 228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           G                            P   DLL+ ML  +P+KR + R+  +H +F+
Sbjct: 234 GDCG-------------------------PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  150 bits (380), Expect = 2e-43
 Identities = 67/315 (21%), Positives = 109/315 (34%), Gaps = 71/315 (22%)

Query: 1   RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH- 58
            Y L  + +  G++  V +     TG     K +      +   + ++ E+++L+  K  
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88

Query: 59  ENIVRLLNVQSSVDSIDLVFENLD----FDLL------HFMKTEPTVTKNPLKIKKYLHQ 108
             ++ L  V  +   I L+ E       F L           +E         + + + Q
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV--SEN-------DVIRLIKQ 139

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLC 166
           IL GV Y H   I+H DLKP N L+        +KI DFG++R I           G+  
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPE 198

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTP 221
           Y APE L      +T  D+W +                    G     LL      +G  
Sbjct: 199 YLAPEILNYDP-ITTATDMWNI--------------------GIIAYMLLTHTSPFVGED 237

Query: 222 DSETLP----GFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT 276
           + ET          +  E F    + S                 D ++ +L  +P KR T
Sbjct: 238 NQETYLNISQVNVDYSEETF---SSVS-------------QLATDFIQSLLVKNPEKRPT 281

Query: 277 AREALRHEYFKDFQS 291
           A   L H + + +  
Sbjct: 282 AEICLSHSWLQQWDF 296

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  149 bits (379), Expect = 4e-43
 Identities = 54/315 (17%), Positives = 120/315 (38%), Gaps = 45/315 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKI---------------PIMNPSEGVPSS 45
            Y ++  + +G++  +             +KK                      +     
Sbjct: 32  DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 46  VIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLK 101
              E+ ++ ++K+E  +    + ++ D + +++E ++         +           + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 102 ---IKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN 157
              IK  +  +L+  +Y H++  I HRD+KP+N L+D++  + K++DFG +      + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV-KLSDFGES----EYMVD 204

Query: 158 YTIKG--GSLCYKAPERLLGSGRYSTP-VDVWAVACTFAEMVTHQRLFHSRW-APGLLAA 213
             IKG  G+  +  PE       Y+   VD+W++      M  +   F  +     L   
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK 273
           I +               +  +          K        L  + +D L+  L  +P++
Sbjct: 265 IRT-----------KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 274 RLTAREALRHEYFKD 288
           R+T+ +AL+HE+  D
Sbjct: 314 RITSEDALKHEWLAD 328

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  149 bits (377), Expect = 5e-43
 Identities = 68/311 (21%), Positives = 117/311 (37%), Gaps = 65/311 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
           R  +  V+ EG +  V+ A D  +G    +K++      +    ++I+EV  +K+L  H 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHP 86

Query: 60  NIVRLLNVQSSVDSID--------LVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQ 108
           NIV+  +  S              L+ E     L+ F+K     ++ PL    + K  +Q
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK--MESRGPLSCDTVLKIFYQ 144

Query: 109 ILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP------------ 154
               V + H Q+  I+HRDLK  N L+  ++  +K+ DFG A  I               
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 155 LENYTIKGGSLCYKAPE--RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA 212
           +E    +  +  Y+ PE   L  +       D+WA+ C    +   Q  F       ++ 
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263

Query: 213 AIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS 272
             +SI         P   +    F                         L+R ML ++P 
Sbjct: 264 GKYSI---------PPHDTQYTVF-----------------------HSLIRAMLQVNPE 291

Query: 273 KRLTAREALRH 283
           +RL+  E +  
Sbjct: 292 ERLSIAEVVHQ 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  147 bits (373), Expect = 5e-43
 Identities = 82/305 (26%), Positives = 116/305 (38%), Gaps = 68/305 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN----PSEGVPSSVIREVSLLKEL 56
            Y L + +  G +G V      LTG  V VK   I+N     S  V   + RE+  LK  
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQI 109
           +H +I++L  V S+     +V E +     FD +             ++     +   QI
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEMEARRLFQQI 120

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG------- 162
           L  V YCH   ++HRDLKP N L+D   +  KIADFGL+        N    G       
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLS--------NMMSDGEFLRTSC 171

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           GS  Y APE + G       VD+W+       ++     F     P L   I    G   
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVF- 228

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
              +P + +                              LL  ML +DP KR T ++   
Sbjct: 229 --YIPEYLN-------------------------RSVATLLMHMLQVDPLKRATIKDIRE 261

Query: 283 HEYFK 287
           HE+FK
Sbjct: 262 HEWFK 266

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  148 bits (376), Expect = 7e-43
 Identities = 82/301 (27%), Positives = 118/301 (39%), Gaps = 61/301 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y LL+ I +G +  V  A   LTG  V +K I     +      + REV ++K L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILHGV 113
           IV+L  V  +  ++ L+ E       FD L        V    +K K       QI+  V
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYL--------VAHGRMKEKEARSKFRQIVSAV 127

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-------GSLC 166
            YCH + I+HRDLK  N L+D   +I KIADFG +        N    G       G+  
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNI-KIADFGFS--------NEFTVGGKLDAFCGAPP 178

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           Y APE   G       VDVW++      +V+    F  +    L   +    G      +
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKY---RI 233

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           P + S                          D  +LL+R L L+P KR T  + ++  + 
Sbjct: 234 PFYMS-------------------------TDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

Query: 287 K 287
            
Sbjct: 269 N 269

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  149 bits (377), Expect = 7e-43
 Identities = 78/313 (24%), Positives = 119/313 (38%), Gaps = 80/313 (25%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + +   +  G    V+R     T     +K +      +     V  E+ +L  L H N
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK----IVRTEIGVLLRLSHPN 109

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           I++L  +  +   I LV E +     FD +    ++  +E             + QIL  
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY--SER-------DAADAVKQILEA 160

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           VAY H   I+HRDLKP N L    + D  +KIADFGL++ ++          G+  Y AP
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAP 219

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L G   Y   VD+                    W+ G+   I  I+       L GF 
Sbjct: 220 EILRGCA-YGPEVDM--------------------WSVGI---ITYIL-------LCGFE 248

Query: 231 SFSEE--------------FGFEPNR-SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
            F +E              + F       +   A           DL+R+++ LDP KRL
Sbjct: 249 PFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK----------DLVRKLIVLDPKKRL 298

Query: 276 TAREALRHEYFKD 288
           T  +AL+H +   
Sbjct: 299 TTFQALQHPWVTG 311

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  146 bits (372), Expect = 8e-43
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 51/297 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSSVIREVSLLKELK 57
            + +  ++ +G +  V+RA    TG  V +K I    +     G+   V  EV +  +LK
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--GMVQRVQNEVKIHCQLK 69

Query: 58  HENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMK---TEPTVTKNPLKIKKYLHQIL 110
           H +I+ L N     + + LV E          L       +E          + ++HQI+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-------RHFMHQII 122

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
            G+ Y HS  ILHRDL  +N L+ R+ +I KIADFGLA  + +P E +    G+  Y +P
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNI-KIADFGLATQLKMPHEKHYTLCGTPNYISP 181

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E    S  +    DVW++ C F  ++  +  F +      L  +                
Sbjct: 182 EIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------- 227

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
               ++      S              +  DL+ ++L  +P+ RL+    L H +  
Sbjct: 228 ----DYEMPSFLS-------------IEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  147 bits (373), Expect = 2e-42
 Identities = 83/304 (27%), Positives = 125/304 (41%), Gaps = 67/304 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN----PSEGVPSSVIREVSLLKEL 56
            Y + E + EG +G V  A    T   V +K    ++        +   V RE+S LK L
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD---FDLLHFMKTEPTVTKNPLKIK---KYLHQIL 110
           +H +I++L +V ++   I +V E      FD +        V K  +      ++  QI+
Sbjct: 67  RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI--------VEKKRMTEDEGRRFFQQII 118

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-------G 163
             + YCH  +I+HRDLKP N L+D + ++ KIADFGL+        N    G       G
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNV-KIADFGLS--------NIMTDGNFLKTSCG 169

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           S  Y APE + G       VDVW+       M+  +  F   + P L   + S       
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVY-- 225

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
             +P F S                         P    L+RRM+  DP +R+T +E  R 
Sbjct: 226 -VMPDFLS-------------------------PGAQSLIRRMIVADPMQRITIQEIRRD 259

Query: 284 EYFK 287
            +F 
Sbjct: 260 PWFN 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (369), Expect = 3e-42
 Identities = 71/310 (22%), Positives = 122/310 (39%), Gaps = 74/310 (23%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--EGVPSSVIREVSLLKELKH 58
            + L++ + EG YG V  A + +T + V VK   I++       P ++ +E+ + K L H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 59  ENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILH 111
           EN+V+    +   +   L  E       FD +             +      ++ HQ++ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMA 116

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKA 169
           GV Y H   I HRD+KP N L+D   ++ KI+DFGLA           +    G+L Y A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 170 PERLLGSGRYSTPVDVWAVAC---TFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
           PE L     ++ PVDVW  +C     A                +LA             L
Sbjct: 176 PELLKRREFHAEPVDVW--SCGIVLTA----------------MLAG-----------EL 206

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGG---------LEPDGVDLLRRMLCLDPSKRLTA 277
           P          ++      ++ +              ++   + LL ++L  +PS R+T 
Sbjct: 207 P----------WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

Query: 278 REALRHEYFK 287
            +  +  ++ 
Sbjct: 257 PDIKKDRWYN 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  146 bits (371), Expect = 4e-42
 Identities = 71/313 (22%), Positives = 118/313 (37%), Gaps = 67/313 (21%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HEN 60
               + + EG +    +     +     VK I     S+ + ++  +E++ LK  + H N
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPN 67

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILHG 112
           IV+L  V        LV E L+    F+ +    HF  +E        +    + +++  
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF--SET-------EASYIMRKLVSA 118

Query: 113 VAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
           V++ H   ++HRDLKP N L  D + +  +KI DFG AR      +       +L Y AP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L  +G Y    D+W+                       L  I   M       L G  
Sbjct: 179 ELLNQNG-YDESCDLWS-----------------------LGVILYTM-------LSGQV 207

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGL------EPDGV-----DLLRRMLCLDPSKRLTARE 279
            F          S ++ +  +  G           V     DL++ +L +DP+KRL    
Sbjct: 208 PFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267

Query: 280 ALRHEYFKDFQSL 292
              +E+ +D   L
Sbjct: 268 LRYNEWLQDGSQL 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  144 bits (365), Expect = 2e-41
 Identities = 71/307 (23%), Positives = 123/307 (40%), Gaps = 68/307 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--EGVPSSVIREVSLLKELKH 58
            + L++ + EG YG V  A + +T + V VK   I++       P ++ +E+ + K L H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNH 64

Query: 59  ENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQILH 111
           EN+V+    +   +   L  E       FD +             +      ++ HQ++ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMA 116

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKA 169
           GV Y H   I HRD+KP N L+D   ++ KI+DFGLA           +    G+L Y A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE L     ++ PVDVW  +C     +    L        +LA             LP  
Sbjct: 176 PELLKRREFHAEPVDVW--SCG----IV---LT------AMLAG-----------ELP-- 207

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGG---------LEPDGVDLLRRMLCLDPSKRLTAREA 280
                   ++      ++ +              ++   + LL ++L  +PS R+T  + 
Sbjct: 208 --------WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259

Query: 281 LRHEYFK 287
            +  ++ 
Sbjct: 260 KKDRWYN 266

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  142 bits (360), Expect = 5e-41
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 58/299 (19%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKEL 56
            + +   + +G++G V+ A +  +   + +K   ++  ++    GV   + REV +   L
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMK--TEPTVTKNPLKIKKYLHQIL 110
           +H NI+RL         + L+ E       +  L  +    E            Y+ ++ 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-------ATYITELA 119

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYK 168
           + ++YCHS+ ++HRD+KP N L+  + ++ KIADFG +    V   +       G+L Y 
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGEL-KIADFGWS----VHAPSSRRTDLCGTLDYL 174

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
            PE + G   +   VD+W++     E +  +  F +         I  +           
Sbjct: 175 PPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                 EF F    +                 DL+ R+L  +PS+R   RE L H +  
Sbjct: 223 ------EFTFPDFVT-------------EGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  144 bits (365), Expect = 8e-41
 Identities = 80/336 (23%), Positives = 129/336 (38%), Gaps = 62/336 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +  +I +G +G V +A+D +  + V +K   I+   +   +    EV LL+ +    
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHD 111

Query: 60  -----NIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQ 108
                 IV L                 LVFE L ++L   ++       +    +K+  Q
Sbjct: 112 TEMKYYIVHLK------RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 109 ILHGVAYCHSQE--ILHRDLKPANFLI-DRSKDIVKIADFGLARPIDVPLENYTIKGGSL 165
           +   + +  + E  I+H DLKP N L+ +  +  +KI DFG +  +   +  Y     S 
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SR 222

Query: 166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE- 224
            Y++PE LLG   Y   +D+W++ C   EM T + LF        +  I  ++G P +  
Sbjct: 223 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281

Query: 225 -------------------TLPGFTSFSEEFGFEPNRSPIKDLATVVGGL------EPDG 259
                               L        E+     R     L    GG       E   
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341

Query: 260 --------VDLLRRMLCLDPSKRLTAREALRHEYFK 287
                    DL+ RML  DP  R+    AL+H +FK
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  143 bits (363), Expect = 9e-41
 Identities = 78/315 (24%), Positives = 118/315 (37%), Gaps = 73/315 (23%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKHE 59
            Y + E I  G Y    R     T     VK I               E+  LL+  +H 
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS------KRDPTEEIEILLRYGQHP 76

Query: 60  NIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQILH 111
           NI+ L +V      + +V E +      D +     F  +E        +    L  I  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF--SER-------EASAVLFTITK 127

Query: 112 GVAYCHSQEILHRDLKPANFL-IDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
            V Y H+Q ++HRDLKP+N L +D S +   ++I DFG A+ +            +  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
           APE L   G Y    D+W+                       L  +   M       L G
Sbjct: 188 APEVLERQG-YDAACDIWS-----------------------LGVLLYTM-------LTG 216

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGG----LEP--DGV-----DLLRRMLCLDPSKRLTA 277
           +T F+      P+ +P + LA +  G         + V     DL+ +ML +DP +RLTA
Sbjct: 217 YTPFAN----GPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA 272

Query: 278 REALRHEYFKDFQSL 292
              LRH +   +  L
Sbjct: 273 ALVLRHPWIVHWDQL 287

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  145 bits (368), Expect = 2e-40
 Identities = 87/305 (28%), Positives = 120/305 (39%), Gaps = 68/305 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN----PSEGVPSSVIREVSLLKEL 56
            Y L + +  G +G V      LTG  V VK   I+N     S  V   + RE+  LK  
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLDVVGKIRREIQNLKLF 73

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIK---KYLHQI 109
           +H +I++L  V S+   I +V E +     FD +             L  K   +   QI
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEKESRRLFQQI 125

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG------- 162
           L GV YCH   ++HRDLKP N L+D   +  KIADFGL+        N    G       
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLS--------NMMSDGEFLRTSC 176

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD 222
           GS  Y APE + G       VD+W+       ++     F     P L   I    G   
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIF- 233

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
               P + +                         P  + LL+ ML +DP KR T ++   
Sbjct: 234 --YTPQYLN-------------------------PSVISLLKHMLQVDPMKRATIKDIRE 266

Query: 283 HEYFK 287
           HE+FK
Sbjct: 267 HEWFK 271

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  140 bits (356), Expect = 5e-40
 Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 66/305 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSS--VIREVSLLKEL 56
           +Y +  ++  G +G+V+          V +K +    ++    +P+   V  EV LLK++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 57  KHE--NIVRLLNVQSSVDSIDLVFE--NLDFDLLHFMKTEPTVTKNPLK---IKKYLHQI 109
                 ++RLL+     DS  L+ E      DL  F+       +  L+    + +  Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQV 158

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG------G 163
           L  V +CH+  +LHRD+K  N LID ++  +K+ DFG                      G
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDG 210

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           +  Y  PE +     +     V                    W+ G+L  ++ ++     
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAV--------------------WSLGIL--LYDMV----C 244

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
             +P          FE +   I+        +  +   L+R  L L PS R T  E   H
Sbjct: 245 GDIP----------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294

Query: 284 EYFKD 288
            + +D
Sbjct: 295 PWMQD 299

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  141 bits (358), Expect = 5e-40
 Identities = 73/312 (23%), Positives = 114/312 (36%), Gaps = 78/312 (25%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  ++ I  G +G      D LT + V VK    +     +  +V RE+   + L+H N
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIINHRSLRHPN 77

Query: 61  IVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHG 112
           IVR   V  +   + ++ E      L ++ +                     +  Q+L G
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGEL-YERI--------CNAGRFSEDEARFFFQQLLSG 128

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDI-VKIADFGLARPIDVPLENYTIKG-------GS 164
           V+YCHS +I HRDLK  N L+D S    +KI DFG +          ++         G+
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGT 180

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT---------HQRLFHSRWAPGLLAAIF 215
             Y APE LL         DVW+   T   M+            R +  +    +L+  +
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-KTIQRILSVKY 239

Query: 216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
           SI         P     S                       P+   L+ R+   DP+ R+
Sbjct: 240 SI---------PDDIRIS-----------------------PECCHLISRIFVADPATRI 267

Query: 276 TAREALRHEYFK 287
           +  E   H +F 
Sbjct: 268 SIPEIKTHSWFL 279

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  137 bits (348), Expect = 7e-39
 Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 68/306 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP----IMNPSEGVPSSVIREVSLLKEL 56
            Y L  ++ +G +G V   H       V +K IP    +         +   EV+LL ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 57  ----KHENIVRLLNVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLK---IKKYLH 107
                H  ++RLL+   + +   LV E      DL  ++       K PL     + +  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-----TEKGPLGEGPSRCFFG 146

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG----- 162
           Q++  + +CHS+ ++HRD+K  N LID  +   K+ DFG                     
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--------ALLHDEPYTDF 198

Query: 163 -GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
            G+  Y  PE +     ++ P  V                    W+ G+L  ++ ++   
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATV--------------------WSLGIL--LYDMV--- 233

Query: 222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
               +P          FE ++  ++        + PD   L+RR L   PS R +  E L
Sbjct: 234 -CGDIP----------FERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

Query: 282 RHEYFK 287
              + +
Sbjct: 283 LDPWMQ 288

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  138 bits (349), Expect = 1e-38
 Identities = 80/338 (23%), Positives = 132/338 (39%), Gaps = 68/338 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY ++  + EG +G V    D   G + V  KI I N  +   ++ + E+++LK++K + 
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKI-IRNVGKYREAARL-EINVLKKIKEKD 77

Query: 60  -----NIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKN-----PLK-I 102
                  V +       D  +      + FE L  +   F+K      +N     PL  +
Sbjct: 78  KENKFLCVLMS------DWFNFHGHMCIAFELLGKNTFEFLK------ENNFQPYPLPHV 125

Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI------------------VKIAD 144
           +   +Q+ H + + H  ++ H DLKP N L   S+                    +++AD
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 145 FGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
           FG A               +  Y+ PE +L  G ++ P DVW++ C   E      LF +
Sbjct: 186 FGSATFDHEHHTTIVA---TRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQT 241

Query: 205 RWAPGLLAAIFSIMGTPDSE--------------TLPGFTSFSEEFGFEPNRSPIKDLAT 250
                 L  +  I+G   S                L    + S+    + N  P+K    
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301

Query: 251 VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                     DL+RRML  DP++R+T  EAL H +F  
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  137 bits (346), Expect = 1e-38
 Identities = 71/326 (21%), Positives = 114/326 (34%), Gaps = 75/326 (23%)

Query: 1   RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-H 58
            Y L  +V+ EG +  V    + +T     VK I          S V REV +L + + H
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGH 70

Query: 59  ENIVRLLNVQSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQIL 110
            N++ L+      D   LVFE +        +    HF   E       L+    +  + 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF--NE-------LEASVVVQDVA 121

Query: 111 HGVAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKG------ 162
             + + H++ I HRDLKP N L    ++   VKI DF L   I +  +   I        
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 163 -GSLCYKAPERLLGSG----RYSTPVDVWA---------------VACTFAEMVTHQRLF 202
            GS  Y APE +         Y    D+W+               V    ++    +   
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241

Query: 203 HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDL 262
                  L  +I             G   F      + + + I   A           DL
Sbjct: 242 CPACQNMLFESI-----------QEGKYEFP-----DKDWAHISCAAK----------DL 275

Query: 263 LRRMLCLDPSKRLTAREALRHEYFKD 288
           + ++L  D  +RL+A + L+H + + 
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWVQG 301

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  137 bits (347), Expect = 1e-38
 Identities = 82/337 (24%), Positives = 134/337 (39%), Gaps = 68/337 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE- 59
           RY +++ + EG +G V    D   G   V  KI + N      ++   E+ +L+ L    
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI-VKNVDRYCEAARS-EIQVLEHLNTTD 72

Query: 60  -----NIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKN-----PLK-I 102
                  V++L      +  +      +VFE L      F+K      +N      L  I
Sbjct: 73  PNSTFRCVQML------EWFEHHGHICIVFELLGLSTYDFIK------ENGFLPFRLDHI 120

Query: 103 KKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI------------------VKIAD 144
           +K  +QI   V + HS ++ H DLKP N L  +S                     +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 145 FGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
           FG A   D           +  Y+APE +L  G +S P DVW++ C   E      +F +
Sbjct: 181 FGSATYDDEHHSTLVS---TRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPT 236

Query: 205 RWAPGLLAAIFSIMGTPDSETLPGFTS----FSEEFGFEPNRS-------PIKDLATVVG 253
             +   LA +  I+G      +           +   ++ + S         K L   + 
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296

Query: 254 GLEPDG---VDLLRRMLCLDPSKRLTAREALRHEYFK 287
             + +     DL+++ML  DP+KR+T REAL+H +F 
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  135 bits (343), Expect = 2e-38
 Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 54/297 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVI----REVSLLKEL 56
            + +   + +G++G V+ A +      + +K   ++  S+     V     RE+ +   L
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMK--TEPTVTKNPLKIKKYLHQIL 110
           +H NI+R+ N       I L+ E       +  L       E            ++ ++ 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-------ATFMEELA 124

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAP 170
             + YCH ++++HRD+KP N L+    ++ KIADFG +  +  P        G+L Y  P
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGEL-KIADFGWS--VHAPSLRRRTMCGTLDYLPP 181

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E + G   +   VD+W       E +     F S         I                
Sbjct: 182 EMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
             + +  F P  S                 DL+ ++L   P +RL  +  + H + K
Sbjct: 225 -VNVDLKFPPFLS-------------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  137 bits (346), Expect = 2e-38
 Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 88/315 (27%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP---IMNPSEGVPSS---VIREVSLLK 54
           +Y+ +  +  G +G V  A D      VVVK I    ++            V  E+++L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 55  ELKHENIVRLLNVQSSVDSIDLVFENLD-----FDLLHFMKTEPTVTKNPLK---IKKYL 106
            ++H NI+++L++  +     LV E        F  +             L         
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--------DRHPRLDEPLASYIF 136

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---- 162
            Q++  V Y   ++I+HRD+K  N +I     I K+ DFG A         Y  +G    
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI-KLIDFGSA--------AYLERGKLFY 187

Query: 163 ---GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG 219
              G++ Y APE L+G+      +++                    W+ G+   +++++ 
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEM--------------------WSLGVT--LYTLV- 224

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGG-------LEPDGVDLLRRMLCLDPS 272
               E  P          F        +L   V         +  + + L+  +L   P 
Sbjct: 225 ---FEENP----------FC-------ELEETVEAAIHPPYLVSKELMSLVSGLLQPVPE 264

Query: 273 KRLTAREALRHEYFK 287
           +R T  + +   +  
Sbjct: 265 RRTTLEKLVTDPWVT 279

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  136 bits (345), Expect = 4e-38
 Identities = 69/357 (19%), Positives = 114/357 (31%), Gaps = 102/357 (28%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR-----------E 49
            + ++  + +G +G V             VK              V+R           E
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK--------------VVRNIKKYTRSAKIE 81

Query: 50  VSLLKELKHE-----NIVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKN 98
             +LK+++++     NIV+                  L+FE L   L   +       +N
Sbjct: 82  ADILKKIQNDDINNNNIVKYH------GKFMYYDHMCLIFEPLGPSLYEIIT------RN 129

Query: 99  -----PLK-IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID 152
                 ++ IK Y  +IL  + Y     + H DLKP N L+D       +          
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189

Query: 153 V----PLENYTIKG---GSLC--------------YKAPERLLGSGRYSTPVDVWAVACT 191
                  ++  IK    G                 Y+APE +L  G +    D+W+  C 
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCV 248

Query: 192 FAEMVTHQRLFHSRWAPG-----LLAAIFSIMGTPDSETLPG---------FTSFSEEFG 237
            AE+ T   LF             LA + SI+       L                 +  
Sbjct: 249 LAELYTGSLLF-----RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303

Query: 238 FEPNRSPIKDLATVVGGLE-------PDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           +  N S I  +  V   L            D L  +L +DP+ R +  E L+H++ +
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  136 bits (343), Expect = 1e-37
 Identities = 45/334 (13%), Positives = 91/334 (27%), Gaps = 82/334 (24%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE----VSLLKEL 56
                 V+ +    A   A D  TG++  V                ++E    + LL+ +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  KHENIVR----------LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYL 106
           K++   +          L+        I +  +  D  +L      P +  N     + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 107 H-------------------QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL 147
                               Q++  +A  H   ++H  L+P + ++D+ +  V +  F  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEH 252

Query: 148 ARPIDVPLENYTIKGGSLCYKAPERL----------LGSGRYSTPVDVWAVACTFAEMVT 197
                       +   S  ++ PE                  +   D WA+      +  
Sbjct: 253 LVRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 198 HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEP 257
                    A G    IF        + +P                P++           
Sbjct: 309 ADLPITKDAALGGSEWIFR-----SCKNIP---------------QPVR----------- 337

Query: 258 DGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
               LL   L      RL   +A+    ++  ++
Sbjct: 338 ---ALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  134 bits (338), Expect = 1e-36
 Identities = 46/336 (13%), Positives = 89/336 (26%), Gaps = 82/336 (24%)

Query: 1   RYTLL---EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE----VSLL 53
           R   L    V+ +    A   A D  TG++  V                ++E    + LL
Sbjct: 76  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 54  KELKHENIVR----------LLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK 103
           + +K++   +          L+        I +  +  D  +L      P +  N     
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 104 KYLH-------------------QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIAD 144
           + L                    Q++  +A  H   ++H  L+P + ++D+    V +  
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTG 254

Query: 145 FGLARPIDVPLENYTIKGGSLC----YKAPERLLGS----GRYSTPVDVWAVACTFAEMV 196
           F           +     G         A   L          +   D W +      + 
Sbjct: 255 FEHLVRDG---ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 197 THQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLE 256
                     A G    IF        + +P                P++          
Sbjct: 312 CADLPNTDDAALGGSEWIF-----RSCKNIP---------------QPVR---------- 341

Query: 257 PDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL 292
                LL   L      RL   +A+    ++  ++ 
Sbjct: 342 ----ALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (331), Expect = 2e-36
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            + EV+  G +G V +A        V +K+I     SE    + I E+  L  + H NIV
Sbjct: 11  EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIV 64

Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           +L      ++ + LV E  +    +++LH    EP           +  Q   GVAY HS
Sbjct: 65  KLYGA--CLNPVCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 119 QE---ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            +   ++HRDLKP N L+     ++KI DFG A  I   + N     GS  + APE +  
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE-VFE 176

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFH 203
              YS   DV++      E++T ++ F 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFD 204

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  130 bits (330), Expect = 4e-36
 Identities = 65/315 (20%), Positives = 105/315 (33%), Gaps = 77/315 (24%)

Query: 1   RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KH 58
            Y L  +V+  G  G V       TG    +K +              +EV    +    
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGG 81

Query: 59  ENIVRLLNV----QSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYL 106
            +IV +L+V          + ++ E ++    F  +        TE        +  + +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIM 134

Query: 107 HQILHGVAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGS 164
             I   + + HS  I HRD+KP N L   + KD ++K+ DFG A+              +
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYT 192

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
             Y APE +LG  +Y    D+W+                       L  I  I+      
Sbjct: 193 PYYVAPE-VLGPEKYDKSCDMWS-----------------------LGVIMYIL------ 222

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGG----LEP--DGV-----DLLRRMLCLDPSK 273
            L GF  F                  +  G      P    V      L+R +L  DP++
Sbjct: 223 -LCGFPPFYSN---TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278

Query: 274 RLTAREALRHEYFKD 288
           RLT  + + H +   
Sbjct: 279 RLTITQFMNHPWINQ 293

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  127 bits (320), Expect = 6e-35
 Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 58/317 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y L EVI  G    V  A+ +   + V +K+I +      +   +++E+  + +  H N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPN 74

Query: 61  IVRLLNVQSSVDSIDL--VFENLD----FDLLHFMKTEPTVTKNPLK---IKKYLHQILH 111
           IV      S V   +L  V + L      D++  +  +       L    I   L ++L 
Sbjct: 75  IVSYYT--SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-----GSLC 166
           G+ Y H    +HRD+K  N L+      V+IADFG++  +    +    K      G+ C
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVT----HQRLFHSRWAPGLLAAIFSIM--GT 220
           + APE +     Y    D+W+   T  E+ T    + +    +        +   +    
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDP 244

Query: 221 P----DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT 276
           P      +       + + F                         ++   L  DP KR T
Sbjct: 245 PSLETGVQDKEMLKKYGKSF-----------------------RKMISLCLQKDPEKRPT 281

Query: 277 AREALRHEYFKDFQSLD 293
           A E LRH++F+  ++ +
Sbjct: 282 AAELLRHKFFQKAKNKE 298

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  129 bits (325), Expect = 8e-35
 Identities = 68/313 (21%), Positives = 117/313 (37%), Gaps = 75/313 (23%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHEN 60
               +V+  G  G V +  +  T +   +K +              REV L     +  +
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPH 116

Query: 61  IVRLLNV----QSSVDSIDLVFENLD----FD------LLHFMKTEPTVTKNPLKIKKYL 106
           IVR+++V     +    + +V E LD    F          F  TE        +  + +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TER-------EASEIM 167

Query: 107 HQILHGVAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGS 164
             I   + Y HS  I HRD+KP N L   +  + I+K+ DFG A+       + T    +
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYT 226

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVA-------CTFAEMVTHQRLFHSRWAPGLLAAIFS- 216
             Y APE +LG  +Y    D+W++        C +         F+S     +   + + 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPP-------FYSNHGLAISPGMKTR 278

Query: 217 -IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
             MG  +    P ++  SEE         +K L              +R +L  +P++R+
Sbjct: 279 IRMGQYEFPN-PEWSEVSEE---------VKML--------------IRNLLKTEPTQRM 314

Query: 276 TAREALRHEYFKD 288
           T  E + H +   
Sbjct: 315 TITEFMNHPWIMQ 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  126 bits (318), Expect = 1e-34
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            + E I  G +G VHRA     G  V VK +   +      +  +REV+++K L+H NIV
Sbjct: 40  NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 63  RLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             +   +   ++ +V E L     + LLH  K+      +  +     + +  G+ Y H+
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 119 QE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           +   I+HR+LK  N L+D  K  VK+ DFGL+R       +     G+  + APE +L  
Sbjct: 156 RNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRD 213

Query: 177 GRYSTPVDVWAVACTFA----EMVTHQRLFH 203
              +   DV++    F     E+ T Q+ + 
Sbjct: 214 EPSNEKSDVYS----FGVILWELATLQQPWG 240

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 3e-34
 Identities = 47/312 (15%), Positives = 95/312 (30%), Gaps = 58/312 (18%)

Query: 1   RYTLLEVIREGRYGAVHRA-----HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
              +  ++ EG +  V+ A     +D+      V+K     NP E       + +  LK 
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF--YIGTQLMERLKP 123

Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
                 ++  +     +   LV E        + ++  K  P        +  +  ++L+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDI----------VKIADFGLARPIDVPLENYTIK 161
            +   H  EI+H D+KP NF++                + + D G +  + +  +     
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 162 G--GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG 219
               +  ++  E L     ++  +D + VA T   M+    +                  
Sbjct: 244 AKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNE------------- 289

Query: 220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE 279
                   G       F   P+                   +    ML +     L + +
Sbjct: 290 -------GGECKPEGLFRRLPHLDMWN--------------EFFHVMLNIPDCHHLPSLD 328

Query: 280 ALRHEYFKDFQS 291
            LR +  K FQ 
Sbjct: 329 LLRQKLKKVFQQ 340

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  125 bits (315), Expect = 6e-34
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 34/216 (15%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            + E+I +GR+G V+       G+ V ++ I I   +E    +  REV   ++ +HEN+V
Sbjct: 36  EIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 63  RLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLH---QILHGVA 114
             +    S   + ++        L + ++          K  L + K      +I+ G+ 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTL-YSVVR-------DAKIVLDVNKTRQIAQEIVKGMG 144

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL-----ENYTIKGGSLCYKA 169
           Y H++ ILH+DLK  N   D     V I DFGL     V       +   I+ G LC+ A
Sbjct: 145 YLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 170 PE--------RLLGSGRYSTPVDVWAVACTFAEMVT 197
           PE               +S   DV+A+   + E+  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  123 bits (312), Expect = 7e-34
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 25/197 (12%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+ + I  G +G V++         V VK + +  P+     +   EV +L++ +H NI+
Sbjct: 27  TVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 63  RLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLH---QILHGVA 114
             +   S+   + +V +     +L +  LH        ++   ++KK +    Q   G+ 
Sbjct: 84  LFMGY-STAPQLAIVTQWCEGSSL-YHHLH-------ASETKFEMKKLIDIARQTARGMD 134

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPE- 171
           Y H++ I+HRDLK  N  +    + VKI DFGLA        ++  +   GS+ + APE 
Sbjct: 135 YLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 172 -RLLGSGRYSTPVDVWA 187
            R+  S  YS   DV+A
Sbjct: 194 IRMQDSNPYSFQSDVYA 210

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (314), Expect = 7e-34
 Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 61/302 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + +LE + EG YG+V++A    TG  V +K++P+    E     +I+E+S++++    +
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPH 85

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLK---IKKYLHQILHGV 113
           +V+          + +V E        D++        +    L    I   L   L G+
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-------LRNKTLTEDEIATILQSTLKGL 138

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            Y H    +HRD+K  N L++      K+ADFG+A  +   +       G+  + APE +
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSI--MGTPDSETL 226
              G Y+   D+W++  T  EM   +        P       + AIF I     P   T 
Sbjct: 198 QEIG-YNCVADIWSLGITAIEMAEGK--------PPYADIHPMRAIFMIPTNPPP---TF 245

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
                +S+ F                        D +++ L   P +R TA + L+H + 
Sbjct: 246 RKPELWSDNF-----------------------TDFVKQCLVKSPEQRATATQLLQHPFV 282

Query: 287 KD 288
           + 
Sbjct: 283 RS 284

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  125 bits (315), Expect = 9e-34
 Identities = 62/308 (20%), Positives = 122/308 (39%), Gaps = 23/308 (7%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           +  +  +  G  G V +     +G  +  K I  +     + + +IRE+ +L E     I
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 62  VRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ- 119
           V       S   I +  E++D   L   +K    + +    + K    ++ G+ Y   + 
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLREKH 151

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           +I+HRD+KP+N L++   + +K+ DFG++  +   + N  +  G+  Y +PERL G+  Y
Sbjct: 152 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGTH-Y 207

Query: 180 STPVDVWAVACTFAEMVTHQ-----RLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
           S   D+W++  +  EM   +                         TP     PG      
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 235 EFGFEPNRSPIKDLATVVGGLEP---------DGVDLLRRMLCLDPSKRLTAREALRHEY 285
                P  +  + L  +V    P         +  D + + L  +P++R   ++ + H +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327

Query: 286 FKDFQSLD 293
            K   + +
Sbjct: 328 IKRSDAEE 335

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  124 bits (313), Expect = 9e-34
 Identities = 48/265 (18%), Positives = 96/265 (36%), Gaps = 47/265 (17%)

Query: 39  SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTK 97
           S     +   ++  +     +N V  L   S    + +  +     +L  +M    ++  
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 98  NPLK-IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID---- 152
                      QI   V + HS+ ++HRDLKP+N       D+VK+ DFGL   +D    
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEE 219

Query: 153 --------VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS 204
                        +T + G+  Y +PE++ G+  YS  VD++++     E++        
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME 278

Query: 205 RWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLR 264
           R     +  I  +    + +    FT    +                          +++
Sbjct: 279 R-----VRIITDVR---NLKFPLLFTQKYPQE-----------------------HMMVQ 307

Query: 265 RMLCLDPSKRLTAREALRHEYFKDF 289
            ML   P++R  A + + +  F++ 
Sbjct: 308 DMLSPSPTERPEATDIIENAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 19/65 (29%), Positives = 32/65 (49%), Gaps = 1/65 (1%)

Query: 2  YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
          +  ++ +  G +G V  A + +      +K+I + N  E     V+REV  L +L+H  I
Sbjct: 8  FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGI 66

Query: 62 VRLLN 66
          VR  N
Sbjct: 67 VRYFN 71

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  125 bits (314), Expect = 2e-33
 Identities = 86/372 (23%), Positives = 137/372 (36%), Gaps = 98/372 (26%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--- 57
           RY ++  +  G +  V  + D      V +K   ++  +E    + + E+ LLK ++   
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 58  -----HENIVRLLNVQSSVDSID----------LVFENLDFDLLHFMKTEPTVTKNPLKI 102
                 E +V+LL      D             +VFE L   LL ++            +
Sbjct: 95  PNDPNREMVVQLL------DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 148

Query: 103 KKYLHQILHGVAYCHSQ-EILHRDLKPANFLI---------------------------- 133
           KK + Q+L G+ Y H++  I+H D+KP N L+                            
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 134 --------------------DRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
                               +  K  VKIAD G A  +    +++T    +  Y++ E L
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVL 265

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL------LAAIFSIMGTPDSETLP 227
           +GSG Y+TP D+W+ AC   E+ T   LF              +A I  ++G    + + 
Sbjct: 266 IGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 228 GFTSFSEEF---GFEPNRSPIKDLA---TVVGGLEPDG------VDLLRRMLCLDPSKRL 275
                 E F   G   + + +K       +V   E          D L  ML L P KR 
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

Query: 276 TAREALRHEYFK 287
           TA E LRH +  
Sbjct: 385 TAAECLRHPWLN 396

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  124 bits (312), Expect = 4e-33
 Identities = 59/313 (18%), Positives = 103/313 (32%), Gaps = 28/313 (8%)

Query: 2   YTLLEVIREGR--YGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           Y LL VI +G      V+ A    TG+ V V++I +   S  + + +  E+ + K   H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           NIV       + + + +V   + +      + T      N L I   L  +L  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPID-------VPLENYTIKGGSLCYKAPE 171
              +HR +K ++ LI      V ++       +        V  +        L + +PE
Sbjct: 147 MGYVHRSVKASHILISVDGK-VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 172 RLLGSGR-YSTPVDVWAVACTFAEMVT----------HQRLFH--SRWAPGLLAAIFSIM 218
            L  + + Y    D+++V  T  E+             Q L    +   P LL       
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRM--LCL--DPSKR 274
                       +         +     +  +                   CL  +P  R
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325

Query: 275 LTAREALRHEYFK 287
            +A   L H +FK
Sbjct: 326 PSASTLLNHSFFK 338

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  121 bits (305), Expect = 7e-33
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 51/296 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLK---IKKYLHQILHGV 113
           IV  L+     D + +V E L      D+         VT+  +    I     + L  +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDV---------VTETCMDEGQIAAVCRECLQAL 129

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            + HS +++HRD+K  N L+      VK+ DFG    I       +   G+  + APE +
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI--MGTPDSETLPGFTS 231
                Y   VD+W++     EM+  +   +    P  L A++ I   GTP    L     
Sbjct: 189 TRKA-YGPKVDIWSLGIMAIEMIEGEPP-YLNENP--LRALYLIATNGTP---ELQNPEK 241

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
            S  F                        D L R L +D  KR +A+E L+H++ K
Sbjct: 242 LSAIF-----------------------RDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 2e-32
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 51/296 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
                  I EG  G V  A +  +G  V VK + +          +  EV ++++ +H N
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFN 103

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLK---IKKYLHQILHGV 113
           +V +       + + ++ E L      D+         V++  L    I      +L  +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDI---------VSQVRLNEEQIATVCEAVLQAL 154

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           AY H+Q ++HRD+K  + L+      VK++DFG    I   +       G+  + APE +
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI--MGTPDSETLPGFTS 231
             S  Y+T VD+W++     EMV  +   +   +P  + A+  +     P    L     
Sbjct: 214 SRSL-YATEVDIWSLGIMVIEMVDGEPP-YFSDSP--VQAMKRLRDSPPP---KLKNSHK 266

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
            S                           D L RML  DP +R TA+E L H +  
Sbjct: 267 VSPVL-----------------------RDFLERMLVRDPQERATAQELLDHPFLL 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  119 bits (301), Expect = 3e-32
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVI-----REVSLLKELK 57
              + I +G +G VH+         V +K + + +               REV ++  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H NIV+L  +    +   +V E +   DL H +  +    K  +K++  +  I  G+ Y 
Sbjct: 82  HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR-LMLDIALGIEYM 138

Query: 117 HSQE--ILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLENYTIKG--GSLCYK 168
            +Q   I+HRDL+  N  +    +      K+ADFGL++        +++ G  G+  + 
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193

Query: 169 APERLLG-SGRYSTPVDVWAVACTFA----EMVTHQRLFH 203
           APE +      Y+   D ++    FA     ++T +  F 
Sbjct: 194 APETIGAEEESYTEKADTYS----FAMILYTILTGEGPFD 229

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (299), Expect = 4e-32
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 41/218 (18%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKI--PIMNPSEGVPSSVIREVSLLKELKHEN 60
           TL E+I  G +G V+RA     GD V VK               +V +E  L   LKH N
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 61  IVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLH---QILHGV 113
           I+ L  V     ++ LV E         +L             +     ++   QI  G+
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLS---------GKRIPPDILVNWAVQIARGM 118

Query: 114 AYCHSQ---EILHRDLKPANFLIDRSKD-------IVKIADFGLARPIDVPLENYTIKGG 163
            Y H +    I+HRDLK +N LI +  +       I+KI DFGLAR             G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAG 176

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFA----EMVT 197
           +  + APE ++ +  +S   DVW+    +     E++T
Sbjct: 177 AYAWMAPE-VIRASMFSKGSDVWS----YGVLLWELLT 209

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  118 bits (297), Expect = 2e-31
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
              EV+ +G +G   +     TG+ +V+K++  +   E    + ++EV +++ L+H N++
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 63  RLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           + + V      ++ + E      L   ++  M ++   ++       +   I  G+AY H
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWSQ----RVSFAKDIASGMAYLH 125

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--------------G 163
           S  I+HRDL   N L+  +K  V +ADFGLAR +                         G
Sbjct: 126 SMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR 200
           +  + APE + G   Y   VDV++      E++    
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVN 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  117 bits (296), Expect = 2e-31
 Identities = 61/311 (19%), Positives = 107/311 (34%), Gaps = 92/311 (29%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHEN 60
               +V+  G  G V +  +  T +   +K +              REV L     +  +
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPH 72

Query: 61  IVRLLNV----QSSVDSIDLVFENLD----FDLL----HFMKTEPTVTKNPLKIKKYLHQ 108
           IVR+++V     +    + +V E LD    F  +        TE        +  + +  
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKS 125

Query: 109 ILHGVAYCHSQEILHRDLKPANFL-IDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLC 166
           I   + Y HS  I HRD+KP N L   +  + I+K+ DFG                    
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------- 166

Query: 167 YKAPERLLGSGRYSTPVDVWAVA-------CTFAEMVTHQRLFHSRWAPGLLAAIFS--I 217
             A E      +Y    D+W++        C +         F+S     +   + +   
Sbjct: 167 --AKETT--GEKYDKSCDMWSLGVIMYILLCGY-------PPFYSNHGLAISPGMKTRIR 215

Query: 218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
           MG  +    P ++  SEE         +K L              +R +L  +P++R+T 
Sbjct: 216 MGQYEFPN-PEWSEVSEE---------VKML--------------IRNLLKTEPTQRMTI 251

Query: 278 REALRHEYFKD 288
            E + H +   
Sbjct: 252 TEFMNHPWIMQ 262

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (296), Expect = 2e-31
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 48/294 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +T LE I +G +G V +  D+ T   V +K I +    + +   + +E+++L +     
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPY 81

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           + +          + ++ E L     L  ++  P    +  +I   L +IL G+ Y HS+
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL---DETQIATILREILKGLDYLHSE 138

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           + +HRD+K AN L+    + VK+ADFG+A  +           G+  + APE +  S  Y
Sbjct: 139 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-Y 196

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGL----LAAIFSIM--GTPDSETLPGFTSFS 233
            +  D+W++  T  E+   +        P      +  +F I     P   TL G  ++S
Sbjct: 197 DSKADIWSLGITAIELARGE-------PPHSELHPMKVLFLIPKNNPP---TLEG--NYS 244

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
           +                          + +   L  +PS R TA+E L+H++  
Sbjct: 245 KPL-----------------------KEFVEACLNKEPSFRPTAKELLKHKFIL 275

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  115 bits (291), Expect = 5e-31
 Identities = 39/215 (18%), Positives = 75/215 (34%), Gaps = 29/215 (13%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
             L  + E   G + +      G+ +VVK + + + S         E   L+   H N++
Sbjct: 13  NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 63  RLLNV--QSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            +L            L+   +     +++LH  +    V      + K+   +  G+A+ 
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAV-KFALDMARGMAFL 127

Query: 117 HSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           H+ E  I    L   + +ID      +I+   +             +  +  + APE L 
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKF-----SFQSPGRMYAPAWVAPEALQ 181

Query: 175 G--SGRYSTPVDVWAVACTFA----EMVTHQRLFH 203
                      D+W+    FA    E+VT +  F 
Sbjct: 182 KKPEDTNRRSADMWS----FAVLLWELVTREVPFA 212

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (294), Expect = 5e-31
 Identities = 58/307 (18%), Positives = 107/307 (34%), Gaps = 54/307 (17%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKHEN 60
              L  +  G  G V +     TG  + VK++   + ++     ++ ++  +LK      
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+      +   + +  E +        K         + + K    I+  + Y   + 
Sbjct: 86  IVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-LGKMTVAIVKALYYLKEKH 144

Query: 121 -ILHRDLKPANFLIDRSKDIVKIADFG--------LARPIDVPLENYTIKGGSLCYKAPE 171
            ++HRD+KP+N L+D     +K+ DFG         A+             G   Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRSA---------GCAAYMAPE 194

Query: 172 RL----LGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSETL 226
           R+         Y    DVW++  +  E+ T Q  F +          +  ++       L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCKT-DFEVLTKVLQEE-PPLL 250

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
           PG   FS +F                          ++  L  D  KR    + L H + 
Sbjct: 251 PGHMGFSGDF-----------------------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

Query: 287 KDFQSLD 293
           K +++L+
Sbjct: 288 KRYETLE 294

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (291), Expect = 1e-30
 Identities = 64/306 (20%), Positives = 110/306 (35%), Gaps = 62/306 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + ++  + +G +G V++A +  TG     K I   +  E      I E+ +L    H  
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDHPY 77

Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLK---IKKYLHQILHGV 113
           IV+LL        + ++ E         ++             L    I+    Q+L  +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQMLEAL 130

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE-- 171
            + HS+ I+HRDLK  N L+    D +++ADFG++      L+      G+  + APE  
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGD-IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 172 --RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA-----AIFSI--MGTPD 222
               +    Y    D+W++  T  EM   +        P          +  I     P 
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIE--------PPHHELNPMRVLLKIAKSDPP- 240

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
             TL   + +S EF                        D L+  L  +P  R +A + L 
Sbjct: 241 --TLLTPSKWSVEF-----------------------RDFLKIALDKNPETRPSAAQLLE 275

Query: 283 HEYFKD 288
           H +   
Sbjct: 276 HPFVSS 281

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 1e-30
 Identities = 74/305 (24%), Positives = 117/305 (38%), Gaps = 67/305 (21%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
            ++ L  I  G +GAV+ A D    + V +KK+      S      +I+EV  L++L+H 
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYC 116
           N ++         +  LV E         ++    V K PL+   I    H  L G+AY 
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLA-----RPIDVPLENYTIKGGSLCYKAPE 171
           HS  ++HRD+K  N L+      VK+ DFG A         V         G+  + APE
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSFV---------GTPYWMAPE 220

Query: 172 --RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSI--MGTPD 222
               +  G+Y   VDVW++  T  E+   +        P L     ++A++ I    +P 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK--------PPLFNMNAMSALYHIAQNESP- 271

Query: 223 SETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
              L     +SE F                        + +   L   P  R T+   L+
Sbjct: 272 --ALQS-GHWSEYF-----------------------RNFVDSCLQKIPQDRPTSEVLLK 305

Query: 283 HEYFK 287
           H +  
Sbjct: 306 HRFVL 310

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (286), Expect = 8e-30
 Identities = 64/310 (20%), Positives = 117/310 (37%), Gaps = 55/310 (17%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKHEN 60
              L  I  G YG+V++     +G  + VK+I      E     ++ ++  +++      
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCH 117
           IV+            +  E +      F K   +V  + +    + K     +  + +  
Sbjct: 83  IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 118 SQ-EILHRDLKPANFLIDRSKDIVKIADFG--------LARPIDVPLENYTIKGGSLCYK 168
              +I+HRD+KP+N L+DRS + +K+ DFG        +A+  D          G   Y 
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTRDA---------GCRPYM 192

Query: 169 APERLLGSGR---YSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIM-GTPDS 223
           APER+  S     Y    DVW++  T  E+ T +  F + +W   +   +  ++ G P  
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR--FPYPKWNS-VFDQLTQVVKGDPPQ 249

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
            +      FS  F                       ++ +   L  D SKR   +E L+H
Sbjct: 250 LSNSEEREFSPSF-----------------------INFVNLCLTKDESKRPKYKELLKH 286

Query: 284 EYFKDFQSLD 293
            +   ++   
Sbjct: 287 PFILMYEERA 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (280), Expect = 4e-29
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 3   TLLEVIREGRYGAVHRA----HDSLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKE 55
             L+ + +G +G+V           TG+ V VKK+            +    RE+ +LK 
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKS 67

Query: 56  LKHENIVRLLNV--QSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH 111
           L+H+NIV+   V   +   ++ L+ E L +  L  +++  +  +    L   +Y  QI  
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICK 125

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--- 168
           G+ Y  ++  +HRDL   N L++ +++ VKI DFGL + +    E + +K      +   
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPG---ESPI 181

Query: 169 ---APERLLGSGRYSTPVDVWAVACTFAEMVTH 198
              APE L    ++S   DVW+      E+ T+
Sbjct: 182 FWYAPESLT-ESKFSVASDVWSFGVVLYELFTY 213

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 9e-29
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 3   TLLEVIREGRYGAVHRA----HDSLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKE 55
             L+ + +G +G+V           TG+ V VKK+            +    RE+ +LK 
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKS 98

Query: 56  LKHENIVRLLNV--QSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILH 111
           L+H+NIV+   V   +   ++ L+ E L +  L  +++  +  +    L   +Y  QI  
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICK 156

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--- 168
           G+ Y  ++  +HRDL   N L++ +++ VKI DFGL + +    E Y +K      +   
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPG---ESPI 212

Query: 169 ---APERLLGSGRYSTPVDVWAVACTFAEMVTH 198
              APE L    ++S   DVW+      E+ T+
Sbjct: 213 FWYAPESLT-ESKFSVASDVWSFGVVLYELFTY 244

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  110 bits (277), Expect = 1e-28
 Identities = 73/310 (23%), Positives = 107/310 (34%), Gaps = 55/310 (17%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE--VSLLKELKHEN 60
           TLLE + +GRYG V R   S  G+ V VK     +       S  RE  +     L+HEN
Sbjct: 11  TLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRHEN 63

Query: 61  IVRLL----NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLH---QI 109
           I+  +      + S   + L+    +    +D L             L     L     I
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---------LTTLDTVSCLRIVLSI 114

Query: 110 LHGVAYCHSQE--------ILHRDLKPANFLIDRSKDIVKIADFGLARPID----VPLEN 157
             G+A+ H +         I HRDLK  N L+ ++     IAD GLA             
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVG 173

Query: 158 YTIKGGSLCYKAPERLLGS-----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA 212
              + G+  Y APE L  +           VD+WA      E+    R+  +        
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKP 231

Query: 213 AIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS 272
             F  +   D    P F    +    +  R  I +       L      L++     +PS
Sbjct: 232 P-FYDVVPND----PSFEDMRKVVCVDQQRPNIPNRWFSDPTL-TSLAKLMKECWYQNPS 285

Query: 273 KRLTAREALR 282
            RLTA    +
Sbjct: 286 ARLTALRIKK 295

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 3e-28
 Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 70/313 (22%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHE 59
            + L+E++  G YG V++     TG    +K + +    E     + +E+++LK+   H 
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHR 81

Query: 60  NIVRLL------NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLK---IKKYL 106
           NI          N     D + LV E        DL+   K       N LK   I    
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWIAYIC 135

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC 166
            +IL G+++ H  +++HRD+K  N L+  + + VK+ DFG++  +D  +       G+  
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 167 YKAPE----RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-----LAAIFSI 217
           + APE           Y    D+W++  T  EM            P L     + A+F I
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA--------PPLCDMHPMRALFLI 246

Query: 218 --MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
                P    L     +S++F                          +   L  + S+R 
Sbjct: 247 PRNPAP---RLKS-KKWSKKF-----------------------QSFIESCLVKNHSQRP 279

Query: 276 TAREALRHEYFKD 288
              + ++H + +D
Sbjct: 280 ATEQLMKHPFIRD 292

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (274), Expect = 3e-28
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             +  + EG +G V        GD     V VK +          + + +E+ +L+ L H
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYH 82

Query: 59  ENIVRLLNV--QSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVA 114
           ENIV+   +  +   + I L+ E L    L  ++   +  +        KY  QI  G+ 
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL--KYAVQICKGMD 140

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------ 168
           Y  S++ +HRDL   N L++ S+  VKI DFGL + I+   E YT+K             
Sbjct: 141 YLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDR---DSPVFWY 196

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           APE L+   ++    DVW+   T  E++T+
Sbjct: 197 APECLM-QSKFYIASDVWSFGVTLHELLTY 225

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (274), Expect = 4e-28
 Identities = 67/308 (21%), Positives = 105/308 (34%), Gaps = 51/308 (16%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            LLEV   GR+G V +A   L  + V VK   I    +        EV  L  +KHENI+
Sbjct: 27  QLLEVKARGRFGCVWKA--QLLNEYVAVK---IFPIQDKQSWQNEYEVYSLPGMKHENIL 81

Query: 63  RLL--NVQSSVDSID--LVFE-----NLDFDLLHFMKTEPTVTKNPLKIKK--------- 104
           + +    + +   +D  L+       +L  D L           N +   +         
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSL-SDFLK---------ANVVSWNELCHIAETMA 131

Query: 105 ----YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
               YLH+ + G+   H   I HRD+K  N L+  +     IADFGLA   +        
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKSAGDT 190

Query: 161 KG--GSLCYKAPE----RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI 214
            G  G+  Y APE     +         +D++A+     E+ +            +L   
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP-- 248

Query: 215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR 274
           F           P      E    +  R  ++D      G+     + +      D   R
Sbjct: 249 FEEEIGQH----PSLEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEAR 303

Query: 275 LTAREALR 282
           L+A     
Sbjct: 304 LSAGCVGE 311

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (273), Expect = 6e-28
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 23/210 (10%)

Query: 3   TLLEVIREGRYGAVHRA----HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             +  + +G +G+V           TG  V VK++    P +       RE+ +LK L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHS 83

Query: 59  ENIVRLLNV--QSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVA 114
           + IV+   V       S+ LV E L    L  F++     +  + L    Y  QI  G+ 
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL--LYSSQICKGME 141

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------ 168
           Y  S+  +HRDL   N L++ S+  VKIADFGLA+ + +  + Y ++      +      
Sbjct: 142 YLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPG---QSPIFWY 197

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTH 198
           APE L     +S   DVW+      E+ T+
Sbjct: 198 APESLS-DNIFSRQSDVWSFGVVLYELFTY 226

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 9e-28
 Identities = 61/310 (19%), Positives = 101/310 (32%), Gaps = 55/310 (17%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE--VSLLKELKHEN 60
            +++ I +GRYG V        G+ V VK       +     S  RE  +     ++HEN
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHEN 92

Query: 61  IVRLL----NVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLH---QI 109
           I+  +        S   + L+ +  +    +D L             L  K  L      
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---------STTLDAKSMLKLAYSS 143

Query: 110 LHGVAYCHSQE--------ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
           + G+ + H++         I HRDLK  N L+ ++     IAD GLA           I 
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIP 202

Query: 162 G----GSLCYKAPERLLGS-----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA 212
                G+  Y  PE L  S      +     D+++      E+    R            
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVSGGIVEEYQL 260

Query: 213 AIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS 272
             +  +   D    P +    E    +  R    +  +    L      L+      +P+
Sbjct: 261 P-YHDLVPSD----PSYEDMREIVCIKKLRPSFPNRWSSDECL-RQMGKLMTECWAHNPA 314

Query: 273 KRLTAREALR 282
            RLTA    +
Sbjct: 315 SRLTALRVKK 324

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (279), Expect = 1e-27
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 30/222 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHD-SLTGDTVVVKKIPIMNPSEGVPSSV---IREVSLLKEL 56
           +Y +   I  G  G ++ A D ++ G  VV+K    +  S     +    + E   L E+
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGD-AEAQAMAMAERQFLAEV 136

Query: 57  KHENIVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLKIKK---YLHQ 108
            H +IV++ N     D        +V E +    L             L + +   YL +
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK------RSKGQKLPVAEAIAYLLE 190

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           IL  ++Y HS  +++ DLKP N ++    + +K+ D G    I+     Y    G+  ++
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF--GYLY--GTPGFQ 244

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL 210
           APE +      +   D++ V  T A +       + R+  GL
Sbjct: 245 APEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  108 bits (271), Expect = 1e-27
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 28/212 (13%)

Query: 3   TLLEVIREGRYGAVHRA----HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             +  + EG +G V        +  TG+ V VK +   +      S   +E+ +L+ L H
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYH 92

Query: 59  ENIVRLLNV--QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKK---YLHQILHG 112
           E+I++       +   S+ LV E +    L  ++       ++ + + +   +  QI  G
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEG 146

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK---- 168
           +AY H+Q  +HRDL   N L+D +  +VKI DFGLA+ +    E Y ++           
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG---DSPVF 202

Query: 169 --APERLLGSGRYSTPVDVWAVACTFAEMVTH 198
             APE L    ++    DVW+   T  E++TH
Sbjct: 203 WYAPECLK-EYKFYYASDVWSFGVTLYELLTH 233

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  107 bits (269), Expect = 2e-27
 Identities = 66/310 (21%), Positives = 106/310 (34%), Gaps = 55/310 (17%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE--VSLLKELKHEN 60
            L E I +GR+G V R      G+ V VK             S  RE  +     L+HEN
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHEN 97

Query: 61  IVRLLNVQSSVDSID----LVFENLD----FDLLHFMKTEPTVTKNPLKIKKYLH---QI 109
           I+  +   +  +       LV +  +    FD L+         +  + ++  +      
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---------RYTVTVEGMIKLALST 148

Query: 110 LHGVAYCHSQE--------ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK 161
             G+A+ H +         I HRDLK  N L+        IAD GLA   D   +   I 
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 162 G----GSLCYKAPERLLGSG-----RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA 212
                G+  Y APE L  S            D++A+   F E+         R + G + 
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-------RCSIGGIH 260

Query: 213 AIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS 272
             + +       + P      +    +  R  I +       L      ++R     + +
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGA 319

Query: 273 KRLTAREALR 282
            RLTA    +
Sbjct: 320 ARLTALRIKK 329

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (267), Expect = 3e-27
 Identities = 65/308 (21%), Positives = 114/308 (37%), Gaps = 55/308 (17%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKHEN 60
              +  +  G YG V +     +G  + VK+I     +      ++ ++   ++ +    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLK---IKKYLHQILHGVAYCH 117
            V           + +  E +D  L  F K      +  +    + K    I+  + + H
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLH 126

Query: 118 SQE-ILHRDLKPANFLIDRSKDIVKIADFG--------LARPIDVPLENYTIKGGSLCYK 168
           S+  ++HRD+KP+N LI+     VK+ DFG        +A+ ID          G   Y 
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVAKDIDA---------GCKPYM 176

Query: 169 APERLLGSGR---YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
           APER+        YS   D+W++  T  E+   +  + S   P     +  ++  P S  
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEP-SPQ 233

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
           LP    FS EF                       VD   + L  +  +R T  E ++H +
Sbjct: 234 LPA-DKFSAEF-----------------------VDFTSQCLKKNSKERPTYPELMQHPF 269

Query: 286 FKDFQSLD 293
           F   +S  
Sbjct: 270 FTLHESKG 277

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (268), Expect = 7e-27
 Identities = 58/190 (30%), Positives = 89/190 (46%), Gaps = 11/190 (5%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L E I  G +G V           V VK          + +  ++E  +LK+  H NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           RL+ V +    I +V E +   D L F++TE    +    + + +     G+ Y  S+  
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL-QMVGDAAAGMEYLESKCC 234

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--LCYK--APERLLGSG 177
           +HRDL   N L+   K+++KI+DFG++R  +     Y   GG   +  K  APE L   G
Sbjct: 235 IHRDLAARNCLVT-EKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALN-YG 290

Query: 178 RYSTPVDVWA 187
           RYS+  DVW+
Sbjct: 291 RYSSESDVWS 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (258), Expect = 8e-26
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             ++V+  G +G V++      G+     V +K++     S      ++ E  ++  + +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDN 76

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYC 116
            ++ RLL +     ++ L+ + + F  LL +++  +  +      +  +  QI  G+ Y 
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYL 133

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLL 174
             + ++HRDL   N L+  +   VKI DFGLA+ +    + Y  +GG +  K  A E +L
Sbjct: 134 EDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
               Y+   DVW+   T  E++T
Sbjct: 193 -HRIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (255), Expect = 1e-25
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGDT--VVVK--KIPIMNPSEGVPSSVIREVSLLKELK 57
            LLE + +G +G V R   D+ +G T  V VK  K  +++  E      IREV+ +  L 
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVNAMHSLD 79

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H N++RL  V  +   + +V E      LL  ++           + +Y  Q+  G+ Y 
Sbjct: 80  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL 137

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERL 173
            S+  +HRDL   N L+  ++D+VKI DFGL R +    ++Y ++    + +   APE L
Sbjct: 138 ESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
             +  +S   D W    T  EM T
Sbjct: 197 K-TRTFSHASDTWMFGVTLWEMFT 219

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (260), Expect = 2e-25
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+   +  G+YG V+         TV VK    +          ++E +++KE+KH N+V
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +LL V +      ++ E + + +LL +++       + + +     QI   + Y   +  
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC-YK--APERLLGSGR 178
           +HR+L   N L+     +VK+ADFGL+R +    + YT   G+    K  APE L    +
Sbjct: 340 IHRNLAARNCLVG-ENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLA-YNK 395

Query: 179 YSTPVDVWAVACTFAEMVT 197
           +S   DVWA      E+ T
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  103 bits (259), Expect = 3e-25
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L + +  G++G V  A  +     V VK    M P      + + E +++K L+H+ +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVK---TMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V +  + I ++ E +    LL F+K++    +   K+  +  QI  G+A+   +  
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYK--APERLLGSGR 178
           +HRDL+ AN L+  +  + KIADFGLAR   +    YT + G     K  APE +   G 
Sbjct: 306 IHRDLRAANILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAIN-FGS 361

Query: 179 YSTPVDVWAVACTFAEMVTH 198
           ++   DVW+      E+VT+
Sbjct: 362 FTIKSDVWSFGILLMEIVTY 381

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (251), Expect = 9e-25
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 14/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             L+V+  G +G VH+      G+     V +K I           +V   +  +  L H
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAIGSLDH 74

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYC 116
            +IVRLL +     S+ LV + L    LL  ++     +   P  +  +  QI  G+ Y 
Sbjct: 75  AHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALG--PQLLLNWGVQIAKGMYYL 131

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLL 174
               ++HR+L   N L+  S   V++ADFG+A  +    +           K  A E + 
Sbjct: 132 EEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
             G+Y+   DVW+   T  E++T
Sbjct: 191 -FGKYTHQSDVWSYGVTVWELMT 212

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 22/203 (10%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           TL  ++ +G +G+V  A           V VK +     +       +RE + +KE  H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 60  NIVRLLNV------QSSVDSIDLVFENLDF-DLLHFMKTE-PTVTKNPLKIKKYLH---Q 108
           ++ +L+ V      +  +    ++   +   DL  F+           L ++  +     
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--LC 166
           I  G+ Y  S+  +HRDL   N ++      V +ADFGL+R   +   +Y  +G +  L 
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSR--KIYSGDYYRQGCASKLP 202

Query: 167 YK--APERLLGSGRYSTPVDVWA 187
            K  A E L     Y+   DVWA
Sbjct: 203 VKWLALESLA-DNLYTVHSDVWA 224

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 17/211 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVI----REVSLLKEL 56
            Y L  ++  G  G V+ A D++    V +K   +M+ +            RE      L
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALK---LMSETLSSDPVFRTRMQREARTAGRL 91

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           +  ++V + +       + +    ++  DL   ++ +  +   P +    + QI   +  
Sbjct: 92  QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA--PPRAVAIVRQIGSALDA 149

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPER 172
            H+    HRD+KP N L+    D   + DFG+A       E  T  G   G+L Y APER
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPER 206

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFH 203
                  +   D++A+ C   E +T    + 
Sbjct: 207 FSE-SHATYRADIYALTCVLYECLTGSPPYQ 236

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           TLL+ +  G++G V        G   V VK   ++           +E   + +L H  +
Sbjct: 11  TLLKELGSGQFGVVKLG--KWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLSHPKL 65

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           V+   V S    I +V E +    LL+++++     + P ++ +  + +  G+A+  S +
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE-PSQLLEMCYDVCEGMAFLESHQ 124

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLLGSG 177
            +HRDL   N L+D     VK++DFG+ R   V  + Y    G+    K  APE      
Sbjct: 125 FIHRDLAARNCLVD-RDLCVKVSDFGMTR--YVLDDQYVSSVGTKFPVKWSAPEVFH-YF 180

Query: 178 RYSTPVDVWAVACTFAEMVT 197
           +YS+  DVWA      E+ +
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
           T+   +  G+YG V+         TV VK    +          ++E +++KE+KH N+V
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +LL V +      ++ E + + +LL +++       + + +     QI   + Y   +  
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLLGSGR 178
           +HRDL   N L+     +VK+ADFGL+R +    + YT   G+    K  APE L    +
Sbjct: 133 IHRDLAARNCLVG-ENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLA-YNK 188

Query: 179 YSTPVDVWAVACTFAEMVT 197
           +S   DVWA      E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.0 bits (245), Expect = 2e-24
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 21/193 (10%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSV--IREVSLLKELKHE 59
           T ++ I  G++G VH           V +K I      EG  S    I E  ++ +L H 
Sbjct: 11  TFVQEIGSGQFGLVHLG--YWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHP 63

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCH 117
            +V+L  V      I LV E ++   L  +++T         L        +  G+AY  
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYLE 121

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLL 174
              ++HRDL   N L+     ++K++DFG+ R   V  + YT   G+    K  +PE   
Sbjct: 122 EACVIHRDLAARNCLVG-ENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 175 GSGRYSTPVDVWA 187
              RYS+  DVW+
Sbjct: 179 -FSRYSSKSDVWS 190

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
            L+E +  G++G V   +    G T V VK    +      P + + E +L+K+L+H+ +
Sbjct: 16  KLVERLGAGQFGEVWMGY--YNGHTKVAVK---SLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           VRL  V +  + I ++ E ++   L+ F+KT   +     K+     QI  G+A+   + 
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLLGSG 177
            +HRDL+ AN L+       KIADFGLAR   +    YT + G+    K  APE +   G
Sbjct: 130 YIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAIN-YG 185

Query: 178 RYSTPVDVWAVACTFAEMVTH 198
            ++   DVW+      E+VTH
Sbjct: 186 TFTIKSDVWSFGILLTEIVTH 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 2e-24
 Identities = 66/313 (21%), Positives = 121/313 (38%), Gaps = 66/313 (21%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           +   +++ EG +  V  A +  T       +++K  I+  ++     V RE  ++  L H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV--PYVTRERDVMSRLDH 89

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
              V+L       + +      L +    +LL +++   +  +   +   Y  +I+  + 
Sbjct: 90  PFFVKLYFTFQDDEKLYFG---LSYAKNGELLKYIRKIGSFDETCTRF--YTAEIVSALE 144

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKAP 170
           Y H + I+HRDLKP N L++    I +I DFG A+   +  E+   +  S      Y +P
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAK--VLSPESKQARANSFVGTAQYVSP 201

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E L          D+WA+ C   ++V                      G P     P F 
Sbjct: 202 ELLTEKS-ACKSSDLWALGCIIYQLVA---------------------GLP-----P-FR 233

Query: 231 SFSEEFGFEPNRSPIKDLATVV---GGLEPDGVDLLRRMLCLDPSKRLT------AREAL 281
           + +E   F+      K +           P   DL+ ++L LD +KRL            
Sbjct: 234 AGNEYLIFQ------KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 282 RHEYFK--DFQSL 292
            H +F+   +++L
Sbjct: 288 AHPFFESVTWENL 300

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.1 bits (245), Expect = 3e-24
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 17/191 (8%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           T L+ +  G++G V        G   V +K   ++          I E  ++  L HE +
Sbjct: 27  TFLKELGTGQFGVVKYGK--WRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 62  VRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           V+L  V +    I ++ E +    LL++++          L   +    +   + Y  S+
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLESK 139

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS-LCYK--APERLLGS 176
           + LHRDL   N L++  + +VK++DFGL+R   V  + YT   GS    +   PE L+  
Sbjct: 140 QFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLM-Y 195

Query: 177 GRYSTPVDVWA 187
            ++S+  D+WA
Sbjct: 196 SKFSSKSDIWA 206

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 99.1 bits (247), Expect = 3e-24
 Identities = 69/312 (22%), Positives = 107/312 (34%), Gaps = 48/312 (15%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIRE--VSLLKELKHEN 60
            LLE+I  GRYGAV++   SL    V VK     N       + I E  +  +  ++H+N
Sbjct: 16  KLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQ-----NFINEKNIYRVPLMEHDN 68

Query: 61  IVRLL-----NVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           I R +               LV E      L  ++    +   +  ++    H +  G+A
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL---AHSVTRGLA 125

Query: 115 YCHSQE---------ILHRDLKPANFLIDRSKDIVKIADFGLAR--------PIDVPLEN 157
           Y H++          I HRDL   N L+        I+DFGL+                 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 158 YTIKGGSLCYKAPERLLGS------GRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGL 210
              + G++ Y APE L G+            VD++A+   + E+      LF     P  
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

Query: 211 LAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLD 270
             A  + +G       P F         E  R    +             + +      D
Sbjct: 245 QMAFQTEVGNH-----PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 271 PSKRLTAREALR 282
              RLTA+ A  
Sbjct: 300 AEARLTAQXAEE 311

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 3e-24
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
             ++V+  G +G V++      G+     V +K++     S      ++ E  ++  + +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDN 76

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYC 116
            ++ RLL +     ++ L+ + + F  LL +++  +  +      +  +  QI  G+ Y 
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYL 133

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLL 174
             + ++HRDL   N L+  +   VKI DFGLA+ +    + Y  +GG +  K  A E +L
Sbjct: 134 EDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
               Y+   DVW+   T  E++T
Sbjct: 193 -HRIYTHQSDVWSYGVTVWELMT 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 13/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
           ++ +V+  G +G V      L      +V +K +  +  +E      + E S++ +  H 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHP 106

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCH 117
           NI+RL  V +    + +V E ++   L  F++  +   T   L     L  I  G+ Y  
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLS 164

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYK--APERLL 174
               +HRDL   N LI+ S  + K++DFGL R + D P   YT +GG +  +  +PE + 
Sbjct: 165 DMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
              ++++  DVW+      E+++
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMS 245

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L +++ EG +G+V              V VK + + N S+      + E + +K+  H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 60  NIVRLLNVQSSVDSID-----LVFENLDF-DLLHFMKTE-PTVTKNPLKIKKYLH---QI 109
           N++RLL V   + S       ++   + + DL  ++           + ++  L     I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--LCY 167
             G+ Y  ++  LHRDL   N ++      V +ADFGL++   +   +Y  +G    +  
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPV 213

Query: 168 K--APERLLGSGRYSTPVDVWA 187
           K  A E L     Y++  DVWA
Sbjct: 214 KWIAIESLA-DRVYTSKSDVWA 234

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  100 bits (250), Expect = 4e-24
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L   + +G +G V     + T   V +K    + P    P + ++E  ++K+L+HE +V
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSGRY 179
           +HRDL+ AN L+     + K+ADFGLAR I+   E    +G     K  APE  L  GR+
Sbjct: 302 VHRDLRAANILVG-ENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAAL-YGRF 358

Query: 180 STPVDVWAVACTFAEMVTH 198
           +   DVW+      E+ T 
Sbjct: 359 TIKSDVWSFGILLTELTTK 377

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           T  +VI  G +G V++     +       V +K +     +E      + E  ++ +  H
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSH 105

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYC 116
            NI+RL  V S    + ++ E ++   L  F++  +   +   L     L  I  G+ Y 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV--GMLRGIAAGMKYL 163

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYK--APERL 173
            +   +HRDL   N L++ S  + K++DFGL+R + D P   YT  GG +  +  APE +
Sbjct: 164 ANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 174 LGSGRYSTPVDVWAVACTFAEMVT 197
               ++++  DVW+      E++T
Sbjct: 223 S-YRKFTSASDVWSFGIVMWEVMT 245

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.7 bits (244), Expect = 4e-24
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 19/190 (10%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHENI 61
            LL+ I +G +G V        G+ V VK I            + + E S++ +L+H N+
Sbjct: 24  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 76

Query: 62  VRLLNVQS-SVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           V+LL V       + +V E +    L+ ++++          + K+   +   + Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSG 177
             +HRDL   N L+    ++ K++DFGL +         T   G L  K  APE L    
Sbjct: 137 NFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALR-EK 189

Query: 178 RYSTPVDVWA 187
           ++ST  DVW+
Sbjct: 190 KFSTKSDVWS 199

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  100 bits (251), Expect = 5e-24
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIV 62
            L   + +G +G V     + T   V +K    + P    P + ++E  ++K+L+HE +V
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 63  RLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           +L  V S  + I +V E +    LL F+K E        ++     QI  G+AY      
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSGRY 179
           +HRDL+ AN L+     + K+ADFGLAR I+   E    +G     K  APE  L  GR+
Sbjct: 385 VHRDLRAANILVG-ENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAAL-YGRF 441

Query: 180 STPVDVWAVACTFAEMVTH 198
           +   DVW+      E+ T 
Sbjct: 442 TIKSDVWSFGILLTELTTK 460

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 98.5 bits (246), Expect = 5e-24
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           T+   + +G +G V+      +  D     V +K +     S       + E S++KE  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFN 86

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-----KTEPTVTKNPLKIKKYLH---Q 108
             ++VRLL V S      ++ E +   DL  ++              P  + K +    +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 109 ILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS--LC 166
           I  G+AY ++ + +HRDL   N ++      VKI DFG+ R  D+   +Y  KGG   L 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 203

Query: 167 YK--APERLLGSGRYSTPVDVWAVACTFAEMVT 197
            +  +PE L   G ++T  DVW+      E+ T
Sbjct: 204 VRWMSPESLK-DGVFTTYSDVWSFGVVLWEIAT 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 8e-24
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+      +  D     V VK +P    SE      + E  ++ +  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN 91

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKN-PLKIKKYLH---QILH 111
           H+NIVR + V        ++ E +   DL  F++   P  ++   L +   LH    I  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+   +Y  KGG     +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPV 209

Query: 166 CYKAPERLLGSGRYSTPVDVWA 187
            +  PE  +  G +++  D W+
Sbjct: 210 KWMPPEAFM-EGIFTSKTDTWS 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 99.3 bits (248), Expect = 8e-24
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 21/202 (10%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-PSSVIREVSLLKELKHENI 61
            LL+ I +G +G V        G+ V VK I            + + E S++ +L+H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNL 248

Query: 62  VRLLNVQS-SVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           V+LL V       + +V E +    L+ ++++          + K+   +   + Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYK--APERLLGS 176
             +HRDL   N L+    ++ K++DFGL +      E  + +  G L  K  APE L   
Sbjct: 309 NFVHRDLAARNVLVS-EDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR-E 360

Query: 177 GRYSTPVDVWAVACTFAEMVTH 198
            ++ST  DVW+      E+ + 
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSF 382

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.9 bits (242), Expect = 9e-24
 Identities = 43/198 (21%), Positives = 87/198 (43%), Gaps = 17/198 (8%)

Query: 10  EGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
            G +G V + +  +      V VK +        +   ++ E +++++L +  IVR++ +
Sbjct: 27  SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86

Query: 68  QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
             + +S  LV E  +   L  +++    V    +   + +HQ+  G+ Y      +HRDL
Sbjct: 87  CEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEESNFVHRDL 143

Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------APERLLGSGRYS 180
              N L+  ++   KI+DFGL++ +      Y  +      K      APE +    ++S
Sbjct: 144 AARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHG---KWPVKWYAPECIN-YYKFS 198

Query: 181 TPVDVWAVACTFAEMVTH 198
           +  DVW+      E  ++
Sbjct: 199 SKSDVWSFGVLMWEAFSY 216

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 13/203 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            + ++I  G  G V      + G     V +K +     +E      + E S++ +  H 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHP 110

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCH 117
           NI+RL  V +      +V E ++   L  F++T +   T   L     L  +  G+ Y  
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV--GMLRGVGAGMRYLS 168

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYK--APERLL 174
               +HRDL   N L+D S  + K++DFGL+R + D P   YT  GG +  +  APE + 
Sbjct: 169 DLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
               +S+  DVW+      E++ 
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLA 249

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.5 bits (241), Expect = 1e-23
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 12/201 (5%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            L  ++ EG +G V+     +       V  K    + +       + E  ++K L H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHS 118
           IV+L+ +    +   ++ E   + +L H+++  + ++    L +  Y  QI   +AY  S
Sbjct: 75  IVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLK--VLTLVLYSLQICKAMAYLES 131

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGS 176
              +HRD+   N L+  S + VK+ DFGL+R I+   + Y      L  K  +PE +   
Sbjct: 132 INCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESIN-F 188

Query: 177 GRYSTPVDVWAVACTFAEMVT 197
            R++T  DVW  A    E+++
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.1 bits (240), Expect = 2e-23
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSV---IREVSLLKEL 56
           RY +++ +  G    V+ A D++    V +K    +         ++    REV    +L
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIK---AIFIPPREKEETLKRFEREVHNSSQL 68

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
            H+NIV +++V    D   LV E ++   L  ++++   ++        + +QIL G+ +
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLS--VDTAINFTNQILDGIKH 126

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPER 172
            H   I+HRD+KP N LID +K  +KI DFG+A+ +     + T      G++ Y +PE+
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSPEQ 183

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
             G        D++++     EM+  +  F
Sbjct: 184 AKG-EATDECTDIYSIGIVLYEMLVGEPPF 212

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 95.8 bits (239), Expect = 2e-23
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 14/202 (6%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L   I EG++G VH+       +    V +K       S+ V    ++E   +++  H 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHP 76

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCH 117
           +IV+L+ V +  + + ++ E     +L  F++  + ++      +  Y +Q+   +AY  
Sbjct: 77  HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLD--LASLILYAYQLSTALAYLE 133

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLG 175
           S+  +HRD+   N L+  S D VK+ DFGL+R ++     Y    G L  K  APE +  
Sbjct: 134 SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESIN- 190

Query: 176 SGRYSTPVDVWAVACTFAEMVT 197
             R+++  DVW       E++ 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.4 bits (238), Expect = 3e-23
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
            L   + EG +G V  A   +L+       V VK +   +P+        RE  LL  L+
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLTNLQ 75

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHF-----------MKTEPTVTKNPLKIKKY 105
           HE+IV+   V    D + +VFE +   DL  F           +  +P   K  L + + 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           LH   QI  G+ Y  SQ  +HRDL   N L+  +  +VKI DFG++R  DV   +Y   G
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSR--DVYSTDYYRVG 192

Query: 163 GS--LCYK--APERLLGSGRYSTPVDVWA 187
           G   L  +   PE ++   +++T  DVW+
Sbjct: 193 GHTMLPIRWMPPESIM-YRKFTTESDVWS 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 33/221 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSV---IREVSLLKEL 56
           RY L E++  G    VH A D      V VK   ++       PS      RE      L
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVK---VLRADLARDPSFYLRFRREAQNAAAL 69

Query: 57  KHENIVRLLNV-QSSVDSIDLVF--------ENLDFDLLHFMKTEPTVTKNPLKIKK--- 104
            H  IV + +  ++   +  L +          L  D++H        T+ P+  K+   
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR-DIVH--------TEGPMTPKRAIE 120

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
            +      + + H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T     
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 163 -GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF 202
            G+  Y +PE+  G        DV+++ C   E++T +  F
Sbjct: 180 IGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF 219

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 96.7 bits (241), Expect = 4e-23
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           TL+  +  G +G V+      +  D     V VK +P    SE      + E  ++ +  
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN 132

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFM-KTEPTVTKN-PLKIKKYLH---QILH 111
           H+NIVR + V        ++ E +   DL  F+ +T P  ++   L +   LH    I  
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGS----L 165
           G  Y      +HRD+   N L+       + KI DFG+AR  D+    Y  KGG     +
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPV 250

Query: 166 CYKAPERLLGSGRYSTPVDVWA 187
            +  PE  +  G +++  D W+
Sbjct: 251 KWMPPEAFM-EGIFTSKTDTWS 271

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.7 bits (236), Expect = 6e-23
 Identities = 35/211 (16%), Positives = 78/211 (36%), Gaps = 24/211 (11%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP----IMNP-SEGVPSSVIREVSLLKELK 57
              E + +G +  + +      GD   + +      +++        S     S++ +L 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           H+++V    V    D   LV E + F  L  ++K          K+ +   Q+   + + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL-EVAKQLAAAMHFL 129

Query: 117 HSQEILHRDLKPANFLIDRSKD-------IVKIADFGLARPIDVPLENYT---IKGGSLC 166
               ++H ++   N L+ R +D        +K++D G++    V  ++     I      
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQERIP----- 182

Query: 167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVT 197
           +  PE +      +   D W+   T  E+ +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 23/199 (11%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
              EVI  G +G V+     D+        VK +       G  S  + E  ++K+  H 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHP 86

Query: 60  NIVRLLNVQSSVDS-IDLVFENLDF-DLLHFMKTEPTVTKNPLKIK---KYLHQILHGVA 114
           N++ LL +    +    +V   +   DL +F++ E     +   +K    +  Q+  G+ 
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMK 142

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------ 168
           Y  S++ +HRDL   N ++D  K  VK+ADFGLAR  D+  + Y         K      
Sbjct: 143 YLASKKFVHRDLAARNCMLD-EKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWM 199

Query: 169 APERLLGSGRYSTPVDVWA 187
           A E L  + +++T  DVW+
Sbjct: 200 ALESLQ-TQKFTTKSDVWS 217

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 64/305 (20%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +L  I +G +G V     + T        + K   +  +E    +V +E+ +++ L+H  
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPF 76

Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMK-----TEPTVTKNPLKIKKYLHQILH 111
           +V L     S    + +F  +D     DL + ++      E TV       K ++ +++ 
Sbjct: 77  LVNL---WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFICELVM 126

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----Y 167
            + Y  +Q I+HRD+KP N L+D    +  I DF +A    +P E       ++     Y
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHV-HITDFNIAA--MLPRETQI---TTMAGTKPY 180

Query: 168 KAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
            APE         YS  VD W++  T  E++  +R +H R +      + +        T
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVT 238

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-TAREALRHE 284
            P   S                          + V LL+++L  +P +R     +     
Sbjct: 239 YPSAWS-------------------------QEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273

Query: 285 YFKDF 289
           Y  D 
Sbjct: 274 YMNDI 278

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 17/198 (8%)

Query: 10  EGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
            G +G+V +    +      V +K +      +     ++RE  ++ +L +  IVRL+ V
Sbjct: 20  CGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78

Query: 68  QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
             + +++ LV E      L  F+  +         + + LHQ+  G+ Y   +  +HRDL
Sbjct: 79  CQA-EALMLVMEMAGGGPLHKFLVGKREEIPVS-NVAELLHQVSMGMKYLEEKNFVHRDL 136

Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------APERLLGSGRYS 180
              N L+  ++   KI+DFGL++ +      YT +      K      APE +    ++S
Sbjct: 137 AARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAG---KWPLKWYAPECIN-FRKFS 191

Query: 181 TPVDVWAVACTFAEMVTH 198
           +  DVW+   T  E +++
Sbjct: 192 SRSDVWSYGVTMWEALSY 209

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.7 bits (236), Expect = 1e-22
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 29/208 (13%)

Query: 3   TLLEVIREGRYGAVHRAH----DSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELK 57
            L   + EG +G V  A            +V VK +   + S        RE  LL  L+
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTMLQ 101

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHF----------MKTEPTVTKNPLKIKKYL 106
           H++IVR   V +    + +VFE +   DL  F          +     V   PL + + L
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 107 H---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
               Q+  G+ Y      +HRDL   N L+     +VKI DFG++R  D+   +Y   GG
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSR--DIYSTDYYRVGG 218

Query: 164 S--LCYK--APERLLGSGRYSTPVDVWA 187
              L  +   PE +L   +++T  DVW+
Sbjct: 219 RTMLPIRWMPPESIL-YRKFTTESDVWS 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 27/211 (12%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
               VI +G +G V+     D         +K +           + +RE  L++ L H 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHP 82

Query: 60  NIVRLLNVQSSVDSIDL-VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLH---QILHGVA 114
           N++ L+ +    + +   +   +   DLL F+++     +    +K  +    Q+  G+ 
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGME 138

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK------ 168
           Y   Q+ +HRDL   N ++D     VK+ADFGLAR  D+    Y         +      
Sbjct: 139 YLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWT 195

Query: 169 APERLLGSGRYSTPVDVWA--VACTFAEMVT 197
           A E L  + R++T  DVW+  V     E++T
Sbjct: 196 ALESLQ-TYRFTTKSDVWSFGVLLW--ELLT 223

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL- 56
           +  + +  G +G V  A    L       TV VK +   +       +++ E+ +L  L 
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLG 84

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-------------EPTVTKNPLKI 102
            H NIV LL   +      ++ E   + DLL+F++                   +  L +
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 103 KKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           +  L    Q+  G+A+  S+  +HRDL   N L+   + I KI DFGLAR  D+  ++  
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLAR--DIKNDSNY 201

Query: 160 IKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
           +  G+  L  K  APE +  +  Y+   DVW+
Sbjct: 202 VVKGNARLPVKWMAPESIF-NCVYTFESDVWS 232

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 16/203 (7%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
            L   I EG++G VH+       +    V +K       S+ V    ++E   +++  H 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHP 451

Query: 60  NIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCH 117
           +IV+L+ V  + + + ++ E     +L  F++  + ++      +  Y +Q+   +AY  
Sbjct: 452 HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLD--LASLILYAYQLSTALAYLE 508

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---YKAPERLL 174
           S+  +HRD+   N L+  S D VK+ DFGL+R ++     Y           + APE + 
Sbjct: 509 SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMED--STYYKASKGKLPIKWMAPESIN 565

Query: 175 GSGRYSTPVDVWAVACTFAEMVT 197
              R+++  DVW       E++ 
Sbjct: 566 -FRRFTSASDVWMFGVCMWEILM 587

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 90.7 bits (226), Expect = 1e-21
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 27/208 (12%)

Query: 3   TLLEVIREGRYGAVHR--AHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
             +E + E R+G V++        G+    V +K +        +      E  L   L+
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQ 70

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKIKKY 105
           H N+V LL V +    + ++F      DL  F+             +    K+ L+   +
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           +H   QI  G+ Y  S  ++H+DL   N L+   K  VKI+D GL R +    + Y + G
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLFREVYAA-DYYKLLG 188

Query: 163 GSL---CYKAPERLLGSGRYSTPVDVWA 187
            SL    + APE ++  G++S   D+W+
Sbjct: 189 NSLLPIRWMAPEAIM-YGKFSIDSDIWS 215

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 3   TLLEVIREGRYGAVHRA------HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKE 55
           TL + + EG +G V  A       D       V VK +   + +E   S ++ E+ ++K 
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKM 96

Query: 56  L-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKI 102
           + KH+NI+ LL   +    + ++ E     +L  +++               V +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 103 KKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           K  +    Q+  G+ Y  SQ+ +HRDL   N L+  +  ++KIADFGLAR  D+   +Y 
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLAR--DINNIDYY 213

Query: 160 IKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
            K  +  L  K  APE L     Y+   DVW+
Sbjct: 214 KKTTNGRLPVKWMAPEALF-DRVYTHQSDVWS 244

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.7 bits (230), Expect = 3e-21
 Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 10  EGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV 67
            G +G+V +    +      V +K +      +     ++RE  ++ +L +  IVRL+ V
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 68  QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDL 126
             + +++ LV E      L  F+  +         + + LHQ+  G+ Y   +  +HR+L
Sbjct: 405 CQA-EALMLVMEMAGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 127 KPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYK--APERLLGSGRYSTPV 183
              N L+  ++   KI+DFGL++ +      YT +  G    K  APE +    ++S+  
Sbjct: 463 AARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRS 520

Query: 184 DVWAVACTFAEMVTH 198
           DVW+   T  E +++
Sbjct: 521 DVWSYGVTMWEALSY 535

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL- 56
              + +  G +G V  A    L  +     V VK +           +++ E+ ++  L 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLG 107

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT---------EPTVTKNPLKIKKYL 106
           +HENIV LL   +    + ++ E   + DLL+F++             +  +    +  L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 107 H---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
           H   Q+  G+A+  S+  +HRD+   N L+     + KI DFGLAR  D+  ++  I  G
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLAR--DIMNDSNYIVKG 224

Query: 164 S--LCYK--APERLLGSGRYSTPVDVWA 187
           +  L  K  APE +     Y+   DVW+
Sbjct: 225 NARLPVKWMAPESIF-DCVYTVQSDVWS 251

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 89.6 bits (223), Expect = 6e-21
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 37/217 (17%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
            L + + EG +G V +A    L G     TV VK +   N S      ++ E ++LK++ 
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVN 84

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-------------------EPTVTK 97
           H ++++L    S    + L+ E   +  L  F++                         +
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 98  NPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP 154
             L +   +    QI  G+ Y    +++HRDL   N L+   +  +KI+DFGL+R  DV 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSR--DVY 201

Query: 155 LENYTIKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
            E+  +K     +  K  A E L     Y+T  DVW+
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWS 237

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.5 bits (225), Expect = 7e-21
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 3   TLLEVIREGRYGAVHRA-------HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
            L + + EG +G V  A               V VK +   + +E   S +I E+ ++K 
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKM 130

Query: 56  L-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKI 102
           + KH+NI+ LL   +    + ++ E     +L  +++                 +  L  
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 103 KKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           K  +    Q+  G+ Y  S++ +HRDL   N L+     ++KIADFGLAR  D+   +Y 
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLAR--DIHHIDYY 247

Query: 160 IKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
            K  +  L  K  APE L     Y+   DVW+
Sbjct: 248 KKTTNGRLPVKWMAPEALF-DRIYTHQSDVWS 278

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL- 56
            L + +  G +G V  A    +       TV VK +     +     +++ E+ +L  + 
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIG 88

Query: 57  KHENIVRLLNVQSSVDS-IDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKIK 103
            H N+V LL   +     + ++ E   F +L  ++++              + K+ L ++
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 104 KYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI 160
             +    Q+  G+ +  S++ +HRDL   N L+     +VKI DFGLAR  D+  +   +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLAR--DIYKDPDYV 205

Query: 161 KGGS--LCYK--APERLLGSGRYSTPVDVWA 187
           + G   L  K  APE +     Y+   DVW+
Sbjct: 206 RKGDARLPLKWMAPETIF-DRVYTIQSDVWS 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 19/197 (9%)

Query: 3   TLLEVIREGRYGAVHRA--HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHE 59
              EVI  G +G V+     D+        VK +       G  S  + E  ++K+  H 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHP 150

Query: 60  NIVRLLNVQSSVDS-IDLVFENLDF-DLLHFMKTEPTVTKNPLKIK---KYLHQILHGVA 114
           N++ LL +    +    +V   +   DL +F++ E     +   +K    +  Q+  G+ 
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMK 206

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLENYTIKGGSLCYK--AP 170
           +  S++ +HRDL   N ++D  K  VK+ADFGLAR +        +   G  L  K  A 
Sbjct: 207 FLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

Query: 171 ERLLGSGRYSTPVDVWA 187
           E L  + +++T  DVW+
Sbjct: 266 ESLQ-TQKFTTKSDVWS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 3   TLLEVIREGRYGAVHRA------HDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKE 55
           TL + + EG +G V  A       D       V VK +   + +E   S ++ E+ ++K 
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKM 142

Query: 56  L-KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKI 102
           + KH+NI+ LL   +    + ++ E     +L  +++               V +  +  
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 103 KKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT 159
           K  +    Q+  G+ Y  SQ+ +HRDL   N L+  +  ++KIADFGLAR  D+   +Y 
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLAR--DINNIDYY 259

Query: 160 IKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
            K  +  L  K  APE L     Y+   DVW+
Sbjct: 260 KKTTNGRLPVKWMAPEALF-DRVYTHQSDVWS 290

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 39/192 (20%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  QI+ G+ + H + I++RDLKP N L+D   ++ +I+D GLA   ++       KG  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV-RISDLGLAV--ELKAGQTKTKGYA 350

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF-SIMGTP 221
           G+  + APE LLG   Y   VD +A+  T  EM+  +  F +R        +   ++   
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-- 407

Query: 222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----T 276
            + T P   S                         P   D    +L  DP KRL     +
Sbjct: 408 QAVTYPDKFS-------------------------PASKDFCEALLQKDPEKRLGFRDGS 442

Query: 277 AREALRHEYFKD 288
                 H  F+D
Sbjct: 443 CDGLRTHPLFRD 454

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 32/208 (15%)

Query: 3   TLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-K 57
              +VI EG +G V +A   +  D       +K++     S+        E+ +L +L  
Sbjct: 28  KFQDVIGEGNFGQVLKAR--IKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGH 84

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT-----------EPTVTKNPLKIKKY 105
           H NI+ LL        + L  E     +LL F++                T + L  ++ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 106 LH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG 162
           LH    +  G+ Y   ++ +HRDL   N L+  +  + KIADFGL+R  +V    Y  K 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEV----YVKKT 199

Query: 163 GS-LCYK--APERLLGSGRYSTPVDVWA 187
              L  +  A E L     Y+T  DVW+
Sbjct: 200 MGRLPVRWMAIESLN-YSVYTTNSDVWS 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 45/199 (22%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+ G+ + H++ +++RDLKPAN L+D    + +I+D GLA       +    K  +
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLAC------DFSKKKPHA 349

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
                 Y APE L     Y +  D +++ C   +++     F               +  
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----- 275
                LP   S                         P+   LL  +L  D ++RL     
Sbjct: 410 A--VELPDSFS-------------------------PELRSLLEGLLQRDVNRRLGCLGR 442

Query: 276 TAREALRHEYFK--DFQSL 292
            A+E     +F+  D+Q +
Sbjct: 443 GAQEVKESPFFRSLDWQMV 461

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 88.7 bits (220), Expect = 7e-20
 Identities = 58/198 (29%), Positives = 82/198 (41%), Gaps = 42/198 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-- 162
           Y  +I  G+   H + I++RDLKP N L+D    I +I+D GLA  +    E  TIKG  
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHI-RISDLGLAVHVP---EGQTIKGRV 346

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF-SIMGTP 221
           G++ Y APE +     Y+   D WA+ C   EM+  Q  F  R        +   +   P
Sbjct: 347 GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

Query: 222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----T 276
             E      S                         P    L  ++LC DP++RL     +
Sbjct: 406 --EEYSERFS-------------------------PQARSLCSQLLCKDPAERLGCRGGS 438

Query: 277 AREALRHEYFK--DFQSL 292
           ARE   H  FK  +F+ L
Sbjct: 439 AREVKEHPLFKKLNFKRL 456

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.0 bits (216), Expect = 8e-20
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 37/217 (17%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL- 56
              +V+  G +G V  A    ++       V VK +           +++ E+ ++ +L 
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLG 106

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKT------------------EPTVTK 97
            HENIV LL   +    I L+FE   + DLL+++++                  E     
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 98  NPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP 154
           N L  +  L    Q+  G+ +   +  +HRDL   N L+   K +VKI DFGLAR  D+ 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLAR--DIM 223

Query: 155 LENYTIKGGS--LCYK--APERLLGSGRYSTPVDVWA 187
            ++  +  G+  L  K  APE L   G Y+   DVW+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWS 259

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 85.7 bits (211), Expect = 2e-19
 Identities = 51/342 (14%), Positives = 93/342 (27%), Gaps = 84/342 (24%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP------SEGVPSSVIREVSLLK 54
           +    E I EG +G V +         V +K I I  P       +     ++ E+ + K
Sbjct: 21  KLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 55  EL---------KHENIVRLLN---VQSSVDS----------------------------- 73
           EL         + E  + L +   VQ S                                
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 74  IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFL 132
           I L FE    DL        ++       K  LHQ+   +A   +     HRDL   N L
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLA----TAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 133 IDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF 192
           + ++    K+      +   +P     +                  Y+           F
Sbjct: 195 LKKTSL-KKLHYTLNGKSSTIPSCGLQVS--------------IIDYTLSRLERDGIVVF 239

Query: 193 AEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT--------SFSEEFGFEPNRSP 244
            ++   + LF           I+ +M   ++     +          +  +   +     
Sbjct: 240 CDVSMDEDLFTGDGDY--QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK 297

Query: 245 IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
            K     +  ++    +  R ML        +A + L     
Sbjct: 298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 62/304 (20%), Positives = 115/304 (37%), Gaps = 62/304 (20%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           +  ++ +  G +G V       +G+     ++ K  ++   +      + E  +L+ +  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVNF 100

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
             +V+L        ++ +V   +++    ++   ++     ++   +   Y  QI+    
Sbjct: 101 PFLVKLEFSFKDNSNLYMV---MEYVAGGEMFSHLRRIGRFSEPHARF--YAAQIVLTFE 155

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKAP 170
           Y HS ++++RDLKP N LID+   I ++ DFG A+   V    +T     LC      AP
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYI-QVTDFGFAK--RVKGRTWT-----LCGTPEALAP 207

Query: 171 ERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT 230
           E +L  G Y+  VD WA+     EM      F +     +   I           + G  
Sbjct: 208 EIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-----------VSGKV 255

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEY 285
            F   F                     D  DLLR +L +D +KR         +   H++
Sbjct: 256 RFPSHFS-------------------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 286 FKDF 289
           F   
Sbjct: 297 FATT 300

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 3   TLLEVIREGRYGAVHRAH-DSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELK 57
             +  I EG +G V +A    L        V VK +     S  + +   RE +L+ E  
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFD 108

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF-DLLHF-------------------MKTEPTVTK 97
           + NIV+LL V +    + L+FE + + DL  F                        +   
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 98  NPLKIKKYLH---QILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP 154
            PL   + L    Q+  G+AY   ++ +HRDL   N L+     +VKIADFGL+R I   
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSA 227

Query: 155 LENYTIKGGS-LCYK--APERLLGSGRYSTPVDVWA 187
            + Y   G   +  +   PE +    RY+T  DVWA
Sbjct: 228 -DYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWA 261

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 64/308 (20%), Positives = 109/308 (35%), Gaps = 58/308 (18%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           + +L+VI  G +  V       TG      ++ K  ++   E   S    E  +L     
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGDR 120

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLL-HFMKTEPTVTKNPLKIKKYLHQILHGV 113
             I +L     +    + ++  +++    DLL    K    +     +   YL +I+  +
Sbjct: 121 RWITQL---HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF--YLAEIVMAI 175

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKA 169
              H    +HRD+KP N L+DR   I ++ADFG    +     + T++         Y +
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHI-RLADFGSCLKLR---ADGTVRSLVAVGTPDYLS 231

Query: 170 PERLLGSG------RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           PE L   G       Y    D WA+     EM   Q  F++            I+   + 
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKEH 288

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREA 280
            +LP                          G+  +  D ++R+LC  P  RL    A + 
Sbjct: 289 LSLPLVDE----------------------GVPEEARDFIQRLLC-PPETRLGRGGAGDF 325

Query: 281 LRHEYFKD 288
             H +F  
Sbjct: 326 RTHPFFFG 333

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 62/306 (20%), Positives = 116/306 (37%), Gaps = 56/306 (18%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           + +L+VI  G +G V               ++ K  ++  +E   +    E  +L     
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE--TACFREERDVLVNGDS 133

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLL-HFMKTEPTVTKNPLKIKKYLHQILHGV 113
           + I  L     +    + ++  +D+    DLL    K E  + +   +   YL +++  +
Sbjct: 134 KWITTL---HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--YLAEMVIAI 188

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKA 169
              H    +HRD+KP N L+D +  I ++ADFG    +   +E+ T++         Y +
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKL---MEDGTVQSSVAVGTPDYIS 244

Query: 170 PERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
           PE L     G GRY    D W++     EM+  +  F++     L+     IM   +   
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERFQ 301

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREALR 282
            P   +                       +  +  DL+RR++C     RL      +  +
Sbjct: 302 FPTQVT----------------------DVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338

Query: 283 HEYFKD 288
           H +F  
Sbjct: 339 HPFFSG 344

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 64/310 (20%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           Y +++VI  G +G V       T       ++ K  ++  S+   +    E  ++     
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFANS 128

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMK----TEPTVTKNPLKIKKYLHQIL 110
             +V+L     +      ++  +++    DL++ M      E          + Y  +++
Sbjct: 129 PWVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVV 178

Query: 111 HGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC---- 166
             +   HS   +HRD+KP N L+D+S  + K+ADFG    ++   +   ++  +      
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMN---KEGMVRCDTAVGTPD 234

Query: 167 YKAPERLLGSG---RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
           Y +PE L   G    Y    D W+V     EM+     F++    G  +    IM   +S
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KIMNHKNS 291

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT---AREA 280
            T P     S                        +  +L+   L  D   RL      E 
Sbjct: 292 LTFPDDNDIS-----------------------KEAKNLICAFLT-DREVRLGRNGVEEI 327

Query: 281 LRHEYFKDFQ 290
            RH +FK+ Q
Sbjct: 328 KRHLFFKNDQ 337

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.5 bits (204), Expect = 1e-18
 Identities = 26/226 (11%), Positives = 57/226 (25%), Gaps = 41/226 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSS----VIREVSLLKEL 56
           RY LL            +A D+     V +     ++P   +P       +     L  +
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTALDRQVALT---FVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
               + R+L+V  +     +V E +    L     T P+    P+   + +  +      
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS----PVGAIRAMQSLAAAADA 144

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
            H   +      P+   +      V +A        +                       
Sbjct: 145 AHRAGVALSIDHPSRVRVSID-GDVVLAYPATMPDAN----------------------- 180

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTP 221
                   D+  +  +   ++ ++           LA         
Sbjct: 181 -----PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 71/308 (23%), Positives = 114/308 (37%), Gaps = 72/308 (23%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKH 58
           + +L  +  G +G VH       G      V+KK  ++   +        E  +L  + H
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLSIVTH 65

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMK-----TEPTVTKNPLKIKKYLHQI 109
             I+R+         I ++   +D+    +L   ++       P         K Y  ++
Sbjct: 66  PFIIRMWGTFQDAQQIFMI---MDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEV 115

Query: 110 LHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC--- 166
              + Y HS++I++RDLKP N L+D++  I KI DFG A+   VP   YT     LC   
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHI-KITDFGFAK--YVPDVTYT-----LCGTP 167

Query: 167 -YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET 225
            Y APE +     Y+  +D W+      EM+     F+          I           
Sbjct: 168 DYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------- 215

Query: 226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREA 280
                  + E  F P                 D  DLL R++  D S+RL        + 
Sbjct: 216 ------LNAELRFPPF-------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256

Query: 281 LRHEYFKD 288
             H +FK+
Sbjct: 257 KNHPWFKE 264

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 41/189 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+ G+ + HS+ I++RDLK  N L+D+   I KIADFG+ +  ++  +  T    +
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKE-NMLGDAKT---NT 177

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE LLG   Y+  VD W+      EM+  Q  FH +    L  +I      
Sbjct: 178 FCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM---- 232

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA 280
            D+   P +                            +  DLL ++   +P KRL  R  
Sbjct: 233 -DNPFYPRWLE-------------------------KEAKDLLVKLFVREPEKRLGVRGD 266

Query: 281 LR-HEYFKD 288
           +R H  F++
Sbjct: 267 IRQHPLFRE 275

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 43/195 (22%), Positives = 76/195 (38%), Gaps = 42/195 (21%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y+ +I+  + + H   I++RD+K  N L+D +  +  + DFGL++     + + T +   
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV-VLTDFGLSK---EFVADETERAYD 219

Query: 165 LC----YKAPERLLGSGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF-SIM 218
            C    Y AP+ + G    +   VD W++     E++T    F         A I   I+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL--- 275
            +      P +                         +     DL++R+L  DP KRL   
Sbjct: 280 KSE-----PPYPQE----------------------MSALAKDLIQRLLMKDPKKRLGCG 312

Query: 276 --TAREALRHEYFKD 288
              A E   H +F+ 
Sbjct: 313 PRDADEIKEHLFFQK 327

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 45/193 (23%), Positives = 70/193 (36%), Gaps = 45/193 (23%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I  G+ +  S+ I++RDLK  N ++D    I KIADFG+ +  ++     T    +
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKE-NIWDGVTT---KT 501

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE +     Y   VD WA      EM+  Q  F       L  +I      
Sbjct: 502 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---- 556

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----- 275
             +   P   S                          + V + + ++   P KRL     
Sbjct: 557 -HNVAYPKSMS-------------------------KEAVAICKGLMTKHPGKRLGCGPE 590

Query: 276 TAREALRHEYFKD 288
             R+   H +F+ 
Sbjct: 591 GERDIKEHAFFRY 603

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 8e-16
 Identities = 48/193 (24%), Positives = 72/193 (37%), Gaps = 45/193 (23%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           YL ++   + + HS  I++RDLKP N L+D    I K+ DFGL++   +  E       S
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKE-SIDHEKKA---YS 185

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE +   G ++   D W+      EM+T    F  +     +  I      
Sbjct: 186 FCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---- 240

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----- 275
                +P F S                         P+   LLR +   +P+ RL     
Sbjct: 241 -AKLGMPQFLS-------------------------PEAQSLLRMLFKRNPANRLGAGPD 274

Query: 276 TAREALRHEYFKD 288
              E  RH +F  
Sbjct: 275 GVEEIKRHSFFST 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.3 bits (186), Expect = 9e-16
 Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 55/198 (27%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG- 163
           Y  +I+  + Y HS+++++RD+K  N ++D+   I KI DFGL +      E   I  G 
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI-KITDFGLCK------EG--ISDGA 160

Query: 164 ---SLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
              + C    Y APE L  +  Y   VD W +     EM+  +  F+++           
Sbjct: 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ----------- 208

Query: 217 IMGTPDSETLPGFTSF-SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
                D E L  F     EE  F    S             P+   LL  +L  DP +RL
Sbjct: 209 -----DHERL--FELILMEEIRFPRTLS-------------PEAKSLLAGLLKKDPKQRL 248

Query: 276 -----TAREALRHEYFKD 288
                 A+E + H +F  
Sbjct: 249 GGGPSDAKEVMEHRFFLS 266

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 61/304 (20%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTV------VVKKIPIMNPSEGVPSSVIREVSLLKELK 57
           LL V+ +G YG V +       +T       V+KK  I+  ++   +    E ++L+E+K
Sbjct: 21  LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVK 79

Query: 58  HENIVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
           H  IV L     +  +   ++  L++    +L   ++ E    ++      YL +I   +
Sbjct: 80  HPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF--YLAEISMAL 134

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKA 169
            + H + I++RDLKP N +++    + K+ DFGL +   +     T    + C    Y A
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHV-KLTDFGLCK-ESIHDGTVT---HTFCGTIEYMA 189

Query: 170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF 229
           PE L+ SG ++  VD W++     +M+T    F        +  I           LP +
Sbjct: 190 PEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-----CKLNLPPY 243

Query: 230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHE 284
            +                          +  DLL+++L  + + RL      A E   H 
Sbjct: 244 LT-------------------------QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278

Query: 285 YFKD 288
           +F+ 
Sbjct: 279 FFRH 282

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 47/193 (24%), Positives = 73/193 (37%), Gaps = 46/193 (23%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I   + Y HS  I++RDLKP N L+D    I  + DFGL +  ++   + T    +
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI-VLTDFGLCKE-NIEHNSTT---ST 198

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE L     Y   VD W +     EM+     F+SR               
Sbjct: 199 FCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSR--------------- 242

Query: 221 PDSETLPGFTS-FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL---- 275
            ++  +  + +  ++    +PN +                  LL  +L  D +KRL    
Sbjct: 243 -NTAEM--YDNILNKPLQLKPNIT-------------NSARHLLEGLLQKDRTKRLGAKD 286

Query: 276 TAREALRHEYFKD 288
              E   H +F  
Sbjct: 287 DFMEIKSHVFFSL 299

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 48/197 (24%), Positives = 71/197 (36%), Gaps = 53/197 (26%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG- 163
           Y  +I  G+ +  S+ I++RDLK  N ++D    I KIADFG+ +      EN  I  G 
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI-KIADFGMCK------EN--IWDGV 176

Query: 164 ---SLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
              + C    Y APE +     Y   VD WA      EM+  Q  F       L  +I  
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL- 275
                 +   P   S                          + V + + ++   P KRL 
Sbjct: 236 -----HNVAYPKSMS-------------------------KEAVAICKGLMTKHPGKRLG 265

Query: 276 ----TAREALRHEYFKD 288
                 R+   H +F+ 
Sbjct: 266 CGPEGERDIKEHAFFRY 282

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 65/308 (21%), Positives = 123/308 (39%), Gaps = 62/308 (20%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTV---VVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            L+++ +G +G V    +  TG      ++KK  I+   E   +  + E  +L+  +H  
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--AHTLTENRVLQNSRHPF 209

Query: 61  IVRLLNVQSSVDSIDLVFENLDF----DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +  L   + S  + D +   +++    +L   +  E   +++  +   Y  +I+  + Y 
Sbjct: 210 LTAL---KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF--YGAEIVSALDYL 264

Query: 117 HSQE-ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLC----YKAPE 171
           HS++ +++RDLK  N ++D+   I KI DFGL +   +          + C    Y APE
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHI-KITDFGLCKE-GIKDGATM---KTFCGTPEYLAPE 319

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
            L  +  Y   VD W +     EM+  +  F+++    L   I       +    P    
Sbjct: 320 VLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 373

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYF 286
                                    P+   LL  +L  DP +RL      A+E ++H +F
Sbjct: 374 -------------------------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

Query: 287 K--DFQSL 292
               +Q +
Sbjct: 409 AGIVWQHV 416

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.4 bits (181), Expect = 4e-15
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 45/198 (22%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG- 163
           Y  +I   + Y H + I++RDLK  N L+D    I K+ D+G+ +      E   ++ G 
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCK------EG--LRPGD 165

Query: 164 ---SLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
              + C    Y APE L G   Y   VD WA+     EM+  +  F    +         
Sbjct: 166 TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------- 216

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL- 275
               PD          +E++ F+     ++    +   L      +L+  L  DP +RL 
Sbjct: 217 --DNPDQN--------TEDYLFQ---VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLG 263

Query: 276 -----TAREALRHEYFKD 288
                   +   H +F++
Sbjct: 264 CHPQTGFADIQGHPFFRN 281

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 6e-15
 Identities = 46/194 (23%), Positives = 71/194 (36%), Gaps = 46/194 (23%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGS 164
           Y  +I+  + + H + I++RDLK  N L+D      K+ADFG+ +   +     T    +
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKE-GICNGVTT---AT 183

Query: 165 LC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGT 220
            C    Y APE L     Y   VD WA+     EM+     F +     L  AI +    
Sbjct: 184 FCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---- 238

Query: 221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL----- 275
            D    P +                            D   +L+  +  +P+ RL     
Sbjct: 239 -DEVVYPTWLH-------------------------EDATGILKSFMTKNPTMRLGSLTQ 272

Query: 276 -TAREALRHEYFKD 288
                 LRH +FK+
Sbjct: 273 GGEHAILRHPFFKE 286

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 45/198 (22%)

Query: 105 YLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG- 163
           Y  +I   + Y H + I++RDLK  N L+D    I K+ D+G+ +      E   ++ G 
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCK------EG--LRPGD 208

Query: 164 ---SLC----YKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS 216
              + C    Y APE L G   Y   VD WA+     EM+  +  F    +         
Sbjct: 209 TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSS-------- 259

Query: 217 IMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL- 275
               PD          +E++ F+     ++    +   L      +L+  L  DP +RL 
Sbjct: 260 --DNPDQN--------TEDYLFQ---VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLG 306

Query: 276 -----TAREALRHEYFKD 288
                   +   H +F++
Sbjct: 307 CHPQTGFADIQGHPFFRN 324

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 44/191 (23%), Positives = 82/191 (42%), Gaps = 29/191 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-E 59
            + + + I  G +G +    +  T + V +K    + P +     +  E    K+L   +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGD 65

Query: 60  NIVRLL----NVQSSVDSIDLVFENLDFDLLHFMK---TEPTVTKNPLKIKKYLHQILHG 112
            I ++       + +   ++L+  +L+ DL        +  TV    L I     Q++  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLE-DLFDLCDRTFSLKTV----LMIAI---QLISR 117

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           + Y HS+ +++RD+KP NFLI R  +    ++ I DF LA+    P     I      Y+
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-----YR 172

Query: 169 APERLLGSGRY 179
             + L G+ RY
Sbjct: 173 EHKSLTGTARY 183

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 25/188 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-E 59
           RY L   I  G +G ++   D   G+ V +K    +   +     +  E  + K ++   
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGV 65

Query: 60  NIVRLL----NVQSSVDSIDLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
            I  +         +V  ++L+  +L+  F+      +  TV    L +     Q++  +
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTV----LLLAD---QMISRI 118

Query: 114 AYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            Y HS+  +HRD+KP NFL+   K   +V I DFGLA+       +  I      Y+  +
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI-----PYRENK 173

Query: 172 RLLGSGRY 179
            L G+ RY
Sbjct: 174 NLTGTARY 181

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 34/135 (25%), Positives = 55/135 (40%), Gaps = 7/135 (5%)

Query: 68  QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIK---KYLHQILHGVAYCHSQEILHR 124
            S   +     E      +   +    + K+ L ++    Y  Q+  G+ +  S++ +HR
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 217

Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYK--APERLLGSGRYSTP 182
           DL   N L+     +VKI DFGLAR I    +        L  K  APE +     Y+  
Sbjct: 218 DLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQ 275

Query: 183 VDVWAVACTFAEMVT 197
            DVW+      E+ +
Sbjct: 276 SDVWSFGVLLWEIFS 290

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 21/186 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
           ++ L   I  G +G ++   +  T + V +K   +          ++ E  + + L+   
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGT 63

Query: 60  NIVRLL----NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
            I  +         +V  +DL+  +L+ DL +F   + ++ K  L +     Q+++ V +
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLE-DLFNFCSRKLSL-KTVLMLAD---QMINRVEF 118

Query: 116 CHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
            HS+  LHRD+KP NFL+   +    V I DFGLA+       +  I      Y+  + L
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----PYRENKNL 173

Query: 174 LGSGRY 179
            G+ RY
Sbjct: 174 TGTARY 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 47/191 (24%), Positives = 74/191 (38%), Gaps = 29/191 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-E 59
            Y +   I EG +G +    + L    V +K      P       +  E    K L    
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCT 66

Query: 60  NIVRLL----NVQSSVDSIDLVFENLDFDLLHFMK---TEPTVTKNPLKIKKYLHQILHG 112
            I  +         +V  IDL+  +L+ DLL       +  TV        K   Q+L  
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTV----AMAAK---QMLAR 118

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLENYTIKGGSLCYK 168
           V   H + +++RD+KP NFLI R       ++ + DFG+ +    P+    I      Y+
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-----YR 173

Query: 169 APERLLGSGRY 179
             + L G+ RY
Sbjct: 174 EKKNLSGTARY 184

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 32/174 (18%), Positives = 66/174 (37%), Gaps = 35/174 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           ++ L + I  G +G ++ A  +   +      + +     G    +  E+   + +  ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKD 94

Query: 61  IVRLLNVQSSVDSID-------------------LVFENLDFDLLHFMK-----TEPTVT 96
            ++    +  +D +                    +V E L  DL           + TV 
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV- 153

Query: 97  KNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-DIVKIADFGLAR 149
              L++     ++L  + Y H  E +H D+K AN L+     D V +AD+GL+ 
Sbjct: 154 ---LQLGI---RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 64.1 bits (157), Expect = 4e-12
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 45/203 (22%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSV--IREVSLLKELKHENIVRL 64
            + EG +G V++ +  +   TV VKK+  M             +E+ ++ + +HEN+V L
Sbjct: 38  KMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 65  LNVQSSVDSID-----LVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQIL---H 111
           L       S D     LV+      +L   L     T P       KI           +
Sbjct: 96  LGF-----SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI------AQGAAN 144

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIV-KIADFGLARPIDVPLENYT-----IKG--G 163
           G+ + H    +HRD+K AN L+D  +    KI+DFGLAR         T     I G   
Sbjct: 145 GINFLHENHHIHRDIKSANILLD--EAFTAKISDFGLAR--ASEKFAQTVMTSRIVGTTA 200

Query: 164 SLCYKAPERLLGSGRYSTPVDVW 186
              Y APE L   G  +   D++
Sbjct: 201 ---YMAPEAL--RGEITPKSDIY 218

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 33/221 (14%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLL 65
           ++  G +G V++    L   T+V VK++     ++G       EV ++    H N++RL 
Sbjct: 37  ILGRGGFGKVYKGR--LADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 66  NVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVT-KNPLKIKKYLHQIL---HGVAYC 116
               +     LV+      ++   L    +++P +      +I       L    G+AY 
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI------ALGSARGLAYL 147

Query: 117 HSQ---EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-----IKGGSLCYK 168
           H     +I+HRD+K AN L+D  +    + DFGLA+ +D      T     ++ G++ + 
Sbjct: 148 HDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD---YKDTHVTTAVR-GTIGHI 202

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG 209
           APE L  +G+ S   DV+       E++T QR F       
Sbjct: 203 APEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 31/180 (17%), Positives = 61/180 (33%), Gaps = 44/180 (24%)

Query: 1   RYTLLEVIREGRYGAVHRAH-----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
            + +   I +G +G ++ A         +    VVK  P  N        +  E+   + 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP------LFTELKFYQR 89

Query: 56  LKHENIVRLLNVQSSVDSID-------------------LVFENLDFDLLHFMK------ 90
                 ++       +  +                    ++ +    DL    +      
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 91  TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-DIVKIADFGLAR 149
           +  TV    L++     +IL  + Y H  E +H D+K +N L++    D V + D+GLA 
Sbjct: 150 SRKTV----LQLSL---RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 10/43 (23%), Positives = 20/43 (46%), Gaps = 1/43 (2%)

Query: 108 QILHGVAYCHSQEILHRDLKPANFLIDRSK-DIVKIADFGLAR 149
           ++L  + + H  E +H ++   N  +D      V +A +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 41/186 (22%)

Query: 7   VIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSV------IREVSLLKELKHE 59
           +I  G +G V++    L     V +K+          P S         E+  L   +H 
Sbjct: 46  LIGHGVFGKVYKGV--LRDGAKVALKR--------RTPESSQGIEEFETEIETLSFCRHP 95

Query: 60  NIVRLLNVQSSVDSIDLVFE-----NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++V L+      + + L+++     NL    L+       +    +  ++ L +I  G A
Sbjct: 96  HLVSLIGFCDERNEMILIYKYMENGNLK-RHLY----GSDLPTMSMSWEQRL-EICIGAA 149

Query: 115 ----YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT-----IKGGSL 165
               Y H++ I+HRD+K  N L+D    + KI DFG+++       + T     +K G+L
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISK--KGTELDQTHLSTVVK-GTL 205

Query: 166 CYKAPE 171
            Y  PE
Sbjct: 206 GYIDPE 211

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	293
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.33
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.83
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.65
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.6
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.51
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.19
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.66
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.59
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.49
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.24
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.85
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.7
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.62

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-65  Score=428.66  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=219.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|++++++++||||+++++++.+++.+|+||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            79999999999999999999999999999999976554444567889999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |++.+.+.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..........
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~~~~  183 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVELAR  183 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC-EEECSTTEESCCCHHHHHHH
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC-EEEcccccceeecCCccccc
Confidence            98 56777777666667899999999999999999999999999999999999999998 99999999987654323333


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...++.....                    
T Consensus       184 ~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------------------  242 (350)
T 4b9d_A          184 ACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------------------  242 (350)
T ss_dssp             HHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------------------
T ss_pred             ccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------------------
Confidence            44599999999998876 689999999999999999999999999988888888765211                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                               ...+..+|+++.+||.+||+.||++|||+.|+|+||||++
T Consensus       243 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 ---------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                     1123457899999999999999999999999999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-64  Score=410.20  Aligned_cols=254  Identities=31%  Similarity=0.516  Sum_probs=209.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||+||+|.+..+|+.||+|+++..... ......+.+|++++++++||||+++++++.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            699999999999999999999999999999999654433 3445678999999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++|++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++..... ....
T Consensus        94 y~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~-~~~~  169 (275)
T 3hyh_A           94 YAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDG-NFLK  169 (275)
T ss_dssp             CCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC-EEECCSSCC-----------
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC-EEEeecCCCeecCCC-CccC
Confidence            99999999887754  5889999999999999999999999999999999999999888 999999999866443 2233


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....                    
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------------------  229 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------------------  229 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------------------
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            455999999999998876667899999999999999999999999888877777654211                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                ..+..+|+++.+||.+||+.||++|||++|+++||||+.
T Consensus       230 ----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                      123347899999999999999999999999999999973

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-63  Score=415.78  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=221.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||+|+||+||+|.++.+|+.||||++....  ....+.+.+|++++++++||||+++++++.+++.+|+||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            4899999999999999999999999999999996543  33457789999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+.+..+....  .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++...........
T Consensus       153 ~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          153 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC-EEEecCcCceecCCCCCcccc
Confidence            9865554444432  4889999999999999999999999999999999999999998 999999999887655455556


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......                   
T Consensus       230 ~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------------  289 (346)
T 4fih_A          230 LVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-------------------  289 (346)
T ss_dssp             CCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-------------------
T ss_pred             cccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-------------------
Confidence            6799999999988766 68999999999999999999999999988888777765411100                   


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                              ...+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       290 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          290 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             --------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                    01123478999999999999999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.5e-64  Score=411.02  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=222.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|++++++++||||+++++++.+++.+|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            8999999999999999999999999999999964332 234457789999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC--cc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL--EN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~--~~  157 (293)
                      ++| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+++......  ..
T Consensus       114 ~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~-vKl~DFGla~~~~~~~~~~~  190 (311)
T 4aw0_A          114 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR  190 (311)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECCTTTTCCC
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC-EEEEEcCCceecCCCCCccc
Confidence            985 6666665543  5889999999999999999999999999999999999999998 9999999998764332  22


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+...++.....                  
T Consensus       191 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------------  251 (311)
T 4aw0_A          191 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY------------------  251 (311)
T ss_dssp             BCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------------
T ss_pred             ccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            3445699999999998876 689999999999999999999999999988888888765211                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHH------HhcCcccccCcCC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE------ALRHEYFKDFQSL  292 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~~p~~~~~~~~  292 (293)
                                  ..+..+++++.+||.+||..||++|||++|      |++||||+.++|-
T Consensus       252 ------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          252 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             ------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence                        122347889999999999999999999987      6899999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3e-62  Score=416.81  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=221.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.++||+|+||+||+|.+..+|+.||||++....  ....+.+.+|+++|+.++||||+++++++.+++.+|+||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            4899999999999999999999999999999996543  34457899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      |+|+.+..+....  .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++............
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~-vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC-EEECCCTTCEECCSSCCCBCC
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEecCccceECCCCCccccc
Confidence            9965555554433  4889999999999999999999999999999999999999998 999999999877655455555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..||+.|||||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......                   
T Consensus       307 ~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------------  366 (423)
T 4fie_A          307 LVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-------------------  366 (423)
T ss_dssp             CEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------------
T ss_pred             cccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-------------------
Confidence            6699999999988766 68999999999999999999999999988888777765421100                   


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                              ...+..+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       367 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          367 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             --------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                    01223578999999999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-63  Score=409.78  Aligned_cols=257  Identities=24%  Similarity=0.322  Sum_probs=212.8

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++++.||+|+||+||+|++.   .+++.||+|+++...........+.+|++++++++||||+++++++.+++.+|+|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            5999999999999999999863   4678999999865443333445688899999999999999999999999999999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||++| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus       105 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             ECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC-EEEESSEEEEC-----C
T ss_pred             EEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC-EEecccccceeccCCCc
Confidence            999985 5666665543  5889999999999999999999999999999999999999998 99999999987654444


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....                 
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------  243 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-----------------  243 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             cccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------------
Confidence            44455699999999998876 689999999999999999999999999988888888764211                 


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                   ..+..+|+++.+||.+||+.||++|||     ++|+++||||+.++|
T Consensus       244 -------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          244 -------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence                         123357899999999999999999998     589999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-62  Score=415.66  Aligned_cols=287  Identities=30%  Similarity=0.534  Sum_probs=236.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec------CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS------VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   74 (293)
                      ||++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+++|+.++||||+++++++..      .+.+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            6999999999999999999999999999999996544444445678899999999999999999998654      3578


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||++|++...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+++.....
T Consensus       135 ~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~-~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          135 YVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE-LKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCC---
T ss_pred             EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC-EEEeecceeeecccC
Confidence            9999999999888887653  5889999999999999999999999999999999999999988 999999999866432


Q ss_pred             C----cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          155 L----ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       155 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      .    .......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+.........
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence            1    222344599999999998887778999999999999999999999999999999999999998888766554332


Q ss_pred             Cccccc-CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEEF-GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ...... ...........+....+.+++++.+||.+||..||.+|||+.|+|+||||+++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            211110 000111222344556678899999999999999999999999999999999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-61  Score=395.65  Aligned_cols=254  Identities=24%  Similarity=0.314  Sum_probs=207.1

Q ss_pred             Cc-eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----CCcce
Q 038154            1 RY-TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----VDSID   75 (293)
Q Consensus         1 ry-~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   75 (293)
                      || ++.++||+|+||+||+|.+..++..||+|++............+.+|++++++++||||+++++++.+    .+.+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 67788999999999999999999999999997655444455778999999999999999999998865    34689


Q ss_pred             eEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeC-CCCeEEEccCCCcccC
Q 038154           76 LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDR-SKDIVKIADFGLARPI  151 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~  151 (293)
                      +||||++| ++.+.+...  ..+++..++.++.||+.||+|||++|  ++||||||+|||++. ++. +||+|||+++..
T Consensus       106 lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~-vKl~DFGla~~~  182 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC-EEECCTTGGGGC
T ss_pred             EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC-EEEEeCcCCEeC
Confidence            99999985 555666543  35788899999999999999999998  999999999999974 566 999999999865


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...  ......||+.|+|||++.+  .++.++|||||||++|+|+||..||.+.+....+.........           
T Consensus       183 ~~~--~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-----------  247 (290)
T 3fpq_A          183 RAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----------  247 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----------
T ss_pred             CCC--ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-----------
Confidence            433  2334569999999998754  5899999999999999999999999876554433332211000           


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                      ....+...++++.+||.+||..||++|||+.++|+||||++
T Consensus       248 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            01223446789999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-60  Score=396.93  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=212.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |++.++||+|+||+||+|+++.+|+.||||+++....       ..+|+++++.++||||+++++++.+++.+|+||||+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            6788999999999999999999999999999864322       247999999999999999999999999999999999


Q ss_pred             Cc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc---
Q 038154           82 DF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---  157 (293)
Q Consensus        82 ~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~---  157 (293)
                      +| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++..+||+|||+++........   
T Consensus       133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            85 5556665443  58899999999999999999999999999999999999988755999999999876432211   


Q ss_pred             --eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          158 --YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       158 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        .....||+.|||||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                 
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------  272 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-----------------  272 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-----------------
T ss_pred             ecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-----------------
Confidence              1223599999999998876 68999999999999999999999999887777777765410                 


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHH-------------hcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA-------------LRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l-------------l~~p~~~~~~  290 (293)
                                .....+++.+++++.++|.+||..||.+|||+.|+             |+|||+..++
T Consensus       273 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          273 ----------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             ----------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             ----------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence                      11123456789999999999999999999999998             6799998875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4e-58  Score=388.04  Aligned_cols=281  Identities=22%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.++||+|+||+||+|.++   .+++.||+|++...    .....+.+|+++++.+ .||||+++++++.+.+.+|+
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            6999999999999999999864   45788999987432    2345788999999998 69999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ||||++| ++.+.+ .    .+++..++.++.||+.||+|||++|++||||||+||+++.+...+||+|||.++......
T Consensus        98 vmE~~~g~~L~~~~-~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           98 AMPYLEHESFLDIL-N----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEECCCCCCHHHHH-T----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCcccHHHHH-c----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999985 555554 2    478899999999999999999999999999999999999874459999999997543221


Q ss_pred             c----------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 038154          156 E----------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-W  206 (293)
Q Consensus       156 ~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~  206 (293)
                      .                            ......||+.|+|||++.+...++.++|+||+||++|+|++|..||... +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence            1                            1122359999999999988767899999999999999999999999554 4


Q ss_pred             chHHHHHHHHHhCCCCCCC--------------CCCC--cCccccc--------CCCCCCCcccchhhhcCCCCchHHHH
Q 038154          207 APGLLAAIFSIMGTPDSET--------------LPGF--TSFSEEF--------GFEPNRSPIKDLATVVGGLEPDGVDL  262 (293)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~--------------~~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l  262 (293)
                      ..+.+..+....+.+....              .+..  ....+..        ...............+..+++++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            5566666655444221100              0000  0000000        00000000111223355689999999


Q ss_pred             HHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          263 LRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       263 i~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      |.+||..||++|||++|+|+||||++++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-56  Score=374.63  Aligned_cols=288  Identities=43%  Similarity=0.736  Sum_probs=242.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|++|+||++.+. +|+.+|+|++............+.+|++++++++||||+++++++.+.+..++|||+
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            6999999999999999999985 589999999876554444556788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+............
T Consensus       101 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          101 MEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             CSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEETTSCCC---C
T ss_pred             CCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC-EEEccCcCceecCCCcccccC
Confidence            9998888877654 35889999999999999999999999999999999999999888 999999999877655455555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+....++.............
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            56899999999988766789999999999999999999999999999999999999888887777766555433332222


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ............+.+++++.+||.+||+.||.+|||+.++|+||||++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            223334456677788999999999999999999999999999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-58  Score=378.99  Aligned_cols=256  Identities=24%  Similarity=0.396  Sum_probs=191.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC---------
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD---------   72 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---------   72 (293)
                      |++++.||+|+||+||+|.++.+|+.||+|+++... .....+.+.+|++++++++||||+++++++.+.+         
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            789999999999999999999999999999986543 2233457889999999999999999999886544         


Q ss_pred             ---cceeEeecCCc-chHHHhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           73 ---SIDLVFENLDF-DLLHFMKTEPTV-TKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        73 ---~~~lv~e~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                         .+|+||||+.| ++.+.+...... ..+...++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~-vKl~DFGl  164 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGL  164 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc-EEEccCcc
Confidence               36899999985 555555544332 2344568899999999999999999999999999999999988 99999999


Q ss_pred             cccCCCCCcc------------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 038154          148 ARPIDVPLEN------------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       148 ~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  215 (293)
                      ++........            .....||+.|+|||++.+. .++.++|||||||++|+|++   ||....  +....+.
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~  238 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLT  238 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHH
Confidence            9876543221            1223599999999998876 68999999999999999996   775432  2222222


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ......                          ........++.+.+||.+||+.||.+|||+.++|+||||+++.+
T Consensus       239 ~~~~~~--------------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          239 DVRNLK--------------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHTTC--------------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHhcCC--------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            111100                          01112234667889999999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-57  Score=373.18  Aligned_cols=253  Identities=20%  Similarity=0.248  Sum_probs=199.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      +++.++||+|+||+||+|...   ..+|||+++.........+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        38 l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           38 VMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             CCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             eEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            568899999999999999643   359999987655444556789999999999999999999998765 5689999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC--ccee
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL--ENYT  159 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~--~~~~  159 (293)
                      +|+.+..+.......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++......  ....
T Consensus       114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~-~Ki~DFGla~~~~~~~~~~~~~  192 (307)
T 3omv_A          114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT-VKIGDFGLATVKSRWSGSQQVE  192 (307)
T ss_dssp             SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE-EEECCCSSCBC-----------
T ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc-EEEeeccCceecccCCcceeec
Confidence            955444433333446899999999999999999999999999999999999998887 9999999998654321  2233


Q ss_pred             ccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...||+.|||||++.+.  ..++.++|||||||++|+|+||..||.+.+.......+.......                
T Consensus       193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----------------  256 (307)
T 3omv_A          193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----------------  256 (307)
T ss_dssp             -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----------------
T ss_pred             ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----------------
Confidence            45699999999988643  358999999999999999999999999877666555554321111                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                              ......++.+++++.+|+.+||+.||++|||+.+|+++
T Consensus       257 --------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          257 --------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             --------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             --------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    11223345678999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.6e-58  Score=375.81  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=207.7

Q ss_pred             ceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      |.+.+.||+|+||+||+|...     .++..||||+++..  .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            788999999999999999754     35778999998642  23345678999999999999999999999999999999


Q ss_pred             EeecCC-cchHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEcc
Q 038154           77 VFENLD-FDLLHFMKTE-----------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIAD  144 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~d  144 (293)
                      ||||++ |++.+++...           ....+++..+..++.||+.||+|||+++++||||||+||+++.++. +||+|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-~Ki~D  171 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKIGD  171 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc-EEECC
Confidence            999998 5666666543           2456899999999999999999999999999999999999999888 99999


Q ss_pred             CCCcccCCCCCccee--ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 038154          145 FGLARPIDVPLENYT--IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       145 f~~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      ||.++..........  ...|++.|+|||++.+. .++.++||||||+++|||+| |..||.+.+..+....+.....  
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~--  248 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--  248 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC--
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999976543322211  22378999999988766 69999999999999999998 8999999888888777754211  


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                                 ...+..+|+++.+|+.+||+.||++|||+.+|+  +|++++
T Consensus       249 ---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          249 ---------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             ---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence                                       122345788999999999999999999999994  476654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-56  Score=366.15  Aligned_cols=286  Identities=41%  Similarity=0.726  Sum_probs=244.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|+||+|.+..+++.||+|++............+.+|++++++++||||+++++++.+++..++|||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            79999999999999999999999999999999976655555557888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+.... ..+++..++.++.|++.||++||++|++|+||||+||+++.++. +||+|||.+............
T Consensus        83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCSCCSCCCS
T ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceecCCccccccC
Confidence            9999988877643 35889999999999999999999999999999999999999888 999999999877655555555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||++.+...++.++||||||+++|+|++|..| |...+..+....+....+.+....++........... 
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-  239 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-  239 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC-
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc-
Confidence            56899999999988776689999999999999999988877 5667778888888888888877776665443332221 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .............+.+++++.+||.+||+.||++|||++++|+||||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            11122233445566789999999999999999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.8e-57  Score=371.64  Aligned_cols=257  Identities=20%  Similarity=0.288  Sum_probs=209.8

Q ss_pred             ceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +++.++||+|+||+||+|..     ..+++.||||+++.. ......+.+.+|+.++++++||||+++++++..++..++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            56789999999999999974     246678999998643 334455789999999999999999999999999999999


Q ss_pred             EeecCC-cchHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           77 VFENLD-FDLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      ||||++ |++.+++....              ...+++..+..++.||+.||+|||+++++||||||+||+++.++. +|
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-~K  185 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VK  185 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-EE
Confidence            999998 56666665432              235788899999999999999999999999999999999999888 99


Q ss_pred             EccCCCcccCCCCC--cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHh
Q 038154          142 IADFGLARPIDVPL--ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       142 l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      |+|||+++......  .......|++.|+|||++.+. .++.++||||||+++|||+| |..||.+.+..+....+....
T Consensus       186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~  264 (308)
T 4gt4_A          186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ  264 (308)
T ss_dssp             ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred             ECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999997653321  112234588999999988766 69999999999999999998 899999988888777764311


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                                                   ....+..+|+++.+|+.+||+.||++|||+.+|++  .+++|.++
T Consensus       265 -----------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~--~L~a~~nl  307 (308)
T 4gt4_A          265 -----------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS--RLRAWGNL  307 (308)
T ss_dssp             -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTSCC-
T ss_pred             -----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHhccCC
Confidence                                         11223457889999999999999999999999998  45666554

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-56  Score=398.51  Aligned_cols=259  Identities=24%  Similarity=0.412  Sum_probs=221.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|.++.+|+.||+|++....  ......+.+|+++|+.++||||+++++++.+++.+|+||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            6999999999999999999999999999999985432  22346788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC--CCeEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS--KDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~--~~~v~l~df~~~~~~~~~~~~  157 (293)
                      +.| ++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||+++.+  +. +||+|||+++..... ..
T Consensus       236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~-vKl~DFG~a~~~~~~-~~  312 (573)
T 3uto_A          236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPK-QS  312 (573)
T ss_dssp             CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC-EEECCCSSCEECCTT-SE
T ss_pred             cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCC-EEEeeccceeEccCC-Cc
Confidence            985 566666543 3468899999999999999999999999999999999999864  45 999999999887654 33


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......++               
T Consensus       313 ~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------  376 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------------  376 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------------
T ss_pred             eeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------------
Confidence            3445699999999998876 689999999999999999999999999988888888765322211               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                 ...+..+++++.+||.+||..||.+|||+.|+|+||||+..++
T Consensus       377 -----------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          377 -----------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             -----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             -----------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence                       1234467899999999999999999999999999999997653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5e-56  Score=370.12  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=198.9

Q ss_pred             ceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            2 YTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      |.+.++||+|+||+||+|...     .++..||||+++..  .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            567899999999999999753     36788999998532  23345679999999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEE
Q 038154           77 VFENLDF-DLLHFMKTEP-------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKI  142 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l  142 (293)
                      ||||+++ ++.+++....             ...+++..+..++.||+.||.|||+++++||||||+||+++.++. +||
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-~Ki  199 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-VKI  199 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-EEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-EEE
Confidence            9999984 5555554432             245889999999999999999999999999999999999998887 999


Q ss_pred             ccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 038154          143 ADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMG  219 (293)
Q Consensus       143 ~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~  219 (293)
                      +|||+++.......  ......|++.|+|||++.+. .++.++||||||+++|||+| |..||.+.+..+....+.....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999986543221  12234489999999988766 68999999999999999999 8999999888887777654111


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                                   ...+..+++++.+|+.+||+.||++|||+.||++
T Consensus       279 -----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          279 -----------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             -----------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             -----------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                         1123457899999999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-55  Score=360.37  Aligned_cols=285  Identities=44%  Similarity=0.741  Sum_probs=233.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|++|+||+|.+ .+|+.+|+|++............+.+|+++++.++||||+++++++...+..++|||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            799999999999999999988 5789999999866554445567888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++.+.+.... ..+++..++.++.|++.||++||++|++|+||||+||+++.++. +||+|||.+............
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-------
T ss_pred             cCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEeECccccccCcccccccc
Confidence            9998877776543 45888899999999999999999999999999999999998888 999999999876544344444


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+....++.......... ..
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-NF  238 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc-cc
Confidence            45899999999987766789999999999999999999999999988888888888877776666554433221110 01


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ..............+++++.++|.+||+.||++|||+.++++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            1111123344556789999999999999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-55  Score=369.07  Aligned_cols=288  Identities=40%  Similarity=0.675  Sum_probs=237.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|+||++.+..+++.||+|++..... ......+.+|+++++.++||||+++++++...+..++|||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            69999999999999999999999999999999864332 22233555799999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|++.+.+..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           82 LDKDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC-EEECSSSEEECC---------
T ss_pred             cccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC-EEEccCcccccccCCcccccc
Confidence            99998888876543 5788899999999999999999999999999999999999888 999999999876554444444


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+....++.............
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            55899999999988766789999999999999999999999999999999999999999888887776554333222222


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ............+.+++++.+||.+||+.||.+|||+.|+|+||||.++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            233334455667788999999999999999999999999999999998753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.3e-56  Score=394.71  Aligned_cols=255  Identities=21%  Similarity=0.329  Sum_probs=209.3

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHH---HHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIRE---VSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      |+++++||+|+||+||+|+++.+|+.||+|++...... ........+|   +++++.++||||+++++++.+.+.+|+|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            89999999999999999999999999999998643211 1222334444   5566667899999999999999999999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||+.| ++...+....  .+++..++.++.||+.||+|||++||+||||||+||+++.+|. +||+|||+++...... 
T Consensus       271 mEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~-vKL~DFGlA~~~~~~~-  346 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKK-  346 (689)
T ss_dssp             ECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSCC-
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC-EEecccceeeecCCCC-
Confidence            999985 6666665543  5889999999999999999999999999999999999999998 9999999998765432 


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---LLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                       ....+||+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+...   ....+..                 
T Consensus       347 -~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-----------------  408 (689)
T 3v5w_A          347 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------  408 (689)
T ss_dssp             -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-----------------
T ss_pred             -CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-----------------
Confidence             2344699999999998765578999999999999999999999997654332   2222221                 


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                   .....+..+|+++.+||.+||+.||.+|++     ++|+++||||+.++|
T Consensus       409 -------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          409 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             -------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             -------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                         011233457899999999999999999998     799999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.7e-55  Score=368.86  Aligned_cols=291  Identities=41%  Similarity=0.674  Sum_probs=233.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|+||++.+..+++.||+|++............+.+|++++++++||||+++++++...+..++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            69999999999999999999999999999999976655555567788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC----eEEEccCCCcccCCCCCc
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~----~v~l~df~~~~~~~~~~~  156 (293)
                      ++|++.+.+.....  +++..++.++.||+.||+|||++|++|+||||+||+++.++.    .+||+|||.+........
T Consensus       115 ~~~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~  192 (329)
T 3gbz_A          115 AENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR  192 (329)
T ss_dssp             CSEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred             CCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence            99998888876643  788899999999999999999999999999999999964332    499999999987655444


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....++.........
T Consensus       193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (329)
T 3gbz_A          193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK  272 (329)
T ss_dssp             -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhh
Confidence            44445579999999998876678999999999999999999999999999999999999888888777766655443332


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCCC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD  293 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~~  293 (293)
                      ..................+++++.+||.+||+.||.+|||+.++|+||||+...+.+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P  329 (329)
T 3gbz_A          273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP  329 (329)
T ss_dssp             TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred             hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence            222222222223334455789999999999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-54  Score=362.35  Aligned_cols=288  Identities=38%  Similarity=0.655  Sum_probs=225.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|.||+|.+..+|+.||+|++.... .......+.+|++++++++||||+++++++..++..++|||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            6999999999999999999999999999999986543 334457788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LDFDLLHFMKTE----PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++++.+.+...    ....+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+........
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCSSCEETTSCCC
T ss_pred             cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC-EEECcCccceecCCCcc
Confidence            999888877543    2245788899999999999999999999999999999999999888 99999999987765444


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+....++.........
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T 2pmi_A          164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN  243 (317)
T ss_dssp             CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred             cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence            44445589999999998776678999999999999999999999999999999999998888877766655443322111


Q ss_pred             CCCCCCCcc----cchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          237 GFEPNRSPI----KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       237 ~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .........    .........++.++.+||.+||+.||++|||+.++|+||||+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            000000000    001123346789999999999999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=352.89  Aligned_cols=284  Identities=37%  Similarity=0.619  Sum_probs=236.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcC---CCCcceeeeeeecCC--
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELK---HENIVRLLNVQSSVD--   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~--   72 (293)
                      ||++.+.||+|++|+||++.+..+++.||+|++......   ......+.+|+++++.+.   ||||+++++++....  
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            799999999999999999999999999999998654422   233456778888887775   999999999987755  


Q ss_pred             ---cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154           73 ---SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus        73 ---~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                         ..+++||++++++.+.+.......+++..++.++.|++.||+|||++|++|+||||+||+++.++. +||+|||.+.
T Consensus        90 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~  168 (308)
T 3g33_A           90 REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLAR  168 (308)
T ss_dssp             SEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC-EEECSCSCTT
T ss_pred             CceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-EEEeeCcccc
Confidence               479999999999999888777667899999999999999999999999999999999999998887 9999999998


Q ss_pred             cCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          150 PIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ....... .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.++...++..
T Consensus       169 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (308)
T 3g33_A          169 IYSYQMA-LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  246 (308)
T ss_dssp             TSTTCCC-SGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred             ccCCCcc-cCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence            7654322 2334489999999988766 6899999999999999999999999999999999999998888887777655


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .......-   ............+.+++++.+||.+||+.||.+|||+.++|+||||++-+
T Consensus       247 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          247 VSLPRGAF---PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CSSCGGGS---CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhcccccc---CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            44332211   11222334556678999999999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-54  Score=356.86  Aligned_cols=290  Identities=31%  Similarity=0.526  Sum_probs=224.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|++|+||++.+..+|+.+|+|++............+.+|++++++++||||+++++++...+..++|||+
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            79999999999999999999999999999999865444334456678899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        84 ~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           84 CDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECC--------
T ss_pred             CCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC-EEEeeCCCchhccCcccccCC
Confidence            9988877665543 35788999999999999999999999999999999999998887 999999999877654444444


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC-C
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF-E  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (293)
                      ..+++.|+|||++.+...++.++|+||||+++|+|++|..||.+....+....+....+................... .
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            558999999999887667899999999999999999999999998888777776665444322110000000000000 0


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                      .............+.+++++.+++.+||+.||.+|||++++++||||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            01111122333446789999999999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-53  Score=358.28  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=220.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...+..|+||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            69999999999999999999999999999999976554444556788999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ +++.+.+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||.+...... ....
T Consensus        96 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~-~~~~  171 (328)
T 3fe3_A           96 ASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVG-GKLD  171 (328)
T ss_dssp             CTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTCCGGGSSS-CGGG
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC-EEEeeccCceecCCC-Cccc
Confidence            97 56666665543  4788899999999999999999999999999999999999888 999999999766543 2334


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...|++.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+.....                    
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------  231 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--------------------  231 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------------
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence            445999999999998775556899999999999999999999999888887777654211                    


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                ..+..+++++.+++.+||..||.+|||+.++++||||+...
T Consensus       232 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          232 ----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             ----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                      11234688999999999999999999999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-52  Score=355.27  Aligned_cols=286  Identities=35%  Similarity=0.605  Sum_probs=236.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||++.+.||+|++|.||++.+..+|+.||+|++......   ......+.+|+++++.++||||+++++++...+..++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            699999999999999999999989999999998653322   22345788999999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++++++...+.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. +||+|||.+.........
T Consensus        91 ~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~  168 (346)
T 1ua2_A           91 FDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRA  168 (346)
T ss_dssp             EECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCCC
T ss_pred             EEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC-EEEEecccceeccCCccc
Confidence            9999998777766543 45778899999999999999999999999999999999999888 999999999877655444


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+....++......+...
T Consensus       169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T 1ua2_A          169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  248 (346)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc
Confidence            44556899999999987766689999999999999999999999999999999999998888887777776655443332


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      +..  ............++.++.+||.+||..||++|||+.++|+||||++..
T Consensus       249 ~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          249 FKS--FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCC--CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccc--cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            211  111223445677899999999999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.3e-53  Score=349.47  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=217.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|+||++.+..+|+.||+|++....  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            6999999999999999999999999999999986543  23346788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++| ++.+.+...   .+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+...........
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTCCBC
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC-EEEeeCCCceecCCcccccC
Confidence            975 444555443   4788899999999999999999999999999999999999888 99999999987765545455


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+........                 
T Consensus       175 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  236 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----------------  236 (297)
T ss_dssp             CCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------------
T ss_pred             CccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence            55699999999988776 689999999999999999999999988777666555543221110                 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                ..+..++..+.+++.+||+.||.+|||+.++++||||+..+.
T Consensus       237 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          237 ----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                      112346888999999999999999999999999999987654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-52  Score=355.64  Aligned_cols=288  Identities=33%  Similarity=0.567  Sum_probs=234.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--------CC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--------VD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~~   72 (293)
                      ||++++.||+|++|+||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++..        .+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            6999999999999999999999999999999987665555556788899999999999999999998876        34


Q ss_pred             cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           73 SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ..++|||++++++...+..... .+++..++.++.||+.||++||++|++|+||||+||+++.++. ++|+|||.+....
T Consensus        98 ~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           98 SIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFS  175 (351)
T ss_dssp             EEEEEEECCSEEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECC
T ss_pred             eEEEEEeccCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC-EEEccchhccccc
Confidence            6899999999988888766543 5889999999999999999999999999999999999998887 9999999997654


Q ss_pred             CC----CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VP----LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ..    ........+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....+......++.
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            22    12223344789999999988766789999999999999999999999999999999999988888887777665


Q ss_pred             CcCcccccCCCCCCCcccchhh--hcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLAT--VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ......................  .....++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            5433222111111111111100  0111367899999999999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.6e-54  Score=374.13  Aligned_cols=282  Identities=31%  Similarity=0.467  Sum_probs=221.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+      ..
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            699999999999999999999999999999998654333444567889999999999999999999986654      46


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||+++++...+..    .+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||.+......
T Consensus       143 ~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          143 YLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  217 (464)
T ss_dssp             EEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCCC-----C
T ss_pred             EEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC-EEEEEEEeeeecCCC
Confidence            99999999998887754    3788899999999999999999999999999999999999888 999999999876543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.+.............
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          218 -FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             -cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence             222334589999999998876 689999999999999999999999999999999999988888775544433221111


Q ss_pred             ccCCCCCCCcccchhhhcC------------CCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          235 EFGFEPNRSPIKDLATVVG------------GLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .+................+            ..++++.+||.+||..||.+|||++|+|+||||+.+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            1100000000001111111            125679999999999999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8e-54  Score=359.56  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=202.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCC-----CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC-CCcceeeeeeecC-Cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT-----GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-ENIVRLLNVQSSV-DS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-~~   73 (293)
                      +|++++.||+|+||+||+|.....     ++.||+|+++... .......+.+|++++.++.| |||+++++++... +.
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            588999999999999999986543     3579999885432 22334678899999999975 9999999998664 57


Q ss_pred             ceeEeecCC-cchHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC
Q 038154           74 IDLVFENLD-FDLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD  138 (293)
Q Consensus        74 ~~lv~e~~~-~~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~  138 (293)
                      +++||||++ |++.+++....              ...+++..+..++.||+.||+|||+++++||||||+||+++.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            899999998 56666665422              245788899999999999999999999999999999999998888


Q ss_pred             eEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 038154          139 IVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       139 ~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~  215 (293)
                       +||+|||+++........  .....+++.|||||++.+. .++.++|||||||++|||+| |..||.+.+..+......
T Consensus       224 -vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          224 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             -EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             -EEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             999999999876543322  2233478999999998766 68999999999999999998 899999876555444433


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                            ...+..+++++.+++.+||+.||++|||+.+|++|
T Consensus       302 ~~g~~----------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          302 KEGTR----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCC----------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            21111                            12234468899999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-52  Score=354.59  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=219.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC----CcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++++.||+|+||+||++.++.+|..||+|+++.......    ....+.+|+.+++.+.||||+++++++.+.+..++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            59999999999999999999999999999999976543322    34678899999999999999999999999999999


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~  152 (293)
                      |||++. |++.+.+...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.   .+||+|||.+....
T Consensus        93 v~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           93 ILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            999997 5566666543  35889999999999999999999999999999999999987762   49999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+......            
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------------  236 (361)
T 2yab_A          171 DGV-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD------------  236 (361)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC------------
T ss_pred             CCC-ccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence            432 22334599999999988765 6899999999999999999999999998888877777542111            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                    .....+..+++++.+||.+||..||.+|||+.++++||||+...
T Consensus       237 --------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          237 --------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             --------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                          11233456789999999999999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.4e-53  Score=354.51  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=218.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||.||++.++.+|+.||+|+++.... .......+.+|+++++.++||||+++++++...+..|+|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            58999999999999999999999999999999864321 23345678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++| ++...+...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+..........
T Consensus        86 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           86 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTCCB
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC-EEEeeccchhhcccCCCcc
Confidence            9986 555555443  25788899999999999999999999999999999999999998 9999999998654443444


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.....                   
T Consensus       163 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  222 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------  222 (337)
T ss_dssp             CCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             cccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            445589999999988766 689999999999999999999999998887777766653111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                 ..+..+++++.++|.+||+.||.+||     ++.++++||||+.+.|
T Consensus       223 -----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                       12235788999999999999999999     9999999999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-53  Score=358.26  Aligned_cols=284  Identities=36%  Similarity=0.530  Sum_probs=224.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++....      .+
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            699999999999999999999999999999998554333334467889999999999999999999987664      45


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+|||++++++.+.+..   ..+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||.+......
T Consensus       106 ~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~  181 (367)
T 1cm8_A          106 YLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSE  181 (367)
T ss_dssp             EEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCSS
T ss_pred             EEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC-EEEEeeecccccccc
Confidence            99999997777776655   25788899999999999999999999999999999999999888 999999999876533


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....++++|+|||++.+...++.++|+|||||++++|++|..||.+.+..+....+....+.++............
T Consensus       182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence               22334899999999988766799999999999999999999999999999889999988888776544332221100


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                       .+................+..++++.+|+.+||..||++|||+.++|+||||+.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence             000000111123344556678999999999999999999999999999999998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.6e-53  Score=368.45  Aligned_cols=288  Identities=35%  Similarity=0.566  Sum_probs=214.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-----CCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-----VDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (293)
                      ||++++.||+|+||+||+|.+..+++.||+|++............+.+|+++++.++||||+++++++..     ....|
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            6999999999999999999999999999999986443333345678899999999999999999999843     35689


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +|||++++++...+....  .+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+|||.++......
T Consensus       134 lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          134 VVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPE  210 (458)
T ss_dssp             EEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCTTSCT
T ss_pred             EEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC-EeecccccchhccCcc
Confidence            999999999888886543  5888999999999999999999999999999999999999988 9999999998764321


Q ss_pred             c---------------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 038154          156 E---------------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-----------  197 (293)
Q Consensus       156 ~---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-----------  197 (293)
                      .                           ......+|++|+|||++.....++.++|||||||++|+|++           
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~  290 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD  290 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence            1                           11223478999999987666679999999999999999999           


Q ss_pred             CCCCCCCCC--------------------chHHHHHHHHHhCCCCCCCCCCCcCccc-ccCCCCCCCcccchhhhcCCCC
Q 038154          198 HQRLFHSRW--------------------APGLLAAIFSIMGTPDSETLPGFTSFSE-EFGFEPNRSPIKDLATVVGGLE  256 (293)
Q Consensus       198 g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  256 (293)
                      |..||.+..                    ..+.+..+....+.+............. .+................+..+
T Consensus       291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  370 (458)
T 3rp9_A          291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS  370 (458)
T ss_dssp             CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred             ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence            666775543                    1455666666666665443332221100 0000011112233445566789


Q ss_pred             chHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          257 PDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       257 ~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      +++.+||.+||..||.+|||++|+|+||||+.+.+
T Consensus       371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            99999999999999999999999999999998854

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.8e-53  Score=361.26  Aligned_cols=287  Identities=30%  Similarity=0.518  Sum_probs=218.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCC--cceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVD--SIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~lv   77 (293)
                      ||++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++...+  ..|+|
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            799999999999999999999999999999998644334444567788999999997 999999999986544  68999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC---
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP---  154 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~---  154 (293)
                      ||++++++...+...   .+++..+..++.||+.||+|||+.|++||||||+||+++.++. +||+|||.++.....   
T Consensus        90 ~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           90 FDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEESSSCCCC
T ss_pred             ecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC-EEecCCcccccccccccc
Confidence            999999888877653   5788899999999999999999999999999999999999888 999999999765321   


Q ss_pred             ------------------CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 038154          155 ------------------LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS  216 (293)
Q Consensus       155 ------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  216 (293)
                                        ........++++|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                              11122235899999999998766799999999999999999999999999999999998888


Q ss_pred             HhCCCCCCCCCCCcCcccc-----c----C--CCCCCCcccc------hhhhcCCCCchHHHHHHHhhccCCCCCCCHHH
Q 038154          217 IMGTPDSETLPGFTSFSEE-----F----G--FEPNRSPIKD------LATVVGGLEPDGVDLLRRMLCLDPSKRLTARE  279 (293)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~-----~----~--~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  279 (293)
                      ..+.+..........-...     .    .  ..........      .......+++++.+|+.+||..||.+|||+++
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            7776654433221110000     0    0  0000000000      00112367899999999999999999999999


Q ss_pred             HhcCcccccCcC
Q 038154          280 ALRHEYFKDFQS  291 (293)
Q Consensus       280 ll~~p~~~~~~~  291 (293)
                      +|+||||+.+.+
T Consensus       326 ~l~Hp~~~~~~~  337 (388)
T 3oz6_A          326 ALKHPFVSIFHN  337 (388)
T ss_dssp             HTTSTTTTTTCC
T ss_pred             HhCCHHHHHhcC
Confidence            999999987753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-52  Score=362.60  Aligned_cols=258  Identities=29%  Similarity=0.421  Sum_probs=219.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||++.+..+|+.+|+|++............+.+|+++++.++||||+++++++.+.+..|+|||+
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            58999999999999999999999999999999865544334456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccCCCCCc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +.| ++.+.+....  .+++..+..++.||+.||.|||++|++|+||||+||+++.   ++. +||+|||.+........
T Consensus        92 ~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~-vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           92 VTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCC-EEECCCSSCBCCCTTCC
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCc-EEEccCceeEEecCCCc
Confidence            985 6667776653  4889999999999999999999999999999999999985   344 99999999987765544


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.......+..            
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------  235 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP------------  235 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT------------
T ss_pred             eeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc------------
Confidence            44455699999999988765 68999999999999999999999999988888887776533322211            


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                    .++.+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus       236 --------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          236 --------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             --------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             --------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence                          12357889999999999999999999999999999964

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.3e-53  Score=357.74  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=215.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||+||++.++.+|+.||+|+++.... .......+.+|.++++.+ +||||+++++++.+.+..|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            59999999999999999999999999999999864321 223446678899999988 6999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+.| ++...+...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+.........
T Consensus       104 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~-ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          104 EFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCC----
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC-EEEccccceeecccCCcc
Confidence            99985 555555543  34889999999999999999999999999999999999999998 999999999865444344


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....                  
T Consensus       181 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------  241 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------------------  241 (353)
T ss_dssp             -----CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             ccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            4455699999999988766 589999999999999999999999999988888888764211                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH------HHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA------REALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~p~~~~~~~  291 (293)
                                  ..+..+++++.++|.+||+.||++||++      .++++||||+.+.|
T Consensus       242 ------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          242 ------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                        1123468899999999999999999999      99999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-52  Score=343.48  Aligned_cols=257  Identities=28%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC------------------------CCCcccHHHHHHHHHhc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS------------------------EGVPSSVIREVSLLKEL   56 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l   56 (293)
                      +|++.+.||+|++|.||+|.+..+++.||+|++......                        ....+.+.+|+++++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            699999999999999999999999999999998654321                        11246788999999999


Q ss_pred             CCCCcceeeeeeec--CCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe
Q 038154           57 KHENIVRLLNVQSS--VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID  134 (293)
Q Consensus        57 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~  134 (293)
                      +||||+++++++.+  .+..++|||+++++.+..+...  ..+++..++.++.||+.||+|||++|++|+||+|+||+++
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  171 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG  171 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence            99999999999876  5678999999986655544333  3588999999999999999999999999999999999999


Q ss_pred             CCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 038154          135 RSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLA  212 (293)
Q Consensus       135 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~  212 (293)
                      .++. +||+|||.+..............+++.|+|||++.+...  .+.++||||||+++|+|++|..||..........
T Consensus       172 ~~~~-~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             TTSC-EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCC-EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            8888 999999999877654444445568999999998876532  3678999999999999999999998877666555


Q ss_pred             HHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          213 AIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      .+.......                            ...+.+++++.++|.+||+.||++|||+.++++||||++
T Consensus       251 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          251 KIKSQALEF----------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHCCCCC----------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHhcccCCC----------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            554311110                            012347889999999999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-52  Score=353.60  Aligned_cols=287  Identities=34%  Similarity=0.530  Sum_probs=223.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..+|+.||+|++............+.+|+++++.++||||+++++++...+..++|||+
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            69999999999999999999999999999999865443333445677899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++++..+..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus       106 ~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  183 (331)
T 4aaa_A          106 VDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDD  183 (331)
T ss_dssp             CSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCTTC------------
T ss_pred             CCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc-EEEEeCCCceeecCCccccCC
Confidence            99888877654433 5888999999999999999999999999999999999998887 999999999876554444445


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC-C
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF-E  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (293)
                      ..+++.|+|||++.+...++.++||||||+++|+|++|..||......+....+....+................... .
T Consensus       184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (331)
T 4aaa_A          184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL  263 (331)
T ss_dssp             CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred             CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence            558999999999887667899999999999999999999999998888777777665544322110000000000000 0


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .............+.+++++.+|+.+||+.||.+|||+.++|+||||+.-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            01111122334556789999999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.7e-52  Score=361.73  Aligned_cols=288  Identities=32%  Similarity=0.492  Sum_probs=223.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC-----Ccce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV-----DSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (293)
                      ||++++.||+|++|.||+|.+..+++.||+|++............+.+|+++++.++||||+++++++...     ...|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            69999999999999999999999999999999865433334456788999999999999999999998766     5689


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +|||++++++.+.+...  ..+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+|||.++......
T Consensus       107 lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          107 IVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEEC----
T ss_pred             EEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC-EEEccCCCcccccccc
Confidence            99999999888887654  34889999999999999999999999999999999999999888 9999999998764432


Q ss_pred             c----------------------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-----------
Q 038154          156 E----------------------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-----------  202 (293)
Q Consensus       156 ~----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-----------  202 (293)
                      .                      ......++++|+|||++.....++.++|||||||++|+|++|..||           
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f  263 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF  263 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence            1                      1233458999999998766667999999999999999999854444           


Q ss_pred             CCCC-----------------chHHHHHHHHHhCCCCCCCCCCCcCcccc-cCCCCCCCcccchhhhcCCCCchHHHHHH
Q 038154          203 HSRW-----------------APGLLAAIFSIMGTPDSETLPGFTSFSEE-FGFEPNRSPIKDLATVVGGLEPDGVDLLR  264 (293)
Q Consensus       203 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~  264 (293)
                      .+.+                 ..+.+..+....+.+.............. .................+.+++++.+||.
T Consensus       264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  343 (432)
T 3n9x_A          264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE  343 (432)
T ss_dssp             CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            3322                 24556667777776655433322110000 00001111223334455678999999999


Q ss_pred             HhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          265 RMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       265 ~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      +||..||.+|||++++|+||||+.+.+
T Consensus       344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          344 SMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHhcCCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999998864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-51  Score=342.91  Aligned_cols=286  Identities=37%  Similarity=0.626  Sum_probs=236.7

Q ss_pred             CceeeeeeccccceeEEEEEeC-CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeeeee-----cC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNVQS-----SV   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~~   71 (293)
                      +|++.+.||+|++|.||++.+. .+|+.||+|++............+.+|+.+++.+   .||||+++++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            6999999999999999999985 6788999999976555555556788888888877   7999999999986     55


Q ss_pred             CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           72 DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ...++|||+++|++.+.+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus        92 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~  170 (326)
T 1blx_A           92 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIY  170 (326)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCCCC
T ss_pred             ceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC-EEEecCcccccc
Confidence            6789999999999888888776667899999999999999999999999999999999999998887 999999999765


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.+....++....
T Consensus       171 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          171 SFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CGG-GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cCC-CCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            432 222334488999999988766 689999999999999999999999999988888888888777766655554332


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                      ......   ............+.++.++.+|+.+||+.||.+|||+.++++||||++++.+
T Consensus       249 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          249 LPRQAF---HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             SCGGGS---CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cchhhh---cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            222111   1111223445567789999999999999999999999999999999988653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-52  Score=352.29  Aligned_cols=254  Identities=30%  Similarity=0.483  Sum_probs=213.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            69999999999999999999999999999999854321 22344678899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++|++++.+....  .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+...... ....
T Consensus        90 ~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~DFG~s~~~~~~-~~~~  165 (336)
T 3h4j_B           90 YAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDG-NFLK  165 (336)
T ss_dssp             CCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC-EEECCSSCTBTTTTS-BTTC
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC-EEEEEeccceeccCC-cccc
Confidence            99999999887654  4788899999999999999999999999999999999998888 999999999866543 2233


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...|++.|+|||++.+....+.++||||||+++|+|++|..||.+.........+                         
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------------------  220 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------------------  220 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------------------------
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------------
Confidence            4458999999999887755578999999999999999999999764332211000                         


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                           .......+..+++++.++|.+||..||.+|||+.++++||||+.
T Consensus       221 -----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          221 -----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                 01111234457899999999999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.8e-52  Score=355.11  Aligned_cols=282  Identities=35%  Similarity=0.540  Sum_probs=228.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI------   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------   74 (293)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            69999999999999999999999999999999865444444456788999999999999999999999877654      


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++|||++++++...+..    .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus       123 ~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          123 YLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAE  197 (371)
T ss_dssp             EEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECSTTCC------
T ss_pred             EEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC-EEEEecCcccccccC
Confidence            99999999988776632    3889999999999999999999999999999999999999888 999999999865432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+.............
T Consensus       198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence               23345899999999988756789999999999999999999999999999999988888777765544333221100


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                       .+................+.+++++.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence             00000111122334455677899999999999999999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-52  Score=349.81  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=216.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||++.+..++..+|+|.+...   ......+.+|+++++.++||||+++++++.+.+..++|||+
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            699999999999999999999999999999988532   22345678899999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC--CCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR--SKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~--~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ++| ++.+.+.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.  ++. ++|+|||.+...... ..
T Consensus        83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~-~kl~Dfg~a~~~~~~-~~  159 (321)
T 1tki_A           83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC-EEECCCTTCEECCTT-CE
T ss_pred             CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCC-EEEEECCCCeECCCC-Cc
Confidence            986 55555543 3446889999999999999999999999999999999999987  455 999999999877543 23


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.......                
T Consensus       160 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------  222 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF----------------  222 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----------------
T ss_pred             cccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC----------------
Confidence            3344589999999988765 57899999999999999999999999988888777775422211                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                ....++.++.++.++|.+||..||.+|||+.++|+||||++-
T Consensus       223 ----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          223 ----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ----------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                      112345678999999999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-52  Score=356.59  Aligned_cols=283  Identities=37%  Similarity=0.544  Sum_probs=215.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||++++.||+|++|.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...      ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            79999999999999999999999999999999865433333456778999999999999999999998654      568


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+++|++++++...+..   ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+......
T Consensus       110 ~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kL~DFG~a~~~~~~  185 (367)
T 2fst_X          110 YLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTADE  185 (367)
T ss_dssp             EEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECC----------
T ss_pred             EEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC-EEEeecccccccccc
Confidence            99999998777766654   35888999999999999999999999999999999999999888 999999999765432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+.+..+....+.+.............
T Consensus       186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence               22334899999999988766789999999999999999999999999999899999988888776554443322100


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                       .+................+..++++.+||.+||..||++|||+.++|+||||+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence             00000111122334455667899999999999999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.8e-52  Score=354.00  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=211.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|+++++||+|+||+||++.++.+++.||+|+++.... .......+..|..+++++ +||||+++++++.+.+..|+||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            48999999999999999999999999999999965433 234456788999999887 8999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++| ++...+...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++........
T Consensus       133 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTCC
T ss_pred             EcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC-EEEeecceeeecccCCCc
Confidence            99986 555555443  35889999999999999999999999999999999999999998 999999999864444344


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHHHhCCCCCCCCCC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---------PGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.....         ......+..            
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~------------  276 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------------  276 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH------------
T ss_pred             cccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc------------
Confidence            4555699999999988776 689999999999999999999999964321         112222221            


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH------HHHhcCcccccCcC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA------REALRHEYFKDFQS  291 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~p~~~~~~~  291 (293)
                                        .....+..+++++.+||.+||+.||.+||++      .++++||||+.+.|
T Consensus       277 ------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 ------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             ------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             ------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                              0112334578999999999999999999985      89999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.6e-52  Score=351.69  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=218.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+..|.+++..+ +||||+++++++.+.+..|+||
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            58999999999999999999999999999999865321 123446678899999887 8999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++| ++...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+.........
T Consensus        98 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTCC
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC-EEEeEChhhhhcccCCCc
Confidence            99975 5556655433  4788899999999999999999999999999999999999998 999999999865443334


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....                  
T Consensus       175 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------  235 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------------  235 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             ccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            4455699999999988776 689999999999999999999999998888877777653111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH-HHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR-EALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~p~~~~~~~  291 (293)
                                  ..+..+++++.++|.+||..||++||++. ++++||||+.+.|
T Consensus       236 ------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          236 ------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                        11234688999999999999999999998 9999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.5e-52  Score=354.19  Aligned_cols=282  Identities=27%  Similarity=0.461  Sum_probs=221.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----------   70 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (293)
                      ||++++.||+|+||+||+|.+..+|+.||+|++....      ....+|+++++.++||||+++++++..          
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            6999999999999999999999999999999885332      223379999999999999999998733          


Q ss_pred             ----------------------------CCcceeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038154           71 ----------------------------VDSIDLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQE  120 (293)
Q Consensus        71 ----------------------------~~~~~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~  120 (293)
                                                  ....++||||+++++.+.+..  .....+++..++.++.||+.||.|||+.|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                        334889999999986666543  23346888999999999999999999999


Q ss_pred             ceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 038154          121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR  200 (293)
Q Consensus       121 ~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~  200 (293)
                      ++|+||||+||+++.....+||+|||.+....... ......+++.|+|||++.+...++.++||||||+++|+|++|..
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            99999999999998544449999999998664432 22334478999999998877678999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHH
Q 038154          201 LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA  280 (293)
Q Consensus       201 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  280 (293)
                      ||.+.+..+....+....+.+................+.. .....-....+...++++.+||.+||..||.+|||+.|+
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT-LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA  319 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCc-cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            9999999888888887777664432221111111111100 011112223455688999999999999999999999999


Q ss_pred             hcCcccccCc
Q 038154          281 LRHEYFKDFQ  290 (293)
Q Consensus       281 l~~p~~~~~~  290 (293)
                      |+||||+.+.
T Consensus       320 l~hp~f~~~~  329 (383)
T 3eb0_A          320 MAHPFFDHLR  329 (383)
T ss_dssp             HTSGGGHHHH
T ss_pred             hcCHHHHHHH
Confidence            9999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-51  Score=343.19  Aligned_cols=259  Identities=27%  Similarity=0.383  Sum_probs=217.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC----CcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|+||.||++.+..+|..+|+|++........    ....+.+|+++++.++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            58999999999999999999999999999999865443322    34678899999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~  152 (293)
                      |||+++| ++.+.+...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   .+||+|||.+....
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            9999975 555555443  35889999999999999999999999999999999999987762   39999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.......           
T Consensus       170 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------  236 (326)
T 2y0a_A          170 FGN-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-----------  236 (326)
T ss_dssp             TTS-CCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC-----------
T ss_pred             CCC-ccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc-----------
Confidence            432 22334589999999988655 68999999999999999999999999888777776665421111           


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                     .......++..+.++|.+||..||.+|||+.++|+||||+..
T Consensus       237 ---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          237 ---------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ---------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                           122345678899999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-52  Score=345.18  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=216.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|+++.... .......+.+|..+++.++||||+++++++.+.+..|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            58999999999999999999999999999999864321 22344677889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.| ++.+.+....  .+++..++.++.||+.||++||++|++|+||+|+||+++.++. +||+|||.+......   .
T Consensus        87 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~Dfg~a~~~~~~---~  160 (318)
T 1fot_A           87 YIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDV---T  160 (318)
T ss_dssp             CCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSSC---B
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC-EEEeecCcceecCCc---c
Confidence            9985 5666665543  4788899999999999999999999999999999999999888 999999999876432   2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.....                   
T Consensus       161 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------  220 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-------------------  220 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            334589999999988766 689999999999999999999999998887777777654111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                 ..++.+++++.++|.+||..||++||     +++++++||||+.+.|
T Consensus       221 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          221 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                       12234688999999999999999999     9999999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-51  Score=349.57  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=217.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||++.+..+|..+|+|++............+.+|+++++.++||||+++++++.+.+..|+|||+
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~  109 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL  109 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            48999999999999999999999999999999875544444456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +.| ++.+.+....  .+++..++.++.||+.||.|||++|++|+||||+||+++.++.  .+||+|||.+...... ..
T Consensus       110 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~  186 (362)
T 2bdw_A          110 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA  186 (362)
T ss_dssp             CCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CS
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cc
Confidence            985 6666665543  5788999999999999999999999999999999999986532  4999999999876543 22


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+.......+.              
T Consensus       187 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------------  251 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------------  251 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--------------
T ss_pred             cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--------------
Confidence            2334589999999988765 6899999999999999999999999988877777776543222111              


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                  ..+..+++++.+||.+||..||.+|||+.++|+||||..
T Consensus       252 ------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          252 ------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             ------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                        112346889999999999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-51  Score=351.10  Aligned_cols=284  Identities=32%  Similarity=0.564  Sum_probs=230.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC-----Ccce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV-----DSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (293)
                      ||++++.||+|++|.||++.+..++..||+|++... ........+.+|++++++++||||+++++++...     ...+
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            799999999999999999999999999999998532 2223336788999999999999999999998655     3689


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +|||++++++.+.+...   .+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus       107 iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGGG
T ss_pred             EEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC-EEEEeCcceEecCCCC
Confidence            99999999888877653   4788899999999999999999999999999999999998888 9999999998665332


Q ss_pred             cc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 EN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..   .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+...........
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            21   123358999999998877667899999999999999999999999999999999998887777655433322211


Q ss_pred             ccc-cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEE-FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ... +................+.+++++.+||.+||+.||.+|||+.++|+||||+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            110 000011112233445567789999999999999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-51  Score=354.13  Aligned_cols=290  Identities=20%  Similarity=0.197  Sum_probs=214.6

Q ss_pred             Cceeeeeeccc--cceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREG--RYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      ||++++.||+|  ++|+||++.+..+|+.||+|++............+.+|+++++.++||||+++++++...+..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            69999999999  9999999999999999999999765554555567888999999999999999999999999999999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC--
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL--  155 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~--  155 (293)
                      |+++ |++.+.+.......+++..++.++.||+.||+|||++|++|+||||+||+++.++. ++|+|||.+.......  
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~-~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCGGGCEECEETTEE
T ss_pred             EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccccceeecccccc
Confidence            9998 45666666655566899999999999999999999999999999999999998887 9999999875432111  


Q ss_pred             -----cceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC-------
Q 038154          156 -----ENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPD-------  222 (293)
Q Consensus       156 -----~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  222 (293)
                           .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+.........+........       
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP  264 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred             ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence                 111222478889999998763 4689999999999999999999999988766655544332111100       


Q ss_pred             -CCCCCCC------cCcccccCCC--CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          223 -SETLPGF------TSFSEEFGFE--PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       223 -~~~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                       .......      ..........  ...............+++++.+||.+||+.||++|||+.++|+||||+.+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence             0000000      0000000000  0000001122345668899999999999999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.7e-52  Score=355.20  Aligned_cols=283  Identities=30%  Similarity=0.439  Sum_probs=211.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      +|++++.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            699999999999999999999999999999998654433344467888999999999999999999987665      67


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+|||++++++.+.+..    .+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||.+......
T Consensus       106 ~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          106 YIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCCCC-------
T ss_pred             EEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEEEeecccccccc
Confidence            99999999998887753    4788899999999999999999999999999999999998888 999999999866433


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.+.............
T Consensus       181 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          181 F-MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             ----------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             c-ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            2 22334488999999988776 689999999999999999999999999888888777776555443322221110000


Q ss_pred             ccCCCCCCCcccchh------------hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 EFGFEPNRSPIKDLA------------TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .+.............            ......+.++.+||.+||..||++|||++++|+||||+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            000000000000000            01111256889999999999999999999999999998763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-51  Score=348.96  Aligned_cols=257  Identities=23%  Similarity=0.301  Sum_probs=218.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++.+.||+|+||.||++.+..+|+.||+|+++.... .......+..|.+++..+ .||+|+++++++.+.+..|+||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999865321 233456778899999887 7999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++| ++...+....  .+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.+.........
T Consensus       101 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTCC
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc-EEEEeCCcccccccCCcc
Confidence            99985 5656655433  4788999999999999999999999999999999999999998 999999999865443344


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....                  
T Consensus       178 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------  238 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------  238 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            4455699999999988766 689999999999999999999999999888888777764111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                  ..+..+++++.+||.+||..||.+||     ++.++++||||+.+.|
T Consensus       239 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          239 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence                        12235788999999999999999999     4799999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-51  Score=347.79  Aligned_cols=286  Identities=30%  Similarity=0.499  Sum_probs=223.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC---------cccHHHHHHHHHhcCCCCcceeeeeeec-
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV---------PSSVIREVSLLKELKHENIVRLLNVQSS-   70 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   70 (293)
                      +|++.+.||+|++|.||++.+.. |..||+|++.........         ...+.+|++++++++||||+++++++.. 
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            69999999999999999998764 899999998654443322         1568899999999999999999998843 


Q ss_pred             ----CCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           71 ----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        71 ----~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                          ....++|||+++|++.+.+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus       102 ~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg  179 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFN  179 (362)
T ss_dssp             CTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCTT
T ss_pred             cCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC-EEEEecC
Confidence                34689999999999988887543 46889999999999999999999999999999999999998888 9999999


Q ss_pred             CcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          147 LARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      .+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+.....
T Consensus       180 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          180 LAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             C----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99755433 22233448899999999887567899999999999999999999999999988888888887776654322


Q ss_pred             CCCcC--cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          227 PGFTS--FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       227 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .....  .....................+..++.+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            21111  00001111111222344556677899999999999999999999999999999999873

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-51  Score=346.36  Aligned_cols=257  Identities=24%  Similarity=0.330  Sum_probs=211.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||.||++.++.+++.||+|++....... .....+.+|..+++++ +||||+++++++.+.+..|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            5899999999999999999999999999999996543322 2345677899999988 8999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++| ++...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+.........
T Consensus        90 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCGGGCBCSCCTTCC
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEEeccccccccCCCCc
Confidence            99985 5555555432  5788999999999999999999999999999999999999988 999999999865443344


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------chHHHHHHHHHhCCCCCCCCCC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW---------APGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||....         .......+...           
T Consensus       167 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-----------  234 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-----------  234 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-----------
T ss_pred             ccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-----------
Confidence            4455699999999988766 68999999999999999999999996521         12222222210           


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH------HHHhcCcccccCcC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA------REALRHEYFKDFQS  291 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~p~~~~~~~  291 (293)
                                         ....+..++.++.++|.+||+.||.+||++      .++++||||+.+.|
T Consensus       235 -------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 -------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                               011234578899999999999999999995      89999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.5e-51  Score=353.59  Aligned_cols=282  Identities=29%  Similarity=0.470  Sum_probs=220.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      +|++.+.||+|+||+||++.+..+|+.||||++....      ....+|+++++.++||||+++++++...      ...
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            5899999999999999999999999999999885322      2234799999999999999999987432      246


Q ss_pred             eeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ++||||+++++...+..  .....+++..++.++.||+.||.|||++|++|+||||+||+++.++..+||+|||.++...
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            79999999887765542  2334688889999999999999999999999999999999999776668999999998664


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .... .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+......
T Consensus       209 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          209 RGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             TTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             cCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            3322 223348999999999877667899999999999999999999999998888888888776665543322111110


Q ss_pred             ccccCCCCCCCcccch-hhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDL-ATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ...+.+..  .....+ ....+..++++.+||.+||..||.+|||+.++++||||+.+..
T Consensus       288 ~~~~~~p~--~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          288 YTEFKFPQ--IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CCCCCCCC--CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhhccCc--cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            01111100  011111 1234567899999999999999999999999999999987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4e-51  Score=343.07  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=205.6

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|+||.||++.+.   .+|+.+|+|+++....  .......+.+|+++++.++||||+++++++...+..|
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            5899999999999999999874   6889999999865432  2233456788999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +||||+.| ++.+.+....  .+++..++.++.||+.||.|||++|++|+||+|+||+++.++. +||+|||.+......
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC-EEECCCSCC------
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc-EEEEeCCcccccccC
Confidence            99999984 5555555432  4788899999999999999999999999999999999998888 999999998765433


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ........|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.....               
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------------  238 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL---------------  238 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------------
T ss_pred             CccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence            3333444589999999988765 689999999999999999999999998888777777654211               


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                     ..++.+++++.++|.+||..||.+||     ++.++++||||+.+.|
T Consensus       239 ---------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          239 ---------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                           12234688999999999999999999     8999999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=347.24  Aligned_cols=282  Identities=35%  Similarity=0.537  Sum_probs=224.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc------c
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS------I   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~   74 (293)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+.      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            6999999999999999999999999999999986544333344678889999999999999999999877654      4


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++|||++++++.+.+..    .+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus       105 ~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          105 YLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAE  179 (353)
T ss_dssp             EEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC-EEECSTTCTTC----
T ss_pred             EEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc-EEEeecccccCCCCC
Confidence            99999999877766532    4889999999999999999999999999999999999998888 999999999765432


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.+.............
T Consensus       180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence               22334889999999988756789999999999999999999999999988888888877766655433322211100


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                       .+................+.+++++.++|.+||+.||++|||+.++++||||+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence             00000011111223345567899999999999999999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-51  Score=353.22  Aligned_cols=261  Identities=22%  Similarity=0.300  Sum_probs=217.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||+||++.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5899999999999999999999999999999985422 122334678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-c
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-N  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~  157 (293)
                      |++| ++.+.+...   .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+........ .
T Consensus       150 ~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          150 YMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSEEE
T ss_pred             CCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC-EEEeccceeEeeccCCccc
Confidence            9975 555555432   4788899999999999999999999999999999999999998 99999999987654322 2


Q ss_pred             eeccCccccccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 YTIKGGSLCYKAPERLLGSG---RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      .....|++.|+|||++.+..   .++.++|+||||+++|+|++|..||.+.+..+...++.........           
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  294 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-----------  294 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-----------
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC-----------
Confidence            23455999999999887653   2678999999999999999999999998888888887642211100           


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~~  291 (293)
                                     .....+++++.+||.+||..+|.+  ||+++++++||||+.+.|
T Consensus       295 ---------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          295 ---------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             ---------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             ---------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence                           011247899999999999999988  999999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.9e-51  Score=341.36  Aligned_cols=257  Identities=25%  Similarity=0.424  Sum_probs=207.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|+||++.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            69999999999999999999999999999999854332 23346788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                      ++| ++.+.+...  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. +||+|||.+........  .
T Consensus        87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEECC
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC-EEEEEeeccceeccCCcccc
Confidence            986 555555433  34888999999999999999999999999999999999998888 99999999976532211  1


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-LAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      .....|++.|+|||++.+....+.++||||||+++|+|++|..||........ ...+.. ...                
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~----------------  226 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKT----------------  226 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-TCT----------------
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-ccc----------------
Confidence            22345899999999988775567899999999999999999999987654322 222211 000                


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 .......++.++.+||.+||..||.+|||+.|+++||||++.
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                       001123468899999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=347.79  Aligned_cols=258  Identities=23%  Similarity=0.385  Sum_probs=212.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            5899999999999999999999999999999985432 223445678899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|+.+..+.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||.+...... ....
T Consensus        96 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~-~~~~  172 (384)
T 4fr4_A           96 LLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRE-TQIT  172 (384)
T ss_dssp             CCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTT-CCBC
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC-EEEeccceeeeccCC-Ccee
Confidence            99865554443332 35889999999999999999999999999999999999999998 999999999876543 2334


Q ss_pred             ccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          160 IKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---LLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ...|++.|+|||++.+.  ..++.++|+||||+++|+|++|..||.......   ....+..                  
T Consensus       173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------------  234 (384)
T 4fr4_A          173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------------------  234 (384)
T ss_dssp             CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------------------
T ss_pred             ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------------------
Confidence            45599999999988642  357899999999999999999999997543332   2222211                  


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-HHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-AREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~p~~~~~~~  291 (293)
                                  .....+..+++++.+||.+||+.||.+||+ +.++++||||+.+.|
T Consensus       235 ------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          235 ------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                        111223457889999999999999999998 999999999998865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-51  Score=355.70  Aligned_cols=282  Identities=27%  Similarity=0.417  Sum_probs=226.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc------CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL------KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~   74 (293)
                      ||++++.||+|+||+||+|.+..+++.||+|++...   ......+.+|+++++.+      +|+||+++++++...+..
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            799999999999999999999999999999998532   22235677788888887      467999999999999999


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-eEEEccCCCcccCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-IVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~~~  153 (293)
                      ++|||++++++.+.+.......+++..++.++.||+.||+|||+.|++|+||||+||+++.++. .+||+|||.+.....
T Consensus       175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            9999999999999988877667899999999999999999999999999999999999998765 389999999976543


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+....+.++...........
T Consensus       255 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  330 (429)
T 3kvw_A          255 R---VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK  330 (429)
T ss_dssp             C---CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred             c---ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence            3   2233589999999998876 68999999999999999999999999999999999888877766544322221111


Q ss_pred             cccCCC-----------------------------CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          234 EEFGFE-----------------------------PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       234 ~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                      ..+...                             ...........+....++++.+||.+||+.||++|||+.|+|+||
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp  410 (429)
T 3kvw_A          331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP  410 (429)
T ss_dssp             HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence            111000                             000000111123334578899999999999999999999999999


Q ss_pred             ccccC
Q 038154          285 YFKDF  289 (293)
Q Consensus       285 ~~~~~  289 (293)
                      ||++.
T Consensus       411 w~~~~  415 (429)
T 3kvw_A          411 WLRRR  415 (429)
T ss_dssp             TTC--
T ss_pred             hhccC
Confidence            99875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-51  Score=356.19  Aligned_cols=265  Identities=21%  Similarity=0.306  Sum_probs=219.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|+++++||+|+||+||++.++.+++.||+|++.... ........+.+|..++..++||||+++++++.+.+..|+|||
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E  154 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD  154 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence            5899999999999999999999999999999986422 122334568899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |+.| ++.+.+.. ....+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+|||.+......... 
T Consensus       155 y~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          155 YYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             CCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSCEE
T ss_pred             cCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC-EEEcchhhhhhcccCCCcc
Confidence            9975 55555544 3446899999999999999999999999999999999999999998 999999999766543222 


Q ss_pred             eeccCccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTIKGGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .....|++.|+|||++.    +...++.++|+||||+++|+|++|..||.+.+..+...++........           
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  301 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-----------  301 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-----------
Confidence            23345999999999886    244689999999999999999999999999888888887764221110           


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCC--CCCHHHHhcCcccccCcCC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSK--RLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~p~~~~~~~~  292 (293)
                                    .......+++++.+||++||+.+|.+  ||+++++++||||+.+.|.
T Consensus       302 --------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          302 --------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             --------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             --------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence                          01112347899999999999988888  9999999999999988764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-51  Score=346.66  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=217.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||.||++.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            58999999999999999999999999999999854321 23445678889999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++ |++.+.+....  .+++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+|||.+......   .
T Consensus       122 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFg~a~~~~~~---~  195 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSC---B
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC-EEEcccccceeccCC---c
Confidence            997 56666665543  4788999999999999999999999999999999999999888 999999999876533   2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....                   
T Consensus       196 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  255 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------------  255 (350)
T ss_dssp             CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            233489999999988766 689999999999999999999999998888777777754211                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                 ..+..+++++.++|.+||+.||.+||+     +.++++||||+.+.|
T Consensus       256 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                       122346889999999999999999998     999999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.1e-51  Score=349.65  Aligned_cols=281  Identities=32%  Similarity=0.479  Sum_probs=218.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      +|++.+.||+|+||+||+|.+..++. +|+|++....      ....+|+++++.++||||+++++++...+      ..
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            59999999999999999999876665 8888774322      12237999999999999999999985443      38


Q ss_pred             eeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe-CCCCeEEEccCCCcccC
Q 038154           75 DLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID-RSKDIVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~-~~~~~v~l~df~~~~~~  151 (293)
                      ++||||++++++..+..  .....+++..++.++.||+.||.|||++|++||||||+||+++ .++. +||+|||.+...
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~-~kL~DFG~a~~~  192 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV-LKLIDFGSAKIL  192 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE-EEECCCTTCEEC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc-EEEeeCCCcccc
Confidence            89999999887765542  2234688889999999999999999999999999999999999 4555 999999999876


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ..... .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+....+.+..........
T Consensus       193 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          193 IAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             cCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            44322 23344889999999988776799999999999999999999999999998888888887776665432211110


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ......+ .............+..++++.+||.+||+.||.+|||+.++++||||+.+++
T Consensus       272 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          272 NYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             GGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            0000000 0011111222344568899999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-50  Score=340.01  Aligned_cols=262  Identities=23%  Similarity=0.356  Sum_probs=217.2

Q ss_pred             Cceee-eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      ||.+. +.||+|++|+||++.+..+++.||+|++............+.+|+.+++.+. ||||+++++++...+..++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            47777 8999999999999999999999999998765555555678889999999995 699999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccCCCC
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~~~~  154 (293)
                      ||+.| ++.+.+.......+++..++.++.|++.||++||+.|++|+||+|+||+++.   ++. ++|+|||.+......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~-~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD-IKIVDFGMSRKIGHA  187 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC-EEECCGGGCEEC---
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc-EEEeeCccccccCCc
Confidence            99985 5556665555567899999999999999999999999999999999999987   455 999999999876543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+.........           
T Consensus       188 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  254 (327)
T 3lm5_A          188 C-ELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-----------  254 (327)
T ss_dssp             -------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred             c-ccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-----------
Confidence            2 22334589999999988765 6899999999999999999999999988887777666543322211           


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                     .....+++.+.++|.+||+.||.+|||++++|+||||+.+.+
T Consensus       255 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          255 ---------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             ---------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             ---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence                           122346889999999999999999999999999999998865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-51  Score=347.61  Aligned_cols=261  Identities=30%  Similarity=0.430  Sum_probs=213.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC---CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN---PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||+||++.+..+|+.||+|++....   ......+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            5899999999999999999999999999999985422   2223456789999999999999999999999999999999


Q ss_pred             eecCCc-chHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCC
Q 038154           78 FENLDF-DLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPID  152 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~  152 (293)
                      |||++| ++...+...  ....+++..++.++.||+.||+|||++|++|+||||+||+++.+++  .+||+|||.+....
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            999985 554555432  2345788999999999999999999999999999999999986543  49999999998776


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..........+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.. ......+.....             
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~-------------  249 (351)
T 3c0i_A          185 ESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY-------------  249 (351)
T ss_dssp             TTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCC-------------
T ss_pred             CCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCC-------------
Confidence            544334445589999999988766 68999999999999999999999998743 333333322110             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                   ......+..+++++.+||.+||..||++|||+.++|+||||+..
T Consensus       250 -------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          250 -------------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -------------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                         01112335678999999999999999999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.9e-50  Score=332.59  Aligned_cols=261  Identities=29%  Similarity=0.402  Sum_probs=219.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|..+|+|++............+.+|++++++++||||+++++++...+..++|||+
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            69999999999999999999999999999999876554444456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +.+ ++.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  .++|+|||.+....... .
T Consensus        87 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~  163 (284)
T 3kk8_A           87 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-A  163 (284)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-B
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-c
Confidence            985 5556665543  4788899999999999999999999999999999999986543  48999999997765432 2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.......+.              
T Consensus       164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  228 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------------  228 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--------------
T ss_pred             ccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc--------------
Confidence            2334589999999988766 6899999999999999999999999988877777776543222211              


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                  .....+++++.+++.+||+.||++|||+.++++||||++-++
T Consensus       229 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          229 ------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                        112346889999999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-51  Score=358.29  Aligned_cols=257  Identities=24%  Similarity=0.353  Sum_probs=208.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||.||++.+..+|+.||+|++.... ........+.+|+++++.++||||+++++++...+..++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            5899999999999999999999999999999986532 223344667789999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |++| ++...+....  .+++..++.++.||+.||+|||+ .|++|+||||+||+++.++. +||+|||.+.........
T Consensus       229 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          229 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC-EEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC-EEEccCCCceeccCCCcc
Confidence            9986 4545554432  57888999999999999999998 99999999999999999887 999999999865444444


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.....                  
T Consensus       306 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------  366 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------  366 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            4555699999999988766 689999999999999999999999998888777777653111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                  ..+..+++++.+||.+||+.||.+||     ++.++++||||+.+.+
T Consensus       367 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          367 ------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                        12334688999999999999999999     9999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.8e-50  Score=336.29  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=214.5

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |...+.||+|++|.||+|.+..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            677889999999999999999899999999986432  344567889999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceecc
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK  161 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~  161 (293)
                      +|+.+..+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus       125 ~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          125 QGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc-EEEeeeeeeeecccCccccccc
Confidence            87666555543  35889999999999999999999999999999999999998887 9999999998765544444455


Q ss_pred             CccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCC
Q 038154          162 GGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPN  241 (293)
Q Consensus       162 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
                      .|++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.......                    
T Consensus       202 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------  260 (321)
T 2c30_A          202 VGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK--------------------  260 (321)
T ss_dssp             CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC--------------------
T ss_pred             cCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------------
Confidence            689999999988765 68999999999999999999999998877766665554311100                    


Q ss_pred             CCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          242 RSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                             ......+++++.+++.+||+.||++|||+.++++||||...
T Consensus       261 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          261 -------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             -------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             -------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                   00122367889999999999999999999999999999865

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-50  Score=346.99  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=214.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||+|.+..+|+.+|+|++....  ......+.+|+++++.++||||+++++++.+....++||||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            5899999999999999999999999999999985432  12235688899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC-CeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-DIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~-~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +.|+.+..........+++..++.++.||+.||+|||++|++|+||+|+||+++.++ ..+||+|||.+....... ...
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~  208 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVK  208 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-cee
Confidence            986444444434444688999999999999999999999999999999999998532 249999999998765442 233


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+........                 
T Consensus       209 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-----------------  270 (387)
T 1kob_A          209 VTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-----------------  270 (387)
T ss_dssp             EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-----------------
T ss_pred             eeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence            34589999999988765 689999999999999999999999998887777776654221111                 


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                               ......+++++.++|.+||..||.+|||+.++|+||||+.-
T Consensus       271 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          271 ---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             ---------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                     11223578899999999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-50  Score=338.17  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=217.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC----CcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..+|..+|+|++........    ....+.+|+++++.+.||||+++++++.+.+..++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            58999999999999999999999999999999865443322    34568899999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~  152 (293)
                      |||+++| ++.+.+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   .++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            9999975 555555543  35788899999999999999999999999999999999998772   49999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+......            
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------  236 (321)
T 2a2a_A          171 DGV-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD------------  236 (321)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC------------
T ss_pred             ccc-cccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc------------
Confidence            432 22334489999999988765 6899999999999999999999999988877777666432111            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                    ........++..+.++|.+||+.||.+|||+.++++||||+...
T Consensus       237 --------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          237 --------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             --------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             --------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                          11123456788999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-50  Score=344.07  Aligned_cols=279  Identities=25%  Similarity=0.332  Sum_probs=221.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-----CCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-----HENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.++||+|+||+||++.+..+++.||+|++...   ......+..|+++++.+.     ||||+++++++...+..+
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            699999999999999999999999999999998521   223356677999999986     999999999999999999


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC--------------------
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR--------------------  135 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~--------------------  135 (293)
                      +|||++++++.+.+.......+++..++.++.||+.||+|||+.|++|+||||+||+++.                    
T Consensus       113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            999999888888888777667899999999999999999999999999999999999975                    


Q ss_pred             -----CCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH
Q 038154          136 -----SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL  210 (293)
Q Consensus       136 -----~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  210 (293)
                           ++. +||+|||.+......   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+.
T Consensus       193 ~~~~~~~~-~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  267 (360)
T 3llt_A          193 IYRTKSTG-IKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH  267 (360)
T ss_dssp             EEEESCCC-EEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCC-EEEEeccCceecCCC---CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence                 455 999999999865432   2234489999999988776 689999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCCCCCCCCcCcccc---------cCCCCCCCcccc-------hhhhcCCCCchHHHHHHHhhccCCCCC
Q 038154          211 LAAIFSIMGTPDSETLPGFTSFSEE---------FGFEPNRSPIKD-------LATVVGGLEPDGVDLLRRMLCLDPSKR  274 (293)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~R  274 (293)
                      ...+.......+.............         ..+.........       ........++.+.+||.+||+.||.+|
T Consensus       268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  347 (360)
T 3llt_A          268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR  347 (360)
T ss_dssp             HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence            8888776665543321111100000         000000000000       111122245788899999999999999


Q ss_pred             CCHHHHhcCcccc
Q 038154          275 LTAREALRHEYFK  287 (293)
Q Consensus       275 ps~~~ll~~p~~~  287 (293)
                      ||+.++|+||||+
T Consensus       348 pta~elL~hp~f~  360 (360)
T 3llt_A          348 PSPAELLKHKFLE  360 (360)
T ss_dssp             CCHHHHTTSGGGC
T ss_pred             CCHHHHhcCcccC
Confidence            9999999999996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-51  Score=340.23  Aligned_cols=252  Identities=24%  Similarity=0.273  Sum_probs=203.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.++||+|+||+||+|.+..+|+.||+|++...............|+..+..+ .||||+++++++.+.+..++|||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e  137 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE  137 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence            48999999999999999999999999999998754433333334455566666555 89999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++++++.+.+.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. +||+|||.+....... ...
T Consensus       138 ~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~DFG~a~~~~~~~-~~~  214 (311)
T 3p1a_A          138 LCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG-AGE  214 (311)
T ss_dssp             CCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC-EEECCCTTCEECC-------
T ss_pred             ccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEccceeeeecccCC-CCc
Confidence            99998888776653 35889999999999999999999999999999999999998888 9999999987765432 223


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...|++.|+|||++.+  .++.++||||||+++|+|++|..|+....   ....+..   .                   
T Consensus       215 ~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~---~-------------------  267 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQ---G-------------------  267 (311)
T ss_dssp             CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTT---T-------------------
T ss_pred             ccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhc---c-------------------
Confidence            3448999999998765  58999999999999999999976664321   1111110   0                   


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                            .........+++++.++|.+||+.||++|||+.++|+||||++
T Consensus       268 ------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          268 ------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                  0112344568899999999999999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7e-51  Score=343.10  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=210.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||+||++.++.+|+.||+|++....      ....+|++++.++ +||||+++++++.+.+..|+|||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4899999999999999999999999999999986432      2356789999888 79999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC-C--eEEEccCCCcccCCCCC
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK-D--IVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~-~--~v~l~df~~~~~~~~~~  155 (293)
                      |+.| ++.+.+....  .+++..++.++.||+.||+|||++|++|+||||+||++.... +  .+||+|||.+.......
T Consensus        97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            9975 6666665543  588999999999999999999999999999999999985442 2  49999999998765544


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR---WAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...   +..+....+........          
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~----------  243 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS----------  243 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC----------
T ss_pred             CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC----------
Confidence            444455689999999988765 5788999999999999999999999763   33444444433111110          


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                                      ...+..+++++.+||.+||..||++|||+.++++||||.+|..+
T Consensus       244 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~  287 (342)
T 2qr7_A          244 ----------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL  287 (342)
T ss_dssp             ----------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred             ----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence                            11234578999999999999999999999999999999887543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-50  Score=332.91  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.+..++..+|+|++.... .......+.+|++++++++||||+++++++.+....++|||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5899999999999999999999999999999986543 233457888999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccCCCC
Q 038154           81 LDF-DLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        81 ~~~-~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~~~~  154 (293)
                      +++ ++.+.+...  ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.   ++. ++|+|||.+......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~-~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP-IKIIDFGLAELFKSD  180 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCC-EEECCCCCCCC----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCC-EEEEeeecceecCCc
Confidence            985 666666432  2346888999999999999999999999999999999999954   344 999999999766543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       .......+++.|+|||++.+  .++.++|+||||+++|+|++|..||......+.............            
T Consensus       181 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------  245 (285)
T 3is5_A          181 -EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------------  245 (285)
T ss_dssp             -------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred             -ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------------
Confidence             22334458999999998753  578999999999999999999999998877776665543111110            


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                     .....+++++.+++.+||+.||++|||+.++|+||||++
T Consensus       246 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 ---------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                           011236789999999999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=353.36  Aligned_cols=264  Identities=24%  Similarity=0.322  Sum_probs=217.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.++.+|+.||+|+++.... .......+.+|..++..++||+|+++++++.+.+..|+|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            48999999999999999999999999999999854221 12334678899999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |+. |++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+......... 
T Consensus       142 ~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~-vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          142 YYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             CCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSCEE
T ss_pred             CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC-EEEeechhheeccCCCccc
Confidence            997 5555555443 235889999999999999999999999999999999999999998 999999999876543222 


Q ss_pred             eeccCccccccCcccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          158 YTIKGGSLCYKAPERLLG------SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .....|++.|+|||++..      ...++.++|+||||+++|+|++|..||.+.+..+...++........         
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  290 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS---------  290 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC---------
Confidence            223459999999998863      33589999999999999999999999999888887777754211100         


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCC---CCHHHHhcCcccccCcCC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKR---LTAREALRHEYFKDFQSL  292 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~p~~~~~~~~  292 (293)
                                      .......+++++.+||.+||+ +|.+|   |+++++++||||+.+.|-
T Consensus       291 ----------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          291 ----------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             ----------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             ----------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence                            011123578999999999999 99998   699999999999988763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-50  Score=344.50  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|+||+||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            7999999999999999999999999999999986432   2336788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-eEEEccCCCcccCCCCCcce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~~~~~~~~  158 (293)
                      +.| ++.+.+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++. .+||+|||.+...... ...
T Consensus        98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~  174 (361)
T 3uc3_A           98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  174 (361)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCC
Confidence            975 6656665433  4788999999999999999999999999999999999986653 4999999998754322 222


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+....+.++||||||+++|+|++|..||......................              
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------------  240 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--------------  240 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC--------------
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC--------------
Confidence            334489999999998877444455999999999999999999998755433322222211110000              


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                ......+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus       241 ----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          241 ----------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                      00112468899999999999999999999999999999654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-50  Score=343.43  Aligned_cols=285  Identities=27%  Similarity=0.449  Sum_probs=213.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-------   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-------   73 (293)
                      ||++.+.||+|+||.||++.+..+|..||+|++...   ........++++.+..++||||+++++++...+.       
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            699999999999999999999999999999988543   2334567788888999999999999999865443       


Q ss_pred             ceeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecccCCCceeEeC-CCCeEEEccCCCc
Q 038154           74 IDLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCH--SQEILHRDLKPANFLIDR-SKDIVKIADFGLA  148 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~  148 (293)
                      .++||||+++++...+..  .....+++..++.++.|++.||.+||  +.|++|+||||+||+++. ++. +||+|||.+
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~-~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT-LKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE-EEECCCTTC
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc-EEEeeCCCc
Confidence            789999999987766543  34456788899999999999999999  999999999999999997 554 999999999


Q ss_pred             ccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          149 RPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....+.+.......
T Consensus       180 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          180 KKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             BCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             eecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            8765432 223345899999999987776789999999999999999999999999998888888887766654433221


Q ss_pred             CcCcccccCCC--CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          229 FTSFSEEFGFE--PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       229 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ...........  ................++++.+||.+||+.||.+|||+.++|+||||+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            11111111000  000011111222334678899999999999999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-50  Score=341.24  Aligned_cols=286  Identities=34%  Similarity=0.568  Sum_probs=227.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC-----Ccce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV-----DSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++... ........+.+|+++++.++||||+++++++...     ...+
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            699999999999999999999999999999998532 1222335677899999999999999999987654     6789


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +|||++++++.+.+...   .+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        91 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECC---
T ss_pred             EEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc-EEEEeccccccccccc
Confidence            99999999888777653   5788999999999999999999999999999999999998888 9999999998664322


Q ss_pred             cc----------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCC
Q 038154          156 EN----------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSET  225 (293)
Q Consensus       156 ~~----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  225 (293)
                      ..          .....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+....
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence            11          11234789999999887666789999999999999999999999999988888888888777665443


Q ss_pred             CCCCcCcccc--cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          226 LPGFTSFSEE--FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       226 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ..........  .................+.+++++.++|.+||+.||++|||+.++++||||+.+.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            3222111100  00000111122344556788999999999999999999999999999999998754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-50  Score=357.11  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=217.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|++|+||++.+..+++.||+|++............+.+|++++++++||||+++++++.+.+..|+|||+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  102 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence            69999999999999999999999999999999865444445567889999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +.| ++.+.+....  .+++..++.++.||+.||.|||++|++|+||||+||+++..+.  .+||+|||.+...... ..
T Consensus       103 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~  179 (486)
T 3mwu_A          103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TK  179 (486)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-Cc
Confidence            985 6666665543  4788999999999999999999999999999999999964321  4999999999876543 22


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+........               
T Consensus       180 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  242 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---------------  242 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---------------
T ss_pred             cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            334458999999998865  488999999999999999999999999888887777754222111               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                 ...+..+++++.++|.+||..||++|||+.++|+||||++..+
T Consensus       243 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             -----------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             -----------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                       1123457889999999999999999999999999999987643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-50  Score=354.37  Aligned_cols=254  Identities=31%  Similarity=0.490  Sum_probs=216.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|.+++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            69999999999999999999999999999999864321 22345678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++| ++.+.+...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||.+...... ...
T Consensus        97 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~-vkL~DFG~a~~~~~~-~~~  172 (476)
T 2y94_A           97 YVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDG-EFL  172 (476)
T ss_dssp             CCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC-EEECCCSSCEECCTT-CCB
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC-eEEEeccchhhcccc-ccc
Confidence            9974 555665543  35889999999999999999999999999999999999999888 999999999876543 223


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+.....                   
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------  233 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------------------  233 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------------------
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------------------
Confidence            3445899999999988775557899999999999999999999998888777777653211                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 ..+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus       234 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 -----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                       112346789999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=334.99  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=190.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.+|+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            58999999999999999999988999999999854321 22344678899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++++.+..+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~  170 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHY  170 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC-EEECCCTTCEECC-------
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEEeecceeeccCCCCcce
Confidence            99865554444444456889999999999999999999999999999999999998888 99999999987654433334


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+..                       
T Consensus       171 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------------------  226 (278)
T 3cok_A          171 TLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------------------  226 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------------------
T ss_pred             eccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------------------
Confidence            44588999999988765 678999999999999999999999976544333222100                       


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                             .....+..++.++.++|.+||+.||++|||+.++++||||.+-.+
T Consensus       227 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          227 -------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                   000123457889999999999999999999999999999987543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.9e-51  Score=346.79  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=208.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHH-HHhcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSL-LKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||.||++.++.++..||+|++...... ......+..|..+ ++.++||||+++++++.+.+..|+||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            489999999999999999999999999999999654322 2333456667666 46679999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+.| ++...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++........
T Consensus       119 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          119 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCBCGGGBCCCCC
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEeeCccccccccCCCc
Confidence            99985 5555555432  4788899999999999999999999999999999999999998 999999999864433334


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....                   
T Consensus       196 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------  255 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------------  255 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------------------
T ss_pred             cccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------
Confidence            4455699999999988766 68999999999999999999999999988888777775411                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH----HHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA----REALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~p~~~~~~~  291 (293)
                                 ...++.++.++.++|.+||+.||.+||++    .++++||||+.+.|
T Consensus       256 -----------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          256 -----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             -----------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                       01234578899999999999999999987    69999999998765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-50  Score=355.06  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=213.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|.+..++..+|+|++............+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            59999999999999999999999999999999976655555567899999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +.| ++.+.+....  .+++..++.++.||+.||.|||++|++|+||||+||+++..+.  .+||+|||.+...... ..
T Consensus       118 ~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~  194 (494)
T 3lij_A          118 YKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KK  194 (494)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BC
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-cc
Confidence            985 6666665543  4788899999999999999999999999999999999976432  4999999999876543 22


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+........               
T Consensus       195 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  257 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD---------------  257 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred             ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            334458999999998753  589999999999999999999999999888888877765322221               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ...+..+++++.++|.+||+.||.+|||+.++|+||||+..
T Consensus       258 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          258 -----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -----------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -----------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                       11234578999999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=341.61  Aligned_cols=286  Identities=30%  Similarity=0.503  Sum_probs=214.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee-----------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS-----------   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----------   69 (293)
                      ||++.+.||+|++|.||++.+..+|+.||+|++...  .......+.+|++++++++||||+++++++.           
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            799999999999999999999999999999988543  2233467889999999999999999998863           


Q ss_pred             ---cCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           70 ---SVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        70 ---~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                         .....++|||+++|++.+.+..   ..+++..++.++.|++.||++||++|++|+||+|+||+++.++..+||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence               3457899999999988777754   3578889999999999999999999999999999999998655559999999


Q ss_pred             CcccCCCCCc---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLE---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+........   ......+++.|+|||++.+...++.++|+||||+++|+|++|..||...+..+....+.........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE  246 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            9987643211   1222336888999998877567899999999999999999999999998887777777654333221


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      .............................+.++.++.++|.+||+.||++|||+.++++||||+.+.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            11100000000000000001112234455678999999999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-50  Score=330.04  Aligned_cols=255  Identities=28%  Similarity=0.396  Sum_probs=214.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..++..+++|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            59999999999999999999999999999999865432  3357888999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE---eCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i---~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++ ++.+.+....  .+++..++.++.|++.||++||++|++|+||+|+||++   +.++. ++|+|||.+...... .
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~-~~l~Dfg~~~~~~~~-~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP-LKLIDFGLAARFKPG-K  163 (277)
T ss_dssp             CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC-EEECCCTTCEECCTT-S
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc-EEEEecccceeccCc-c
Confidence            985 5556555433  47888999999999999999999999999999999999   55566 999999999876543 2


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......+++.|+|||++.+.  ++.++|+||||+++|+|++|..||...+..+....+.......               
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  226 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF---------------  226 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred             chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence            23344589999999987644  8999999999999999999999999888877777765422111               


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 .......+++++.+++.+||+.||.+|||+.++|+||||++.
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          227 -----------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             -----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             -----------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                       112233578899999999999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-50  Score=355.57  Aligned_cols=258  Identities=29%  Similarity=0.466  Sum_probs=217.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++.+.||+|++|.||++.+..+|+.||+|++...... ......+.+|++++++++||||+++++++...+..++|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            599999999999999999999999999999998654433 3455678899999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe---CCCCeEEEccCCCcccCCCCC
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID---RSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~---~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++. |++.+.+....  .+++..++.++.||+.||.|||++|++|+||||+||+++   .++. +||+|||.+.......
T Consensus       107 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          107 VYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN-IRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC-EEECCTTHHHHBCCCC
T ss_pred             cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc-EEEEeeeeeEEccccc
Confidence            997 56666665543  478899999999999999999999999999999999995   4455 9999999998765442


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                       ......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+........             
T Consensus       184 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  247 (484)
T 3nyv_A          184 -KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-------------  247 (484)
T ss_dssp             -SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             -ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence             2233458999999998865  489999999999999999999999999888887777754221111             


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                   ...+..+++++.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus       248 -------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          248 -------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             -------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             -------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                         112345789999999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-49  Score=352.88  Aligned_cols=259  Identities=25%  Similarity=0.369  Sum_probs=215.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-----------CCcccHHHHHHHHHhcCCCCcceeeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-----------GVPSSVIREVSLLKELKHENIVRLLNVQS   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (293)
                      +|+++++||+|+||+||+|.+..++..+|+|++.......           .....+.+|++++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            6999999999999999999999999999999986543221           33467889999999999999999999999


Q ss_pred             cCCcceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCC
Q 038154           70 SVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFG  146 (293)
Q Consensus        70 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~  146 (293)
                      +.+..++||||++| ++.+.+....  .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.  .+||+|||
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            99999999999985 6666665543  4788999999999999999999999999999999999997763  49999999


Q ss_pred             CcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          147 LARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      .+....... ......|++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.......     
T Consensus       195 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----  266 (504)
T 3q5i_A          195 LSSFFSKDY-KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF-----  266 (504)
T ss_dssp             TCEECCTTS-CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred             CCEEcCCCC-ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            998765442 2334458999999998763  58999999999999999999999999988888877775421111     


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                           ....++.+++++.+||.+||..||.+|||+.++|+||||++..
T Consensus       267 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          267 ---------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             ---------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ---------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                                 1123456889999999999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-50  Score=340.45  Aligned_cols=265  Identities=27%  Similarity=0.373  Sum_probs=211.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC---CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN---PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||++.+.||+|++|+||++.+..++..+|+|++....   ........+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            5999999999999999999999999999999985432   2344557888999999999999999999999999999999


Q ss_pred             eecCCc-chHHHhhcC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 038154           78 FENLDF-DLLHFMKTE--------------------------------------PTVTKNPLKIKKYLHQILHGVAYCHS  118 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~--------------------------------------~~~~~~~~~~~~i~~~i~~~l~~lh~  118 (293)
                      |||++| ++.+.+...                                      ....+++..++.++.|++.||++||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999975 554544310                                      01123466788899999999999999


Q ss_pred             CCceecccCCCceeEeCCCC-eEEEccCCCcccCCCCCc----ceeccCccccccCcccccC-CCCCCCchhHHHHHHHH
Q 038154          119 QEILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLE----NYTIKGGSLCYKAPERLLG-SGRYSTPVDVWAVACTF  192 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll  192 (293)
                      .|++|+||+|+||+++.++. .+||+|||.+........    ......+++.|+|||++.+ ...++.++||||||+++
T Consensus       187 ~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il  266 (345)
T 3hko_A          187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL  266 (345)
T ss_dssp             TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred             CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence            99999999999999987662 499999999975532111    1234458999999998865 25788999999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCC
Q 038154          193 AEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPS  272 (293)
Q Consensus       193 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  272 (293)
                      |+|++|..||...+..+....+........                          ......+++++.++|.+||+.||.
T Consensus       267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          267 HLLLMGAVPFPGVNDADTISQVLNKKLCFE--------------------------NPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCTT--------------------------SGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHCCCCCCCCChHHHHHHHHhcccccC--------------------------CcccccCCHHHHHHHHHHcCCChh
Confidence            999999999999888777777654221111                          011234688999999999999999


Q ss_pred             CCCCHHHHhcCcccccCcC
Q 038154          273 KRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       273 ~Rps~~~ll~~p~~~~~~~  291 (293)
                      +|||+.++|+||||+++.+
T Consensus       321 ~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          321 ERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             TSCCHHHHHHSHHHHTTSS
T ss_pred             HCCCHHHHhcChhhccChH
Confidence            9999999999999998864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-50  Score=345.90  Aligned_cols=284  Identities=34%  Similarity=0.564  Sum_probs=208.9

Q ss_pred             cee-eeeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee--ecCCccee
Q 038154            2 YTL-LEVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ--SSVDSIDL   76 (293)
Q Consensus         2 y~i-~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l   76 (293)
                      |++ +++||+|+||+||+|.+.  .++..||+|++...    .....+.+|+++++.++||||+++++++  ......++
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            566 458999999999999855  57889999988532    2335788999999999999999999998  44678999


Q ss_pred             EeecCCcchHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE----eCCCCeEEEccC
Q 038154           77 VFENLDFDLLHFMKTE-------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI----DRSKDIVKIADF  145 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i----~~~~~~v~l~df  145 (293)
                      ||||+++++.+.+...       ....+++..++.++.||+.||.|||+.|++|+||||+||++    +.++. +||+||
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-~kl~Df  176 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADM  176 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC-EEECCT
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc-EEEEEC
Confidence            9999999888877522       22358889999999999999999999999999999999999    44555 999999


Q ss_pred             CCcccCCCCC---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHH
Q 038154          146 GLARPIDVPL---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---------PGLLAA  213 (293)
Q Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---------~~~~~~  213 (293)
                      |.+.......   .......+++.|+|||++.+...++.++|||||||++|+|++|..||.....         .+.+..
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            9998765332   1223344899999999988766789999999999999999999999976544         477888


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccC----CCC----CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFG----FEP----NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                      +....+.+....+...........    +..    ...............+.++.+||.+||..||.+|||+.++|+|||
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            888888877766654433221110    000    000001111222334788999999999999999999999999999


Q ss_pred             cccCc
Q 038154          286 FKDFQ  290 (293)
Q Consensus       286 ~~~~~  290 (293)
                      |+...
T Consensus       337 f~~~~  341 (405)
T 3rgf_A          337 FLEDP  341 (405)
T ss_dssp             GTSSS
T ss_pred             hccCC
Confidence            98754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=337.03  Aligned_cols=255  Identities=27%  Similarity=0.366  Sum_probs=196.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++....    ..+.+.+|+++++++.||||+++++++...+..++||||
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            5899999999999999999999999999999986432    235677899999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccCCCCCc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++ ++.+.+....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++. +||+|||.+...... .
T Consensus       130 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~-~kl~Dfg~a~~~~~~-~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAP-LKIADFGLSKIVEHQ-V  205 (349)
T ss_dssp             CCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCC-EEECCCC----------
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCC-EEEccCccccccCcc-c
Confidence            985 5656665443  4788999999999999999999999999999999999975   555 999999999866433 2


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ......+++.|+|||++.+. .++.++||||||+++|+|++|..||....... ....+.......              
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~--------------  270 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF--------------  270 (349)
T ss_dssp             -------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC--------------
T ss_pred             ccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc--------------
Confidence            22334589999999988766 68999999999999999999999998776654 334443211111              


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                  .......++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus       271 ------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 ------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             ------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             ------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                        1112345788999999999999999999999999999998653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.1e-50  Score=356.48  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=215.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            48999999999999999999999999999999854321 22334667889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |+.| ++...+.......+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.+....... ..
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~-vKL~DFGla~~~~~~~-~~  342 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQ-TI  342 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTC-CE
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC-eEEEecccceecccCc-cc
Confidence            9975 5556666555556899999999999999999999999999999999999999888 9999999998765432 23


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP----GLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ....|++.|+|||++.+. .++.++|+||||+++|+|++|..||......    .....+...                 
T Consensus       343 ~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----------------  404 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------------  404 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------------
T ss_pred             cccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------------
Confidence            344699999999988765 6899999999999999999999999876432    222222210                 


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                   ....+..+++++.+||.+||+.||++||     ++.++++||||+.+.|
T Consensus       405 -------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 -------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             -------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                         0112245789999999999999999999     8999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-50  Score=331.72  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=212.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|++..... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            59999999999999999999999999999999854321 12334678889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......  .
T Consensus        90 ~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~Dfg~~~~~~~~~--~  164 (279)
T 3fdn_A           90 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSR--R  164 (279)
T ss_dssp             CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC-EEECSCCEESCC-------
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC-EEEEeccccccCCccc--c
Confidence            9985 5555555433  4788899999999999999999999999999999999998888 9999999886554322  2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+......                  
T Consensus       165 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  225 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------------  225 (279)
T ss_dssp             ---CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------------------
T ss_pred             cccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC------------------
Confidence            333488999999988765 6889999999999999999999999988877777766442111                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                  .+..+++++.++|.+||+.||.+|||+.++++||||+...+
T Consensus       226 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          226 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                        12336788999999999999999999999999999987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=337.51  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=208.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC------CcccHHHHHHHHHhcCCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG------VPSSVIREVSLLKELKHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (293)
                      ||++.+.||+|++|+||++.+..+++.||+|++........      ....+.+|++++++++||||+++++++.+.+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            59999999999999999999999999999999876543222      446788899999999999999999999999999


Q ss_pred             eeEeecCC-c-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLD-F-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~-~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ++|||++. | ++...+....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~  181 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECC
T ss_pred             EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc-EEEeecccceECC
Confidence            99999986 4 5556555443  4888999999999999999999999999999999999998887 9999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .... .....+++.|+|||++.+....+.++||||||+++|+|++|..||.......                       
T Consensus       182 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------------  237 (335)
T 3dls_A          182 RGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------------  237 (335)
T ss_dssp             TTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------------
T ss_pred             CCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------------
Confidence            4432 2334589999999998877555889999999999999999999996421100                       


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                   ......+..+++++.++|.+||+.||.+|||+.++++||||++-
T Consensus       238 -------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          238 -------------EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -------------TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -------------hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                         00011123468899999999999999999999999999999764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-50  Score=334.24  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=210.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|.||++.+..++..+++|++...  .......+.+|+++++.++||||+++++++...+..++|||+
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            699999999999999999999999999999998543  234457888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+..+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD-IRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC-EEECCCHHHHHHHHHHHC---
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC-EEEEECCCCcccccccccccc
Confidence            9876665544333345889999999999999999999999999999999999998888 999999987533211111223


Q ss_pred             cCccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          161 KGGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       161 ~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ..+++.|+|||++.    ....++.++|+||||+++|+|++|..||...+.......+.......               
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  241 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---------------  241 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred             ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc---------------
Confidence            34889999999874    34468899999999999999999999999887766655554311100               


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                  ...+..++.++.+++.+||+.||.+|||+.++++||||+.+.+
T Consensus       242 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          242 ------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             ------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                        0112346788999999999999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.2e-50  Score=338.68  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=213.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|++++++++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            488999999999999999999899999999998654322 2233568899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|++.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||.+......    .
T Consensus       135 ~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~----~  208 (348)
T 1u5q_A          135 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPA----N  208 (348)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE-EEECCCTTCBSSSSB----C
T ss_pred             cCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEeeccCceecCCC----C
Confidence            99998888775433 35788999999999999999999999999999999999998887 999999999765432    2


Q ss_pred             ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...+++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.......+.......                
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------------  272 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------  272 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Confidence            3348999999998853  4468899999999999999999999998877666555543311100                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                  .....+++.+.++|.+||+.||++|||+.++++||||..-
T Consensus       273 ------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          273 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                        0122467889999999999999999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-51  Score=339.31  Aligned_cols=251  Identities=24%  Similarity=0.259  Sum_probs=181.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHH--HHHHHHhcCCCCcceeeeeeecCC----cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIR--EVSLLKELKHENIVRLLNVQSSVD----SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~--e~~~l~~l~~~~i~~~~~~~~~~~----~~   74 (293)
                      +|.+.++||+|+||+||+|..  +|+.||||+++...     ...+..  |+..+.+++||||+++++++..++    .+
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            478899999999999999965  58899999985321     223333  555556789999999999987654    47


Q ss_pred             eeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecccCCCceeEeCCCCeEEEccC
Q 038154           75 DLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ--------EILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      |+||||++ |++.+.+...   .+++..+.+++.|++.||+|||++        |++||||||+||+++.++. +||+||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~-~Ki~DF  152 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECCC
T ss_pred             EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC-EEEEeC
Confidence            99999998 5555666543   478889999999999999999987        9999999999999999988 999999


Q ss_pred             CCcccCCCCCcce----eccCccccccCcccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-------
Q 038154          146 GLARPIDVPLENY----TIKGGSLCYKAPERLLGSG-----RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-------  209 (293)
Q Consensus       146 ~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-------  209 (293)
                      |+++.........    ....||+.|+|||++.+..     .++.++|||||||++|||+||..||......+       
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            9997664433222    2234999999999886542     35678999999999999999987764322110       


Q ss_pred             ----HHHHHHHHh-CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          210 ----LLAAIFSIM-GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       210 ----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                          ....+.... ........+                    ........++.+.+|+.+||+.||++|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIP--------------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCC--------------------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCC--------------------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                001110000 000000000                    00001113356889999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4e-50  Score=331.64  Aligned_cols=259  Identities=23%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|.||++.+..+|+.||+|++............+.++...++.+.||||+++++++...+..++|||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~   87 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL   87 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence            59999999999999999999999999999999864433222233344455557778999999999999999999999999


Q ss_pred             CCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ++|++.+.+..  .....+++..++.++.|++.||++||++ |++|+||+|+||+++.++. ++|+|||.+........ 
T Consensus        88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~-  165 (290)
T 3fme_A           88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVA-  165 (290)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC-EEBCCC------------
T ss_pred             hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeecCCccccccccc-
Confidence            99987766543  2334688999999999999999999998 9999999999999998887 99999999977654322 


Q ss_pred             eeccCccccccCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 YTIKGGSLCYKAPERL---LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .....+++.|+|||++   .....++.++|+||||+++|+|++|..||...... ........... +.           
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-----------  233 (290)
T 3fme_A          166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ-----------  233 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC-----------
T ss_pred             ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC-----------
Confidence            2233488999999986   23446889999999999999999999999864333 33333222100 00           


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                      .....+++++.+++.+||+.||.+|||+.++++||||+..
T Consensus       234 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          234 ----------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                            0112467899999999999999999999999999999854

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-49  Score=334.83  Aligned_cols=279  Identities=29%  Similarity=0.472  Sum_probs=211.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeec--CCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSS--VDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv   77 (293)
                      +|++++.||+|++|.||++.+..+++.||+|++..     .....+.+|+++++++. ||||+++++++..  ....++|
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            58999999999999999999999999999999852     23467889999999997 9999999999987  5678999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++.+..+..+..    .+++..++.++.||+.||++||++|++|+||||+||+++.++..++|+|||.+....... .
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~  186 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-E  186 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-C
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-c
Confidence            99999665555543    378889999999999999999999999999999999999887569999999998665432 2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCC---------CCCC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-WAPGLLAAIFSIMGTPDS---------ETLP  227 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~---------~~~~  227 (293)
                      .....+++.|+|||++.+...++.++||||||+++|+|++|..||... ...+.+..+....+.+..         ...+
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence            333458899999999887667899999999999999999999999554 333334333332221100         0000


Q ss_pred             CCcCcccccCCCCCCCc-ccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          228 GFTSFSEEFGFEPNRSP-IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                      ....   .......... ..........+++++.+||.+||+.||.+|||++++|+||||+.+.+.
T Consensus       267 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          267 RFND---ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             HHHH---HHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             chhh---hhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence            0000   0000000000 000111223378999999999999999999999999999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-50  Score=348.38  Aligned_cols=281  Identities=28%  Similarity=0.386  Sum_probs=216.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC--------CCCcceeeeeee---
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--------HENIVRLLNVQS---   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~---   69 (293)
                      ||++.+.||+|+||+||+|.+..+++.||+|++...   ......+.+|+++++.+.        |+||+++++++.   
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            699999999999999999999999999999998532   223467788999999985        778999999887   


Q ss_pred             -cCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCC----------
Q 038154           70 -SVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSK----------  137 (293)
Q Consensus        70 -~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~----------  137 (293)
                       .....++|||++++++++.+.......+++..++.++.||+.||+|||++ |++|+||||+||+++.++          
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence             55689999999999999999887666789999999999999999999998 999999999999998765          


Q ss_pred             --------------------------------------CeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCC
Q 038154          138 --------------------------------------DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY  179 (293)
Q Consensus       138 --------------------------------------~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  179 (293)
                                                            ..++|+|||.+......   .....+++.|+|||++.+. .+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~  270 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS-GY  270 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS-CC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC-CC
Confidence                                                  14999999999876532   2333589999999998876 58


Q ss_pred             CCchhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCC-----cccc-
Q 038154          180 STPVDVWAVACTFAEMVTHQRLFHSRW------APGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRS-----PIKD-  247 (293)
Q Consensus       180 ~~~~Di~slG~ll~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-  247 (293)
                      +.++||||||+++|+|++|..||...+      .......+....+.++.............+.......     .... 
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            999999999999999999999998654      3344555555555543322111111111110000000     0000 


Q ss_pred             ------hhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          248 ------LATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       248 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                            ........+.++.+||.+||+.||++|||+.++|+||||++
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                  00112224567899999999999999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.9e-49  Score=328.56  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=214.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++..... ......+.+|+.+++.+.||||+++++++......++|||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            58999999999999999999999999999999865432 34457889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++..+..+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC-EEEeecccceecCccccccCc
Confidence            986555444433  35788999999999999999999999999999999999998888 999999999876544333444


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+....                      
T Consensus       179 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  235 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN----------------------  235 (303)
T ss_dssp             CCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------------------
T ss_pred             cCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC----------------------
Confidence            5588999999988765 68899999999999999999999998877666555443210                      


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                             .......++..+.+++.+||+.||.+|||+.++++||||.+
T Consensus       236 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          236 -------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             -------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             -------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence                   01123346888999999999999999999999999999965

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.2e-50  Score=328.64  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=214.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC----CcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..+|+.+|+|+++.......    ..+.+.+|++++++++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            58999999999999999999999999999999866543322    34678899999999999999999999999999999


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~  152 (293)
                      |||+++ +++.+.+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   .++|+|||.+....
T Consensus        86 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999997 5565666543  24788899999999999999999999999999999999987762   39999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+.....             
T Consensus       164 ~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  228 (283)
T 3bhy_A          164 AGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-------------  228 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------
T ss_pred             CCCc-ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-------------
Confidence            4322 2333488999999988665 689999999999999999999999998877776666543111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                   ..........+..+.+++.+||..||++|||+.++++||||+.++
T Consensus       229 -------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          229 -------------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             -------------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             -------------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                         111233456788999999999999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.2e-50  Score=335.93  Aligned_cols=257  Identities=25%  Similarity=0.335  Sum_probs=190.5

Q ss_pred             Cceee---eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCccee
Q 038154            1 RYTLL---EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~---~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.   +.||+|+||+||++.+..+++.||+|++...     ....+.+|+.+++.+. ||||+++++++.+....|+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            35664   7899999999999999999999999998532     3356788999999997 9999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDV  153 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~  153 (293)
                      |||+++| ++.+.+...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  .++|+|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            9999985 666666654  35889999999999999999999999999999999999987652  599999999987655


Q ss_pred             CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHhCCCCCCCC
Q 038154          154 PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-------PGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~  226 (293)
                      .........+++.|+|||++.+. .++.++||||||+++|+|++|..||...+.       .+....+.....       
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------  233 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------  233 (325)
T ss_dssp             ----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------
T ss_pred             CCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------
Confidence            44444555589999999988766 689999999999999999999999976433       222222211000       


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                         ......+..+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       234 -------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          234 -------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             -------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             -------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                               0111223457899999999999999999999999999999987543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-50  Score=353.21  Aligned_cols=259  Identities=25%  Similarity=0.341  Sum_probs=215.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.++.+|+.||+|++..... .......+.+|++++++++||||+++++++...+..|+|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            48899999999999999999999999999999854322 12344678889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDF-DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |++| ++...+....  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+........
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~-vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTCC
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC-EEEeecceeeeccCCCc
Confidence            9985 5555554432  346889999999999999999999999999999999999999998 99999999987765444


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA----PGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||.....    .+....+....              
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--------------  409 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--------------  409 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--------------
T ss_pred             ccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--------------
Confidence            34444699999999988775 689999999999999999999999987532    33333332210              


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                      ...+..+++++.++|.+||+.||++||+     ++++++||||+.+.|
T Consensus       410 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          410 ----------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ----------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                            1123457899999999999999999995     599999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9e-50  Score=330.22  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=215.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++.+.||+|++|.||++.+..+++.+++|++...... ....+.+.+|+++++.+.||||+++++++...+..++|||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE   95 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence            699999999999999999999999999999998654322 2334677889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        96 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           96 LCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             CCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCSTTCCB
T ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC-EEEEeccCceecccCcccc
Confidence            9985 455544433  25788899999999999999999999999999999999998888 9999999998765444444


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||......+....+.....                   
T Consensus       173 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  232 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------------  232 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred             ccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-------------------
Confidence            445589999999988765 689999999999999999999999988777666555432110                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ..+..+++.+.+++.+||+.||++|||+.++++||||.+.
T Consensus       233 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          233 -----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -----------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence                       1223467889999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=343.65  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=206.5

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc-
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF-   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-   83 (293)
                      .+.||+|+||.||++.+..+|..||+|+++...  ......+.+|++++++++||||+++++++...+..++||||+++ 
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            678999999999999999999999999986432  12346788999999999999999999999999999999999985 


Q ss_pred             chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-CCCeEEEccCCCcccCCCCCcceeccC
Q 038154           84 DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDIVKIADFGLARPIDVPLENYTIKG  162 (293)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~~~~~~~~~~~~  162 (293)
                      ++.+.+... ...+++..++.++.||+.||.|||+.|++|+||+|+||++.. ....+||+|||.+....... ......
T Consensus       172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~  249 (373)
T 2x4f_A          172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNF  249 (373)
T ss_dssp             EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCC
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccccc
Confidence            555655543 335788899999999999999999999999999999999953 22349999999998765432 223345


Q ss_pred             ccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCC
Q 038154          163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNR  242 (293)
Q Consensus       163 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
                      +++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+........                    
T Consensus       250 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------  308 (373)
T 2x4f_A          250 GTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------------------  308 (373)
T ss_dssp             SSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC--------------------
T ss_pred             CCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------------------
Confidence            89999999987655 688999999999999999999999999888877777765321111                    


Q ss_pred             CcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          243 SPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                            ......+++++.+||.+||+.||.+|||+.++|+||||++.+
T Consensus       309 ------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          309 ------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                  112345789999999999999999999999999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.9e-50  Score=331.60  Aligned_cols=259  Identities=26%  Similarity=0.408  Sum_probs=215.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhcCCCCcceeeeee--ecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVRLLNVQ--SSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l   76 (293)
                      ||++++.||+|++|.||++.+..++..+++|++.....  .......+.+|+++++.++||||+++++++  ......++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            79999999999999999999999999999999864321  123446788999999999999999999988  45568899


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC--
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--  154 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~--  154 (293)
                      |||++++++.+.+.......+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+......  
T Consensus        86 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~-~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           86 VMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAA  164 (305)
T ss_dssp             EEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECCTTCS
T ss_pred             EehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc-EEeeccccccccCcccc
Confidence            99999988888887766667899999999999999999999999999999999999998887 999999999876432  


Q ss_pred             CcceeccCccccccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSG-RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+..+....+.....              
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--------------  230 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--------------  230 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--------------
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC--------------
Confidence            12233445899999999887542 246799999999999999999999998877766666543110              


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                      ..+..+++.+.+++.+||+.||.+|||+.++++||||++..
T Consensus       231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                            12234678999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=329.31  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=210.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|.+...    .....+.+|+++++.++||||+++++++...+..++|||+
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            689999999999999999999999999999998642    2346789999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++++.+..+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECBTTBSCBCC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC-EEEeecccchhhhhhccccCc
Confidence            9865444443323346889999999999999999999999999999999999998888 999999999876544344444


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+...  ....                 
T Consensus       185 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-----------------  244 (314)
T 3com_A          185 VIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPT-----------------  244 (314)
T ss_dssp             CCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-----------------
T ss_pred             cCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCcc-----------------
Confidence            5589999999988765 6899999999999999999999999877655444333221  0000                 


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                              ...+..++.++.++|.+||..||.+|||+.++++||||+....
T Consensus       245 --------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          245 --------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             --------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             --------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence                    0112336788999999999999999999999999999987653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-50  Score=337.49  Aligned_cols=283  Identities=28%  Similarity=0.436  Sum_probs=221.8

Q ss_pred             CceeeeeeccccceeEEEEEe-CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC------CcceeeeeeecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE------NIVRLLNVQSSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~   73 (293)
                      ||++.+.||+|++|.||++.+ ..+++.||+|+++..   ......+.+|+++++.++|+      +++++++++...+.
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            799999999999999999988 567899999998532   22345678899999988654      59999999999999


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC------------------
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR------------------  135 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~------------------  135 (293)
                      .++|||++++++.+.+.......+++..++.++.||+.||+|||++|++|+||+|+||+++.                  
T Consensus        92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            99999999999999988877667899999999999999999999999999999999999987                  


Q ss_pred             -CCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 038154          136 -SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       136 -~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~  214 (293)
                       ++. ++|+|||.+......   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+
T Consensus       172 ~~~~-~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  246 (339)
T 1z57_A          172 INPD-IKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM  246 (339)
T ss_dssp             SCCC-EEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred             cCCC-ceEeeCcccccCccc---cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence             344 999999999865432   2234589999999988766 6899999999999999999999999998888887777


Q ss_pred             HHHhCCCCCCCCCCCcCccc----ccCCCCCCC----------cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHH
Q 038154          215 FSIMGTPDSETLPGFTSFSE----EFGFEPNRS----------PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA  280 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  280 (293)
                      ....+..+............    ...+.....          ............++++.+||.+||+.||.+|||+.++
T Consensus       247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence            77666554332221111000    000000000          0000001112235678999999999999999999999


Q ss_pred             hcCcccccCcC
Q 038154          281 LRHEYFKDFQS  291 (293)
Q Consensus       281 l~~p~~~~~~~  291 (293)
                      ++||||+.++.
T Consensus       327 l~hp~f~~~~~  337 (339)
T 1z57_A          327 LKHPFFDLLKK  337 (339)
T ss_dssp             TTSGGGGGGGC
T ss_pred             hcCHHHHHHhc
Confidence            99999998763

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-49  Score=362.46  Aligned_cols=257  Identities=23%  Similarity=0.301  Sum_probs=219.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||.||++.+..+++.||+|+++... ........+..|.+++..+ .||+|+++++++.+.+.+|+||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            5899999999999999999999999999999986432 1234456788899999987 6999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||+.| ++...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+.........
T Consensus       422 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC-EEECCCTTCEECCCTTCC
T ss_pred             eCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc-EEEeecceeeccccCCcc
Confidence            99985 5555555433  4889999999999999999999999999999999999999998 999999999865444344


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+.....                  
T Consensus       499 ~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------------------  559 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------  559 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC------------------
T ss_pred             cccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            4555699999999988766 689999999999999999999999999988888888754111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH-----HHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-----REALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~p~~~~~~~  291 (293)
                                  ..+..+++++.+||.+||+.||++||++     ++|++||||+.+.|
T Consensus       560 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          560 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             ------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                        1234578999999999999999999997     99999999998765

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.1e-49  Score=326.75  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=211.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|+.+|+|++....  ......+.+|+++++.++||||+++++++...+..++|||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            5899999999999999999999999999999986432  22335788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE---eCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i---~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++ ++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++. ++|+|||.+......  
T Consensus        88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~-~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK-IMITDFGLSKMEQNG--  162 (304)
T ss_dssp             CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC-EEBCSCSTTCCCCCB--
T ss_pred             CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC-EEEccCCcceecCCC--
Confidence            975 6666665443  47888999999999999999999999999999999999   55565 999999998765432  


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+........              
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  227 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE--------------  227 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC--------------
T ss_pred             ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence            12223388999999988765 688999999999999999999999998887777766654221111              


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                  ......+++++.++|.+||..||++|||+.++++||||+...
T Consensus       228 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          228 ------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                        112345788999999999999999999999999999998653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-49  Score=335.51  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=215.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||.+.+.||+|+||.||++.+..+++.+++|++...... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            699999999999999999999999999999998654322 2334678889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus       122 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          122 LCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSTTCCB
T ss_pred             cCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC-EEEeeccCceecccCcccc
Confidence            9985 555554443  35788899999999999999999999999999999999998888 9999999998765444444


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++|..||......+....+.....                   
T Consensus       199 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------  258 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------------  258 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------------------
T ss_pred             cccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-------------------
Confidence            455589999999988766 678999999999999999999999988777666555543111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ..+..+++++.++|.+||+.||++|||+.++++||||...
T Consensus       259 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          259 -----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                       1223467889999999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-49  Score=327.14  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=217.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|++|.||++.+..+++.||+|++............+.+|++++++++||||+++++++...+..++|+|+
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  102 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence            69999999999999999999998999999999976555555667889999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCCcc
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~~~  157 (293)
                      +. +++.+.+....  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.  .++|+|||.+........ 
T Consensus       103 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-  179 (287)
T 2wei_A          103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-  179 (287)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence            97 46666665443  4788899999999999999999999999999999999976442  499999999886654322 


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+  .++.++|+||||+++|+|++|..||...+..+....+........               
T Consensus       180 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------  242 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---------------  242 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred             cccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence            222237889999998765  388999999999999999999999998877776666544211110               


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                 ......+++++.++|.+||..||++|||+.++++||||+++.+
T Consensus       243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                       1122457889999999999999999999999999999998765

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.8e-50  Score=327.02  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=207.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.+++|++..... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            69999999999999999999998999999999854321 23445678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++.+ ++.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus        92 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~-~~  167 (276)
T 2h6d_A           92 YVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGE-FL  167 (276)
T ss_dssp             CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC-EEECCCCGGGCCCC-----
T ss_pred             ccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC-EEEeecccccccCCCc-ce
Confidence            9975 6666665443  4788899999999999999999999999999999999998888 9999999998765432 22


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+....+.++|+||||+++|+|++|..||...........+.....                   
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  228 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-------------------  228 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------------------
Confidence            2334889999999887765457899999999999999999999988777766665543110                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ..+..++.++.+++.+||+.||++|||+.++++||||++.
T Consensus       229 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 -----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                       1123467889999999999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-49  Score=328.67  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|+||++.+..+++.||+|++............+.+|+..+..+ .||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            58999999999999999999999999999999876554454556788899999999 89999999999999999999999


Q ss_pred             cCCc-chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC------------------C
Q 038154           80 NLDF-DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK------------------D  138 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~------------------~  138 (293)
                      +++| ++.+.+....  ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++                  .
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CC
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            9975 6666665432  24578899999999999999999999999999999999998543                  1


Q ss_pred             eEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 038154          139 IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       139 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      .++|+|||.+........    ..+++.|+|||++.+...++.++||||||+++|+|++|..|+....   ....+..  
T Consensus       172 ~~kl~Dfg~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~--  242 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQV----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ--  242 (289)
T ss_dssp             CEEECCCTTCEETTCSCC----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT--
T ss_pred             EEEEcccccccccCCccc----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc--
Confidence            389999999987654322    2389999999998776567789999999999999999987764432   1222211  


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                                 ......+..+++++.+++.+||+.||++|||+.++++||||++.
T Consensus       243 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 ---------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ---------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ---------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                                       01112334578999999999999999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.8e-50  Score=337.20  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--------   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (293)
                      +|++++.||+|++|.||+|.+..+|+.||+|++.... .....+.+.+|++++++++||||+++++++.+..        
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            5899999999999999999999999999999986543 3344577889999999999999999999875543        


Q ss_pred             -------------------------------------------------cceeEeecCCc-chHHHhhcCCC-CCCCHHH
Q 038154           73 -------------------------------------------------SIDLVFENLDF-DLLHFMKTEPT-VTKNPLK  101 (293)
Q Consensus        73 -------------------------------------------------~~~lv~e~~~~-~~~~~~~~~~~-~~~~~~~  101 (293)
                                                                       ..++|||+++| ++.+.+..... ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             27999999986 45555544332 2234556


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc------------ceeccCccccccC
Q 038154          102 IKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE------------NYTIKGGSLCYKA  169 (293)
Q Consensus       102 ~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~------------~~~~~~~~~~~~a  169 (293)
                      ++.++.|++.||+|||++|++|+||||+||+++.++. +||+|||.+........            ......+++.|+|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC-EEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            8899999999999999999999999999999998887 99999999987654321            1223348999999


Q ss_pred             cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchh
Q 038154          170 PERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLA  249 (293)
Q Consensus       170 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (293)
                      ||++.+. .++.++||||||+++|+|++|..|+..     ....+......                          ...
T Consensus       245 PE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~--------------------------~~~  292 (332)
T 3qd2_B          245 PEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL--------------------------KFP  292 (332)
T ss_dssp             HHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT--------------------------CCC
T ss_pred             hHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc--------------------------CCC
Confidence            9988776 689999999999999999998776421     11111111000                          011


Q ss_pred             hhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          250 TVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       250 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ......++++.++|.+||+.||.+|||+.++++||||+++
T Consensus       293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            1122346788999999999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-49  Score=329.05  Aligned_cols=259  Identities=21%  Similarity=0.322  Sum_probs=206.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec------CCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS------VDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~   73 (293)
                      +|++.+.||+|++|.||+|.+..+|+.+|+|++....   .....+.+|+.+++++ .||||+++++++..      .+.
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            6999999999999999999998899999999986432   3347888999999999 79999999999876      457


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      .++|||++++ ++.+.+.......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC-EEEeeCcCceecC
Confidence            8999999986 6666666554456888999999999999999999999999999999999998888 9999999988765


Q ss_pred             CCCcceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ..........+++.|+|||++..    ...++.++||||||+++|+|++|..||...........+.....  +      
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------  252 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--P------  252 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--c------
Confidence            44333344458999999998863    34678999999999999999999999988776555544432100  0      


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                          ......++..+.++|.+||..||.+|||+.++++||||++..+
T Consensus       253 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          253 --------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             --------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             --------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence                                0012346789999999999999999999999999999987653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7e-49  Score=334.09  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=212.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC------CCcccHHHHHHHHHhc-CCCCcceeeeeeecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE------GVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   73 (293)
                      +|++.+.||+|++|.||+|.+..+|+.||||++.......      .....+.+|+.+++++ +||||+++++++...+.
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            5899999999999999999998899999999986543221      1134677899999999 79999999999999999


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      .++||||++| ++.+.+...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~-ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEEecCcccccC
Confidence            9999999986 555555543  35788899999999999999999999999999999999998888 9999999988765


Q ss_pred             CCCcceeccCccccccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLG-----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      ... ......+++.|+|||++.+     ...++.++||||||+++|+|++|..||...+.......+.......      
T Consensus       252 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  324 (365)
T 2y7j_A          252 PGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF------  324 (365)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------
T ss_pred             CCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            432 2334458999999998753     2357889999999999999999999998877766666654321111      


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                          ....+..++.++.++|.+||+.||.+|||+.++|+||||++
T Consensus       325 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 --------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             --------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                                11223457889999999999999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.7e-49  Score=342.33  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=200.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC------CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP------SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.+|++++++++||||+++++++.. +..
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence            69999999999999999999999999999999865321      12333568899999999999999999999865 457


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~  151 (293)
                      ++|||++++ ++.+.+...  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.  .+||+|||.+...
T Consensus       215 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            899999985 555555443  35889999999999999999999999999999999999975432  4999999999876


Q ss_pred             CCCCcceeccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ... .......|++.|+|||++.+  ...++.++|+||||+++|+|++|..||.................          
T Consensus       293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~----------  361 (419)
T 3i6u_A          293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----------  361 (419)
T ss_dssp             C------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC----------
T ss_pred             CCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC----------
Confidence            543 22233458999999998753  34678899999999999999999999976544333222221000          


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                     .......+..+++++.++|.+||+.||.+|||+.++|+||||++.
T Consensus       362 ---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          362 ---------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             ---------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ---------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence                           011223445688999999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.4e-49  Score=322.56  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=209.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.+|+|++..... ......+.+|+++++.++||||+++++++...+..++|||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            58999999999999999999999999999999864332 23446788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                      +++ ++.+.+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........  .
T Consensus        87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC-EEEeeCCCccccCCCcchhc
Confidence            986 555554432  35788899999999999999999999999999999999998888 99999999876532211  1


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      .....+++.|+|||++.+....+.++|+||||+++|+|++|..||....... ....+... ..                
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------------  226 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT----------------  226 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT----------------
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc----------------
Confidence            2234488999999988776545789999999999999999999998765432 22222110 00                


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 .......++.++.++|.+||+.||++|||+.++++||||++.
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence                       001123468899999999999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.3e-49  Score=326.22  Aligned_cols=254  Identities=24%  Similarity=0.304  Sum_probs=206.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----CCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----VDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l   76 (293)
                      +|++.+.||+|++|+||+|.+..++..+++|++............+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3788999999999999999999999999999987655555556778899999999999999999998765    356899


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEe-CCCCeEEEccCCCcccCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLID-RSKDIVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~-~~~~~v~l~df~~~~~~~  152 (293)
                      |||++++ ++.+.+...  ..+++..++.++.|++.||.+||+.|  ++|+||+|+||+++ .++. ++|+|||.+....
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~-~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC-EEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC-EEEeeCCCccccc
Confidence            9999975 555555543  34788899999999999999999999  99999999999998 5565 9999999997654


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...  .....+++.|+|||++.+  .++.++|+||||+++|+|++|..||..................            
T Consensus       184 ~~~--~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  247 (290)
T 1t4h_A          184 ASF--AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------  247 (290)
T ss_dssp             TTS--BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------
T ss_pred             ccc--cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------------
Confidence            432  233458999999997763  4899999999999999999999999876554443333211100            


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                     ........++++.++|.+||+.||.+|||+.++++||||++
T Consensus       248 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                           11223345788999999999999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3e-49  Score=338.60  Aligned_cols=282  Identities=27%  Similarity=0.407  Sum_probs=218.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CC-----CcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE-----NIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~   74 (293)
                      ||++.+.||+|+||+||+|.+..+++.||+|+++..   ......+..|+++++.+. |+     +++++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            699999999999999999999999999999998532   222356677888888885 44     489999999999999


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecccCCCceeEeC--CCCeEEEccCCCccc
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH--SQEILHRDLKPANFLIDR--SKDIVKIADFGLARP  150 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~h~dl~~~Ni~i~~--~~~~v~l~df~~~~~  150 (293)
                      ++|||++++++.+.+.......+++..++.++.|++.||.+||  +.|++|+||||+||+++.  ++. +||+|||.+..
T Consensus       132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~-~kL~DFG~a~~  210 (382)
T 2vx3_A          132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQ  210 (382)
T ss_dssp             EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC-EEECCCTTCEE
T ss_pred             EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc-EEEEeccCcee
Confidence            9999999999999888776667899999999999999999999  579999999999999964  444 99999999987


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ....   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.++........
T Consensus       211 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          211 LGQR---IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             TTCC---CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             cccc---cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            6533   2234589999999988776 68999999999999999999999999999988888888877766543332211


Q ss_pred             CcccccCC--------C--------CCCCcccchhhhc-----------CC-------CCchHHHHHHHhhccCCCCCCC
Q 038154          231 SFSEEFGF--------E--------PNRSPIKDLATVV-----------GG-------LEPDGVDLLRRMLCLDPSKRLT  276 (293)
Q Consensus       231 ~~~~~~~~--------~--------~~~~~~~~~~~~~-----------~~-------~~~~~~~li~~~l~~dp~~Rps  276 (293)
                      .....+..        .        ........+....           .+       .++++.+||.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence            11000000        0        0000000000000           00       1137899999999999999999


Q ss_pred             HHHHhcCcccccCc
Q 038154          277 AREALRHEYFKDFQ  290 (293)
Q Consensus       277 ~~~ll~~p~~~~~~  290 (293)
                      +.++|+||||++..
T Consensus       367 a~e~L~hp~f~~~~  380 (382)
T 2vx3_A          367 PYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHTTSGGGCC--
T ss_pred             HHHHhcCcccccCC
Confidence            99999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.4e-49  Score=326.09  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=213.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|++..... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            58999999999999999999999999999999854321 12334678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.......  .
T Consensus        95 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~--~  169 (284)
T 2vgo_A           95 FAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLR--R  169 (284)
T ss_dssp             CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC-EEECCCTTCEECSSSC--B
T ss_pred             eCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC-EEEecccccccCcccc--c
Confidence            9975 6666665543  4788899999999999999999999999999999999998888 9999999987654322  2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||......+....+.....                   
T Consensus       170 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------  229 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-------------------  229 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred             ccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-------------------
Confidence            234488999999988765 689999999999999999999999988777666665543110                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ..+..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       230 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          230 -----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                       1223468899999999999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.6e-50  Score=332.70  Aligned_cols=269  Identities=24%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++..... ......+.+|++++++++||||+++++++...+..++|||+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            69999999999999999999888999999998854332 23456788899999999999999999999999999999999


Q ss_pred             CCc-chHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           81 LDF-DLLHFMKT------EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        81 ~~~-~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++| ++.+.+..      .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLAT  173 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCHHHHHCC-
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC-EEEEeccchheecc
Confidence            975 55555542      13345889999999999999999999999999999999999998888 99999998876543


Q ss_pred             CC-----cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          154 PL-----ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       154 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ..     .......+++.|+|||++.+...++.++|+||||+++|+|++|..||.....................     
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  248 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE-----  248 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT-----
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc-----
Confidence            21     11223348899999998876446899999999999999999999999887666554433221110000     


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                     ...........+++++.+++.+||+.||++|||+.++++||||++.++
T Consensus       249 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          249 ---------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             ---------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ---------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                           001112234557889999999999999999999999999999998764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-48  Score=323.25  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=215.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-------CCcccHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-------GVPSSVIREVSLLKELK-HENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   72 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++.......       .....+.+|+++++++. ||||+++++++...+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            6999999999999999999999999999999986543211       12346778999999995 999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ..++|||++++ ++.+.+...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus        98 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~  174 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQL  174 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc-EEEecccchhhc
Confidence            99999999985 666666543  35788899999999999999999999999999999999998888 999999999876


Q ss_pred             CCCCcceeccCccccccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLL-----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      .... ......+++.|+|||++.     ....++.++|+||||+++|+|++|..||...+.......+.........   
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 1phk_A          175 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS---  250 (298)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             CCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc---
Confidence            5432 233345889999999875     2346789999999999999999999999888777766666542221110   


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                             .....++.++.+++.+||+.||.+|||+.++++||||+++.
T Consensus       251 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          251 -----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             -----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             -----------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence                                   11234688999999999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=333.36  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||.||++.+. ++..||+|++............+.+|+++++.+.|  |||+++++++...+..++||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            5999999999999999999875 68899999987655444445678899999999976  99999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |+.++++.+.+....  .+++..++.++.||+.||.|||+.|++|+||||+||+++ ++. +||+|||.+......... 
T Consensus        89 e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~-~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           89 ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM-LKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             CCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE-EEECCCSSSCCC-------
T ss_pred             eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc-EEEeecccccccCcccccc
Confidence            987888888887654  578889999999999999999999999999999999998 454 999999999876543222 


Q ss_pred             -eeccCccccccCcccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCC
Q 038154          158 -YTIKGGSLCYKAPERLLG----------SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSET  225 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  225 (293)
                       .....|++.|+|||++.+          ...++.++||||||+++|+|++|..||...... .....+..   ....  
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~--  239 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PNHE--  239 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---TTSC--
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---CCcc--
Confidence             223458999999998854          246788999999999999999999999765433 22222211   1000  


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                             ...+...+.++.+++.+||..||.+|||+.++|+||||+.
T Consensus       240 -----------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          240 -----------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             -----------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             -----------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence                                   0112234678999999999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-49  Score=336.46  Aligned_cols=282  Identities=25%  Similarity=0.384  Sum_probs=220.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC------cceeeeeeecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN------IVRLLNVQSSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~   73 (293)
                      ||++.+.||+|++|+||++.+..++ ..||+|+++..   ......+.+|+++++.+.|++      ++.+.+++...+.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            7999999999999999999987766 68999988532   223456778999999987654      8899999999999


Q ss_pred             ceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE-------------------e
Q 038154           74 IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI-------------------D  134 (293)
Q Consensus        74 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i-------------------~  134 (293)
                      .++|||++++++++.+.......+++..++.++.||+.||++||++|++|+||||+||++                   +
T Consensus        97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A           97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence            999999999999999988776678999999999999999999999999999999999999                   4


Q ss_pred             CCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 038154          135 RSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       135 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~  214 (293)
                      .++. ++|+|||.+......   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+
T Consensus       177 ~~~~-~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          177 KNTS-IRVADFGSATFDHEH---HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             SCCC-EEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCc-EEEeecCcccccccc---ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            4555 999999999865432   2334589999999988766 6899999999999999999999999998888887777


Q ss_pred             HHHhCCCCCCCCCCCcCccccc----CCCCCCCc----------ccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHH
Q 038154          215 FSIMGTPDSETLPGFTSFSEEF----GFEPNRSP----------IKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA  280 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  280 (293)
                      ....+..+..............    .+......          ...........+.++.+||.+||+.||++|||+.++
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            7766655443222111110000    00000000          000000111224578999999999999999999999


Q ss_pred             hcCcccccCc
Q 038154          281 LRHEYFKDFQ  290 (293)
Q Consensus       281 l~~p~~~~~~  290 (293)
                      |+||||+.+.
T Consensus       332 l~hp~f~~~~  341 (355)
T 2eu9_A          332 LLHPFFAGLT  341 (355)
T ss_dssp             TTSGGGGGCC
T ss_pred             hcChhhcCCC
Confidence            9999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.9e-50  Score=329.31  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=212.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee--ecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ--SSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~   78 (293)
                      +|++.+.||+|++|.||++.+..+++.+++|++..........+.+.+|++++++++||||+++++++  ......++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            59999999999999999999999999999999976554444556788999999999999999999977  4466899999


Q ss_pred             ecCCc-chHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154           79 ENLDF-DLLHFMKTE--PTVTKNPLKIKKYLHQILHGVAYCHSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus        79 e~~~~-~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                      ||+++ ++.+.+...  ....+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++. ++|+|||.+..
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~-~kl~dfg~~~~  165 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARI  165 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC-EEECCCCHHHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC-EEEecCchhee
Confidence            99985 666665432  2345889999999999999999999999     999999999999998887 99999999987


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ............+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+.....           
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----------  233 (279)
T 2w5a_A          166 LNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----------  233 (279)
T ss_dssp             C---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred             eccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-----------
Confidence            65443333334488999999988766 688999999999999999999999998877766666543111           


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                        ...+..++.++.+++.+||+.||++|||+.++++|+|+..
T Consensus       234 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 ------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                              1123347889999999999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-49  Score=333.49  Aligned_cols=274  Identities=20%  Similarity=0.348  Sum_probs=214.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCc---------------ccHHHHHHHHHhcCCCCcceee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVP---------------SSVIREVSLLKELKHENIVRLL   65 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~~   65 (293)
                      +|++.+.||+|++|.||++.+  +|+.||+|++..........               ..+.+|++++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            699999999999999999987  89999999986543322211               6788999999999999999999


Q ss_pred             eeeecCCcceeEeecCCc-chHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCC
Q 038154           66 NVQSSVDSIDLVFENLDF-DLLHF------MKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        66 ~~~~~~~~~~lv~e~~~~-~~~~~------~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~  137 (293)
                      +++.+.+..++|||++++ ++.+.      +.......+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence            999999999999999986 55555      444335678999999999999999999999 9999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYST-PVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIF  215 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~  215 (293)
                      . ++|+|||.+......  ......+++.|+|||++.+...++. ++|+||||+++|+|++|..||..... .+....+.
T Consensus       190 ~-~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          190 R-VKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             C-EEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             c-EEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            7 999999999876443  3334458999999998876644555 99999999999999999999988766 55555543


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      ......+.....    ..       ..............++.++.+++.+||+.||++|||+.++++||||++.+
T Consensus       267 ~~~~~~~~~~~~----~~-------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          267 TKNIEYPLDRNH----FL-------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             SCCCCCCCSSSS----ST-------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccCcCCccchhh----hh-------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            221111111000    00       00000111223356889999999999999999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-48  Score=335.72  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=204.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC--CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++++.||+|+||+||++.+.. +..||+|++............+.+|+++++.+.  ||||+++++++...+..|+||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            49999999999999999998765 889999998765444445577889999999996  599999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |+.++++.+.+....  .+++..++.++.||+.||.|||+.|++|+||||+||+++ ++. +||+|||.+......... 
T Consensus       136 E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~-~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          136 ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM-LKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             ECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC-EEECCCSSSCCC-------
T ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe-EEEEecCccccccCCCccc
Confidence            977788888877654  578889999999999999999999999999999999996 455 999999999876543221 


Q ss_pred             -eeccCccccccCcccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCC
Q 038154          158 -YTIKGGSLCYKAPERLLGS----------GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSET  225 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  225 (293)
                       .....|++.|+|||++.+.          ..++.++||||||+++|+|++|..||...... .....+......     
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~-----  286 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-----  286 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC-----
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc-----
Confidence             2334589999999988652          35788999999999999999999999875433 223332211000     


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                             ...+...+.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       287 -----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          287 -----------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             -----------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             -----------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence                                   01122246789999999999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-48  Score=335.13  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             ceee-eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec----CCcce
Q 038154            2 YTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS----VDSID   75 (293)
Q Consensus         2 y~i~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~~   75 (293)
                      |.+. +.||+|+||+||++.+..+|+.||+|++..       ...+.+|++++.++ +||||+++++++..    ....|
T Consensus        63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            6665 789999999999999999999999999852       24677899887554 79999999998765    56789


Q ss_pred             eEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccC
Q 038154           76 LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPI  151 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~  151 (293)
                      +||||+. |++.+.+.......+++..++.++.||+.||.|||+.|++|+||||+||+++.   ++. +||+|||.+...
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~-~kl~DFG~a~~~  214 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFAKET  214 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCC-EEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCcc-EEEEeccccccc
Confidence            9999997 46777776665567899999999999999999999999999999999999997   455 999999999866


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHHHhCCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG----LLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~  227 (293)
                      ... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.......    ....+.......+     
T Consensus       215 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-----  287 (400)
T 1nxk_A          215 TSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-----  287 (400)
T ss_dssp             C------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-----
T ss_pred             CCC-CccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC-----
Confidence            533 222344589999999987655 68999999999999999999999997654322    2222221111000     


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                           ...+..++.++.+||.+||+.||++|||+.++++||||..-
T Consensus       288 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 ---------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ---------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                                 11224578999999999999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-48  Score=326.30  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=204.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC------CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP------SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++.....      .......+.+|++++++++||||+++++++.... .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            58999999999999999999999999999999864332      1233457889999999999999999999987655 8


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~  151 (293)
                      ++|||++++ ++.+.+...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.  .++|+|||.+...
T Consensus        90 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            999999985 565656543  35788899999999999999999999999999999999987553  4999999999876


Q ss_pred             CCCCcceeccCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL-LAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (293)
                      ... .......+++.|+|||++.  +...++.++||||||+++|+|++|..||........ ...+.....         
T Consensus       168 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  237 (322)
T 2ycf_A          168 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY---------  237 (322)
T ss_dssp             CCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC---------
T ss_pred             ccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc---------
Confidence            543 2222334889999999874  344688999999999999999999999976544322 222221000         


Q ss_pred             CcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          229 FTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                       ......+..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       238 -----------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 -----------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             -----------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             -----------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                             11123345678999999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.6e-49  Score=325.98  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||++.+  +|..+|+|++............+.+|++++++++||||+++++++...+..++||||
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            589999999999999999965  578899999865544444456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           81 LDF-DLLHFMKTEPT-VTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      +++ ++.+.+..... ..+++..++.++.|++.||++||+.|  ++|+||||+||+++.++. +||+|||.+........
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC-EEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc-EEECCCCCCcccccccc
Confidence            986 55555544321 23788899999999999999999999  999999999999998887 99999999976554433


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+......                
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------  257 (309)
T 3p86_A          195 SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----------------  257 (309)
T ss_dssp             -------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------------
T ss_pred             ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence            34445589999999988766 6899999999999999999999999988777766655321111                


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc--Ccccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR--HEYFK  287 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~p~~~  287 (293)
                                  ...+..+++++.++|.+||+.||.+|||+.++++  +++++
T Consensus       258 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          258 ------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                        1223457889999999999999999999999998  44544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-49  Score=329.15  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=201.7

Q ss_pred             Cceee-eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++. +.||+|++|.||++.+..+++.||+|++...  .......+.+|++++.++ .||||+++++++.+.+..++||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            58885 7899999999999999999999999998643  234456788999999985 7999999999999999999999


Q ss_pred             ecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccCCCCC
Q 038154           79 ENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPL  155 (293)
Q Consensus        79 e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~~~~~  155 (293)
                      |+++ +++.+.+....  .+++..++.++.||+.||++||++|++|+||+|+||+++.++.  .+||+|||.+.......
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9998 56666665543  4788899999999999999999999999999999999987654  38999999987653221


Q ss_pred             c-------ceeccCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH---------------
Q 038154          156 E-------NYTIKGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG---------------  209 (293)
Q Consensus       156 ~-------~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---------------  209 (293)
                      .       ......+++.|+|||++.+    ...++.++||||||+++|+|++|..||......+               
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1       1122348899999998864    1347899999999999999999999997654321               


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ....+.....                          .........+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       249 ~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          249 LFESIQEGKY--------------------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHCCC--------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHhccCc--------------------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            1222211000                          00112234578899999999999999999999999999999875


Q ss_pred             c
Q 038154          290 Q  290 (293)
Q Consensus       290 ~  290 (293)
                      .
T Consensus       303 ~  303 (316)
T 2ac3_A          303 A  303 (316)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4e-50  Score=343.43  Aligned_cols=251  Identities=15%  Similarity=0.131  Sum_probs=196.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHH---HHHhcCCCCcceee-------eeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVS---LLKELKHENIVRLL-------NVQS   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~~~   69 (293)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|++   ++++++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            48899999999999999999888999999999975432 2334567889995   45555799999998       5555


Q ss_pred             cCC-----------------cceeEeecCCcchHHHhhcCCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecccC
Q 038154           70 SVD-----------------SIDLVFENLDFDLLHFMKTEPTV-----TKNPLKIKKYLHQILHGVAYCHSQEILHRDLK  127 (293)
Q Consensus        70 ~~~-----------------~~~lv~e~~~~~~~~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~  127 (293)
                      ..+                 ..|++||+++|++.+.+......     .+++..++.++.||+.||+|||++|++|+|||
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik  233 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  233 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            543                 37899999999888887654321     12246788899999999999999999999999


Q ss_pred             CCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCC----------CCCCCchhHHHHHHHHHHHHh
Q 038154          128 PANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS----------GRYSTPVDVWAVACTFAEMVT  197 (293)
Q Consensus       128 ~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~  197 (293)
                      |+||+++.++. +||+|||.+.....   ......| +.|+|||++.+.          ..++.++||||||+++|+|++
T Consensus       234 p~NIll~~~~~-~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          234 PVDIVLDQRGG-VFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             GGGEEECTTCC-EEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCC-EEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            99999998887 99999999986442   3334447 999999988755          258899999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCH
Q 038154          198 HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA  277 (293)
Q Consensus       198 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  277 (293)
                      |..||...+.......                                  .......+++++.++|.+||+.||++|||+
T Consensus       309 g~~Pf~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          309 ADLPITKDAALGGSEW----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             SSCCC------CCSGG----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             CCCCCcccccccchhh----------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999965432221111                                  111124678999999999999999999999


Q ss_pred             HHHhcCcccccCc
Q 038154          278 REALRHEYFKDFQ  290 (293)
Q Consensus       278 ~~ll~~p~~~~~~  290 (293)
                      .++++||||+.+.
T Consensus       355 ~e~l~hp~f~~~~  367 (377)
T 3byv_A          355 LQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHTSHHHHHHH
T ss_pred             HHHhhChHHHHHH
Confidence            9999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=329.91  Aligned_cols=275  Identities=20%  Similarity=0.299  Sum_probs=204.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--cceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--SIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~   78 (293)
                      ||++.+.||+|++|+||+|.+..+++.||+|++..... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            69999999999999999999999999999999864332 233467789999999999999999999987665  679999


Q ss_pred             ecCCc-chHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE----eCCCCeEEEccCCCcccCC
Q 038154           79 ENLDF-DLLHFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI----DRSKDIVKIADFGLARPID  152 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i----~~~~~~v~l~df~~~~~~~  152 (293)
                      ||+++ ++.+.+.... ...+++..++.++.|++.||+|||+.|++|+||||+||++    +.++. +||+|||.+....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-~kL~Dfg~a~~~~  167 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV-YKLTDFGAARELE  167 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE-EEECCCTTCEECC
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce-EEEccCCCceecC
Confidence            99985 5555554432 2338899999999999999999999999999999999998    44444 9999999998765


Q ss_pred             CCCcceeccCccccccCcccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHHHhCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLG-------SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA----PGLLAAIFSIMGTP  221 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~  221 (293)
                      .... .....+++.|+|||++..       ...++.++||||||+++|+|++|..||.....    .+.+..+...   .
T Consensus       168 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~  243 (319)
T 4euu_A          168 DDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---K  243 (319)
T ss_dssp             TTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---C
T ss_pred             CCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---C
Confidence            4422 233458999999998752       34688999999999999999999999976443    2333333322   2


Q ss_pred             CCCCCCCCcCccc-ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          222 DSETLPGFTSFSE-EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       222 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                      +............ .+.+....   .........++..+.+++.+||+.||++|||++|+|+||
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccC---CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            2111111111000 00000000   011122234567889999999999999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-48  Score=321.74  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=205.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++++.||+|++|.||++.+..++..+|+|++....... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            7999999999999999999999999999999985443322 334578889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |++| ++.+.+....  .+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+......... 
T Consensus        92 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEEeCCCccccccccccc
Confidence            9986 5555555433  5788899999999999999999999999999999999998888 999999999876433222 


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+...........                    
T Consensus       169 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--------------------  227 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--------------------  227 (294)
T ss_dssp             ------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--------------------
T ss_pred             cCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--------------------
Confidence            2233489999999988776 6899999999999999999999999887766655444320                    


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                           ..........+.+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus       228 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          228 -----SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             -----CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             -----cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence                 001112334566899999999999999999999555555555543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-49  Score=337.18  Aligned_cols=283  Identities=27%  Similarity=0.372  Sum_probs=214.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-----------CCCcceeeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-----------HENIVRLLNVQS   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~   69 (293)
                      ||++.+.||+|++|+||+|.+..+++.||+|++...   ......+.+|+.+++++.           ||||+++++++.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            699999999999999999999999999999998532   123356778999998886           789999999987


Q ss_pred             cCC----cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCC-----Ce
Q 038154           70 SVD----SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSK-----DI  139 (293)
Q Consensus        70 ~~~----~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~-----~~  139 (293)
                      ..+    ..+++||++++++.+.+.......+++..++.++.||+.||++||++ |++|+||||+||+++.++     ..
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence            654    78999999988888888876666789999999999999999999998 999999999999996433     14


Q ss_pred             EEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------chHHHHH
Q 038154          140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW------APGLLAA  213 (293)
Q Consensus       140 v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~------~~~~~~~  213 (293)
                      ++|+|||.+......   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+      .......
T Consensus       177 ~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          177 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             EEEcccccccccCCC---CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            999999999876533   2233489999999998876 68999999999999999999999998654      3445566


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccCCCCC-----CCcc-------cchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHh
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFGFEPN-----RSPI-------KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL  281 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  281 (293)
                      +....+..+.............+.....     ....       ......+...+.++.+||.+||+.||.+|||+.++|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            6665555443221111111000000000     0000       000112233567889999999999999999999999


Q ss_pred             cCcccccCc
Q 038154          282 RHEYFKDFQ  290 (293)
Q Consensus       282 ~~p~~~~~~  290 (293)
                      +||||++..
T Consensus       333 ~hp~f~~~~  341 (373)
T 1q8y_A          333 NHPWLKDTL  341 (373)
T ss_dssp             TCGGGTTCT
T ss_pred             hChhhhccc
Confidence            999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.5e-49  Score=328.55  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=206.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc----e
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI----D   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~   75 (293)
                      ||++.+.||+|++|.||++.+..+++.||+|++....... .....+.+|++++++++||||+++++++......    |
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            7999999999999999999999999999999986543222 2234678899999999999999999998776654    9


Q ss_pred             eEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +||||++| ++.+.+....  .+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+......
T Consensus        93 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC-EEECCCSCC------
T ss_pred             EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC-EEEeeccCccccccc
Confidence            99999985 5555554433  5788899999999999999999999999999999999999888 999999999766433


Q ss_pred             Cc---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          155 LE---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       155 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ..   ......|++.|+|||++.+. .++.++||||||+++|+|++|..||......+..........            
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------------  236 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------------  236 (311)
T ss_dssp             ------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------------
T ss_pred             ccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC------------
Confidence            22   12223489999999988766 689999999999999999999999988877666555543111            


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                    .........++.++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       237 --------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 --------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             --------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                          11122345678999999999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-49  Score=332.92  Aligned_cols=262  Identities=23%  Similarity=0.327  Sum_probs=207.0

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|+||.||++.+.   .+++.||+|+++....  .......+.+|+++++.+ .||||+++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            5899999999999999999874   5889999999864321  223345677899999999 699999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++||||+++ ++.+.+....  .+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+.....
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEECCG
T ss_pred             EEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc-EEEeeCCCCeeccc
Confidence            999999985 6666665443  4788899999999999999999999999999999999998888 99999999876543


Q ss_pred             CC-cceeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          154 PL-ENYTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       154 ~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .. .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...........+.....            
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------  279 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------------  279 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH------------
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh------------
Confidence            21 122233489999999988753 3578999999999999999999999976443322222211100            


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                    ......+..++..+.+||.+||..||.+||     +++++++||||+++++
T Consensus       280 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          280 --------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             --------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             --------------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                          000112345678899999999999999999     9999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-49  Score=336.37  Aligned_cols=263  Identities=14%  Similarity=0.097  Sum_probs=189.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhc--CCCCcceee-------eeeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKEL--KHENIVRLL-------NVQSSV   71 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~~   71 (293)
                      |++.+.||+|+||+||++.+..+|+.||+|++...... ......+.+|+++++.+  +|||+++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            88999999999999999999999999999999764432 23345667785555555  699988755       343332


Q ss_pred             -----------------CcceeEeecCCcchHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecccCC
Q 038154           72 -----------------DSIDLVFENLDFDLLHFMKTEPTVTKNPLKI------KKYLHQILHGVAYCHSQEILHRDLKP  128 (293)
Q Consensus        72 -----------------~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~~h~dl~~  128 (293)
                                       ...|+||||++|++.+++..... .+.+..+      ..++.||+.||+|||++|++|+||||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp  222 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP  222 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence                             23799999999988888865422 2233345      57779999999999999999999999


Q ss_pred             CceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCcccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 038154          129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG-SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA  207 (293)
Q Consensus       129 ~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  207 (293)
                      +||+++.++. +||+|||.+......   .....+++.|+|||++.+ ...++.++||||||+++|+|++|..||...+.
T Consensus       223 ~NIll~~~~~-~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          223 DNLFIMPDGR-LMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             GGEEECTTSC-EEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             HHEEECCCCC-EEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            9999999888 999999999876532   213336699999998875 23689999999999999999999999976533


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          208 PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                      ...                ...    ..... .............+.+++++.+||.+||+.||++|||+.++|+||||+
T Consensus       299 ~~~----------------~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          299 GIK----------------GSW----KRPSL-RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             TCT----------------TCC----CBCCT-TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             ccc----------------cch----hhhhh-hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            210                000    00000 000000111122346899999999999999999999999999999998


Q ss_pred             cCc
Q 038154          288 DFQ  290 (293)
Q Consensus       288 ~~~  290 (293)
                      +++
T Consensus       358 ~~~  360 (371)
T 3q60_A          358 QLQ  360 (371)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-49  Score=335.26  Aligned_cols=283  Identities=22%  Similarity=0.342  Sum_probs=209.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            5899999999999999999999999999999986432 233346788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++| ++.+.+....  .+++..+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||.+......  ..
T Consensus       113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~--~~  187 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDS--MA  187 (360)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHH--C-
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC-EEEEECCCCcccccc--cc
Confidence            986 5555555433  478889999999999999999996 9999999999999999888 999999998654321  12


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc---
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE---  235 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  235 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+............+........   
T Consensus       188 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ---CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             cCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            223488999999988766 6899999999999999999999999887766554433211111111110000000000   


Q ss_pred             cCCCCC-CCcc----------cchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          236 FGFEPN-RSPI----------KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       236 ~~~~~~-~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      +..... ....          .........++.++.+||.+||..||++|||+.++|+||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence            000000 0000          000011233688999999999999999999999999999998753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=325.32  Aligned_cols=261  Identities=20%  Similarity=0.271  Sum_probs=192.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++............+.++..+++.+.||||+++++++...+..++|||+
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~  105 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL  105 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence            58899999999999999999998999999999865433222223344455667788999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      +++.+. .+.......+++..++.++.|++.||.+||++ |++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus       106 ~~~~~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~-~~~  182 (318)
T 2dyl_A          106 MGTCAE-KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDK-AKD  182 (318)
T ss_dssp             CSEEHH-HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC-EEECCCTTC-----------
T ss_pred             cCCcHH-HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC-EEEEECCCchhccCCc-ccc
Confidence            965444 44333334688999999999999999999996 9999999999999998887 9999999987654332 222


Q ss_pred             ccCccccccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          160 IKGGSLCYKAPERLL----GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ...+++.|+|||++.    ....++.++||||||+++|+|++|..||..... .+....+.......             
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  249 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-------------  249 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------------
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------------
Confidence            334889999999885    234678999999999999999999999987433 34444443211100             


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                    ......+++++.+++.+||+.||.+|||+.++++||||+.++.
T Consensus       250 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          250 --------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             --------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             --------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                          0011246889999999999999999999999999999987653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=325.15  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=204.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||++.+.||+|+||.||++.+..++.   .||+|+++.. ........+.+|+++++.++||||+++++++...+..++|
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            68999999999999999999876555   4999998532 2233346788999999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||++|+.+..+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV-CKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCSSCEECC----C
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC-EEECCCCcccccccCccc
Confidence            9999865554444444456889999999999999999999999999999999999998887 999999999876543222


Q ss_pred             e---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 Y---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .   ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+......             
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------  273 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-------------  273 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------
T ss_pred             eeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-------------
Confidence            2   122256789999988765 68899999999999999999 99999988888777776442111             


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ..+..+++++.+++.+||..||.+|||+.++++
T Consensus       274 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 ----------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                            122357889999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=316.27  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=202.1

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ....||+|++|.||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++++...+..++|||++++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            3458999999999999999999999999986432  34457788999999999999999999999999999999999975


Q ss_pred             -chHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-CCCeEEEccCCCcccCCCCCcceec
Q 038154           84 -DLLHFMKTE-PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-SKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        84 -~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                       ++.+.+... .....++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||.+............
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC-EEECCTTTCEESCC-----CC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC-EEEeecccccccCCCCCcccc
Confidence             555555443 2345678889999999999999999999999999999999998 555 999999999876543333334


Q ss_pred             cCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||++.+. ..++.++|+||||+++|+|++|..||..................                   
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  243 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------------  243 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------------
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------------
Confidence            4588999999988654 24788999999999999999999999765443322111111110                   


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                              ....+..+++++.+++.+||+.||++|||+.++++||||+...
T Consensus       244 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          244 --------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             --------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                    0112345788999999999999999999999999999998654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-48  Score=325.87  Aligned_cols=259  Identities=21%  Similarity=0.284  Sum_probs=192.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc---
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI---   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---   74 (293)
                      +|++++.||+|++|+||+|.+..++.   .+|+|+++.........+.+.+|++++++++||||+++++++......   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            69999999999999999998776664   799999876554555567889999999999999999999998777655   


Q ss_pred             ---eeEeecCCc-chHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           75 ---DLVFENLDF-DLLHFMKTE----PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        75 ---~lv~e~~~~-~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                         ++|||++.+ ++.+.+...    ....+++..++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-~kl~Dfg  182 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-VCVADFG  182 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC-EEEeecc
Confidence               999999986 555555322    2235888999999999999999999999999999999999998887 9999999


Q ss_pred             CcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+........  ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....    
T Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----  257 (323)
T 3qup_A          183 LSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR----  257 (323)
T ss_dssp             C-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----
Confidence            9976643321  11223367789999988766 68999999999999999999 9999998888777776643111    


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-------HHHHhcCcccccCc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-------AREALRHEYFKDFQ  290 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~~p~~~~~~  290 (293)
                                               ...++.+++++.+++.+||+.||.+|||       ++++++|||+....
T Consensus       258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                                     1123457789999999999999999999       88999999987643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.6e-48  Score=315.98  Aligned_cols=248  Identities=22%  Similarity=0.260  Sum_probs=205.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+. ++..+|+|++....   ...+.+.+|++++++++||||+++++++.+.+..++|||+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            5899999999999999999876 56779999986432   2336789999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-ee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~  159 (293)
                      ++++.+..+.......+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC-EEECCTTGGGGBCCHHHHSTT
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC-EEecccccccccccccccccc
Confidence            9865555444444456889999999999999999999999999999999999998887 999999999765432111 11


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+......                  
T Consensus       166 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------------------  226 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------------  226 (269)
T ss_dssp             STTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------------------
T ss_pred             CcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC------------------
Confidence            22356789999988755 68999999999999999999 99999988887777776432111                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ..+...++++.+++.+||+.||++|||+.+++++
T Consensus       227 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 -----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                       1123357889999999999999999999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.5e-48  Score=323.70  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=206.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhcC--CCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELK--HENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~   74 (293)
                      ||++.+.||+|++|.||++.+..+++.||+|++.......    .....+.+|+.+++++.  |||++++++++...+..
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~  123 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF  123 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence            6999999999999999999999999999999996554332    23467788999999996  59999999999999999


Q ss_pred             eeEeecCC--cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLD--FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ++|+|++.  +++.+.+....  .+++..++.++.|++.||++||+.|++|+||+|+||+++.+...+||+|||.+....
T Consensus       124 ~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          124 VLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            99999997  56777666543  478889999999999999999999999999999999999443349999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...  .....+++.|+|||++.+....+.++||||||+++|+|++|..||....      .+..  .             
T Consensus       202 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~-------------  258 (320)
T 3a99_A          202 DTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G-------------  258 (320)
T ss_dssp             SSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C-------------
T ss_pred             ccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--c-------------
Confidence            432  2233489999999988766555788999999999999999999996431      1110  0             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                     .......+++++.++|.+||+.||++|||+.++++||||+++.
T Consensus       259 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          259 ---------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                           0012235788999999999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-47  Score=313.69  Aligned_cols=247  Identities=22%  Similarity=0.255  Sum_probs=203.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+. ++..+|+|++.....   ....+.+|++++++++||||+++++++...+..++|||+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            6899999999999999999766 566799999864332   336788999999999999999999999999999999999


Q ss_pred             CCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      ++++ +.+.+... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC-VKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC-EEECCTTCEEECCTTCEEEC
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC-EEEccCccceecchhhhhcc
Confidence            9855 55555433 335888999999999999999999999999999999999998887 9999999998765443222 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+......                 
T Consensus       163 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  224 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-----------------  224 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------
T ss_pred             cCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-----------------
Confidence            222356789999988765 58899999999999999999 99999988877776665431111                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                  ..+...++++.+++.+||+.||++|||+.+++++
T Consensus       225 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        1123357889999999999999999999999984

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=317.84  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=203.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|+||++.+..+++.+|+|++..  ........+.+|++++++++||||+++++++.+++..++||||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            58999999999999999999999999999998743  2334456788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce--
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY--  158 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~--  158 (293)
                      ++++.+..+.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+..........  
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC-EEECCCTTCEECC--------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC-EEEeecccceecccccccccc
Confidence            9865544444433446889999999999999999999999999999999999998888 9999999998664332211  


Q ss_pred             ------------eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          159 ------------TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       159 ------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                                  ....|++.|+|||++.+. .++.++||||||+++|+|++|..||..........              
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------------  232 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------------  232 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------------
T ss_pred             cccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------------
Confidence                        133489999999988765 68999999999999999999999986532211000              


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                   ............++.+++++.+++.+||+.||++|||+.++++  |++++
T Consensus       233 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          233 -------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             -------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence                         0000001111234567899999999999999999999999987  55543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-47  Score=324.73  Aligned_cols=251  Identities=24%  Similarity=0.295  Sum_probs=204.5

Q ss_pred             CceeeeeeccccceeEEEEEeC-------CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-------LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      +|++++.||+|+||.||+|.+.       .++..||+|+++.. ........+.+|+++++.+ +||||+++++++...+
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            5899999999999999999863       34557999998543 2223345788999999999 8999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..|+||||+++ ++.+++....              ...+++..++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            99999999985 6666665443              23478889999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . +||+|||.+........  ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+
T Consensus       241 ~-~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          241 V-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             C-EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             C-EEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8 99999999986643322  12223367889999988766 68999999999999999999 99999988777766655


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ....                             ....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       319 ~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          319 KEGH-----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HTTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3311                             111234578899999999999999999999999873

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-47  Score=318.65  Aligned_cols=255  Identities=29%  Similarity=0.444  Sum_probs=197.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----------   70 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (293)
                      +|++++.||+|++|.||+|.+..+|+.||+|++...   ......+.+|+++++.++||||+++++++.+          
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            589999999999999999999999999999998542   2234678889999999999999999998754          


Q ss_pred             ---CCcceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           71 ---VDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        71 ---~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                         .+..++|||++++ ++.+.+... ...+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg  161 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFG  161 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC-EEEeeCc
Confidence               4568999999985 555555543 345778899999999999999999999999999999999998888 9999999


Q ss_pred             CcccCCCCC--------------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHH
Q 038154          147 LARPIDVPL--------------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW-APGLL  211 (293)
Q Consensus       147 ~~~~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~~~  211 (293)
                      .+.......              .......+++.|+|||++.+...++.++|+||||+++|+|++   ||.... .....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            997664321              112233478899999998876678999999999999999998   554322 22222


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ..+.......+                          .......++.+.+++.+||+.||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          239 KKLRSVSIEFP--------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHSTTCCCC--------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HhccccccccC--------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            23221111000                          11223456789999999999999999999999999999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-47  Score=321.77  Aligned_cols=263  Identities=21%  Similarity=0.303  Sum_probs=186.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHH-HHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||.||++.+..+|+.||+|++..... ......+..|+. +++.++||||+++++++...+..++|||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            58899999999999999999999999999999864322 122234445555 6677799999999999999999999999


Q ss_pred             cCCcchHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKT---EPTVTKNPLKIKKYLHQILHGVAYCHSQ-EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++++++.+.+..   .....+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. +||+|||.+.......
T Consensus       102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSI  180 (327)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE-EEECCCSSSCC-----
T ss_pred             ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC-EEEccCCCceeccccc
Confidence            999987766642   3345688899999999999999999999 9999999999999998887 9999999997664432


Q ss_pred             cceeccCccccccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENYTIKGGSLCYKAPERLL---GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      . .....+++.|+|||++.   ....++.++||||||+++|+|++|..||.......  ..+    .....         
T Consensus       181 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~~~~---------  244 (327)
T 3aln_A          181 A-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQL----TQVVK---------  244 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC---------
T ss_pred             c-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHH----HHHhc---------
Confidence            2 22234889999999874   23358899999999999999999999997643210  000    00000         


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                               .............+++++.+++.+||+.||++|||+.++++||||...+
T Consensus       245 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          245 ---------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ---------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                     0000001112245788999999999999999999999999999998653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.2e-47  Score=315.92  Aligned_cols=256  Identities=26%  Similarity=0.383  Sum_probs=202.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC--CCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK--HENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++.+.||+|++|.||++.+. +++.+|+|++............+.+|+++++++.  ||||+++++++...+..++||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            5999999999999999999875 5889999998655444445567889999999997  599999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-  157 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-  157 (293)
                      |+.++++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+......... 
T Consensus       108 e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~-~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          108 ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM-LKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             CCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE-EEECCCSSSCC--------
T ss_pred             ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce-EEEeeccccccccCccccc
Confidence            977788888887654  5788899999999999999999999999999999999974 54 999999999866433221 


Q ss_pred             -eeccCccccccCcccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCCCC
Q 038154          158 -YTIKGGSLCYKAPERLLGS----------GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSET  225 (293)
Q Consensus       158 -~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  225 (293)
                       .....+++.|+|||++.+.          ..++.++||||||+++|+|++|..||....... ....+.....      
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------  257 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------  257 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS------
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc------
Confidence             1233489999999988652          357889999999999999999999997754432 2222211000      


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                            ....+...+.++.+++.+||+.||.+|||+.++++||||+..
T Consensus       258 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          258 ----------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ----------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ----------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                                  001122346789999999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-47  Score=313.56  Aligned_cols=248  Identities=20%  Similarity=0.216  Sum_probs=200.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.+. ++..+|+|++....   .....+.+|+++++.++||||+++++++...+..++|||+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            5899999999999999999766 56789999986432   2336788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-ee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~  159 (293)
                      +++..+..+.......+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC-EEECSTTGGGGBCCHHHHSTT
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC-EEEcccccccccccccccccc
Confidence            9754444443333345889999999999999999999999999999999999998887 999999999766432111 11


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+......                  
T Consensus       180 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------  240 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------------  240 (283)
T ss_dssp             STTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------------------
T ss_pred             CCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC------------------
Confidence            22256789999988765 58999999999999999998 99999988887777766432111                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       241 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 -----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                       1123357889999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.2e-47  Score=317.09  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=200.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCe----EEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDT----VVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|+||+||+|.+..++..    +++|.+... ........+.+|+.+++.++||||+++++++. ++..++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            699999999999999999998877776    677766432 23344567888999999999999999999986 466889


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      |+||+. |++.+.+... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+.......
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ-VQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC-EEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe-EEECCCCcccccCccc
Confidence            999998 5565655543 335778899999999999999999999999999999999998888 9999999998765432


Q ss_pred             cc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 EN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....             
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  235 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------------  235 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------------
T ss_pred             ccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------
Confidence            22  2333467789999988765 68999999999999999999 9999998877776666543111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                      ...+..++.++.+++.+||..||.+|||+.+++++
T Consensus       236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 ----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            11123356788999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3e-47  Score=313.10  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=191.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ||++.+.||+|++|.||++.+..+   +..+++|++... ........+.+|+.++++++||||+++++++. ++..++|
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            689999999999999999987643   446899987532 22233467889999999999999999999975 4678999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ||++++ ++.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECC------------
T ss_pred             EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC-EEECccccccccCcccc
Confidence            999986 555555443 346889999999999999999999999999999999999998887 99999999987643322


Q ss_pred             c-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 N-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . .....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+.....               
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---------------  235 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---------------  235 (281)
T ss_dssp             -------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------
T ss_pred             cccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---------------
Confidence            1 2223366789999988755 68899999999999999996 9999998877777666543111               


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                    ...++.+++++.+++.+||+.||++|||+.+++++
T Consensus       236 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 --------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          11234578899999999999999999999999873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.9e-47  Score=312.36  Aligned_cols=248  Identities=23%  Similarity=0.279  Sum_probs=210.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..++..+|+|++...   ......+.+|+++++.++||||+++++++...+..++|||+
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            589999999999999999999988999999998532   33446788999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      ++ +++.+.+.......+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC-EEECCCCGGGTSCSSSSEEE
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC-EEEccCccceeccCCccccc
Confidence            98 57777777666667899999999999999999999999999999999999998887 9999999998765443222 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+.......+.....                  
T Consensus       170 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------------  230 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------  230 (288)
T ss_dssp             TTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------
T ss_pred             cCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------------------
Confidence            222356789999988765 68999999999999999999 9999998877776666543111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..+++++.+++.+||..||.+|||+.++++
T Consensus       231 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                       1122356889999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=317.54  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=196.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhc----CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKEL----KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~~   72 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|+++......    .....+..|+.+++++    .||||+++++++...+
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~  111 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE  111 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence            6999999999999999999998899999999986543322    2335667799999998    8999999999999999


Q ss_pred             cceeEeec-CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe-CCCCeEEEccCCCcc
Q 038154           73 SIDLVFEN-LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID-RSKDIVKIADFGLAR  149 (293)
Q Consensus        73 ~~~lv~e~-~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~-~~~~~v~l~df~~~~  149 (293)
                      ..++|+|+ +. +++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+|||.+.
T Consensus       112 ~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~kl~dfg~~~  188 (312)
T 2iwi_A          112 GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGA  188 (312)
T ss_dssp             -CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE-EEECCCSSCE
T ss_pred             eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe-EEEEEcchhh
Confidence            99999999 55 56666665533  478899999999999999999999999999999999999 5555 9999999998


Q ss_pred             cCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          150 PIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ......  .....+++.|+|||++.+....+.++||||||+++|+|++|..||....      .+...            
T Consensus       189 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~------------  248 (312)
T 2iwi_A          189 LLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------------  248 (312)
T ss_dssp             ECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT------------
T ss_pred             hcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh------------
Confidence            765432  2334488999999988766444568999999999999999999996431      11110            


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                        ....+..++.++.++|.+||+.||++|||+.++++||||+...
T Consensus       249 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 ------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                              0012245788999999999999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-47  Score=327.63  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||+|.+..++..||+|+++.. ........+.+|++++++++||||+++++++...+..++|||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            478999999999999999999889999999998532 2223345788899999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |++.+.+... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+...........
T Consensus       194 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~-~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc-EEECcCCCceecCCCceeec
Confidence            97 5666666543 235788899999999999999999999999999999999998887 99999999876543211111


Q ss_pred             --ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          160 --IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       160 --~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                        ...+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....                 
T Consensus       272 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------------  333 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-----------------  333 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-----------------
T ss_pred             CCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence              11145679999988755 58899999999999999998 9999998877666555432111                 


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ...+..+++++.+++.+||+.||++|||+.++++
T Consensus       334 ------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                        1122346789999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=326.52  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=204.5

Q ss_pred             CceeeeeeccccceeEEEEE-----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAH-----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++++.||+|+||+||+|.     +..++..||+|+++.. ........+.+|+.++++++||||+++++++......+
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            58899999999999999998     4456778999998532 22233356788999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCC
Q 038154           76 LVFENLDF-DLLHFMKTEP-----TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGL  147 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~  147 (293)
                      +|||++.| ++.+.+....     ...+++..++.++.||+.||+|||++|++||||||+||+++.++.  .+||+|||.
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            99999975 6666665432     245788899999999999999999999999999999999985442  499999999


Q ss_pred             cccCCC--CCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDV--PLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +.....  .........+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+......    
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~----  305 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM----  305 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            864421  11122233478899999988765 68999999999999999998 99999988887777666432111    


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                               ..+..++.++.+|+.+||+.||.+|||+.+++++.++
T Consensus       306 -------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          306 -------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                                     1123467889999999999999999999999998765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-47  Score=322.98  Aligned_cols=251  Identities=24%  Similarity=0.292  Sum_probs=206.1

Q ss_pred             CceeeeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      ||++++.||+|+||.||+|.+..       .+..+|+|++... ........+.+|+++++++ +||||+++++++...+
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            68999999999999999998643       3357999988543 2223346788999999999 8999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++|||++++ ++.+.+....              ...+++..++.++.||+.||++||+.|++|+||||+||+++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            99999999985 6666665543              24588999999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . +||+|||.+........  ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+
T Consensus       229 ~-~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~  306 (382)
T 3tt0_A          229 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  306 (382)
T ss_dssp             C-EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             c-EEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7 99999999986643321  22233367889999988765 68999999999999999999 99999988877776666


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                             ...+..+++++.+++.+||+.||++|||+.+++++
T Consensus       307 ~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          307 KEGHR-----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HTTCC-----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43111                             11223468899999999999999999999999974

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-47  Score=316.46  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=205.0

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||++.+     ..++..+|+|+++.. ........+.+|+++++.++||||+++++++...+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            589999999999999999986     345588999998532 22233467888999999999999999999999999999


Q ss_pred             eEeecCC-cchHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           76 LVFENLD-FDLLHFMKTEPT----------------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      +|||+++ +++.+.+.....                      ..+++..++.++.||+.||.+||++|++|+||+|+||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            9999998 566666654332                      34788899999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~  209 (293)
                      ++.++. ++|+|||.+..........  ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.....
T Consensus       183 i~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          183 VAEGRK-MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EETTTE-EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EcCCCC-EEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            998887 9999999998664432221  223367889999988765 58899999999999999999 999999887777


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ....+.....                             ...+..+++++.+++.+||+.||++|||+.+++++
T Consensus       261 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          261 LFNLLKTGHR-----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhhcCCc-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6665533110                             11223578899999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-46  Score=310.25  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=192.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.++||+|+||+||++.+.   ..+|+|+++...........+.+|++++++++||||++++++. .....++|||+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             ceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            6999999999999999999643   3599999876554445556788999999999999999999965 45678999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC--Ccce
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENY  158 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~--~~~~  158 (293)
                      +.+..+..........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......  ....
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-EEECCCC--------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC-EEEccceeccccccccccccc
Confidence            9865554444444456889999999999999999999999999999999999998887 999999998755432  1222


Q ss_pred             eccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          159 TIKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ....+++.|+|||++..  ...++.++||||||+++|+|++|..||......+............               
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  244 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS---------------  244 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC---------------
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC---------------
Confidence            23348999999998852  3357889999999999999999999998876665555544322111               


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                               .........+++++.+++.+||+.||.+|||+.++++
T Consensus       245 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 ---------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ---------CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                     1111233457889999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.3e-47  Score=318.72  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=178.8

Q ss_pred             Cceeee-eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHH-HHHHhcCCCCcceeeeeeec----CCcc
Q 038154            1 RYTLLE-VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREV-SLLKELKHENIVRLLNVQSS----VDSI   74 (293)
Q Consensus         1 ry~i~~-~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~----~~~~   74 (293)
                      +|++.+ .||+|++|+||++.+..+|+.||+|++...       ....+|+ ..++.+.|||++++++++..    ....
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            588855 699999999999999999999999998431       2233344 34566689999999999866    4458


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~  151 (293)
                      ++||||+.| ++.+.+.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.  .++|+|||.+...
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999999985 6777777666667899999999999999999999999999999999999986332  4999999999866


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...  ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...................          
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  248 (336)
T 3fhr_A          182 TQN--ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG----------  248 (336)
T ss_dssp             ------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             ccc--ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc----------
Confidence            432  22334478999999987655 57889999999999999999999997655433321111100000          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                  ...........+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       249 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 ------------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ------------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                        0001112234578999999999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.6e-47  Score=308.03  Aligned_cols=247  Identities=22%  Similarity=0.276  Sum_probs=203.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+. ++..+|+|++.....   ..+.+.+|++++++++||||+++++++...+..++|||+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            5899999999999999999876 567899999864332   336788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +++ ++.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC-EEECCTTGGGGBCCHHHHST
T ss_pred             CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC-EEEccccccccccccccccc
Confidence            985 555555443 346789999999999999999999999999999999999998887 999999998765432111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+.....                  
T Consensus       163 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~------------------  223 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------------  223 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------------
T ss_pred             ccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence            122366789999988755 68899999999999999999 8999998887777666643111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       224 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 -----------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       01123367889999999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-45  Score=304.90  Aligned_cols=250  Identities=21%  Similarity=0.265  Sum_probs=199.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC-----CcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG-----VPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|+||++.+..+++.||+|++........     ....+.+|++++++++||||+++++++.+..  +
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            69999999999999999999999999999999865443322     2267889999999999999999999986654  7


Q ss_pred             eEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCC----eEEEccCCCc
Q 038154           76 LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKD----IVKIADFGLA  148 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~----~v~l~df~~~  148 (293)
                      +|||++. +++.+.+... ...+++..++.++.|++.||++||+.|  ++|+||+|+||+++.++.    .++|+|||.+
T Consensus        98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             EEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            9999998 5555666544 346889999999999999999999999  999999999999987654    3899999999


Q ss_pred             ccCCCCCcceeccCccccccCcccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          149 RPIDVPLENYTIKGGSLCYKAPERLLG-SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      .....   ......+++.|+|||++.. ...++.++||||||+++|+|++|..||...................      
T Consensus       177 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  247 (287)
T 4f0f_A          177 QQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL------  247 (287)
T ss_dssp             BCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC------
T ss_pred             ccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC------
Confidence            75443   3334458999999998743 3356889999999999999999999998765544321111111110      


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                          ....+..+++++.+++.+||+.||.+|||+.++++
T Consensus       248 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 --------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                01123457889999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-46  Score=305.54  Aligned_cols=247  Identities=28%  Similarity=0.314  Sum_probs=191.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC--CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      +|++.+.||+|++|.||++.+.  ++.+|+|++......  ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            6899999999999999999764  788999998654332  233467889999999999999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecccCCCceeEeC--------CCCeEEEccCCC
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE---ILHRDLKPANFLIDR--------SKDIVKIADFGL  147 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~h~dl~~~Ni~i~~--------~~~~v~l~df~~  147 (293)
                      |+++++.+..+...  ..+++..++.++.|++.||.+||++|   ++|+||+|+||+++.        ++. ++|+|||.
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~-~kl~Dfg~  162 (271)
T 3dtc_A           86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI-LKITDFGL  162 (271)
T ss_dssp             ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC-EEECCCCC
T ss_pred             EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc-eEEccCCc
Confidence            99986666555543  35788999999999999999999999   889999999999986        444 99999999


Q ss_pred             cccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          148 ARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      +.........  ...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..............       
T Consensus       163 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  232 (271)
T 3dtc_A          163 AREWHRTTKM--SAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-------  232 (271)
T ss_dssp             ---------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC-------
T ss_pred             cccccccccc--CCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC-------
Confidence            9866543222  33489999999988765 6899999999999999999999999887766655544321110       


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                           ...+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 ---------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                 11234568899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=310.26  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=202.8

Q ss_pred             Cceeee-eeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLE-VIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~-~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|.+.+ .||+|++|.||++.+.  .++..+|+|+++... .......+.+|++++++++||||+++++++ ..+..++|
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            466776 9999999999999753  467789999986432 223456788999999999999999999998 45678999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++++..+..+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-EEECCCTTCEECTTCSCE
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC-EEECcccceeeeccCcce
Confidence            9999975555444444456889999999999999999999999999999999999998887 999999999876543222


Q ss_pred             e---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 Y---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .   ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+....               
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~---------------  230 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------------  230 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---------------
T ss_pred             eeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---------------
Confidence            2   122357889999988655 58899999999999999998 999999888777666654311               


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                                    ....++.+++++.+++.+||+.||.+||++.+++++.
T Consensus       231 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          231 --------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             --------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                          1112345789999999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7e-46  Score=307.38  Aligned_cols=251  Identities=19%  Similarity=0.188  Sum_probs=205.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++...    .....+.+|+++++.+ .|++++++++++......++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            699999999999999999999899999999988532    2345788999999999 79999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC----eEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~----~v~l~df~~~~~~~~~~  155 (293)
                      ++++++.+.+.... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.    .++|+|||.+.......
T Consensus        87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99777777766543 35889999999999999999999999999999999999986543    39999999998765432


Q ss_pred             cc-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhCCCCCCC
Q 038154          156 EN-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP---GLLAAIFSIMGTPDSET  225 (293)
Q Consensus       156 ~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~  225 (293)
                      ..       .....+++.|+|||++.+. .++.++||||||+++|+|++|..||......   .....+......     
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  239 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-----  239 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-----
T ss_pred             ccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-----
Confidence            21       2333488999999988765 6899999999999999999999999875432   333333221100     


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                          .......+.+++++.+++.+||+.||++|||+.++++
T Consensus       240 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 --------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             --------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                                1122344568899999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-46  Score=313.34  Aligned_cols=250  Identities=20%  Similarity=0.237  Sum_probs=202.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++.+..+|+.||+|++....    ....+.+|+++++.+ .||||+++++++...+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            6999999999999999999999999999999986432    235789999999999 89999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC----eEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD----IVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~----~v~l~df~~~~~~~~~~  155 (293)
                      ++++++.+.+... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.    .++|+|||.+.......
T Consensus        86 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9977777766654 346899999999999999999999999999999999999987654    28999999998654332


Q ss_pred             cc-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHhCCCCCCC
Q 038154          156 EN-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGL---LAAIFSIMGTPDSET  225 (293)
Q Consensus       156 ~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  225 (293)
                      ..       .....|++.|+|||++.+. .++.++|+||||+++|+|++|..||.+......   ...+......     
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-----  238 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-----  238 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-----
T ss_pred             CCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-----
Confidence            21       2344589999999988775 689999999999999999999999988554433   3333221110     


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                          ..........| ++.+++.+||+.||.+||+++++++
T Consensus       239 --------------------~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 --------------------TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             --------------------SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------------CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                00111222344 8999999999999999999998876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.5e-47  Score=316.87  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=195.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeE----EEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTV----VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|+||+||+|.+..+++.+    ++|.+... ........+.+|++++++++||||+++++++.... .++
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5899999999999999999987777654    77776432 23344578899999999999999999999998754 778


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++++. |++.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+.......
T Consensus        94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC-EEEccCcceeEccCCc
Confidence            888887 56666665543 46888999999999999999999999999999999999998887 9999999998664432


Q ss_pred             cc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 EN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....             
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------  237 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------------  237 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------
T ss_pred             ccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-------------
Confidence            22  2223367789999988765 68999999999999999999 9999998877766555533111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                      ...+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       238 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 ----------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                            11233467889999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.8e-47  Score=322.54  Aligned_cols=250  Identities=19%  Similarity=0.268  Sum_probs=192.3

Q ss_pred             CceeeeeeccccceeEEEEEeC---CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS---LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||.||+|.+.   .++..||+|+++... .......+.+|++++++++||||+++++++...+..++|
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            4889999999999999999866   457789999985432 223346788999999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||++++.+..+.......+++..++.++.|++.||+|||++|++|+||||+||+++.++. +||+|||.+.........
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV-CKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC------------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC-EEECcCccccccccCCcc
Confidence            9999754444444444456889999999999999999999999999999999999998887 999999999876543221


Q ss_pred             e---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          158 Y---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       158 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                      .   ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+.....              
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--------------  268 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--------------  268 (373)
T ss_dssp             ----------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE--------------
T ss_pred             ceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            1   111246789999988765 68999999999999999998 9999988877776665532111              


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                     ...+..++.++.+++.+||+.||.+||++.++++
T Consensus       269 ---------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 ---------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                           0112346788999999999999999999999886

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-47  Score=320.19  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=204.1

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|+||.||++.+.     .++..||+|+++... .......+.+|++++++++||||+++++++...+..+
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            5899999999999999999876     345789999986432 2233467889999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           76 LVFENLDF-DLLHFMKTEP----------------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      +||||+++ ++.+.+....                      ...+++..++.++.||+.||.+||++|++|+||+|+||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            99999985 6666665432                      146888999999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCC--cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPL--ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~  209 (293)
                      ++.++. ++|+|||.+.......  .......+++.|+|||++.+. .++.++|+||||+++|+|++ |..||.+.+..+
T Consensus       207 ~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  284 (343)
T 1luf_A          207 VGENMV-VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  284 (343)
T ss_dssp             ECGGGC-EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             ECCCCe-EEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence            998887 9999999987653221  112233477889999988765 68999999999999999999 999999887777


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ....+....                             ....+..+++++.+++.+||+.||++|||+.++++
T Consensus       285 ~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          285 VIYYVRDGN-----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCC-----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            666654311                             11123457889999999999999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-46  Score=319.08  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=201.2

Q ss_pred             CceeeeeeccccceeEEEEE-----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC-c
Q 038154            1 RYTLLEVIREGRYGAVHRAH-----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD-S   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~   73 (293)
                      +|++++.||+|+||.||++.     +..+++.||+|+++.. ........+.+|+++++++ +||||+++++++...+ .
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            68999999999999999998     5667789999998532 2222335688999999999 7899999999987765 4


Q ss_pred             ceeEeecCCc-chHHHhhcCCC----------------------------------------------------------
Q 038154           74 IDLVFENLDF-DLLHFMKTEPT----------------------------------------------------------   94 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~----------------------------------------------------------   94 (293)
                      .++||||+.+ ++.+.+.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999985 55555544321                                                          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--ceeccCcccc
Q 038154           95 ------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--NYTIKGGSLC  166 (293)
Q Consensus        95 ------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~~~~~~~~~~  166 (293)
                            ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.+........  ......+++.
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc-EEEEeccceeeecccccchhccccCCCce
Confidence                  12788899999999999999999999999999999999998887 99999999986643322  2223347788


Q ss_pred             ccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          167 YKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       167 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      |+|||++.+. .++.++||||||+++|+|++ |..||.+....+............                        
T Consensus       261 y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  315 (359)
T 3vhe_A          261 WMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------------  315 (359)
T ss_dssp             GCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------------
T ss_pred             eEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------------
Confidence            9999988765 68999999999999999998 999998876655444443322111                        


Q ss_pred             cchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                          ..+..+++++.+++.+||..||++|||+.++++|
T Consensus       316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                1223467899999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-46  Score=309.86  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=200.5

Q ss_pred             Cceeee-eeccccceeEEEEE--eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLE-VIREGRYGAVHRAH--DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~-~lg~g~~~~vy~~~--~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+ .||+|++|+||++.  ...++..+|+|+++...........+.+|+++++.++||||+++++++ ..+..++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            588888 99999999999994  456778999999876544444457788999999999999999999998 55778999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ||++++ ++.+.+....  .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        96 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADEN  172 (291)
T ss_dssp             EECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECCTTCS
T ss_pred             EEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc-EEEccCCcceeeccCCC
Confidence            999985 5555665543  4788899999999999999999999999999999999998887 99999999987654433


Q ss_pred             cee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 NYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...   ...+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+....              
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  237 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------------  237 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------
T ss_pred             cccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            221   12256789999988655 57889999999999999999 999999887777666553311              


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                     ....+..+++++.+++.+||+.||.+|||+.++++
T Consensus       238 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 ---------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           01123457889999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=313.61  Aligned_cols=248  Identities=20%  Similarity=0.305  Sum_probs=196.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeE----EEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTV----VVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++++.||+|+||.||++.+..+++.+    ++|.+.. .........+.+|+.+++.++||||+++++++.... .++
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC-CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc-ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            6999999999999999999988787765    6665532 223445578889999999999999999999988755 778


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++++. |++.+.+... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+.......
T Consensus        94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC-EEEccCcceeEccCcc
Confidence            888887 5666666554 346888999999999999999999999999999999999998887 9999999998764332


Q ss_pred             cc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 EN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....             
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------  237 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------------  237 (327)
T ss_dssp             --------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------
T ss_pred             ccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            22  2222357789999988765 68999999999999999999 9999998877776665543111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ...+..++.++.+++.+||..||.+|||+.++++
T Consensus       238 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 ----------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            1123346788999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=314.47  Aligned_cols=253  Identities=22%  Similarity=0.267  Sum_probs=201.8

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|++|.||+|.+     ..++..||+|+++... .......+.+|+++++++ .||||+++++++...+..
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            588999999999999999986     3456689999986432 334557899999999999 899999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           75 DLVFENLDF-DLLHFMKTEPT---------------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      ++|||++++ ++.+.+.....                     ..+++..++.++.||+.||.+||+.|++|+||+|+||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            999999975 66666654432                     23688899999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~  209 (293)
                      ++.++. ++|+|||.+.........  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.....
T Consensus       205 l~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          205 VTHGKV-VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EETTTE-EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EcCCCc-EEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            998887 999999999766433222  1222367789999988765 68999999999999999998 999998876655


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                      ...........+                            ..+..+++++.+++.+||+.||.+|||+.+++++.
T Consensus       283 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          283 NFYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            554443311110                            11234678999999999999999999999999854

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=326.31  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|+||.. ...+|+.||||++..     .....+.+|+++++.+ +||||+++++++.+....|+|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECT-----TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            4889999999999996543 356789999998843     2335677899999999 79999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC---C-eEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK---D-IVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~---~-~v~l~df~~~~~~~~~~  155 (293)
                      +++|++.+.+..... ...+..++.++.||+.||.|||++|++||||||+||+++.++   . .++|+|||.+.......
T Consensus        99 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCSEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            999988888776543 344456778999999999999999999999999999996432   2 48899999998765332


Q ss_pred             ---cceeccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          156 ---ENYTIKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       156 ---~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                         .......|++.|+|||++.+  ...++.++||||||+++|+|++ |..||............    ........   
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~----~~~~~~~~---  250 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----GACSLDCL---  250 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----TCCCCTTS---
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----ccCCcccc---
Confidence               12233458999999998864  3457789999999999999999 89999765444332211    10000000   


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                          ......+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus       251 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          251 --------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             --------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             --------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                                00011245688999999999999999999999999998653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-46  Score=305.17  Aligned_cols=246  Identities=19%  Similarity=0.258  Sum_probs=203.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--CcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (293)
                      +|++.+.||+|++|+||++.+.  +..+|+|++............+.+|++++++++||||+++++++.+.  +..++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            5899999999999999999764  88899999876554444456788999999999999999999999887  7889999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      |++++ ++.+.+.......+++..++.++.|++.||+|||+.|  ++|+||+|+||+++.++. ++++|||+....... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~l~~~~~~~~~~~~-  166 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSP-  166 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC-EEEEGGGSCCTTSCT-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc-eeEEeccceeeeccc-
Confidence            99985 6767776665556899999999999999999999999  999999999999998887 888888876543322 


Q ss_pred             cceeccCccccccCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGR--YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS  233 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
                          ...+++.|+|||++.+...  ++.++||||||+++|+|++|..||...+..............             
T Consensus       167 ----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------  229 (271)
T 3kmu_A          167 ----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-------------  229 (271)
T ss_dssp             ----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-------------
T ss_pred             ----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-------------
Confidence                2237899999998876522  233799999999999999999999988777665555431111             


Q ss_pred             cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                     ...+..+++++.+++.+||+.||++|||+.++++
T Consensus       230 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ---------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           1123457889999999999999999999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.2e-47  Score=312.29  Aligned_cols=264  Identities=25%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             CceeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   74 (293)
                      +|++++.||+|+||+||++.    +..+++.||+|++...  .......+.+|++++++++||||+++++++...  ...
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            69999999999999999998    5678899999998532  223346788999999999999999999987543  568


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|||++++ ++.+.+... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCCSCC----
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe-EEEccCcccccccC
Confidence            999999975 555555544 335888899999999999999999999999999999999998887 99999999987644


Q ss_pred             CCcc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLEN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ....   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.....+. ...    ............ 
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~----~~~~~~~~~~~~-  239 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-MRM----IGNDKQGQMIVF-  239 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-HHH----HCTTCCTHHHHH-
T ss_pred             CcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHH-Hhh----hcCccccchhHH-
Confidence            3221   1222366779999988766 68999999999999999999999986432110 000    000000000000 


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...+..       ........+..+++++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELL-------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHH-------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHH-------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000000       000011224457899999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-46  Score=311.48  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=195.4

Q ss_pred             CceeeeeeccccceeEEEEEeCC---CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   72 (293)
                      +|++.+.||+|++|.||+|....   ++..+|+|+++...........+.+|++++++++||||+++++++...+     
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            58999999999999999997654   4558999998755444444567889999999999999999999987765     


Q ss_pred             cceeEeecCCc-chHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKT----EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGL  147 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~  147 (293)
                      ..++|||++.+ ++.+.+..    .....+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-~kl~Dfg~  193 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT-VCVADFGL  193 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-EEECSCSC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEEeecCc
Confidence            35999999985 55555532    23456889999999999999999999999999999999999998887 99999999


Q ss_pred             cccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +........  ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||...........+.....     
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  267 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-----  267 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----
T ss_pred             ceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-----
Confidence            976643321  12223367889999988765 68999999999999999999 8899988877776666543111     


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                              ...+..+++++.+++.+||..||.+|||+.+++++
T Consensus       268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    11234578899999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.6e-46  Score=329.03  Aligned_cols=248  Identities=23%  Similarity=0.277  Sum_probs=208.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||++.+..++..||+|+++...   ...+.+.+|++++++++||||+++++++...+..++|||+
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3788999999999999999998889999999986432   3357899999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +. |++.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++. +||+|||.+.......... 
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEECCTTCEECCTTCCEECC
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc-EEEeecccceeccCCceeec
Confidence            98 67777777666667889999999999999999999999999999999999998887 9999999998764432221 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++... .++.++||||||+++|+|++ |..||.+.+..+....+.....                  
T Consensus       377 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------  437 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------  437 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------
T ss_pred             CCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            122256789999988755 58999999999999999999 9999998877776665532110                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..+++++.+|+.+||+.||.+|||+.++++
T Consensus       438 -----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                       1123457889999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.7e-47  Score=312.18  Aligned_cols=245  Identities=17%  Similarity=0.240  Sum_probs=196.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-------CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-------DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (293)
                      +|++.+.||+|++|+||++.+..++       ..+++|++....  ....+.+.+|++++++++||||+++++++...+.
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            5899999999999999999887766       469999885432  3344678899999999999999999999999999


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCe-------EEEccC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDI-------VKIADF  145 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~-------v~l~df  145 (293)
                      .++|||+++| ++.+.+... ...+++..++.++.|++.||.+||++|++|+||||+||+++.++..       ++|+||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            9999999985 555555443 3347888999999999999999999999999999999999977652       899999


Q ss_pred             CCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHhCCCCCC
Q 038154          146 GLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      |.+......    ....+++.|+|||++.+...++.++||||||+++|+|++|.. ||..............        
T Consensus       166 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--------  233 (289)
T 4fvq_A          166 GISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--------  233 (289)
T ss_dssp             CSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--------
T ss_pred             cccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--------
Confidence            998655322    222378889999998875578999999999999999999654 4444444333332211        


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                             ....+...++++.+++.+||+.||.+|||+.+++++
T Consensus       234 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 -----------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -----------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                   011223357789999999999999999999999983

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-46  Score=312.25  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=195.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|+||+|.+..++    ..||+|+++... .......+.+|+++++.++||||+++++++...+..++
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            5889999999999999999876543    359999885322 22334568889999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      |||++++ ++.+.+.. ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus       124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc-EEECCCCcchhhcccc
Confidence            9999986 45455543 3346889999999999999999999999999999999999998887 9999999998765432


Q ss_pred             cc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          156 EN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       156 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ..   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......           
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-----------  269 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-----------  269 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------
T ss_pred             ccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-----------
Confidence            21   1122256789999988765 68899999999999999999 99999888777766665431110           


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                        ..+..++.++.+++.+||+.||.+||++.+++++
T Consensus       270 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              1123467889999999999999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-46  Score=312.15  Aligned_cols=251  Identities=24%  Similarity=0.295  Sum_probs=202.9

Q ss_pred             CceeeeeeccccceeEEEEEeC-------CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-------LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      +|++++.||+|+||.||+|.+.       .++..||+|++.... .......+.+|+++++++ +||||+++++++...+
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            5899999999999999999865       456789999985332 223345688899999999 8999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEPT--------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++|||++++ ++.+.+.....              ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            99999999985 66666654331              2478889999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . +||+|||.+.........  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+
T Consensus       195 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  272 (334)
T 2pvf_A          195 V-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  272 (334)
T ss_dssp             C-EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             C-EEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence            7 999999999876543222  1222367889999988765 58899999999999999999 99999988777766665


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                             ...+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       273 ~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          273 KEGHR-----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43111                             11223467899999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.9e-47  Score=316.17  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=202.9

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++.+.||+|++|.||+|.+.     .++..+|+|.+.... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            5899999999999999999765     356789999885322 2223346788999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLDF-DLLHFMKTE--------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      +|||++++ ++.+.+...        ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~-~kl~Dfg  183 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  183 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCTT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe-EEECcCc
Confidence            99999985 665655432        1245688899999999999999999999999999999999998887 9999999


Q ss_pred             CcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .+..........  ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....     
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  257 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-----  257 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----
T ss_pred             cccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-----
Confidence            987654321111  122257889999988765 68999999999999999999 899999887777666654311     


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                              ....+..++.++.+++.+||+.||++|||+.+++++
T Consensus       258 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 ------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    011223578899999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-45  Score=322.12  Aligned_cols=242  Identities=22%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-cceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-SIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e   79 (293)
                      +|++.+.||+|+||.||++...  |..||+|+++..    .....+.+|++++++++||||+++++++.... ..++|||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4789999999999999999754  779999998643    24578999999999999999999999976655 7899999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +++ |++.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+.......   
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC-EEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC-EEEeeCCCcccccccc---
Confidence            998 57777777655555788899999999999999999999999999999999998887 9999999998654321   


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+....                   
T Consensus       344 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------------------  403 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------  403 (450)
T ss_dssp             ---CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------------
T ss_pred             cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence            122467889999988766 68999999999999999998 999999887777666654311                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ....+..+++++.+++.+||+.||.+|||+.++++
T Consensus       404 ----------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ----------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      01123457889999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.9e-46  Score=309.15  Aligned_cols=252  Identities=23%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|++|.||++.+     ..++..+|+|+++... .......+.+|+++++++ +||||+++++++...+..
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            689999999999999999974     4577899999986432 222346788999999999 899999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPT----------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ++|||++++ ++.+.+.....                ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            999999975 66666655432                2488999999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++|+|||.+..........  ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||............
T Consensus       183 ~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  260 (313)
T 1t46_A          183 I-TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (313)
T ss_dssp             E-EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             C-EEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence            7 9999999998765443321  122366789999988765 68999999999999999999 99999887665554444


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .......                            ..+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       261 ~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          261 IKEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCCCC----------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3321111                            1123467899999999999999999999999873

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-46  Score=315.61  Aligned_cols=256  Identities=20%  Similarity=0.257  Sum_probs=201.4

Q ss_pred             CceeeeeeccccceeEEEEE-----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAH-----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++++.||+|++|.||++.     +..++..||+|++... ........+.+|+.++++++||||+++++++...+..+
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            68999999999999999998     4567889999998532 22233457888999999999999999999999999999


Q ss_pred             eEeecCC-cchHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC--CeEEEccCCC
Q 038154           76 LVFENLD-FDLLHFMKTEPT-----VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK--DIVKIADFGL  147 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~  147 (293)
                      +|||+++ +++.+++.....     ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++  ..++|+|||.
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999996 566666655432     3478889999999999999999999999999999999998433  2499999999


Q ss_pred             cccCCCCC--cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCC
Q 038154          148 ARPIDVPL--ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSE  224 (293)
Q Consensus       148 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  224 (293)
                      +.......  .......+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....     
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----  263 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-----  263 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC-----
Confidence            87543221  112233368899999988765 68999999999999999998 9999998877766665543111     


Q ss_pred             CCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                              ...+..++..+.+++.+||+.||.+|||+.+++++.|+.
T Consensus       264 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 ------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                    112234678999999999999999999999999988753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-46  Score=310.58  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             CceeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   74 (293)
                      +|++++.||+|++|.||++.    +..+++.||+|++.... .......+.+|+++++.++||||+++++++...  ...
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            58999999999999999998    56789999999986443 334457788999999999999999999998876  568


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|||++++ ++.+.+... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC-EEECcccccccccC
Confidence            999999986 555555333 345889999999999999999999999999999999999998887 99999999987765


Q ss_pred             CCcc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHhC
Q 038154          154 PLEN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-----------PGLLAAIFSIMG  219 (293)
Q Consensus       154 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~  219 (293)
                      ....   .....+++.|+|||++.+. .++.++|+||||+++|+|++|..|+.....           ......+.....
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            4332   2223367789999988765 578999999999999999999998643211           111111111000


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .                         ......+..+++++.+++.+||+.||.+|||+.++++
T Consensus       258 ~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 E-------------------------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             T-------------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             c-------------------------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0                         0111233467899999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.8e-46  Score=323.41  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=192.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|.+.+.||+|++|+||.+. ..+|+.||+|++...     ..+.+.+|+++++++ +||||+++++++.+.+..|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            46778999999999998653 457999999988542     234677899999887 89999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC------------CeEEE
Q 038154           80 NLDFDLLHFMKTEPTVTK-----NPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK------------DIVKI  142 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~-----~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~------------~~v~l  142 (293)
                      +++|++.+.+........     ++..++.++.||+.||+|||++|++|+||||+||+++.++            ..+||
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            999988887765433211     2334678999999999999999999999999999998643            25999


Q ss_pred             ccCCCcccCCCCCcc----eeccCccccccCcccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 038154          143 ADFGLARPIDVPLEN----YTIKGGSLCYKAPERLLG------SGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLL  211 (293)
Q Consensus       143 ~df~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~  211 (293)
                      +|||.+.........    .....|++.|+|||++.+      ...++.++||||||+++|+|++ |..||.......  
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence            999999876543221    123358999999998865      2468999999999999999999 899997665443  


Q ss_pred             HHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      ..+..........  .                     ......+++++.++|.+||+.||.+|||+.++++||||..
T Consensus       248 ~~i~~~~~~~~~~--~---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 SNIIRGIFSLDEM--K---------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHTCCCCCCC--T---------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHhcCCCCcccc--c---------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            2222211110000  0                     0001124578999999999999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3e-46  Score=313.62  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeE--EEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTV--VVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|++|.||++.+..++..+  ++|.+... ........+.+|+++++++ +||||+++++++...+..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            5899999999999999999988888755  88988532 3344557789999999999 899999999999999999999


Q ss_pred             eecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEE
Q 038154           78 FENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKI  142 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l  142 (293)
                      ||++++ ++.+.+....              ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~kL  183 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKI  183 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe-EEE
Confidence            999975 6666665432              246889999999999999999999999999999999999998887 999


Q ss_pred             ccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 038154          143 ADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       143 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      +|||.+....... ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....   
T Consensus       184 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---  258 (327)
T 1fvr_A          184 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  258 (327)
T ss_dssp             CCTTCEESSCEEC-CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC---
T ss_pred             cccCcCccccccc-cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC---
Confidence            9999987543221 12223367889999988655 57899999999999999998 999998887766655542210   


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                ....+..+++++.++|.+||..||.+|||+.+++++
T Consensus       259 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 --------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                      011223467899999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-45  Score=307.38  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=190.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|..+|+|++...... ......+.+|++++++++||||+++++++...+..++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            589999999999999999999899999999998653322 2334578889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDF-DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~-~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++++ ++.+.+..  .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~-~kl~Dfg~~~~~~~~~~  191 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTT  191 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCC-----------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC-EEEEeccceeeecCCCc
Confidence            9986 55555432  23445788999999999999999999999999999999999998887 99999999887654433


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP--GLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||......  .....+..... +             
T Consensus       192 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-------------  256 (310)
T 2wqm_A          192 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-P-------------  256 (310)
T ss_dssp             -------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS-C-------------
T ss_pred             cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC-C-------------
Confidence            33444588999999988765 6899999999999999999999999764322  22222221000 0             


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                    ......++.++.+++.+||+.||.+|||+.++++
T Consensus       257 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 --------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             --------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                          0011346889999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-45  Score=307.98  Aligned_cols=251  Identities=21%  Similarity=0.282  Sum_probs=195.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++....... .....+.+|++++++++||||+++++++..++..++|+|
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            6999999999999999999999999999999986543222 223678889999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC-cc
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL-EN  157 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~-~~  157 (293)
                      +++| ++.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus       115 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSCCC-----------
T ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC-EEEecCccCcccccccccc
Confidence            9986 5555555432  4788899999999999999999999999999999999998887 9999999987654332 12


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+..   ..                
T Consensus       192 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~----------------  251 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AI----------------  251 (309)
T ss_dssp             -----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CC----------------
T ss_pred             ccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CC----------------
Confidence            2233488999999988765 688999999999999999999999987665533333211   00                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-CHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-TAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~  282 (293)
                              .......+.+++++.++|.+||+.||++|| +++++++
T Consensus       252 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 --------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             --------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                    111233456889999999999999999999 7888775

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-46  Score=305.85  Aligned_cols=249  Identities=22%  Similarity=0.292  Sum_probs=197.0

Q ss_pred             CceeeeeeccccceeEEEEEeCC---CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|++|+||++.+..   ++..+|+|.+.... .......+.+|+++++.++||||+++++++.+ +..++|
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            58999999999999999998543   33459999875432 22334678899999999999999999999865 457899


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ||++++ ++.+.+.. ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus        91 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE-EEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc-EEeCccCCCcccccccc
Confidence            999985 45455543 3345788899999999999999999999999999999999998887 99999999986644322


Q ss_pred             -ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 -NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       ......+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+......              
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--------------  233 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--------------  233 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--------------
T ss_pred             cccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--------------
Confidence             12233367889999988655 68899999999999999998 99999887777666555431111              


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                     ..+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       234 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 ---------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                           1123467889999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=303.70  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=195.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcc-ee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSI-DL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~l   76 (293)
                      +|.+.+.||+|++|+||+|.+..++.   .+|+|.+... ......+.+.+|+++++.++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            36778999999999999998654444   7999987532 2223346788999999999999999999998776655 99


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++|++.+ ++.+.+. .....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus       101 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          101 LLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT-VKVADFGLARDILDRE  178 (298)
T ss_dssp             EECCCTTCBHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECCTTSSCTTTTGG
T ss_pred             EEecccCCCHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEeCcCCCcccccCCc
Confidence            9999975 5555554 44456788899999999999999999999999999999999998887 9999999997654321


Q ss_pred             ----cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          156 ----ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       156 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                          .......+++.|+|||.+.+. .++.++||||||+++|+|++|..| |...+..+....+.....           
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-----------  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-----------  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-----------
T ss_pred             ccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-----------
Confidence                122233467899999988765 689999999999999999996554 555555555544432111           


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                        ...+..++.++.+++.+||+.||.+|||+.++++
T Consensus       247 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 ------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              1112346788999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-46  Score=336.04  Aligned_cols=281  Identities=25%  Similarity=0.326  Sum_probs=204.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec------CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS------VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   74 (293)
                      ||++.+.||+|+||+||++.+..+|..||+|++... ........+.+|++++++++||||+++++++..      .+..
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            699999999999999999999889999999987542 223334668889999999999999999998765      6778


Q ss_pred             eeEeecCCc-chHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCccc
Q 038154           75 DLVFENLDF-DLLHFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARP  150 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~  150 (293)
                      ++||||++| ++.+.+.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.  .++|+|||.+..
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            999999975 5555555432 235778899999999999999999999999999999999997654  489999999987


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ..... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||............   .............
T Consensus       174 ~~~~~-~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~  248 (676)
T 3qa8_A          174 LDQGE-LCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVYD  248 (676)
T ss_dssp             TTSCC-CCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSCC
T ss_pred             ccccc-ccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhhh
Confidence            65432 22334589999999988765 6899999999999999999999999765433211000   0000000000000


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .......+..   .........+.+++.+.++|.+||..||++|||+.++++||||+.+.
T Consensus       249 ~l~g~~~~~~---~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          249 DLTGAVKFSS---VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCSSSCCCCS---SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhcccccccc---ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            0001111100   00111223444678899999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-45  Score=304.71  Aligned_cols=250  Identities=21%  Similarity=0.228  Sum_probs=194.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC---CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee-ecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ-SSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l   76 (293)
                      +|++.+.||+|++|+||+|.+..++   ..+++|.+... ........+.+|+.++++++||||+++++++ ..++..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            5899999999999999999865333   35788887532 2223346788999999999999999999984 55668899


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC-
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL-  155 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~-  155 (293)
                      |||+++++.+..+.......+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....... 
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSCGGGCCCSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC-EEECcccccccccccch
Confidence            99999874444444444456788999999999999999999999999999999999998887 9999999997654321 


Q ss_pred             ---cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          156 ---ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       156 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                         .......+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+.....            
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------  250 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------------  250 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred             hccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC------------
Confidence               112223367789999988765 68999999999999999999 5677777666666555543111            


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                       ...+..++..+.+++.+||+.||.+|||+.++++
T Consensus       251 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -----------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             1112346788999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-45  Score=302.10  Aligned_cols=244  Identities=26%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----------   70 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (293)
                      +|++.+.||+|++|.||++.+..+++.||+|++...      ...+.+|++++++++||||+++++++..          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            589999999999999999999989999999998642      2568899999999999999999998754          


Q ss_pred             ------CCcceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEc
Q 038154           71 ------VDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIA  143 (293)
Q Consensus        71 ------~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~  143 (293)
                            ....++|||++++ ++.+.+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~  164 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIG  164 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEEC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC-EEEC
Confidence                  3458999999986 6666666554556889999999999999999999999999999999999998887 9999


Q ss_pred             cCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCC
Q 038154          144 DFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       144 df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      |||.+....... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..|+...  ......+..       
T Consensus       165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~-------  233 (284)
T 2a19_B          165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD-------  233 (284)
T ss_dssp             CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT-------
T ss_pred             cchhheeccccc-cccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc-------
Confidence            999988765432 22333488999999988765 6899999999999999999999887421  111111110       


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                               ......++.++.+++.+||+.||.+|||+.+++++++.-
T Consensus       234 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 -------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             -------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                     011234678899999999999999999999999987643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-45  Score=302.14  Aligned_cols=246  Identities=25%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|++|.||++.+. ++..+|+|++....   ...+.+.+|+++++.++||||+++++++.. +..++|||+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            5899999999999999999865 56689999885432   234678899999999999999999999764 568999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      +++ ++.+.+.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......... 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCEECC
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC-EEECCCcccccccCcccccc
Confidence            975 5555554433335788899999999999999999999999999999999998887 9999999998765432221 


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.....                  
T Consensus       168 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------  228 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------  228 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             cCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------------------
Confidence            222356789999988655 57899999999999999999 8999998877776666543110                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..+++++.+++.+||+.||++|||+.++++
T Consensus       229 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 -----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       0112346789999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-46  Score=312.45  Aligned_cols=263  Identities=18%  Similarity=0.216  Sum_probs=200.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++.+. +|..||+|++...  .......+.+|+++++.++||||+++++++...+..++||||
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             ccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            5889999999999999999864 6889999987543  233456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           81 LDF-DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        81 ~~~-~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      +++ ++.+.+....  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. +||+|||.+........ 
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQT  195 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC-EEECCCTTCEECSSSSCC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC-EEEeeccccccccccccc
Confidence            985 5555554332  235788999999999999999999999999999999999998887 99999999976532211 


Q ss_pred             -ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---HHhCCCCCCCCCCCcCc
Q 038154          157 -NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF---SIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  232 (293)
                       ......+++.|+|||++.+. .++.++||||||+++|+|++|..||......+......   ..........       
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  267 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ-------  267 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS-------
T ss_pred             ccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH-------
Confidence             12223378999999988765 68999999999999999999999997654432211110   0000000000       


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                        ..       .........+..+..+.+++.+||+.||++|||+.+++++.
T Consensus       268 --~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          268 --IV-------DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             --SS-------SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --hc-------ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence              00       00001112233467889999999999999999999999854

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-45  Score=323.24  Aligned_cols=246  Identities=24%  Similarity=0.315  Sum_probs=202.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||++... ++..||+|+++...   ...+.+.+|++++++++||||+++++++. ....++|||+
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            4889999999999999999876 46789999986432   34578999999999999999999999986 5678999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +. |++.+.+.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++. +||+|||.+......... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV-CKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC-EEECSTTGGGGBCCHHHHTT
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc-EEEeeCCCceEcCCCceecc
Confidence            97 56667766544345788899999999999999999999999999999999998887 999999999876432111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++... .++.++||||||+++|+|++ |..||.+.+..+....+......                 
T Consensus       343 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----------------  404 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------------  404 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-----------------
T ss_pred             CCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence            122256789999988755 68999999999999999999 99999988887777766442111                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ..+..+++++.+++.+||+.||++|||+.+|++
T Consensus       405 ------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                        112346889999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=323.37  Aligned_cols=273  Identities=21%  Similarity=0.310  Sum_probs=201.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--cceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--SIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~   78 (293)
                      ||++.+.||+|++|+||+|.+..+|+.||+|++..... ......+.+|++++++++||||+++++++...+  ..++||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            69999999999999999999999999999999864322 233467789999999999999999999987765  679999


Q ss_pred             ecCCc-chHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE----eCCCCeEEEccCCCcccCC
Q 038154           79 ENLDF-DLLHFMKTEP-TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI----DRSKDIVKIADFGLARPID  152 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i----~~~~~~v~l~df~~~~~~~  152 (293)
                      ||+.| ++.+.+.... ...+++..++.++.||+.||+|||+.|++|+||||+||++    +.++. +||+|||.+....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-~kL~DFG~a~~~~  167 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV-YKLTDFGAARELE  167 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE-EEECCGGGCEECC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee-EEEecCCCceEcc
Confidence            99985 5555554332 2338899999999999999999999999999999999998    44444 9999999998765


Q ss_pred             CCCcceeccCccccccCcccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHHHhCCC
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGS-------GRYSTPVDVWAVACTFAEMVTHQRLFHSRWA----PGLLAAIFSIMGTP  221 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~  221 (293)
                      .. .......+++.|+|||++.+.       ..++.++||||||+++|+|++|..||.....    .+.+..+..   ..
T Consensus       168 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~  243 (396)
T 4eut_A          168 DD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GK  243 (396)
T ss_dssp             CG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---SC
T ss_pred             CC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---CC
Confidence            43 223344589999999987642       3567899999999999999999999975432    233333322   22


Q ss_pred             CCCCCCCCcCcc-cccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          222 DSETLPGFTSFS-EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       222 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      +........... ..+.+....   .....+...++..+.+++.+||+.||++|||++++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CcccchhheeccCCCcccCccC---CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            222211111100 000000000   0111222345678899999999999999999999855

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-45  Score=306.54  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC-c
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD-S   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~   73 (293)
                      +|++.+.||+|++|+||++.+     ..+++.||+|++.... .......+.+|+++++++ +||||+++++++...+ .
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            689999999999999999974     4567899999985432 222335688899999999 6899999999987654 5


Q ss_pred             ceeEeecCCc-chHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPT--------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD  138 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~  138 (293)
                      .++|||++++ ++.+.+.....              ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999985 55555554332              12778899999999999999999999999999999999998887


Q ss_pred             eEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 038154          139 IVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       139 ~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~  215 (293)
                       ++|+|||.+..........  ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.............
T Consensus       187 -~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          187 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             -EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             -EEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence             9999999998664432222  223367889999988765 68999999999999999998 999998876554433333


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....                            ...+..+++++.+++.+||+.||.+|||+.++++|
T Consensus       265 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          265 KEGTR----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCcc----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21111                            11223467899999999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.8e-45  Score=300.20  Aligned_cols=250  Identities=19%  Similarity=0.185  Sum_probs=198.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeee-eecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV-QSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e   79 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++....    ....+.+|+.+++.+.|++++..+.. ....+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            6999999999999999999998999999999875432    23578899999999998776655554 466677899999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe---CCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID---RSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~---~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++++++.+.+.... ..+++..++.++.|++.||++||++|++|+||+|+||+++   .++. +||+|||.+........
T Consensus        86 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~-~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           86 LLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC-EEECCCTTCEECBCTTT
T ss_pred             ecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe-EEEeeCCCccccccccc
Confidence            99777777665433 3688999999999999999999999999999999999995   5565 99999999987654322


Q ss_pred             c-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCCCCCCC
Q 038154          157 N-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA---PGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       157 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  226 (293)
                      .       .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.....   ......+......      
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  236 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------  236 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------
T ss_pred             ccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC------
Confidence            1       2333488999999988766 589999999999999999999999986432   2222222211000      


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                         .........+++++.+++.+||+.||++|||+.++++
T Consensus       237 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 -------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                               1112234567899999999999999999999999887

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-45  Score=303.04  Aligned_cols=242  Identities=21%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (293)
                      +|++.+.||+|++|+||++.+  +|+.+|+|+++..    ...+.+.+|++++++++|||++++++++.. .+..++|||
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            589999999999999999975  4789999988532    345678899999999999999999998654 457999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++++ ++.+.+.......+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.......   
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC-----------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc-EEEeeccccccccccc---
Confidence            9985 6666665543334678899999999999999999999999999999999998887 9999999987654322   


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+....+....                   
T Consensus       172 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------------  231 (278)
T 1byg_A          172 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------  231 (278)
T ss_dssp             ----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------------
T ss_pred             cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence            222367889999988765 68999999999999999998 999998877766665542210                   


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ....+..+++++.+++.+||+.||.+|||+.++++
T Consensus       232 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ----------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                      01123457889999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-44  Score=298.48  Aligned_cols=250  Identities=19%  Similarity=0.187  Sum_probs=197.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeee-eecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNV-QSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e   79 (293)
                      ||++.+.||+|++|.||++.+..+++.||+|++....    ....+.+|+++++.+.|++++..+.. +...+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            6999999999999999999999999999999864432    23568899999999998776666554 466778899999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE---eCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i---~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++++++.+.+.... ..+++..++.++.|++.||+|||+.|++|+||+|+||++   +.++. +||+|||.+........
T Consensus        86 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~-~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           86 LLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC-EEECCCTTCEECBCTTT
T ss_pred             ccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe-EEEecCccceeccCccc
Confidence            99777777665433 358899999999999999999999999999999999999   66666 99999999986644322


Q ss_pred             -------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhCCCCCCCC
Q 038154          157 -------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP---GLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       157 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  226 (293)
                             ......+++.|+|||++.+. .++.++||||||+++|+|++|..||......   .....+......      
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  236 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------  236 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------
T ss_pred             CccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc------
Confidence                   12233489999999988766 6899999999999999999999999764332   222222110000      


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                         .........+++++.+++.+||+.||++|||+.++++
T Consensus       237 -------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 -------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                               1122333567899999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=312.28  Aligned_cols=253  Identities=11%  Similarity=0.102  Sum_probs=197.4

Q ss_pred             CceeeeeeccccceeEEEEEeCC--------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcce---------
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL--------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVR---------   63 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~---------   63 (293)
                      +|++.+.||+|++|.||+|.+..        .++.||+|++...       ..+.+|++++++++|||+++         
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            58999999999999999999887        4889999998532       46889999999999999887         


Q ss_pred             ------eeeeeec-CCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC
Q 038154           64 ------LLNVQSS-VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS  136 (293)
Q Consensus        64 ------~~~~~~~-~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~  136 (293)
                            +++++.. ++..++|||++++++.+.+.......+++..++.++.||+.||.|||++|++|+||+|+||+++.+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                  5556554 678899999997788887776544568999999999999999999999999999999999999987


Q ss_pred             CC-eEEEccCCCcccCCCCCc-------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-c
Q 038154          137 KD-IVKIADFGLARPIDVPLE-------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW-A  207 (293)
Q Consensus       137 ~~-~v~l~df~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~  207 (293)
                      +. .++|+|||.+........       ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.... .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            71 499999999976543211       11223588999999988766 68999999999999999999999998764 2


Q ss_pred             -hHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          208 -PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                       .............+....                     ........+++++.+++.+||+.||++|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFV---------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEE---------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhccCChhhhh---------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             233332222111111000                     000112346899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=310.07  Aligned_cols=255  Identities=17%  Similarity=0.157  Sum_probs=190.9

Q ss_pred             CceeeeeeccccceeEEEEEeCC---CCCeEEEEEecccCCC---------CCCcccHHHHHHHHHhcCCCCcceeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPIMNPS---------EGVPSSVIREVSLLKELKHENIVRLLNVQ   68 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (293)
                      +|++.+.||+|++|.||+|.+..   ++..+|+|++......         ......+.+|+..++.+.||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            58999999999999999999876   7889999988643211         01223466778888888999999999998


Q ss_pred             ec----CCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC--CeEEE
Q 038154           69 SS----VDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK--DIVKI  142 (293)
Q Consensus        69 ~~----~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l  142 (293)
                      ..    ....++|||++++++.+.+....  .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++  . +||
T Consensus       118 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~kL  194 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYL  194 (345)
T ss_dssp             EEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS-EEE
T ss_pred             ccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc-EEE
Confidence            77    67899999999666666665443  688999999999999999999999999999999999999876  5 999


Q ss_pred             ccCCCcccCCCCC-------cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chH-HHHH
Q 038154          143 ADFGLARPIDVPL-------ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRW-APG-LLAA  213 (293)
Q Consensus       143 ~df~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-~~~-~~~~  213 (293)
                      +|||.+.......       .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.... ... ....
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999997653221       111333588999999988766 68999999999999999999999996532 222 2222


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhc--CCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVV--GGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ........+                       .......  ..+++++.+++.+||+.||.+|||+.++++
T Consensus       274 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELP-----------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHTTT-----------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhccccc-----------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            111111100                       0011111  157889999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-45  Score=309.24  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=199.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++... +|+.||+|++..... ......+.+|+++++.+.||||+++++++...+..++|||+
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             ccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            6899999999999999999744 688999999865432 23334789999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           81 LDF-DLLHFMKTEP--TVTKNPLKIKKYLHQILHGVAYCHSQ---EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        81 ~~~-~~~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +.+ ++.+.+....  ...+++..++.++.|++.||++||+.   |++|+||+|+||+++.++. ++|+|||.+......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~  187 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK  187 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC-EEECCCSSCEECCSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC-EEeccCccccccCcc
Confidence            986 5555555433  23488889999999999999999999   9999999999999998887 999999999876543


Q ss_pred             Ccc-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC----CCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          155 LEN-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHS----RWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       155 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~----~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      ... .....+++.|+|||++.+. .++.++||||||+++|+|++|..||..    .........+.......  ..... 
T Consensus       188 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-  263 (326)
T 3uim_A          188 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--KKLEA-  263 (326)
T ss_dssp             SSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS--CCSTT-
T ss_pred             cccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc--hhhhh-
Confidence            333 2334489999999988665 589999999999999999999999952    11111122221100000  00000 


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY  285 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~  285 (293)
                           ..       ............+..+.+++.+||+.||.+|||+.++++|-.
T Consensus       264 -----~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 -----LV-------DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             -----SS-------CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             -----hc-------ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                 00       000001112224578999999999999999999999999754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=309.72  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=183.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeee--------cC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQS--------SV   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~~   71 (293)
                      ||++.+.||+|++|.||++.+..+++.||+|++...  .......+.+|+.+++++. ||||+++++++.        ..
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            689999999999999999999999999999988443  2233457788999999996 999999999883        34


Q ss_pred             CcceeEeecCCcchHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeCCCCeEEEccCCCc
Q 038154           72 DSIDLVFENLDFDLLHFMKT-EPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDRSKDIVKIADFGLA  148 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~~~~~v~l~df~~~  148 (293)
                      ...+++||+++|++.+.+.. .....+++..++.++.||+.||.|||+.|  ++|+||+|+||+++.++. ++|+|||.+
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~  185 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSA  185 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC-EEBCCCTTC
T ss_pred             ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC-EEEecCccc
Confidence            45899999999998887764 22345889999999999999999999999  999999999999998887 999999999


Q ss_pred             ccCCCCCcce------------eccCccccccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 038154          149 RPIDVPLENY------------TIKGGSLCYKAPERLL--GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       149 ~~~~~~~~~~------------~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~  214 (293)
                      ..........            ....+++.|+|||++.  ....++.++||||||+++|+|++|..||............
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  265 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK  265 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence            8765432211            1233788999999873  3346788999999999999999999999754332211110


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                      .                                ........+..+.+++.+||+.||.+|||+.+++++.
T Consensus       266 ~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          266 Y--------------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             C--------------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             c--------------------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            0                                0011233567789999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.3e-45  Score=308.08  Aligned_cols=251  Identities=21%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC-----eEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD-----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|++.+.||+|++|.||++.+..++.     .+|+|.+.... .......+.+|+++++.+ +||||+++++++...+..
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            58999999999999999999876554     79999885332 223346788999999999 899999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEE
Q 038154           75 DLVFENLDF-DLLHFMKTEP------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVK  141 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~  141 (293)
                      ++|||++++ ++.+.+....            ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~k  204 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AK  204 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE-EE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe-EE
Confidence            999999985 6666654321            235788899999999999999999999999999999999998887 99


Q ss_pred             EccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHh
Q 038154          142 IADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIM  218 (293)
Q Consensus       142 l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~  218 (293)
                      |+|||.+.........  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.........+....
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  283 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG  283 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence            9999999765433221  1222356789999988765 68999999999999999998 899998876655554444322


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...                            ..+...++++.+++.+||+.||.+|||+.++++
T Consensus       284 ~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          284 YQM----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            111                            112335788999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.6e-45  Score=320.32  Aligned_cols=246  Identities=25%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||++.+.. +..||+|+++...   ...+.+.+|++++++++||||+++++++.. +..++|||+
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            48899999999999999998764 4679999986432   234678999999999999999999999876 778999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +. |++.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++. +||+|||.+......... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC----------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC-EEECCCccceecCCCceecc
Confidence            98 56667765443445788899999999999999999999999999999999998887 999999999866432111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+.....                  
T Consensus       339 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------  399 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------  399 (452)
T ss_dssp             ----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             cCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            222356789999988755 68999999999999999999 9999998887777666543111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..+++.+.+++.+||+.||++|||+.++++
T Consensus       400 -----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          400 -----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       1123357889999999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=300.20  Aligned_cols=243  Identities=29%  Similarity=0.408  Sum_probs=189.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|+||++...  ++.+|+|++..    ......+.+|++++++++||||+++++++.+  ..++||||
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            5899999999999999999754  78899998742    2344678899999999999999999998774  48999999


Q ss_pred             CCc-chHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           81 LDF-DLLHFMKTEPT-VTKNPLKIKKYLHQILHGVAYCHS---QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++| ++.+.+..... ..++...++.++.|++.||.+||+   +|++|+||+|+||+++.++..+||+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            985 55565554432 246788899999999999999999   8999999999999999888768999999997654322


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                         ....+++.|+|||++.+. .++.++||||||+++|+|++|..||..................               
T Consensus       161 ---~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------  221 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------------  221 (307)
T ss_dssp             -------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---------------
T ss_pred             ---ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---------------
Confidence               223489999999988765 6899999999999999999999999865443322221111111               


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  .......++..+.+++.+||+.||++|||+.++++
T Consensus       222 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        11123457889999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=304.72  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|++|.||++.+..   .+++|+++...........+.+|+.++++++||||+++++++...+..++|||+
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            68999999999999999997653   499999876665566667888999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC-----C
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP-----L  155 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~-----~  155 (293)
                      ++|..+..+.......+++..++.++.|++.||++||+.|++|+||+|+||+++ ++. ++|+|||.+......     .
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~-~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK-VVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C-CEECCCSCCC----------C
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC-EEEeecCCccccccccccccc
Confidence            986555555544445688899999999999999999999999999999999998 555 999999987654321     1


Q ss_pred             cceeccCccccccCcccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCC
Q 038154          156 ENYTIKGGSLCYKAPERLLG--------SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLP  227 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  227 (293)
                      .......+++.|+|||++.+        ...++.++||||||+++|+|++|..||...........+.......      
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------  262 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN------  262 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC------
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC------
Confidence            22223347889999998864        2357889999999999999999999999887776665553311100      


Q ss_pred             CCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          228 GFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                            .....++.++.+++.+||..||.+|||+.++++
T Consensus       263 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 ----------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             ----------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  001236788999999999999999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.5e-46  Score=311.19  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=197.4

Q ss_pred             CceeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee--cCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS--SVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~   74 (293)
                      +|++.+.||+|++|.||++.    +..++..||+|++...  .......+.+|++++++++||||+++++++.  .....
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            69999999999999999998    5678899999998543  2233456889999999999999999999875  45568


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|||++++ ++.+.+... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCGGGCEECCT
T ss_pred             EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC-EEEcccccceeccc
Confidence            999999975 555555432 235889999999999999999999999999999999999998887 99999999987654


Q ss_pred             CCcce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH-----------HHHHHHhC
Q 038154          154 PLENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL-----------AAIFSIMG  219 (293)
Q Consensus       154 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-----------~~~~~~~~  219 (293)
                      .....   ....+++.|+|||++.+. .++.++||||||+++|+|++|..||.....+...           ..+.....
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            43322   222367789999988765 5789999999999999999999998653322110           00000000


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .                         ......+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       259 ~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          259 E-------------------------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             T-------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-------------------------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                         01112234578999999999999999999999999763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-44  Score=300.21  Aligned_cols=237  Identities=21%  Similarity=0.325  Sum_probs=187.5

Q ss_pred             Cceee-eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHH-HhcCCCCcceeeeeeec----CCcc
Q 038154            1 RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLL-KELKHENIVRLLNVQSS----VDSI   74 (293)
Q Consensus         1 ry~i~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~   74 (293)
                      +|.+. +.||+|++|.||++.+..+++.||+|++..       ...+.+|+.++ +.++||||+++++++..    ....
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            47777 789999999999999999999999999842       25677899988 55589999999999876    6779


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCccc
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARP  150 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~  150 (293)
                      ++|||+++| ++.+.+.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++. ++|+|||.+..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~-~kl~Dfg~a~~  169 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFAKE  169 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC-EEECCCTTCEE
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCc-EEEeccccccc
Confidence            999999975 7777777766667899999999999999999999999999999999999998   455 99999998854


Q ss_pred             CCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          151 IDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ..                       ...++.++|+||||+++|+|++|..||.............               
T Consensus       170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------------  211 (299)
T 3m2w_A          170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------------  211 (299)
T ss_dssp             CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------------
T ss_pred             cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------------
Confidence            32                       1246789999999999999999999997653322110000               


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                         ..    ...............+++++.+++.+||+.||++|||+.++++||||++..
T Consensus       212 ---~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          212 ---TR----IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ---CS----SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ---HH----HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence               00    000001111223356899999999999999999999999999999998653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=312.21  Aligned_cols=249  Identities=22%  Similarity=0.246  Sum_probs=188.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee-cCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS-SVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l   76 (293)
                      +|++.+.||+|+||+||++....+   +..+|+|.++.. ........+.+|+.++++++||||+++++++. .++..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            377889999999999999986433   245888887532 22334467889999999999999999999864 4568899


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ||||+++ ++.+.+. .....+++..++.++.||+.||+|||++|++|+||+|+||+++.++. +||+|||.+.......
T Consensus       169 v~e~~~~g~L~~~l~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEECCTTCBHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC----------
T ss_pred             EEECCCCCCHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC-EEEeeccccccccccc
Confidence            9999986 5555554 44446788899999999999999999999999999999999998887 9999999997653321


Q ss_pred             c----ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          156 E----NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       156 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      .    ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+.....           
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-----------  314 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-----------  314 (373)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-----------
T ss_pred             cccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            1    11222366789999988765 68999999999999999999 6788877766655555432110           


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                        ...+..++..+.+++.+||+.||++|||+.++++
T Consensus       315 ------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          315 ------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              0112346789999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.4e-45  Score=310.85  Aligned_cols=258  Identities=14%  Similarity=0.135  Sum_probs=189.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCC-----CCeEEEEEecccCCC---------CCCcccHHHHHHHHHhcCCCCcceeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT-----GDTVVVKKIPIMNPS---------EGVPSSVIREVSLLKELKHENIVRLLN   66 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (293)
                      +|++++.||+|+||+||+|.+..+     ++.||+|++......         .........|+..++.+.||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            589999999999999999987654     578999987532210         001112233444555667999999999


Q ss_pred             eeecC----CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEe--CCCCeE
Q 038154           67 VQSSV----DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLID--RSKDIV  140 (293)
Q Consensus        67 ~~~~~----~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~--~~~~~v  140 (293)
                      ++...    ...++|||++++++.+.+... ...+++..++.++.||+.||+|||+.|++|+||||+||+++  .++. +
T Consensus       116 ~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~-~  193 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRFGSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ-V  193 (364)
T ss_dssp             EEEEEETTEEEEEEEEECEEEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC-E
T ss_pred             eeeeccCCcceEEEEEeCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe-E
Confidence            98665    458999999966666665543 34689999999999999999999999999999999999999  6666 9


Q ss_pred             EEccCCCcccCCCCCcc-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 038154          141 KIADFGLARPIDVPLEN-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAA  213 (293)
Q Consensus       141 ~l~df~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  213 (293)
                      ||+|||.+.........       .....|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            99999999765432111       1223389999999988766 589999999999999999999999986433322222


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhh--hcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLAT--VVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .........                     .......  ....++.++.+++..|+..||.+||++.+|++
T Consensus       273 ~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYREN---------------------IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHC---------------------HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhh---------------------HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111000000                     0000000  01457899999999999999999999999886

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.5e-46  Score=309.84  Aligned_cols=266  Identities=24%  Similarity=0.252  Sum_probs=189.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc----cee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS----IDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~l   76 (293)
                      +|++.++||+|+||+||+|.+.  ++.||+|++....   ........|+.++++++||||+++++++.....    +++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            5899999999999999999755  7899999985432   222345568888999999999999999877553    699


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecccCCCceeEeCCCCeEEEccC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ----------EILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ||||+++ ++.+.+...   .+++..++.++.|++.||+|||+.          |++|+||||+||+++.++. +||+||
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~-~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC-EEECCC
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe-EEEccC
Confidence            9999985 565666543   378889999999999999999999          9999999999999998887 999999


Q ss_pred             CCcccCCCCCcc--eeccCccccccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 038154          146 GLARPIDVPLEN--YTIKGGSLCYKAPERLLGS----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMG  219 (293)
Q Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  219 (293)
                      |.+.........  .....+++.|+|||++.+.    ..++.++||||||+++|+|++|..||.................
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999766443222  2224589999999988763    2345688999999999999999999976433211110000000


Q ss_pred             CCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          220 TPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .+....      ............... ........+.++.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          256 HPSLED------MQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SCCHHH------HHHHHTTSCCCCCCC-GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhh------hhhhhhcccCCCCcc-ccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            000000      000000000000000 00000112356899999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=324.75  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=197.1

Q ss_pred             eeee-eeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            3 TLLE-VIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         3 ~i~~-~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .+.+ .||+|+||.||+|...  .++..||+|+++.. ........+.+|++++++++||||+++++++.. +..++|||
T Consensus       338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            3444 8999999999999764  35567999998643 233456789999999999999999999999876 56999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce-
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY-  158 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~-  158 (293)
                      |+.++.+..+.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++. +||+|||.+.......... 
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY-AKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCSTTTTCC-------
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc-EEEeeccCcccccCCCceee
Confidence            99865554444334456889999999999999999999999999999999999998887 9999999998764332211 


Q ss_pred             --eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          159 --TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       159 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....                 
T Consensus       495 ~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----------------  556 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----------------  556 (613)
T ss_dssp             -------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-----------------
T ss_pred             eccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              122245789999988755 68999999999999999998 999999988888777664311                 


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                  ....+..+++++.+++.+||..||.+||++.++++
T Consensus       557 ------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 ------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                        11123457899999999999999999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.5e-45  Score=302.14  Aligned_cols=255  Identities=25%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             CceeeeeeccccceeEEEEEeCC-CCC--eEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-TGD--TVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-~~~--~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|++|+||++.+.. ++.  .|++|+++.... .......+.+|++++++++||||+++++++.... .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            58999999999999999997543 333  589998864432 2234567889999999999999999999988755 889


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      |+|++. +++.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus        98 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQND  175 (291)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECCC-C
T ss_pred             eEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC-EEEccccccccccccc
Confidence            999998 5666666543 235788899999999999999999999999999999999998887 9999999998765443


Q ss_pred             cce---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          156 ENY---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       156 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...   ....+++.|+|||++.+. .++.++|+||||+++|+|++ |..||...+..+....+.......          
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  244 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL----------  244 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------
T ss_pred             cchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC----------
Confidence            322   122367789999988765 57899999999999999999 999999888777666654311110          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                        .....++.++.+++.+||..||.+|||+.++++  +|++.
T Consensus       245 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          245 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                              112347889999999999999999999999998  55544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=306.56  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeee----cCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQS----SVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~l   76 (293)
                      +|++.+.||+|++|.||++.+..+|+.||+|++...  .......+.+|+++++.++||||+++++++.    .....++
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            599999999999999999999899999999988542  2234467889999999999999999999986    3347899


Q ss_pred             EeecCCc-chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           77 VFENLDF-DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      |||++.+ ++.+.+..  .....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~dfg~~~~~~~  186 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACI  186 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCSSCEESCE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC-EEEEecCcchhccc
Confidence            9999986 55555543  13456889999999999999999999999999999999999998888 99999998875532


Q ss_pred             CCcc---------eeccCccccccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHHHhCC
Q 038154          154 PLEN---------YTIKGGSLCYKAPERLLGSG--RYSTPVDVWAVACTFAEMVTHQRLFHSRW--APGLLAAIFSIMGT  220 (293)
Q Consensus       154 ~~~~---------~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~--~~~~~~~~~~~~~~  220 (293)
                      ....         .....+++.|+|||++.+..  .++.++||||||+++|+|++|..||....  .......+..   .
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~  263 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---Q  263 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---c
Confidence            1111         01122588999999876542  36889999999999999999999995321  1111111110   0


Q ss_pred             CCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          221 PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .                          .......++.++.++|.+||+.||.+|||+.+++++
T Consensus       264 ~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 L--------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            0                          001123468899999999999999999999999984

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.6e-45  Score=302.11  Aligned_cols=261  Identities=24%  Similarity=0.307  Sum_probs=198.0

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      |..++.||+|++|.||++..  ++..+|+|++.....  .......+.+|++++++++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45568999999999999964  688999999864332  23345678899999999999999999999999999999999


Q ss_pred             cCC-cchHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           80 NLD-FDLLHFMKTE-PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        80 ~~~-~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      +++ +++.+.+... ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT-AKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSCSSC
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc-EEEeeccccccccccccc
Confidence            997 4555555432 2345888999999999999999999999999999999999998887 999999998766543222


Q ss_pred             --eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          158 --YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       158 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        .....+++.|+|||++.+  .++.++|+||||+++|+|++|..||...........+..........       ....
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  260 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-------IEDY  260 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-------HHHH
T ss_pred             ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-------hhhh
Confidence              222348899999998765  37899999999999999999999998765544333332211111000       0000


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..        ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       261 ~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          261 ID--------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             SC--------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cc--------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00        0000111223567899999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7e-45  Score=314.14  Aligned_cols=250  Identities=16%  Similarity=0.134  Sum_probs=191.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCC-CCcceee--------------
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKH-ENIVRLL--------------   65 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~i~~~~--------------   65 (293)
                      |++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+.| ++...+.              
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            678899999999999999999999999999986332 223446788899999999876 3221111              


Q ss_pred             -------eeeec-----CCcceeEeecCCcchHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCC
Q 038154           66 -------NVQSS-----VDSIDLVFENLDFDLLHFMK-----TEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKP  128 (293)
Q Consensus        66 -------~~~~~-----~~~~~lv~e~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~  128 (293)
                             .++..     ...++++|+...+++.+.+.     ......+++..+..++.|++.||+|||++|++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp  239 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP  239 (413)
T ss_dssp             CC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             CCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCccc
Confidence                   11111     22467888888888877764     22334466778888999999999999999999999999


Q ss_pred             CceeEeCCCCeEEEccCCCcccCCCCCcceeccCccccccCccccc---------CCCCCCCchhHHHHHHHHHHHHhCC
Q 038154          129 ANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL---------GSGRYSTPVDVWAVACTFAEMVTHQ  199 (293)
Q Consensus       129 ~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~Di~slG~ll~~l~~g~  199 (293)
                      +||+++.++. +||+|||.++.....   .....| +.|+|||++.         ....++.++||||||+++|+|++|.
T Consensus       240 ~NILl~~~~~-~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~  314 (413)
T 3dzo_A          240 VDIVLDQRGG-VFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD  314 (413)
T ss_dssp             GGEEECTTCC-EEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred             ceEEEecCCe-EEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999998 999999998765532   334447 9999999883         3335788999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHH
Q 038154          200 RLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE  279 (293)
Q Consensus       200 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  279 (293)
                      .||...+..+....                                  .......+|+++.+||.+||+.||.+|||+.+
T Consensus       315 ~Pf~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          315 LPNTDDAALGGSEW----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             CCCCTTGGGSCSGG----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCcchhhhHHH----------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            99976543221110                                  01112357899999999999999999999999


Q ss_pred             HhcCcccccCc
Q 038154          280 ALRHEYFKDFQ  290 (293)
Q Consensus       280 ll~~p~~~~~~  290 (293)
                      +++||||+.+.
T Consensus       361 ~l~~~~~~~~~  371 (413)
T 3dzo_A          361 AMETPEYEQLR  371 (413)
T ss_dssp             HTTSHHHHHHH
T ss_pred             HHhCHHHHHHH
Confidence            99999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.1e-45  Score=303.72  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=193.5

Q ss_pred             Cc-eeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC--Cc
Q 038154            1 RY-TLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV--DS   73 (293)
Q Consensus         1 ry-~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   73 (293)
                      || ++++.||+|++|+||++.    +..+++.||+|++... ........+.+|++++++++||||+++++++.+.  ..
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            45 999999999999997764    4457889999998643 2223345688999999999999999999998874  56


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      .++|||++++ ++.+.+...   .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVP  185 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEECC
T ss_pred             EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-EEECCcccccccc
Confidence            8999999986 555555443   3788899999999999999999999999999999999998887 9999999998775


Q ss_pred             CCCcc---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-----------HHHHHHHHh
Q 038154          153 VPLEN---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-----------LLAAIFSIM  218 (293)
Q Consensus       153 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-----------~~~~~~~~~  218 (293)
                      .....   .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.......           ....+....
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54322   1223367789999988765 57899999999999999999999997532211           000111100


Q ss_pred             CCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..                         ......+..+++++.++|.+||+.||.+|||+.++++
T Consensus       265 ~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ER-------------------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HT-------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hc-------------------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00                         0011223457889999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=321.80  Aligned_cols=246  Identities=25%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||.||++.+.. +..||+|+++...   ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            48899999999999999998764 4679999986432   234678999999999999999999999876 678999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +.+ ++.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++. +||+|||.+......... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCTTSTTTCCCHHHHTT
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc-EEEcccccceecCCCceecc
Confidence            984 6667765443345788899999999999999999999999999999999998887 999999999866432111 1


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....++..|+|||++... .++.++||||||+++|+|++ |..||.+....+....+.....                  
T Consensus       422 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------  482 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------  482 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             cCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            122256789999988755 68999999999999999999 9999998887777666643111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                 ...+..++.++.+||.+||+.||++|||+.+|++
T Consensus       483 -----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 -----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                       1122356889999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-43  Score=309.00  Aligned_cols=253  Identities=19%  Similarity=0.206  Sum_probs=201.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC-CCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-ENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|+++++||+|+||.||++.+..+++.||||++....    ....+..|+++++.+.| +++..+..++......++|||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            6999999999999999999999999999999875432    23568899999999986 566666777778888999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeE---eCCCCeEEEccCCCcccCCCCCc
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLI---DRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i---~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++++++.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||++   +.++. +||+|||.+........
T Consensus        84 ~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~-vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           84 LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC-EEECCCTTCEECBCTTT
T ss_pred             CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe-EEEEeCCcceeccCCcc
Confidence            99777777765433 368999999999999999999999999999999999999   45566 99999999987654322


Q ss_pred             c-------eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCC
Q 038154          157 N-------YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGF  229 (293)
Q Consensus       157 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (293)
                      .       .....+++.|+|||++.+. .++.++||||||+++|+|++|..||...........+......         
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---------  231 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------  231 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH---------
T ss_pred             ccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc---------
Confidence            1       1234589999999988766 6899999999999999999999999875543322222110000         


Q ss_pred             cCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          230 TSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                   ........+...++.++.+++.+||+.||.+||++.+|++
T Consensus       232 -------------~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          232 -------------KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             -------------HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -------------cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         0002223344678899999999999999999999998876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-44  Score=325.07  Aligned_cols=243  Identities=21%  Similarity=0.291  Sum_probs=197.4

Q ss_pred             eeeccccceeEEEEEe--CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHD--SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      +.||+|+||.||++..  ...++.||+|+++...........+.+|++++++++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            5899999999999954  4567889999997654444556789999999999999999999999865 568899999985


Q ss_pred             -chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc---ee
Q 038154           84 -DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN---YT  159 (293)
Q Consensus        84 -~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~---~~  159 (293)
                       ++.+.+...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||.+.........   ..
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC-EEEEEcCCccccccCcccccccc
Confidence             555666543  35788899999999999999999999999999999999998887 999999999866443221   12


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....                   
T Consensus       531 ~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------------------  590 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------------  590 (635)
T ss_dssp             ----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred             CCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            22356789999988665 68999999999999999998 9999999888877776643111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                ...+..+++++.+|+.+||+.||.+|||+.+|++
T Consensus       591 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 ----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                      1123457889999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=302.16  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             CceeeeeeccccceeEEEEE----eCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC--cc
Q 038154            1 RYTLLEVIREGRYGAVHRAH----DSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD--SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   74 (293)
                      +|++++.||+|++|.||++.    +..+++.||+|++...  .......+.+|++++++++||||+++++++...+  ..
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            58999999999999999998    4668899999998642  2334467889999999999999999999876654  78


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      ++|||++++ ++.+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc-EEEecCcchhhccc
Confidence            999999985 555555543 345888999999999999999999999999999999999998887 99999999987654


Q ss_pred             CCccee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          154 PLENYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       154 ~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                      ......   ...++..|+|||++.+. .++.++||||||+++|+|++|..||.....+ ...    ..+......... .
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~----~~~~~~~~~~~~-~  270 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMR----MIGNDKQGQMIV-F  270 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHH----HHCTTCCTHHHH-H
T ss_pred             cccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHH----hhccccchhhhH-H
Confidence            433221   22356779999988765 5789999999999999999999998642111 000    000000000000 0


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ...+...       .......+..+++++.+++.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          271 HLIELLK-------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhh-------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000000       00001123457889999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-44  Score=296.43  Aligned_cols=249  Identities=25%  Similarity=0.326  Sum_probs=187.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHh--cCCCCcceeeeeeec----CCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE--LKHENIVRLLNVQSS----VDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~   74 (293)
                      +|++.+.||+|+||+||++.+  +++.||+|++...     ....+..|.+++..  ++||||+++++++..    ....
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            699999999999999999975  6889999998532     23456677787777  789999999998544    3468


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecccCCCceeEeCCCCeEEEccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH--------SQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ++||||+++ ++.+.+..   ..+++..++.++.|++.||+|||        +.|++|+||||+||+++.++. +||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECCC
T ss_pred             EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC-EEEeeC
Confidence            999999985 55555532   35888999999999999999999        999999999999999998887 999999


Q ss_pred             CCcccCCCCCcce----eccCccccccCcccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 038154          146 GLARPIDVPLENY----TIKGGSLCYKAPERLLGSGR-----YSTPVDVWAVACTFAEMVTH----------QRLFHSRW  206 (293)
Q Consensus       146 ~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g----------~~pf~~~~  206 (293)
                      |.+..........    ....+++.|+|||++.+...     ++.++||||||+++|+|++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9987654433322    22258999999998876532     33689999999999999999          78885532


Q ss_pred             ch----HHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          207 AP----GLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       207 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ..    .............+  .                    ..........++++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~--~--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRP--N--------------------IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCC--C--------------------CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCC--C--------------------CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            21    11122111000000  0                    0000112234578999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.1e-44  Score=322.63  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCC---CCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT---GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||.||+|.+..+   +..+|+|.+... ........+.+|+.++++++||||+++++++.+ +..++|
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv  468 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII  468 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence            588999999999999999987543   456899987532 222334678899999999999999999999854 678999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||+++ ++.+.+... ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||.+........
T Consensus       469 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~-vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC-EEEEecCCCeecCCCcc
Confidence            999985 555555443 446888999999999999999999999999999999999998887 99999999987644322


Q ss_pred             c-eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          157 N-YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       157 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                      . .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+.....               
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---------------  610 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---------------  610 (656)
T ss_dssp             -------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC---------------
T ss_pred             eeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            1 1223366889999988765 68999999999999999997 9999998888777766644211               


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                    ...++.+++++.+++.+||..||.+|||+.++++
T Consensus       611 --------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 --------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          1123457889999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=301.39  Aligned_cols=242  Identities=19%  Similarity=0.186  Sum_probs=188.0

Q ss_pred             CceeeeeeccccceeEEEE-----EeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC---CCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRA-----HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---HENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~   72 (293)
                      +|++.+.||+|+||+||+|     .+..+++.||+|++..     .....+..|+++++.+.   |++++.+++++...+
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4899999999999999999     4677889999999753     23457888888888886   899999999999999


Q ss_pred             cceeEeecCC-cchHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC-----------CC
Q 038154           73 SIDLVFENLD-FDLLHFMKT---EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR-----------SK  137 (293)
Q Consensus        73 ~~~lv~e~~~-~~~~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~-----------~~  137 (293)
                      ..++||||++ |++.+.+..   .....+++..++.++.||+.||+|||++|++||||||+||+++.           ++
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            9999999998 455555542   13456899999999999999999999999999999999999987           66


Q ss_pred             CeEEEccCCCcccCC--CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 038154          138 DIVKIADFGLARPID--VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF  215 (293)
Q Consensus       138 ~~v~l~df~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  215 (293)
                      . +||+|||.+....  ..........|++.|+|||++.+. .++.++||||||+++|+|++|..||........     
T Consensus       221 ~-~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          221 G-LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             T-EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             C-EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence            6 9999999996543  222334445589999999988776 589999999999999999999999854311000     


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                           ......      ..  ...++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       294 ---------------------~~~~~~------~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 ---------------------KPEGLF------RR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---------------------EECSCC------TT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---------------------eechhc------cc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                 000000      00  0135678899999999999999655444443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-43  Score=296.03  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=184.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc--CCCCcceeeeeeecC----Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL--KHENIVRLLNVQSSV----DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~~   74 (293)
                      +|++.+.||+|+||.||++.+.  ++.||+|++...     .......|.+++...  +||||+++++++...    ...
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            5899999999999999999764  889999998532     224455666666655  899999999998777    678


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecccCCCceeEeCCCCeEEEccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ--------EILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ++||||+++ ++.+.+...   .+++..++.++.|++.||.|||+.        |++|+||||+||+++.++. +||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC-EEEEeC
Confidence            999999985 666666443   478889999999999999999998        9999999999999998887 999999


Q ss_pred             CCcccCCCCCcce----eccCccccccCcccccCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCCC
Q 038154          146 GLARPIDVPLENY----TIKGGSLCYKAPERLLGSGRYST------PVDVWAVACTFAEMVTH----------QRLFHSR  205 (293)
Q Consensus       146 ~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~------~~Di~slG~ll~~l~~g----------~~pf~~~  205 (293)
                      |.+..........    ....+++.|+|||++.+.. ...      ++||||||+++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9997664432221    1335899999999887653 334      39999999999999999          6666543


Q ss_pred             CchH-HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          206 WAPG-LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       206 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .... ....+........                  .... .........+++++.+++.+||+.||++|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKK------------------LRPS-FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSC------------------CCCC-CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhc------------------cCcc-ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2211 1111111000000                  0000 00000112356779999999999999999999999984

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-44  Score=305.02  Aligned_cols=247  Identities=22%  Similarity=0.220  Sum_probs=187.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC------CCCCcccHHHHHHHHHhcC---------CCCcce--
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP------SEGVPSSVIREVSLLKELK---------HENIVR--   63 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i~~--   63 (293)
                      +|++.+.||+|+||+||+|.+  +|+.||+|++.....      .......+.+|+++++.++         |||+++  
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            588999999999999999986  679999999976542      2233367889999999886         555554  


Q ss_pred             ---------------eeeeeec-------------CCcceeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038154           64 ---------------LLNVQSS-------------VDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA  114 (293)
Q Consensus        64 ---------------~~~~~~~-------------~~~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~  114 (293)
                                     +++++..             .+..|+||||+. |++++.+..   ..+++..++.++.||+.||+
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence                           4444443             678999999997 557777654   35789999999999999999


Q ss_pred             HHH-hCCceecccCCCceeEeCCCC-------------------eEEEccCCCcccCCCCCcceeccCccccccCccccc
Q 038154          115 YCH-SQEILHRDLKPANFLIDRSKD-------------------IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL  174 (293)
Q Consensus       115 ~lh-~~~~~h~dl~~~Ni~i~~~~~-------------------~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  174 (293)
                      ||| +.|++||||||+||+++.++.                   .+||+|||.++.....     ...|++.|+|||++.
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence            999 999999999999999998761                   4999999999876532     124899999999987


Q ss_pred             CCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhc
Q 038154          175 GSGRYSTPVDVWAVACT-FAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVV  252 (293)
Q Consensus       175 ~~~~~~~~~Di~slG~l-l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (293)
                      +..  +.++|||||+.+ .+++++|..||....+ ......+.......                       .......+
T Consensus       251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~  305 (336)
T 2vuw_A          251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------------TKCNTPAM  305 (336)
T ss_dssp             CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------------SCCCSHHH
T ss_pred             CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------------cccchhhh
Confidence            663  889999998776 7778889999854322 11222222100000                       01111233


Q ss_pred             CCCCchHHHHHHHhhccCCCCCCCHHHHh-cCcccc
Q 038154          253 GGLEPDGVDLLRRMLCLDPSKRLTAREAL-RHEYFK  287 (293)
Q Consensus       253 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll-~~p~~~  287 (293)
                      +.+++++.+||.+||+.|     |+.++| +||||+
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            446789999999999977     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-42  Score=285.64  Aligned_cols=226  Identities=13%  Similarity=0.071  Sum_probs=180.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++.+.||+|++|.||++.+..+|+.||+|++....... .....+.+|++++.+++||||+++++++...+..|+|||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            7999999999999999999999999999999986543322 233678899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |++|..+..+....   ..+..+..++.|++.||+|||++|++|+||||+||+++.++. ++|++++             
T Consensus       112 ~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~-~kl~~~~-------------  174 (286)
T 3uqc_A          112 WIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD-VVLAYPA-------------  174 (286)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC-EEECSCC-------------
T ss_pred             ecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC-EEEEecc-------------
Confidence            99865554444332   356678889999999999999999999999999999999888 8887443             


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                             |++        .++.++||||||+++|+|++|..||.+.+.......                       ...
T Consensus       175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------------------~~~  216 (286)
T 3uqc_A          175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------------------AER  216 (286)
T ss_dssp             -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------------------CCB
T ss_pred             -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------------------HHH
Confidence                   222        368899999999999999999999976533211000                       000


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .............+.+++++.++|.+||+.||.+| |+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            00111122335567789999999999999999999 9999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.2e-42  Score=290.82  Aligned_cols=252  Identities=24%  Similarity=0.294  Sum_probs=190.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHh--cCCCCcceeeeeeecCC----cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE--LKHENIVRLLNVQSSVD----SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~   74 (293)
                      +|++.+.||+|++|.||++.+  +|+.||+|++...     ....+.+|.++++.  ++||||+++++++....    ..
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            589999999999999999976  5889999998532     23567789999988  68999999999988776    78


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecccCCCceeEeCCCCeEEEccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH--------SQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ++|||++++ ++.+.+...   .+++..++.++.|++.||.+||        +.|++|+||+|+||+++.++. ++|+||
T Consensus       116 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~-~kL~Df  191 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADL  191 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC-EEECCC
T ss_pred             EEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC-EEEEEC
Confidence            999999986 666666543   4788899999999999999999        899999999999999998887 999999


Q ss_pred             CCcccCCCCCcc----eeccCccccccCcccccCCCCC-----CCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 038154          146 GLARPIDVPLEN----YTIKGGSLCYKAPERLLGSGRY-----STPVDVWAVACTFAEMVTH----------QRLFHSRW  206 (293)
Q Consensus       146 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~ll~~l~~g----------~~pf~~~~  206 (293)
                      |.+.........    .....+++.|+|||++.+....     +.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            999766543322    1233488999999988765322     2689999999999999999          78886643


Q ss_pred             chH-HHHHHHHHhCC-CCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          207 APG-LLAAIFSIMGT-PDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       207 ~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      ... ....+...... ......+                  .  .......+..+.+++.+||+.||++|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~------------------~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIP------------------N--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCC------------------G--GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCc------------------c--cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            211 11111111100 0000000                  0  00011234678999999999999999999999984

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=293.80  Aligned_cols=266  Identities=24%  Similarity=0.302  Sum_probs=179.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHH--hcCCCCcceeeeee-----ecCCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLK--ELKHENIVRLLNVQ-----SSVDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~-----~~~~~   73 (293)
                      +|++++.||+|+||+||++..  +++.||+|++....     ...+..|.+++.  .+.||||+++++.+     .....
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            699999999999999999964  68899999985322     234455555544  47899999998743     22335


Q ss_pred             ceeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecccCCCceeEeCCCCeEEEc
Q 038154           74 IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ---------EILHRDLKPANFLIDRSKDIVKIA  143 (293)
Q Consensus        74 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~~~h~dl~~~Ni~i~~~~~~v~l~  143 (293)
                      +++||||+++ ++.+.+....   .++..++.++.||+.||.|||+.         |++|+||||+||+++.++. +||+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~kL~  162 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVIS  162 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC-EEEC
T ss_pred             EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc-EEEe
Confidence            7899999975 6666664432   37788999999999999999999         9999999999999998887 9999


Q ss_pred             cCCCcccCCCCC--------cceeccCccccccCcccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-h
Q 038154          144 DFGLARPIDVPL--------ENYTIKGGSLCYKAPERLLGS------GRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-P  208 (293)
Q Consensus       144 df~~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~  208 (293)
                      |||.+.......        .......|++.|+|||++.+.      ..++.++||||||+++|+|++|..||-.... .
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999997654321        112233489999999988763      2456789999999999999999877643211 1


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          209 GLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      .....+.......+..     ..........................++++.++|.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTF-----EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCTTHHHHCSSCCH-----HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhcccCCCchH-----HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            1000000000000000     00000000000000000000001123457999999999999999999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-43  Score=318.34  Aligned_cols=240  Identities=25%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             CceeeeeeccccceeEEEEEeCC-CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCc-----c
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDS-----I   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~   74 (293)
                      ||++.+.||+|+||.||++.+.. +|+.||+|++... ........+.+|++++++++||||+++++++...+.     .
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            69999999999999999999875 7899999987532 222334567889999999999999999999987765     6


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||++|..+......   .+++..++.++.||+.||.|||++|++|+||||+||+++.+ . +||+|||.+......
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~-~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q-LKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C-EEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c-EEEEecccchhcccC
Confidence            999999997666544333   58899999999999999999999999999999999999975 4 999999999876543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                          ....|++.|+|||++.+.  ++.++||||||+++|+|++|..||.......                .+       
T Consensus       235 ----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-------  285 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-------  285 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC-------
T ss_pred             ----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------------cc-------
Confidence                233489999999988654  4889999999999999999998886421100                00       


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                              .. .    .....++.+.++|.+||+.||.+||+..+.+.|+|+.-
T Consensus       286 --------~~-~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 --------ED-D----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --------TT-C----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------cc-c----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                    00 0    00113578899999999999999999999999888753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.2e-34  Score=258.55  Aligned_cols=187  Identities=19%  Similarity=0.085  Sum_probs=127.7

Q ss_pred             eccccceeEEEEEeCCCCCeEEEEEecccCCCC--------CCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeEe
Q 038154            8 IREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE--------GVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         8 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .+.|+.|.+..++....|+.+++|++.......        ...+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456667777777777789999999986543221        2235688999999999 6999999999999999999999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||++|..+..+..... .+++   ..|+.||+.||+|+|++||+||||||+||+++.++. +||+|||.++.........
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~-vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH-ARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC-EEECCCTTEESCC---CCS
T ss_pred             ecCCCCcHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC-EEEeecccCeeCCCCCccc
Confidence            9999766655544332 3443   358999999999999999999999999999999998 9999999998776554444


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL  201 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  201 (293)
                      ....||+.|+|||++.+.  +..++|+||+|++++.+.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            445599999999988654  56789999999998877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.9e-28  Score=215.42  Aligned_cols=184  Identities=18%  Similarity=0.208  Sum_probs=137.4

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC------CcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG------VPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      ..+.||+|+||.||++  ...+..+++|+.........      ..+.+.+|++++++++||||+++..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3568999999999999  55678899998643222111      123478999999999999999666666677888999


Q ss_pred             eecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           78 FENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        78 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||++| ++.+.+..          +..++.|++.+|+|||++|++|+||||+||+++.  . +||+|||.++.......
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~-~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D-LYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S-EEECCCTTCEECCCHHH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e-EEEEECccCEECCCccc
Confidence            999985 55555443          5579999999999999999999999999999997  4 99999999988754322


Q ss_pred             c-------eeccCccccccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 038154          157 N-------YTIKGGSLCYKAPERLLGS-GRYSTPVDVWAVACTFAEMVTHQRLF  202 (293)
Q Consensus       157 ~-------~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf  202 (293)
                      .       .....||+.|+|||++... ..|+...|+||..+-..+.+.++-+|
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1       1233489999999988651 24677789999998888888776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.5e-24  Score=177.37  Aligned_cols=145  Identities=22%  Similarity=0.177  Sum_probs=111.7

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCC----------------CcccHHHHHHHHHhcCCCCcceee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEG----------------VPSSVIREVSLLKELKHENIVRLL   65 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~   65 (293)
                      |.+++.||+|++|.||++.+ .+|+.+|+|+++.......                ....+.+|+++++++.  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            56779999999999999998 7899999999854322111                1345789999999998  4 6666


Q ss_pred             eeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccC
Q 038154           66 NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        66 ~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      +++.. +..|+||||++|..+..+.      .  .....++.|++.||.+||+.|++|+||||+||+++ ++. ++|+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~-vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYRVR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG-IWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGGCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE-EEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHHcc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc-EEEEEC
Confidence            65443 6679999999875544331      1  24557999999999999999999999999999999 666 999999


Q ss_pred             CCcccCCCCCcceeccCccccccCccccc
Q 038154          146 GLARPIDVPLENYTIKGGSLCYKAPERLL  174 (293)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  174 (293)
                      |.+....             .+.|||.+.
T Consensus       237 G~a~~~~-------------~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVEVG-------------EEGWREILE  252 (282)
T ss_dssp             TTCEETT-------------STTHHHHHH
T ss_pred             CCCeECC-------------CCCHHHHHH
Confidence            9986432             357788653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=7.6e-22  Score=159.41  Aligned_cols=138  Identities=19%  Similarity=0.200  Sum_probs=104.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCe--EEEEEecccCCCCCC----------------------cccHHHHHHHHHhcC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGV----------------------PSSVIREVSLLKELK   57 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~--~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~   57 (293)
                      |++.+.||+|++|.||+|.+..+|..  +|+|+++........                      ...+.+|+++++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999987667888  999987543211100                      025778999999998


Q ss_pred             CCCc--ceeeeeeecCCcceeEeecCCc------chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecccCC
Q 038154           58 HENI--VRLLNVQSSVDSIDLVFENLDF------DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH-SQEILHRDLKP  128 (293)
Q Consensus        58 ~~~i--~~~~~~~~~~~~~~lv~e~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~h~dl~~  128 (293)
                      |+++  +.+++.    +..++||||+++      .+.+....     .++..+..++.|++.+|.+|| +.|++|+||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8754  444432    467899999953      33333221     124477889999999999999 99999999999


Q ss_pred             CceeEeCCCCeEEEccCCCcccC
Q 038154          129 ANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus       129 ~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      +||+++.  . ++|+|||.+...
T Consensus       200 ~NILl~~--~-~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--K-VYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--S-EEECCCTTCEET
T ss_pred             HHEEEcC--c-EEEEECcccccC
Confidence            9999997  4 999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=7.5e-19  Score=147.56  Aligned_cols=139  Identities=19%  Similarity=0.206  Sum_probs=98.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC------------cccH--------HHHHHHHHhcCCCCc
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV------------PSSV--------IREVSLLKELKHENI   61 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~------------~~~~--------~~e~~~l~~l~~~~i   61 (293)
                      |++++.||.|++|.||+|.+. +|+.+|||+++........            ....        ..|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999875 6899999988543211100            0011        235556666644433


Q ss_pred             c--eeeeeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-
Q 038154           62 V--RLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-  138 (293)
Q Consensus        62 ~--~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-  138 (293)
                      .  ..++.    ...++|||+++|..+..+..     .  .....++.|++.+|.+||+.|++||||||.||+++.++. 
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence            2  22222    23579999999866654432     1  245678899999999999999999999999999998763 


Q ss_pred             --------eEEEccCCCcccCC
Q 038154          139 --------IVKIADFGLARPID  152 (293)
Q Consensus       139 --------~v~l~df~~~~~~~  152 (293)
                              .+.++||+.+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                    37899999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=2.3e-13  Score=109.98  Aligned_cols=137  Identities=15%  Similarity=0.146  Sum_probs=107.1

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++...++.|+.+.||++..  .+..+++|..+....  .....+.+|+++++.+. +..+++++++....+..|+|||+
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            77888889999999999964  367899998754221  22357899999999985 67788899998888899999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS------------------------------------------  118 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------  118 (293)
                      ++|..+.....      +......++.+++.+|..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99877765421      112345688899999999998                                          


Q ss_pred             -----------------CCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          119 -----------------QEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       119 -----------------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                                       ..++|||++|.||+++. +..+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence                             45899999999999985 4435699998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=7.5e-12  Score=100.80  Aligned_cols=132  Identities=14%  Similarity=0.097  Sum_probs=95.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceeeeeeecCCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e   79 (293)
                      |.+....+.|..+.||++.. .+|..+++|.....     ....+..|+++++.+.+.+  +++++++....+..++|||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            34433334566699999954 45678999986432     2357889999999985434  5668888888788999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE---------------------------------------  120 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------------  120 (293)
                      +++|..+. . ..    .   ....++.+++..|..||+..                                       
T Consensus        96 ~i~G~~l~-~-~~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL-S-SH----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT-T-SC----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC-c-Cc----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99987664 1 11    1   12356777888888888643                                       


Q ss_pred             -------------------ceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          121 -------------------ILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       121 -------------------~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                                         ++|||++|.||+++.++ .+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                               99999999999998543 35699999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.33  E-value=1.7e-11  Score=103.56  Aligned_cols=140  Identities=14%  Similarity=0.235  Sum_probs=103.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEec--ccCCCCCCcccHHHHHHHHHhcC--CCCcceeeeeeecC---CcceeE
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELK--HENIVRLLNVQSSV---DSIDLV   77 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~~~lv   77 (293)
                      ++.|+.|.++.+|++...  +..+++|+.+  ... .......+.+|.++++.+.  +..+++++.++.+.   +..++|
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            578899999999999643  5678999764  221 1123457889999999997  35578888887766   458999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS---------------------------------------  118 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---------------------------------------  118 (293)
                      ||+++|..+..   .....+++.....++.+++.+|..||+                                       
T Consensus       120 me~v~G~~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999866532   111235677788899999999999996                                       


Q ss_pred             -------------------CCceecccCCCceeEeCCC-CeEEEccCCCccc
Q 038154          119 -------------------QEILHRDLKPANFLIDRSK-DIVKIADFGLARP  150 (293)
Q Consensus       119 -------------------~~~~h~dl~~~Ni~i~~~~-~~v~l~df~~~~~  150 (293)
                                         .+++|||+++.||+++.++ ..+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               3699999999999999765 3468999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=1.1e-10  Score=96.16  Aligned_cols=185  Identities=15%  Similarity=0.092  Sum_probs=115.5

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCC--cceeeeeeecCC---cceeEe
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HEN--IVRLLNVQSSVD---SIDLVF   78 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~   78 (293)
                      ++.++.|..+.||++.     ..+++|+....    .....+.+|.++++.+. +..  ++.++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            3568899999999982     46899975321    23457888999998884 332  445555443333   458899


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS----------------------------------------  118 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~----------------------------------------  118 (293)
                      ++++|..+.....   ..++......++.+++..|..||+                                        
T Consensus        96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9999865542111   124555666677777777777774                                        


Q ss_pred             ------------------CCceecccCCCceeEeCC-CCeEEEccCCCcccCCCCCcceeccCccccccCccccc----C
Q 038154          119 ------------------QEILHRDLKPANFLIDRS-KDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL----G  175 (293)
Q Consensus       119 ------------------~~~~h~dl~~~Ni~i~~~-~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~  175 (293)
                                        ..++|||++|.||+++.+ +..+.++||+.+................ .-..|+...    .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence                              247999999999999975 4457899999886543211111000000 001222111    0


Q ss_pred             CCC---------CCCchhHHHHHHHHHHHHhCCCCC
Q 038154          176 SGR---------YSTPVDVWAVACTFAEMVTHQRLF  202 (293)
Q Consensus       176 ~~~---------~~~~~Di~slG~ll~~l~~g~~pf  202 (293)
                      .+.         .....+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111         112368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.83  E-value=4e-08  Score=79.35  Aligned_cols=132  Identities=17%  Similarity=0.139  Sum_probs=92.8

Q ss_pred             eeccccce-eEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEeecCCcc
Q 038154            7 VIREGRYG-AVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus         7 ~lg~g~~~-~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (293)
                      .+..|..+ .||+......+..+++|+-+.     .....+.+|..+|+.+. +--+.++++++.+++..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445544 689987777778899997542     22456788999999885 333678888888889999999999986


Q ss_pred             hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 038154           85 LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS----------------------------------------------  118 (293)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~----------------------------------------------  118 (293)
                      .+......     .......+..++...|..||.                                              
T Consensus       106 ~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            65443221     112334455666666666663                                              


Q ss_pred             ------------CCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          119 ------------QEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       119 ------------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                                  ..++|||+++.||+++..+ .+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                        1289999999999998654 36699998774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.4e-07  Score=77.68  Aligned_cols=135  Identities=19%  Similarity=0.150  Sum_probs=88.7

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCC---Ccceeeeeee-cCCcceeEeec
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHE---NIVRLLNVQS-SVDSIDLVFEN   80 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~   80 (293)
                      ++.++.|....||++     |..+++|+-.    .......+..|.++++.+.+.   .+++++.+.. ..+..++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            356788888899998     4668888742    112345788999999999642   3566666653 45667899999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS------------------------------------------  118 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------  118 (293)
                      ++|..+....-.   .++......+..++...|..||+                                          
T Consensus        95 i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           95 VQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             cCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            998665432100   12233333344444444444442                                          


Q ss_pred             ------------------CCceecccCCCceeEeC---CCCeEEEccCCCcccC
Q 038154          119 ------------------QEILHRDLKPANFLIDR---SKDIVKIADFGLARPI  151 (293)
Q Consensus       119 ------------------~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~  151 (293)
                                        ..++|+|+++.||+++.   ++..+.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              24699999999999997   3554589999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.60  E-value=5.9e-07  Score=76.67  Aligned_cols=77  Identities=16%  Similarity=0.117  Sum_probs=50.4

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCC--C---CCCcccHHHHHHHHHhcCC--C-CcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--S---EGVPSSVIREVSLLKELKH--E-NIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~---~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~l   76 (293)
                      .+.+|.|..+.||++....++..+++|.......  .   ......+..|.++++.+..  | .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5688999999999997665678899997642211  0   1234567789999988742  3 34455544  3455789


Q ss_pred             EeecCCc
Q 038154           77 VFENLDF   83 (293)
Q Consensus        77 v~e~~~~   83 (293)
                      |||+++|
T Consensus       113 vmE~l~g  119 (397)
T 2olc_A          113 VMEDLSH  119 (397)
T ss_dssp             EECCCTT
T ss_pred             EEEeCCC
Confidence            9999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.51  E-value=5.6e-07  Score=75.66  Aligned_cols=81  Identities=5%  Similarity=0.005  Sum_probs=54.0

Q ss_pred             eeee-ccccceeEEEEEeCC------CCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcC-C--CCcceeeeeeecC--
Q 038154            5 LEVI-REGRYGAVHRAHDSL------TGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELK-H--ENIVRLLNVQSSV--   71 (293)
Q Consensus         5 ~~~l-g~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~--   71 (293)
                      .+.| +.|..+.+|++....      ++..+++|....... .......+.+|..+++.+. +  -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3667 888889999985430      156789987543210 0111357888999998884 2  3567788776555  


Q ss_pred             -CcceeEeecCCcch
Q 038154           72 -DSIDLVFENLDFDL   85 (293)
Q Consensus        72 -~~~~lv~e~~~~~~   85 (293)
                       +..++|||+++|..
T Consensus       105 ~g~~~~v~e~l~G~~  119 (357)
T 3ats_A          105 LGTPFFLMDYVEGVV  119 (357)
T ss_dssp             TSSCEEEEECCCCBC
T ss_pred             cCCceEEEEecCCCC
Confidence             35789999998754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.33  E-value=5.3e-06  Score=69.11  Aligned_cols=71  Identities=15%  Similarity=0.203  Sum_probs=40.9

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeee------eeecCCcceeE
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLN------VQSSVDSIDLV   77 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~lv   77 (293)
                      +.|+.|..+.||++...  +..+++|+...      ....+..|..+++.|..  -.+++++.      +....+..+++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR------PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECS------CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCC------CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            45666778899999643  33589998753      12345556666666531  12344443      12345668899


Q ss_pred             eecCCcc
Q 038154           78 FENLDFD   84 (293)
Q Consensus        78 ~e~~~~~   84 (293)
                      +++++|.
T Consensus       110 ~~~i~G~  116 (346)
T 2q83_A          110 YDWIEGR  116 (346)
T ss_dssp             EECCCCB
T ss_pred             EEeecCc
Confidence            9999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.19  E-value=2e-05  Score=60.16  Aligned_cols=133  Identities=12%  Similarity=-0.033  Sum_probs=87.2

Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceeccCccc
Q 038154           87 HFMKTEPTVTKNPLKIKKYLHQILHGVAYCH-SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSL  165 (293)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~  165 (293)
                      ..+......++++.++|.++.|.+.+|..+- .+.-...-+.|..|++..+|+ |-+.+ ..+.            ....
T Consensus        36 ~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s~------------~~~~  101 (229)
T 2yle_A           36 EEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AADD------------AGEP  101 (229)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C-------------------
T ss_pred             HHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-cccc------------cccc
Confidence            3333333458999999999999999988762 222224456779999999998 55442 1110            1233


Q ss_pred             cccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcc
Q 038154          166 CYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPI  245 (293)
Q Consensus       166 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (293)
                      .+.|||...  ...+.+.-|||||+++|.-+--..|-                                           
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-------------------------------------------  136 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-------------------------------------------  136 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------------------------------
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-------------------------------------------
Confidence            467888542  24567889999999999998755542                                           


Q ss_pred             cchhhhcCCCCchHHHHHHHhhcc-------------------------CCCCCCCHHHHhc
Q 038154          246 KDLATVVGGLEPDGVDLLRRMLCL-------------------------DPSKRLTAREALR  282 (293)
Q Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~-------------------------dp~~Rps~~~ll~  282 (293)
                          .....+|+.+.+||..|..-                         .+..|++..+|++
T Consensus       137 ----~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          137 ----NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ----TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ----ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                23445889999999999865                         2467889988875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.12  E-value=3.8e-05  Score=62.82  Aligned_cols=69  Identities=13%  Similarity=0.005  Sum_probs=45.0

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEeecC-C
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFENL-D   82 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~   82 (293)
                      .+.|+.|....+|++      ..+++|+.....   .......+|..+++.+...++ +++++.  +....++++|++ +
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            577888999999999      458999875321   122345678888887743222 456654  334457899999 6


Q ss_pred             cc
Q 038154           83 FD   84 (293)
Q Consensus        83 ~~   84 (293)
                      |.
T Consensus        92 g~   93 (301)
T 3dxq_A           92 AQ   93 (301)
T ss_dssp             CE
T ss_pred             Cc
Confidence            64

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.10  E-value=4.2e-05  Score=65.71  Aligned_cols=75  Identities=11%  Similarity=0.106  Sum_probs=46.1

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCC--CCC---CcccHHHHHHHHHhc---CCCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEG---VPSSVIREVSLLKEL---KHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~l   76 (293)
                      .+.+|.|..+.||++.  .++..+++|.......  ...   .......|.+++..+   ....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            4678899999999995  3567899995432111  111   112333344444433   234566777664  567899


Q ss_pred             EeecC-Cc
Q 038154           77 VFENL-DF   83 (293)
Q Consensus        77 v~e~~-~~   83 (293)
                      |||++ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=98.04  E-value=3.5e-05  Score=64.98  Aligned_cols=139  Identities=16%  Similarity=0.120  Sum_probs=79.4

Q ss_pred             eeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   76 (293)
                      ++.|..|-...+|++....       .+..+++|+...   .........+|.++++.+. +.-.+++++.+.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            3567778888899997542       357899997532   1223456678999998884 3334666766554    28


Q ss_pred             EeecCCcchHHH------------------hhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 038154           77 VFENLDFDLLHF------------------MKTEP---TVTKN--PLKIKKYLHQILH-------------------GVA  114 (293)
Q Consensus        77 v~e~~~~~~~~~------------------~~~~~---~~~~~--~~~~~~i~~~i~~-------------------~l~  114 (293)
                      |+|+++|..+..                  +....   .....  ...+.++..++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998743320                  11110   11111  2334444433321                   223


Q ss_pred             HHH----h----CCceecccCCCceeEeCC---CCeEEEccCCCccc
Q 038154          115 YCH----S----QEILHRDLKPANFLIDRS---KDIVKIADFGLARP  150 (293)
Q Consensus       115 ~lh----~----~~~~h~dl~~~Ni~i~~~---~~~v~l~df~~~~~  150 (293)
                      .|.    .    ..++|+|+.+.||+++.+   ...+.++||.++..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    2    259999999999999876   12489999998853

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=4.2e-05  Score=62.79  Aligned_cols=73  Identities=22%  Similarity=0.145  Sum_probs=56.9

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC---CCCcceeeeeeecCCcceeEeecC
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK---HENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      .+.|+.|....+|++..  .+..+++|+....     ....+..|.+.|+.|.   ...+++++.+....+..++|||++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            46788999999999964  4678999976432     2456788999998884   356788888887778899999999


Q ss_pred             Ccc
Q 038154           82 DFD   84 (293)
Q Consensus        82 ~~~   84 (293)
                      +|.
T Consensus       114 ~G~  116 (312)
T 3jr1_A          114 NKS  116 (312)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.90  E-value=0.00012  Score=62.87  Aligned_cols=71  Identities=14%  Similarity=0.098  Sum_probs=48.4

Q ss_pred             eeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l   76 (293)
                      ++.|+.|-...+|++....       .+..+++|+....    .....+.+|..+++.+...+ .+++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            4678888889999997542       2578999987321    11246668999998885333 3566766543    28


Q ss_pred             EeecCCc
Q 038154           77 VFENLDF   83 (293)
Q Consensus        77 v~e~~~~   83 (293)
                      |+||++|
T Consensus       150 v~e~l~G  156 (429)
T 1nw1_A          150 LEEYIPS  156 (429)
T ss_dssp             EECCCCE
T ss_pred             EEEEeCC
Confidence            9999987

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=0.00048  Score=55.82  Aligned_cols=73  Identities=16%  Similarity=0.090  Sum_probs=51.0

Q ss_pred             eeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC---CCcceeeeeeecCCcceeEeec
Q 038154            4 LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH---ENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      -++.+|.|..+.||++... +|+.+++|+.+...  ......+..|...|+.|..   --+++++++    +..++|||+
T Consensus        19 ~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             EEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             EEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3578899999999999744 67899999764322  2223457789999998852   234555554    235789999


Q ss_pred             CCc
Q 038154           81 LDF   83 (293)
Q Consensus        81 ~~~   83 (293)
                      +.+
T Consensus        92 l~~   94 (288)
T 3f7w_A           92 VDE   94 (288)
T ss_dssp             CCC
T ss_pred             ecc
Confidence            874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.66  E-value=0.00033  Score=57.69  Aligned_cols=139  Identities=14%  Similarity=0.087  Sum_probs=75.8

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceeeee------eecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLLNV------QSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l   76 (293)
                      .+.|+.|....+|++... +| .+++|.....    .....+..|..+++.+...+  +++++..      ....+..++
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            356777888899999644 33 6889987532    12356777888888774212  3333322      122355789


Q ss_pred             EeecCCcchHH---------------Hhhc-CCC--CC----CCHHHHHH---------------HHHHHHHHHHHHHh-
Q 038154           77 VFENLDFDLLH---------------FMKT-EPT--VT----KNPLKIKK---------------YLHQILHGVAYCHS-  118 (293)
Q Consensus        77 v~e~~~~~~~~---------------~~~~-~~~--~~----~~~~~~~~---------------i~~~i~~~l~~lh~-  118 (293)
                      ++++++|....               .+.. ...  ..    ........               +...+...++.+.+ 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            99999874311               1111 000  00    01000000               00113344555542 


Q ss_pred             ------CCceecccCCCceeEeCCCCeEEEccCCCccc
Q 038154          119 ------QEILHRDLKPANFLIDRSKDIVKIADFGLARP  150 (293)
Q Consensus       119 ------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~  150 (293)
                            .+++|+|+++.||+++.++ .+.++||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                  3699999999999998653 257999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.59  E-value=0.0011  Score=57.34  Aligned_cols=73  Identities=14%  Similarity=0.075  Sum_probs=47.3

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc-ceeeeeeecCCcceeEeecCCc
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI-VRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ++.|+.|-...+|++.....+..+++|++...   ....-...+|..+++.|...++ +++++.+..    ..|+||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~---~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK---TDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC----CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCC---hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence            46788888899999976543478899987432   1222233689999999864444 566776632    259999987


Q ss_pred             c
Q 038154           84 D   84 (293)
Q Consensus        84 ~   84 (293)
                      .
T Consensus       186 ~  186 (458)
T 2qg7_A          186 Y  186 (458)
T ss_dssp             E
T ss_pred             c
Confidence            3

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.56  E-value=0.00038  Score=57.66  Aligned_cols=33  Identities=27%  Similarity=0.265  Sum_probs=26.8

Q ss_pred             CCceecccCCCceeEeCC---CCeEEEccCCCcccC
Q 038154          119 QEILHRDLKPANFLIDRS---KDIVKIADFGLARPI  151 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~---~~~v~l~df~~~~~~  151 (293)
                      ..++|||+.+.||+++.+   ...+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999864   134899999988654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.54  E-value=0.00067  Score=57.06  Aligned_cols=73  Identities=16%  Similarity=0.026  Sum_probs=43.5

Q ss_pred             eeeeccccceeEEEEEeCC--------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCcce
Q 038154            5 LEVIREGRYGAVHRAHDSL--------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSID   75 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~   75 (293)
                      .+.++.|....+|++....        .+..+++|+....   .........|.++++.+...+ .+++++..  .  .+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            4567788888999996542        1367888876421   111123567888888885333 44666543  2  36


Q ss_pred             eEeecCCcc
Q 038154           76 LVFENLDFD   84 (293)
Q Consensus        76 lv~e~~~~~   84 (293)
                      +|+++++|.
T Consensus       111 ~v~e~i~G~  119 (369)
T 3c5i_A          111 RIEEWLYGD  119 (369)
T ss_dssp             EEEECCCSE
T ss_pred             EEEEEecCC
Confidence            899999874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.49  E-value=0.0015  Score=53.85  Aligned_cols=74  Identities=12%  Similarity=0.047  Sum_probs=46.3

Q ss_pred             eeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC--cceeeee-----eecCCcceeEe
Q 038154            6 EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN--IVRLLNV-----QSSVDSIDLVF   78 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~   78 (293)
                      ..++ |....||++.. .+|+.+++|......   .....+..|..+++.+....  +++++..     ...++..++++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            3465 77788999853 246679999875221   23356777888888874222  3444432     12234567899


Q ss_pred             ecCCcc
Q 038154           79 ENLDFD   84 (293)
Q Consensus        79 e~~~~~   84 (293)
                      ++++|.
T Consensus       107 ~~i~G~  112 (328)
T 1zyl_A          107 PSVGGR  112 (328)
T ss_dssp             ECCCCE
T ss_pred             EecCCC
Confidence            999874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.24  E-value=0.0033  Score=53.73  Aligned_cols=74  Identities=9%  Similarity=-0.032  Sum_probs=48.6

Q ss_pred             eeeeccccceeEEEEEeCCC-------CCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLT-------GDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   76 (293)
                      ++.+..|-...+|++.....       +..+++++....   ....-+..+|.++++.+. +.-.+++++.+.    .+.
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence            46777788888999975421       578999986332   222344568999998885 333455665432    368


Q ss_pred             EeecCCcch
Q 038154           77 VFENLDFDL   85 (293)
Q Consensus        77 v~e~~~~~~   85 (293)
                      |+++++|..
T Consensus       148 I~efI~G~~  156 (424)
T 3mes_A          148 IEEFIDGEP  156 (424)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEeCCcc
Confidence            999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.0086  Score=49.64  Aligned_cols=32  Identities=19%  Similarity=0.324  Sum_probs=27.0

Q ss_pred             CCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154          119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ..++|||+.+.||+++.++. +.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~-~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEES-IYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGC-EEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCe-EEEEECCCCeeC
Confidence            46999999999999987665 899999887543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.85  E-value=0.0091  Score=50.75  Aligned_cols=30  Identities=23%  Similarity=0.355  Sum_probs=24.2

Q ss_pred             ceecccCCCceeEeC-----CCCeEEEccCCCccc
Q 038154          121 ILHRDLKPANFLIDR-----SKDIVKIADFGLARP  150 (293)
Q Consensus       121 ~~h~dl~~~Ni~i~~-----~~~~v~l~df~~~~~  150 (293)
                      +||+|+.+.||++..     ....+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            789999999999943     233599999998853

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.70  E-value=0.26  Score=37.59  Aligned_cols=115  Identities=13%  Similarity=0.076  Sum_probs=76.6

Q ss_pred             CCCCcceeeeeeecCCcceeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC
Q 038154           57 KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR  135 (293)
Q Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~  135 (293)
                      .+|++++. .+-..++.+.+.++.-+ +.....+..     .+....++++.+|+....++  ..-+|--|+|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            58889877 45566666666666544 334444432     45668888888888877443  33478889999999999


Q ss_pred             CCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          136 SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       136 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                      ++. +++.-.|....                 ++|.      ..+...-.-.+=+++..++++++.|.
T Consensus       115 ~~~-p~i~~RGik~~-----------------l~P~------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGL-PIAKTRGLQNV-----------------VDPL------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSC-EEESCCEETTT-----------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCC-EEEEEccCccC-----------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            988 88876654321                 2332      23333445566788899999988884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.06  E-value=1.8  Score=33.00  Aligned_cols=115  Identities=16%  Similarity=0.209  Sum_probs=74.4

Q ss_pred             CCCCcceeeeeeecCCcceeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC
Q 038154           57 KHENIVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR  135 (293)
Q Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~  135 (293)
                      .||++  -..+-.+++.+.+.++.-+ +.....+.     ..+....++++.+|+.... -|...-+|--|+|+|++++.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeC
Confidence            68888  4444466677777777653 44444443     3556678888888877554 12345688899999999999


Q ss_pred             CCCeEEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 038154          136 SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFH  203 (293)
Q Consensus       136 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  203 (293)
                      ++. +++.-.|...                 -++|.      ..+...-+-++=+++..++.+++.|.
T Consensus       120 ~~~-p~i~hRGi~~-----------------~lpP~------e~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          120 ALE-PFFLHVGVKE-----------------SLPPD------EWDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             TCC-EEESCCEETT-----------------TBSSC------SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCc-EEEEEcCCcc-----------------cCCCC------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            988 8887766542                 23443      22333334456678888888877763

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.62  E-value=0.049  Score=47.15  Aligned_cols=61  Identities=16%  Similarity=0.153  Sum_probs=15.5

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEE------EEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVV------KKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQ   68 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~i------K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (293)
                      .+.||   ||.||.+.......+||+      |..+......+....+.++..+.+.++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            34565   999999976544457888      66544333344445677888888889999999988763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	293
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-74
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-72
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-68
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-65
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-64
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-64
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-63
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-63
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-62
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-61
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-56
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-50
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-48
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-33
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 7e-74
 Identities = 133/288 (46%), Positives = 179/288 (62%), Gaps = 2/288 (0%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +  +E I EG YG V++A + LTG+ V +KKI +   +EGVPS+ IRE+SLLKEL H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+LL+V  + + + LVFE L  DL  FM            IK YL Q+L G+A+CHS  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+ ++  +K+ADFGLAR   VP+  YT +  +L Y+APE LLG   YS
Sbjct: 123 VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           T VD+W++ C FAEMVT + LF        L  IF  +GTPD    PG TS  +     P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             +  +D + VV  L+ DG  LL +ML  DP+KR++A+ AL H +F+D
Sbjct: 242 KWAR-QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  222 bits (567), Expect = 2e-72
 Identities = 125/288 (43%), Positives = 180/288 (62%), Gaps = 4/288 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V++A ++  G+T  +KKI +    EG+PS+ IRE+S+LKELKH N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+L +V  +   + LVFE+LD DL   +          +  K +L Q+L+G+AYCH + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+  +  +KIADFGLAR   +P+  YT +  +L Y+AP+ L+GS +YS
Sbjct: 121 VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
           T +D+W+V C FAEMV    LF        L  IF I+GTP+S+  P  T   +      
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
              P+    + + GL+  G+DLL +ML LDP++R+TA++AL H YFK+
Sbjct: 240 VYEPL-PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 5e-71
 Identities = 118/290 (40%), Positives = 169/290 (58%), Gaps = 4/290 (1%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  LE I EG YG V +A +  T + V +K++ + +  EGVPSS +RE+ LLKELKH+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IVRL +V  S   + LVFE  D DL  +  +      +P  +K +L Q+L G+ +CHS+ 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +LHRDLKP N LI+R    +K+A+FGLAR   +P+  Y+ +  +L Y+ P+ L G+  YS
Sbjct: 122 VLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 181 TPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
           T +D+W+  C FAE+    R LF        L  IF ++GTP  E  P  T    ++   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPY 239

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
           P       L  VV  L   G DLL+ +L  +P +R++A EAL+H YF DF
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 2e-70
 Identities = 99/288 (34%), Positives = 148/288 (51%), Gaps = 7/288 (2%)

Query: 4   LLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE---GVPSSVIREVSLLKELKHEN 60
            L+ + EG++  V++A D  T   V +KKI + + SE   G+  + +RE+ LL+EL H N
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           I+ LL+      +I LVF+ ++ DL   +K        P  IK Y+   L G+ Y H   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ILHRDLKP N L+D    ++K+ADFGLA+    P   YT +  +  Y+APE L G+  Y 
Sbjct: 121 ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+WAV C  AE++              L  IF  +GTP  E  P   S  +   F+ 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK- 238

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
              P   L  +      D +DL++ +   +P  R+TA +AL+ +YF +
Sbjct: 239 -SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-68
 Identities = 95/302 (31%), Positives = 152/302 (50%), Gaps = 16/302 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y  L  I +G +G V +A    TG  V +KK+ + N  EG P + +RE+ +L+ LKHEN
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 61  IVRLLNVQSSVDS--------IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHG 112
           +V L+ +  +  S        I LVF+  + DL   +           +IK+ +  +L+G
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQMLLNG 129

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP----LENYTIKGGSLCYK 168
           + Y H  +ILHRD+K AN LI R   ++K+ADFGLAR   +        YT +  +L Y+
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
            PE LLG   Y  P+D+W   C  AEM T   +         LA I  + G+   E  P 
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 229 FTSFSEEFGFEPNRSPIKDLATVVGG--LEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             ++      E  +   + +   +     +P  +DL+ ++L LDP++R+ + +AL H++F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

Query: 287 KD 288
             
Sbjct: 309 WS 310

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 2e-65
 Identities = 84/298 (28%), Positives = 138/298 (46%), Gaps = 16/298 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            YT  +VI  G +G V++A    +G+ V +KK+              RE+ ++++L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74

Query: 61  IVRLLNVQSSVDS------IDLVFENLDFDLLHFMK--TEPTVTKNPLKIKKYLHQILHG 112
           IVRL     S         ++LV + +   +    +  +    T   + +K Y++Q+   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 113 VAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPER 172
           +AY HS  I HRD+KP N L+D    ++K+ DFG A+ +     N +    S  Y+APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           + G+  Y++ +DVW+  C  AE++  Q +F        L  I  ++GTP  E +      
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
             EF F P                P+ + L  R+L   P+ RLT  EA  H +F + +
Sbjct: 254 YTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 4e-65
 Identities = 90/298 (30%), Positives = 146/298 (48%), Gaps = 14/298 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RYT L  I EG YG V  A+D++    V +KKI      +      +RE+ +L   +HEN
Sbjct: 9   RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHEN 67

Query: 61  IVRLLNVQSSVDSID-----LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+ + ++  +          LV   +  DL   +KT+     +   I  +L+QIL G+ Y
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL---SNDHICYFLYQILRGLKY 124

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPER 172
            HS  +LHRDLKP+N L++ +   +KI DFGLAR  D   ++         +  Y+APE 
Sbjct: 125 IHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
           +L S  Y+  +D+W+V C  AEM++++ +F  +     L  I  I+G+P  E L    + 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 233 -SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
            +  +              +    +   +DLL +ML  +P KR+   +AL H Y + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-64
 Identities = 105/299 (35%), Positives = 159/299 (53%), Gaps = 15/299 (5%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVV-VKKIPIMNPSEGVPSSVIREVSLLKELK-- 57
           +Y  +  I EG YG V +A D   G   V +K++ +    EG+P S IREV++L+ L+  
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 58  -HENIVRLLNVQSSVDS-----IDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILH 111
            H N+VRL +V +   +     + LVFE++D DL  ++   P        IK  + Q+L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           G+ + HS  ++HRDLKP N L+  S   +K+ADFGLAR     +   ++   +L Y+APE
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPE 185

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
            LL    Y+TPVD+W+V C FAEM   + LF        L  I  ++G P  E  P   +
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
              +     +  PI+   T    ++  G DLL + L  +P+KR++A  AL H YF+D +
Sbjct: 245 LPRQAFHSKSAQPIEKFVT---DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 5e-64
 Identities = 104/297 (35%), Positives = 152/297 (51%), Gaps = 14/297 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y  L+ +  G YGAV  A D  TG  V +KK+     SE       RE+ LLK ++HEN
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 78

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +  +++D      LV   +  DL   MK E        +I+  ++Q+L G+ 
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---GEDRIQFLVYQMLKGLR 135

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y H+  I+HRDLKP N  ++     +KI DFGLAR  D      T    +  Y+APE +L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQAD---SEMTGYVVTRWYRAPEVIL 191

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS-FS 233
              RY+  VD+W+V C  AEM+T + LF        L  I  + GTP +E +    S  +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ 290
           + +         KD A+++    P  V+LL +ML LD  +R+TA EAL H YF+   
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 6e-64
 Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 21/306 (6%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            +  +  +  G  G V +     +G  +  K I  +     + + +IRE+ +L E     
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPY 65

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV       S   I +  E++D   L  +  +       + + K    ++ G+ Y   + 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKH 124

Query: 121 -ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            I+HRD+KP+N L++ S+  +K+ DFG++  +   + N  +  G+  Y +PERL G   Y
Sbjct: 125 KIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG-THY 180

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM-----GTPDSETLPGFTSFSE 234
           S   D+W++  +  EM   +       A  L       +      TP     PG    S 
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 235 EFGFEPNRSPIKDLATVVGGLEP---------DGVDLLRRMLCLDPSKRLTAREALRHEY 285
                P  +  + L  +V    P         +  D + + L  +P++R   ++ + H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 286 FKDFQS 291
            K   +
Sbjct: 301 IKRSDA 306

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 6e-64
 Identities = 60/291 (20%), Positives = 109/291 (37%), Gaps = 34/291 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + ++  + +G +G V++A +  T      K I   +  E      + E+ +L    H N
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPN 70

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV+LL+     +++ ++ E      +  +  E        +I+    Q L  + Y H  +
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG----S 176
           I+HRDLK  N L       +K+ADFG++      ++      G+  + APE ++      
Sbjct: 131 IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             Y    DVW++  T  EM   +   H      +L  I      P +   P   S     
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKSEPPTLAQPSRWS----- 242

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                +  D L++ L  +   R T  + L+H +  
Sbjct: 243 --------------------SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  199 bits (508), Expect = 9e-63
 Identities = 63/290 (21%), Positives = 115/290 (39%), Gaps = 31/290 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y + E +  G +G VHR  +  TG+    K +  M P E    +V +E+  +  L+H  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPT 84

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V L +     + + +++E +    L     +     +  +  +Y+ Q+  G+ + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 121 ILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            +H DLKP N +    +   +K+ DFGL   +D P ++  +  G+  + APE   G    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEG-KPV 202

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
               D+W+V      +++    F        L  + S     D     G +         
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS--------- 253

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF 289
                             DG D +R++L  DP+ R+T  +AL H +    
Sbjct: 254 -----------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 9e-63
 Identities = 107/300 (35%), Positives = 154/300 (51%), Gaps = 14/300 (4%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L  +  G YG+V  A D+ TG  V VKK+     S        RE+ LLK +KHEN
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++ LL+V +   S++      LV   +  DL + +K +         ++  ++QIL G+ 
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---TDDHVQFLIYQILRGLK 135

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           Y HS +I+HRDLKP+N  ++     +KI DFGLAR  D      T    +  Y+APE +L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIML 191

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS- 233
               Y+  VD+W+V C  AE++T + LF        L  I  ++GTP +E L   +S S 
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
             +     + P  + A V  G  P  VDLL +ML LD  KR+TA +AL H YF  +   D
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-62
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 33/293 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +YT  E I +G  G V+ A D  TG  V ++++ +    +     +I E+ +++E K+ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           IV  L+     D + +V E L    L  + TE  + +   +I     + L  + + HS +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           ++HRD+K  N L+      VK+ DFG    I       +   G+  + APE +     Y 
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG 194

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD+W++     EM+  +  + +      L  I +  GTP+   L      S  F    
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE---LQNPEKLSAIF---- 246

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
                               D L R L +D  KR +A+E L+H++ K  + L 
Sbjct: 247 -------------------RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 6e-62
 Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 32/289 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            + L++ + EG YG V  A + +T + V VK +  M  +   P ++ +E+ + K L HEN
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHEN 64

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V+    +   +   L  E        F + EP +       +++ HQ++ GV Y H   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSGR 178
           I HRD+KP N L+D  +D +KI+DFGLA           +    G+L Y APE L     
Sbjct: 124 ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
           ++ PVDVW+       M+  +  +          + +    T     L  +         
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----LNPWKKIDSAP-- 236

Query: 239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                + LL ++L  +PS R+T  +  +  ++ 
Sbjct: 237 ---------------------LALLHKILVENPSARITIPDIKKDRWYN 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  196 bits (500), Expect = 1e-61
 Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 31/292 (10%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y +LE +  G +G VHR  +  TG   V K I    P +    +V  E+S++ +L H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPK 87

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           ++ L +       + L+ E L    L           +  ++  Y+ Q   G+ + H   
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147

Query: 121 ILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           I+H D+KP N + +  K   VKI DFGLA  ++ P E   +   +  + APE +      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDR-EPV 205

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
               D+WA+      +++    F        L  +       D +     +         
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--------- 256

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                            P+  D ++ +L  +P KRLT  +AL H + K   S
Sbjct: 257 -----------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-61
 Identities = 61/289 (21%), Positives = 117/289 (40%), Gaps = 34/289 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           +Y + E +  G +G VHR  ++ +  T + K + +    +     V +E+S+L   +H N
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRN 62

Query: 61  IVRLLNVQSSVDSIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           I+ L     S++ + ++FE +   D+   + T      N  +I  Y+HQ+   + + HS 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH 121

Query: 120 EILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
            I H D++P N +    +   +KI +FG AR +        +      Y           
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHDV 179

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
            ST  D+W++      +++    F +     ++  I +   T D E     +        
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS-------- 231

Query: 239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                              + +D + R+L  +   R+TA EAL+H + K
Sbjct: 232 ------------------IEAMDFVDRLLVKERKSRMTASEALQHPWLK 262

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-61
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 36/288 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
            + +   + +G++G V+ A +  +   + +K +        GV   + REV +   L+H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           NI+RL         + L+ E      ++    + +      +   Y+ ++ + ++YCHS+
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-RTATYITELANALSYCHSK 125

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
            ++HRD+KP N L+  S   +KIADFG +     P    T   G+L Y  PE + G   +
Sbjct: 126 RVIHRDIKPENLLLG-SAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIEG-RMH 181

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
              VD+W++     E +  +  F +         I  +  T                   
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--------------- 226

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                          +     DL+ R+L  +PS+R   RE L H +  
Sbjct: 227 ---------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 4e-58
 Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 37/290 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHE 59
            ++ L  I  G +GAV+ A D    + V +KK+      S      +I+EV  L++L+H 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           N ++         +  LV E         ++         ++I    H  L G+AY HS 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSH 134

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS--G 177
            ++HRD+K  N L+     +VK+ DFG A  +           G+  + APE +L    G
Sbjct: 135 NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEG 189

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           +Y   VDVW++  T  E+   +    +  A   L  I       +         +SE F 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NESPALQSGHWSEYF- 243

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                  + +   L   P  R T+   L+H +  
Sbjct: 244 ----------------------RNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 4e-58
 Identities = 74/296 (25%), Positives = 117/296 (39%), Gaps = 34/296 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
            Y   +V+  G +  V  A D  T   V +K I      EG   S+  E+++L ++KH N
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPN 68

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           IV L ++  S   + L+ + +   +L   +  +   T       + + Q+L  V Y H  
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT--ERDASRLIFQVLDAVKYLHDL 126

Query: 120 EILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
            I+HRDLKP N L     +   + I+DFGL++  D P    +   G+  Y APE L    
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQ-K 184

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
            YS  VD W++      ++     F+      L   I       DS      +       
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS------- 237

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSLD 293
                                  D +R ++  DP KR T  +AL+H +     +LD
Sbjct: 238 -------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  186 bits (474), Expect = 5e-58
 Identities = 84/300 (28%), Positives = 137/300 (45%), Gaps = 23/300 (7%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HE 59
            Y L+  +  G+Y  V  A +    + VVVK +  +   +     + RE+ +L+ L+   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGP 90

Query: 60  NIVRLLNVQSSVDS--IDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           NI+ L ++     S    LVFE+++  D     +T          I+ Y+++IL  + YC
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEILKALDYC 145

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           HS  I+HRD+KP N +ID     +++ D+GLA     P + Y ++  S  +K PE L+  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDY 204

Query: 177 GRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
             Y   +D+W++ C  A M+  +   FH       L  I  ++GT D        +   +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 236 FGFE--PNRSPIKDLATVV-----GGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             F     R   K     V       + P+ +D L ++L  D   RLTAREA+ H YF  
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  181 bits (460), Expect = 2e-56
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 44/303 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-------EGVPSSVIREVSLL 53
            Y   E++  G    V R     T     VK I +           + +  + ++EV +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 54  KELK-HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILH 111
           +++  H NI++L +   +     LVF+ +   +L  ++  + T+++   + +K +  +L 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK--ETRKIMRALLE 121

Query: 112 GVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            +   H   I+HRDLKP N L+D     +K+ DFG +  +D P E      G+  Y APE
Sbjct: 122 VICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPE 179

Query: 172 RLLGS-----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL 226
            +  S       Y   VD+W+       ++     F  R    +L  I S      S   
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF 286
             ++                              DL+ R L + P KR TA EAL H +F
Sbjct: 240 DDYS--------------------------DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

Query: 287 KDF 289
           + +
Sbjct: 274 QQY 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 9e-56
 Identities = 71/298 (23%), Positives = 120/298 (40%), Gaps = 36/298 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP----IMNPSEGVPSSVIREVSLLKEL 56
            Y   E +  G++  V +  +  TG     K I       +        + REVS+LKE+
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
           +H N++ L  V  +   + L+ E +    L     E   +    +  ++L QIL+GV Y 
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL 129

Query: 117 HSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           HS +I H DLKP N ++      K  +KI DFGLA  ID     +    G+  + APE +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIV 188

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
                     D+W++      +++    F        LA + ++    + E     +   
Sbjct: 189 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS--- 244

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS 291
                                      D +RR+L  DP KR+T +++L+H + K   +
Sbjct: 245 -----------------------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 5e-55
 Identities = 91/307 (29%), Positives = 142/307 (46%), Gaps = 25/307 (8%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY  L+ I  G  G V  A+D++    V +KK+     ++       RE+ L+K + H+N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 61  IVRLLNVQSSVDSID------LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           I+ LLNV +   +++      LV E +D +L   ++ E        ++   L+Q+L G+ 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIK 133

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           + HS  I+HRDLKP+N ++  S   +KI DFGLAR         T    +  Y+APE +L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 191

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
           G G Y   VD+W+V C   EMV H+ LF  R        +   +GTP  E +        
Sbjct: 192 GMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 235 EFGFE------------PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
            +                  S     +           DLL +ML +DP+KR++  +AL+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 283 HEYFKDF 289
           H Y   +
Sbjct: 311 HPYINVW 317

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 6e-55
 Identities = 61/292 (20%), Positives = 103/292 (35%), Gaps = 38/292 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
                 I  G +  V++  D+ T   V   ++     ++        E  +LK L+H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 62  VRLLNVQSSV----DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
           VR  +   S       I LV E +    L        V K  + ++ +  QIL G+ + H
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV-LRSWCRQILKGLQFLH 129

Query: 118 SQ--EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLG 175
           ++   I+HRDLK  N  I      VKI D GLA           I  G+  + APE    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTPEFMAPEMY-- 185

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
             +Y   VDV+A      EM T +  +        +     +       +          
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAI---- 239

Query: 236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK 287
                                P+  +++   +  +  +R + ++ L H +F+
Sbjct: 240 ---------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 7e-55
 Identities = 69/294 (23%), Positives = 116/294 (39%), Gaps = 41/294 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
           Y +L  I  G YG   +      G  +V K++   + +E     ++ EV+LL+ELKH NI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 62  VRLLNV--QSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPL---KIKKYLHQILHGVAYC 116
           VR  +     +  ++ +V E  +   L  + T+ T  +  L    + + + Q+   +  C
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 117 HSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
           H +      +LHRDLKPAN  +D  K  VK+ DFGLAR ++          G+  Y +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
           ++     Y+   D+W++ C   E+      F +     L   I                 
Sbjct: 185 QMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS---- 239

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEY 285
                                     +  +++ RML L    R +  E L +  
Sbjct: 240 -------------------------DELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 7e-53
 Identities = 58/299 (19%), Positives = 105/299 (35%), Gaps = 39/299 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
            +   +++ EG +  V  A +  T     +K +   +   E     V RE  ++  L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
             V+L       + +           L     +   + +    + Y  +I+  + Y H +
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK 127

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGSG 177
            I+HRDLKP N L++     ++I DFG A+ +    +        G+  Y +PE L    
Sbjct: 128 GIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-K 185

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
                 D+WA+ C   ++V     F +     +   I  +      +             
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK------------- 232

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD---FQSLD 293
                              P   DL+ ++L LD +KRL   E   +   K    F+S+ 
Sbjct: 233 -----------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 9e-52
 Identities = 65/294 (22%), Positives = 107/294 (36%), Gaps = 44/294 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVP----SSVIREVSLLKEL 56
           +Y +  ++  G +G+V+          V +K +     S+       + V  EV LLK++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 57  K--HENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
                 ++RLL+     DS  L+ E  +     F              + +  Q+L  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLL 174
           +CH+  +LHRD+K  N LID ++  +K+ DFG    +      YT   G+  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIR 182

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
               +     VW++     +MV     F                   D E + G   F +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----------------DEEIIRGQVFFRQ 225

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
                                  +   L+R  L L PS R T  E   H + +D
Sbjct: 226 RVS-------------------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  169 bits (430), Expect = 5e-51
 Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 40/299 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP----IMNPSEGVPSSVIREVSLLKEL 56
            +++  +I  G +G V+    + TG    +K +      M   E +  +    +SL+   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
               IV +     + D +  + + ++   LH+  ++     +   ++ Y  +I+ G+ + 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM 123

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGS 176
           H++ +++RDLKPAN L+D     V+I+D GLA   D   +      G+  Y APE L   
Sbjct: 124 HNRFVVYRDLKPANILLD-EHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             Y +  D +++ C   +++     F           I  +  T   E    F+      
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS------ 233

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQ 290
                               P+   LL  +L  D ++RL      A+E     +F+   
Sbjct: 234 --------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-50
 Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 35/288 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           + T+ + I  G +G V++         V VK + +  P+     +   EV +L++ +H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           I+  +   ++   + +V +  +   L H +    T     +K+     Q   G+ Y H++
Sbjct: 66  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLG-- 175
            I+HRDLK  N  +      VKI DFGLA        ++  +   GS+ + APE +    
Sbjct: 124 SIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE 235
              YS   DV+A      E++T Q  + +      +  +                     
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------- 223

Query: 236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                      DL+ V          L+   L     +R    + L  
Sbjct: 224 -----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-50
 Identities = 62/298 (20%), Positives = 116/298 (38%), Gaps = 42/298 (14%)

Query: 1   RYTLL-EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS-LLKELKH 58
            Y +  +V+  G  G V +  +  T +   +K +              REV    +  + 
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQC 64

Query: 59  ENIVRLLNVQSSVDSID----LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
            +IVR+++V  ++ +      +V E LD  +L   ++          +  + +  I   +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 114 AYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPIDVPLENYTIKGGSLCYKAPE 171
            Y HS  I HRD+KP N L    +   I+K+ DFG A+       + T    +  Y APE
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPE 183

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE-TLPGFT 230
            +LG  +Y    D+W++      ++     F+S     +   + + +     E   P ++
Sbjct: 184 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD 288
             SEE                          L+R +L  +P++R+T  E + H +   
Sbjct: 243 EVSEEV-----------------------KMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-49
 Identities = 65/294 (22%), Positives = 124/294 (42%), Gaps = 38/294 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIP--IMNPSEGVPSSVIREVSLLKELKH 58
            + L +++ +G +G V  A    T     +K +   ++   + V  +++ +  L    +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCH 117
             +  +     + +++  V E L+  DL++ +++      +  +   Y  +I+ G+ + H
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLH 120

Query: 118 SQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSG 177
           S+ I++RDLK  N L+D     +KIADFG+ +   +         G+  Y APE LLG  
Sbjct: 121 SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-Q 178

Query: 178 RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           +Y+  VD W+      EM+  Q  FH +    L  +I       D+   P +        
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLE------ 227

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR-EALRHEYFKDFQ 290
                               +  DLL ++   +P KRL  R +  +H  F++  
Sbjct: 228 -------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (411), Expect = 9e-49
 Identities = 61/295 (20%), Positives = 106/295 (35%), Gaps = 42/295 (14%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHEN 60
           + +L  +  G +G VH       G    +K +   +            E  +L  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           I+R+         I ++ + ++   L  +    +        K Y  ++   + Y HS++
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           I++RDLKP N L+D     +KI DFG A+ +    +      G+  Y APE +     Y+
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVST-KPYN 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             +D W+      EM+     F+          I                  + E  F P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----------------LNAELRFPP 222

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQ 290
             +              D  DLL R++  D S+RL        +   H +FK+  
Sbjct: 223 FFN-------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (411), Expect = 3e-48
 Identities = 72/329 (21%), Positives = 125/329 (37%), Gaps = 40/329 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L+  +  G +  V  A D +    V +K   I+   +    +   E+ LL+ +   +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDAD 70

Query: 61  IVRLLNVQS---------------SVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKY 105
             +  ++ +               +   + +VFE L  +LL  +K         + +K+ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 106 LHQILHGVAYCHSQE-ILHRDLKPANFLIDRSKDIVKIADFGLARPID--VPLENYTIKG 162
             Q+L G+ Y H +  I+H D+KP N L++       +    +A   +     E+YT   
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 163 GSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR------WAPGLLAAIFS 216
            +  Y++PE LLG   +    D+W+ AC   E++T   LF              +A I  
Sbjct: 191 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 217 IMGTPDSETLPGFTSFSEEF------------GFEPNRSPIKDLATVVGGLEPDGVDLLR 264
           ++G   S  L         F             F P    + +          +  D L 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 265 RMLCLDPSKRLTAREALRHEYFKDFQSLD 293
            ML LDP KR  A   + H + KD   ++
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 5e-48
 Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 39/295 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHEN 60
           +  L+++ +G +G V    +  TG    +K +   +  ++   +  + E  +L+  +H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +  L     + D +  V E  +   L F  +   V     + + Y  +I+  + Y HS++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRD 125

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           +++RD+K  N ++D     +KI DFGL +             G+  Y     +L    Y 
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEY-LAPEVLEDNDYG 183

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             VD W +     EM+  +  F+++    L   I                   EE  F  
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----------------LMEEIRFPR 226

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQ 290
             S             P+   LL  +L  DP +RL      A+E + H +F    
Sbjct: 227 TLS-------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (396), Expect = 5e-47
 Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 37/292 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI-MNPSEGVPSSVIREVSLLKELKHE 59
           RY L E++  G    VH A D      V VK +   +           RE      L H 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 60  NIVRLLNVQSSVDSID----LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
            IV + +   +         +V E +D   L  +         P +  + +      + +
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNF 126

Query: 116 CHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPER 172
            H   I+HRD+KPAN +I  + + VK+ DFG+AR I     + T      G+  Y +PE+
Sbjct: 127 SHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 173 LLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
             G        DV+++ C   E++T +  F       +          P S    G +  
Sbjct: 186 ARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS-- 242

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE 284
                                    D   ++ + L  +P  R      +R +
Sbjct: 243 ------------------------ADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-46
 Identities = 52/285 (18%), Positives = 94/285 (32%), Gaps = 37/285 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
             T ++ I  G++G VH  +  L  D V +K I             I E  ++ +L H  
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 61

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
           +V+L  V      I LVFE ++   L               +      +  G+AY     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 121 ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK-GGSLCYKAPERLLGSGRY 179
           ++HRDL   N L+     ++K++DFG+ R +       +      + + +PE      RY
Sbjct: 122 VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
           S+  DVW+      E+ +  ++ +   +   ++  I +                      
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS----------- 228

Query: 239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                                  ++       P  R      LR 
Sbjct: 229 ------------------THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-46
 Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 41/291 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
              L+E +  G++G V   + +     V VK +         P + + E +L+K+L+H+ 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +VRL  V +  + I ++ E ++   L  F+KT   +     K+     QI  G+A+   +
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGSGR 178
             +HRDL+ AN L+       KIADFGLAR I D            + + APE +   G 
Sbjct: 129 NYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186

Query: 179 YSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           ++   DVW+      E+VTH R+ +     P ++  +         +  P          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP---------- 236

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR--HEYF 286
                               +   L+R      P  R T         ++F
Sbjct: 237 -------------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-45
 Identities = 55/285 (19%), Positives = 109/285 (38%), Gaps = 41/285 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
              LL+ I +G +G V        G+ V VK I     ++    + + E S++ +L+H N
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61

Query: 61  IVRLLNV-QSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
           +V+LL V       + +V E +    L+ ++++          + K+   +   + Y   
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
              +HRDL   N L+    ++ K++DFGL +               + + APE L    +
Sbjct: 122 NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALRE-KK 176

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF 238
           +ST  DVW+      E+ +  R+ +                 P  + +P         G+
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYP--------------RIPLKDVVPRVEK-----GY 217

Query: 239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
           + +            G  P   ++++    LD + R +  +    
Sbjct: 218 KMDAPD---------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 4e-45
 Identities = 51/291 (17%), Positives = 104/291 (35%), Gaps = 39/291 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKH 58
              + +VI  G +G V   H  L G   +   I  +    +E      + E S++ +  H
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            N++ L  V +    + ++ E ++   L     +       +++   L  I  G+ Y   
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG-----GSLCYKAPERL 173
              +HRDL   N L++ S  + K++DFGL+R ++    + T          + + APE +
Sbjct: 147 MNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
               ++++  DVW+      E++++ +R +       ++ AI      P     P     
Sbjct: 206 QY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP----- 259

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                                        L+      D + R    + +  
Sbjct: 260 ------------------------SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-45
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 41/292 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
              L   + +G +G V     +     V +K +    P    P + ++E  ++K+L+HE 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 61  IVRLLNVQSSVDSIDLVFENLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +V+L  V S  + I +V E +    LL F+K E        ++     QI  G+AY    
Sbjct: 74  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGSGR 178
             +HRDL+ AN L+     + K+ADFGLAR I D            + + APE  L  GR
Sbjct: 133 NYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           ++   DVW+      E+ T  R+ +       +L  +      P     P          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP---------- 240

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR--HEYFK 287
                                  DL+ +    +P +R T         +YF 
Sbjct: 241 -------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-44
 Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 34/286 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKH 58
           R  L   I EG++G VH+       +  +   I       S+ V    ++E   +++  H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            +IV+L+ V +  + + ++ E      L         + +   +  Y +Q+   +AY  S
Sbjct: 68  PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGR 178
           +  +HRD+   N L+  S D VK+ DFGL+R ++        KG           +   R
Sbjct: 127 KRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           +++  DVW       E++ H            ++  I +    P     P          
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP---------- 235

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                              P    L+ +    DPS+R    E    
Sbjct: 236 -------------------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (378), Expect = 1e-43
 Identities = 59/296 (19%), Positives = 105/296 (35%), Gaps = 42/296 (14%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHE 59
           ++  ++ +  G +G V       +G+   +K +              + E  +L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            +V+L        ++ +V E +    +            P   + Y  QI+    Y HS 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEYLHSL 160

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
           ++++RDLKP N LID+ +  +++ DFG A+ +           G+    APE +L  G Y
Sbjct: 161 DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILSKG-Y 215

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
           +  VD WA+     EM      F +     +   I S      S                
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--------------- 260

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQ 290
                             D  DLLR +L +D +KR         +   H++F    
Sbjct: 261 ---------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-42
 Identities = 50/284 (17%), Positives = 98/284 (34%), Gaps = 37/284 (13%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI 61
            T L+ +  G++G V           V +K I             I E  ++  L HE +
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 62  VRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEI 121
           V+L  V +    I ++ E +    L     E        ++ +    +   + Y  S++ 
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 122 LHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERLLGSGRYS 180
           LHRDL   N L++  + +VK++DFGL+R + D    +       + +  PE L+   ++S
Sbjct: 122 LHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFS 179

Query: 181 TPVDVWAVACTFAEMVTHQRLFHSRWAPG-LLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
           +  D+WA      E+ +  ++ + R+        I   +                     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS------------ 227

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                                 ++         +R T +  L +
Sbjct: 228 -----------------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-41
 Identities = 57/312 (18%), Positives = 106/312 (33%), Gaps = 58/312 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPI----MNPSEGVPSSVIREVSLLKEL 56
                +V+  G +G V  A       T V  ++ +             +++ E+ ++ +L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 57  -KHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPL-------------- 100
             HENIV LL   +    I L+FE   + DLL++++++                      
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 101 -------KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-- 151
                   +  + +Q+  G+ +   +  +HRDL   N L+     +VKI DFGLAR I  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMS 216

Query: 152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL 211
           D            + + APE L   G Y+   DVW+      E+ +     +        
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--D 273

Query: 212 AAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDP 271
           A  + ++        P + +                          +   +++     D 
Sbjct: 274 ANFYKLIQNGFKMDQPFYAT-------------------------EEIYIIMQSCWAFDS 308

Query: 272 SKRLTAREALRH 283
            KR +       
Sbjct: 309 RKRPSFPNLTSF 320

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 3e-41
 Identities = 56/283 (19%), Positives = 102/283 (36%), Gaps = 33/283 (11%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
             T+   +  G+YG V+         TV VK +             ++E +++KE+KH N
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 61  IVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
           +V+LL V +      ++ E + + +LL +++       + + +     QI   + Y   +
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 120 EILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRY 179
             +HRDL   N L+     +VK+ADFGL+R +                      L   ++
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 180 STPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE 239
           S   DVWA      E+ T+    +       +  +                    E  + 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKDYR 234

Query: 240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
             R           G      +L+R     +PS R +  E  +
Sbjct: 235 MERPE---------GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-41
 Identities = 59/288 (20%), Positives = 99/288 (34%), Gaps = 37/288 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP----SEGVPSSVIREVSLLKEL 56
              LLE + +G +G V R          V   +  + P            IREV+ +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            H N++RL  V  +   + +V E      L     +         + +Y  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLL 174
            S+  +HRDL   N L+   +D+VKI DFGL R +    ++Y ++              L
Sbjct: 128 ESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 175 GSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
            +  +S   D W    T  EM T+ +  +       +L  I       + E LP      
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----EGERLPRPEDCP 241

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL 281
           ++                         +++ +     P  R T     
Sbjct: 242 QDI-----------------------YNVMVQCWAHKPEDRPTFVALR 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 5e-41
 Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 39/305 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
           RY L   I  G +G ++   D   G+ V +K   +          +  E  + K ++   
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGV 63

Query: 61  IVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE 120
            +  +    +    +++   L    L  +    +   +   +     Q++  + Y HS+ 
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 121 ILHRDLKPANFLIDRSK--DIVKIADFGLARPID-------VPLENYTIKGGSLCYKAPE 171
            +HRD+KP NFL+   K  ++V I DFGLA+          +P        G+  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 172 RLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS 231
             LG    S   D+ ++             +    A                        
Sbjct: 184 THLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------------- 225

Query: 232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA---REALRHEYFKD 288
             E    +   +PI+ L     G   +    L     L    +      R+  R+ + + 
Sbjct: 226 --ERISEKKMSTPIEVL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

Query: 289 FQSLD 293
             S D
Sbjct: 281 GFSYD 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-41
 Identities = 54/287 (18%), Positives = 108/287 (37%), Gaps = 36/287 (12%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVK---KIPIMNPSEGVPSSVIREVSLLKELKH 58
           +  ++V+  G +G V++      G+ V +    K      S      ++ E  ++  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
            ++ RLL +  +  ++ L+ + + F  L     E         +  +  QI  G+ Y   
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG--GSLCYKAPERLLGS 176
           + ++HRDL   N L+  +   VKI DFGLA+ +    + Y  +G    + + A E +L  
Sbjct: 130 RRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 177 GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF 236
             Y+   DVW+   T  E++T     +       +++I         E LP     + + 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQPPICTIDV 242

Query: 237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                                    ++ +   +D   R   RE +  
Sbjct: 243 -----------------------YMIMVKCWMIDADSRPKFRELIIE 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-40
 Identities = 54/290 (18%), Positives = 105/290 (36%), Gaps = 42/290 (14%)

Query: 7   VIREGRYGAVHRA--HDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRL 64
            +  G +G V +          TV VK +        +   ++ E +++++L +  IVR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 65  LNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHR 124
           + +    +S  LV E  +   L+    +    K+   I + +HQ+  G+ Y      +HR
Sbjct: 74  IGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLEESNFVHR 131

Query: 125 DLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIK---GGSLCYKAPERLLGSGRYST 181
           DL   N L+  ++   KI+DFGL++ +      Y  +      + + APE +    ++S+
Sbjct: 132 DLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSS 189

Query: 182 PVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP 240
             DVW+      E  ++ Q+ +       + A +            P             
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP------------- 236

Query: 241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE---ALRHEYFK 287
                            +  DL+      D   R         LR+ Y+ 
Sbjct: 237 ----------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-40
 Identities = 59/303 (19%), Positives = 110/303 (36%), Gaps = 41/303 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSL---TGDTVVVKKIPI--MNPSEGVPSSVIREVSLLKE 55
            + LL+V+  G YG V          TG    +K +    +            E  +L+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 56  LKHE-NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVA 114
           ++    +V L     +   + L+ + ++   L    ++        +++ Y+ +I+  + 
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALE 143

Query: 115 YCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKGGSLCYKAPERL 173
           + H   I++RD+K  N L+D S   V + DFGL++       E      G++ Y AP+ +
Sbjct: 144 HLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 174 LGSGR-YSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF 232
            G    +   VD W++     E++T    F         A I   +   +       +  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS-- 260

Query: 233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFK 287
                                       DL++R+L  DP KRL      A E   H +F+
Sbjct: 261 ------------------------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

Query: 288 DFQ 290
              
Sbjct: 297 KIN 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-39
 Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 38/289 (13%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL 56
             T  +VI  G +G V++     +       V +K +     +E      + E  ++ + 
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQF 66

Query: 57  KHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYC 116
            H NI+RL  V S    + ++ E ++   L     E     + L++   L  I  G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 117 HSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI-DVPLENYTIKG--GSLCYKAPERL 173
            +   +HRDL   N L++ S  + K++DFGL+R + D P   YT  G    + + APE +
Sbjct: 127 ANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 174 LGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFS 233
               ++++  DVW+      E++T+    +   +   +    +     D   LP      
Sbjct: 186 SY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----DGFRLPTPMDCP 239

Query: 234 EEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR 282
                                       L+ +    + ++R    + + 
Sbjct: 240 SAI-----------------------YQLMMQCWQQERARRPKFADIVS 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-39
 Identities = 56/302 (18%), Positives = 111/302 (36%), Gaps = 41/302 (13%)

Query: 1   RYTLLEV-IREGRYGAVHRAHDSLTGDTVVVK-KIPIMNPSEGVPSSVIREVSLLKELKH 58
              + ++ +  G +G+V +    +    + V  K+      +     ++RE  ++ +L +
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS 118
             IVRL+ V  + +++ LV E      LH              + + LHQ+  G+ Y   
Sbjct: 69  PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127

Query: 119 QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG---GSLCYKAPERLLG 175
           +  +HRDL   N L+  ++   KI+DFGL++ +      YT +      L + APE +  
Sbjct: 128 KNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 176 SGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE 234
             ++S+  DVW+   T  E +++ +  +     P ++A I            P       
Sbjct: 187 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP------- 238

Query: 235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE---ALRHEYFKDFQS 291
                                 P+   L+          R         +R  Y+     
Sbjct: 239 ----------------------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

Query: 292 LD 293
           ++
Sbjct: 277 VE 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (342), Expect = 7e-39
 Identities = 54/313 (17%), Positives = 93/313 (29%), Gaps = 49/313 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-E 59
            Y +   I EG +G +    + L    V +K  P  + +      +  E    K L    
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCT 61

Query: 60  NIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQ 119
            I  +           LV + L   L   +        +   +     Q+L  V   H +
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF-SVKTVAMAAKQMLARVQSIHEK 120

Query: 120 EILHRDLKPANFLIDR----SKDIVKIADFGLARPIDVPLENYTIKG-------GSLCYK 168
            +++RD+KP NFLI R    + +++ + DFG+ +    P+    I         G+  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 169 APERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG 228
           +    LG    S   D+ A+   F   +     +    A         I     S  L  
Sbjct: 181 SINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 229 FTS-FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA-------REA 280
             + F EEF                          +     L                + 
Sbjct: 240 LCAGFPEEF-----------------------YKYMHYARNLAFDATPDYDYLQGLFSKV 276

Query: 281 LRHEYFKDFQSLD 293
           L      + ++ D
Sbjct: 277 LERLNTTEDENFD 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-38
 Identities = 61/300 (20%), Positives = 104/300 (34%), Gaps = 48/300 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVK-KIPIMNPSEGVPSSVIREVSLLKEL-KH 58
                +VI EG +G V +A     G  +    K      S+        E+ +L +L  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 59  ENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNP--------------LKIK 103
            NI+ LL        + L  E     +LL F++    +  +P               ++ 
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 104 KYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGG 163
            +   +  G+ Y   ++ +HRDL   N L+     + KIADFGL+R  +V ++       
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG-RL 188

Query: 164 SLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDS 223
            + + A E L     Y+T  DVW+      E+V+     +       L         P  
Sbjct: 189 PVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQG 242

Query: 224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
             L    +  +E                         DL+R+     P +R +  + L  
Sbjct: 243 YRLEKPLNCDDEV-----------------------YDLMRQCWREKPYERPSFAQILVS 279

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-37
 Identities = 66/304 (21%), Positives = 103/304 (33%), Gaps = 39/304 (12%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN 60
              L E I +GR+G V R      G+ V VK   I +  E        E+     L+HEN
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVK---IFSSREERSWFREAEIYQTVMLRHEN 58

Query: 61  IVRLLNVQSSVDS----IDLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAY 115
           I+  +   +  +     + LV +  +   L  ++            + K       G+A+
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 115

Query: 116 CHSQE--------ILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKG----G 163
            H +         I HRDLK  N L+        IAD GLA   D   +   I      G
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 164 SLCYKAPERLLGS-----GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIM 218
           +  Y APE L  S            D++A+   F E+   +           L     + 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVP 233

Query: 219 GTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR 278
             P  E +       +     PNR    +   V+         ++R     + + RLTA 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-------AKIMRECWYANGAARLTAL 286

Query: 279 EALR 282
              +
Sbjct: 287 RIKK 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (334), Expect = 1e-37
 Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 63/313 (20%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
               +  I EG +G V +A             V VK +     S  + +   RE +L+ E
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAE 72

Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMKTEPTVTKNPL-------------- 100
             + NIV+LL V +    + L+FE + + DL  F+++    T   L              
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 101 --------KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI- 151
                   +      Q+  G+AY   ++ +HRDL   N L+     +VKIADFGL+R I 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIY 191

Query: 152 -DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRL-FHSRWAPG 209
                +        + +  PE +  + RY+T  DVWA      E+ ++    ++      
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCL 269
           ++  +                        + N     +          +  +L+R     
Sbjct: 251 VIYYV-----------------------RDGNILACPE------NCPLELYNLMRLCWSK 281

Query: 270 DPSKRLTAREALR 282
            P+ R +     R
Sbjct: 282 LPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-36
 Identities = 60/307 (19%), Positives = 110/307 (35%), Gaps = 55/307 (17%)

Query: 1   RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
           R +  + +  G +G V  A       S    TV VK +   +       +++ E+ +L  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSY 82

Query: 56  LK-HENIVRLLNVQSSVDSIDLVFENLDF-DLLHFMK----------------TEPTVTK 97
           L  H NIV LL   +      ++ E   + DLL+F++                 +  +  
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 98  NPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPL 155
           +   +  + +Q+  G+A+  S+  +HRDL   N L+     I KI DFGLAR I  D   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLARDIKNDSNY 201

Query: 156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
                    + + APE +     Y+   DVW+      E+ +     +        +  +
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSKFY 258

Query: 216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
            ++        P                              +  D+++     DP KR 
Sbjct: 259 KMIKEGFRMLSPEHAP-------------------------AEMYDIMKTCWDADPLKRP 293

Query: 276 TAREALR 282
           T ++ ++
Sbjct: 294 TFKQIVQ 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 6e-36
 Identities = 53/286 (18%), Positives = 98/286 (34%), Gaps = 39/286 (13%)

Query: 6   EVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKHENIVR 63
           EVI  G +G V+           +   +  +N     G  S  + E  ++K+  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 64  LLNVQSSVD-SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEIL 122
           LL +    + S  +V   +    L       T       +  +  Q+  G+ +  S++ +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 123 HRDLKPANFLIDRSKDIVKIADFGLARPIDVP----LENYTIKGGSLCYKAPERLLGSGR 178
           HRDL   N ++D  K  VK+ADFGLAR +       + N T     + + A E L    +
Sbjct: 153 HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QK 210

Query: 179 YSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETLPGFTSFSEEFG 237
           ++T  DVW+      E++T     +       +   +         E  P          
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP---------- 260

Query: 238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
                                  +++ +        R +  E +  
Sbjct: 261 -------------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 6e-34
 Identities = 57/299 (19%), Positives = 102/299 (34%), Gaps = 47/299 (15%)

Query: 1   RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
           + T+   + +G +G V+               V +K +     S       + E S++KE
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKE 79

Query: 56  LKHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKT-----EPTVTKNPLKIKKYL 106
               ++VRLL V S      ++ E +        L  ++            +  K+ +  
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 107 HQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP--LENYTIKGGS 164
            +I  G+AY ++ + +HRDL   N ++      VKI DFG+ R I               
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 165 LCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSE 224
           + + +PE L   G ++T  DVW+      E+ T     +               G  + +
Sbjct: 199 VRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY--------------QGLSNEQ 243

Query: 225 TLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH 283
            L         F  E       D             +L+R     +P  R +  E +  
Sbjct: 244 VL--------RFVMEGGLLDKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-33
 Identities = 61/306 (19%), Positives = 99/306 (32%), Gaps = 52/306 (16%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKE 55
           R  L + +  G +G V  A         T  TV VK +          + +     L+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 56  LKHENIVRLLNV-QSSVDSIDLVFENLD----FDLLHFMKTEPTVTK-----------NP 99
             H N+V LL         + ++ E          L   + E    K             
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 100 LKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPLEN 157
             +  Y  Q+  G+ +  S++ +HRDL   N L+   K++VKI DFGLAR I  D     
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 192

Query: 158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSI 217
                  L + APE +     Y+   DVW+      E+ +     +      +       
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGV--KIDEEFCRR 249

Query: 218 MGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTA 277
           +        P +T+                         P+    +      +PS+R T 
Sbjct: 250 LKEGTRMRAPDYTT-------------------------PEMYQTMLDCWHGEPSQRPTF 284

Query: 278 REALRH 283
            E + H
Sbjct: 285 SELVEH 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-33
 Identities = 61/308 (19%), Positives = 110/308 (35%), Gaps = 56/308 (18%)

Query: 1   RYTLLEVIREGRYGAVHRAHDSLTGD-------TVVVKKIPIMNPSEGVPSSVIREVSLL 53
           R  L + + EG +G V  A               V VK +   + +E   S +I E+ ++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMM 72

Query: 54  KEL-KHENIVRLLNVQSSVDSIDLVFENLD----FDLLHFMKTEPTVTKNPL-------- 100
           K + KH+NI+ LL   +    + ++ E        + L   +                  
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 101 ---KIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI--DVPL 155
               +    +Q+  G+ Y  S++ +HRDL   N L+    +++KIADFGLAR I      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYY 191

Query: 156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIF 215
           +  T     + + APE L     Y+   DVW+      E+ T     +       L  + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL 275
                 +   +   ++ + E                          ++R      PS+R 
Sbjct: 251 K-----EGHRMDKPSNCTNEL-----------------------YMMMRDCWHAVPSQRP 282

Query: 276 TAREALRH 283
           T ++ +  
Sbjct: 283 TFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 1e-20
 Identities = 27/201 (13%), Positives = 59/201 (29%), Gaps = 19/201 (9%)

Query: 2   YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS--------EGVPSSVIREVSLL 53
             + +++ EG+  AV   +        VVK   + + S        +             
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 54  KELKHENIVRLLNVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGV 113
              +   + +L  +              +  L+  +  +           + L  IL  V
Sbjct: 61  ARNEFRALQKLQGLAV-PKVYAW---EGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 114 AYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTIKGGSLCYKAPERL 173
           A  + + I+H DL   N L+   ++ + I DF  +  +        ++            
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS--EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 174 LGSGRYSTPVDVWAVACTFAE 194
                Y T  D+ +      +
Sbjct: 174 ---RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	293
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.02
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.32
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.71
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.57

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=399.31  Aligned_cols=289  Identities=46%  Similarity=0.736  Sum_probs=244.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++++.||+|+||+||+|.+..+|+.||+|+++...........+.+|++++++++||||+++++++.+++..|+|||+
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            59999999999999999999999999999999976555555668899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +++++...+.......+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++...........
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~-~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTHHHHHCCCSBCTTC
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc-ceeccCCcceeccCCccccee
Confidence            9999888887777778999999999999999999999999999999999999998887 999999999877655455555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||++.....++.++|+||||+++|+|++|..||.+.+..+....+....+.+.....+.......... ..
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SF  240 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TS
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc-cc
Confidence            56999999999988877788999999999999999999999999998888888888888777666665433322221 11


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ............+.+++++.+|+++||+.||++|||++|+|+||||++++.
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            122223344566678999999999999999999999999999999998753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-62  Score=397.88  Aligned_cols=257  Identities=26%  Similarity=0.356  Sum_probs=219.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++.+.||+|+||+||+|.+..+|+.||+|+++....  ...+.+.+|++++++++||||+++++++.+++.+|+||||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            69999999999999999999999999999999865432  3346789999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+.+..+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++...........
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~-vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTCCBCC
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc-Eeeccchhheeeccccccccc
Confidence            9865555554433  4889999999999999999999999999999999999998888 999999999887655445555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......                   
T Consensus       176 ~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------------------  235 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------------------  235 (293)
T ss_dssp             CCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-------------------
T ss_pred             cccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------------
Confidence            5699999999988776 68999999999999999999999999887776666654421111                   


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                              ...+..+++++.+||.+||+.||.+|||+.|+|+||||+.-+
T Consensus       236 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             --------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence                    012234788999999999999999999999999999997543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-62  Score=392.99  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=216.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            48999999999999999999999999999999864332 23445678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+......  ..
T Consensus        87 y~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-~kl~DFG~a~~~~~~--~~  161 (263)
T d2j4za1          87 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSS--RR  161 (263)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCSCSCCCCC--CC
T ss_pred             ecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC-EeecccceeeecCCC--cc
Confidence            9985 5555655433  4789999999999999999999999999999999999999888 999999999876543  23


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....                   
T Consensus       162 ~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------------------  221 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------------------  221 (263)
T ss_dssp             EETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred             cccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            345599999999998876 689999999999999999999999998888877777643111                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 ..+..+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       222 -----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                       122347889999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=391.85  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++++.||+|+||+||+|.++.+|+.||+|+++.... ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            48999999999999999999999999999999865432 23346789999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                      ++| ++.+.+...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++.......  .
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~-~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC-EEEccchhheeeccCCcccc
Confidence            985 555555433  35889999999999999999999999999999999999998888 99999999987643222  2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....||+.|+|||++.+...++.++||||||+++|+|++|..||..................                 
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-----------------  224 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------------  224 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-----------------
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------------
Confidence            234459999999999887755678899999999999999999999776543332222211100                 


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                .......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                      01112347889999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=394.13  Aligned_cols=284  Identities=35%  Similarity=0.594  Sum_probs=238.2

Q ss_pred             eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC---CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            3 TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS---EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         3 ~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +.+++||+|+||+||+|.+..+|+.||||+++.....   ......+.+|++++++++||||+++++++..++..|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3578999999999999999999999999998654322   2234678899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|+++..+.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++..........
T Consensus        81 ~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~-~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          81 FMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCCCCC
T ss_pred             hhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc-cccccCccccccCCCccccc
Confidence            99988887766543 35788899999999999999999999999999999999998888 99999999987765544445


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ...+++.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+.++....+.+....++..........+.
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            55689999999998777678999999999999999999999999999999999999988888887777665544333222


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                        ...........+.+++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       239 --~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         239 --SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             --CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             --cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence              1122334556677899999999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-61  Score=394.37  Aligned_cols=258  Identities=23%  Similarity=0.302  Sum_probs=217.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      .|++++.||+|+||+||+|.+..+|..||+|+++..  .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            389999999999999999999999999999998643  344557889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      ++|+.+..+.......+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+............
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~-~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC-EEEEechhhhccCCCcccccc
Confidence            9866655543333446899999999999999999999999999999999999999988 999999999765433223334


Q ss_pred             cCccccccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          161 KGGSLCYKAPERLLG----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ..|++.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+....+......                
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~----------------  233 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP----------------  233 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC----------------
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            559999999998842    345789999999999999999999999998888877776542110                


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                 ....++.+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       234 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 -----------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                       00122347889999999999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4e-60  Score=388.37  Aligned_cols=284  Identities=44%  Similarity=0.752  Sum_probs=240.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||+++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.++++++||||+++++++.+++..++++|+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            7999999999999999999886 789999999976655556678899999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.++++..+.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++. +|++|||.+............
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~-~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-------
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC-EEecccccceecccCccccce
Confidence            9998888776554 46899999999999999999999999999999999999999988 999999999877655444445


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+...++....+.+....++.......... ..
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-NF  238 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc-cc
Confidence            55889999999998877789999999999999999999999999998888999888888887777765544333221 12


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      ............+.+++++.+||++||+.||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            222233445666778999999999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-61  Score=392.81  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--CCcceeEee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--VDSIDLVFE   79 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e   79 (293)
                      |++.+.||+|+||+||+|+++.+|+.||+|++..........+.+.+|++++++++||||+++++++.+  ++.+|+|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            899999999999999999999999999999987655444455678899999999999999999998854  457899999


Q ss_pred             cCCc-chHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           80 NLDF-DLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQE-----ILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        80 ~~~~-~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      |++| ++.+.+..  .....+++..++.++.||+.||+|||++|     ++||||||+||+++.++. +||+|||.+...
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~-vkl~DFG~a~~~  164 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARIL  164 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC-EEECCHHHHHHC
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc-EEEeeccceeec
Confidence            9985 55555432  22346889999999999999999999876     999999999999999888 999999999877


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ...........||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....             
T Consensus       165 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------------  230 (269)
T d2java1         165 NHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------------  230 (269)
T ss_dssp             -----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------------
T ss_pred             ccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            6544444455689999999988766 68999999999999999999999999988888777765411             


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYF  286 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~  286 (293)
                                      ....+..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       231 ----------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ----------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                            112234578899999999999999999999999999996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=388.51  Aligned_cols=286  Identities=37%  Similarity=0.627  Sum_probs=239.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCC-CCeEEEEEecccCCCCCCcccHHHHHHHHHhc---CCCCcceeeeeeec-----C
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLT-GDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL---KHENIVRLLNVQSS-----V   71 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~   71 (293)
                      ||++++.||+|+||+||+|.+..+ ++.||+|+++...........+.+|+++++.+   +||||+++++++..     .
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            799999999999999999998655 66789999977665566666788888888776   79999999998743     3


Q ss_pred             CcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           72 DSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        72 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ...+++||+++++++..........+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||.+...
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~-~kl~dfg~~~~~  166 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCCCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC-eeecchhhhhhh
Confidence            4689999999998887777777778899999999999999999999999999999999999998888 999999998765


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....+.+....++....
T Consensus       167 ~~~-~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         167 SFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CGG-GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             ccc-ccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            433 233445599999999988776 689999999999999999999999999999999999998888877766665444


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcCC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQSL  292 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~~  292 (293)
                      .......   .............+++++.+||.+||+.||++|||+.|+|+||||++++++
T Consensus       245 ~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         245 LPRQAFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             SCGGGSC---CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             chhhhhc---cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            3332211   111223345566789999999999999999999999999999999999765

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-61  Score=390.96  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=216.6

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|++++++++||||+++++++.+++..|+||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            999999999999999999999999999999986433 2234456789999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                      ++| ++.+.+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||.++.......  .
T Consensus        90 ~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~-vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          90 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECC-------
T ss_pred             cCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce-EEecccccceecccCCcccc
Confidence            985 5556555443  5889999999999999999999999999999999999999988 99999999987653322  2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...++.....                  
T Consensus       167 ~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------------------  227 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------------  227 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC------------------
T ss_pred             cccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC------------------
Confidence            2344599999999998876 689999999999999999999999999888887777653111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHH------HhcCcccccCcCC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTARE------ALRHEYFKDFQSL  292 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~~p~~~~~~~~  292 (293)
                                  ..+..+++++.+||.+||+.||++|||++|      +++||||+.++|.
T Consensus       228 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         228 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             ------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             ------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence                        122357889999999999999999999987      6889999988653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-60  Score=397.40  Aligned_cols=259  Identities=24%  Similarity=0.412  Sum_probs=219.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|+||+||+|.+..+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            6999999999999999999999999999999985432  22346788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC--CCCeEEEccCCCcccCCCCCcc
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR--SKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~--~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ++| ++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||+++.  ++. +||+|||.++...... .
T Consensus       105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~-vkL~DFG~a~~~~~~~-~  181 (350)
T d1koaa2         105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQ-S  181 (350)
T ss_dssp             CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCC-EEECCCTTCEECCTTS-C
T ss_pred             CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCe-EEEeecchheeccccc-c
Confidence            985 555555433 346899999999999999999999999999999999999975  344 9999999998776543 3


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+.              
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------------  246 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------------  246 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------------
T ss_pred             cceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------------
Confidence            3344599999999998876 6889999999999999999999999998888888887653332211              


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                                  ...+.+++++.+||.+||..||++|||++|+|+||||+..++
T Consensus       247 ------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         247 ------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             ------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             ------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                        223457889999999999999999999999999999987653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-60  Score=388.61  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|.+..+|+.||+|++...... .....+.+|++++++++||||+++++++.+++..|+||||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            599999999999999999999999999999998654432 2335678899999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC---CCCeEEEccCCCcccCCCCCc
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR---SKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~---~~~~v~l~df~~~~~~~~~~~  156 (293)
                      ++ |++.+.+...  ..+++..+..++.||+.||+|||++|++||||||+||++..   ++. +||+|||.++..... .
T Consensus        89 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~-vkl~DFG~a~~~~~~-~  164 (307)
T d1a06a_          89 VSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPG-S  164 (307)
T ss_dssp             CCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC-EEECCC-----------
T ss_pred             cCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCce-EEEeccceeEEccCC-C
Confidence            98 5666666554  35889999999999999999999999999999999999963   455 999999999866543 2


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEF  236 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+              
T Consensus       165 ~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------  229 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------------  229 (307)
T ss_dssp             --------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------------
T ss_pred             eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------
Confidence            22334599999999988776 689999999999999999999999999888887777754222111              


Q ss_pred             CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          237 GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                  ....+.+|+++.+||.+||+.||++|||+.|+++||||+.-
T Consensus       230 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 ------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                        12234578999999999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=385.09  Aligned_cols=260  Identities=27%  Similarity=0.381  Sum_probs=219.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      ||++++.||+|+||+||+|.++.+|+.||+|+++......    ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            6999999999999999999999999999999986544322    234678899999999999999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC---eEEEccCCCcccCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD---IVKIADFGLARPID  152 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~---~v~l~df~~~~~~~  152 (293)
                      ||||++| ++.+.+....  .+++..++.++.|++.||+|||+.|++||||||+||+++.++.   .+|++|||.+....
T Consensus        91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            9999985 5556655543  5889999999999999999999999999999999999987763   49999999998775


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....             
T Consensus       169 ~~~-~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------------  233 (293)
T d1jksa_         169 FGN-EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-------------  233 (293)
T ss_dssp             TSC-BCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-------------
T ss_pred             CCc-cccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-------------
Confidence            442 23334589999999988765 689999999999999999999999999888888777754211             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                   ......++.+|+++.+||++||+.||++|||++++|+||||+..+
T Consensus       234 -------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         234 -------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -------------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -------------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                         111234456889999999999999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=391.04  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=221.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCC-CCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNP-SEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      .|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            38999999999999999999999999999999864321 23445778899999999999999999999999999999999


Q ss_pred             cCCcc-hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDFD-LLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++|+ +...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++.........
T Consensus        86 y~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~-vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          86 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTCCB
T ss_pred             ccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC-EEEeecccccccccCCccc
Confidence            99855 445554433  4788899999999999999999999999999999999999998 9999999998765544444


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+.....                   
T Consensus       163 ~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-------------------  222 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------  222 (337)
T ss_dssp             CCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-------------------
Confidence            555699999999988776 689999999999999999999999999988888777754211                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                 ..++.+|+++.+||.+||+.||.+||+     +.++++||||+.++|
T Consensus       223 -----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                       123457899999999999999999994     999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-59  Score=393.89  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=218.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|.+..+|+.||+|+++...  ......+.+|++++++++||||+++++++.+++.+|+||||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5999999999999999999999999999999986432  22235678899999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeC--CCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDR--SKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~--~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++|+.+..........+++..++.++.||+.||+|||++|++||||||+||+++.  ++. +||+|||.+...... ...
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~-vkL~DFGla~~~~~~-~~~  185 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPD-EIV  185 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC-EEECCCTTCEECCTT-SCE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCe-EEEeecccceecCCC-Cce
Confidence            9965554333344456899999999999999999999999999999999999983  455 999999999887654 333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......++.               
T Consensus       186 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------  249 (352)
T d1koba_         186 KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---------------  249 (352)
T ss_dssp             EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS---------------
T ss_pred             eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------------
Confidence            444589999999988766 6899999999999999999999999998888888777653332221               


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                 ...+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       250 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                       1234578999999999999999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-60  Score=388.90  Aligned_cols=254  Identities=25%  Similarity=0.339  Sum_probs=214.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||+||+|.+..+|+.||||+++...... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4899999999999999999999999999999986543322 233568899999999999999999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      |+.|+++..+.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.+......    .
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~-~Kl~DFG~a~~~~~~----~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPA----N  169 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE-EEECCCTTCBSSSSB----C
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC-EEEeecccccccCCC----C
Confidence            99987776554332 35889999999999999999999999999999999999998887 999999999865432    2


Q ss_pred             ccCccccccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 IKGGSLCYKAPERLLG--SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ...||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+..+....+.......                
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  233 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------  233 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence            3459999999998864  3458899999999999999999999999887777666654311110                


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                  .....+|+++.+||.+||+.||++|||++++|+||||.+
T Consensus       234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                        012346889999999999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=379.36  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             Cc-eeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec----CCcce
Q 038154            1 RY-TLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS----VDSID   75 (293)
Q Consensus         1 ry-~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   75 (293)
                      || ++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|++++++++||||+++++++.+    ...+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 67789999999999999999999999999987655444445678899999999999999999998764    34689


Q ss_pred             eEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecccCCCceeEeC-CCCeEEEccCCCcccC
Q 038154           76 LVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQE--ILHRDLKPANFLIDR-SKDIVKIADFGLARPI  151 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~h~dl~~~Ni~i~~-~~~~v~l~df~~~~~~  151 (293)
                      +||||++| ++.+.+.+..  .+++..++.++.||+.||+|||++|  ++||||||+||+++. ++. +||+|||.++..
T Consensus        89 ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~-~Kl~DFGla~~~  165 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLK  165 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC-EEECCTTGGGGC
T ss_pred             EEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC-EEEeecCcceec
Confidence            99999985 5555555433  5788899999999999999999998  999999999999974 566 999999999865


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHHHhCCCCCCCCCCCc
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL-AAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (293)
                      ...  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||........+ ..+.. ...          
T Consensus       166 ~~~--~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~----------  230 (270)
T d1t4ha_         166 RAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVK----------  230 (270)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCC----------
T ss_pred             cCC--ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCC----------
Confidence            433  2334459999999998764  4899999999999999999999999876554433 33311 000          


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFK  287 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~  287 (293)
                                       ........++++.+||.+||+.||++|||++|+|+||||+
T Consensus       231 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             0122345688999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-59  Score=388.18  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=217.8

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      |++++.||+|+||+||+|+++.+|+.||+|+++... ......+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            899999999999999999999999999999986432 2234457788999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.|+.+..+..... ..++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++.....   ...
T Consensus        86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~-vkL~DFG~a~~~~~~---~~~  160 (316)
T d1fota_          86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDV---TYT  160 (316)
T ss_dssp             CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSSC---BCC
T ss_pred             cCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC-EEEecCccceEeccc---ccc
Confidence            98655544443322 4677888999999999999999999999999999999999888 999999999876533   233


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFEP  240 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....                     
T Consensus       161 ~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------------------  218 (316)
T d1fota_         161 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------------------  218 (316)
T ss_dssp             CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------------------
T ss_pred             ccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------------------
Confidence            4599999999988766 689999999999999999999999999888888877754211                     


Q ss_pred             CCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          241 NRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                               ..++.+++++.+++.+||..||.+|+     |++++++||||+++.|
T Consensus       219 ---------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         219 ---------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ---------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                     12345788999999999999999996     9999999999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-58  Score=374.49  Aligned_cols=259  Identities=26%  Similarity=0.397  Sum_probs=219.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC-------cccHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV-------PSSVIREVSLLKELK-HENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   72 (293)
                      +|++.+.||+|+||+||+|.+..+|+.||+|+++........       .+.+.+|+.+++++. ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            699999999999999999999999999999998765443322       235778999999997 999999999999999


Q ss_pred             cceeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccC
Q 038154           73 SIDLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPI  151 (293)
Q Consensus        73 ~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~  151 (293)
                      ..|+||||++ |++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++..
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~~  160 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEEC
T ss_pred             ceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC-eEEccchheeEc
Confidence            9999999998 56666665543  5889999999999999999999999999999999999998888 999999999887


Q ss_pred             CCCCcceeccCccccccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLG-----SGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETL  226 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  226 (293)
                      ..... .....|++.|+|||.+.+     ...++.++||||+|+++|+|++|+.||.+.+.......+......++    
T Consensus       161 ~~~~~-~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~----  235 (277)
T d1phka_         161 DPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG----  235 (277)
T ss_dssp             CTTCC-BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             cCCCc-eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence            65432 333458999999998853     34568899999999999999999999999888887777765322211    


Q ss_pred             CCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          227 PGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                            ....+.+|+++.+|+.+||+.||++|||++|+|+||||+.+
T Consensus       236 ----------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 ----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                  11233578999999999999999999999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-58  Score=376.07  Aligned_cols=286  Identities=40%  Similarity=0.711  Sum_probs=243.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||+++++||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.+....++++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            89999999999999999999999999999999976665556667889999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcceec
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYTI  160 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~~  160 (293)
                      +.|..+..+.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. +||+|||.+............
T Consensus        83 ~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~-~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSCCSCCCS
T ss_pred             ccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc-eeeeecchhhcccCCCcccee
Confidence            9988877766543 35788899999999999999999999999999999999998887 999999999887665555555


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+.+....++............
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            557889999998887767899999999999999999999885 5567777888888888887777666655544433222


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      .. ..........+.+++++.+||++||+.||.+|||++|+|+||||+++
T Consensus       241 ~~-~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         241 MY-PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CC-CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cc-cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence            22 12234445566789999999999999999999999999999999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=391.08  Aligned_cols=281  Identities=22%  Similarity=0.337  Sum_probs=209.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|.+..+|+.||+|+++.. ........+.+|++++++++||||+++++++.+++..|+||||
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            489999999999999999999999999999998653 2344456788999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      +.| ++.+.+.+..  .+++..++.++.|++.||+|||+ +|++||||||+||+++.++. +||+|||.+......  ..
T Consensus        86 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~--~~  160 (322)
T d1s9ja_          86 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDS--MA  160 (322)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHH--TC
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC-EEEeeCCCccccCCC--cc
Confidence            996 5555554433  47899999999999999999997 49999999999999999988 999999999865322  12


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-HhCCCCCCCCCCCcCc-----
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFS-IMGTPDSETLPGFTSF-----  232 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----  232 (293)
                      ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......... ..+.... ..+.....     
T Consensus       161 ~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE-TPPRPRTPGRPLS  238 (322)
T ss_dssp             ---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc-CCccccccccccc
Confidence            234599999999999876 699999999999999999999999987665443222111 1111110 00000000     


Q ss_pred             ccccCCCCCCCcccch--------hh-hcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          233 SEEFGFEPNRSPIKDL--------AT-VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ................        .. -...++.++.+||.+||..||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence            0000000000000000        00 012357899999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-58  Score=387.37  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=218.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++.||+|+||+||+|.++.+|+.||+|++.... ........+.+|+++++.++||||+++++++......++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            5999999999999999999999999999999985432 223445678899999999999999999999999999999999


Q ss_pred             cCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++.| ++...+....  .+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.++.....   .
T Consensus       122 ~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~-ikL~DFG~a~~~~~~---~  195 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSC---B
T ss_pred             cccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC-EEeeeceeeeecccc---c
Confidence            9985 5555555443  4789999999999999999999999999999999999999988 999999999877543   2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.....                   
T Consensus       196 ~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------------------  255 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------------  255 (350)
T ss_dssp             CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------------
Confidence            234499999999998876 689999999999999999999999999888877777754211                   


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                 ..+..+++++.++|++||..||.+|+     |++++++||||+.++|
T Consensus       256 -----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                       12335789999999999999999994     9999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-59  Score=384.56  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=217.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      ||++++.||+|+||+||+|.++.+|+.||+|+++...   .....+.+|+++|++++||||+++++++.+++.+|+||||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            7999999999999999999999999999999986432   2234677999999999999999999999999999999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC-eEEEccCCCcccCCCCCcce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD-IVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~-~v~l~df~~~~~~~~~~~~~  158 (293)
                      ++| ++.+.+.. ....+++..++.++.||+.||+|||++|++||||||+||+++.++. .++|+|||.+...... ...
T Consensus        83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~  160 (321)
T d1tkia_          83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNF  160 (321)
T ss_dssp             CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEE
T ss_pred             CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Ccc
Confidence            986 55555544 3446899999999999999999999999999999999999986542 4999999999876544 333


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ....+++.|+|||...+. .++.++|||||||++|+|++|..||.+.+..+....+......+                 
T Consensus       161 ~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----------------  222 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-----------------  222 (321)
T ss_dssp             EEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----------------
T ss_pred             cccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------
Confidence            444589999999987766 68999999999999999999999999998888888876522211                 


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                               ....++.+|+++.+||.+||..||.+|||++|+++||||+.
T Consensus       223 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         223 ---------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                     12334568899999999999999999999999999999964

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=375.30  Aligned_cols=286  Identities=34%  Similarity=0.581  Sum_probs=227.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec--------CC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS--------VD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~~   72 (293)
                      ||++++.||+|+||+||+|.+..+|+.||||++............+.+|++++++++|||++++++++..        .+
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            7999999999999999999999999999999987766666667788999999999999999999998744        34


Q ss_pred             cceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           73 SIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        73 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ..|++||+++++++...... ...+++..++.++.||+.||.|||++|++||||||+||+++.++. +|++|||.+....
T Consensus        91 ~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~-~kl~dfg~~~~~~  168 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFS  168 (318)
T ss_dssp             CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECC
T ss_pred             eEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc-EEeeecceeeecc
Confidence            68999999998887765544 346888899999999999999999999999999999999999988 9999999997654


Q ss_pred             CCC----cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCC
Q 038154          153 VPL----ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPG  228 (293)
Q Consensus       153 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (293)
                      ...    .......+|+.|+|||++.+...++.++||||||+++|+|++|+.||.+.+.......+....+.+.......
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            321    1122234899999999988776789999999999999999999999999999999999988888877766555


Q ss_pred             CcCcccccCCCCCCCcccchhh--hcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          229 FTSFSEEFGFEPNRSPIKDLAT--VVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                      ......................  .....++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            4433322221111111111111  11224678899999999999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-58  Score=385.59  Aligned_cols=283  Identities=36%  Similarity=0.522  Sum_probs=226.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC------cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD------SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~   74 (293)
                      ||++++.||+|+||+||+|.+..+|+.||||+++.........+.+.+|+++|+.++||||+++++++...+      .+
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            799999999999999999999999999999998654444444567889999999999999999999987655      47


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||++..+......   ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +|++|||.+......
T Consensus        99 ~lv~e~~~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~-~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_          99 YLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSE  174 (346)
T ss_dssp             EEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCSS
T ss_pred             EEEEecccccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc-cccccccceeccCCc
Confidence            99999997766655543   25889999999999999999999999999999999999999988 999999999876543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.++............
T Consensus       175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence               23445899999999998877789999999999999999999999999988888888888777776554333222111


Q ss_pred             cc-CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 EF-GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .. ................+.+++++.+||.+||..||++|||+.|+|+||||+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00 000111122334455667899999999999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-58  Score=381.22  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=218.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccC-CCCCCcccHHHHHHHHH-hcCCCCcceeeeeeecCCcceeEe
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN-PSEGVPSSVIREVSLLK-ELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      .|++++.||+|+||+||+|.++.+|+.||+|+++... ........+..|..++. .++||||+++++++.+++..|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            4899999999999999999999999999999986432 12334456667777665 679999999999999999999999


Q ss_pred             ecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           79 ENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        79 e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      ||++| ++.+.+....  .+++..++.++.||+.||+|||++|++||||||+||+++.+++ +||+|||.++........
T Consensus        83 Ey~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~-~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTCC
T ss_pred             eecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc-eeccccchhhhccccccc
Confidence            99985 5555555443  4788899999999999999999999999999999999999888 999999999877655555


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....                  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------------  220 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------------  220 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             ccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            5556699999999998876 689999999999999999999999999888888777753110                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH-HHhcCcccccCcC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR-EALRHEYFKDFQS  291 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~p~~~~~~~  291 (293)
                                  ..++.+|+++.+||.+||+.||++|||+. ++++||||+++++
T Consensus       221 ------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 ------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                        12335789999999999999999999995 8999999998753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=373.88  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC----CCcccHHHHHHHHHhcC--CCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE----GVPSSVIREVSLLKELK--HENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~   74 (293)
                      ||++++.||+|+||+||+|.+..+|+.||+|++.......    .....+.+|++++++++  ||||+++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            7999999999999999999999999999999986543322    23356778999999996  89999999999999999


Q ss_pred             eeEeecCCc--chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLDF--DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      ++|||++.+  .+...+....  .+++..++.++.||+.||+|||++|++||||||+||+++.+...+||+|||.+....
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            999999964  4445554433  588999999999999999999999999999999999999775559999999998654


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ..  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+      .+...               
T Consensus       163 ~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~---------------  219 (273)
T d1xwsa_         163 DT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG---------------  219 (273)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC---------------
T ss_pred             cc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc---------------
Confidence            43  22334599999999998776556778999999999999999999996531      11110               


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                                     ....++.+|+++.+||.+||+.||++|||++|+++||||+++.
T Consensus       220 ---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ---------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                           0012345789999999999999999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-57  Score=379.99  Aligned_cols=283  Identities=29%  Similarity=0.459  Sum_probs=225.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      +|+.+++||+|+||+||+|++..+|+.||||++....      ....+|++++++++||||+++++++...      .+.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            4889999999999999999999999999999986432      2234799999999999999999987432      347


Q ss_pred             eeEeecCCcchHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCC
Q 038154           75 DLVFENLDFDLLHFMKT--EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPID  152 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~  152 (293)
                      |+||||+++++...+..  .....+++..++.++.||+.||+|||++|++||||||+||+++.++..+||+|||.+....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            89999999887665542  3345689999999999999999999999999999999999999887559999999998765


Q ss_pred             CCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          153 VPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ... ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+....+.+...........
T Consensus       175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            432 2233458999999999887778999999999999999999999999999988888888877776654433322221


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      .....+... ..........+..++++.+||.+||..||++|||+.|+|+||||+++..
T Consensus       254 ~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 YTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             --CCCCCCC-CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhcccccc-ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            111111111 1111122334567899999999999999999999999999999998743

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-57  Score=383.63  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=209.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCC-CCCcccHHHH---HHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPS-EGVPSSVIRE---VSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      .|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|   +++++.++||||+++++++.+.+.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            489999999999999999999999999999998542211 1222333444   566667789999999999999999999


Q ss_pred             EeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ||||++| ++.+.+....  .+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.++......
T Consensus        85 vmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~-iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKK  161 (364)
T ss_dssp             EECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC-EEECCCTTCEECSSSC
T ss_pred             EEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc-EEEeeeceeeecCCCc
Confidence            9999985 5555555443  4788899999999999999999999999999999999999888 9999999998765432


Q ss_pred             cceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          156 ENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                        .....||+.|+|||++.....++.++|||||||++|+|++|..||.+.+.............                
T Consensus       162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----------------  223 (364)
T d1omwa3         162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------------  223 (364)
T ss_dssp             --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS----------------
T ss_pred             --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------------
Confidence              23345999999999987665789999999999999999999999987655443332211111                


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCC-----HHHHhcCcccccCcC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLT-----AREALRHEYFKDFQS  291 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~p~~~~~~~  291 (293)
                                 .....+..+++++.+||.+||+.||.+|||     ++++++||||++++|
T Consensus       224 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         224 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             -----------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                       011223457899999999999999999999     799999999998754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=361.34  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=203.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||+||+|...   ..||||+++.........+.+.+|++++++++||||+++++++.. +..++||||
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            5889999999999999999643   359999997666666666789999999999999999999998754 568999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc--c
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE--N  157 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~--~  157 (293)
                      ++| ++.+.+.. ....+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||.++.......  .
T Consensus        85 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~-~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          85 CEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             CCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS-EEECCCCCSCC---------
T ss_pred             CCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC-EEEccccceeeccccCCccc
Confidence            995 44455543 3446899999999999999999999999999999999999999888 99999999976643222  2


Q ss_pred             eeccCccccccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          158 YTIKGGSLCYKAPERLLGS--GRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      .....||+.|+|||++.+.  ..++.++||||||+++|+|+||..||.+.+...............              
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------------  228 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--------------  228 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC--------------
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence            2344589999999988643  357889999999999999999999999877665555544322111              


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                ......+..+|+++.+|+.+||+.||++|||+.+++++
T Consensus       229 ----------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 ----------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ----------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                      12233455678999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=371.19  Aligned_cols=258  Identities=22%  Similarity=0.319  Sum_probs=205.0

Q ss_pred             Cceeee-eeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec----CCcc
Q 038154            1 RYTLLE-VIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS----VDSI   74 (293)
Q Consensus         1 ry~i~~-~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~   74 (293)
                      +|+|.+ .||+|+||+||+|.+..+|+.||||+++.       ...+.+|++++.++ +||||+++++++.+    ...+
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            488875 59999999999999999999999999852       25678899987655 79999999999865    4578


Q ss_pred             eeEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC--eEEEccCCCcccC
Q 038154           75 DLVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD--IVKIADFGLARPI  151 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~--~v~l~df~~~~~~  151 (293)
                      |+||||++ |++.+.+.......+++..++.++.||+.||+|||++|++||||||+||+++.++.  .+||+|||.++..
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence            99999998 56777777666667999999999999999999999999999999999999986332  4999999999876


Q ss_pred             CCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          152 DVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ... .......|++.|+|||++.+. .++.++|||||||++|+|+||..||.+.+.......+........         
T Consensus       165 ~~~-~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~---------  233 (335)
T d2ozaa1         165 TSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---------  233 (335)
T ss_dssp             CCC-CCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS---------
T ss_pred             cCC-CccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC---------
Confidence            543 233445599999999988766 689999999999999999999999987655544433322111000         


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                   ..........+|+++.+||.+||+.||++|||+.++++||||.+-
T Consensus       234 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         234 -------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                         001112233578999999999999999999999999999999653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-56  Score=362.72  Aligned_cols=253  Identities=23%  Similarity=0.263  Sum_probs=209.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||+|.+..+|..||||+++..   ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            478899999999999999999989999999998643   23346789999999999999999999999999999999999


Q ss_pred             CC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee
Q 038154           81 LD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT  159 (293)
Q Consensus        81 ~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~  159 (293)
                      ++ |++...+.......+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||.++..........
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCCTTTCCSSSSEEE
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc-EEEccccceeecCCCCceee
Confidence            98 67777777766778899999999999999999999999999999999999999888 99999999987655433322


Q ss_pred             -ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          160 -IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSR-WAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       160 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                       ...+++.|+|||++.+. .++.++||||||+++|+|++|..||... +.......+.. ..                  
T Consensus       174 ~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~------------------  233 (287)
T d1opja_         174 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DY------------------  233 (287)
T ss_dssp             TTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TC------------------
T ss_pred             ccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CC------------------
Confidence             22378899999988766 6899999999999999999987766544 44443333321 11                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                                ....+..+++++.+|+.+||+.||.+|||+.++++  +|+.+
T Consensus       234 ----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 ----------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                      01223457889999999999999999999999976  45443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-56  Score=372.90  Aligned_cols=284  Identities=37%  Similarity=0.544  Sum_probs=223.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||+++++||+|+||+||+|.+..+|+.||||++............+.+|++++++++|||++++++++....     ..+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            799999999999999999999999999999998755444444567889999999999999999999875332     334


Q ss_pred             eEeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      ++++++. |++.+.+..   ..+++..++.++.||+.||+|||++|++||||||+||+++.++. ++++|||.+....  
T Consensus        99 ~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~-~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--  172 (348)
T ss_dssp             EEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCC----CCT--
T ss_pred             EEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc-ccccccchhcccC--
Confidence            4455555 565555533   25899999999999999999999999999999999999999988 9999999987654  


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       .......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....+.+.............
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             2333445889999999988877789999999999999999999999999998888888887777665443332222111


Q ss_pred             -ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          235 -EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                       ....................+++++.+||.+||..||++|||+.|+|+||||+++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence             111111222223444556678999999999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=369.81  Aligned_cols=285  Identities=32%  Similarity=0.540  Sum_probs=221.9

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCC-----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVD-----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (293)
                      ||++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+++|++++|||++++++++..+.     .++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            7999999999999999999999999999999985432 2233457889999999999999999999986654     356


Q ss_pred             eEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           76 LVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        76 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ++++..+|++.+.+...   .+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||.+.......
T Consensus        88 l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~-~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGGG
T ss_pred             EEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC-EEEcccCceeeccCCC
Confidence            66666667777777653   5889999999999999999999999999999999999998888 9999999997654321


Q ss_pred             c---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 E---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .   ......+++.|+|||++.....++.++||||+|+++|+|++|..||.+.+..+...........+...........
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            1   1233448899999999877667899999999999999999999999998887777777666555543332222111


Q ss_pred             cccc-CCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          233 SEEF-GFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .... ................+.+++++.+|+.+||+.||.+|||+.++|+||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence            1100 001111122334456677899999999999999999999999999999998654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-55  Score=362.28  Aligned_cols=251  Identities=19%  Similarity=0.265  Sum_probs=196.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC---eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD---TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.+.||+|+||+||+|.+..+++   .+|+|.+... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            47889999999999999999876654   4778876432 2233346788999999999999999999999999999999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||++++.+..+.......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||.++........
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC------------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc-EEECCcccceEccCCCCc
Confidence            9999976666555555556899999999999999999999999999999999999999888 999999999866433221


Q ss_pred             e-----eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          158 Y-----TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       158 ~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .     ....+++.|+|||.+.+. .++.++||||||+++|+|+| |..||.+.+..+....+.....            
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------  251 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR------------  251 (299)
T ss_dssp             -----------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------
T ss_pred             ceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            1     122368899999988765 68999999999999999998 8999999888877776643111            


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                       ...+..+++++.+|+.+||+.||++|||+.+|+++
T Consensus       252 -----------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 -----------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                             11233478899999999999999999999998874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=354.16  Aligned_cols=248  Identities=22%  Similarity=0.262  Sum_probs=195.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||+|... ++..||||+++..   ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            5899999999999999999876 5678999998642   23346799999999999999999999999999999999999


Q ss_pred             CCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-ee
Q 038154           81 LDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-YT  159 (293)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~~  159 (293)
                      ++++.+..+.......+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||.++........ ..
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC-EEECSCC--------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC-eEecccchheeccCCCceeec
Confidence            9865554444444456888899999999999999999999999999999999999888 999999999876543222 22


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTH-QRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|+|+ ..||...+..+....+......                  
T Consensus       161 ~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------------  221 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------------  221 (263)
T ss_dssp             ----CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------------------
T ss_pred             ceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence            33478999999988766 689999999999999999995 5666666666666666442111                  


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                 ..+...++++.+++.+||+.||++|||+++++++
T Consensus       222 -----------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                       1123457899999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=371.03  Aligned_cols=283  Identities=31%  Similarity=0.456  Sum_probs=216.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecC------Ccc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSV------DSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (293)
                      ||+++++||+|+||+||+|.+..+|+.||||+++...........+.+|+.++++++||||+++++++...      ...
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            79999999999999999999999999999999976554444456788999999999999999999998543      578


Q ss_pred             eeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           75 DLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        75 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      |+||||+.++++..+..    .+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++++|||.+......
T Consensus        98 ~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~-~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          98 YLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC-------
T ss_pred             EEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc-eeeechhhhhccccc
Confidence            99999999998887743    4788999999999999999999999999999999999999888 899999988766543


Q ss_pred             CcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          155 LENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                       .......+++.|+|||++.+. .++.++||||+||++++|++|..||.+.+......++......+....+........
T Consensus       173 -~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         173 -FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ---------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             -cccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence             223334488999999998876 789999999999999999999999999988888888877666654443332222111


Q ss_pred             ccCCCCCCC------------cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCc
Q 038154          235 EFGFEPNRS------------PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQ  290 (293)
Q Consensus       235 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~  290 (293)
                      .........            ............++++.+||++||..||++||||+|+|+||||+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            100000000            00001111222467889999999999999999999999999998753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=357.91  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=205.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++.+.||+|+||+||+|..+ ++..||||+++..   ....+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            5889999999999999999875 5678999998643   2334679999999999999999999998765 567999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc-e
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN-Y  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~-~  158 (293)
                      +++ ++.+.+.......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||.++........ .
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~-~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCEECC
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc-eeeccccceEEccCCccccc
Confidence            985 4545554444445889999999999999999999999999999999999999888 999999999876543222 2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQR-LFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|+||.. ||...+..+....+.....                  
T Consensus       168 ~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------------------  228 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------  228 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             cccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence            234478899999988755 68999999999999999999655 5555566666665533111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc--CcccccC
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR--HEYFKDF  289 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~p~~~~~  289 (293)
                                 ...+..+++++.+|+.+||+.||++|||+++|++  ++||.+.
T Consensus       229 -----------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         229 -----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence                       1123357889999999999999999999999999  8898753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=360.14  Aligned_cols=281  Identities=28%  Similarity=0.467  Sum_probs=214.0

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeec--CCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSS--VDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv   77 (293)
                      +|+++++||+|+||+||+|++..+|+.||+|+++.     ...+.+.+|+++|+.+. ||||+++++++..  ....++|
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            59999999999999999999999999999999853     23467889999999995 9999999999874  3568999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN  157 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~  157 (293)
                      |||+.++.+..+.    ..+++..++.++.||+.||+|||++|++|+||||+||+++.++..++|+|||.+....... .
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-~  185 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-E  185 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-C
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-c
Confidence            9999976665443    3588999999999999999999999999999999999999877669999999998765442 2


Q ss_pred             eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCCCCC------CCCc
Q 038154          158 YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAP-GLLAAIFSIMGTPDSETL------PGFT  230 (293)
Q Consensus       158 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~------~~~~  230 (293)
                      .....+++.|+|||.+.+...++.++|+||+|+++++|++|..||...... +....+....+.+.....      ....
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  265 (328)
T d3bqca1         186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  265 (328)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred             ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence            334458999999999888767899999999999999999999999776443 333333332221100000      0000


Q ss_pred             CcccccCCCCCCC-cccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccCcC
Q 038154          231 SFSEEFGFEPNRS-PIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDFQS  291 (293)
Q Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~~~  291 (293)
                      ............. ...........+++++.+||++||..||.+|||++|+|+||||+.+.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0000000000000 001111223447889999999999999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=351.11  Aligned_cols=247  Identities=20%  Similarity=0.219  Sum_probs=207.9

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecC
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENL   81 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (293)
                      |+++++||+|+||+||+|+.+ ++..||||+++....   ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             CEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            788999999999999999875 677899999875432   3468999999999999999999999999999999999999


Q ss_pred             CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ceec
Q 038154           82 DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NYTI  160 (293)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~~~  160 (293)
                      .++.+..+.......+++..+.+++.|++.||.|||++|++||||+|+||+++.++. +||+|||.++....... ....
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC-EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc-EEECcchhheeccCCCceeecc
Confidence            865555454444446788899999999999999999999999999999999998887 99999999976644322 2223


Q ss_pred             cCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCCC
Q 038154          161 KGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGFE  239 (293)
Q Consensus       161 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
                      ..+++.|+|||.+.+. .++.++||||||+++|+|+| |..||...+..+....+......                   
T Consensus       161 ~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-------------------  220 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------------------  220 (258)
T ss_dssp             SCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred             cCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence            4588899999988765 68999999999999999998 89999999988888777542111                   


Q ss_pred             CCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          240 PNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                ..+...++++.+|+.+||+.||++|||+.++++|
T Consensus       221 ----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                      1123467899999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=357.38  Aligned_cols=248  Identities=21%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             eeeccccceeEEEEEeC--CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeecCCc
Q 038154            6 EVIREGRYGAVHRAHDS--LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         6 ~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      ++||+|+||+||+|...  ..++.||||+++.........+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999754  455789999987555444455789999999999999999999999865 457899999985


Q ss_pred             -chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCccee---
Q 038154           84 -DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENYT---  159 (293)
Q Consensus        84 -~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~~---  159 (293)
                       ++.+.+....  .+++..+..++.||+.||+|||++|++||||||+||+++.++. +|++|||.++..........   
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~-~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc-ccccchhhhhhcccccccccccc
Confidence             4555555443  4788999999999999999999999999999999999998887 99999999987654433322   


Q ss_pred             ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccCC
Q 038154          160 IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFGF  238 (293)
Q Consensus       160 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
                      ...+++.|+|||++.+. .++.++||||||+++|+|+| |..||.+.+..+....+....                    
T Consensus       169 ~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--------------------  227 (277)
T d1xbba_         169 HGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------------------  227 (277)
T ss_dssp             --CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------------
T ss_pred             ccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            23478999999988765 68999999999999999998 899999888777666654311                    


Q ss_pred             CCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHh---cCcccc
Q 038154          239 EPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL---RHEYFK  287 (293)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll---~~p~~~  287 (293)
                               ....+..+|+++.+|+.+||+.||++|||+++|+   +++|+.
T Consensus       228 ---------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                     1122345789999999999999999999999984   566654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=356.89  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             ceeeee-eccccceeEEEEEeCC--CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEe
Q 038154            2 YTLLEV-IREGRYGAVHRAHDSL--TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVF   78 (293)
Q Consensus         2 y~i~~~-lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (293)
                      |.+.+. ||+|+||+||+|.+..  ++..||||+++... .....+.+.+|++++++++||||+++++++.. +..|+||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            566774 9999999999997653  44579999986432 23345678899999999999999999999875 4688999


Q ss_pred             ecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           79 ENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        79 e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      ||++++.+..+.......+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||.++.........
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-EEECCCTTCEECTTCSCEE
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc-eeeccchhhhccccccccc
Confidence            999965555444444456889999999999999999999999999999999999998887 9999999998775432222


Q ss_pred             ---eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          159 ---TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       159 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                         ....+++.|+|||++.+. .++.++||||||+++|+|+| |..||.+.+..+....+....                
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~----------------  229 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------  229 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------------
T ss_pred             ccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence               223478899999988765 68999999999999999998 899999988877777664311                


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHH---hcCccccc
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREA---LRHEYFKD  288 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l---l~~p~~~~  288 (293)
                                   ....++.+|+++.+|+.+||+.||++|||+.+|   |+++|+.-
T Consensus       230 -------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 -------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                         112344578999999999999999999999888   56788753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-54  Score=353.60  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCC-CCcccHHHHHHHHHhcCCCCcceeeeeeecCC----cce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSE-GVPSSVIREVSLLKELKHENIVRLLNVQSSVD----SID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   75 (293)
                      ||++.+.||+|+||+||+|.+..+|+.||+|+++...... .....+.+|+++++.++||||+++++++...+    ..|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            7999999999999999999999999999999986544332 33456889999999999999999999887654    378


Q ss_pred             eEeecCCcchHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCC
Q 038154           76 LVFENLDFDLLH-FMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVP  154 (293)
Q Consensus        76 lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~  154 (293)
                      +||||++|+.+. .+....  .+++..++.++.||+.||+|||++|++||||||+||+++.++. ++++|||.+......
T Consensus        88 lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~-~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC-EEECCCTTCEECC--
T ss_pred             EEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc-ceeehhhhhhhhccc
Confidence            999999965554 444433  5788999999999999999999999999999999999999888 899999988755332


Q ss_pred             Cc---ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          155 LE---NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       155 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ..   ......|++.|+|||++.+. .++.++||||||+++|+|+||..||.+.+..+...++......+          
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----------  233 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----------  233 (277)
T ss_dssp             --------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----------
T ss_pred             cccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC----------
Confidence            22   23334589999999998765 68999999999999999999999999888777766664421111          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-CHHHHhcCcccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-TAREALRHEYFK  287 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~p~~~  287 (293)
                                      .....+.+|+++.++|.+||+.||.+|| |+++ |.|+|.+
T Consensus       234 ----------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~-l~~~l~r  273 (277)
T d1o6ya_         234 ----------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAE-MRADLVR  273 (277)
T ss_dssp             ----------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH-HHHHHHH
T ss_pred             ----------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHH-HHHHHHH
Confidence                            1223456889999999999999999999 5555 5566654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=354.60  Aligned_cols=252  Identities=22%  Similarity=0.260  Sum_probs=202.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC-----eEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD-----TVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|+++++||+|+||+||+|++...++     .||+|.+.... .......+.+|+.++.++ +||||+++++++.+.+..
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            47899999999999999998765443     58888875432 334456788999999998 899999999999999999


Q ss_pred             eeEeecCC-cchHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           75 DLVFENLD-FDLLHFMKTEPT---------------------VTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        75 ~lv~e~~~-~~~~~~~~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      ++||||++ |++.+.+.....                     ..+++..++.++.|++.||+|||++|++||||||+||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999998 566666654321                     34788899999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~  209 (293)
                      ++.++. +||+|||.++.........  ....+++.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+
T Consensus       197 l~~~~~-~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         197 VTHGKV-VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EETTTE-EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccCCe-EEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            998887 9999999998664433322  233378999999988766 68999999999999999998 899999877766


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .+..+......+                            ..+..+|+++.+||.+||+.||++|||+++|++|
T Consensus       275 ~~~~~~~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         275 NFYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            666554421111                            1234568899999999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=349.06  Aligned_cols=254  Identities=26%  Similarity=0.325  Sum_probs=200.6

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeEeec
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLVFEN   80 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (293)
                      +|++++.||+|+||.||+|.+..+ ..||||+++...   ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            589999999999999999987654 579999986432   234679999999999999999999999854 568999999


Q ss_pred             CCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-ce
Q 038154           81 LDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-NY  158 (293)
Q Consensus        81 ~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-~~  158 (293)
                      +.+ ++...+.......+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++....... ..
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~-~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC----------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc-EEEcccchhhhccCCCceee
Confidence            985 4555555444456899999999999999999999999999999999999998887 99999999986643322 22


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++... .++.++||||||+++|+|++|+.|| ......+....+.....                  
T Consensus       172 ~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------------------  232 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------  232 (285)
T ss_dssp             ----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred             ccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence            334588999999988765 6899999999999999999976555 44555555555532111                  


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc--CcccccCc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR--HEYFKDFQ  290 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~p~~~~~~  290 (293)
                                 ...++.+++++.+++.+||+.||++|||+++|++  ++||....
T Consensus       233 -----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         233 -----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -----------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                       1223457889999999999999999999999998  88887653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=349.00  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=194.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC---CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++++.||+|+||+||+|.+..++   ..+|+|.++.. ........+.+|++++++++||||+++++++. ++..++|
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            6899999999999999999876443   45788876432 22333467889999999999999999999986 4678999


Q ss_pred             eecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc-
Q 038154           78 FENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        78 ~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~-  156 (293)
                      |||+.++.+..+.......+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||.++....... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~-~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECC-------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc-EEEccchhheeccCCcce
Confidence            9999865554444344456899999999999999999999999999999999999998887 99999999987643322 


Q ss_pred             ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccc
Q 038154          157 NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEE  235 (293)
Q Consensus       157 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
                      ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+....                 
T Consensus       165 ~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-----------------  226 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-----------------  226 (273)
T ss_dssp             ------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------------
T ss_pred             eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            22333478999999988765 68999999999999999998 899999988888877765311                 


Q ss_pred             cCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          236 FGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                  ....++.+|+++.+||.+||+.||++|||+.+|+++
T Consensus       227 ------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 ------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        112345678999999999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=356.26  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=212.0

Q ss_pred             CceeeeeeccccceeEEEEEe---CCCCCeEEEEEecccCC--CCCCcccHHHHHHHHHhcCC-CCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD---SLTGDTVVVKKIPIMNP--SEGVPSSVIREVSLLKELKH-ENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~---~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~   74 (293)
                      +|++++.||+|+||+||+|.+   +.+|+.||+|+++....  .....+.+.+|++++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            489999999999999999986   44789999999864322  22345678899999999976 8999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDV  153 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~  153 (293)
                      +++||++.| ++...+....  ..++..++.++.||+.||+|||++|++|+||||+||+++.++. ++|+|||.+.....
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEECCG
T ss_pred             eeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC-EEEeeccchhhhcc
Confidence            999999985 5555555544  3567899999999999999999999999999999999999888 99999999976643


Q ss_pred             CC-cceeccCccccccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          154 PL-ENYTIKGGSLCYKAPERLLGSG-RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       154 ~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      .. .......+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+........         
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~---------  252 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------  252 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---------
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC---------
Confidence            22 2233445899999999886543 468899999999999999999999988766655555543221111         


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCC-----CHHHHhcCcccccCcC
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRL-----TAREALRHEYFKDFQS  291 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~p~~~~~~~  291 (293)
                                       ...++.+++++.+|+.+||+.||.+||     |++|+++||||+.+++
T Consensus       253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                             112345789999999999999999999     5899999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=345.98  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=194.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC----CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG----DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.++||+|+||+||+|....++    ..||||+++... .......+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4889999999999999999876544    368999985432 22334568899999999999999999999999999999


Q ss_pred             EeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCc
Q 038154           77 VFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLE  156 (293)
Q Consensus        77 v~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~  156 (293)
                      |||++.++++..+.......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||.++.......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC---------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe-EEEcccchhhcccCCCc
Confidence            99999976665554444456889999999999999999999999999999999999999888 99999999987644322


Q ss_pred             c---eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          157 N---YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLF-HSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       157 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      .   .....|++.|+|||++.+. .++.++||||||+++|+|++|..|+ ...+..+....+.....             
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------------  231 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------------  231 (283)
T ss_dssp             --------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------------
T ss_pred             cceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-------------
Confidence            2   2223478899999988766 6899999999999999999976555 44455555544432111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                      ...+..++.++.+|+.+||+.||++|||+.+|++
T Consensus       232 ----------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ----------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                            1123346788999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=347.77  Aligned_cols=250  Identities=20%  Similarity=0.302  Sum_probs=199.2

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCC----eEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGD----TVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      .|++++.||+|+||+||+|.+..+|+    .||+|+++.. ......+.+.+|++++++++||||+++++++.++. .++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            38999999999999999999887776    4788877532 33445578999999999999999999999998754 556


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      +++++. |++...+... ...+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++......
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~-~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCCSHHHHTTTTC
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC-eEeeccccceeccccc
Confidence            667665 6677666554 346888999999999999999999999999999999999998887 9999999998765432


Q ss_pred             cce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCc
Q 038154          156 ENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSF  232 (293)
Q Consensus       156 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
                      ...  ....+++.|+|||++.+. .++.++||||||+++|+|+| |..||.+.+..+....+.....             
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-------------  231 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------------  231 (317)
T ss_dssp             C--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-------------
T ss_pred             ccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            222  223478999999988766 68999999999999999998 7899998887777666643111             


Q ss_pred             ccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCc
Q 038154          233 SEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHE  284 (293)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p  284 (293)
                                      ...++.+++++.+|+.+||+.||++|||+.+++.|.
T Consensus       232 ----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         232 ----------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             ----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                            122345788999999999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=338.17  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=194.4

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (293)
                      +|++++.||+|+||+||+|..  +|..||+|+++.    ....+.+.+|++++++++||||+++++++.+ .+.+++|||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            478999999999999999976  478899999853    2344679999999999999999999998854 467899999


Q ss_pred             cCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcce
Q 038154           80 NLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLENY  158 (293)
Q Consensus        80 ~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~~  158 (293)
                      |++ |++.+++.......+++..++.++.||+.||.|||+.+++||||+|+||+++.++. ++++|||.+......   .
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~s~~~~~~---~  157 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASST---Q  157 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC-----------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC-EeecccccceecCCC---C
Confidence            998 55666665544445788899999999999999999999999999999999999998 999999999865432   2


Q ss_pred             eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcCcccccC
Q 038154          159 TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTSFSEEFG  237 (293)
Q Consensus       159 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
                      ....+++.|+|||++.+. .++.++||||||+++|+|+| |..||...+..+....+...                    
T Consensus       158 ~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------------  216 (262)
T d1byga_         158 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------  216 (262)
T ss_dssp             ----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------------------
T ss_pred             ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------------------
Confidence            233478899999988765 68999999999999999998 78888888777777666321                    


Q ss_pred             CCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          238 FEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                               .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       217 ---------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         217 ---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                     111233457889999999999999999999999988

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=336.99  Aligned_cols=254  Identities=25%  Similarity=0.326  Sum_probs=196.8

Q ss_pred             CceeeeeeccccceeEEEEEeC-CCC--CeEEEEEecccCCC-CCCcccHHHHHHHHHhcCCCCcceeeeeeecCCccee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-LTG--DTVVVKKIPIMNPS-EGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-~~~--~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (293)
                      +|++.+.||+|+||.||+|... .++  ..||||+++..... ....+.+.+|++++++++||||+++++++.+ ...++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            4899999999999999999754 333  36899988654432 2334678999999999999999999999976 46789


Q ss_pred             EeecCC-cchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCC
Q 038154           77 VFENLD-FDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        77 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~  155 (293)
                      ||||+. |++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.++......
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~-vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECCC-C
T ss_pred             eeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc-eeeccchhhhhcccCC
Confidence            999998 4555554443 345889999999999999999999999999999999999998886 9999999998775543


Q ss_pred             ccee---ccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCcC
Q 038154          156 ENYT---IKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFTS  231 (293)
Q Consensus       156 ~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (293)
                      ....   ...+++.|+|||++.+. .++.++||||||+++|+|+| |..||.+.+..+....+......+          
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~----------  234 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL----------  234 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------
T ss_pred             CcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC----------
Confidence            3322   22367889999988765 68999999999999999998 899999998888887775421111          


Q ss_pred             cccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCccccc
Q 038154          232 FSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKD  288 (293)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~  288 (293)
                                        ..++.+|+++.+|+.+||+.||++|||+.+|++  +|++
T Consensus       235 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~--~L~~  271 (273)
T d1u46a_         235 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE  271 (273)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             ------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence                              123457889999999999999999999999974  5543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=334.99  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=198.1

Q ss_pred             CceeeeeeccccceeEEEEEeCCCC-------CeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTG-------DTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVD   72 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   72 (293)
                      +|++++.||+|+||.||+|+....+       ..||+|+++... .......+.+|...+.++ +||||+++++++.+++
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            5899999999999999999865443       468999885432 223346778899999888 7999999999999999


Q ss_pred             cceeEeecCCc-chHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           73 SIDLVFENLDF-DLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        73 ~~~lv~e~~~~-~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ..++||||+.+ ++.+.+....              ...+++..++.++.||+.||+|||+.|++||||||+||+++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            99999999985 5555554332              24578999999999999999999999999999999999999998


Q ss_pred             CeEEEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . +||+|||.+........  ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       173 ~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i  250 (299)
T d1fgka_         173 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  250 (299)
T ss_dssp             C-EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             C-eEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            8 99999999986643322  22333478899999988765 78999999999999999998 68999888877766655


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ....                             ....+..+++++.+||.+||+.||++|||+.||++
T Consensus       251 ~~~~-----------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         251 KEGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HTTC-----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCC-----------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            3311                             11123457889999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-51  Score=337.22  Aligned_cols=255  Identities=24%  Similarity=0.297  Sum_probs=205.8

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++++.||+|+||+||+|+.+     .+++.||||+++... .......+.+|++++++++|||++++++++...+..+
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            4899999999999999999864     355789999985432 2233467899999999999999999999999999999


Q ss_pred             eEeecCC-cchHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCcee
Q 038154           76 LVFENLD-FDLLHFMKTEP----------------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFL  132 (293)
Q Consensus        76 lv~e~~~-~~~~~~~~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~  132 (293)
                      ++||+++ |++.+.+....                      ...+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999998 55555554321                      234778889999999999999999999999999999999


Q ss_pred             EeCCCCeEEEccCCCcccCCCCCc--ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchH
Q 038154          133 IDRSKDIVKIADFGLARPIDVPLE--NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ-RLFHSRWAPG  209 (293)
Q Consensus       133 i~~~~~~v~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~  209 (293)
                      ++.++. +||+|||.+........  ......+++.|+|||.+.+. .++.++||||||+++|+|++|. .||.+.+..+
T Consensus       173 ld~~~~-~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         173 VGENMV-VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             ECGGGC-EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             ECCCCc-EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            999888 99999999875533211  12234478899999988766 6899999999999999999996 6788888888


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcCcccccC
Q 038154          210 LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRHEYFKDF  289 (293)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~p~~~~~  289 (293)
                      ....+....                             ....+..+++++.+|+.+||+.||++|||+.+|++  +|+++
T Consensus       251 ~~~~v~~~~-----------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i  299 (301)
T d1lufa_         251 VIYYVRDGN-----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  299 (301)
T ss_dssp             HHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             HHHHHHcCC-----------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence            777764311                             11233457889999999999999999999999976  55544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=336.82  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCe--EEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcceeE
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDT--VVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSIDLV   77 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (293)
                      +|++.++||+|+||+||+|.++.+|..  ||||+++.. ......+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            478999999999999999998877764  567776432 2334557899999999998 799999999999999999999


Q ss_pred             eecCC-cchHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEE
Q 038154           78 FENLD-FDLLHFMKTE--------------PTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKI  142 (293)
Q Consensus        78 ~e~~~-~~~~~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l  142 (293)
                      |||++ |++.+.+...              ....+++..+..++.||+.||.|||+.|++||||||+||+++.++. +||
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-~kl  168 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKI  168 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-eEE
Confidence            99998 4555555432              2356889999999999999999999999999999999999999887 999


Q ss_pred             ccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCC
Q 038154          143 ADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ-RLFHSRWAPGLLAAIFSIMGTP  221 (293)
Q Consensus       143 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~  221 (293)
                      +|||.++........ ....++..|+|||.+.+. .++.++||||||+++|+|++|. .||.+.+..+....+....   
T Consensus       169 ~DfG~a~~~~~~~~~-~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~---  243 (309)
T d1fvra_         169 ADFGLSRGQEVYVKK-TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  243 (309)
T ss_dssp             CCTTCEESSCEECCC-----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC---
T ss_pred             ccccccccccccccc-cceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC---
Confidence            999999765433222 233488999999988766 6899999999999999999976 5788887777766653210   


Q ss_pred             CCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          222 DSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                                ....+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       244 --------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 --------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             --------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                      112234578899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=335.52  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=208.9

Q ss_pred             CceeeeeeccccceeEEEEEeC-----CCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeecCCcce
Q 038154            1 RYTLLEVIREGRYGAVHRAHDS-----LTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSSVDSID   75 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (293)
                      +|++++.||+|+||+||+|.+.     ..+..||||+++... .......+.+|++++++++||||+++++++..+...+
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            5789999999999999999764     235689999986432 2233356889999999999999999999999999999


Q ss_pred             eEeecCCc-chHHHhhc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCC
Q 038154           76 LVFENLDF-DLLHFMKT--------EPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFG  146 (293)
Q Consensus        76 lv~e~~~~-~~~~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~  146 (293)
                      +|||++.+ ++..++..        .....+++..+..++.|++.||.|||+++++||||||+||+++.++. +||+|||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~-~Kl~DFG  178 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  178 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce-EEEeecc
Confidence            99999984 45454432        22244678889999999999999999999999999999999998888 9999999


Q ss_pred             CcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCCC
Q 038154          147 LARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ-RLFHSRWAPGLLAAIFSIMGTPDS  223 (293)
Q Consensus       147 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~  223 (293)
                      .++.........  ....+++.|+|||.+.+. .++.++||||||+++|+|+||. .||.+.+..+....+....     
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-----  252 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-----  252 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-----
Confidence            997654332222  222378999999988766 6889999999999999999984 8888888888777765311     


Q ss_pred             CCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc------CcccccCc
Q 038154          224 ETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR------HEYFKDFQ  290 (293)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~p~~~~~~  290 (293)
                                              ....++.+++.+.+++.+||+.||++|||+.+|++      +|+|++.+
T Consensus       253 ------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~  301 (308)
T d1p4oa_         253 ------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  301 (308)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             ------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence                                    11223457889999999999999999999999998      88887653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=331.10  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=189.7

Q ss_pred             CceeeeeeccccceeEEEEEeCC-----CCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeec-CCc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSL-----TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSS-VDS   73 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~   73 (293)
                      +|+++++||+|+||.||+|.+..     +++.||+|+++... .......+.+|..++.++ +|+||+.+++++.. +..
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            58999999999999999998643     44679999985432 222335677788888777 58999999998655 456


Q ss_pred             ceeEeecCC-cchHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCC
Q 038154           74 IDLVFENLD-FDLLHFMKTEP--------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKD  138 (293)
Q Consensus        74 ~~lv~e~~~-~~~~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~  138 (293)
                      .++||||++ |++.+++....              ...+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            899999998 55556554322              234788899999999999999999999999999999999998888


Q ss_pred             eEEEccCCCcccCCCCCcc--eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHH
Q 038154          139 IVKIADFGLARPIDVPLEN--YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQ-RLFHSRWAPGLLAAIF  215 (293)
Q Consensus       139 ~v~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~pf~~~~~~~~~~~~~  215 (293)
                       +||+|||.++........  .....||+.|+|||++.+. .++.++||||||+++|+|++|. .||.+....+......
T Consensus       173 -~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         173 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             -EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             -EEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             999999999765433222  2234589999999988765 6899999999999999999875 6887766555444443


Q ss_pred             HHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          216 SIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                      .....+                            ..+..+++++.+++.+||+.||++|||+.++++|
T Consensus       251 ~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         251 KEGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            321111                            1233468899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=330.37  Aligned_cols=248  Identities=20%  Similarity=0.211  Sum_probs=194.5

Q ss_pred             eeeeeccccceeEEEEEeCCCC---CeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCcceeeeeeec-CCcceeEee
Q 038154            4 LLEVIREGRYGAVHRAHDSLTG---DTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENIVRLLNVQSS-VDSIDLVFE   79 (293)
Q Consensus         4 i~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (293)
                      +.++||+|+||+||+|....++   ..||||+++.. ........+.+|++++++++||||+++++++.. ++..++|||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            3678999999999999875533   35889988532 233345678999999999999999999998765 567899999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccCCCcccCCCCCcc--
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADFGLARPIDVPLEN--  157 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~~~~~~~~~--  157 (293)
                      |++++.+..+........++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||.++........  
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~-~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSSGGGCCTTTTTCCCT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC-EEEecccchhhccccccccc
Confidence            99977776666666667788889999999999999999999999999999999998887 999999999866433221  


Q ss_pred             --eeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCCCCCCCCcCccc
Q 038154          158 --YTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA-PGLLAAIFSIMGTPDSETLPGFTSFSE  234 (293)
Q Consensus       158 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
                        .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+....+... ..              
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~--------------  252 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR--------------  252 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CC--------------
T ss_pred             eecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CC--------------
Confidence              1123478899999987765 689999999999999999998888865433 3333333221 10              


Q ss_pred             ccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhcC
Q 038154          235 EFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALRH  283 (293)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  283 (293)
                                    ...++.+++++.+|+.+||..||++|||+.||+++
T Consensus       253 --------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 --------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                          11223467899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-49  Score=327.96  Aligned_cols=259  Identities=19%  Similarity=0.208  Sum_probs=201.5

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCC-cceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHEN-IVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||++++.||+|+||+||+|.+..+|+.||||++....    ....+..|+++++.++|++ ++.+.+++...+..++|||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            7999999999999999999999999999999876432    2356889999999998765 5555666788888999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC--CeEEEccCCCcccCCCCCc-
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK--DIVKIADFGLARPIDVPLE-  156 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~--~~v~l~df~~~~~~~~~~~-  156 (293)
                      ++++++...+.... ..+++..+..++.|++.||+|||++|++||||||+||+++..+  ..++++|||.++....... 
T Consensus        84 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          84 LLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            99998887766544 3688999999999999999999999999999999999986532  2499999999987643321 


Q ss_pred             ------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCCCCCCCCc
Q 038154          157 ------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLLAAIFSIMGTPDSETLPGFT  230 (293)
Q Consensus       157 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
                            ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+......          
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----------  231 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----------  231 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----------
T ss_pred             cceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----------
Confidence                  12333589999999988876 6899999999999999999999999876554433322110000          


Q ss_pred             CcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHH---HHhcCcccc
Q 038154          231 SFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAR---EALRHEYFK  287 (293)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---~ll~~p~~~  287 (293)
                                  ..........+.+|+++.+++.+|++.||++||++.   ++|+++|.+
T Consensus       232 ------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         232 ------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                        000112334567899999999999999999999986   456777654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=327.26  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=202.5

Q ss_pred             CceeeeeeccccceeEEEEEe-----CCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhc-CCCCcceeeeeeecCCcc
Q 038154            1 RYTLLEVIREGRYGAVHRAHD-----SLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKEL-KHENIVRLLNVQSSVDSI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   74 (293)
                      +|+++++||+|+||.||+|+.     ..+++.||||+++... .......+.+|+.+++++ +||||+++++++.+.+..
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            578899999999999999974     3466789999986433 233345788999999999 699999999999999999


Q ss_pred             eeEeecCCc-chHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCC
Q 038154           75 DLVFENLDF-DLLHFMKTEP----------------TVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSK  137 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~  137 (293)
                      ++||||+++ ++...+....                ...+++..+..++.||+.||+|||++|++||||||+||+++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            999999985 5555554322                23578889999999999999999999999999999999999888


Q ss_pred             CeEEEccCCCcccCCCCCcce--eccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 038154          138 DIVKIADFGLARPIDVPLENY--TIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVT-HQRLFHSRWAPGLLAAI  214 (293)
Q Consensus       138 ~~v~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~  214 (293)
                      . ++++|||.++.........  ....+++.|+|||++.+. .++.++||||||+++|+|+| |..||......+....+
T Consensus       183 ~-~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~  260 (311)
T d1t46a_         183 I-TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (311)
T ss_dssp             E-EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             c-ccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7 9999999998765433222  234478999999988765 68999999999999999998 55667676666666555


Q ss_pred             HHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          215 FSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                      ......+                            ..+..+++++.+||.+||+.||.+|||+++|++
T Consensus       261 i~~~~~~----------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         261 IKEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCCC----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4422211                            122346889999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-48  Score=319.02  Aligned_cols=251  Identities=19%  Similarity=0.182  Sum_probs=203.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC-CCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH-ENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      ||+++++||+|+||+||+|.+..+|+.||+|+++...    ....+.+|++.++.+.| ++++.+++++......++|||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            7999999999999999999999999999999875432    23568889999999975 899999999999999999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCC----CCeEEEccCCCcccCCCCC
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRS----KDIVKIADFGLARPIDVPL  155 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~----~~~v~l~df~~~~~~~~~~  155 (293)
                      ++++++...+.... ..+++..+..++.|++.||++||++|++||||||+||+++..    ...++|+|||.++......
T Consensus        82 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99988888776544 368889999999999999999999999999999999999752    2249999999998664321


Q ss_pred             c-------ceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHHHhCCCCCCC
Q 038154          156 E-------NYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWAPGLL---AAIFSIMGTPDSET  225 (293)
Q Consensus       156 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  225 (293)
                      .       ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.......   ..+.....      
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~------  233 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ------  233 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH------
T ss_pred             cccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC------
Confidence            1       12233489999999988876 6899999999999999999999999865443332   22221100      


Q ss_pred             CCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          226 LPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                                         ......+.+.+|+++.+++..|+..+|++||+.+.+..
T Consensus       234 -------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 -------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                               01223445678899999999999999999998876654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-49  Score=332.80  Aligned_cols=284  Identities=26%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-----------CCCcceeeeeee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-----------HENIVRLLNVQS   69 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~   69 (293)
                      ||+++++||+|+||+||+|++..+|+.||||+++...   ...+.+.+|+++++.+.           |+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            7999999999999999999999999999999985321   22356778999988875           578999998875


Q ss_pred             cC--CcceeEeecC--CcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecccCCCceeEeCCCC-----e
Q 038154           70 SV--DSIDLVFENL--DFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-QEILHRDLKPANFLIDRSKD-----I  139 (293)
Q Consensus        70 ~~--~~~~lv~e~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~h~dl~~~Ni~i~~~~~-----~  139 (293)
                      ..  ...+++++++  .+.............+++..++.++.|++.||.+||+ .|++||||||+||+++.++.     .
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            54  3445555554  4555566666666778899999999999999999997 89999999999999987653     4


Q ss_pred             EEEccCCCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHH
Q 038154          140 VKIADFGLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTFAEMVTHQRLFHSRWA------PGLLAA  213 (293)
Q Consensus       140 v~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~  213 (293)
                      ++++|||.+......   .....+++.|+|||++... .++.++|+||+|+++++|++|..||.....      .+....
T Consensus       171 ~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeecccccccccc---cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            899999998765432   2344589999999988866 689999999999999999999999975432      344555


Q ss_pred             HHHHhCCCCCCCCCCCcCcccccCCC-------CCC-Cccc----chhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHh
Q 038154          214 IFSIMGTPDSETLPGFTSFSEEFGFE-------PNR-SPIK----DLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREAL  281 (293)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  281 (293)
                      .....+..+.............+...       ... ....    .........++++.+||.+||..||++|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            55555544333222211111111100       000 0000    01112233567899999999999999999999999


Q ss_pred             cCcccccCcC
Q 038154          282 RHEYFKDFQS  291 (293)
Q Consensus       282 ~~p~~~~~~~  291 (293)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999996643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=313.34  Aligned_cols=252  Identities=24%  Similarity=0.258  Sum_probs=180.8

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHH--HHHhcCCCCcceeeeeeecCC----cc
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVS--LLKELKHENIVRLLNVQSSVD----SI   74 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~--~l~~l~~~~i~~~~~~~~~~~----~~   74 (293)
                      +|.+.+.||+|+||.||+|+.  +|+.||||+++...     ......|.+  .+..++||||+++++++...+    ..
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            478899999999999999964  68899999985432     233444444  445678999999999987654    47


Q ss_pred             eeEeecCCc-chHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecccCCCceeEeCCCCeEEEccC
Q 038154           75 DLVFENLDF-DLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS--------QEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        75 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ++||||+.+ ++...+...   .+++..++.++.|++.||++||.        +|++||||||+||+++.++. +||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~-~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECCC
T ss_pred             EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC-eEEEec
Confidence            899999985 555666543   47888999999999999999996        59999999999999999888 999999


Q ss_pred             CCcccCCCCCcc----eeccCccccccCcccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-------
Q 038154          146 GLARPIDVPLEN----YTIKGGSLCYKAPERLLGSG-----RYSTPVDVWAVACTFAEMVTHQRLFHSRWAPG-------  209 (293)
Q Consensus       146 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-------  209 (293)
                      |.+.........    .....|++.|+|||++.+..     .++.++||||||+++|+|+||..||.......       
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            999866443222    22334899999999876542     24668999999999999999998875322111       


Q ss_pred             ----HHHHHHHHhCCCCCCCCCCCcCcccccCCCCCCCcccchhhhcCCCCchHHHHHHHhhccCCCCCCCHHHHhc
Q 038154          210 ----LLAAIFSIMGTPDSETLPGFTSFSEEFGFEPNRSPIKDLATVVGGLEPDGVDLLRRMLCLDPSKRLTAREALR  282 (293)
Q Consensus       210 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  282 (293)
                          ....+.....                  .......... .......+..+.+|+.+||+.||++|||+.||++
T Consensus       233 ~~~~~~~~~~~~~~------------------~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         233 PSDPSVEEMRKVVC------------------EQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CSSCCHHHHHHHHT------------------TSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccchHHHHHHHHh------------------ccccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                0000000000                  0000000000 0001112346889999999999999999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.1e-25  Score=171.99  Aligned_cols=172  Identities=19%  Similarity=0.138  Sum_probs=119.2

Q ss_pred             ceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCC----------------cccHHHHHHHHHhcCCCCcceee
Q 038154            2 YTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGV----------------PSSVIREVSLLKELKHENIVRLL   65 (293)
Q Consensus         2 y~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~~~i~~~~   65 (293)
                      |.++++||+|+||+||+|.+. +|+.||+|+++........                ......|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999875 6889999987542221100                12233577888889999998887


Q ss_pred             eeeecCCcceeEeecCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecccCCCceeEeCCCCeEEEccC
Q 038154           66 NVQSSVDSIDLVFENLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHSQEILHRDLKPANFLIDRSKDIVKIADF  145 (293)
Q Consensus        66 ~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~h~dl~~~Ni~i~~~~~~v~l~df  145 (293)
                      ++.    ..+++||++++.....        ++...+..++.|++.+|++||++|++|+||||+||++++++  ++|+||
T Consensus        81 ~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~--~~liDF  146 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDF  146 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE--EEECCC
T ss_pred             Eec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC--EEEEEC
Confidence            653    3479999999765433        23346678999999999999999999999999999999654  899999


Q ss_pred             CCcccCCCCCcceeccCccccccCcccccCCCCCCCchhHHHHHHHH
Q 038154          146 GLARPIDVPLENYTIKGGSLCYKAPERLLGSGRYSTPVDVWAVACTF  192 (293)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll  192 (293)
                      |.+.....+....... .+.. .-.+.+ . ..++.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~~~l~-rd~~-~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILE-RDVR-NIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHH-HHHH-HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHH-HHHH-HHHHHH-c-CCCCCcccHHHHHHHH
Confidence            9987654332211000 0000 001111 1 2478899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.02  E-value=2.5e-09  Score=84.13  Aligned_cols=138  Identities=16%  Similarity=0.142  Sum_probs=92.7

Q ss_pred             CceeeeeeccccceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCcceeEee
Q 038154            1 RYTLLEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDLVFE   79 (293)
Q Consensus         1 ry~i~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (293)
                      +|++++..+.++.+.||++.  .++..+++|......  ......+.+|...++.+. +--+++++.+...++..++||+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            36677766666667899984  556778888764332  223456888999988874 3336778888888888999999


Q ss_pred             cCCcchHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 038154           80 NLDFDLLHFMKTEPTVTKNPLKIKKYLHQILHGVAYCHS-----------------------------------------  118 (293)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-----------------------------------------  118 (293)
                      +++|..+.......      .....++.++...+..||+                                         
T Consensus        91 ~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          91 EADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             CCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             eccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            99986654322111      0122234444444444542                                         


Q ss_pred             ------------------CCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          119 ------------------QEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       119 ------------------~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                                        ..++|+|+.|.||+++.++. +.|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~-~~lIDwe~a~  212 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV-SGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE-EEECCCTTCE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce-EEEeechhcc
Confidence                              13899999999999986543 5699998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.52  E-value=5.8e-07  Score=69.79  Aligned_cols=74  Identities=19%  Similarity=0.076  Sum_probs=51.6

Q ss_pred             eecccc-ceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCC--CCcceeeeeeecCCcceeEeecCCc
Q 038154            7 VIREGR-YGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKH--ENIVRLLNVQSSVDSIDLVFENLDF   83 (293)
Q Consensus         7 ~lg~g~-~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~   83 (293)
                      .+..|. .+.||++... .+..+++|....     .....+..|...++.+..  -.+++++.+..+++..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~-----~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLS-----GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECS-----CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCc-----cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            344444 3678999643 566688886532     223568889999988743  2356778888888889999999987


Q ss_pred             chH
Q 038154           84 DLL   86 (293)
Q Consensus        84 ~~~   86 (293)
                      ..+
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.32  E-value=5.4e-06  Score=68.50  Aligned_cols=77  Identities=17%  Similarity=0.124  Sum_probs=49.8

Q ss_pred             eeeeccccceeEEEEEeCCCCCeEEEEEecccC--C---CCCCcccHHHHHHHHHhcC-C--CCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSLTGDTVVVKKIPIMN--P---SEGVPSSVIREVSLLKELK-H--ENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~---~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~l   76 (293)
                      .+.+|.|....||++.+..+++.+++|.-....  .   -.....+...|.+.|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457899999999999887778889999643211  1   1223455677888888763 2  345566654  4556789


Q ss_pred             EeecCCc
Q 038154           77 VFENLDF   83 (293)
Q Consensus        77 v~e~~~~   83 (293)
                      |||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.86  E-value=8.7e-05  Score=61.12  Aligned_cols=72  Identities=14%  Similarity=0.089  Sum_probs=49.1

Q ss_pred             eeeeccccceeEEEEEeCC-------CCCeEEEEEecccCCCCCCcccHHHHHHHHHhcC-CCCcceeeeeeecCCccee
Q 038154            5 LEVIREGRYGAVHRAHDSL-------TGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELK-HENIVRLLNVQSSVDSIDL   76 (293)
Q Consensus         5 ~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   76 (293)
                      +++|+.|-.-.+|++..+.       .+..++++++- .   ........+|..+++.+. +.-.+++++++.+    ..
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            4678888888999997543       34567777653 1   222345667999999885 4445677777653    57


Q ss_pred             EeecCCcc
Q 038154           77 VFENLDFD   84 (293)
Q Consensus        77 v~e~~~~~   84 (293)
                      |+|+++|.
T Consensus       119 I~efi~g~  126 (395)
T d1nw1a_         119 LEEYIPSR  126 (395)
T ss_dssp             EECCCCEE
T ss_pred             EEEEeccc
Confidence            89999874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.71  E-value=4.5e-05  Score=60.81  Aligned_cols=30  Identities=23%  Similarity=0.275  Sum_probs=25.3

Q ss_pred             CCceecccCCCceeEeCCCCeEEEccCCCcc
Q 038154          119 QEILHRDLKPANFLIDRSKDIVKIADFGLAR  149 (293)
Q Consensus       119 ~~~~h~dl~~~Ni~i~~~~~~v~l~df~~~~  149 (293)
                      .|++|+|+.++||+++.+.- .-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v-~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDEL-SGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEE-EEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccc-eeEecccccc
Confidence            47999999999999996543 5799999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.57  E-value=0.00023  Score=56.80  Aligned_cols=68  Identities=13%  Similarity=0.065  Sum_probs=43.1

Q ss_pred             ceeEEEEEeCCCCCeEEEEEecccCCCCCCcccHHHHHHHHHhcCCCCc--ceee-----eeeecCCcceeEeecCCcc
Q 038154           13 YGAVHRAHDSLTGDTVVVKKIPIMNPSEGVPSSVIREVSLLKELKHENI--VRLL-----NVQSSVDSIDLVFENLDFD   84 (293)
Q Consensus        13 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~-----~~~~~~~~~~lv~e~~~~~   84 (293)
                      ...||++.. .+|..+++|+....   ....+.+..|+..+..|....+  +...     ..+...+..+.++++++|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            457999964 46788999987432   2234678889988888742221  1111     1234456678889988863